Citrus Sinensis ID: 044615
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 571 | 2.2.26 [Sep-21-2011] | |||||||
| Q8VZG8 | 1045 | Probable LRR receptor-lik | yes | no | 0.835 | 0.456 | 0.415 | 2e-97 | |
| Q9LP24 | 1120 | Probable leucine-rich rep | no | no | 0.838 | 0.427 | 0.395 | 4e-94 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.828 | 0.429 | 0.322 | 1e-64 | |
| Q9M2Z1 | 1002 | Leucine-rich repeat recep | no | no | 0.814 | 0.464 | 0.346 | 3e-62 | |
| O49545 | 1003 | Leucine-rich repeat recep | no | no | 0.807 | 0.459 | 0.342 | 8e-60 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.840 | 0.383 | 0.324 | 1e-59 | |
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.845 | 0.425 | 0.332 | 5e-58 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.831 | 0.431 | 0.315 | 1e-57 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.796 | 0.364 | 0.321 | 1e-56 | |
| Q6XAT2 | 967 | LRR receptor-like serine/ | no | no | 0.821 | 0.485 | 0.318 | 1e-55 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 357 bits (916), Expect = 2e-97, Method: Compositional matrix adjust.
Identities = 205/493 (41%), Positives = 296/493 (60%), Gaps = 16/493 (3%)
Query: 89 IPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLS 148
+PD I L +L L +N G +P +L + +L+ + N SG I +F +L+
Sbjct: 398 LPDTICRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNSFSGDISEAFGVYPTLN 457
Query: 149 ILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVG 208
+ L N+ + L LS+N + G+IP + N+T L L LSSN I G
Sbjct: 458 FIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQ-LSQLDLSSNRITG 516
Query: 209 EIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKL 268
E+P ++ + +L LN N LSG++ + L LEYLDLS+N F IP +L+NL +L
Sbjct: 517 ELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPRL 576
Query: 269 HYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSG 328
+Y+NLS N Q IP + KL L LDLS+N EI SQ S+Q+LE+L+LSHNNLSG
Sbjct: 577 YYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSG 636
Query: 329 SIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDI---KRLPPC- 384
IP F++M L+ +D+S+N LQG IP++ AFR+AP A +GNK LCG + + L PC
Sbjct: 637 QIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCS 696
Query: 385 --KAFKSHKQSMKKIWVVIVFPLLGTVALLISLIGLFFNFRQRKNGSQTQQSSPRNTLG- 441
+ KSHK + + + I+ P++G + +L G+F FR+R Q ++ + + G
Sbjct: 697 ITSSKKSHKD--RNLIIYILVPIIGAIIILSVCAGIFICFRKRT--KQIEEHTDSESGGE 752
Query: 442 LLSVLTFDGKIVHEEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDE 501
LS+ +FDGK+ ++EII+AT FD + IG GG G VYKAKLP I+ VKK +
Sbjct: 753 TLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLNETTDSS 811
Query: 502 M---ACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSNDAAA 558
+ + +QEFLNE+ ALT+IRHRN+VK +GFCSH ++F+VYEY+E GSL L ND A
Sbjct: 812 ISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEA 871
Query: 559 EQFCWTKRMNAIK 571
++ W KR+N +K
Sbjct: 872 KKLDWGKRINVVK 884
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 345 bits (886), Expect = 4e-94, Method: Compositional matrix adjust.
Identities = 215/543 (39%), Positives = 304/543 (55%), Gaps = 64/543 (11%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANL 144
L S+PD GN L L L N L+G+IP + N ++L L L TN +G P +
Sbjct: 426 LTGSVPDSFGNFTKLESLYLRVNHLSGAIPPGVANSSHLTTLILDTNNFTGFFPETVCKG 485
Query: 145 TSLSILYLYENSLCDSIPKEIGNMNSL------------------------SILDLSSNK 180
L + L N L IPK + + SL + +D S NK
Sbjct: 486 RKLQNISLDYNHLEGPIPKSLRDCKSLIRARFLGNKFTGDIFEAFGIYPDLNFIDFSHNK 545
Query: 181 ------------------------LNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGM 216
+ G+IP + N+T L L LS+N++ GE+P G
Sbjct: 546 FHGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMT-QLVELDLSTNNLFGELPEAIGN 604
Query: 217 LSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNN 276
L++L +L LN N+LSG++ L L LE LDLS+N F IP++ + +KLH +NLS N
Sbjct: 605 LTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLSRN 664
Query: 277 QFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEE 336
+F IP ++ KL L++LDLSHN EIPSQ+ S+QSL+KL+LSHNNLSG IP FE
Sbjct: 665 KFDGSIP-RLSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEG 723
Query: 337 MHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDI--KRLPPCKAFKSHKQSM 394
M L+ +DIS N L+G +P++ FR A AL+ N LC +I +RL PC+ K K++
Sbjct: 724 MIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSNIPKQRLKPCRELKKPKKN- 782
Query: 395 KKIWVVIVFPLLGTVALLISLIGLF-FNFRQRK--NGSQTQQSSPRNTLGLLSVLTFDGK 451
+ V I+ P+LG + +L F + R+RK NG T + N +S+ + DGK
Sbjct: 783 GNLVVWILVPILGVLVILSICANTFTYCIRKRKLQNGRNTDPETGEN----MSIFSVDGK 838
Query: 452 IVHEEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMA---CQQEF 508
+++II +TN FD H IG GG VY+A L I+ VK+ H + +E++ +QEF
Sbjct: 839 FKYQDIIESTNEFDPTHLIGTGGYSKVYRANL-QDTIIAVKRLHDTIDEEISKPVVKQEF 897
Query: 509 LNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMN 568
LNEV ALT+IRHRN+VK +GFCSH H+F++YEY+E GSL L+ND A++ WTKR+N
Sbjct: 898 LNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRIN 957
Query: 569 AIK 571
+K
Sbjct: 958 VVK 960
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 248 bits (632), Expect = 1e-64, Method: Compositional matrix adjust.
Identities = 175/543 (32%), Positives = 266/543 (48%), Gaps = 70/543 (12%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANL 144
L +IP E+ + L DLQL +N L G IP +G +N VLD+S N LSG IP F
Sbjct: 367 LNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRF 426
Query: 145 TSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTN---------- 194
+L +L L N L +IP+++ SL+ L L N+L GS+P+ L NL N
Sbjct: 427 QTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNW 486
Query: 195 -------------SLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSL 241
+L+ L L++N+ GEIP G L+ ++ +++N+L+G + ELGS
Sbjct: 487 LSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSC 546
Query: 242 IQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNI 301
+ ++ LDLS N F I + L LV L L LS+N+ + +IP+ L L EL L N+
Sbjct: 547 VTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNL 606
Query: 302 FREEIPSQICSMQSLE-KLNLSHNNLSGSIPRCFEEMHWLSCI----------------- 343
E IP ++ + SL+ LN+SHNNLSG+IP + L +
Sbjct: 607 LSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGN 666
Query: 344 -------DISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDIKRLPPCKAFKSHKQSMKK 396
+IS N L G +P++ F+ GN LC + C+ H S K
Sbjct: 667 LMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRS--HCQPLVPHSDS-KL 723
Query: 397 IWVV----------IVFPLLGTVALLISLIGLFFNFRQRKNG--SQTQQSSPRNTLGLLS 444
W++ I ++G+V LI+ +GL + ++R+ + Q+ P ++
Sbjct: 724 NWLINGSQRQKILTITCIVIGSV-FLITFLGLCWTIKRREPAFVALEDQTKP----DVMD 778
Query: 445 VLTFDGK-IVHEEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMA 503
F K ++ ++ AT NF + +G G G+VYKA++ GE++ VKK +S + +
Sbjct: 779 SYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSR-GEGAS 837
Query: 504 CQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSNDAAAEQFCW 563
F E++ L KIRHRNIVK YGFC H + ++YEY+ GSL L W
Sbjct: 838 SDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDW 897
Query: 564 TKR 566
R
Sbjct: 898 NAR 900
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 239 bits (611), Expect = 3e-62, Method: Compositional matrix adjust.
Identities = 168/485 (34%), Positives = 251/485 (51%), Gaps = 20/485 (4%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANL 144
LY +IP+ IG M L LQL EN GSIP LG LV+LDLS+NKL+G++P + +
Sbjct: 323 LYGAIPEFIGEMPELEVLQLWENNFTGSIPQKLGENGRLVILDLSSNKLTGTLPPNMCSG 382
Query: 145 TSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSN 204
L L N L SIP +G SL+ + + N LNGSIP L L L + L N
Sbjct: 383 NRLMTLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKELFGLPK-LSQVELQDN 441
Query: 205 HIVGEIPL-GHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLS 263
++ GE+P+ G G+ L Q++L+NN+LSG L +G+L ++ L L N F SIP +
Sbjct: 442 YLTGELPISGGGVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSIPPEIG 501
Query: 264 NLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSH 323
L +L L+ S+N FS +I +I + L+ +DLS N +IP+++ M+ L LNLS
Sbjct: 502 RLQQLSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNLSR 561
Query: 324 NNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDIKRLPP 383
N+L GSIP M L+ +D SYN L GL+P++ F + GN LCG L P
Sbjct: 562 NHLVGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSHLCG--PYLGP 619
Query: 384 CK--AFKSHKQSMKKIWVVIVFPLLGTVALLISLIGLFFNFRQRKNGSQTQQSSPRNTLG 441
C +SH + + +++ L +++ +++ + R +N S+ + L
Sbjct: 620 CGKGTHQSHVKPLSATTKLLLVLGLLFCSMVFAIVAII-KARSLRNASEAKAWR----LT 674
Query: 442 LLSVLTFDGKIVHEEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDE 501
L F V ++ + + IG GG G VYK +P G++V VK+ + +
Sbjct: 675 AFQRLDFTCDDV-------LDSLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRLAT-MSHG 726
Query: 502 MACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSNDAAAEQF 561
+ F E+ L +IRHR+IV+ GFCS+ + +VYEY+ GSL L
Sbjct: 727 SSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGG-HL 785
Query: 562 CWTKR 566
W R
Sbjct: 786 HWNTR 790
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 231 bits (590), Expect = 8e-60, Method: Compositional matrix adjust.
Identities = 169/493 (34%), Positives = 250/493 (50%), Gaps = 32/493 (6%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANL 144
L+ IP+ IG++ L LQL EN GSIP LG L ++DLS+NKL+G++P + +
Sbjct: 323 LHGEIPEFIGDLPELEVLQLWENNFTGSIPQKLGENGKLNLVDLSSNKLTGTLPPNMCSG 382
Query: 145 TSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSN 204
L L N L SIP +G SL+ + + N LNGSIP L L L + L N
Sbjct: 383 NKLETLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKGLFGLPK-LTQVELQDN 441
Query: 205 HIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSN 264
++ GE+P+ G+ +L Q++L+NN+LSG L P +G+ ++ L L N F IP +
Sbjct: 442 YLSGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTGVQKLLLDGNKFQGPIPSEVGK 501
Query: 265 LVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHN 324
L +L ++ S+N FS +I +I + L+ +DLS N EIP++I +M+ L LNLS N
Sbjct: 502 LQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPNEITAMKILNYLNLSRN 561
Query: 325 NLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDIKRLPPC 384
+L GSIP M L+ +D SYN L GL+P + F + GN LCG L PC
Sbjct: 562 HLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYTSFLGNPDLCG--PYLGPC 619
Query: 385 K------AFKSHKQ-----SMKKIWVVIVFPLLGTVALLISLIGLFFNFRQRKNGSQTQQ 433
K +SH + SMK + V+ + ++A + I R K S+++
Sbjct: 620 KDGVAKGGHQSHSKGPLSASMKLLLVLGLLVC--SIAFAVVAI---IKARSLKKASESRA 674
Query: 434 SSPRNTLGLLSVLTFDGKIVHEEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKK 493
L L F V ++ + + IG GG G VYK +P G++V VK+
Sbjct: 675 WR----LTAFQRLDFTCDDV-------LDSLKEDNIIGKGGAGIVYKGVMPNGDLVAVKR 723
Query: 494 FHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLS 553
+ + + F E+ L +IRHR+IV+ GFCS+ + +VYEY+ GSL L
Sbjct: 724 LAA-MSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLH 782
Query: 554 NDAAAEQFCWTKR 566
W R
Sbjct: 783 GKKGG-HLHWDTR 794
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 231 bits (589), Expect = 1e-59, Method: Compositional matrix adjust.
Identities = 194/598 (32%), Positives = 278/598 (46%), Gaps = 118/598 (19%)
Query: 82 DW---PLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIP 138
DW L IP IG +K L+ L L EN L G+IP +LGN + V+DL+ N+LSGSIP
Sbjct: 463 DWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIP 522
Query: 139 LSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGS-------------- 184
SF LT+L + +Y NSL ++P + N+ +L+ ++ SSNK NGS
Sbjct: 523 SSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISPLCGSSSYLSFD 582
Query: 185 ---------IPLSLANLTN-----------------------SLKVLYLSSNHIVGEIPL 212
IPL L TN L +L +S N + G IP+
Sbjct: 583 VTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPV 642
Query: 213 GHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTF------------------ 254
G+ L + LNNN LSG + LG L L L LS+N F
Sbjct: 643 ELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLF 702
Query: 255 ------HKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHL---------------- 292
+ SIP+ + NL L+ LNL NQ S +P+ I KL L
Sbjct: 703 LDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPV 762
Query: 293 ---------SELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCI 343
S LDLS+N F IPS I ++ LE L+LSHN L G +P +M L +
Sbjct: 763 EIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYL 822
Query: 344 DISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDIKRLPPC-KAFKSHKQSMKKIWVVIV 402
++SYN L+G + + A A GN LCG L C +A +++S+ VVI+
Sbjct: 823 NLSYNNLEGKLKKQFSRWQAD--AFVGNAGLCG--SPLSHCNRAGSKNQRSLSPKTVVII 878
Query: 403 FPL--LGTVALLISLIGLFFN-----FRQRKNGSQTQQSSPRNTLG-LLSVLTFDGKIVH 454
+ L +AL++ +I LFF F++ + G+ S+ ++ L S I
Sbjct: 879 SAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKW 938
Query: 455 EEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNA 514
++I+ AT+ ++ IG+GG G VYKA+L GE + VKK D++ + F EV
Sbjct: 939 DDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKIL--WKDDLMSNKSFNREVKT 996
Query: 515 LTKIRHRNIVKFYGFCSHALH--SFVVYEYLEMGSLAMNL---SNDAAAEQFCWTKRM 567
L IRHR++VK G+CS + ++YEY+ GS+ L N E W R+
Sbjct: 997 LGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRL 1054
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 226 bits (575), Expect = 5e-58, Method: Compositional matrix adjust.
Identities = 169/509 (33%), Positives = 254/509 (49%), Gaps = 26/509 (5%)
Query: 78 FTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSI 137
F G L +IPDE+ ++L L LS+N L GS+P L L NL L L +N +SG I
Sbjct: 400 FLGWQNKLEGNIPDELAGCQNLQALDLSQNYLTGSLPAGLFQLRNLTKLLLISNAISGVI 459
Query: 138 PLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLK 197
PL N TSL L L N + IPK IG + +LS LDLS N L+G +PL ++N L+
Sbjct: 460 PLEIGNCTSLVRLRLVNNRITGEIPKGIGFLQNLSFLDLSENNLSGPVPLEISN-CRQLQ 518
Query: 198 VLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKS 257
+L LS+N + G +PL L+ L L +++N+L+G++ LG LI L L LS N+F+
Sbjct: 519 MLNLSNNTLQGYLPLSLSSLTKLQVLDVSSNDLTGKIPDSLGHLISLNRLILSKNSFNGE 578
Query: 258 IPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELD----LSHNIFREEIPSQICSM 313
IP SL + L L+LS+N S IP E+L + +LD LS N IP +I ++
Sbjct: 579 IPSSLGHCTNLQLLDLSSNNISGTIP---EELFDIQDLDIALNLSWNSLDGFIPERISAL 635
Query: 314 QSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKR 373
L L++SHN LSG + + L ++IS+N G +P+S FR ++GN
Sbjct: 636 NRLSVLDISHNMLSGDL-SALSGLENLVSLNISHNRFSGYLPDSKVFRQLIGAEMEGNNG 694
Query: 374 LCGDIKRLPPCKAFKSHKQSMKKI----WVVIVFPLLGTVALLISLIGLFFNFRQRKNGS 429
LC K C S + + ++ + I LL +V +++++G+ R ++
Sbjct: 695 LCS--KGFRSCFVSNSSQLTTQRGVHSHRLRIAIGLLISVTAVLAVLGVLAVIRAKQMIR 752
Query: 430 QTQQSSPRNTLGLLSVLTFDG-KIVHEEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEI 488
S L F E +++ +G+ IG G G VYKA++P E+
Sbjct: 753 DDNDSETGENLWTWQFTPFQKLNFTVEHVLKC---LVEGNVIGKGCSGIVYKAEMPNREV 809
Query: 489 VDVKK-FHSPLPD------EMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541
+ VKK + +P+ + F EV L IRH+NIV+F G C + ++Y+
Sbjct: 810 IAVKKLWPVTVPNLNEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYD 869
Query: 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570
Y+ GSL L + W R I
Sbjct: 870 YMSNGSLGSLLHERSGVCSLGWEVRYKII 898
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 224 bits (571), Expect = 1e-57, Method: Compositional matrix adjust.
Identities = 163/517 (31%), Positives = 251/517 (48%), Gaps = 42/517 (8%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANL 144
L +IP ++G L L +S+N L+G IP L +N+++L+L TN LSG+IP
Sbjct: 397 LSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTC 456
Query: 145 TSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSN 204
+L L L N+L P + +++ ++L N+ GSIP + N + +L+ L L+ N
Sbjct: 457 KTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCS-ALQRLQLADN 515
Query: 205 HIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSN 264
GE+P GMLS L L +++N+L+G++ E+ + L+ LD+ N F ++P + +
Sbjct: 516 GFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGS 575
Query: 265 LVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLE-KLNLSH 323
L +L L LSNN S IP + L L+EL + N+F IP ++ S+ L+ LNLS+
Sbjct: 576 LYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSY 635
Query: 324 NNL------------------------SGSIPRCFEEMHWLSCIDISYNALQGLIPNSTA 359
N L SG IP F + L + SYN+L G IP
Sbjct: 636 NKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP---L 692
Query: 360 FRDAPMLALQGNKRLCG-------DIKRLPPCKAFKSHKQSMKKIWVVIVFPLLGTVAL- 411
R+ M + GN+ LCG + P ++ + I ++G V+L
Sbjct: 693 LRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLM 752
Query: 412 LISLIGLFFNFRQRKNGSQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATNNFDDGHCIG 471
LI+LI R S Q P + + L ++++ AT+NFD+ +G
Sbjct: 753 LIALIVYLMRRPVRTVASSAQDGQP-SEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVG 811
Query: 472 NGGQGSVYKAKLPTGEIVDVKKFHS--PLPDEMACQQEFLNEVNALTKIRHRNIVKFYGF 529
G G+VYKA LP G + VKK S + F E+ L IRHRNIVK +GF
Sbjct: 812 RGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGF 871
Query: 530 CSHALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKR 566
C+H + ++YEY+ GSL L + + W+KR
Sbjct: 872 CNHQGSNLLLYEYMPKGSLGEILHDPSC--NLDWSKR 906
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 221 bits (562), Expect = 1e-56, Method: Compositional matrix adjust.
Identities = 183/569 (32%), Positives = 258/569 (45%), Gaps = 114/569 (20%)
Query: 89 IPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLS 148
IP IG +K L+ L L +N L G +P +LGN L +LDL+ N+LSGSIP SF L L
Sbjct: 472 IPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLE 531
Query: 149 ILYLYENSL-------------------------------C----------------DSI 161
L LY NSL C D I
Sbjct: 532 QLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEI 591
Query: 162 PKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLI 221
P E+GN +L L L N+L G IP +L + L +L +SSN + G IPL + L
Sbjct: 592 PLELGNSQNLDRLRLGKNQLTGKIPWTLGKI-RELSLLDMSSNALTGTIPLQLVLCKKLT 650
Query: 222 QLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQK 281
+ LNNN LSG + P LG L QL L LS+N F +S+P L N KL L+L N +
Sbjct: 651 HIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGS 710
Query: 282 IPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWL- 340
IP +I L L+ L+L N F +P + + L +L LS N+L+G IP ++ L
Sbjct: 711 IPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQ 770
Query: 341 SCIDISYNALQGLIPNSTA----------------------------------------- 359
S +D+SYN G IP++
Sbjct: 771 SALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGG 830
Query: 360 -----FRDAPMLALQGNKRLCGDIKRLPPCKAFKSHKQ----SMKKIWVVIVFPLLGTVA 410
F P + GN LCG L C +S+ + S + + ++ L +
Sbjct: 831 KLKKQFSRWPADSFLGNTGLCG--SPLSRCNRVRSNNKQQGLSARSVVIISAISALTAIG 888
Query: 411 LLISLIGLFFN-----FRQRKNGSQTQQSSPRNTLGLLSVLTFDGK----IVHEEIIRAT 461
L+I +I LFF F++ +GS SS ++ L +G I E+I+ AT
Sbjct: 889 LMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEAT 948
Query: 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHR 521
+N + IG+GG G VYKA+L GE V VKK D++ + F EV L +IRHR
Sbjct: 949 HNLSEEFMIGSGGSGKVYKAELENGETVAVKKIL--WKDDLMSNKSFSREVKTLGRIRHR 1006
Query: 522 NIVKFYGFCSHALH--SFVVYEYLEMGSL 548
++VK G+CS + ++YEY++ GS+
Sbjct: 1007 HLVKLMGYCSSKSEGLNLLIYEYMKNGSI 1035
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6XAT2|ERL2_ARATH LRR receptor-like serine/threonine-protein kinase ERL2 OS=Arabidopsis thaliana GN=ERL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 218 bits (554), Expect = 1e-55, Method: Compositional matrix adjust.
Identities = 156/490 (31%), Positives = 245/490 (50%), Gaps = 21/490 (4%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANL 144
L IP+ IG M++L+ L LS+N L G IP LGNL+ L L NKL+G IP N+
Sbjct: 276 LTGRIPEVIGLMQALAVLDLSDNELTGPIPPILGNLSFTGKLYLHGNKLTGQIPPELGNM 335
Query: 145 TSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSN 204
+ LS L L +N L IP E+G + L L+L++N L G IP ++++ +L + N
Sbjct: 336 SRLSYLQLNDNELVGKIPPELGKLEQLFELNLANNNLVGLIPSNISSCA-ALNQFNVHGN 394
Query: 205 HIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSN 264
+ G +PL L SL L L++N G++ ELG +I L+ LDLS N F SIP +L +
Sbjct: 395 FLSGAVPLEFRNLGSLTYLNLSSNSFKGKIPAELGHIINLDTLDLSGNNFSGSIPLTLGD 454
Query: 265 LVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHN 324
L L LNLS N + +P + L + +D+S N IP+++ +Q++ L L++N
Sbjct: 455 LEHLLILNLSRNHLNGTLPAEFGNLRSIQIIDVSFNFLAGVIPTELGQLQNINSLILNNN 514
Query: 325 NLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDI------ 378
+ G IP L+ ++IS+N L G+IP F + GN LCG+
Sbjct: 515 KIHGKIPDQLTNCFSLANLNISFNNLSGIIPPMKNFTRFSPASFFGNPFLCGNWVGSICG 574
Query: 379 KRLPPCKAFKSHKQSMKKIWVVIVFPLLGTVALLISLIGLFFNFRQRKNGSQTQQSSPRN 438
LP + F V ++ +LG + L+ + + +Q+K + P
Sbjct: 575 PSLPKSQVFTR---------VAVICMVLGFITLICMIFIAVYKSKQQKPVLKGSSKQPEG 625
Query: 439 TLGLLSVLTFDGKI-VHEEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSP 497
+ L+ +L D I ++I+R T N D+ + IG G +VYK T + +K+ ++
Sbjct: 626 STKLV-ILHMDMAIHTFDDIMRVTENLDEKYIIGYGASSTVYKCTSKTSRPIAIKRIYNQ 684
Query: 498 LPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSNDAA 557
P +EF E+ + IRHRNIV +G+ + + Y+Y+E GSL L
Sbjct: 685 YPSNF---REFETELETIGSIRHRNIVSLHGYALSPFGNLLFYDYMENGSLWDLLHGPGK 741
Query: 558 AEQFCWTKRM 567
+ W R+
Sbjct: 742 KVKLDWETRL 751
|
Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ERL1 and ER. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 571 | ||||||
| 147772402 | 996 | hypothetical protein VITISV_022117 [Viti | 0.844 | 0.483 | 0.470 | 1e-123 | |
| 359491512 | 1078 | PREDICTED: probable LRR receptor-like se | 0.844 | 0.447 | 0.479 | 1e-123 | |
| 225456159 | 1038 | PREDICTED: probable LRR receptor-like se | 0.844 | 0.464 | 0.472 | 1e-123 | |
| 225456161 | 1037 | PREDICTED: probable LRR receptor-like se | 0.844 | 0.464 | 0.468 | 1e-122 | |
| 147767326 | 1032 | hypothetical protein VITISV_008862 [Viti | 0.851 | 0.470 | 0.453 | 1e-113 | |
| 359491509 | 1032 | PREDICTED: probable LRR receptor-like se | 0.851 | 0.470 | 0.453 | 1e-113 | |
| 255545702 | 1008 | receptor protein kinase, putative [Ricin | 0.849 | 0.481 | 0.431 | 1e-109 | |
| 297734328 | 2131 | unnamed protein product [Vitis vinifera] | 0.814 | 0.218 | 0.447 | 1e-100 | |
| 297846642 | 1007 | hypothetical protein ARALYDRAFT_891227 [ | 0.831 | 0.471 | 0.409 | 1e-98 | |
| 297846638 | 1123 | hypothetical protein ARALYDRAFT_473694 [ | 0.833 | 0.423 | 0.411 | 3e-98 |
| >gi|147772402|emb|CAN73988.1| hypothetical protein VITISV_022117 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 450 bits (1157), Expect = e-123, Method: Compositional matrix adjust.
Identities = 265/563 (47%), Positives = 341/563 (60%), Gaps = 81/563 (14%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNL--------------------- 123
L IP EIGN+KSL DL+LSEN LNGSIP +LGNLTNL
Sbjct: 275 LSGPIPQEIGNLKSLVDLELSENQLNGSIPTSLGNLTNLETLFLRDNQLSGYIPQEIGKL 334
Query: 124 ---VVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSI------- 173
VVL++ TN+L GS+P SL + +N L IPK + N +L+
Sbjct: 335 HKLVVLEIDTNQLFGSLPEGICQGGSLERFTVSDNHLSGPIPKSLKNCKNLTRALFGGNQ 394
Query: 174 -----------------------------------------LDLSSNKLNGSIPLSLANL 192
L+++ N + GSIP +
Sbjct: 395 LTGNISEVVGDCPNLEYINVSYNSFHGELSHNWGRYPRLQRLEMAWNNITGSIPEDFG-I 453
Query: 193 TNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSAN 252
+ L +L LSSNH+ GEIP G ++SL +L LN+N+LSG + PELGSL L YLDLSAN
Sbjct: 454 STDLTLLDLSSNHLFGEIPKKMGSVTSLWKLILNDNQLSGNIPPELGSLADLGYLDLSAN 513
Query: 253 TFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICS 312
+ SIPE L + + L+YLNLSNN+ S IP ++ KL HLS+LDLSHN+ +IP QI
Sbjct: 514 RLNGSIPEHLGDCLGLNYLNLSNNKLSHGIPVQMGKLGHLSQLDLSHNLLTGDIPPQIEG 573
Query: 313 MQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNK 372
+QSLE LNLSHNNLSG IP+ FEEM LS +DISYN LQG IPNS AFRDA + AL+GNK
Sbjct: 574 LQSLENLNLSHNNLSGFIPKAFEEMLGLSDVDISYNQLQGPIPNSKAFRDATIEALKGNK 633
Query: 373 RLCGDIKRLPPCKAFKS-HKQSMK---KIWVVIVFPLLGTVALLISLIGLFFNFRQRKNG 428
LCG++KRL PCK +Q +K K+ +I+FPLLG + LL + IG+F +R+
Sbjct: 634 GLCGNVKRLRPCKYGSGVDQQPVKKSHKVVFIIIFPLLGALVLLFAFIGIFLIAARRERT 693
Query: 429 SQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEI 488
+ ++ +N L S+ TFDG+ ++EEII+AT +FD +CIG GG GSVYKA+LP+ I
Sbjct: 694 PEIKEGEVQND--LFSISTFDGRTMYEEIIKATKDFDPMYCIGKGGHGSVYKAELPSSNI 751
Query: 489 VDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
V VKK H P EMA Q++FLNE+ ALT+I+HRNIVK GFCSH H F+VYEYLE GSL
Sbjct: 752 VAVKKLH-PSDTEMANQKDFLNEIRALTEIKHRNIVKLLGFCSHPRHKFLVYEYLERGSL 810
Query: 549 AMNLSNDAAAEQFCWTKRMNAIK 571
A LS + A++ W R+N IK
Sbjct: 811 ATILSRE-EAKKLGWATRVNIIK 832
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491512|ref|XP_002278614.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 450 bits (1157), Expect = e-123, Method: Compositional matrix adjust.
Identities = 270/563 (47%), Positives = 341/563 (60%), Gaps = 81/563 (14%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNL--------------------- 123
L IP EIGN+KSL DL+LSEN LNGSIP +LGNLTNL
Sbjct: 324 LSGPIPPEIGNLKSLVDLELSENQLNGSIPTSLGNLTNLEILFLRDNHLSGYFPKEIGKL 383
Query: 124 ---VVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKE---------------- 164
VVL++ TN+LSGS+P SL + +N L IPK
Sbjct: 384 HKLVVLEIDTNRLSGSLPEGICQGGSLVRFTVSDNLLSGPIPKSMKNCRNLTRALFGGNQ 443
Query: 165 --------IGNMNSLSILDLSSNK------------------------LNGSIPLSLANL 192
+G+ +L +DLS N+ + GSIP
Sbjct: 444 LTGNISEVVGDCPNLEYIDLSYNRFHGELSHNWGRCPQLQRLEMAGNDITGSIPEDFGIS 503
Query: 193 TNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSAN 252
TN L +L LSSNH+VGEIP G L+SL++L LN+N+LSG + PELGSL L +LDLSAN
Sbjct: 504 TN-LTLLDLSSNHLVGEIPKKMGSLTSLLELKLNDNQLSGSIPPELGSLFSLAHLDLSAN 562
Query: 253 TFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICS 312
+ SI E+L + LHYLNLSNN+ S +IP ++ KL HLS+LDLSHN+ EIP QI
Sbjct: 563 RLNGSITENLGACLNLHYLNLSNNKLSNRIPAQMGKLSHLSQLDLSHNLLSGEIPPQIEG 622
Query: 313 MQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNK 372
++SLE LNLSHNNLSG IP+ FEEM LS IDISYN LQG IPNS AFRDA + L+GNK
Sbjct: 623 LESLENLNLSHNNLSGFIPKAFEEMRGLSDIDISYNQLQGPIPNSKAFRDATIELLKGNK 682
Query: 373 RLCGDIKRLPPCK----AFKSHKQSMKKIWVVIVFPLLGTVALLISLIGLFFNFRQRKNG 428
LCG++K L PCK A + + KI +IVFPLLG + LL + IG+F + K
Sbjct: 683 DLCGNVKGLQPCKNDSGAGQQPVKKGHKIVFIIVFPLLGALVLLFAFIGIFLIAERTKRT 742
Query: 429 SQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEI 488
+ ++ +N L S+ TFDG+ ++EEII+AT +FD +CIG GG GSVYKA+L +G I
Sbjct: 743 PEIEEGDVQND--LFSISTFDGRAMYEEIIKATKDFDPMYCIGKGGHGSVYKAELSSGNI 800
Query: 489 VDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
V VKK ++ D MA Q++F NEV ALT+I+HRNIVK GFCSH HSF+VYEYLE GSL
Sbjct: 801 VAVKKLYASDID-MANQRDFFNEVRALTEIKHRNIVKLLGFCSHPRHSFLVYEYLERGSL 859
Query: 549 AMNLSNDAAAEQFCWTKRMNAIK 571
A LS + A++ W R+N IK
Sbjct: 860 AAMLSRE-EAKKLGWATRINIIK 881
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225456159|ref|XP_002278561.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 449 bits (1156), Expect = e-123, Method: Compositional matrix adjust.
Identities = 266/563 (47%), Positives = 340/563 (60%), Gaps = 81/563 (14%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNL--------------------- 123
L IP EIGN+KSL DL+LSEN LNGSIP +LGNLTNL
Sbjct: 317 LSGPIPQEIGNLKSLVDLELSENQLNGSIPTSLGNLTNLEILFLRDNQLSGYIPQEIGKL 376
Query: 124 ---VVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKE---------------- 164
VVL++ TN+L GS+P SL + +N L IPK
Sbjct: 377 HKLVVLEIDTNQLFGSLPEGICQAGSLVRFAVSDNHLSGPIPKSLKNCRNLTRALFQGNR 436
Query: 165 --------IGNMNSLSILDLSSNK------------------------LNGSIPLSLANL 192
+G+ +L +DLS N+ + GSIP
Sbjct: 437 LTGNISEVVGDCPNLEFIDLSYNRFHGELSHNWGRCPQLQRLEIAGNNITGSIPEDFGIS 496
Query: 193 TNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSAN 252
TN L +L LSSNH+VGEIP G L+SL+ L LN+N+LSG + PELGSL LEYLDLSAN
Sbjct: 497 TN-LTLLDLSSNHLVGEIPKKMGSLTSLLGLILNDNQLSGSIPPELGSLSHLEYLDLSAN 555
Query: 253 TFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICS 312
+ SIPE L + + LHYLNLSNN+ S IP ++ KL HLS+LDLSHN+ IP QI
Sbjct: 556 RLNGSIPEHLGDCLDLHYLNLSNNKLSHGIPVQMGKLSHLSQLDLSHNLLAGGIPPQIQG 615
Query: 313 MQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNK 372
+QSLE L+LSHNNL G IP+ FE+M LS +DISYN LQG IP+S AFR+A + L+GNK
Sbjct: 616 LQSLEMLDLSHNNLCGFIPKAFEDMPALSYVDISYNQLQGPIPHSNAFRNATIEVLKGNK 675
Query: 373 RLCGDIKRLPPCK-AFKSHKQSMK---KIWVVIVFPLLGTVALLISLIGLFFNFRQRKNG 428
LCG++K L PCK F +Q +K K+ +I+FPLLG + LL + IG+F +R+
Sbjct: 676 DLCGNVKGLQPCKYGFGVDQQPVKKSHKVVFIIIFPLLGALVLLFAFIGIFLIAERRERT 735
Query: 429 SQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEI 488
+ ++ +N L S+ FDG+ ++EEII+AT +FD +CIG GG GSVYKA+LP+ I
Sbjct: 736 PEIEEGDVQND--LFSISNFDGRTMYEEIIKATKDFDPMYCIGKGGHGSVYKAELPSSNI 793
Query: 489 VDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
V VKK H P EMA Q++FLNE+ ALT+I+HRNIVK GFCSH H F+VYEYLE GSL
Sbjct: 794 VAVKKLH-PSDTEMANQKDFLNEIRALTEIKHRNIVKLLGFCSHPRHKFLVYEYLERGSL 852
Query: 549 AMNLSNDAAAEQFCWTKRMNAIK 571
A LS + A++ W R+N IK
Sbjct: 853 ATILSRE-EAKKLGWATRVNIIK 874
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225456161|ref|XP_002278590.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 445 bits (1144), Expect = e-122, Method: Compositional matrix adjust.
Identities = 264/563 (46%), Positives = 344/563 (61%), Gaps = 81/563 (14%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNL--------------------- 123
L IP EIGN+KSL DL+LSEN LNGSIP +LGNLTNL
Sbjct: 317 LSGPIPQEIGNLKSLVDLELSENQLNGSIPTSLGNLTNLEILFLRDNRLSGYFPQEIGKL 376
Query: 124 ---VVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKE---------------- 164
VVL++ TN+L GS+P SL + +N L IPK
Sbjct: 377 HKLVVLEIDTNQLFGSLPEGICQGGSLERFTVSDNHLSGPIPKSLKNCRNLTRALFQGNR 436
Query: 165 --------IGNMNSLSILDLSSNK------------------------LNGSIPLSLANL 192
+G+ +L +DLS N+ + GSIP
Sbjct: 437 LTGNVSEVVGDCPNLEFIDLSYNRFHGELSHNWGRCPQLQRLEIAGNNITGSIPEDFGIS 496
Query: 193 TNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSAN 252
TN L +L LSSNH+VGEIP G L+SL+ L LN+N+LSG + PELGSL LEYLDLSAN
Sbjct: 497 TN-LILLDLSSNHLVGEIPKKMGSLTSLLGLILNDNQLSGSIPPELGSLSHLEYLDLSAN 555
Query: 253 TFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICS 312
+ SIPE L + + LHYLNLSNN+ S IP ++ KL HLS+LDLSHN+ IP+QI
Sbjct: 556 RLNGSIPEHLGDCLDLHYLNLSNNKLSHGIPVQMGKLSHLSQLDLSHNLLTGGIPAQIQG 615
Query: 313 MQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNK 372
++SLE L+LSHNNL G IP+ FE+M LS +DISYN LQG IP+S AFR+A + L+GNK
Sbjct: 616 LESLEMLDLSHNNLCGFIPKAFEDMPALSYVDISYNQLQGPIPHSNAFRNATIEVLKGNK 675
Query: 373 RLCGDIKRLPPCK-AFKSHKQSMK---KIWVVIVFPLLGTVALLISLIGLFFNFRQRKNG 428
LCG++K L PCK F +Q +K K+ +I+FPLLG + LL + IG+F +R+
Sbjct: 676 DLCGNVKGLQPCKYGFGVDQQPVKKSHKVVFIIIFPLLGALVLLSAFIGIFLIAERRERT 735
Query: 429 SQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEI 488
+ ++ +N LLS+ TFDG+ ++EEII+AT +FD +CIG GG GSVYKA+LP+G I
Sbjct: 736 PEIEEGDVQNN--LLSISTFDGRAMYEEIIKATKDFDPMYCIGKGGHGSVYKAELPSGNI 793
Query: 489 VDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
V VKK H P +MA Q++FLN+V A+T+I+HRNIV+ GFCS+ HSF+VYEYLE GSL
Sbjct: 794 VAVKKLH-PSDMDMANQKDFLNKVRAMTEIKHRNIVRLLGFCSYPRHSFLVYEYLERGSL 852
Query: 549 AMNLSNDAAAEQFCWTKRMNAIK 571
A LS + A++ W R+ IK
Sbjct: 853 ATILSRE-EAKKLGWATRVKIIK 874
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147767326|emb|CAN68996.1| hypothetical protein VITISV_008862 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 416 bits (1069), Expect = e-113, Method: Compositional matrix adjust.
Identities = 255/562 (45%), Positives = 335/562 (59%), Gaps = 76/562 (13%)
Query: 82 DWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNL------------------ 123
D L IP E+GN++SL DL++S+N LNGSIP +LGNL NL
Sbjct: 311 DNQLSGPIPQEMGNLRSLVDLEISQNQLNGSIPTSLGNLINLEILYLRDNKLSSSIPPEI 370
Query: 124 ------VVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLS----- 172
V L++ TN+LSG +P SL +++N L IP+ + N SL+
Sbjct: 371 GKLHKLVELEIDTNQLSGFLPEGICQGGSLENFTVFDNFLIGPIPESLKNCPSLARARLQ 430
Query: 173 -------------------------------------------ILDLSSNKLNGSIPLSL 189
LD++ N + GSIP
Sbjct: 431 RNQLTGNISEAFGVCPNLYHINLSNNKFYGELSQNWGRCHKLQWLDIAGNNITGSIPADF 490
Query: 190 ANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDL 249
++ L VL LSSNH+VGEIP G +SSL +L LN+N LSG + PELGSL L YLDL
Sbjct: 491 G-ISTQLTVLNLSSNHLVGEIPKKLGSVSSLWKLILNDNRLSGNIPPELGSLADLGYLDL 549
Query: 250 SANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQ 309
S N + SIPE L N + L+YLNLSNN+ S IP ++ KL HLS LDLSHN+ EIPSQ
Sbjct: 550 SGNRLNGSIPEHLGNCLDLNYLNLSNNKLSHGIPVQMGKLSHLSLLDLSHNLLTGEIPSQ 609
Query: 310 ICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQ 369
I +QSLEKLNLSHNNLSG IP+ FE+MH L +DISYN LQG IPNS AF++ + LQ
Sbjct: 610 IQGLQSLEKLNLSHNNLSGIIPKAFEDMHGLWQVDISYNDLQGSIPNSEAFQNVTIEVLQ 669
Query: 370 GNKRLCGDIKRLPPCKAFKSHKQSMKKIWVVIVFPLLGTVALLISLIGLFFNFRQRKNGS 429
GNK LCG +K L PC+ + K + K ++ +I+F LLG + +L + IG+ + R+N +
Sbjct: 670 GNKGLCGSVKGLQPCENRSATKGTHKAVF-IIIFSLLGALLILSAFIGISLISQGRRN-A 727
Query: 430 QTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEIV 489
+ +++ T L S+ TFDG+ +E II AT +FD +CIG GG GSVYKA+LP+G IV
Sbjct: 728 KMEKAGDVQTENLFSISTFDGRTTYEAIIEATKDFDPMYCIGEGGHGSVYKAELPSGNIV 787
Query: 490 DVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLA 549
VKK H +MA Q++F+NE+ ALT+I+HRNIVK GFCSH+ HSF+VYEYLE GSL
Sbjct: 788 AVKKLHR-FDIDMAHQKDFMNEIRALTEIKHRNIVKLLGFCSHSRHSFLVYEYLERGSLG 846
Query: 550 MNLSNDAAAEQFCWTKRMNAIK 571
LS + A++ W R+N IK
Sbjct: 847 TILSKELQAKEVGWGTRVNIIK 868
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491509|ref|XP_002278522.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 414 bits (1065), Expect = e-113, Method: Compositional matrix adjust.
Identities = 255/562 (45%), Positives = 334/562 (59%), Gaps = 76/562 (13%)
Query: 82 DWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNL------------------ 123
D L IP E+GN++SL DL++S+N LNGSIP LGNL NL
Sbjct: 311 DNQLSGPIPQEMGNLRSLVDLEISQNQLNGSIPTLLGNLINLEILYLRDNKLSSSIPPEI 370
Query: 124 ------VVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLS----- 172
V L++ TN+LSG +P SL +++N L IP+ + N SL+
Sbjct: 371 GKLHKLVELEIDTNQLSGFLPEGICQGGSLENFTVFDNFLIGPIPESLKNCPSLARARLQ 430
Query: 173 -------------------------------------------ILDLSSNKLNGSIPLSL 189
LD++ N + GSIP
Sbjct: 431 GNQLTGNISEAFGVCPNLYHINLSNNKFYGELSQNWGRCHKLQWLDIAGNNITGSIPADF 490
Query: 190 ANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDL 249
++ L VL LSSNH+VGEIP G +SSL +L LN+N LSG + PELGSL L YLDL
Sbjct: 491 G-ISTQLTVLNLSSNHLVGEIPKKLGSVSSLWKLILNDNRLSGNIPPELGSLADLGYLDL 549
Query: 250 SANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQ 309
S N + SIPE L N + L+YLNLSNN+ S IP ++ KL HLS LDLSHN+ EIPSQ
Sbjct: 550 SGNRLNGSIPEHLGNCLDLNYLNLSNNKLSHGIPVQMGKLSHLSLLDLSHNLLTGEIPSQ 609
Query: 310 ICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQ 369
I +QSLEKLNLSHNNLSG IP+ FE+MH L +DISYN LQG IPNS AF++ + LQ
Sbjct: 610 IQGLQSLEKLNLSHNNLSGIIPKAFEDMHGLWQVDISYNDLQGSIPNSEAFQNVTIEVLQ 669
Query: 370 GNKRLCGDIKRLPPCKAFKSHKQSMKKIWVVIVFPLLGTVALLISLIGLFFNFRQRKNGS 429
GNK LCG +K L PC+ + K + K ++ +I+F LLG + +L + IG+ + R+N +
Sbjct: 670 GNKGLCGSVKGLQPCENRSATKGTHKAVF-IIIFSLLGALLILSAFIGISLISQGRRN-A 727
Query: 430 QTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEIV 489
+ +++ T L S+ TFDG+ +E II AT +FD +CIG GG GSVYKA+LP+G IV
Sbjct: 728 KMEKAGDVQTENLFSISTFDGRTTYEAIIEATKDFDPMYCIGEGGHGSVYKAELPSGNIV 787
Query: 490 DVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLA 549
VKK H +MA Q++F+NE+ ALT+I+HRNIVK GFCSH+ HSF+VYEYLE GSL
Sbjct: 788 AVKKLHR-FDIDMAHQKDFVNEIRALTEIKHRNIVKLLGFCSHSRHSFLVYEYLERGSLG 846
Query: 550 MNLSNDAAAEQFCWTKRMNAIK 571
LS + A++ W R+N IK
Sbjct: 847 TILSKELQAKEVGWGTRVNIIK 868
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545702|ref|XP_002513911.1| receptor protein kinase, putative [Ricinus communis] gi|223546997|gb|EEF48494.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 401 bits (1031), Expect = e-109, Method: Compositional matrix adjust.
Identities = 243/563 (43%), Positives = 331/563 (58%), Gaps = 78/563 (13%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSI------- 137
L +IP E+GN+ SLS+L+LSEN L GSIP +LGNL+ L +L L N+LSG I
Sbjct: 288 LSGTIPKELGNLNSLSNLELSENKLTGSIPASLGNLSRLELLFLKNNQLSGPIPEQIANL 347
Query: 138 -----------------------------------------PLSFANLTSLSILYLYENS 156
P S + SL L+L N
Sbjct: 348 SKLSLLQLQSNQLTGYLPQNICQSKVLQNFSVNDNRLEGPIPKSMRDCKSLVRLHLEGNQ 407
Query: 157 LCDSIPKEIGNMNSLSILDLSSNKLNGSI------------------------PLSLANL 192
+I ++ G L +D+ NK +G I P + N
Sbjct: 408 FIGNISEDFGVYPYLQFVDIRYNKFHGEISSKWGMCPHLGTLLISGNNISGIIPPEIGNA 467
Query: 193 TNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSAN 252
L+ L SSN +VG IP G L+SL+++ L +N+LS + E GSL LE LDLSAN
Sbjct: 468 AR-LQGLDFSSNQLVGRIPKELGKLTSLVRVNLEDNQLSDGVPSEFGSLTDLESLDLSAN 526
Query: 253 TFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICS 312
F++SIP ++ NLVKL+YLNLSNNQFSQ+IP ++ KL+HLS+LDLS N EIPS++
Sbjct: 527 RFNQSIPGNIGNLVKLNYLNLSNNQFSQEIPIQLGKLVHLSKLDLSQNFLIGEIPSELSG 586
Query: 313 MQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNK 372
MQSLE LNLS NNLSG IP +EMH LS IDISYN L+G +P++ AF+++ + A QGNK
Sbjct: 587 MQSLEVLNLSRNNLSGFIPGDLKEMHGLSSIDISYNKLEGPVPDNKAFQNSSIEAFQGNK 646
Query: 373 RLCGDIKRLPPCKAFKSHKQSM----KKIWVVIVFPLLGTVALLISLIGLFFNFRQRKNG 428
LCG ++ L PCK + + S K++++VI PL G +L L LFF ++ K
Sbjct: 647 GLCGHVQGLQPCKPSSTEQGSSIKFHKRLFLVISLPLFGAFLILSFLGVLFFQSKRSKEA 706
Query: 429 SQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEI 488
+ ++SS + + +L + +FDGK +H+EII AT++F+D +CIG GG GSVYKAKL +G
Sbjct: 707 LEAEKSS-QESEEILLITSFDGKSMHDEIIEATDSFNDIYCIGKGGCGSVYKAKLSSGST 765
Query: 489 VDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
V VKK H Q+EF +E+ ALT+I+HRNIVKFYGFCS++ +SF+VYE +E GSL
Sbjct: 766 VAVKKLHQSHDAWKPYQKEFWSEIRALTEIKHRNIVKFYGFCSYSAYSFLVYECIEKGSL 825
Query: 549 AMNLSNDAAAEQFCWTKRMNAIK 571
A L ++ AA++ W KR N IK
Sbjct: 826 ATILRDNEAAKELEWFKRANIIK 848
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297734328|emb|CBI15575.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 372 bits (955), Expect = e-100, Method: Compositional matrix adjust.
Identities = 230/514 (44%), Positives = 309/514 (60%), Gaps = 49/514 (9%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANL 144
L SIP EIG + SL +L L N L GSIP +LGNL+NL L L N+LSG IP +F NL
Sbjct: 124 LNGSIPHEIGQLTSLYELALYTNQLEGSIPASLGNLSNLASLYLYENQLSGPIPSTFGNL 183
Query: 145 TSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSN 204
L++LYL+ NSL IP EIGN+ SL L L N L+G IP+SL +L+ L +L+L +N
Sbjct: 184 KHLTVLYLFNNSLSGPIPPEIGNLKSLQGLSLYGNNLSGPIPVSLCDLS-GLTLLHLYAN 242
Query: 205 HIVGEIPLGHGMLSS-LIQLTLNNNELSGQLSPE-------------------LGSLIQL 244
+ G IP G L S L+ L ++ N+L G L PE +G L
Sbjct: 243 QLSGPIPQEIGNLKSLLVVLEIDTNQLFGSL-PEGICQGGSLERFTVSDNHLSVGDCPNL 301
Query: 245 EYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFRE 304
E++DLS N FH + + +L L ++ N + IP +L LDLS N
Sbjct: 302 EFIDLSYNRFHGELSHNWGRCPQLQRLEIAGNNITGSIPEDFGISTNLILLDLSSNHLVG 361
Query: 305 EIPSQICSMQSLEKLNLSHNNLSGSIP-------RCFEEMHWLSCIDISYNALQGLIPNS 357
EIP ++ S+ SL L L+ N LSGSIP + FE+M LS +DISYN LQG IP+S
Sbjct: 362 EIPKKMGSLTSLLGLILNDNQLSGSIPPELGSLSKAFEDMPALSYVDISYNQLQGPIPHS 421
Query: 358 TAFRDAPMLALQGNKRLCGDIKRLPPCKAFKSHKQSMKKIWVVIVFPLLGTVALLISLIG 417
AFR+A + L+GNK LCG+ SH K+ +I+FPLLG + LL + IG
Sbjct: 422 NAFRNATIEVLKGNKDLCGN-----------SH-----KVVFIIIFPLLGALVLLSAFIG 465
Query: 418 LFFNFRQRKNGSQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATNNFDDGHCIGNGGQGS 477
+F +R+ + ++ +N LLS+ TFDG+ ++EEII+AT +FD +CIG GG GS
Sbjct: 466 IFLIAERRERTPEIEEGDVQNN--LLSISTFDGRAMYEEIIKATKDFDPMYCIGKGGHGS 523
Query: 478 VYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSF 537
VYKA+LP+G IV VKK H P +MA Q++FLN+V A+T+I+HRNIV+ GFCS+ HSF
Sbjct: 524 VYKAELPSGNIVAVKKLH-PSDMDMANQKDFLNKVRAMTEIKHRNIVRLLGFCSYPRHSF 582
Query: 538 VVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAIK 571
+VYEYLE GSLA LS + A++ W R+ IK
Sbjct: 583 LVYEYLERGSLATILSRE-EAKKLGWATRVKIIK 615
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297846642|ref|XP_002891202.1| hypothetical protein ARALYDRAFT_891227 [Arabidopsis lyrata subsp. lyrata] gi|297337044|gb|EFH67461.1| hypothetical protein ARALYDRAFT_891227 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 367 bits (941), Expect = 1e-98, Method: Compositional matrix adjust.
Identities = 232/567 (40%), Positives = 323/567 (56%), Gaps = 92/567 (16%)
Query: 89 IPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLS 148
IP E+GNM+S+ DL+LS+N L GSIP + GN T L L LS N LSG+IP AN + L+
Sbjct: 289 IPPELGNMESMIDLELSQNNLTGSIPSSFGNFTKLKSLYLSYNHLSGAIPPGVANSSELT 348
Query: 149 ------------------------ILYLYENSLCDSIPKE-----------------IGN 167
+ LY+N L IPK +GN
Sbjct: 349 ELQLAINNFSGFLPKNICKGGKLQFIALYDNHLKGPIPKSLRDCKSLIRAKFVGNKFVGN 408
Query: 168 MN-------SLSILDLSSNKLNGSIP-------------LSLANLTNS----------LK 197
++ L+ +DLS NK NG I +S N+T + L
Sbjct: 409 ISEAFGVYPDLNFIDLSHNKFNGEISSNWQKSPKLGALIMSNNNITGAIPPEIWNMKQLG 468
Query: 198 VLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKS 257
L LS+N++ GE+P G L++L +L LN N+LSG++ + L LE LDLS+N F
Sbjct: 469 ELDLSANNLSGELPEAIGNLTNLSRLRLNGNQLSGRVPAGISFLTNLESLDLSSNRFSSQ 528
Query: 258 IPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLE 317
IP++ + +KLH +NLS N F +IP + KL L+ LDLSHN EIPSQ+ S+QSL+
Sbjct: 529 IPQTFDSFLKLHEMNLSRNNFDGRIPG-LTKLTQLTHLDLSHNQLDGEIPSQLSSLQSLD 587
Query: 318 KLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCGD 377
KLNLSHNNLSG IP FE M L+ IDIS N L+G +P++ AF++A AL+GN+ LC +
Sbjct: 588 KLNLSHNNLSGFIPTTFESMKALTFIDISNNKLEGPLPDNPAFQNATSDALEGNRGLCSN 647
Query: 378 I--KRLPPCKAFKSHKQSMKK-----IWVVIVFPLLGTVALLISLIGLF-FNFRQRK--N 427
I +RL C Q KK +W+++ P+LG + +L G F + R+RK N
Sbjct: 648 IPKQRLKSCPITSGGFQKPKKNGNLLVWILV--PILGALVILSICAGAFTYYIRKRKPHN 705
Query: 428 GSQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGE 487
G T + N +S+ + DGK +++II +TN FD + IG+GG VYKA LP
Sbjct: 706 GRNTDSETGEN----MSIFSVDGKFKYQDIIESTNEFDQRYLIGSGGYSKVYKANLPDA- 760
Query: 488 IVDVKKFHSPLPDEMA---CQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLE 544
IV VK+ H + +E++ +QEFLNEV ALT+IRHRN+VK +GFCSH H+F++YEY+E
Sbjct: 761 IVAVKRLHDTIDEEISKPVVKQEFLNEVRALTEIRHRNVVKLFGFCSHRRHTFLIYEYME 820
Query: 545 MGSLAMNLSNDAAAEQFCWTKRMNAIK 571
GSL L+N+ A++ WTKR+N +K
Sbjct: 821 KGSLNKLLANEEEAKRLTWTKRINIVK 847
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297846638|ref|XP_002891200.1| hypothetical protein ARALYDRAFT_473694 [Arabidopsis lyrata subsp. lyrata] gi|297337042|gb|EFH67459.1| hypothetical protein ARALYDRAFT_473694 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 365 bits (938), Expect = 3e-98, Method: Compositional matrix adjust.
Identities = 231/562 (41%), Positives = 319/562 (56%), Gaps = 86/562 (15%)
Query: 89 IPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLS 148
IP E+GNM+S+ DL LS+N L GSIP + GN T L L L N LSG+IP AN + L+
Sbjct: 409 IPPELGNMESMIDLALSQNNLTGSIPSSFGNFTKLESLYLRDNHLSGTIPRGVANSSELT 468
Query: 149 ILYLYENSLCDSIP-----------------------------------------KEIGN 167
L L N+ +P K IGN
Sbjct: 469 ELLLDINNFTGFLPENICKGGKLQNFSLDYNHLEGHIPKSLRDCKSLIRAKFVGNKFIGN 528
Query: 168 MN-------SLSILDLSSNKLNGSIP-------------LSLANLTNS----------LK 197
++ L +DLS NK NG I +S N+T + L
Sbjct: 529 ISEAFGVYPDLDFIDLSHNKFNGEISSNWQKSPKLGALIMSNNNITGAIPPEIWNMKQLG 588
Query: 198 VLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKS 257
L LS+N++ GE+P G L+ L +L LN N+LSG++ L L LE LDLS+N F
Sbjct: 589 ELDLSTNNLTGELPEAIGNLTGLSKLLLNGNKLSGRVPTGLSFLTNLESLDLSSNRFSSQ 648
Query: 258 IPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLE 317
IP++ + +KLH +NLS N F +IP + KL L+ LDLSHN EIPSQ+ S+QSL+
Sbjct: 649 IPQTFDSFLKLHEMNLSKNNFDGRIPG-LTKLTQLTHLDLSHNQLDGEIPSQLSSLQSLD 707
Query: 318 KLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCGD 377
KLNLSHNNLSG IP FE M L+ IDIS N L+G +P++ AF++A AL+GN+ LC +
Sbjct: 708 KLNLSHNNLSGFIPTTFESMKALTFIDISNNKLEGPLPDNPAFQNATSDALEGNRGLCSN 767
Query: 378 I--KRLPPCKAFKSHKQSMKKIWVVIVFPLLGTVALLISLIGLF-FNFRQRK--NGSQTQ 432
I +RL C+ F+ K++ + V I+ P+LG + +L G F + R+RK NG T
Sbjct: 768 IPKQRLKSCRGFQKPKKN-GNLLVWILVPILGALVILSICAGAFTYYIRKRKPHNGRNTD 826
Query: 433 QSSPRNTLGLLSVLTFDGKIVHEEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVK 492
+ N +S+ + DGK +++II +TN FD + IG+GG VYKA LP IV VK
Sbjct: 827 SETGEN----MSIFSVDGKFKYQDIIESTNEFDQRYLIGSGGYSKVYKANLPDA-IVAVK 881
Query: 493 KFHSPLPDEMA---CQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLA 549
+ H + +E++ +QEFLNEV ALT+IRHRN+VK +GFCSH H+F++YEY+E GSL
Sbjct: 882 RLHDTIDEEISKPVVKQEFLNEVRALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLN 941
Query: 550 MNLSNDAAAEQFCWTKRMNAIK 571
L+N+ A++ WTKR+N +K
Sbjct: 942 KLLANEEEAKRLTWTKRINIVK 963
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 571 | ||||||
| TAIR|locus:2138268 | 1045 | AT4G08850 [Arabidopsis thalian | 0.835 | 0.456 | 0.415 | 7e-93 | |
| TAIR|locus:2011339 | 1120 | AT1G35710 [Arabidopsis thalian | 0.828 | 0.422 | 0.407 | 1.5e-90 | |
| TAIR|locus:2097310 | 1002 | BAM2 "BARELY ANY MERISTEM 2" [ | 0.782 | 0.446 | 0.354 | 3.5e-62 | |
| TAIR|locus:2169965 | 1003 | BAM1 "BARELY ANY MERISTEM 1" [ | 0.793 | 0.451 | 0.358 | 9.5e-61 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.847 | 0.439 | 0.329 | 1.2e-60 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.793 | 0.361 | 0.359 | 6.8e-60 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.782 | 0.357 | 0.354 | 1.4e-59 | |
| TAIR|locus:2182855 | 967 | ERL2 "ERECTA-like 2" [Arabidop | 0.830 | 0.490 | 0.319 | 3.3e-59 | |
| TAIR|locus:2167948 | 966 | ERL1 "ERECTA-like 1" [Arabidop | 0.823 | 0.486 | 0.331 | 5.4e-59 | |
| TAIR|locus:2154344 | 1135 | AT5G48940 [Arabidopsis thalian | 0.851 | 0.428 | 0.330 | 7.4e-59 |
| TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 925 (330.7 bits), Expect = 7.0e-93, P = 7.0e-93
Identities = 205/493 (41%), Positives = 295/493 (59%)
Query: 89 IPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLS 148
+PD I L +L L +N G +P +L + +L+ + N SG I +F +L+
Sbjct: 398 LPDTICRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNSFSGDISEAFGVYPTLN 457
Query: 149 ILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVG 208
+ L N+ + L LS+N + G+IP + N+T L L LSSN I G
Sbjct: 458 FIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQ-LSQLDLSSNRITG 516
Query: 209 EIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKL 268
E+P ++ + +L LN N LSG++ + L LEYLDLS+N F IP +L+NL +L
Sbjct: 517 ELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPRL 576
Query: 269 HYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSG 328
+Y+NLS N Q IP + KL L LDLS+N EI SQ S+Q+LE+L+LSHNNLSG
Sbjct: 577 YYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSG 636
Query: 329 SIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDIKR---LPPCK 385
IP F++M L+ +D+S+N LQG IP++ AFR+AP A +GNK LCG + L PC
Sbjct: 637 QIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCS 696
Query: 386 ---AFKSHKQSMKKIWVVIVFPLLGTVALLISLIGLFFNFRQRKNGSQTQQSSPRNTLG- 441
+ KSHK + + + I+ P++G + +L G+F FR+R Q ++ + + G
Sbjct: 697 ITSSKKSHKD--RNLIIYILVPIIGAIIILSVCAGIFICFRKRTK--QIEEHTDSESGGE 752
Query: 442 LLSVLTFDGKIVHEEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDE 501
LS+ +FDGK+ ++EII+AT FD + IG GG G VYKAKLP I+ VKK +
Sbjct: 753 TLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLNETTDSS 811
Query: 502 MA---CQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSNDAAA 558
++ +QEFLNE+ ALT+IRHRN+VK +GFCSH ++F+VYEY+E GSL L ND A
Sbjct: 812 ISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEA 871
Query: 559 EQFCWTKRMNAIK 571
++ W KR+N +K
Sbjct: 872 KKLDWGKRINVVK 884
|
|
| TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 903 (322.9 bits), Expect = 1.5e-90, P = 1.5e-90
Identities = 200/491 (40%), Positives = 295/491 (60%)
Query: 90 PDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSI 149
P+ + + L ++ L N L G IP +L + +L+ NK +G I +F L+
Sbjct: 479 PETVCKGRKLQNISLDYNHLEGPIPKSLRDCKSLIRARFLGNKFTGDIFEAFGIYPDLNF 538
Query: 150 LYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGE 209
+ N I L L +S+N + G+IP + N+T ++ L LS+N++ GE
Sbjct: 539 IDFSHNKFHGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLVE-LDLSTNNLFGE 597
Query: 210 IPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLH 269
+P G L++L +L LN N+LSG++ L L LE LDLS+N F IP++ + +KLH
Sbjct: 598 LPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTFDSFLKLH 657
Query: 270 YLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGS 329
+NLS N+F IP ++ KL L++LDLSHN EIPSQ+ S+QSL+KL+LSHNNLSG
Sbjct: 658 DMNLSRNKFDGSIP-RLSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLSGL 716
Query: 330 IPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDI--KRLPPCKAF 387
IP FE M L+ +DIS N L+G +P++ FR A AL+ N LC +I +RL PC+
Sbjct: 717 IPTTFEGMIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSNIPKQRLKPCREL 776
Query: 388 KSHKQSMKKI-WVVIVFPLLGTVALLISLIGLF-FNFRQRK--NGSQTQQSSPRNTLGLL 443
K K++ + W+++ P+LG + +L F + R+RK NG T + N +
Sbjct: 777 KKPKKNGNLVVWILV--PILGVLVILSICANTFTYCIRKRKLQNGRNTDPETGEN----M 830
Query: 444 SVLTFDGKIVHEEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMA 503
S+ + DGK +++II +TN FD H IG GG VY+A L I+ VK+ H + +E++
Sbjct: 831 SIFSVDGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANLQD-TIIAVKRLHDTIDEEIS 889
Query: 504 ---CQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSNDAAAEQ 560
+QEFLNEV ALT+IRHRN+VK +GFCSH H+F++YEY+E GSL L+ND A++
Sbjct: 890 KPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKR 949
Query: 561 FCWTKRMNAIK 571
WTKR+N +K
Sbjct: 950 LTWTKRINVVK 960
|
|
| TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 641 (230.7 bits), Expect = 3.5e-62, P = 3.5e-62
Identities = 166/468 (35%), Positives = 253/468 (54%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANL 144
LY +IP+ IG M L LQL EN GSIP LG LV+LDLS+NKL+G++P + +
Sbjct: 323 LYGAIPEFIGEMPELEVLQLWENNFTGSIPQKLGENGRLVILDLSSNKLTGTLPPNMCSG 382
Query: 145 TSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSN 204
L L N L SIP +G SL+ + + N LNGSIP L L L + L N
Sbjct: 383 NRLMTLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKELFGLPK-LSQVELQDN 441
Query: 205 HIVGEIPL-GHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLS 263
++ GE+P+ G G+ L Q++L+NN+LSG L +G+L ++ L L N F SIP +
Sbjct: 442 YLTGELPISGGGVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSIPPEIG 501
Query: 264 NLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSH 323
L +L L+ S+N FS +I +I + L+ +DLS N +IP+++ M+ L LNLS
Sbjct: 502 RLQQLSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNLSR 561
Query: 324 NNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDIKRLPP 383
N+L GSIP M L+ +D SYN L GL+P++ F + GN LCG L P
Sbjct: 562 NHLVGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSHLCGPY--LGP 619
Query: 384 CK--AFKSHKQSMKKIW-VVIVFPLLGTVALLISLIGLFFNFRQRKNGSQTQQSSPRNTL 440
C +SH + + +++V LL +++ +++ + R +N S+ + L
Sbjct: 620 CGKGTHQSHVKPLSATTKLLLVLGLL-FCSMVFAIVAII-KARSLRNASEAKAWR----L 673
Query: 441 GLLSVLTFDGKIVHEEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPD 500
L F ++++ ++ + + IG GG G VYK +P G++V VK+ + +
Sbjct: 674 TAFQRLDF----TCDDVL---DSLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRL-ATMSH 725
Query: 501 EMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
+ F E+ L +IRHR+IV+ GFCS+ + +VYEY+ GSL
Sbjct: 726 GSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSL 773
|
|
| TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 628 (226.1 bits), Expect = 9.5e-61, P = 9.5e-61
Identities = 167/466 (35%), Positives = 246/466 (52%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANL 144
L+ IP+ IG++ L LQL EN GSIP LG L ++DLS+NKL+G++P + +
Sbjct: 323 LHGEIPEFIGDLPELEVLQLWENNFTGSIPQKLGENGKLNLVDLSSNKLTGTLPPNMCSG 382
Query: 145 TSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSN 204
L L N L SIP +G SL+ + + N LNGSIP L L +V L N
Sbjct: 383 NKLETLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKGLFGLPKLTQV-ELQDN 441
Query: 205 HIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSN 264
++ GE+P+ G+ +L Q++L+NN+LSG L P +G+ ++ L L N F IP +
Sbjct: 442 YLSGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTGVQKLLLDGNKFQGPIPSEVGK 501
Query: 265 LVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHN 324
L +L ++ S+N FS +I +I + L+ +DLS N EIP++I +M+ L LNLS N
Sbjct: 502 LQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPNEITAMKILNYLNLSRN 561
Query: 325 NLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDIKRLPPC 384
+L GSIP M L+ +D SYN L GL+P + F + GN LCG L PC
Sbjct: 562 HLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYTSFLGNPDLCGPY--LGPC 619
Query: 385 K--AFKSHKQSMKKIWVVIVFPLLGTVALLISLIGLFFNFRQRKNGSQTQQSSPRNTLGL 442
K K QS K + LL + LL+ I F K S + S R L
Sbjct: 620 KDGVAKGGHQSHSKGPLSASMKLLLVLGLLVCSIA-FAVVAIIKARSLKKASESR-AWRL 677
Query: 443 LSVLTFDGKIVHEEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEM 502
+ D ++++ ++ + + IG GG G VYK +P G++V VK+ + +
Sbjct: 678 TAFQRLD--FTCDDVL---DSLKEDNIIGKGGAGIVYKGVMPNGDLVAVKRL-AAMSRGS 731
Query: 503 ACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
+ F E+ L +IRHR+IV+ GFCS+ + +VYEY+ GSL
Sbjct: 732 SHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSL 777
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 629 (226.5 bits), Expect = 1.2e-60, P = 1.2e-60
Identities = 168/510 (32%), Positives = 257/510 (50%)
Query: 71 AHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLST 130
++FSVL + L IP ++L L L N L+G+IP L +L L L
Sbjct: 403 SNFSVLDMSANS--LSGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGD 460
Query: 131 NKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLA 190
N+L+GS+P+ NL +L+ L L++N L +I ++G + +L L L++N G IP +
Sbjct: 461 NQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIG 520
Query: 191 NLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLS 250
NLT + +SSN + G IP G ++ +L L+ N+ SG ++ ELG L+ LE L LS
Sbjct: 521 NLTKIVG-FNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLS 579
Query: 251 ANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLS-ELDLSHNIFREEIPSQ 309
N IP S +L +L L L N S+ IP ++ KL L L++SHN IP
Sbjct: 580 DNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDS 639
Query: 310 ICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQ 369
+ ++Q LE L L+ N LSG IP + L +IS N L G +P++ F+
Sbjct: 640 LGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFA 699
Query: 370 GNKRLCGDIKRLPPCKAFKSHKQSMKKIWVV----------IVFPLLGTVALLISLIGLF 419
GN LC + C+ H S K W++ I ++G+V LI+ +GL
Sbjct: 700 GNHGLCNSQRS--HCQPLVPHSDS-KLNWLINGSQRQKILTITCIVIGSV-FLITFLGLC 755
Query: 420 FNFRQRKNG--SQTQQSSPRNTLGLLSVLTFDGK-IVHEEIIRATNNFDDGHCIGNGGQG 476
+ ++R+ + Q+ P ++ F K ++ ++ AT NF + +G G G
Sbjct: 756 WTIKRREPAFVALEDQTKP----DVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGACG 811
Query: 477 SVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHS 536
+VYKA++ GE++ VKK +S + + F E++ L KIRHRNIVK YGFC H +
Sbjct: 812 TVYKAEMSGGEVIAVKKLNSR-GEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSN 870
Query: 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKR 566
++YEY+ GSL L W R
Sbjct: 871 LLLYEYMSKGSLGEQLQRGEKNCLLDWNAR 900
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 624 (224.7 bits), Expect = 6.8e-60, P = 6.8e-60
Identities = 170/473 (35%), Positives = 254/473 (53%)
Query: 88 SIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSL 147
SI G+ LS ++EN G IPL LG TNL L L N+ +G IP +F ++ L
Sbjct: 568 SISPLCGSSSYLS-FDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISEL 626
Query: 148 SILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIV 207
S+L + NSL IP E+G L+ +DL++N L+G IP L L L L LSSN V
Sbjct: 627 SLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLP-LLGELKLSSNKFV 685
Query: 208 GEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVK 267
G +P L++++ L L+ N L+G + E+G+L L L+L N +P ++ L K
Sbjct: 686 GSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSK 745
Query: 268 LHYLNLSNNQFSQKIPNKIEKLIHL-SELDLSHNIFREEIPSQICSMQSLEKLNLSHNNL 326
L L LS N + +IP +I +L L S LDLS+N F IPS I ++ LE L+LSHN L
Sbjct: 746 LFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQL 805
Query: 327 SGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDIKRLPPC-K 385
G +P +M L +++SYN L+G + + A A GN LCG L C +
Sbjct: 806 VGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQFSRWQAD--AFVGNAGLCGS--PLSHCNR 861
Query: 386 AFKSHKQSMKKIWVVIVFPL--LGTVALLISLIGLFFN-----FRQRKNGSQTQQSSPRN 438
A +++S+ VVI+ + L +AL++ +I LFF F++ + G+ S+ +
Sbjct: 862 AGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSS 921
Query: 439 TLG-LLSVLTFDGKIVHEEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSP 497
+ L S I ++I+ AT+ ++ IG+GG G VYKA+L GE + VKK
Sbjct: 922 SQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKIL-- 979
Query: 498 LPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALH--SFVVYEYLEMGSL 548
D++ + F EV L IRHR++VK G+CS + ++YEY+ GS+
Sbjct: 980 WKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSV 1032
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 621 (223.7 bits), Expect = 1.4e-59, P = 1.4e-59
Identities = 167/471 (35%), Positives = 253/471 (53%)
Query: 94 GNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLY 153
G+ LS ++ N IPL LGN NL L L N+L+G IP + + LS+L +
Sbjct: 573 GSSSYLS-FDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMS 631
Query: 154 ENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLG 213
N+L +IP ++ L+ +DL++N L+G IP L L+ L L LSSN V +P
Sbjct: 632 SNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQ-LGELKLSSNQFVESLPTE 690
Query: 214 HGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNL 273
+ L+ L+L+ N L+G + E+G+L L L+L N F S+P+++ L KL+ L L
Sbjct: 691 LFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRL 750
Query: 274 SNNQFSQKIPNKIEKLIHL-SELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPR 332
S N + +IP +I +L L S LDLS+N F +IPS I ++ LE L+LSHN L+G +P
Sbjct: 751 SRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPG 810
Query: 333 CFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDIKRLPPCKAFKSH-K 391
+M L +++S+N L G + F P + GN LCG L C +S+ K
Sbjct: 811 SVGDMKSLGYLNVSFNNLGGKLKKQ--FSRWPADSFLGNTGLCGS--PLSRCNRVRSNNK 866
Query: 392 Q---SMKKIWVVIVFPLLGTVALLISLIGLFFN-----FRQRKNGSQTQQSSPRNTLGLL 443
Q S + + ++ L + L+I +I LFF F++ +GS SS ++
Sbjct: 867 QQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATH 926
Query: 444 SVLTFDGK----IVHEEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLP 499
L +G I E+I+ AT+N + IG+GG G VYKA+L GE V VKK
Sbjct: 927 KPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKIL--WK 984
Query: 500 DEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALH--SFVVYEYLEMGSL 548
D++ + F EV L +IRHR++VK G+CS + ++YEY++ GS+
Sbjct: 985 DDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSI 1035
|
|
| TAIR|locus:2182855 ERL2 "ERECTA-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 613 (220.8 bits), Expect = 3.3e-59, P = 3.3e-59
Identities = 155/485 (31%), Positives = 247/485 (50%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANL 144
L IP+ IG M++L+ L LS+N L G IP LGNL+ L L NKL+G IP N+
Sbjct: 276 LTGRIPEVIGLMQALAVLDLSDNELTGPIPPILGNLSFTGKLYLHGNKLTGQIPPELGNM 335
Query: 145 TSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSN 204
+ LS L L +N L IP E+G + L L+L++N L G IP ++++ +L + N
Sbjct: 336 SRLSYLQLNDNELVGKIPPELGKLEQLFELNLANNNLVGLIPSNISSCA-ALNQFNVHGN 394
Query: 205 HIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSN 264
+ G +PL L SL L L++N G++ ELG +I L+ LDLS N F SIP +L +
Sbjct: 395 FLSGAVPLEFRNLGSLTYLNLSSNSFKGKIPAELGHIINLDTLDLSGNNFSGSIPLTLGD 454
Query: 265 LVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHN 324
L L LNLS N + +P + L + +D+S N IP+++ +Q++ L L++N
Sbjct: 455 LEHLLILNLSRNHLNGTLPAEFGNLRSIQIIDVSFNFLAGVIPTELGQLQNINSLILNNN 514
Query: 325 NLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCGD-IKRLPP 383
+ G IP L+ ++IS+N L G+IP F + GN LCG+ + +
Sbjct: 515 KIHGKIPDQLTNCFSLANLNISFNNLSGIIPPMKNFTRFSPASFFGNPFLCGNWVGSI-- 572
Query: 384 CKAFKSHKQSMKKIWVVIVFPLLGTVALLISLIGLFFNFRQRKNGSQTQQSSPRNTLGLL 443
C Q ++ V+ + +LG + L+ + + +Q+K + P + L+
Sbjct: 573 CGPSLPKSQVFTRVAVICM--VLGFITLICMIFIAVYKSKQQKPVLKGSSKQPEGSTKLV 630
Query: 444 SVLTFDGKI-VHEEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEM 502
+L D I ++I+R T N D+ + IG G +VYK T + +K+ ++ P
Sbjct: 631 -ILHMDMAIHTFDDIMRVTENLDEKYIIGYGASSTVYKCTSKTSRPIAIKRIYNQYPSNF 689
Query: 503 ACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSNDAAAEQFC 562
+EF E+ + IRHRNIV +G+ + + Y+Y+E GSL L +
Sbjct: 690 ---REFETELETIGSIRHRNIVSLHGYALSPFGNLLFYDYMENGSLWDLLHGPGKKVKLD 746
Query: 563 WTKRM 567
W R+
Sbjct: 747 WETRL 751
|
|
| TAIR|locus:2167948 ERL1 "ERECTA-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 611 (220.1 bits), Expect = 5.4e-59, P = 5.4e-59
Identities = 162/488 (33%), Positives = 252/488 (51%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANL 144
L IP+ IG M++L+ L LS+N L G IP LGNL+ L L N L+G IP N+
Sbjct: 274 LTGRIPEVIGLMQALAVLDLSDNELVGPIPPILGNLSFTGKLYLHGNMLTGPIPSELGNM 333
Query: 145 TSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSN 204
+ LS L L +N L +IP E+G + L L+L++N+L G IP ++++ +L + N
Sbjct: 334 SRLSYLQLNDNKLVGTIPPELGKLEQLFELNLANNRLVGPIPSNISSCA-ALNQFNVHGN 392
Query: 205 HIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSN 264
+ G IPL L SL L L++N G++ ELG +I L+ LDLS N F SIP +L +
Sbjct: 393 LLSGSIPLAFRNLGSLTYLNLSSNNFKGKIPVELGHIINLDKLDLSGNNFSGSIPLTLGD 452
Query: 265 LVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHN 324
L L LNLS N S ++P + L + +D+S N+ IP+++ +Q+L L L++N
Sbjct: 453 LEHLLILNLSRNHLSGQLPAEFGNLRSIQMIDVSFNLLSGVIPTELGQLQNLNSLILNNN 512
Query: 325 NLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAF-RDAPMLALQGNKRLCGD-IKRLP 382
L G IP L +++S+N L G++P F R AP + GN LCG+ + +
Sbjct: 513 KLHGKIPDQLTNCFTLVNLNVSFNNLSGIVPPMKNFSRFAPA-SFVGNPYLCGNWVGSI- 570
Query: 383 PCKAFKSHKQSMKKIWVVIVFPLLGTVALLISLIGLFFNFRQRKNGSQTQQSSPRNTLGL 442
C + + + IV LG + LL + + Q+K + Q S + GL
Sbjct: 571 -CGPLPKSRVFSRGALICIV---LGVITLLCMIFLAVYKSMQQK---KILQGSSKQAEGL 623
Query: 443 --LSVLTFDGKI-VHEEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLP 499
L +L D I ++I+R T N ++ IG G +VYK L + + +K+ ++ P
Sbjct: 624 TKLVILHMDMAIHTFDDIMRVTENLNEKFIIGYGASSTVYKCALKSSRPIAIKRLYNQYP 683
Query: 500 DEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSNDAAAE 559
+ +EF E+ + IRHRNIV +G+ + + Y+Y+E GSL L
Sbjct: 684 HNL---REFETELETIGSIRHRNIVSLHGYALSPTGNLLFYDYMENGSLWDLLHGSLKKV 740
Query: 560 QFCWTKRM 567
+ W R+
Sbjct: 741 KLDWETRL 748
|
|
| TAIR|locus:2154344 AT5G48940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 613 (220.8 bits), Expect = 7.4e-59, P = 7.4e-59
Identities = 167/506 (33%), Positives = 253/506 (50%)
Query: 78 FTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSI 137
F G L +IPDE+ ++L L LS+N L GS+P L L NL L L +N +SG I
Sbjct: 400 FLGWQNKLEGNIPDELAGCQNLQALDLSQNYLTGSLPAGLFQLRNLTKLLLISNAISGVI 459
Query: 138 PLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLK 197
PL N TSL L L N + IPK IG + +LS LDLS N L+G +PL ++N L+
Sbjct: 460 PLEIGNCTSLVRLRLVNNRITGEIPKGIGFLQNLSFLDLSENNLSGPVPLEISNC-RQLQ 518
Query: 198 VLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKS 257
+L LS+N + G +PL L+ L L +++N+L+G++ LG LI L L LS N+F+
Sbjct: 519 MLNLSNNTLQGYLPLSLSSLTKLQVLDVSSNDLTGKIPDSLGHLISLNRLILSKNSFNGE 578
Query: 258 IPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLS-ELDLSHNIFREEIPSQICSMQSL 316
IP SL + L L+LS+N S IP ++ + L L+LS N IP +I ++ L
Sbjct: 579 IPSSLGHCTNLQLLDLSSNNISGTIPEELFDIQDLDIALNLSWNSLDGFIPERISALNRL 638
Query: 317 EKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCG 376
L++SHN LSG + + L ++IS+N G +P+S FR ++GN LC
Sbjct: 639 SVLDISHNMLSGDLS-ALSGLENLVSLNISHNRFSGYLPDSKVFRQLIGAEMEGNNGLCS 697
Query: 377 DIKRLPPCKAFKSHKQSMKK-IW---VVIVFPLLGTVALLISLIGLFFNFRQRKNGSQTQ 432
K C S + + ++ + + I LL +V +++++G+ R ++
Sbjct: 698 --KGFRSCFVSNSSQLTTQRGVHSHRLRIAIGLLISVTAVLAVLGVLAVIRAKQMIRDDN 755
Query: 433 QSSPRNTLGLLSVLTFDG-KIVHEEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEIVDV 491
S L F E +++ +G+ IG G G VYKA++P E++ V
Sbjct: 756 DSETGENLWTWQFTPFQKLNFTVEHVLKC---LVEGNVIGKGCSGIVYKAEMPNREVIAV 812
Query: 492 KKFHS-PLPD------EMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLE 544
KK +P+ + F EV L IRH+NIV+F G C + ++Y+Y+
Sbjct: 813 KKLWPVTVPNLNEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYMS 872
Query: 545 MGSLAMNLSNDAAAEQFCWTKRMNAI 570
GSL L + W R I
Sbjct: 873 NGSLGSLLHERSGVCSLGWEVRYKII 898
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 571 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-66 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-47 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-47 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-46 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-32 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-19 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 8e-18 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-16 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-13 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-13 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-13 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-12 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-12 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 3e-12 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-12 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-11 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-11 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-11 | |
| pfam14223 | 119 | pfam14223, UBN2, gag-polypeptide of LTR copia-type | 7e-11 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-10 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-09 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-09 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-08 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-08 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-07 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-07 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-07 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-06 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-06 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-06 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-06 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-06 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-06 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-06 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-06 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-06 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 2e-05 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 2e-05 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-05 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-05 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-05 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-05 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-05 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-05 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-04 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-04 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-04 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-04 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-04 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-04 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-04 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-04 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-04 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-04 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-04 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-04 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-04 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-04 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-04 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-04 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-04 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-04 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-04 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 0.001 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 0.001 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 0.001 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 0.001 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 0.002 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 0.002 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 0.002 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 0.002 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 0.002 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 0.002 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 0.002 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 0.002 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 0.003 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 0.003 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 0.003 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 0.003 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 232 bits (593), Expect = 3e-66
Identities = 164/528 (31%), Positives = 244/528 (46%), Gaps = 81/528 (15%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANL 144
L IP I +++ L L LS+N L+G IP + L NL +L L +N +G IP++ +L
Sbjct: 272 LSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSL 331
Query: 145 TSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSN 204
L +L L+ N IPK +G N+L++LDLS+N L G IP L + N K L L SN
Sbjct: 332 PRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFK-LILFSN 390
Query: 205 HIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSL----------------------- 241
+ GEIP G SL ++ L +N SG+L E L
Sbjct: 391 SLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWD 450
Query: 242 -IQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHN 300
L+ L L+ N F +P+S +L L+LS NQFS +P K+ L L +L LS N
Sbjct: 451 MPSLQMLSLARNKFFGGLPDS-FGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSEN 509
Query: 301 IFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLI------ 354
EIP ++ S + L L+LSHN LSG IP F EM LS +D+S N L G I
Sbjct: 510 KLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGN 569
Query: 355 ------------------PNSTAFRDAPMLALQGNKRLCGDIKR--LPPCKAFKSHKQSM 394
P++ AF A+ GN LCG LPPCK +
Sbjct: 570 VESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK----- 624
Query: 395 KKIWVVIVFPLLGTVALLISLIGLFFNFRQRKNGSQTQQSSPRNTLGLLSVLTFDGK--- 451
W + LG L+++L+ F F + +N + ++ N G + FD K
Sbjct: 625 TPSWWFYITCTLG-AFLVLALVAFGFVFIRGRNNLELKRV--ENEDGTWELQFFDSKVSK 681
Query: 452 -IVHEEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEI----VDVKKFHSPLPDEMACQQ 506
I +I+ + + + I G +G+ YK K + ++ +S +P
Sbjct: 682 SITINDILSSLK---EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-IP------- 730
Query: 507 EFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSN 554
+E+ + K++H NIVK G C +++++EY+E +L+ L N
Sbjct: 731 --SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN 776
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 3e-47
Identities = 122/311 (39%), Positives = 166/311 (53%), Gaps = 30/311 (9%)
Query: 89 IPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLS 148
IP++IG+ SL L L N+L G IP +L NLT+L L L++N+L G IP + SL
Sbjct: 156 IPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLK 215
Query: 149 ILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVG 208
+YL N+L IP EIG + SL+ LDL N L G IP SL NL N L+ L+L N + G
Sbjct: 216 WIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKN-LQYLFLYQNKLSG 274
Query: 209 EIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKL 268
IP L LI L L++N LSG++ + L LE L L +N F IP +L++L +L
Sbjct: 275 PIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRL 334
Query: 269 HYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKL--------- 319
L L +N+FS +IP + K +L+ LDLS N EIP +CS +L KL
Sbjct: 335 QVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEG 394
Query: 320 ---------------NLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAP 364
L N+ SG +P F ++ + +DIS N LQG I ++ D P
Sbjct: 395 EIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRI--NSRKWDMP 452
Query: 365 ---MLALQGNK 372
ML+L NK
Sbjct: 453 SLQMLSLARNK 463
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 5e-47
Identities = 113/274 (41%), Positives = 150/274 (54%), Gaps = 4/274 (1%)
Query: 85 LYSSIPDEIGNM-KSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFAN 143
L IPD+I SL L LS N GSIP G++ NL LDLS N LSG IP +
Sbjct: 105 LSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGS 162
Query: 144 LTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSS 203
+SL +L L N L IP + N+ SL L L+SN+L G IP L + SLK +YL
Sbjct: 163 FSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQM-KSLKWIYLGY 221
Query: 204 NHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLS 263
N++ GEIP G L+SL L L N L+G + LG+L L+YL L N IP S+
Sbjct: 222 NNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIF 281
Query: 264 NLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSH 323
+L KL L+LS+N S +IP + +L +L L L N F +IP + S+ L+ L L
Sbjct: 282 SLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWS 341
Query: 324 NNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNS 357
N SG IP+ + + L+ +D+S N L G IP
Sbjct: 342 NKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEG 375
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 6e-46
Identities = 106/258 (41%), Positives = 137/258 (53%), Gaps = 4/258 (1%)
Query: 99 LSDLQLSENILNGSIPLALGNLT-NLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSL 157
+ + LS N L+G IP + + +L L+LS N +GSIP L L L N L
Sbjct: 95 IQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPN--LETLDLSNNML 152
Query: 158 CDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGML 217
IP +IG+ +SL +LDL N L G IP SL NLT SL+ L L+SN +VG+IP G +
Sbjct: 153 SGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLT-SLEFLTLASNQLVGQIPRELGQM 211
Query: 218 SSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQ 277
SL + L N LSG++ E+G L L +LDL N IP SL NL L YL L N+
Sbjct: 212 KSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNK 271
Query: 278 FSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEM 337
S IP I L L LDLS N EIP + +Q+LE L+L NN +G IP +
Sbjct: 272 LSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSL 331
Query: 338 HWLSCIDISYNALQGLIP 355
L + + N G IP
Sbjct: 332 PRLQVLQLWSNKFSGEIP 349
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 9e-32
Identities = 86/238 (36%), Positives = 123/238 (51%), Gaps = 4/238 (1%)
Query: 119 NLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNM-NSLSILDLS 177
N + +V +DLS +SG I + L + + L N L IP +I +SL L+LS
Sbjct: 67 NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126
Query: 178 SNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPE 237
+N GSIP L+ L LS+N + GEIP G SSL L L N L G++
Sbjct: 127 NNNFTGSIPRGSIPN---LETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNS 183
Query: 238 LGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDL 297
L +L LE+L L++N IP L + L ++ L N S +IP +I L L+ LDL
Sbjct: 184 LTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDL 243
Query: 298 SHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIP 355
+N IPS + ++++L+ L L N LSG IP + L +D+S N+L G IP
Sbjct: 244 VYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP 301
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 4e-19
Identities = 64/168 (38%), Positives = 89/168 (52%), Gaps = 7/168 (4%)
Query: 193 TNS--LKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLI-QLEYLDL 249
NS + + LS +I G+I L + + L+NN+LSG + ++ + L YL+L
Sbjct: 66 NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNL 125
Query: 250 SANTFHKSIPE-SLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPS 308
S N F SIP S+ N L L+LSNN S +IPN I L LDL N+ +IP+
Sbjct: 126 SNNNFTGSIPRGSIPN---LETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPN 182
Query: 309 QICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPN 356
+ ++ SLE L L+ N L G IPR +M L I + YN L G IP
Sbjct: 183 SLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPY 230
|
Length = 968 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 8e-18
Identities = 85/241 (35%), Positives = 121/241 (50%), Gaps = 10/241 (4%)
Query: 88 SIPDEIGNMKSLSDLQLSENILN--GSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLT 145
S D N+ +L L + LN S L LTNL LDL N ++ PL +
Sbjct: 81 SSLDGSENLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKS 140
Query: 146 SLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNH 205
+L L L +N + +P + N+ +L LDLS N L+ +P L+NL+N L L LS N
Sbjct: 141 NLKELDLSDNKIES-LPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSN-LNNLDLSGNK 197
Query: 206 IVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNL 265
I ++P +LS+L +L L+NN + +L L +L L L+LS N + +PES+ NL
Sbjct: 198 I-SDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKL-EDLPESIGNL 254
Query: 266 VKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNN 325
L L+LSNNQ S + + L +L ELDLS N +P + LE L
Sbjct: 255 SNLETLDLSNNQISS--ISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLT 312
Query: 326 L 326
L
Sbjct: 313 L 313
|
Length = 394 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 85/290 (29%), Positives = 136/290 (46%), Gaps = 13/290 (4%)
Query: 103 QLSENILNGSIPLALGNLTNLVVLDLSTNKL--SGSIPLSFANLTSLSILYLYENSLCDS 160
+L+ N+ + ++ L +L+ L+ LDL + S + NL L L L N L +
Sbjct: 49 RLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSN 108
Query: 161 IPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSL 220
I E+ + +L+ LDL +N + IP + L ++LK L LS N I +P L +L
Sbjct: 109 IS-ELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNL 165
Query: 221 IQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQ 280
L L+ N+LS L L +L L LDLS N +P + L L L+LSNN
Sbjct: 166 KNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNS-II 222
Query: 281 KIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWL 340
++ + + L +LS L+LS+N E++P I ++ +LE L+LS+N + S + L
Sbjct: 223 ELLSSLSNLKNLSGLELSNN-KLEDLPESIGNLSNLETLDLSNNQI--SSISSLGSLTNL 279
Query: 341 SCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDIKRLPPCKAFKSH 390
+D+S N+L +P L N L L ++
Sbjct: 280 RELDLSGNSLSNALPLIALLLLLL--ELLLNLLLTLKALELKLNSILLNN 327
|
Length = 394 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-16
Identities = 37/78 (47%), Positives = 51/78 (65%)
Query: 89 IPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLS 148
IP++I ++ L + LS N + G+IP +LG++T+L VLDLS N +GSIP S LTSL
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493
Query: 149 ILYLYENSLCDSIPKEIG 166
IL L NSL +P +G
Sbjct: 494 ILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 5e-16
Identities = 53/169 (31%), Positives = 80/169 (47%), Gaps = 10/169 (5%)
Query: 271 LNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSI 330
L L N IPN I KL HL ++LS N R IP + S+ SLE L+LS+N+ +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 331 PRCFEEMHWLSCIDISYNALQGLIPNSTAFR--DAPMLALQGNKRLCGDIKRLPPCKAFK 388
P ++ L ++++ N+L G +P + R N LCG I L C
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCG-IPGLRAC---G 538
Query: 389 SHKQSMKKIWVVIVFPLLGTVALLISLIGLFFNFRQRKNGSQTQQSSPR 437
H KI + +VA L +I +++R+N + Q+ + R
Sbjct: 539 PHLSVGAKIGIA----FGVSVAFLFLVICAMCWWKRRQNILRAQRIAAR 583
|
Length = 623 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 5e-15
Identities = 32/80 (40%), Positives = 43/80 (53%), Gaps = 3/80 (3%)
Query: 470 IGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYG 528
+G GG G+VY A+ TG+ V +K D + +E L E+ L K+ H NIVK YG
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKII--KKEDSSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 529 FCSHALHSFVVYEYLEMGSL 548
H ++V EY E GSL
Sbjct: 59 VFEDENHLYLVMEYCEGGSL 78
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-13
Identities = 37/86 (43%), Positives = 50/86 (58%), Gaps = 1/86 (1%)
Query: 126 LDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSI 185
L L L G IP + L L + L NS+ +IP +G++ SL +LDLS N NGSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 186 PLSLANLTNSLKVLYLSSNHIVGEIP 211
P SL LT SL++L L+ N + G +P
Sbjct: 483 PESLGQLT-SLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 3e-13
Identities = 27/84 (32%), Positives = 36/84 (42%), Gaps = 7/84 (8%)
Query: 470 IGNGGQGSVYKAKL-----PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIV 524
+G G G VYK L V VK ++ +EFL E + K+ H NIV
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQ--IEEFLREARIMRKLDHPNIV 64
Query: 525 KFYGFCSHALHSFVVYEYLEMGSL 548
K G C+ +V EY+ G L
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDL 88
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 3e-13
Identities = 28/84 (33%), Positives = 39/84 (46%), Gaps = 7/84 (8%)
Query: 470 IGNGGQGSVYKAKL-----PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIV 524
+G G G VYK KL V VK ++ +EFL E + K+ H N+V
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQ--IEEFLREARIMRKLDHPNVV 64
Query: 525 KFYGFCSHALHSFVVYEYLEMGSL 548
K G C+ ++V EY+E G L
Sbjct: 65 KLLGVCTEEEPLYIVMEYMEGGDL 88
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 8e-13
Identities = 36/91 (39%), Positives = 54/91 (59%)
Query: 99 LSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLC 158
+ L L L G IP + L +L ++LS N + G+IP S ++TSL +L L NS
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 159 DSIPKEIGNMNSLSILDLSSNKLNGSIPLSL 189
SIP+ +G + SL IL+L+ N L+G +P +L
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 1e-12
Identities = 30/87 (34%), Positives = 45/87 (51%), Gaps = 4/87 (4%)
Query: 464 FDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRN 522
F+ IG GG G VYKA+ TG+ V +K + +++ +NE+ L K +H N
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK---LESKEKKEKIINEIQILKKCKHPN 58
Query: 523 IVKFYGFCSHALHSFVVYEYLEMGSLA 549
IVK+YG ++V E+ GSL
Sbjct: 59 IVKYYGSYLKKDELWIVMEFCSGGSLK 85
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 2e-12
Identities = 25/86 (29%), Positives = 40/86 (46%), Gaps = 3/86 (3%)
Query: 464 FDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRN 522
++ +G G G VY A+ TG++V +K ++ L E+ L K++H N
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIK--KKKIKKDRERILREIKILKKLKHPN 58
Query: 523 IVKFYGFCSHALHSFVVYEYLEMGSL 548
IV+ Y ++V EY E G L
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDL 84
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 69/267 (25%), Positives = 96/267 (35%), Gaps = 48/267 (17%)
Query: 99 LSDLQLSENILN-GSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLT---SLSILYLYE 154
LS + S+ L L LDLS N L +L SL L L
Sbjct: 58 LSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNN 117
Query: 155 NSLCDSIPKEIG-----NMNSLSILDLSSNKLNGSIPLSLANL---TNSLKVLYLSSNHI 206
N L D + + +L L L N+L G+ +LA LK L L++N I
Sbjct: 118 NGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGI 177
Query: 207 VGE--IPLGHGM--LSSLIQLTLNNNEL----SGQLSPELGSLIQLEYLDLSAN------ 252
L G+ +L L LNNN L + L+ L SL LE L+L N
Sbjct: 178 GDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAG 237
Query: 253 --TFHKSIPESLSNLVKLHYLNLSNN--------QFSQKIPNKIEKLIHLSELDLSHNIF 302
++ +L+ L+LS N ++ + K L ELDL N F
Sbjct: 238 AAALASALLSPNISLLT---LSLSCNDITDDGAKDLAEVLAEKES----LLELDLRGNKF 290
Query: 303 REEIPSQICSMQ-----SLEKLNLSHN 324
EE + LE L + +
Sbjct: 291 GEEGAQLLAESLLEPGNELESLWVKDD 317
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 4e-12
Identities = 28/86 (32%), Positives = 41/86 (47%), Gaps = 11/86 (12%)
Query: 470 IGNGGQGSVYKAKL-----PTGEIVDVKKFHSPLPDEMACQQ--EFLNEVNALTKIRHRN 522
+G G G VYK L T V VK L + + ++ EFL E + + K+ H N
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKT----LKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 523 IVKFYGFCSHALHSFVVYEYLEMGSL 548
IV+ G C+ ++V EY+ G L
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDL 88
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 9e-12
Identities = 28/87 (32%), Positives = 40/87 (45%), Gaps = 2/87 (2%)
Query: 464 FDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRN 522
++ +G+G G+VYKAK TG+IV VK Q E+ L ++ H N
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSK-KDQTARREIRILRRLSHPN 59
Query: 523 IVKFYGFCSHALHSFVVYEYLEMGSLA 549
IV+ H ++V EY E G L
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLF 86
|
Length = 260 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 5e-11
Identities = 37/94 (39%), Positives = 53/94 (56%), Gaps = 1/94 (1%)
Query: 208 GEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVK 267
G IP L L + L+ N + G + P LGS+ LE LDLS N+F+ SIPESL L
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 268 LHYLNLSNNQFSQKIPNKI-EKLIHLSELDLSHN 300
L LNL+ N S ++P + +L+H + + + N
Sbjct: 492 LRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 6e-11
Identities = 29/88 (32%), Positives = 45/88 (51%), Gaps = 2/88 (2%)
Query: 463 NFDDGHCIGNGGQGSVYKA-KLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHR 521
N+ G IG G G VYK L TG+ V +K+ S + + + E++ L ++H
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQI-SLEKIKEEALKSIMQEIDLLKNLKHP 59
Query: 522 NIVKFYGFCSHALHSFVVYEYLEMGSLA 549
NIVK+ G + +++ EY E GSL
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLR 87
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 6e-11
Identities = 27/83 (32%), Positives = 40/83 (48%), Gaps = 6/83 (7%)
Query: 470 IGNGGQGSVYKAKL----PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVK 525
+G G G VYK KL V VK +E +++FL E + K+ H N+V+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEE--RKDFLKEARVMKKLGHPNVVR 60
Query: 526 FYGFCSHALHSFVVYEYLEMGSL 548
G C+ ++V EY+E G L
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDL 83
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|222605 pfam14223, UBN2, gag-polypeptide of LTR copia-type | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 7e-11
Identities = 20/70 (28%), Positives = 43/70 (61%), Gaps = 2/70 (2%)
Query: 1 MTVTDFLHSVKARTDELAILGAPMEEEDLIEKILDGLGDDYKELVRAV-QARDTS-ISFD 58
++ D+L + ++L LG + +ED++EKIL L + Y+++V ++ +++D S ++ +
Sbjct: 41 ESIDDYLDRLSEIVNKLRSLGEKISDEDVVEKILRSLPEKYEQIVTSIEESKDLSTLTLE 100
Query: 59 ELHEKLLTFE 68
EL +L E
Sbjct: 101 ELVGRLKAHE 110
|
This family is found in Plants and fungi, and contains LTR-polyproteins, or retrotransposons of the copia-type. Length = 119 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (149), Expect = 2e-10
Identities = 27/88 (30%), Positives = 43/88 (48%), Gaps = 8/88 (9%)
Query: 467 GHCIGNGGQGSVYKAKLP-TGEIVDVKK--FHSPLPDEMACQQEFLNEVNALTKIRHRNI 523
G +G G GSVY A TGE++ VK +E+ + E+ L+ ++H NI
Sbjct: 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEEL---EALEREIRILSSLQHPNI 61
Query: 524 VKFYGFCSHALHSF--VVYEYLEMGSLA 549
V++YG + + EY+ GSL+
Sbjct: 62 VRYYGSERDEEKNTLNIFLEYVSGGSLS 89
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 6e-10
Identities = 28/93 (30%), Positives = 46/93 (49%), Gaps = 11/93 (11%)
Query: 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH 520
++ + +G G G VYK + PTG+I +KK H + + +++ L E+ L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIH--VDGDEEFRKQLLRELKTLRSCES 58
Query: 521 RNIVKFYGFCSHALHS----FVVYEYLEMGSLA 549
+VK YG A + +V EY++ GSLA
Sbjct: 59 PYVVKCYG----AFYKEGEISIVLEYMDGGSLA 87
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 69/224 (30%), Positives = 104/224 (46%), Gaps = 38/224 (16%)
Query: 86 YSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLT 145
S+P + N+ +L +L LS N L+ +P L NL+NL LDLS NK+S
Sbjct: 152 IESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS----------- 199
Query: 146 SLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNH 205
+P EI +++L LDLS+N + + SL+NL N L L LS+N
Sbjct: 200 --------------DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKN-LSGLELSNNK 243
Query: 206 IVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNL 265
+ ++P G LS+L L L+NN++S LGSL L LDLS N+ ++P
Sbjct: 244 LE-DLPESIGNLSNLETLDLSNNQISS--ISSLGSLTNLRELDLSGNSLSNALPL----- 295
Query: 266 VKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQ 309
+ L L + + L+ + L++NI S
Sbjct: 296 --IALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGETSS 337
|
Length = 394 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 27/86 (31%), Positives = 42/86 (48%), Gaps = 8/86 (9%)
Query: 470 IGNGGQGSVYKAKL----PTGE--IVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNI 523
+G G G V+ + P + +V VK ++ +++F E LT +H NI
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDA--RKDFEREAELLTNFQHENI 70
Query: 524 VKFYGFCSHALHSFVVYEYLEMGSLA 549
VKFYG C+ +V+EY+E G L
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLN 96
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 31/107 (28%), Positives = 48/107 (44%), Gaps = 17/107 (15%)
Query: 469 CIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFY 527
IG G G+V K + G+I+ K+ E QQ ++EVN L +++H NIV++Y
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQ-LVSEVNILRELKHPNIVRYY 65
Query: 528 GFCSHALHS------FVVYEYLEMGSLAMNLS-----NDAAAEQFCW 563
+ ++V EY E G LA + E+F W
Sbjct: 66 ----DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW 108
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 31/89 (34%), Positives = 40/89 (44%), Gaps = 2/89 (2%)
Query: 470 IGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGF 529
IG G G VYK L V VK S LP ++ +++FL E L + H NIVK G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDL--KRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 530 CSHALHSFVVYEYLEMGSLAMNLSNDAAA 558
C ++V E + GSL L
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNR 89
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 42/124 (33%), Positives = 63/124 (50%), Gaps = 4/124 (3%)
Query: 250 SANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQ 309
S+ + +N ++ ++LS S KI + I +L ++ ++LS+N IP
Sbjct: 53 SSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDD 112
Query: 310 I-CSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTA-FRDAPMLA 367
I + SL LNLS+NN +GSIPR + L +D+S N L G IPN F +L
Sbjct: 113 IFTTSSSLRYLNLSNNNFTGSIPRGS--IPNLETLDLSNNMLSGEIPNDIGSFSSLKVLD 170
Query: 368 LQGN 371
L GN
Sbjct: 171 LGGN 174
|
Length = 968 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 1e-07
Identities = 29/94 (30%), Positives = 45/94 (47%), Gaps = 13/94 (13%)
Query: 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQE--FLNEVNALTK 517
+ + IG G G VYKA TG+ V +KK + Q + +NE+ +
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR------LRKQNKELIINEILIMKD 71
Query: 518 IRHRNIVKFYGFCSHAL--HSFVVYEYLEMGSLA 549
+H NIV +Y S+ + +VV EY++ GSL
Sbjct: 72 CKHPNIVDYYD--SYLVGDELWVVMEYMDGGSLT 103
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 29/84 (34%), Positives = 42/84 (50%), Gaps = 2/84 (2%)
Query: 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH 520
N ++ +G G G V K + TGEIV +KKF DE ++ L EV L ++RH
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDV-KKTALREVKVLRQLRH 59
Query: 521 RNIVKFYGFCSHALHSFVVYEYLE 544
NIV ++V+EY+E
Sbjct: 60 ENIVNLKEAFRRKGRLYLVFEYVE 83
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 57/201 (28%), Positives = 89/201 (44%), Gaps = 10/201 (4%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANL 144
S +P EI + +L +L LS N + + +L NL NL L+LS NKL +P S NL
Sbjct: 197 KISDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNL 254
Query: 145 TSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSN 204
++L L L N + +G++ +L LDLS N L+ ++PL L +L L
Sbjct: 255 SNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLT 312
Query: 205 HIVGEIPLGHGMLSSLI---QLTLNNNELSGQLSPELGSLIQLEYLDLSANTF---HKSI 258
E+ L +L++ I T + LS S + + + N + + +
Sbjct: 313 LKALELKLNSILLNNNILSNGETSSPEALSILESLNNLWTLDNALDESNLNRYIVKNPNA 372
Query: 259 PESLSNLVKLHYLNLSNNQFS 279
SL +LVK H L
Sbjct: 373 IGSLLDLVKKHVNQLLEKVNY 393
|
Length = 394 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 28/82 (34%), Positives = 38/82 (46%), Gaps = 5/82 (6%)
Query: 467 GHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKF 526
G IG G G V G+ V VK L D+ Q FL E + +T +RH N+V+
Sbjct: 11 GATIGKGEFGDVMLGDY-RGQKVAVKC----LKDDSTAAQAFLAEASVMTTLRHPNLVQL 65
Query: 527 YGFCSHALHSFVVYEYLEMGSL 548
G ++V EY+ GSL
Sbjct: 66 LGVVLQGNPLYIVTEYMAKGSL 87
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 9e-07
Identities = 25/85 (29%), Positives = 40/85 (47%), Gaps = 8/85 (9%)
Query: 470 IGNGGQGSVYKAKLPTGE------IVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNI 523
+G G G V+ AK E +V VK + Q EF E++ K+ H+N+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT--KDENLQSEFRRELDMFRKLSHKNV 70
Query: 524 VKFYGFCSHALHSFVVYEYLEMGSL 548
V+ G C A +++ EY ++G L
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDL 95
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 26/77 (33%), Positives = 39/77 (50%), Gaps = 2/77 (2%)
Query: 470 IGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYG 528
IG G G VYKA+ TGEIV +KK E + L E+ L ++ H NI+K
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTA-LREIKLLKELNHPNIIKLLD 65
Query: 529 FCSHALHSFVVYEYLEM 545
H ++V+E+++
Sbjct: 66 VFRHKGDLYLVFEFMDT 82
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (120), Expect = 1e-06
Identities = 27/81 (33%), Positives = 40/81 (49%), Gaps = 8/81 (9%)
Query: 469 CIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDE---MACQQEFLNEVNALTKIRHRNIV 524
+G G G VYKA+ TGEIV +KK +E L E++ L +++H NIV
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA----LREISLLKELKHPNIV 61
Query: 525 KFYGFCSHALHSFVVYEYLEM 545
K ++V+EY +M
Sbjct: 62 KLLDVIHTERKLYLVFEYCDM 82
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 30/84 (35%), Positives = 43/84 (51%), Gaps = 8/84 (9%)
Query: 470 IGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYG 528
IG+G G VYKA+ + TGE+V +K D+ Q E++ L + RH NIV ++G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQ---QEISMLKECRHPNIVAYFG 67
Query: 529 --FCSHALHSFVVYEYLEMGSLAM 550
L ++V EY GSL
Sbjct: 68 SYLRRDKL--WIVMEYCGGGSLQD 89
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 2e-06
Identities = 31/83 (37%), Positives = 43/83 (51%), Gaps = 12/83 (14%)
Query: 469 CIGNGGQGSVYKAK-LPTGEIVDVK----KFHSPLPDEMACQQEFLNEVNALTKI-RHRN 522
+G+G GSVY A+ TGE+V +K KF+S +E C L EV +L K+ H N
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEE--CMN--LREVKSLRKLNEHPN 59
Query: 523 IVKFYGFCSHALHSFVVYEYLEM 545
IVK + V+EY+E
Sbjct: 60 IVKLKEVFRENDELYFVFEYMEG 82
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 29/86 (33%), Positives = 43/86 (50%), Gaps = 6/86 (6%)
Query: 467 GHCIGNGGQGSVYKA-KLPTGEIVDVK--KFHSPLPDEMACQQEFLNEVNALTKIRHRNI 523
G+ IG G G VY A L TGE++ VK + P +E +E+ L ++H N+
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDP---KTIKEIADEMKVLELLKHPNL 61
Query: 524 VKFYGFCSHALHSFVVYEYLEMGSLA 549
VK+YG H ++ EY G+L
Sbjct: 62 VKYYGVEVHREKVYIFMEYCSGGTLE 87
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 26/95 (27%), Positives = 41/95 (43%), Gaps = 9/95 (9%)
Query: 470 IGNGGQGSVYKA--KLPTGEI--VDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVK 525
+G+G G V + G++ V VK S + +FL E + + H N+++
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSD--IMDDFLKEAAIMHSLDHENLIR 60
Query: 526 FYGFC-SHALHSFVVYEYLEMGSLAMNLSNDAAAE 559
YG +H L +V E +GSL L DA
Sbjct: 61 LYGVVLTHPL--MMVTELAPLGSLLDRLRKDALGH 93
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 29/85 (34%), Positives = 45/85 (52%), Gaps = 9/85 (10%)
Query: 470 IGNGGQGSVYKAKL----PTGE--IVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNI 523
+G G G V+ A+ PT + +V VK P +A +++F E LT ++H +I
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQHEHI 69
Query: 524 VKFYGFCSHALHSFVVYEYLEMGSL 548
VKFYG C +V+EY++ G L
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDL 94
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 49.0 bits (115), Expect = 4e-06
Identities = 26/80 (32%), Positives = 39/80 (48%), Gaps = 3/80 (3%)
Query: 470 IGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH-RNIVKFYG 528
+G G G VY A+ ++V +K L + + FL E+ L + H NIVK Y
Sbjct: 8 LGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 529 FCSHALHSFVVYEYLEMGSL 548
F ++V EY++ GSL
Sbjct: 66 FFQDEGSLYLVMEYVDGGSL 85
|
Length = 384 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 27/88 (30%), Positives = 40/88 (45%), Gaps = 14/88 (15%)
Query: 470 IGNGGQGSVYKAKL--PTGE-------IVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH 520
+G G G VYK +L P I +K+ P QQEF E ++ ++H
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP-----KVQQEFRQEAELMSDLQH 67
Query: 521 RNIVKFYGFCSHALHSFVVYEYLEMGSL 548
NIV G C+ + +++EYL G L
Sbjct: 68 PNIVCLLGVCTKEQPTCMLFEYLAHGDL 95
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 7e-06
Identities = 27/86 (31%), Positives = 38/86 (44%), Gaps = 13/86 (15%)
Query: 470 IGNGGQGSVYKAK-LPTGEIVDVKKFHSP-----LPDEMACQQEFLNEVNALTKIRHRNI 523
IG G G V+KAK TGE V +KK +P++ L E+ AL +H +
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQA------LREIKALQACQHPYV 61
Query: 524 VKFYGFCSHALHSFVVYEYLEMGSLA 549
VK H +V EY+ L+
Sbjct: 62 VKLLDVFPHGSGFVLVMEYM-PSDLS 86
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 61/199 (30%), Positives = 86/199 (43%), Gaps = 33/199 (16%)
Query: 158 CDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANL------TNSLKVLYLSSNHIVGEIP 211
++ + SL L LS N+ G IP L +L L+ L LS N + P
Sbjct: 40 AKALASALRPQPSLKELCLSLNET-GRIPRGLQSLLQGLTKGCGLQELDLSDNALG---P 95
Query: 212 LGHGMLSSLIQ------LTLNNNELSGQLSPELGSLIQ-----LEYLDLSANTFHKSIPE 260
G G+L SL++ L LNNN L + L ++ LE L L N + E
Sbjct: 96 DGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCE 155
Query: 261 SLSNLV----KLHYLNLSNNQFS-QKIPNKIEKLIHLSEL---DLSHNIFREEIPSQIC- 311
+L+ + L LNL+NN I E L L DL++N +E S +
Sbjct: 156 ALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAE 215
Query: 312 ---SMQSLEKLNLSHNNLS 327
S++SLE LNL NNL+
Sbjct: 216 TLASLKSLEVLNLGDNNLT 234
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 68/241 (28%), Positives = 117/241 (48%), Gaps = 19/241 (7%)
Query: 89 IPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLS-TNKLSGSIPLSFANL-TS 146
+P I + L DL +S +P + NL +L L+LS ++L SF ++ T+
Sbjct: 673 LPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLK-----SFPDISTN 726
Query: 147 LSILYLYENSLCDSIPKEI--GNMNSLSILDLSSNKLNGSI-PLS--LANLTNSLKVLYL 201
+S L L E ++ + P + N++ L + ++ S KL + PL+ + L+ SL L+L
Sbjct: 727 ISWLDLDETAI-EEFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFL 785
Query: 202 SSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPES 261
S + E+P L L L + N L P +L LE LDLS + ++ P+
Sbjct: 786 SDIPSLVELPSSIQNLHKLEHLEIENCINLETL-PTGINLESLESLDLSGCSRLRTFPDI 844
Query: 262 LSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNL 321
+N+ L NLS +++P IEK +LS LD++ + + I ++ LE ++
Sbjct: 845 STNISDL---NLSRTGI-EEVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDF 900
Query: 322 S 322
S
Sbjct: 901 S 901
|
syringae 6; Provisional. Length = 1153 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 26/88 (29%), Positives = 44/88 (50%), Gaps = 7/88 (7%)
Query: 467 GHCIGNGGQGSVYKA-KLPTGEIVDVKKFHSPLPDEMA----CQQEFLNEVNALTKIRHR 521
G +G+G GSVY+ L G+ VK+ L D+ ++ E+ L+K++H
Sbjct: 5 GELLGSGSFGSVYEGLNLDDGDFFAVKE--VSLADDGQTGQEAVKQLEQEIALLSKLQHP 62
Query: 522 NIVKFYGFCSHALHSFVVYEYLEMGSLA 549
NIV++ G + ++ E + GSLA
Sbjct: 63 NIVQYLGTEREEDNLYIFLELVPGGSLA 90
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 30/86 (34%), Positives = 43/86 (50%), Gaps = 10/86 (11%)
Query: 470 IGNGGQGSVYKAKLP-----TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIV 524
+G G GSV + TGE+V VKK + + ++F E+ L ++H NIV
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHL---RDFEREIEILKSLQHDNIV 68
Query: 525 KFYGFCSHA--LHSFVVYEYLEMGSL 548
K+ G C A + +V EYL GSL
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSL 94
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 27/71 (38%), Positives = 35/71 (49%), Gaps = 6/71 (8%)
Query: 460 ATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI 518
T F+ IG G G VYKA+ TG++V +K + DE ++E E N L K
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD-IIEDE---EEEIKEEYNILRKY 59
Query: 519 -RHRNIVKFYG 528
H NI FYG
Sbjct: 60 SNHPNIATFYG 70
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 7/101 (6%)
Query: 467 GHCIGNGGQGSVYKA-KLPTGEIVDVKKFHSPLPDEMACQQE------FLNEVNALTKIR 519
G IG+G GSVY +GE++ VK+ P + ++ E+ L +++
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 520 HRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSNDAAAEQ 560
H NIV++ G A H + EY+ GS+A L+N A E+
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEE 105
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 3e-05
Identities = 32/100 (32%), Positives = 51/100 (51%), Gaps = 8/100 (8%)
Query: 464 FDDGHCIGNGGQGSVYKA-KLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRN 522
FD +G G GSVYKA TG++V +K P+ +++ QE + E++ L +
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDL---QEIIKEISILKQCDSPY 59
Query: 523 IVKFYGFCSHALHSFVVYEYLEMGSL--AMNLSNDAAAEQ 560
IVK+YG ++V EY GS+ M ++N E+
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEE 99
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 5e-05
Identities = 20/58 (34%), Positives = 24/58 (41%)
Query: 243 QLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHN 300
L+ LDLS N + L L L+LS N + P L L LDLS N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
|
Length = 60 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 29/85 (34%), Positives = 45/85 (52%), Gaps = 9/85 (10%)
Query: 470 IGNGGQGSVYKAK----LPTGE--IVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNI 523
+G G G V+ A+ LP + +V VK E A +Q+F E LT ++H++I
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESA-RQDFQREAELLTVLQHQHI 69
Query: 524 VKFYGFCSHALHSFVVYEYLEMGSL 548
V+FYG C+ +V+EY+ G L
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDL 94
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (105), Expect = 9e-05
Identities = 25/81 (30%), Positives = 39/81 (48%), Gaps = 2/81 (2%)
Query: 470 IGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYG 528
IG G G VY + G++ +K+ E +++ LNEV L K+ H NI+K+Y
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSE-KEREDALNEVKILKKLNHPNIIKYYE 66
Query: 529 FCSHALHSFVVYEYLEMGSLA 549
+V EY + G L+
Sbjct: 67 SFEEKGKLCIVMEYADGGDLS 87
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 1e-04
Identities = 20/60 (33%), Positives = 30/60 (50%)
Query: 291 HLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNAL 350
+L LDLS+N + +L+ L+LS NNL+ P F + L +D+S N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 1e-04
Identities = 26/60 (43%), Positives = 31/60 (51%)
Query: 98 SLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSL 157
+L L LS N L A L NL VLDLS N L+ P +F+ L SL L L N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 26/86 (30%), Positives = 37/86 (43%), Gaps = 9/86 (10%)
Query: 470 IGNGGQGSVYKAKLP-----TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIV 524
+G G G V + TGE V VK + + + +F E+ L + H NIV
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIV 69
Query: 525 KFYGFC--SHALHSFVVYEYLEMGSL 548
K+ G C ++ EYL GSL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSL 95
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 28/84 (33%), Positives = 40/84 (47%), Gaps = 10/84 (11%)
Query: 470 IGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR---HRNIVK 525
IG G G+VYKA+ L TG V +KK PL E L E+ L ++ H NIV+
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPL-SEEGIPLSTLREIALLKQLESFEHPNIVR 65
Query: 526 FYGFC-----SHALHSFVVYEYLE 544
C L +V+E+++
Sbjct: 66 LLDVCHGPRTDRELKLTLVFEHVD 89
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 24/79 (30%), Positives = 43/79 (54%), Gaps = 3/79 (3%)
Query: 470 IGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGF 529
+G+G G V++ V +K S D++ QQ+F EV AL ++RH++++ +
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKS---DDLLKQQDFQKEVQALKRLRHKHLISLFAV 70
Query: 530 CSHALHSFVVYEYLEMGSL 548
CS +++ E +E GSL
Sbjct: 71 CSVGEPVYIITELMEKGSL 89
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 26/77 (33%), Positives = 36/77 (46%), Gaps = 2/77 (2%)
Query: 470 IGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGF 529
+G G G V+K L V VK LP E+ + FL+E L + H NIVK G
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK--FLSEARILKQYDHPNIVKLIGV 60
Query: 530 CSHALHSFVVYEYLEMG 546
C+ ++V E + G
Sbjct: 61 CTQRQPIYIVMELVPGG 77
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 8/98 (8%)
Query: 470 IGNGGQGSVYKAK-LPTGEIVDVKKFHSPLP-DEMACQQEFLNEVNALTKIRH---RNIV 524
IG G G+VY+ K +PTG +V +K + P D+++ Q EV L+++R NI
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQR---EVALLSQLRQSQPPNIT 65
Query: 525 KFYGFCSHALHSFVVYEYLEMGSLAMNLSNDAAAEQFC 562
K+YG +++ EY E GS+ + AE++
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYI 103
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 2e-04
Identities = 29/82 (35%), Positives = 45/82 (54%), Gaps = 12/82 (14%)
Query: 470 IGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEF----LNEVNALTKIRHRNIV 524
IG G G VYKA+ TGE+V +KK + +E ++ F + E+ L K+RH NIV
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKI--RMENE---KEGFPITAIREIKLLQKLRHPNIV 61
Query: 525 KFYGFC-SHALHS-FVVYEYLE 544
+ S S ++V+EY++
Sbjct: 62 RLKEIVTSKGKGSIYMVFEYMD 83
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 23/86 (26%), Positives = 44/86 (51%), Gaps = 3/86 (3%)
Query: 467 GHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLN---EVNALTKIRHRNI 523
G +G G G+VY G+++ VK+ + +A ++E+ EV+ L ++H NI
Sbjct: 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 524 VKFYGFCSHALHSFVVYEYLEMGSLA 549
V++ G C + E++ GS++
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSIS 90
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 16/56 (28%), Positives = 26/56 (46%)
Query: 506 QEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSNDAAAEQF 561
++FL EV L+++ NI + G C+ ++ EY+E G L L A
Sbjct: 64 EDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSG 119
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 15/44 (34%), Positives = 25/44 (56%)
Query: 505 QQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
+ +F+ E + K+ H N+V+ YG C+ F+V EY+ G L
Sbjct: 43 EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCL 86
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 23/88 (26%), Positives = 35/88 (39%), Gaps = 14/88 (15%)
Query: 470 IGNGGQGSVYKAKLPTGEIVDVKKFHSPLP------DEMACQQ---EFLNEVNALTKIRH 520
+G+G G VY+ G L E +Q +FL E ++K H
Sbjct: 14 LGHGAFGEVYE-----GLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNH 68
Query: 521 RNIVKFYGFCSHALHSFVVYEYLEMGSL 548
+NIV+ G L F++ E + G L
Sbjct: 69 QNIVRLIGVSFERLPRFILLELMAGGDL 96
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 25/89 (28%), Positives = 39/89 (43%), Gaps = 3/89 (3%)
Query: 470 IGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYG 528
IG G G V+ +L V VK LP ++ + +FL E L + H NIV+ G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDL--KAKFLQEARILKQYSHPNIVRLIG 60
Query: 529 FCSHALHSFVVYEYLEMGSLAMNLSNDAA 557
C+ ++V E ++ G L +
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGP 89
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 29/104 (27%), Positives = 48/104 (46%), Gaps = 10/104 (9%)
Query: 470 IGNGGQGSVYKA--KLPTGEIVDV--KKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVK 525
IG G G V + KLP + +DV K + D+ +FL E + + + H NI++
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL--DFLTEASIMGQFDHPNIIR 69
Query: 526 FYGFCSHALHSFVVYEYLEMGSLAMNL-SNDAAAEQFCWTKRMN 568
G + + ++ EY+E GSL L ND +F + +
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLREND---GKFTVGQLVG 110
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 24/82 (29%), Positives = 39/82 (47%), Gaps = 5/82 (6%)
Query: 468 HCIGNGGQGSVYKAKLPT-GEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKF 526
H +G G G VY+ V VK D M + EFL E + +I+H N+V+
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVE-EFLKEAAVMKEIKHPNLVQL 67
Query: 527 YGFCSHALHSFVVYEYLEMGSL 548
G C+ +++ E++ G+L
Sbjct: 68 LGVCTREPPFYIITEFMTYGNL 89
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 24/77 (31%), Positives = 39/77 (50%), Gaps = 2/77 (2%)
Query: 470 IGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYG 528
IG G G VYKA+ T E + +KK DE + E++ L +++H NIV+
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDE-GVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 529 FCSHALHSFVVYEYLEM 545
++V+EYL++
Sbjct: 69 VVHSEKRLYLVFEYLDL 85
|
Length = 294 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 21/102 (20%), Positives = 47/102 (46%), Gaps = 4/102 (3%)
Query: 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKF---HSPLPDEMACQQEFLNEVNALTKI 518
+ G +G G S Y+A+ + TG ++ VK+ + ++ + E+ + ++
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 519 RHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSNDAAAEQ 560
H +I++ G H + E++ GS++ LS A ++
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE 102
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 28/81 (34%), Positives = 40/81 (49%), Gaps = 3/81 (3%)
Query: 470 IGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYG 528
+G G G V K PTG+I+ VK +E A Q++ L E++ L K IV FYG
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLE-INE-AIQKQILRELDILHKCNSPYIVGFYG 66
Query: 529 FCSHALHSFVVYEYLEMGSLA 549
+ + EY++ GSL
Sbjct: 67 AFYNNGDISICMEYMDGGSLD 87
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 28/81 (34%), Positives = 43/81 (53%), Gaps = 10/81 (12%)
Query: 470 IGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYG 528
IG G G VYKA+ TGEIV +KK DE + E++ L ++ H NIV+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDE-GVPSTAIREISLLKELNHPNIVRLL- 64
Query: 529 FCSHALHS----FVVYEYLEM 545
+HS ++V+E+L++
Sbjct: 65 ---DVVHSENKLYLVFEFLDL 82
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 6e-04
Identities = 33/106 (31%), Positives = 49/106 (46%), Gaps = 16/106 (15%)
Query: 459 RATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQE-----FLNEV 512
R+ F+ + IG G G VY+A+ +GEIV +KK M +++ L E+
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKV------RMDNERDGIPISSLREI 57
Query: 513 NALTKIRHRNIVKFYGFC--SHALHSFVVYEYLE--MGSLAMNLSN 554
L +RH NIV+ H F+V EY E + SL N+
Sbjct: 58 TLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPT 103
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 7e-04
Identities = 25/90 (27%), Positives = 39/90 (43%), Gaps = 3/90 (3%)
Query: 462 NNFDDGHCIGNGGQGSVYKA-KLPTGEIVDVKKFH-SPLPDEMACQQEFL-NEVNALTKI 518
N+ G +G G G VY + TG + VK+ P E + L E+ L +
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 519 RHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
+H IV++YG + EY+ GS+
Sbjct: 62 QHERIVQYYGCLRDDETLSIFMEYMPGGSV 91
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 8e-04
Identities = 31/91 (34%), Positives = 38/91 (41%), Gaps = 23/91 (25%)
Query: 470 IGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEF---LNEVNALTKIRHRNIVK 525
IG G VY A LP E V +K+ D CQ EV A+++ H N+VK
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRI-----DLEKCQTSVDELRKEVQAMSQCNHPNVVK 63
Query: 526 FYGFCSHALHSFV-------VYEYLEMGSLA 549
+Y SFV V YL GSL
Sbjct: 64 YYT-------SFVVGDELWLVMPYLSGGSLL 87
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.001
Identities = 21/57 (36%), Positives = 27/57 (47%), Gaps = 2/57 (3%)
Query: 223 LTLNNNELSGQLSPE-LGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQF 278
L L+NN L+ + L L+ LDLS N PE+ S L L L+LS N
Sbjct: 5 LDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.001
Identities = 22/62 (35%), Positives = 31/62 (50%), Gaps = 3/62 (4%)
Query: 146 SLSILYLYENSLCDSIPKEI-GNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSN 204
+L L L N L IP + +L +LDLS N L P + + L SL+ L LS N
Sbjct: 1 NLKSLDLSNNRL-TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLP-SLRSLDLSGN 58
Query: 205 HI 206
++
Sbjct: 59 NL 60
|
Length = 60 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.001
Identities = 23/86 (26%), Positives = 37/86 (43%), Gaps = 8/86 (9%)
Query: 470 IGNGGQGSVYK---AKLPTGEI---VDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNI 523
+G G G VY+ + GE V +K + M + EFLNE + + + ++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN--ASMRERIEFLNEASVMKEFNCHHV 71
Query: 524 VKFYGFCSHALHSFVVYEYLEMGSLA 549
V+ G S + VV E + G L
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLK 97
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 14/44 (31%), Positives = 24/44 (54%)
Query: 505 QQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
+ EF+ E + K+ H +V+ YG C+ ++V EY+ G L
Sbjct: 43 EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL 86
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.001
Identities = 26/86 (30%), Positives = 38/86 (44%), Gaps = 4/86 (4%)
Query: 470 IGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGF 529
+G G G V+ V VK P M+ + FL E + K+RH +V+ Y
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLK---PGTMS-PEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 530 CSHALHSFVVYEYLEMGSLAMNLSND 555
CS ++V EY+ GSL L +
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSG 95
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 33/92 (35%), Positives = 44/92 (47%), Gaps = 14/92 (15%)
Query: 463 NFDDGHCIGNGGQGSVYKA-KLPTGEIVDVKKFHSPLPDEMACQQ--EFL-NEVNALTKI 518
D+ IG G G V A TG V VKK ++ QQ E L NEV +
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKM------DLRKQQRRELLFNEVVIMRDY 73
Query: 519 RHRNIVKFYGFCSHALHS--FVVYEYLEMGSL 548
+H NIV+ Y S+ + +VV E+LE G+L
Sbjct: 74 QHPNIVEMYS--SYLVGDELWVVMEFLEGGAL 103
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.002
Identities = 26/81 (32%), Positives = 38/81 (46%), Gaps = 5/81 (6%)
Query: 469 CIGNGGQGSVYKAKL---PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVK 525
CIG G G VYKAK G+ +KKF Q E+ L +++H N+V
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 526 FYG-FCSHALHS-FVVYEYLE 544
F HA S +++++Y E
Sbjct: 67 LVEVFLEHADKSVYLLFDYAE 87
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.002
Identities = 17/44 (38%), Positives = 27/44 (61%)
Query: 505 QQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
+++F E LT ++H +IVKFYG C +V+EY++ G L
Sbjct: 51 RKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDL 94
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 27/81 (33%), Positives = 43/81 (53%), Gaps = 3/81 (3%)
Query: 464 FDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRN 522
F D IG+G G+VY A+ + T E+V +KK Q+ + EV L ++RH N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 523 IVKFYGFCSHALHS-FVVYEY 542
+++ G C H+ ++V EY
Sbjct: 77 TIEYKG-CYLREHTAWLVMEY 96
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 27/83 (32%), Positives = 40/83 (48%), Gaps = 7/83 (8%)
Query: 471 GNGGQGSVYK---AKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFY 527
G+ G+ S+Y A TGE+V VK + + E+N L + H NIVK+
Sbjct: 15 GHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQN--TSGWKKEINILKTLYHENIVKYK 72
Query: 528 GFCSHALHSFV--VYEYLEMGSL 548
G CS + + EY+ +GSL
Sbjct: 73 GCCSEQGGKGLQLIMEYVPLGSL 95
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.002
Identities = 25/85 (29%), Positives = 41/85 (48%), Gaps = 11/85 (12%)
Query: 470 IGNGGQGSVYKA--KLPTGEIVDV--KKFHSPLPDEMACQ-QEFLNEVNALTKIRHRNIV 524
+G+G GSV K + +G+ V+V K + +A +EFL E + + ++ H IV
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLK---QEHIAAGKKEFLREASVMAQLDHPCIV 59
Query: 525 KFYGFC-SHALHSFVVYEYLEMGSL 548
+ G C L +V E +G L
Sbjct: 60 RLIGVCKGEPL--MLVMELAPLGPL 82
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 27/82 (32%), Positives = 39/82 (47%), Gaps = 2/82 (2%)
Query: 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHR 521
NF IG G G VYKA+ TGE+V +KK E + E++ L ++ H
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHP 59
Query: 522 NIVKFYGFCSHALHSFVVYEYL 543
NIVK ++V+E+L
Sbjct: 60 NIVKLLDVIHTENKLYLVFEFL 81
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 29/83 (34%), Positives = 42/83 (50%), Gaps = 9/83 (10%)
Query: 467 GHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKF 526
G IG G G+V + + TG+ V VK D A Q FL E +TK+ H+N+V+
Sbjct: 11 GEIIGEGEFGAVLQGEY-TGQKVAVKNIKC---DVTA--QAFLEETAVMTKLHHKNLVRL 64
Query: 527 YGFCSH-ALHSFVVYEYLEMGSL 548
G H L+ +V E + G+L
Sbjct: 65 LGVILHNGLY--IVMELMSKGNL 85
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 29/80 (36%), Positives = 42/80 (52%), Gaps = 10/80 (12%)
Query: 470 IGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYG 528
IG G G+V+KAK T EIV +K+ DE L E+ L +++H+NIV+ Y
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLY- 65
Query: 529 FCSHALHS----FVVYEYLE 544
LHS +V+EY +
Sbjct: 66 ---DVLHSDKKLTLVFEYCD 82
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 70/264 (26%), Positives = 106/264 (40%), Gaps = 41/264 (15%)
Query: 101 DLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDS 160
DL+ S+N+ IP L TNL L LS +P S L L L + +
Sbjct: 640 DLRGSKNLK--EIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEI 696
Query: 161 IPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSL 220
+P I N+ SL L+LS S P +++ ++ L L I E P S+L
Sbjct: 697 LPTGI-NLKSLYRLNLSGCSRLKSFP----DISTNISWLDLDETAI-EEFP------SNL 744
Query: 221 IQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQ 280
L+ L S +L +Q + SL+ L LS+
Sbjct: 745 RLENLDELILCEMKSEKLWERVQP------LTPLMTMLSPSLTRLF------LSDIPSLV 792
Query: 281 KIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWL 340
++P+ I+ L L L++ + I E +P+ I +++SLE L+LS S R F
Sbjct: 793 ELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSG----CSRLRTFP----- 842
Query: 341 SCIDISYNALQGLIPNSTAFRDAP 364
DIS N L + T + P
Sbjct: 843 ---DISTNISD-LNLSRTGIEEVP 862
|
syringae 6; Provisional. Length = 1153 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 20/79 (25%), Positives = 39/79 (49%), Gaps = 4/79 (5%)
Query: 470 IGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGF 529
+G+G G V+ K V +K + + +++F+ E + K+ H +V+ YG
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAIN----EGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 530 CSHALHSFVVYEYLEMGSL 548
C+ ++V E++E G L
Sbjct: 68 CTQQKPLYIVTEFMENGCL 86
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 26/85 (30%), Positives = 39/85 (45%), Gaps = 8/85 (9%)
Query: 470 IGNGGQGSVYKAK----LPTGE--IVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNI 523
IG G G V++A+ LP +V VK +M Q +F E + + H NI
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM--QADFQREAALMAEFDHPNI 70
Query: 524 VKFYGFCSHALHSFVVYEYLEMGSL 548
VK G C+ +++EY+ G L
Sbjct: 71 VKLLGVCAVGKPMCLLFEYMAYGDL 95
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.003
Identities = 25/81 (30%), Positives = 38/81 (46%), Gaps = 3/81 (3%)
Query: 470 IGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYG- 528
+G G GSV K +L ++ K + P+ Q++ L E+ + IVK+YG
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDL-QKQILRELEINKSCKSPYIVKYYGA 67
Query: 529 FCSHALHSF-VVYEYLEMGSL 548
F + S + EY E GSL
Sbjct: 68 FLDESSSSIGIAMEYCEGGSL 88
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 21/80 (26%), Positives = 37/80 (46%), Gaps = 4/80 (5%)
Query: 470 IGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGF 529
IG+G G V+ V +K E ++F+ E + K+ H +V+ YG
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE----EDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 530 CSHALHSFVVYEYLEMGSLA 549
C+ +V+E++E G L+
Sbjct: 68 CTERSPICLVFEFMEHGCLS 87
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 571 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.97 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.94 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.94 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.93 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.9 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.89 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.88 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.88 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.86 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.86 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.86 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.86 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.85 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.82 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.81 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.81 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.78 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.77 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 99.73 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.72 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.63 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.62 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.59 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.57 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.56 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.56 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.54 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.54 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.53 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.53 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.5 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.48 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.47 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.45 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.42 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.41 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.41 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.41 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.41 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.41 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.39 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.39 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.39 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.38 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.38 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.38 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.38 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.38 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.37 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.37 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.37 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.36 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.36 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.36 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.36 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.35 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.35 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.34 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.34 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.34 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.34 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.34 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.33 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.33 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.33 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.33 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.32 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.32 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.31 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.31 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.31 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.31 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.31 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.31 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.31 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.31 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.31 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.3 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.3 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.3 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.3 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.3 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.3 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.3 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.3 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.3 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.3 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.3 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.3 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.29 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.29 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.29 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.29 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.29 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.29 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.29 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.28 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.28 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.28 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.28 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.27 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.27 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.27 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.27 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.27 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.27 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.27 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.27 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.27 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.27 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.27 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.27 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.26 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.26 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.26 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.25 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.25 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.25 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.25 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.25 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.25 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.25 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.24 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.24 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.24 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.24 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.24 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.24 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.24 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.23 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.23 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.23 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.23 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.23 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.23 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.22 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.22 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.22 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.22 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.22 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.22 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.22 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.22 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.22 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.22 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.22 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.22 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.21 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.21 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.21 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.21 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.21 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.21 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.21 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.21 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.21 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.21 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.21 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.21 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.21 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.21 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.21 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.2 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.2 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.2 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.2 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.2 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.2 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.2 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.2 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.2 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.19 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.19 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.19 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.19 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.19 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.19 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.19 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.19 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.19 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.18 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.18 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.18 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.18 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.18 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.18 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.18 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.18 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.18 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.18 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.18 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.18 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.18 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.18 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.18 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.18 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.18 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.18 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.18 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.18 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.17 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.17 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.17 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.17 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.17 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.17 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.17 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.17 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.17 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.17 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.17 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.16 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.16 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.16 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.16 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.16 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.16 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.15 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.15 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.15 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.15 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.15 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.15 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.15 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.15 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.15 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.15 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.15 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.15 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.15 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.15 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.14 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.14 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.14 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.14 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.14 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.14 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.14 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.14 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.14 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.13 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.13 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.13 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.13 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.13 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.13 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.13 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.13 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.13 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.13 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.13 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.13 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.12 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.12 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.12 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.12 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.12 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.12 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.12 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.12 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.12 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.12 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.11 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.11 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.11 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.11 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.11 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.11 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.11 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.11 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.11 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.1 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.1 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.1 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.1 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.1 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.1 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.1 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.1 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.1 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.1 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.1 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.09 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.09 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.09 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.09 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.09 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.08 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.08 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.08 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.08 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.08 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.08 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.07 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.07 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.07 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.07 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.07 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.06 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.06 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.06 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.06 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.06 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.06 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.06 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.06 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.06 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.06 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.06 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.06 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.05 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.05 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.05 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.05 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.05 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.05 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.04 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.04 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.04 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.04 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.04 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.04 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.04 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.04 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.04 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.03 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.03 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.03 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.03 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.03 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.02 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.01 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.01 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.01 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.01 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.01 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.01 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.01 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.01 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.01 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 98.99 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 98.99 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 98.99 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 98.99 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 98.98 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 98.98 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.98 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 98.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 98.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 98.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 98.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 98.97 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.96 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 98.96 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 98.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 98.96 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 98.96 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 98.96 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 98.96 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 98.95 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.95 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 98.95 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 98.94 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 98.94 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 98.94 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 98.94 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 98.93 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 98.93 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 98.93 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 98.92 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 98.92 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 98.91 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 98.9 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.9 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 98.89 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 98.89 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 98.89 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.88 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 98.88 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 98.87 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 98.86 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 98.86 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.85 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.85 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 98.85 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 98.85 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 98.85 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 98.85 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 98.85 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 98.83 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 98.83 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 98.83 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 98.82 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 98.82 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 98.82 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 98.82 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 98.81 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 98.81 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 98.81 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 98.8 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 98.8 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 98.79 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 98.79 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 98.79 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 98.78 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 98.77 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 98.77 | |
| PTZ00284 | 467 | protein kinase; Provisional | 98.76 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.75 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 98.74 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 98.73 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 98.72 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 98.71 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 98.66 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 98.65 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 98.62 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 98.62 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 98.6 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 98.59 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 98.57 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 98.56 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 98.56 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 98.55 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 98.54 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 98.53 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.53 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.52 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.52 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.49 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 98.47 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 98.43 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.42 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 98.36 | |
| KOG2120 | 419 | consensus SCF ubiquitin ligase, Skp2 component [Po | 98.36 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 98.34 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 98.33 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 98.33 | |
| smart00090 | 237 | RIO RIO-like kinase. | 98.23 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.22 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.09 | |
| KOG2120 | 419 | consensus SCF ubiquitin ligase, Skp2 component [Po | 98.07 | |
| PRK15386 | 426 | type III secretion protein GogB; Provisional | 98.05 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.03 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 98.03 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 98.01 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 97.98 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 97.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 97.96 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 97.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 97.93 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 97.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 97.92 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 97.92 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 97.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 97.83 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.82 | |
| KOG1644 | 233 | consensus U2-associated snRNP A' protein [RNA proc | 97.82 | |
| KOG1644 | 233 | consensus U2-associated snRNP A' protein [RNA proc | 97.77 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 97.76 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 97.75 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 97.73 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 97.72 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 97.72 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 97.71 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 97.68 | |
| PRK15386 | 426 | type III secretion protein GogB; Provisional | 97.67 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 97.67 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 97.66 | |
| KOG3665 | 699 | consensus ZYG-1-like serine/threonine protein kina | 97.64 | |
| KOG3665 | 699 | consensus ZYG-1-like serine/threonine protein kina | 97.59 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 97.46 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 97.41 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 97.38 | |
| PF13306 | 129 | LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_ | 97.37 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 97.36 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 97.35 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 97.29 | |
| PF13306 | 129 | LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_ | 97.19 | |
| KOG2739 | 260 | consensus Leucine-rich acidic nuclear protein [Cel | 97.11 | |
| KOG2739 | 260 | consensus Leucine-rich acidic nuclear protein [Cel | 96.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 96.82 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 96.76 | |
| KOG2123 | 388 | consensus Uncharacterized conserved protein [Funct | 96.64 | |
| KOG2123 | 388 | consensus Uncharacterized conserved protein [Funct | 96.46 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 96.17 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 95.95 | |
| KOG1947 | 482 | consensus Leucine rich repeat proteins, some prote | 95.6 | |
| PF00560 | 22 | LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le | 95.25 | |
| KOG4341 | 483 | consensus F-box protein containing LRR [General fu | 95.14 | |
| PF00560 | 22 | LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le | 95.0 | |
| KOG1947 | 482 | consensus Leucine rich repeat proteins, some prote | 94.93 | |
| KOG4308 | 478 | consensus LRR-containing protein [Function unknown | 94.73 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-56 Score=509.62 Aligned_cols=500 Identities=31% Similarity=0.451 Sum_probs=339.5
Q ss_pred CCchhhcCCCCCCEEEccCCccc------cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCccc
Q 044615 39 DDYKELVRAVQARDTSISFDELH------EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGS 112 (571)
Q Consensus 39 ~~~~~l~~~~~l~~l~l~~n~l~------~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~ 112 (571)
..|..+.++++|+.|+++.|.+. +..+.+|+.|++++|.+++ .+|..+.++++|++|++++|.+.+.
T Consensus 251 ~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~-------~~p~~~~~l~~L~~L~l~~n~~~~~ 323 (968)
T PLN00113 251 PIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSG-------EIPELVIQLQNLEILHLFSNNFTGK 323 (968)
T ss_pred ccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeecc-------CCChhHcCCCCCcEEECCCCccCCc
Confidence 45677777777888887777664 4566777777777777776 5666666666666666666666666
Q ss_pred ccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhc
Q 044615 113 IPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANL 192 (571)
Q Consensus 113 ~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l 192 (571)
.|..+..+++|+.|++++|.+.+.+|..++.+++|+.|++++|.+.+.+|..+..+++|+.|++++|++.+.+|..+..+
T Consensus 324 ~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~ 403 (968)
T PLN00113 324 IPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGAC 403 (968)
T ss_pred CChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCC
Confidence 66666666666666666666666666666666666666666666655555555555555555555555554444444444
Q ss_pred cC-----------------------CCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEc
Q 044615 193 TN-----------------------SLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDL 249 (571)
Q Consensus 193 ~~-----------------------~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 249 (571)
++ +|+.|++++|.+++.+|..+..+++|+.|++++|.+.+..|..+ ..++|+.|++
T Consensus 404 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~l 482 (968)
T PLN00113 404 RSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDL 482 (968)
T ss_pred CCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEEC
Confidence 43 14445555554444444444445555555555555555444433 3456777777
Q ss_pred ccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccc
Q 044615 250 SANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGS 329 (571)
Q Consensus 250 ~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 329 (571)
++|.+.+..|..+.++++|+.|++++|.+.+.+|..+..+++|+.|+|++|.+++.+|..+..+++|+.|+|++|++++.
T Consensus 483 s~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 562 (968)
T PLN00113 483 SRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGE 562 (968)
T ss_pred cCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCccccc
Confidence 77777777788888889999999999999988999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCEEECcCCcCcccCCCCCccCCCCcccccCCcCCCCCCC--CCCCCCCccccccccceeEEEEeehhhh
Q 044615 330 IPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDIK--RLPPCKAFKSHKQSMKKIWVVIVFPLLG 407 (571)
Q Consensus 330 ~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~l~l~~n~~~c~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~i~~ 407 (571)
+|..+..++.|+.+++++|++.+.+|....+..+....+.||+..|+... ..++|.... .. ...+. ++..+++
T Consensus 563 ~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~--~~--~~~~~-~~~~~~~ 637 (968)
T PLN00113 563 IPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVR--KT--PSWWF-YITCTLG 637 (968)
T ss_pred CChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcccc--cc--ceeee-ehhHHHH
Confidence 99999999999999999999999999877777777888899999997542 356674321 11 12222 2222222
Q ss_pred hHHHHHHHHhhhhhhccccCCCCccCCCCCCccCcceeeec----CccccHHHHHHHccCCCccCeeeccCcceEEEEEc
Q 044615 408 TVALLISLIGLFFNFRQRKNGSQTQQSSPRNTLGLLSVLTF----DGKIVHEEIIRATNNFDDGHCIGNGGQGSVYKAKL 483 (571)
Q Consensus 408 ~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~ 483 (571)
+++++++++++++++++++........... +.+..... ...++.+++. ..|...+.||+|+||.||+|+.
T Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~ 711 (968)
T PLN00113 638 AFLVLALVAFGFVFIRGRNNLELKRVENED---GTWELQFFDSKVSKSITINDIL---SSLKEENVISRGKKGASYKGKS 711 (968)
T ss_pred HHHHHHHHHHHHHHHHhhhccccccccccc---ccccccccccccchhhhHHHHH---hhCCcccEEccCCCeeEEEEEE
Confidence 222222222222222222211111000000 00111001 1123444443 3467788999999999999994
Q ss_pred -CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEeccCCCChhhhhccCCCccCCC
Q 044615 484 -PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSNDAAAEQFC 562 (571)
Q Consensus 484 -~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~G~L~~~l~~~~~~~~l~ 562 (571)
.++..||||++...... ...|++.+++++|||||+++|+|.+.+..|+||||+++|+|.++++ .++
T Consensus 712 ~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~------~l~ 778 (968)
T PLN00113 712 IKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR------NLS 778 (968)
T ss_pred CCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh------cCC
Confidence 68999999998643221 1256888999999999999999999999999999999999999996 378
Q ss_pred HHHHhhhc
Q 044615 563 WTKRMNAI 570 (571)
Q Consensus 563 w~~r~~ia 570 (571)
|.++.+||
T Consensus 779 ~~~~~~i~ 786 (968)
T PLN00113 779 WERRRKIA 786 (968)
T ss_pred HHHHHHHH
Confidence 99988876
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=352.95 Aligned_cols=301 Identities=35% Similarity=0.465 Sum_probs=172.7
Q ss_pred CCCCCCEEEccCCccc------cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccccccccC
Q 044615 46 RAVQARDTSISFDELH------EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGN 119 (571)
Q Consensus 46 ~~~~l~~l~l~~n~l~------~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~ 119 (571)
.+.+|++|+|+.|.+. ++.+++|+.|+|++|.+.+ .+|..++++++|++|+|++|.+.+.+|..+++
T Consensus 138 ~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~-------~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~ 210 (968)
T PLN00113 138 SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVG-------KIPNSLTNLTSLEFLTLASNQLVGQIPRELGQ 210 (968)
T ss_pred ccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccc-------cCChhhhhCcCCCeeeccCCCCcCcCChHHcC
Confidence 4556666666666554 4556666666666666655 55666666666666666666666556666666
Q ss_pred CCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEE
Q 044615 120 LTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVL 199 (571)
Q Consensus 120 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L 199 (571)
+++|++|+|++|.+.+.+|..++++++|++|++++|.+.+.+|..++++++|++|++++|++.+..|..+..+.+ |+.|
T Consensus 211 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~-L~~L 289 (968)
T PLN00113 211 MKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQK-LISL 289 (968)
T ss_pred cCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccC-cCEE
Confidence 666666666666666556666666666666666666665555656666666666666666665555555555554 6666
Q ss_pred EccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCc
Q 044615 200 YLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFS 279 (571)
Q Consensus 200 ~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~ 279 (571)
++++|.+.+.+|..+..+++|+.|++++|.+.+..|..+..+++|+.|++++|.+.+.+|..+..+++|+.|++++|.++
T Consensus 290 ~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~ 369 (968)
T PLN00113 290 DLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLT 369 (968)
T ss_pred ECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeE
Confidence 66666655555555555555666666665555555555555555555555555555555555555555555555555555
Q ss_pred cCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCcccC
Q 044615 280 QKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLI 354 (571)
Q Consensus 280 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 354 (571)
+..|..+..+++|+.|++++|.+.+.+|..+..+++|+.|++++|++++..|..|..++.|+.|++++|.+++.+
T Consensus 370 ~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 444 (968)
T PLN00113 370 GEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRI 444 (968)
T ss_pred eeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCcc
Confidence 555555544455555555555554444444444555555555555554444444444444444444444444433
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=291.21 Aligned_cols=329 Identities=22% Similarity=0.189 Sum_probs=230.9
Q ss_pred CchhhcCCCCCCEEEccCCccc------cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccc
Q 044615 40 DYKELVRAVQARDTSISFDELH------EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSI 113 (571)
Q Consensus 40 ~~~~l~~~~~l~~l~l~~n~l~------~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~ 113 (571)
+|.......+++.|+|.+|.++ .+.++.|+.+||+.|.++.... ..|..-.++++|+|++|+|+...
T Consensus 117 IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~-------~sfp~~~ni~~L~La~N~It~l~ 189 (873)
T KOG4194|consen 117 IPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPK-------PSFPAKVNIKKLNLASNRITTLE 189 (873)
T ss_pred cccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccC-------CCCCCCCCceEEeeccccccccc
Confidence 3444444444555555555444 3445556666666666654211 23444456777777777777666
Q ss_pred cccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhcc
Q 044615 114 PLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLT 193 (571)
Q Consensus 114 ~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~ 193 (571)
...|.++.+|.+|.|+.|+|+...+..|.+|++|+.|+|..|.|...---.|.+|++|+.|.|..|++...-...|..+.
T Consensus 190 ~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~ 269 (873)
T KOG4194|consen 190 TGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLE 269 (873)
T ss_pred cccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeec
Confidence 67777777777777777777766666777777777777777777533334567777777777777777644344455555
Q ss_pred CCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEc
Q 044615 194 NSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNL 273 (571)
Q Consensus 194 ~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 273 (571)
+ +++|+|+.|++...-..++.+++.|+.|++++|.+..+.++.+...++|+.|+|++|+++...+.+|..+..|++|+|
T Consensus 270 k-me~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnL 348 (873)
T KOG4194|consen 270 K-MEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNL 348 (873)
T ss_pred c-cceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcc
Confidence 4 888888888887666677777888888888888888777777777888888888888888777778888888888888
Q ss_pred CCccCccCcchhhhcccCCCEEEccCCcCCcccc---hhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcC
Q 044615 274 SNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIP---SQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNAL 350 (571)
Q Consensus 274 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~---~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l 350 (571)
++|.++..-...|..+.+|+.|||++|.+...+. ..|.++++|+.|+|.+|+|..+.-.+|..++.|++|||.+|.+
T Consensus 349 s~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~Nai 428 (873)
T KOG4194|consen 349 SHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAI 428 (873)
T ss_pred cccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcc
Confidence 8888877666777888888888888888765443 3567788888888888888877677888888888888888888
Q ss_pred cccCCCCCccCCCCcccccCCcCCCC
Q 044615 351 QGLIPNSTAFRDAPMLALQGNKRLCG 376 (571)
Q Consensus 351 ~~~~~~~~~~~~~~~l~l~~n~~~c~ 376 (571)
..+.|+...-..++.+.+.....+|.
T Consensus 429 aSIq~nAFe~m~Lk~Lv~nSssflCD 454 (873)
T KOG4194|consen 429 ASIQPNAFEPMELKELVMNSSSFLCD 454 (873)
T ss_pred eeecccccccchhhhhhhcccceEEe
Confidence 87777643333566666666556664
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=287.55 Aligned_cols=323 Identities=25% Similarity=0.252 Sum_probs=218.5
Q ss_pred CEEEccCCccc------cCCCCccceeecccccccCCCCC---------------CCc-cccccccCCCCCCEEecccCc
Q 044615 51 RDTSISFDELH------EKLLTFEATAHFSVLAFTGQDWP---------------LYS-SIPDEIGNMKSLSDLQLSENI 108 (571)
Q Consensus 51 ~~l~l~~n~l~------~~~l~~l~~l~l~~n~l~~~~~~---------------~~~-~~p~~~~~l~~L~~L~L~~n~ 108 (571)
+.|++++|.++ |.++++|+..++..|.++.+... .+. .-.+.++.++.|+.||||.|.
T Consensus 81 ~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~ 160 (873)
T KOG4194|consen 81 QTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTRIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNL 160 (873)
T ss_pred eeeeccccccccCcHHHHhcCCcceeeeeccchhhhcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhch
Confidence 45777777666 55666777777766666631000 000 112233444555555555555
Q ss_pred CcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChh
Q 044615 109 LNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLS 188 (571)
Q Consensus 109 i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~ 188 (571)
|+.+...+|..-.++++|+|++|.|+..-.+.|..+.+|..|.|+.|+++...+..|.+|++|+.|+|..|+|.-.--..
T Consensus 161 is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~lt 240 (873)
T KOG4194|consen 161 ISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLT 240 (873)
T ss_pred hhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhh
Confidence 54333334444445555555555555555555555555555555555555444445555555555555555554222334
Q ss_pred hhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCC
Q 044615 189 LANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKL 268 (571)
Q Consensus 189 ~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L 268 (571)
|..+.+ |+.|.+..|.+.......|..+.+++.|+|..|++...-..++.+++.|+.|++|+|.+....+++...+++|
T Consensus 241 FqgL~S-l~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL 319 (873)
T KOG4194|consen 241 FQGLPS-LQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKL 319 (873)
T ss_pred hcCchh-hhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccc
Confidence 444443 6666666666655555667777888888888888887777788888888999999998888888888888899
Q ss_pred CEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCcccccc---ccccCCCCCEEEC
Q 044615 269 HYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPR---CFEEMHWLSCIDI 345 (571)
Q Consensus 269 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~---~~~~l~~L~~L~l 345 (571)
++|+|+.|+++...+..|..+..|++|+|++|++...-...|..+.+|++|||++|.|++.+.+ .|..++.|+.|++
T Consensus 320 ~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l 399 (873)
T KOG4194|consen 320 KELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRL 399 (873)
T ss_pred eeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheee
Confidence 9999999999888888888888999999999988877777888899999999999998876654 5778899999999
Q ss_pred cCCcCcccCCC-CCccCCCCcccccCCcCC
Q 044615 346 SYNALQGLIPN-STAFRDAPMLALQGNKRL 374 (571)
Q Consensus 346 s~N~l~~~~~~-~~~~~~~~~l~l~~n~~~ 374 (571)
.+|++..+... ...+..+..+++.+|+..
T Consensus 400 ~gNqlk~I~krAfsgl~~LE~LdL~~Naia 429 (873)
T KOG4194|consen 400 TGNQLKSIPKRAFSGLEALEHLDLGDNAIA 429 (873)
T ss_pred cCceeeecchhhhccCcccceecCCCCcce
Confidence 99998866543 455677888888888754
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-34 Score=281.91 Aligned_cols=335 Identities=28% Similarity=0.320 Sum_probs=289.6
Q ss_pred HHHHhhccCCCCCchhhcCCCCCCEEEccCCccc-----cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEE
Q 044615 28 DLIEKILDGLGDDYKELVRAVQARDTSISFDELH-----EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDL 102 (571)
Q Consensus 28 ~~~~~~~~~~~~~~~~l~~~~~l~~l~l~~n~l~-----~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L 102 (571)
.+++....++..+|++++++.+|+.|.+++|++. .+.++.|+.+.++.|++.. +.+|+.+..+..|+.|
T Consensus 35 ~WLkLnrt~L~~vPeEL~~lqkLEHLs~~HN~L~~vhGELs~Lp~LRsv~~R~N~LKn------sGiP~diF~l~dLt~l 108 (1255)
T KOG0444|consen 35 TWLKLNRTKLEQVPEELSRLQKLEHLSMAHNQLISVHGELSDLPRLRSVIVRDNNLKN------SGIPTDIFRLKDLTIL 108 (1255)
T ss_pred eEEEechhhhhhChHHHHHHhhhhhhhhhhhhhHhhhhhhccchhhHHHhhhcccccc------CCCCchhcccccceee
Confidence 3334345677888999999999999999999988 6788899999999999976 2589999999999999
Q ss_pred ecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCC
Q 044615 103 QLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLN 182 (571)
Q Consensus 103 ~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~ 182 (571)
|||+|++. ..|..+..-+++-+|+|++|+|..++...|.+|+.|-+|+|++|++. .+|..+..|..|++|+|++|.+.
T Consensus 109 DLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~ 186 (1255)
T KOG0444|consen 109 DLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLN 186 (1255)
T ss_pred ecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhh
Confidence 99999998 88999999999999999999998666667889999999999999995 57778999999999999999886
Q ss_pred ccCChhhhhccCCCcEEEccCCccc-ccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchh
Q 044615 183 GSIPLSLANLTNSLKVLYLSSNHIV-GEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPES 261 (571)
Q Consensus 183 ~~~p~~~~~l~~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 261 (571)
...-..+..++. |++|.+++.+-+ ..+|..+..+.+|..++++.|.+. ..|..+..+++|+.|+||+|.++. +...
T Consensus 187 hfQLrQLPsmts-L~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~ite-L~~~ 263 (1255)
T KOG0444|consen 187 HFQLRQLPSMTS-LSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITE-LNMT 263 (1255)
T ss_pred HHHHhcCccchh-hhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceee-eecc
Confidence 432223334454 888999886654 357888999999999999999998 688999999999999999999974 4455
Q ss_pred hccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCc-ccchhccCCCCCCEEEccCCcCccccccccccCCCC
Q 044615 262 LSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFRE-EIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWL 340 (571)
Q Consensus 262 l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L 340 (571)
.....+|++|++|.|+++ .+|..+..++.|+.|++.+|+++- -+|+.++.+.+|+.+..++|.+. ..|+.++.+..|
T Consensus 264 ~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL 341 (1255)
T KOG0444|consen 264 EGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKL 341 (1255)
T ss_pred HHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHH
Confidence 667789999999999998 789999999999999999998763 38889999999999999999997 889999999999
Q ss_pred CEEECcCCcCcccCCCCCccCCCCcccccCCcCCC
Q 044615 341 SCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLC 375 (571)
Q Consensus 341 ~~L~ls~N~l~~~~~~~~~~~~~~~l~l~~n~~~c 375 (571)
+.|.|+.|.+-..+.....+..+..+++..|+.+-
T Consensus 342 ~kL~L~~NrLiTLPeaIHlL~~l~vLDlreNpnLV 376 (1255)
T KOG0444|consen 342 QKLKLDHNRLITLPEAIHLLPDLKVLDLRENPNLV 376 (1255)
T ss_pred HHhcccccceeechhhhhhcCCcceeeccCCcCcc
Confidence 99999999998887777778889999999998654
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-29 Score=248.94 Aligned_cols=302 Identities=29% Similarity=0.380 Sum_probs=260.5
Q ss_pred CchhhcCCCCCCEEEccCCccc-------cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCccc
Q 044615 40 DYKELVRAVQARDTSISFDELH-------EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGS 112 (571)
Q Consensus 40 ~~~~l~~~~~l~~l~l~~n~l~-------~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~ 112 (571)
+.-+++.++.|+.+.+..|++. +..+..|+.|||++|++. ++|..+..-+++-+|+||+|+|..+
T Consensus 70 vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~--------EvP~~LE~AKn~iVLNLS~N~IetI 141 (1255)
T KOG0444|consen 70 VHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR--------EVPTNLEYAKNSIVLNLSYNNIETI 141 (1255)
T ss_pred hhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh--------hcchhhhhhcCcEEEEcccCccccC
Confidence 3556788888999999999888 667889999999999998 4899998889999999999999865
Q ss_pred ccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCC-ccCChhhhh
Q 044615 113 IPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLN-GSIPLSLAN 191 (571)
Q Consensus 113 ~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~-~~~p~~~~~ 191 (571)
....|.+|+.|-.|||++|++. ..|+.+..|.+|++|.|++|.+...--..+-.+++|++|.+++.+-+ ..+|.++..
T Consensus 142 Pn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~ 220 (1255)
T KOG0444|consen 142 PNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDD 220 (1255)
T ss_pred CchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhh
Confidence 5566789999999999999997 67778899999999999999986433344556778889999887643 368888888
Q ss_pred ccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEE
Q 044615 192 LTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYL 271 (571)
Q Consensus 192 l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 271 (571)
+.+ |..+++|.|.+. ..|..+..+.+|+.|+|++|+++. +....+...+|+.|+||.|.++ .+|.++..+++|+.|
T Consensus 221 l~N-L~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~ite-L~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kL 296 (1255)
T KOG0444|consen 221 LHN-LRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITE-LNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKL 296 (1255)
T ss_pred hhh-hhhccccccCCC-cchHHHhhhhhhheeccCcCceee-eeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHH
Confidence 886 999999999997 789999999999999999999984 4555666788999999999997 789999999999999
Q ss_pred EcCCccCcc-CcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcC
Q 044615 272 NLSNNQFSQ-KIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNAL 350 (571)
Q Consensus 272 ~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l 350 (571)
.+.+|+++- -+|..++.+.+|+.+..++|.+ +.+|..++.+..|+.|.|++|++- .+|+.+.-++.|+.||+..|+-
T Consensus 297 y~n~NkL~FeGiPSGIGKL~~Levf~aanN~L-ElVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpn 374 (1255)
T KOG0444|consen 297 YANNNKLTFEGIPSGIGKLIQLEVFHAANNKL-ELVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPN 374 (1255)
T ss_pred HhccCcccccCCccchhhhhhhHHHHhhcccc-ccCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcC
Confidence 999999863 4788999999999999999988 579999999999999999999997 6899999999999999999975
Q ss_pred cccCCC
Q 044615 351 QGLIPN 356 (571)
Q Consensus 351 ~~~~~~ 356 (571)
--.+|.
T Consensus 375 LVMPPK 380 (1255)
T KOG0444|consen 375 LVMPPK 380 (1255)
T ss_pred ccCCCC
Confidence 544554
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-29 Score=237.12 Aligned_cols=328 Identities=29% Similarity=0.406 Sum_probs=176.6
Q ss_pred CCCCchhhcCCCCCCEEEccCCccc-----cCCCCccceeecccccccCC---------------CCCCCccccccccCC
Q 044615 37 LGDDYKELVRAVQARDTSISFDELH-----EKLLTFEATAHFSVLAFTGQ---------------DWPLYSSIPDEIGNM 96 (571)
Q Consensus 37 ~~~~~~~l~~~~~l~~l~l~~n~l~-----~~~l~~l~~l~l~~n~l~~~---------------~~~~~~~~p~~~~~l 96 (571)
+...|+.++.+.++..+++++|.+. ++.+..+..++...|+++.. ....+..+|...-++
T Consensus 103 ls~lp~~i~s~~~l~~l~~s~n~~~el~~~i~~~~~l~dl~~~~N~i~slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m 182 (565)
T KOG0472|consen 103 LSELPEQIGSLISLVKLDCSSNELKELPDSIGRLLDLEDLDATNNQISSLPEDMVNLSKLSKLDLEGNKLKALPENHIAM 182 (565)
T ss_pred HhhccHHHhhhhhhhhhhccccceeecCchHHHHhhhhhhhccccccccCchHHHHHHHHHHhhccccchhhCCHHHHHH
Confidence 3445666666666666666666555 34444455555555544420 000011233333334
Q ss_pred CCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccc-cCCCCCCEEE
Q 044615 97 KSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEI-GNMNSLSILD 175 (571)
Q Consensus 97 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l-~~l~~L~~L~ 175 (571)
+.|+.||...|-+. .+|..++.+.+|.-|+|..|+|. ..| .|..+..|++|+++.|.+. .+|.+. ..+++|.+||
T Consensus 183 ~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLD 258 (565)
T KOG0472|consen 183 KRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLD 258 (565)
T ss_pred HHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeee
Confidence 55555555555443 45555555555555555555554 333 4555555556666555554 334333 3666777777
Q ss_pred ccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCC---------------------
Q 044615 176 LSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQL--------------------- 234 (571)
Q Consensus 176 L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~--------------------- 234 (571)
|.+|++. +.|+++.-+.+ |..||+|+|.|+ .+|..++++ .|+.|.+.+|.+...-
T Consensus 259 LRdNklk-e~Pde~clLrs-L~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~ 334 (565)
T KOG0472|consen 259 LRDNKLK-EVPDEICLLRS-LERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKD 334 (565)
T ss_pred ccccccc-cCchHHHHhhh-hhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhcc
Confidence 7777776 66766665554 777777777776 455666666 6666666666542000
Q ss_pred ----------------Ch----hhhCCCCCC--------------------------EEEcccCccc-------------
Q 044615 235 ----------------SP----ELGSLIQLE--------------------------YLDLSANTFH------------- 255 (571)
Q Consensus 235 ----------------~~----~~~~l~~L~--------------------------~L~L~~n~l~------------- 255 (571)
+. ....+.+.+ ..+++.|++.
T Consensus 335 dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelv 414 (565)
T KOG0472|consen 335 DGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELV 414 (565)
T ss_pred CCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHH
Confidence 00 000011122 2223333321
Q ss_pred ----------cccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCc
Q 044615 256 ----------KSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNN 325 (571)
Q Consensus 256 ----------~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 325 (571)
+.+|..++.+++|..|+|++|.+. .+|..++.+..|+.|+++.|++.. +|..+..+..|+.+-.++|+
T Consensus 415 T~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr~-lP~~~y~lq~lEtllas~nq 492 (565)
T KOG0472|consen 415 TDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFRM-LPECLYELQTLETLLASNNQ 492 (565)
T ss_pred HHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheeccccccccc-chHHHhhHHHHHHHHhcccc
Confidence 112223334445555555554443 344444444445555555554432 44444444444444444455
Q ss_pred CccccccccccCCCCCEEECcCCcCcccCCCCCccCCCCcccccCCcCC
Q 044615 326 LSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRL 374 (571)
Q Consensus 326 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~l~l~~n~~~ 374 (571)
+....|+.+.++.+|..|||.+|.+..++|....+.++..+.+.||++.
T Consensus 493 i~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 493 IGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred ccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence 5545555577888899999999999988888888888999999999854
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-28 Score=229.25 Aligned_cols=269 Identities=30% Similarity=0.442 Sum_probs=220.3
Q ss_pred CCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCccccccccc-C
Q 044615 65 LTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFA-N 143 (571)
Q Consensus 65 l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~-~ 143 (571)
++.|+.+|...|.+. .+|+.++.+.+|.-|+|.+|.+. .+| .|.+++.|..|++..|.|+ .+|...+ +
T Consensus 182 m~~L~~ld~~~N~L~--------tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~ 250 (565)
T KOG0472|consen 182 MKRLKHLDCNSNLLE--------TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKH 250 (565)
T ss_pred HHHHHhcccchhhhh--------cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcc
Confidence 444555555554444 68999999999999999999997 677 8999999999999999998 6666655 9
Q ss_pred CCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCcccccC-------------
Q 044615 144 LTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEI------------- 210 (571)
Q Consensus 144 l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~------------- 210 (571)
+++|..|||..|++. ..|+++.-+.+|.+||+++|.++ .+|.+++++ . |+.|-+.+|.+...-
T Consensus 251 L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-h-L~~L~leGNPlrTiRr~ii~~gT~~vLK 326 (565)
T KOG0472|consen 251 LNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-H-LKFLALEGNPLRTIRREIISKGTQEVLK 326 (565)
T ss_pred cccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-e-eeehhhcCCchHHHHHHHHcccHHHHHH
Confidence 999999999999996 68999999999999999999999 689899998 3 999999999863100
Q ss_pred -------------------------Cccc---cCCC--------------------------CCcEEeCccCcCc-----
Q 044615 211 -------------------------PLGH---GMLS--------------------------SLIQLTLNNNELS----- 231 (571)
Q Consensus 211 -------------------------~~~~---~~l~--------------------------~L~~L~l~~n~l~----- 231 (571)
+..+ ..+- -....+++.|++.
T Consensus 327 yLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~ 406 (565)
T KOG0472|consen 327 YLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKR 406 (565)
T ss_pred HHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHhhhhhh
Confidence 0000 0000 1334455555443
Q ss_pred ------------------CCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCC
Q 044615 232 ------------------GQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLS 293 (571)
Q Consensus 232 ------------------~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 293 (571)
+.+|..+..+++|..|+|++|.+. .+|..++.+..|+.|+++.|++. ..|..+..+..++
T Consensus 407 L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lE 484 (565)
T KOG0472|consen 407 LVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLE 484 (565)
T ss_pred hHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHH
Confidence 244556778899999999999886 67888999999999999999997 6888888888888
Q ss_pred EEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCc
Q 044615 294 ELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQ 351 (571)
Q Consensus 294 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~ 351 (571)
.+-.++|++....+..+.+|.+|..|||.+|.+. .+|..+.++.+|++|++++|+|.
T Consensus 485 tllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 485 TLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred HHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 8888889998877777999999999999999998 78889999999999999999998
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-22 Score=230.50 Aligned_cols=310 Identities=23% Similarity=0.232 Sum_probs=176.0
Q ss_pred chhhcCCCCCCEEEccCCccc------------cCCC-CccceeecccccccCCCCCCCccccccccCCCCCCEEecccC
Q 044615 41 YKELVRAVQARDTSISFDELH------------EKLL-TFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSEN 107 (571)
Q Consensus 41 ~~~l~~~~~l~~l~l~~n~l~------------~~~l-~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n 107 (571)
+..+..+.+|+.|.+..+... +..+ ..|+.|++..+.+. .+|..| ...+|++|+|++|
T Consensus 551 ~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~--------~lP~~f-~~~~L~~L~L~~s 621 (1153)
T PLN03210 551 ENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR--------CMPSNF-RPENLVKLQMQGS 621 (1153)
T ss_pred HHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC--------CCCCcC-CccCCcEEECcCc
Confidence 455677778887777544211 1222 24566666555444 345444 2455666666665
Q ss_pred cCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCCh
Q 044615 108 ILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPL 187 (571)
Q Consensus 108 ~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~ 187 (571)
.+. .++..+..+++|+.|+|++|.....+| .++.+++|++|+|++|.....+|..+..+++|+.|++++|.....+|.
T Consensus 622 ~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~ 699 (1153)
T PLN03210 622 KLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPT 699 (1153)
T ss_pred ccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCC
Confidence 554 345555555566666665544333344 255555666666655554445555555556666666655543334444
Q ss_pred hhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCCh------------------------------h
Q 044615 188 SLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSP------------------------------E 237 (571)
Q Consensus 188 ~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~------------------------------~ 237 (571)
.+ ++.+ |+.|++++|.....+|.. .++|+.|++++|.+.. +|. .
T Consensus 700 ~i-~l~s-L~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~-lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~ 773 (1153)
T PLN03210 700 GI-NLKS-LYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEE-FPSNLRLENLDELILCEMKSEKLWERVQPLTPLM 773 (1153)
T ss_pred cC-CCCC-CCEEeCCCCCCccccccc---cCCcCeeecCCCcccc-ccccccccccccccccccchhhccccccccchhh
Confidence 33 3332 555555555433333321 2344455555554432 221 1
Q ss_pred hhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCC
Q 044615 238 LGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLE 317 (571)
Q Consensus 238 ~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 317 (571)
+...++|+.|++++|.....+|.+++++++|+.|++++|...+.+|..+ .+++|+.|++++|.....+|.. .++|+
T Consensus 774 ~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~ 849 (1153)
T PLN03210 774 TMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNIS 849 (1153)
T ss_pred hhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccC
Confidence 2223567777777776666677777777778888877775444556544 5677777777776544444432 35677
Q ss_pred EEEccCCcCccccccccccCCCCCEEECcC-CcCcccCCCCCccCCCCcccccCCc
Q 044615 318 KLNLSHNNLSGSIPRCFEEMHWLSCIDISY-NALQGLIPNSTAFRDAPMLALQGNK 372 (571)
Q Consensus 318 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~-N~l~~~~~~~~~~~~~~~l~l~~n~ 372 (571)
.|+|++|.++ .+|.++..+++|+.|++++ |+++..++....+..+..+.+.++.
T Consensus 850 ~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 850 DLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred EeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence 7888888776 5677777788888888877 5666655555555666666665543
|
syringae 6; Provisional |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-25 Score=232.34 Aligned_cols=210 Identities=31% Similarity=0.383 Sum_probs=140.8
Q ss_pred CCCEEEccCCCCCccCChhhhhccCCCcEEEccCCcccc----------------------cCCccccCCCCCcEEeCcc
Q 044615 170 SLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVG----------------------EIPLGHGMLSSLIQLTLNN 227 (571)
Q Consensus 170 ~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~----------------------~~~~~~~~l~~L~~L~l~~ 227 (571)
+|+++++++|+++ .+|.++..+.+ |+.+...+|++.. -+|.....++.|++|+|..
T Consensus 242 nl~~~dis~n~l~-~lp~wi~~~~n-le~l~~n~N~l~~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~ 319 (1081)
T KOG0618|consen 242 NLQYLDISHNNLS-NLPEWIGACAN-LEALNANHNRLVALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQS 319 (1081)
T ss_pred cceeeecchhhhh-cchHHHHhccc-ceEecccchhHHhhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeehh
Confidence 5566666666665 45555555554 6666666666531 2333444566677777777
Q ss_pred CcCcCCCChhhh-------------------------CCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCc
Q 044615 228 NELSGQLSPELG-------------------------SLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKI 282 (571)
Q Consensus 228 n~l~~~~~~~~~-------------------------~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~ 282 (571)
|.+....+..+. .++.|+.|.+.+|.+++..-+.+.+..+|+.|+|++|++....
T Consensus 320 N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fp 399 (1081)
T KOG0618|consen 320 NNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFP 399 (1081)
T ss_pred ccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCC
Confidence 766643221111 1233556666667666666666777778888888888887555
Q ss_pred chhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCcccC-CCCCccC
Q 044615 283 PNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLI-PNSTAFR 361 (571)
Q Consensus 283 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~-~~~~~~~ 361 (571)
...+.+++.|++|+||+|+++. +|..+..++.|+.|...+|++. ..| .+..++.|+.+|+|.|+++... |.....+
T Consensus 400 as~~~kle~LeeL~LSGNkL~~-Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p 476 (1081)
T KOG0618|consen 400 ASKLRKLEELEELNLSGNKLTT-LPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSP 476 (1081)
T ss_pred HHHHhchHHhHHHhcccchhhh-hhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCc
Confidence 5667778888888888888864 6677788888888888888876 556 7788999999999999998654 3333337
Q ss_pred CCCcccccCCcCCCCCCCCCCCC
Q 044615 362 DAPMLALQGNKRLCGDIKRLPPC 384 (571)
Q Consensus 362 ~~~~l~l~~n~~~c~~~~~~~~~ 384 (571)
+++.++++||.+.-.+.+.++.|
T Consensus 477 ~LkyLdlSGN~~l~~d~~~l~~l 499 (1081)
T KOG0618|consen 477 NLKYLDLSGNTRLVFDHKTLKVL 499 (1081)
T ss_pred ccceeeccCCcccccchhhhHHh
Confidence 89999999999765554444433
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-24 Score=206.38 Aligned_cols=285 Identities=23% Similarity=0.240 Sum_probs=158.8
Q ss_pred cccccccCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeeccc-CcCcccCCcccc
Q 044615 88 SIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYE-NSLCDSIPKEIG 166 (571)
Q Consensus 88 ~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~l~ 166 (571)
++|..+. +.-..|+|..|+|+.+.|.+|+.+++|+.|||++|.|+.+-|++|.++++|..|-+.+ |.|+....+.|.
T Consensus 60 eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~ 137 (498)
T KOG4237|consen 60 EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFG 137 (498)
T ss_pred cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhh
Confidence 4555443 3456677777777766677777777777777777777777777777777776665555 667655445677
Q ss_pred CCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCc------------CCC
Q 044615 167 NMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELS------------GQL 234 (571)
Q Consensus 167 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~------------~~~ 234 (571)
+|..|+.|.+.-|++.....+.|..++. |..|.+..|.+.......+..+..++.+++..|.+. ...
T Consensus 138 gL~slqrLllNan~i~Cir~~al~dL~~-l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~ 216 (498)
T KOG4237|consen 138 GLSSLQRLLLNANHINCIRQDALRDLPS-LSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMN 216 (498)
T ss_pred hHHHHHHHhcChhhhcchhHHHHHHhhh-cchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhc
Confidence 7777777777777776555556666664 777777777776444446666777777777666521 122
Q ss_pred ChhhhCCCCCCEEEcccCccccccchhhccC-CCCCEEEcCCccCccCcc-hhhhcccCCCEEEccCCcCCcccchhccC
Q 044615 235 SPELGSLIQLEYLDLSANTFHKSIPESLSNL-VKLHYLNLSNNQFSQKIP-NKIEKLIHLSELDLSHNIFREEIPSQICS 312 (571)
Q Consensus 235 ~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l-~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 312 (571)
|.+++.........+.++++....+..|... ..+.+--.+.+...+..| ..|..+++|+.|+|++|+++++-+.+|.+
T Consensus 217 ~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~ 296 (498)
T KOG4237|consen 217 PIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEG 296 (498)
T ss_pred hhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcc
Confidence 3334444333333344444333222222111 111111111111112222 34555555555555555555555555555
Q ss_pred CCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCcccCCCC-CccCCCCcccccCCcCCC
Q 044615 313 MQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNS-TAFRDAPMLALQGNKRLC 375 (571)
Q Consensus 313 l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~-~~~~~~~~l~l~~n~~~c 375 (571)
...+++|.|..|+|.......|.++..|+.|+|.+|+|+...|.. .....+..+.+-+||+.|
T Consensus 297 ~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~C 360 (498)
T KOG4237|consen 297 AAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNC 360 (498)
T ss_pred hhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccC
Confidence 555555555555555555555555555555555555555554431 222334445555555555
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-21 Score=222.83 Aligned_cols=289 Identities=22% Similarity=0.210 Sum_probs=210.3
Q ss_pred chhhcCC-CCCCEEEccCCccc----cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccccc
Q 044615 41 YKELVRA-VQARDTSISFDELH----EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPL 115 (571)
Q Consensus 41 ~~~l~~~-~~l~~l~l~~n~l~----~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~ 115 (571)
|..+..+ .+|+.|++.++.+. .....+|+.|+++++++.. +|..+..+++|+.|+|+++.....+|
T Consensus 581 p~~~~~lp~~Lr~L~~~~~~l~~lP~~f~~~~L~~L~L~~s~l~~--------L~~~~~~l~~Lk~L~Ls~~~~l~~ip- 651 (1153)
T PLN03210 581 PEGFDYLPPKLRLLRWDKYPLRCMPSNFRPENLVKLQMQGSKLEK--------LWDGVHSLTGLRNIDLRGSKNLKEIP- 651 (1153)
T ss_pred CcchhhcCcccEEEEecCCCCCCCCCcCCccCCcEEECcCccccc--------cccccccCCCCCEEECCCCCCcCcCC-
Confidence 4444444 35777777777655 1245677778887777653 56666777888888887765444555
Q ss_pred cccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCC
Q 044615 116 ALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNS 195 (571)
Q Consensus 116 ~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~ 195 (571)
.++.+++|++|+|++|.....+|..+.++++|+.|++++|.....+|..+ ++++|+.|++++|.....+|.. ..+
T Consensus 652 ~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~----~~n 726 (1153)
T PLN03210 652 DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI----STN 726 (1153)
T ss_pred ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc----cCC
Confidence 36777788888887776656777777788888888887765555666554 6777777777777654444432 224
Q ss_pred CcEEEccCCcccccCCcc------------------------------ccCCCCCcEEeCccCcCcCCCChhhhCCCCCC
Q 044615 196 LKVLYLSSNHIVGEIPLG------------------------------HGMLSSLIQLTLNNNELSGQLSPELGSLIQLE 245 (571)
Q Consensus 196 L~~L~l~~n~~~~~~~~~------------------------------~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 245 (571)
|+.|++++|.+.. +|.. ....++|+.|++++|.....+|..++++++|+
T Consensus 727 L~~L~L~~n~i~~-lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~ 805 (1153)
T PLN03210 727 ISWLDLDETAIEE-FPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLE 805 (1153)
T ss_pred cCeeecCCCcccc-ccccccccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCC
Confidence 7777777776642 3321 11235788999999988878999999999999
Q ss_pred EEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCc
Q 044615 246 YLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNN 325 (571)
Q Consensus 246 ~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 325 (571)
.|++++|...+.+|..+ ++++|+.|++++|.....+|.. ..+|+.|+|++|.+.. +|.++..+++|+.|++++|+
T Consensus 806 ~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~~-iP~si~~l~~L~~L~L~~C~ 880 (1153)
T PLN03210 806 HLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIEE-VPWWIEKFSNLSFLDMNGCN 880 (1153)
T ss_pred EEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCcc-ChHHHhcCCCCCEEECCCCC
Confidence 99999986555677665 7899999999998765555543 3689999999999975 78899999999999999954
Q ss_pred CccccccccccCCCCCEEECcCCc
Q 044615 326 LSGSIPRCFEEMHWLSCIDISYNA 349 (571)
Q Consensus 326 l~~~~p~~~~~l~~L~~L~ls~N~ 349 (571)
--..+|..+..++.|+.++++++.
T Consensus 881 ~L~~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 881 NLQRVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred CcCccCcccccccCCCeeecCCCc
Confidence 434577788889999999998874
|
syringae 6; Provisional |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-23 Score=218.21 Aligned_cols=300 Identities=27% Similarity=0.305 Sum_probs=233.6
Q ss_pred CchhhcCCCCCCEEEccCCccc---cCCCCccceeecccccccCCCCCC------------Cc-cccccccCCCCCCEEe
Q 044615 40 DYKELVRAVQARDTSISFDELH---EKLLTFEATAHFSVLAFTGQDWPL------------YS-SIPDEIGNMKSLSDLQ 103 (571)
Q Consensus 40 ~~~~l~~~~~l~~l~l~~n~l~---~~~l~~l~~l~l~~n~l~~~~~~~------------~~-~~p~~~~~l~~L~~L~ 103 (571)
++.++..+.+ .|+|++|.+. ..++.+|+.+....|+++...... +. ..+ -..-.+|++++
T Consensus 172 ~~~~i~~l~~--~ldLr~N~~~~~dls~~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~--~p~p~nl~~~d 247 (1081)
T KOG0618|consen 172 FLIDIYNLTH--QLDLRYNEMEVLDLSNLANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLDV--HPVPLNLQYLD 247 (1081)
T ss_pred hhcchhhhhe--eeecccchhhhhhhhhccchhhhhhhhcccceEEecCcchheeeeccCcceeecc--ccccccceeee
Confidence 3445555555 6888888777 556666666666666555311100 00 001 11225789999
Q ss_pred cccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCc
Q 044615 104 LSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNG 183 (571)
Q Consensus 104 L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 183 (571)
+++|+++ .+|..++.+.+|+.|+...|.++ ..|..+....+|+.|.+..|.+. -+|....+++.|++|+|..|++.
T Consensus 248 is~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~- 323 (1081)
T KOG0618|consen 248 ISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP- 323 (1081)
T ss_pred cchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-
Confidence 9999998 56788899999999999999995 77888888999999999999986 56777888999999999999997
Q ss_pred cCChhhhhccCC-CcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhh
Q 044615 184 SIPLSLANLTNS-LKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESL 262 (571)
Q Consensus 184 ~~p~~~~~l~~~-L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l 262 (571)
.+|+.+....+. |+.|+.+.|.+.......-..++.|+.|++.+|.+++...+.+.++++|+.|+|++|++.......+
T Consensus 324 ~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~ 403 (1081)
T KOG0618|consen 324 SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKL 403 (1081)
T ss_pred ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHH
Confidence 677766655543 7888888888874443333456789999999999999888889999999999999999986666778
Q ss_pred ccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCE
Q 044615 263 SNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSC 342 (571)
Q Consensus 263 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 342 (571)
.++..|+.|+||+|+++ .+|..+..++.|+.|...+|++.. .| .+..++.|+.+|+|.|+|+...-..-..-++|++
T Consensus 404 ~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~-fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~Lky 480 (1081)
T KOG0618|consen 404 RKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLS-FP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKY 480 (1081)
T ss_pred hchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceee-ch-hhhhcCcceEEecccchhhhhhhhhhCCCcccce
Confidence 99999999999999998 577899999999999999999864 66 7899999999999999998543332222388999
Q ss_pred EECcCCcC
Q 044615 343 IDISYNAL 350 (571)
Q Consensus 343 L~ls~N~l 350 (571)
||+++|.-
T Consensus 481 LdlSGN~~ 488 (1081)
T KOG0618|consen 481 LDLSGNTR 488 (1081)
T ss_pred eeccCCcc
Confidence 99999973
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.5e-21 Score=205.56 Aligned_cols=259 Identities=24% Similarity=0.317 Sum_probs=193.0
Q ss_pred CCCEEEccCCccc---cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccccccccCCCCCCE
Q 044615 49 QARDTSISFDELH---EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVV 125 (571)
Q Consensus 49 ~l~~l~l~~n~l~---~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~ 125 (571)
.-..|+++.+.++ ......++.|++..|+++. +|.. +++|++|+|++|+++ .+|.. .++|+.
T Consensus 202 ~~~~LdLs~~~LtsLP~~l~~~L~~L~L~~N~Lt~--------LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~ 266 (788)
T PRK15387 202 GNAVLNVGESGLTTLPDCLPAHITTLVIPDNNLTS--------LPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLE 266 (788)
T ss_pred CCcEEEcCCCCCCcCCcchhcCCCEEEccCCcCCC--------CCCC---CCCCcEEEecCCccC-cccCc---ccccce
Confidence 3567888888777 1123468888999888885 4542 478999999999988 45543 367889
Q ss_pred EEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCc
Q 044615 126 LDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNH 205 (571)
Q Consensus 126 L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~ 205 (571)
|++++|.++ .+|.. ..+|+.|++++|.++. +|. .+++|+.|++++|++.+ +|. ++.+|+.|++++|.
T Consensus 267 L~Ls~N~L~-~Lp~l---p~~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L~~-Lp~----lp~~L~~L~Ls~N~ 333 (788)
T PRK15387 267 LSIFSNPLT-HLPAL---PSGLCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQLAS-LPA----LPSELCKLWAYNNQ 333 (788)
T ss_pred eeccCCchh-hhhhc---hhhcCEEECcCCcccc-ccc---cccccceeECCCCcccc-CCC----CcccccccccccCc
Confidence 999999887 34432 3568889999999874 454 34789999999999884 554 23348889999999
Q ss_pred ccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchh
Q 044615 206 IVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNK 285 (571)
Q Consensus 206 ~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~ 285 (571)
+++ +|. ...+|+.|++++|+++. +|.. .++|+.|++++|.+.. +|.. ..+|+.|++++|++++ +|..
T Consensus 334 L~~-LP~---lp~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l 400 (788)
T PRK15387 334 LTS-LPT---LPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL 400 (788)
T ss_pred ccc-ccc---cccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCc
Confidence 874 443 22578999999999985 4432 3578888999998874 5543 3578999999999885 4432
Q ss_pred hhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCcccCCC
Q 044615 286 IEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPN 356 (571)
Q Consensus 286 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~ 356 (571)
.++|+.|++++|.+++ +|.. ..+|+.|++++|+|+ .+|..+..++.|+.|+|++|++++..+.
T Consensus 401 ---~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 401 ---PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred ---ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 3578999999999876 5543 346788999999998 6788899999999999999999887554
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.8e-24 Score=201.80 Aligned_cols=291 Identities=22% Similarity=0.246 Sum_probs=220.0
Q ss_pred EEccCCccc--cCCC-CccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccccccccCCCCCCEEEcc
Q 044615 53 TSISFDELH--EKLL-TFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLS 129 (571)
Q Consensus 53 l~l~~n~l~--~~~l-~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~ 129 (571)
.+-+.-++. -.++ +....++|..|.++. .-|..|+.+++|+.||||+|+|+.+.|++|.++.+|.+|-+.
T Consensus 51 VdCr~~GL~eVP~~LP~~tveirLdqN~I~~-------iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvly 123 (498)
T KOG4237|consen 51 VDCRGKGLTEVPANLPPETVEIRLDQNQISS-------IPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLY 123 (498)
T ss_pred EEccCCCcccCcccCCCcceEEEeccCCccc-------CChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhh
Confidence 444444444 2233 467788999999986 334578999999999999999999999999999998888777
Q ss_pred c-CcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCccc-
Q 044615 130 T-NKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIV- 207 (571)
Q Consensus 130 ~-n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~- 207 (571)
+ |+|+....+.|++|..|+.|.+.-|++.-...+.|..|++|..|.+.+|.+....-..|..+.. ++.+.+..|.+-
T Consensus 124 g~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~-i~tlhlA~np~ic 202 (498)
T KOG4237|consen 124 GNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAA-IKTLHLAQNPFIC 202 (498)
T ss_pred cCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhc-cchHhhhcCcccc
Confidence 6 9999888888999999999999999998777788999999999999999988433336767665 888888888732
Q ss_pred -----------ccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEE--Ecc-cCccccc-cchhhccCCCCCEEE
Q 044615 208 -----------GEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYL--DLS-ANTFHKS-IPESLSNLVKLHYLN 272 (571)
Q Consensus 208 -----------~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L--~L~-~n~l~~~-~~~~l~~l~~L~~L~ 272 (571)
...|..+++.....-..+.++++..+.+..|... ++.+ .++ .+...+. +...|..+++|+.|+
T Consensus 203 dCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~--~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~ln 280 (498)
T KOG4237|consen 203 DCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCS--LESLPSRLSSEDFPDSICPAKCFKKLPNLRKLN 280 (498)
T ss_pred ccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhh--HHhHHHhhccccCcCCcChHHHHhhcccceEec
Confidence 1223344444444444455555554433333321 2222 112 2222222 234588999999999
Q ss_pred cCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCcc
Q 044615 273 LSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQG 352 (571)
Q Consensus 273 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 352 (571)
|++|+++++.+.+|.++..+++|+|..|++...-...|.++..|+.|+|.+|+|+...|..|..+..|..|+|-.|++.+
T Consensus 281 lsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~C 360 (498)
T KOG4237|consen 281 LSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNC 360 (498)
T ss_pred cCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccC
Confidence 99999998888999999999999999999987777788999999999999999999999999999999999999998865
Q ss_pred c
Q 044615 353 L 353 (571)
Q Consensus 353 ~ 353 (571)
-
T Consensus 361 n 361 (498)
T KOG4237|consen 361 N 361 (498)
T ss_pred c
Confidence 4
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-21 Score=193.35 Aligned_cols=119 Identities=38% Similarity=0.679 Sum_probs=106.4
Q ss_pred CccccHHHHHHHccCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEE
Q 044615 449 DGKIVHEEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYG 528 (571)
Q Consensus 449 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~ 528 (571)
...|++.++..+|++|...+.||+|+||.||+|...+|..||||++....... .++|.+|++++++++|||+|+++|
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEE
Confidence 34688999999999999999999999999999999888999999887544321 355999999999999999999999
Q ss_pred EEEeCC-eeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhcC
Q 044615 529 FCSHAL-HSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAIK 571 (571)
Q Consensus 529 ~~~~~~-~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia~ 571 (571)
||.+.+ +.++|||||++|+|.++|+.+... +|+|.+|++||+
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~ 181 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIAL 181 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHH
Confidence 999998 599999999999999999976554 899999999984
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.5e-21 Score=203.12 Aligned_cols=255 Identities=25% Similarity=0.280 Sum_probs=201.4
Q ss_pred CCCCCchhhcCCCCCCEEEccCCccc--cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccc
Q 044615 36 GLGDDYKELVRAVQARDTSISFDELH--EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSI 113 (571)
Q Consensus 36 ~~~~~~~~l~~~~~l~~l~l~~n~l~--~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~ 113 (571)
++..+|..+. .+++.|+++.|.++ ....++|+.|++++|+++. +|.. .++|+.|+|++|.++ .+
T Consensus 212 ~LtsLP~~l~--~~L~~L~L~~N~Lt~LP~lp~~Lk~LdLs~N~Lts--------LP~l---p~sL~~L~Ls~N~L~-~L 277 (788)
T PRK15387 212 GLTTLPDCLP--AHITTLVIPDNNLTSLPALPPELRTLEVSGNQLTS--------LPVL---PPGLLELSIFSNPLT-HL 277 (788)
T ss_pred CCCcCCcchh--cCCCEEEccCCcCCCCCCCCCCCcEEEecCCccCc--------ccCc---ccccceeeccCCchh-hh
Confidence 4445677665 37999999999988 3346799999999999985 4542 368999999999987 45
Q ss_pred cccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhcc
Q 044615 114 PLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLT 193 (571)
Q Consensus 114 ~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~ 193 (571)
|..+ ++|+.|++++|+++. +|. .+++|+.|+|++|.+.+ +|.. ..+|+.|++++|+++ .+|. ++
T Consensus 278 p~lp---~~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~-~LP~----lp 341 (788)
T PRK15387 278 PALP---SGLCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLT-SLPT----LP 341 (788)
T ss_pred hhch---hhcCEEECcCCcccc-ccc---cccccceeECCCCcccc-CCCC---cccccccccccCccc-cccc----cc
Confidence 5433 578899999999984 454 35789999999999985 4543 246888999999998 4664 33
Q ss_pred CCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEc
Q 044615 194 NSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNL 273 (571)
Q Consensus 194 ~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 273 (571)
.+|+.|++++|+++. +|.. ..+|+.|++++|++.. +|.. ..+|+.|++++|.++. +|.. .++|+.|++
T Consensus 342 ~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdL 409 (788)
T PRK15387 342 SGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL---PSELKELMV 409 (788)
T ss_pred cccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCc---ccCCCEEEc
Confidence 459999999999985 4532 3578899999999985 5543 3679999999999985 4543 368999999
Q ss_pred CCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccC
Q 044615 274 SNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEM 337 (571)
Q Consensus 274 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l 337 (571)
++|++++ +|.. ..+|+.|++++|+++ .+|..++.+++|+.|+|++|+|++..|..+..+
T Consensus 410 S~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l 468 (788)
T PRK15387 410 SGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI 468 (788)
T ss_pred cCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHHH
Confidence 9999985 5643 346889999999997 478899999999999999999999888877443
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.2e-20 Score=197.63 Aligned_cols=245 Identities=28% Similarity=0.445 Sum_probs=126.8
Q ss_pred cceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCC
Q 044615 68 EATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSL 147 (571)
Q Consensus 68 l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L 147 (571)
...|+++.++++. +|..+. ++|+.|+|++|.++ .+|..+. ++|++|++++|+++ .+|..+. .+|
T Consensus 180 ~~~L~L~~~~Lts--------LP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L 243 (754)
T PRK15370 180 KTELRLKILGLTT--------IPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTI 243 (754)
T ss_pred ceEEEeCCCCcCc--------CCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccc
Confidence 4455555555443 344332 35666666666665 3444332 35666666666665 3343332 356
Q ss_pred CeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCcc
Q 044615 148 SILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNN 227 (571)
Q Consensus 148 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~ 227 (571)
+.|+|++|.+. .+|..+. .+|+.|++++|++. .+|..+. .+|+.|++++|.++. +|..+. ++|+.|++++
T Consensus 244 ~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~---~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~ 313 (754)
T PRK15370 244 QEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP---EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQS 313 (754)
T ss_pred cEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC---CCCcEEECCCCcccc-Ccccch--hhHHHHHhcC
Confidence 66666666654 3444332 35666666666665 3454332 236666666666653 332221 3556666666
Q ss_pred CcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccc
Q 044615 228 NELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIP 307 (571)
Q Consensus 228 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 307 (571)
|.++. +|..+ .++|+.|++++|.++. +|..+. ++|+.|++++|+++ .+|..+ .+.|+.|+|++|.++. +|
T Consensus 314 N~Lt~-LP~~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~l--p~~L~~LdLs~N~Lt~-LP 383 (754)
T PRK15370 314 NSLTA-LPETL--PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETL--PPTITTLDVSRNALTN-LP 383 (754)
T ss_pred Ccccc-CCccc--cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhh--cCCcCEEECCCCcCCC-CC
Confidence 66653 23222 2456666666666653 343332 45666666666665 244333 2456666666666654 33
Q ss_pred hhccCCCCCCEEEccCCcCcccccc----ccccCCCCCEEECcCCcCc
Q 044615 308 SQICSMQSLEKLNLSHNNLSGSIPR----CFEEMHWLSCIDISYNALQ 351 (571)
Q Consensus 308 ~~~~~l~~L~~L~Ls~n~l~~~~p~----~~~~l~~L~~L~ls~N~l~ 351 (571)
..+. .+|+.|++++|+++ .+|. ++..++.+..|++.+|+++
T Consensus 384 ~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 384 ENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred HhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 3332 24666666666665 2333 2233455666666666654
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.4e-21 Score=189.90 Aligned_cols=274 Identities=23% Similarity=0.273 Sum_probs=154.2
Q ss_pred eeecccccccCCCCCCCccccccccCCCCCCEEecccCcCccc----ccccccCCCCCCEEEcccCcCcc------cccc
Q 044615 70 TAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGS----IPLALGNLTNLVVLDLSTNKLSG------SIPL 139 (571)
Q Consensus 70 ~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~L~~n~i~~------~~~~ 139 (571)
.|+|+.+.+++.+ .+..+..+.+|++|+++++.++.. ++..+...++|++|+++++.+.+ .++.
T Consensus 2 ~l~L~~~~l~~~~------~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~ 75 (319)
T cd00116 2 QLSLKGELLKTER------ATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQ 75 (319)
T ss_pred ccccccCcccccc------hHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHH
Confidence 3566666666422 234455666788888888877432 44455666778888888777652 2344
Q ss_pred cccCCCCCCeeecccCcCcccCCccccCCCC---CCEEEccCCCCCc----cCChhhhhccCCCcEEEccCCccccc---
Q 044615 140 SFANLTSLSILYLYENSLCDSIPKEIGNMNS---LSILDLSSNKLNG----SIPLSLANLTNSLKVLYLSSNHIVGE--- 209 (571)
Q Consensus 140 ~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~---L~~L~L~~n~l~~----~~p~~~~~l~~~L~~L~l~~n~~~~~--- 209 (571)
.+..+++|+.|++++|.+.+..+..+..+.+ |++|++++|++.+ .+...+..+.++|+.|++++|.+++.
T Consensus 76 ~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~ 155 (319)
T cd00116 76 GLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCE 155 (319)
T ss_pred HHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHH
Confidence 5666778888888888776545555544444 8888888877763 12223334412477777777776632
Q ss_pred -CCccccCCCCCcEEeCccCcCcCC----CChhhhCCCCCCEEEcccCccccc----cchhhccCCCCCEEEcCCccCcc
Q 044615 210 -IPLGHGMLSSLIQLTLNNNELSGQ----LSPELGSLIQLEYLDLSANTFHKS----IPESLSNLVKLHYLNLSNNQFSQ 280 (571)
Q Consensus 210 -~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~Ls~n~l~~ 280 (571)
++..+..+++|+.|++++|.+++. ++..+..+++|+.|++++|.+++. +...+..+++|+.|++++|.+++
T Consensus 156 ~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~ 235 (319)
T cd00116 156 ALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTD 235 (319)
T ss_pred HHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCch
Confidence 222344455666777776666532 122334455677777776666432 22334555666666666666654
Q ss_pred Ccchhhhc-----ccCCCEEEccCCcCCc----ccchhccCCCCCCEEEccCCcCccc----cccccccC-CCCCEEECc
Q 044615 281 KIPNKIEK-----LIHLSELDLSHNIFRE----EIPSQICSMQSLEKLNLSHNNLSGS----IPRCFEEM-HWLSCIDIS 346 (571)
Q Consensus 281 ~~~~~~~~-----l~~L~~L~Ls~n~l~~----~~~~~~~~l~~L~~L~Ls~n~l~~~----~p~~~~~l-~~L~~L~ls 346 (571)
.....+.. .+.|+.|++++|.++. .+...+..+++|+.+++++|.++.. ....+... +.|+.+++.
T Consensus 236 ~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (319)
T cd00116 236 AGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVK 315 (319)
T ss_pred HHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccC
Confidence 22222211 2466666666666542 1223344455666666666666533 22222222 455555555
Q ss_pred CCc
Q 044615 347 YNA 349 (571)
Q Consensus 347 ~N~ 349 (571)
.|+
T Consensus 316 ~~~ 318 (319)
T cd00116 316 DDS 318 (319)
T ss_pred CCC
Confidence 554
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-19 Score=196.06 Aligned_cols=245 Identities=21% Similarity=0.356 Sum_probs=192.4
Q ss_pred CCCCEEEccCCccc---cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccccccccCCCCCC
Q 044615 48 VQARDTSISFDELH---EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLV 124 (571)
Q Consensus 48 ~~l~~l~l~~n~l~---~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 124 (571)
.+...|+++.++++ ..-.+.++.|+|++|+++. +|..+. ++|++|++++|.++ .+|..+. .+|+
T Consensus 178 ~~~~~L~L~~~~LtsLP~~Ip~~L~~L~Ls~N~Lts--------LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~ 244 (754)
T PRK15370 178 NNKTELRLKILGLTTIPACIPEQITTLILDNNELKS--------LPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQ 244 (754)
T ss_pred cCceEEEeCCCCcCcCCcccccCCcEEEecCCCCCc--------CChhhc--cCCCEEECCCCccc-cCChhhh--cccc
Confidence 34678999888777 2233579999999999885 676554 58999999999998 5676554 4799
Q ss_pred EEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCC
Q 044615 125 VLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSN 204 (571)
Q Consensus 125 ~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n 204 (571)
.|+|++|.+. .+|..+. .+|+.|++++|.+. .+|..+. ++|+.|++++|+++ .+|..+. .+|+.|++++|
T Consensus 245 ~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp---~sL~~L~Ls~N 314 (754)
T PRK15370 245 EMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP---SGITHLNVQSN 314 (754)
T ss_pred EEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch---hhHHHHHhcCC
Confidence 9999999998 5676654 58999999999997 4676554 58999999999998 5665543 35999999999
Q ss_pred cccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcch
Q 044615 205 HIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPN 284 (571)
Q Consensus 205 ~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~ 284 (571)
.++. +|..+ .++|+.|++++|.++. +|..+ .++|+.|++++|.++ .+|..+. ++|+.|++++|.++. +|.
T Consensus 315 ~Lt~-LP~~l--~~sL~~L~Ls~N~Lt~-LP~~l--~~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt~-LP~ 384 (754)
T PRK15370 315 SLTA-LPETL--PPGLKTLEAGENALTS-LPASL--PPELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALTN-LPE 384 (754)
T ss_pred cccc-CCccc--cccceeccccCCcccc-CChhh--cCcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCCC-CCH
Confidence 9985 45433 3689999999999986 56555 379999999999997 4666553 689999999999985 555
Q ss_pred hhhcccCCCEEEccCCcCCcccch----hccCCCCCCEEEccCCcCcc
Q 044615 285 KIEKLIHLSELDLSHNIFREEIPS----QICSMQSLEKLNLSHNNLSG 328 (571)
Q Consensus 285 ~~~~l~~L~~L~Ls~n~l~~~~~~----~~~~l~~L~~L~Ls~n~l~~ 328 (571)
.+. ..|+.|++++|++.. +|. ....++.+..|++.+|+++.
T Consensus 385 ~l~--~sL~~LdLs~N~L~~-LP~sl~~~~~~~~~l~~L~L~~Npls~ 429 (754)
T PRK15370 385 NLP--AALQIMQASRNNLVR-LPESLPHFRGEGPQPTRIIVEYNPFSE 429 (754)
T ss_pred hHH--HHHHHHhhccCCccc-CchhHHHHhhcCCCccEEEeeCCCccH
Confidence 553 369999999999975 444 34556889999999999973
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.4e-20 Score=186.98 Aligned_cols=260 Identities=27% Similarity=0.287 Sum_probs=167.0
Q ss_pred CCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcc------cccccccCCCCCCEEEcccCcCccc
Q 044615 63 KLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNG------SIPLALGNLTNLVVLDLSTNKLSGS 136 (571)
Q Consensus 63 ~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~------~~~~~~~~l~~L~~L~L~~n~i~~~ 136 (571)
..+..++.++++++.++... ...++..+...++|+.|+++++.+.+ .++..+..+++|+.|++++|.+...
T Consensus 20 ~~l~~L~~l~l~~~~l~~~~---~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~ 96 (319)
T cd00116 20 PKLLCLQVLRLEGNTLGEEA---AKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPD 96 (319)
T ss_pred HHHhhccEEeecCCCCcHHH---HHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChh
Confidence 34455677777777665411 11345556666777777777776651 2334566677777777777777655
Q ss_pred ccccccCCCC---CCeeecccCcCcc----cCCccccCC-CCCCEEEccCCCCCccC----ChhhhhccCCCcEEEccCC
Q 044615 137 IPLSFANLTS---LSILYLYENSLCD----SIPKEIGNM-NSLSILDLSSNKLNGSI----PLSLANLTNSLKVLYLSSN 204 (571)
Q Consensus 137 ~~~~~~~l~~---L~~L~L~~n~l~~----~~~~~l~~l-~~L~~L~L~~n~l~~~~----p~~~~~l~~~L~~L~l~~n 204 (571)
.+..+..+.+ |++|++++|.+.+ .+...+..+ ++|+.|++++|.+++.. +..+..+.. |+.|++++|
T Consensus 97 ~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~-L~~L~l~~n 175 (319)
T cd00116 97 GCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRD-LKELNLANN 175 (319)
T ss_pred HHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCC-cCEEECcCC
Confidence 5555554444 7788887777753 222344555 77788888888776322 223333333 888888888
Q ss_pred ccccc----CCccccCCCCCcEEeCccCcCcCCC----ChhhhCCCCCCEEEcccCccccccchhhc-----cCCCCCEE
Q 044615 205 HIVGE----IPLGHGMLSSLIQLTLNNNELSGQL----SPELGSLIQLEYLDLSANTFHKSIPESLS-----NLVKLHYL 271 (571)
Q Consensus 205 ~~~~~----~~~~~~~l~~L~~L~l~~n~l~~~~----~~~~~~l~~L~~L~L~~n~l~~~~~~~l~-----~l~~L~~L 271 (571)
.+++. ++..+...++|+.|++++|.+.+.. ...+..+++|+.|++++|.+++.....+. ..+.|+.|
T Consensus 176 ~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L 255 (319)
T cd00116 176 GIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTL 255 (319)
T ss_pred CCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEE
Confidence 77632 2233445568888888888776432 33456678899999999888753333322 23789999
Q ss_pred EcCCccCcc----CcchhhhcccCCCEEEccCCcCCcc----cchhccCC-CCCCEEEccCCcC
Q 044615 272 NLSNNQFSQ----KIPNKIEKLIHLSELDLSHNIFREE----IPSQICSM-QSLEKLNLSHNNL 326 (571)
Q Consensus 272 ~Ls~n~l~~----~~~~~~~~l~~L~~L~Ls~n~l~~~----~~~~~~~l-~~L~~L~Ls~n~l 326 (571)
++++|.++. .+...+..+++|+.+++++|.+... ....+... +.|+.+++.+|.+
T Consensus 256 ~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 256 SLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred EccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 999998862 2334556668899999999998754 44445555 7888898888764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.5e-21 Score=160.27 Aligned_cols=161 Identities=35% Similarity=0.580 Sum_probs=127.9
Q ss_pred cccccccCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccC
Q 044615 88 SIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGN 167 (571)
Q Consensus 88 ~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~ 167 (571)
.+|. +.++.+++.|.||+|.++ .+|..++.+.+|+.|++++|+|+ ..|.+++.++.|++|+++-|++. ..|..|+.
T Consensus 25 ~~~g-Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs 100 (264)
T KOG0617|consen 25 ELPG-LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGS 100 (264)
T ss_pred hccc-ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCC
Confidence 4443 456788899999999998 67788999999999999999997 67888999999999999999985 78999999
Q ss_pred CCCCCEEEccCCCCCc-cCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCE
Q 044615 168 MNSLSILDLSSNKLNG-SIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEY 246 (571)
Q Consensus 168 l~~L~~L~L~~n~l~~-~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 246 (571)
++.|+.|||.+|++.. .+|..|+-++. |+.|+++.|.+. .+|..++.+++|+.|.+..|.+- .+|..++.+++|+.
T Consensus 101 ~p~levldltynnl~e~~lpgnff~m~t-lralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lre 177 (264)
T KOG0617|consen 101 FPALEVLDLTYNNLNENSLPGNFFYMTT-LRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRE 177 (264)
T ss_pred CchhhhhhccccccccccCCcchhHHHH-HHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHH
Confidence 9999999999998864 57777887776 888888888876 56666677777777777666665 35666666666666
Q ss_pred EEcccCccc
Q 044615 247 LDLSANTFH 255 (571)
Q Consensus 247 L~L~~n~l~ 255 (571)
|.+.+|+++
T Consensus 178 lhiqgnrl~ 186 (264)
T KOG0617|consen 178 LHIQGNRLT 186 (264)
T ss_pred Hhcccceee
Confidence 666666665
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=7.3e-18 Score=161.38 Aligned_cols=97 Identities=23% Similarity=0.372 Sum_probs=86.0
Q ss_pred HHccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeE
Q 044615 459 RATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSF 537 (571)
Q Consensus 459 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~ 537 (571)
+..++|...+.||+|+||+||+|+ .+++..||||.+.+... ..+..+....||++|+.++|||||++++++++++.+|
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~ 85 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIY 85 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEE
Confidence 345679999999999999999999 45789999999987643 2355677899999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhccCC
Q 044615 538 VVYEYLEMGSLAMNLSNDA 556 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~~ 556 (571)
+|||||.||||.+||+.++
T Consensus 86 lVMEyC~gGDLs~yi~~~~ 104 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRG 104 (429)
T ss_pred EEEEeCCCCCHHHHHHHcC
Confidence 9999999999999999764
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=8.8e-20 Score=153.83 Aligned_cols=163 Identities=30% Similarity=0.504 Sum_probs=140.5
Q ss_pred CCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccC
Q 044615 64 LLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFAN 143 (571)
Q Consensus 64 ~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~ 143 (571)
.+...+.|.|++|+++ .+|..+..+.+|+.|++++|++. .+|.+++.+++|+.|++.-|++. ..|..|+.
T Consensus 31 ~~s~ITrLtLSHNKl~--------~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs 100 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT--------VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGS 100 (264)
T ss_pred chhhhhhhhcccCcee--------ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCC
Confidence 4556677778888887 47888999999999999999997 78889999999999999999986 78899999
Q ss_pred CCCCCeeecccCcCcc-cCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcE
Q 044615 144 LTSLSILYLYENSLCD-SIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQ 222 (571)
Q Consensus 144 l~~L~~L~L~~n~l~~-~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~ 222 (571)
+|.|+.|||.+|++.. .+|..|..++.|+.|+|++|.+. .+|..++++++ |+.|.+..|.+- .+|..++.++.|++
T Consensus 101 ~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~-lqil~lrdndll-~lpkeig~lt~lre 177 (264)
T KOG0617|consen 101 FPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTN-LQILSLRDNDLL-SLPKEIGDLTRLRE 177 (264)
T ss_pred CchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcc-eeEEeeccCchh-hCcHHHHHHHHHHH
Confidence 9999999999988874 57888888999999999999997 88999999987 999999999886 67888999999999
Q ss_pred EeCccCcCcCCCChhhhC
Q 044615 223 LTLNNNELSGQLSPELGS 240 (571)
Q Consensus 223 L~l~~n~l~~~~~~~~~~ 240 (571)
|++.+|+++ .+|+.++.
T Consensus 178 lhiqgnrl~-vlppel~~ 194 (264)
T KOG0617|consen 178 LHIQGNRLT-VLPPELAN 194 (264)
T ss_pred Hhcccceee-ecChhhhh
Confidence 999999998 46666654
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.63 E-value=5.5e-16 Score=148.46 Aligned_cols=95 Identities=26% Similarity=0.365 Sum_probs=81.7
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchH----hHHHHHHHHHHHhhcCCCCcccEEEEEEeCCe
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMA----CQQEFLNEVNALTKIRHRNIVKFYGFCSHALH 535 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~----~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~ 535 (571)
.+.|.+.+.+|+|+||.|..|. .++|+.||||++.+....... ....+.+|+++|++++|||||+++++|..++.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 3457889999999999999998 679999999999875543311 22346799999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhhccC
Q 044615 536 SFVVYEYLEMGSLAMNLSND 555 (571)
Q Consensus 536 ~~lv~e~~~~G~L~~~l~~~ 555 (571)
.|||||||+||+|++++-..
T Consensus 251 ~YmVlE~v~GGeLfd~vv~n 270 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVAN 270 (475)
T ss_pred eEEEEEEecCccHHHHHHhc
Confidence 99999999999999999754
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.2e-15 Score=151.96 Aligned_cols=104 Identities=31% Similarity=0.513 Sum_probs=88.4
Q ss_pred ccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC-eeEEEEeccC
Q 044615 466 DGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL-HSFVVYEYLE 544 (571)
Q Consensus 466 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~-~~~lv~e~~~ 544 (571)
..+.+|+|+||+||+|.+.....||||++......... .+.|.+|+.+|.+++|||||+++|+|.++. ..++|||||+
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 34559999999999999865445999999866544433 678999999999999999999999999887 7899999999
Q ss_pred CCChhhhhccCCCccCCCHHHHhhhcC
Q 044615 545 MGSLAMNLSNDAAAEQFCWTKRMNAIK 571 (571)
Q Consensus 545 ~G~L~~~l~~~~~~~~l~w~~r~~ia~ 571 (571)
+|+|.++++.. ....++|..+++||.
T Consensus 124 ~GsL~~~l~~~-~~~~l~~~~~l~~al 149 (362)
T KOG0192|consen 124 GGSLSVLLHKK-RKRKLPLKVRLRIAL 149 (362)
T ss_pred CCcHHHHHhhc-ccCCCCHHHHHHHHH
Confidence 99999999864 334799999999873
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.1e-15 Score=151.15 Aligned_cols=113 Identities=24% Similarity=0.368 Sum_probs=90.9
Q ss_pred HHHHHccCCCccCeeeccCcceEEEEEcC--CC--CE-EEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEE
Q 044615 456 EIIRATNNFDDGHCIGNGGQGSVYKAKLP--TG--EI-VDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFC 530 (571)
Q Consensus 456 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~--~~-vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~ 530 (571)
.+.-..++-...+.||+|+||.||+|.++ ++ .. ||||..............+|++|+++|+.++|||||+++|++
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 33334445556689999999999999843 22 23 899998754433345578899999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 531 SHALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 531 ~~~~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
.....+|+|||+|.||+|.++|+..+. .+++.++++.+
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~ 268 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFC 268 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHH
Confidence 999999999999999999999986544 57888887754
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.57 E-value=6.7e-15 Score=153.88 Aligned_cols=107 Identities=23% Similarity=0.405 Sum_probs=87.0
Q ss_pred cCCCccCeeeccCcceEEEEEcC------CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLP------TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALH 535 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~ 535 (571)
.+.+..+.||+|+||+||+|+.. +...||||.++... +.+.+++|.||+++++.++|||||+++|.|..++.
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 44556688999999999999832 34679999998543 33467899999999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhhccCCC-----------ccCCCHHHHhhhc
Q 044615 536 SFVVYEYLEMGSLAMNLSNDAA-----------AEQFCWTKRMNAI 570 (571)
Q Consensus 536 ~~lv~e~~~~G~L~~~l~~~~~-----------~~~l~w~~r~~ia 570 (571)
.|+|+|||..|||.++|+-..+ ..+|+-.+-+.||
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA 609 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIA 609 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHH
Confidence 9999999999999999985322 1236666666655
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=7.4e-15 Score=147.85 Aligned_cols=94 Identities=32% Similarity=0.548 Sum_probs=87.1
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
..|..++.||+|||+.||.++ ..+|+.||+|++.+.........+...+||++.++++|||||+++++|++.+.+|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 459999999999999999999 5899999999999877666677888999999999999999999999999999999999
Q ss_pred eccCCCChhhhhccC
Q 044615 541 EYLEMGSLAMNLSND 555 (571)
Q Consensus 541 e~~~~G~L~~~l~~~ 555 (571)
|+|++|+|..+++++
T Consensus 98 ELC~~~sL~el~Krr 112 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR 112 (592)
T ss_pred EecCCccHHHHHHhc
Confidence 999999999999844
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.7e-15 Score=144.38 Aligned_cols=95 Identities=19% Similarity=0.295 Sum_probs=88.0
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
..|++.+.+|+|.||+|-+|. ...|+.||||.|+++...+.++.-.+.+||+||+.++||||++++++|+..+...|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 358888999999999999998 6799999999999988887777788999999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCC
Q 044615 541 EYLEMGSLAMNLSNDA 556 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~ 556 (571)
||..+|+|+||+.+++
T Consensus 133 EYaS~GeLYDYiSer~ 148 (668)
T KOG0611|consen 133 EYASGGELYDYISERG 148 (668)
T ss_pred EecCCccHHHHHHHhc
Confidence 9999999999998654
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.9e-15 Score=151.65 Aligned_cols=102 Identities=24% Similarity=0.397 Sum_probs=86.2
Q ss_pred CCccCeeeccCcceEEEEEcC----CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 464 FDDGHCIGNGGQGSVYKAKLP----TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
..+.++||.|.||+||+|+++ ....||||.++.... .+.+.+|..|+.||.+++||||+++-|+.......+||
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt--ekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc--HHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 345789999999999999954 345799999986543 35578899999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
.|||+||+|..+|+..++ +++|.+.+.+
T Consensus 709 TEyMENGsLDsFLR~~DG--qftviQLVgM 736 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDG--QFTVIQLVGM 736 (996)
T ss_pred hhhhhCCcHHHHHhhcCC--ceEeehHHHH
Confidence 999999999999997765 4777665543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.1e-14 Score=144.85 Aligned_cols=100 Identities=26% Similarity=0.414 Sum_probs=83.3
Q ss_pred CccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEeccC
Q 044615 465 DDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLE 544 (571)
Q Consensus 465 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 544 (571)
...+.||+|.||+||.|.+.....||+|.+...... .+.|.+|+++|++++|+|||+++|+|..++.+|||||||+
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 445779999999999999977779999999765322 4789999999999999999999999999889999999999
Q ss_pred CCChhhhhccCCCccCCCHHHHhhh
Q 044615 545 MGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 545 ~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
.|+|.++|+.+++ ..+.-.+.+.+
T Consensus 285 ~GsLl~yLr~~~~-~~l~~~~Ll~~ 308 (468)
T KOG0197|consen 285 KGSLLDYLRTREG-GLLNLPQLLDF 308 (468)
T ss_pred cCcHHHHhhhcCC-CccchHHHHHH
Confidence 9999999986322 34555544444
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.1e-14 Score=138.57 Aligned_cols=96 Identities=27% Similarity=0.368 Sum_probs=87.3
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.++|++.++||+|+||+||.++ ..+++.+|+|++++...-..+..+...+|..++.+++||.||+++..|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 4679999999999999999999 568999999999987666556678899999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCC
Q 044615 540 YEYLEMGSLAMNLSNDA 556 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~ 556 (571)
+||+.||+|+.+|++++
T Consensus 104 ld~~~GGeLf~hL~~eg 120 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG 120 (357)
T ss_pred EeccCCccHHHHHHhcC
Confidence 99999999999998543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.8e-14 Score=142.87 Aligned_cols=105 Identities=22% Similarity=0.280 Sum_probs=92.4
Q ss_pred HccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEE
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFV 538 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l 538 (571)
..++|+....||+|+||.||.|+ ..+|..+|+|++++.........+.+..|-.+|...++|+||+++..|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 45789999999999999999999 56899999999998776666667889999999999999999999999999999999
Q ss_pred EEeccCCCChhhhhccCCCccCCCHHH
Q 044615 539 VYEYLEMGSLAMNLSNDAAAEQFCWTK 565 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~~~~~~l~w~~ 565 (571)
||||+||||+..+|...+. ..-+|++
T Consensus 219 iMEylPGGD~mTLL~~~~~-L~e~~ar 244 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDT-LTEDWAR 244 (550)
T ss_pred EEEecCCccHHHHHHhcCc-CchHHHH
Confidence 9999999999999986543 3456654
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=9.2e-15 Score=130.50 Aligned_cols=95 Identities=24% Similarity=0.464 Sum_probs=85.0
Q ss_pred HccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEE
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFV 538 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l 538 (571)
+.++|++++.+|+|.||.||.|+ .+++-.||+|++.+......+..+++.+||+|-+.++||||.+++++|.+....|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 34679999999999999999999 56788999999977654444556789999999999999999999999999999999
Q ss_pred EEeccCCCChhhhhcc
Q 044615 539 VYEYLEMGSLAMNLSN 554 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~ 554 (571)
++||.++|+++..|++
T Consensus 100 ilEya~~gel~k~L~~ 115 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQE 115 (281)
T ss_pred EEEecCCchHHHHHHh
Confidence 9999999999999984
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.1e-15 Score=137.53 Aligned_cols=92 Identities=26% Similarity=0.433 Sum_probs=79.7
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEE-EEEeCCe-eEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYG-FCSHALH-SFV 538 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~-~~~~~~~-~~l 538 (571)
.+|++.++||+|+||.||++. ..+|..+|.|.++-. ..+.+..+.+..||.+|++++|||||++++ .+.+..+ ++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~-~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG-MMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchh-hccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 358888999999999999999 779999999999843 344567888999999999999999999998 5555554 899
Q ss_pred EEeccCCCChhhhhcc
Q 044615 539 VYEYLEMGSLAMNLSN 554 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~ 554 (571)
|||||..|||...|+.
T Consensus 98 vmE~c~~GDLsqmIk~ 113 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKH 113 (375)
T ss_pred HHHhhcccCHHHHHHH
Confidence 9999999999999974
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.2e-13 Score=147.01 Aligned_cols=117 Identities=34% Similarity=0.554 Sum_probs=102.2
Q ss_pred CCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcC
Q 044615 268 LHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISY 347 (571)
Q Consensus 268 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~ 347 (571)
++.|+|++|.+.+.+|..+..+++|+.|+|++|.+.+.+|..++.+++|+.|+|++|++++.+|+.+..+++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 77899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCcccCCCCC--ccCCCCcccccCCcCCCCCCCCCCCCC
Q 044615 348 NALQGLIPNST--AFRDAPMLALQGNKRLCGDIKRLPPCK 385 (571)
Q Consensus 348 N~l~~~~~~~~--~~~~~~~l~l~~n~~~c~~~~~~~~~~ 385 (571)
|+++|.+|... .......+.+.+|+..|+. +.++.|.
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~-p~l~~C~ 538 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGI-PGLRACG 538 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCccccCC-CCCCCCc
Confidence 99999988632 1234456788999999974 3456774
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=6.5e-14 Score=139.64 Aligned_cols=93 Identities=27% Similarity=0.425 Sum_probs=82.7
Q ss_pred cCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
....+.++||+|.||+|..+....+..||||.++..... ..+.+|.+||++|.+++|||||+++|+|..++.+++|+|
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~--~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATK--NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccch--hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 445677899999999999999877899999999875433 336889999999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCC
Q 044615 542 YLEMGSLAMNLSNDA 556 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~ 556 (571)
||++|||.+++..+.
T Consensus 616 YmEnGDLnqFl~ahe 630 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHE 630 (807)
T ss_pred HHhcCcHHHHHHhcc
Confidence 999999999998653
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.2e-13 Score=137.24 Aligned_cols=93 Identities=28% Similarity=0.360 Sum_probs=82.7
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|.+.+.||+|+||.||||+. .+.+.||+|.+.+....+ +..+...+|++++++++|||||.++++|++..++|+|.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~-k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE-KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch-HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 4677888899999999999994 478999999998776543 56778999999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCC
Q 044615 541 EYLEMGSLAMNLSNDA 556 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~ 556 (571)
|||.| +|+.+|.+++
T Consensus 81 e~a~g-~L~~il~~d~ 95 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDG 95 (808)
T ss_pred hhhhh-hHHHHHHhcc
Confidence 99987 9999998654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=5.7e-13 Score=126.91 Aligned_cols=90 Identities=30% Similarity=0.417 Sum_probs=78.3
Q ss_pred CCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC-eeEEEEe
Q 044615 464 FDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL-HSFVVYE 541 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~-~~~lv~e 541 (571)
.+..+.||+|..|+||++++ ++++.+|+|.+... .+...++++.+|++++.+++||+||.+||+|.... ..+|+||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 44567899999999999994 58999999999543 23355788999999999999999999999999998 5999999
Q ss_pred ccCCCChhhhhccC
Q 044615 542 YLEMGSLAMNLSND 555 (571)
Q Consensus 542 ~~~~G~L~~~l~~~ 555 (571)
||++|+|.+.++..
T Consensus 159 YMDgGSLd~~~k~~ 172 (364)
T KOG0581|consen 159 YMDGGSLDDILKRV 172 (364)
T ss_pred hcCCCCHHHHHhhc
Confidence 99999999999853
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.7e-13 Score=133.51 Aligned_cols=92 Identities=32% Similarity=0.503 Sum_probs=78.0
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC--CeeEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA--LHSFV 538 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~--~~~~l 538 (571)
+.|+..+.||+|.||.||+|+ ..+|+.||+|++..+.... ....-..|||.||++++|||||++.+...+. ..+||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~-~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKE-GFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCC-cchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 457778899999999999999 7799999999998665332 3345567999999999999999999999876 68999
Q ss_pred EEeccCCCChhhhhccC
Q 044615 539 VYEYLEMGSLAMNLSND 555 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~ 555 (571)
|+|||+. ||.-++...
T Consensus 196 VFeYMdh-DL~GLl~~p 211 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSP 211 (560)
T ss_pred EEecccc-hhhhhhcCC
Confidence 9999997 898877653
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=6.2e-13 Score=129.89 Aligned_cols=97 Identities=30% Similarity=0.453 Sum_probs=81.2
Q ss_pred CCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHh--hcCCCCcccEEEEEEeCC----ee
Q 044615 463 NFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALT--KIRHRNIVKFYGFCSHAL----HS 536 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~--~l~H~niv~l~~~~~~~~----~~ 536 (571)
+.+....+|+|+||.||+|++ +++.||||++.. ...+.|..|-.|.+ .++|+||++++++-.... ++
T Consensus 211 pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred chhhHHHhhcCccceeehhhc-cCceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 445667899999999999998 469999999863 33567888887765 579999999999887665 78
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+||+||.+.|+|.+||+.. .++|....+||
T Consensus 284 wLVt~fh~kGsL~dyL~~n----tisw~~~cria 313 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKAN----TISWNSLCRIA 313 (534)
T ss_pred eEEeeeccCCcHHHHHHhc----cccHHHHHHHH
Confidence 9999999999999999854 58999988876
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.8e-13 Score=123.92 Aligned_cols=95 Identities=22% Similarity=0.337 Sum_probs=86.3
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|+..+.+|.|+||.|..++ ..+|..+|+|++++...-..+..++..+|..+++.+.||++|++++.|.+.+.+||||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 468889999999999999999 4578999999998876666677788999999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCC
Q 044615 541 EYLEMGSLAMNLSNDA 556 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~ 556 (571)
||++||.|+.++++.+
T Consensus 124 eyv~GGElFS~Lrk~~ 139 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG 139 (355)
T ss_pred eccCCccHHHHHHhcC
Confidence 9999999999998643
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.8e-13 Score=122.94 Aligned_cols=92 Identities=24% Similarity=0.460 Sum_probs=80.1
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
.|...+.+|+|.||.||+|+ .++|+.||||+++.....+ +-.....|||+.++.++|||||.++++|-..+.+.+|+|
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 47788899999999999999 7799999999998764432 223457899999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCC
Q 044615 542 YLEMGSLAMNLSNDA 556 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~ 556 (571)
||+. ||+..|++..
T Consensus 82 fm~t-dLe~vIkd~~ 95 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKN 95 (318)
T ss_pred eccc-cHHHHhcccc
Confidence 9997 9999998654
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.39 E-value=9.1e-13 Score=134.61 Aligned_cols=94 Identities=23% Similarity=0.291 Sum_probs=81.3
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|++.+.||+|+||.||+|+ ..+++.||||++.............+.+|++++..++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 368899999999999999999 4579999999997543222234566889999999999999999999999999999999
Q ss_pred eccCCCChhhhhccC
Q 044615 541 EYLEMGSLAMNLSND 555 (571)
Q Consensus 541 e~~~~G~L~~~l~~~ 555 (571)
||+++|+|.+++...
T Consensus 81 E~~~~g~L~~~l~~~ 95 (364)
T cd05599 81 EYLPGGDMMTLLMKK 95 (364)
T ss_pred CCCCCcHHHHHHHHc
Confidence 999999999999754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.2e-12 Score=134.38 Aligned_cols=93 Identities=18% Similarity=0.163 Sum_probs=81.6
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
.|+..+.||+|+||+||+|+ ..+++.||+|++.+.........+.+.+|++++++++|||||++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 58889999999999999998 56889999999976443333445679999999999999999999999999999999999
Q ss_pred ccCCCChhhhhccC
Q 044615 542 YLEMGSLAMNLSND 555 (571)
Q Consensus 542 ~~~~G~L~~~l~~~ 555 (571)
|+++|+|.+++.+.
T Consensus 82 ~~~gg~L~~~l~~~ 95 (381)
T cd05626 82 YIPGGDMMSLLIRM 95 (381)
T ss_pred cCCCCcHHHHHHhc
Confidence 99999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.39 E-value=6.7e-13 Score=131.06 Aligned_cols=104 Identities=18% Similarity=0.257 Sum_probs=85.7
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|+..+.||+|+||.||+|.. .+++.||+|++...........+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 3688899999999999999994 579999999997543333334567889999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMN 568 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ 568 (571)
||+++|+|.+++...+ .+++.....
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~ 105 (291)
T cd05612 81 EYVPGGELFSYLRNSG---RFSNSTGLF 105 (291)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHH
Confidence 9999999999997543 345554443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.38 E-value=2e-14 Score=143.04 Aligned_cols=176 Identities=38% Similarity=0.611 Sum_probs=88.1
Q ss_pred CEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccC
Q 044615 124 VVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSS 203 (571)
Q Consensus 124 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~ 203 (571)
...||+.|++. .+|..++.+..|+.+.|+.|.+. .+|..+..+..|++|+|+.|+++ .+|..+..++ |+.|.+++
T Consensus 78 ~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp--Lkvli~sN 152 (722)
T KOG0532|consen 78 VFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP--LKVLIVSN 152 (722)
T ss_pred hhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc--ceeEEEec
Confidence 33444444444 34444444444555555555543 34444555555555555555554 4444444443 55555555
Q ss_pred CcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcc
Q 044615 204 NHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIP 283 (571)
Q Consensus 204 n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~ 283 (571)
|+++ .+|..++....|..|+.+.|.+. .+|..++++.+|+.|.+..|++. .+|..+..| .|..||+|.|+++ .+|
T Consensus 153 Nkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iP 227 (722)
T KOG0532|consen 153 NKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLP 227 (722)
T ss_pred Cccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecc
Confidence 5554 34444444555555555555554 24445555555555555555554 233444433 3555555555554 445
Q ss_pred hhhhcccCCCEEEccCCcCCcccchhc
Q 044615 284 NKIEKLIHLSELDLSHNIFREEIPSQI 310 (571)
Q Consensus 284 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~ 310 (571)
-.|.++.+|++|-|.+|.++. .|..+
T Consensus 228 v~fr~m~~Lq~l~LenNPLqS-PPAqI 253 (722)
T KOG0532|consen 228 VDFRKMRHLQVLQLENNPLQS-PPAQI 253 (722)
T ss_pred hhhhhhhhheeeeeccCCCCC-ChHHH
Confidence 555555555555555555543 34333
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.1e-12 Score=131.95 Aligned_cols=95 Identities=23% Similarity=0.316 Sum_probs=84.5
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcC-CCCcccEEEEEEeCCeeEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR-HRNIVKFYGFCSHALHSFV 538 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~l 538 (571)
...|+..+.||+|.||.||+++ ..+|+.+|+|.+.+.........+.+.+|+++|+++. |||||+++++|++....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 4468888999999999999999 4569999999998766554444678999999999998 9999999999999999999
Q ss_pred EEeccCCCChhhhhccC
Q 044615 539 VYEYLEMGSLAMNLSND 555 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~ 555 (571)
|||+|.||+|++.|...
T Consensus 114 vmEL~~GGeLfd~i~~~ 130 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK 130 (382)
T ss_pred EEEecCCchHHHHHHHc
Confidence 99999999999999754
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.5e-12 Score=133.64 Aligned_cols=94 Identities=21% Similarity=0.236 Sum_probs=81.1
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|.+.+.||+|+||.||++. ..+++.||||++.+.........+.+.+|++++++++|||||++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 368889999999999999998 5689999999986543222234567889999999999999999999999999999999
Q ss_pred eccCCCChhhhhccC
Q 044615 541 EYLEMGSLAMNLSND 555 (571)
Q Consensus 541 e~~~~G~L~~~l~~~ 555 (571)
||+++|+|.+++...
T Consensus 81 E~~~gg~L~~~l~~~ 95 (377)
T cd05629 81 EFLPGGDLMTMLIKY 95 (377)
T ss_pred eCCCCCcHHHHHHhc
Confidence 999999999999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.2e-12 Score=125.62 Aligned_cols=105 Identities=21% Similarity=0.306 Sum_probs=87.1
Q ss_pred cCCCccCeeeccCcceEEEEEc----CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL----PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSF 537 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~ 537 (571)
.+|++.+.||+|+||.||+|.. ..+..||+|.++.... ....+.|.+|+..+++++||||+++++++..++..+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 4588889999999999999974 2456899999975432 233567999999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 538 VVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+||||+++|+|.+++.... ..++|.+.+.++
T Consensus 83 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~ 113 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHE--GQLVAGQLMGML 113 (266)
T ss_pred EEEEeCCCCcHHHHHHhCC--CCCCHHHHHHHH
Confidence 9999999999999997543 257788777654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.6e-12 Score=131.06 Aligned_cols=103 Identities=25% Similarity=0.317 Sum_probs=85.1
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|++.+.||+|+||.||+|+. .+++.||||++.+.........+.+.+|++++..++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 3688999999999999999994 478999999997543322334567899999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRM 567 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~ 567 (571)
||+++|+|.+++.... .+++....
T Consensus 81 e~~~g~~L~~~l~~~~---~l~~~~~~ 104 (333)
T cd05600 81 EYVPGGDFRTLLNNLG---VLSEDHAR 104 (333)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHH
Confidence 9999999999997543 34444433
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.7e-12 Score=132.39 Aligned_cols=104 Identities=18% Similarity=0.218 Sum_probs=85.8
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|+..+.||+|+||+||+|. ..+++.||+|++.+.........+.+.+|+.++.+++||||+++++.+.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 368899999999999999998 5578999999997543322334567889999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMN 568 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ 568 (571)
||+++|+|.+++.+.+ .+++.....
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~ 105 (363)
T cd05628 81 EFLPGGDMMTLLMKKD---TLTEEETQF 105 (363)
T ss_pred cCCCCCcHHHHHHhcC---CCCHHHHHH
Confidence 9999999999997543 355554443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.3e-12 Score=126.90 Aligned_cols=107 Identities=21% Similarity=0.230 Sum_probs=87.1
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
.|+..+.||+|+||.||++. ..+++.||||++.............+.+|+.++++++||||+++++++.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 37788999999999999999 45789999999975433332334567899999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+++|+|.+++.... ...+++.....++
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~ 108 (285)
T cd05605 81 LMNGGDLKFHIYNMG-NPGFDEERAVFYA 108 (285)
T ss_pred ccCCCcHHHHHHhcC-cCCCCHHHHHHHH
Confidence 999999999886432 2357777666553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.7e-12 Score=130.72 Aligned_cols=97 Identities=25% Similarity=0.393 Sum_probs=82.7
Q ss_pred HccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCC-c-hHhHHHHHHHHHHHhhcC-CCCcccEEEEEEeCCe
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPD-E-MACQQEFLNEVNALTKIR-HRNIVKFYGFCSHALH 535 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-~-~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~~~ 535 (571)
..+.|..++.||+|+||+|+.|. ..+++.||+|.+.+.... . ....+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 45679999999999999999998 568899999987764221 1 123456779999999999 9999999999999999
Q ss_pred eEEEEeccCCCChhhhhccCC
Q 044615 536 SFVVYEYLEMGSLAMNLSNDA 556 (571)
Q Consensus 536 ~~lv~e~~~~G~L~~~l~~~~ 556 (571)
.|+|||||.||+|++++.+++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g 115 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKG 115 (370)
T ss_pred EEEEEEecCCccHHHHHHHcC
Confidence 999999999999999998743
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.6e-12 Score=126.53 Aligned_cols=106 Identities=21% Similarity=0.230 Sum_probs=87.0
Q ss_pred CCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEec
Q 044615 464 FDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEY 542 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 542 (571)
|+..+.||+|+||.||+|. ..+|+.||||.+.+...........+.+|+.++++++||||+++.+++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 6778899999999999998 568999999998754433323345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 543 LEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 543 ~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+++|+|.+++.... ...+++.+...++
T Consensus 82 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~ 108 (285)
T cd05631 82 MNGGDLKFHIYNMG-NPGFDEQRAIFYA 108 (285)
T ss_pred cCCCcHHHHHHhhC-CCCCCHHHHHHHH
Confidence 99999998886432 2357777766654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.9e-12 Score=130.11 Aligned_cols=94 Identities=24% Similarity=0.310 Sum_probs=81.7
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|++.+.||+|+||.||+|+. .+++.||||++...........+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 5688999999999999999994 578999999997543222234567899999999999999999999999999999999
Q ss_pred eccCCCChhhhhccC
Q 044615 541 EYLEMGSLAMNLSND 555 (571)
Q Consensus 541 e~~~~G~L~~~l~~~ 555 (571)
||+++|+|.+++.+.
T Consensus 98 e~~~~~~L~~~l~~~ 112 (329)
T PTZ00263 98 EFVVGGELFTHLRKA 112 (329)
T ss_pred cCCCCChHHHHHHHc
Confidence 999999999999754
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.9e-12 Score=124.02 Aligned_cols=103 Identities=20% Similarity=0.372 Sum_probs=86.6
Q ss_pred cCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
++|+..+.||+|+||.||++..+++..+|+|.+...... .++|.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 79 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE 79 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence 357888999999999999999877788999998644222 3578899999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+++|+|.++++.... .++|..++.++
T Consensus 80 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~ 106 (256)
T cd05114 80 FMENGCLLNYLRQRQG--KLSKDMLLSMC 106 (256)
T ss_pred cCCCCcHHHHHHhCcc--CCCHHHHHHHH
Confidence 9999999999975432 47777766654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.36 E-value=4.1e-12 Score=124.89 Aligned_cols=100 Identities=22% Similarity=0.335 Sum_probs=83.5
Q ss_pred cCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEe----CCeeEEEEec
Q 044615 467 GHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSH----ALHSFVVYEY 542 (571)
Q Consensus 467 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~----~~~~~lv~e~ 542 (571)
...+|+|++|.||+|.. +|+.||||.+...........+.|.+|+.++++++|||||+++|++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999998 688999999976544443345778999999999999999999999977 4568999999
Q ss_pred cCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 543 LEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 543 ~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+++|+|.+++++.. .++|..++++|
T Consensus 104 ~~~g~L~~~l~~~~---~~~~~~~~~i~ 128 (283)
T PHA02988 104 CTRGYLREVLDKEK---DLSFKTKLDMA 128 (283)
T ss_pred CCCCcHHHHHhhCC---CCChhHHHHHH
Confidence 99999999998542 57787777664
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.6e-12 Score=131.81 Aligned_cols=94 Identities=18% Similarity=0.180 Sum_probs=81.0
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|++.+.||+|+||.||+|+ ..+++.||||++.+.........+.+.+|++++++++||||+++++.+.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 368999999999999999999 5579999999986533222233566889999999999999999999999999999999
Q ss_pred eccCCCChhhhhccC
Q 044615 541 EYLEMGSLAMNLSND 555 (571)
Q Consensus 541 e~~~~G~L~~~l~~~ 555 (571)
||+++|+|.+++.+.
T Consensus 81 E~~~~g~L~~~i~~~ 95 (376)
T cd05598 81 DYIPGGDMMSLLIRL 95 (376)
T ss_pred eCCCCCcHHHHHHhc
Confidence 999999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.9e-12 Score=129.52 Aligned_cols=97 Identities=24% Similarity=0.315 Sum_probs=85.2
Q ss_pred HHccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeE
Q 044615 459 RATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSF 537 (571)
Q Consensus 459 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~ 537 (571)
...+.|.+...||+|.|++|..|+ ..++..||+|.+++..-.. ...+.+.+|+++|+.++|||||+++.+.++...+|
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~-~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP-SKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh-HHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 345678999999999999999999 4589999999998765443 44456889999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhccCC
Q 044615 538 VVYEYLEMGSLAMNLSNDA 556 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~~ 556 (571)
+||||+.+|++++++...+
T Consensus 132 lV~eya~~ge~~~yl~~~g 150 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHG 150 (596)
T ss_pred EEEEeccCchhHHHHHhcc
Confidence 9999999999999998654
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.34 E-value=5e-12 Score=138.27 Aligned_cols=109 Identities=26% Similarity=0.336 Sum_probs=89.6
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|++.+.||+|+||.||+|. ..+|+.||+|++...........++|.+|++++++++|||||++++++.+++..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 578999999999999999999 4579999999997654444445678999999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCC--------CccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDA--------AAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~--------~~~~l~w~~r~~ia 570 (571)
||++||+|.+++.... ....++|...++|+
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~ 119 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHH
Confidence 9999999999986421 12345666655543
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.34 E-value=3e-12 Score=129.16 Aligned_cols=104 Identities=20% Similarity=0.222 Sum_probs=84.0
Q ss_pred cCCCccCeeeccCcceEEEEEcC-C-CCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLP-T-GEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
++|+..+.||+|+||.||+|..+ . +..||+|++.+.........+.+.+|+++++.++|||||++++++.+.+..|+|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 46889999999999999999843 3 468999998654322233456788999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhh
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMN 568 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ 568 (571)
|||+++|+|.+++.... .+++.....
T Consensus 110 ~Ey~~~g~L~~~i~~~~---~~~~~~~~~ 135 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK---RFPNDVGCF 135 (340)
T ss_pred EeCCCCCcHHHHHHHcC---CCCHHHHHH
Confidence 99999999999997543 355554443
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.34 E-value=2.8e-12 Score=131.30 Aligned_cols=92 Identities=26% Similarity=0.416 Sum_probs=78.3
Q ss_pred ccCCCccCeeeccCcceEEEEEc------CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeC
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKL------PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHA 533 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~ 533 (571)
.++|++.+.||+|+||.||+|.. .++..||||+++.... ....+.+.+|++++..+ +|||||+++++|.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 34688899999999999999962 2456899999975432 23356789999999999 899999999999999
Q ss_pred CeeEEEEeccCCCChhhhhcc
Q 044615 534 LHSFVVYEYLEMGSLAMNLSN 554 (571)
Q Consensus 534 ~~~~lv~e~~~~G~L~~~l~~ 554 (571)
+..++|||||++|+|.++++.
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~ 132 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRR 132 (375)
T ss_pred CcceeeehhccCCcHHHHHHh
Confidence 999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.34 E-value=5.4e-12 Score=125.47 Aligned_cols=91 Identities=25% Similarity=0.410 Sum_probs=77.3
Q ss_pred cCCCccCeeeccCcceEEEEEcC-----------------CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcc
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLP-----------------TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIV 524 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv 524 (571)
++|.+.+.||+|+||.||+|... ++..||+|.+..... .....+|.+|++++.+++||||+
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN--KNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC--HHHHHHHHHHHHHHhhcCCCCee
Confidence 46888899999999999999742 234699999875432 23356799999999999999999
Q ss_pred cEEEEEEeCCeeEEEEeccCCCChhhhhcc
Q 044615 525 KFYGFCSHALHSFVVYEYLEMGSLAMNLSN 554 (571)
Q Consensus 525 ~l~~~~~~~~~~~lv~e~~~~G~L~~~l~~ 554 (571)
++++++.+.+..++||||+++|+|.+++..
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 112 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSS 112 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHh
Confidence 999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.34 E-value=3e-12 Score=131.60 Aligned_cols=93 Identities=17% Similarity=0.169 Sum_probs=81.0
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
.|+..+.||+|+||.||+|+ ..+++.||+|++.+.........+.+.+|++++++++|||||++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 48889999999999999999 55789999999975433223345678999999999999999999999999999999999
Q ss_pred ccCCCChhhhhccC
Q 044615 542 YLEMGSLAMNLSND 555 (571)
Q Consensus 542 ~~~~G~L~~~l~~~ 555 (571)
||++|+|.+++.+.
T Consensus 82 ~~~gg~L~~~l~~~ 95 (382)
T cd05625 82 YIPGGDMMSLLIRM 95 (382)
T ss_pred CCCCCcHHHHHHhc
Confidence 99999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.8e-12 Score=139.41 Aligned_cols=106 Identities=25% Similarity=0.391 Sum_probs=84.5
Q ss_pred CCCccCeeeccCcceEEEEEcC--CCC----EEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCee
Q 044615 463 NFDDGHCIGNGGQGSVYKAKLP--TGE----IVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHS 536 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~ 536 (571)
..+..+.||+|+||.||.|... .|. .||||.+.+. .+.+...+|.+|..+|+.++|||||+++|+|.+....
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3456788999999999999853 343 4899998754 3345678899999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhccCCC----ccCCCHHHHhhhc
Q 044615 537 FVVYEYLEMGSLAMNLSNDAA----AEQFCWTKRMNAI 570 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~----~~~l~w~~r~~ia 570 (571)
+|++|||++|||..+|++.+. ...|+-...+.+|
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a 808 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFA 808 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHH
Confidence 999999999999999987532 2235544444443
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.33 E-value=4.3e-12 Score=127.70 Aligned_cols=93 Identities=24% Similarity=0.226 Sum_probs=80.3
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|++.+.||+|+||.||+++ ..+++.||+|++.+.........+.+.+|+.++..++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 368899999999999999999 4578999999987532222233566889999999999999999999999999999999
Q ss_pred eccCCCChhhhhcc
Q 044615 541 EYLEMGSLAMNLSN 554 (571)
Q Consensus 541 e~~~~G~L~~~l~~ 554 (571)
||+++|+|.+++.+
T Consensus 81 e~~~g~~L~~~l~~ 94 (331)
T cd05597 81 DYYVGGDLLTLLSK 94 (331)
T ss_pred ecCCCCcHHHHHHH
Confidence 99999999999975
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.33 E-value=5.6e-12 Score=129.63 Aligned_cols=92 Identities=24% Similarity=0.382 Sum_probs=78.0
Q ss_pred ccCCCccCeeeccCcceEEEEEc-C-----CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcC-CCCcccEEEEEEeC
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKL-P-----TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR-HRNIVKFYGFCSHA 533 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~-~-----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~ 533 (571)
.+.|.+.+.||+|+||.||+|.. . .+..||||++..... ....+.|.+|+++++++. |||||+++++|.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR--SSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 45788999999999999999973 2 234699999975432 233567999999999996 99999999999999
Q ss_pred CeeEEEEeccCCCChhhhhcc
Q 044615 534 LHSFVVYEYLEMGSLAMNLSN 554 (571)
Q Consensus 534 ~~~~lv~e~~~~G~L~~~l~~ 554 (571)
+..|+|||||++|+|.++|+.
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~ 134 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHK 134 (400)
T ss_pred CceEEEEEecCCCcHHHHHHH
Confidence 999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=9.2e-13 Score=123.26 Aligned_cols=95 Identities=32% Similarity=0.421 Sum_probs=78.7
Q ss_pred HHccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC--Ce
Q 044615 459 RATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA--LH 535 (571)
Q Consensus 459 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~--~~ 535 (571)
+..++|+..+.|++|.||.||+|+ .++++.||+|+++.+.... +..---.|||.++.+++|||||.+..+.... +.
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~-GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~ 151 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKE-GFPITSLREINILLKARHPNIVEVKEVVVGSNMDK 151 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccC-CCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence 344568889999999999999999 6689999999998765332 2233457999999999999999999988754 57
Q ss_pred eEEEEeccCCCChhhhhccC
Q 044615 536 SFVVYEYLEMGSLAMNLSND 555 (571)
Q Consensus 536 ~~lv~e~~~~G~L~~~l~~~ 555 (571)
+|||||||+. ||...++.-
T Consensus 152 iy~VMe~~Eh-DLksl~d~m 170 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMETM 170 (419)
T ss_pred eeeeHHHHHh-hHHHHHHhc
Confidence 9999999997 999988753
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.32 E-value=6.4e-13 Score=122.69 Aligned_cols=90 Identities=26% Similarity=0.465 Sum_probs=75.1
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
+.|+...++|+|+||+||+++ ..+|+.||||++..+. ++....+-.+|||+++++++|||+|.++++|.....+++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 358888999999999999999 4589999999996543 33344566789999999999999999999999999999999
Q ss_pred eccCCCChhhhhc
Q 044615 541 EYLEMGSLAMNLS 553 (571)
Q Consensus 541 e~~~~G~L~~~l~ 553 (571)
|||+. ++.+-|.
T Consensus 81 E~~dh-TvL~eLe 92 (396)
T KOG0593|consen 81 EYCDH-TVLHELE 92 (396)
T ss_pred eecch-HHHHHHH
Confidence 99987 4433343
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.32 E-value=5.6e-12 Score=126.88 Aligned_cols=93 Identities=24% Similarity=0.170 Sum_probs=79.9
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|++.+.||+|+||.||+++ ..+++.||+|.+.+.........+.+.+|+.++..++||||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 368899999999999999999 4578899999986532222233456888999999999999999999999999999999
Q ss_pred eccCCCChhhhhcc
Q 044615 541 EYLEMGSLAMNLSN 554 (571)
Q Consensus 541 e~~~~G~L~~~l~~ 554 (571)
||+++|+|.+++..
T Consensus 81 Ey~~gg~L~~~l~~ 94 (331)
T cd05624 81 DYYVGGDLLTLLSK 94 (331)
T ss_pred eCCCCCcHHHHHHH
Confidence 99999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.31 E-value=3.2e-12 Score=131.95 Aligned_cols=199 Identities=40% Similarity=0.522 Sum_probs=114.2
Q ss_pred EEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCC-CCCeeecccCcCcccCCccccCCCCCCEEEccCC
Q 044615 101 DLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLT-SLSILYLYENSLCDSIPKEIGNMNSLSILDLSSN 179 (571)
Q Consensus 101 ~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n 179 (571)
.+++..|.+.. ....+..++.++.|++.+|.++ .++.....+. +|+.|++++|.+. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 45555555531 2233344456666666666665 3344444443 6666666666664 34445566666666666666
Q ss_pred CCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccc
Q 044615 180 KLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIP 259 (571)
Q Consensus 180 ~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 259 (571)
++. .+|......+. |+.|++++|.+. .+|...+....|++|.+++|.+. ..+..+..+.++..+.+.+|.+.. .+
T Consensus 174 ~l~-~l~~~~~~~~~-L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~ 248 (394)
T COG4886 174 DLS-DLPKLLSNLSN-LNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LP 248 (394)
T ss_pred hhh-hhhhhhhhhhh-hhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-cc
Confidence 665 44444334443 666666666665 34443344445666666666433 234456666666666666666542 24
Q ss_pred hhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchh
Q 044615 260 ESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQ 309 (571)
Q Consensus 260 ~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~ 309 (571)
..+..+++++.|++++|+++...+ +..+.+++.|++++|.+....+..
T Consensus 249 ~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 249 ESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred chhccccccceecccccccccccc--ccccCccCEEeccCccccccchhh
Confidence 556666677777777777764332 666667777777777766555443
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.4e-12 Score=123.96 Aligned_cols=95 Identities=20% Similarity=0.205 Sum_probs=82.6
Q ss_pred CCCccCeeeccCcceEEEEEcC-CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAKLP-TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
.|+..+.||.|.-|+||.++.+ ++..+|+|++.+......+...+...|-+||+.++||.++.+|+.+++....|+|||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 3566788999999999999954 578999999988766555556678889999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCCC
Q 044615 542 YLEMGSLAMNLSNDAA 557 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~ 557 (571)
||+||||+...+++..
T Consensus 158 yCpGGdL~~LrqkQp~ 173 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPG 173 (459)
T ss_pred cCCCccHHHHHhhCCC
Confidence 9999999998886543
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.31 E-value=6.4e-12 Score=128.10 Aligned_cols=94 Identities=20% Similarity=0.254 Sum_probs=80.9
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|+..+.||+|+||.||+|. ..+++.||+|++.+.........+.+.+|+.++.+++||||+++++.+.+.+..|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 368889999999999999998 4579999999997533222233567889999999999999999999999999999999
Q ss_pred eccCCCChhhhhccC
Q 044615 541 EYLEMGSLAMNLSND 555 (571)
Q Consensus 541 e~~~~G~L~~~l~~~ 555 (571)
||+++|+|.+++.+.
T Consensus 81 E~~~gg~L~~~l~~~ 95 (360)
T cd05627 81 EFLPGGDMMTLLMKK 95 (360)
T ss_pred eCCCCccHHHHHHhc
Confidence 999999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.31 E-value=7.8e-12 Score=125.41 Aligned_cols=99 Identities=20% Similarity=0.183 Sum_probs=80.8
Q ss_pred CeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEeccCCC
Q 044615 468 HCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMG 546 (571)
Q Consensus 468 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~G 546 (571)
+.||+|+||.||+|+ ..+|+.||+|++.+...........+.+|++++++++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999998 5689999999997543323334567889999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCccCCCHHHHhhh
Q 044615 547 SLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 547 ~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
+|.+++...+ .+++.+...|
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~ 100 (323)
T cd05571 81 ELFFHLSRER---VFSEDRARFY 100 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHH
Confidence 9999997532 3555554433
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.31 E-value=4.8e-12 Score=129.17 Aligned_cols=96 Identities=18% Similarity=0.212 Sum_probs=81.9
Q ss_pred HccCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEE
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFV 538 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l 538 (571)
..++|+..+.||+|+||.||+++. .+++.||+|.+.+.........+.+.+|+.+++.++||||+++++++.+....|+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 346799999999999999999994 5789999999865332222334568899999999999999999999999999999
Q ss_pred EEeccCCCChhhhhccC
Q 044615 539 VYEYLEMGSLAMNLSND 555 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~ 555 (571)
||||+++|+|.+++...
T Consensus 121 v~Ey~~gg~L~~~l~~~ 137 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY 137 (370)
T ss_pred EEcCCCCCcHHHHHHhc
Confidence 99999999999999753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.31 E-value=7.3e-12 Score=125.60 Aligned_cols=99 Identities=19% Similarity=0.173 Sum_probs=80.8
Q ss_pred CeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEeccCCC
Q 044615 468 HCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMG 546 (571)
Q Consensus 468 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~G 546 (571)
+.||+|+||.||+++ ..+|..||+|++.............+.+|++++++++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 468999999999999 5579999999997543222234567889999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCccCCCHHHHhhh
Q 044615 547 SLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 547 ~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
+|.+++.... .+++.....+
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~ 100 (323)
T cd05595 81 ELFFHLSRER---VFTEERARFY 100 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHH
Confidence 9999887442 3566555444
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.31 E-value=5e-12 Score=122.54 Aligned_cols=102 Identities=36% Similarity=0.539 Sum_probs=82.4
Q ss_pred ccCeeeccCcceEEEEEcC-----CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 466 DGHCIGNGGQGSVYKAKLP-----TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 466 ~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
..+.||.|+||.||+|.+. .+..|+||.+... ......+.|.+|++.+++++||||++++|++...+..++||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccccccccccccccccccccccccc
Confidence 3568999999999999854 3567999999643 22334678999999999999999999999999888899999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||+++|+|.++|+.. ....++|.++.+|+
T Consensus 81 e~~~~g~L~~~L~~~-~~~~~~~~~~~~i~ 109 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSK-NKEPLSEQQRLSIA 109 (259)
T ss_dssp E--TTEBHHHHHHHT-CTTTSBHHHHHHHH
T ss_pred ccccccccccccccc-cccccccccccccc
Confidence 999999999999865 22468899888876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1e-13 Score=138.02 Aligned_cols=172 Identities=34% Similarity=0.519 Sum_probs=104.9
Q ss_pred ccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCC
Q 044615 67 FEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTS 146 (571)
Q Consensus 67 ~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~ 146 (571)
-....||+.|++. .+|..+..+-.|+.+.|..|.+. .+|..++++..|..|||+.|+++ ..|..++.|+
T Consensus 76 dt~~aDlsrNR~~--------elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp- 144 (722)
T KOG0532|consen 76 DTVFADLSRNRFS--------ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP- 144 (722)
T ss_pred chhhhhccccccc--------cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-
Confidence 3445566666655 35666666666666666666665 56666666666666666666665 5555566554
Q ss_pred CCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCc
Q 044615 147 LSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLN 226 (571)
Q Consensus 147 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~ 226 (571)
|+.|-+++|+++ .+|+.++.++.|..||.+.|.+. .+|..+..+.. |+.|.+..|++. .+|..+.. -.|..||++
T Consensus 145 Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~s-lr~l~vrRn~l~-~lp~El~~-LpLi~lDfS 219 (722)
T KOG0532|consen 145 LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTS-LRDLNVRRNHLE-DLPEELCS-LPLIRLDFS 219 (722)
T ss_pred ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHH-HHHHHHhhhhhh-hCCHHHhC-Cceeeeecc
Confidence 666666666664 45666666666666666666665 55666666664 666666666665 23434442 235666666
Q ss_pred cCcCcCCCChhhhCCCCCCEEEcccCccc
Q 044615 227 NNELSGQLSPELGSLIQLEYLDLSANTFH 255 (571)
Q Consensus 227 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 255 (571)
.|+++ .+|-.|.+|..|++|-|.+|.+.
T Consensus 220 cNkis-~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 220 CNKIS-YLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred cCcee-ecchhhhhhhhheeeeeccCCCC
Confidence 66666 35556666666666666666664
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.31 E-value=6.9e-12 Score=126.27 Aligned_cols=104 Identities=21% Similarity=0.190 Sum_probs=85.7
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|.+.+.||+|+||.||+|. ..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 368889999999999999999 5589999999997543323334567889999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRM 567 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~ 567 (571)
||+++|+|.+++.+... .+++....
T Consensus 81 e~~~~~~L~~~l~~~~~--~l~~~~~~ 105 (330)
T cd05601 81 EYQPGGDLLSLLNRYED--QFDEDMAQ 105 (330)
T ss_pred CCCCCCCHHHHHHHhcC--CCCHHHHH
Confidence 99999999999975422 34554443
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.30 E-value=7.6e-12 Score=121.07 Aligned_cols=103 Identities=22% Similarity=0.372 Sum_probs=86.8
Q ss_pred cCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
++|...+.||+|+||.||.|....+..+|+|.+..... ..++|.+|+.++++++||||+++++++.+.+..|+|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE 79 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence 35788899999999999999876667799999874432 23678999999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+++|+|.+++..... .++|.+.++|+
T Consensus 80 ~~~~~~l~~~i~~~~~--~~~~~~~~~~~ 106 (256)
T cd05113 80 YMSNGCLLNYLREHGK--RFQPSQLLEMC 106 (256)
T ss_pred cCCCCcHHHHHHhcCC--CCCHHHHHHHH
Confidence 9999999999975432 57888777765
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.7e-12 Score=130.39 Aligned_cols=97 Identities=23% Similarity=0.358 Sum_probs=86.0
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.+.|+.++.+|+|+-|.|..|+ ..+|+.+|||++.+...........+.+||.+|+-+.|||+++++++++...++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 4568889999999999999999 679999999999876444444456788999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCCC
Q 044615 540 YEYLEMGSLAMNLSNDAA 557 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~ 557 (571)
.||+++|.|++++.+++.
T Consensus 91 lEyv~gGELFdylv~kG~ 108 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGP 108 (786)
T ss_pred EEecCCchhHHHHHhhCC
Confidence 999999999999987654
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.30 E-value=1e-11 Score=120.49 Aligned_cols=104 Identities=21% Similarity=0.364 Sum_probs=88.9
Q ss_pred cCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
++|+..+.||+|+||.||+|...+++.||+|.+..... ..++|.+|++++++++||||+++++++...+..|+|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 45888899999999999999976778899999875432 24678999999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+++|+|.+++.... ...++|.+..+++
T Consensus 82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~ 109 (261)
T cd05068 82 LMKYGSLLEYLQGGA-GRALKLPQLIDMA 109 (261)
T ss_pred cccCCcHHHHHhccC-CCCCCHHHHHHHH
Confidence 999999999997543 3457888877764
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.2e-11 Score=124.33 Aligned_cols=99 Identities=19% Similarity=0.195 Sum_probs=81.7
Q ss_pred CeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEeccCCC
Q 044615 468 HCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMG 546 (571)
Q Consensus 468 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~G 546 (571)
+.||+|+||.||+++ ..+++.||||++.+...........+.+|+++++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 368999999999998 5579999999997543333334567889999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCccCCCHHHHhhh
Q 044615 547 SLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 547 ~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
+|.+++.... .+++.+...+
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~ 100 (328)
T cd05593 81 ELFFHLSRER---VFSEDRTRFY 100 (328)
T ss_pred CHHHHHHhcC---CCCHHHHHHH
Confidence 9999887432 4666655544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.5e-11 Score=119.62 Aligned_cols=109 Identities=22% Similarity=0.260 Sum_probs=89.8
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|+..+.||+|+||.||+|.. .+|+.||+|.++..........+.+.+|++++++++|+|++++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5788999999999999999995 489999999987544343344678999999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCC-CccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDA-AAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~-~~~~l~w~~r~~ia 570 (571)
||+++|+|.+++.+.. ....+++.+..+++
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~ 112 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYF 112 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHH
Confidence 9999999999986422 22346676665543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.30 E-value=4.1e-12 Score=131.08 Aligned_cols=200 Identities=42% Similarity=0.538 Sum_probs=135.8
Q ss_pred CEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCC-CCCEEEccCCCCCccCChhhhhccCCCcEEEcc
Q 044615 124 VVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMN-SLSILDLSSNKLNGSIPLSLANLTNSLKVLYLS 202 (571)
Q Consensus 124 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~ 202 (571)
..+++..|.+.. ....+..++.++.|++.+|.+.. ++.....+. +|+.|++++|++. .+|..+..++. |+.|+++
T Consensus 96 ~~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~~-i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~-L~~L~l~ 171 (394)
T COG4886 96 PSLDLNLNRLRS-NISELLELTNLTSLDLDNNNITD-IPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPN-LKNLDLS 171 (394)
T ss_pred ceeecccccccc-CchhhhcccceeEEecCCccccc-Cccccccchhhcccccccccchh-hhhhhhhcccc-ccccccC
Confidence 357777777632 23344556777888888888764 455555563 7888888888877 55556666665 8888888
Q ss_pred CCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCc
Q 044615 203 SNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKI 282 (571)
Q Consensus 203 ~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~ 282 (571)
.|++. .+|...+..+.|+.|++++|++.. +|.....+..|+.|.+++|.+. ..+..+..+.++..+.+.+|++.. .
T Consensus 172 ~N~l~-~l~~~~~~~~~L~~L~ls~N~i~~-l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~ 247 (394)
T COG4886 172 FNDLS-DLPKLLSNLSNLNNLDLSGNKISD-LPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-L 247 (394)
T ss_pred Cchhh-hhhhhhhhhhhhhheeccCCcccc-CchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-c
Confidence 88876 344444466778888888888774 4554455566888888887532 345667777777777777777753 3
Q ss_pred chhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccc
Q 044615 283 PNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRC 333 (571)
Q Consensus 283 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~ 333 (571)
+..+..++.++.|++++|.+....+ +..+.+++.|++++|.++...|..
T Consensus 248 ~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 248 PESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred cchhccccccceecccccccccccc--ccccCccCEEeccCccccccchhh
Confidence 5566777778888888888765433 777788888888888777655543
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.30 E-value=7.9e-12 Score=124.73 Aligned_cols=97 Identities=19% Similarity=0.213 Sum_probs=79.8
Q ss_pred eeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEeccCCCCh
Q 044615 470 IGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548 (571)
Q Consensus 470 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~G~L 548 (571)
||+|+||.||+|. ..+++.||+|++.+...........+.+|+.++++++||||+++++++.+.+..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 6999999999999 457889999999754322333456788999999999999999999999999999999999999999
Q ss_pred hhhhccCCCccCCCHHHHhhh
Q 044615 549 AMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 549 ~~~l~~~~~~~~l~w~~r~~i 569 (571)
.+++...+ .+++.....+
T Consensus 81 ~~~l~~~~---~~~~~~~~~~ 98 (312)
T cd05585 81 FHHLQREG---RFDLSRARFY 98 (312)
T ss_pred HHHHHhcC---CCCHHHHHHH
Confidence 99997542 3566655544
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.6e-11 Score=119.60 Aligned_cols=108 Identities=20% Similarity=0.233 Sum_probs=87.3
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|++.+.||+|+||.||+|+ ..+++.||||.+.............+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 478999999999999999999 4588999999987544444455667999999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCC-CccCCCHHHHhhh
Q 044615 541 EYLEMGSLAMNLSNDA-AAEQFCWTKRMNA 569 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~-~~~~l~w~~r~~i 569 (571)
||+++|+|.+++.... ....++.....++
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ 111 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKY 111 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHH
Confidence 9999999999886321 1223455444443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.6e-11 Score=123.64 Aligned_cols=92 Identities=26% Similarity=0.383 Sum_probs=80.9
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|+..+.||+|+||.||+++ ..++..+|+|.+.... .....+.+.+|++++++++||||+++++++...+..++||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 578999999999999999999 4578999999987542 2234567999999999999999999999999999999999
Q ss_pred eccCCCChhhhhccC
Q 044615 541 EYLEMGSLAMNLSND 555 (571)
Q Consensus 541 e~~~~G~L~~~l~~~ 555 (571)
||+++|+|.+++...
T Consensus 83 e~~~~~~L~~~l~~~ 97 (331)
T cd06649 83 EHMDGGSLDQVLKEA 97 (331)
T ss_pred ecCCCCcHHHHHHHc
Confidence 999999999999753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.6e-12 Score=129.10 Aligned_cols=108 Identities=21% Similarity=0.311 Sum_probs=89.3
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCe-eEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALH-SFVV 539 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~-~~lv 539 (571)
++|...+.+|+|+||.++.++. .++..+|+|.+....... ..++...+|+.++++++|||||.+.+.|...+. .+||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~-~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTE-PERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCc-hhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 5688999999999999999984 467899999998766544 334578899999999999999999999999888 9999
Q ss_pred EeccCCCChhhhhccCCC-----ccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAA-----AEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~-----~~~l~w~~r~~ia 570 (571)
|+||+||++.+.|.+..+ ..-..|..++..|
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~a 118 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLA 118 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHH
Confidence 999999999999986542 2235677666554
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.6e-11 Score=123.66 Aligned_cols=92 Identities=26% Similarity=0.400 Sum_probs=80.6
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|+..+.||+|+||.||++.. .++..+|+|.+..... ....+.+.+|++++++++|||||+++++|.+.+..|+||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC--HHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 5799999999999999999994 4788999999875422 233567999999999999999999999999999999999
Q ss_pred eccCCCChhhhhccC
Q 044615 541 EYLEMGSLAMNLSND 555 (571)
Q Consensus 541 e~~~~G~L~~~l~~~ 555 (571)
||+++|+|.+++...
T Consensus 83 e~~~~~~L~~~l~~~ 97 (333)
T cd06650 83 EHMDGGSLDQVLKKA 97 (333)
T ss_pred ecCCCCcHHHHHHHc
Confidence 999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.5e-11 Score=119.64 Aligned_cols=105 Identities=22% Similarity=0.367 Sum_probs=87.5
Q ss_pred cCCCccCeeeccCcceEEEEEcC----CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLP----TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSF 537 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~ 537 (571)
++|+..+.||+|+||.||+|..+ +...||||.+.... ......+|.+|+.++++++||||+++++++.+.+..+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 46888999999999999999853 24579999987543 2234567999999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 538 VVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+||||+++|+|.+++....+ .++|.+.++++
T Consensus 82 iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~ 112 (266)
T cd05033 82 IITEYMENGSLDKFLRENDG--KFTVGQLVGML 112 (266)
T ss_pred EEEEcCCCCCHHHHHHhccC--CCCHHHHHHHH
Confidence 99999999999999975433 57888877664
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.3e-11 Score=124.03 Aligned_cols=100 Identities=16% Similarity=0.163 Sum_probs=81.6
Q ss_pred CeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCeeEEEEeccCC
Q 044615 468 HCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHSFVVYEYLEM 545 (571)
Q Consensus 468 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 545 (571)
+.||+|+||.||+|+ ..+++.||||++.+.........+.+.+|+.++.++ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 468999999999998 457899999999765433334456688999999888 799999999999999999999999999
Q ss_pred CChhhhhccCCCccCCCHHHHhhhc
Q 044615 546 GSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 546 G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+|.+++...+ .+++.....++
T Consensus 81 g~L~~~~~~~~---~l~~~~~~~~~ 102 (329)
T cd05588 81 GDLMFHMQRQR---KLPEEHARFYS 102 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHH
Confidence 99999886432 46666655543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.29 E-value=5e-12 Score=128.42 Aligned_cols=104 Identities=22% Similarity=0.238 Sum_probs=85.5
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|.+.+.||+|+||.||+|+ ..+++.||||++.+.........+.+.+|++++..++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 368899999999999999999 4589999999997543222233567899999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMN 568 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ 568 (571)
||+++|+|.+++...+ .+++.....
T Consensus 81 e~~~~~~L~~~l~~~~---~l~~~~~~~ 105 (350)
T cd05573 81 EYMPGGDLMNLLIRKD---VFPEETARF 105 (350)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHH
Confidence 9999999999997542 344444433
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.29 E-value=9.4e-12 Score=120.76 Aligned_cols=104 Identities=22% Similarity=0.358 Sum_probs=87.3
Q ss_pred cCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
++|++.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 4688899999999999999997778889999986532 224679999999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+++|+|.++++... ...++|.++++++
T Consensus 82 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~ 109 (261)
T cd05072 82 YMAKGSLLDFLKSDE-GGKVLLPKLIDFS 109 (261)
T ss_pred cCCCCcHHHHHHHhc-CCCCCHHHHHHHH
Confidence 999999999997543 2356777766543
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.29 E-value=5.4e-12 Score=128.93 Aligned_cols=95 Identities=20% Similarity=0.207 Sum_probs=81.2
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.++|+..+.||+|+||.||+|+ ..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 4579999999999999999998 457899999999753322223345688999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccC
Q 044615 540 YEYLEMGSLAMNLSND 555 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~ 555 (571)
|||+++|+|.+++.+.
T Consensus 122 ~Ey~~gg~L~~~l~~~ 137 (370)
T cd05596 122 MEYMPGGDLVNLMSNY 137 (370)
T ss_pred EcCCCCCcHHHHHHhc
Confidence 9999999999998753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.29 E-value=7e-12 Score=121.63 Aligned_cols=107 Identities=23% Similarity=0.373 Sum_probs=90.4
Q ss_pred HccCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
...+|+..+.||+|+||.||+|..+.+..+|+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 3456889999999999999999976789999999875432 2356789999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||+++|+|.+++++... ..++|.+..+++
T Consensus 81 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~ 110 (261)
T cd05148 81 TELMEKGSLLAFLRSPEG-QVLPVASLIDMA 110 (261)
T ss_pred EeecccCCHHHHHhcCCC-CCCCHHHHHHHH
Confidence 999999999999986432 357888776654
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.3e-11 Score=121.26 Aligned_cols=101 Identities=20% Similarity=0.203 Sum_probs=81.9
Q ss_pred eeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEeccCCCCh
Q 044615 470 IGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548 (571)
Q Consensus 470 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~G~L 548 (571)
||+|+||+||++. ..+++.||||.+.+.........+.+..|++++++++||||+++.+++.+....|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 6999999999998 457899999998754333333346788999999999999999999999999999999999999999
Q ss_pred hhhhccCC-CccCCCHHHHhhhc
Q 044615 549 AMNLSNDA-AAEQFCWTKRMNAI 570 (571)
Q Consensus 549 ~~~l~~~~-~~~~l~w~~r~~ia 570 (571)
.+++.... ....+++.....++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~ 103 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYT 103 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHH
Confidence 98886422 23457777766654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.1e-12 Score=132.42 Aligned_cols=97 Identities=28% Similarity=0.468 Sum_probs=79.5
Q ss_pred CCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC------ee
Q 044615 464 FDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL------HS 536 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~------~~ 536 (571)
|...+.+|+||||.||+|+ ..+|+.||||.+.... .....+...+|+++|++++|||||+++++-++.. ..
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 4556789999999999999 6799999999998654 2344678899999999999999999999876543 46
Q ss_pred EEEEeccCCCChhhhhccCCCccCCC
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFC 562 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~ 562 (571)
.+|||||.||||+..+.+-.....|.
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLp 118 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLP 118 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCC
Confidence 79999999999999998644333343
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.28 E-value=8.6e-12 Score=126.02 Aligned_cols=91 Identities=24% Similarity=0.424 Sum_probs=75.5
Q ss_pred cCCCccCeeeccCcceEEEEEc------CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeC-
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL------PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHA- 533 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~- 533 (571)
++|++.+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|++++.++ +|||||+++++|...
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 4688999999999999999962 245689999987432 223356799999999999 899999999998764
Q ss_pred CeeEEEEeccCCCChhhhhcc
Q 044615 534 LHSFVVYEYLEMGSLAMNLSN 554 (571)
Q Consensus 534 ~~~~lv~e~~~~G~L~~~l~~ 554 (571)
...|+||||+++|+|.+++..
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~ 105 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRA 105 (338)
T ss_pred CceEEEEecCCCCcHHHHHHh
Confidence 458899999999999999974
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.9e-11 Score=120.35 Aligned_cols=106 Identities=19% Similarity=0.226 Sum_probs=87.3
Q ss_pred CCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEec
Q 044615 464 FDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEY 542 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 542 (571)
|+..+.||+|+||+||+|. ..+++.||+|.+.............+.+|++++++++|+||+++.+++.+.+..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 6677889999999999998 457999999999765433333345678999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 543 LEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 543 ~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+++|+|.+++.... ...++|.....+|
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~ 108 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYA 108 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHH
Confidence 99999999887432 2357888777664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.1e-11 Score=120.55 Aligned_cols=109 Identities=21% Similarity=0.267 Sum_probs=90.3
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|+..+.||+|+||.||+|. ..+++.+|||.+...........+++.+|+++++.++||||+++++++.+.+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 468888999999999999999 5689999999987544444445678999999999999999999999999999999999
Q ss_pred eccCCCChhhhhccC-CCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSND-AAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~-~~~~~l~w~~r~~ia 570 (571)
||+++|+|.+++... .....++|.+..+++
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~ 112 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYF 112 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHH
Confidence 999999999998742 223457777766554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.28 E-value=2.6e-11 Score=130.99 Aligned_cols=113 Identities=32% Similarity=0.442 Sum_probs=102.7
Q ss_pred CCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEcc
Q 044615 243 QLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLS 322 (571)
Q Consensus 243 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls 322 (571)
.++.|+|++|.+.+.+|..+..+++|+.|+|++|.+++.+|..+..+++|+.|+|++|.+.+.+|..++.+++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 37889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcCccccccccccC-CCCCEEECcCCcCcccCC
Q 044615 323 HNNLSGSIPRCFEEM-HWLSCIDISYNALQGLIP 355 (571)
Q Consensus 323 ~n~l~~~~p~~~~~l-~~L~~L~ls~N~l~~~~~ 355 (571)
+|+++|.+|..+... ..+..+++.+|...+..|
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCC
Confidence 999999999988764 467789999997655444
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.6e-11 Score=118.79 Aligned_cols=102 Identities=23% Similarity=0.351 Sum_probs=85.8
Q ss_pred CCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEec
Q 044615 463 NFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEY 542 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 542 (571)
+|++.+.||+|+||.||+|..+++..+|+|.+..... ....|.+|++++++++||||+++++++.+.+..|+||||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 4778899999999999999977777899999864322 235688999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 543 LEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 543 ~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+++|+|.+++..... .++|...+.|+
T Consensus 81 ~~~~~L~~~l~~~~~--~~~~~~~~~i~ 106 (256)
T cd05059 81 MANGCLLNYLRERKG--KLGTEWLLDMC 106 (256)
T ss_pred CCCCCHHHHHHhccc--CCCHHHHHHHH
Confidence 999999999975433 56777766654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.8e-11 Score=122.91 Aligned_cols=99 Identities=21% Similarity=0.177 Sum_probs=81.2
Q ss_pred CeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEeccCCC
Q 044615 468 HCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMG 546 (571)
Q Consensus 468 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~G 546 (571)
+.||+|+||.||++. ..+|+.||+|++.+...........+.+|++++..++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 368999999999998 5689999999997543333334567889999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCccCCCHHHHhhh
Q 044615 547 SLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 547 ~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
+|.+++.... .++|.+...|
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~ 100 (325)
T cd05594 81 ELFFHLSRER---VFSEDRARFY 100 (325)
T ss_pred cHHHHHHhcC---CCCHHHHHHH
Confidence 9999887432 4566655544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.2e-11 Score=119.92 Aligned_cols=106 Identities=20% Similarity=0.225 Sum_probs=85.9
Q ss_pred CCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEec
Q 044615 464 FDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEY 542 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 542 (571)
|+..+.||+|+||.||++. ..+++.||||.+.+.........+.+.+|+.++++++|++++++++.+.+.+..|+||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 6777899999999999998 558999999998765433333345678999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 543 LEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 543 ~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+++|+|.+++..... ..+.+.++..++
T Consensus 82 ~~g~~L~~~l~~~~~-~~l~~~~~~~~~ 108 (285)
T cd05630 82 MNGGDLKFHIYHMGE-AGFEEGRAVFYA 108 (285)
T ss_pred cCCCcHHHHHHHhcc-cCCCHHHHHHHH
Confidence 999999999864322 346666655543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.3e-11 Score=124.37 Aligned_cols=103 Identities=19% Similarity=0.150 Sum_probs=83.0
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|++.+.||+|+||.||+++. .+++.+|+|++.+.........+.|.+|+.++..++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 3688899999999999999994 468899999986432222233455889999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHH
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKR 566 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r 566 (571)
||+++|+|.+++.+... .+++...
T Consensus 81 ey~~~g~L~~~l~~~~~--~l~~~~~ 104 (332)
T cd05623 81 DYYVGGDLLTLLSKFED--RLPEDMA 104 (332)
T ss_pred eccCCCcHHHHHHHhcC--CCCHHHH
Confidence 99999999999975322 3444443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.8e-11 Score=120.58 Aligned_cols=92 Identities=26% Similarity=0.368 Sum_probs=80.0
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|++.+.||+|+||.||++. ..++..+|+|.+.... .....+++.+|++++.+++||||+++++++.+.+..|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 368899999999999999998 4578889999986532 2233567889999999999999999999999999999999
Q ss_pred eccCCCChhhhhccC
Q 044615 541 EYLEMGSLAMNLSND 555 (571)
Q Consensus 541 e~~~~G~L~~~l~~~ 555 (571)
||+++|+|.++++..
T Consensus 79 ey~~~~~L~~~l~~~ 93 (308)
T cd06615 79 EHMDGGSLDQVLKKA 93 (308)
T ss_pred eccCCCcHHHHHHhc
Confidence 999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.27 E-value=7.8e-12 Score=127.74 Aligned_cols=100 Identities=17% Similarity=0.197 Sum_probs=83.8
Q ss_pred HHHHHccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC
Q 044615 456 EIIRATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL 534 (571)
Q Consensus 456 ~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~ 534 (571)
++....++|++.+.||+|+||.||+|+ ..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 334445789999999999999999999 4578999999986533222233456889999999999999999999999999
Q ss_pred eeEEEEeccCCCChhhhhccC
Q 044615 535 HSFVVYEYLEMGSLAMNLSND 555 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~~ 555 (571)
..|+||||+++|+|.+++...
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~ 137 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY 137 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc
Confidence 999999999999999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.4e-11 Score=123.63 Aligned_cols=103 Identities=22% Similarity=0.268 Sum_probs=81.1
Q ss_pred CCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHH---hhcCCCCcccEEEEEEeCCeeEEE
Q 044615 464 FDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNAL---TKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l---~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
|++.+.||+|+||.||+|. ..+++.||||++.+.........+.+.+|++++ +.++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 5677899999999999998 457999999999754322223345677777654 567899999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||+++|+|..+++.. .++|.....++
T Consensus 81 ~E~~~~~~L~~~~~~~----~l~~~~~~~~~ 107 (324)
T cd05589 81 MEYAAGGDLMMHIHTD----VFSEPRAVFYA 107 (324)
T ss_pred EcCCCCCcHHHHhhcC----CCCHHHHHHHH
Confidence 9999999999888642 46666655543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.7e-11 Score=126.07 Aligned_cols=91 Identities=26% Similarity=0.441 Sum_probs=77.1
Q ss_pred cCCCccCeeeccCcceEEEEEcC------CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcC-CCCcccEEEEEEeCC
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLP------TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR-HRNIVKFYGFCSHAL 534 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~~ 534 (571)
++|.+.+.||+|+||.||+|+.. .+..||+|++...... ...+.+.+|++++.++. |||||+++++|.+..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS--SEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh--hHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 35778899999999999999842 3467999999754322 23457899999999997 999999999999999
Q ss_pred eeEEEEeccCCCChhhhhcc
Q 044615 535 HSFVVYEYLEMGSLAMNLSN 554 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~ 554 (571)
..++||||+++|+|.++++.
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~ 134 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHR 134 (401)
T ss_pred CcEEEEeccCCCcHHHHHHh
Confidence 99999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.4e-11 Score=118.33 Aligned_cols=105 Identities=24% Similarity=0.380 Sum_probs=86.2
Q ss_pred cCCCccCeeeccCcceEEEEEcC-C---CCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLP-T---GEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSF 537 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~ 537 (571)
++|++.+.||+|+||.||+|... + +..+|+|.+..... ....+.|.+|+.++++++||||+++++++.+.+..|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 45888899999999999999842 2 33799999865432 234568999999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 538 VVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+||||+++|+|.+++..... .++|.+.++|+
T Consensus 82 lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~ 112 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDG--QFTVIQLVGML 112 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCC--CCCHHHHHHHH
Confidence 99999999999999975432 57887777654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.2e-12 Score=127.04 Aligned_cols=99 Identities=24% Similarity=0.289 Sum_probs=85.6
Q ss_pred HHHccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCe
Q 044615 458 IRATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALH 535 (571)
Q Consensus 458 ~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~ 535 (571)
.+...+|..++.||+|+|++|++|+ ..+++.||||++.+...-..+..+-+.+|-.+|.++ .||.||+++..|++...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 3455689999999999999999999 668999999999876544434445577888899999 99999999999999999
Q ss_pred eEEEEeccCCCChhhhhccCC
Q 044615 536 SFVVYEYLEMGSLAMNLSNDA 556 (571)
Q Consensus 536 ~~lv~e~~~~G~L~~~l~~~~ 556 (571)
+|+|+||+++|+|.++|++-+
T Consensus 149 LYFvLe~A~nGdll~~i~K~G 169 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYG 169 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhC
Confidence 999999999999999998643
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.1e-11 Score=120.38 Aligned_cols=105 Identities=23% Similarity=0.315 Sum_probs=86.8
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|+..+.||+|+||.||++. ..+++.||+|.+...........+.+.+|++++++++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 368888999999999999999 4578999999987544333344577999999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
||+++|+|.+++.... .+++..+..+
T Consensus 81 e~~~~~~L~~~~~~~~---~l~~~~~~~~ 106 (290)
T cd05580 81 EYVPGGELFSHLRKSG---RFPEPVARFY 106 (290)
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHH
Confidence 9999999999997542 3555554443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.2e-11 Score=117.47 Aligned_cols=102 Identities=25% Similarity=0.315 Sum_probs=84.6
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
.+|++.+.||+|+||.||+|. ..+++.||+|++...... ....+.+|+.++++++||||+++++++...+..|+||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD---DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc---hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 469999999999999999999 567899999998644222 2356889999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
||+++|+|.++++..+ .+++.....+
T Consensus 86 e~~~~~~L~~~~~~~~---~~~~~~~~~~ 111 (267)
T cd06646 86 EYCGGGSLQDIYHVTG---PLSELQIAYV 111 (267)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHH
Confidence 9999999999987432 3555555443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.3e-11 Score=120.02 Aligned_cols=92 Identities=25% Similarity=0.370 Sum_probs=82.9
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.++|+...+||.|..++||+|+ .+.++.||||++..+.... ..+...+|+..|+.++|||||+++..|.....+|+|
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN--DLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 4579999999999999999999 6789999999998665433 257789999999999999999999999999999999
Q ss_pred EeccCCCChhhhhcc
Q 044615 540 YEYLEMGSLAMNLSN 554 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~ 554 (571)
|.||.+|++.+.++.
T Consensus 103 mpfMa~GS~ldIik~ 117 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKT 117 (516)
T ss_pred ehhhcCCcHHHHHHH
Confidence 999999999999874
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.3e-11 Score=119.22 Aligned_cols=100 Identities=20% Similarity=0.238 Sum_probs=79.9
Q ss_pred eeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEeccCCCCh
Q 044615 470 IGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548 (571)
Q Consensus 470 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~G~L 548 (571)
||+|+||.||++. ..+|+.||+|.+...........+.+..|++++++++||||+++++++.+....|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 6999999999998 457999999998653322222234566799999999999999999999999999999999999999
Q ss_pred hhhhccCCCccCCCHHHHhhhc
Q 044615 549 AMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 549 ~~~l~~~~~~~~l~w~~r~~ia 570 (571)
.+++.... ...++|...+.++
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~ 101 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYS 101 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHH
Confidence 99886433 2347777766543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.7e-11 Score=117.47 Aligned_cols=103 Identities=20% Similarity=0.344 Sum_probs=85.8
Q ss_pred cCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
++|++.+.||+|+||.||+|..++++.||+|.+...... .++|.+|+.++++++||||+++++++. .+..|++||
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 458889999999999999999878899999998754322 467899999999999999999999874 556899999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+++|+|.+++..... ..++|.+++.++
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~i~ 108 (260)
T cd05067 81 YMENGSLVDFLKTPEG-IKLTINKLIDMA 108 (260)
T ss_pred cCCCCCHHHHHHhcCC-CCCCHHHHHHHH
Confidence 9999999999975432 467888777654
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.2e-11 Score=116.98 Aligned_cols=105 Identities=23% Similarity=0.399 Sum_probs=88.6
Q ss_pred ccCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
.++|.+.+.||+|+||.||+|...++..||||.+...... .+++.+|+.++++++||||+++++++.+....++||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 3568889999999999999999777788999998754322 367899999999999999999999999888999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||+++|+|.+++.... ...++|.++..++
T Consensus 81 e~~~~~~L~~~i~~~~-~~~~~~~~~~~~~ 109 (261)
T cd05034 81 EYMSKGSLLDFLKSGE-GKKLRLPQLVDMA 109 (261)
T ss_pred eccCCCCHHHHHhccc-cCCCCHHHHHHHH
Confidence 9999999999997643 2357887776654
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.3e-12 Score=128.34 Aligned_cols=91 Identities=26% Similarity=0.473 Sum_probs=80.3
Q ss_pred ccCCCccCeeeccCcceEEEEEcC-CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKLP-TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
..+..+..++|-|.||.||.|.++ ..-.||||.++.+ ....++|..|+.+|+.++|||+|+++|+|.....+|||
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED----tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIi 341 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYII 341 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhhc----chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEE
Confidence 345667789999999999999965 5778999999754 34478999999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccC
Q 044615 540 YEYLEMGSLAMNLSND 555 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~ 555 (571)
.|||.+|+|.+||++.
T Consensus 342 TEfM~yGNLLdYLRec 357 (1157)
T KOG4278|consen 342 TEFMCYGNLLDYLREC 357 (1157)
T ss_pred EecccCccHHHHHHHh
Confidence 9999999999999864
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1e-12 Score=135.99 Aligned_cols=100 Identities=21% Similarity=0.425 Sum_probs=80.3
Q ss_pred CCccCeeeccCcceEEEEE-cCCC----CEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEE
Q 044615 464 FDDGHCIGNGGQGSVYKAK-LPTG----EIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFV 538 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~-~~~~----~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l 538 (571)
....++||+|+||.||+|. .+.| .+||+|++.... ..+...++..|+-+|.+++|||+++++|+|.... +.|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 3456889999999999998 4444 468999987543 2344678999999999999999999999997665 789
Q ss_pred EEeccCCCChhhhhccCCCc----cCCCHHHH
Q 044615 539 VYEYLEMGSLAMNLSNDAAA----EQFCWTKR 566 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~~~~----~~l~w~~r 566 (571)
|.+||+.|+|.+|++.++.. ..|.|...
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~Q 806 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQ 806 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHH
Confidence 99999999999999875442 34667544
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.4e-11 Score=119.27 Aligned_cols=93 Identities=30% Similarity=0.463 Sum_probs=78.4
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC--eeEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL--HSFV 538 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~--~~~l 538 (571)
.+|...+.||+|+||.||.+. .++|+..|||.+.... ... .+...+|+++|.+++|||||+++|...... .+++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--SPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeeccc--chh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 457778999999999999999 4569999999987652 111 567899999999999999999999865555 6899
Q ss_pred EEeccCCCChhhhhccCCC
Q 044615 539 VYEYLEMGSLAMNLSNDAA 557 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~~~ 557 (571)
.|||+++|+|.+++.+.++
T Consensus 94 ~mEy~~~GsL~~~~~~~g~ 112 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGG 112 (313)
T ss_pred eeeccCCCcHHHHHHHcCC
Confidence 9999999999999987653
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.9e-11 Score=120.29 Aligned_cols=106 Identities=25% Similarity=0.325 Sum_probs=88.0
Q ss_pred CCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
+|++.+.||+|+||.||++.. .++..||+|.+.... .....+.+.+|+.++++++||||+++++++...+..|+|||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 588889999999999999995 489999999986432 22335679999999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+++|+|.+++........++|.....++
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 108 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRIT 108 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHH
Confidence 99999999998754333457777666554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.25 E-value=4.6e-11 Score=115.49 Aligned_cols=106 Identities=18% Similarity=0.242 Sum_probs=87.7
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
.|+..+.||+|+||.||.++ ..+++.+|+|.+....... ...+++.+|++++++++||||+++++++.+.+..+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 47888999999999999998 5678999999987543222 345678999999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+++|+|.+++.+.. ...+++.....++
T Consensus 80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~ 107 (256)
T cd08221 80 YANGGTLYDKIVRQK-GQLFEEEMVLWYL 107 (256)
T ss_pred ecCCCcHHHHHHhcc-ccCCCHHHHHHHH
Confidence 999999999997543 2356776666543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.5e-11 Score=116.06 Aligned_cols=99 Identities=24% Similarity=0.441 Sum_probs=81.6
Q ss_pred CeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEeccCCC
Q 044615 468 HCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMG 546 (571)
Q Consensus 468 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~G 546 (571)
+.||+|+||.||+|.. .+++.||+|.+.... .......|.+|++++++++||||+++++++......|+||||+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 3589999999999984 578999999886432 2233567999999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCccCCCHHHHhhhc
Q 044615 547 SLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 547 ~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+|.+++...+ ..++|...+.++
T Consensus 79 ~L~~~~~~~~--~~~~~~~~~~~~ 100 (252)
T cd05084 79 DFLTFLRTEG--PRLKVKELIQMV 100 (252)
T ss_pred cHHHHHHhCC--CCCCHHHHHHHH
Confidence 9999997543 246777666543
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.24 E-value=3.5e-11 Score=116.23 Aligned_cols=106 Identities=20% Similarity=0.251 Sum_probs=88.2
Q ss_pred CCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
+|+..+.||+|+||.||+|.. .+++.||+|.+...... ....+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 477888999999999999994 57899999998754332 3446789999999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+++++|.++++... ...++|.+..+|+
T Consensus 80 ~~~~~~L~~~l~~~~-~~~~~~~~~~~i~ 107 (256)
T cd08529 80 YAENGDLHKLLKMQR-GRPLPEDQVWRFF 107 (256)
T ss_pred eCCCCcHHHHHHHhc-CCCCCHHHHHHHH
Confidence 999999999998542 2356777666554
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.24 E-value=5e-11 Score=115.92 Aligned_cols=103 Identities=21% Similarity=0.360 Sum_probs=84.3
Q ss_pred CCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCc---hHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 463 NFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDE---MACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
+|...+.||+|+||.||+|...+++.+|+|.+....... ....+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999997789999999987543221 12345689999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhh
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMN 568 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ 568 (571)
|||+++|+|.+++.+.. .+.+.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~ 106 (265)
T cd06631 81 MEFVPGGSISSILNRFG---PLPEPVFCK 106 (265)
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHH
Confidence 99999999999997543 344554433
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.8e-11 Score=121.51 Aligned_cols=104 Identities=16% Similarity=0.154 Sum_probs=83.2
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCC-CcccEEEEEEeCCeeEEEE
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHR-NIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~-niv~l~~~~~~~~~~~lv~ 540 (571)
+|++.+.||+|+||.||+|+ ..+++.||||++.+.........+.+..|++++..++|+ +|+++++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 47888999999999999998 457889999999754332333456788999999999775 5888999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
||+++|+|.+++.... .+++.....+
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~ 106 (324)
T cd05587 81 EYVNGGDLMYHIQQVG---KFKEPHAVFY 106 (324)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHH
Confidence 9999999999997432 3555555544
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.24 E-value=3.1e-11 Score=117.60 Aligned_cols=94 Identities=24% Similarity=0.300 Sum_probs=80.4
Q ss_pred HHccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeE
Q 044615 459 RATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSF 537 (571)
Q Consensus 459 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~ 537 (571)
.++.++.....||+|+||.||+|. ..++..||+|.+.... ....+.+.+|++++++++||||+++++++..++..+
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 445556666789999999999999 5578899999986543 233567999999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhccC
Q 044615 538 VVYEYLEMGSLAMNLSND 555 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~ 555 (571)
+||||+++|+|.+++...
T Consensus 82 lv~e~~~~~~L~~~l~~~ 99 (268)
T cd06624 82 IFMEQVPGGSLSALLRSK 99 (268)
T ss_pred EEEecCCCCCHHHHHHHh
Confidence 999999999999999854
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.24 E-value=4e-11 Score=120.52 Aligned_cols=99 Identities=17% Similarity=0.190 Sum_probs=79.6
Q ss_pred CeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCeeEEEEeccCC
Q 044615 468 HCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHSFVVYEYLEM 545 (571)
Q Consensus 468 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 545 (571)
+.||+|+||.||+|. ..+++.||+|++.+.........+.+.+|+.++.++ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 469999999999999 457899999999865433334456688899988776 899999999999999999999999999
Q ss_pred CChhhhhccCCCccCCCHHHHhhh
Q 044615 546 GSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 546 G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
|+|.+++.... .+++.....|
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~i 101 (329)
T cd05618 81 GDLMFHMQRQR---KLPEEHARFY 101 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHH
Confidence 99998886432 3555544443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.7e-12 Score=126.97 Aligned_cols=100 Identities=27% Similarity=0.373 Sum_probs=81.0
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcC-CCCcccEEEEEEeCC-eeEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR-HRNIVKFYGFCSHAL-HSFV 538 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~~-~~~l 538 (571)
+.|...+.+|.|.||.||+|+ ..+|..||||++++..... .+. .=.||++.|++++ |||||++.+++.+++ .+|+
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~-ee~-~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSW-EEC-MNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccH-HHH-HHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 458888999999999999999 6689999999997654332 211 1368999999998 999999999999988 9999
Q ss_pred EEeccCCCChhhhhccCCCccCCCHHHH
Q 044615 539 VYEYLEMGSLAMNLSNDAAAEQFCWTKR 566 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~~~~~~l~w~~r 566 (571)
|||||+. +|++.+++++ ..++-..-
T Consensus 88 VfE~Md~-NLYqLmK~R~--r~fse~~i 112 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDRN--RLFSESDI 112 (538)
T ss_pred eHHhhhh-hHHHHHhhcC--CcCCHHHH
Confidence 9999987 9999998763 24444433
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.9e-12 Score=122.12 Aligned_cols=247 Identities=25% Similarity=0.274 Sum_probs=144.1
Q ss_pred ccCCCCCCEEecccCcCccc----ccccccCCCCCCEEEcccCc---Ccccccc-------cccCCCCCCeeecccCcCc
Q 044615 93 IGNMKSLSDLQLSENILNGS----IPLALGNLTNLVVLDLSTNK---LSGSIPL-------SFANLTSLSILYLYENSLC 158 (571)
Q Consensus 93 ~~~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~L~~n~---i~~~~~~-------~~~~l~~L~~L~L~~n~l~ 158 (571)
+-.+..++.|+|++|.+... +...+.+.++|+..++++-- ....+|. ++...+.|++|+||.|.+.
T Consensus 26 ~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G 105 (382)
T KOG1909|consen 26 LEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFG 105 (382)
T ss_pred hcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccC
Confidence 44567788888888877532 33455666777777776532 1112232 3445667888888888876
Q ss_pred ccCCcc----ccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCC
Q 044615 159 DSIPKE----IGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQL 234 (571)
Q Consensus 159 ~~~~~~----l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 234 (571)
...+.. +.++..|++|.|.+|.+.-.-...+++ .|..|. .+. ..+.-+.|+.+....|++....
T Consensus 106 ~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~---al~~l~--~~k-------k~~~~~~Lrv~i~~rNrlen~g 173 (382)
T KOG1909|consen 106 PKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR---ALFELA--VNK-------KAASKPKLRVFICGRNRLENGG 173 (382)
T ss_pred ccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH---HHHHHH--HHh-------ccCCCcceEEEEeecccccccc
Confidence 444433 345777888888877765211111111 122211 111 1122345666666666654322
Q ss_pred ----ChhhhCCCCCCEEEcccCccccc----cchhhccCCCCCEEEcCCccCccCc----chhhhcccCCCEEEccCCcC
Q 044615 235 ----SPELGSLIQLEYLDLSANTFHKS----IPESLSNLVKLHYLNLSNNQFSQKI----PNKIEKLIHLSELDLSHNIF 302 (571)
Q Consensus 235 ----~~~~~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~Ls~n~l~~~~----~~~~~~l~~L~~L~Ls~n~l 302 (571)
...|...+.|+.+.+..|.+... +...+..+++|+.|||.+|-++... ...+..+++|++|++++|.+
T Consensus 174 a~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll 253 (382)
T KOG1909|consen 174 ATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLL 253 (382)
T ss_pred HHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccccccc
Confidence 22345566777777777765321 2344667777777777777775432 33455566777777777776
Q ss_pred Ccccchhc-----cCCCCCCEEEccCCcCcc----ccccccccCCCCCEEECcCCcCc
Q 044615 303 REEIPSQI-----CSMQSLEKLNLSHNNLSG----SIPRCFEEMHWLSCIDISYNALQ 351 (571)
Q Consensus 303 ~~~~~~~~-----~~l~~L~~L~Ls~n~l~~----~~p~~~~~l~~L~~L~ls~N~l~ 351 (571)
.......+ ...|+|+.|.+.+|.++. .+..+....+.|..|+|++|.+.
T Consensus 254 ~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 254 ENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred ccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 54433222 346788888888887763 23345566788888888888873
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.23 E-value=2e-11 Score=124.94 Aligned_cols=93 Identities=27% Similarity=0.434 Sum_probs=78.3
Q ss_pred HccCCCccCeeeccCcceEEEEEc-C-----CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEe
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAKL-P-----TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSH 532 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~~-~-----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~ 532 (571)
..++|++.+.||+|+||.||+|.. . ++..||||++...... ...+.+.+|+++++.+ +|||||+++++|.+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--DEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--HHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 345689999999999999999872 2 3357999999754322 3356789999999999 89999999999999
Q ss_pred CCeeEEEEeccCCCChhhhhcc
Q 044615 533 ALHSFVVYEYLEMGSLAMNLSN 554 (571)
Q Consensus 533 ~~~~~lv~e~~~~G~L~~~l~~ 554 (571)
.+..|+||||+++|+|.++++.
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~ 135 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRK 135 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHh
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=8.9e-12 Score=122.74 Aligned_cols=96 Identities=23% Similarity=0.313 Sum_probs=84.0
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
+-|+..+.||+|.|++|..|++ =+|..||||++++.+.+. ....++.+|+++|+-++|||||++|++..++..+|+|+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 3477888999999999999983 489999999999877654 33567889999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCc
Q 044615 541 EYLEMGSLAMNLSNDAAA 558 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~ 558 (571)
|.=.+|||+|||-.++.+
T Consensus 97 ELGD~GDl~DyImKHe~G 114 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEG 114 (864)
T ss_pred EecCCchHHHHHHhhhcc
Confidence 999999999999866543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.7e-11 Score=119.95 Aligned_cols=90 Identities=22% Similarity=0.318 Sum_probs=75.1
Q ss_pred HccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCc-----------hHhHHHHHHHHHHHhhcCCCCcccEE
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDE-----------MACQQEFLNEVNALTKIRHRNIVKFY 527 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-----------~~~~~~~~~Ei~~l~~l~H~niv~l~ 527 (571)
..+.|++.+.||+|.||.|.+|+ ..+++.||||++.+..... ....+.+.+||.+|++++|||||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 34679999999999999999999 5689999999997643211 01245789999999999999999999
Q ss_pred EEEEeC--CeeEEEEeccCCCChh
Q 044615 528 GFCSHA--LHSFVVYEYLEMGSLA 549 (571)
Q Consensus 528 ~~~~~~--~~~~lv~e~~~~G~L~ 549 (571)
++..++ +.+|||+|||..|.+.
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~ 198 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVK 198 (576)
T ss_pred EeecCcccCceEEEEEeccCCccc
Confidence 999775 5799999999999864
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.23 E-value=4.4e-11 Score=116.59 Aligned_cols=105 Identities=23% Similarity=0.413 Sum_probs=86.4
Q ss_pred cCCCccCeeeccCcceEEEEEcC-CC---CEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLP-TG---EIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSF 537 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~ 537 (571)
++|++.+.||+|+||.||+|..+ ++ ..||||.+.... .....++|..|+.++++++||||+++++++.+....+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence 35778899999999999999843 33 369999987542 2344678999999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 538 VVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+||||+++|+|.+++....+ .++|.+++.++
T Consensus 82 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~ 112 (269)
T cd05065 82 IITEFMENGALDSFLRQNDG--QFTVIQLVGML 112 (269)
T ss_pred EEEecCCCCcHHHHHhhCCC--CCCHHHHHHHH
Confidence 99999999999999975432 57888777654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.23 E-value=3.5e-11 Score=118.38 Aligned_cols=103 Identities=23% Similarity=0.351 Sum_probs=85.2
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|+..+.||+|+||+||++. .++++.||+|++..... ....+.+.+|+++++.++||||+++++++...+..|+||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc--chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 457888999999999999999 55789999998865422 233577999999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
||+++|+|.+++...+ .++|....++
T Consensus 83 e~~~~~~L~~~~~~~~---~~~~~~~~~~ 108 (284)
T cd06620 83 EFMDCGSLDRIYKKGG---PIPVEILGKI 108 (284)
T ss_pred ecCCCCCHHHHHHhcc---CCCHHHHHHH
Confidence 9999999999987532 3556555443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.23 E-value=4.2e-11 Score=116.59 Aligned_cols=104 Identities=21% Similarity=0.345 Sum_probs=85.8
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCc---hHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEE
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDE---MACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFV 538 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l 538 (571)
+|+..+.||+|+||.||+|. ..+++.||+|.+....... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 47888999999999999998 5689999999987543221 1235679999999999999999999999999999999
Q ss_pred EEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 539 VYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
||||+++|+|.+++.+.+ ++++....++
T Consensus 81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~ 108 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG---AFKEAVIINY 108 (268)
T ss_pred EEeccCCCcHHHHHHHhC---CCCHHHHHHH
Confidence 999999999999997532 4566655544
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.22 E-value=3.3e-11 Score=120.82 Aligned_cols=105 Identities=16% Similarity=0.157 Sum_probs=83.8
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcC-CCCcccEEEEEEeCCeeEEEE
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR-HRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~lv~ 540 (571)
+|+..+.||+|+||.||+|+ ..+|+.||+|++.+.........+.+..|+.++..+. ||+|+++++++.+.+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 47778999999999999998 5579999999997543222233566888999988885 577888999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||+++|+|.+++...+ .+++.+...||
T Consensus 81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~ 107 (323)
T cd05615 81 EYVNGGDLMYHIQQVG---KFKEPQAVFYA 107 (323)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHH
Confidence 9999999999987432 46677666654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.22 E-value=6.3e-11 Score=114.10 Aligned_cols=99 Identities=26% Similarity=0.419 Sum_probs=82.5
Q ss_pred CeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEeccCCCC
Q 044615 468 HCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGS 547 (571)
Q Consensus 468 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~G~ 547 (571)
+.||+|+||.||+|..+++..+|+|.+..... ......|.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP--QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 36899999999999977889999999875432 2334578999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCccCCCHHHHhhhc
Q 044615 548 LAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 548 L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|.+++..... .++|..++.++
T Consensus 79 L~~~~~~~~~--~~~~~~~~~~~ 99 (250)
T cd05085 79 FLSFLRKKKD--ELKTKQLVKFA 99 (250)
T ss_pred HHHHHHhcCC--CCCHHHHHHHH
Confidence 9999875432 46777776653
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.22 E-value=2e-11 Score=118.29 Aligned_cols=104 Identities=21% Similarity=0.245 Sum_probs=86.7
Q ss_pred CCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
+|+..+.||.|+||.||+|.. .++..||+|.+.+.........+.+.+|++++++++||||+++++++.++...|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 478889999999999999994 4789999999976543333446789999999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
|+++++|.+++... ..+++.....|
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~ 105 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFW 105 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHH
Confidence 99999999999754 24555555544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.22 E-value=3.9e-11 Score=120.27 Aligned_cols=99 Identities=19% Similarity=0.221 Sum_probs=79.0
Q ss_pred CeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCeeEEEEeccCC
Q 044615 468 HCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHSFVVYEYLEM 545 (571)
Q Consensus 468 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 545 (571)
+.||+|+||.||+|+. .+++.||||++.+.........+.+..|++++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3689999999999984 57899999999754332233456678899998865 899999999999999999999999999
Q ss_pred CChhhhhccCCCccCCCHHHHhhh
Q 044615 546 GSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 546 G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
|+|.+++.... .+++.....+
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~ 101 (321)
T cd05591 81 GDLMFQIQRSR---KFDEPRSRFY 101 (321)
T ss_pred CcHHHHHHHcC---CCCHHHHHHH
Confidence 99999987442 3556555443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.22 E-value=3.9e-11 Score=120.10 Aligned_cols=100 Identities=20% Similarity=0.241 Sum_probs=80.5
Q ss_pred CeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCeeEEEEeccCC
Q 044615 468 HCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHSFVVYEYLEM 545 (571)
Q Consensus 468 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 545 (571)
+.||+|+||.||+|.. .+++.||||++.+...........+.+|++++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4689999999999984 57889999999754322223356678899998887 799999999999999999999999999
Q ss_pred CChhhhhccCCCccCCCHHHHhhhc
Q 044615 546 GSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 546 G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+|.+++.+.+ .++|.....|+
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~ 102 (318)
T cd05570 81 GDLMFHIQRSG---RFDEPRARFYA 102 (318)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHH
Confidence 99999887542 46676665543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.22 E-value=5.4e-11 Score=119.58 Aligned_cols=103 Identities=19% Similarity=0.186 Sum_probs=82.9
Q ss_pred ccCeeecc--CcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEec
Q 044615 466 DGHCIGNG--GQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEY 542 (571)
Q Consensus 466 ~~~~lg~G--~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 542 (571)
..++||+| +|++||++. ..+|+.||+|++....... ...+.+.+|+++++.++|||||+++++|.+++..|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTN-EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccH-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 35679999 688999998 5689999999997543322 3345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 543 LEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 543 ~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+++|+|.+++..... ..++|.....|+
T Consensus 81 ~~~~~l~~~~~~~~~-~~l~~~~~~~i~ 107 (327)
T cd08227 81 MAYGSAKDLICTHFM-DGMSELAIAYIL 107 (327)
T ss_pred cCCCcHHHHHHhhcc-CCCCHHHHHHHH
Confidence 999999999964322 246777666554
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.22 E-value=4.3e-11 Score=119.60 Aligned_cols=99 Identities=20% Similarity=0.262 Sum_probs=77.7
Q ss_pred CeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhh-cCCCCcccEEEEEEeCCeeEEEEeccCC
Q 044615 468 HCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTK-IRHRNIVKFYGFCSHALHSFVVYEYLEM 545 (571)
Q Consensus 468 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~ 545 (571)
+.||+|+||.||+|+. .+++.||||+++..........+.+..|..++.. .+||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4689999999999994 5788999999975432212234557778888876 5999999999999999999999999999
Q ss_pred CChhhhhccCCCccCCCHHHHhhh
Q 044615 546 GSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 546 G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
|+|.+++.... .+++.+...+
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~ 101 (316)
T cd05619 81 GDLMFHIQSCH---KFDLPRATFY 101 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHH
Confidence 99999997532 3566555544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.22 E-value=5.9e-11 Score=118.06 Aligned_cols=103 Identities=23% Similarity=0.203 Sum_probs=85.6
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
+|+..+.||+|+||.||++. ..+++.||+|.+...........+.+.+|+++++.++||||+++++.+.+++..|+|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 68889999999999999999 45788999999876533333345678899999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhh
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMN 568 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~ 568 (571)
|+++|+|.+++...+ .+.|.....
T Consensus 82 ~~~g~~L~~~l~~~~---~~~~~~~~~ 105 (305)
T cd05609 82 YVEGGDCATLLKNIG---ALPVDMARM 105 (305)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHH
Confidence 999999999997542 355555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.22 E-value=4.3e-11 Score=119.82 Aligned_cols=98 Identities=18% Similarity=0.255 Sum_probs=78.8
Q ss_pred CeeeccCcceEEEEEc----CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEecc
Q 044615 468 HCIGNGGQGSVYKAKL----PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYL 543 (571)
Q Consensus 468 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 543 (571)
+.||+|+||.||+++. .+|+.||+|++...... ......+.+|++++++++||||+++++++.+.+..|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 5799999999999873 36889999999753322 123456788999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCccCCCHHHHhhh
Q 044615 544 EMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 544 ~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
++|+|.+++.+.. .+++.....+
T Consensus 81 ~~~~L~~~l~~~~---~l~~~~~~~~ 103 (318)
T cd05582 81 RGGDLFTRLSKEV---MFTEEDVKFY 103 (318)
T ss_pred CCCcHHHHHHHcC---CCCHHHHHHH
Confidence 9999999997432 3555555444
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.22 E-value=5.2e-11 Score=117.10 Aligned_cols=104 Identities=32% Similarity=0.442 Sum_probs=84.1
Q ss_pred cCCCccCeeeccCcceEEEEEc-----CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC--C
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-----PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA--L 534 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~--~ 534 (571)
.+|++.+.||+|+||.||+|.. .++..||+|.+.... ....+.|.+|++++++++||||+++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 3678889999999999999973 357899999986542 23356789999999999999999999987543 4
Q ss_pred eeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 535 HSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
..++||||+++|+|.+++.+.. ..++|..+..++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~ 114 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYA 114 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHH
Confidence 6889999999999999997543 247788776654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.22 E-value=6.3e-11 Score=116.48 Aligned_cols=91 Identities=23% Similarity=0.352 Sum_probs=77.5
Q ss_pred cCCCccCeeeccCcceEEEEEc-----CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCee
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-----PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHS 536 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~ 536 (571)
.+|++.+.||+|+||.||+|.. .++..||+|.+.... .....+.|.+|++++++++||||+++++++......
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence 3577889999999999999973 256789999987432 223356799999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhcc
Q 044615 537 FVVYEYLEMGSLAMNLSN 554 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~ 554 (571)
|+||||+++|+|.+++..
T Consensus 83 ~lv~e~~~~~~L~~~l~~ 100 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIM 100 (283)
T ss_pred EEEEEcCCCCcHHHHHHh
Confidence 999999999999999963
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=3.5e-11 Score=116.95 Aligned_cols=86 Identities=29% Similarity=0.436 Sum_probs=71.3
Q ss_pred CCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhh--cCCCCcccEEEEEEeC----Cee
Q 044615 463 NFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTK--IRHRNIVKFYGFCSHA----LHS 536 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~~~~~~~----~~~ 536 (571)
.....+.||+|.||+||+|.+ .|+.||||++.... .+.+.+|.+|..+ ++|+||..+++.-... .++
T Consensus 212 qI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred eeEEEEEecCccccceeeccc-cCCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 466788999999999999998 58899999996432 2457788888765 5999999998876543 368
Q ss_pred EEEEeccCCCChhhhhccC
Q 044615 537 FVVYEYLEMGSLAMNLSND 555 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~ 555 (571)
|+|.||-+.|||+|||.+.
T Consensus 285 wLvTdYHe~GSL~DyL~r~ 303 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNRN 303 (513)
T ss_pred EEeeecccCCcHHHHHhhc
Confidence 9999999999999999863
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.7e-11 Score=118.47 Aligned_cols=97 Identities=16% Similarity=0.336 Sum_probs=77.0
Q ss_pred eeeccCcceEEEEEcC-C------------------------CCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCc
Q 044615 469 CIGNGGQGSVYKAKLP-T------------------------GEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNI 523 (571)
Q Consensus 469 ~lg~G~~g~V~~~~~~-~------------------------~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~ni 523 (571)
.||+|+||.||+|... + ...||+|.+.... .....+|.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 5899999999999731 1 1358889886432 2234678899999999999999
Q ss_pred ccEEEEEEeCCeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 524 VKFYGFCSHALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 524 v~l~~~~~~~~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+++++++.+....++||||+++|+|.+++..... .++|..+++++
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~i~ 123 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--RVPVAWKITVA 123 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHH
Confidence 9999999999999999999999999999875333 46677676654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.21 E-value=5.4e-11 Score=119.35 Aligned_cols=104 Identities=16% Similarity=0.164 Sum_probs=83.1
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCeeEEEE
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 540 (571)
+|.+.+.||+|+||.||+|. ..+++.||||++.+.........+.+..|..++..+ +||+|+++++++.+.+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 57888999999999999998 457889999999764333333345677888888777 6899999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
||+++|+|.+++.... .+++.+...+
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~ 106 (323)
T cd05616 81 EYVNGGDLMYQIQQVG---RFKEPHAVFY 106 (323)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHH
Confidence 9999999999987542 3566655544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.21 E-value=3.8e-11 Score=120.20 Aligned_cols=99 Identities=19% Similarity=0.272 Sum_probs=78.4
Q ss_pred CeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCeeEEEEeccCC
Q 044615 468 HCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHSFVVYEYLEM 545 (571)
Q Consensus 468 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 545 (571)
+.||+|+||.||+|+. .+++.||||++.+.........+.+.+|++++... +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3689999999999994 57899999998754322223356678899888876 799999999999999999999999999
Q ss_pred CChhhhhccCCCccCCCHHHHhhh
Q 044615 546 GSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 546 G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
|+|.+++.... .+++.....+
T Consensus 81 g~L~~~i~~~~---~l~~~~~~~~ 101 (320)
T cd05590 81 GDLMFHIQKSR---RFDEARARFY 101 (320)
T ss_pred chHHHHHHHcC---CCCHHHHHHH
Confidence 99999987543 3555554443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.21 E-value=5.9e-11 Score=119.23 Aligned_cols=100 Identities=15% Similarity=0.170 Sum_probs=81.9
Q ss_pred CeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCeeEEEEeccCC
Q 044615 468 HCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHSFVVYEYLEM 545 (571)
Q Consensus 468 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 545 (571)
+.||+|+||+||+|+ ..+++.||+|++.+.........+.+.+|+.++.++ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999 457899999999865433334456788999999888 699999999999999999999999999
Q ss_pred CChhhhhccCCCccCCCHHHHhhhc
Q 044615 546 GSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 546 G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+|.+++...+ .+++..+..|+
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~ 102 (327)
T cd05617 81 GDLMFHMQRQR---KLPEEHARFYA 102 (327)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHH
Confidence 99999886432 46666665553
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.21 E-value=6.5e-11 Score=114.78 Aligned_cols=103 Identities=23% Similarity=0.370 Sum_probs=85.4
Q ss_pred cCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
++|++.+.||+|+||.||+|..+++..+|+|.+...... .+.|.+|+.++++++|||++++++++. ....|++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 358888999999999999999777888999998754332 356899999999999999999999885 456899999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+++|+|.+++++.. ...++|.++.+|+
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~ 108 (260)
T cd05070 81 YMSKGSLLDFLKDGE-GRALKLPNLVDMA 108 (260)
T ss_pred ecCCCcHHHHHHhcC-CCCCCHHHHHHHH
Confidence 999999999997542 2357888777764
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.21 E-value=6.1e-11 Score=115.81 Aligned_cols=104 Identities=27% Similarity=0.370 Sum_probs=83.5
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCc-------hHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDE-------MACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL 534 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-------~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~ 534 (571)
.|...+.||+|+||.||+|. ..+++.||+|.+....... ....+.+.+|+.++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 36778899999999999998 4578999999886432111 112356889999999999999999999999999
Q ss_pred eeEEEEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 535 HSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
..++||||+++|+|.+++++. ..+++.....|
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~ 113 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFF 113 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHH
Confidence 999999999999999999754 24666655443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.21 E-value=7.8e-11 Score=116.13 Aligned_cols=102 Identities=21% Similarity=0.295 Sum_probs=82.0
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|+..+.||+|+||.||+|. ..+++.||+|.+...... .....+.+|++++++++||||+++++++.+.+..|+||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 468999999999999999998 457899999998754322 22356789999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMN 568 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ 568 (571)
||+++ +|.+++...+. .+++.....
T Consensus 83 e~~~~-~l~~~l~~~~~--~~~~~~~~~ 107 (288)
T cd07871 83 EYLDS-DLKQYLDNCGN--LMSMHNVKI 107 (288)
T ss_pred eCCCc-CHHHHHHhcCC--CCCHHHHHH
Confidence 99985 99998875432 345544433
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.21 E-value=5.7e-11 Score=116.23 Aligned_cols=107 Identities=24% Similarity=0.463 Sum_probs=87.2
Q ss_pred cCCCccCeeeccCcceEEEEEcC------CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLP------TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALH 535 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~ 535 (571)
++|+....||+|+||.||+|+.+ +...||+|.+...... ...+.|.+|++++++++||||+++++++.+.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE--NLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccch--HHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 46888899999999999999843 3467999988643221 235679999999999999999999999999899
Q ss_pred eEEEEeccCCCChhhhhccCCCc------cCCCHHHHhhhc
Q 044615 536 SFVVYEYLEMGSLAMNLSNDAAA------EQFCWTKRMNAI 570 (571)
Q Consensus 536 ~~lv~e~~~~G~L~~~l~~~~~~------~~l~w~~r~~ia 570 (571)
.|+||||+++|+|.+++...... ..++|..++.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~ 123 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHH
Confidence 99999999999999999754422 258888887764
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.21 E-value=7.2e-11 Score=114.14 Aligned_cols=102 Identities=22% Similarity=0.415 Sum_probs=84.6
Q ss_pred cCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
.+|+..+.||+|+||.||+|....+..+|+|.+...... ..+|.+|++++++++|||++++++++......++|||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE 79 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence 357788999999999999998766888999998754322 3568899999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
|+++|+|.+++..... .+.|.....+
T Consensus 80 ~~~~~~L~~~~~~~~~--~~~~~~~~~~ 105 (256)
T cd05112 80 FMEHGCLSDYLRAQRG--KFSQETLLGM 105 (256)
T ss_pred cCCCCcHHHHHHhCcc--CCCHHHHHHH
Confidence 9999999999975432 3566655444
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.21 E-value=6.4e-11 Score=116.02 Aligned_cols=109 Identities=21% Similarity=0.323 Sum_probs=87.0
Q ss_pred HccCCCccCeeeccCcceEEEEEcC------CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAKLP------TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA 533 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~ 533 (571)
..++|+..+.||+|+||.||+|... .+..||+|.+.... ......+|.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 3456899999999999999998732 35679999986432 223456799999999999999999999999999
Q ss_pred CeeEEEEeccCCCChhhhhccCCC-------ccCCCHHHHhhhc
Q 044615 534 LHSFVVYEYLEMGSLAMNLSNDAA-------AEQFCWTKRMNAI 570 (571)
Q Consensus 534 ~~~~lv~e~~~~G~L~~~l~~~~~-------~~~l~w~~r~~ia 570 (571)
...++||||+++|+|.+++++... ...++|.+.+.++
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 125 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMA 125 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHH
Confidence 999999999999999999975322 2346777776653
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.21 E-value=4.5e-11 Score=117.75 Aligned_cols=104 Identities=25% Similarity=0.334 Sum_probs=81.9
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|++.+.||+|+||.||+|+. .+++.||||++...... ....+.+.+|++++++++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 3688999999999999999995 57889999999754322 233567889999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
||+++|.+..+.... ..+++.....+
T Consensus 80 e~~~~~~l~~~~~~~---~~~~~~~~~~~ 105 (287)
T cd07848 80 EYVEKNMLELLEEMP---NGVPPEKVRSY 105 (287)
T ss_pred ecCCCCHHHHHHhcC---CCCCHHHHHHH
Confidence 999998776554322 23555544433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.21 E-value=6.7e-11 Score=117.51 Aligned_cols=107 Identities=24% Similarity=0.398 Sum_probs=84.3
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCE--EEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCeeE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEI--VDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHSF 537 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~ 537 (571)
++|++.+.||+|+||.||+|.. .++.. +|+|.+.... .....+.+.+|++++.++ +||||+++++++.+.+..|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC--CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 4688889999999999999984 45543 5777765322 223356789999999999 8999999999999999999
Q ss_pred EEEeccCCCChhhhhccCCC-------------ccCCCHHHHhhhc
Q 044615 538 VVYEYLEMGSLAMNLSNDAA-------------AEQFCWTKRMNAI 570 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~~~-------------~~~l~w~~r~~ia 570 (571)
+||||+++|+|.+++++... ...+++.+.+.++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 130 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHH
Confidence 99999999999999975421 1246777766654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.21 E-value=4.8e-11 Score=115.95 Aligned_cols=103 Identities=22% Similarity=0.380 Sum_probs=86.5
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
+|+..+.||+|+||.||+|. .+.+..||+|.+.... ...+++.+|++++++++||||+++++++...+..++|||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 47788899999999999998 4568899999986432 224678999999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+++|+|.+++.... ...++|..++.++
T Consensus 83 ~~~~~~L~~~~~~~~-~~~l~~~~~~~~~ 110 (263)
T cd05052 83 FMTYGNLLDYLRECN-RQEVNAVVLLYMA 110 (263)
T ss_pred eCCCCcHHHHHHhCC-CCCCCHHHHHHHH
Confidence 999999999997543 2357888776654
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.21 E-value=1e-10 Score=113.70 Aligned_cols=106 Identities=25% Similarity=0.319 Sum_probs=87.5
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|++.+.||.|+||.||+|. ..++..+|+|++....... ..+.+.+|+++++.++||||+++++.+...+..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 368899999999999999999 4578899999987543322 4577999999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
||+++|+|.++++.......++|.....+
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 107 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATV 107 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHH
Confidence 99999999999975433234666655443
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.21 E-value=5.9e-11 Score=115.25 Aligned_cols=103 Identities=21% Similarity=0.354 Sum_probs=83.6
Q ss_pred cCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
+.|.+.+.||+|+||.||+|...+...||+|++..... ..++|.+|++++++++||||+++++++. ....|+|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTE 80 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEE
Confidence 45889999999999999999866666799999975332 2357899999999999999999999875 456799999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+++|+|.+++.... ...++|..+..++
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~ 108 (262)
T cd05071 81 YMSKGSLLDFLKGEM-GKYLRLPQLVDMA 108 (262)
T ss_pred cCCCCcHHHHHhhcc-ccCCCHHHHHHHH
Confidence 999999999997542 2356777776654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.20 E-value=8.1e-11 Score=113.81 Aligned_cols=103 Identities=26% Similarity=0.419 Sum_probs=87.1
Q ss_pred cCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
++|+..+.||+|+||.||+|... |+.||+|.+..... ..+++.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence 46888999999999999999864 78899999975432 35779999999999999999999999998899999999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+++|+|.+++..... ..++|.....++
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~ 108 (256)
T cd05039 81 YMAKGSLVDYLRSRGR-AVITLAQQLGFA 108 (256)
T ss_pred ecCCCcHHHHHHhcCC-CCCCHHHHHHHH
Confidence 9999999999975432 257777776654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.20 E-value=3.7e-11 Score=117.91 Aligned_cols=104 Identities=20% Similarity=0.269 Sum_probs=86.4
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|++.+.||+|+||.||+|.. .++..+|+|.+... .....+.|.+|++++++++||||+++++++.++...|+||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 4588889999999999999994 57899999998643 2234567999999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||+++|+|.+++...+. .+++.....++
T Consensus 82 e~~~~~~L~~~~~~~~~--~l~~~~~~~~~ 109 (280)
T cd06611 82 EFCDGGALDSIMLELER--GLTEPQIRYVC 109 (280)
T ss_pred eccCCCcHHHHHHHhcC--CCCHHHHHHHH
Confidence 99999999999875332 46666555543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.2e-10 Score=114.05 Aligned_cols=101 Identities=22% Similarity=0.288 Sum_probs=84.1
Q ss_pred CCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEec
Q 044615 464 FDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEY 542 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 542 (571)
|+..+.||+|+||.||+|. ..++..||+|.+..... ....+.+.+|+.++++++||||+++++++...+..|+||||
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 6778899999999999998 45789999999864322 23356789999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 543 LEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 543 ~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+++|+|.+++... .++|.....++
T Consensus 84 ~~~~~l~~~i~~~----~~~~~~~~~~~ 107 (277)
T cd06641 84 LGGGSALDLLEPG----PLDETQIATIL 107 (277)
T ss_pred CCCCcHHHHHhcC----CCCHHHHHHHH
Confidence 9999999998642 46676665543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.20 E-value=8.7e-11 Score=113.58 Aligned_cols=105 Identities=20% Similarity=0.260 Sum_probs=85.8
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
+|+..+.||+|+||.||.+. ..+|+.||+|.+...... ....+++.+|++++++++||||+++++++.+.+..|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 47888999999999999998 557899999998754322 2345678999999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
|+++|+|.+++..... ..+++.+.+++
T Consensus 80 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~ 106 (256)
T cd08218 80 YCEGGDLYKKINAQRG-VLFPEDQILDW 106 (256)
T ss_pred cCCCCcHHHHHHhccC-CCCCHHHHHHH
Confidence 9999999999975322 23556655544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.20 E-value=1e-10 Score=115.05 Aligned_cols=105 Identities=22% Similarity=0.320 Sum_probs=85.3
Q ss_pred CCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
+|+..+.||+|+||.||+|.. .++..||+|.+...... ....+.+.+|+.++.+++||||+++++++.+++..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 478889999999999999994 57899999998754322 2234678899999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
|++ |+|.+++........+++.....+
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~ 106 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSY 106 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHH
Confidence 998 689998875443345777666554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.20 E-value=8.7e-11 Score=114.42 Aligned_cols=105 Identities=23% Similarity=0.451 Sum_probs=86.1
Q ss_pred cCCCccCeeeccCcceEEEEEcC-CCC---EEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLP-TGE---IVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSF 537 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~-~~~---~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~ 537 (571)
.+|+..+.||+|+||.||+|..+ ++. .+|+|.+..... ....+++.+|++++++++||||+++++++.+.+..|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT--EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC--HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 35788899999999999999853 333 789999865422 233567999999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 538 VVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+||||+++|+|.+++.... ..++|.++++++
T Consensus 83 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ 113 (268)
T cd05063 83 IITEYMENGALDKYLRDHD--GEFSSYQLVGML 113 (268)
T ss_pred EEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHH
Confidence 9999999999999997543 257788777654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.20 E-value=6.4e-11 Score=114.86 Aligned_cols=103 Identities=21% Similarity=0.322 Sum_probs=85.5
Q ss_pred cCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
++|...+.||+|+||.||+|....+..+|+|.+.... ...+.|.+|++++++++|+||+++++++.+ ...|++||
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 4688899999999999999997677789999886432 234678999999999999999999999987 77899999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+++|+|.+++.... ...++|.+++.++
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~ 108 (260)
T cd05073 81 FMAKGSLLDFLKSDE-GSKQPLPKLIDFS 108 (260)
T ss_pred eCCCCcHHHHHHhCC-ccccCHHHHHHHH
Confidence 999999999997543 2357787776654
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.1e-10 Score=116.04 Aligned_cols=92 Identities=21% Similarity=0.355 Sum_probs=77.7
Q ss_pred ccCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.++|++.+.||+|+||.||+|+. .+++.||||++....... ....+.+|+.++++++||||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG--TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc--cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 35799999999999999999994 578999999997543221 234578899999999999999999999999999999
Q ss_pred EeccCCCChhhhhccC
Q 044615 540 YEYLEMGSLAMNLSND 555 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~ 555 (571)
|||++ |+|.+++...
T Consensus 82 ~e~~~-~~l~~~~~~~ 96 (303)
T cd07869 82 FEYVH-TDLCQYMDKH 96 (303)
T ss_pred EECCC-cCHHHHHHhC
Confidence 99996 6888888654
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.20 E-value=1e-10 Score=115.84 Aligned_cols=101 Identities=24% Similarity=0.325 Sum_probs=85.3
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
.+|+..+.||+|+||.||+|. ..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++..++..|+||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 568899999999999999999 568999999998754322 2466889999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
||+++|+|.+++.+. .+++.++..+
T Consensus 96 e~~~~~~L~~~~~~~----~~~~~~~~~~ 120 (297)
T cd06656 96 EYLAGGSLTDVVTET----CMDEGQIAAV 120 (297)
T ss_pred cccCCCCHHHHHHhC----CCCHHHHHHH
Confidence 999999999998642 3566665554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.19 E-value=8.2e-11 Score=115.97 Aligned_cols=92 Identities=29% Similarity=0.496 Sum_probs=78.9
Q ss_pred ccCCCccCeeeccCcceEEEEEcC------CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKLP------TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL 534 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~ 534 (571)
.++|+..+.||+|+||.||+|..+ ++..||+|.+.... .....++|.+|+.++++++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 356888999999999999999842 46789999987543 2233567999999999999999999999999999
Q ss_pred eeEEEEeccCCCChhhhhcc
Q 044615 535 HSFVVYEYLEMGSLAMNLSN 554 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~ 554 (571)
..++||||+++|+|.+++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~ 101 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRH 101 (288)
T ss_pred ccEEEEecCCCCCHHHHHHH
Confidence 99999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.19 E-value=7.9e-11 Score=115.40 Aligned_cols=108 Identities=21% Similarity=0.327 Sum_probs=88.1
Q ss_pred ccCCCccCeeeccCcceEEEEEcC------CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKLP------TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL 534 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~ 534 (571)
.++|.+.+.||+|+||.||+|... .+..||+|.+..... ......|.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS--EQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 356888999999999999999853 456789998864322 233467999999999999999999999999999
Q ss_pred eeEEEEeccCCCChhhhhccCCC----ccCCCHHHHhhhc
Q 044615 535 HSFVVYEYLEMGSLAMNLSNDAA----AEQFCWTKRMNAI 570 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~~~~----~~~l~w~~r~~ia 570 (571)
..++||||+++|+|.+++++... ...++|..+++|+
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~ 122 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHH
Confidence 99999999999999999975432 2358888877764
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.19 E-value=5.6e-11 Score=116.58 Aligned_cols=106 Identities=26% Similarity=0.481 Sum_probs=85.8
Q ss_pred cCCCccCeeeccCcceEEEEEcC------CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLP------TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALH 535 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~ 535 (571)
++|.+.+.||+|+||.||+|... +++.||||.+..... ....+.|.+|++++++++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 45788899999999999999742 357899999875432 2235789999999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhhccCCC-----------ccCCCHHHHhhh
Q 044615 536 SFVVYEYLEMGSLAMNLSNDAA-----------AEQFCWTKRMNA 569 (571)
Q Consensus 536 ~~lv~e~~~~G~L~~~l~~~~~-----------~~~l~w~~r~~i 569 (571)
.++||||+++|+|.+++...+. ...++|.+...+
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 127 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHH
Confidence 9999999999999999975421 234667666554
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.2e-12 Score=117.72 Aligned_cols=88 Identities=27% Similarity=0.429 Sum_probs=78.3
Q ss_pred CCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEec
Q 044615 464 FDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEY 542 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 542 (571)
|++..++|+|+||.||+|. ..+|..+|+|.+..+ .+.+++..||.+|.+++.|.+|++||.|.....+||||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 5667889999999999998 558999999998754 2367899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCC
Q 044615 543 LEMGSLAMNLSNDA 556 (571)
Q Consensus 543 ~~~G~L~~~l~~~~ 556 (571)
|-.|+..+.++-+.
T Consensus 110 CGAGSiSDI~R~R~ 123 (502)
T KOG0574|consen 110 CGAGSISDIMRARR 123 (502)
T ss_pred cCCCcHHHHHHHhc
Confidence 99999999987543
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.19 E-value=7.7e-11 Score=116.62 Aligned_cols=107 Identities=20% Similarity=0.356 Sum_probs=85.2
Q ss_pred cCCCccCeeeccCcceEEEEEcCC---------------CCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPT---------------GEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKF 526 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l 526 (571)
.+|++.+.||+|+||.||+|.... ...||+|.+..... ....+.|.+|++++++++|||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT--KTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 468889999999999999987421 23589999875422 2335679999999999999999999
Q ss_pred EEEEEeCCeeEEEEeccCCCChhhhhccCCC---------ccCCCHHHHhhhc
Q 044615 527 YGFCSHALHSFVVYEYLEMGSLAMNLSNDAA---------AEQFCWTKRMNAI 570 (571)
Q Consensus 527 ~~~~~~~~~~~lv~e~~~~G~L~~~l~~~~~---------~~~l~w~~r~~ia 570 (571)
++++...+..++||||+++|+|.+++..... ...++|..+++|+
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~ 135 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMA 135 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHH
Confidence 9999999999999999999999999965321 1246777776654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.2e-10 Score=112.59 Aligned_cols=106 Identities=18% Similarity=0.245 Sum_probs=87.7
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
+|+..+.||+|+||.||++. ..+++.+|+|.+....... ...+.+.+|++++++++|||++++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 47888999999999999998 4578999999997643322 345779999999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+++|+|.+++.... ...+++.....++
T Consensus 80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~ 107 (256)
T cd08220 80 YAPGGTLAEYIQKRC-NSLLDEDTILHFF 107 (256)
T ss_pred cCCCCCHHHHHHHhc-ccCCCHHHHHHHH
Confidence 999999999997543 2346676665543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.19 E-value=7.8e-11 Score=118.19 Aligned_cols=98 Identities=23% Similarity=0.288 Sum_probs=75.9
Q ss_pred CeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHH-HHhhcCCCCcccEEEEEEeCCeeEEEEeccCC
Q 044615 468 HCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVN-ALTKIRHRNIVKFYGFCSHALHSFVVYEYLEM 545 (571)
Q Consensus 468 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 545 (571)
+.||+|+||+||+|+ ..+|+.||+|++.+.........+++..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 468999999999999 4589999999997543222223445666655 46789999999999999999999999999999
Q ss_pred CChhhhhccCCCccCCCHHHHhh
Q 044615 546 GSLAMNLSNDAAAEQFCWTKRMN 568 (571)
Q Consensus 546 G~L~~~l~~~~~~~~l~w~~r~~ 568 (571)
|+|.+++.... .+.+.....
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~ 100 (323)
T cd05575 81 GELFFHLQRER---SFPEPRARF 100 (323)
T ss_pred CCHHHHHHhcC---CCCHHHHHH
Confidence 99999987532 345544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.1e-10 Score=116.66 Aligned_cols=106 Identities=18% Similarity=0.214 Sum_probs=88.3
Q ss_pred CCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
+|+..+.||+|+||.||+|.. .+++.||+|.+...........+.+.+|++++++++||||+++++.+.+....|+|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 688889999999999999994 4689999999986544433456679999999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
|+++|+|.+++.... ...+++.....+
T Consensus 82 ~~~~~~L~~~~~~~~-~~~l~~~~~~~~ 108 (316)
T cd05574 82 YCPGGELFRLLQRQP-GKCLSEEVARFY 108 (316)
T ss_pred ecCCCCHHHHHHhCC-CCccCHHHHHHH
Confidence 999999999987432 235666665544
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.19 E-value=9.7e-11 Score=128.34 Aligned_cols=105 Identities=21% Similarity=0.165 Sum_probs=87.4
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|.+.+.||+|+||.||+|.. .+++.||||++.............+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 5788999999999999999994 478999999997654444444577899999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
||+++|+|.++++..+ .+++.....|
T Consensus 84 Ey~~g~~L~~li~~~~---~l~~~~~~~i 109 (669)
T cd05610 84 EYLIGGDVKSLLHIYG---YFDEEMAVKY 109 (669)
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHH
Confidence 9999999999997432 3455544443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.18 E-value=9.1e-11 Score=114.94 Aligned_cols=99 Identities=23% Similarity=0.253 Sum_probs=80.7
Q ss_pred eeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEeccCCCCh
Q 044615 470 IGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548 (571)
Q Consensus 470 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~G~L 548 (571)
||+|+||+||+|. ..+|+.||+|.+.+.........+.+.+|++++++++||||+++++++...+..|+||||+++|+|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6899999999998 457999999998754332223345678899999999999999999999999999999999999999
Q ss_pred hhhhccCCCccCCCHHHHhhh
Q 044615 549 AMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 549 ~~~l~~~~~~~~l~w~~r~~i 569 (571)
.+++..... ..+++.....+
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~ 100 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFY 100 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHH
Confidence 999975432 34677666554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.18 E-value=6.8e-11 Score=114.32 Aligned_cols=106 Identities=24% Similarity=0.324 Sum_probs=87.5
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
+|+..+.||+|+||.||+|. ..+|..+|+|.+...... ....+.+.+|+.++++++||||+++++.+.+....|+|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP-VKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc-chhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 47788899999999999999 457889999998754322 1334678899999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+++++|.+++.+... ..++|..+..++
T Consensus 80 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~ 107 (257)
T cd08225 80 YCDGGDLMKRINRQRG-VLFSEDQILSWF 107 (257)
T ss_pred cCCCCcHHHHHHhccC-CCCCHHHHHHHH
Confidence 9999999999975432 357887776654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.4e-10 Score=112.59 Aligned_cols=94 Identities=24% Similarity=0.375 Sum_probs=80.6
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCc--hHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDE--MACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFV 538 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l 538 (571)
++|+..+.||+|+||.||+|. ..+++.||+|.+....... ....+.+.+|++++++++||||+++++++.+.+..|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 468899999999999999998 4578999999987543221 1234678999999999999999999999999999999
Q ss_pred EEeccCCCChhhhhccC
Q 044615 539 VYEYLEMGSLAMNLSND 555 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~ 555 (571)
||||+++|+|.+++...
T Consensus 82 v~e~~~~~~l~~~~~~~ 98 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY 98 (263)
T ss_pred EEEECCCCcHHHHHHHh
Confidence 99999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.5e-10 Score=111.84 Aligned_cols=103 Identities=24% Similarity=0.324 Sum_probs=84.9
Q ss_pred CCccCeeeccCcceEEEEEcC-CCCEEEEEEccCCCCC--chHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 464 FDDGHCIGNGGQGSVYKAKLP-TGEIVDVKKFHSPLPD--EMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
|+..+.||+|+||+||+|... +++.||+|.+...... .....+.+.+|++++++++||||+++++++.+....|+||
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 677789999999999999954 8999999998654322 1233567999999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
||+++++|.+++.+.. .++|.....+
T Consensus 82 e~~~~~~L~~~~~~~~---~~~~~~~~~~ 107 (258)
T cd06632 82 ELVPGGSLAKLLKKYG---SFPEPVIRLY 107 (258)
T ss_pred EecCCCcHHHHHHhcC---CCCHHHHHHH
Confidence 9999999999997542 3666665544
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.18 E-value=4.6e-11 Score=117.55 Aligned_cols=105 Identities=22% Similarity=0.370 Sum_probs=86.7
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|+..+.||+|+||.||+|.. .+++.||+|.+....... ...+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 3688889999999999999995 468999999987543322 33567889999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||+++++|.++.... ..++|.+...|+
T Consensus 80 e~~~~~~l~~~~~~~---~~~~~~~~~~~~ 106 (286)
T cd07846 80 EFVDHTVLDDLEKYP---NGLDESRVRKYL 106 (286)
T ss_pred ecCCccHHHHHHhcc---CCCCHHHHHHHH
Confidence 999999998877643 237788777654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.18 E-value=7.8e-11 Score=124.49 Aligned_cols=104 Identities=15% Similarity=0.038 Sum_probs=82.8
Q ss_pred CCCccCeeeccCcceEEEEE-cCC-CCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPT-GEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~-~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
.|...+.||+|+||.||+|. ..+ ++.||+|.+.... ......+.+|+.+++.++|||||++++++...+..|+||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 38889999999999999998 344 6788999875432 233456888999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCC-CccCCCHHHHhhh
Q 044615 541 EYLEMGSLAMNLSNDA-AAEQFCWTKRMNA 569 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~-~~~~l~w~~r~~i 569 (571)
||+++|+|.+++++.. ...++++.+...+
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i 174 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLL 174 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHH
Confidence 9999999999886431 2234565554433
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.6e-10 Score=112.45 Aligned_cols=105 Identities=21% Similarity=0.277 Sum_probs=82.6
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCC--CchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC--Cee
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLP--DEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA--LHS 536 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~--~~~ 536 (571)
.+|+..+.||+|+||.||.|. ..++..||+|.+..... ......+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 468889999999999999998 45789999999864321 2223456789999999999999999999998764 568
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
++||||+++|+|.+++.+.. .+++...+++
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~ 111 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKY 111 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---CCCHHHHHHH
Confidence 89999999999999997542 2444444433
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.2e-10 Score=114.42 Aligned_cols=105 Identities=22% Similarity=0.380 Sum_probs=86.7
Q ss_pred CCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
+|+..+.||+|++|.||+|+. .+|+.||||.+...... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 478889999999999999995 47899999998754322 224567889999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+++ +|.+++........++|....+++
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~ 106 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFT 106 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHH
Confidence 9985 899988765444467888776654
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.1e-10 Score=115.05 Aligned_cols=92 Identities=24% Similarity=0.372 Sum_probs=77.7
Q ss_pred ccCCCccCeeeccCcceEEEEEcC------CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKLP------TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL 534 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~ 534 (571)
.++|++.+.||+|+||.||+|..+ .+..||+|.+.... .......+.+|+.++++++||||+++++++.+++
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 456889999999999999999632 24579999986442 2233456889999999999999999999999999
Q ss_pred eeEEEEeccCCCChhhhhcc
Q 044615 535 HSFVVYEYLEMGSLAMNLSN 554 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~ 554 (571)
..|+||||+++|+|.+++++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~ 102 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRS 102 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHH
Confidence 99999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.18 E-value=9.3e-11 Score=117.73 Aligned_cols=98 Identities=21% Similarity=0.275 Sum_probs=76.4
Q ss_pred CeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHH-HHhhcCCCCcccEEEEEEeCCeeEEEEeccCC
Q 044615 468 HCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVN-ALTKIRHRNIVKFYGFCSHALHSFVVYEYLEM 545 (571)
Q Consensus 468 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 545 (571)
+.||+|+||+||+|+ ..+|+.||+|++.+..........++.+|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 368999999999998 5589999999997543222233455667765 46789999999999999999999999999999
Q ss_pred CChhhhhccCCCccCCCHHHHhh
Q 044615 546 GSLAMNLSNDAAAEQFCWTKRMN 568 (571)
Q Consensus 546 G~L~~~l~~~~~~~~l~w~~r~~ 568 (571)
|+|.+++.... .+++.+...
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~ 100 (325)
T cd05604 81 GELFFHLQRER---SFPEPRARF 100 (325)
T ss_pred CCHHHHHHHcC---CCCHHHHHH
Confidence 99999887432 345554443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.18 E-value=8.9e-11 Score=117.34 Aligned_cols=88 Identities=23% Similarity=0.300 Sum_probs=71.6
Q ss_pred CeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhh-cCCCCcccEEEEEEeCCeeEEEEeccCC
Q 044615 468 HCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTK-IRHRNIVKFYGFCSHALHSFVVYEYLEM 545 (571)
Q Consensus 468 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~ 545 (571)
+.||+|+||.||+|. ..+++.||||++...........+.+..|..++.. .+||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 368999999999999 45788999999975432222334556677777765 4899999999999999999999999999
Q ss_pred CChhhhhccC
Q 044615 546 GSLAMNLSND 555 (571)
Q Consensus 546 G~L~~~l~~~ 555 (571)
|+|.+++...
T Consensus 81 g~L~~~~~~~ 90 (316)
T cd05592 81 GDLMFHIQSS 90 (316)
T ss_pred CcHHHHHHHc
Confidence 9999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.1e-10 Score=115.73 Aligned_cols=105 Identities=22% Similarity=0.358 Sum_probs=86.4
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCC--chHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPD--EMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
+|+..+.||+|+||.||+|. ..+++.||||.+...... .......+..|++++++++||||+++++++.+.+..|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 37778899999999999999 457899999999765433 112245678899999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||+ +|+|.+++.... ..++|.....++
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~ 108 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYM 108 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHH
Confidence 9999 899999997543 257888777664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.1e-10 Score=116.00 Aligned_cols=106 Identities=23% Similarity=0.331 Sum_probs=86.3
Q ss_pred cCCCccCeeeccCcceEEEEEc------CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCC
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL------PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHAL 534 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~ 534 (571)
++|...+.||+|+||.||+|.. .++..||||.+..... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 4588899999999999999962 1355799999875432 23356799999999999 8999999999999999
Q ss_pred eeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 535 HSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
..|+||||+++|+|.+++++... ..++|.+...|+
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~ 147 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFS 147 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHH
Confidence 99999999999999999975332 247888777654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.4e-10 Score=114.72 Aligned_cols=102 Identities=23% Similarity=0.316 Sum_probs=85.9
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
..|+..+.||+|+||.||+|. ..+++.||+|.+...... ..+.+.+|+.+++.++|||++++++++......|+||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 468888999999999999998 457899999998754432 2467889999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||+++|+|.+++.+. .++|.+...++
T Consensus 97 e~~~~~~L~~~~~~~----~~~~~~~~~i~ 122 (296)
T cd06654 97 EYLAGGSLTDVVTET----CMDEGQIAAVC 122 (296)
T ss_pred cccCCCCHHHHHHhc----CCCHHHHHHHH
Confidence 999999999998642 35666666543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.7e-10 Score=111.44 Aligned_cols=90 Identities=21% Similarity=0.343 Sum_probs=78.6
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
+|+..+.||+|+||.||++. ..+++.+|+|.+..... ....+.+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 47888999999999999999 45789999999864332 2345678899999999999999999999999999999999
Q ss_pred ccCCCChhhhhcc
Q 044615 542 YLEMGSLAMNLSN 554 (571)
Q Consensus 542 ~~~~G~L~~~l~~ 554 (571)
|+++|+|.+++..
T Consensus 79 ~~~~~~l~~~~~~ 91 (255)
T cd08219 79 YCDGGDLMQKIKL 91 (255)
T ss_pred eCCCCcHHHHHHh
Confidence 9999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.18 E-value=6.4e-11 Score=119.83 Aligned_cols=91 Identities=25% Similarity=0.434 Sum_probs=75.3
Q ss_pred cCCCccCeeeccCcceEEEEEc------CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeC-
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL------PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHA- 533 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~- 533 (571)
++|++.+.||+|+||.||+|.. .+++.||||.++.... ....+.+.+|+.++.++ +|||||++++++...
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 4688999999999999999962 3578899999975432 22346788999999999 789999999988654
Q ss_pred CeeEEEEeccCCCChhhhhcc
Q 044615 534 LHSFVVYEYLEMGSLAMNLSN 554 (571)
Q Consensus 534 ~~~~lv~e~~~~G~L~~~l~~ 554 (571)
...++||||+++|+|.++++.
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~ 105 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRS 105 (343)
T ss_pred CceEEEEeccCCCcHHHHHHh
Confidence 567899999999999999974
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=8.7e-12 Score=124.77 Aligned_cols=89 Identities=30% Similarity=0.419 Sum_probs=79.1
Q ss_pred CCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEec
Q 044615 464 FDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEY 542 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 542 (571)
|...+.||.|+||.||.|+ .++.+.||||++.-........++++..|++.+.+++|||+|.+.|+|....+.|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 5566789999999999999 668899999999877766667789999999999999999999999999999999999999
Q ss_pred cCCCChhhhhc
Q 044615 543 LEMGSLAMNLS 553 (571)
Q Consensus 543 ~~~G~L~~~l~ 553 (571)
|-| +-.|.+.
T Consensus 108 ClG-SAsDlle 117 (948)
T KOG0577|consen 108 CLG-SASDLLE 117 (948)
T ss_pred Hhc-cHHHHHH
Confidence 975 7777664
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.18 E-value=1e-10 Score=128.71 Aligned_cols=110 Identities=21% Similarity=0.282 Sum_probs=87.1
Q ss_pred HccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEe--CCee
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSH--ALHS 536 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~--~~~~ 536 (571)
..++|++.+.||+|+||.||+|. ..++..||+|.+....... .....|.+|+.++++++|||||+++++|.. ...+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e-~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34579999999999999999999 4578889999987554332 345679999999999999999999998854 4578
Q ss_pred EEEEeccCCCChhhhhccCC-CccCCCHHHHhhhc
Q 044615 537 FVVYEYLEMGSLAMNLSNDA-AAEQFCWTKRMNAI 570 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~-~~~~l~w~~r~~ia 570 (571)
|+||||+++|+|.++|.... ....++|...+.|+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia 124 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDIT 124 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHH
Confidence 99999999999999997532 12346666655543
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.2e-10 Score=116.08 Aligned_cols=107 Identities=23% Similarity=0.368 Sum_probs=86.4
Q ss_pred cCCCccCeeeccCcceEEEEEcC--------CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLP--------TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSH 532 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~ 532 (571)
++|.+.+.||+|+||.||+|... ++..+|+|.+..... .....++.+|++++.++ +||||+++++++..
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC--hHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 45889999999999999999731 235799999975422 23356788999999999 89999999999999
Q ss_pred CCeeEEEEeccCCCChhhhhccCCC-------------ccCCCHHHHhhhc
Q 044615 533 ALHSFVVYEYLEMGSLAMNLSNDAA-------------AEQFCWTKRMNAI 570 (571)
Q Consensus 533 ~~~~~lv~e~~~~G~L~~~l~~~~~-------------~~~l~w~~r~~ia 570 (571)
.+..|+||||+++|+|.+++..... ...++|.++++|+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 146 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCA 146 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHH
Confidence 9999999999999999999975422 1357888777764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.2e-10 Score=114.48 Aligned_cols=104 Identities=24% Similarity=0.357 Sum_probs=84.7
Q ss_pred CCCccCeeeccCcceEEEEEc-----CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC--Ce
Q 044615 463 NFDDGHCIGNGGQGSVYKAKL-----PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA--LH 535 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~--~~ 535 (571)
.|++.+.||+|+||.||.+.. .++..||+|.+..... ....+.+.+|++++++++||||+++++++... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc--HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 477889999999999999973 3578899999875432 23356799999999999999999999999775 56
Q ss_pred eEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 536 SFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 536 ~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
.++||||+++|+|.+++.+.. ..++|..++.++
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~ 115 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYA 115 (284)
T ss_pred eEEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHH
Confidence 899999999999999996442 257888777664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.1e-10 Score=115.30 Aligned_cols=104 Identities=19% Similarity=0.238 Sum_probs=86.6
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
+.|++.+.||+|+||.||+|+. .++..+|+|.+.... ....+.+.+|+++++.++||||+++++++......|+||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 5688999999999999999994 578999999986532 334677899999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||+++|+|..++.+... .++|.....++
T Consensus 89 e~~~~~~l~~~~~~~~~--~l~~~~~~~~~ 116 (292)
T cd06644 89 EFCPGGAVDAIMLELDR--GLTEPQIQVIC 116 (292)
T ss_pred ecCCCCcHHHHHHhhcC--CCCHHHHHHHH
Confidence 99999999888764332 46676665543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.4e-10 Score=113.94 Aligned_cols=105 Identities=27% Similarity=0.380 Sum_probs=86.1
Q ss_pred cCCCccCeeeccCcceEEEEEcC-----CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEe--CC
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLP-----TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSH--AL 534 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~--~~ 534 (571)
+.|+..+.||+|+||.||+|... ++..+|||.+...... ...+.|.+|++++++++||||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 35777889999999999999842 4788999999755432 345789999999999999999999999987 55
Q ss_pred eeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 535 HSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
..++||||+++|+|.+++..... .++|..++.++
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~ 115 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFS 115 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHH
Confidence 78999999999999999975432 47887777654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.17 E-value=6.2e-11 Score=120.50 Aligned_cols=87 Identities=28% Similarity=0.443 Sum_probs=75.0
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
+|+..+.||+|+||.||+|. ..+++.||||++.... .....+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 46677889999999999999 4579999999986432 22345679999999999999999999999999999999999
Q ss_pred ccCCCChhhh
Q 044615 542 YLEMGSLAMN 551 (571)
Q Consensus 542 ~~~~G~L~~~ 551 (571)
|+++|+|.+.
T Consensus 153 ~~~~~~L~~~ 162 (353)
T PLN00034 153 FMDGGSLEGT 162 (353)
T ss_pred cCCCCccccc
Confidence 9999998654
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=9.1e-12 Score=120.90 Aligned_cols=92 Identities=24% Similarity=0.369 Sum_probs=81.9
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
.|...+.||+|+||.||+|. .++++.||+|++..+...+ ..++..+|+.++.+++||||.++||.|..+..++++||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~d--eIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAED--EIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcch--hhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 47777899999999999999 6789999999998765443 36788999999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCC
Q 044615 542 YLEMGSLAMNLSNDA 556 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~ 556 (571)
||.||++.+.++...
T Consensus 92 y~~gGsv~~lL~~~~ 106 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGN 106 (467)
T ss_pred HhcCcchhhhhccCC
Confidence 999999999998543
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.17 E-value=5.9e-12 Score=116.16 Aligned_cols=131 Identities=25% Similarity=0.314 Sum_probs=78.6
Q ss_pred CCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEc
Q 044615 218 SSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDL 297 (571)
Q Consensus 218 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 297 (571)
..|+++||++|.++ .+.....-+|.++.|++++|.+... ..+..+++|+.||||+|.++. +..+-..+.+++.|.|
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAE-CVGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHh-hhhhHhhhcCEeeeeh
Confidence 45566666666655 3444455556666666666666432 336666666667777666652 3334445666677777
Q ss_pred cCCcCCcccchhccCCCCCCEEEccCCcCccc-cccccccCCCCCEEECcCCcCcccC
Q 044615 298 SHNIFREEIPSQICSMQSLEKLNLSHNNLSGS-IPRCFEEMHWLSCIDISYNALQGLI 354 (571)
Q Consensus 298 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~p~~~~~l~~L~~L~ls~N~l~~~~ 354 (571)
++|.+.. -+.++.+-+|..||+++|+|... ....+.++|-|+.+.|.+|++.+.+
T Consensus 360 a~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 360 AQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred hhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 7776632 23355666677777777776532 1235566777777777777776654
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.17 E-value=5.3e-11 Score=115.28 Aligned_cols=103 Identities=28% Similarity=0.408 Sum_probs=83.4
Q ss_pred CCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEec
Q 044615 464 FDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEY 542 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 542 (571)
|+..+.||+|+||.||++.. .+++.||+|.+....... .......+|+.++++++||||+++++++.+....++||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEE-EEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHH-HHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccc-cccchhhhhhhccccccccccccccccccccccccccccc
Confidence 56788999999999999994 567789999998764332 2233456699999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 543 LEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 543 ~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+++|+|.+++... ..+++..+..++
T Consensus 80 ~~~~~L~~~l~~~---~~~~~~~~~~~~ 104 (260)
T PF00069_consen 80 CPGGSLQDYLQKN---KPLSEEEILKIA 104 (260)
T ss_dssp ETTEBHHHHHHHH---SSBBHHHHHHHH
T ss_pred ccccccccccccc---cccccccccccc
Confidence 9999999999822 245666665553
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.17 E-value=1e-10 Score=117.32 Aligned_cols=88 Identities=25% Similarity=0.330 Sum_probs=71.8
Q ss_pred CeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHH-HHhhcCCCCcccEEEEEEeCCeeEEEEeccCC
Q 044615 468 HCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVN-ALTKIRHRNIVKFYGFCSHALHSFVVYEYLEM 545 (571)
Q Consensus 468 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 545 (571)
+.||+|+||.||+|+. .+++.||+|++.+...........+.+|+. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999994 578999999997543222233455666664 57889999999999999999999999999999
Q ss_pred CChhhhhccC
Q 044615 546 GSLAMNLSND 555 (571)
Q Consensus 546 G~L~~~l~~~ 555 (571)
|+|.+++...
T Consensus 81 ~~L~~~l~~~ 90 (321)
T cd05603 81 GELFFHLQRE 90 (321)
T ss_pred CCHHHHHHHc
Confidence 9999888643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.17 E-value=9.3e-11 Score=117.60 Aligned_cols=88 Identities=25% Similarity=0.390 Sum_probs=73.8
Q ss_pred CeeeccCcceEEEEEc----CCCCEEEEEEccCCCC-CchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEec
Q 044615 468 HCIGNGGQGSVYKAKL----PTGEIVDVKKFHSPLP-DEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEY 542 (571)
Q Consensus 468 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 542 (571)
+.||+|+||.||+++. .+++.||||++..... ........+.+|+.++++++||||+++++++.+.+..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999973 3678999999875321 1123345678999999999999999999999999999999999
Q ss_pred cCCCChhhhhccC
Q 044615 543 LEMGSLAMNLSND 555 (571)
Q Consensus 543 ~~~G~L~~~l~~~ 555 (571)
+++|+|.+++...
T Consensus 82 ~~~~~L~~~~~~~ 94 (323)
T cd05584 82 LSGGELFMHLERE 94 (323)
T ss_pred CCCchHHHHHHHc
Confidence 9999999999754
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.2e-10 Score=113.48 Aligned_cols=99 Identities=24% Similarity=0.297 Sum_probs=77.5
Q ss_pred CeeeccCcceEEEEEcC---CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEeccC
Q 044615 468 HCIGNGGQGSVYKAKLP---TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLE 544 (571)
Q Consensus 468 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 544 (571)
+.||+|+||.||+|... ++..+|+|.+..... ......|.+|+.++++++||||+++++++.+....++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 35899999999999743 346799999875432 2234578999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCC--ccCCCHHHHhh
Q 044615 545 MGSLAMNLSNDAA--AEQFCWTKRMN 568 (571)
Q Consensus 545 ~G~L~~~l~~~~~--~~~l~w~~r~~ 568 (571)
+|+|.++++.... ....+|....+
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~ 104 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQR 104 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHH
Confidence 9999999975332 22345554443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.17 E-value=4.4e-12 Score=122.93 Aligned_cols=184 Identities=29% Similarity=0.284 Sum_probs=84.3
Q ss_pred cCCCCCCEEecccCcCccccc--ccccCCCCCCEEEcccCcCcccc--cccccCCCCCCeeecccCcCcccCCcc-ccCC
Q 044615 94 GNMKSLSDLQLSENILNGSIP--LALGNLTNLVVLDLSTNKLSGSI--PLSFANLTSLSILYLYENSLCDSIPKE-IGNM 168 (571)
Q Consensus 94 ~~l~~L~~L~L~~n~i~~~~~--~~~~~l~~L~~L~L~~n~i~~~~--~~~~~~l~~L~~L~L~~n~l~~~~~~~-l~~l 168 (571)
+++.+|+.+.|.+..+. ..+ .....+++++.|||+.|-+.... ......||+|+.|+|+.|.+....... -..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 34555555555555543 122 23344555555555555544321 122345556666666666554211111 1134
Q ss_pred CCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCC-ChhhhCCCCCCEE
Q 044615 169 NSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQL-SPELGSLIQLEYL 247 (571)
Q Consensus 169 ~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L 247 (571)
+.|+.|.|+.|.++..--..+....++|+.|++..|............+..|+.|+|++|++-... ....+.++.|+.|
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~L 276 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQL 276 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhh
Confidence 556666666666653222222222223666666666322122222333445566666665554321 1234455666666
Q ss_pred EcccCcccccc-chh-----hccCCCCCEEEcCCccC
Q 044615 248 DLSANTFHKSI-PES-----LSNLVKLHYLNLSNNQF 278 (571)
Q Consensus 248 ~L~~n~l~~~~-~~~-----l~~l~~L~~L~Ls~n~l 278 (571)
+++.+.+...- |+. ...+++|++|+++.|++
T Consensus 277 nls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I 313 (505)
T KOG3207|consen 277 NLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNI 313 (505)
T ss_pred hccccCcchhcCCCccchhhhcccccceeeecccCcc
Confidence 66665554321 111 13344555555555554
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.17 E-value=8.9e-11 Score=114.31 Aligned_cols=102 Identities=23% Similarity=0.307 Sum_probs=83.8
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|...+.||+|+||.||+|. ..+++.||+|.++.... .....+.+|+.+++.++||||+++++++...+..|+||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 357788899999999999998 55789999999875432 22456889999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
||+++|+|.+++...+ .+++.+...+
T Consensus 86 e~~~~~~L~~~~~~~~---~~~~~~~~~~ 111 (267)
T cd06645 86 EFCGGGSLQDIYHVTG---PLSESQIAYV 111 (267)
T ss_pred eccCCCcHHHHHHhcC---CCCHHHHHHH
Confidence 9999999999987443 3455544443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.16 E-value=6.9e-11 Score=116.35 Aligned_cols=112 Identities=22% Similarity=0.287 Sum_probs=86.0
Q ss_pred cHHHHHHHccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEE
Q 044615 453 VHEEIIRATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFC 530 (571)
Q Consensus 453 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~ 530 (571)
.++.+..+.++|++.+.||+|+||.||+|. ..+++.+|+|.+..... ..+.+.+|+.++.++ +||||+++++++
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 84 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD----IDEEIEAEYNILKALSDHPNVVKFYGMY 84 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc----hHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence 345566778899999999999999999998 45788999999864321 135678899999999 799999999988
Q ss_pred E-----eCCeeEEEEeccCCCChhhhhccCC-CccCCCHHHHhh
Q 044615 531 S-----HALHSFVVYEYLEMGSLAMNLSNDA-AAEQFCWTKRMN 568 (571)
Q Consensus 531 ~-----~~~~~~lv~e~~~~G~L~~~l~~~~-~~~~l~w~~r~~ 568 (571)
. .++..++||||+++|+|.++++... ....+++.....
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 128 (286)
T cd06638 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY 128 (286)
T ss_pred eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHH
Confidence 4 3456899999999999999886321 123455544433
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.6e-10 Score=112.15 Aligned_cols=102 Identities=21% Similarity=0.324 Sum_probs=83.5
Q ss_pred CCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEec
Q 044615 463 NFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEY 542 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 542 (571)
+|.+...||+|+||.||+|....+..+|+|.+..... ..+.|.+|++++++++|||++++++++. .+..++||||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 4788899999999999999976667799999865432 2367889999999999999999999885 4568899999
Q ss_pred cCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 543 LEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 543 ~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+++|+|.++++... ...++|..++.++
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~ 108 (260)
T cd05069 82 MGKGSLLDFLKEGD-GKYLKLPQLVDMA 108 (260)
T ss_pred CCCCCHHHHHhhCC-CCCCCHHHHHHHH
Confidence 99999999997543 2357888777664
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.6e-10 Score=113.72 Aligned_cols=105 Identities=25% Similarity=0.348 Sum_probs=85.4
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|+..+.||+|+||.||+|.. .+++.||+|++....... ...+.+.+|++++++++|||++++++++......++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP-VIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc-cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 3588889999999999999995 478999999986443221 22456889999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||++++.|..++... ..++|..+.+++
T Consensus 80 e~~~~~~l~~~~~~~---~~~~~~~~~~~~ 106 (286)
T cd07847 80 EYCDHTVLNELEKNP---RGVPEHLIKKII 106 (286)
T ss_pred eccCccHHHHHHhCC---CCCCHHHHHHHH
Confidence 999999888876533 247777776654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.6e-10 Score=115.51 Aligned_cols=104 Identities=19% Similarity=0.388 Sum_probs=82.1
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCC----EEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCee
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGE----IVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHS 536 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~ 536 (571)
.+|+..+.||+|+||.||+|.. .++. .||+|.+.... .....++|.+|+.+++.++||||++++|+|... ..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 4689999999999999999984 3444 38999986432 233456799999999999999999999999764 56
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
++|+||+++|+|.++++.... .++|...++++
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~ 115 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHKD--NIGSQYLLNWC 115 (316)
T ss_pred eeeeecCCCCCHHHHHHhccc--cCCHHHHHHHH
Confidence 799999999999999985432 46666655543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=6.1e-12 Score=118.75 Aligned_cols=247 Identities=25% Similarity=0.286 Sum_probs=160.2
Q ss_pred cccCCCCCCEEEcccCcCccc----ccccccCCCCCCeeecccCcCc---ccCCc-------cccCCCCCCEEEccCCCC
Q 044615 116 ALGNLTNLVVLDLSTNKLSGS----IPLSFANLTSLSILYLYENSLC---DSIPK-------EIGNMNSLSILDLSSNKL 181 (571)
Q Consensus 116 ~~~~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~L~~n~l~---~~~~~-------~l~~l~~L~~L~L~~n~l 181 (571)
....+..++.|+|++|.+... +...+.+.++|+..++++--.. ..+|+ .+...++|++|+||+|.+
T Consensus 25 ~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~ 104 (382)
T KOG1909|consen 25 ELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAF 104 (382)
T ss_pred HhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeecccccc
Confidence 445567889999999988643 3445667778888887653221 12332 344567888888888887
Q ss_pred CccCChhhhhccC---CCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccc-
Q 044615 182 NGSIPLSLANLTN---SLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKS- 257 (571)
Q Consensus 182 ~~~~p~~~~~l~~---~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~- 257 (571)
.-..+..+..+.+ +|++|+|.+|.+...-...++ ..|..|. .+ .-...-++|+.+..+.|++...
T Consensus 105 G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~--~al~~l~--~~-------kk~~~~~~Lrv~i~~rNrlen~g 173 (382)
T KOG1909|consen 105 GPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLG--RALFELA--VN-------KKAASKPKLRVFICGRNRLENGG 173 (382)
T ss_pred CccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHH--HHHHHHH--HH-------hccCCCcceEEEEeecccccccc
Confidence 6444444433221 255555555554311111111 0122221 11 1123457899999999998643
Q ss_pred ---cchhhccCCCCCEEEcCCccCccC----cchhhhcccCCCEEEccCCcCCcc----cchhccCCCCCCEEEccCCcC
Q 044615 258 ---IPESLSNLVKLHYLNLSNNQFSQK----IPNKIEKLIHLSELDLSHNIFREE----IPSQICSMQSLEKLNLSHNNL 326 (571)
Q Consensus 258 ---~~~~l~~l~~L~~L~Ls~n~l~~~----~~~~~~~l~~L~~L~Ls~n~l~~~----~~~~~~~l~~L~~L~Ls~n~l 326 (571)
+...|...+.|+.+.++.|.|... +...+..+++|+.|||.+|-++.. +...++.++.|++|++++|.+
T Consensus 174 a~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll 253 (382)
T KOG1909|consen 174 ATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLL 253 (382)
T ss_pred HHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccccccc
Confidence 234577789999999999998532 234577899999999999988753 345678899999999999999
Q ss_pred cccccccc----c-cCCCCCEEECcCCcCcccCC-----CCCccCCCCcccccCCcC
Q 044615 327 SGSIPRCF----E-EMHWLSCIDISYNALQGLIP-----NSTAFRDAPMLALQGNKR 373 (571)
Q Consensus 327 ~~~~p~~~----~-~l~~L~~L~ls~N~l~~~~~-----~~~~~~~~~~l~l~~n~~ 373 (571)
...-...| . ..+.|+.|.+.+|.++.--. .....+.+..|.+++|+.
T Consensus 254 ~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 254 ENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred ccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 75443333 2 35899999999999864211 112256778889999975
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.16 E-value=2e-10 Score=113.05 Aligned_cols=104 Identities=26% Similarity=0.339 Sum_probs=86.6
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
+|++.+.||+|+||.||+|. ..+|+.||+|++....... ...+.+.+|+.++++++||||+++++++......|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 47888999999999999999 4578999999997654222 335679999999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+ +++|.+++.... ..+++.++..++
T Consensus 80 ~~-~~~L~~~~~~~~--~~~~~~~~~~~~ 105 (286)
T cd07832 80 YM-PSDLSEVLRDEE--RPLPEAQVKSYM 105 (286)
T ss_pred cc-CCCHHHHHHhcC--CCCCHHHHHHHH
Confidence 99 999999987543 357777666553
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.6e-11 Score=122.33 Aligned_cols=94 Identities=22% Similarity=0.294 Sum_probs=81.1
Q ss_pred HccCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCeeE
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHSF 537 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~ 537 (571)
..++|...+++|+|.||+|+.+.. .+++.+|||++++...-...+.+..+.|-+|+... +||.+++++..|++.+.+|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 446799999999999999999994 47889999999987665555678888999888766 5999999999999999999
Q ss_pred EEEeccCCCChhhhhc
Q 044615 538 VVYEYLEMGSLAMNLS 553 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~ 553 (571)
.||||+.|||+..+.+
T Consensus 446 fvmey~~Ggdm~~~~~ 461 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIH 461 (694)
T ss_pred EEEEecCCCcEEEEEe
Confidence 9999999999655444
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.3e-10 Score=114.12 Aligned_cols=102 Identities=19% Similarity=0.248 Sum_probs=85.2
Q ss_pred CCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEec
Q 044615 464 FDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEY 542 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 542 (571)
|++.+.||+|+||.||+|.. .++..+|+|.+.... ....+.+.+|+++++.++|||++++++++...+..|+||||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 56778899999999999994 468889999986432 23456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 543 LEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 543 ~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+++|+|.+++.+.. ..++|..+..++
T Consensus 84 ~~~~~l~~~~~~~~--~~l~~~~~~~~~ 109 (282)
T cd06643 84 CAGGAVDAVMLELE--RPLTEPQIRVVC 109 (282)
T ss_pred cCCCcHHHHHHhcC--CCCCHHHHHHHH
Confidence 99999999886432 257887776654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.15 E-value=3e-10 Score=110.53 Aligned_cols=103 Identities=31% Similarity=0.417 Sum_probs=83.6
Q ss_pred CCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCch------HhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCee
Q 044615 464 FDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEM------ACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHS 536 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~ 536 (571)
|.....||+|+||.||+|. ..+++.+|+|.+........ ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 6778899999999999998 45788999998865433221 2235688999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
++||||+++++|.+++...+ .+++.....+
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~ 111 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYG---AFEETLVRNF 111 (267)
T ss_pred EEEEEecCCCCHHHHHHhcc---CccHHHHHHH
Confidence 99999999999999997542 3556555444
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.7e-10 Score=114.22 Aligned_cols=107 Identities=19% Similarity=0.343 Sum_probs=85.1
Q ss_pred cCCCccCeeeccCcceEEEEEcC-----------------CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcc
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLP-----------------TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIV 524 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv 524 (571)
++|++.+.||+|+||.||++... ++..||+|.+.... .....++|.+|++++++++||||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 46889999999999999998522 23468999987542 223356899999999999999999
Q ss_pred cEEEEEEeCCeeEEEEeccCCCChhhhhccCCC--------ccCCCHHHHhhhc
Q 044615 525 KFYGFCSHALHSFVVYEYLEMGSLAMNLSNDAA--------AEQFCWTKRMNAI 570 (571)
Q Consensus 525 ~l~~~~~~~~~~~lv~e~~~~G~L~~~l~~~~~--------~~~l~w~~r~~ia 570 (571)
++++++...+..++||||+++|+|.+++..... ...++|.+..+++
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMA 136 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHH
Confidence 999999999999999999999999999975321 1246677666554
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.4e-10 Score=115.95 Aligned_cols=98 Identities=21% Similarity=0.272 Sum_probs=76.4
Q ss_pred CeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhh-cCCCCcccEEEEEEeCCeeEEEEeccCC
Q 044615 468 HCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTK-IRHRNIVKFYGFCSHALHSFVVYEYLEM 545 (571)
Q Consensus 468 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~ 545 (571)
+.||+|+||.||+|+. .+|+.||+|.+++.........+.+..|++++.. .+||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999994 5789999999975432112234556778888775 4999999999999999999999999999
Q ss_pred CChhhhhccCCCccCCCHHHHhh
Q 044615 546 GSLAMNLSNDAAAEQFCWTKRMN 568 (571)
Q Consensus 546 G~L~~~l~~~~~~~~l~w~~r~~ 568 (571)
|+|.+++.... .+++.+...
T Consensus 81 g~L~~~i~~~~---~~~~~~~~~ 100 (316)
T cd05620 81 GDLMFHIQDKG---RFDLYRATF 100 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHH
Confidence 99999987542 345544433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.15 E-value=2e-10 Score=112.30 Aligned_cols=101 Identities=26% Similarity=0.300 Sum_probs=85.0
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
+|+..+.||.|+||.||+|. ..+++.||+|.+..... ......+.+|+++++.++||||+++++++.+....|+|+|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 57888999999999999999 45789999999875432 2334678899999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
|+++|+|.+++... .++|.....+
T Consensus 80 ~~~~~~L~~~~~~~----~~~~~~~~~~ 103 (274)
T cd06609 80 YCGGGSCLDLLKPG----KLDETYIAFI 103 (274)
T ss_pred eeCCCcHHHHHhhc----CCCHHHHHHH
Confidence 99999999999753 4666665554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.6e-10 Score=113.04 Aligned_cols=107 Identities=21% Similarity=0.297 Sum_probs=86.5
Q ss_pred cCCCccCeeeccCcceEEEEEcC------CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLP------TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALH 535 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~ 535 (571)
++|.+.+.||+|+||.||+|... .+..||+|.+.... .......+.+|+.+++.++||||+++++++.....
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 46888899999999999999843 24689999986442 22335678999999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhhccCCC-------ccCCCHHHHhhhc
Q 044615 536 SFVVYEYLEMGSLAMNLSNDAA-------AEQFCWTKRMNAI 570 (571)
Q Consensus 536 ~~lv~e~~~~G~L~~~l~~~~~-------~~~l~w~~r~~ia 570 (571)
.|+||||+++|+|.+++..... ...++|...++|+
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 125 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA 125 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHH
Confidence 9999999999999999975322 1246787777654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.9e-12 Score=136.30 Aligned_cols=108 Identities=19% Similarity=0.154 Sum_probs=90.4
Q ss_pred HHHHccCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCe
Q 044615 457 IIRATNNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALH 535 (571)
Q Consensus 457 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~ 535 (571)
+.-..++|++.++||+|+||.|..++. .+++.||+|++.+..+-......-|..|-.+|..-+.+.||+++.+|.+..+
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY 149 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence 333457899999999999999999994 5799999999987433322334568889999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhhccCCCccCCCHHH
Q 044615 536 SFVVYEYLEMGSLAMNLSNDAAAEQFCWTK 565 (571)
Q Consensus 536 ~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~ 565 (571)
+|+|||||+||||-.++.+.+ ..+-+|++
T Consensus 150 LYlVMdY~pGGDlltLlSk~~-~~pE~~Ar 178 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFD-RLPEDWAR 178 (1317)
T ss_pred eEEEEecccCchHHHHHhhcC-CChHHHHH
Confidence 999999999999999998665 45667764
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.9e-10 Score=110.34 Aligned_cols=102 Identities=27% Similarity=0.395 Sum_probs=85.9
Q ss_pred CCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
+|+..+.||+|+||.||+|.. .+++.||||++...... ...+.+.+|++.+.+++|||++++++++...+..++|||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 688889999999999999995 46999999998765332 345779999999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
|+++++|.+++... ..+++.....+
T Consensus 80 ~~~~~~L~~~l~~~---~~l~~~~~~~~ 104 (264)
T cd06623 80 YMDGGSLADLLKKV---GKIPEPVLAYI 104 (264)
T ss_pred ecCCCcHHHHHHHc---CCCCHHHHHHH
Confidence 99999999999754 24555555544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.1e-10 Score=112.70 Aligned_cols=92 Identities=29% Similarity=0.487 Sum_probs=77.7
Q ss_pred cCCCccCeeeccCcceEEEEEcC-CC-----CEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLP-TG-----EIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALH 535 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~-~~-----~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~ 535 (571)
++|+..+.||+|+||.||+|... .+ ..||+|.+.... .....+.|.+|++++++++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP 82 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence 35888899999999999999843 22 579999987443 22345679999999999999999999999999899
Q ss_pred eEEEEeccCCCChhhhhccC
Q 044615 536 SFVVYEYLEMGSLAMNLSND 555 (571)
Q Consensus 536 ~~lv~e~~~~G~L~~~l~~~ 555 (571)
.|++|||+++|+|.+++...
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~ 102 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRN 102 (283)
T ss_pred eEEEEecCCCCcHHHHHHhc
Confidence 99999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.5e-10 Score=114.17 Aligned_cols=106 Identities=25% Similarity=0.452 Sum_probs=86.0
Q ss_pred cCCCccCeeeccCcceEEEEEc------CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL------PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALH 535 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~ 535 (571)
.+|.+.+.+|+|+||.||++.. .++..+|+|.+.... ....+.+.+|++++++++||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 4688889999999999999973 134568999886432 2335679999999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhhccCCC----------ccCCCHHHHhhhc
Q 044615 536 SFVVYEYLEMGSLAMNLSNDAA----------AEQFCWTKRMNAI 570 (571)
Q Consensus 536 ~~lv~e~~~~G~L~~~l~~~~~----------~~~l~w~~r~~ia 570 (571)
.++||||+++|+|.+++...+. ...++|.+.++++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 126 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIA 126 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHH
Confidence 9999999999999999975321 2347888777664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.7e-10 Score=111.74 Aligned_cols=104 Identities=20% Similarity=0.371 Sum_probs=83.8
Q ss_pred cCCCccCeeeccCcceEEEEEcC-CCC----EEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCee
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLP-TGE----IVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHS 536 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~ 536 (571)
.+|+..+.||+|+||.||+|..+ +|. .+|+|.+..... .....++.+|+.++++++||||+++++++.+ ...
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 45788899999999999999843 343 589998875432 2345679999999999999999999999987 788
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
++||||+++|+|.+++.+... .++|...++++
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~ 115 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKD--NIGSQYLLNWC 115 (279)
T ss_pred EEEEecCCCCcHHHHHHhccC--CCCHHHHHHHH
Confidence 999999999999999975433 36777666554
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.8e-10 Score=111.41 Aligned_cols=99 Identities=25% Similarity=0.390 Sum_probs=81.1
Q ss_pred CeeeccCcceEEEEEcC--CCC--EEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEecc
Q 044615 468 HCIGNGGQGSVYKAKLP--TGE--IVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYL 543 (571)
Q Consensus 468 ~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 543 (571)
+.||+|+||.||+|... .++ .||+|.+...... ...+.|.+|++++++++||||+++++++.+ ...++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 36899999999999843 333 6899999765432 446789999999999999999999999988 8899999999
Q ss_pred CCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 544 EMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 544 ~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
++|+|.+++.+... ..++|.....++
T Consensus 78 ~~~~L~~~l~~~~~-~~~~~~~~~~~~ 103 (257)
T cd05040 78 PLGSLLDRLRKDAL-GHFLISTLCDYA 103 (257)
T ss_pred CCCcHHHHHHhccc-ccCcHHHHHHHH
Confidence 99999999986543 457888776554
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.5e-10 Score=114.41 Aligned_cols=108 Identities=23% Similarity=0.364 Sum_probs=87.1
Q ss_pred ccCCCccCeeeccCcceEEEEEcC------CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeC
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKLP------TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHA 533 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~ 533 (571)
.++|+..+.||+|+||.||++... ....+|+|.+..... .....++.+|++++.++ +||||+++++++...
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 346888899999999999999842 236799999875432 23356789999999999 899999999999999
Q ss_pred CeeEEEEeccCCCChhhhhccCC-------------CccCCCHHHHhhhc
Q 044615 534 LHSFVVYEYLEMGSLAMNLSNDA-------------AAEQFCWTKRMNAI 570 (571)
Q Consensus 534 ~~~~lv~e~~~~G~L~~~l~~~~-------------~~~~l~w~~r~~ia 570 (571)
+..+++|||+++|+|.++++... ....++|...++|+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 138 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHH
Confidence 99999999999999999997431 23457888777664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.8e-11 Score=104.55 Aligned_cols=90 Identities=27% Similarity=0.423 Sum_probs=76.3
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
+|...++||+|.||+||+|+ ..+++.||+|.++.+..+ .+......+||-+++.++|.|||++++...+...+-+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddd-egvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCC-CCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 46667889999999999999 668999999999765433 2344567899999999999999999999999999999999
Q ss_pred ccCCCChhhhhcc
Q 044615 542 YLEMGSLAMNLSN 554 (571)
Q Consensus 542 ~~~~G~L~~~l~~ 554 (571)
||.. +|.++...
T Consensus 82 ~cdq-dlkkyfds 93 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDS 93 (292)
T ss_pred HhhH-HHHHHHHh
Confidence 9986 77777653
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.14 E-value=2e-10 Score=112.54 Aligned_cols=90 Identities=23% Similarity=0.324 Sum_probs=78.5
Q ss_pred CCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
.|+..+.||+|+||.||+|.. .++..||+|.+..... ....+.+.+|++++++++||||+++++++.+....|+|||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 477788899999999999984 5788999999875422 2335779999999999999999999999999999999999
Q ss_pred ccCCCChhhhhcc
Q 044615 542 YLEMGSLAMNLSN 554 (571)
Q Consensus 542 ~~~~G~L~~~l~~ 554 (571)
|+++|+|.+++..
T Consensus 83 ~~~~~~L~~~i~~ 95 (277)
T cd06640 83 YLGGGSALDLLRA 95 (277)
T ss_pred cCCCCcHHHHHhc
Confidence 9999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.14 E-value=3.1e-10 Score=110.19 Aligned_cols=103 Identities=29% Similarity=0.421 Sum_probs=86.2
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
.|+..+.||+|+||.||+|. ..+++.||+|.+...... ....+.+.+|+.++++++||||+++++++...+..++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 37788999999999999998 457899999999765433 3456789999999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
|+++++|.+++.... .+++..+..|
T Consensus 80 ~~~~~~L~~~~~~~~---~~~~~~~~~i 104 (264)
T cd06626 80 YCSGGTLEELLEHGR---ILDEHVIRVY 104 (264)
T ss_pred cCCCCcHHHHHhhcC---CCChHHHHHH
Confidence 999999999997542 3555555544
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.6e-10 Score=116.36 Aligned_cols=103 Identities=17% Similarity=0.243 Sum_probs=82.0
Q ss_pred CCCccCeeeccCcceEEEEEc----CCCCEEEEEEccCCCC-CchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCee
Q 044615 463 NFDDGHCIGNGGQGSVYKAKL----PTGEIVDVKKFHSPLP-DEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHS 536 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~ 536 (571)
+|++.+.||+|+||.||+++. .+++.||+|++.+... ......+.+.+|+.++.++ +||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999873 3688999999865321 1223346688999999999 589999999999999999
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhh
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMN 568 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ 568 (571)
|+||||+++|+|.+++.++. .+++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~ 109 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRF 109 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHH
Confidence 99999999999999997543 345544433
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.14 E-value=3.5e-10 Score=110.93 Aligned_cols=87 Identities=28% Similarity=0.414 Sum_probs=75.8
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
+|+..+.||+|+||.||+|. ..+++.||+|.+..... ....+++.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT--VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC--hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 57888999999999999998 56889999999865422 2335679999999999999999999999999999999999
Q ss_pred ccCCCChhhh
Q 044615 542 YLEMGSLAMN 551 (571)
Q Consensus 542 ~~~~G~L~~~ 551 (571)
|+++|+|..+
T Consensus 80 ~~~~~~l~~~ 89 (279)
T cd06619 80 FMDGGSLDVY 89 (279)
T ss_pred cCCCCChHHh
Confidence 9999999654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.5e-10 Score=113.77 Aligned_cols=103 Identities=18% Similarity=0.277 Sum_probs=82.4
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|...+.||+|+||.||+|+. .+++.||+|.+...... .....+.+|++++++++||||+++++++...+..|+||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 4688899999999999999984 47889999998754322 22346789999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
||+++ +|.+++...+. .+++.....+
T Consensus 84 e~~~~-~l~~~~~~~~~--~~~~~~~~~~ 109 (309)
T cd07872 84 EYLDK-DLKQYMDDCGN--IMSMHNVKIF 109 (309)
T ss_pred eCCCC-CHHHHHHhcCC--CCCHHHHHHH
Confidence 99985 88888865432 3555554443
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.7e-10 Score=112.68 Aligned_cols=106 Identities=25% Similarity=0.372 Sum_probs=84.2
Q ss_pred HccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeC----
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHA---- 533 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~---- 533 (571)
+.+.|+..+.||+|+||.||+|. ..+++.||+|.+..... ....+.+|+.++.++ +||||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 45668888999999999999998 45789999999865432 235688999999998 799999999998753
Q ss_pred --CeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 534 --LHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 534 --~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
...|+||||+++|+|.+++..... ..+.|.....++
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~~~ 117 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYIC 117 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccC-CCCCHHHHHHHH
Confidence 468999999999999999975322 346776655543
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.4e-10 Score=113.11 Aligned_cols=102 Identities=25% Similarity=0.348 Sum_probs=86.5
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
..|+..+.||.|+||.||+|. ..+++.||+|.+...... ..+.+.+|+++++.++|||++++++++...+..|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP---KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc---hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 358889999999999999998 568999999998654322 2467889999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||+++|+|.+++.+. .++|.++..|+
T Consensus 96 e~~~~~~L~~~~~~~----~l~~~~~~~i~ 121 (296)
T cd06655 96 EYLAGGSLTDVVTET----CMDEAQIAAVC 121 (296)
T ss_pred EecCCCcHHHHHHhc----CCCHHHHHHHH
Confidence 999999999988642 46777776653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.2e-10 Score=109.54 Aligned_cols=105 Identities=21% Similarity=0.309 Sum_probs=84.0
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCC--chHhHHHHHHHHHHHhhcCCCCcccEEEEEEe--CCee
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPD--EMACQQEFLNEVNALTKIRHRNIVKFYGFCSH--ALHS 536 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~--~~~~ 536 (571)
.+|+..+.||+|+||.||+|. ..++..||+|.+...... ..+..+.+.+|+.++++++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 368899999999999999998 457899999998654322 22345678999999999999999999999875 3678
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
+++|||+++++|.+++.... .+++.....+
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~ 111 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKY 111 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHH
Confidence 89999999999999997532 3566655544
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.4e-10 Score=113.73 Aligned_cols=106 Identities=26% Similarity=0.324 Sum_probs=85.9
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
..|+..+.||+|+||.||+|.. .+++.||+|.+...........+++.+|++++++++||||++++++|.+.+..|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 3488889999999999999984 578999999987544444444567899999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||++ |++.+++..... .++|..+..++
T Consensus 95 e~~~-g~l~~~~~~~~~--~l~~~~~~~~~ 121 (307)
T cd06607 95 EYCL-GSASDILEVHKK--PLQEVEIAAIC 121 (307)
T ss_pred HhhC-CCHHHHHHHccc--CCCHHHHHHHH
Confidence 9997 577777754322 47777766553
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.5e-10 Score=114.28 Aligned_cols=113 Identities=25% Similarity=0.320 Sum_probs=89.1
Q ss_pred HHHHHHHccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEE
Q 044615 454 HEEIIRATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCS 531 (571)
Q Consensus 454 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~ 531 (571)
.+++..++++|++.+.||+|+||.||+|. ..+++.+|+|.+..... ....+.+|+.++.++ +|||++++++++.
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD----VDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc----HHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 34555678889999999999999999999 45789999999864321 235678899999998 8999999999997
Q ss_pred eC-----CeeEEEEeccCCCChhhhhccCC-CccCCCHHHHhhhc
Q 044615 532 HA-----LHSFVVYEYLEMGSLAMNLSNDA-AAEQFCWTKRMNAI 570 (571)
Q Consensus 532 ~~-----~~~~lv~e~~~~G~L~~~l~~~~-~~~~l~w~~r~~ia 570 (571)
.. +..|+||||+++|+|.++++... ....+.|.....|+
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~ 134 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYIL 134 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHH
Confidence 54 35899999999999999886421 22356777766554
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.8e-10 Score=111.69 Aligned_cols=108 Identities=19% Similarity=0.267 Sum_probs=87.2
Q ss_pred ccCCCccCeeeccCcceEEEEEcCC-----CCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEe-CC
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKLPT-----GEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSH-AL 534 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~-~~ 534 (571)
.++|...+.||+|+||.||+|.... +..||+|.+.... .....+.+.+|+.++++++||||+++++++.. +.
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 3468888999999999999998543 6789999986432 23446778999999999999999999998876 46
Q ss_pred eeEEEEeccCCCChhhhhccCCCc-----cCCCHHHHhhhc
Q 044615 535 HSFVVYEYLEMGSLAMNLSNDAAA-----EQFCWTKRMNAI 570 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~~~~~-----~~l~w~~r~~ia 570 (571)
..++++||+++|+|.+++...... ..++|.+++.|+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~ 123 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMA 123 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHH
Confidence 789999999999999999754322 468888877765
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.5e-10 Score=112.41 Aligned_cols=105 Identities=26% Similarity=0.358 Sum_probs=89.9
Q ss_pred HccCCCccCeeeccCcceEEEEEcC-CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEE
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAKLP-TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFV 538 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l 538 (571)
.+..|+..+.+|+|+||.||+|... ++..||+|.+..... ..+.+.+|++++++++|||++++++++......|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 4456888899999999999999954 788999999975432 35678899999999999999999999999999999
Q ss_pred EEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 539 VYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+||+++++|.+++.... ..++|..+..|+
T Consensus 93 v~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~ 122 (286)
T cd06614 93 VMEYMDGGSLTDIITQNF--VRMNEPQIAYVC 122 (286)
T ss_pred EEeccCCCcHHHHHHHhc--cCCCHHHHHHHH
Confidence 999999999999998653 368888877765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.1e-10 Score=113.34 Aligned_cols=101 Identities=25% Similarity=0.341 Sum_probs=84.6
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|...+.||+|+||.||++. ..++..||+|.+..... ...+.+.+|+.++++++|||++++++++...+..|+|+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc---hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 468889999999999999998 45788999999864322 23467889999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
||+++|+|.+++.+. .++|.++..|
T Consensus 96 e~~~~~~L~~~~~~~----~l~~~~~~~i 120 (293)
T cd06647 96 EYLAGGSLTDVVTET----CMDEGQIAAV 120 (293)
T ss_pred ecCCCCcHHHHHhhc----CCCHHHHHHH
Confidence 999999999999743 3566665554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.13 E-value=3.1e-10 Score=112.67 Aligned_cols=102 Identities=21% Similarity=0.295 Sum_probs=82.1
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|+..+.||+|+||.||+|.. .+++.||+|.+....... ....+.+|+.++++++||||+++++++...+..|+||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC--chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 4688999999999999999984 478999999987543222 2346778999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMN 568 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ 568 (571)
||++ |+|.+++..... .+++.....
T Consensus 84 e~~~-~~l~~~l~~~~~--~~~~~~~~~ 108 (301)
T cd07873 84 EYLD-KDLKQYLDDCGN--SINMHNVKL 108 (301)
T ss_pred eccc-cCHHHHHHhcCC--CCCHHHHHH
Confidence 9998 599998875432 345554443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.13 E-value=3.4e-10 Score=113.27 Aligned_cols=104 Identities=27% Similarity=0.361 Sum_probs=85.5
Q ss_pred CCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEec
Q 044615 464 FDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEY 542 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 542 (571)
|+..+.||+|+||.||+|+ ..++..||+|.+...........+.+.+|++++++++|||++++++++.+.+..|+||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 6778899999999999999 457899999998765444434456799999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 543 LEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 543 ~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
++ |++.+.+.... ..++|.++..++
T Consensus 107 ~~-g~l~~~~~~~~--~~l~~~~~~~i~ 131 (317)
T cd06635 107 CL-GSASDLLEVHK--KPLQEVEIAAIT 131 (317)
T ss_pred CC-CCHHHHHHHhc--CCCCHHHHHHHH
Confidence 97 58888776432 247888776654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.2e-10 Score=115.66 Aligned_cols=103 Identities=23% Similarity=0.343 Sum_probs=80.8
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC-----Cee
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA-----LHS 536 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~-----~~~ 536 (571)
.|++.+.||+|+||.||+|. ..++..||||++...... .....++.+|++++++++||||+++++++... ...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc-chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 37888999999999999999 558999999998743222 22345788999999999999999999988653 247
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+|||||+ ++|.+++.... .++|.....|+
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~ 109 (338)
T cd07859 80 YVVFELME-SDLHQVIKAND---DLTPEHHQFFL 109 (338)
T ss_pred EEEEecCC-CCHHHHHHhcc---cCCHHHHHHHH
Confidence 99999996 68999887432 46666665543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.9e-10 Score=110.27 Aligned_cols=107 Identities=24% Similarity=0.326 Sum_probs=85.6
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEe--CCeeEEE
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSH--ALHSFVV 539 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~--~~~~~lv 539 (571)
+|+..+.+|+|+||.||++. ..+++.||+|.+...... ....+++.+|++++++++||||+++++++.. ....|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 47888999999999999998 557899999998754332 3445678999999999999999999998864 4568999
Q ss_pred EeccCCCChhhhhccCC-CccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDA-AAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~-~~~~l~w~~r~~ia 570 (571)
|||+++|+|.+++.... ....++|...+.++
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~ 111 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRIL 111 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHH
Confidence 99999999999997532 23457777666553
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.13 E-value=9.4e-11 Score=114.88 Aligned_cols=106 Identities=21% Similarity=0.191 Sum_probs=88.3
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcC-CCCcccEEEEEEeCCeeEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR-HRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~lv 539 (571)
++|...+.||+|+||.||+|. ..++..||+|++.+.........+.+.+|++++.+++ ||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 368889999999999999999 4589999999987644333344567889999999998 99999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||+++|+|.+++...+ .++|.....|+
T Consensus 81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~ 108 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---SLDEKCTRFYA 108 (280)
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHH
Confidence 99999999999997543 46777666553
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.13 E-value=3.5e-10 Score=110.77 Aligned_cols=101 Identities=28% Similarity=0.438 Sum_probs=83.5
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcC---CCCcccEEEEEEeCCeeEE
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR---HRNIVKFYGFCSHALHSFV 538 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~~~~~~~~~~~l 538 (571)
.|+..+.||+|+||.||+|. ..+++.||+|.+...... ...+++.+|++++++++ |||++++++++......|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD--DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCc--hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 47778899999999999999 568999999998754322 23467889999999986 9999999999999999999
Q ss_pred EEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 539 VYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
||||+++|+|.++++.. .++|.....+
T Consensus 80 v~e~~~~~~L~~~~~~~----~l~~~~~~~i 106 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG----PIAEKYISVI 106 (277)
T ss_pred EEecCCCCcHHHHHHcc----CCCHHHHHHH
Confidence 99999999999998643 4666655544
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.1e-10 Score=110.76 Aligned_cols=102 Identities=27% Similarity=0.363 Sum_probs=86.6
Q ss_pred cCCCccCeeeccCcceEEEEEcC-CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLP-TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|+..+.||+|+||.||+|... +++.+|+|.+.... ..+++.+|++++++++||||+++++++.+....|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 56888999999999999999954 58899999986432 1578999999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||+++++|.+++.... ..++|.....++
T Consensus 78 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~ 105 (256)
T cd06612 78 EYCGAGSVSDIMKITN--KTLTEEEIAAIL 105 (256)
T ss_pred ecCCCCcHHHHHHhCc--cCCCHHHHHHHH
Confidence 9999999999997433 356777766554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.6e-10 Score=113.38 Aligned_cols=107 Identities=22% Similarity=0.383 Sum_probs=85.1
Q ss_pred cCCCccCeeeccCcceEEEEEc--------CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL--------PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSH 532 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~ 532 (571)
.+|.+.+.||+|+||.||+|+. .++..||+|.+.... .....+++.+|+.+++.+ +||||+++++++..
T Consensus 15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 4588889999999999999962 134579999986432 223356789999999999 89999999999999
Q ss_pred CCeeEEEEeccCCCChhhhhccCCC-------------ccCCCHHHHhhhc
Q 044615 533 ALHSFVVYEYLEMGSLAMNLSNDAA-------------AEQFCWTKRMNAI 570 (571)
Q Consensus 533 ~~~~~lv~e~~~~G~L~~~l~~~~~-------------~~~l~w~~r~~ia 570 (571)
....|+||||+++|+|.+++.+... ...++|.++++++
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCT 143 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHH
Confidence 9999999999999999999975421 2346777666554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.8e-10 Score=110.39 Aligned_cols=97 Identities=23% Similarity=0.215 Sum_probs=80.1
Q ss_pred eeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEeccCCCCh
Q 044615 470 IGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548 (571)
Q Consensus 470 lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~G~L 548 (571)
||.|+||.||+|.. .+++.||+|.+.+.........+.+.+|++++++++||||+++++++.++...|+||||+++|+|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999994 46899999999765444334457799999999999999999999999999999999999999999
Q ss_pred hhhhccCCCccCCCHHHHhhh
Q 044615 549 AMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 549 ~~~l~~~~~~~~l~w~~r~~i 569 (571)
.+++.+.. .+++.....+
T Consensus 81 ~~~l~~~~---~l~~~~~~~~ 98 (262)
T cd05572 81 WTILRDRG---LFDEYTARFY 98 (262)
T ss_pred HHHHhhcC---CCCHHHHHHH
Confidence 99997543 2555544443
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.12 E-value=3.2e-10 Score=112.23 Aligned_cols=108 Identities=21% Similarity=0.372 Sum_probs=86.7
Q ss_pred ccCCCccCeeeccCcceEEEEEcC-----------------CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCc
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKLP-----------------TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNI 523 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~ni 523 (571)
.++|++.+.||+|+||.||+|... .+..||+|.+..... ....+.|.+|++++++++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCCE
Confidence 356889999999999999998732 224589999875432 2346789999999999999999
Q ss_pred ccEEEEEEeCCeeEEEEeccCCCChhhhhccCCC--------ccCCCHHHHhhhc
Q 044615 524 VKFYGFCSHALHSFVVYEYLEMGSLAMNLSNDAA--------AEQFCWTKRMNAI 570 (571)
Q Consensus 524 v~l~~~~~~~~~~~lv~e~~~~G~L~~~l~~~~~--------~~~l~w~~r~~ia 570 (571)
+++++++...+..++||||+++|+|.+++.+... ...++|...+.++
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMA 136 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHH
Confidence 9999999999999999999999999999975431 1257777766554
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.12 E-value=4.1e-10 Score=111.14 Aligned_cols=90 Identities=30% Similarity=0.446 Sum_probs=75.8
Q ss_pred CCCccCeeeccCcceEEEEEcC------CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCee
Q 044615 463 NFDDGHCIGNGGQGSVYKAKLP------TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHS 536 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~ 536 (571)
+|++.+.||+|+||.||+|... ....+|+|.+..... ....+++.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 4778899999999999999732 235688998865432 23356799999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhcc
Q 044615 537 FVVYEYLEMGSLAMNLSN 554 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~ 554 (571)
++||||+++|+|.+++..
T Consensus 79 ~lv~e~~~~~~L~~~l~~ 96 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRE 96 (290)
T ss_pred EEEEEecCCCCHHHHHHh
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.12 E-value=6.3e-12 Score=121.84 Aligned_cols=211 Identities=29% Similarity=0.242 Sum_probs=116.2
Q ss_pred cCCCCCCEEEcccCcCccccc-ccccCCCCCCeeecccCcCcccCC--ccccCCCCCCEEEccCCCCCccCChhhhhccC
Q 044615 118 GNLTNLVVLDLSTNKLSGSIP-LSFANLTSLSILYLYENSLCDSIP--KEIGNMNSLSILDLSSNKLNGSIPLSLANLTN 194 (571)
Q Consensus 118 ~~l~~L~~L~L~~n~i~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~--~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~ 194 (571)
.++.+|+...|+++.+..... .....+++++.|||+.|-+....| .....||+|+.|+++.|++..........
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~--- 194 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTL--- 194 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchh---
Confidence 356778888888888752221 355678888888888887765332 33456788888888888776221111111
Q ss_pred CCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCC-hhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEc
Q 044615 195 SLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLS-PELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNL 273 (571)
Q Consensus 195 ~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 273 (571)
.++.|+.|.++.|.++.... .....+|+|+.|+|..|...........-+..|++|+|
T Consensus 195 ---------------------~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdL 253 (505)
T KOG3207|consen 195 ---------------------LLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDL 253 (505)
T ss_pred ---------------------hhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccc
Confidence 23345555555555553211 12334566666666666321122222334455666666
Q ss_pred CCccCccCc-chhhhcccCCCEEEccCCcCCcc-cchh-----ccCCCCCCEEEccCCcCccc-cccccccCCCCCEEEC
Q 044615 274 SNNQFSQKI-PNKIEKLIHLSELDLSHNIFREE-IPSQ-----ICSMQSLEKLNLSHNNLSGS-IPRCFEEMHWLSCIDI 345 (571)
Q Consensus 274 s~n~l~~~~-~~~~~~l~~L~~L~Ls~n~l~~~-~~~~-----~~~l~~L~~L~Ls~n~l~~~-~p~~~~~l~~L~~L~l 345 (571)
++|++-... -...+.++.|..|+++.+.+... .|+. ...+++|+.|+++.|++... .-..+..+++|+.|.+
T Consensus 254 s~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~ 333 (505)
T KOG3207|consen 254 SNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRI 333 (505)
T ss_pred cCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhc
Confidence 666654221 12345566666666666665442 1211 24467777777777777421 1123344566667776
Q ss_pred cCCcCcc
Q 044615 346 SYNALQG 352 (571)
Q Consensus 346 s~N~l~~ 352 (571)
..|.++.
T Consensus 334 ~~n~ln~ 340 (505)
T KOG3207|consen 334 TLNYLNK 340 (505)
T ss_pred ccccccc
Confidence 6776653
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.12 E-value=3.7e-10 Score=110.22 Aligned_cols=106 Identities=24% Similarity=0.396 Sum_probs=82.0
Q ss_pred CCccCeeeccCcceEEEEEcC----CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCe----
Q 044615 464 FDDGHCIGNGGQGSVYKAKLP----TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALH---- 535 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~---- 535 (571)
|.+.+.||+|+||.||+|... .+..||+|.+...... ....+.+.+|++.+++++||||+++++++.+...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 567789999999999999843 2467999998754322 2345679999999999999999999999876554
Q ss_pred --eEEEEeccCCCChhhhhccCC---CccCCCHHHHhhhc
Q 044615 536 --SFVVYEYLEMGSLAMNLSNDA---AAEQFCWTKRMNAI 570 (571)
Q Consensus 536 --~~lv~e~~~~G~L~~~l~~~~---~~~~l~w~~r~~ia 570 (571)
.+++|||+++|+|.+++.... ....++|.....++
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~ 119 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHH
Confidence 799999999999999986432 22356776665543
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.5e-10 Score=112.05 Aligned_cols=105 Identities=26% Similarity=0.460 Sum_probs=85.1
Q ss_pred CCCccCeeeccCcceEEEEEc------CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCee
Q 044615 463 NFDDGHCIGNGGQGSVYKAKL------PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHS 536 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~ 536 (571)
+|...+.||+|+||.||++.. .++..+|+|.+.... ....+.|.+|++++++++||||+++++++...+..
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 567788999999999999962 245678999886432 23456899999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhccCCC------------ccCCCHHHHhhhc
Q 044615 537 FVVYEYLEMGSLAMNLSNDAA------------AEQFCWTKRMNAI 570 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~------------~~~l~w~~r~~ia 570 (571)
+++|||+++|+|.++++.... ...++|.+++.++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 128 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHH
Confidence 999999999999999975432 1347787777654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.12 E-value=7.8e-11 Score=114.12 Aligned_cols=98 Identities=20% Similarity=0.393 Sum_probs=77.8
Q ss_pred CeeeccCcceEEEEEcC-CC-------CEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 468 HCIGNGGQGSVYKAKLP-TG-------EIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 468 ~~lg~G~~g~V~~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
+.||+|+||.||+|... .+ ..+|+|.+.... ....+.+..|+.+++.++|||||++++++..++..++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 35899999999999842 22 347888875432 23356788999999999999999999999998999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||+++|+|.++++..+. .++|..++.++
T Consensus 78 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~ 106 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKN--LINISWKLEVA 106 (258)
T ss_pred EecCCCCcHHHHHhcCCC--CCCHHHHHHHH
Confidence 999999999999985443 46777766553
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.4e-10 Score=112.90 Aligned_cols=106 Identities=26% Similarity=0.498 Sum_probs=85.9
Q ss_pred cCCCccCeeeccCcceEEEEEc------CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL------PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALH 535 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~ 535 (571)
++|...+.||+|+||.||+|+. .++..+|+|.+.... ....+.+.+|++++++++||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP 81 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence 3577889999999999999973 234568899886432 2334678999999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhhccCCC-------------ccCCCHHHHhhhc
Q 044615 536 SFVVYEYLEMGSLAMNLSNDAA-------------AEQFCWTKRMNAI 570 (571)
Q Consensus 536 ~~lv~e~~~~G~L~~~l~~~~~-------------~~~l~w~~r~~ia 570 (571)
.++||||+++|+|.+++..... ...++|..++.|+
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 129 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHH
Confidence 9999999999999999975321 2347888887765
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=5e-11 Score=120.19 Aligned_cols=103 Identities=30% Similarity=0.430 Sum_probs=86.4
Q ss_pred cCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
+.......||+|+||+||+|++- | .||||.+....... ...+.|..|+..+++-+|.||+=+.|||..+.. .||..
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~-~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq 467 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTP-EQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ 467 (678)
T ss_pred HHhhccceeccccccceeecccc-c-ceEEEEEecCCCCH-HHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence 34556788999999999999973 3 59999998776554 357889999999999999999999999987776 89999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+|+|-+|+.+||..+ ..++-.+.+.||
T Consensus 468 wCeGsSLY~hlHv~e--tkfdm~~~idIA 494 (678)
T KOG0193|consen 468 WCEGSSLYTHLHVQE--TKFDMNTTIDIA 494 (678)
T ss_pred hccCchhhhhccchh--hhhhHHHHHHHH
Confidence 999999999999654 356777777766
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.1e-10 Score=114.29 Aligned_cols=100 Identities=24% Similarity=0.292 Sum_probs=82.6
Q ss_pred CCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEec
Q 044615 464 FDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEY 542 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 542 (571)
|+..+.||+|+||.||+|. ..+++.||+|.+..... ....+.+.+|++++++++||||+++++++...+..|+||||
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 5666789999999999998 45788999999875432 23356789999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 543 LEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 543 ~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
+++|+|.+++... .++|.....+
T Consensus 84 ~~~~~L~~~~~~~----~~~~~~~~~~ 106 (277)
T cd06642 84 LGGGSALDLLKPG----PLEETYIATI 106 (277)
T ss_pred cCCCcHHHHhhcC----CCCHHHHHHH
Confidence 9999999988642 3566655544
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.11 E-value=5.2e-10 Score=108.00 Aligned_cols=104 Identities=26% Similarity=0.328 Sum_probs=88.0
Q ss_pred CCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC--CeeEEE
Q 044615 463 NFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA--LHSFVV 539 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~--~~~~lv 539 (571)
+|...+.||+|++|.||+|.. .+++.|++|++...... ....+.+.+|++++++++||||+++++.+.+. ...++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 477788999999999999995 47999999998765432 23457899999999999999999999999988 889999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||+++++|.+++.+.. .++|..+..++
T Consensus 80 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~ 107 (260)
T cd06606 80 LEYVSGGSLSSLLKKFG---KLPEPVIRKYT 107 (260)
T ss_pred EEecCCCcHHHHHHHcC---CCCHHHHHHHH
Confidence 99999999999997543 67888777664
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.11 E-value=3.9e-10 Score=111.13 Aligned_cols=105 Identities=24% Similarity=0.252 Sum_probs=81.7
Q ss_pred CCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC--CeeEEE
Q 044615 463 NFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA--LHSFVV 539 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~--~~~~lv 539 (571)
+|+..+.||.|++|.||+|.. .+++.+|+|.+...... ....++.+|++++++++||||++++++|.+. ...|+|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP--DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch--HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 578889999999999999994 57889999998754322 3356789999999999999999999998653 468999
Q ss_pred EeccCCCChhhhhccCC-CccCCCHHHHhhh
Q 044615 540 YEYLEMGSLAMNLSNDA-AAEQFCWTKRMNA 569 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~-~~~~l~w~~r~~i 569 (571)
|||+++|+|.+++.... ....+++.....|
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i 110 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKI 110 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHH
Confidence 99999999998876321 1223455444433
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.11 E-value=3.6e-10 Score=111.56 Aligned_cols=101 Identities=20% Similarity=0.343 Sum_probs=81.5
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|+..+.||+|+||.||+|.. .+++.||+|.+....... ....+.+|++++++++||||+++++++.+.+..|+||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 5688999999999999999994 478999999987543221 2345778999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRM 567 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~ 567 (571)
||+++ +|.+++..... .+++....
T Consensus 83 e~~~~-~L~~~~~~~~~--~~~~~~~~ 106 (291)
T cd07844 83 EYLDT-DLKQYMDDCGG--GLSMHNVR 106 (291)
T ss_pred ecCCC-CHHHHHHhCCC--CCCHHHHH
Confidence 99985 99998875432 34554433
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.11 E-value=5.7e-10 Score=108.42 Aligned_cols=105 Identities=23% Similarity=0.306 Sum_probs=83.0
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCC--CchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC--Cee
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLP--DEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA--LHS 536 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~--~~~ 536 (571)
.+|.+.+.||+|+||.||+|. ..++..||+|.+..... ......+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 468899999999999999998 45799999999854321 1223456799999999999999999999998764 468
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
++||||+++|+|.+++.... .+++....++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~ 111 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRY 111 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHH
Confidence 89999999999999997532 2455544443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.11 E-value=3.5e-10 Score=113.01 Aligned_cols=107 Identities=22% Similarity=0.374 Sum_probs=85.1
Q ss_pred cCCCccCeeeccCcceEEEEEcC--------CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLP--------TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSH 532 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~ 532 (571)
++|.+.+.||+|+||.||+|+.. ....+|+|.+..... ......+.+|+++++++ +||||+++++++..
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--hHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 45788899999999999999731 245789999875422 23356789999999999 69999999999999
Q ss_pred CCeeEEEEeccCCCChhhhhccCCC-------------ccCCCHHHHhhhc
Q 044615 533 ALHSFVVYEYLEMGSLAMNLSNDAA-------------AEQFCWTKRMNAI 570 (571)
Q Consensus 533 ~~~~~lv~e~~~~G~L~~~l~~~~~-------------~~~l~w~~r~~ia 570 (571)
.+..|+||||+++|+|.+++..... ...++|.+.++|+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 140 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCA 140 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHH
Confidence 9999999999999999999975321 2357887766654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=5e-11 Score=119.55 Aligned_cols=90 Identities=30% Similarity=0.467 Sum_probs=79.6
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
..|....+||+|+.|.||.|. ..+++.||||++....... .+-..+|+.+|+..+|+|||.+++.|...+++|+||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 457777889999999999998 6789999999998654333 466889999999999999999999999999999999
Q ss_pred eccCCCChhhhhcc
Q 044615 541 EYLEMGSLAMNLSN 554 (571)
Q Consensus 541 e~~~~G~L~~~l~~ 554 (571)
|||+||+|.|.+..
T Consensus 350 Eym~ggsLTDvVt~ 363 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTK 363 (550)
T ss_pred eecCCCchhhhhhc
Confidence 99999999998864
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.11 E-value=3.8e-10 Score=109.14 Aligned_cols=106 Identities=17% Similarity=0.200 Sum_probs=85.1
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEe-CCeeEEEE
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSH-ALHSFVVY 540 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~-~~~~~lv~ 540 (571)
+|++.+.||+|+||.||.+. ..+++.||+|.+...... ....+.+.+|++++++++|||++++++.+.. ....|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 48889999999999999998 456889999999754322 2335678899999999999999999998864 44689999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||+++|+|.+++.... ...+++.+..+++
T Consensus 80 e~~~~~~l~~~l~~~~-~~~l~~~~~~~~~ 108 (257)
T cd08223 80 GFCEGGDLYHKLKEQK-GKLLPENQVVEWF 108 (257)
T ss_pred cccCCCcHHHHHHHhc-CCCCCHHHHHHHH
Confidence 9999999999997532 2357777776654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.11 E-value=3.3e-10 Score=116.03 Aligned_cols=102 Identities=17% Similarity=0.260 Sum_probs=81.4
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC-----ee
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL-----HS 536 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~-----~~ 536 (571)
+|+..+.||+|+||.||+|. ..+++.||||++.... ......+++.+|+++++.++||||+++++++...+ ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 47888999999999999999 4589999999986532 22234567889999999999999999999998776 78
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
|+||||+. ++|.+++.... .+++.....+
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~---~l~~~~~~~~ 108 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQ---PLSSDHVKVF 108 (372)
T ss_pred EEEeeccc-cCHHHHHhcCC---CCCHHHHHHH
Confidence 99999997 58888886432 4566554443
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.10 E-value=4.6e-10 Score=108.15 Aligned_cols=98 Identities=33% Similarity=0.486 Sum_probs=81.1
Q ss_pred CeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEeccCCCC
Q 044615 468 HCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGS 547 (571)
Q Consensus 468 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~G~ 547 (571)
+.||+|+||.||++....++.||+|.+...... ...+.|.+|++++++++||||+++++++.+....++||||+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 368999999999999655999999998754332 345779999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCccCCCHHHHhhh
Q 044615 548 LAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 548 L~~~l~~~~~~~~l~w~~r~~i 569 (571)
|.+++..... .+++...+.+
T Consensus 79 l~~~l~~~~~--~~~~~~~~~~ 98 (251)
T cd05041 79 LLTFLRKKKN--RLTVKKLLQM 98 (251)
T ss_pred HHHHHHhcCC--CCCHHHHHHH
Confidence 9999975432 4566655544
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.10 E-value=3.9e-10 Score=113.69 Aligned_cols=106 Identities=23% Similarity=0.360 Sum_probs=85.0
Q ss_pred CCCccCeeeccCcceEEEEEcC--------CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeC
Q 044615 463 NFDDGHCIGNGGQGSVYKAKLP--------TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHA 533 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~ 533 (571)
.|++.+.||+|+||.||+|+.. .+..||+|.+.... .....+++.+|+++++++ +||||++++++|...
T Consensus 13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 5888999999999999999731 12368999886432 223457899999999999 899999999999999
Q ss_pred CeeEEEEeccCCCChhhhhccCC-------------CccCCCHHHHhhhc
Q 044615 534 LHSFVVYEYLEMGSLAMNLSNDA-------------AAEQFCWTKRMNAI 570 (571)
Q Consensus 534 ~~~~lv~e~~~~G~L~~~l~~~~-------------~~~~l~w~~r~~ia 570 (571)
+..|++|||+++|+|.+++.... ....++|..++.++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 140 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCA 140 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHH
Confidence 99999999999999999997532 12357888776654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.6e-10 Score=112.13 Aligned_cols=105 Identities=27% Similarity=0.394 Sum_probs=84.4
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
+|+..+.||+|+||.||+|+ ..+++.||||.+....... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc-ccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 47888999999999999998 4578999999987543222 234578899999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+. ++|.+++..... ..++|.....++
T Consensus 80 ~~~-~~l~~~~~~~~~-~~l~~~~~~~~~ 106 (284)
T cd07860 80 FLH-QDLKKFMDASPL-SGIPLPLIKSYL 106 (284)
T ss_pred ccc-cCHHHHHHhCCC-CCCCHHHHHHHH
Confidence 996 689998875432 346776655543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.10 E-value=6.1e-11 Score=112.98 Aligned_cols=84 Identities=30% Similarity=0.391 Sum_probs=69.4
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC-----ee
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL-----HS 536 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~-----~~ 536 (571)
.|...+.+|.|+||.||+|. ..+++.||||+...+.... -+|+++|+.++|||||++..+|.... ..
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 46677899999999999999 5578999999986554322 27999999999999999999997642 23
Q ss_pred EEEEeccCCCChhhhhcc
Q 044615 537 FVVYEYLEMGSLAMNLSN 554 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~ 554 (571)
.+||||||. +|++.++.
T Consensus 98 nlVleymP~-tL~~~~r~ 114 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRH 114 (364)
T ss_pred HHHHHhchH-HHHHHHHH
Confidence 489999997 99999983
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.10 E-value=7.2e-10 Score=106.81 Aligned_cols=104 Identities=28% Similarity=0.428 Sum_probs=87.7
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
+|+..+.||+|++|.||++. ..+++.||+|.+...... ....+.+.+|++++++++|||++++++++.+.+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 47788999999999999998 457889999999765432 2346789999999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+++++|.+++... ..++|..+..++
T Consensus 80 ~~~~~~L~~~~~~~---~~l~~~~~~~~~ 105 (254)
T cd06627 80 YAENGSLRQIIKKF---GPFPESLVAVYV 105 (254)
T ss_pred cCCCCcHHHHHHhc---cCCCHHHHHHHH
Confidence 99999999999754 356777766553
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.10 E-value=3.5e-10 Score=109.81 Aligned_cols=98 Identities=18% Similarity=0.385 Sum_probs=77.6
Q ss_pred CeeeccCcceEEEEEcCC-------------CCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC
Q 044615 468 HCIGNGGQGSVYKAKLPT-------------GEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL 534 (571)
Q Consensus 468 ~~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~ 534 (571)
+.||+|+||.||+|.... ...||+|.+.... ......|.+|+.+++.++||||+++++++.+..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 358999999999998421 2358889876532 223457889999999999999999999999999
Q ss_pred eeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 535 HSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
..++||||+++|+|..+++.... .++|..+++|+
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~ 111 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSD--VLTTPWKFKVA 111 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCC--CCCHHHHHHHH
Confidence 99999999999999998875433 46777666654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.10 E-value=3.1e-10 Score=110.29 Aligned_cols=91 Identities=31% Similarity=0.426 Sum_probs=79.7
Q ss_pred CCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
+|+..+.||+|+||.||++.. .+++.+|+|.+...... ...+++.+|++++++++||||+++++++...+..++|+|
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 577888999999999999994 47899999998764322 345678999999999999999999999999999999999
Q ss_pred ccCCCChhhhhccC
Q 044615 542 YLEMGSLAMNLSND 555 (571)
Q Consensus 542 ~~~~G~L~~~l~~~ 555 (571)
|+++++|.+++...
T Consensus 80 ~~~~~~L~~~~~~~ 93 (265)
T cd06605 80 YMDGGSLDKILKEV 93 (265)
T ss_pred ecCCCcHHHHHHHc
Confidence 99999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.10 E-value=4.4e-10 Score=108.75 Aligned_cols=101 Identities=28% Similarity=0.497 Sum_probs=83.7
Q ss_pred CeeeccCcceEEEEEcC-C---CCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEecc
Q 044615 468 HCIGNGGQGSVYKAKLP-T---GEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYL 543 (571)
Q Consensus 468 ~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 543 (571)
+.||+|+||.||+|... . +..||+|.+....... ..+.+.+|++.+..++||||+++++++......++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 46899999999999843 3 7889999997654322 4578999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCC------ccCCCHHHHhhhc
Q 044615 544 EMGSLAMNLSNDAA------AEQFCWTKRMNAI 570 (571)
Q Consensus 544 ~~G~L~~~l~~~~~------~~~l~w~~r~~ia 570 (571)
++|+|.+++..... ...++|.++..++
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 111 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFA 111 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHH
Confidence 99999999986421 2467888777654
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.10 E-value=5.6e-10 Score=108.24 Aligned_cols=103 Identities=27% Similarity=0.344 Sum_probs=85.3
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|+..+.+|+|+||.||+|.. .+++.+|+|.+...... ..+.+.+|++++++++||||+++++++.+....|++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 5688899999999999999984 57889999999754322 3577899999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
||+++++|.+++.... ..++......|
T Consensus 80 e~~~~~~l~~~~~~~~--~~l~~~~~~~~ 106 (262)
T cd06613 80 EYCGGGSLQDIYQVTR--GPLSELQIAYV 106 (262)
T ss_pred eCCCCCcHHHHHHhhc--cCCCHHHHHHH
Confidence 9999999999887542 23555554443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.10 E-value=3.9e-10 Score=115.85 Aligned_cols=96 Identities=16% Similarity=0.153 Sum_probs=80.7
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
..|++.+.||+|+||.||+|. ..+++.||+|... .+.+.+|++++++++|||||++++++......++||
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 579999999999999999999 5689999999753 234679999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||+. |+|.+++.... .++|...+.|+
T Consensus 163 e~~~-~~L~~~l~~~~---~l~~~~~~~i~ 188 (391)
T PHA03212 163 PRYK-TDLYCYLAAKR---NIAICDILAIE 188 (391)
T ss_pred ecCC-CCHHHHHHhcC---CCCHHHHHHHH
Confidence 9996 68998887542 46666665543
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.10 E-value=4.2e-10 Score=109.75 Aligned_cols=104 Identities=23% Similarity=0.354 Sum_probs=82.7
Q ss_pred cCCCccCeeeccCcceEEEEEcCC----CCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPT----GEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSF 537 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~ 537 (571)
.+|...+.||+|+||.||+|...+ ...||||....... ....+.+.+|+.++++++||||+++++++.+ +..|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 347788999999999999998432 34689998864432 2345689999999999999999999999875 5578
Q ss_pred EEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 538 VVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+||||+++|+|.+++.... ..++|..++.++
T Consensus 83 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ 113 (270)
T cd05056 83 IVMELAPLGELRSYLQVNK--YSLDLASLILYS 113 (270)
T ss_pred EEEEcCCCCcHHHHHHhCC--CCCCHHHHHHHH
Confidence 9999999999999997533 247888777664
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.09 E-value=2.1e-11 Score=112.62 Aligned_cols=127 Identities=32% Similarity=0.373 Sum_probs=86.9
Q ss_pred CcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCC
Q 044615 196 LKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSN 275 (571)
Q Consensus 196 L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~ 275 (571)
|+++|+|+|.|+ .+..+..-++.++.|++++|.+... ..+..+++|+.|||++|.++ .+..+-..+.+.+.|.|++
T Consensus 286 LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~ 361 (490)
T KOG1259|consen 286 LTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQ 361 (490)
T ss_pred hhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhh
Confidence 777888888776 4555566677788888888877643 23677778888888887775 3444555667777788888
Q ss_pred ccCccCcchhhhcccCCCEEEccCCcCCcc-cchhccCCCCCCEEEccCCcCcc
Q 044615 276 NQFSQKIPNKIEKLIHLSELDLSHNIFREE-IPSQICSMQSLEKLNLSHNNLSG 328 (571)
Q Consensus 276 n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~~~~~~~l~~L~~L~Ls~n~l~~ 328 (571)
|.+.. -..+..+-+|..||+++|+|... -...++++|.|+.+.|.+|++.+
T Consensus 362 N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 362 NKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred hhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 77742 23456666777788888777542 12346777788888888887764
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.09 E-value=5.1e-10 Score=108.27 Aligned_cols=97 Identities=25% Similarity=0.344 Sum_probs=77.8
Q ss_pred CeeeccCcceEEEEEc-CC---CCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEecc
Q 044615 468 HCIGNGGQGSVYKAKL-PT---GEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYL 543 (571)
Q Consensus 468 ~~lg~G~~g~V~~~~~-~~---~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 543 (571)
+.||+|+||.||+|.. .. +..+|+|.+...... ...+++.+|++++++++|||||++++++. .+..++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 4689999999999973 22 368999998755432 34567999999999999999999999876 45679999999
Q ss_pred CCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 544 EMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 544 ~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
++|+|.+++.+.. .++|..++.++
T Consensus 78 ~~~~L~~~l~~~~---~~~~~~~~~~~ 101 (257)
T cd05060 78 PLGPLLKYLKKRR---EIPVSDLKELA 101 (257)
T ss_pred CCCcHHHHHHhCC---CCCHHHHHHHH
Confidence 9999999998543 46777766654
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.09 E-value=4.4e-10 Score=109.58 Aligned_cols=86 Identities=27% Similarity=0.404 Sum_probs=71.6
Q ss_pred eeeccCcceEEEEEcC---CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEeccCC
Q 044615 469 CIGNGGQGSVYKAKLP---TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEM 545 (571)
Q Consensus 469 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 545 (571)
.||+|+||+||+|... ....+|+|.+.... .......|.+|+++++.++||||+++++++.+....|+||||+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 5899999999999732 34568888876432 223356789999999999999999999999999999999999999
Q ss_pred CChhhhhccCC
Q 044615 546 GSLAMNLSNDA 556 (571)
Q Consensus 546 G~L~~~l~~~~ 556 (571)
|+|.+++....
T Consensus 80 g~L~~~l~~~~ 90 (269)
T cd05042 80 GDLKNYLRSNR 90 (269)
T ss_pred CcHHHHHHhcc
Confidence 99999997643
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.3e-10 Score=116.11 Aligned_cols=89 Identities=28% Similarity=0.493 Sum_probs=73.6
Q ss_pred cCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEeccCCC
Q 044615 467 GHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMG 546 (571)
Q Consensus 467 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~G 546 (571)
.+-+|+|+-|.||.|++ .++.||||+++.-+ ..+|+-|++++|||||.+.|+|.....++||||||+.|
T Consensus 129 LeWlGSGaQGAVF~Grl-~netVAVKKV~elk----------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL-HNETVAVKKVRELK----------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhccCcccceeeeec-cCceehhHHHhhhh----------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 46699999999999998 47889999875321 25788899999999999999999999999999999999
Q ss_pred ChhhhhccCCCc---cCCCHHHH
Q 044615 547 SLAMNLSNDAAA---EQFCWTKR 566 (571)
Q Consensus 547 ~L~~~l~~~~~~---~~l~w~~r 566 (571)
-|+..|+.+..- .-.+|..-
T Consensus 198 qL~~VLka~~~itp~llv~Wsk~ 220 (904)
T KOG4721|consen 198 QLYEVLKAGRPITPSLLVDWSKG 220 (904)
T ss_pred cHHHHHhccCccCHHHHHHHHHH
Confidence 999999865432 22466543
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.09 E-value=4.4e-10 Score=112.86 Aligned_cols=88 Identities=22% Similarity=0.297 Sum_probs=70.3
Q ss_pred CeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHH-HHhhcCCCCcccEEEEEEeCCeeEEEEeccCC
Q 044615 468 HCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVN-ALTKIRHRNIVKFYGFCSHALHSFVVYEYLEM 545 (571)
Q Consensus 468 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 545 (571)
+.||+|+||.||+|+ ..+++.||+|++.+...........+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 368999999999999 4578899999997533222222344555554 56789999999999999999999999999999
Q ss_pred CChhhhhccC
Q 044615 546 GSLAMNLSND 555 (571)
Q Consensus 546 G~L~~~l~~~ 555 (571)
|+|.+++...
T Consensus 81 ~~L~~~~~~~ 90 (325)
T cd05602 81 GELFYHLQRE 90 (325)
T ss_pred CcHHHHHHhc
Confidence 9999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.8e-10 Score=121.60 Aligned_cols=104 Identities=16% Similarity=0.267 Sum_probs=82.1
Q ss_pred CCCccCeeeccCcceEEEEEcC-CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcC-CCCcccEEEEE-Ee---C---
Q 044615 463 NFDDGHCIGNGGQGSVYKAKLP-TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR-HRNIVKFYGFC-SH---A--- 533 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~-~~---~--- 533 (571)
.+++.+.|.+|||+.||.|+.. .|..||+|++-.. +....+.+.+||.+|+.++ |||||.+++.. .. .
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 4667889999999999999954 4599999998543 3455788999999999997 99999999933 21 1
Q ss_pred CeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 534 LHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 534 ~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
-+++|.||||.||.|-|++..+... .|+-.+-++|+
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf 150 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIF 150 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHH
Confidence 3578999999999999999855433 37777777664
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.08 E-value=6.7e-10 Score=107.49 Aligned_cols=97 Identities=21% Similarity=0.316 Sum_probs=76.6
Q ss_pred eeeccCcceEEEEEcC---CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEeccCC
Q 044615 469 CIGNGGQGSVYKAKLP---TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEM 545 (571)
Q Consensus 469 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 545 (571)
.||+|+||.||+|... .+..||+|.+..... ....+.|.+|+.++++++||||+++++++. .+..++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE--KSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccC--hHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 3899999999999742 455799999865422 233567999999999999999999999885 4568999999999
Q ss_pred CChhhhhccCCCccCCCHHHHhhhc
Q 044615 546 GSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 546 G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+|.+++.... ..+++...++++
T Consensus 79 ~~L~~~l~~~~--~~~~~~~~~~~~ 101 (257)
T cd05115 79 GPLNKFLSGKK--DEITVSNVVELM 101 (257)
T ss_pred CCHHHHHHhCC--CCCCHHHHHHHH
Confidence 99999997433 246777766654
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.08 E-value=6.1e-10 Score=110.29 Aligned_cols=107 Identities=21% Similarity=0.345 Sum_probs=84.0
Q ss_pred cCCCccCeeeccCcceEEEEEcC-CCC--EEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCeeE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLP-TGE--IVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHSF 537 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~ 537 (571)
++|++.+.||+|+||+||+|..+ ++. .+|+|.+.... .....+.|.+|++++.++ +||||+++++++.+.+..|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 46888999999999999999853 443 47888876322 223356799999999999 7999999999999999999
Q ss_pred EEEeccCCCChhhhhccCCC-------------ccCCCHHHHhhhc
Q 044615 538 VVYEYLEMGSLAMNLSNDAA-------------AEQFCWTKRMNAI 570 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~~~-------------~~~l~w~~r~~ia 570 (571)
+||||+++|+|.++++.... ...+.|...+.|+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 125 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHH
Confidence 99999999999999975321 1246777666553
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.5e-10 Score=102.73 Aligned_cols=123 Identities=33% Similarity=0.372 Sum_probs=39.7
Q ss_pred CCCcEEeCccCcCcCCCChhhh-CCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEE
Q 044615 218 SSLIQLTLNNNELSGQLSPELG-SLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELD 296 (571)
Q Consensus 218 ~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 296 (571)
..+++|+|.+|.++.. ..++ .+.+|+.|++++|.++.. +.+..+++|+.|++++|.|+...+.....+++|+.|+
T Consensus 19 ~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 19 VKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELY 94 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT--EEE
T ss_pred cccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccccchHHhCCcCCEEE
Confidence 3455566666655532 2233 356666777777766533 3456667777777777777643222223567777777
Q ss_pred ccCCcCCcc-cchhccCCCCCCEEEccCCcCcccccc----ccccCCCCCEEEC
Q 044615 297 LSHNIFREE-IPSQICSMQSLEKLNLSHNNLSGSIPR----CFEEMHWLSCIDI 345 (571)
Q Consensus 297 Ls~n~l~~~-~~~~~~~l~~L~~L~Ls~n~l~~~~p~----~~~~l~~L~~L~l 345 (571)
+++|++... .-..+..+++|+.|+|.+|+++.. +. .+..+|+|+.||-
T Consensus 95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp -TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEETT
T ss_pred CcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeCC
Confidence 777776542 123456677777777777777632 21 3445677777653
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.08 E-value=4.1e-10 Score=108.97 Aligned_cols=96 Identities=23% Similarity=0.457 Sum_probs=76.5
Q ss_pred CeeeccCcceEEEEEcC-CC----------CEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCee
Q 044615 468 HCIGNGGQGSVYKAKLP-TG----------EIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHS 536 (571)
Q Consensus 468 ~~lg~G~~g~V~~~~~~-~~----------~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~ 536 (571)
+.||+|+||.||+|..+ ++ ..+|+|.+...... ...|.+|+.++++++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD----SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh----HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 36899999999999854 33 24777876543211 4778999999999999999999999988 778
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
++||||+++|+|.+++..... .++|..++.++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~ 107 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKN--NVSLHWKLDVA 107 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHH
Confidence 999999999999999986443 56777776654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.08 E-value=7.3e-10 Score=107.07 Aligned_cols=104 Identities=29% Similarity=0.474 Sum_probs=84.0
Q ss_pred CCccCeeeccCcceEEEEEcC-CC----CEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEE
Q 044615 464 FDDGHCIGNGGQGSVYKAKLP-TG----EIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFV 538 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~~~-~~----~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l 538 (571)
+++.+.||.|+||.||++... .+ ..||+|.+...... ...+.+.+|++++.+++||||+++++++.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE--QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh--HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 356788999999999999843 33 88999999654322 245789999999999999999999999999999999
Q ss_pred EEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 539 VYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+|||+++|+|.+++..... ..++|.+...++
T Consensus 79 i~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~ 109 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRP-KELSLSDLLSFA 109 (258)
T ss_pred EEeccCCCCHHHHHHhhhh-ccCCHHHHHHHH
Confidence 9999999999999975332 126777766553
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=4.7e-10 Score=118.72 Aligned_cols=108 Identities=21% Similarity=0.178 Sum_probs=84.5
Q ss_pred HccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC----
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL---- 534 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~---- 534 (571)
..++|.+.+.||+|+||.||+|+ ..+|+.||||++...... ......+.+|+.++..++|+||+++++.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 34689999999999999999998 568999999999765433 244567889999999999999999988775432
Q ss_pred ----eeEEEEeccCCCChhhhhccCCC-ccCCCHHHHhh
Q 044615 535 ----HSFVVYEYLEMGSLAMNLSNDAA-AEQFCWTKRMN 568 (571)
Q Consensus 535 ----~~~lv~e~~~~G~L~~~l~~~~~-~~~l~w~~r~~ 568 (571)
..++||||+++|+|.++++.+.. ...+++.....
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~ 147 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGL 147 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHH
Confidence 36899999999999999975322 23455544433
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.07 E-value=3e-10 Score=110.21 Aligned_cols=98 Identities=27% Similarity=0.275 Sum_probs=81.7
Q ss_pred eeccCcceEEEEEcC-CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEeccCCCCh
Q 044615 470 IGNGGQGSVYKAKLP-TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548 (571)
Q Consensus 470 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~G~L 548 (571)
||+|+||.||++... +|+.+|+|.+...........+.+.+|++++++++||||+++++.+.+....|+||||+++|+|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 589999999999954 6999999999765433334467799999999999999999999999999999999999999999
Q ss_pred hhhhccCCCccCCCHHHHhhhc
Q 044615 549 AMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 549 ~~~l~~~~~~~~l~w~~r~~ia 570 (571)
.+++++.+ .+++..+.+|+
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~ 99 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYI 99 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHH
Confidence 99997543 46776666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.07 E-value=4.6e-10 Score=109.62 Aligned_cols=106 Identities=27% Similarity=0.307 Sum_probs=85.2
Q ss_pred HccCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCC---
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHAL--- 534 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~--- 534 (571)
.+++|+..+.||+|+||.||+|.. .+++.+|+|.+..... ..+++.+|+.+++++ +||||+++++++.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 467899999999999999999995 4788999999875432 246789999999998 7999999999997654
Q ss_pred ---eeEEEEeccCCCChhhhhccCC-CccCCCHHHHhhh
Q 044615 535 ---HSFVVYEYLEMGSLAMNLSNDA-AAEQFCWTKRMNA 569 (571)
Q Consensus 535 ---~~~lv~e~~~~G~L~~~l~~~~-~~~~l~w~~r~~i 569 (571)
..|+||||+++|+|.+++.... ....+++.....+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ 118 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYI 118 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHH
Confidence 4899999999999999987532 1235666665554
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.07 E-value=9e-10 Score=107.43 Aligned_cols=101 Identities=25% Similarity=0.410 Sum_probs=79.0
Q ss_pred CeeeccCcceEEEEEc-CCCC--EEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCeeEEEEecc
Q 044615 468 HCIGNGGQGSVYKAKL-PTGE--IVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHSFVVYEYL 543 (571)
Q Consensus 468 ~~lg~G~~g~V~~~~~-~~~~--~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~ 543 (571)
+.||+|+||.||+|.. .++. .+|+|.+.... .....+.+.+|++++.++ +||||+++++++...+..|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 3589999999999985 3454 46888876432 223356789999999999 8999999999999999999999999
Q ss_pred CCCChhhhhccCCC-------------ccCCCHHHHhhhc
Q 044615 544 EMGSLAMNLSNDAA-------------AEQFCWTKRMNAI 570 (571)
Q Consensus 544 ~~G~L~~~l~~~~~-------------~~~l~w~~r~~ia 570 (571)
++|+|.++++.... ...+.|.+...++
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 118 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHH
Confidence 99999999975321 1246777766653
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.07 E-value=5.4e-10 Score=107.92 Aligned_cols=101 Identities=27% Similarity=0.449 Sum_probs=82.4
Q ss_pred cCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
++|++.+.||+|+||.||++.. +++.||+|.+.... ..+.+.+|+.++++++|||++++++++... ..++|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e 78 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME 78 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence 4588899999999999999875 67889999986432 235789999999999999999999998654 4799999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+++|+|.+++..... ..+++..+++++
T Consensus 79 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~ 106 (254)
T cd05083 79 LMSKGNLVNFLRTRGR-ALVSVIQLLQFS 106 (254)
T ss_pred CCCCCCHHHHHHhcCc-CCCCHHHHHHHH
Confidence 9999999999975432 346777766554
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.06 E-value=8e-10 Score=109.08 Aligned_cols=105 Identities=19% Similarity=0.239 Sum_probs=82.2
Q ss_pred HccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEE
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFV 538 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l 538 (571)
++++|...+.||+|+||.||+|. ..++..||+|.+...... .....+.+|+.++++++|+||+++++++.+.+..|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 80 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTF 80 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence 35679999999999999999998 457899999998654322 223457789999999999999999999999999999
Q ss_pred EEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 539 VYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
||||+. +++.+++..... .+.+.+...+
T Consensus 81 v~e~~~-~~l~~~~~~~~~--~~~~~~~~~~ 108 (291)
T cd07870 81 VFEYMH-TDLAQYMIQHPG--GLHPYNVRLF 108 (291)
T ss_pred EEeccc-CCHHHHHHhCCC--CCCHHHHHHH
Confidence 999996 688777754322 3445444433
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.3e-09 Score=108.83 Aligned_cols=104 Identities=27% Similarity=0.329 Sum_probs=84.1
Q ss_pred CCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEec
Q 044615 464 FDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEY 542 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 542 (571)
|...+.||+|+||+||+|+ ..+++.||+|.+...........+.+.+|+++++.++|||++++++++.+.+..|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 5556789999999999998 457899999999765444434456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 543 LEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 543 ~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+. |++.+++.... ..++|.+++.++
T Consensus 103 ~~-~~l~~~l~~~~--~~l~~~~~~~~~ 127 (313)
T cd06633 103 CL-GSASDLLEVHK--KPLQEVEIAAIT 127 (313)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHH
Confidence 96 58888776433 247777766543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.8e-10 Score=109.80 Aligned_cols=93 Identities=24% Similarity=0.445 Sum_probs=78.0
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCC-cccEEEEEEeCC-----
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRN-IVKFYGFCSHAL----- 534 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~~~~~~~~----- 534 (571)
..|+..+++|+|+||+||+|+ ..+|+.||+|++...... .+......+|+.++++++|+| ||++++++.+.+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 346777889999999999999 668999999999865432 122345679999999999999 999999999877
Q ss_pred -eeEEEEeccCCCChhhhhccCC
Q 044615 535 -HSFVVYEYLEMGSLAMNLSNDA 556 (571)
Q Consensus 535 -~~~lv~e~~~~G~L~~~l~~~~ 556 (571)
.+++|+||++. ||.+++....
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~ 111 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLP 111 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhcc
Confidence 89999999986 9999998644
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.06 E-value=4.5e-10 Score=109.43 Aligned_cols=85 Identities=33% Similarity=0.500 Sum_probs=70.1
Q ss_pred eeeccCcceEEEEEcCCC---CEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEeccCC
Q 044615 469 CIGNGGQGSVYKAKLPTG---EIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEM 545 (571)
Q Consensus 469 ~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 545 (571)
.||+|+||.||+|...++ ..+++|.+..... ....+.|.+|+.+++.++||||++++++|.+....|+||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 589999999999974332 3466777654322 23457899999999999999999999999999999999999999
Q ss_pred CChhhhhccC
Q 044615 546 GSLAMNLSND 555 (571)
Q Consensus 546 G~L~~~l~~~ 555 (571)
|+|.+++++.
T Consensus 80 ~~L~~~l~~~ 89 (268)
T cd05086 80 GDLKSYLSQE 89 (268)
T ss_pred CcHHHHHHhh
Confidence 9999999754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.06 E-value=8.1e-10 Score=107.66 Aligned_cols=108 Identities=19% Similarity=0.367 Sum_probs=83.2
Q ss_pred CCCccCeeeccCcceEEEEEcC--CCCEEEEEEccCCCC-------CchHhHHHHHHHHHHHhh-cCCCCcccEEEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAKLP--TGEIVDVKKFHSPLP-------DEMACQQEFLNEVNALTK-IRHRNIVKFYGFCSH 532 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~-------~~~~~~~~~~~Ei~~l~~-l~H~niv~l~~~~~~ 532 (571)
+|++.+.||+|+||.||+|..+ .++.+|+|.+..... .......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4778899999999999999954 478899998864321 122345668889988865 799999999999999
Q ss_pred CCeeEEEEeccCCCChhhhhccC-CCccCCCHHHHhhhc
Q 044615 533 ALHSFVVYEYLEMGSLAMNLSND-AAAEQFCWTKRMNAI 570 (571)
Q Consensus 533 ~~~~~lv~e~~~~G~L~~~l~~~-~~~~~l~w~~r~~ia 570 (571)
.+..++||||+++++|.+++... .....+++..+++++
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~ 119 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIF 119 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHH
Confidence 99999999999999999988532 122346666665543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=9.6e-11 Score=119.67 Aligned_cols=86 Identities=24% Similarity=0.437 Sum_probs=74.0
Q ss_pred ccCeeeccCcceEEEEEcC--CCC--EEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 466 DGHCIGNGGQGSVYKAKLP--TGE--IVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 466 ~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
..+.||+|.||.|++|.+. .|+ .||||++....... ...+|.+|+.+|.+++|||+|++||+..+ ....||||
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 3467999999999999864 454 58999998665442 46789999999999999999999999987 66789999
Q ss_pred ccCCCChhhhhcc
Q 044615 542 YLEMGSLAMNLSN 554 (571)
Q Consensus 542 ~~~~G~L~~~l~~ 554 (571)
.++.|+|.+.|++
T Consensus 191 LaplGSLldrLrk 203 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRK 203 (1039)
T ss_pred hcccchHHHHHhh
Confidence 9999999999987
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.06 E-value=8.6e-10 Score=108.17 Aligned_cols=104 Identities=21% Similarity=0.303 Sum_probs=80.3
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCC----EEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCee
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGE----IVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHS 536 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~ 536 (571)
++|+..+.||+|+||.||+|.. .+++ .+|+|.+.... ......++..|+..+++++||||+++++++. ....
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~ 83 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASL 83 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCcc
Confidence 4688889999999999999984 4555 47778775321 1233467888999999999999999999885 4557
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
++++||+++|+|.+++..... .++|...+.|+
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~ 115 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHRD--SLDPQRLLNWC 115 (279)
T ss_pred EEEEEeCCCCcHHHHHHhccc--CCCHHHHHHHH
Confidence 899999999999999975432 47777766654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.06 E-value=6.4e-10 Score=109.27 Aligned_cols=104 Identities=26% Similarity=0.394 Sum_probs=85.1
Q ss_pred CCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEec
Q 044615 464 FDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEY 542 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 542 (571)
|+..+.||+|++|.||+|. ..+|..||+|++....... ...+.+.+|++++++++|||++++++++.+.+..|++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE-GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc-cchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 5677899999999999998 4589999999987543222 2245688999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 543 LEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 543 ~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
++ ++|.+++..... ..++|..+++++
T Consensus 80 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~ 105 (283)
T cd07835 80 LD-LDLKKYMDSSPL-TGLDPPLIKSYL 105 (283)
T ss_pred cC-cCHHHHHhhCCC-CCCCHHHHHHHH
Confidence 95 699999875432 357888777664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.06 E-value=5.5e-10 Score=112.64 Aligned_cols=91 Identities=25% Similarity=0.429 Sum_probs=74.4
Q ss_pred cCCCccCeeeccCcceEEEEEc------CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeC-
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL------PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHA- 533 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~- 533 (571)
+.|++.+.||+|+||.||+|.. .+++.||+|++..... ....+.+.+|+.++.++ +||||++++++|...
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC--HHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 3588899999999999999962 2357899999874332 23346788999999999 899999999988654
Q ss_pred CeeEEEEeccCCCChhhhhcc
Q 044615 534 LHSFVVYEYLEMGSLAMNLSN 554 (571)
Q Consensus 534 ~~~~lv~e~~~~G~L~~~l~~ 554 (571)
...+++|||+++|+|.+++..
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~ 105 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRS 105 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHh
Confidence 568899999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.06 E-value=3.1e-10 Score=110.53 Aligned_cols=101 Identities=24% Similarity=0.405 Sum_probs=80.8
Q ss_pred CeeeccCcceEEEEEcCC-------CCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 468 HCIGNGGQGSVYKAKLPT-------GEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 468 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
+.||+|+||.||+|+..+ +..+|+|.+..... ......|.+|+.++++++||||+++++++...+..++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 358999999999998431 25799998864321 133567899999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCC----CccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDA----AAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~----~~~~l~w~~r~~ia 570 (571)
||+++|+|.+++.+.. ....++|.+++.|+
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~ 112 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDIC 112 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHH
Confidence 9999999999997532 22347888777665
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.06 E-value=9e-10 Score=106.56 Aligned_cols=97 Identities=25% Similarity=0.388 Sum_probs=77.0
Q ss_pred eeeccCcceEEEEEc---CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEeccCC
Q 044615 469 CIGNGGQGSVYKAKL---PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEM 545 (571)
Q Consensus 469 ~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 545 (571)
.||+|+||.||+|.. .++..+|+|++.... ......+++.+|+.++++++||||+++++++. .+..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 589999999999963 367889999986443 22344678999999999999999999999885 4567899999999
Q ss_pred CChhhhhccCCCccCCCHHHHhhhc
Q 044615 546 GSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 546 G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+|.+++.... .+++....+++
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~i~ 101 (257)
T cd05116 80 GPLNKFLQKNK---HVTEKNITELV 101 (257)
T ss_pred CcHHHHHHhcC---CCCHHHHHHHH
Confidence 99999997432 45666665553
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=5.1e-12 Score=113.32 Aligned_cols=92 Identities=20% Similarity=0.276 Sum_probs=79.4
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.+.|++.+.||+|.|+.||++. .++|+.+|+|++....... ...++..+|++|-..++|||||++.+.+.+....|+|
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~-~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc-ccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 3457888899999999999998 6789999999997554332 2467899999999999999999999999999999999
Q ss_pred EeccCCCChhhhhc
Q 044615 540 YEYLEMGSLAMNLS 553 (571)
Q Consensus 540 ~e~~~~G~L~~~l~ 553 (571)
+|+|+||+|+.-|-
T Consensus 89 Fe~m~G~dl~~eIV 102 (355)
T KOG0033|consen 89 FDLVTGGELFEDIV 102 (355)
T ss_pred EecccchHHHHHHH
Confidence 99999999976554
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.1e-10 Score=108.89 Aligned_cols=94 Identities=21% Similarity=0.378 Sum_probs=80.2
Q ss_pred HHHHHHHccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEE
Q 044615 454 HEEIIRATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCS 531 (571)
Q Consensus 454 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~ 531 (571)
++++-.-|+ +.+|+|+||.|--+. ..+|..||||++.+... ..+.++.+|++++.++ .|+||++++++|+
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g---HsR~RvfREVe~f~~Cqgh~nilqLiefFE 146 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG---HSRSRVFREVETFYQCQGHKNILQLIEFFE 146 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCc---hHHHHHHHHHHHHHHhcCCccHHHHHHHhc
Confidence 456544443 579999999999888 78999999999987632 3367788999999998 6999999999999
Q ss_pred eCCeeEEEEeccCCCChhhhhccC
Q 044615 532 HALHSFVVYEYLEMGSLAMNLSND 555 (571)
Q Consensus 532 ~~~~~~lv~e~~~~G~L~~~l~~~ 555 (571)
+...+|+|||-|.||.|..+|+++
T Consensus 147 dd~~FYLVfEKm~GGplLshI~~~ 170 (463)
T KOG0607|consen 147 DDTRFYLVFEKMRGGPLLSHIQKR 170 (463)
T ss_pred ccceEEEEEecccCchHHHHHHHh
Confidence 999999999999999999999854
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.05 E-value=9.1e-10 Score=108.21 Aligned_cols=101 Identities=27% Similarity=0.369 Sum_probs=81.2
Q ss_pred CCccCeeeccCcceEEEEE-----cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC--Cee
Q 044615 464 FDDGHCIGNGGQGSVYKAK-----LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA--LHS 536 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~--~~~ 536 (571)
|+..+.||+|+||+||.+. ..++..||+|.+..... ....+.|.+|++++++++||||+++++++... ...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 4788999999999998764 23678899999875422 22356788999999999999999999998653 468
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+||||+++|+|.+++... .++|.++..|+
T Consensus 84 ~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~ 113 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKH----KLNLAQLLLFA 113 (283)
T ss_pred EEEecCCCCCCHHHHHHHc----CCCHHHHHHHH
Confidence 8999999999999999743 37787777664
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.05 E-value=5.6e-10 Score=112.35 Aligned_cols=96 Identities=21% Similarity=0.233 Sum_probs=74.0
Q ss_pred eeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc---CCCCcccEEEEEEeCCeeEEEEeccCC
Q 044615 470 IGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI---RHRNIVKFYGFCSHALHSFVVYEYLEM 545 (571)
Q Consensus 470 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l---~H~niv~l~~~~~~~~~~~lv~e~~~~ 545 (571)
||+|+||.||+|+ ..+++.||||++.+...........+..|..++.+. +||||+++++++.+.+..|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 6999999999999 457999999998643222222344566777777665 799999999999999999999999999
Q ss_pred CChhhhhccCCCccCCCHHHHhh
Q 044615 546 GSLAMNLSNDAAAEQFCWTKRMN 568 (571)
Q Consensus 546 G~L~~~l~~~~~~~~l~w~~r~~ 568 (571)
|+|.+++.+.+ .+++.....
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~ 100 (330)
T cd05586 81 GELFWHLQKEG---RFSEDRAKF 100 (330)
T ss_pred ChHHHHHHhcC---CCCHHHHHH
Confidence 99999987543 345444433
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.05 E-value=5.7e-10 Score=110.27 Aligned_cols=105 Identities=28% Similarity=0.371 Sum_probs=85.0
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC--CeeEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA--LHSFV 538 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~--~~~~l 538 (571)
++|+..+.||+|+||.||+|.. .+++.+|+|.++...... .....+.+|+.++++++||||+++++++... ...|+
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKE-GFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccc-cchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 4688899999999999999995 478999999997543221 2234577899999999999999999999887 88999
Q ss_pred EEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 539 VYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||||++ ++|.+++..... .+++.....|+
T Consensus 84 v~e~~~-~~L~~~~~~~~~--~l~~~~~~~i~ 112 (293)
T cd07843 84 VMEYVE-HDLKSLMETMKQ--PFLQSEVKCLM 112 (293)
T ss_pred EehhcC-cCHHHHHHhccC--CCCHHHHHHHH
Confidence 999998 599998875432 57777776654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.4e-09 Score=105.05 Aligned_cols=107 Identities=23% Similarity=0.368 Sum_probs=88.9
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
+|...+.||+|+||.||++. ..++..||+|++...... ....+.+.+|++++++++|||++++++.+......++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 47788899999999999999 457899999999764432 2345678999999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCC-CccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDA-AAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~-~~~~l~w~~r~~ia 570 (571)
|+++++|.+++.+.. ....+++.+...|+
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~ 109 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWF 109 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHH
Confidence 999999999997642 13467777776664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.05 E-value=9.6e-10 Score=107.99 Aligned_cols=106 Identities=19% Similarity=0.271 Sum_probs=81.8
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHH-HhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNA-LTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~-l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
++|++.+.||+|+||.||+|. ..+|+.||+|++....... ...++..|+.. ++..+||||+++++++...+..|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 368889999999999999999 4579999999987643222 23456667665 6677999999999999999999999
Q ss_pred EeccCCCChhhhhccC-CCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSND-AAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~-~~~~~l~w~~r~~ia 570 (571)
|||++ |+|.+++... .....++|....+++
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~ 109 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIA 109 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHH
Confidence 99997 6888887642 222457777665554
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.7e-10 Score=101.12 Aligned_cols=82 Identities=32% Similarity=0.406 Sum_probs=15.4
Q ss_pred CCCCCEEecccCcCccccccccc-CCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccc-cCCCCCCE
Q 044615 96 MKSLSDLQLSENILNGSIPLALG-NLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEI-GNMNSLSI 173 (571)
Q Consensus 96 l~~L~~L~L~~n~i~~~~~~~~~-~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l-~~l~~L~~ 173 (571)
...+++|+|++|.|+.+ +.++ .+.+|+.|+|++|.|+.. ..+..++.|++|++++|.++.. ++.+ ..+++|++
T Consensus 18 ~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp~L~~ 92 (175)
T PF14580_consen 18 PVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSI-SEGLDKNLPNLQE 92 (175)
T ss_dssp --------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--E
T ss_pred ccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCcc-ccchHHhCCcCCE
Confidence 33455556655555522 2233 345555555555555432 1244445555555555555432 2222 23444445
Q ss_pred EEccCCCCC
Q 044615 174 LDLSSNKLN 182 (571)
Q Consensus 174 L~L~~n~l~ 182 (571)
|++++|++.
T Consensus 93 L~L~~N~I~ 101 (175)
T PF14580_consen 93 LYLSNNKIS 101 (175)
T ss_dssp EE-TTS---
T ss_pred EECcCCcCC
Confidence 554444443
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=6.6e-11 Score=110.39 Aligned_cols=95 Identities=22% Similarity=0.246 Sum_probs=83.3
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.++|+..+++|+|.||+|..++ ..+++.+|+|++++...-.......-..|-+++...+||.+..+...|++++.+|.|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 4578889999999999999998 668999999999876544434456677899999999999999999999999999999
Q ss_pred EeccCCCChhhhhccC
Q 044615 540 YEYLEMGSLAMNLSND 555 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~ 555 (571)
|||+.||+|+-+|.+.
T Consensus 247 MeyanGGeLf~HLsre 262 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRE 262 (516)
T ss_pred EEEccCceEeeehhhh
Confidence 9999999999988753
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.04 E-value=6.4e-10 Score=109.51 Aligned_cols=103 Identities=27% Similarity=0.379 Sum_probs=82.4
Q ss_pred CCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
+|+..+.||+|+||.||+|.. .+++.||+|.++..... ....+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD-EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc-ccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 588899999999999999994 47889999998754322 2335678999999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
|++++.+..+..... .+++.....+
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~ 105 (288)
T cd07833 81 YVERTLLELLEASPG---GLPPDAVRSY 105 (288)
T ss_pred cCCCCHHHHHHhcCC---CCCHHHHHHH
Confidence 999877776654322 3555554443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.1e-09 Score=105.91 Aligned_cols=102 Identities=25% Similarity=0.345 Sum_probs=82.6
Q ss_pred cCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEE-eCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCS-HALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~-~~~~~~lv~ 540 (571)
.+|++.+.||+|+||.||++.. .|..||+|.+.... ..+.|.+|+.++++++|||++++++++. ..+..|+||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence 3588889999999999999976 47789999986432 2457899999999999999999999764 456789999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||+++|+|.++++.... ..++|...++++
T Consensus 80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~ 108 (256)
T cd05082 80 EYMAKGSLVDYLRSRGR-SVLGGDCLLKFS 108 (256)
T ss_pred ECCCCCcHHHHHHhcCC-CCCCHHHHHHHH
Confidence 99999999999975432 346777776654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=3.7e-10 Score=114.04 Aligned_cols=90 Identities=28% Similarity=0.469 Sum_probs=73.1
Q ss_pred CccCeeeccCcceEEEEEcC---CCC--EEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 465 DDGHCIGNGGQGSVYKAKLP---TGE--IVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 465 ~~~~~lg~G~~g~V~~~~~~---~~~--~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
...+.||.|.||.||+|.+. .|+ .||||.-+.+... ...+.|.+|..+|+.++|||||+++|+|.+. ..|||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~--d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wiv 468 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP--DDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIV 468 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh--hhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEE
Confidence 44578999999999999832 333 4788887654332 3368899999999999999999999999654 57899
Q ss_pred EeccCCCChhhhhccCCC
Q 044615 540 YEYLEMGSLAMNLSNDAA 557 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~ 557 (571)
||.++-|.|..||+....
T Consensus 469 mEL~~~GELr~yLq~nk~ 486 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKD 486 (974)
T ss_pred EecccchhHHHHHHhccc
Confidence 999999999999986543
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.04 E-value=7e-10 Score=108.93 Aligned_cols=110 Identities=25% Similarity=0.352 Sum_probs=85.4
Q ss_pred cHHHHHHHccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEE
Q 044615 453 VHEEIIRATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFC 530 (571)
Q Consensus 453 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~ 530 (571)
+..++..+.+.|++.+.+|+|+||.||+|. ..+++.+|+|.+.... ....++..|+.++.++ +||||+++++++
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~ 82 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAF 82 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeeh
Confidence 344555566789999999999999999999 4578999999986432 2245688999999998 799999999998
Q ss_pred Ee------CCeeEEEEeccCCCChhhhhccCCCccCCCHHHHh
Q 044615 531 SH------ALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRM 567 (571)
Q Consensus 531 ~~------~~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~ 567 (571)
.. ....|++|||+++|+|.+++..... ..+++....
T Consensus 83 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~ 124 (282)
T cd06636 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIA 124 (282)
T ss_pred hcccccCCCCEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHH
Confidence 53 4578999999999999999975322 234554443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.04 E-value=5.9e-10 Score=110.39 Aligned_cols=100 Identities=23% Similarity=0.305 Sum_probs=81.3
Q ss_pred CCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEec
Q 044615 464 FDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEY 542 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 542 (571)
|+....||+|+||.||+|. ..+++.||+|.+..... ...+.+.+|+.++..++|||++++++++..++..|+||||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 4445679999999999998 45789999999865432 2246788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 543 LEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 543 ~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+++|+|.+++... .++|.....++
T Consensus 100 ~~~~~L~~~~~~~----~~~~~~~~~~~ 123 (297)
T cd06659 100 LQGGALTDIVSQT----RLNEEQIATVC 123 (297)
T ss_pred CCCCCHHHHHhhc----CCCHHHHHHHH
Confidence 9999999987642 35666655543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.8e-09 Score=103.81 Aligned_cols=103 Identities=30% Similarity=0.413 Sum_probs=87.2
Q ss_pred CCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
+|+..+.||+|++|.||++.. .++..+|+|++..... ...+.+.+|++.+++++|||++++++++......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 477889999999999999995 4789999999976543 235789999999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+++++|.+++.... ..++|.....|+
T Consensus 78 ~~~~~~L~~~~~~~~--~~~~~~~~~~i~ 104 (253)
T cd05122 78 FCSGGSLKDLLKSTN--QTLTESQIAYVC 104 (253)
T ss_pred cCCCCcHHHHHhhcC--CCCCHHHHHHHH
Confidence 999999999987543 356777766554
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.4e-09 Score=106.07 Aligned_cols=105 Identities=20% Similarity=0.350 Sum_probs=79.3
Q ss_pred CccCeeeccCcceEEEEEcC-CCC--EEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC------Ce
Q 044615 465 DDGHCIGNGGQGSVYKAKLP-TGE--IVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA------LH 535 (571)
Q Consensus 465 ~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~------~~ 535 (571)
.+.+.||+|+||.||+|... .+. .+|+|.++.... .....+.|.+|+++++.++||||+++++++... ..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 45688999999999999854 343 589999875432 234467899999999999999999999987532 24
Q ss_pred eEEEEeccCCCChhhhhccCC---CccCCCHHHHhhhc
Q 044615 536 SFVVYEYLEMGSLAMNLSNDA---AAEQFCWTKRMNAI 570 (571)
Q Consensus 536 ~~lv~e~~~~G~L~~~l~~~~---~~~~l~w~~r~~ia 570 (571)
.+++|||+++|+|.+++.... ....++|.....++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 118 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFM 118 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHH
Confidence 689999999999999885321 22347777665543
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.03 E-value=5.1e-10 Score=108.07 Aligned_cols=107 Identities=21% Similarity=0.309 Sum_probs=87.6
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
+|++.+.||+|+||.||++. ..+++.+|+|.+...... .....++.+|++++++++||||+++++++.+....|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 47788999999999999998 557899999998754432 2345678899999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCC-CccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDA-AAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~-~~~~l~w~~r~~ia 570 (571)
|+++++|.+++.+.. ....++|.....++
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~ 109 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIF 109 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHH
Confidence 999999999987532 12457777665543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=6.9e-10 Score=116.59 Aligned_cols=105 Identities=27% Similarity=0.404 Sum_probs=85.1
Q ss_pred HHHHHHccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEe
Q 044615 455 EEIIRATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSH 532 (571)
Q Consensus 455 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~ 532 (571)
+.+...++.|++..+||.|.+|.||+++ .++++.+|||+.......+ ++...|..+++.. +|||++.++|+|..
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d----eEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE----EEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc----HHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 3344456678999999999999999999 6789999999998765443 5677788887765 89999999999964
Q ss_pred -----CCeeEEEEeccCCCChhhhhccCCCccCCCHH
Q 044615 533 -----ALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWT 564 (571)
Q Consensus 533 -----~~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~ 564 (571)
++++|+|||||.+|+.-|++++-. +..++|.
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~ 123 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEE 123 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhH
Confidence 578999999999999999998643 3456665
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.03 E-value=1e-09 Score=109.65 Aligned_cols=89 Identities=16% Similarity=0.128 Sum_probs=68.7
Q ss_pred HHccCCCccCeeeccCcceEEEEEc-C-CCCEEEEEEccCCCC--CchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC
Q 044615 459 RATNNFDDGHCIGNGGQGSVYKAKL-P-TGEIVDVKKFHSPLP--DEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL 534 (571)
Q Consensus 459 ~~~~~~~~~~~lg~G~~g~V~~~~~-~-~~~~vavK~~~~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~ 534 (571)
...++|...+.||+|+||+||+|.. . +++.||||++..... ......+.|.+|++++++++|+|+|+.+.. .+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 3456799999999999999999984 3 677889998753311 122335679999999999999999963332 24
Q ss_pred eeEEEEeccCCCChhh
Q 044615 535 HSFVVYEYLEMGSLAM 550 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~ 550 (571)
..|+||||++|++|..
T Consensus 92 ~~~LVmE~~~G~~L~~ 107 (365)
T PRK09188 92 KDGLVRGWTEGVPLHL 107 (365)
T ss_pred CcEEEEEccCCCCHHH
Confidence 5799999999999973
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.6e-09 Score=106.87 Aligned_cols=105 Identities=21% Similarity=0.358 Sum_probs=78.1
Q ss_pred CCCccCeeeccCcceEEEEEc-C-CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc---CCCCcccEEEEEEe-----
Q 044615 463 NFDDGHCIGNGGQGSVYKAKL-P-TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI---RHRNIVKFYGFCSH----- 532 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l---~H~niv~l~~~~~~----- 532 (571)
.|++.+.||+|+||.||+|+. . +++.||+|.+....... .....+.+|+.+++.+ +||||++++++|..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 588899999999999999984 3 46889999987543222 2234566787776655 79999999999853
Q ss_pred CCeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 533 ALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 533 ~~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
....++||||++ |+|.+++..... ..++|.....|+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~ 116 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMM 116 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHH
Confidence 356899999997 699999875332 346777666554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.1e-09 Score=107.99 Aligned_cols=93 Identities=18% Similarity=0.280 Sum_probs=77.8
Q ss_pred CCCccCeeeccCcceEEEEEc----CCCCEEEEEEccCCCCCc-hHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCee
Q 044615 463 NFDDGHCIGNGGQGSVYKAKL----PTGEIVDVKKFHSPLPDE-MACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHS 536 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~ 536 (571)
+|++.+.||+|+||.||.|.. .+|..||+|.+....... ....+++.+|++++.++ +||||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999984 378999999987533211 12346788999999999 699999999999999999
Q ss_pred EEEEeccCCCChhhhhccC
Q 044615 537 FVVYEYLEMGSLAMNLSND 555 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~ 555 (571)
|+||||+++|+|.+++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~ 99 (290)
T cd05613 81 HLILDYINGGELFTHLSQR 99 (290)
T ss_pred EEEEecCCCCcHHHHHHHc
Confidence 9999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.6e-09 Score=106.13 Aligned_cols=104 Identities=19% Similarity=0.358 Sum_probs=82.5
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCC----EEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCee
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGE----IVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHS 536 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~----~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~ 536 (571)
.+|+..+.||+|+||.||+|. ..++. .||+|.+..... ....+++.+|+.+++.++||||+++++++.. ...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~ 83 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS--PKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV 83 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC--HHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence 468888999999999999998 44554 489999865432 2335678999999999999999999999975 457
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+++|||+++|+|.++++.... .+++...+.++
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~~--~~~~~~~~~~~ 115 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENKD--RIGSQDLLNWC 115 (279)
T ss_pred EEEEEcCCCCCHHHHHhhccC--CCCHHHHHHHH
Confidence 899999999999999975432 46776666654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.2e-09 Score=108.37 Aligned_cols=107 Identities=28% Similarity=0.406 Sum_probs=83.8
Q ss_pred HccCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC----
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL---- 534 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~---- 534 (571)
..++|++.+.+|+|+||.||+|.. .+++.||+|.+....... .....+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE-GFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc-CchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 456799999999999999999995 478999999997543221 22356789999999999999999999987654
Q ss_pred ------eeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 535 ------HSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 535 ------~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
..|+|+||+++ ++.+.+.... ..++|.....|+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~ 122 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFM 122 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHH
Confidence 78999999986 7777776432 246777766554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.6e-09 Score=108.95 Aligned_cols=99 Identities=26% Similarity=0.265 Sum_probs=79.1
Q ss_pred eeecc--CcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEeccCC
Q 044615 469 CIGNG--GQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEM 545 (571)
Q Consensus 469 ~lg~G--~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 545 (571)
.||+| +||+||+++ ..+|+.||+|++....... ...+.+.+|+.+++.++||||++++++|..++..++||||+++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 45655 999999999 4589999999987543332 3457889999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCccCCCHHHHhhh
Q 044615 546 GSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 546 G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
|++.+++.+... ..+++.....+
T Consensus 84 ~~l~~~l~~~~~-~~~~~~~~~~~ 106 (328)
T cd08226 84 GSANSLLKTYFP-EGMSEALIGNI 106 (328)
T ss_pred CCHHHHHHhhcc-cCCCHHHHHHH
Confidence 999999875432 23556554443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.01 E-value=5.5e-10 Score=109.79 Aligned_cols=104 Identities=25% Similarity=0.355 Sum_probs=82.8
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
.|+..+.||+|+||.||+|. ..+|+.||+|.+...... ......+.+|++++++++||||+++++++.+....|+|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc-ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 37788899999999999999 457999999999754322 1223567889999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|++ |+|.+++..... .+++.....++
T Consensus 80 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~ 105 (284)
T cd07839 80 YCD-QDLKKYFDSCNG--DIDPEIVKSFM 105 (284)
T ss_pred cCC-CCHHHHHHhcCC--CCCHHHHHHHH
Confidence 997 588888764332 46666655543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.3e-09 Score=107.74 Aligned_cols=107 Identities=22% Similarity=0.354 Sum_probs=83.0
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcC-CCCcccEEEEEEeCCe----
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR-HRNIVKFYGFCSHALH---- 535 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~~~---- 535 (571)
++|+..+.||+|+||.||+|. ..+++.||+|.+....... .....+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEE-GIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcccc-CCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 368889999999999999999 4579999999986543221 22456889999999995 6999999999987665
Q ss_pred -eEEEEeccCCCChhhhhccCCC--ccCCCHHHHhhhc
Q 044615 536 -SFVVYEYLEMGSLAMNLSNDAA--AEQFCWTKRMNAI 570 (571)
Q Consensus 536 -~~lv~e~~~~G~L~~~l~~~~~--~~~l~w~~r~~ia 570 (571)
.|+||||+++ +|.+++..... ...++|.....++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~ 116 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFM 116 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHH
Confidence 8999999985 89998865322 2356777666553
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.1e-09 Score=107.63 Aligned_cols=90 Identities=21% Similarity=0.283 Sum_probs=76.2
Q ss_pred CCCccCeeeccCcceEEEEEcC------CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCee
Q 044615 463 NFDDGHCIGNGGQGSVYKAKLP------TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHS 536 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~ 536 (571)
+|...+.||+|+||.||+|... .+..||+|.+..... ....+.|.+|+.+++.++||||+++++++.+.+..
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE--GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 4667788999999999999842 357899999975432 23356789999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhcc
Q 044615 537 FVVYEYLEMGSLAMNLSN 554 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~ 554 (571)
++++||+++++|.+++..
T Consensus 84 ~~~~e~~~~~~l~~~l~~ 101 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVM 101 (283)
T ss_pred EEEEEcCCCCcHHHHHHh
Confidence 999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.01 E-value=2e-09 Score=105.60 Aligned_cols=99 Identities=20% Similarity=0.166 Sum_probs=74.9
Q ss_pred eeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHH---HhhcCCCCcccEEEEEEeCCeeEEEEeccC
Q 044615 469 CIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNA---LTKIRHRNIVKFYGFCSHALHSFVVYEYLE 544 (571)
Q Consensus 469 ~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~---l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 544 (571)
.||+|+||.||++. ..+++.+|+|.+.+...........+.+|..+ +...+||||+.+++++.+.+..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999 45789999999876543322222334455433 344589999999999999999999999999
Q ss_pred CCChhhhhccCCCccCCCHHHHhhhc
Q 044615 545 MGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 545 ~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+|+|.+++...+ .+.|.....|+
T Consensus 81 ~~~L~~~i~~~~---~l~~~~~~~i~ 103 (279)
T cd05633 81 GGDLHYHLSQHG---VFSEKEMRFYA 103 (279)
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHH
Confidence 999999987442 47777666554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.9e-09 Score=106.60 Aligned_cols=92 Identities=26% Similarity=0.460 Sum_probs=77.4
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|+..+.||+|+||.||+|.. .+++.||+|.+...... ....+.+.+|++++++++||||+++++++.+....|+||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 4688899999999999999994 57899999998654322 123456889999999999999999999999999999999
Q ss_pred eccCCCChhhhhccC
Q 044615 541 EYLEMGSLAMNLSND 555 (571)
Q Consensus 541 e~~~~G~L~~~l~~~ 555 (571)
||++ +++.+++...
T Consensus 81 e~~~-~~l~~~~~~~ 94 (294)
T PLN00009 81 EYLD-LDLKKHMDSS 94 (294)
T ss_pred eccc-ccHHHHHHhC
Confidence 9996 5888887643
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.5e-09 Score=106.72 Aligned_cols=103 Identities=27% Similarity=0.423 Sum_probs=83.6
Q ss_pred CCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC--CeeEEEE
Q 044615 464 FDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA--LHSFVVY 540 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~--~~~~lv~ 540 (571)
|++.+.||+|+||.||+|.. .+++.+|+|.+.... ......+.+.+|++++++++|||++++++++... +..++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 56778999999999999994 468899999998653 2223346788999999999999999999999988 8899999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||+++ +|.+++.... ..+++.....++
T Consensus 80 e~~~~-~l~~~~~~~~--~~~~~~~~~~i~ 106 (287)
T cd07840 80 EYMDH-DLTGLLDSPE--VKFTESQIKCYM 106 (287)
T ss_pred ccccc-cHHHHHhccC--CCCCHHHHHHHH
Confidence 99985 8998887543 356777766553
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.4e-09 Score=113.34 Aligned_cols=98 Identities=13% Similarity=0.121 Sum_probs=81.9
Q ss_pred ccCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
...|.+.+.||+|+||.||+|.. .+++.||||... ...+.+|++++++++|||||++++++...+..++|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 34688999999999999999994 468899999632 13456899999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||+. |+|.+++..... .++|.++++|+
T Consensus 239 ~e~~~-~~L~~~l~~~~~--~l~~~~~~~i~ 266 (461)
T PHA03211 239 LPKYR-SDLYTYLGARLR--PLGLAQVTAVA 266 (461)
T ss_pred EEccC-CCHHHHHHhcCC--CCCHHHHHHHH
Confidence 99995 799998875332 58888887765
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.00 E-value=6.4e-10 Score=109.86 Aligned_cols=100 Identities=27% Similarity=0.314 Sum_probs=81.4
Q ss_pred CCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEec
Q 044615 464 FDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEY 542 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 542 (571)
|.....||+|+||.||++. ..++..||||.+.... ....+.+.+|+.+++.++||||+++++.+..++..|+||||
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 3344679999999999998 4578999999986432 23356789999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 543 LEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 543 ~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+++|+|.+++... .+++.+...++
T Consensus 101 ~~~~~L~~~~~~~----~l~~~~~~~~~ 124 (292)
T cd06658 101 LEGGALTDIVTHT----RMNEEQIATVC 124 (292)
T ss_pred CCCCcHHHHHhcC----CCCHHHHHHHH
Confidence 9999999988642 35666655543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.9e-09 Score=105.70 Aligned_cols=99 Identities=20% Similarity=0.168 Sum_probs=76.1
Q ss_pred eeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHH---HHHhhcCCCCcccEEEEEEeCCeeEEEEeccC
Q 044615 469 CIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEV---NALTKIRHRNIVKFYGFCSHALHSFVVYEYLE 544 (571)
Q Consensus 469 ~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei---~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 544 (571)
.||+|+||.||+|. ..+++.||+|.+.+...........+..|. +.++...||+|+++++++.+.+..|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 47999999999998 457899999999765433222222344443 34555689999999999999999999999999
Q ss_pred CCChhhhhccCCCccCCCHHHHhhhc
Q 044615 545 MGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 545 ~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+|+|.+++... ..+.|..+..|+
T Consensus 81 g~~L~~~l~~~---~~l~~~~~~~~~ 103 (278)
T cd05606 81 GGDLHYHLSQH---GVFSEAEMRFYA 103 (278)
T ss_pred CCcHHHHHHhc---CCCCHHHHHHHH
Confidence 99999988643 257888877764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.7e-09 Score=107.75 Aligned_cols=107 Identities=30% Similarity=0.399 Sum_probs=83.7
Q ss_pred HccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC--Cee
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA--LHS 536 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~--~~~ 536 (571)
..++|++.+.||+|+||.||+|. ..+|+.||+|.+....... .....+.+|+.++++++||||+++++++... +..
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 34679999999999999999999 4579999999987543222 1223567899999999999999999998765 568
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+||||+++ +|.+++.... ..++|.+...++
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~ 114 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMP--TPFSESQVKCLM 114 (309)
T ss_pred EEEEecCCC-CHHHHHHhcc--cCCCHHHHHHHH
Confidence 999999974 8888887432 357777766654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.6e-09 Score=106.99 Aligned_cols=96 Identities=26% Similarity=0.340 Sum_probs=78.9
Q ss_pred cCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEeccCC
Q 044615 467 GHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEM 545 (571)
Q Consensus 467 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 545 (571)
...||+|+||.||++.. .++..||||.+.... ......+.+|+.+++.++|||++++++++...+..|+||||+++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 35699999999999984 578999999985432 23356799999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCccCCCHHHHhhh
Q 044615 546 GSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 546 G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
++|.+++... .++|.....+
T Consensus 102 ~~L~~~~~~~----~~~~~~~~~~ 121 (292)
T cd06657 102 GALTDIVTHT----RMNEEQIAAV 121 (292)
T ss_pred CcHHHHHhcC----CCCHHHHHHH
Confidence 9999987543 3555554443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=98.99 E-value=2.4e-09 Score=106.58 Aligned_cols=103 Identities=27% Similarity=0.373 Sum_probs=82.5
Q ss_pred CCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEec
Q 044615 464 FDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEY 542 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 542 (571)
|+..+.||+|+||.||+|. ..++..+|+|.+...........+++.+|++++++++|||++++++++......|+||||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 6667889999999999999 457889999998754333334456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 543 LEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 543 ~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
+. |++.+.+.... ..+++.+...+
T Consensus 97 ~~-~~l~~~~~~~~--~~l~~~~~~~~ 120 (308)
T cd06634 97 CL-GSASDLLEVHK--KPLQEVEIAAV 120 (308)
T ss_pred cC-CCHHHHHHHcC--CCCCHHHHHHH
Confidence 97 68888775432 24666665544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=98.99 E-value=2.1e-09 Score=106.71 Aligned_cols=103 Identities=21% Similarity=0.371 Sum_probs=79.9
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCC----EEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCee
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGE----IVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHS 536 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~ 536 (571)
++|+..+.||+|+||.||+|.. .++. .||+|.+..... .....++.+|+.++++++||||++++++|... ..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 4578889999999999999984 4554 478898864322 23345789999999999999999999999754 46
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
++++||+++|+|.+++..... .+.|...+.+
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~--~~~~~~~~~~ 114 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKD--NIGSQLLLNW 114 (303)
T ss_pred eeeehhcCCCCHHHHHHhccc--CCCHHHHHHH
Confidence 799999999999999975432 3566655544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.5e-09 Score=110.43 Aligned_cols=99 Identities=14% Similarity=0.126 Sum_probs=81.9
Q ss_pred HccCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEE
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFV 538 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l 538 (571)
...+|++.+.||+|+||.||+|.. .+++.||+|..... ....|+.++++++|||||++++++.+....++
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence 345799999999999999999994 46788999985432 23468999999999999999999999999999
Q ss_pred EEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 539 VYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||||+. |+|.+++.... ..++|..+.+|+
T Consensus 135 v~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~ 163 (357)
T PHA03209 135 VLPHYS-SDLYTYLTKRS--RPLPIDQALIIE 163 (357)
T ss_pred EEEccC-CcHHHHHHhcc--CCCCHHHHHHHH
Confidence 999995 68999887533 357888877765
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.2e-09 Score=105.10 Aligned_cols=97 Identities=25% Similarity=0.284 Sum_probs=80.6
Q ss_pred eeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEeccCCCCh
Q 044615 470 IGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548 (571)
Q Consensus 470 lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~G~L 548 (571)
||+|+||.||++.. .+++.+|+|.+.............+..|++++++++||||+++++.+..+...|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999994 46899999998765444333466799999999999999999999999999999999999999999
Q ss_pred hhhhccCCCccCCCHHHHhhh
Q 044615 549 AMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 549 ~~~l~~~~~~~~l~w~~r~~i 569 (571)
.+++.... .++|.....+
T Consensus 81 ~~~l~~~~---~l~~~~~~~~ 98 (250)
T cd05123 81 FSHLSKEG---RFSEERARFY 98 (250)
T ss_pred HHHHHhcC---CCCHHHHHHH
Confidence 99997543 3566655544
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.9e-09 Score=104.80 Aligned_cols=99 Identities=28% Similarity=0.333 Sum_probs=81.5
Q ss_pred CCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEec
Q 044615 464 FDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEY 542 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 542 (571)
|...+.||+|++|.||++. ..+++.+|+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 4455789999999999998 4578999999986432 22346688999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 543 LEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 543 ~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
+++++|.+++... .+++.+...|
T Consensus 98 ~~~~~L~~~~~~~----~~~~~~~~~~ 120 (285)
T cd06648 98 LEGGALTDIVTHT----RMNEEQIATV 120 (285)
T ss_pred cCCCCHHHHHHhC----CCCHHHHHHH
Confidence 9999999998752 3566655544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=5.6e-11 Score=122.92 Aligned_cols=225 Identities=32% Similarity=0.354 Sum_probs=102.0
Q ss_pred ccCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCC
Q 044615 93 IGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLS 172 (571)
Q Consensus 93 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~ 172 (571)
+..+.+|+.|++.+|.|... ...+..+++|++|++++|.|+... .+..++.|+.|++.+|.+... ..+..+++|+
T Consensus 91 l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~ 165 (414)
T KOG0531|consen 91 LSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSGNLISDI--SGLESLKSLK 165 (414)
T ss_pred cccccceeeeeccccchhhc-ccchhhhhcchheecccccccccc--chhhccchhhheeccCcchhc--cCCccchhhh
Confidence 44455566666666665522 222455556666666666655332 234455556666666665432 2344455555
Q ss_pred EEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccC
Q 044615 173 ILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSAN 252 (571)
Q Consensus 173 ~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n 252 (571)
.+++++|.+...-+.....+.. ++.+++.+|.+... ..+..+..+..+++..|
T Consensus 166 ~l~l~~n~i~~ie~~~~~~~~~-l~~l~l~~n~i~~i--------------------------~~~~~~~~l~~~~l~~n 218 (414)
T KOG0531|consen 166 LLDLSYNRIVDIENDELSELIS-LEELDLGGNSIREI--------------------------EGLDLLKKLVLLSLLDN 218 (414)
T ss_pred cccCCcchhhhhhhhhhhhccc-hHHHhccCCchhcc--------------------------cchHHHHHHHHhhcccc
Confidence 5556555555222100123332 55555555544311 11222222333344444
Q ss_pred ccccccchhhccCC--CCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccc-
Q 044615 253 TFHKSIPESLSNLV--KLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGS- 329 (571)
Q Consensus 253 ~l~~~~~~~l~~l~--~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~- 329 (571)
.++..- .+..+. +|+.+++++|.+.. .+..+..+..+..|++.+|++...- .+...+.+..+.+..|.+...
T Consensus 219 ~i~~~~--~l~~~~~~~L~~l~l~~n~i~~-~~~~~~~~~~l~~l~~~~n~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 293 (414)
T KOG0531|consen 219 KISKLE--GLNELVMLHLRELYLSGNRISR-SPEGLENLKNLPVLDLSSNRISNLE--GLERLPKLSELWLNDNKLALSE 293 (414)
T ss_pred cceecc--CcccchhHHHHHHhcccCcccc-ccccccccccccccchhhccccccc--cccccchHHHhccCcchhcchh
Confidence 443211 111111 24555555555542 1133444555556666655554321 133344445555555554421
Q ss_pred --cccc-cccCCCCCEEECcCCcCcccC
Q 044615 330 --IPRC-FEEMHWLSCIDISYNALQGLI 354 (571)
Q Consensus 330 --~p~~-~~~l~~L~~L~ls~N~l~~~~ 354 (571)
.... ....+.++.+.+.+|......
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (414)
T KOG0531|consen 294 AISQEYITSAAPTLVTLTLELNPIRKIS 321 (414)
T ss_pred hhhccccccccccccccccccCcccccc
Confidence 1111 334456666666666665443
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=6.9e-10 Score=105.70 Aligned_cols=94 Identities=27% Similarity=0.392 Sum_probs=77.7
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEe-----CC
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSH-----AL 534 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~-----~~ 534 (571)
...|...+.||+|+||.|+.+. ..+|+.||||++...- ......++-.||++++++++|+|||.+.+.+.. -+
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F-~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF-ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh-hchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3456667899999999999998 6689999999996332 333456788899999999999999999999866 35
Q ss_pred eeEEEEeccCCCChhhhhccCC
Q 044615 535 HSFVVYEYLEMGSLAMNLSNDA 556 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~~~ 556 (571)
.+|+|+|+|+. ||.+.|+.+.
T Consensus 100 DvYiV~elMet-DL~~iik~~~ 120 (359)
T KOG0660|consen 100 DVYLVFELMET-DLHQIIKSQQ 120 (359)
T ss_pred eeEEehhHHhh-HHHHHHHcCc
Confidence 78999999965 9999998654
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.97 E-value=2e-09 Score=112.39 Aligned_cols=100 Identities=22% Similarity=0.267 Sum_probs=74.7
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC------
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA------ 533 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~------ 533 (571)
..+|...+.||+|+||.||+|. ..+++.||||++.... ....+|+.++++++|||||++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 4579999999999999999998 4578999999885432 2234799999999999999999987542
Q ss_pred --CeeEEEEeccCCCChhhhhccC-CCccCCCHHHHhh
Q 044615 534 --LHSFVVYEYLEMGSLAMNLSND-AAAEQFCWTKRMN 568 (571)
Q Consensus 534 --~~~~lv~e~~~~G~L~~~l~~~-~~~~~l~w~~r~~ 568 (571)
..+++||||+++ ++.+++... .....+++.....
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~ 174 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKL 174 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHH
Confidence 246799999985 777776531 1223455554443
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.1e-09 Score=102.97 Aligned_cols=88 Identities=23% Similarity=0.205 Sum_probs=69.3
Q ss_pred CeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHH-HhhcCCCCcccEEEEEEeCCeeEEEEeccCC
Q 044615 468 HCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNA-LTKIRHRNIVKFYGFCSHALHSFVVYEYLEM 545 (571)
Q Consensus 468 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~-l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 545 (571)
+.||+|+||.||+|. ..+++.||+|.+.+...........+..|..+ ....+|||++++++++...+..|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 468999999999998 45789999999875432222223345556554 4456999999999999999999999999999
Q ss_pred CChhhhhccC
Q 044615 546 GSLAMNLSND 555 (571)
Q Consensus 546 G~L~~~l~~~ 555 (571)
|+|.+++...
T Consensus 82 ~~L~~~l~~~ 91 (260)
T cd05611 82 GDCASLIKTL 91 (260)
T ss_pred CCHHHHHHHc
Confidence 9999999753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=98.97 E-value=8.1e-10 Score=107.04 Aligned_cols=108 Identities=19% Similarity=0.140 Sum_probs=82.3
Q ss_pred CCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCC--chHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 463 NFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPD--EMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.|.+.+.||+|+||.||++.. ..+..+++|.++..... ......++.+|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 377889999999999999984 34555666665532221 112344677899999999999999999999999999999
Q ss_pred EeccCCCChhhhhccC-CCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSND-AAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~-~~~~~l~w~~r~~ia 570 (571)
|||+++++|.+++... .....++|...+.++
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 112 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWF 112 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHH
Confidence 9999999999988642 223467887766654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.3e-09 Score=107.36 Aligned_cols=105 Identities=18% Similarity=0.339 Sum_probs=82.4
Q ss_pred HccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC----
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL---- 534 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~---- 534 (571)
..++|+..+.||+|+||.||+|. ..++..||||++.... ......+.+.+|++++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 35679999999999999999998 5689999999986432 22233456889999999999999999999987653
Q ss_pred --eeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 535 --HSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 535 --~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
..++||||+ +++|.+++... .++|.....|+
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~ 124 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLV 124 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHH
Confidence 458999999 77998888642 35666555443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=3.7e-10 Score=124.79 Aligned_cols=126 Identities=25% Similarity=0.254 Sum_probs=83.5
Q ss_pred CCCCEEEccCCccc----cCCCCccceeecccccccCCCCCCCccccc-cccCCCCCCEEecccCcCcccccccccCCCC
Q 044615 48 VQARDTSISFDELH----EKLLTFEATAHFSVLAFTGQDWPLYSSIPD-EIGNMKSLSDLQLSENILNGSIPLALGNLTN 122 (571)
Q Consensus 48 ~~l~~l~l~~n~l~----~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~-~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~ 122 (571)
...+...+-.|.+. -...+.|++|-+..|.. .+..++. .|..++.|++|||++|.-.+.+|..++.|-+
T Consensus 523 ~~~rr~s~~~~~~~~~~~~~~~~~L~tLll~~n~~------~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~ 596 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIEHIAGSSENPKLRTLLLQRNSD------WLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVH 596 (889)
T ss_pred hheeEEEEeccchhhccCCCCCCccceEEEeecch------hhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhh
Confidence 45566666666554 22344566666666642 0012333 3566788888888877666677777888888
Q ss_pred CCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCC
Q 044615 123 LVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNK 180 (571)
Q Consensus 123 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~ 180 (571)
|+.|+|+++.++ .+|..+++|..|.+|++..+.....+|.....|++|++|.+....
T Consensus 597 LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 597 LRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred hhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence 888888888776 677777888888888877776655556666667778877775543
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=98.96 E-value=3.6e-09 Score=102.57 Aligned_cols=97 Identities=22% Similarity=0.360 Sum_probs=74.2
Q ss_pred CeeeccCcceEEEEEcC----CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEe-CCeeEEEEec
Q 044615 468 HCIGNGGQGSVYKAKLP----TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSH-ALHSFVVYEY 542 (571)
Q Consensus 468 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~ 542 (571)
+.||+|+||.||+|... .+..||+|.+.... .....+.+.+|+.+++.++||||+++++++.. ++..++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 36899999999999842 24579999985422 22345778999999999999999999998764 5568899999
Q ss_pred cCCCChhhhhccCCCccCCCHHHHhh
Q 044615 543 LEMGSLAMNLSNDAAAEQFCWTKRMN 568 (571)
Q Consensus 543 ~~~G~L~~~l~~~~~~~~l~w~~r~~ 568 (571)
+++|+|.+++.+... .+.|...+.
T Consensus 79 ~~~~~L~~~~~~~~~--~~~~~~~~~ 102 (262)
T cd05058 79 MKHGDLRNFIRSETH--NPTVKDLIG 102 (262)
T ss_pred CCCCCHHHHHHhcCC--CCCHHHHHH
Confidence 999999999975432 245554443
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=98.96 E-value=3.5e-09 Score=103.84 Aligned_cols=102 Identities=20% Similarity=0.211 Sum_probs=80.4
Q ss_pred CCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcC-CCCcccEEEEEEeC--CeeEEE
Q 044615 464 FDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR-HRNIVKFYGFCSHA--LHSFVV 539 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~--~~~~lv 539 (571)
|+..+.+|+|+||.||+|. ..+++.||+|++....... ......+|+.++.++. |||++++++++.+. +..++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL--EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc--hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 5677889999999999999 5578999999987543222 1234457999998885 99999999999987 889999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||++ |++.+++.... ..++|.+...++
T Consensus 79 ~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ 106 (282)
T cd07831 79 FELMD-MNLYELIKGRK--RPLPEKRVKSYM 106 (282)
T ss_pred EecCC-ccHHHHHHhcc--CCCCHHHHHHHH
Confidence 99997 58888887533 357888777654
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.96 E-value=3e-09 Score=106.26 Aligned_cols=91 Identities=25% Similarity=0.422 Sum_probs=74.8
Q ss_pred CCCccCeeeccCcceEEEEEc-C--CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC--CeeE
Q 044615 463 NFDDGHCIGNGGQGSVYKAKL-P--TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA--LHSF 537 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~-~--~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~--~~~~ 537 (571)
.|+..+.||+|+||.||+|.. . +++.||+|.+...........+.+.+|+.++++++||||+++++++.+. ...|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 377888999999999999994 4 5889999999864322223346678999999999999999999999988 8899
Q ss_pred EEEeccCCCChhhhhcc
Q 044615 538 VVYEYLEMGSLAMNLSN 554 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~ 554 (571)
+||||+++ ++.+++..
T Consensus 81 lv~e~~~~-~l~~~~~~ 96 (316)
T cd07842 81 LLFDYAEH-DLWQIIKF 96 (316)
T ss_pred EEEeCCCc-CHHHHHHh
Confidence 99999985 77777753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=98.96 E-value=4e-09 Score=102.69 Aligned_cols=105 Identities=17% Similarity=0.167 Sum_probs=78.7
Q ss_pred HHHHHHccCCCccCee--eccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhh-cCCCCcccEEEEE
Q 044615 455 EEIIRATNNFDDGHCI--GNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTK-IRHRNIVKFYGFC 530 (571)
Q Consensus 455 ~~~~~~~~~~~~~~~l--g~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~-l~H~niv~l~~~~ 530 (571)
.+.....++|++.+.+ |+|+||.||++. ..++..+|+|.+....... .|+..... .+||||+++++++
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~ 78 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSV 78 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEE
Confidence 3444445677777766 999999999999 4578999999986542211 12222221 2799999999999
Q ss_pred EeCCeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 531 SHALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 531 ~~~~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
...+..|+||||+++|+|.+++.... .++|.+...++
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~ 115 (267)
T PHA03390 79 TTLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKII 115 (267)
T ss_pred ecCCeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHH
Confidence 99999999999999999999997543 57787776654
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.6e-09 Score=108.96 Aligned_cols=96 Identities=26% Similarity=0.351 Sum_probs=78.9
Q ss_pred HHHHccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEe-CC
Q 044615 457 IIRATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSH-AL 534 (571)
Q Consensus 457 ~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~-~~ 534 (571)
+...+++|+..+.||+|+||.||+|. ..++..||||++.+.... ....+.+.+|++++.+++||||+++++++.. ..
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST-PVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 34567789999999999999999998 558999999998654322 2334678899999999999999999999876 56
Q ss_pred eeEEEEeccCCCChhhhhcc
Q 044615 535 HSFVVYEYLEMGSLAMNLSN 554 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~ 554 (571)
..|+||||+ +++|.++++.
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~ 102 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTS 102 (328)
T ss_pred cEEEEeehh-ccCHHHHHhc
Confidence 789999998 5689888864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=98.96 E-value=3.5e-09 Score=107.28 Aligned_cols=112 Identities=20% Similarity=0.286 Sum_probs=86.9
Q ss_pred cHHHHHHHccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEE
Q 044615 453 VHEEIIRATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCS 531 (571)
Q Consensus 453 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~ 531 (571)
..+++...+++|+..+.||+|+||.||+|. ..+++.||+|++..... .....+.+.+|+.++.+++||||+++++++.
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 345666778899999999999999999998 56899999999875322 2233466889999999999999999999886
Q ss_pred eC------CeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 532 HA------LHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 532 ~~------~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
.. ...|+++|++ +++|.+++... .++|..+..|+
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~ 126 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLI 126 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHH
Confidence 43 3467888876 78998887642 36676666553
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=98.95 E-value=2.1e-09 Score=105.89 Aligned_cols=104 Identities=16% Similarity=0.223 Sum_probs=82.0
Q ss_pred CCCccCeeeccCcceEEEEEc----CCCCEEEEEEccCCCCC-chHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCee
Q 044615 463 NFDDGHCIGNGGQGSVYKAKL----PTGEIVDVKKFHSPLPD-EMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHS 536 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~ 536 (571)
+|++.+.||+|+||.||+++. .+++.||||.+.+.... .....+.+.+|++++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477888999999999999873 35788999998743221 123346788999999999 699999999999999999
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
|+||||+++|+|.+++.... .+.+.....+
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~ 110 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE---HFTESEVRVY 110 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC---CcCHHHHHHH
Confidence 99999999999999987432 3555544433
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=6.1e-11 Score=122.65 Aligned_cols=219 Identities=35% Similarity=0.396 Sum_probs=142.8
Q ss_pred CCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcE
Q 044615 119 NLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKV 198 (571)
Q Consensus 119 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~ 198 (571)
.+..++.++++.|.|.. +-..+..+.+|+.|++.+|.+... ...+..+++|++|++++|.|+... .+..++. |+.
T Consensus 70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~-L~~ 144 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLE--GLSTLTL-LKE 144 (414)
T ss_pred HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhc-ccchhhhhcchheecccccccccc--chhhccc-hhh
Confidence 44455555566666542 223355666666666666666532 222556677777777777776432 2344444 777
Q ss_pred EEccCCcccccCCccccCCCCCcEEeCccCcCcCCCC-hhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCcc
Q 044615 199 LYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLS-PELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQ 277 (571)
Q Consensus 199 L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~ 277 (571)
|++++|.|+.. ..+..++.|+.+++++|++...-+ . ...+.+++.+++.+|.+... ..+..+..+..+++..|.
T Consensus 145 L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~ 219 (414)
T KOG0531|consen 145 LNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNK 219 (414)
T ss_pred heeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhccccc
Confidence 77777777532 234457788888888888875544 2 57788999999999988533 445555666667899999
Q ss_pred CccCcchhhhccc--CCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCcc
Q 044615 278 FSQKIPNKIEKLI--HLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQG 352 (571)
Q Consensus 278 l~~~~~~~~~~l~--~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 352 (571)
++...+ +..+. +|+.+++++|.+.. .+..+..+..+..|++.+|++... ..+.....+..+....|.+..
T Consensus 220 i~~~~~--l~~~~~~~L~~l~l~~n~i~~-~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~ 291 (414)
T KOG0531|consen 220 ISKLEG--LNELVMLHLRELYLSGNRISR-SPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLAL 291 (414)
T ss_pred ceeccC--cccchhHHHHHHhcccCcccc-ccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcc
Confidence 875432 22233 38999999999875 335577888999999999998743 234445556666677777653
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=98.95 E-value=3.8e-09 Score=107.69 Aligned_cols=92 Identities=23% Similarity=0.354 Sum_probs=74.7
Q ss_pred HccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC----
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL---- 534 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~---- 534 (571)
..++|+..+.||+|+||.||+|. ..+|..||||++...... ......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN-QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccc-hhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 34679999999999999999998 457999999999754322 234567889999999999999999999986543
Q ss_pred --eeEEEEeccCCCChhhhhc
Q 044615 535 --HSFVVYEYLEMGSLAMNLS 553 (571)
Q Consensus 535 --~~~lv~e~~~~G~L~~~l~ 553 (571)
..|+||||+++ ++.+.++
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~ 117 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH 117 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh
Confidence 57999999975 5766664
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=98.94 E-value=3.7e-09 Score=105.27 Aligned_cols=105 Identities=28% Similarity=0.428 Sum_probs=80.6
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC------
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL------ 534 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~------ 534 (571)
++|+..+.||+|+||.||+|. ..+++.||||.+....... .....+.+|++++++++||||+++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 468999999999999999999 4579999999986543222 22345678999999999999999999987654
Q ss_pred --eeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 535 --HSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 535 --~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
..++||||+.+ ++.+++.... ..+++.+...++
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~ 125 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVM 125 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHH
Confidence 35999999974 8888886543 246666655543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=98.94 E-value=5.4e-09 Score=102.03 Aligned_cols=106 Identities=23% Similarity=0.336 Sum_probs=79.9
Q ss_pred CCccCeeeccCcceEEEEEcC----CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC-----
Q 044615 464 FDDGHCIGNGGQGSVYKAKLP----TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL----- 534 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~----- 534 (571)
|.+.+.||+|+||.||+|... +++.||||.+...... ....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS-SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC-hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 566788999999999999742 4688999999754433 234577899999999999999999999886532
Q ss_pred -eeEEEEeccCCCChhhhhccCC---CccCCCHHHHhhhc
Q 044615 535 -HSFVVYEYLEMGSLAMNLSNDA---AAEQFCWTKRMNAI 570 (571)
Q Consensus 535 -~~~lv~e~~~~G~L~~~l~~~~---~~~~l~w~~r~~ia 570 (571)
..++++||+++|+|.+++.... ....+++....+++
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~ 119 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHH
Confidence 2478999999999998875321 11245666555543
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.6e-09 Score=107.45 Aligned_cols=85 Identities=27% Similarity=0.319 Sum_probs=73.2
Q ss_pred cCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEeccCC
Q 044615 467 GHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEM 545 (571)
Q Consensus 467 ~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 545 (571)
.+++|+|.||+||-|. .++|+.||||+|++.+... +...+..+|+.|+..++||.||.+-.-|++.+..+.|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~-kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPT-KQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCC-chHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 4789999999999998 5699999999998876544 3346788999999999999999999999999999999998875
Q ss_pred CChhhhhc
Q 044615 546 GSLAMNLS 553 (571)
Q Consensus 546 G~L~~~l~ 553 (571)
|..+.|-
T Consensus 648 -DMLEMIL 654 (888)
T KOG4236|consen 648 -DMLEMIL 654 (888)
T ss_pred -hHHHHHH
Confidence 6555554
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=98.94 E-value=4.1e-09 Score=103.77 Aligned_cols=105 Identities=22% Similarity=0.367 Sum_probs=77.2
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc---CCCCcccEEEEEEeC-----
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI---RHRNIVKFYGFCSHA----- 533 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l---~H~niv~l~~~~~~~----- 533 (571)
.|++.+.||+|+||.||+|. ..+++.||+|.+....... .....+.+|+.+++++ +||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 47888999999999999998 4579999999987543222 1223456777776655 799999999998652
Q ss_pred CeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 534 LHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 534 ~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
...++||||+++ +|.+++..... ..+++.....++
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~ 114 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPP-PGLPAETIKDLM 114 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCC-CCCCHHHHHHHH
Confidence 457899999984 89988875322 346666655543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=98.93 E-value=3.1e-09 Score=107.34 Aligned_cols=104 Identities=23% Similarity=0.344 Sum_probs=82.1
Q ss_pred ccCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeC--Cee
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHA--LHS 536 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~--~~~ 536 (571)
.++|+..+.||+|+||.||+|.. .+++.+|||++....... .....+.+|+.+++++ +||||++++++|... ...
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA-TDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcc-hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 45688889999999999999994 478899999986432222 2345678899999999 999999999998653 468
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+||||++ ++|.+++... .++|..+..++
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~ 113 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIM 113 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHH
Confidence 99999998 5999988743 46777666543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.9e-09 Score=105.80 Aligned_cols=103 Identities=29% Similarity=0.397 Sum_probs=82.6
Q ss_pred CCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcC-CCCcccEEEEEEeCCeeEEEEe
Q 044615 464 FDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR-HRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~lv~e 541 (571)
|++.+.||+|+||.||+|.. .+++.||+|++...... .......+|+..+++++ |||++++++++.+.+..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 56778999999999999995 46889999998754322 12234567999999999 9999999999999999999999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+ +|+|.+++.... ...++|.+.+.++
T Consensus 79 ~~-~~~l~~~~~~~~-~~~~~~~~~~~~~ 105 (283)
T cd07830 79 YM-EGNLYQLMKDRK-GKPFSESVIRSII 105 (283)
T ss_pred cC-CCCHHHHHHhcc-cccCCHHHHHHHH
Confidence 99 789999987543 2357787776654
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.9e-09 Score=107.85 Aligned_cols=105 Identities=17% Similarity=0.260 Sum_probs=80.8
Q ss_pred HHccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC----
Q 044615 459 RATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA---- 533 (571)
Q Consensus 459 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~---- 533 (571)
...+.|+..+.||+|+||.||+|. ..+++.||||.+...... ....+.+.+|++++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS-LIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh-hHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 345679999999999999999998 568899999998754222 23345678999999999999999999988543
Q ss_pred --CeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 534 --LHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 534 --~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
...|+++|++ +++|.+++... .+++.....|
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i 123 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFL 123 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHH
Confidence 4578999988 78998887632 3555554443
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=8.3e-10 Score=112.81 Aligned_cols=84 Identities=26% Similarity=0.377 Sum_probs=73.7
Q ss_pred eeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEeccCCCC
Q 044615 469 CIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGS 547 (571)
Q Consensus 469 ~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~G~ 547 (571)
++|+|.||+||.|+ ..+...+|||.+..... ...+....||.+.++++|.|||+++|.+.+++.+-|.||-+|||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds---r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS---REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccc---hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 69999999999999 55677899999975432 335678899999999999999999999999999999999999999
Q ss_pred hhhhhccC
Q 044615 548 LAMNLSND 555 (571)
Q Consensus 548 L~~~l~~~ 555 (571)
|.++|+..
T Consensus 659 LSsLLrsk 666 (1226)
T KOG4279|consen 659 LSSLLRSK 666 (1226)
T ss_pred HHHHHHhc
Confidence 99999853
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.9e-09 Score=105.69 Aligned_cols=103 Identities=27% Similarity=0.390 Sum_probs=84.5
Q ss_pred CCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEec
Q 044615 464 FDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEY 542 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 542 (571)
|+..+.||+|+||.||+|.. .+++.||+|.+..... .....+.+.+|+.++++++|||++++++++.+.+..++||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE-EEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc-cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 55667899999999999994 5699999999976531 223346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 543 LEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 543 ~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
++ ++|.+++.+.. ..+++..+.+++
T Consensus 80 ~~-~~l~~~i~~~~--~~~~~~~~~~~~ 104 (282)
T cd07829 80 CD-MDLKKYLDKRP--GPLSPNLIKSIM 104 (282)
T ss_pred cC-cCHHHHHHhhc--cCCCHHHHHHHH
Confidence 98 59999998543 247777777654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=98.91 E-value=5.8e-09 Score=106.50 Aligned_cols=92 Identities=20% Similarity=0.343 Sum_probs=74.7
Q ss_pred HccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC-----
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA----- 533 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~----- 533 (571)
..++|...+.||+|+||.||+|. ..+++.||||++...... ....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccC-chhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 34679999999999999999998 457899999999754322 23356788999999999999999999988543
Q ss_pred -CeeEEEEeccCCCChhhhhc
Q 044615 534 -LHSFVVYEYLEMGSLAMNLS 553 (571)
Q Consensus 534 -~~~~lv~e~~~~G~L~~~l~ 553 (571)
...|+||||+++ +|.+++.
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~ 120 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQ 120 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHH
Confidence 357999999975 7777775
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=98.90 E-value=4.8e-09 Score=108.17 Aligned_cols=97 Identities=14% Similarity=0.151 Sum_probs=79.7
Q ss_pred cCCCccCeeeccCcceEEEEEc---CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL---PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFV 538 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l 538 (571)
..|.+.+.||+|+||.||++.. ..+..||+|.+... +.+.+|++++++++|||||++++++......|+
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 4699999999999999999973 24678999988643 234589999999999999999999999999999
Q ss_pred EEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 539 VYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||||+. ++|.+++... ..+.|..++.|+
T Consensus 164 v~e~~~-~~l~~~l~~~---~~l~~~~~~~i~ 191 (392)
T PHA03207 164 VMPKYK-CDLFTYVDRS---GPLPLEQAITIQ 191 (392)
T ss_pred EehhcC-CCHHHHHHhc---CCCCHHHHHHHH
Confidence 999996 6899988432 357777776654
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.1e-09 Score=79.93 Aligned_cols=59 Identities=42% Similarity=0.535 Sum_probs=31.6
Q ss_pred CCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCc
Q 044615 98 SLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENS 156 (571)
Q Consensus 98 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 156 (571)
+|++|++++|+++...+..|.++++|++|++++|.++...|..|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 45555555555554444455555555555555555555555555555555555555554
|
... |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=98.89 E-value=3.6e-09 Score=106.68 Aligned_cols=103 Identities=20% Similarity=0.271 Sum_probs=81.1
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEe----CCee
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSH----ALHS 536 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~----~~~~ 536 (571)
.+|+..+.||+|+||.||+|. ..+|..||+|++...... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV-PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc-ccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 578999999999999999999 557999999998754322 2235667889999999999999999998763 3568
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
|+||||+. |+|.+++.... .+++.....+
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i 112 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ---PLTEEHIRYF 112 (334)
T ss_pred EEEEehhh-hhHHHHhccCC---CCCHHHHHHH
Confidence 99999996 68999887432 3566555544
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=98.89 E-value=6.5e-09 Score=105.79 Aligned_cols=92 Identities=20% Similarity=0.349 Sum_probs=74.7
Q ss_pred HccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC-----
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA----- 533 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~----- 533 (571)
..++|+..+.||+|+||.||+|. ..+++.||||.+...... ....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccC-hHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 45679999999999999999998 457899999998754322 23356788999999999999999999998653
Q ss_pred -CeeEEEEeccCCCChhhhhc
Q 044615 534 -LHSFVVYEYLEMGSLAMNLS 553 (571)
Q Consensus 534 -~~~~lv~e~~~~G~L~~~l~ 553 (571)
...|+||||+++ ++.+.+.
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~ 113 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ 113 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh
Confidence 357999999975 6776664
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=6.1e-10 Score=108.08 Aligned_cols=95 Identities=26% Similarity=0.285 Sum_probs=76.9
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCch----HhHHHHHHHHHHHhhcCCCCcccEEEEEEe-CCe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEM----ACQQEFLNEVNALTKIRHRNIVKFYGFCSH-ALH 535 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~-~~~ 535 (571)
+.|-....+|+|||+.||+|. ....+.||||+-+..+.... ...+...+|.+|.+.++||.||++|++|.- .+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 346677889999999999998 55678899998765443221 124557899999999999999999999964 567
Q ss_pred eEEEEeccCCCChhhhhccCC
Q 044615 536 SFVVYEYLEMGSLAMNLSNDA 556 (571)
Q Consensus 536 ~~lv~e~~~~G~L~~~l~~~~ 556 (571)
+|-|+|||+|.||..||+...
T Consensus 543 FCTVLEYceGNDLDFYLKQhk 563 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHK 563 (775)
T ss_pred ceeeeeecCCCchhHHHHhhh
Confidence 889999999999999998643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.3e-10 Score=116.51 Aligned_cols=91 Identities=27% Similarity=0.417 Sum_probs=79.9
Q ss_pred HccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEE
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFV 538 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l 538 (571)
...+|+....+|+|.||.|||++ ..+++..|+|.++.....+ ..-..+||-+++.++|||||.++|.|...+..+|
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd---~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD---FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc---ccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 34578899999999999999999 5689999999998765444 3456789999999999999999999999999999
Q ss_pred EEeccCCCChhhhhc
Q 044615 539 VYEYLEMGSLAMNLS 553 (571)
Q Consensus 539 v~e~~~~G~L~~~l~ 553 (571)
.||||.+|+|.+.-+
T Consensus 90 cMEycgggslQdiy~ 104 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYH 104 (829)
T ss_pred EEEecCCCcccceee
Confidence 999999999988665
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.88 E-value=7.7e-09 Score=104.31 Aligned_cols=92 Identities=23% Similarity=0.293 Sum_probs=73.8
Q ss_pred CCC-ccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchH-----------hHHHHHHHHHHHhhcCCCCcccEEEE
Q 044615 463 NFD-DGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMA-----------CQQEFLNEVNALTKIRHRNIVKFYGF 529 (571)
Q Consensus 463 ~~~-~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~-----------~~~~~~~Ei~~l~~l~H~niv~l~~~ 529 (571)
.|. ..+.||+|+||+||+|. ..+++.||||.+......... ....+.+|++++++++||||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 354 45679999999999999 457999999998653222100 11247899999999999999999999
Q ss_pred EEeCCeeEEEEeccCCCChhhhhccC
Q 044615 530 CSHALHSFVVYEYLEMGSLAMNLSND 555 (571)
Q Consensus 530 ~~~~~~~~lv~e~~~~G~L~~~l~~~ 555 (571)
+...+..++||||++ |+|.+++...
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~l~~~ 113 (335)
T PTZ00024 89 YVEGDFINLVMDIMA-SDLKKVVDRK 113 (335)
T ss_pred EecCCcEEEEEeccc-cCHHHHHHhc
Confidence 999999999999997 6999998643
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.5e-08 Score=95.53 Aligned_cols=102 Identities=32% Similarity=0.496 Sum_probs=83.4
Q ss_pred CCccCeeeccCcceEEEEEcC-CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEec
Q 044615 464 FDDGHCIGNGGQGSVYKAKLP-TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEY 542 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 542 (571)
|...+.||+|++|.||++... +++.+|+|.+...... ...+.+.+|++.+.+++|+|++++++++......++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 456788999999999999954 5899999999765433 2457899999999999999999999999998999999999
Q ss_pred cCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 543 LEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 543 ~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
+++++|.+++...... ++|.....+
T Consensus 79 ~~~~~L~~~~~~~~~~--~~~~~~~~~ 103 (225)
T smart00221 79 CEGGDLFDYLRKKGGK--LSEEEARFY 103 (225)
T ss_pred cCCCCHHHHHHhcccC--CCHHHHHHH
Confidence 9999999999754321 555554443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.86 E-value=7.7e-09 Score=101.48 Aligned_cols=103 Identities=25% Similarity=0.389 Sum_probs=84.1
Q ss_pred CCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEec
Q 044615 464 FDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEY 542 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 542 (571)
|+..+.||+|++|.||+|.. .+++.+|+|.+...... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 56678899999999999994 57899999998754332 23356788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 543 LEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 543 ~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+++ ++.+++.... ..++|..+..++
T Consensus 80 ~~~-~l~~~l~~~~--~~~~~~~~~~~~ 104 (283)
T cd05118 80 MDT-DLYKLIKDRQ--RGLPESLIKSYL 104 (283)
T ss_pred cCC-CHHHHHHhhc--ccCCHHHHHHHH
Confidence 985 8988887543 357777766654
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=98.86 E-value=5.5e-09 Score=105.13 Aligned_cols=103 Identities=21% Similarity=0.307 Sum_probs=83.6
Q ss_pred CCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC-----ee
Q 044615 463 NFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL-----HS 536 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~-----~~ 536 (571)
+|++.+.||+|+||.||+|.. .++..||+|++..... .....+.+.+|+++++.++||||+++++++.... ..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 478889999999999999994 4689999999875432 1233567899999999999999999999998775 78
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+||||++ ++|.+++.+.. .++|.....|+
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~ 109 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQ---PLTDDHIQYFL 109 (330)
T ss_pred EEEecchh-hhHHHHHhCCC---CCCHHHHHHHH
Confidence 99999998 48999887543 57777666554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.1e-09 Score=78.39 Aligned_cols=61 Identities=46% Similarity=0.580 Sum_probs=53.7
Q ss_pred CCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCC
Q 044615 121 TNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKL 181 (571)
Q Consensus 121 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l 181 (571)
++|++|++++|+++...+..|.++++|++|++++|.+....|+.|.++++|++|++++|++
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4788999999999877778899999999999999999887788899999999999998874
|
... |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.85 E-value=4.9e-09 Score=115.98 Aligned_cols=103 Identities=33% Similarity=0.328 Sum_probs=44.9
Q ss_pred CCCEEEcccCc--CcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEE
Q 044615 122 NLVVLDLSTNK--LSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVL 199 (571)
Q Consensus 122 ~L~~L~L~~n~--i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L 199 (571)
+|++|-+.+|. +....+..|..++.|+.|||++|.-.+.+|+.+++|-+|++|++++..+. .+|.++.++.. |.+|
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~-L~~L 623 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKK-LIYL 623 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHh-hhee
Confidence 34444444443 22222233444444444444444444444444444444444444444444 44444444443 4444
Q ss_pred EccCCcccccCCccccCCCCCcEEeCc
Q 044615 200 YLSSNHIVGEIPLGHGMLSSLIQLTLN 226 (571)
Q Consensus 200 ~l~~n~~~~~~~~~~~~l~~L~~L~l~ 226 (571)
++..+.....+|.....+++|++|.+.
T Consensus 624 nl~~~~~l~~~~~i~~~L~~Lr~L~l~ 650 (889)
T KOG4658|consen 624 NLEVTGRLESIPGILLELQSLRVLRLP 650 (889)
T ss_pred ccccccccccccchhhhcccccEEEee
Confidence 444443332333333334444444443
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.4e-08 Score=103.31 Aligned_cols=93 Identities=22% Similarity=0.385 Sum_probs=75.4
Q ss_pred HccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC-----
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA----- 533 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~----- 533 (571)
..+.|+..+.||+|+||.||+|. ..+++.||+|.+..... .....+.+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 34679999999999999999999 55899999999865332 223346678999999999999999999998644
Q ss_pred -CeeEEEEeccCCCChhhhhcc
Q 044615 534 -LHSFVVYEYLEMGSLAMNLSN 554 (571)
Q Consensus 534 -~~~~lv~e~~~~G~L~~~l~~ 554 (571)
...|+||||+. |+|.+.+..
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~ 113 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQM 113 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhh
Confidence 35799999996 588888763
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=4.6e-09 Score=107.64 Aligned_cols=90 Identities=28% Similarity=0.371 Sum_probs=77.2
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcC-C-----CCcccEEEEEEeCCe
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR-H-----RNIVKFYGFCSHALH 535 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H-----~niv~l~~~~~~~~~ 535 (571)
.|++.+.||+|+||+|.+|. .++++.||||+++... ....+-..|+++|..++ | -|+|+++++|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 68999999999999999999 7789999999997543 22455678999999987 4 389999999999999
Q ss_pred eEEEEeccCCCChhhhhccCCC
Q 044615 536 SFVVYEYLEMGSLAMNLSNDAA 557 (571)
Q Consensus 536 ~~lv~e~~~~G~L~~~l~~~~~ 557 (571)
.|||+|.+.. +|+++|+....
T Consensus 263 lciVfELL~~-NLYellK~n~f 283 (586)
T KOG0667|consen 263 LCIVFELLST-NLYELLKNNKF 283 (586)
T ss_pred eeeeehhhhh-hHHHHHHhcCC
Confidence 9999999876 99999996543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.2e-08 Score=94.17 Aligned_cols=87 Identities=13% Similarity=0.186 Sum_probs=67.2
Q ss_pred CCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-----CCCCcccEEEEEEeCC---e
Q 044615 464 FDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-----RHRNIVKFYGFCSHAL---H 535 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-----~H~niv~l~~~~~~~~---~ 535 (571)
+.....||+|+||.||. ...++.. +||++...... ..+.+.+|+++++++ +||||++++|++++.. .
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~---~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~ 78 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDG---GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY 78 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccc---hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence 34467899999999995 3334444 79998754322 346799999999999 6799999999999873 4
Q ss_pred eE-EEEec--cCCCChhhhhccC
Q 044615 536 SF-VVYEY--LEMGSLAMNLSND 555 (571)
Q Consensus 536 ~~-lv~e~--~~~G~L~~~l~~~ 555 (571)
.+ +|+|| +++|+|.+++.+.
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~ 101 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQC 101 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHcc
Confidence 34 78999 6689999999753
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.4e-08 Score=99.93 Aligned_cols=104 Identities=29% Similarity=0.433 Sum_probs=80.9
Q ss_pred CCccCeeeccCcceEEEEEcC-CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc---CCCCcccEEEEEEeCCe----
Q 044615 464 FDDGHCIGNGGQGSVYKAKLP-TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI---RHRNIVKFYGFCSHALH---- 535 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l---~H~niv~l~~~~~~~~~---- 535 (571)
|++.+.||+|+||.||+|..+ ++..||+|.+....... .....+.+|+.++.++ +|||++++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 567789999999999999954 68999999997543322 2235577888777665 69999999999988776
Q ss_pred -eEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 536 -SFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 536 -~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
.+++|||+++ +|.+++..... ..++|.....++
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~ 113 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLM 113 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHH
Confidence 9999999984 89998875432 357888777664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=98.85 E-value=8e-09 Score=104.29 Aligned_cols=103 Identities=20% Similarity=0.289 Sum_probs=80.0
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC-----Ce
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA-----LH 535 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~-----~~ 535 (571)
..|.+.+.||+|+||.||+|. ..++..||||.+...... ......+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDN-RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 468889999999999999998 568999999998754222 22345677899999999999999999988654 34
Q ss_pred eEEEEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 536 SFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 536 ~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
.|+||||+. ++|.+++...+ .+++.....|
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i 113 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ---TLSDDHCQYF 113 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC---CCCHHHHHHH
Confidence 799999996 68998886432 3555554444
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.3e-08 Score=100.03 Aligned_cols=97 Identities=19% Similarity=0.248 Sum_probs=73.0
Q ss_pred cCeeeccCcceEEEEEcC---CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEe--CCeeEEEEe
Q 044615 467 GHCIGNGGQGSVYKAKLP---TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSH--ALHSFVVYE 541 (571)
Q Consensus 467 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~--~~~~~lv~e 541 (571)
+..||+|+||.||+|..+ ++..||+|.+..... ...+.+|++++++++||||+++++++.. ....|+|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 367999999999999843 457899999865421 2457799999999999999999999854 467899999
Q ss_pred ccCCCChhhhhccCC------CccCCCHHHHhhh
Q 044615 542 YLEMGSLAMNLSNDA------AAEQFCWTKRMNA 569 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~------~~~~l~w~~r~~i 569 (571)
|+++ +|.+++.... ....++|.....|
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i 113 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSL 113 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHH
Confidence 9875 7888775321 1224666655544
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.3e-08 Score=102.76 Aligned_cols=101 Identities=23% Similarity=0.311 Sum_probs=79.0
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC-----C
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA-----L 534 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~-----~ 534 (571)
.++|++.+.||+|+||.||+|. ..+|+.||+|.+..... ......+.+|+.++++++||||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH--QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 4679999999999999999998 56899999999864321 22346688999999999999999999987654 3
Q ss_pred eeEEEEeccCCCChhhhhccCCCccCCCHHHHhh
Q 044615 535 HSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMN 568 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ 568 (571)
..|+||||+++ ++.+++... .+++.....
T Consensus 82 ~~~lv~e~~~~-~l~~~~~~~----~l~~~~~~~ 110 (336)
T cd07849 82 DVYIVQELMET-DLYKLIKTQ----HLSNDHIQY 110 (336)
T ss_pred eEEEEehhccc-CHHHHHhcC----CCCHHHHHH
Confidence 57999999974 888877643 355554443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.83 E-value=3.2e-10 Score=114.53 Aligned_cols=88 Identities=20% Similarity=0.273 Sum_probs=74.4
Q ss_pred CCCccCeeeccCcceEEEEEcC-CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAKLP-TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
-|+++..+|.|+||+||+|..+ ++...|.|+|.... ....++|+-||+||+.++||+||++++.|...+.+||+.|
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks---eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS---EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc---hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 3566778999999999999944 56667889986432 3447889999999999999999999999999999999999
Q ss_pred ccCCCChhhhhc
Q 044615 542 YLEMGSLAMNLS 553 (571)
Q Consensus 542 ~~~~G~L~~~l~ 553 (571)
||.||-....+-
T Consensus 110 FC~GGAVDaiml 121 (1187)
T KOG0579|consen 110 FCGGGAVDAIML 121 (1187)
T ss_pred ecCCchHhHHHH
Confidence 999999876654
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=98.82 E-value=2.1e-08 Score=100.25 Aligned_cols=82 Identities=21% Similarity=0.315 Sum_probs=66.7
Q ss_pred cCeeeccCcceEEEEEcC---CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEe--CCeeEEEEe
Q 044615 467 GHCIGNGGQGSVYKAKLP---TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSH--ALHSFVVYE 541 (571)
Q Consensus 467 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~--~~~~~lv~e 541 (571)
++.||+|+||.||+|+.+ +++.||+|.+..... ...+.+|++++++++||||+++++++.. ....|+|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 468999999999999843 567899999865422 2456789999999999999999999864 456899999
Q ss_pred ccCCCChhhhhcc
Q 044615 542 YLEMGSLAMNLSN 554 (571)
Q Consensus 542 ~~~~G~L~~~l~~ 554 (571)
|+.+ +|.+++..
T Consensus 81 ~~~~-~l~~~~~~ 92 (317)
T cd07868 81 YAEH-DLWHIIKF 92 (317)
T ss_pred ccCC-CHHHHHHh
Confidence 9874 88888753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.4e-09 Score=98.18 Aligned_cols=91 Identities=21% Similarity=0.307 Sum_probs=78.9
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC-----Ce
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA-----LH 535 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~-----~~ 535 (571)
+.|.+.+.+|+|||+.||.++ ..++..||+|++.... ....+..++||+..++++|||+++++++.... .+
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 458999999999999999999 7789999999997654 24467889999999999999999999887543 35
Q ss_pred eEEEEeccCCCChhhhhccC
Q 044615 536 SFVVYEYLEMGSLAMNLSND 555 (571)
Q Consensus 536 ~~lv~e~~~~G~L~~~l~~~ 555 (571)
.||++.|...|+|.+.+...
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~ 117 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERL 117 (302)
T ss_pred EEEEeehhccccHHHHHHHH
Confidence 89999999999999999753
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.5e-08 Score=100.18 Aligned_cols=105 Identities=22% Similarity=0.296 Sum_probs=81.7
Q ss_pred ccCCCccCeeeccCcceEEEEEcC-CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCeeEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKLP-TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHSFV 538 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~l 538 (571)
.++|+..+.||+|+||.||+|... +++.||||.+...... ....++.+|+.++.+. .||||+++++++.+....|+
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 356888999999999999999954 5899999999754322 2245677788777666 49999999999999999999
Q ss_pred EEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 539 VYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||||++ +++.+.+..... .++|..+..|+
T Consensus 92 v~e~~~-~~l~~l~~~~~~--~l~~~~~~~i~ 120 (296)
T cd06618 92 CMELMS-TCLDKLLKRIQG--PIPEDILGKMT 120 (296)
T ss_pred EeeccC-cCHHHHHHHhcC--CCCHHHHHHHH
Confidence 999986 477776654322 67888776664
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.1e-08 Score=100.73 Aligned_cols=86 Identities=28% Similarity=0.443 Sum_probs=70.7
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcC-CCCcccEEEEEEeCCeeEEEE
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR-HRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~lv~ 540 (571)
+|+..+.||+|+||.||++. ..+++.||+|.+...... .....+.+|+.++.++. ||||+++++++......+++|
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 45566789999999999998 557899999998754332 34567899999999996 999999999999999999999
Q ss_pred eccCCCChhhh
Q 044615 541 EYLEMGSLAMN 551 (571)
Q Consensus 541 e~~~~G~L~~~ 551 (571)
||++. ++.++
T Consensus 83 e~~~~-~l~~l 92 (288)
T cd06616 83 ELMDI-SLDKF 92 (288)
T ss_pred ecccC-CHHHH
Confidence 99874 55443
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.2e-08 Score=101.84 Aligned_cols=100 Identities=19% Similarity=0.111 Sum_probs=74.1
Q ss_pred ccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEeccCC
Q 044615 466 DGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEM 545 (571)
Q Consensus 466 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 545 (571)
+++.+|.|+++.||++.. +++.||||++..... .....+.+.+|++++++++||||+++++++.+.+..|++|||+++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 334445555544444444 799999999976422 223457799999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCccCCCHHHHhh
Q 044615 546 GSLAMNLSNDAAAEQFCWTKRMN 568 (571)
Q Consensus 546 G~L~~~l~~~~~~~~l~w~~r~~ 568 (571)
|+|.+++..... ..+++.....
T Consensus 84 ~~l~~~l~~~~~-~~~~~~~~~~ 105 (314)
T cd08216 84 GSCEDLLKTHFP-EGLPELAIAF 105 (314)
T ss_pred CCHHHHHHHhcc-cCCCHHHHHH
Confidence 999999975422 2344444433
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.1e-09 Score=101.80 Aligned_cols=93 Identities=19% Similarity=0.288 Sum_probs=75.8
Q ss_pred HccCCCccCeeeccCcceEEEEE-cC--C--CCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEe-C
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAK-LP--T--GEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSH-A 533 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~-~~--~--~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~-~ 533 (571)
....|+....||+|.||.||+|. .+ + ...+|+|+++..+.+. +......|||.+++.++|||+|.+..++.+ .
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t-GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT-GISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC-CcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 34568999999999999999996 32 2 2378999998654332 334567799999999999999999999987 6
Q ss_pred CeeEEEEeccCCCChhhhhcc
Q 044615 534 LHSFVVYEYLEMGSLAMNLSN 554 (571)
Q Consensus 534 ~~~~lv~e~~~~G~L~~~l~~ 554 (571)
..+++++||++. ||...|+-
T Consensus 101 ~~v~l~fdYAEh-DL~~II~f 120 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKF 120 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHH
Confidence 789999999997 89888874
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=7.1e-10 Score=120.99 Aligned_cols=96 Identities=33% Similarity=0.519 Sum_probs=83.4
Q ss_pred HHccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeE
Q 044615 459 RATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSF 537 (571)
Q Consensus 459 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~ 537 (571)
..+-.++.+.+||.|.||.||-|. ..+|+..|||.+...... .+....+.+|..++..++|||+|+++|+-.+.+..+
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 345678888999999999999998 778999999998754333 344567889999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhccC
Q 044615 538 VVYEYLEMGSLAMNLSND 555 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~ 555 (571)
|.||||++|+|.+.+...
T Consensus 1311 IFMEyC~~GsLa~ll~~g 1328 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHG 1328 (1509)
T ss_pred HHHHHhccCcHHHHHHhc
Confidence 999999999999999754
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.80 E-value=3.5e-09 Score=107.26 Aligned_cols=103 Identities=17% Similarity=0.153 Sum_probs=86.2
Q ss_pred cHHHHHHHcc---CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEE
Q 044615 453 VHEEIIRATN---NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYG 528 (571)
Q Consensus 453 ~~~~~~~~~~---~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~ 528 (571)
.+-.+.++.. -|..++.||-|+||+|..++ ..+...||+|.+.+...-.......+..|-.||...+.+.||+++.
T Consensus 617 nYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyy 696 (1034)
T KOG0608|consen 617 NYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYY 696 (1034)
T ss_pred hHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEE
Confidence 3445555543 47888999999999999998 5577789999998765544445667889999999999999999999
Q ss_pred EEEeCCeeEEEEeccCCCChhhhhccC
Q 044615 529 FCSHALHSFVVYEYLEMGSLAMNLSND 555 (571)
Q Consensus 529 ~~~~~~~~~lv~e~~~~G~L~~~l~~~ 555 (571)
.|.+.+.+|+||||++|||+-.+|.+-
T Consensus 697 SFQDkdnLYFVMdYIPGGDmMSLLIrm 723 (1034)
T KOG0608|consen 697 SFQDKDNLYFVMDYIPGGDMMSLLIRM 723 (1034)
T ss_pred EeccCCceEEEEeccCCccHHHHHHHh
Confidence 999999999999999999999888754
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.80 E-value=2.5e-09 Score=104.46 Aligned_cols=96 Identities=23% Similarity=0.267 Sum_probs=82.7
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
+.|..-++||+||||.||-++ ..+|+.+|+|++.+......+.......|-.++.+++.|.||.+-.+|++.+.+++||
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 457778899999999999998 5589999999997665444333455778999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCC
Q 044615 541 EYLEMGSLAMNLSNDAA 557 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~ 557 (571)
..|.||||..+|.+.+.
T Consensus 265 tlMNGGDLkfHiyn~g~ 281 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGN 281 (591)
T ss_pred EeecCCceeEEeeccCC
Confidence 99999999999987653
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=98.79 E-value=2.4e-08 Score=101.07 Aligned_cols=90 Identities=23% Similarity=0.423 Sum_probs=72.7
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC-----
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL----- 534 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~----- 534 (571)
..+|...+.||+|+||.||+|. ..+|+.||||++.+.... ......+.+|++++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS-EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc-ccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 3679999999999999999999 457999999998754322 223456889999999999999999999987543
Q ss_pred -eeEEEEeccCCCChhhhh
Q 044615 535 -HSFVVYEYLEMGSLAMNL 552 (571)
Q Consensus 535 -~~~lv~e~~~~G~L~~~l 552 (571)
..|+|+||+.+ ++.++.
T Consensus 93 ~~~~lv~e~~~~-~l~~~~ 110 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIM 110 (342)
T ss_pred ceEEEEeccccc-CHHHHH
Confidence 46899999974 777655
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.5e-08 Score=105.97 Aligned_cols=95 Identities=15% Similarity=0.264 Sum_probs=69.2
Q ss_pred HccCCCccCeeeccCcceEEEEEc-----------------CCCCEEEEEEccCCCCCch-----------HhHHHHHHH
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAKL-----------------PTGEIVDVKKFHSPLPDEM-----------ACQQEFLNE 511 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~-----------~~~~~~~~E 511 (571)
..++|++.++||+|+||.||+|.. ..++.||||++........ ...+.+..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999962 2356799999865322110 011234557
Q ss_pred HHHHhhcCCCCc-----ccEEEEEEe--------CCeeEEEEeccCCCChhhhhcc
Q 044615 512 VNALTKIRHRNI-----VKFYGFCSH--------ALHSFVVYEYLEMGSLAMNLSN 554 (571)
Q Consensus 512 i~~l~~l~H~ni-----v~l~~~~~~--------~~~~~lv~e~~~~G~L~~~l~~ 554 (571)
+..+.+++|.++ ++++++|.. .+..++||||+++|+|.++++.
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~ 278 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDG 278 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhh
Confidence 777788877655 677777753 3568999999999999999975
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=98.79 E-value=1e-08 Score=103.73 Aligned_cols=105 Identities=17% Similarity=0.264 Sum_probs=82.4
Q ss_pred HccCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCe---
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALH--- 535 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~--- 535 (571)
..++|+..+.||+|+||.||+|+. .++..||||++...... ....+.+.+|+.++++++|||++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS-AIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch-hhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 345799999999999999999994 57889999998654222 2334668899999999999999999998876554
Q ss_pred ---eEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 536 ---SFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 536 ---~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
.|+|+||+ +++|.+++... .+++.....++
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~ 124 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLV 124 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHH
Confidence 89999998 57999988742 46666655543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.1e-08 Score=103.42 Aligned_cols=89 Identities=29% Similarity=0.421 Sum_probs=74.0
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC-------
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA------- 533 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~------- 533 (571)
++|...+.||+|+||.||+|. ..++..||+|.+..... ...+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 568899999999999999998 56799999999865433 2346788999999999999999999876543
Q ss_pred -------CeeEEEEeccCCCChhhhhcc
Q 044615 534 -------LHSFVVYEYLEMGSLAMNLSN 554 (571)
Q Consensus 534 -------~~~~lv~e~~~~G~L~~~l~~ 554 (571)
...|+||||++ ++|.+++..
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~ 108 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ 108 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc
Confidence 35789999997 599888864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.7e-08 Score=100.59 Aligned_cols=105 Identities=23% Similarity=0.352 Sum_probs=79.8
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC-----
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL----- 534 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~----- 534 (571)
.++|++.+.||+|+||.||+|. ..+++.+|||++......+ .....+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 4679999999999999999999 4578999999986543222 12345778999999999999999999875433
Q ss_pred ---eeEEEEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 535 ---HSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 535 ---~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
..|+||||+.+ ++...+.... ..+++.+...+
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i 120 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCY 120 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHH
Confidence 46999999975 7777776432 24666665554
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.7e-08 Score=92.36 Aligned_cols=84 Identities=18% Similarity=0.189 Sum_probs=59.3
Q ss_pred cCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHh-----------------------HHHHHHHHHHHhhcCCCCc
Q 044615 467 GHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMAC-----------------------QQEFLNEVNALTKIRHRNI 523 (571)
Q Consensus 467 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~-----------------------~~~~~~Ei~~l~~l~H~ni 523 (571)
...||+|+||.||+|..++|+.||||+++......... .....+|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 36799999999999997789999999997643211000 1123459999999988887
Q ss_pred ccEEEEEEeCCeeEEEEeccCCCChhhhh
Q 044615 524 VKFYGFCSHALHSFVVYEYLEMGSLAMNL 552 (571)
Q Consensus 524 v~l~~~~~~~~~~~lv~e~~~~G~L~~~l 552 (571)
.....+.. ...+|||||++++++....
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~ 108 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPR 108 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchh
Confidence 54433322 2238999999998876553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.9e-08 Score=106.31 Aligned_cols=107 Identities=19% Similarity=0.171 Sum_probs=78.6
Q ss_pred HHHHHccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCC------CCcccEEE
Q 044615 456 EIIRATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH------RNIVKFYG 528 (571)
Q Consensus 456 ~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H------~niv~l~~ 528 (571)
++...+++|++.+.||+|+||.||+|. ..+++.||||+++... .....+..|++++.+++| ++++++++
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~ 198 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQR 198 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEE
Confidence 334456789999999999999999998 4578899999986422 123445667777766654 45888999
Q ss_pred EEEeC-CeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 529 FCSHA-LHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 529 ~~~~~-~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
++... ...|+|||++ +|+|.+++.+.+ .++|.....|+
T Consensus 199 ~~~~~~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~ 237 (467)
T PTZ00284 199 YFQNETGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQII 237 (467)
T ss_pred EEEcCCceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHH
Confidence 88764 5688999988 679999887542 46666655543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.75 E-value=3.3e-09 Score=115.31 Aligned_cols=82 Identities=28% Similarity=0.433 Sum_probs=66.5
Q ss_pred HHHccCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCee
Q 044615 458 IRATNNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHS 536 (571)
Q Consensus 458 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~ 536 (571)
-+...+|+....+|+||||.||+++. -+|+.||||+|.... ..+......+|++++++++|||||+++..+.+....
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~ 552 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAE 552 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCc
Confidence 35566889999999999999999994 499999999998654 334456688999999999999999999988765544
Q ss_pred EEEEe
Q 044615 537 FVVYE 541 (571)
Q Consensus 537 ~lv~e 541 (571)
.-++|
T Consensus 553 ~~~~e 557 (1351)
T KOG1035|consen 553 LTVLE 557 (1351)
T ss_pred ccccc
Confidence 44444
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.74 E-value=1e-08 Score=103.14 Aligned_cols=97 Identities=18% Similarity=0.114 Sum_probs=78.4
Q ss_pred HHccCCCccCeeeccCcceEEEEEcC-CCCEEEEEEccCCCCCc--hH---hHHHHHHHHHHHhhcC---CCCcccEEEE
Q 044615 459 RATNNFDDGHCIGNGGQGSVYKAKLP-TGEIVDVKKFHSPLPDE--MA---CQQEFLNEVNALTKIR---HRNIVKFYGF 529 (571)
Q Consensus 459 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~---~~~~~~~Ei~~l~~l~---H~niv~l~~~ 529 (571)
....+|...+.+|+|+||+|+.|.++ ....|+||.|.+.+.-. +. ....+-.||.||.+++ |+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 34567999999999999999999954 56779999998765321 11 1223668999999997 9999999999
Q ss_pred EEeCCeeEEEEec-cCCCChhhhhccC
Q 044615 530 CSHALHSFVVYEY-LEMGSLAMNLSND 555 (571)
Q Consensus 530 ~~~~~~~~lv~e~-~~~G~L~~~l~~~ 555 (571)
|++++.+||+||- =++-||+++|..+
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE~k 664 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIEFK 664 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhhcc
Confidence 9999999999995 4678999999754
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=98.73 E-value=8.1e-08 Score=89.12 Aligned_cols=97 Identities=33% Similarity=0.519 Sum_probs=79.7
Q ss_pred eeccCcceEEEEEcC-CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEeccCCCCh
Q 044615 470 IGNGGQGSVYKAKLP-TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548 (571)
Q Consensus 470 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~G~L 548 (571)
||+|++|.||++... +++.+++|.+....... ..+.+.+|++.++.++|++++++++++......+++|||+++++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999954 58999999997654321 346799999999999999999999999998999999999999999
Q ss_pred hhhhccCCCccCCCHHHHhhhc
Q 044615 549 AMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 549 ~~~l~~~~~~~~l~w~~r~~ia 570 (571)
.+++.... ..+++..+..++
T Consensus 79 ~~~~~~~~--~~~~~~~~~~~~ 98 (215)
T cd00180 79 KDLLKENE--GKLSEDEILRIL 98 (215)
T ss_pred HHHHHhcc--CCCCHHHHHHHH
Confidence 99997542 245666655543
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=3.2e-08 Score=106.99 Aligned_cols=92 Identities=30% Similarity=0.480 Sum_probs=77.2
Q ss_pred CCCccCeeeccCcceEEEEEcC----C----CCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeC
Q 044615 463 NFDDGHCIGNGGQGSVYKAKLP----T----GEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHA 533 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~ 533 (571)
+..+.+.+|+|+||+|++|... . ...||||.++..... ...+.+..|+++|+.+ +|||||.++|+|...
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 3455568999999999999731 1 456999999765433 4568899999999998 699999999999999
Q ss_pred CeeEEEEeccCCCChhhhhccCC
Q 044615 534 LHSFVVYEYLEMGSLAMNLSNDA 556 (571)
Q Consensus 534 ~~~~lv~e~~~~G~L~~~l~~~~ 556 (571)
+..++|+||++.|+|.++++..+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r 397 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKR 397 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhcc
Confidence 99999999999999999998655
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=98.71 E-value=4e-08 Score=91.17 Aligned_cols=105 Identities=15% Similarity=0.082 Sum_probs=80.0
Q ss_pred ecCccccHHHHHH--HccCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHH------HHHHHHHHhhc
Q 044615 447 TFDGKIVHEEIIR--ATNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQE------FLNEVNALTKI 518 (571)
Q Consensus 447 ~~~~~~~~~~~~~--~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~Ei~~l~~l 518 (571)
..+..+.+.++.. ..+.|...+.+|.|+||.||.+.. ++..+|+|.+.+.........+. +.+|++.+.++
T Consensus 14 ~~~~~~~~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL 92 (232)
T PRK10359 14 YKDNDNKYKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRV 92 (232)
T ss_pred ecCCcccHHHHHHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHH
Confidence 3333444444432 356799999999999999999766 57789999998655444333333 68999999999
Q ss_pred CCCCcccEEEEEEeC--------CeeEEEEeccCCCChhhhh
Q 044615 519 RHRNIVKFYGFCSHA--------LHSFVVYEYLEMGSLAMNL 552 (571)
Q Consensus 519 ~H~niv~l~~~~~~~--------~~~~lv~e~~~~G~L~~~l 552 (571)
.||+|..+.+++... ...++||||++|.+|.++.
T Consensus 93 ~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~ 134 (232)
T PRK10359 93 RSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP 134 (232)
T ss_pred HHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhh
Confidence 999999999987644 3578999999999998764
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=98.66 E-value=9.3e-09 Score=94.08 Aligned_cols=94 Identities=18% Similarity=0.307 Sum_probs=78.7
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCc-----hHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCC
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDE-----MACQQEFLNEVNALTKI-RHRNIVKFYGFCSHAL 534 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-----~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~ 534 (571)
+.|+..+.+|.|..+.|.++. .++|..+|+|++....... ....+.-.+|+.|++++ .||+|+++.++|+++.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 457888899999999999887 5689999999997543222 12345577899999987 7999999999999999
Q ss_pred eeEEEEeccCCCChhhhhccC
Q 044615 535 HSFVVYEYLEMGSLAMNLSND 555 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~~ 555 (571)
..++|+|.|+.|.|+|+|...
T Consensus 97 F~FlVFdl~prGELFDyLts~ 117 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSK 117 (411)
T ss_pred hhhhhhhhcccchHHHHhhhh
Confidence 999999999999999999753
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.4e-07 Score=95.11 Aligned_cols=103 Identities=20% Similarity=0.251 Sum_probs=77.2
Q ss_pred CCCccCeeeccCcceEEEEEc-CC--CCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeC----C
Q 044615 463 NFDDGHCIGNGGQGSVYKAKL-PT--GEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHA----L 534 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~-~~--~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~----~ 534 (571)
+|+..+.||+|+||.||++.. .+ +..||+|++...... ....+.+.+|++++.++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK-KILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 377788999999999999994 35 788999998643222 22346688999999999 599999999976433 4
Q ss_pred eeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 535 HSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
..|+++||+. ++|.+++... ..+++.....++
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~ 111 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSG---QPLTDAHFQSFI 111 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcC---CCCCHHHHHHHH
Confidence 5789999986 6899988643 246666655543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=98.62 E-value=8.3e-08 Score=91.60 Aligned_cols=87 Identities=16% Similarity=0.034 Sum_probs=69.2
Q ss_pred cCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEeccCCCChhhh
Q 044615 473 GGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMN 551 (571)
Q Consensus 473 G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~G~L~~~ 551 (571)
|.||.||+++ ..+++.||+|.+.... .+.+|...+....||||+++++++.+.+..|+||||+++|+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 8999999999 5689999999997542 233455556667799999999999999999999999999999999
Q ss_pred hccCCCccCCCHHHHhhhc
Q 044615 552 LSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 552 l~~~~~~~~l~w~~r~~ia 570 (571)
+.+.. .++|.....++
T Consensus 76 l~~~~---~l~~~~~~~~~ 91 (237)
T cd05576 76 ISKFL---NIPEECVKRWA 91 (237)
T ss_pred HHHhc---CCCHHHHHHHH
Confidence 97542 36666655543
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=98.62 E-value=5.3e-08 Score=103.46 Aligned_cols=93 Identities=16% Similarity=0.207 Sum_probs=69.0
Q ss_pred ccCCCccCeeeccCcceEEEEEcC--CCCEEEEEEc--------------cCCCCCchHhHHHHHHHHHHHhhcCCCCcc
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKLP--TGEIVDVKKF--------------HSPLPDEMACQQEFLNEVNALTKIRHRNIV 524 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~--------------~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv 524 (571)
.++|++.+.||+|+||+||+|..+ .+..++.|.+ .+...........+.+|+.++++++|||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 467999999999999999998742 2332333311 111111112345688999999999999999
Q ss_pred cEEEEEEeCCeeEEEEeccCCCChhhhhcc
Q 044615 525 KFYGFCSHALHSFVVYEYLEMGSLAMNLSN 554 (571)
Q Consensus 525 ~l~~~~~~~~~~~lv~e~~~~G~L~~~l~~ 554 (571)
++++++.+.+..|+|+|++. +++.+++..
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~ 255 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYD 255 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhh
Confidence 99999999999999999986 578887764
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.6e-07 Score=84.82 Aligned_cols=82 Identities=17% Similarity=0.211 Sum_probs=60.2
Q ss_pred cCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchH-----------------------hHHHHHHHHHHHhhcCCCCc
Q 044615 467 GHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMA-----------------------CQQEFLNEVNALTKIRHRNI 523 (571)
Q Consensus 467 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~-----------------------~~~~~~~Ei~~l~~l~H~ni 523 (571)
...||+|+||+||+|...+|+.||||++++....... ....+.+|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999668999999999865321000 01224689999999999998
Q ss_pred ccEEEEEEeCCeeEEEEeccCCCChhh
Q 044615 524 VKFYGFCSHALHSFVVYEYLEMGSLAM 550 (571)
Q Consensus 524 v~l~~~~~~~~~~~lv~e~~~~G~L~~ 550 (571)
.....+.... .|+||||++|+++..
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~ 106 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPA 106 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchh
Confidence 6555544332 489999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.59 E-value=5.7e-08 Score=97.46 Aligned_cols=100 Identities=21% Similarity=0.295 Sum_probs=83.3
Q ss_pred cCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 540 (571)
..|++.+.||+||.++||++...+.+.||+|++.... .+.+....|.+||..|.++ .|.+||++++|-...+.+||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 4589999999999999999998888889999886543 3446678899999999999 6899999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHH
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWT 564 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~ 564 (571)
||=+ -||..+|+++... ..+|.
T Consensus 440 E~Gd-~DL~kiL~k~~~~-~~~~~ 461 (677)
T KOG0596|consen 440 ECGD-IDLNKILKKKKSI-DPDWF 461 (677)
T ss_pred eccc-ccHHHHHHhccCC-CchHH
Confidence 9755 5999999866543 34453
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=98.57 E-value=9.8e-09 Score=91.60 Aligned_cols=85 Identities=15% Similarity=0.328 Sum_probs=72.5
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcC-CCCcccEEEEEEeC--Cee
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR-HRNIVKFYGFCSHA--LHS 536 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~--~~~ 536 (571)
.++|++.+++|+|.|++||.|. ..+.+.++||++++.+ .+.+.+|++++..+. |||||++++...++ ...
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 4578999999999999999998 6688899999997643 466889999999997 99999999999875 456
Q ss_pred EEEEeccCCCChhhh
Q 044615 537 FVVYEYLEMGSLAMN 551 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~ 551 (571)
.+|+||+.+-|....
T Consensus 111 aLiFE~v~n~Dfk~l 125 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQL 125 (338)
T ss_pred hhHhhhhccccHHHH
Confidence 799999999876543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=98.56 E-value=2.4e-07 Score=88.21 Aligned_cols=91 Identities=25% Similarity=0.373 Sum_probs=74.8
Q ss_pred CcceEEEEEcC-CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEeccCCCChhhhh
Q 044615 474 GQGSVYKAKLP-TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNL 552 (571)
Q Consensus 474 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~G~L~~~l 552 (571)
+||.||+|... +++.+|+|++........ .+.+.+|++.+++++|+|++++++++......+++|||+++|+|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 58999999954 689999999976543321 578999999999999999999999999999999999999999999998
Q ss_pred ccCCCccCCCHHHHhhh
Q 044615 553 SNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 553 ~~~~~~~~l~w~~r~~i 569 (571)
..... +++....++
T Consensus 79 ~~~~~---~~~~~~~~~ 92 (244)
T smart00220 79 KKRGR---LSEDEARFY 92 (244)
T ss_pred HhccC---CCHHHHHHH
Confidence 75432 566655544
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=9.7e-09 Score=99.09 Aligned_cols=94 Identities=18% Similarity=0.201 Sum_probs=77.1
Q ss_pred cCCCccCeeeccCcceEEEEEcC-CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCeeEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLP-TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lv 539 (571)
.+|....+||+|+||+|..|..+ +.+.+|||+++++..-...+.+--+.|-++|+-. +-|.+|+++.+|++-+.+|.|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 46899999999999999999854 6788999999876543333334445677777766 568999999999999999999
Q ss_pred EeccCCCChhhhhccC
Q 044615 540 YEYLEMGSLAMNLSND 555 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~ 555 (571)
|||+.||||-.++++-
T Consensus 429 MEyvnGGDLMyhiQQ~ 444 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQV 444 (683)
T ss_pred EEEecCchhhhHHHHh
Confidence 9999999999998864
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=2.8e-08 Score=101.31 Aligned_cols=102 Identities=20% Similarity=0.293 Sum_probs=77.3
Q ss_pred ccCeeeccCcceEEEEE-cCCCCEEEEEEccCC-CCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCe--eEEEEe
Q 044615 466 DGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSP-LPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALH--SFVVYE 541 (571)
Q Consensus 466 ~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~--~~lv~e 541 (571)
...+||+|+|-+||+|. -.+|..||=-.++.. ........++|..|+++|+.++|||||++++++.+... .-+|.|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 34679999999999998 457877763222211 12334556889999999999999999999999987654 778999
Q ss_pred ccCCCChhhhhccCCCc---cCCCHHHHh
Q 044615 542 YLEMGSLAMNLSNDAAA---EQFCWTKRM 567 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~---~~l~w~~r~ 567 (571)
.+..|+|+.|+++.+.. ..-.|.+.+
T Consensus 124 L~TSGtLr~Y~kk~~~vn~kaik~W~RQI 152 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRRVNIKAIKSWCRQI 152 (632)
T ss_pred cccCCcHHHHHHHhccCCHHHHHHHHHHH
Confidence 99999999999875431 234677654
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.54 E-value=2.6e-07 Score=86.43 Aligned_cols=86 Identities=14% Similarity=0.137 Sum_probs=69.8
Q ss_pred CeeeccCcceEEEEEcCCCCEEEEEEccCCCCCch-----HhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEec
Q 044615 468 HCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEM-----ACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEY 542 (571)
Q Consensus 468 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 542 (571)
+.||+|++|.||+|.. .|..+++|.......... .....+.+|++++..+.|++++....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5689999999999987 677899998764332211 1234688999999999999998888888778888999999
Q ss_pred cCCCChhhhhcc
Q 044615 543 LEMGSLAMNLSN 554 (571)
Q Consensus 543 ~~~G~L~~~l~~ 554 (571)
++|++|.+++..
T Consensus 81 ~~G~~L~~~~~~ 92 (211)
T PRK14879 81 IEGEPLKDLINS 92 (211)
T ss_pred eCCcCHHHHHHh
Confidence 999999998864
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.8e-08 Score=93.43 Aligned_cols=95 Identities=19% Similarity=0.246 Sum_probs=79.0
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCeeEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHSFV 538 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~l 538 (571)
..+|...++||+|+|++|..++ .++.+.+|+|++++.-..+..+..=+..|-.+.... +||.+|.++.+|.+...++.
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 4578999999999999999999 568899999999877655554445556676666554 89999999999999999999
Q ss_pred EEeccCCCChhhhhccC
Q 044615 539 VYEYLEMGSLAMNLSND 555 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~ 555 (571)
|.||++||+|--+.++.
T Consensus 329 vieyv~ggdlmfhmqrq 345 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQ 345 (593)
T ss_pred EEEEecCcceeeehhhh
Confidence 99999999997776643
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.2e-09 Score=112.23 Aligned_cols=181 Identities=27% Similarity=0.259 Sum_probs=96.1
Q ss_pred CccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCcccc---cCCc---cccC---CCCCcEEeCccCcCcC
Q 044615 162 PKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVG---EIPL---GHGM---LSSLIQLTLNNNELSG 232 (571)
Q Consensus 162 ~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~---~~~~---~~~~---l~~L~~L~l~~n~l~~ 232 (571)
|-.+..+.+|+.|.+.++.+.. ..++..+-..|+.|... |.+.. .+.. .+.+ ...|...+.+.|.+.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~-~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~- 177 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICH-NSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV- 177 (1096)
T ss_pred CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhh-ccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-
Confidence 5567788899999999998863 23344443345555432 22211 0100 1111 124555566666665
Q ss_pred CCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccC
Q 044615 233 QLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICS 312 (571)
Q Consensus 233 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 312 (571)
.....+.-++.|+.|+|++|+++.. +.+..|++|+.|||+.|.++...--...++ .|+.|.|++|.++... .+.+
T Consensus 178 ~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc-~L~~L~lrnN~l~tL~--gie~ 252 (1096)
T KOG1859|consen 178 LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGC-KLQLLNLRNNALTTLR--GIEN 252 (1096)
T ss_pred hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhh-hheeeeecccHHHhhh--hHHh
Confidence 3444556666677777777766543 356666677777777776653221122222 3666666666654321 2455
Q ss_pred CCCCCEEEccCCcCccccc-cccccCCCCCEEECcCCcCc
Q 044615 313 MQSLEKLNLSHNNLSGSIP-RCFEEMHWLSCIDISYNALQ 351 (571)
Q Consensus 313 l~~L~~L~Ls~n~l~~~~p-~~~~~l~~L~~L~ls~N~l~ 351 (571)
+++|+.||++.|-|.+.-. .-+..+..|+.|.|.+|++.
T Consensus 253 LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 253 LKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred hhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 6666666666665543211 11223344555555555554
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.52 E-value=2.2e-08 Score=92.87 Aligned_cols=62 Identities=19% Similarity=0.183 Sum_probs=28.1
Q ss_pred CCCCEEEcCCccCccCc-chhhhcccCCCEEEccCCcCCcc-cchhccCCCCCCEEEccCCcCc
Q 044615 266 VKLHYLNLSNNQFSQKI-PNKIEKLIHLSELDLSHNIFREE-IPSQICSMQSLEKLNLSHNNLS 327 (571)
Q Consensus 266 ~~L~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~Ls~n~l~~~-~~~~~~~l~~L~~L~Ls~n~l~ 327 (571)
+++..+.+..|.+...- ...+..++.+..|+|+.|++... -...+..+++|..|.+++|++.
T Consensus 199 pnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~ 262 (418)
T KOG2982|consen 199 PNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLS 262 (418)
T ss_pred ccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCccc
Confidence 34444444444443211 12233344444555555554332 1223455556666666666554
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=3e-09 Score=109.46 Aligned_cols=179 Identities=32% Similarity=0.350 Sum_probs=126.0
Q ss_pred cccccCCCCCCeeecccCcCcccCCccccCCC-CCCEEEccCCCCC----------ccCChhhhhccCCCcEEEccCCcc
Q 044615 138 PLSFANLTSLSILYLYENSLCDSIPKEIGNMN-SLSILDLSSNKLN----------GSIPLSLANLTNSLKVLYLSSNHI 206 (571)
Q Consensus 138 ~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~-~L~~L~L~~n~l~----------~~~p~~~~~l~~~L~~L~l~~n~~ 206 (571)
|-.+..+..|+.|.|.++.+.. ...+..+. .|++|.. .|.+. |.+..++.. +.|...+.++|.+
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC-~~Sl~Al~~v~ascggd~~ns~~W--n~L~~a~fsyN~L 176 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLIC-HNSLDALRHVFASCGGDISNSPVW--NKLATASFSYNRL 176 (1096)
T ss_pred CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhh-hccHHHHHHHHHHhccccccchhh--hhHhhhhcchhhH
Confidence 6677888999999999999864 22232221 3444432 22221 122222211 2388889999998
Q ss_pred cccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhh
Q 044615 207 VGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKI 286 (571)
Q Consensus 207 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~ 286 (571)
. .+..++.-++.|+.|+|++|++... ..+..+++|++|||++|.+....--...++. |+.|.+++|.++.. ..+
T Consensus 177 ~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~tL--~gi 250 (1096)
T KOG1859|consen 177 V-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTTL--RGI 250 (1096)
T ss_pred H-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeeeecccHHHhh--hhH
Confidence 7 5566777788999999999999864 3788899999999999998744333334444 99999999998743 357
Q ss_pred hcccCCCEEEccCCcCCccc-chhccCCCCCCEEEccCCcCc
Q 044615 287 EKLIHLSELDLSHNIFREEI-PSQICSMQSLEKLNLSHNNLS 327 (571)
Q Consensus 287 ~~l~~L~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~Ls~n~l~ 327 (571)
.++.+|+.||+++|-+.+.- -..+..+..|..|+|.+|++-
T Consensus 251 e~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 251 ENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred HhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 78899999999999876521 112456678899999999884
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.3e-08 Score=92.78 Aligned_cols=79 Identities=19% Similarity=0.253 Sum_probs=43.0
Q ss_pred CCCcEEeCccCcCcCCC-ChhhhCCCCCCEEEcccCccccc-cchhhccCCCCCEEEcCCccCccCcch------hhhcc
Q 044615 218 SSLIQLTLNNNELSGQL-SPELGSLIQLEYLDLSANTFHKS-IPESLSNLVKLHYLNLSNNQFSQKIPN------KIEKL 289 (571)
Q Consensus 218 ~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~Ls~n~l~~~~~~------~~~~l 289 (571)
+++..+.+..|.+.... -..+..++.+..|+|+.|++... -.+.+.++++|..|.+++|.+...+.. .++.+
T Consensus 199 pnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~l~~~err~llIaRL 278 (418)
T KOG2982|consen 199 PNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDPLRGGERRFLLIARL 278 (418)
T ss_pred ccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccccccCCcceEEEEeec
Confidence 44555555555544321 12334455566666766666432 224466677777777777776543321 24556
Q ss_pred cCCCEEE
Q 044615 290 IHLSELD 296 (571)
Q Consensus 290 ~~L~~L~ 296 (571)
++++.|+
T Consensus 279 ~~v~vLN 285 (418)
T KOG2982|consen 279 TKVQVLN 285 (418)
T ss_pred cceEEec
Confidence 6777765
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=98.47 E-value=5e-07 Score=83.66 Aligned_cols=85 Identities=16% Similarity=0.171 Sum_probs=66.3
Q ss_pred eeeccCcceEEEEEcCCCCEEEEEEccCCCCCc-----hHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEecc
Q 044615 469 CIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDE-----MACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYL 543 (571)
Q Consensus 469 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 543 (571)
.||+|+||.||+|.. ++..+++|......... .....++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 379999999999985 57889999865432211 112466889999999999988776666666777789999999
Q ss_pred CCCChhhhhcc
Q 044615 544 EMGSLAMNLSN 554 (571)
Q Consensus 544 ~~G~L~~~l~~ 554 (571)
+|++|.+.+..
T Consensus 80 ~g~~l~~~~~~ 90 (199)
T TIGR03724 80 EGKPLKDVIEE 90 (199)
T ss_pred CCccHHHHHhh
Confidence 99999988764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.43 E-value=3.2e-09 Score=95.97 Aligned_cols=93 Identities=29% Similarity=0.452 Sum_probs=72.3
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC-------
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA------- 533 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~------- 533 (571)
+.|+...+||+|.||+||+|+ ..+|+.||+|++-...... +....-.+|++++..++|+|++.+++.|.+.
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKe-GfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcccc-CCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 457777889999999999999 5578889998764322221 2234467999999999999999999888542
Q ss_pred -CeeEEEEeccCCCChhhhhccCC
Q 044615 534 -LHSFVVYEYLEMGSLAMNLSNDA 556 (571)
Q Consensus 534 -~~~~lv~e~~~~G~L~~~l~~~~ 556 (571)
..+|+||++|+. ||+-.|.+..
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~~ 118 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNRK 118 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCcc
Confidence 358999999997 8998887653
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.42 E-value=8e-08 Score=88.08 Aligned_cols=211 Identities=21% Similarity=0.219 Sum_probs=118.6
Q ss_pred cCCCCCCEEecccCcCccc----ccccccCCCCCCEEEcccCcCc---cc-------ccccccCCCCCCeeecccCcCcc
Q 044615 94 GNMKSLSDLQLSENILNGS----IPLALGNLTNLVVLDLSTNKLS---GS-------IPLSFANLTSLSILYLYENSLCD 159 (571)
Q Consensus 94 ~~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~L~~n~i~---~~-------~~~~~~~l~~L~~L~L~~n~l~~ 159 (571)
.-+..++.++||+|-|... +...+.+-.+|+..+++.-... .. ..+.+.++|.|+..+|+.|.+..
T Consensus 27 ~~~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg~ 106 (388)
T COG5238 27 EMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFGS 106 (388)
T ss_pred HhhcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccCc
Confidence 3456677777777776543 2334445566776666653211 11 22235567777777777777765
Q ss_pred cCCcc----ccCCCCCCEEEccCCCCCccCChhhh----hc--------cCCCcEEEccCCcccccCC----ccccCCCC
Q 044615 160 SIPKE----IGNMNSLSILDLSSNKLNGSIPLSLA----NL--------TNSLKVLYLSSNHIVGEIP----LGHGMLSS 219 (571)
Q Consensus 160 ~~~~~----l~~l~~L~~L~L~~n~l~~~~p~~~~----~l--------~~~L~~L~l~~n~~~~~~~----~~~~~l~~ 219 (571)
..|+. ++.-+.|.+|.+++|.+.-.-...++ ++ .+.|++.....|++..... ..+..-..
T Consensus 107 ~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicgrNRlengs~~~~a~~l~sh~~ 186 (388)
T COG5238 107 EFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGRNRLENGSKELSAALLESHEN 186 (388)
T ss_pred ccchHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEeccchhccCcHHHHHHHHHhhcC
Confidence 55543 45566777777777766421111111 11 1237777777777652211 11222246
Q ss_pred CcEEeCccCcCcCCCCh-----hhhCCCCCCEEEcccCccccc----cchhhccCCCCCEEEcCCccCccCcchhh----
Q 044615 220 LIQLTLNNNELSGQLSP-----ELGSLIQLEYLDLSANTFHKS----IPESLSNLVKLHYLNLSNNQFSQKIPNKI---- 286 (571)
Q Consensus 220 L~~L~l~~n~l~~~~~~-----~~~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~---- 286 (571)
|+.+.+..|.|...... .+..+.+|+.|||..|.++.. +...+..++.|+.|.+.+|.++......+
T Consensus 187 lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrEL~lnDClls~~G~~~v~~~f 266 (388)
T COG5238 187 LKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRELRLNDCLLSNEGVKSVLRRF 266 (388)
T ss_pred ceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhhccccchhhccccHHHHHHHh
Confidence 77777777776533221 233467788888888877532 23345566677888888887765433322
Q ss_pred --hcccCCCEEEccCCcCCc
Q 044615 287 --EKLIHLSELDLSHNIFRE 304 (571)
Q Consensus 287 --~~l~~L~~L~Ls~n~l~~ 304 (571)
...|+|..|...+|.+.+
T Consensus 267 ~e~~~p~l~~L~~~Yne~~~ 286 (388)
T COG5238 267 NEKFVPNLMPLPGDYNERRG 286 (388)
T ss_pred hhhcCCCccccccchhhhcC
Confidence 124567777777776544
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.6e-06 Score=93.00 Aligned_cols=91 Identities=16% Similarity=0.104 Sum_probs=68.5
Q ss_pred cCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCC-CC----chHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCee
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPL-PD----EMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHS 536 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~ 536 (571)
..|...+.||+|+||.||+|..... .+++|+..... .. .....+++.+|++++..++|++++....++.+....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 3456678999999999999986443 34444332211 11 112245689999999999999999888888887788
Q ss_pred EEEEeccCCCChhhhhc
Q 044615 537 FVVYEYLEMGSLAMNLS 553 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~ 553 (571)
++||||+++++|.+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~ 428 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE 428 (535)
T ss_pred EEEEEecCCCcHHHHHH
Confidence 99999999999998875
|
|
| >KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.2e-08 Score=94.49 Aligned_cols=180 Identities=23% Similarity=0.171 Sum_probs=85.3
Q ss_pred CCCEEecccCcCccc-ccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCC--ccccCCCCCCEE
Q 044615 98 SLSDLQLSENILNGS-IPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIP--KEIGNMNSLSIL 174 (571)
Q Consensus 98 ~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~l~~l~~L~~L 174 (571)
.|++|||+...|+.. .-.-+..+++|+.|.|.++.+...+...+++-.+|+.|+|+.+.=-.... --+.+++.|+.|
T Consensus 186 Rlq~lDLS~s~it~stl~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~~L 265 (419)
T KOG2120|consen 186 RLQHLDLSNSVITVSTLHGILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRLDEL 265 (419)
T ss_pred hhHHhhcchhheeHHHHHHHHHHHHhhhhccccccccCcHHHHHHhccccceeeccccccccchhHHHHHHHhhhhHhhc
Confidence 356666666555421 12223445566666666666665555555666666666665543111000 113455666666
Q ss_pred EccCCCCCccCC-hhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCc
Q 044615 175 DLSSNKLNGSIP-LSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANT 253 (571)
Q Consensus 175 ~L~~n~l~~~~p-~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 253 (571)
+|++|.+....- ..+.+...+|+.|+++++.-.- ....+..-...+|+|.+|||+.|.
T Consensus 266 NlsWc~l~~~~Vtv~V~hise~l~~LNlsG~rrnl---------------------~~sh~~tL~~rcp~l~~LDLSD~v 324 (419)
T KOG2120|consen 266 NLSWCFLFTEKVTVAVAHISETLTQLNLSGYRRNL---------------------QKSHLSTLVRRCPNLVHLDLSDSV 324 (419)
T ss_pred CchHhhccchhhhHHHhhhchhhhhhhhhhhHhhh---------------------hhhHHHHHHHhCCceeeecccccc
Confidence 666665543211 1122233335555555433210 000111112345666666666543
Q ss_pred -cccccchhhccCCCCCEEEcCCccCccCcchh---hhcccCCCEEEccCC
Q 044615 254 -FHKSIPESLSNLVKLHYLNLSNNQFSQKIPNK---IEKLIHLSELDLSHN 300 (571)
Q Consensus 254 -l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~---~~~l~~L~~L~Ls~n 300 (571)
++......|.+++.|++|.++.|.. .+|.. +...|.|.+|++.++
T Consensus 325 ~l~~~~~~~~~kf~~L~~lSlsRCY~--i~p~~~~~l~s~psl~yLdv~g~ 373 (419)
T KOG2120|consen 325 MLKNDCFQEFFKFNYLQHLSLSRCYD--IIPETLLELNSKPSLVYLDVFGC 373 (419)
T ss_pred ccCchHHHHHHhcchheeeehhhhcC--CChHHeeeeccCcceEEEEeccc
Confidence 3323334455566666666666653 34443 234456666666554
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.4e-06 Score=80.56 Aligned_cols=95 Identities=21% Similarity=0.143 Sum_probs=67.6
Q ss_pred HHHHHHccCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCch-------------------HhHHHHHHHHHHH
Q 044615 455 EEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEM-------------------ACQQEFLNEVNAL 515 (571)
Q Consensus 455 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-------------------~~~~~~~~Ei~~l 515 (571)
+++.....-|...+.||+|+||.||++..++|+.||||++........ .....+.+|+.++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 344444444788899999999999999987899999998765331100 0112367899999
Q ss_pred hhcCCCC--cccEEEEEEeCCeeEEEEeccCCCChhhhhc
Q 044615 516 TKIRHRN--IVKFYGFCSHALHSFVVYEYLEMGSLAMNLS 553 (571)
Q Consensus 516 ~~l~H~n--iv~l~~~~~~~~~~~lv~e~~~~G~L~~~l~ 553 (571)
..+.|++ +++.++ ....++||||++|++|.+...
T Consensus 88 ~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~ 123 (198)
T cd05144 88 KALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV 123 (198)
T ss_pred HHHHHcCCCCCceee----cCCceEEEEEeCCcchhhccc
Confidence 9998874 444443 244589999999999977653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.33 E-value=1e-07 Score=87.14 Aligned_cols=84 Identities=31% Similarity=0.410 Sum_probs=68.5
Q ss_pred CccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHH-HhhcCCCCcccEEEEEEeCCeeEEEEec
Q 044615 465 DDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNA-LTKIRHRNIVKFYGFCSHALHSFVVYEY 542 (571)
Q Consensus 465 ~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~-l~~l~H~niv~l~~~~~~~~~~~lv~e~ 542 (571)
+....||.|+||+|++.. .++|+..|||+|+.... .+..+++..|.+. ++.-+.||||+++|++...+..||-||.
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 344679999999999998 56899999999986543 3557889999865 6666899999999999999999999999
Q ss_pred cCCCChhhh
Q 044615 543 LEMGSLAMN 551 (571)
Q Consensus 543 ~~~G~L~~~ 551 (571)
|.- ++..+
T Consensus 145 Md~-SlDkl 152 (361)
T KOG1006|consen 145 MDI-SLDKL 152 (361)
T ss_pred Hhh-hHHHH
Confidence 974 55433
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.4e-07 Score=87.79 Aligned_cols=90 Identities=20% Similarity=0.236 Sum_probs=71.3
Q ss_pred HccCCCcc-CeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhh-cCCCCcccEEEEEEe----
Q 044615 460 ATNNFDDG-HCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTK-IRHRNIVKFYGFCSH---- 532 (571)
Q Consensus 460 ~~~~~~~~-~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~-l~H~niv~l~~~~~~---- 532 (571)
.+++|.+. .+||-|-.|+|..+. ..+++.+|+|++... ....+|+++.-. -.|||||.++++|+.
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~ 130 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQG 130 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence 45567654 579999999999998 558999999998632 334588887544 479999999999864
Q ss_pred CCeeEEEEeccCCCChhhhhccCCC
Q 044615 533 ALHSFVVYEYLEMGSLAMNLSNDAA 557 (571)
Q Consensus 533 ~~~~~lv~e~~~~G~L~~~l~~~~~ 557 (571)
...+.+|||+|+||+|+..+++++.
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~g~ 155 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDRGD 155 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHccc
Confidence 3467899999999999999987643
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=98.23 E-value=3.4e-06 Score=79.94 Aligned_cols=86 Identities=19% Similarity=0.188 Sum_probs=62.4
Q ss_pred CCCccCeeeccCcceEEEEE--cCCCCEEEEEEccCCCCCc-------------------h--HhHHHHHHHHHHHhhcC
Q 044615 463 NFDDGHCIGNGGQGSVYKAK--LPTGEIVDVKKFHSPLPDE-------------------M--ACQQEFLNEVNALTKIR 519 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~~~-------------------~--~~~~~~~~Ei~~l~~l~ 519 (571)
.|.+.+.||+|+||.||+|. ..+|+.||||.+....... . .....+.+|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 57888999999999999998 5689999999987543110 0 01234678999999997
Q ss_pred CCC--cccEEEEEEeCCeeEEEEeccCCCChhhhh
Q 044615 520 HRN--IVKFYGFCSHALHSFVVYEYLEMGSLAMNL 552 (571)
Q Consensus 520 H~n--iv~l~~~~~~~~~~~lv~e~~~~G~L~~~l 552 (571)
+.. +.++++ . ...++||||++++++....
T Consensus 109 ~~~i~~p~~~~---~-~~~~lV~E~~~g~~L~~~~ 139 (237)
T smart00090 109 EAGVPVPKPIA---W-RRNVLVMEFIGGDGLPAPR 139 (237)
T ss_pred hcCCCCCeeeE---e-cCceEEEEEecCCcccccc
Confidence 643 333333 2 2358999999999887655
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.22 E-value=6.5e-08 Score=79.56 Aligned_cols=105 Identities=28% Similarity=0.276 Sum_probs=59.1
Q ss_pred CCEEecccCcCcccccccc---cCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEE
Q 044615 99 LSDLQLSENILNGSIPLAL---GNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILD 175 (571)
Q Consensus 99 L~~L~L~~n~i~~~~~~~~---~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 175 (571)
+..+||+.+++. .+++.. .....|...+|++|.+....+..-...+.+++|+|++|.++ .+|.++..++.|+.|+
T Consensus 29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lN 106 (177)
T KOG4579|consen 29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLN 106 (177)
T ss_pred hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcc
Confidence 455666666654 233332 33344555566666665333333334446666666666665 3565666666666666
Q ss_pred ccCCCCCccCChhhhhccCCCcEEEccCCccc
Q 044615 176 LSSNKLNGSIPLSLANLTNSLKVLYLSSNHIV 207 (571)
Q Consensus 176 L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~ 207 (571)
++.|.+. ..|.-+..+.+ +..|+..+|.+.
T Consensus 107 l~~N~l~-~~p~vi~~L~~-l~~Lds~~na~~ 136 (177)
T KOG4579|consen 107 LRFNPLN-AEPRVIAPLIK-LDMLDSPENARA 136 (177)
T ss_pred cccCccc-cchHHHHHHHh-HHHhcCCCCccc
Confidence 6666665 45555555554 666666665554
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.09 E-value=3.1e-06 Score=77.89 Aligned_cols=223 Identities=23% Similarity=0.241 Sum_probs=119.8
Q ss_pred ccCCCCCCEEEcccCcCcccc----cccccCCCCCCeeecccCcCc---ccCC-------ccccCCCCCCEEEccCCCCC
Q 044615 117 LGNLTNLVVLDLSTNKLSGSI----PLSFANLTSLSILYLYENSLC---DSIP-------KEIGNMNSLSILDLSSNKLN 182 (571)
Q Consensus 117 ~~~l~~L~~L~L~~n~i~~~~----~~~~~~l~~L~~L~L~~n~l~---~~~~-------~~l~~l~~L~~L~L~~n~l~ 182 (571)
+..+..+..++|++|.|...- ...+.+-.+|+..+++.-... +.++ ..+.++|.|+..+|++|.+.
T Consensus 26 l~~~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg 105 (388)
T COG5238 26 LEMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFG 105 (388)
T ss_pred HHhhcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccC
Confidence 344678899999999987543 334556678888887654322 1112 24567888888888888887
Q ss_pred ccCChhhhhc----cCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCcccccc
Q 044615 183 GSIPLSLANL----TNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSI 258 (571)
Q Consensus 183 ~~~p~~~~~l----~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 258 (571)
...|..+..+ ++ |.+|.+++|.+...-...++. .|.. |..| .-..+-|.|+......|++..-.
T Consensus 106 ~~~~e~L~d~is~~t~-l~HL~l~NnGlGp~aG~rigk--al~~--la~n-------KKaa~kp~Le~vicgrNRlengs 173 (388)
T COG5238 106 SEFPEELGDLISSSTD-LVHLKLNNNGLGPIAGGRIGK--ALFH--LAYN-------KKAADKPKLEVVICGRNRLENGS 173 (388)
T ss_pred cccchHHHHHHhcCCC-ceeEEeecCCCCccchhHHHH--HHHH--HHHH-------hhhccCCCceEEEeccchhccCc
Confidence 6666554432 33 666666666553211111110 0000 0000 01123356667777766654221
Q ss_pred c----hhhccCCCCCEEEcCCccCccCcc-----hhhhcccCCCEEEccCCcCCcc----cchhccCCCCCCEEEccCCc
Q 044615 259 P----ESLSNLVKLHYLNLSNNQFSQKIP-----NKIEKLIHLSELDLSHNIFREE----IPSQICSMQSLEKLNLSHNN 325 (571)
Q Consensus 259 ~----~~l~~l~~L~~L~Ls~n~l~~~~~-----~~~~~l~~L~~L~Ls~n~l~~~----~~~~~~~l~~L~~L~Ls~n~ 325 (571)
. ..+..-.+|+.+.+..|.|....- ..+..+.+|+.|||.+|-++-. +...++.++.|++|.+..|-
T Consensus 174 ~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrEL~lnDCl 253 (388)
T COG5238 174 KELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRELRLNDCL 253 (388)
T ss_pred HHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhhccccchh
Confidence 1 112223466777777776542211 1123345677777777766532 23345666777888887777
Q ss_pred Cccccccc----cc--cCCCCCEEECcCCcCc
Q 044615 326 LSGSIPRC----FE--EMHWLSCIDISYNALQ 351 (571)
Q Consensus 326 l~~~~p~~----~~--~l~~L~~L~ls~N~l~ 351 (571)
++..-... |. ..++|..|-..+|-..
T Consensus 254 ls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~ 285 (388)
T COG5238 254 LSNEGVKSVLRRFNEKFVPNLMPLPGDYNERR 285 (388)
T ss_pred hccccHHHHHHHhhhhcCCCccccccchhhhc
Confidence 76433322 22 1345555555555443
|
|
| >KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.07 E-value=1.5e-07 Score=87.57 Aligned_cols=80 Identities=19% Similarity=0.130 Sum_probs=42.4
Q ss_pred CCCCEEEccCCccc-------cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCc-Cccc-cccccc
Q 044615 48 VQARDTSISFDELH-------EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENI-LNGS-IPLALG 118 (571)
Q Consensus 48 ~~l~~l~l~~n~l~-------~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~-i~~~-~~~~~~ 118 (571)
+.++++|||...++ .+.+.+|+-|.|.++.+.+ .+-..++.-.+|+.|+|+.+. ++.. ..--+.
T Consensus 185 sRlq~lDLS~s~it~stl~~iLs~C~kLk~lSlEg~~LdD-------~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~ 257 (419)
T KOG2120|consen 185 SRLQHLDLSNSVITVSTLHGILSQCSKLKNLSLEGLRLDD-------PIVNTIAKNSNLVRLNLSMCSGFTENALQLLLS 257 (419)
T ss_pred hhhHHhhcchhheeHHHHHHHHHHHHhhhhccccccccCc-------HHHHHHhccccceeeccccccccchhHHHHHHH
Confidence 34666666666555 3445556666666666655 444455555666666666542 2211 111234
Q ss_pred CCCCCCEEEcccCcCc
Q 044615 119 NLTNLVVLDLSTNKLS 134 (571)
Q Consensus 119 ~l~~L~~L~L~~n~i~ 134 (571)
+++.|..|+|+.|.+.
T Consensus 258 scs~L~~LNlsWc~l~ 273 (419)
T KOG2120|consen 258 SCSRLDELNLSWCFLF 273 (419)
T ss_pred hhhhHhhcCchHhhcc
Confidence 5566666666666554
|
|
| >PRK15386 type III secretion protein GogB; Provisional | Back alignment and domain information |
|---|
Probab=98.05 E-value=1.4e-05 Score=79.86 Aligned_cols=92 Identities=18% Similarity=0.308 Sum_probs=47.0
Q ss_pred cCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCE
Q 044615 94 GNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSI 173 (571)
Q Consensus 94 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 173 (571)
..+.+++.|++++|.++ .+|. + -.+|++|++++|.--..+|..+ .++|++|++++|.....+|. +|+.
T Consensus 49 ~~~~~l~~L~Is~c~L~-sLP~-L--P~sLtsL~Lsnc~nLtsLP~~L--P~nLe~L~Ls~Cs~L~sLP~------sLe~ 116 (426)
T PRK15386 49 EEARASGRLYIKDCDIE-SLPV-L--PNELTEITIENCNNLTTLPGSI--PEGLEKLTVCHCPEISGLPE------SVRS 116 (426)
T ss_pred HHhcCCCEEEeCCCCCc-ccCC-C--CCCCcEEEccCCCCcccCCchh--hhhhhheEccCccccccccc------ccce
Confidence 34567777777777665 3441 1 1357777776644333445433 24667777766632223332 3555
Q ss_pred EEccCCCCCccCChhhhhccCCCcEEEcc
Q 044615 174 LDLSSNKLNGSIPLSLANLTNSLKVLYLS 202 (571)
Q Consensus 174 L~L~~n~l~~~~p~~~~~l~~~L~~L~l~ 202 (571)
|++..+... .+..++++|+.|.+.
T Consensus 117 L~L~~n~~~-----~L~~LPssLk~L~I~ 140 (426)
T PRK15386 117 LEIKGSATD-----SIKNVPNGLTSLSIN 140 (426)
T ss_pred EEeCCCCCc-----ccccCcchHhheecc
Confidence 555544432 122344445555553
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.03 E-value=4.1e-07 Score=74.95 Aligned_cols=57 Identities=32% Similarity=0.471 Sum_probs=22.4
Q ss_pred CcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccC
Q 044615 220 LIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQF 278 (571)
Q Consensus 220 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l 278 (571)
++.|++++|.++ .+|.++..++.|+.|+++.|.+. ..|..+..+.+|-.|+..+|.+
T Consensus 79 ~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~ 135 (177)
T KOG4579|consen 79 ATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENAR 135 (177)
T ss_pred hhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCcc
Confidence 333444444443 23333444444444444444443 2233333344444444444433
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.03 E-value=3e-07 Score=91.33 Aligned_cols=95 Identities=19% Similarity=0.221 Sum_probs=82.2
Q ss_pred cCCCccCeeeccCcceEEEEEcCC-CCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPT-GEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
.+++.+..+|-||||.|-.+.... ...+|+|++++...-+.+..+++..|-.+|..++.|.||++|..|.+..+.|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 456677889999999999888543 3458999998776666667788999999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCC
Q 044615 541 EYLEMGSLAMNLSNDA 556 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~ 556 (571)
|-|-||++-..+++++
T Consensus 500 EaClGGElWTiLrdRg 515 (732)
T KOG0614|consen 500 EACLGGELWTILRDRG 515 (732)
T ss_pred HhhcCchhhhhhhhcC
Confidence 9999999999998654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=98.01 E-value=8.6e-06 Score=87.43 Aligned_cols=89 Identities=21% Similarity=0.243 Sum_probs=59.3
Q ss_pred HccCCCccCeeeccCcceEEEEEc-CC----CCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEE-----
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAKL-PT----GEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGF----- 529 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~~-~~----~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~----- 529 (571)
..++|+..+.||+|+||.||+|.. .+ +..||||++...... +.+..| .+.+..+.+++.+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 467899999999999999999994 45 789999997643211 112222 1122222222222211
Q ss_pred -EEeCCeeEEEEeccCCCChhhhhccC
Q 044615 530 -CSHALHSFVVYEYLEMGSLAMNLSND 555 (571)
Q Consensus 530 -~~~~~~~~lv~e~~~~G~L~~~l~~~ 555 (571)
+......++||||+++|+|.++++..
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~ 229 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSK 229 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhc
Confidence 23556789999999999999998754
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=97.98 E-value=1.7e-05 Score=69.42 Aligned_cols=79 Identities=18% Similarity=0.081 Sum_probs=65.1
Q ss_pred ccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCC--CCcccEEEEEEeCCeeEEEEecc
Q 044615 466 DGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH--RNIVKFYGFCSHALHSFVVYEYL 543 (571)
Q Consensus 466 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~~~~~~~~~~~lv~e~~ 543 (571)
+.+.+|+|.++.||++.... ..+++|....... ...+.+|+..+..++| +.++++++++...+..+++|||+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~ 75 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI 75 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence 34679999999999999744 7899999865432 3568899999999977 58999999888878899999999
Q ss_pred CCCChhh
Q 044615 544 EMGSLAM 550 (571)
Q Consensus 544 ~~G~L~~ 550 (571)
+++.+..
T Consensus 76 ~g~~~~~ 82 (155)
T cd05120 76 EGETLDE 82 (155)
T ss_pred CCeeccc
Confidence 9987764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.97 E-value=1.9e-05 Score=78.53 Aligned_cols=90 Identities=20% Similarity=0.285 Sum_probs=72.2
Q ss_pred HccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcC-----C---CCcccEEEEE
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR-----H---RNIVKFYGFC 530 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----H---~niv~l~~~~ 530 (571)
..+.|.+.++||-|.|++||.|. ..+.+.||+|+.+... ...+.-+.||++|++++ | ..||+++++|
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F 151 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF 151 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence 34679999999999999999998 6678899999986432 23456789999998873 3 3699999999
Q ss_pred Ee----CCeeEEEEeccCCCChhhhhcc
Q 044615 531 SH----ALHSFVVYEYLEMGSLAMNLSN 554 (571)
Q Consensus 531 ~~----~~~~~lv~e~~~~G~L~~~l~~ 554 (571)
.. +.+++||+|++ |-+|..+|+.
T Consensus 152 khsGpNG~HVCMVfEvL-GdnLLklI~~ 178 (590)
T KOG1290|consen 152 KHSGPNGQHVCMVFEVL-GDNLLKLIKY 178 (590)
T ss_pred eecCCCCcEEEEEehhh-hhHHHHHHHH
Confidence 75 35799999988 5588888874
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.96 E-value=6.3e-06 Score=87.08 Aligned_cols=84 Identities=20% Similarity=0.362 Sum_probs=69.4
Q ss_pred CCccCeeeccCcce-EEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCeeEEEEe
Q 044615 464 FDDGHCIGNGGQGS-VYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 464 ~~~~~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 541 (571)
|...+.+|.|+-|+ ||+|.+ .|+.||||++-... .....+||..+..- +|||||++++.-.+....||..|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 44456788998886 899998 58899999986432 34457999998887 79999999999888999999999
Q ss_pred ccCCCChhhhhccC
Q 044615 542 YLEMGSLAMNLSND 555 (571)
Q Consensus 542 ~~~~G~L~~~l~~~ 555 (571)
.|.. +|.+++...
T Consensus 584 LC~~-sL~dlie~~ 596 (903)
T KOG1027|consen 584 LCAC-SLQDLIESS 596 (903)
T ss_pred Hhhh-hHHHHHhcc
Confidence 9986 999999864
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.96 E-value=9.4e-06 Score=54.10 Aligned_cols=36 Identities=44% Similarity=0.675 Sum_probs=18.3
Q ss_pred CCCEEecccCcCcccccccccCCCCCCEEEcccCcCc
Q 044615 98 SLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLS 134 (571)
Q Consensus 98 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~ 134 (571)
+|++|++++|+|+ .+|..++++++|++|++++|+|+
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 4555555555555 33444555555555555555554
|
... |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.94 E-value=5.5e-06 Score=85.19 Aligned_cols=103 Identities=21% Similarity=0.262 Sum_probs=80.4
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhh-cCCCCcccEEEEEEeCCeeEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTK-IRHRNIVKFYGFCSHALHSFV 538 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~-l~H~niv~l~~~~~~~~~~~l 538 (571)
++.|+....+|.|+|+.|-.+. ..+++..|||++.+.... -.+|+.++.. -+||||+++++.+.++.+.|+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccc-------cccccchhhhhcCCCcceeecceecCCceeee
Confidence 5678888889999999999998 568899999999865222 2366756544 489999999999999999999
Q ss_pred EEeccCCCChhhhhccCCCc--cCCCHHHHhhhc
Q 044615 539 VYEYLEMGSLAMNLSNDAAA--EQFCWTKRMNAI 570 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~~~~--~~l~w~~r~~ia 570 (571)
|||++.||.+.+.+...... ..-.|...+-+|
T Consensus 394 v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~A 427 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKPEFCSEASQWAAELVSA 427 (612)
T ss_pred eehhccccHHHHHHHhcchhHHHHHHHHHHHHHH
Confidence 99999999998888754332 223476666554
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.93 E-value=3.8e-06 Score=77.32 Aligned_cols=91 Identities=19% Similarity=0.276 Sum_probs=72.3
Q ss_pred cCCCccCeeeccCcceEEEEEcC-CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEE-EEEeCCeeEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLP-TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYG-FCSHALHSFV 538 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~-~~~~~~~~~l 538 (571)
+.|.+.+.+|+|.||.+..++++ +.+.+|+|.+.... ...++|.+|..---.+ .|.||+.-++ .|++.+.++.
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 34888899999999999999954 67789999987653 2357899998654344 6889997775 5677788889
Q ss_pred EEeccCCCChhhhhccCC
Q 044615 539 VYEYLEMGSLAMNLSNDA 556 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~~ 556 (571)
++||+|.|||..-+...+
T Consensus 100 ~qE~aP~gdL~snv~~~G 117 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEAAG 117 (378)
T ss_pred eeccCccchhhhhcCccc
Confidence 999999999998887543
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.93 E-value=6.7e-05 Score=74.08 Aligned_cols=91 Identities=20% Similarity=0.226 Sum_probs=59.2
Q ss_pred cCCCccCeeeccCcceEEEEEcC-C---CCEEEEEEccCCCCCchHh--------HHHHHHHHHHHhhcCCCCcccEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLP-T---GEIVDVKKFHSPLPDEMAC--------QQEFLNEVNALTKIRHRNIVKFYGF 529 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~~~~~--------~~~~~~Ei~~l~~l~H~niv~l~~~ 529 (571)
..|.+.+.||+|+||.||+|... + +..+|+|............ ......+...+..++|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 46999999999999999999853 3 4566777644322111000 1112334455667899999999997
Q ss_pred EEeCC----eeEEEEeccCCCChhhhhc
Q 044615 530 CSHAL----HSFVVYEYLEMGSLAMNLS 553 (571)
Q Consensus 530 ~~~~~----~~~lv~e~~~~G~L~~~l~ 553 (571)
+.... ..++++|++.. ++.+.+.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 118 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFK 118 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHH
Confidence 76543 34788887754 5655554
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=97.92 E-value=7.5e-06 Score=80.03 Aligned_cols=94 Identities=24% Similarity=0.333 Sum_probs=78.6
Q ss_pred HHHHHccCCCccCeeeccCcceEEEEE-cC---CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEE
Q 044615 456 EIIRATNNFDDGHCIGNGGQGSVYKAK-LP---TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFC 530 (571)
Q Consensus 456 ~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~---~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~ 530 (571)
.+......|...++||+|.|+.||++. .. ..+.||+|.+..... ..+...|+++|..+ -|.||+++.+++
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~~ 104 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGCF 104 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhhh
Confidence 344556678999999999999999998 33 567899999975432 35688999999998 689999999999
Q ss_pred EeCCeeEEEEeccCCCChhhhhcc
Q 044615 531 SHALHSFVVYEYLEMGSLAMNLSN 554 (571)
Q Consensus 531 ~~~~~~~lv~e~~~~G~L~~~l~~ 554 (571)
..++...+|+||++.-+..++...
T Consensus 105 rnnd~v~ivlp~~~H~~f~~l~~~ 128 (418)
T KOG1167|consen 105 RNNDQVAIVLPYFEHDRFRDLYRS 128 (418)
T ss_pred ccCCeeEEEecccCccCHHHHHhc
Confidence 999999999999999888877764
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.92 E-value=5.1e-05 Score=69.24 Aligned_cols=83 Identities=7% Similarity=-0.074 Sum_probs=61.7
Q ss_pred CccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCch-HhHHHHHHHHHHHhhcCC-CCcccEEEEEEeCCeeEEEEec
Q 044615 465 DDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEM-ACQQEFLNEVNALTKIRH-RNIVKFYGFCSHALHSFVVYEY 542 (571)
Q Consensus 465 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~Ei~~l~~l~H-~niv~l~~~~~~~~~~~lv~e~ 542 (571)
.+...+++|+||+||.+.. .+..++.+.+........ .....|.+|+++|+++.| +++++++++ +..|++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999997665 677777777754332111 113358899999999954 889999886 346899999
Q ss_pred cCCCChhhhh
Q 044615 543 LEMGSLAMNL 552 (571)
Q Consensus 543 ~~~G~L~~~l 552 (571)
++|++|.+.+
T Consensus 80 I~G~~L~~~~ 89 (218)
T PRK12274 80 LAGAAMYQRP 89 (218)
T ss_pred ecCccHHhhh
Confidence 9999997654
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=97.91 E-value=2.8e-05 Score=71.09 Aligned_cols=78 Identities=22% Similarity=0.248 Sum_probs=51.5
Q ss_pred cCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHH---------------------HHHHHHHHHhhcCCCC--c
Q 044615 467 GHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQ---------------------EFLNEVNALTKIRHRN--I 523 (571)
Q Consensus 467 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~---------------------~~~~Ei~~l~~l~H~n--i 523 (571)
.+.||+|+||+||+|...+++.||||++............ ....|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999778999999998754322111111 1135666666665443 4
Q ss_pred ccEEEEEEeCCeeEEEEeccCCCCh
Q 044615 524 VKFYGFCSHALHSFVVYEYLEMGSL 548 (571)
Q Consensus 524 v~l~~~~~~~~~~~lv~e~~~~G~L 548 (571)
.+.+++ ...++||||+++|++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~ 102 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGI 102 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCc
Confidence 444433 245899999999543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.83 E-value=3.3e-05 Score=70.06 Aligned_cols=87 Identities=20% Similarity=0.235 Sum_probs=69.1
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCC-CCcccEEEEEEeCCeeEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH-RNIVKFYGFCSHALHSFV 538 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~~~~~~~~~~~l 538 (571)
.++|...++||+|+||.+|.|. ..+|+.||||.=..... ..+...|.++-.-++| ..|..+.-+..+...-.+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 3579999999999999999999 77899999998543321 2356788888888876 577777777778888889
Q ss_pred EEeccCCCChhhhhc
Q 044615 539 VYEYLEMGSLAMNLS 553 (571)
Q Consensus 539 v~e~~~~G~L~~~l~ 553 (571)
|||.. |-+|+++..
T Consensus 89 VMdLL-GPsLEdLfn 102 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFN 102 (341)
T ss_pred eeecc-CccHHHHHH
Confidence 99976 568887764
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.82 E-value=1.9e-05 Score=52.57 Aligned_cols=36 Identities=39% Similarity=0.611 Sum_probs=20.2
Q ss_pred CCCEEEcccCcCcccccccccCCCCCCeeecccCcCc
Q 044615 122 NLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLC 158 (571)
Q Consensus 122 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~ 158 (571)
+|++|++++|+|+ .+|..+++|++|++|++++|.++
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 5666666666665 33444566666666666666654
|
... |
| >KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.82 E-value=4.3e-05 Score=67.62 Aligned_cols=102 Identities=27% Similarity=0.318 Sum_probs=65.5
Q ss_pred CCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCccc-chhccCCCCCCEEEc
Q 044615 243 QLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEI-PSQICSMQSLEKLNL 321 (571)
Q Consensus 243 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~L 321 (571)
+...+||++|.+... ..|..++.|.+|.+.+|+|+.+-|..-.-+++|+.|.|.+|.+.... -.-+..+|.|++|.+
T Consensus 43 ~~d~iDLtdNdl~~l--~~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~LtnNsi~~l~dl~pLa~~p~L~~Ltl 120 (233)
T KOG1644|consen 43 QFDAIDLTDNDLRKL--DNLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTNNSIQELGDLDPLASCPKLEYLTL 120 (233)
T ss_pred ccceecccccchhhc--ccCCCccccceEEecCCcceeeccchhhhccccceEEecCcchhhhhhcchhccCCccceeee
Confidence 455667777766422 44566777777777777777666655556677777888777765421 123566778888888
Q ss_pred cCCcCcccc---ccccccCCCCCEEECc
Q 044615 322 SHNNLSGSI---PRCFEEMHWLSCIDIS 346 (571)
Q Consensus 322 s~n~l~~~~---p~~~~~l~~L~~L~ls 346 (571)
-+|+.+..- --.+..+++|+.||.+
T Consensus 121 l~Npv~~k~~YR~yvl~klp~l~~LDF~ 148 (233)
T KOG1644|consen 121 LGNPVEHKKNYRLYVLYKLPSLRTLDFQ 148 (233)
T ss_pred cCCchhcccCceeEEEEecCcceEeehh
Confidence 888775321 1134567777777765
|
|
| >KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.77 E-value=4.5e-05 Score=67.46 Aligned_cols=82 Identities=26% Similarity=0.226 Sum_probs=38.7
Q ss_pred CcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCcccccc-chhhccCCCCCEEEcC
Q 044615 196 LKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSI-PESLSNLVKLHYLNLS 274 (571)
Q Consensus 196 L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~l~~l~~L~~L~Ls 274 (571)
...+||++|.+.. ...|..++.|.+|.+.+|+|+.+.|.--..+++|..|.|.+|++.... -.-+..+|+|++|.+-
T Consensus 44 ~d~iDLtdNdl~~--l~~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~LtnNsi~~l~dl~pLa~~p~L~~Ltll 121 (233)
T KOG1644|consen 44 FDAIDLTDNDLRK--LDNLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTNNSIQELGDLDPLASCPKLEYLTLL 121 (233)
T ss_pred cceecccccchhh--cccCCCccccceEEecCCcceeeccchhhhccccceEEecCcchhhhhhcchhccCCccceeeec
Confidence 4555555555531 123344455555555555555444433334455555555555543210 1123444455555555
Q ss_pred CccCc
Q 044615 275 NNQFS 279 (571)
Q Consensus 275 ~n~l~ 279 (571)
+|.++
T Consensus 122 ~Npv~ 126 (233)
T KOG1644|consen 122 GNPVE 126 (233)
T ss_pred CCchh
Confidence 55443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=97.76 E-value=4.5e-05 Score=79.13 Aligned_cols=86 Identities=14% Similarity=0.155 Sum_probs=57.6
Q ss_pred CeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchH-------------------------------------hHHHHHH
Q 044615 468 HCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMA-------------------------------------CQQEFLN 510 (571)
Q Consensus 468 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~-------------------------------------~~~~~~~ 510 (571)
+.+|+|++|+||+|++++|+.||||+..+....... ..-+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 679999999999999889999999998764311100 0012556
Q ss_pred HHHHHhhc----CCCCcccEEEEEE-eCCeeEEEEeccCCCChhhhhc
Q 044615 511 EVNALTKI----RHRNIVKFYGFCS-HALHSFVVYEYLEMGSLAMNLS 553 (571)
Q Consensus 511 Ei~~l~~l----~H~niv~l~~~~~-~~~~~~lv~e~~~~G~L~~~l~ 553 (571)
|++.+.++ +|.+-|.+-..|. .....++||||++|++|.+...
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~ 250 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAA 250 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHH
Confidence 66655554 2333333333332 2345789999999999988765
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.75 E-value=2e-05 Score=76.22 Aligned_cols=90 Identities=24% Similarity=0.241 Sum_probs=73.6
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCC------CcccEEEEEEeC
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHR------NIVKFYGFCSHA 533 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~------niv~l~~~~~~~ 533 (571)
+..|.+...+|+|.||+|..+. .+++..||||+++... +..+.-+-|++++.++.+. -+|++.++|...
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 5679999999999999999998 5578999999987432 3345667899999998432 478888999999
Q ss_pred CeeEEEEeccCCCChhhhhccC
Q 044615 534 LHSFVVYEYLEMGSLAMNLSND 555 (571)
Q Consensus 534 ~~~~lv~e~~~~G~L~~~l~~~ 555 (571)
+..+||+|.+ |-++++++.+.
T Consensus 164 ghiCivfell-G~S~~dFlk~N 184 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKEN 184 (415)
T ss_pred CceEEEEecc-ChhHHHHhccC
Confidence 9999999977 45999999864
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.73 E-value=2.4e-05 Score=69.39 Aligned_cols=88 Identities=20% Similarity=0.341 Sum_probs=70.0
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHH-HhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNA-LTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~-l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
+...+..||+|+||.|-+-+ ..+|...|+|.+..... .+..++..+|+.+ ++....|.+|+++|.+......+|.|
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn--~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN--SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC--hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 34456779999999998888 45899999999975432 3456778889977 55568999999999999999999999
Q ss_pred eccCCCChhhhhc
Q 044615 541 EYLEMGSLAMNLS 553 (571)
Q Consensus 541 e~~~~G~L~~~l~ 553 (571)
|.|.. +|..+-+
T Consensus 125 E~M~t-Sldkfy~ 136 (282)
T KOG0984|consen 125 ELMDT-SLDKFYR 136 (282)
T ss_pred HHhhh-hHHHHHH
Confidence 99975 6755543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.72 E-value=4e-06 Score=77.05 Aligned_cols=88 Identities=19% Similarity=0.334 Sum_probs=70.9
Q ss_pred cCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEeccCCC
Q 044615 467 GHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMG 546 (571)
Q Consensus 467 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~G 546 (571)
.-++.+.-.|+.|+|++. |..+++|++...... ....++|..|.-.++-+.||||.+++|.|.++..+.++..||+.|
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t-~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVT-ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhccCCCccccccccc-Ccchhhhhhhhhhcc-hhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 345777888999999984 556667877643222 122467888988899999999999999999999999999999999
Q ss_pred ChhhhhccCC
Q 044615 547 SLAMNLSNDA 556 (571)
Q Consensus 547 ~L~~~l~~~~ 556 (571)
+|+..+++..
T Consensus 273 slynvlhe~t 282 (448)
T KOG0195|consen 273 SLYNVLHEQT 282 (448)
T ss_pred HHHHHHhcCc
Confidence 9999999653
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=97.72 E-value=1.5e-05 Score=83.70 Aligned_cols=89 Identities=13% Similarity=0.157 Sum_probs=59.8
Q ss_pred cCCCccCeeeccCcceEEEEEcCC-CCEEEEEEccCCCCCc---------------------------h----HhHH---
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPT-GEIVDVKKFHSPLPDE---------------------------M----ACQQ--- 506 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~---------------------------~----~~~~--- 506 (571)
.+|+. +.+|+|++|+||+|+.++ |+.||||++.+..... . ...+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45776 789999999999999766 9999999998653110 0 0011
Q ss_pred ---HHHHHHHHHhhc----CCCCcccEEEEEEe-CCeeEEEEeccCCCChhhh
Q 044615 507 ---EFLNEVNALTKI----RHRNIVKFYGFCSH-ALHSFVVYEYLEMGSLAMN 551 (571)
Q Consensus 507 ---~~~~Ei~~l~~l----~H~niv~l~~~~~~-~~~~~lv~e~~~~G~L~~~ 551 (571)
+|.+|+.-+.++ .+.+.|.+-.++.+ ....++||||++|+.+.+.
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~ 251 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDV 251 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhH
Confidence 245555544444 35555554455543 4567899999999999764
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00018 Score=71.74 Aligned_cols=90 Identities=30% Similarity=0.456 Sum_probs=76.0
Q ss_pred CCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCC-CcccEEEEEEeCCeeEEEEec
Q 044615 464 FDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHR-NIVKFYGFCSHALHSFVVYEY 542 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~-niv~l~~~~~~~~~~~lv~e~ 542 (571)
|.....+|.|+||.||++... ..+|+|.+.............|.+|+.+++.+.|+ +++++.+++......++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999865 78899999866544433467899999999999998 799999999777778999999
Q ss_pred cCCCChhhhhccC
Q 044615 543 LEMGSLAMNLSND 555 (571)
Q Consensus 543 ~~~G~L~~~l~~~ 555 (571)
+.++++.+++...
T Consensus 80 ~~~~~l~~~~~~~ 92 (384)
T COG0515 80 VDGGSLEDLLKKI 92 (384)
T ss_pred CCCCcHHHHHHhc
Confidence 9999999777643
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.68 E-value=2.7e-06 Score=78.19 Aligned_cols=89 Identities=21% Similarity=0.359 Sum_probs=70.3
Q ss_pred CCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC-----CeeE
Q 044615 464 FDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA-----LHSF 537 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~-----~~~~ 537 (571)
.+..+.||-|+||.||.+. -++|+.||.|++... .......+++.+|++++.-++|.|+...++....+ .++|
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 4566889999999999998 568999999988532 23334457788999999999999999999887654 3578
Q ss_pred EEEeccCCCChhhhhcc
Q 044615 538 VVYEYLEMGSLAMNLSN 554 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~ 554 (571)
.+.|.|.. ||.+.|-.
T Consensus 134 V~TELmQS-DLHKIIVS 149 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVS 149 (449)
T ss_pred HHHHHHHh-hhhheecc
Confidence 88898864 88877653
|
|
| >PRK15386 type III secretion protein GogB; Provisional | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.0001 Score=73.81 Aligned_cols=75 Identities=19% Similarity=0.292 Sum_probs=42.5
Q ss_pred ccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCC-cccccCCccccCCCC
Q 044615 141 FANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSN-HIVGEIPLGHGMLSS 219 (571)
Q Consensus 141 ~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n-~~~~~~~~~~~~l~~ 219 (571)
+..+.+++.|++++|.+. .+|. -..+|+.|.+++|.-...+|..+ +.+|+.|++++| .+. .+| .+
T Consensus 48 ~~~~~~l~~L~Is~c~L~-sLP~---LP~sLtsL~Lsnc~nLtsLP~~L---P~nLe~L~Ls~Cs~L~-sLP------~s 113 (426)
T PRK15386 48 IEEARASGRLYIKDCDIE-SLPV---LPNELTEITIENCNNLTTLPGSI---PEGLEKLTVCHCPEIS-GLP------ES 113 (426)
T ss_pred HHHhcCCCEEEeCCCCCc-ccCC---CCCCCcEEEccCCCCcccCCchh---hhhhhheEccCccccc-ccc------cc
Confidence 344577888888877665 3452 12357788877654333555433 334777777776 332 233 24
Q ss_pred CcEEeCccCc
Q 044615 220 LIQLTLNNNE 229 (571)
Q Consensus 220 L~~L~l~~n~ 229 (571)
|+.|++..+.
T Consensus 114 Le~L~L~~n~ 123 (426)
T PRK15386 114 VRSLEIKGSA 123 (426)
T ss_pred cceEEeCCCC
Confidence 5556655444
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.67 E-value=2.6e-05 Score=71.99 Aligned_cols=87 Identities=21% Similarity=0.354 Sum_probs=67.5
Q ss_pred CCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCeeEEEEe
Q 044615 464 FDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 541 (571)
.+....+|+|..|+|++++ .++|...|||.+.... .....+++...+.++... +.|.||+.+|||..+...++.||
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 3445679999999999999 5579999999997653 334456777888776655 58999999999999999999999
Q ss_pred ccCCCChhhhhc
Q 044615 542 YLEMGSLAMNLS 553 (571)
Q Consensus 542 ~~~~G~L~~~l~ 553 (571)
.|.. .+.++++
T Consensus 172 lMs~-C~ekLlk 182 (391)
T KOG0983|consen 172 LMST-CAEKLLK 182 (391)
T ss_pred HHHH-HHHHHHH
Confidence 8853 3444444
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00012 Score=73.18 Aligned_cols=103 Identities=20% Similarity=0.239 Sum_probs=75.3
Q ss_pred CCCccCeeeccCcceEEEEEcC-C-CCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCC----CCcccEEEEE-EeCCe
Q 044615 463 NFDDGHCIGNGGQGSVYKAKLP-T-GEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH----RNIVKFYGFC-SHALH 535 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H----~niv~l~~~~-~~~~~ 535 (571)
.|.+.+.||+|+||.||.|... + ...+|+|.-....... ...+..|+.++..+.+ +++.++++.. .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 6999999999999999999943 3 3578888876432221 1257788888888863 5888999888 47778
Q ss_pred eEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 536 SFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 536 ~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
.|+||+.+ |-+|.++..... ...++-...++||
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia 128 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIA 128 (322)
T ss_pred eEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHH
Confidence 89999966 679999775443 3456666655554
|
|
| >KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.64 E-value=1.5e-05 Score=86.42 Aligned_cols=85 Identities=22% Similarity=0.298 Sum_probs=40.0
Q ss_pred CCCCCCEEecccCcCcc-cccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcc-cCCccccCCCCCC
Q 044615 95 NMKSLSDLQLSENILNG-SIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCD-SIPKEIGNMNSLS 172 (571)
Q Consensus 95 ~l~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~l~~l~~L~ 172 (571)
-+|+|+.|.+++-.+.. ..-....++++|..||+++++++.. ..+++|++|+.|.+.+=.+.. ..-..+..|++|+
T Consensus 146 ~LPsL~sL~i~~~~~~~~dF~~lc~sFpNL~sLDIS~TnI~nl--~GIS~LknLq~L~mrnLe~e~~~~l~~LF~L~~L~ 223 (699)
T KOG3665|consen 146 MLPSLRSLVISGRQFDNDDFSQLCASFPNLRSLDISGTNISNL--SGISRLKNLQVLSMRNLEFESYQDLIDLFNLKKLR 223 (699)
T ss_pred hCcccceEEecCceecchhHHHHhhccCccceeecCCCCccCc--HHHhccccHHHHhccCCCCCchhhHHHHhcccCCC
Confidence 34555555555543321 1122334455555555555555433 345555555555554433321 1112344555666
Q ss_pred EEEccCCCC
Q 044615 173 ILDLSSNKL 181 (571)
Q Consensus 173 ~L~L~~n~l 181 (571)
.||+|....
T Consensus 224 vLDIS~~~~ 232 (699)
T KOG3665|consen 224 VLDISRDKN 232 (699)
T ss_pred eeecccccc
Confidence 666555443
|
|
| >KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.59 E-value=4.9e-05 Score=82.59 Aligned_cols=136 Identities=22% Similarity=0.273 Sum_probs=74.1
Q ss_pred CCcEEEccCCcccc-cCCccc-cCCCCCcEEeCccCcCcCC-CChhhhCCCCCCEEEcccCccccccchhhccCCCCCEE
Q 044615 195 SLKVLYLSSNHIVG-EIPLGH-GMLSSLIQLTLNNNELSGQ-LSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYL 271 (571)
Q Consensus 195 ~L~~L~l~~n~~~~-~~~~~~-~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 271 (571)
+|+.|++++...-. ..|..+ ..+|+|+.|.+.+-.+... +.....++|+|..||+|+.+++.. ..++.+++|+.|
T Consensus 123 nL~~LdI~G~~~~s~~W~~kig~~LPsL~sL~i~~~~~~~~dF~~lc~sFpNL~sLDIS~TnI~nl--~GIS~LknLq~L 200 (699)
T KOG3665|consen 123 NLQHLDISGSELFSNGWPKKIGTMLPSLRSLVISGRQFDNDDFSQLCASFPNLRSLDISGTNISNL--SGISRLKNLQVL 200 (699)
T ss_pred hhhhcCccccchhhccHHHHHhhhCcccceEEecCceecchhHHHHhhccCccceeecCCCCccCc--HHHhccccHHHH
Confidence 48888887754321 111122 2467777777777555432 223345677777777777766533 556667777777
Q ss_pred EcCCccCcc-CcchhhhcccCCCEEEccCCcCCccc--c----hhccCCCCCCEEEccCCcCcccccc
Q 044615 272 NLSNNQFSQ-KIPNKIEKLIHLSELDLSHNIFREEI--P----SQICSMQSLEKLNLSHNNLSGSIPR 332 (571)
Q Consensus 272 ~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~--~----~~~~~l~~L~~L~Ls~n~l~~~~p~ 332 (571)
.+.+=.+.. ..-..+-.|++|+.||+|..+..... . +.-..+|.|+.||.|++.+....-+
T Consensus 201 ~mrnLe~e~~~~l~~LF~L~~L~vLDIS~~~~~~~~~ii~qYlec~~~LpeLrfLDcSgTdi~~~~le 268 (699)
T KOG3665|consen 201 SMRNLEFESYQDLIDLFNLKKLRVLDISRDKNNDDTKIIEQYLECGMVLPELRFLDCSGTDINEEILE 268 (699)
T ss_pred hccCCCCCchhhHHHHhcccCCCeeeccccccccchHHHHHHHHhcccCccccEEecCCcchhHHHHH
Confidence 666655432 11123445667777777665433211 1 1123356666666666666544433
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00033 Score=68.09 Aligned_cols=91 Identities=20% Similarity=0.215 Sum_probs=70.3
Q ss_pred ccCCCccCeeeccCcceEEEEEcCC------CCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEe-C
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKLPT------GEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSH-A 533 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~-~ 533 (571)
...++....+-+|.||.||+|.+.. .+.|-||.++.. .+......+.+|.-.+..+.|||+.++.+++.+ .
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY 360 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence 3446667788999999999996432 234556666432 223345678999999999999999999999865 4
Q ss_pred CeeEEEEeccCCCChhhhhc
Q 044615 534 LHSFVVYEYLEMGSLAMNLS 553 (571)
Q Consensus 534 ~~~~lv~e~~~~G~L~~~l~ 553 (571)
...+.+|.++.-|+|..+|.
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~ 380 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQ 380 (563)
T ss_pred CcceEEEeccCcchHHHHHH
Confidence 66789999999999999998
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00029 Score=67.19 Aligned_cols=85 Identities=21% Similarity=0.257 Sum_probs=65.4
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCeeEEEE
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 540 (571)
.|.++++||+|+||+.+.|+ +-+++.||||.=...... .+...|.+.-+.+ ..+.|...+.+-..+-+-.+||
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A-----PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA-----PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCc-----chHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 58999999999999999999 668999999985433222 3455666665555 4589998888877777778999
Q ss_pred eccCCCChhhhhc
Q 044615 541 EYLEMGSLAMNLS 553 (571)
Q Consensus 541 e~~~~G~L~~~l~ 553 (571)
|.+ |-+|+|+..
T Consensus 104 dLL-GPSLEDLFD 115 (449)
T KOG1165|consen 104 DLL-GPSLEDLFD 115 (449)
T ss_pred hhh-CcCHHHHHH
Confidence 976 568887765
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.00078 Score=64.02 Aligned_cols=87 Identities=13% Similarity=0.119 Sum_probs=62.5
Q ss_pred cCeee-ccCcceEEEEEcCCCCEEEEEEccCCCC----------CchHhHHHHHHHHHHHhhcCCCCc--ccEEEEEEeC
Q 044615 467 GHCIG-NGGQGSVYKAKLPTGEIVDVKKFHSPLP----------DEMACQQEFLNEVNALTKIRHRNI--VKFYGFCSHA 533 (571)
Q Consensus 467 ~~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~~~Ei~~l~~l~H~ni--v~l~~~~~~~ 533 (571)
...+| .||.|+||.+... +..+|||.+..... ........+.+|++++.+++|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35688 8999999998874 77889998853211 011234568899999999999885 6777765432
Q ss_pred -C---eeEEEEeccCC-CChhhhhcc
Q 044615 534 -L---HSFVVYEYLEM-GSLAMNLSN 554 (571)
Q Consensus 534 -~---~~~lv~e~~~~-G~L~~~l~~ 554 (571)
. ..++||||++| ++|.+++.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~ 140 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE 140 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc
Confidence 2 23599999997 699988864
|
|
| >PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.00059 Score=57.94 Aligned_cols=122 Identities=17% Similarity=0.221 Sum_probs=45.1
Q ss_pred cccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCC
Q 044615 213 GHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHL 292 (571)
Q Consensus 213 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L 292 (571)
.|...++|+.+.+.. .+.......|.++++|+.+.+.++ +.......|.++++|+.+.+.+ .+.......|..+++|
T Consensus 7 ~F~~~~~l~~i~~~~-~~~~I~~~~F~~~~~l~~i~~~~~-~~~i~~~~F~~~~~l~~i~~~~-~~~~i~~~~F~~~~~l 83 (129)
T PF13306_consen 7 AFYNCSNLESITFPN-TIKKIGENAFSNCTSLKSINFPNN-LTSIGDNAFSNCKSLESITFPN-NLKSIGDNAFSNCTNL 83 (129)
T ss_dssp TTTT-TT--EEEETS-T--EE-TTTTTT-TT-SEEEESST-TSCE-TTTTTT-TT-EEEEETS-TT-EE-TTTTTT-TTE
T ss_pred HHhCCCCCCEEEECC-CeeEeChhhccccccccccccccc-ccccceeeeecccccccccccc-cccccccccccccccc
Confidence 344444555555443 333333444555555555555543 3333334455555566666644 3322333445555566
Q ss_pred CEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCC
Q 044615 293 SELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWL 340 (571)
Q Consensus 293 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L 340 (571)
+.+++..+ +.......|.+. .|+.+.+.. .++.....+|.++++|
T Consensus 84 ~~i~~~~~-~~~i~~~~f~~~-~l~~i~~~~-~~~~i~~~~F~~~~~l 128 (129)
T PF13306_consen 84 KNIDIPSN-ITEIGSSSFSNC-NLKEINIPS-NITKIEENAFKNCTKL 128 (129)
T ss_dssp CEEEETTT--BEEHTTTTTT--T--EEE-TT-B-SS----GGG-----
T ss_pred cccccCcc-ccEEchhhhcCC-CceEEEECC-CccEECCccccccccC
Confidence 66665543 333344445554 566665554 3333444455555443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.00013 Score=80.56 Aligned_cols=98 Identities=23% Similarity=0.277 Sum_probs=69.4
Q ss_pred HccCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcC---CCCcccEEEEEEeCCee
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR---HRNIVKFYGFCSHALHS 536 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~~~~~~~~~~ 536 (571)
....|.+.+.+|+|+||+||+|...+|+.||+|+=.+....+ |---.+++.|++ -+.|.++..++.-.+.-
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE------fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE------FYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee------eeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 345688889999999999999997779999999976554332 111123444554 23455555556667778
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHH
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKR 566 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r 566 (571)
++|+||.+.|+|.+++. ....++|...
T Consensus 770 ~lv~ey~~~Gtlld~~N---~~~~m~e~lv 796 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN---TNKVMDEYLV 796 (974)
T ss_pred eeeeeccccccHHHhhc---cCCCCCchhh
Confidence 89999999999999998 3334666543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.35 E-value=7.6e-05 Score=74.98 Aligned_cols=91 Identities=20% Similarity=0.291 Sum_probs=73.9
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcC------CCCcccEEEEEEeCC
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR------HRNIVKFYGFCSHAL 534 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~------H~niv~l~~~~~~~~ 534 (571)
..|.+....|+|-|+.|.+|. ...|..||||+|...... .+.=.+|+++|++++ --++++++..|...+
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M----~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM----HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH----hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 458888899999999999998 557889999999754322 234458999999984 237899999999999
Q ss_pred eeEEEEeccCCCChhhhhccCCC
Q 044615 535 HSFVVYEYLEMGSLAMNLSNDAA 557 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~~~~ 557 (571)
++|||+|-+.. +|.+.|+.-+.
T Consensus 508 HLClVFE~Lsl-NLRevLKKyG~ 529 (752)
T KOG0670|consen 508 HLCLVFEPLSL-NLREVLKKYGR 529 (752)
T ss_pred eeEEEehhhhc-hHHHHHHHhCc
Confidence 99999998765 89999986544
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.00068 Score=63.64 Aligned_cols=84 Identities=14% Similarity=0.165 Sum_probs=63.3
Q ss_pred CeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCC--CCcccEEEEEEeCC---eeEEEEec
Q 044615 468 HCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH--RNIVKFYGFCSHAL---HSFVVYEY 542 (571)
Q Consensus 468 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~~~~~~~~---~~~lv~e~ 542 (571)
+.++.|.++.||++...+|+.+++|........ .....+.+|+++++.+.+ ..+.+++++..... ..++||||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 568999999999998766788999997654321 123567899999999876 34677777776542 56899999
Q ss_pred cCCCChhhhhc
Q 044615 543 LEMGSLAMNLS 553 (571)
Q Consensus 543 ~~~G~L~~~l~ 553 (571)
++|+++.+.+.
T Consensus 82 i~G~~l~~~~~ 92 (223)
T cd05154 82 VDGRVLRDRLL 92 (223)
T ss_pred eCCEecCCCCC
Confidence 99998877653
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0016 Score=55.30 Aligned_cols=84 Identities=20% Similarity=0.226 Sum_probs=37.4
Q ss_pred cccCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCC
Q 044615 92 EIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSL 171 (571)
Q Consensus 92 ~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L 171 (571)
.|.++++|+.+.+.. .+.......|.++++|+.+.+..+ +.......|.++++|+.+.+.+ .+.......|..+++|
T Consensus 7 ~F~~~~~l~~i~~~~-~~~~I~~~~F~~~~~l~~i~~~~~-~~~i~~~~F~~~~~l~~i~~~~-~~~~i~~~~F~~~~~l 83 (129)
T PF13306_consen 7 AFYNCSNLESITFPN-TIKKIGENAFSNCTSLKSINFPNN-LTSIGDNAFSNCKSLESITFPN-NLKSIGDNAFSNCTNL 83 (129)
T ss_dssp TTTT-TT--EEEETS-T--EE-TTTTTT-TT-SEEEESST-TSCE-TTTTTT-TT-EEEEETS-TT-EE-TTTTTT-TTE
T ss_pred HHhCCCCCCEEEECC-CeeEeChhhccccccccccccccc-ccccceeeeecccccccccccc-cccccccccccccccc
Confidence 355556666666653 344444555666666666666554 4444445556665566666643 3222233345555555
Q ss_pred CEEEccC
Q 044615 172 SILDLSS 178 (571)
Q Consensus 172 ~~L~L~~ 178 (571)
+.+++..
T Consensus 84 ~~i~~~~ 90 (129)
T PF13306_consen 84 KNIDIPS 90 (129)
T ss_dssp CEEEETT
T ss_pred cccccCc
Confidence 5555544
|
|
| >KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0002 Score=66.25 Aligned_cols=64 Identities=27% Similarity=0.391 Sum_probs=25.7
Q ss_pred CCCCCCEEEcccC--cCcccccccccCCCCCCeeecccCcCccc-CCccccCCCCCCEEEccCCCCC
Q 044615 119 NLTNLVVLDLSTN--KLSGSIPLSFANLTSLSILYLYENSLCDS-IPKEIGNMNSLSILDLSSNKLN 182 (571)
Q Consensus 119 ~l~~L~~L~L~~n--~i~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~L~~n~l~ 182 (571)
.|++|+.|.++.| ++.+.++.....+|+|++|+|++|.+... --..+..+++|..|++.+|..+
T Consensus 63 ~Lp~LkkL~lsdn~~~~~~~l~vl~e~~P~l~~l~ls~Nki~~lstl~pl~~l~nL~~Ldl~n~~~~ 129 (260)
T KOG2739|consen 63 KLPKLKKLELSDNYRRVSGGLEVLAEKAPNLKVLNLSGNKIKDLSTLRPLKELENLKSLDLFNCSVT 129 (260)
T ss_pred CcchhhhhcccCCcccccccceehhhhCCceeEEeecCCccccccccchhhhhcchhhhhcccCCcc
Confidence 3444444444444 33332222233334444444444444310 0011233444455555555443
|
|
| >KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.00037 Score=64.51 Aligned_cols=40 Identities=38% Similarity=0.397 Sum_probs=18.4
Q ss_pred cCCCCCEEEcCCc--cCccCcchhhhcccCCCEEEccCCcCC
Q 044615 264 NLVKLHYLNLSNN--QFSQKIPNKIEKLIHLSELDLSHNIFR 303 (571)
Q Consensus 264 ~l~~L~~L~Ls~n--~l~~~~~~~~~~l~~L~~L~Ls~n~l~ 303 (571)
.+++|+.|.++.| .+++.++.....+++|+.|++++|++.
T Consensus 63 ~Lp~LkkL~lsdn~~~~~~~l~vl~e~~P~l~~l~ls~Nki~ 104 (260)
T KOG2739|consen 63 KLPKLKKLELSDNYRRVSGGLEVLAEKAPNLKVLNLSGNKIK 104 (260)
T ss_pred CcchhhhhcccCCcccccccceehhhhCCceeEEeecCCccc
Confidence 3444555555555 333333333333455555555555543
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.00037 Score=66.09 Aligned_cols=89 Identities=20% Similarity=0.312 Sum_probs=68.7
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC------Ce
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA------LH 535 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~------~~ 535 (571)
.|.-...+|.|+- .|..+. .-.++.||+|+.... .......++..+|..++..+.|+||++++.+|... ..
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 3666677888876 555555 337899999998765 33345567788999999999999999999999654 35
Q ss_pred eEEEEeccCCCChhhhhcc
Q 044615 536 SFVVYEYLEMGSLAMNLSN 554 (571)
Q Consensus 536 ~~lv~e~~~~G~L~~~l~~ 554 (571)
.|+|||||.. +|...++.
T Consensus 96 ~y~v~e~m~~-nl~~vi~~ 113 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVILM 113 (369)
T ss_pred HHHHHHhhhh-HHHHHHHH
Confidence 7999999974 89888873
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.0032 Score=56.27 Aligned_cols=77 Identities=16% Similarity=0.090 Sum_probs=55.0
Q ss_pred cCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcc-cEEEEEEeCCeeEEEEeccCC
Q 044615 467 GHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIV-KFYGFCSHALHSFVVYEYLEM 545 (571)
Q Consensus 467 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~~~~~~~~~~~lv~e~~~~ 545 (571)
.+.++.|.++.||++... +..|++|........ ...+.+|++++..+.+.+++ +++++. ....++||||++|
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G 75 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTEL----LINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEG 75 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCccc----ccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCC
Confidence 356899999999999864 778999997644211 23467899999888666555 444433 3345799999999
Q ss_pred CChhh
Q 044615 546 GSLAM 550 (571)
Q Consensus 546 G~L~~ 550 (571)
.++.+
T Consensus 76 ~~l~~ 80 (170)
T cd05151 76 SELLT 80 (170)
T ss_pred Ccccc
Confidence 88864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG2123 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.00013 Score=67.74 Aligned_cols=98 Identities=20% Similarity=0.203 Sum_probs=51.9
Q ss_pred CCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCccc-chhccCCCCCCEEEc
Q 044615 243 QLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEI-PSQICSMQSLEKLNL 321 (571)
Q Consensus 243 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~L 321 (571)
+.+.|+.-++.++++ .....++.|+.|.||-|.|+..- .+..++.|++|+|..|.|.... -..+.++++|+.|+|
T Consensus 20 ~vkKLNcwg~~L~DI--sic~kMp~lEVLsLSvNkIssL~--pl~rCtrLkElYLRkN~I~sldEL~YLknlpsLr~LWL 95 (388)
T KOG2123|consen 20 NVKKLNCWGCGLDDI--SICEKMPLLEVLSLSVNKISSLA--PLQRCTRLKELYLRKNCIESLDELEYLKNLPSLRTLWL 95 (388)
T ss_pred HhhhhcccCCCccHH--HHHHhcccceeEEeeccccccch--hHHHHHHHHHHHHHhcccccHHHHHHHhcCchhhhHhh
Confidence 344444444444332 22344555666666666665332 2455566666666666654321 124566677777777
Q ss_pred cCCcCcccccc-----ccccCCCCCEEE
Q 044615 322 SHNNLSGSIPR-----CFEEMHWLSCID 344 (571)
Q Consensus 322 s~n~l~~~~p~-----~~~~l~~L~~L~ 344 (571)
..|+-.|..+. .+.-+|+|+.||
T Consensus 96 ~ENPCc~~ag~nYR~~VLR~LPnLkKLD 123 (388)
T KOG2123|consen 96 DENPCCGEAGQNYRRKVLRVLPNLKKLD 123 (388)
T ss_pred ccCCcccccchhHHHHHHHHcccchhcc
Confidence 77766554432 234456666655
|
|
| >KOG2123 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.00014 Score=67.55 Aligned_cols=79 Identities=30% Similarity=0.293 Sum_probs=34.9
Q ss_pred CCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccc-cccccCCCCCCeeecccCcCcccCCc-----cccCC
Q 044615 95 NMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSI-PLSFANLTSLSILYLYENSLCDSIPK-----EIGNM 168 (571)
Q Consensus 95 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~-~~~~~~l~~L~~L~L~~n~l~~~~~~-----~l~~l 168 (571)
.|+.|++|.||-|.|+.. ..|..+++|+.|+|..|.|...- -..+.++++|+.|.|..|.=.+..+. .+.-|
T Consensus 39 kMp~lEVLsLSvNkIssL--~pl~rCtrLkElYLRkN~I~sldEL~YLknlpsLr~LWL~ENPCc~~ag~nYR~~VLR~L 116 (388)
T KOG2123|consen 39 KMPLLEVLSLSVNKISSL--APLQRCTRLKELYLRKNCIESLDELEYLKNLPSLRTLWLDENPCCGEAGQNYRRKVLRVL 116 (388)
T ss_pred hcccceeEEeeccccccc--hhHHHHHHHHHHHHHhcccccHHHHHHHhcCchhhhHhhccCCcccccchhHHHHHHHHc
Confidence 344444555554444422 22344444555555555443211 11234555555555555554433222 13345
Q ss_pred CCCCEEE
Q 044615 169 NSLSILD 175 (571)
Q Consensus 169 ~~L~~L~ 175 (571)
|+|+.||
T Consensus 117 PnLkKLD 123 (388)
T KOG2123|consen 117 PNLKKLD 123 (388)
T ss_pred ccchhcc
Confidence 5555553
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.012 Score=51.80 Aligned_cols=79 Identities=16% Similarity=0.156 Sum_probs=57.8
Q ss_pred ccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEeccCC
Q 044615 466 DGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEM 545 (571)
Q Consensus 466 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 545 (571)
..+.||+|.+|.||.|.+. |..+|+|+-..+. .+..+..|++++..+...++-+=+..+ +..++.|||+.|
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~y---g~~~i~me~i~G 96 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFY---GEDFIRMEYIDG 96 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEe---chhhhhhhhhcC
Confidence 4567999999999999984 5588999865432 246788999999998877776533333 223466999999
Q ss_pred CChhhhhc
Q 044615 546 GSLAMNLS 553 (571)
Q Consensus 546 G~L~~~l~ 553 (571)
-.|.+.-.
T Consensus 97 ~~L~~~~~ 104 (201)
T COG2112 97 RPLGKLEI 104 (201)
T ss_pred cchhhhhh
Confidence 78766554
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.0012 Score=68.38 Aligned_cols=86 Identities=17% Similarity=0.255 Sum_probs=69.0
Q ss_pred eeeccCcceEEEEE----cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcC-CCCcccEEEEEEeCCeeEEEEecc
Q 044615 469 CIGNGGQGSVYKAK----LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR-HRNIVKFYGFCSHALHSFVVYEYL 543 (571)
Q Consensus 469 ~lg~G~~g~V~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~ 543 (571)
++|+|+||.|+.++ ...|..+|+|.+.+..... +.......|..++..++ ||.+|+++..+++....+++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~-~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKV-RDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccc-ccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 36999999999775 2357789999987654332 22225667788888887 999999999999999999999999
Q ss_pred CCCChhhhhccC
Q 044615 544 EMGSLAMNLSND 555 (571)
Q Consensus 544 ~~G~L~~~l~~~ 555 (571)
.||+++..+.+.
T Consensus 80 rgg~lft~l~~~ 91 (612)
T KOG0603|consen 80 RGGDLFTRLSKE 91 (612)
T ss_pred ccchhhhccccC
Confidence 999999888754
|
|
| >KOG1947 consensus Leucine rich repeat proteins, some proteins contain F-box [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.0016 Score=68.98 Aligned_cols=15 Identities=33% Similarity=0.188 Sum_probs=7.2
Q ss_pred ccCCCCCEEEcCCcc
Q 044615 263 SNLVKLHYLNLSNNQ 277 (571)
Q Consensus 263 ~~l~~L~~L~Ls~n~ 277 (571)
..+++++.+.+..+.
T Consensus 359 ~~~~~l~~~~l~~~~ 373 (482)
T KOG1947|consen 359 RSCPKLTDLSLSYCG 373 (482)
T ss_pred hcCCCcchhhhhhhh
Confidence 344445555544444
|
|
| >PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=95.25 E-value=0.0086 Score=33.08 Aligned_cols=18 Identities=50% Similarity=0.593 Sum_probs=8.4
Q ss_pred CCEEecccCcCcccccccc
Q 044615 99 LSDLQLSENILNGSIPLAL 117 (571)
Q Consensus 99 L~~L~L~~n~i~~~~~~~~ 117 (571)
|++|||++|+++ .+|..|
T Consensus 2 L~~Ldls~n~l~-~ip~~~ 19 (22)
T PF00560_consen 2 LEYLDLSGNNLT-SIPSSF 19 (22)
T ss_dssp ESEEEETSSEES-EEGTTT
T ss_pred ccEEECCCCcCE-eCChhh
Confidence 445555555554 344333
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A .... |
| >KOG4341 consensus F-box protein containing LRR [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.14 E-value=0.0014 Score=64.43 Aligned_cols=277 Identities=18% Similarity=0.089 Sum_probs=0.0
Q ss_pred CccceeecccccccCCCCCCCccccccccCCCCCCEEecccC-cCcccccccc-cCCCCCCEEEccc-CcCcccccc-cc
Q 044615 66 TFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSEN-ILNGSIPLAL-GNLTNLVVLDLST-NKLSGSIPL-SF 141 (571)
Q Consensus 66 ~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n-~i~~~~~~~~-~~l~~L~~L~L~~-n~i~~~~~~-~~ 141 (571)
.+|+.|.++++.=.+.. .+-....++++++.|++.++ .++...-..+ ..+++|+.|+|.. -.++...-. -.
T Consensus 138 g~lk~LSlrG~r~v~~s-----slrt~~~~CpnIehL~l~gc~~iTd~s~~sla~~C~~l~~l~L~~c~~iT~~~Lk~la 212 (483)
T KOG4341|consen 138 GFLKELSLRGCRAVGDS-----SLRTFASNCPNIEHLALYGCKKITDSSLLSLARYCRKLRHLNLHSCSSITDVSLKYLA 212 (483)
T ss_pred cccccccccccccCCcc-----hhhHHhhhCCchhhhhhhcceeccHHHHHHHHHhcchhhhhhhcccchhHHHHHHHHH
Q ss_pred cCCCCCCeeecccCcCccc--CCccccCCCCCCEEEccCCCCCccCChhhhhccCC---CcEEEccCCcccccCCccc--
Q 044615 142 ANLTSLSILYLYENSLCDS--IPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNS---LKVLYLSSNHIVGEIPLGH-- 214 (571)
Q Consensus 142 ~~l~~L~~L~L~~n~l~~~--~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~---L~~L~l~~n~~~~~~~~~~-- 214 (571)
..+++|++|+++.+.--.. +.....++..++.+.+.+|. ..--..+...... +..+++..+..-.......
T Consensus 213 ~gC~kL~~lNlSwc~qi~~~gv~~~~rG~~~l~~~~~kGC~--e~~le~l~~~~~~~~~i~~lnl~~c~~lTD~~~~~i~ 290 (483)
T KOG4341|consen 213 EGCRKLKYLNLSWCPQISGNGVQALQRGCKELEKLSLKGCL--ELELEALLKAAAYCLEILKLNLQHCNQLTDEDLWLIA 290 (483)
T ss_pred HhhhhHHHhhhccCchhhcCcchHHhccchhhhhhhhcccc--cccHHHHHHHhccChHhhccchhhhccccchHHHHHh
Q ss_pred cCCCCCcEEeCccCcCcCCCChh--hhCCCCCCEEEcccCc-cccccchhh-ccCCCCCEEEcCCccC--ccCcchhhhc
Q 044615 215 GMLSSLIQLTLNNNELSGQLSPE--LGSLIQLEYLDLSANT-FHKSIPESL-SNLVKLHYLNLSNNQF--SQKIPNKIEK 288 (571)
Q Consensus 215 ~~l~~L~~L~l~~n~l~~~~~~~--~~~l~~L~~L~L~~n~-l~~~~~~~l-~~l~~L~~L~Ls~n~l--~~~~~~~~~~ 288 (571)
..+..|+.|+.+++.-.+..+-+ -.+.++|+.|.++.++ |+..-...+ .+++.|+.+++.++.. .+.+-..-.+
T Consensus 291 ~~c~~lq~l~~s~~t~~~d~~l~aLg~~~~~L~~l~l~~c~~fsd~~ft~l~rn~~~Le~l~~e~~~~~~d~tL~sls~~ 370 (483)
T KOG4341|consen 291 CGCHALQVLCYSSCTDITDEVLWALGQHCHNLQVLELSGCQQFSDRGFTMLGRNCPHLERLDLEECGLITDGTLASLSRN 370 (483)
T ss_pred hhhhHhhhhcccCCCCCchHHHHHHhcCCCceEEEeccccchhhhhhhhhhhcCChhhhhhcccccceehhhhHhhhccC
Q ss_pred ccCCCEEEccCCcCCccc-----chhccCCCCCCEEEccCCcC-ccccccccccCCCCCEEECcCCc
Q 044615 289 LIHLSELDLSHNIFREEI-----PSQICSMQSLEKLNLSHNNL-SGSIPRCFEEMHWLSCIDISYNA 349 (571)
Q Consensus 289 l~~L~~L~Ls~n~l~~~~-----~~~~~~l~~L~~L~Ls~n~l-~~~~p~~~~~l~~L~~L~ls~N~ 349 (571)
.+.|+.|.++++...... ...-+++..|+.+.|++++. +...-+.+..++.|+.+++-..+
T Consensus 371 C~~lr~lslshce~itD~gi~~l~~~~c~~~~l~~lEL~n~p~i~d~~Le~l~~c~~Leri~l~~~q 437 (483)
T KOG4341|consen 371 CPRLRVLSLSHCELITDEGIRHLSSSSCSLEGLEVLELDNCPLITDATLEHLSICRNLERIELIDCQ 437 (483)
T ss_pred CchhccCChhhhhhhhhhhhhhhhhccccccccceeeecCCCCchHHHHHHHhhCcccceeeeechh
|
|
| >PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=95.00 E-value=0.011 Score=32.69 Aligned_cols=21 Identities=67% Similarity=0.865 Sum_probs=11.2
Q ss_pred CCCEEEcccCcCcccccccccC
Q 044615 122 NLVVLDLSTNKLSGSIPLSFAN 143 (571)
Q Consensus 122 ~L~~L~L~~n~i~~~~~~~~~~ 143 (571)
+|++|||++|+++ .+|..|++
T Consensus 1 ~L~~Ldls~n~l~-~ip~~~~~ 21 (22)
T PF00560_consen 1 NLEYLDLSGNNLT-SIPSSFSN 21 (22)
T ss_dssp TESEEEETSSEES-EEGTTTTT
T ss_pred CccEEECCCCcCE-eCChhhcC
Confidence 3556666666665 44444443
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A .... |
| >KOG1947 consensus Leucine rich repeat proteins, some proteins contain F-box [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.93 E-value=0.0038 Score=66.21 Aligned_cols=32 Identities=28% Similarity=0.064 Sum_probs=18.7
Q ss_pred hhhCCCCCCEEEcccCcccccc-chhhccCCCC
Q 044615 237 ELGSLIQLEYLDLSANTFHKSI-PESLSNLVKL 268 (571)
Q Consensus 237 ~~~~l~~L~~L~L~~n~l~~~~-~~~l~~l~~L 268 (571)
....+++++.+.+..+...... ...+.++++|
T Consensus 357 ~~~~~~~l~~~~l~~~~~~~~~~~~~l~gc~~l 389 (482)
T KOG1947|consen 357 ILRSCPKLTDLSLSYCGISDLGLELSLRGCPNL 389 (482)
T ss_pred HHhcCCCcchhhhhhhhccCcchHHHhcCCccc
Confidence 4566788888888777643222 2334555555
|
|
| >KOG4308 consensus LRR-containing protein [Function unknown] | Back alignment and domain information |
|---|
Probab=94.73 E-value=0.00034 Score=72.86 Aligned_cols=36 Identities=42% Similarity=0.416 Sum_probs=18.2
Q ss_pred CCEEecccCcCcccc----cccccCCCCCCEEEcccCcCc
Q 044615 99 LSDLQLSENILNGSI----PLALGNLTNLVVLDLSTNKLS 134 (571)
Q Consensus 99 L~~L~L~~n~i~~~~----~~~~~~l~~L~~L~L~~n~i~ 134 (571)
+..|+|.+|.+.... ...+.....|+.|++++|.+.
T Consensus 89 l~~L~L~~~~l~~~~~~~l~~~l~t~~~L~~L~l~~n~l~ 128 (478)
T KOG4308|consen 89 LLHLSLANNRLGDRGAEELAQALKTLPTLGQLDLSGNNLG 128 (478)
T ss_pred HHHhhhhhCccccchHHHHHHHhcccccHhHhhcccCCCc
Confidence 555666666555332 223344455555555555554
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 571 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 5e-31 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-30 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 4e-19 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-07 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 2e-12 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 2e-12 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 3e-12 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 2e-11 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 3e-11 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 3e-11 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 3e-11 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-10 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-10 | ||
| 3zyn_A | 321 | Crystal Structure Of The N-Terminal Leucine Rich Re | 6e-08 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 7e-08 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 6e-06 | ||
| 3zyo_A | 411 | Crystal Structure Of The N-Terminal Leucine Rich Re | 1e-07 | ||
| 3zyj_A | 440 | Netring1 In Complex With Ngl1 Length = 440 | 2e-07 | ||
| 2id5_A | 477 | Crystal Structure Of The Lingo-1 Ectodomain Length | 2e-07 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-07 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-07 | ||
| 4b8c_D | 727 | Nuclease Module Of The Yeast Ccr4-Not Complex Lengt | 3e-07 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 7e-07 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-06 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-06 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-06 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-05 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-05 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-05 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-05 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-05 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-05 | ||
| 3e6j_A | 229 | Crystal Structure Of Variable Lymphocyte Receptor ( | 3e-05 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-05 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-05 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-05 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-05 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-05 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-05 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-05 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-05 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-05 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-05 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-05 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-04 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-04 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-04 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-04 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-04 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-04 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-04 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-04 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-04 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-04 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-04 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-04 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-04 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-04 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-04 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-04 | ||
| 2z64_A | 599 | Crystal Structure Of Mouse Tlr4 And Mouse Md-2 Comp | 2e-04 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-04 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-04 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-04 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-04 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-04 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-04 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-04 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-04 | ||
| 3vq1_A | 606 | Crystal Structure Of Mouse Tlr4MD-2LIPID IVA COMPLE | 2e-04 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-04 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-04 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-04 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-04 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-04 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-04 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-04 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-04 | ||
| 3zyi_A | 452 | Netring2 In Complex With Ngl2 Length = 452 | 3e-04 | ||
| 3b2d_A | 603 | Crystal Structure Of Human Rp105MD-1 Complex Length | 3e-04 | ||
| 3fxi_A | 605 | Crystal Structure Of The Human Tlr4-Human Md-2-E.Co | 3e-04 | ||
| 2o6s_A | 208 | Structural Diversity Of The Hagfish Variable Lympho | 4e-04 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-04 | ||
| 3rfj_A | 279 | Design Of A Binding Scaffold Based On Variable Lymp | 4e-04 | ||
| 3oja_B | 597 | Crystal Structure Of Lrim1APL1C COMPLEX Length = 59 | 4e-04 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-04 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-04 | ||
| 1ozn_A | 285 | 1.5a Crystal Structure Of The Nogo Receptor Ligand | 6e-04 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 6e-04 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-04 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-04 | ||
| 4g8a_A | 635 | Crystal Structure Of Human Tlr4 Polymorphic Variant | 7e-04 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-04 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-04 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 9e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3ZYN|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats Of Netrin-G Ligand-3 Length = 321 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|3ZYO|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats And Immunoglobulin Domain Of Netrin-G Ligand-3 Length = 411 | Back alignment and structure |
|
| >pdb|3ZYJ|A Chain A, Netring1 In Complex With Ngl1 Length = 440 | Back alignment and structure |
|
| >pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2Z64|A Chain A, Crystal Structure Of Mouse Tlr4 And Mouse Md-2 Complex Length = 599 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3VQ1|A Chain A, Crystal Structure Of Mouse Tlr4MD-2LIPID IVA COMPLEX Length = 606 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3ZYI|A Chain A, Netring2 In Complex With Ngl2 Length = 452 | Back alignment and structure |
|
| >pdb|3B2D|A Chain A, Crystal Structure Of Human Rp105MD-1 Complex Length = 603 | Back alignment and structure |
|
| >pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps Ra Complex Length = 605 | Back alignment and structure |
|
| >pdb|2O6S|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors B59 Length = 208 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279 | Back alignment and structure |
|
| >pdb|3OJA|B Chain B, Crystal Structure Of Lrim1APL1C COMPLEX Length = 597 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4G8A|A Chain A, Crystal Structure Of Human Tlr4 Polymorphic Variant D299g And T399i In Complex With Md-2 And Lps Length = 635 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 571 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-90 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-81 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-80 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-78 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-72 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 5e-71 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-63 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 7e-53 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 5e-79 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 4e-71 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 5e-60 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 4e-59 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-57 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 6e-51 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 4e-45 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-39 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-57 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 6e-57 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-56 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 9e-55 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-52 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-42 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-30 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 3e-54 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 3e-50 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-38 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-37 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 7e-21 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-49 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-48 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-46 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 4e-44 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-43 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-43 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-28 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 6e-27 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 3e-21 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-49 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 5e-48 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 7e-43 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-41 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 4e-40 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-32 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-18 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 4e-49 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 3e-45 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 4e-44 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 6e-41 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-48 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 4e-48 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 8e-48 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-47 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-47 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-45 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 7e-43 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-28 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-25 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 5e-09 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 9e-47 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-40 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-26 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 5e-13 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-45 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-42 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-42 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 4e-41 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 3e-38 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-24 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 5e-15 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 3e-43 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 3e-37 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 4e-27 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 5e-23 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-41 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 8e-41 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-40 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 5e-40 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 3e-36 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-34 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 5e-10 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 4e-38 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 6e-35 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 6e-28 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 6e-08 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 4e-38 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 3e-37 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 9e-35 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 3e-14 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 9e-38 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 5e-35 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-28 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 4e-37 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 1e-35 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 1e-31 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-21 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 4e-13 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-09 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 1e-34 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 1e-32 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 4e-30 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 1e-24 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-34 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-33 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-31 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 5e-30 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-29 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-29 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-20 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 5e-34 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-11 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 8e-34 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 1e-33 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 3e-32 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-31 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 1e-27 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 6e-27 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 3e-26 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-17 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 1e-33 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 3e-31 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 2e-05 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 5e-33 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 2e-31 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 4e-32 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 5e-32 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 5e-32 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-31 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 4e-15 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-09 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 5e-32 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 5e-28 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 5e-28 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-27 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 4e-26 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-18 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-12 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-04 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 1e-31 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 4e-28 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 2e-22 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 4e-31 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 5e-29 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 1e-20 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 1e-29 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 8e-25 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 7e-07 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 8e-29 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 3e-28 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 6e-05 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 8e-29 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 1e-26 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-13 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 3e-28 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 5e-27 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 7e-27 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 8e-20 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 7e-28 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-27 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 7e-26 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 9e-05 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 1e-26 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 1e-24 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 1e-21 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 1e-19 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 8e-12 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 3e-06 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 2e-26 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 5e-26 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 2e-24 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 9e-22 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 3e-21 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-11 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 5e-07 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 7e-26 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-24 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-19 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 2e-12 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-25 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 1e-24 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 7e-04 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 8e-04 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 7e-25 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-20 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 7e-19 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-24 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-04 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 5e-24 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 1e-20 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 1e-13 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-23 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 5e-21 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 5e-18 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 5e-12 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-22 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-21 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-20 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 1e-18 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 1e-12 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 5e-21 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-19 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-15 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-10 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 6e-21 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 1e-15 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 1e-04 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 5e-20 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 3e-19 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-15 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 9e-20 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 1e-17 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 7e-17 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 1e-15 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 1e-15 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 4e-11 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 1e-10 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 3e-19 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 1e-15 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-13 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 3e-04 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 7e-19 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 2e-16 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 1e-14 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 1e-06 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 1e-18 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 1e-18 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 8e-18 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-17 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 4e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-06 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 1e-17 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 3e-17 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 1e-10 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 2e-07 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 3e-17 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 8e-17 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 6e-16 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 6e-13 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 2e-07 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 4e-06 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 5e-17 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 1e-16 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 1e-15 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 5e-15 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 5e-15 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-14 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 8e-14 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 8e-14 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 3e-10 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 3e-04 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 1e-13 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 5e-12 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 4e-11 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 1e-05 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 3e-13 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-09 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 1e-12 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 2e-12 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 3e-12 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 7e-09 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 8e-09 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 1e-08 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 4e-12 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 5e-12 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 7e-12 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 1e-11 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 1e-11 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-11 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 6e-11 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 2e-10 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 7e-10 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 3e-11 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 3e-11 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 4e-11 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 4e-11 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 4e-11 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 6e-11 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 8e-11 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 8e-11 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 9e-11 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 1e-10 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 1e-10 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 2e-10 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 3e-09 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 1e-10 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 8e-08 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 1e-10 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 1e-10 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 2e-10 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 2e-10 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 3e-10 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 3e-10 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 3e-04 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 3e-10 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 3e-10 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 5e-09 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 6e-09 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 9e-08 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-07 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 8e-07 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 6e-04 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 3e-10 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 3e-10 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 3e-10 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 3e-10 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 4e-10 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 4e-10 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 6e-10 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 6e-10 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 7e-10 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 4e-09 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-08 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 7e-10 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 8e-10 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 9e-10 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 1e-09 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-09 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 6e-08 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 5e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 5e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 5e-05 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 1e-09 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 1e-09 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 2e-09 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 2e-09 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-09 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-09 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-07 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 3e-07 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-06 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-06 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 3e-05 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 3e-09 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 3e-09 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 3e-09 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 1e-08 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 2e-08 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 4e-09 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 4e-09 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 4e-09 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 5e-05 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 3e-04 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 4e-04 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 6e-09 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 6e-09 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 7e-09 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 7e-09 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 7e-09 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 1e-08 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 4e-07 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 3e-05 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 1e-08 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 1e-08 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-08 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 2e-08 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 2e-07 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 2e-08 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 2e-08 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 4e-08 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 4e-08 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 4e-08 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 4e-08 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 1e-06 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 1e-06 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 2e-06 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 5e-08 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 5e-08 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 6e-08 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 6e-08 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 7e-08 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 7e-08 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 8e-08 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 9e-08 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-07 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 1e-07 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 1e-07 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 1e-07 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 1e-07 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 1e-07 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-07 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 1e-07 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-07 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-07 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 2e-07 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 2e-04 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 8e-04 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 2e-07 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 2e-07 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-07 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 2e-07 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 2e-07 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-07 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-07 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 3e-07 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 3e-07 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 3e-07 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 3e-07 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 4e-07 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 4e-07 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 4e-07 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 5e-07 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 6e-07 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 8e-07 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 8e-07 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 9e-07 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-06 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 1e-06 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 1e-06 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 1e-06 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 1e-06 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 2e-06 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 2e-06 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 2e-06 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-06 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 2e-06 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 3e-06 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 3e-06 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 4e-06 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 4e-06 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 5e-06 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 6e-06 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 6e-06 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 8e-04 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 8e-06 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 9e-06 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 1e-05 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 1e-05 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 1e-05 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 1e-05 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 1e-05 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 1e-05 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 1e-05 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 2e-05 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 2e-05 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 2e-05 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 2e-05 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-05 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 2e-05 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 2e-05 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 2e-05 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 2e-05 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 2e-05 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 3e-05 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 3e-05 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 3e-05 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 3e-05 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 4e-05 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 4e-05 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 5e-05 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 5e-05 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 6e-05 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 6e-05 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 6e-05 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 7e-05 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 8e-05 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 8e-05 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 8e-05 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 8e-05 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 9e-05 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 1e-04 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 1e-04 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-04 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 3e-04 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 3e-04 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 4e-04 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 4e-04 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 7e-04 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 293 bits (753), Expect = 2e-90
Identities = 97/302 (32%), Positives = 145/302 (48%), Gaps = 9/302 (2%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANL 144
L IP E+ +K+L L L N L G IP L N TNL + LS N+L+G IP L
Sbjct: 454 LEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRL 513
Query: 145 TSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSN 204
+L+IL L NS +IP E+G+ SL LDL++N NG+IP ++ + + ++N
Sbjct: 514 ENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKI-----AAN 568
Query: 205 HIVGEIP--LGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESL 262
I G+ + + + N E G S +L L ++++ + +
Sbjct: 569 FIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTF 628
Query: 263 SNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLS 322
N + +L++S N S IP +I + +L L+L HN IP ++ ++ L L+LS
Sbjct: 629 DNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLS 688
Query: 323 HNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDIKRLP 382
N L G IP+ + L+ ID+S N L G IP F P N LCG LP
Sbjct: 689 SNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP--LP 746
Query: 383 PC 384
C
Sbjct: 747 RC 748
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 269 bits (690), Expect = 3e-81
Identities = 94/274 (34%), Positives = 142/274 (51%), Gaps = 4/274 (1%)
Query: 88 SIPDEI-GNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPL-SFANLT 145
IPD + G +L+ L LS N G++P G+ + L L LS+N SG +P+ + +
Sbjct: 284 EIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMR 343
Query: 146 SLSILYLYENSLCDSIPKEIGNM-NSLSILDLSSNKLNGSIPLSLANLT-NSLKVLYLSS 203
L +L L N +P+ + N+ SL LDLSSN +G I +L N+L+ LYL +
Sbjct: 344 GLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQN 403
Query: 204 NHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLS 263
N G+IP S L+ L L+ N LSG + LGSL +L L L N IP+ L
Sbjct: 404 NGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELM 463
Query: 264 NLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSH 323
+ L L L N + +IP+ + +L+ + LS+N EIP I +++L L LS+
Sbjct: 464 YVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSN 523
Query: 324 NNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNS 357
N+ SG+IP + L +D++ N G IP +
Sbjct: 524 NSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAA 557
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 267 bits (686), Expect = 1e-80
Identities = 96/277 (34%), Positives = 137/277 (49%), Gaps = 9/277 (3%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANL 144
+ + + +L L +S N + IP LG+ + L LD+S NKLSG + +
Sbjct: 190 ISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTC 246
Query: 145 TSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSN 204
T L +L + N IP + SL L L+ NK G IP L+ ++L L LS N
Sbjct: 247 TELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGN 304
Query: 205 HIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPE-LGSLIQLEYLDLSANTFHKSIPESLS 263
H G +P G S L L L++N SG+L + L + L+ LDLS N F +PESL+
Sbjct: 305 HFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLT 364
Query: 264 NL-VKLHYLNLSNNQFSQKIPNKIEK--LIHLSELDLSHNIFREEIPSQICSMQSLEKLN 320
NL L L+LS+N FS I + + L EL L +N F +IP + + L L+
Sbjct: 365 NLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLH 424
Query: 321 LSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNS 357
LS N LSG+IP + L + + N L+G IP
Sbjct: 425 LSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQE 461
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 261 bits (670), Expect = 2e-78
Identities = 97/277 (35%), Positives = 142/277 (51%), Gaps = 9/277 (3%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILNGSIPL-ALGNLTNLVVLDLSTNKLSGSIPLSFAN 143
Y ++P G+ L L LS N +G +P+ L + L VLDLS N+ SG +P S N
Sbjct: 306 FYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTN 365
Query: 144 LT-SLSILYLYENSLCDSIPKEIGN--MNSLSILDLSSNKLNGSIPLSLANLTNSLKVLY 200
L+ SL L L N+ I + N+L L L +N G IP +L+N + L L+
Sbjct: 366 LSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSE-LVSLH 424
Query: 201 LSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPE 260
LS N++ G IP G LS L L L N L G++ EL + LE L L N IP
Sbjct: 425 LSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPS 484
Query: 261 SLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLN 320
LSN L++++LSNN+ + +IP I +L +L+ L LS+N F IP+++ +SL L+
Sbjct: 485 GLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLD 544
Query: 321 LSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNS 357
L+ N +G+IP + I+ N + G
Sbjct: 545 LNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVY 577
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 3e-72
Identities = 84/280 (30%), Positives = 134/280 (47%), Gaps = 12/280 (4%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIP--LSFA 142
+S++ + ++ L L LS + +NGS+ +L LDLS N LSG + S
Sbjct: 65 GFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLG 123
Query: 143 NLTSLSILYLYENSLCDSIPKEIG-NMNSLSILDLSSNKLNGSIPLSLANLTN--SLKVL 199
+ + L L + N+L G +NSL +LDLS+N ++G+ + LK L
Sbjct: 124 SCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHL 183
Query: 200 YLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIP 259
+S N I G++ + +L L +++N S + P LG L++LD+S N
Sbjct: 184 AISGNKISGDVDVSR--CVNLEFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFS 240
Query: 260 ESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQIC-SMQSLEK 318
++S +L LN+S+NQF IP L L L L+ N F EIP + + +L
Sbjct: 241 RAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTG 298
Query: 319 LNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNST 358
L+LS N+ G++P F L + +S N G +P T
Sbjct: 299 LDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDT 338
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 5e-71
Identities = 86/276 (31%), Positives = 133/276 (48%), Gaps = 11/276 (3%)
Query: 88 SIPDE-IGNMKSLSDLQLSENILNGSIPLALGNLT-NLVVLDLSTNKLSGSIPLSFAN-- 143
+P + + M+ L L LS N +G +P +L NL+ +L+ LDLS+N SG I +
Sbjct: 333 ELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNP 392
Query: 144 LTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSS 203
+L LYL N IP + N + L L LS N L+G+IP SL +L+ L+ L L
Sbjct: 393 KNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSK-LRDLKLWL 451
Query: 204 NHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLS 263
N + GEIP + +L L L+ N+L+G++ L + L ++ LS N IP+ +
Sbjct: 452 NMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIG 511
Query: 264 NLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSH 323
L L L LSNN FS IP ++ L LDL+ N+F IP+ + ++
Sbjct: 512 RLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAA 567
Query: 324 NNLSGSIPRCFEEMHWLSCIDISYNALQ--GLIPNS 357
N ++G + + N L+ G+
Sbjct: 568 NFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQ 603
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 3e-63
Identities = 81/269 (30%), Positives = 129/269 (47%), Gaps = 15/269 (5%)
Query: 98 SLSDLQLSENILN---GSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYE 154
++ + LS LN ++ +L +LT L L LS + ++GS+ F SL+ L L
Sbjct: 51 KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSR 109
Query: 155 NSLCDSIP--KEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIP- 211
NSL + +G+ + L L++SSN L+ +S NSL+VL LS+N I G
Sbjct: 110 NSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVV 169
Query: 212 --LGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLH 269
+ L L ++ N++SG + + + LE+LD+S+N F IP L + L
Sbjct: 170 GWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQ 226
Query: 270 YLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGS 329
+L++S N+ S I L L++S N F IP SL+ L+L+ N +G
Sbjct: 227 HLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLK--SLQYLSLAENKFTGE 284
Query: 330 IPRCFE-EMHWLSCIDISYNALQGLIPNS 357
IP L+ +D+S N G +P
Sbjct: 285 IPDFLSGACDTLTGLDLSGNHFYGAVPPF 313
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 7e-53
Identities = 70/248 (28%), Positives = 114/248 (45%), Gaps = 16/248 (6%)
Query: 119 NLTNLVVLDLSTNKLS---GSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILD 175
+ +DLS+ L+ ++ S +LT L L+L + + S+ SL+ LD
Sbjct: 48 RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLD 106
Query: 176 LSSNKLNGSIP--LSLANLTNSLKVLYLSSNHIVGEIPLGHGM-LSSLIQLTLNNNELSG 232
LS N L+G + SL + + LK L +SSN + + G+ L+SL L L+ N +SG
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSG-LKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISG 165
Query: 233 QLSPEL---GSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKL 289
+L++L +S N + +S V L +L++S+N FS IP +
Sbjct: 166 ANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDC 222
Query: 290 IHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNA 349
L LD+S N + I + L+ LN+S N G IP + L + ++ N
Sbjct: 223 SALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENK 280
Query: 350 LQGLIPNS 357
G IP+
Sbjct: 281 FTGEIPDF 288
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 250 bits (641), Expect = 5e-79
Identities = 71/298 (23%), Positives = 120/298 (40%), Gaps = 53/298 (17%)
Query: 88 SIPDEIGNMKSLSDLQLS-ENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTS 146
IP + N+ L+ L + N L G IP A+ LT L L ++ +SG+IP + + +
Sbjct: 67 PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKT 126
Query: 147 LSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHI 206
L L N+L ++P I ++ +L + N+++G+IP S + + + +S N +
Sbjct: 127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL 186
Query: 207 VGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLV 266
G+IP P +L L ++DLS N +
Sbjct: 187 TGKIP------------------------PTFANL-NLAFVDLSRNMLEGDASVLFGSDK 221
Query: 267 KLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNL 326
++L+ N + + K+ +L+ LDL +N +P + ++ L LN+S NNL
Sbjct: 222 NTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL 280
Query: 327 SGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDIKRLPPC 384
G IP + + A NK LCG LP C
Sbjct: 281 CGE------------------------IPQGGNLQRFDVSAYANNKCLCGSP--LPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 4e-71
Identities = 68/229 (29%), Positives = 111/229 (48%), Gaps = 5/229 (2%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANL 144
L IP I + L L ++ ++G+IP L + LV LD S N LSG++P S ++L
Sbjct: 89 LVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSL 148
Query: 145 TSLSILYLYENSLCDSIPKEIGNMNSLS-ILDLSSNKLNGSIPLSLANLTNSLKVLYLSS 203
+L + N + +IP G+ + L + +S N+L G IP + ANL +L + LS
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL--NLAFVDLSR 206
Query: 204 NHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLS 263
N + G+ + G + ++ L N L+ L ++G L LDL N + ++P+ L+
Sbjct: 207 NMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLT 265
Query: 264 NLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICS 312
L LH LN+S N +IP + L ++N P C+
Sbjct: 266 QLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPLPACT 313
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 5e-60
Identities = 50/302 (16%), Positives = 102/302 (33%), Gaps = 36/302 (11%)
Query: 88 SIPDEIGNMKSLSDLQLSEN--------ILNGSIPLALGNLTNLVVLDLSTNKL-SGSIP 138
+P + + + + ++ N + + ++ + N L + +
Sbjct: 264 KLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVE 323
Query: 139 LSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKV 198
S + L +L N L + G+ L+ L+L+ N++ IP + T ++
Sbjct: 324 TSLQKMKKLGMLECLYNQL-EGKLPAFGSEIKLASLNLAYNQITE-IPANFCGFTEQVEN 381
Query: 199 LYLSSNHIVGEIP--LGHGMLSSLIQLTLNNNELSG-------QLSPELGSLIQLEYLDL 249
L + N + IP +S + + + NE+ L P I + ++L
Sbjct: 382 LSFAHNKL-KYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINL 440
Query: 250 SANTFHKSIPESLSNLVKLHYLNLSNNQFS-------QKIPNKIEKLIHLSELDLSHNIF 302
S N K E S L +NL N + + + L+ +DL N
Sbjct: 441 SNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKL 500
Query: 303 REEIPS-QICSMQSLEKLNLSHNNLSGSIPRCF------EEMHWLSCIDISYNALQGLIP 355
+ + ++ L ++LS+N+ S P + + D N P
Sbjct: 501 TKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWP 559
Query: 356 NS 357
Sbjct: 560 EG 561
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 4e-59
Identities = 46/289 (15%), Positives = 104/289 (35%), Gaps = 26/289 (8%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTS 146
+ + + + L + + N + + L + NL
Sbjct: 196 TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENS-----EYAQQYKTEDLKWDNLKD 250
Query: 147 LSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKL--------NGSIPLSLANLTNSLKV 198
L+ + +Y +P + + + +++++ N+ + +++
Sbjct: 251 LTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEK-IQI 309
Query: 199 LYLSSNHI-VGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKS 257
+Y+ N++ + + L L N+L G P GS I+L L+L+ N +
Sbjct: 310 IYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEI 368
Query: 258 IPESLSNLVKLHYLNLSNNQFSQKIPNKIE--KLIHLSELDLSHNIFR-------EEIPS 308
++ L+ ++N+ IPN + + +S +D S+N + +
Sbjct: 369 PANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDP 427
Query: 309 QICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNS 357
++ +NLS+N +S F LS I++ N L + NS
Sbjct: 428 TPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNS 476
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 1e-57
Identities = 57/330 (17%), Positives = 122/330 (36%), Gaps = 32/330 (9%)
Query: 79 TGQDWPLYSSIPDEIGNMKSLSDLQLSEN-ILNGSIPLALGNLTNLVVLDLSTNKLSGSI 137
+G+ + + + + + N + + +L + L +L+ N+L G +
Sbjct: 287 SGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKL 346
Query: 138 PLSFANLTSLSILYLYENSLCDSIPKEI-GNMNSLSILDLSSNKLNG-SIPLSLANLTNS 195
P +F + L+ L L N + IP G + L + NKL +++
Sbjct: 347 P-AFGSEIKLASLNLAYNQI-TEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSV- 403
Query: 196 LKVLYLSSNHIVG-------EIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLD 248
+ + S N I + ++ + L+NN++S + L ++
Sbjct: 404 MSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSIN 463
Query: 249 LSANTFH-------KSIPESLSNLVKLHYLNLSNNQFSQKIPNKIE--KLIHLSELDLSH 299
L N K E+ N L ++L N+ + K+ + L +L +DLS+
Sbjct: 464 LMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSY 522
Query: 300 NIFREEIPSQICSMQSLEKLNLSH------NNLSGSIPRCFEEMHWLSCIDISYNALQGL 353
N F + P+Q + +L+ + + N P L+ + I N ++ +
Sbjct: 523 NSF-SKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKV 581
Query: 354 IPNSTAFRDAPMLALQGNKRLCGDIKRLPP 383
+ +L ++ N + D+ + P
Sbjct: 582 NEKI--TPNISVLDIKDNPNISIDLSYVCP 609
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 6e-51
Identities = 47/288 (16%), Positives = 97/288 (33%), Gaps = 29/288 (10%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSG-SIPLSFANLT 145
G+ L+ L L+ N + G + L + NKL +++
Sbjct: 343 EGKLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVS 402
Query: 146 SLSILYLYENSL-------CDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKV 198
+S + N + D + ++S ++LS+N+++ + + L
Sbjct: 403 VMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSP-LSS 461
Query: 199 LYLSSNHIVG-------EIPLGHGMLSSLIQLTLNNNELSGQLSPEL--GSLIQLEYLDL 249
+ L N + + L + L N+L+ LS + +L L +DL
Sbjct: 462 INLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDL 520
Query: 250 SANTFHKSIPESLSNLVKL------HYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFR 303
S N+F P N L + + N+ ++ P I L++L + N
Sbjct: 521 SYNSF-SKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI- 578
Query: 304 EEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQ 351
++ +I ++ L++ N + Y+ Q
Sbjct: 579 RKVNEKITP--NISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 4e-45
Identities = 50/312 (16%), Positives = 104/312 (33%), Gaps = 38/312 (12%)
Query: 77 AFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGS 136
A G++W N +L + ++L + + L L SG
Sbjct: 41 ALNGKNWSQQGFGTQPGANWNFNKELDMW----GAQPGVSLNSNGRVTGLSLEGFGASGR 96
Query: 137 IPLSFANLTSLSILYLYENSL----CDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANL 192
+P + LT L +L L + PK I S +
Sbjct: 97 VPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPRE 156
Query: 193 TNS-LKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSA 251
S L ++S+ I + Q+ +N ++ +S + L +L +
Sbjct: 157 DFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGN 215
Query: 252 NTF-------------------HKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHL 292
+ F +K+ NL L + + N K+P ++ L +
Sbjct: 216 SPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEM 275
Query: 293 SELDLSHNIFR--EEIPSQICSMQSL------EKLNLSHNNL-SGSIPRCFEEMHWLSCI 343
++++ N E++ ++ + + + +NNL + + ++M L +
Sbjct: 276 QLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGML 335
Query: 344 DISYNALQGLIP 355
+ YN L+G +P
Sbjct: 336 ECLYNQLEGKLP 347
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-39
Identities = 46/257 (17%), Positives = 77/257 (29%), Gaps = 42/257 (16%)
Query: 78 FTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSI 137
D + + ++S + LS N ++ + L ++L N L+ I
Sbjct: 414 IGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE-I 472
Query: 138 PLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIP-LSLANLTNSL 196
P + + N L+ +DL NKL L L
Sbjct: 473 P----------------KNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPY-L 515
Query: 197 KVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHK 256
+ LS N + P S+L + N D N +
Sbjct: 516 VGIDLSYNSF-SKFPTQPLNSSTLKGFGIRNQ------------------RDAQGNRTLR 556
Query: 257 SIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSL 316
PE ++ L L + +N K+ KI ++S LD+ N S +C
Sbjct: 557 EWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEA 613
Query: 317 EKLNLSHNNLSGSIPRC 333
L ++ I C
Sbjct: 614 GMYMLFYDKTQ-DIRGC 629
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 1e-57
Identities = 65/302 (21%), Positives = 115/302 (38%), Gaps = 17/302 (5%)
Query: 84 PLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFAN 143
L +L++L L N + NL+ LDLS N LS + +
Sbjct: 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ 143
Query: 144 LTSLSILYLYENSLCDSIPKEIGNMN--SLSILDLSSNKLNGSIPLSLANLTNSLKVLYL 201
L +L L L N + +E+ SL L+LSSN++ P + L L+L
Sbjct: 144 LENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGR-LFGLFL 202
Query: 202 SSNHIVGEIPLGHGM---LSSLIQLTLNNNELSGQLSPELGSL--IQLEYLDLSANTFHK 256
++ + + + +S+ L+L+N++LS + L L LDLS N +
Sbjct: 203 NNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNV 262
Query: 257 SIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEI---------P 307
+S + L +L Y L N + + L ++ L+L + ++ I
Sbjct: 263 VGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDD 322
Query: 308 SQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLA 367
++ LE LN+ N++ G F + L + +S + + F
Sbjct: 323 FSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSP 382
Query: 368 LQ 369
L
Sbjct: 383 LH 384
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 6e-57
Identities = 68/278 (24%), Positives = 112/278 (40%), Gaps = 10/278 (3%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTS 146
+ +PD++ +++ L L+ N L + L LD+ N +S P L
Sbjct: 17 TQVPDDLPT--NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPM 74
Query: 147 LSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHI 206
L +L L N L K +L+ L L SN + N L L LS N +
Sbjct: 75 LKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKN-LITLDLSHNGL 133
Query: 207 VGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSL--IQLEYLDLSANTFHKSIPESLSN 264
L +L +L L+NN++ S EL L+ L+LS+N + P
Sbjct: 134 SSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHA 193
Query: 265 LVKLHYLNLSNNQFSQKIPNKI---EKLIHLSELDLSHNIFREEIPSQICSMQ--SLEKL 319
+ +L L L+N Q + K+ + L LS++ + ++ +L L
Sbjct: 194 IGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTML 253
Query: 320 NLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNS 357
+LS+NNL+ F + L + YN +Q L +S
Sbjct: 254 DLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHS 291
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 3e-56
Identities = 66/288 (22%), Positives = 105/288 (36%), Gaps = 15/288 (5%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANL 144
+ P+ + L L L N L+ TNL L L +N + F
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120
Query: 145 TSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTN-SLKVLYLSS 203
+L L L N L + + +L L LS+NK+ L N SLK L LSS
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180
Query: 204 NHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELG---SLIQLEYLDLSANTFHKSIPE 260
N I P + L L LNN +L L+ +L + + L LS + +
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240
Query: 261 SLSNL--VKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEK 318
+ L L L+LS N + + L L L +N + + + ++
Sbjct: 241 TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRY 300
Query: 319 LNLSHN---------NLSGSIPRCFEEMHWLSCIDISYNALQGLIPNS 357
LNL + +L F+ + L +++ N + G+ N
Sbjct: 301 LNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNM 348
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 9e-55
Identities = 67/277 (24%), Positives = 110/277 (39%), Gaps = 8/277 (2%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTS 146
L+ L + N ++ P L L VL+L N+LS +FA T+
Sbjct: 39 RLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTN 98
Query: 147 LSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHI 206
L+ L+L NS+ +L LDLS N L+ + + L N L+ L LS+N I
Sbjct: 99 LTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLEN-LQELLLSNNKI 157
Query: 207 VGEIP--LGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLS- 263
L SSL +L L++N++ ++ +L L L+ S+ E L
Sbjct: 158 QALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCL 217
Query: 264 --NLVKLHYLNLSNNQFSQKIPNKIE--KLIHLSELDLSHNIFREEIPSQICSMQSLEKL 319
+ L+LSN+Q S K +L+ LDLS+N + LE
Sbjct: 218 ELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYF 277
Query: 320 NLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPN 356
L +NN+ + + +++ + + I
Sbjct: 278 FLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISL 314
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 3e-52
Identities = 70/310 (22%), Positives = 116/310 (37%), Gaps = 17/310 (5%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILNGS--IPLALGNLTN--LVVLDLSTNKLSGSIPLS 140
+ + + +L L LS + + +L + L +L+L+ NK+S +
Sbjct: 341 IPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDA 400
Query: 141 FANLTSLSILYLYENSLCDSIP-KEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVL 199
F+ L L +L L N + + +E + ++ + LS NK S A + + L+ L
Sbjct: 401 FSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPS-LQRL 459
Query: 200 YLSSNHI--VGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSAN----- 252
L + V P L +L L L+NN ++ L L +LE LDL N
Sbjct: 460 MLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARL 519
Query: 253 ---TFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQ 309
L L LH LNL +N F + + L L +DL N S
Sbjct: 520 WKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASV 579
Query: 310 ICSMQSLEKLNLSHNNLSGSIPRCFEE-MHWLSCIDISYNALQGLIPNSTAFRDAPMLAL 368
+ SL+ LNL N ++ + F L+ +D+ +N + F +
Sbjct: 580 FNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETH 639
Query: 369 QGNKRLCGDI 378
L
Sbjct: 640 TNIPELSSHY 649
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-42
Identities = 54/242 (22%), Positives = 92/242 (38%), Gaps = 9/242 (3%)
Query: 121 TNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNK 180
+ V D S KL+ +P T++++L L N L + L+ LD+ N
Sbjct: 4 VSHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 181 LNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGS 240
++ P L LKVL L N + ++L +L L +N + +
Sbjct: 61 ISKLEPELCQKLPM-LKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119
Query: 241 LIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIE--KLIHLSELDLS 298
L LDLS N + + L L L LSNN+ +++ L +L+LS
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELS 179
Query: 299 HNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPR---CFEEMHWLSCIDISYNALQGLIP 355
N +E P ++ L L L++ L S+ + + +S + L
Sbjct: 180 SNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSN 239
Query: 356 NS 357
+
Sbjct: 240 TT 241
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-30
Identities = 50/194 (25%), Positives = 79/194 (40%), Gaps = 11/194 (5%)
Query: 193 TNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSAN 252
T S +V S + ++P + +++ L L +N+L + QL LD+ N
Sbjct: 3 TVSHEVADCSHLKLT-QVP--DDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFN 59
Query: 253 TFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICS 312
T K PE L L LNL +N+ SQ +L+EL L N ++ +
Sbjct: 60 TISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119
Query: 313 MQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLA---LQ 369
++L L+LSHN LS + ++ L + +S N +Q L L L
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELS 179
Query: 370 GNKRLCGDIKRLPP 383
N+ IK P
Sbjct: 180 SNQ-----IKEFSP 188
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 3e-54
Identities = 59/321 (18%), Positives = 116/321 (36%), Gaps = 33/321 (10%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNG-SIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLT 145
+ + D+ + + N L +L + L +LD NK+ + +F
Sbjct: 538 TRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNV 595
Query: 146 SLSILYLYENSLCDSIPKEIG-NMNSLSILDLSSNKLNGSIP--LSLANLTNSLKVLYLS 202
L+ L L N + + IP++ + + L S NKL IP + ++ + + S
Sbjct: 596 KLTDLKLDYNQI-EEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYV-MGSVDFS 652
Query: 203 SNHIVGEIP-----LGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTF--- 254
N I E + + +TL+ NE+ + + + + LS N
Sbjct: 653 YNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSI 712
Query: 255 ----HKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIE--KLIHLSELDLSHNIFREEIPS 308
K + N L ++L N+ + + + L +LS +D+S+N F P+
Sbjct: 713 PENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCF-SSFPT 770
Query: 309 QICSMQSLEKLNLSH------NNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRD 362
Q + L+ + H N + P L + I N ++ +
Sbjct: 771 QPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDEK--LTPQ 828
Query: 363 APMLALQGNKRLCGDIKRLPP 383
+L + N + D+ + P
Sbjct: 829 LYILDIADNPNISIDVTSVCP 849
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 185 bits (470), Expect = 3e-50
Identities = 54/290 (18%), Positives = 108/290 (37%), Gaps = 30/290 (10%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTS 146
+ I I + L + + + + + K + LS++NL
Sbjct: 438 TFISKAIQRLTKLQIIYFANSPFTYDNIA-----VDWEDANSDYAKQYENEELSWSNLKD 492
Query: 147 LSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNG---------SIPLSLANLTNSLK 197
L+ + LY +P + ++ L L+++ N+ + ++
Sbjct: 493 LTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPK-IQ 551
Query: 198 VLYLSSNHIVGEIPLGH--GMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFH 255
+ Y+ N++ E P + L L +N++ L G+ ++L L L N
Sbjct: 552 IFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HL-EAFGTNVKLTDLKLDYNQI- 607
Query: 256 KSIPESL-SNLVKLHYLNLSNNQFSQKIPNK--IEKLIHLSELDLSHNIFREEIPSQICS 312
+ IPE + ++ L S+N+ IPN + + + +D S+N E + CS
Sbjct: 608 EEIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCS 666
Query: 313 MQ-----SLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNS 357
M + + LS+N + F +S I +S N + + NS
Sbjct: 667 MDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENS 716
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-38
Identities = 39/296 (13%), Positives = 97/296 (32%), Gaps = 21/296 (7%)
Query: 77 AFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGS 136
A G++W YS + + + + ++ + L N + L L+ G
Sbjct: 280 ALDGKNWRYYSGTINNTIHSLNW-NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGR 338
Query: 137 IPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSL 196
+P + LT L +L +S S + + + +++ + L
Sbjct: 339 VPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRL 398
Query: 197 KVLYLSSNHI-----VGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSA 251
+ L + I + I + Q+ N ++ +S + L +L+ + +
Sbjct: 399 NLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFAN 457
Query: 252 NTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQIC 311
+ F N + + L L++++L + ++P +
Sbjct: 458 SPFTYDNIAVDWED-----ANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLY 512
Query: 312 SMQSLEKLNLSHNNLSG---------SIPRCFEEMHWLSCIDISYNALQGLIPNST 358
+ L+ LN++ N + + + + YN L+ +++
Sbjct: 513 DLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASAS 568
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-37
Identities = 44/257 (17%), Positives = 78/257 (30%), Gaps = 40/257 (15%)
Query: 87 SSIPD--EIGNMKSLSDLQLSENIL-----NGSIPLALGNLTNLVVLDLSTNKLSGSIPL 139
IP+ ++ + + S N + N S + N + LS N++
Sbjct: 632 KYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTE 691
Query: 140 SFANLTSLSILYLYENSL-------CDSIPKEIGNMNSLSILDLSSNKLNGSIP--LSLA 190
FA + +S + L N + N L+ +DL NKL S+
Sbjct: 692 LFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRAT 750
Query: 191 NLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLS 250
L L + +S N P S L + + D
Sbjct: 751 TLPY-LSNMDVSYNCF-SSFPTQPLNSSQLKAFGIRHQ------------------RDAE 790
Query: 251 ANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQI 310
N + P ++ L L + +N K+ K+ L LD++ N + +
Sbjct: 791 GNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSV 847
Query: 311 CSMQSLEKLNLSHNNLS 327
C L ++
Sbjct: 848 CPYIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 7e-21
Identities = 30/156 (19%), Positives = 52/156 (33%), Gaps = 16/156 (10%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILNGSIP--LALGNLTNLVVLDLSTNKLSGSIPLSFA 142
N L+ + L N L S+ L L +D+S N S S P
Sbjct: 716 SLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPL 773
Query: 143 NLTSLSILYLYE------NSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSL 196
N + L + N + P I SL L + SN + + LT L
Sbjct: 774 NSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVD---EKLTPQL 829
Query: 197 KVLYLSSNHI-VGEIP-LGHGMLSSLIQLTLNNNEL 230
+L ++ N ++ + + + + L + +
Sbjct: 830 YILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQD 865
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 1e-49
Identities = 60/297 (20%), Positives = 104/297 (35%), Gaps = 28/297 (9%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLS---------- 134
I D + ++S L + + L+L K
Sbjct: 270 YLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCKFGQFPTLKLKSL 327
Query: 135 ---------GSIPLSFANLTSLSILYLYENSL--CDSIPKEIGNMNSLSILDLSSNKLNG 183
G S +L SL L L N L + SL LDLS N +
Sbjct: 328 KRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT 387
Query: 184 SIPLSLANLTNSLKVLYLSSNHIVGEIPLGH-GMLSSLIQLTLNNNELSGQLSPELGSLI 242
+ + L L+ L +++ L +LI L +++ + L
Sbjct: 388 -MSSNFLGLEQ-LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 445
Query: 243 QLEYLDLSANTFHKSI-PESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNI 301
LE L ++ N+F ++ P+ + L L +L+LS Q Q P L L L++SHN
Sbjct: 446 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNN 505
Query: 302 FREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEM-HWLSCIDISYNALQGLIPNS 357
F + SL+ L+ S N++ S + + L+ ++++ N +
Sbjct: 506 FFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQ 562
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 2e-48
Identities = 67/286 (23%), Positives = 111/286 (38%), Gaps = 19/286 (6%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTS 146
IPD + S +L LS N L + + L VLDLS ++ ++ +L+
Sbjct: 20 YKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSH 77
Query: 147 LSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHI 206
LS L L N + ++SL L L + +L LK L ++ N I
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT-LKELNVAHNLI 136
Query: 207 VG-EIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEY----LDLSANTFHKSIPES 261
++P L++L L L++N++ +L L Q+ LDLS N + P +
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGA 196
Query: 262 LSNLVKLHYLNLSNNQFSQKIP-NKIEKLIHLSELDLSHNIFREEI---PSQICSMQSLE 317
+ +LH L L NN S + I+ L L L FR E +++ L
Sbjct: 197 FKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLC 255
Query: 318 KLNLSHNNLS------GSIPRCFEEMHWLSCIDISYNALQGLIPNS 357
L + L+ I F + +S + ++ + S
Sbjct: 256 NLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS 301
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 2e-46
Identities = 54/288 (18%), Positives = 106/288 (36%), Gaps = 19/288 (6%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANL 144
L + L L LS + A +L++L L L+ N + +F+ L
Sbjct: 40 LRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGL 99
Query: 145 TSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNG-SIPLSLANLTNSLKVLYLSS 203
+SL L E +L IG++ +L L+++ N + +P +NLTN L+ L LSS
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTN-LEHLDLSS 158
Query: 204 NHIVGEIPLGHGMLSSL----IQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIP 259
N I +L + + L L+ N ++ + P I+L L L N ++
Sbjct: 159 NKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVM 217
Query: 260 E-SLSNLVKLHYLNLSNNQFS------QKIPNKIEKLIHLSELDLSHN---IFREEIPSQ 309
+ + L L L +F + + +E L +L+ + + ++I
Sbjct: 218 KTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDL 277
Query: 310 ICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNS 357
+ ++ +L + + +++
Sbjct: 278 FNCLTNVSSFSLVSVTIERVKDFSYNFG--WQHLELVNCKFGQFPTLK 323
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 4e-44
Identities = 59/285 (20%), Positives = 99/285 (34%), Gaps = 22/285 (7%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIP-LALGNLTNLVVLDLSTNKLSGSIPL------ 139
+ I L L L N + ++ + L L V L + L
Sbjct: 190 NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS 249
Query: 140 SFANLTSLSILYLYENSL---CDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSL 196
+ L +L+I L D I + ++S L S + S
Sbjct: 250 ALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY---NFGW 306
Query: 197 KVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSAN--TF 254
+ L L + L SL +LT +N+ S L LE+LDLS N +F
Sbjct: 307 QHLELVNCKFGQ---FPTLKLKSLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSF 361
Query: 255 HKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQI-CSM 313
+S L YL+LS N + + L L LD H+ ++ + S+
Sbjct: 362 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 420
Query: 314 QSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNST 358
++L L++SH + + F + L + ++ N+ Q
Sbjct: 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 465
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-43
Identities = 70/347 (20%), Positives = 116/347 (33%), Gaps = 55/347 (15%)
Query: 84 PLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKL-SGSIPLSFA 142
P+ S + SL L E L +G+L L L+++ N + S +P F+
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 143 NLTSLSILYLYENSLCDSIPKEIGNMNSLSI----LDLSSNKLNGSIPLSLANLTNSLKV 198
NLT+L L L N + ++ ++ + + LDLS N +N P + + L
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI--RLHK 204
Query: 199 LYLSSNHIVGEIP----------------------------LGHGMLSSLIQLTLNNNEL 230
L L +N + L L LT+ L
Sbjct: 205 LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264
Query: 231 S------GQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPN 284
+ + L + L + T + S +L L N +F Q
Sbjct: 265 AYLDYYLDDIIDLFNCLTNVSSFSLVSVTI--ERVKDFSYNFGWQHLELVNCKFGQFPTL 322
Query: 285 KIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLS--GSIPRCFEEMHWLSC 342
K++ L L+ + SLE L+LS N LS G + L
Sbjct: 323 KLKSLKRLTFTSNKGG-----NAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKY 377
Query: 343 IDISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDIKRLPPCKAFKS 389
+D+S+N + + N L Q + +K++ F S
Sbjct: 378 LDLSFNGVITMSSNFLGLEQLEHLDFQHSN-----LKQMSEFSVFLS 419
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-43
Identities = 55/254 (21%), Positives = 95/254 (37%), Gaps = 9/254 (3%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILN--GSIPLALGNLTNLVVLDLSTNKLSGSIPLSFA 142
++ SL L LS N L+ G + T+L LDLS N + + +F
Sbjct: 335 NKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFL 393
Query: 143 NLTSLSILYLYENSLCDSIPKEI-GNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYL 201
L L L ++L + ++ +L LD+S + L+ SL+VL +
Sbjct: 394 GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS-SLEVLKM 452
Query: 202 SSNHIVGEIPLGH-GMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPE 260
+ N L +L L L+ +L SL L+ L++S N F
Sbjct: 453 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTF 512
Query: 261 SLSNLVKLHYLNLSNNQFSQKIPNKIEKLI-HLSELDLSHNIFREEIPSQ--ICSMQSLE 317
L L L+ S N +++ L+ L+L+ N F Q + ++
Sbjct: 513 PYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQR 572
Query: 318 KLNLSHNNLSGSIP 331
+L + + + P
Sbjct: 573 QLLVEVERMECATP 586
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-28
Identities = 37/169 (21%), Positives = 65/169 (38%), Gaps = 4/169 (2%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILNGSI-PLALGNLTNLVVLDLSTNKLSGSIPLSFAN 143
+ + SL L+++ N + P L NL LDLS +L P +F +
Sbjct: 433 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 492
Query: 144 LTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSS 203
L+SL +L + N+ +NSL +LD S N + S L + +SL L L+
Sbjct: 493 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQ 552
Query: 204 NHIVGEIPLGH--GMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLS 250
N + QL + + + + + L+++
Sbjct: 553 NDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGM-PVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-27
Identities = 38/186 (20%), Positives = 59/186 (31%), Gaps = 29/186 (15%)
Query: 173 ILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSG 232
IP NL S K L LS N +
Sbjct: 11 TYQCMELNFY-KIP---DNLPFSTKNLDLSFNPLRHLGS--------------------- 45
Query: 233 QLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHL 292
S +L+ LDLS + +L L L L+ N L L
Sbjct: 46 ---YSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSL 102
Query: 293 SELDLSHNIFREEIPSQICSMQSLEKLNLSHNNL-SGSIPRCFEEMHWLSCIDISYNALQ 351
+L I +++L++LN++HN + S +P F + L +D+S N +Q
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
Query: 352 GLIPNS 357
+
Sbjct: 163 SIYCTD 168
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-21
Identities = 26/115 (22%), Positives = 44/115 (38%)
Query: 244 LEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFR 303
+ LDLS N S + +L L+LS + + L HLS L L+ N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 304 EEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNST 358
+ SL+KL NL+ + L +++++N +Q
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-49
Identities = 68/264 (25%), Positives = 124/264 (46%), Gaps = 18/264 (6%)
Query: 88 SIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSL 147
+ + N+ +L +L L+E+ ++ PL NLT + L+L N + +N+T L
Sbjct: 101 TDISALQNLTNLRELYLNEDNISDISPL--ANLTKMYSLNLGANHNLSDLS-PLSNMTGL 157
Query: 148 SILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIV 207
+ L + E+ + D P I N+ L L L+ N++ PL+ +LT+ L N I
Sbjct: 158 NYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISPLA--SLTS-LHYFTAYVNQIT 212
Query: 208 GEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVK 267
P+ + ++ L L + NN+++ L +L QL +L++ N S ++ +L K
Sbjct: 213 DITPVAN--MTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQI--SDINAVKDLTK 266
Query: 268 LHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLS 327
L LN+ +NQ S I + L L+ L L++N E I + +L L LS N+++
Sbjct: 267 LKMLNVGSNQIS-DISV-LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT 324
Query: 328 GSIPRCFEEMHWLSCIDISYNALQ 351
P + + D + ++
Sbjct: 325 DIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 5e-48
Identities = 71/265 (26%), Positives = 122/265 (46%), Gaps = 18/265 (6%)
Query: 91 DEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSIL 150
+ N+ L++L + N + + AL NLTNL L L+ + +S PL+ NLT + L
Sbjct: 82 SPLSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISPLA--NLTKMYSL 137
Query: 151 YLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEI 210
L N S + NM L+ L ++ +K+ P++ NLT+ L L L+ N I
Sbjct: 138 NLGANHN-LSDLSPLSNMTGLNYLTVTESKVKDVTPIA--NLTD-LYSLSLNYNQIEDIS 193
Query: 211 PLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHY 270
PL L+SL T N+++ + ++ +L L + N P L+NL +L +
Sbjct: 194 PLAS--LTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITDLSP--LANLSQLTW 247
Query: 271 LNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSI 330
L + NQ S I ++ L L L++ N + S + ++ L L L++N L
Sbjct: 248 LEIGTNQIS-DINA-VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNED 303
Query: 331 PRCFEEMHWLSCIDISYNALQGLIP 355
+ L+ + +S N + + P
Sbjct: 304 MEVIGGLTNLTTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 7e-43
Identities = 60/266 (22%), Positives = 121/266 (45%), Gaps = 20/266 (7%)
Query: 90 PDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSI 149
++S++ L ++ + SI + LTNL L+L+ N+++ PLS NL L+
Sbjct: 37 VVTQEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITDISPLS--NLVKLTN 92
Query: 150 LYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGE 209
LY+ N + + + N+ +L L L+ + ++ PL+ NLT + L L +NH + +
Sbjct: 93 LYIGTNKI--TDISALQNLTNLRELYLNEDNISDISPLA--NLTK-MYSLNLGANHNLSD 147
Query: 210 IPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLH 269
+ ++ L LT+ +++ + +L L L L+ N P L++L LH
Sbjct: 148 LS-PLSNMTGLNYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIEDISP--LASLTSLH 202
Query: 270 YLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGS 329
Y NQ + P + + L+ L + +N + P + ++ L L + N +S
Sbjct: 203 YFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD- 257
Query: 330 IPRCFEEMHWLSCIDISYNALQGLIP 355
+++ L +++ N + +
Sbjct: 258 -INAVKDLTKLKMLNVGSNQISDISV 282
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 2e-41
Identities = 62/257 (24%), Positives = 110/257 (42%), Gaps = 20/257 (7%)
Query: 99 LSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLC 158
+ L +N P A +L + L ++ + L S++ L + +
Sbjct: 2 AATLATLPAPINQIFPDA--DLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKV- 56
Query: 159 DSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLS 218
+ + I + +L L+L+ N++ PLS NL L LY+ +N I L + L+
Sbjct: 57 -ASIQGIEYLTNLEYLNLNGNQITDISPLS--NLVK-LTNLYIGTNKITDISALQN--LT 110
Query: 219 SLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQF 278
+L +L LN + +S L +L ++ L+L AN S LSN+ L+YL ++ ++
Sbjct: 111 NLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKV 167
Query: 279 SQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMH 338
+ I L L L L++N + P + S+ SL N ++ P M
Sbjct: 168 K-DVTP-IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMT 221
Query: 339 WLSCIDISYNALQGLIP 355
L+ + I N + L P
Sbjct: 222 RLNSLKIGNNKITDLSP 238
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-40
Identities = 63/261 (24%), Positives = 115/261 (44%), Gaps = 20/261 (7%)
Query: 93 IGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYL 152
++ L + + + L ++ L ++ K++ SI LT+L L L
Sbjct: 18 DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNL 73
Query: 153 YENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPL 212
N + D P + N+ L+ L + +NK+ + +L NLTN L+ LYL+ ++I PL
Sbjct: 74 NGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTN-LRELYLNEDNISDISPL 128
Query: 213 GHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLN 272
+ L+ + L L N LSP L ++ L YL ++ + P ++NL L+ L+
Sbjct: 129 AN--LTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLS 183
Query: 273 LSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPR 332
L+ NQ P + L L N + P + +M L L + +N ++ P
Sbjct: 184 LNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP- 238
Query: 333 CFEEMHWLSCIDISYNALQGL 353
+ L+ ++I N + +
Sbjct: 239 -LANLSQLTWLEIGTNQISDI 258
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 55/194 (28%), Positives = 95/194 (48%), Gaps = 14/194 (7%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTS 146
+ I N+ L L L+ N + PL +LT+L N+++ P++ N+T
Sbjct: 168 KDVT-PIANLTDLYSLSLNYNQIEDISPL--ASLTSLHYFTAYVNQITDITPVA--NMTR 222
Query: 147 LSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHI 206
L+ L + N + D P + N++ L+ L++ +N+++ I ++ +LT LK+L + SN I
Sbjct: 223 LNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQIS-DIN-AVKDLTK-LKMLNVGSNQI 277
Query: 207 VGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLV 266
L + LS L L LNNN+L + +G L L L LS N P L++L
Sbjct: 278 SDISVLNN--LSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLS 333
Query: 267 KLHYLNLSNNQFSQ 280
K+ + +N +
Sbjct: 334 KMDSADFANQVIKK 347
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 1e-18
Identities = 29/161 (18%), Positives = 58/161 (36%), Gaps = 12/161 (7%)
Query: 196 LKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFH 255
L I P L+ I+ L ++ L + L ++
Sbjct: 2 AATLATLPAPINQIFPDAD--LAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57
Query: 256 KSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQS 315
+ + L L YLNL+ NQ + P + L+ L+ L + N S + ++ +
Sbjct: 58 S--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTN 111
Query: 316 LEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPN 356
L +L L+ +N+S P + + +++ N +
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP 150
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 4e-49
Identities = 56/251 (22%), Positives = 96/251 (38%), Gaps = 15/251 (5%)
Query: 87 SSIPDEIGN--MKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANL 144
+ D + + L+L L P L++L + + L +P +
Sbjct: 69 KATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQF 126
Query: 145 TSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTN--------SL 196
L L L N L ++P I ++N L L + + +P LA+ +L
Sbjct: 127 AGLETLTLARNPL-RALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNL 185
Query: 197 KVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHK 256
+ L L I +P L +L L + N+ LS L P + L +LE LDL T +
Sbjct: 186 QSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALR 243
Query: 257 SIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSL 316
+ P L L L + +P I +L L +LDL + +PS I + +
Sbjct: 244 NYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPAN 303
Query: 317 EKLNLSHNNLS 327
+ + + +
Sbjct: 304 CIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-45
Identities = 53/281 (18%), Positives = 97/281 (34%), Gaps = 22/281 (7%)
Query: 88 SIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTS- 146
D + + + + N N + + L + + T
Sbjct: 27 PYHDVLSQWQRHYNADRNRW----HSAWRQANSNNPQIETRTGRALK-ATADLLEDATQP 81
Query: 147 -LSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNH 205
L L L P + ++ L + + + L +P ++ L+ L L+ N
Sbjct: 82 GRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAG-LETLTLARNP 138
Query: 206 IVGEIPLGHGMLSSLIQLTL-NNNEL--------SGQLSPELGSLIQLEYLDLSANTFHK 256
+ +P L+ L +L++ EL S S E L+ L+ L L +
Sbjct: 139 LR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGI-R 196
Query: 257 SIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSL 316
S+P S++NL L L + N+ S + I L L ELDL P L
Sbjct: 197 SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPL 255
Query: 317 EKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNS 357
++L L + ++P + L +D+ +P+
Sbjct: 256 KRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSL 296
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 4e-44
Identities = 47/236 (19%), Positives = 91/236 (38%), Gaps = 14/236 (5%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTS 146
PD+ + L + + L +P + L L L+ N L ++P S A+L
Sbjct: 94 PQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNR 151
Query: 147 LSILYLYENSLCDSIPKEIGN---------MNSLSILDLSSNKLNGSIPLSLANLTNSLK 197
L L + +P+ + + + +L L L + S+P S+ANL N LK
Sbjct: 152 LRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQN-LK 209
Query: 198 VLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKS 257
L + ++ + + L L +L L P G L+ L L + +
Sbjct: 210 SLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT 268
Query: 258 IPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSM 313
+P + L +L L+L ++P+ I +L + + ++ + + +
Sbjct: 269 LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 6e-41
Identities = 52/283 (18%), Positives = 92/283 (32%), Gaps = 24/283 (8%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTS 146
S + +L + L D + + N +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNN 57
Query: 147 LSILYLYENSLCDSIPKEIGN--MNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSN 204
I +L + + + L+L S L P L++ L+ + + +
Sbjct: 58 PQIETRTGRAL-KATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSH-LQHMTIDAA 114
Query: 205 HIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSN 264
++ E+P + L LTL N L L + SL +L L + A +PE L++
Sbjct: 115 GLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAS 172
Query: 265 ---------LVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQS 315
LV L L L +P I L +L L + ++ + I +
Sbjct: 173 TDASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPK 230
Query: 316 LEKLNLSHNNLSGSIPRCFEEMHWLSCIDIS-YNALQGLIPNS 357
LE+L+L + P F L + + + L L P
Sbjct: 231 LEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTL-PLD 272
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 1e-48
Identities = 59/273 (21%), Positives = 106/273 (38%), Gaps = 9/273 (3%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSI-PLSFANLT 145
S +P + + +L L LS N ++ N +L L + N + NL
Sbjct: 291 SELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLE 350
Query: 146 SLSILYLYENSL--CDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSS 203
+L L L + + D ++ N++ L L+LS N+ + L++L L+
Sbjct: 351 NLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQ-LELLDLAF 409
Query: 204 NHIVGEIPLGH-GMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSAN---TFHKSIP 259
+ + L L L L+++ L L L++L+L N +
Sbjct: 410 TRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKT 469
Query: 260 ESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKL 319
SL L +L L LS S + L ++ +DLSHN + ++ + L
Sbjct: 470 NSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-L 528
Query: 320 NLSHNNLSGSIPRCFEEMHWLSCIDISYNALQG 352
NL+ N++S +P + I++ N L
Sbjct: 529 NLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 4e-48
Identities = 58/298 (19%), Positives = 106/298 (35%), Gaps = 20/298 (6%)
Query: 89 IPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLS 148
+ +L+ L L+ + + L L L+ N L + + +L
Sbjct: 49 QNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALK 108
Query: 149 ILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVG 208
L+ + + + N +L L L SN ++ LKVL +N I
Sbjct: 109 HLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEK-LKVLDFQNNAIHY 167
Query: 209 EIPLGHGMLSSLIQLT-----LNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLS 263
L +SSL Q T LN N+++G + P + L+ I + L
Sbjct: 168 ---LSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLK 223
Query: 264 N--LVKLHYLNLSNNQFSQKIPNKIEKLIHLS--ELDLSHNIFREEIPSQICSMQSLEKL 319
N + L + P E L +S ++L + F + L++L
Sbjct: 224 NSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQEL 283
Query: 320 NLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLA---LQGNKRL 374
+L+ +LS +P + L + +S N + L + + P L ++GN +
Sbjct: 284 DLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQI--SASNFPSLTHLSIKGNTKR 338
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 8e-48
Identities = 55/310 (17%), Positives = 109/310 (35%), Gaps = 18/310 (5%)
Query: 84 PLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFAN 143
PL + K+L L + ++ + L N L L L +N +S
Sbjct: 92 PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP 151
Query: 144 LTSLSILYLYENSLCDSIPKEIGNMNSLSI--LDLSSNKLNGSIPLSLANLTNSLKVLYL 201
L +L N++ +++ ++ + L+L+ N + I + + L
Sbjct: 152 TEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI-AGIEPGAFDSAV-FQSLNF 209
Query: 202 SSNHIVGEIP--LGHGMLSSLIQLTLNNNELSG--QLSPELGSLIQLEYLDLSANTFHKS 257
+ I L + + SL T + + E + +E ++L + F
Sbjct: 210 GGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNI 269
Query: 258 IPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLE 317
+ L L+L+ S+ +P+ + L L +L LS N F + SL
Sbjct: 270 SSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLT 328
Query: 318 KLNLSHNNLSGSI-PRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPML---ALQGNKR 373
L++ N + C E + L +D+S++ ++ + R+ L L N+
Sbjct: 329 HLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNE- 387
Query: 374 LCGDIKRLPP 383
L
Sbjct: 388 ----PLSLKT 393
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 2e-47
Identities = 71/282 (25%), Positives = 108/282 (38%), Gaps = 9/282 (3%)
Query: 98 SLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSL 157
S+ + L ++ + L LDL+ LS +P L++L L L N
Sbjct: 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKF 313
Query: 158 CDSIPKEIGNMNSLSILDLSSNKLNGSI-PLSLANLTNSLKVLYLSSNHI--VGEIPLGH 214
+ N SL+ L + N + L NL N L+ L LS + I L
Sbjct: 314 ENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLEN-LRELDLSHDDIETSDCCNLQL 372
Query: 215 GMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPES-LSNLVKLHYLNL 273
LS L L L+ NE + QLE LDL+ +S NL L LNL
Sbjct: 373 RNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNL 432
Query: 274 SNNQFSQKIPNKIEKLIHLSELDLSHNIFREEI---PSQICSMQSLEKLNLSHNNLSGSI 330
S++ + L L L+L N F + + + ++ LE L LS +LS
Sbjct: 433 SHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSID 492
Query: 331 PRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNK 372
F + ++ +D+S+N L + + L L N
Sbjct: 493 QHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNH 534
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 3e-47
Identities = 58/281 (20%), Positives = 113/281 (40%), Gaps = 13/281 (4%)
Query: 95 NMKSLSDLQLSENILNGSIPLALGNL--TNLVVLDLSTNKLSGSIPLSFANLTSLSILYL 152
++SL + P L ++ ++L + +F + L L L
Sbjct: 226 TIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDL 285
Query: 153 YENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPL 212
L +P + +++L L LS+NK +S +N + L L + N E+
Sbjct: 286 TATHL-SELPSGLVGLSTLKKLVLSANKFENLCQISASNFPS-LTHLSIKGNTKRLELGT 343
Query: 213 GH-GMLSSLIQLTLNNNEL--SGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLH 269
G L +L +L L+++++ S + +L +L L+ L+LS N E+ +L
Sbjct: 344 GCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLE 403
Query: 270 YLNLSNNQFSQKIPNKI-EKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSG 328
L+L+ + K + L L L+LSH++ + +L+ LNL N+
Sbjct: 404 LLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPK 463
Query: 329 SIPRC---FEEMHWLSCIDISYNALQGLIPNSTAFRDAPML 366
+ + + L + +S+ L + + AF M+
Sbjct: 464 GNIQKTNSLQTLGRLEILVLSFCDLSSIDQH--AFTSLKMM 502
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-45
Identities = 58/273 (21%), Positives = 91/273 (33%), Gaps = 10/273 (3%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTS 146
+ IP + N S L+ S N+L L NL LDL+ ++ +F +
Sbjct: 25 NEIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHR 82
Query: 147 LSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHI 206
L L L N L + +L L ++ + L N L+ LYL SNHI
Sbjct: 83 LDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKT-LESLYLGSNHI 141
Query: 207 VGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLE--YLDLSANTFHKSIPESLSN 264
L L NN + ++ SL Q L+L+ N I +
Sbjct: 142 SSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI-AGIEPGAFD 200
Query: 265 LVKLHYLNLSNNQFSQKIPNKIE--KLIHLSELDLSHNIFREEIPS--QICSMQSLEKLN 320
LN Q I ++ + L + P+ + S+E +N
Sbjct: 201 SAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESIN 260
Query: 321 LSHNNLSGSIPRCFEEMHWLSCIDISYNALQGL 353
L + F L +D++ L L
Sbjct: 261 LQKHYFFNISSNTFHCFSGLQELDLTATHLSEL 293
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 7e-43
Identities = 61/247 (24%), Positives = 98/247 (39%), Gaps = 7/247 (2%)
Query: 89 IPDEIGNMKSLSDLQLSENILNGSI-PLALGNLTNLVVLDLSTNKL--SGSIPLSFANLT 145
N SL+ L + N + L NL NL LDLS + + S L NL+
Sbjct: 317 CQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLS 376
Query: 146 SLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNH 205
L L L N + L +LDL+ +L S + LKVL LS +
Sbjct: 377 HLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSL 436
Query: 206 IVGEIPLGHGMLSSLIQLTLNNNELSG---QLSPELGSLIQLEYLDLSANTFHKSIPESL 262
+ L +L L L N Q + L +L +LE L LS +
Sbjct: 437 LDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAF 496
Query: 263 SNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLS 322
++L +++++LS+N+ + + L + L+L+ N +PS + + +NL
Sbjct: 497 TSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLR 555
Query: 323 HNNLSGS 329
N L +
Sbjct: 556 QNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-28
Identities = 40/215 (18%), Positives = 69/215 (32%), Gaps = 6/215 (2%)
Query: 173 ILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSG 232
+ + LN IP L NS + L S N + L +L L L ++
Sbjct: 16 TYNCENLGLN-EIP---GTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71
Query: 233 QLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHL 292
S +L+ L L+AN +LS L +L S + L
Sbjct: 72 IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131
Query: 293 SELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCI--DISYNAL 350
L L N + + L+ L+ +N + + + + +++ N +
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191
Query: 351 QGLIPNSTAFRDAPMLALQGNKRLCGDIKRLPPCK 385
G+ P + L G + L K L
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNST 226
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-25
Identities = 48/220 (21%), Positives = 73/220 (33%), Gaps = 10/220 (4%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILNGSIPL-ALGNLTNLVVLDLSTNKLSGSIPLSFAN 143
S + L L L+ L NL L VL+LS + L S F
Sbjct: 388 PLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDG 447
Query: 144 LTSLSILYLYENSLCDSIPKEIG---NMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLY 200
L +L L L N ++ + L IL LS L+ + +L + +
Sbjct: 448 LPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKM-MNHVD 506
Query: 201 LSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPE 260
LS N + L + L L +N +S L L L Q ++L N
Sbjct: 507 LSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLD----C 561
Query: 261 SLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHN 300
+ SN+ L + + + E L + LS
Sbjct: 562 TCSNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDV 601
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 29/123 (23%), Positives = 50/123 (40%), Gaps = 8/123 (6%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANL 144
L S ++K ++ + LS N L S AL +L + L+L++N +S +P L
Sbjct: 488 LSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPIL 546
Query: 145 TSLSILYLYENSL-CDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSS 203
+ + L +N L C N+ L + KL + N L+ + LS
Sbjct: 547 SQQRTINLRQNPLDCT-----CSNIYFLEWYKENMQKLEDTEDTLCENPP-LLRGVRLSD 600
Query: 204 NHI 206
+
Sbjct: 601 VTL 603
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 9e-47
Identities = 56/265 (21%), Positives = 108/265 (40%), Gaps = 16/265 (6%)
Query: 88 SIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSL 147
+I + N +++++ L ++ + N+ LDLS N LS A T L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 148 SILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIV 207
+L L N L ++ ++++L LDL++N + L + ++ L+ ++N+I
Sbjct: 61 ELLNLSSNVL--YETLDLESLSTLRTLDLNNNYVQ-----ELLVGPS-IETLHAANNNI- 111
Query: 208 GEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHK-SIPESLSNLV 266
+ + L NN+++ + G +++YLDL N + E ++
Sbjct: 112 SRVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 267 KLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNL 326
L +LNL N + ++ L LDLS N + + S + ++L +N L
Sbjct: 170 TLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKL 226
Query: 327 SGSIPRCFEEMHWLSCIDISYNALQ 351
I + L D+ N
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFH 250
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 1e-40
Identities = 61/287 (21%), Positives = 111/287 (38%), Gaps = 18/287 (6%)
Query: 87 SSIPDEIG-NMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLT 145
+ + ++ +L LS N L+ L T L +L+LS+N L +L+
Sbjct: 23 KQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL-DLESLS 80
Query: 146 SLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNH 205
+L L L N + +E+ S+ L ++N ++ + S K +YL++N
Sbjct: 81 TLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCSRG---QGKKNIYLANNK 131
Query: 206 IVGEIPLGHGMLSSLIQLTLNNNELSG-QLSPELGSLIQLEYLDLSANTFHKSIPESLSN 264
I L G S + L L NE+ + S LE+L+L N + +
Sbjct: 132 ITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI-YDVKGQV-V 189
Query: 265 LVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHN 324
KL L+LS+N+ + + + + ++ + L +N I + Q+LE +L N
Sbjct: 190 FAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKL-VLIEKALRFSQNLEHFDLRGN 247
Query: 325 NLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGN 371
R F ++ ++ L + P L G
Sbjct: 248 GFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGA 293
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 40/216 (18%), Positives = 74/216 (34%), Gaps = 13/216 (6%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSG-SIPLSFANLT 145
S + G + ++ L+ N + L G + + LDL N++ + A+
Sbjct: 112 SRVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 146 SLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNH 205
+L L L N + + ++ L LDLSSNKL + + + + L +N
Sbjct: 170 TLEHLNLQYNFI-YDVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAG-VTWISLRNNK 225
Query: 206 IVGEIPLGHGMLSSLIQLTLNNNELS-GQLSPELGSLIQLEYLDLSANTFHKSIPESLSN 264
+V I +L L N G L +++ + K +
Sbjct: 226 LV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV---KKLTGQNEE 281
Query: 265 LVKLHYLNLSNNQFSQKIPN-KIEKLIHLSELDLSH 299
+ L + +P ++LI L H
Sbjct: 282 ECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHHHH 317
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 5e-13
Identities = 27/127 (21%), Positives = 51/127 (40%), Gaps = 11/127 (8%)
Query: 257 SIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSL 316
+I E N + ++++ Q + + + ++ ELDLS N + + + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 317 EKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCG 376
E LNLS N L ++ E + L +D++ N +Q + + L N
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-ELLVGPSIET---LHAANNN---- 110
Query: 377 DIKRLPP 383
I R+
Sbjct: 111 -ISRVSC 116
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-45
Identities = 68/295 (23%), Positives = 114/295 (38%), Gaps = 11/295 (3%)
Query: 66 TFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVV 125
E ++ F +S + + ++S + L+ + +
Sbjct: 254 IMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVP--KHFKWQS 311
Query: 126 LDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSI 185
L + +L +L L L L N SI + + SLS LDLS N L+ S
Sbjct: 312 LSIIRCQLKQ---FPTLDLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSG 366
Query: 186 PLSLANL-TNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPE-LGSLIQ 243
S ++L TNSL+ L LS N + + L L L ++ L SL +
Sbjct: 367 CCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEK 425
Query: 244 LEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKI-EKLIHLSELDLSHNIF 302
L YLD+S L L+ L ++ N F + + +L+ LDLS
Sbjct: 426 LLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQL 485
Query: 303 REEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNS 357
+ ++ L+ LN+SHNNL + +++ LS +D S+N ++
Sbjct: 486 EQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGIL 540
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-42
Identities = 62/279 (22%), Positives = 97/279 (34%), Gaps = 12/279 (4%)
Query: 88 SIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSL 147
+++ L + L +L L L L+ NK S I L SL
Sbjct: 298 KYLEDVPKHFKWQSLSIIRCQLKQ---FPTLDLPFLKSLTLTMNKGS--ISFKKVALPSL 352
Query: 148 SILYLYENSLCDSIPK--EIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNH 205
S L L N+L S NSL LDLS N + + L L+ L +
Sbjct: 353 SYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEE-LQHLDFQHST 410
Query: 206 IVGEIPLGH-GMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPES-LS 263
+ L L+ L ++ L L L ++ N+F + + +
Sbjct: 411 LKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFA 470
Query: 264 NLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSH 323
N L +L+LS Q Q + L L L++SHN S + SL L+ S
Sbjct: 471 NTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSF 530
Query: 324 NNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRD 362
N + S L+ +++ N++ I F
Sbjct: 531 NRIETSKGILQHFPKSLAFFNLTNNSVAC-ICEHQKFLQ 568
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-42
Identities = 66/300 (22%), Positives = 115/300 (38%), Gaps = 19/300 (6%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTS 146
S +PD+I + S ++ LS N L + N + L LDLS ++ ++ L
Sbjct: 24 SKVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHH 81
Query: 147 LSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHI 206
LS L L N + P + SL L KL + L LK L ++ N I
Sbjct: 82 LSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLIT-LKKLNVAHNFI 140
Query: 207 VG-EIPLGHGMLSSLIQLTLNNNELSGQLSPELGSL----IQLEYLDLSANTFHKSIPES 261
++P L++L+ + L+ N + +L L LD+S N I +
Sbjct: 141 HSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPI-DFIQDQ 199
Query: 262 LSNLVKLHYLNLSNNQFSQKIPNK-IEKLIHLSELDLSHNIFREEIPSQICSMQSLEKL- 319
+KLH L L N S I ++ L L L F++E +I +E L
Sbjct: 200 AFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLC 259
Query: 320 -------NLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNK 372
L++ N F + +S + ++ +++ + + L++ +
Sbjct: 260 DVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY-LEDVPKHFKWQSLSIIRCQ 318
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 4e-41
Identities = 59/283 (20%), Positives = 104/283 (36%), Gaps = 18/283 (6%)
Query: 89 IPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLS 148
N L L LS + A L +L L L+ N + P SF+ LTSL
Sbjct: 48 KSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLE 107
Query: 149 ILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNG-SIPLSLANLTNSLKVLYLSSNHIV 207
L E L IG + +L L+++ N ++ +P +NLTN L + LS N+I
Sbjct: 108 NLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTN-LVHVDLSYNYIQ 166
Query: 208 GEIPLG----HGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPE-SL 262
+ L ++ N + + + I+L L L N +I + L
Sbjct: 167 TITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCL 225
Query: 263 SNLVKLHYLNLSNNQFSQKI------PNKIEKLIHLS--ELDLSHNIFREEIPSQICSMQ 314
NL LH L +F + P+ +E L ++ E L++ + + +
Sbjct: 226 QNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLA 285
Query: 315 SLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNS 357
++ ++L+ ++ + I L+
Sbjct: 286 NVSAMSLAGVSIKYLEDVPK--HFKWQSLSIIRCQLKQFPTLD 326
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-38
Identities = 66/344 (19%), Positives = 119/344 (34%), Gaps = 50/344 (14%)
Query: 84 PLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSG-SIPLSFA 142
P+ S P + SL +L E L +G L L L+++ N + +P F+
Sbjct: 91 PIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFS 150
Query: 143 NLTSLSILYLYENSLCDSIPKEIGNMNSLSI----LDLSSNKLNGSIPLSLANLTNSLKV 198
NLT+L + L N + ++ + LD+S N ++ + + L
Sbjct: 151 NLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI--KLHE 208
Query: 199 LYLSSNHIVGEIP-LGHGMLSSLIQLTLNNNELSGQLSPELGSL--------IQLEYLDL 249
L L N I L+ L L E + + E+ + ++ L
Sbjct: 209 LTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRL 268
Query: 250 SANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIP--------------NKIEK-----LI 290
+ L + ++L+ ++++ L
Sbjct: 269 TYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLP 328
Query: 291 HLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLS--CIDISYN 348
L L L+ N + I + ++ SL L+LS N LS S + ++ S +D+S+N
Sbjct: 329 FLKSLTLTMN--KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFN 386
Query: 349 ALQGLIPNSTAFRDAPMLA---LQGNKRLCGDIKRLPPCKAFKS 389
+ S F L Q + +KR+ AF S
Sbjct: 387 GAIIM---SANFMGLEELQHLDFQHST-----LKRVTEFSAFLS 422
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 40/199 (20%), Positives = 71/199 (35%), Gaps = 30/199 (15%)
Query: 160 SIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSS 219
S+ I + +++ KL+ +P ++ +S K + LS N +
Sbjct: 3 SLNPCIEVVPNIT-YQCMDQKLS-KVP---DDIPSSTKNIDLSFNPLKILKS-------- 49
Query: 220 LIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFS 279
+ +L++LDLS ++ L L L L+ N
Sbjct: 50 ----------------YSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93
Query: 280 QKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSG-SIPRCFEEMH 338
P L L L I + +L+KLN++HN + +P F +
Sbjct: 94 SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLT 153
Query: 339 WLSCIDISYNALQGLIPNS 357
L +D+SYN +Q + N
Sbjct: 154 NLVHVDLSYNYIQTITVND 172
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 5e-15
Identities = 23/98 (23%), Positives = 40/98 (40%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANL 144
+++ + N +L+ L LS+ L L L +L++S N L + L
Sbjct: 461 KDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQL 520
Query: 145 TSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLN 182
SLS L N + S SL+ +L++N +
Sbjct: 521 YSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 160 bits (405), Expect = 3e-43
Identities = 56/285 (19%), Positives = 112/285 (39%), Gaps = 16/285 (5%)
Query: 88 SIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSL 147
+I + N +++++ L ++ + N+ LDLS N LS A T L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 148 SILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIV 207
+L L N L ++ ++++L LDL++N + L + ++ L+ ++N+I
Sbjct: 61 ELLNLSSNVL--YETLDLESLSTLRTLDLNNNYVQ-----ELLVGPS-IETLHAANNNI- 111
Query: 208 GEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHK-SIPESLSNLV 266
+ + L NN+++ + G +++YLDL N + E ++
Sbjct: 112 SRVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 267 KLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNL 326
L +LNL N + ++ L LDLS N + + S + ++L +N L
Sbjct: 170 TLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKL 226
Query: 327 SGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGN 371
I + L D+ N ++ + +
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-37
Identities = 61/288 (21%), Positives = 113/288 (39%), Gaps = 17/288 (5%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANL 144
L ++ + ++ +L LS N L+ L T L +L+LS+N L ++ +L
Sbjct: 22 LKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESL 79
Query: 145 TSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSN 204
++L L L N + +E+ S+ L ++N ++ N +YL++N
Sbjct: 80 STLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRVSCSRGQGKKN----IYLANN 130
Query: 205 HIVGEIPLGHGMLSSLIQLTLNNNELSG-QLSPELGSLIQLEYLDLSANTFHKSIPESLS 263
I L G S + L L NE+ + S LE+L+L N + +
Sbjct: 131 KITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI-YDVKGQV- 188
Query: 264 NLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSH 323
KL L+LS+N+ + + + + ++ + L +N I + Q+LE +L
Sbjct: 189 VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKL-VLIEKALRFSQNLEHFDLRG 246
Query: 324 NNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGN 371
N R F ++ ++ L + P L G
Sbjct: 247 NGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGA 293
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-27
Identities = 44/288 (15%), Positives = 82/288 (28%), Gaps = 11/288 (3%)
Query: 90 PDEIGNMKSLSDLQLSENILNG-SIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLS 148
+ G + L L N ++ + + L L+L N + + L
Sbjct: 137 DLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVK-GQVVFAKLK 194
Query: 149 ILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIV- 207
L L N L + E + ++ + L +NKL I +L N L+ L N
Sbjct: 195 TLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQN-LEHFDLRGNGFHC 251
Query: 208 GEIPLGHGMLSSLIQLTLN-NNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNL- 265
G + + + +L+GQ E Y + L L
Sbjct: 252 GTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALK 311
Query: 266 -VKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHN 324
+ L+ ++ +++ + E E+D +R I Q+ L
Sbjct: 312 RKEHALLSGQGSET-ERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKK 370
Query: 325 NLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNK 372
L + L L + +L +
Sbjct: 371 ALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKR 418
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-23
Identities = 37/268 (13%), Positives = 76/268 (28%), Gaps = 32/268 (11%)
Query: 88 SIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSL 147
+ + + +L L L N + + L LDLS+NKL+ + F + +
Sbjct: 160 NFAELAASSDTLEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGV 216
Query: 148 SILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIV 207
+ + L N L I K + +L DL N + + ++ + + +
Sbjct: 217 TWISLRNNKL-VLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKL 275
Query: 208 GEIP-------------------LGHGMLSSLIQLTLNNNEL-------SGQLSPELGSL 241
L LI L + L + +L E +
Sbjct: 276 TGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQ 335
Query: 242 IQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHN- 300
+ +D + I + L +++ N L
Sbjct: 336 ARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVG 395
Query: 301 -IFREEIPSQICSMQSLEKLNLSHNNLS 327
I + + +Q L + + +
Sbjct: 396 QIELQHATEEQSPLQLLRAIVKRYEEMY 423
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-41
Identities = 77/268 (28%), Positives = 133/268 (49%), Gaps = 22/268 (8%)
Query: 88 SIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSL 147
D + + +L+ + S N L P L NLT LV + ++ N+++ PL+ NLT+L
Sbjct: 59 KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLA--NLTNL 114
Query: 148 SILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIV 207
+ L L+ N + D P + N+ +L+ L+LSSN ++ LS LT+ L+ L N +
Sbjct: 115 TGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALS--GLTS-LQQLSF-GNQVT 168
Query: 208 GEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVK 267
PL + L++L +L +++N++S L L LE L + N P L L
Sbjct: 169 DLKPLAN--LTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTN 222
Query: 268 LHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLS 327
L L+L+ NQ I + L +L++LDL++N P + + L +L L N +S
Sbjct: 223 LDELSLNGNQLK-DIGT-LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS 278
Query: 328 GSIPRCFEEMHWLSCIDISYNALQGLIP 355
P + L+ ++++ N L+ + P
Sbjct: 279 NISP--LAGLTALTNLELNENQLEDISP 304
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 8e-41
Identities = 78/269 (28%), Positives = 123/269 (45%), Gaps = 23/269 (8%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTS 146
+ I + N+ L D+ ++ N + PL NLTNL L L N+++ PL NLT+
Sbjct: 81 TDIT-PLKNLTKLVDILMNNNQIADITPL--ANLTNLTGLTLFNNQITDIDPLK--NLTN 135
Query: 147 LSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHI 206
L+ L L N++ S + + SL L + + LANLT L+ L +SSN +
Sbjct: 136 LNRLELSSNTI--SDISALSGLTSLQQLSFGNQVTD---LKPLANLTT-LERLDISSNKV 189
Query: 207 VGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLV 266
L L++L L NN++S LG L L+ L L+ N +L++L
Sbjct: 190 SDISVLAK--LTNLESLIATNNQISD--ITPLGILTNLDELSLNGNQL--KDIGTLASLT 243
Query: 267 KLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNL 326
L L+L+NNQ S P + L L+EL L N P + + +L L L+ N L
Sbjct: 244 NLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQL 299
Query: 327 SGSIPRCFEEMHWLSCIDISYNALQGLIP 355
P + L+ + + +N + + P
Sbjct: 300 EDISP--ISNLKNLTYLTLYFNNISDISP 326
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-40
Identities = 73/269 (27%), Positives = 119/269 (44%), Gaps = 22/269 (8%)
Query: 90 PDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSI 149
+ N+ +L L +S N + S L LTNL L + N++S PL LT+L
Sbjct: 170 LKPLANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITPLG--ILTNLDE 225
Query: 150 LYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGE 209
L L N L + ++ +L+ LDL++N+++ PLS LT L L L +N I
Sbjct: 226 LSLNGNQL--KDIGTLASLTNLTDLDLANNQISNLAPLS--GLTK-LTELKLGANQISNI 280
Query: 210 IPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLH 269
PL L++L L LN N+L + +L L YL L N P +S+L KL
Sbjct: 281 SPLAG--LTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQ 334
Query: 270 YLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGS 329
L NN+ S + + L +++ L HN + P + ++ + +L L+ + +
Sbjct: 335 RLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNA 390
Query: 330 IPRCFEEMHWLSCIDISYNALQGLIPNST 358
+ + + N LI +T
Sbjct: 391 PVNYKANVSIPNTV---KNVTGALIAPAT 416
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-40
Identities = 76/263 (28%), Positives = 120/263 (45%), Gaps = 22/263 (8%)
Query: 93 IGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYL 152
++ ++ LQ + L NL ++ S N+L+ PL NLT L + +
Sbjct: 42 QTDLDQVTTLQADRL--GIKSIDGVEYLNNLTQINFSNNQLTDITPLK--NLTKLVDILM 97
Query: 153 YENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPL 212
N + D P + N+ +L+ L L +N++ PL NLTN L L LSSN I L
Sbjct: 98 NNNQIADITP--LANLTNLTGLTLFNNQITDIDPLK--NLTN-LNRLELSSNTISDISAL 152
Query: 213 GHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLN 272
L+SL QL+ N L +L LE LD+S+N S L+ L L L
Sbjct: 153 SG--LTSLQQLSFGNQVTD---LKPLANLTTLERLDISSNKV--SDISVLAKLTNLESLI 205
Query: 273 LSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPR 332
+NNQ S P + L +L EL L+ N ++ + S+ +L L+L++N +S P
Sbjct: 206 ATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP- 260
Query: 333 CFEEMHWLSCIDISYNALQGLIP 355
+ L+ + + N + + P
Sbjct: 261 -LSGLTKLTELKLGANQISNISP 282
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-36
Identities = 59/258 (22%), Positives = 111/258 (43%), Gaps = 21/258 (8%)
Query: 98 SLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSL 157
L ++++ I L + L ++ ++ + +L ++ L +
Sbjct: 2 PLGSATITQDTPINQIF-TDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI 58
Query: 158 CDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGML 217
+ +N+L+ ++ S+N+L PL NLT L + +++N I PL + L
Sbjct: 59 --KSIDGVEYLNNLTQINFSNNQLTDITPLK--NLTK-LVDILMNNNQIADITPLAN--L 111
Query: 218 SSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQ 277
++L LTL NN+++ L +L L L+LS+NT S +LS L L L+ N
Sbjct: 112 TNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTI--SDISALSGLTSLQQLSFGNQV 167
Query: 278 FSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEM 337
+ L L LD+S N + S + + +LE L ++N +S P +
Sbjct: 168 TD---LKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGIL 220
Query: 338 HWLSCIDISYNALQGLIP 355
L + ++ N L+ +
Sbjct: 221 TNLDELSLNGNQLKDIGT 238
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-34
Identities = 56/242 (23%), Positives = 106/242 (43%), Gaps = 16/242 (6%)
Query: 90 PDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSI 149
+ ++ +L+DL L+ N ++ PL LT L L L N++S PL+ LT+L+
Sbjct: 236 IGTLASLTNLTDLDLANNQISNLAPL--SGLTKLTELKLGANQISNISPLA--GLTALTN 291
Query: 150 LYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGE 209
L L EN L D P I N+ +L+ L L N ++ P+S +LT L+ L+ +N +
Sbjct: 292 LELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVS--SLTK-LQRLFFYNNKVSDV 346
Query: 210 IPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLH 269
L + L+++ L+ +N++S L +L ++ L L+ + + +N+ +
Sbjct: 347 SSLAN--LTNINWLSAGHNQISD--LTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPN 402
Query: 270 YLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGS 329
+ P I +E D++ N+ + + SG+
Sbjct: 403 TVKNVTGALI--APATISDGGSYTEPDITWNLP-SYTNEVSYTFSQPVTIGKGTTTFSGT 459
Query: 330 IP 331
+
Sbjct: 460 VT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 5e-10
Identities = 19/95 (20%), Positives = 40/95 (42%), Gaps = 4/95 (4%)
Query: 88 SIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSL 147
S + N+ +++ L N ++ PL NLT + L L+ + + AN++
Sbjct: 344 SDVSSLANLTNINWLSAGHNQISDLTPL--ANLTRITQLGLNDQAWTNAPVNYKANVSIP 401
Query: 148 SILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLN 182
+ + +L P I + S + D++ N +
Sbjct: 402 NTVKNVTGAL--IAPATISDGGSYTEPDITWNLPS 434
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 4e-38
Identities = 72/288 (25%), Positives = 123/288 (42%), Gaps = 18/288 (6%)
Query: 87 SSIPDEI-GNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLT 145
+P + + + + L L++ + A + L + N + P F N+
Sbjct: 58 RKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVP 117
Query: 146 SLSILYLYENSLCDSIPKEI-GNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSN 204
L++L L N L S+P+ I N L+ L +S+N L + T+ L+ L LSSN
Sbjct: 118 LLTVLVLERNDL-SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTS-LQNLQLSSN 175
Query: 205 HIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSN 264
+ + L ++ SL ++ N LS L I +E LD S N+ + +
Sbjct: 176 RLT-HVDLS--LIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSI-NVVRGPV-- 224
Query: 265 LVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHN 324
V+L L L +N + + L E+DLS+N + + MQ LE+L +S+N
Sbjct: 225 NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNN 282
Query: 325 NLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNK 372
L ++ + + L +D+S+N L + N F L L N
Sbjct: 283 RLV-ALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNS 329
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-35
Identities = 60/295 (20%), Positives = 108/295 (36%), Gaps = 25/295 (8%)
Query: 84 PLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFAN 143
P Y I + D+ + + L N ++ + + +
Sbjct: 8 PEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDS 67
Query: 144 LTSLSILYLYENSLCDSIPKEI-GNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLS 202
+ +L L + + + I +++ L + N + P N+ L VL L
Sbjct: 68 FRQVELLNLNDLQI-EEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPL-LTVLVLE 125
Query: 203 SNHIVGEIPLGH-GMLSSLIQLTLNNNELSGQLSPE-LGSLIQLEYLDLSANTFHKSIPE 260
N + +P G L L+++NN L ++ + + L+ L LS+N +
Sbjct: 126 RNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRL-THVD- 181
Query: 261 SLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLN 320
LS + L + N+S N S + I + ELD SHN + + L L
Sbjct: 182 -LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVN--VELTILK 232
Query: 321 LSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAP---MLALQGNK 372
L HNNL+ L +D+SYN L+ ++ + F L + N+
Sbjct: 233 LQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYH--PFVKMQRLERLYISNNR 283
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 59/258 (22%), Positives = 100/258 (38%), Gaps = 26/258 (10%)
Query: 87 SSIPDEI-GNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLT 145
I D+ SL +LQLS N L + L + +L ++S N LS + A
Sbjct: 154 ERIEDDTFQATTSLQNLQLSSNRLTH---VDLSLIPSLFHANVSYNLLS-----TLAIPI 205
Query: 146 SLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNH 205
++ L NS+ + + + L+IL L N L L N L + LS N
Sbjct: 206 AVEELDASHNSI-NVVRGPV--NVELTILKLQHNNLT-DTA-WLLNYPG-LVEVDLSYNE 259
Query: 206 IVGEIPLGH-GMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSN 264
+ +I + L +L ++NN L L+ + L+ LDLS N + +
Sbjct: 260 LE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL-LHVERNQPQ 316
Query: 265 LVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHN 324
+L L L +N + + L L LSHN + + +++ + +
Sbjct: 317 FDRLENLYLDHNSIVT-LK--LSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDA 371
Query: 325 NLSGSIPRCFEEMHWLSC 342
+ I ++ H L C
Sbjct: 372 DQHCKID--YQLEHGLCC 387
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 23/135 (17%), Positives = 53/135 (39%), Gaps = 10/135 (7%)
Query: 252 NTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQIC 311
+K I +L + +++ + L + + ++ R+ + +
Sbjct: 7 QPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLD 66
Query: 312 SMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAP---MLAL 368
S + +E LNL+ + F H + + + +NA++ L P+ F++ P +L L
Sbjct: 67 SFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPH--VFQNVPLLTVLVL 124
Query: 369 QGNKRLCGDIKRLPP 383
+ N + LP
Sbjct: 125 ERND-----LSSLPR 134
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-38
Identities = 68/293 (23%), Positives = 129/293 (44%), Gaps = 14/293 (4%)
Query: 90 PDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSI 149
DE + L +L+L+ENI++ P A NL NL L L +N+L F L++L+
Sbjct: 49 QDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTK 108
Query: 150 LYLYENSLCDSIPKEI-GNMNSLSILDLSSNKLNGSIP-LSLANLTNSLKVLYLSSNHIV 207
L + EN + + + ++ +L L++ N L I + + L + L+ L L ++
Sbjct: 109 LDISENKI-VILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNS-LEQLTLEKCNLT 165
Query: 208 GEIPLGH-GMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLV 266
IP L LI L L + ++ L +L+ L++S + ++ + +
Sbjct: 166 -SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGL 224
Query: 267 KLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQI-CSMQSLEKLNLSHNN 325
L L++++ + + L++L L+LS+N I + + L+++ L
Sbjct: 225 NLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIST-IEGSMLHELLRLQEIQLVGGQ 283
Query: 326 LSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLA---LQGNKRLC 375
L+ P F +++L +++S N L L + F L L N C
Sbjct: 284 LAVVEPYAFRGLNYLRVLNVSGNQLTTLEES--VFHSVGNLETLILDSNPLAC 334
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-37
Identities = 69/308 (22%), Positives = 126/308 (40%), Gaps = 42/308 (13%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTS 146
++P+ I L L +N + + +L L+L+ N +S P +F NL +
Sbjct: 24 VAVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFN 81
Query: 147 LSILYLYENSLCDSIPKEI-GNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNH 205
L L L N L IP + +++L+ LD+S NK+ + +L N LK L + N
Sbjct: 82 LRTLGLRSNRL-KLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYN-LKSLEVGDND 139
Query: 206 IVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNL 265
+V +++ SG L LE L L E+LS+L
Sbjct: 140 LV----------------YISHRAFSG--------LNSLEQLTLEKCNLTSIPTEALSHL 175
Query: 266 VKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNN 325
L L L + + ++L L L++SH + + + +L L+++H N
Sbjct: 176 HGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCN 235
Query: 326 LSGSIPRC-FEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLA---LQGNKRLCGDIKRL 381
L+ ++P + +L +++SYN + + + + L L G + + +
Sbjct: 236 LT-AVPYLAVRHLVYLRFLNLSYNPISTIEGS--MLHELLRLQEIQLVGGQ-----LAVV 287
Query: 382 PPCKAFKS 389
P AF+
Sbjct: 288 EP-YAFRG 294
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 9e-35
Identities = 65/260 (25%), Positives = 110/260 (42%), Gaps = 15/260 (5%)
Query: 87 SSIPDEI-GNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIP-LSFANL 144
IP + + +L+ L +SEN + + +L NL L++ N L I +F+ L
Sbjct: 93 KLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGL 151
Query: 145 TSLSILYLYENSLCDSIPKEI-GNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSS 203
SL L L + +L SIP E +++ L +L L +N S L LKVL +S
Sbjct: 152 NSLEQLTLEKCNL-TSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYR-LKVLEISH 209
Query: 204 NHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPE-LGSLIQLEYLDLSANTFHKSIPESL 262
+ + +L L++ + L+ + + L+ L +L+LS N L
Sbjct: 210 WPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSML 268
Query: 263 SNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQIC-SMQSLEKLNL 321
L++L + L Q + P L +L L++S N + + S+ +LE L L
Sbjct: 269 HELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLIL 327
Query: 322 SHNNLSGSIPRCFEEMHWLS 341
N L C + W+
Sbjct: 328 DSNPL-----ACDCRLLWVF 342
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 31/126 (24%), Positives = 56/126 (44%), Gaps = 5/126 (3%)
Query: 81 QDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIP-LALGNLTNLVVLDLSTNKLSGSIPL 139
WP ++ +L+ L ++ L ++P LA+ +L L L+LS N +S
Sbjct: 208 SHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGS 266
Query: 140 SFANLTSLSILYLYENSLCDSIPKEI-GNMNSLSILDLSSNKLNGSIPLSLANLTNSLKV 198
L L + L L + +N L +L++S N+L ++ S+ + +L+
Sbjct: 267 MLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLET 324
Query: 199 LYLSSN 204
L L SN
Sbjct: 325 LILDSN 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-37
Identities = 67/298 (22%), Positives = 114/298 (38%), Gaps = 23/298 (7%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTS 146
+P ++ + L L N + NL NL L L NK+S P +FA L
Sbjct: 44 EKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVK 101
Query: 147 LSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHI 206
L LYL +N L +P+++ +L L + N++ L + V+ L +N +
Sbjct: 102 LERLYLSKNQL-KELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQ-MIVVELGTNPL 157
Query: 207 VGEIPLGHGM---LSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLS 263
+ +G + L + + + ++ + G L L L N K SL
Sbjct: 158 -KSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLK 213
Query: 264 NLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSH 323
L L L LS N S + HL EL L++N ++P + + ++ + L +
Sbjct: 214 GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHN 272
Query: 324 NNLSG------SIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAP---MLALQGNK 372
NN+S P + S + + N +Q + FR + L K
Sbjct: 273 NNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 1e-35
Identities = 70/319 (21%), Positives = 127/319 (39%), Gaps = 37/319 (11%)
Query: 87 SSIPDEI-GNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLT 145
+P + + + + L L++ + A + L + N + P F N+
Sbjct: 64 RKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVP 123
Query: 146 SLSILYLYENSLCDSIPKEI-GNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSN 204
L++L L N L S+P+ I N L+ L +S+N L + T+ L+ L LSSN
Sbjct: 124 LLTVLVLERNDL-SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTS-LQNLQLSSN 181
Query: 205 HIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPE---- 260
+ + L ++ SL ++ N LS L I +E LD S N+ + +
Sbjct: 182 RLT-HVDLS--LIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVNV 232
Query: 261 ----------------SLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFRE 304
L N L ++LS N+ + + + K+ L L +S+N
Sbjct: 233 ELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA 292
Query: 305 EIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAP 364
+ + +L+ L+LSHN+L + R + L + + +N++ L +
Sbjct: 293 -LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL--KLSTHHTLK 348
Query: 365 MLALQGNKRLCGDIKRLPP 383
L L N C ++ L
Sbjct: 349 NLTLSHNDWDCNSLRALFR 367
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-31
Identities = 60/295 (20%), Positives = 108/295 (36%), Gaps = 25/295 (8%)
Query: 84 PLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFAN 143
P Y I + D+ + + L N ++ + + +
Sbjct: 14 PEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDS 73
Query: 144 LTSLSILYLYENSLCDSIPKEI-GNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLS 202
+ +L L + + + I +++ L + N + P N+ L VL L
Sbjct: 74 FRQVELLNLNDLQI-EEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPL-LTVLVLE 131
Query: 203 SNHIVGEIPLGH-GMLSSLIQLTLNNNELSGQLSPE-LGSLIQLEYLDLSANTFHKSIPE 260
N + +P G L L+++NN L ++ + + L+ L LS+N +
Sbjct: 132 RNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRL-THVD- 187
Query: 261 SLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLN 320
LS + L + N+S N S + I + ELD SHN + + L L
Sbjct: 188 -LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVN--VELTILK 238
Query: 321 LSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAP---MLALQGNK 372
L HNNL+ L +D+SYN L+ ++ + F L + N+
Sbjct: 239 LQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYH--PFVKMQRLERLYISNNR 289
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 2e-21
Identities = 44/247 (17%), Positives = 86/247 (34%), Gaps = 15/247 (6%)
Query: 128 LSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPL 187
I + +++ + E +N+ I+ ++ +
Sbjct: 10 KPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAA 69
Query: 188 SLANLTNSLKVLYLSSNHIVGEIPLGH-GMLSSLIQLTLNNNELSGQLSPE-LGSLIQLE 245
L + +++L L+ I EI ++ +L + N + L P ++ L
Sbjct: 70 LLDSFRQ-VELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLT 126
Query: 246 YLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREE 305
L L N N KL L++SNN + + + L L LS N
Sbjct: 127 VLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL-TH 185
Query: 306 IPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPM 365
+ + SL N+S+N LS ++ + +D S+N++ + + +
Sbjct: 186 VDLS--LIPSLFHANVSYNLLS-TLAIPIA----VEELDASHNSINVVRGP--VNVELTI 236
Query: 366 LALQGNK 372
L LQ N
Sbjct: 237 LKLQHNN 243
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 4e-13
Identities = 40/221 (18%), Positives = 73/221 (33%), Gaps = 15/221 (6%)
Query: 87 SSIPDEI-GNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLT 145
I M+ L L +S N L ++ L + L VLDLS N L + +
Sbjct: 267 EKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFD 324
Query: 146 SLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNH 205
L LYL NS+ ++ + ++L L LS N + + +L V H
Sbjct: 325 RLENLYLDHNSI-VTLK--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDA-DQH 380
Query: 206 IVGEIPLGHGMLSS--------LIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKS 257
+ L HG+ + + + ++ G + ++ + H
Sbjct: 381 CKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYI 440
Query: 258 IPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLS 298
+ L L N+ ++ + I +L
Sbjct: 441 TQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQG 481
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 22/167 (13%), Positives = 51/167 (30%), Gaps = 15/167 (8%)
Query: 225 LNNNELSGQL---SPELGSLIQLEYLDLSANTFHKSIPESLS--NLVKLHYLNLSNNQFS 279
N Q + + D+ + + + L + N+
Sbjct: 5 QRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR 64
Query: 280 QKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHW 339
+ ++ + L+L+ E +++KL + N + P F+ +
Sbjct: 65 KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPL 124
Query: 340 LSCIDISYNALQGLIPNSTAFRDAPMLA---LQGNKRLCGDIKRLPP 383
L+ + + N L L F + P L + N ++R+
Sbjct: 125 LTVLVLERNDLSSLPRG--IFHNTPKLTTLSMSNNN-----LERIED 164
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-34
Identities = 62/304 (20%), Positives = 116/304 (38%), Gaps = 54/304 (17%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTS 146
+++PD + ++ L + +N L S+P L L ++S N+L+ S+P+ L
Sbjct: 53 TTLPDCLP--AHITTLVIPDNNLT-SLPALPPELRTL---EVSGNQLT-SLPVLPPGLLE 105
Query: 147 LSILYLYENSLCD----------------SIPKEIGNMNSLSILDLSSNKLNGSIPLSLA 190
LSI L S+P L L +S N+L S+P +
Sbjct: 106 LSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVLPPG---LQELSVSDNQLA-SLPALPS 161
Query: 191 NLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLS 250
L L+ +N + +P+ S L +L++++N+L+ L L +L +
Sbjct: 162 ELCK----LWAYNNQLT-SLPML---PSGLQELSVSDNQLA-SLPTLPSELYKLWAYNNR 212
Query: 251 ANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQI 310
S+P S L +L +S N+ + +P L EL +S N +P
Sbjct: 213 ----LTSLPALPSGLKELI---VSGNRLTS-LPVLPS---ELKELMVSGN-RLTSLPMLP 260
Query: 311 CSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQG 370
L L++ N L+ +P + + +++ N L + R+
Sbjct: 261 S---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQA--LREITSAPGYS 314
Query: 371 NKRL 374
+
Sbjct: 315 GPII 318
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-32
Identities = 62/328 (18%), Positives = 110/328 (33%), Gaps = 39/328 (11%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIP----LALGN---------LTNLVVLDLSTNKL 133
+S+P + LS L L + L L +S N+L
Sbjct: 94 TSLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVLPPGLQELSVSDNQL 153
Query: 134 SGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLT 193
+ S+P + L L + Y N L S+P L L +S N+L S+P + L
Sbjct: 154 A-SLPALPSELCKL---WAYNNQL-TSLPMLPSG---LQELSVSDNQLA-SLPTLPSELY 204
Query: 194 NSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANT 253
L+ +N + +P + S L +L ++ N L+ L +L+ L +S N
Sbjct: 205 K----LWAYNNRLT-SLP---ALPSGLKELIVSGNRLT-SLPVLPS---ELKELMVSGNR 252
Query: 254 FHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSM 313
S+P S L+ L ++ NQ ++ +P + L + ++L N E + +
Sbjct: 253 L-TSLPMLPSGLLSL---SVYRNQLTR-LPESLIHLSSETTVNLEGNPLSERTLQALREI 307
Query: 314 QSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKR 373
S + + E L + + A R
Sbjct: 308 TSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADA 367
Query: 374 LCGDIKRLPPCKAFKSHKQSMKKIWVVI 401
+ RL + F +I +
Sbjct: 368 FSLFLDRLSETENFIKDAGFKAQISSWL 395
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-30
Identities = 53/234 (22%), Positives = 88/234 (37%), Gaps = 36/234 (15%)
Query: 120 LTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSN 179
VL++ + L+ ++P ++ L + +N+L S+P L L++S N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNL-TSLPALPPE---LRTLEVSGN 91
Query: 180 KLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELG 239
+L S+P+ L L + H+ S L +L + N+L+ L
Sbjct: 92 QLT-SLPVLPPGLLE-LSIFSNPLTHLPAL-------PSGLCKLWIFGNQLT-SLPVLPP 141
Query: 240 SLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSH 299
L+ L +S N S+P S L K L NNQ + +P L EL +S
Sbjct: 142 G---LQELSVSDNQL-ASLPALPSELCK---LWAYNNQLTS-LPMLPS---GLQELSVSD 190
Query: 300 NIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGL 353
N +P+ + L N +L L + +S N L L
Sbjct: 191 NQL-ASLPTLPSELYKLWAYNNRLTSLPALPSG-------LKELIVSGNRLTSL 236
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 44/218 (20%), Positives = 81/218 (37%), Gaps = 29/218 (13%)
Query: 139 LSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKV 198
+ ++L + E+ L ++P + ++ L + N L S+P L
Sbjct: 34 MRACLNNGNAVLNVGESGL-TTLPDCLP--AHITTLVIPDNNLT-SLPALPPELRT---- 85
Query: 199 LYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSI 258
L +S N + +P+ L L + L S L L + N S+
Sbjct: 86 LEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQL-TSL 136
Query: 259 PESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEK 318
P L L++S+NQ + +P L +L +N +P L++
Sbjct: 137 PVLPPG---LQELSVSDNQLAS-LPALPS---ELCKLWAYNNQL-TSLPMLPS---GLQE 185
Query: 319 LNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPN 356
L++S N L+ S+P E++ L + +L L
Sbjct: 186 LSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSG 222
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-34
Identities = 69/302 (22%), Positives = 111/302 (36%), Gaps = 22/302 (7%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTS 146
IPD + S +L LS N L + + L VLDLS ++ ++ +L+
Sbjct: 20 YKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSH 77
Query: 147 LSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHI 206
LS L L N + ++SL L L + +L LK L ++ N I
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT-LKELNVAHNLI 136
Query: 207 VGEIPLGHGM--LSSLIQLTLNNNELSGQLSPELGSLIQLEY----LDLSANTFHKSIPE 260
L L++L L L++N++ +L L Q+ LDLS N I
Sbjct: 137 Q-SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQP 194
Query: 261 SLSNLVKLHYLNLSNNQFSQKIP-NKIEKLIHLSELDLSHNIFREE---IPSQICSMQSL 316
++LH L L NN S + I+ L L L FR E +++ L
Sbjct: 195 GAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGL 254
Query: 317 EKLNLSHNNLSG------SIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQG 370
L + L+ I F + +S + ++ + + + L L
Sbjct: 255 CNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVN 313
Query: 371 NK 372
K
Sbjct: 314 CK 315
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-33
Identities = 60/258 (23%), Positives = 97/258 (37%), Gaps = 12/258 (4%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTS 146
+ D N L+L L +L L ++NK + S +L S
Sbjct: 295 ERVKDFSYNF-GWQHLELVNCKFGQ---FPTLKLKSLKRLTFTSNKGGNAF--SEVDLPS 348
Query: 147 LSILYLYENSL--CDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSN 204
L L L N L + SL LDLS N + ++ + L L+ L +
Sbjct: 349 LEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQ-LEHLDFQHS 406
Query: 205 HIVGEIPLGH-GMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSI-PESL 262
++ L +LI L +++ + L LE L ++ N+F ++ P+
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF 466
Query: 263 SNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLS 322
+ L L +L+LS Q Q P L L L+++ N + + SL+K+ L
Sbjct: 467 TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLH 526
Query: 323 HNNLSGSIPRCFEEMHWL 340
N S PR WL
Sbjct: 527 TNPWDCSCPRIDYLSRWL 544
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-31
Identities = 55/284 (19%), Positives = 107/284 (37%), Gaps = 18/284 (6%)
Query: 90 PDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSI 149
+ L L LS + A +L++L L L+ N + +F+ L+SL
Sbjct: 45 SYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQK 104
Query: 150 LYLYENSLCDSIPKEIGNMNSLSILDLSSNKLN-GSIPLSLANLTNSLKVLYLSSNHIVG 208
L E +L IG++ +L L+++ N + +P +NLTN L+ L LSSN I
Sbjct: 105 LVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTN-LEHLDLSSNKIQS 163
Query: 209 EIPLGHGMLSSL----IQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPE-SLS 263
+L + + L L+ N ++ + P I+L L L N ++ + +
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQ 222
Query: 264 NLVKLHYLNL------SNNQFSQKIPNKIEKLIHLSELDLSHN---IFREEIPSQICSMQ 314
L L L + + + +E L +L+ + + ++I +
Sbjct: 223 GLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLT 282
Query: 315 SLEKLNLSHNNLSGSIPRCFEE-MHWLSCIDISYNALQGLIPNS 357
++ +L + + L ++ + L S
Sbjct: 283 NVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKS 326
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-30
Identities = 66/284 (23%), Positives = 106/284 (37%), Gaps = 17/284 (5%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILNGSIPLA-LGNLTNLVVLDLSTNKLSGSIPLSFAN 143
I D + ++S L + + +L +++ +
Sbjct: 270 YLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFP------TLK 323
Query: 144 LTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLN--GSIPLSLANLTNSLKVLYL 201
L SL L N + E+ ++ SL LDLS N L+ G S T+ LK L L
Sbjct: 324 LKSLKRLTFTSNKG-GNAFSEV-DLPSLEFLDLSRNGLSFKGCCSQSDFGTTS-LKYLDL 380
Query: 202 SSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPE--LGSLIQLEYLDLSANTFHKSIP 259
S N ++ + L L L ++ L Q+S SL L YLD+S +
Sbjct: 381 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFN 438
Query: 260 ESLSNLVKLHYLNLSNNQFSQKIPNKI-EKLIHLSELDLSHNIFREEIPSQICSMQSLEK 318
+ L L L ++ N F + I +L +L+ LDLS + P+ S+ SL+
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 498
Query: 319 LNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRD 362
LN++ N L F+ + L I + N P
Sbjct: 499 LNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSR 542
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-29
Identities = 68/307 (22%), Positives = 108/307 (35%), Gaps = 35/307 (11%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILN-GSIPLALGNLTNLVVLDLSTNKLSGSIPLSFAN 143
L S IG++K+L +L ++ N++ +P NLTNL LDLS+NK+
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV 171
Query: 144 LTSLSI----LYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVL 199
L + + L L N + + I L L L +N + ++ + L+V
Sbjct: 172 LHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVH 230
Query: 200 YLSSNHIVGEIPLGH---GMLSSLIQLTLNNNELSG------QLSPELGSLIQLEYLDLS 250
L E L L L LT+ L+ + L + L
Sbjct: 231 RLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLV 290
Query: 251 ANTFHKSIPES-LSNLVKLHYLNLSNNQFSQKIP----------NKIE------KLIHLS 293
+ T + S L +N QF NK L L
Sbjct: 291 SVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLE 350
Query: 294 ELDLSHN--IFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQ 351
LDLS N F+ SL+ L+LS N + ++ F + L +D ++ L+
Sbjct: 351 FLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK 409
Query: 352 GLIPNST 358
+ S
Sbjct: 410 QMSEFSV 416
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-29
Identities = 67/341 (19%), Positives = 117/341 (34%), Gaps = 48/341 (14%)
Query: 87 SSIPDEI-GNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKL-SGSIPLSFANL 144
S+ + SL L E L +G+L L L+++ N + S +P F+NL
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 145 TSLSILYLYENSLCDSIPKEIGNMNSLSI----LDLSSNKLNGSIPLSLANLTNSLKVLY 200
T+L L L N + ++ ++ + + LDLS N +N P + + L L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI--RLHKLT 206
Query: 201 LSSNHIVGEIPLGH-GMLSSLIQLTLNNNELSGQ---LSPELGSLIQLEYLDLSAN---- 252
L +N + L+ L L E + + +L L L +
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 253 --TFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKI--------------------EKLI 290
+ I + + L + +L + + + + KL
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFGQFPTLKLK 325
Query: 291 HLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLS--GSIPRCFEEMHWLSCIDISYN 348
L L + N + SLE L+LS N LS G + L +D+S+N
Sbjct: 326 SLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN 383
Query: 349 ALQGLIPNSTAFRDAPMLALQGNKRLCGDIKRLPPCKAFKS 389
+ + N L Q + +K++ F S
Sbjct: 384 GVITMSSNFLGLEQLEHLDFQHSN-----LKQMSEFSVFLS 419
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 3e-20
Identities = 38/184 (20%), Positives = 60/184 (32%), Gaps = 29/184 (15%)
Query: 175 DLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQL 234
IP NL S K L LS N + L +
Sbjct: 13 QCMELNFY-KIP---DNLPFSTKNLDLSFNPLR----------------HLGSYSFFS-- 50
Query: 235 SPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSE 294
+L+ LDLS + +L L L L+ N L L +
Sbjct: 51 ------FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQK 104
Query: 295 LDLSHNIFREEIPSQICSMQSLEKLNLSHNNL-SGSIPRCFEEMHWLSCIDISYNALQGL 353
L I +++L++LN++HN + S +P F + L +D+S N +Q +
Sbjct: 105 LVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164
Query: 354 IPNS 357
Sbjct: 165 YCTD 168
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 61/299 (20%), Positives = 107/299 (35%), Gaps = 24/299 (8%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTS 146
++P EI + L L N ++ L +L L L NK+S +F+ L
Sbjct: 46 KAVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRK 103
Query: 147 LSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHI 206
L LY+ +N L IP + +SL L + N++ + L N + + + N +
Sbjct: 104 LQKLYISKNHL-VEIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRN-MNCIEMGGNPL 159
Query: 207 VGEIPLGHGMLS--SLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSN 264
G L L ++ +L+ L L L N E L
Sbjct: 160 -ENSGFEPGAFDGLKLNYLRISEAKLT---GIPKDLPETLNELHLDHNKIQAIELEDLLR 215
Query: 265 LVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHN 324
KL+ L L +NQ + L L EL L +N +P+ + ++ L+ + L N
Sbjct: 216 YSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKL-SRVPAGLPDLKLLQVVYLHTN 274
Query: 325 NLSGSIP-------RCFEEMHWLSCIDISYNALQGLIPNSTAFRDAP---MLALQGNKR 373
N++ + + + + I + N + FR + K+
Sbjct: 275 NIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYKK 332
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 36/149 (24%), Positives = 58/149 (38%), Gaps = 13/149 (8%)
Query: 244 LEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKI-EKLIHLSELDLSHNIF 302
LDL N + + L L+ L L NN+ S KI K L L +L +S N
Sbjct: 56 TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHL 114
Query: 303 REEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRD 362
EIP + SL +L + N + F + ++CI++ N L+ AF
Sbjct: 115 V-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDG 171
Query: 363 APM--LALQGNKRLCGDIKRLPPCKAFKS 389
+ L + K + +P ++
Sbjct: 172 LKLNYLRISEAK-----LTGIPK-DLPET 194
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 8e-34
Identities = 61/280 (21%), Positives = 113/280 (40%), Gaps = 44/280 (15%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNL-------------TNLVVLDLSTNKL 133
+ +P E N+KS ++ + + + P G L+L+ L
Sbjct: 24 TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGL 83
Query: 134 SGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLT 193
S S+P +L S L NSL +P+ ++ SL + + + L+ +L
Sbjct: 84 S-SLPELPPHLES---LVASCNSL-TELPELPQSLKSLLVDNNNLKALS--------DLP 130
Query: 194 NSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANT 253
L+ L +S+N + L + S L + ++NN L +L S LE++ N
Sbjct: 131 PLLEYLGVSNNQLEKLPELQN--SSFLKIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQ 184
Query: 254 FHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSM 313
+ +PE L NL L + NN K+P + + L + +NI E ++ ++
Sbjct: 185 L-EELPE-LQNLPFLTAIYADNNSLK-KLP---DLPLSLESIVAGNNIL--EELPELQNL 236
Query: 314 QSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGL 353
L + +N L ++P + L +++ N L L
Sbjct: 237 PFLTTIYADNNLLK-TLP---DLPPSLEALNVRDNYLTDL 272
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-33
Identities = 63/281 (22%), Positives = 118/281 (41%), Gaps = 37/281 (13%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGN---------LTNLVVLDLSTNKLSG 135
+ P G + ++ +L + + + L L N +L L S N L+
Sbjct: 46 WERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPELPPHLESLVASCNSLT- 104
Query: 136 SIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNS 195
+P +L SL + +L D P L L +S+N+L +P L N +
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSF- 154
Query: 196 LKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFH 255
LK++ + +N + ++P + SL + NN+L PEL +L L + N+
Sbjct: 155 LKIIDVDNNSLK-KLP---DLPPSLEFIAAGNNQLEEL--PELQNLPFLTAIYADNNSL- 207
Query: 256 KSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQS 315
K +P+ + L + NN + +++ L L+ + +N+ + +P S
Sbjct: 208 KKLPDLPLS---LESIVAGNNILEE--LPELQNLPFLTTIYADNNLL-KTLPDLPP---S 258
Query: 316 LEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPN 356
LE LN+ N L+ +P + + +L + ++ L L PN
Sbjct: 259 LEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPN 298
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-32
Identities = 54/276 (19%), Positives = 109/276 (39%), Gaps = 44/276 (15%)
Query: 95 NMKSLSDLQLSENILNG----SIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSI- 149
N +++S+ L E + + +P+ N+ + + ++ + P +++
Sbjct: 4 NPRNVSNTFLQEPLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVS 63
Query: 150 ------------LYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLK 197
L L L S+P+ + L L S N L +P +L + L
Sbjct: 64 RLRDCLDRQAHELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELPELPQSLKS-LL 117
Query: 198 VLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKS 257
V + + P L L ++NN+L PEL + L+ +D+ N+ K
Sbjct: 118 VDNNNLKALSDLPP-------LLEYLGVSNNQLEK--LPELQNSSFLKIIDVDNNSL-KK 167
Query: 258 IPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLE 317
+P+ +L ++ NNQ ++P ++ L L+ + +N +++P SLE
Sbjct: 168 LPDLPPSLE---FIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSL-KKLPDLPL---SLE 218
Query: 318 KLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGL 353
+ +N L + + +L+ I N L+ L
Sbjct: 219 SIVAGNNIL--EELPELQNLPFLTTIYADNNLLKTL 252
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-31
Identities = 61/270 (22%), Positives = 103/270 (38%), Gaps = 38/270 (14%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTS 146
SS+P+ +++SL S N L +P +L +L+V + + LS P
Sbjct: 84 SSLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP-------L 132
Query: 147 LSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHI 206
L L + N L +P E+ N + L I+D+ +N L +P +L + +N +
Sbjct: 133 LEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLPPSLEF----IAAGNNQL 185
Query: 207 VGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLV 266
L + L L + +NN L +L SL E + N L NL
Sbjct: 186 EELPELQN--LPFLTAIYADNNSLK-KLPDLPLSL---ESIVAGNNIL--EELPELQNLP 237
Query: 267 KLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNL 326
L + NN +P+ L L++ N ++P S+ L+ + L
Sbjct: 238 FLTTIYADNNLLKT-LPDLPP---SLEALNVRDNYL-TDLPELPQSLTFLDVSENIFSGL 292
Query: 327 SGSIPRCFEEMHWLSCIDISYNALQGLIPN 356
S P L ++ S N ++ L
Sbjct: 293 SELPPN-------LYYLNASSNEIRSLCDL 315
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-27
Identities = 63/283 (22%), Positives = 111/283 (39%), Gaps = 53/283 (18%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTS 146
+PD + L + N L +P L NL L + N L +P +L S
Sbjct: 166 KKLPDLPPS---LEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLSLES 219
Query: 147 LSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHI 206
+ N L E+ N+ L+ + +N L ++P +L L + N++
Sbjct: 220 I---VAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEA----LNVRDNYL 269
Query: 207 VGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLV 266
++P + SL L ++ N S LS +L YL+ S+N +S+ + +L
Sbjct: 270 T-DLP---ELPQSLTFLDVSENIFS-GLSELPPNL---YYLNASSNEI-RSLCDLPPSLE 320
Query: 267 KLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNL 326
+L N+SNN+ + +P +L L S N E+P Q+L++L++ +N L
Sbjct: 321 EL---NVSNNKLIE-LPALPPRL---ERLIASFNHL-AEVPELP---QNLKQLHVEYNPL 369
Query: 327 SGSIPRCFEEMHWLSC----------------IDISYNALQGL 353
P E + L + + N L+
Sbjct: 370 R-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLREF 411
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 6e-27
Identities = 62/294 (21%), Positives = 104/294 (35%), Gaps = 61/294 (20%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTS 146
+P E+ N+ L+ + N L +P +L ++ N L +P NL
Sbjct: 186 EELP-ELQNLPFLTAIYADNNSLK-KLPDLPLSLESI---VAGNNILE-ELP-ELQNLPF 238
Query: 147 LSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTN------------ 194
L+ +Y N L ++P + L L++ N L +P +LT
Sbjct: 239 LTTIYADNNLL-KTLPDLPPS---LEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLS 293
Query: 195 ----SLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLS 250
+L L SSN I + + SL +L ++NN+L +L L E L S
Sbjct: 294 ELPPNLYYLNASSNEIR-SLC---DLPPSLEELNVSNNKLI-ELPALPPRL---ERLIAS 345
Query: 251 ANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLS----------------E 294
N +PE NL L++ N + P+ E + L +
Sbjct: 346 FNHL-AEVPELPQNL---KQLHVEYNPLRE-FPDIPESVEDLRMNSHLAEVPELPQNLKQ 400
Query: 295 LDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYN 348
L + N RE P +S+E L ++ + E L ++
Sbjct: 401 LHVETNPLRE-FPD---IPESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHH 450
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-26
Identities = 48/256 (18%), Positives = 100/256 (39%), Gaps = 46/256 (17%)
Query: 88 SIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSL 147
E+ N+ L+ + N+L ++P +L L ++ N L+ +P +LT L
Sbjct: 228 EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEAL---NVRDNYLT-DLPELPQSLTFL 282
Query: 148 SILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIV 207
+ + L + P +L L+ SSN++ SL +L SL+ L +S+N ++
Sbjct: 283 DVSENIFSGLSELPP-------NLYYLNASSNEIR-----SLCDLPPSLEELNVSNNKLI 330
Query: 208 GEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVK 267
E+P + L +L + N L+ ++ +L + L + N + P+ ++
Sbjct: 331 -ELP---ALPPRLERLIASFNHLA-EVPELPQNL---KQLHVEYNPL-REFPDIPESVED 381
Query: 268 LH----------------YLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQIC 311
L L++ N + P+ E + +L ++ +
Sbjct: 382 LRMNSHLAEVPELPQNLKQLHVETNPLRE-FPDIPESV---EDLRMNSERVVDPYEFAHE 437
Query: 312 SMQSLEKLNLSHNNLS 327
+ LE H++
Sbjct: 438 TTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 39/195 (20%), Positives = 69/195 (35%), Gaps = 29/195 (14%)
Query: 86 YSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLT 145
+S + + N+ L+ S N + S+ +L L++S NKL +P A
Sbjct: 289 FSGLSELPPNLYYLN---ASSNEIR-SLC---DLPPSLEELNVSNNKLI-ELP---ALPP 337
Query: 146 SLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNH 205
L L N L +P+ N L L + N L P ++ + L N
Sbjct: 338 RLERLIASFNHLA-EVPELPQN---LKQLHVEYNPLR-EFPDIPESVED------LRMNS 386
Query: 206 IVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNL 265
+ E+P + +L QL + N L + S+ E L +++ +
Sbjct: 387 HLAEVP---ELPQNLKQLHVETNPLR-EFPDIPESV---EDLRMNSERVVDPYEFAHETT 439
Query: 266 VKLHYLNLSNNQFSQ 280
KL ++
Sbjct: 440 DKLEDDVFEHHHHHH 454
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-33
Identities = 73/259 (28%), Positives = 111/259 (42%), Gaps = 17/259 (6%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTS 146
+PD I + L L EN + + +L +L +L LS N + +F L +
Sbjct: 56 REVPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLAN 113
Query: 147 LSILYLYENSLCDSIPKEI-GNMNSLSILDLSSNKLNGSIPLSL-ANLTNSLKVLYLSSN 204
L+ L L++N L +IP ++ L L L +N + SIP + + L+ L L
Sbjct: 114 LNTLELFDNRL-TTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPS-LRRLDLGEL 170
Query: 205 HIVGEIPLG--HGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESL 262
+ I G G LS+L L L L P L LI+L+ LDLS N P S
Sbjct: 171 KRLSYISEGAFEG-LSNLRYLNLAMCNLREI--PNLTPLIKLDELDLSGNHLSAIRPGSF 227
Query: 263 SNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLS 322
L+ L L + +Q N + L L E++L+HN + LE+++L
Sbjct: 228 QGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLH 287
Query: 323 HNNLSGSIPRCFEEMHWLS 341
HN C ++ WLS
Sbjct: 288 HNPW-----NCNCDILWLS 301
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-31
Identities = 73/245 (29%), Positives = 117/245 (47%), Gaps = 14/245 (5%)
Query: 112 SIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEI-GNMNS 170
+P + TN +L+L N++ SF +L L IL L N + +I + +
Sbjct: 57 EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI-RTIEIGAFNGLAN 113
Query: 171 LSILDLSSNKLNGSIPL-SLANLTNSLKVLYLSSNHIVGEIPLGH-GMLSSLIQLTL-NN 227
L+ L+L N+L +IP + L+ LK L+L +N I IP + SL +L L
Sbjct: 114 LNTLELFDNRLT-TIPNGAFVYLSK-LKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGEL 170
Query: 228 NELSGQLSPE-LGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKI 286
LS +S L L YL+L+ IP +L+ L+KL L+LS N S P
Sbjct: 171 KRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSF 227
Query: 287 EKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDIS 346
+ L+HL +L + + + + ++QSL ++NL+HNNL+ F +H L I +
Sbjct: 228 QGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLH 287
Query: 347 YNALQ 351
+N
Sbjct: 288 HNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 22/120 (18%), Positives = 45/120 (37%), Gaps = 13/120 (10%)
Query: 267 KLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNL 326
+ + + +P+ I + L+L N + + ++ LE L LS N++
Sbjct: 44 QFSKVICVRKNLRE-VPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 327 SGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLA---LQGNKRLCGDIKRLPP 383
F + L+ +++ N L + + AF L L+ N I+ +P
Sbjct: 101 RTIEIGAFNGLANLNTLELFDNRLTTI--PNGAFVYLSKLKELWLRNNP-----IESIPS 153
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-33
Identities = 74/260 (28%), Positives = 112/260 (43%), Gaps = 19/260 (7%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTS 146
S +P I + L L EN + +L +L VL L N + +F L S
Sbjct: 67 SEVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLAS 124
Query: 147 LSILYLYENSLCDSIPKEI-GNMNSLSILDLSSNKLNGSIPL-SLANLTNSLKVLYLSSN 204
L+ L L++N L IP ++ L L L +N + SIP + + + L L L
Sbjct: 125 LNTLELFDNWL-TVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPS-LMRLDLGEL 181
Query: 205 HIVGEIPLG--HGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESL 262
+ I G G L +L L L + P L L+ LE L++S N F + P S
Sbjct: 182 KKLEYISEGAFEG-LFNLKYLNLGMCNIKD--MPNLTPLVGLEELEMSGNHFPEIRPGSF 238
Query: 263 SNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQIC-SMQSLEKLNL 321
L L L + N+Q S N + L L EL+L+HN +P + ++ L +L+L
Sbjct: 239 HGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHL 297
Query: 322 SHNNLSGSIPRCFEEMHWLS 341
HN C ++ WL+
Sbjct: 298 HHNPW-----NCDCDILWLA 312
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-31
Identities = 69/259 (26%), Positives = 115/259 (44%), Gaps = 15/259 (5%)
Query: 98 SLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSL 157
S + + L+ +P + +N L+L N + +F +L L +L L NS+
Sbjct: 55 QFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 158 CDSIPKEI-GNMNSLSILDLSSNKLNGSIPL-SLANLTNSLKVLYLSSNHIVGEIPLGH- 214
I + SL+ L+L N L IP + L+ L+ L+L +N I IP
Sbjct: 112 -RQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSK-LRELWLRNNPIE-SIPSYAF 167
Query: 215 GMLSSLIQLTLNNNELSGQLSPE-LGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNL 273
+ SL++L L + +S L L+YL+L +P +L+ LV L L +
Sbjct: 168 NRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEM 225
Query: 274 SNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPR- 332
S N F + P L L +L + ++ + + SL +LNL+HNNLS S+P
Sbjct: 226 SGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHD 284
Query: 333 CFEEMHWLSCIDISYNALQ 351
F + +L + + +N
Sbjct: 285 LFTPLRYLVELHLHHNPWN 303
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 4e-32
Identities = 59/298 (19%), Positives = 112/298 (37%), Gaps = 32/298 (10%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSI-PLSFANLT 145
+ +P + + L LS N + + L L +L+L + +I +F NL
Sbjct: 17 TQVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLP 73
Query: 146 SLSILYLYENSLCDSIPKEI-GNMNSLSILDLSSNKLNGSI--PLSLANLTNSLKVLYLS 202
+L IL L + + + + + L L L L+ ++ NL L L LS
Sbjct: 74 NLRILDLGSSKI-YFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKA-LTRLDLS 131
Query: 203 SNHIVGEIPLGH-GMLSSLIQLTLNNNELSGQLSPELGSL--IQLEYLDLSANTFHKSIP 259
N I G L+SL + ++N++ EL L L + L+AN+ + +
Sbjct: 132 KNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVS 191
Query: 260 ESLSNL------VKLHYLNLSNNQFSQKIPNKIEKLI------------HLSELDLSHNI 301
+ L L++S N ++ I I H+ +
Sbjct: 192 VDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHN 251
Query: 302 FREEIPSQICSMQ--SLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNS 357
++ + + S+ L+LSH + R FE + L ++++YN + + +
Sbjct: 252 IKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEA 309
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-32
Identities = 66/290 (22%), Positives = 112/290 (38%), Gaps = 27/290 (9%)
Query: 90 PDEIGNMKSLSDLQLSEN-ILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLT--S 146
N+K+L+ L LS+N I + + + G L +L +D S+N++ L +
Sbjct: 116 DGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKT 175
Query: 147 LSILYLYENSLCDSIPKEIGNMN------SLSILDLSSNKLNGSIPLSLANLTNSLKVLY 200
LS L NSL + + G L ILD+S N I + +N + +
Sbjct: 176 LSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFS 235
Query: 201 LSSNHIVGEIPLGHGML-------------SSLIQLTLNNNELSGQLSPELGSLIQLEYL 247
L H + G + SS+ L L++ + S +L L+ L
Sbjct: 236 LILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVL 295
Query: 248 DLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIP 307
+L+ N +K E+ L L LNLS N + + L ++ +DL N
Sbjct: 296 NLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQD 355
Query: 308 SQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNS 357
++ L+ L+L N L+ + + I +S N L L +
Sbjct: 356 QTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKIN 400
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-32
Identities = 72/297 (24%), Positives = 112/297 (37%), Gaps = 33/297 (11%)
Query: 90 PDEIGNMKSLSDLQLSENILNGSI-PLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLS 148
++ L L+L +I A NL NL +LDL ++K+ P +F L L
Sbjct: 41 ASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLF 100
Query: 149 ILYLYENSLCDSI--PKEIGNMNSLSILDLSSNKLNG-SIPLSLANLTNSLKVLYLSSNH 205
L LY L D++ N+ +L+ LDLS N++ + S L + LK + SSN
Sbjct: 101 ELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNS-LKSIDFSSNQ 159
Query: 206 IVGEIPLGHGMLSSLIQLTLNNNELSG-----------QLSPELGSLIQLEYLDLSAN-- 252
I + L L TL+ L+ + LE LD+S N
Sbjct: 160 IFL---VCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGW 216
Query: 253 ----------TFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLS--ELDLSHN 300
KS SL + + N L S LDLSH
Sbjct: 217 TVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHG 276
Query: 301 IFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNS 357
+++ L+ LNL++N ++ F + L +++SYN L L ++
Sbjct: 277 FVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSN 333
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-31
Identities = 68/301 (22%), Positives = 110/301 (36%), Gaps = 29/301 (9%)
Query: 98 SLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSL 157
S+ L LS + L +L VL+L+ NK++ +F L +L +L L N L
Sbjct: 267 SVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326
Query: 158 CDSIPKEI-GNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIV--------G 208
+ + ++ +DL N + + L L+ L L N +
Sbjct: 327 -GELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEK-LQTLDLRDNALTTIHFIPSIP 384
Query: 209 EIPLGHGMLSSLIQLTLNNNELSGQ--------LSPELGSLIQLEYLDLSANTFHKSIPE 260
+I L L +L ++ L N + + L + L+ L L+ N F +
Sbjct: 385 DIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGD 444
Query: 261 SL-SNLVKLHYLNLSNNQFSQKIPNKIEK-----LIHLSELDLSHNIFREEIPSQICSMQ 314
S L L L N ++ L HL L L+HN P +
Sbjct: 445 QTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLT 504
Query: 315 SLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRL 374
+L L+L+ N L+ L +DIS N L P+ F +L + NK +
Sbjct: 505 ALRGLSLNSNRLTVLSHNDL--PANLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFI 560
Query: 375 C 375
C
Sbjct: 561 C 561
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 4e-15
Identities = 31/138 (22%), Positives = 50/138 (36%), Gaps = 7/138 (5%)
Query: 241 LIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKI-EKLIHLSELDLSH 299
L E L LS N S L +L L L + I + L +L LDL
Sbjct: 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82
Query: 300 NIFREEIPSQICSMQSLEKLNLSHNNLSGSI--PRCFEEMHWLSCIDISYNALQGLIPNS 357
+ P + L +L L LS ++ F + L+ +D+S N ++ L +
Sbjct: 83 SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHP 142
Query: 358 TAFRDAP---MLALQGNK 372
+F + N+
Sbjct: 143 -SFGKLNSLKSIDFSSNQ 159
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 37/124 (29%), Positives = 54/124 (43%), Gaps = 11/124 (8%)
Query: 94 GNMKSLSDLQLSENILNGSI-----PLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLS 148
SL L L EN+L + L++L VL L+ N L+ P F++LT+L
Sbjct: 448 SENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALR 507
Query: 149 ILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVG 208
L L N L + +L ILD+S N+L P + L VL ++ N +
Sbjct: 508 GLSLNSNRLT-VLSHND-LPANLEILDISRNQLLAPNPDVFVS----LSVLDITHNKFIC 561
Query: 209 EIPL 212
E L
Sbjct: 562 ECEL 565
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 5e-32
Identities = 48/293 (16%), Positives = 94/293 (32%), Gaps = 25/293 (8%)
Query: 88 SIPDEIGNMKSLSDLQLSENILNGSIP-LALGNLTNLVVLDLSTNKLSGSIPLSFANLTS 146
+ N+ +L L++ I + LT+L L++ L S ++
Sbjct: 114 GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRD 173
Query: 147 LSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHI 206
+ L L+ + + ++S+ L+L L S + + +
Sbjct: 174 IHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLA-RFQFSPLPVDEVSSPMKKLAFRG 232
Query: 207 VGEIPLGHGMLSSLIQLTLNNNELSGQLSPELG------------------SLIQLEYLD 248
L L++ L +E+ G + + L
Sbjct: 233 SVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLH 292
Query: 249 LSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPS 308
+ + S L K+ + + N++ + + L L LDLS N+ EE
Sbjct: 293 IPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLK 352
Query: 309 Q---ICSMQSLEKLNLSHNNLS--GSIPRCFEEMHWLSCIDISYNALQGLIPN 356
+ SL+ L LS N+L + L+ +DIS N + +
Sbjct: 353 NSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDS 405
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-28
Identities = 49/266 (18%), Positives = 94/266 (35%), Gaps = 18/266 (6%)
Query: 92 EIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILY 151
E + + + + L + L + L + ++ L + +
Sbjct: 257 EFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRIT 316
Query: 152 LYENSLCDSIPKEIG-NMNSLSILDLSSNKLNGSIPLSLANLTN--SLKVLYLSSNHIVG 208
+ + + +P ++ SL LDLS N + + A SL+ L LS NH+
Sbjct: 317 VENSKV-FLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR- 374
Query: 209 EIPLGHGMLSSLIQLT---LNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNL 265
+ +L +L LT ++ N + ++ +L+LS+ + + +
Sbjct: 375 SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGI-RVVKTCI--P 430
Query: 266 VKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNN 325
L L++SNN L L EL +S N + +P L + +S N
Sbjct: 431 QTLEVLDVSNNNLDS-FS---LFLPRLQELYISRNKLKT-LPD-ASLFPVLLVMKISRNQ 484
Query: 326 LSGSIPRCFEEMHWLSCIDISYNALQ 351
L F+ + L I + N
Sbjct: 485 LKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-28
Identities = 52/298 (17%), Positives = 103/298 (34%), Gaps = 25/298 (8%)
Query: 90 PDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSI 149
++ +L L L + +N A +L +L LDLS N LS F L+SL
Sbjct: 43 HGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKY 102
Query: 150 LYLYENSL-CDSIPKEIGNMNSLSILDLSSNKLNGSIP-LSLANLTNSLKVLYLSSNHIV 207
L L N + N+ +L L + + + I + A LT+ L L + + +
Sbjct: 103 LNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTS-LNELEIKALSL- 160
Query: 208 GEIPLGH-GMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLV 266
+ + LTL+ +E + L L + YL+L + L
Sbjct: 161 RNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDE 220
Query: 267 KLHYLNLSNNQFSQ----------KIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQ-- 314
+ + S K+ I +L + D + N + PS+ +
Sbjct: 221 VSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSEL 280
Query: 315 ------SLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPML 366
++ +L++ L + + + + I + + + + + + L
Sbjct: 281 GKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCS--FSQHLKSL 336
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-27
Identities = 52/267 (19%), Positives = 98/267 (36%), Gaps = 22/267 (8%)
Query: 98 SLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSL 157
+ SIP L + LDLS NK++ +L +L L + +
Sbjct: 11 DGRSRSFT------SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI 62
Query: 158 CDSIPKEI-GNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGH-- 214
++I + ++ SL LDLS N L+ L++ LK L L N + +
Sbjct: 63 -NTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSS-LKYLNLMGNPYQ-TLGVTSLF 119
Query: 215 GMLSSLIQLTLNNNELSGQLSPE-LGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNL 273
L++L L + N E ++ L L L++ A + +SL ++ +H+L L
Sbjct: 120 PNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTL 179
Query: 274 SNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLS------ 327
++ + + + L + L+L S + + + S
Sbjct: 180 HLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDES 239
Query: 328 -GSIPRCFEEMHWLSCIDISYNALQGL 353
+ + + LS ++ L GL
Sbjct: 240 FNELLKLLRYILELSEVEFDDCTLNGL 266
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-26
Identities = 50/222 (22%), Positives = 89/222 (40%), Gaps = 18/222 (8%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSI---PLSF 141
L+ + ++ + + + + + +L +L LDLS N +
Sbjct: 298 LFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACK 357
Query: 142 ANLTSLSILYLYENSLCDSIPKEIG---NMNSLSILDLSSNKLNGSIPLSLANLTNSLKV 198
SL L L +N L S+ K + +L+ LD+S N + +P S ++
Sbjct: 358 GAWPSLQTLVLSQNHL-RSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEK-MRF 414
Query: 199 LYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSI 258
L LSS I + + +L L ++NN L S L L+ L +S N K++
Sbjct: 415 LNLSSTGIRV---VKTCIPQTLEVLDVSNNNLD-SFSLFLPR---LQELYISRNKL-KTL 466
Query: 259 PESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHN 300
P++ S L + +S NQ ++L L ++ L N
Sbjct: 467 PDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-18
Identities = 39/190 (20%), Positives = 74/190 (38%), Gaps = 30/190 (15%)
Query: 170 SLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNE 229
+ + D S SIP + LT ++K L LS N I + + +
Sbjct: 6 ASGVCDGRSRSFT-SIP---SGLTAAMKSLDLSFNKIT----------------YIGHGD 45
Query: 230 LSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKL 289
L L+ L L ++ + ++ +L L +L+LS+N S + L
Sbjct: 46 LRA--------CANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPL 97
Query: 290 IHLSELDLSHNIFRE-EIPSQICSMQSLEKLNLSHNNLSGSIPR-CFEEMHWLSCIDISY 347
L L+L N ++ + S ++ +L+ L + + I R F + L+ ++I
Sbjct: 98 SSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKA 157
Query: 348 NALQGLIPNS 357
+L+ S
Sbjct: 158 LSLRNYQSQS 167
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 29/133 (21%), Positives = 43/133 (32%), Gaps = 5/133 (3%)
Query: 244 LEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFR 303
++ LDLS N L L L L +++ + + L L LDLS N
Sbjct: 28 MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS 87
Query: 304 EEIPSQICSMQSLEKLNLSHNNLSG-SIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRD 362
S + SL+ LNL N + F + L + I I F
Sbjct: 88 SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRID-FAG 146
Query: 363 AP---MLALQGNK 372
L ++
Sbjct: 147 LTSLNELEIKALS 159
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 19/66 (28%), Positives = 31/66 (46%), Gaps = 3/66 (4%)
Query: 95 NMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYE 154
+ L +L +S N L ++P L+V+ +S N+L F LTSL ++L+
Sbjct: 449 FLPRLQELYISRNKLK-TLP-DASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHT 506
Query: 155 NSL-CD 159
N C
Sbjct: 507 NPWDCS 512
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 1e-31
Identities = 56/268 (20%), Positives = 98/268 (36%), Gaps = 33/268 (12%)
Query: 87 SSIPDEIGNM-KSLSDLQLSENILNGSIP-LALGNLTNLVVLDLSTNKLSGSIPLSFANL 144
S + + L N ++ L + L L+ LS S+P +
Sbjct: 23 SGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLS-SLPDNL--P 79
Query: 145 TSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSN 204
+++L + +N+L S+P+ + L LD N+L+ ++P A+L + L + +N
Sbjct: 80 PQITVLEITQNAL-ISLPELPAS---LEYLDACDNRLS-TLPELPASLKH----LDVDNN 130
Query: 205 HIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSN 264
+ +P + + L + +NN+L+ L S LE L + N +PE +
Sbjct: 131 QLT-MLP---ELPALLEYINADNNQLT-MLPELPTS---LEVLSVRNNQL-TFLPELPES 181
Query: 265 LVKLHYLNLSNNQFSQKIPNKIEKLIHLSE----LDLSHNIFREEIPSQICSMQSLEKLN 320
L L++S N +P + H E N IP I S+ +
Sbjct: 182 ---LEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTII 236
Query: 321 LSHNNLSGSIPRCFEEMHWLSCIDISYN 348
L N LS S R
Sbjct: 237 LEDNPLS-SRIRESLSQQTAQPDYHGPR 263
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-28
Identities = 51/227 (22%), Positives = 90/227 (39%), Gaps = 29/227 (12%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTS 146
SS+PD + ++ L++++N L S+P +L L D N+LS ++P A+L
Sbjct: 72 SSLPDNLP--PQITVLEITQNAL-ISLPELPASLEYL---DACDNRLS-TLPELPASLKH 124
Query: 147 LSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHI 206
L + N L +P+ L ++ +N+L L L SL+VL + +N +
Sbjct: 125 L---DVDNNQLT-MLPELPAL---LEYINADNNQLT-----MLPELPTSLEVLSVRNNQL 172
Query: 207 VGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLE----YLDLSANTFHKSIPESL 262
+P + SL L ++ N L L E + N IPE++
Sbjct: 173 -TFLP---ELPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRI-THIPENI 226
Query: 263 SNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQ 309
+L + L +N S +I + + + F Q
Sbjct: 227 LSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ 273
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 100 bits (249), Expect = 2e-22
Identities = 54/254 (21%), Positives = 91/254 (35%), Gaps = 35/254 (13%)
Query: 136 SIPLSFANLTSLSILYLYENSLCDSIPKEIGNM-NSLSILDLSSNKLNGSIPLSLANLTN 194
SI L N SLS Y + + + L N ++ L L N
Sbjct: 2 SIMLPINNNFSLSQNSFYNTIS--GTYADYFSAWDKWEKQALPGENRNEAVSLLKECLIN 59
Query: 195 SLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTF 254
L L+ ++ +P + + L + N L L LEYLD N
Sbjct: 60 QFSELQLNRLNLS-SLP--DNLPPQITVLEITQNALI-SLPELPA---SLEYLDACDNRL 112
Query: 255 HKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQ 314
++PE ++L L++ NNQ + +P L ++ +N +P
Sbjct: 113 -STLPELPASLKH---LDVDNNQLTM-LPELPAL---LEYINADNN-QLTMLPELP---T 160
Query: 315 SLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGL---IPNSTAFRDAP-MLALQG 370
SLE L++ +N L+ +P E + L D+S N L+ L + + +
Sbjct: 161 SLEVLSVRNNQLT-FLPELPESLEAL---DVSTNLLESLPAVPVRNHHSEETEIFFRCRE 216
Query: 371 NKRLCGDIKRLPPC 384
N+ I +P
Sbjct: 217 NR-----ITHIPEN 225
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-31
Identities = 67/272 (24%), Positives = 102/272 (37%), Gaps = 38/272 (13%)
Query: 112 SIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSL 171
S+P + ++ L+L +NKL F LT L+ L L N L
Sbjct: 21 SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL-------------- 64
Query: 172 SILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELS 231
S S T+ LK L LS N ++ + L L L ++ L
Sbjct: 65 SFKGCC--------SQSDFGTTS-LKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK 114
Query: 232 GQLSPE--LGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKI-EK 288
Q+S SL L YLD+S + + L L L ++ N F + I +
Sbjct: 115 -QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 173
Query: 289 LIHLSELDLSHNIFREEIPSQI-CSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISY 347
L +L+ LDLS ++ S+ SL+ LN+SHNN ++ ++ L +D S
Sbjct: 174 LRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL 232
Query: 348 NALQGLIPNSTAFRDAP----MLALQGNKRLC 375
N + + P L L N C
Sbjct: 233 NHIMTS--KKQELQHFPSSLAFLNLTQNDFAC 262
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 54/220 (24%), Positives = 89/220 (40%), Gaps = 9/220 (4%)
Query: 90 PDEIGNMKSLSDLQLSENILN--GSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSL 147
+ L+ L LS N L+ G + T+L LDLS N + ++ +F L L
Sbjct: 45 HGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQL 103
Query: 148 SILYLYENSLCDSIPKEI-GNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHI 206
L ++L + ++ +L LD+S + L++ L+VL ++ N
Sbjct: 104 EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS-LEVLKMAGNSF 162
Query: 207 VGEIPLGH-GMLSSLIQLTLNNNELSGQLSPE-LGSLIQLEYLDLSANTFHKSIPESLSN 264
L +L L L+ +L QLSP SL L+ L++S N F
Sbjct: 163 QENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC 221
Query: 265 LVKLHYLNLSNNQFSQKIPNKIEKLI-HLSELDLSHNIFR 303
L L L+ S N +++ L+ L+L+ N F
Sbjct: 222 LNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 40/174 (22%), Positives = 74/174 (42%), Gaps = 8/174 (4%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPL-ALGNLTNLVVLDLSTNKLSGSIPLSFANLT 145
++ ++ L L + L +L NL+ LD+S + F L+
Sbjct: 91 ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 150
Query: 146 SLSILYLYENSLCDSIPKEI-GNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSN 204
SL +L + NS ++ +I + +L+ LDLS +L + + N +SL+VL +S N
Sbjct: 151 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHN 209
Query: 205 HIVGEIPLG-HGMLSSLIQLTLNNNELSGQLSPEL--GSLIQLEYLDLSANTFH 255
+ + + L+SL L + N + + L +L+L+ N F
Sbjct: 210 NFF-SLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-29
Identities = 51/218 (23%), Positives = 80/218 (36%), Gaps = 10/218 (4%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTS 146
++P I + + L N ++ + NL +L L +N L+ +F L
Sbjct: 24 QAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL 81
Query: 147 LSILYLYENSLCDSIPKEI-GNMNSLSILDLSSNKLNGSIPL-SLANLTNSLKVLYLSSN 204
L L L +N+ S+ + L L L L + L L+ LYL N
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAA-LQYLYLQDN 139
Query: 205 HIVGEIPLGH-GMLSSLIQLTLNNNELSGQLSPE-LGSLIQLEYLDLSANTFHKSIPESL 262
+ +P L +L L L+ N +S + L L+ L L N P +
Sbjct: 140 ALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAF 197
Query: 263 SNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHN 300
+L +L L L N S + L L L L+ N
Sbjct: 198 RDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-25
Identities = 52/221 (23%), Positives = 82/221 (37%), Gaps = 17/221 (7%)
Query: 159 DSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLG--HGM 216
++P I + + L N+++ S N L +L+L SN + I G
Sbjct: 24 QAVPVGI--PAASQRIFLHGNRISHVPAASFRACRN-LTILWLHSNVL-ARIDAAAFTG- 78
Query: 217 LSSLIQLTLNNNELSGQLSPE-LGSLIQLEYLDLSANTFHKSIPE-SLSNLVKLHYLNLS 274
L+ L QL L++N + P L +L L L + L L YL L
Sbjct: 79 LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQ 137
Query: 275 NNQFSQKIPNKI-EKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRC 333
+N Q +P+ L +L+ L L N + SL++L L N ++ P
Sbjct: 138 DNAL-QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHA 196
Query: 334 FEEMHWLSCIDISYNALQGLIPNSTAFRDAP---MLALQGN 371
F ++ L + + N L L A L L N
Sbjct: 197 FRDLGRLMTLYLFANNLSALPTE--ALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 7e-07
Identities = 26/76 (34%), Positives = 37/76 (48%), Gaps = 4/76 (5%)
Query: 87 SSIPDEI-GNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLS-FANL 144
SS+P+ + SL L L +N + P A +L L+ L L N LS ++P A L
Sbjct: 166 SSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPL 224
Query: 145 TSLSILYLYENSL-CD 159
+L L L +N CD
Sbjct: 225 RALQYLRLNDNPWVCD 240
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 8e-29
Identities = 57/241 (23%), Positives = 95/241 (39%), Gaps = 17/241 (7%)
Query: 117 LGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDL 176
+ +L ++ ++ + L S+ + + + S+ + I + +++ L L
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDI-KSV-QGIQYLPNVTKLFL 72
Query: 177 SSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSP 236
+ NKL I L NL N L L+L N I L L L L+L +N +S ++
Sbjct: 73 NGNKLT-DIK-PLTNLKN-LGWLFLDENKIKDLSSLKD--LKKLKSLSLEHNGIS-DING 126
Query: 237 ELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELD 296
L L QLE L L N LS L KL L+L +NQ S I + L L L
Sbjct: 127 -LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLY 181
Query: 297 LSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPN 356
LS N + + +++L+ L L + + + + +L
Sbjct: 182 LSKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEII 239
Query: 357 S 357
S
Sbjct: 240 S 240
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 3e-28
Identities = 62/235 (26%), Positives = 103/235 (43%), Gaps = 17/235 (7%)
Query: 93 IGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYL 152
+ S+ + + + + S+ + L N+ L L+ NKL+ PL+ NL +L L+L
Sbjct: 39 QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKPLT--NLKNLGWLFL 94
Query: 153 YENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPL 212
EN + D + ++ L L L N ++ I L +L L+ LYL +N I L
Sbjct: 95 DENKIKDLSS--LKDLKKLKSLSLEHNGIS-DIN-GLVHLPQ-LESLYLGNNKITDITVL 149
Query: 213 GHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLN 272
L+ L L+L +N++S + P L L +L+ L LS N H S +L+ L L L
Sbjct: 150 SR--LTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKN--HISDLRALAGLKNLDVLE 203
Query: 273 LSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLS 327
L + + K N L+ + + + P I EK N+ +
Sbjct: 204 LFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPE 256
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 6e-05
Identities = 20/99 (20%), Positives = 41/99 (41%), Gaps = 4/99 (4%)
Query: 91 DEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSIL 150
+ + L +L LS+N ++ + AL L NL VL+L + + +NL + +
Sbjct: 169 VPLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV 226
Query: 151 YLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSL 189
+ SL P+ I + ++ + + +S
Sbjct: 227 KNTDGSLVT--PEIISDDGDYEKPNVKWHLPEFTNEVSF 263
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 8e-29
Identities = 51/254 (20%), Positives = 102/254 (40%), Gaps = 18/254 (7%)
Query: 112 SIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEI-GNMNS 170
SIP L + LDLS N+++ +L L L N + ++I ++ ++ S
Sbjct: 45 SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI-NTIEEDSFSSLGS 101
Query: 171 LSILDLSSNKLNGSIPLSL-ANLTNSLKVLYLSSNHIVGEIPLGH-GMLSSLIQLTLNNN 228
L LDLS N L ++ S L++ L L L N L+ L L + N
Sbjct: 102 LEHLDLSYNYL-SNLSSSWFKPLSS-LTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNM 159
Query: 229 ELSGQLSPE-LGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIE 287
+ ++ + L LE L++ A+ P+SL ++ + +L L Q + ++
Sbjct: 160 DTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVD 219
Query: 288 KLIHLSELDLSHNIFREEIPSQICS--------MQSLEKLNLSHNNLSGSIPRCFEEMHW 339
+ L+L S++ + + + ++ +L + + ++
Sbjct: 220 VTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISG 278
Query: 340 LSCIDISYNALQGL 353
L ++ S N L+ +
Sbjct: 279 LLELEFSRNQLKSV 292
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 58/268 (21%), Positives = 104/268 (38%), Gaps = 34/268 (12%)
Query: 95 NMKSLSDLQLSENILNGSIPL-ALGNLTNLVVLDLSTNKLSGSIPLS-FANLTSLSILYL 152
+L L L+ N +N +I + +L +L LDLS N LS ++ S F L+SL+ L L
Sbjct: 74 RCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNL 131
Query: 153 YENSLCDSIPKEI--GNMNSLSILDLSSNKLNGSIPL-SLANLTNSLKVLYLSSNHIVGE 209
N ++ + ++ L IL + + I A LT L+ L + ++ +
Sbjct: 132 LGNPY-KTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTF-LEELEIDASDLQ-S 188
Query: 210 IPLGH-GMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFH----KSIPE---- 260
+ ++ L L+ + L + +E L+L +
Sbjct: 189 YEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETN 248
Query: 261 SLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQIC-SMQSLEKL 319
SL + +++ Q + + ++ L EL+ S N + +P I + SL+K+
Sbjct: 249 SLIKKFTFRNVKITDESLFQ-VMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKI 306
Query: 320 NLSHNNLSGSIPRCFEEMHWLSCIDISY 347
L N C SC I Y
Sbjct: 307 WLHTNPW-----DC-------SCPRIDY 322
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 26/154 (16%), Positives = 58/154 (37%), Gaps = 17/154 (11%)
Query: 87 SSIPDEI-GNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLT 145
+ I + + L +L++ + L P +L ++ N+ L L + + + +
Sbjct: 163 TKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTS 222
Query: 146 SLSILYLYENSLCDSIPKEI--------GNMNSLSILDLSSNKLNGSIPLSLANLTNSLK 197
S+ L L + L E+ + + ++ L + L ++ L
Sbjct: 223 SVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISG-LL 280
Query: 198 VLYLSSNHIVGEIPLGHGM---LSSLIQLTLNNN 228
L S N + + G+ L+SL ++ L+ N
Sbjct: 281 ELEFSRNQLKS---VPDGIFDRLTSLQKIWLHTN 311
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-28
Identities = 49/266 (18%), Positives = 98/266 (36%), Gaps = 28/266 (10%)
Query: 92 EIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILY 151
++ + L++L N L + T L LD S NK++ L + L+ L
Sbjct: 143 DVSHNTQLTELDCHLN--KKITKLDVTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLN 197
Query: 152 LYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIP 211
N++ + + L+ LD SSNKL I ++ LT L S N + E+
Sbjct: 198 CDTNNI-TKLD--LNQNIQLTFLDCSSNKLT-EIDVT--PLTQ-LTYFDCSVNPL-TELD 249
Query: 212 LGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYL 271
+ LS L L +L +L QL Y K + +++ +L+ L
Sbjct: 250 VST--LSKLTTLHCIQTDLL---EIDLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLL 302
Query: 272 NLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIP 331
+ + ++ + + L L L++ E+ + L+ L+ + ++
Sbjct: 303 DCQAAGIT-ELD--LSQNPKLVYLYLNNTEL-TELD--VSHNTKLKSLSCVNAHIQ-DFS 355
Query: 332 RCFEEMHWLSCIDISYNALQGLIPNS 357
++ L+ + + +
Sbjct: 356 -SVGKIPALNNNFEAEGQTITMPKET 380
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-27
Identities = 61/278 (21%), Positives = 108/278 (38%), Gaps = 40/278 (14%)
Query: 92 EIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILY 151
++ +L+ L N L L + LT L L+ TNKL+ L + L+ L
Sbjct: 80 DLSQNTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLN 133
Query: 152 LYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIP 211
N+L + ++ + L+ LD NK + ++ T L L S N I E+
Sbjct: 134 CARNTLTE---IDVSHNTQLTELDCHLNKKITKLDVT--PQTQ-LTTLDCSFNKIT-ELD 186
Query: 212 LGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYL 271
+ L +L + N ++ +L IQL +LD S+N I ++ L +L Y
Sbjct: 187 VSQ--NKLLNRLNCDTNNIT---KLDLNQNIQLTFLDCSSNKL-TEID--VTPLTQLTYF 238
Query: 272 NLSNNQFSQKIPNKIEKLIHL-------SELDLSHNI---------FREEIPSQICSMQS 315
+ S N ++ + + KL L E+DL+HN R+ +
Sbjct: 239 DCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQ 298
Query: 316 LEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGL 353
L L+ ++ + + L + ++ L L
Sbjct: 299 LYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELTEL 333
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 7e-27
Identities = 56/278 (20%), Positives = 102/278 (36%), Gaps = 31/278 (11%)
Query: 80 GQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPL 139
GQ PD+ N S + ++ L L LD + ++ +
Sbjct: 6 GQTQSFNDWFPDD--NFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSITDMTGI 60
Query: 140 SFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVL 199
LT L+ L N++ ++ + +L+ L SNKL L + LT L L
Sbjct: 61 E--KLTGLTKLICTSNNI-TTLD--LSQNTNLTYLACDSNKLTN---LDVTPLTK-LTYL 111
Query: 200 YLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIP 259
+N + ++ + L L N L+ ++ QL LD N K
Sbjct: 112 NCDTNKL-TKLDVSQ--NPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLN--KKITK 163
Query: 260 ESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKL 319
++ +L L+ S N+ + ++ + + L+ L+ N ++ + L L
Sbjct: 164 LDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNI-TKLD--LNQNIQLTFL 217
Query: 320 NLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNS 357
+ S N L+ I + L+ D S N L L ++
Sbjct: 218 DCSSNKLT-EID--VTPLTQLTYFDCSVNPLTELDVST 252
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 8e-20
Identities = 46/245 (18%), Positives = 82/245 (33%), Gaps = 27/245 (11%)
Query: 92 EIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILY 151
++ L+ L S N L I + LT L D S N L+ L + L+ L+ L+
Sbjct: 207 DLNQNIQLTFLDCSSNKLT-EIDV--TPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLH 260
Query: 152 LYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIP 211
+ L I + + L + + ++ + T L +L + I E+
Sbjct: 261 CIQTDL-LEID--LTHNTQLIYFQAEGCRKIKELDVT--HNTQ-LYLLDCQAAGIT-ELD 313
Query: 212 LGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYL 271
L L+ L LNN EL+ ++ +L+ L + + + L+
Sbjct: 314 LSQ--NPKLVYLYLNNTELT---ELDVSHNTKLKSLSCVNAHI-QDFSS-VGKIPALNNN 366
Query: 272 NLSNNQFSQKIP-----NKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNL 326
+ Q N + + LD N I + ++ NL
Sbjct: 367 FEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPM--NIEPGDGGVYDQATNTITWENL 424
Query: 327 SGSIP 331
S P
Sbjct: 425 STDNP 429
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 39/137 (28%), Positives = 61/137 (44%), Gaps = 9/137 (6%)
Query: 433 QSSPRNTLGLLSVLTFDGKIVHEEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVK 492
+ P LG L + E+ A++NF + + +G GG G VYK +L G +V VK
Sbjct: 7 EEDPEVHLGQLKRFSL------RELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK 60
Query: 493 KFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNL 552
+ + +F EV ++ HRN+++ GFC +VY Y+ GS+A L
Sbjct: 61 RLKEE--RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCL 118
Query: 553 -SNDAAAEQFCWTKRMN 568
+ W KR
Sbjct: 119 RERPESQPPLDWPKRQR 135
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 48/240 (20%), Positives = 98/240 (40%), Gaps = 19/240 (7%)
Query: 117 LGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDL 176
L N + + + ++ ++ + +L ++ L + + + + +N+L L+L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLEL 70
Query: 177 SSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSP 236
N++ + L NLT + L LS N + + L S+ L L + +++
Sbjct: 71 KDNQIT-DLA-PLKNLTK-ITELELSGNPLKNVSAIAG--LQSIKTLDLTSTQITDV--T 123
Query: 237 ELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELD 296
L L L+ L L N +I L+ L L YL++ N Q S + + L L+ L
Sbjct: 124 PLAGLSNLQVLYLDLNQI-TNI-SPLAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLK 179
Query: 297 LSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPN 356
N + P + S+ +L +++L +N +S P L + ++ +
Sbjct: 180 ADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVF 235
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 7e-26
Identities = 58/237 (24%), Positives = 100/237 (42%), Gaps = 17/237 (7%)
Query: 91 DEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSIL 150
+ + + +L L+L +N + + L NLT + L+LS N L ++ L S+ L
Sbjct: 57 EGVQYLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSGNPLKNVSAIA--GLQSIKTL 112
Query: 151 YLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEI 210
L + D P + +++L +L L N++ +I LA LTN L+ L + + +
Sbjct: 113 DLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NIS-PLAGLTN-LQYLSIGNAQVSDLT 167
Query: 211 PLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHY 270
PL + LS L L ++N++S L SL L + L N S L+N L
Sbjct: 168 PLAN--LSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNN--QISDVSPLANTSNLFI 221
Query: 271 LNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLS 327
+ L+N + + L+ + P+ I + NL+ N S
Sbjct: 222 VTLTNQTITNQPVFYNNNLVVP--NVVKGPSGAPIAPATISDNGTYASPNLTWNLTS 276
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 9e-05
Identities = 10/96 (10%), Positives = 31/96 (32%), Gaps = 6/96 (6%)
Query: 260 ESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKL 319
L + + + + L ++ L + + +L L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IEGVQYLNNLIGL 68
Query: 320 NLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIP 355
L N ++ + + + ++ +++S N L+ +
Sbjct: 69 ELKDNQIT-DLA-PLKNLTKITELELSGNPLKNVSA 102
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 53/320 (16%), Positives = 107/320 (33%), Gaps = 44/320 (13%)
Query: 98 SLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPL-SFANLTSLSILYLYENS 156
++ + LS N + + L +L L + I +F L+SL IL L N
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 157 LCDSIPKEI-GNMNSLSILDLSSNKLNGSI--PLSLANLTNSLKVLYLSSNHIVGEIPLG 213
+ + +L +L L+ L+G++ LT+ L++L L N+I P
Sbjct: 91 F-LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTS-LEMLVLRDNNIKKIQPAS 148
Query: 214 H-GMLSSLIQLTLNNNELS----------GQLSPELGSLIQLEYLDLSANTFHKSIPESL 262
+ L L N++ L L + D++ +
Sbjct: 149 FFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNP 208
Query: 263 SNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSEL-------------DLSHNIFRE--EIP 307
+ L+LS N F + + + I +++ H F++
Sbjct: 209 FKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFT 268
Query: 308 SQICSMQSLEKLNLSHNNLSGSIPRC-FEEMHWLSCIDISYNALQGLIPNSTAFRDAP-- 364
+ ++ +LS + + ++ + F L + ++ N + + N AF
Sbjct: 269 FKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDN--AFWGLTHL 325
Query: 365 -MLALQGNKRLCGDIKRLPP 383
L L N + +
Sbjct: 326 LKLNLSQNF-----LGSIDS 340
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-24
Identities = 65/299 (21%), Positives = 118/299 (39%), Gaps = 40/299 (13%)
Query: 87 SSIPDEI-GNMKSLSDLQLSENILNGSI--PLALGNLTNLVVLDLSTNKLSGSIPLS--F 141
+ + +L L L++ L+G++ LT+L +L L N + I + F
Sbjct: 92 LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPASFF 150
Query: 142 ANLTSLSILYLYENSLCDSIPKEI---GNMNSLSILDLSSNKLN-------GSIPLSLAN 191
N+ +L L N + SI +E ++L LSS L G
Sbjct: 151 LNMRRFHVLDLTFNKV-KSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPF 209
Query: 192 LTNSLKVLYLSSNHI---VGEIPLGHGMLSSLIQLTLNNNELSGQLSPELG--------- 239
S+ L LS N + + + + L L+N+ G
Sbjct: 210 KNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTF 269
Query: 240 ---SLIQLEYLDLSANTFHKSIPESL-SNLVKLHYLNLSNNQFSQKIPNKI-EKLIHLSE 294
++ DLS + ++ +S+ S+ L L L+ N+ KI + L HL +
Sbjct: 270 KGLEASGVKTCDLSKS-KIFALLKSVFSHFTDLEQLTLAQNEI-NKIDDNAFWGLTHLLK 327
Query: 295 LDLSHNIFREEIPSQIC-SMQSLEKLNLSHNNLSGSIP-RCFEEMHWLSCIDISYNALQ 351
L+LS N I S++ ++ LE L+LS+N++ ++ + F + L + + N L+
Sbjct: 328 LNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK 384
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 1e-21
Identities = 62/282 (21%), Positives = 97/282 (34%), Gaps = 46/282 (16%)
Query: 95 NMKSLSDLQLSENILNGSIPLALGNLTNLVV----------LDLSTNKLSGSIPLSFANL 144
NM+ L L+ N + L N D++ L +
Sbjct: 152 NMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKN 211
Query: 145 TSLSILYLYENSLCDSIPKEIGNMNSLSIL-------------DLSSNKLNGSIPLSLAN 191
TS++ L L N +S+ K + + + + +
Sbjct: 212 TSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKG 271
Query: 192 LT-NSLKVLYLSSNHIVGEIPLGH-GMLSSLIQLTLNNNELSGQLSPE-LGSLIQLEYLD 248
L + +K LS + I + + L QLTL NE++ ++ L L L+
Sbjct: 272 LEASGVKTCDLSKSKI-FALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLN 329
Query: 249 LSANTFHKSIPE-SLSNLVKLHYLNLSNNQFSQKIPNKI-EKLIHLSELDLSHNIFREEI 306
LS N SI NL KL L+LS N + ++ L +L EL L N + +
Sbjct: 330 LSQNFL-GSIDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLKELALDTNQLKS-V 386
Query: 307 PSQI-CSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISY 347
P I + SL+K+ L N C SC I Y
Sbjct: 387 PDGIFDRLTSLQKIWLHTNPW-----DC-------SCPRIDY 416
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 1e-19
Identities = 56/268 (20%), Positives = 96/268 (35%), Gaps = 44/268 (16%)
Query: 121 TNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNK 180
++ +DLS N ++ SF+ L L L + + + I
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNN---------------- 73
Query: 181 LNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGH-GMLSSLIQLTLNNNELSGQLSPE-- 237
+ L++ L +L L N + ++ G L++L LTL L G +
Sbjct: 74 -------TFRGLSS-LIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNF 124
Query: 238 LGSLIQLEYLDLSANTFHKSIPESL-SNLVKLHYLNLSNNQFSQKIPNKI---EKLIHLS 293
L LE L L N K P S N+ + H L+L+ N+ I + + H +
Sbjct: 125 FKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKS-ICEEDLLNFQGKHFT 183
Query: 294 ELDLSHN----IFREEIPSQICS----MQSLEKLNLSHNNLSGSIPRCF---EEMHWLSC 342
L LS + + + C S+ L+LS N S+ + F +
Sbjct: 184 LLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQS 243
Query: 343 IDISYNALQGLIPNSTAFRDAPMLALQG 370
+ +S + G T F+D +G
Sbjct: 244 LILSNSYNMGSSFGHTNFKDPDNFTFKG 271
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 8e-12
Identities = 34/121 (28%), Positives = 58/121 (47%), Gaps = 6/121 (4%)
Query: 87 SSIPDEI-GNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLT 145
++ + + L L L++N +N A LT+L+ L+LS N L F NL
Sbjct: 288 FALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLD 347
Query: 146 SLSILYLYENSLCDSIPKEI-GNMNSLSILDLSSNKLNGSIPLS-LANLTNSLKVLYLSS 203
L +L L N + ++ + + +L L L +N+L S+P LT SL+ ++L +
Sbjct: 348 KLEVLDLSYNHI-RALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLT-SLQKIWLHT 404
Query: 204 N 204
N
Sbjct: 405 N 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 26/77 (33%), Positives = 37/77 (48%), Gaps = 6/77 (7%)
Query: 87 SSIPDEI-GNMKSLSDLQLSENILNGSIPL-ALGNLTNLVVLDLSTNKLSGSIPLS-FAN 143
SI + N+ L L LS N + ++ + L NL L L TN+L S+P F
Sbjct: 336 GSIDSRMFENLDKLEVLDLSYNHI-RALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDR 393
Query: 144 LTSLSILYLYENSL-CD 159
LTSL ++L+ N C
Sbjct: 394 LTSLQKIWLHTNPWDCS 410
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 40/140 (28%), Positives = 63/140 (45%), Gaps = 4/140 (2%)
Query: 429 SQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEI 488
S+ S V ++ ++ ATNNFD IG+G G VYK L G
Sbjct: 6 SKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK 65
Query: 489 VDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
V +K+ P+ +EF E+ L+ RH ++V GFC ++Y+Y+E G+L
Sbjct: 66 VALKRRT---PESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 549 AMNLS-NDAAAEQFCWTKRM 567
+L +D W +R+
Sbjct: 123 KRHLYGSDLPTMSMSWEQRL 142
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-26
Identities = 38/201 (18%), Positives = 83/201 (41%), Gaps = 15/201 (7%)
Query: 100 SDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCD 159
+ L+ S++ +N IP + + L + + ++ A + SL+ + L ++ D
Sbjct: 6 TGLKASQDNVN--IPDS--TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTD 58
Query: 160 SIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSS 219
I +++ L +++ P+S L+N L+ L + + + L+S
Sbjct: 59 L--TGIEYAHNIKDLTINNIHATNYNPIS--GLSN-LERLRIMGKDVTSDKIPNLSGLTS 113
Query: 220 LIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFS 279
L L ++++ + ++ +L ++ +DLS N I L L +L LN+ +
Sbjct: 114 LTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVH 172
Query: 280 QKIPNKIEKLIHLSELDLSHN 300
IE L++L
Sbjct: 173 DYRG--IEDFPKLNQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-24
Identities = 31/192 (16%), Positives = 74/192 (38%), Gaps = 13/192 (6%)
Query: 88 SIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSL 147
+IPD K+ + L ++ + + + +L + L+ ++ + ++
Sbjct: 16 NIPDS--TFKAYLNGLLGQS---STANITEAQMNSLTYITLANINVTDLTGIE--YAHNI 68
Query: 148 SILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIV 207
L + + P I +++L L + + +L+ LT+ L +L +S +
Sbjct: 69 KDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTS-LTLLDISHSAHD 125
Query: 208 GEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVK 267
I L + + L+ N + P L +L +L+ L++ + H + + K
Sbjct: 126 DSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--IEDFPK 182
Query: 268 LHYLNLSNNQFS 279
L+ L +
Sbjct: 183 LNQLYAFSQTIG 194
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 9e-22
Identities = 33/176 (18%), Positives = 74/176 (42%), Gaps = 8/176 (4%)
Query: 178 SNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPE 237
+ + ++ A + + L + L++ ++ + + ++ LT+NN + +P
Sbjct: 29 LLGQSSTANITEAQMNS-LTYITLANINVTDLTGIEY--AHNIKDLTINNIHATN-YNP- 83
Query: 238 LGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDL 297
+ L LE L + +LS L L L++S++ I KI L ++ +DL
Sbjct: 84 ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143
Query: 298 SHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGL 353
S+N +I + ++ L+ LN+ + + E+ L+ + + G
Sbjct: 144 SYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-21
Identities = 31/140 (22%), Positives = 59/140 (42%), Gaps = 6/140 (4%)
Query: 93 IGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYL 152
I ++ DL ++ P++ L+NL L + ++ + + LTSL++L +
Sbjct: 62 IEYAHNIKDLTINNIHATNYNPIS--GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119
Query: 153 YENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPL 212
++ DSI +I + ++ +DLS N I L L LK L + + + +
Sbjct: 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPE-LKSLNIQFDGVHDYRGI 177
Query: 213 GHGMLSSLIQLTLNNNELSG 232
L QL + + G
Sbjct: 178 ED--FPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-11
Identities = 22/97 (22%), Positives = 37/97 (38%), Gaps = 3/97 (3%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTS 146
S + + SL+ L +S + + SI + L + +DLS N I L
Sbjct: 102 SDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPE 160
Query: 147 LSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNG 183
L L + + + D I + L+ L S + G
Sbjct: 161 LKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 5e-07
Identities = 17/97 (17%), Positives = 43/97 (44%), Gaps = 4/97 (4%)
Query: 261 SLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLN 320
+ + + L Y+ L+N + + IE ++ +L +++ + I + +LE+L
Sbjct: 39 TEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATN--YNPISGLSNLERLR 94
Query: 321 LSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNS 357
+ +++ + L+ +DIS++A I
Sbjct: 95 IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 7e-26
Identities = 55/246 (22%), Positives = 87/246 (35%), Gaps = 32/246 (13%)
Query: 92 EIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILY 151
+ + L +L L + G+ P L T + L+ +S + ++ L L
Sbjct: 90 RVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAW--LAELQQWL 147
Query: 152 LYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIP 211
L +L ++ + + +L L LS N +GE
Sbjct: 148 K----------------PGLKVLSIAQAHSL-NFSCEQVRVFPALSTLDLSDNPELGERG 190
Query: 212 LGH----GMLSSLIQLTLNNNE---LSGQLSPELGSLIQLEYLDLSANTFHKSIPESL-S 263
L +L L L N SG S + +QL+ LDLS N+ +
Sbjct: 191 LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD 250
Query: 264 NLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSH 323
+L+ LNLS Q +P + LS LDLS+N PS + + L+L
Sbjct: 251 WPSQLNSLNLSFTGLKQ-VPKGLPA--KLSVLDLSYNRLD-RNPS-PDELPQVGNLSLKG 305
Query: 324 NNLSGS 329
N S
Sbjct: 306 NPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 48/267 (17%), Positives = 90/267 (33%), Gaps = 18/267 (6%)
Query: 99 LSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLC 158
L + ++ + + +L L V L ++ L L L +
Sbjct: 49 LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108
Query: 159 DSIPKEIGN--MNSLSILDLSSNKLNG---SIPLSLANLTNSLKVLYLSSNHIVGEIPLG 213
+ P + L+IL+L + + L LKVL ++ H +
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168
Query: 214 HGMLSSLIQLTLNNNELSGQL----SPELGSLIQLEYLDLSAN---TFHKSIPESLSNLV 266
+ +L L L++N G+ + L+ L L T + V
Sbjct: 169 VRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARV 228
Query: 267 KLHYLNLSNNQFSQKIPNKI-EKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNN 325
+L L+LS+N + L+ L+LS +++P L L+LS+N
Sbjct: 229 QLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL-KQVPK--GLPAKLSVLDLSYNR 285
Query: 326 LSGSIPRCFEEMHWLSCIDISYNALQG 352
L P +E+ + + + N
Sbjct: 286 LD-RNPS-PDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 1e-19
Identities = 43/233 (18%), Positives = 82/233 (35%), Gaps = 17/233 (7%)
Query: 141 FANLTSLSILYLYENSLCDSIP-KEIGNMNSLSILDLSSNKLNGSIPLSLANLTN--SLK 197
+ SL L ++ D +I SL L + + ++ I + L+
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98
Query: 198 VLYLSSNHIVGEIP--LGHGMLSSLIQLTLNNNELSGQLS--PELGSLIQ--LEYLDLSA 251
L L + + G P L L L L N + + + EL ++ L+ L ++
Sbjct: 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQ 158
Query: 252 NTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIE----KLIHLSELDLSHNIFRE--- 304
E + L L+LS+N + K L L L +
Sbjct: 159 AHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSG 218
Query: 305 EIPSQICSMQSLEKLNLSHNNLSGSIPR-CFEEMHWLSCIDISYNALQGLIPN 356
+ + L+ L+LSHN+L + + L+ +++S+ L+ +
Sbjct: 219 VCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKG 271
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 31/132 (23%), Positives = 49/132 (37%), Gaps = 7/132 (5%)
Query: 78 FTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSI 137
G+ + + P + ++ L+ +G L LDLS N L +
Sbjct: 185 ELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAA 244
Query: 138 P-LSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSL 196
S + L+ L L L +PK + LS+LDLS N+L+ P L +
Sbjct: 245 GAPSCDWPSQLNSLNLSFTGL-KQVPKGLP--AKLSVLDLSYNRLD-RNPSPD-ELPQ-V 298
Query: 197 KVLYLSSNHIVG 208
L L N +
Sbjct: 299 GNLSLKGNPFLD 310
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 55/234 (23%), Positives = 93/234 (39%), Gaps = 17/234 (7%)
Query: 117 LGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDL 176
+ +L ++ ++ + L S+ + + + + I + +++ L L
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFL 75
Query: 177 SSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSP 236
+ NKL I LANL N L L+L N + L L L L+L +N +S ++
Sbjct: 76 NGNKLT-DIK-PLANLKN-LGWLFLDENKVKDLSSLKD--LKKLKSLSLEHNGIS-DING 129
Query: 237 ELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELD 296
L L QLE L L N LS L KL L+L +NQ S I + L L L
Sbjct: 130 -LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLY 184
Query: 297 LSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNAL 350
LS N + + +++L+ L L + + + + +L
Sbjct: 185 LSKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 62/235 (26%), Positives = 103/235 (43%), Gaps = 17/235 (7%)
Query: 93 IGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYL 152
+ S+ + + + + S+ + L N+ L L+ NKL+ PL+ NL +L L+L
Sbjct: 42 QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKPLA--NLKNLGWLFL 97
Query: 153 YENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPL 212
EN + D + ++ L L L N ++ I L +L L+ LYL +N I L
Sbjct: 98 DENKVKDLSS--LKDLKKLKSLSLEHNGIS-DIN-GLVHLPQ-LESLYLGNNKITDITVL 152
Query: 213 GHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLN 272
L+ L L+L +N++S + P L L +L+ L LS N H S +L+ L L L
Sbjct: 153 SR--LTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKN--HISDLRALAGLKNLDVLE 206
Query: 273 LSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLS 327
L + + K N L+ + + + P I EK N+ +
Sbjct: 207 LFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 19/92 (20%), Positives = 38/92 (41%), Gaps = 4/92 (4%)
Query: 91 DEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSIL 150
+ + L +L LS+N ++ + AL L NL VL+L + + +NL + +
Sbjct: 172 VPLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV 229
Query: 151 YLYENSLCDSIPKEIGNMNSLSILDLSSNKLN 182
+ SL P+ I + ++ +
Sbjct: 230 KNTDGSLVT--PEIISDDGDYEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 8e-04
Identities = 10/68 (14%), Positives = 26/68 (38%), Gaps = 4/68 (5%)
Query: 260 ESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKL 319
S + NL + + +L + ++ +++ + I + ++ KL
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKL 73
Query: 320 NLSHNNLS 327
L+ N L+
Sbjct: 74 FLNGNKLT 81
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 58/257 (22%), Positives = 96/257 (37%), Gaps = 21/257 (8%)
Query: 87 SSIP-DEIGNMKSLSDLQLSENILNGSIPL-ALGNLTNLVVLDLS-TNKLSGSIPLSFAN 143
I L +++S+N + I NL L + + N L P +F N
Sbjct: 43 RVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQN 102
Query: 144 LTSLSILYLYENSLCDSIPKEI-GNMNSLSILDLSSNKLNGSIP-LSLANLTNSLKVLYL 201
L +L L + + +P + +LD+ N +I S L+ +L+L
Sbjct: 103 LPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWL 161
Query: 202 SSNHIVGEIPLGHGMLSSLIQLTL-NNNELSGQLSPE-LGSLIQLEYLDLSANTFHKSIP 259
+ N I EI + L +L L +NN L +L + LD+S H
Sbjct: 162 NKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPS 219
Query: 260 ESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKL 319
L NL KL + N +K+P +EKL+ L E L++ PS C+ + +
Sbjct: 220 YGLENLKKLRARSTYNL---KKLPT-LEKLVALMEASLTY-------PSHCCAFANWRRQ 268
Query: 320 NLSHNNLSGSIPRCFEE 336
+ + E
Sbjct: 269 ISELHPICNKSILRQEV 285
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 2e-20
Identities = 40/242 (16%), Positives = 83/242 (34%), Gaps = 37/242 (15%)
Query: 112 SIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPK-------- 163
IP L N + L KL +F+ L + + +N + + I
Sbjct: 23 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 164 ----EIGNMN--------------SLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNH 205
I N +L L +S+ + +P + +L + N
Sbjct: 81 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNI 139
Query: 206 IVGEIPLG--HGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPE-SL 262
+ I G+ + L LN N + ++ + QL+ L+LS N + +P
Sbjct: 140 NIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVF 198
Query: 263 SNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLS 322
L++S + +E L L + +++P+ + + +L + +L+
Sbjct: 199 HGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL---KKLPT-LEKLVALMEASLT 254
Query: 323 HN 324
+
Sbjct: 255 YP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 7e-19
Identities = 51/252 (20%), Positives = 95/252 (37%), Gaps = 22/252 (8%)
Query: 146 SLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNH 205
S + E+ + IP ++ + L KL + + + L+ + +S N
Sbjct: 10 SNRVFLCQESKV-TEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGD-LEKIEISQND 65
Query: 206 IVGEIPLG--HGMLSSLIQLTL-NNNELSGQLSPE-LGSLIQLEYLDLSANTFHKSIPE- 260
++ I L L ++ + N L ++PE +L L+YL +S K +P+
Sbjct: 66 VLEVIEADVFSN-LPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGI-KHLPDV 122
Query: 261 SLSNLVKLHYLNLSNNQFSQKIPNK-IEKL-IHLSELDLSHNIFREEIPSQICSMQSLEK 318
+ ++ L++ +N I L L L+ N +E I + + L++
Sbjct: 123 HKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDE 181
Query: 319 LNLSHNNLSGSIPR-CFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCGD 377
LNLS NN +P F +DIS + L + L + L
Sbjct: 182 LNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSY--GLENLKKLRARSTYNL--- 236
Query: 378 IKRLPPCKAFKS 389
K+LP + +
Sbjct: 237 -KKLPTLEKLVA 247
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 65/268 (24%), Positives = 97/268 (36%), Gaps = 49/268 (18%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLS-FANLT 145
IPD + S +L LS N L + + L VLDLS ++ +I + +L+
Sbjct: 20 YKIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLS 76
Query: 146 SLSILYLYENSLCDSIPKEI-GNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSN 204
LS L L N + S+ ++SL L L S+ +LK L ++ N
Sbjct: 77 HLSTLILTGNPI-QSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHN 134
Query: 205 HIVGEIPLGHGMLSSLIQLT---LNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPES 261
I L S+L L L++N++ +
Sbjct: 135 LIQ-SFKL-PEYFSNLTNLEHLDLSSNKIQ----------------SIYCTDLRV----- 171
Query: 262 LSNLVKLHY-LNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQIC-SMQSLEKL 319
L + L+ L+LS N I K I L EL L N + +P I + SL+K+
Sbjct: 172 LHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKI 229
Query: 320 NLSHNNLSGSIPRCFEEMHWLSCIDISY 347
L N C SC I Y
Sbjct: 230 WLHTNPW-----DC-------SCPRIDY 245
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 26/136 (19%), Positives = 40/136 (29%), Gaps = 16/136 (11%)
Query: 257 SIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICS-MQS 315
IP++L L+LS N L LDLS + I +
Sbjct: 21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSH 77
Query: 316 LEKLNLSHNNLSGSIP-RCFEEMHWLSCIDISYNALQGLIPNSTAFRDAP---MLALQGN 371
L L L+ N + S+ F + L + L L + L + N
Sbjct: 78 LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASL--ENFPIGHLKTLKELNVAHN 134
Query: 372 KRLCGDIKRLPPCKAF 387
I+ + F
Sbjct: 135 L-----IQSFKLPEYF 145
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 62/207 (29%), Positives = 83/207 (40%), Gaps = 16/207 (7%)
Query: 98 SLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSL 157
S ++ + L ++P L + +L LS N L + T L+ L L L
Sbjct: 11 SHLEVNCDKRNL-TALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
Query: 158 CDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLG--HG 215
+ G + L LDLS N+L S+PL L L VL +S N + +PLG G
Sbjct: 68 -TKLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPA-LTVLDVSFNRLT-SLPLGALRG 122
Query: 216 MLSSLIQLTLNNNELSGQLSPEL-GSLIQLEYLDLSANTFHKSIPESL-SNLVKLHYLNL 273
L L +L L NEL L P L +LE L L+ N +P L + L L L L
Sbjct: 123 -LGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNL-TELPAGLLNGLENLDTLLL 179
Query: 274 SNNQFSQKIPNKIEKLIHLSELDLSHN 300
N IP L L N
Sbjct: 180 QENSL-YTIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 1e-20
Identities = 53/205 (25%), Positives = 83/205 (40%), Gaps = 13/205 (6%)
Query: 170 SLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNE 229
S ++ L ++P +L +L+LS N + + L QL L+ E
Sbjct: 11 SHLEVNCDKRNL-TALP---PDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66
Query: 230 LSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKI-EK 288
L G+L L LDLS N +S+P L L L++S N+ +P
Sbjct: 67 L--TKLQVDGTLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRL-TSLPLGALRG 122
Query: 289 LIHLSELDLSHNIFREEIPSQIC-SMQSLEKLNLSHNNLSGSIPR-CFEEMHWLSCIDIS 346
L L EL L N + +P + LEKL+L++NNL+ +P + L + +
Sbjct: 123 LGELQELYLKGNELKT-LPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQ 180
Query: 347 YNALQGLIPNSTAFRDAPMLALQGN 371
N+L + P L GN
Sbjct: 181 ENSLYTIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 35/121 (28%), Positives = 51/121 (42%), Gaps = 8/121 (6%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPL-ALGNLTNLVVLDLSTNKLSGSIPLS-FANL 144
S+P + +L+ L +S N L S+PL AL L L L L N+L ++P
Sbjct: 90 QSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPT 147
Query: 145 TSLSILYLYENSLCDSIPKEI-GNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSS 203
L L L N+L +P + + +L L L N L +IP L +L
Sbjct: 148 PKLEKLSLANNNL-TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSH-LLPFAFLHG 204
Query: 204 N 204
N
Sbjct: 205 N 205
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-23
Identities = 50/234 (21%), Positives = 103/234 (44%), Gaps = 11/234 (4%)
Query: 72 HFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTN 131
+FS+ Q + ++K+LS Q+ ++ +N+ + + + +
Sbjct: 251 YFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVS 310
Query: 132 KLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLS--- 188
L + ++ L N L D++ + G++ L L L N+L +
Sbjct: 311 GTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEM 369
Query: 189 LANLTNSLKVLYLSSNHIVGEIPLGH-GMLSSLIQLTLNNNELSGQLSPELGSLIQLEYL 247
+ + L+ L +S N + + G SL+ L +++N L+ + L +++ L
Sbjct: 370 TTQMKS-LQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVL 426
Query: 248 DLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKI-EKLIHLSELDLSHN 300
DL +N KSIP+ + L L LN+++NQ + +P+ I ++L L ++ L N
Sbjct: 427 DLHSNKI-KSIPKQVVKLEALQELNVASNQL-KSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 5e-21
Identities = 57/305 (18%), Positives = 111/305 (36%), Gaps = 40/305 (13%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTS 146
+P ++ + + L +S+N ++ + +L+ L +L +S N++ F
Sbjct: 13 IHVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQE 70
Query: 147 LSILYLYENSL----------------------CDSIPKEIGNMNSLSILDLSSNKLNGS 184
L L L N L I KE GNM+ L L LS+ L S
Sbjct: 71 LEYLDLSHNKLVKISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKS 130
Query: 185 IPLSLANLTNSLKVLYLSSNHIVGEIP--LGHGMLSSLIQLTLNNNELSGQLSPELGSLI 242
L +A+L S +L L + E P L SL + N E L + ++
Sbjct: 131 SVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVA 190
Query: 243 QLEYLDLSANTFHKSIPESLSNLVKLHY------LNLSNNQFSQKIPNKIEKLI---HLS 293
LE ++ LS L KL L L+N + + +I +L+ +
Sbjct: 191 NLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVW 250
Query: 294 ELDLSHNIFREEIPSQI-----CSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYN 348
+S+ + ++ + S+++L + + +E ++ + + +
Sbjct: 251 YFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVS 310
Query: 349 ALQGL 353
+ +
Sbjct: 311 GTRMV 315
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 5e-18
Identities = 50/294 (17%), Positives = 97/294 (32%), Gaps = 25/294 (8%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLA--LGNLTNLVVLDLSTNKLSGSIPLSFANL 144
I +L L LS N + ++P+ GN++ L L LST L S L A+L
Sbjct: 82 VKIS--CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHL 138
Query: 145 TSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLAN----------LTN 194
+L + + + + + + L + + L+N
Sbjct: 139 NISKVLLVLGETYGEKE--DPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSN 196
Query: 195 SLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLI---QLEYLDLSA 251
VL + I L LTLNN E + + L+ + Y +S
Sbjct: 197 IKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISN 256
Query: 252 NTF-----HKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEI 306
+ S ++L L + ++ F E +++ + + + R
Sbjct: 257 VKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVH 316
Query: 307 PSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAF 360
+ L+ S+N L+ ++ + L + + N L+ L +
Sbjct: 317 MLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMT 370
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 5e-12
Identities = 42/210 (20%), Positives = 70/210 (33%), Gaps = 8/210 (3%)
Query: 244 LEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFR 303
L++S N + + +L KL L +S+N+ + + L LDLSHN
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82
Query: 304 EEIPSQICSMQSLEKLNLSHNNLSGSIPRC--FEEMHWLSCIDISYNALQGLIPNSTAFR 361
+I +L+ L+LS N ++P C F M L + +S L+ A
Sbjct: 83 -KISCH--PTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHL 138
Query: 362 DAP--MLALQGNKRLCGDIKRLPPCKAFKSHKQSMKKIWVVIVFPLLGTVALLISLIGLF 419
+ +L L D + L H + + + L +
Sbjct: 139 NISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIK 198
Query: 420 FNFRQRKNGSQTQQSSPRNTLGLLSVLTFD 449
K + T LS LT +
Sbjct: 199 CVLEDNKCSYFLSILAKLQTNPKLSNLTLN 228
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 1e-22
Identities = 39/122 (31%), Positives = 55/122 (45%), Gaps = 10/122 (8%)
Query: 455 EEIIRATNNFDD------GHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQ--Q 506
E+ TNNFD+ G+ +G GG G VYK + V VKK + + D + Q
Sbjct: 18 YELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKL-AAMVDITTEELKQ 75
Query: 507 EFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKR 566
+F E+ + K +H N+V+ GF S +VY Y+ GSL LS W R
Sbjct: 76 QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR 135
Query: 567 MN 568
Sbjct: 136 CK 137
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-21
Identities = 45/211 (21%), Positives = 88/211 (41%), Gaps = 14/211 (6%)
Query: 98 SLSDLQLSENILNGSIP-LALGNLTNLVVLDLSTNKLSGSIPL-SFANLTSLSILYLYEN 155
S L+L E L +IP A NL N+ + +S + + SF NL+ ++ + +
Sbjct: 32 STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90
Query: 156 SLCDSIPKEI-GNMNSLSILDLSSNKLNGSIP-LSLANLTNSLKVLYLSSNHIVGEIPLG 213
I + + L L + + L P L+ T+ +L ++ N + IP+
Sbjct: 91 RNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149
Query: 214 --HGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPE-SLSNLV-KLH 269
G+ + + L L NN + + + +L+ + L+ N + I + + +
Sbjct: 150 AFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPS 208
Query: 270 YLNLSNNQFSQKIPNKIEKLIHLSELDLSHN 300
L++S + +P+K L HL EL +
Sbjct: 209 LLDVSQTSVTA-LPSKG--LEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-20
Identities = 37/198 (18%), Positives = 77/198 (38%), Gaps = 12/198 (6%)
Query: 87 SSIP-DEIGNMKSLSDLQLSENILNGSIPL-ALGNLTNLVVLDLSTNKLSGSIPLS-FAN 143
+IP N+ ++S + +S ++ + + NL+ + +++ + I
Sbjct: 44 RTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKE 103
Query: 144 LTSLSILYLYENSLCDSIPKE--IGNMNSLSILDLSSNKLNGSIPL-SLANLTNSLKVLY 200
L L L ++ L P + + + IL+++ N SIP+ + L N L
Sbjct: 104 LPLLKFLGIFNTGL-KMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLK 162
Query: 201 LSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPEL--GSLIQLEYLDLSANTFHKSI 258
L +N + + L + LN N+ + + G LD+S + ++
Sbjct: 163 LYNNGF-TSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-AL 220
Query: 259 P-ESLSNLVKLHYLNLSN 275
P + L +L +L N
Sbjct: 221 PSKGLEHLKELIARNTWT 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-18
Identities = 39/227 (17%), Positives = 78/227 (34%), Gaps = 37/227 (16%)
Query: 112 SIPLALGNLTNLVVLDLSTNKLSGSIP-LSFANLTSLSILYLYENSLCDSIPKEI-GNMN 169
IP + L L L +IP +F+NL ++S +Y+ + + N++
Sbjct: 25 RIP---SLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLS 80
Query: 170 SLSILDLSSNKLNGSIPLS-LANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNN 228
++ +++ + + I L L LK L + + + P
Sbjct: 81 KVTHIEIRNTRNLTYIDPDALKELPL-LKFLGIFNTGLK-MFPDLTK------------- 125
Query: 229 ELSGQLSPELGSLIQLEYLDLSANTFHKSIPE-SLSNLVK-LHYLNLSNNQFSQKIPNKI 286
+ S L+++ N + SIP + L L L NN F +
Sbjct: 126 ---------VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF-TSVQGYA 175
Query: 287 EKLIHLSELDLSHNIFREEIPSQICS--MQSLEKLNLSHNNLSGSIP 331
L + L+ N + I L++S +++ ++P
Sbjct: 176 FNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALP 221
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 34/190 (17%), Positives = 69/190 (36%), Gaps = 15/190 (7%)
Query: 194 NSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANT 253
+ + ++ I IP + S L L L S +L + + +S +
Sbjct: 11 HQEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDV 66
Query: 254 FHKSIPE-SLSNLVKLHYLNLSNNQFSQKIPNKI-EKLIHLSELDLSHNIFREEIP--SQ 309
+ + S NL K+ ++ + N + I ++L L L + + + P ++
Sbjct: 67 TLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPDLTK 125
Query: 310 ICSMQSLEKLNLSHNNLSGSIP-RCFEEMHWLSC-IDISYNALQGLIPNSTAFRDAPM-- 365
+ S L ++ N SIP F+ + + + + N + AF +
Sbjct: 126 VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGY--AFNGTKLDA 183
Query: 366 LALQGNKRLC 375
+ L NK L
Sbjct: 184 VYLNKNKYLT 193
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 5e-21
Identities = 43/254 (16%), Positives = 83/254 (32%), Gaps = 25/254 (9%)
Query: 72 HFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTN 131
+ ++ T + +KSL + + S + + LS +
Sbjct: 280 YLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSIS 339
Query: 132 KLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLAN 191
+ + +S + L +N DS+ + + L L L N L + +A
Sbjct: 340 DTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFF-KVAL 397
Query: 192 LTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSA 251
+T ++ L + L + + L+LS+
Sbjct: 398 MTKNMSSLETLDVSLNS---LNSHAYDRTCAWAES-----------------ILVLNLSS 437
Query: 252 NTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQIC 311
N S+ L K+ L+L NN+ IP + L L EL+++ N +
Sbjct: 438 NMLTGSVFRCLP--PKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLKSVPDGVFD 494
Query: 312 SMQSLEKLNLSHNN 325
+ SL+ + L N
Sbjct: 495 RLTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 2e-19
Identities = 59/327 (18%), Positives = 106/327 (32%), Gaps = 45/327 (13%)
Query: 87 SSIPDEI-GNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLS--FAN 143
S+ + + L L +S N L +I + +L LDLS N +P+ F N
Sbjct: 89 RSLDFHVFLFNQDLEYLDVSHNRL-QNISC--CPMASLRHLDLSFNDFD-VLPVCKEFGN 144
Query: 144 LTSLSILYLYENSLCDSIPKEIGNMN-SLSILDLSSNKLNGSIPLSLANLTNSLKVLYLS 202
LT L+ L L + +++ S +LDL S + G SL ++ L
Sbjct: 145 LTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFH 204
Query: 203 SN-----------------------------HIVGEIPLGHGMLSSLIQLTLNNNELSGQ 233
N + +L+ +TL + E + +
Sbjct: 205 PNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWK 264
Query: 234 LSPELGSLIQ---LEYLDLSANTFHKSIPE-----SLSNLVKLHYLNLSNNQFSQKIPNK 285
S +L +EYL++ T + I S + L L ++ N F
Sbjct: 265 CSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEAL 324
Query: 286 IEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDI 345
++ LS + S S LN + N + S+ + + L + +
Sbjct: 325 YSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLIL 384
Query: 346 SYNALQGLIPNSTAFRDAPMLALQGNK 372
N L+ + ++ L
Sbjct: 385 QRNGLKNFFKVALMTKNMSSLETLDVS 411
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 3e-15
Identities = 52/241 (21%), Positives = 91/241 (37%), Gaps = 14/241 (5%)
Query: 121 TNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEI-GNMNSLSILDLSSN 179
L LS N +S + L+ L +L L N + S+ + L LD+S N
Sbjct: 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHN 110
Query: 180 KLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGH--GMLSSLIQLTLNNNEL-SGQLSP 236
+L +I + + L+ L LS N +P+ G L+ L L L+ + L P
Sbjct: 111 RL-QNISCC--PMAS-LRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLP 165
Query: 237 ELGSLIQLEYLDLSANTFHKSIPESLS--NLVKLHYLNLSNNQFSQKIPNKIEKLIHL-- 292
+ LDL + ESL N LH + N+ FS ++ + L HL
Sbjct: 166 VAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQL 225
Query: 293 SELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQG 352
S + L+ + + + LN++ ++ + + + + Y +
Sbjct: 226 SNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYN 285
Query: 353 L 353
L
Sbjct: 286 L 286
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 39/209 (18%), Positives = 67/209 (32%), Gaps = 8/209 (3%)
Query: 244 LEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKI-EKLIHLSELDLSHNIF 302
+ L LS N+ + +S L +L L LS+N+ + + + L LD+SHN
Sbjct: 54 TKALSLSQNSISELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHNRL 112
Query: 303 REEIPSQICSMQSLEKLNLSHNNLSGSIPRC--FEEMHWLSCIDISYNALQGLIPNSTAF 360
+ I M SL L+LS N+ +P C F + L+ + +S + L A
Sbjct: 113 Q-NISCC--PMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAH 168
Query: 361 RDAPMLALQGNKRLCGDIKRLPPCKAFKSHKQSMKKIWVVIVFPLLGTVALLISLIGLFF 420
+ L + + + + + +V L L
Sbjct: 169 LHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNI 228
Query: 421 NFRQRKNGSQTQQSSPRNTLGLLSVLTFD 449
S L +T
Sbjct: 229 KLNDENCQRLMTFLSELTRGPTLLNVTLQ 257
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 6e-21
Identities = 43/235 (18%), Positives = 90/235 (38%), Gaps = 18/235 (7%)
Query: 93 IGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYL 152
+ + L + + + L+ + + + + + T+L L+L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQSLAGMQ--FFTNLKELHL 70
Query: 153 YENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPL 212
N + D P + ++ L L ++ N+L + A L+ L+L +N + L
Sbjct: 71 SHNQISDLSP--LKDLTKLEELSVNRNRLKNLNGIPSACLSR----LFLDNNELRDTDSL 124
Query: 213 GHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLN 272
H L +L L++ NN+L + LG L +LE LDL N + L+ L K+++++
Sbjct: 125 IH--LKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGN--EITNTGGLTRLKKVNWID 178
Query: 273 LSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLS 327
L+ + + +L + + + P I + S +
Sbjct: 179 LTGQKCVNEPVKYQPELYITNTVKDPDGRWIS--PYYISNGGSYVDGCVLWELPV 231
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-15
Identities = 42/187 (22%), Positives = 70/187 (37%), Gaps = 14/187 (7%)
Query: 91 DEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSIL 150
+ +L +L LS N ++ + L +LT L L ++ N+L + A L+ L
Sbjct: 57 AGMQFFTNLKELHLSHNQIS-DLS-PLKDLTKLEELSVNRNRLKNLNGIPSACLSR---L 111
Query: 151 YLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEI 210
+L N L D + ++ +L IL + +NKL SI L L+ L+VL L N I
Sbjct: 112 FLDNNELRD--TDSLIHLKNLEILSIRNNKLK-SIV-MLGFLSK-LEVLDLHGNEITNTG 166
Query: 211 PLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHY 270
L L + + L + + L + P +SN
Sbjct: 167 GLTR--LKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGR--WISPYYISNGGSYVD 222
Query: 271 LNLSNNQ 277
+
Sbjct: 223 GCVLWEL 229
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 15/94 (15%), Positives = 40/94 (42%), Gaps = 6/94 (6%)
Query: 260 ESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKL 319
L NL + + + ++L + + ++ + + + +L++L
Sbjct: 13 FPDPGLANAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQS--LAGMQFFTNLKEL 68
Query: 320 NLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGL 353
+LSHN +S + +++ L + ++ N L+ L
Sbjct: 69 HLSHNQIS-DLS-PLKDLTKLEELSVNRNRLKNL 100
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 5e-20
Identities = 61/197 (30%), Positives = 93/197 (47%), Gaps = 17/197 (8%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLS-FANLT 145
++IP I L L N L+ A LT L +L L+ NKL ++P F L
Sbjct: 29 TAIPSNIPA--DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELK 85
Query: 146 SLSILYLYENSLCDSIPKEI-GNMNSLSILDLSSNKLNGSIPLSL-ANLTNSLKVLYLSS 203
+L L++ +N L ++P + + +L+ L L N+L S+P + +LT L L L
Sbjct: 86 NLETLWVTDNKL-QALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTK-LTYLSLGY 142
Query: 204 NHIVGEIPLGHGM---LSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPE 260
N + +P G+ L+SL +L L NN+L L +L+ L L N K +PE
Sbjct: 143 NELQ-SLP--KGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQL-KRVPE 198
Query: 261 -SLSNLVKLHYLNLSNN 276
+ +L KL L L N
Sbjct: 199 GAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-19
Identities = 59/186 (31%), Positives = 84/186 (45%), Gaps = 13/186 (6%)
Query: 121 TNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEI-GNMNSLSILDLSSN 179
+ LDL +NKLS +F LT L +LYL +N L ++P I + +L L ++ N
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDN 95
Query: 180 KLNGSIPLSL-ANLTNSLKVLYLSSNHIVGEIPLG--HGMLSSLIQLTLNNNELSGQLSP 236
KL ++P+ + L N L L L N + +P L+ L L+L NEL L
Sbjct: 96 KLQ-ALPIGVFDQLVN-LAELRLDRNQLK-SLPPRVFDS-LTKLTYLSLGYNELQ-SLPK 150
Query: 237 EL-GSLIQLEYLDLSANTFHKSIPESL-SNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSE 294
+ L L+ L L N K +PE L +L L L NNQ + + L L
Sbjct: 151 GVFDKLTSLKELRLYNNQL-KRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKM 209
Query: 295 LDLSHN 300
L L N
Sbjct: 210 LQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 55/192 (28%), Positives = 95/192 (49%), Gaps = 18/192 (9%)
Query: 169 NSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLG--HGMLSSLIQLTLN 226
N+ + +D SS KL +IP +N+ K L L SN + +P H L+ L L LN
Sbjct: 16 NNKNSVDCSSKKLT-AIP---SNIPADTKKLDLQSNKLS-SLPSKAFHR-LTKLRLLYLN 69
Query: 227 NNELSGQLSPEL-GSLIQLEYLDLSANTFHKSIPESL-SNLVKLHYLNLSNNQFSQKIPN 284
+N+L L + L LE L ++ N +++P + LV L L L NQ + +P
Sbjct: 70 DNKLQ-TLPAGIFKELKNLETLWVTDNK-LQALPIGVFDQLVNLAELRLDRNQL-KSLPP 126
Query: 285 KI-EKLIHLSELDLSHNIFREEIPSQIC-SMQSLEKLNLSHNNLSGSIPR-CFEEMHWLS 341
++ + L L+ L L +N + +P + + SL++L L +N L +P F+++ L
Sbjct: 127 RVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELK 184
Query: 342 CIDISYNALQGL 353
+ + N L+ +
Sbjct: 185 TLKLDNNQLKRV 196
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 9e-20
Identities = 58/295 (19%), Positives = 99/295 (33%), Gaps = 40/295 (13%)
Query: 97 KSLSDLQLSENILN-GSIPLALGNLTNLVVLDLSTNKLS--GSIPLSFA--NLTSLSILY 151
+ L + L+ L L V+ L L+ +S A +L+ L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 152 LYENSLCDSIPKEIGNM-----NSLSILDLSSNKLN--GSIPLSLANLTN-SLKVLYLSS 203
L N L D + + L L + L G LS T +L+ L+LS
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 204 NHI--VGEIPLGHGMLS---SLIQLTLNNNELSGQ----LSPELGSLIQLEYLDLSANTF 254
N + G L G+L L +L L LS L+ L + + L +S N
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 255 H----KSIPESL-SNLVKLHYLNLSNNQFS----QKIPNKIEKLIHLSELDLSHNIFREE 305
+ + + + L + +L L L + + + + + L EL L N +
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242
Query: 306 -----IPSQICSMQSLEKLNLSHNNLS----GSIPRCFEEMHWLSCIDISYNALQ 351
P + L L + ++ G + R L + ++ N L
Sbjct: 243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG 297
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-17
Identities = 65/308 (21%), Positives = 113/308 (36%), Gaps = 44/308 (14%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILN--GSIPLA---LGNLTNLVVLDLSTNKLS--GSIPL 139
+ + + +L +L LS+N+L G L L L L L LS PL
Sbjct: 103 GVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162
Query: 140 SFA--NLTSLSILYLYENSLCDSIPKEIG-----NMNSLSILDLSSNKLN--GSIPLSLA 190
+ L + N + ++ + + + L L L S + L
Sbjct: 163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGI 222
Query: 191 NLTN-SLKVLYLSSNHI--VGEIPLGHGML---SSLIQLTLNNNELSGQ----LSPELGS 240
+ SL+ L L SN + VG L G+L S L L + ++ + L L +
Sbjct: 223 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRA 282
Query: 241 LIQLEYLDLSANTFH----KSIPESL-SNLVKLHYLNLSNNQFS----QKIPNKIEKLIH 291
L+ L L+ N + + E+L +L L + + F+ + + +
Sbjct: 283 KESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRF 342
Query: 292 LSELDLSHNIFREEIPSQICSM-----QSLEKLNLSHNNLS----GSIPRCFEEMHWLSC 342
L EL +S+N + ++C L L L+ ++S S+ H L
Sbjct: 343 LLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRE 402
Query: 343 IDISYNAL 350
+D+S N L
Sbjct: 403 LDLSNNCL 410
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 7e-17
Identities = 58/303 (19%), Positives = 97/303 (32%), Gaps = 44/303 (14%)
Query: 93 IGNMKSLSDLQLSENILNGSIPLALGNL-----TNLVVLDLSTNKLS----GSIPLSFAN 143
+ +L++L L N L + + L L L+ G + +
Sbjct: 52 LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRT 111
Query: 144 LTSLSILYLYENSLCDSIPKEIGNM-----NSLSILDLSSNKL--NGSIPLSLANLTN-S 195
L +L L+L +N L D+ + + L L L L PL+
Sbjct: 112 LPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPD 171
Query: 196 LKVLYLSSNHI--VGEIPLGHGMLSSLIQLT---LNNNELSGQ----LSPELGSLIQLEY 246
K L +S+N I G L G+ S QL L + ++ L + S L
Sbjct: 172 FKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRE 231
Query: 247 LDLSANTFHKSIPESLSNLVK-----LHYLNLSNNQFS----QKIPNKIEKLIHLSELDL 297
L L +N L + L L + + + + L EL L
Sbjct: 232 LALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSL 291
Query: 298 SHNIFREEIPSQICSM-----QSLEKLNLSHNNLSG----SIPRCFEEMHWLSCIDISYN 348
+ N +E +C LE L + + + + +L + IS N
Sbjct: 292 AGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNN 351
Query: 349 ALQ 351
L+
Sbjct: 352 RLE 354
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 58/275 (21%), Positives = 90/275 (32%), Gaps = 40/275 (14%)
Query: 93 IGNMKSLSDLQLSENILN--GSIPLALG---NLTNLVVLDLSTNKLS----GSIPLSFAN 143
+ +L +S N +N G L G + L L L + ++ + A+
Sbjct: 166 LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVAS 225
Query: 144 LTSLSILYLYENSLCDSIPKEIGNM-----NSLSILDLSSNKL--NGSIPLSLANLTN-S 195
SL L L N L D E+ + L L + + G L S
Sbjct: 226 KASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKES 285
Query: 196 LKVLYLSSNHI--VGEIPLGHGMLSSLIQLT---LNNNELSGQ----LSPELGSLIQLEY 246
LK L L+ N + G L +L QL + + + S L L
Sbjct: 286 LKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLE 345
Query: 247 LDLSANTFH----KSIPESL-SNLVKLHYLNLSNNQFS----QKIPNKIEKLIHLSELDL 297
L +S N + + + L L L L++ S + + L ELDL
Sbjct: 346 LQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDL 405
Query: 298 SHNIFREEIPSQICSM-----QSLEKLNLSHNNLS 327
S+N + Q+ LE+L L S
Sbjct: 406 SNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 55/271 (20%), Positives = 93/271 (34%), Gaps = 39/271 (14%)
Query: 98 SLSDLQLSENILN----GSIPLALGNLTNLVVLDLSTNKL--SGSIPLSFANL---TSLS 148
+ L L L G + L L L L LS N L +G L L L
Sbjct: 86 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLE 145
Query: 149 ILYLYENSLCDSIPKEIGNM----NSLSILDLSSNKLNGS----IPLSLANLTNSLKVLY 200
L L SL + + + ++ L +S+N +N + + L + L+ L
Sbjct: 146 KLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALK 205
Query: 201 LSSNHI----VGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQ-----LEYLDLSA 251
L S + ++ +SL +L L +N+L EL + L L +
Sbjct: 206 LESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWE 265
Query: 252 NTFH----KSIPESLSNLVKLHYLNLSNNQFSQKIPNKI-EKLIH----LSELDLSHNIF 302
+ L L L+L+ N+ + + E L+ L L + F
Sbjct: 266 CGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSF 325
Query: 303 REE----IPSQICSMQSLEKLNLSHNNLSGS 329
S + + L +L +S+N L +
Sbjct: 326 TAACCSHFSSVLAQNRFLLELQISNNRLEDA 356
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 4e-11
Identities = 52/216 (24%), Positives = 75/216 (34%), Gaps = 31/216 (14%)
Query: 97 KSLSDLQLSENIL--NGSIPLALGNL---TNLVVLDLSTNKLS--GSIPLSFA--NLTSL 147
SL +L L N L G L G L + L L + ++ G L SL
Sbjct: 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESL 286
Query: 148 SILYLYENSLCDSIPKEIGNM-----NSLSILDLSSNKL--NGSIPLSLANLTN-SLKVL 199
L L N L D + + L L + S S N L L
Sbjct: 287 KELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLEL 346
Query: 200 YLSSNHI--VGEIPLGHGML---SSLIQLTLNNNELSGQ----LSPELGSLIQLEYLDLS 250
+S+N + G L G+ S L L L + ++S L+ L + L LDLS
Sbjct: 347 QISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLS 406
Query: 251 ANTFH----KSIPESL-SNLVKLHYLNLSNNQFSQK 281
N + ES+ L L L + +S++
Sbjct: 407 NNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE 442
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 31/185 (16%), Positives = 69/185 (37%), Gaps = 23/185 (12%)
Query: 168 MN-SLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHI--VGEIPLGHG--MLSSLIQ 222
M+ + LD+ +L+ + L L +V+ L + + + +L +
Sbjct: 1 MSLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 60
Query: 223 LTLNNNELSGQ----LSPELGSL-IQLEYLDLSANTFH----KSIPESLSNLVKLHYLNL 273
L L +NEL + L + +++ L L + +L L L L+L
Sbjct: 61 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHL 120
Query: 274 SNNQFSQKIPNKIEKLI-----HLSELDLSHNIFREEIPSQICSM----QSLEKLNLSHN 324
S+N + + + L +L L + + S+ ++L +S+N
Sbjct: 121 SDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNN 180
Query: 325 NLSGS 329
+++ +
Sbjct: 181 DINEA 185
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 3e-19
Identities = 53/170 (31%), Positives = 79/170 (46%), Gaps = 19/170 (11%)
Query: 121 TNLVVLDLSTNKLSGSIP--LSFANLTSLSILYLYENSLCDSIPKEI-GNMNSLSILDLS 177
+ +LDLS N LS + + LT+L L L N L + I E + +L LDLS
Sbjct: 39 SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLS 96
Query: 178 SNKLNGSIP-LSLANLTNSLKVLYLSSNHIVGEIPLG--HGMLSSLIQLTLNNNELSGQL 234
SN L+ ++ ++L L+VL L +NHIV + ++ L +L L+ N++S +
Sbjct: 97 SNHLH-TLDEFLFSDLQA-LEVLLLYNNHIV-VVDRNAFED-MAQLQKLYLSQNQIS-RF 151
Query: 235 SPE----LGSLIQLEYLDLSANTFHKSIPESLSNLVKL--HYLNLSNNQF 278
E L +L LDLS+N K L L + L L NN
Sbjct: 152 PVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 45/144 (31%), Positives = 70/144 (48%), Gaps = 16/144 (11%)
Query: 95 NMKSLSDLQLSENILNGSIP-LALGNLTNLVVLDLSTNKLSGSIP-LSFANLTSLSILYL 152
+ +L L LS N LN I A + NL LDLS+N L ++ F++L +L +L L
Sbjct: 62 RLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLL 119
Query: 153 YENSLCDSIPKEI-GNMNSLSILDLSSNKLNGSIP----LSLANLTNSLKVLYLSSNHIV 207
Y N + + + +M L L LS N+++ P L L +L LSSN +
Sbjct: 120 YNNHI-VVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLP-KLMLLDLSSNKL- 175
Query: 208 GEIPLGH-GMLSSLIQ--LTLNNN 228
++PL L + ++ L L+NN
Sbjct: 176 KKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 45/163 (27%), Positives = 66/163 (40%), Gaps = 21/163 (12%)
Query: 223 LTLNNNELSGQLSPE--LGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQ 280
L L++N LS +L E L L L LS N + E+ + L YL+LS+N
Sbjct: 44 LDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHL-H 101
Query: 281 KIPNKI-EKLIHLSELDLSHN-IFREEIPSQI-CSMQSLEKLNLSHNNLSGSIP----RC 333
+ + L L L L +N I + M L+KL LS N +S P +
Sbjct: 102 TLDEFLFSDLQALEVLLLYNNHI--VVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKD 158
Query: 334 FEEMHWLSCIDISYNALQGLIPNSTAFRDAP-----MLALQGN 371
++ L +D+S N L+ L + P L L N
Sbjct: 159 GNKLPKLMLLDLSSNKLKKLPLT--DLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 24/81 (29%), Positives = 34/81 (41%), Gaps = 9/81 (11%)
Query: 87 SSIPDEI-GNMKSLSDLQLSENILNGSIP----LALGNLTNLVVLDLSTNKLSGSIPLSF 141
+ +M L L LS+N ++ P L L++LDLS+NKL
Sbjct: 125 VVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDL 183
Query: 142 ANLTSLS--ILYLYENSL-CD 159
L + LYL+ N L CD
Sbjct: 184 QKLPAWVKNGLYLHNNPLECD 204
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 89.0 bits (220), Expect = 7e-19
Identities = 47/251 (18%), Positives = 84/251 (33%), Gaps = 19/251 (7%)
Query: 84 PLYSSIPDEIGNMKSLSDLQLSENIL----NGSIPLALGNLTNLVVLDLSTNKLSGSIPL 139
L +P + E +L L +LS K +
Sbjct: 308 SLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSE 367
Query: 140 --SFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLK 197
S L L + + + + + + L P+ A L +
Sbjct: 368 LESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDL-- 425
Query: 198 VLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKS 257
+ + E + + + L L + +L+ L L L+ + +LDLS N ++
Sbjct: 426 -----RSKFLLENSVLKMEYADVRVLHLAHKDLT-VL-CHLEQLLLVTHLDLSHNRL-RA 477
Query: 258 IPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHN-IFREEIPSQICSMQSL 316
+P +L+ L L L S+N + + L L EL L +N + + + S L
Sbjct: 478 LPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRL 535
Query: 317 EKLNLSHNNLS 327
LNL N+L
Sbjct: 536 VLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 81.3 bits (200), Expect = 2e-16
Identities = 39/210 (18%), Positives = 73/210 (34%), Gaps = 21/210 (10%)
Query: 89 IPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLS 148
+ E+ + K L +L+ +I L + L L+ + S L ++
Sbjct: 364 LQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFS--------TLKAVD 415
Query: 149 ILYLYENSLCDSI-----PKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSS 203
+ S + +L L+ L + L L + L LS
Sbjct: 416 PMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQLLL-VTHLDLSH 472
Query: 204 NHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHK-SIPESL 262
N + +P L L L ++N L + + +L +L+ L L N + + + L
Sbjct: 473 NRLR-ALPPALAALRCLEVLQASDNALE-NV-DGVANLPRLQELLLCNNRLQQSAAIQPL 529
Query: 263 SNLVKLHYLNLSNNQFSQKIPNKIEKLIHL 292
+ +L LNL N + E+L +
Sbjct: 530 VSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 75.9 bits (186), Expect = 1e-14
Identities = 36/185 (19%), Positives = 69/185 (37%), Gaps = 7/185 (3%)
Query: 42 KELVRAVQARDTSISFDELHEKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSD 101
++ ++A D + E + T +A +
Sbjct: 386 LTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRV 445
Query: 102 LQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSI 161
L L+ L + L L + LDLS N+L ++P + A L L +L +N+L +++
Sbjct: 446 LHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNAL-ENV 501
Query: 162 PKEIGNMNSLSILDLSSNKLNG-SIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSL 220
+ N+ L L L +N+L + L + L +L L N + E + + L
Sbjct: 502 D-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPR-LVLLNLQGNSLCQEEGIQERLAEML 559
Query: 221 IQLTL 225
++
Sbjct: 560 PSVSS 564
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 1e-06
Identities = 32/191 (16%), Positives = 68/191 (35%), Gaps = 15/191 (7%)
Query: 201 LSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPE 260
+ L + L+ + + L EL S +L+ L+ +I
Sbjct: 332 VLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIIL 390
Query: 261 SLSNLVKLHYLNLSNNQFSQKIPNKIEKL--IHLSELDLSHNIFREEIPSQICSMQSLEK 318
+ L L Y + F + ++ + + + LD + F E +
Sbjct: 391 LMRALDPLLYEKETLQYF-----STLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRV 445
Query: 319 LNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDI 378
L+L+H +L+ + E++ ++ +D+S+N L+ L P A R +L N +
Sbjct: 446 LHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNA-----L 498
Query: 379 KRLPPCKAFKS 389
+ +
Sbjct: 499 ENVDGVANLPR 509
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 35/109 (32%), Positives = 49/109 (44%), Gaps = 5/109 (4%)
Query: 463 NFDD---GHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR 519
+ D IG G G+V++A+ G V VK EFL EV + ++R
Sbjct: 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAER-VNEFLREVAIMKRLR 92
Query: 520 HRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMN 568
H NIV F G + + +V EYL GSL L A EQ +R++
Sbjct: 93 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLS 141
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 31/107 (28%), Positives = 47/107 (43%), Gaps = 8/107 (7%)
Query: 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHR 521
+ +G G G V KAK + V +K+ S E + F+ E+ L+++ H
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SER---KAFIVELRQLSRVNHP 61
Query: 522 NIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMN 568
NIVK YG C + + +V EY E GSL L + M+
Sbjct: 62 NIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMS 106
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 8e-18
Identities = 27/118 (22%), Positives = 45/118 (38%), Gaps = 13/118 (11%)
Query: 455 EEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNA 514
E + + G G V+KA+L E V VK F P + + EV +
Sbjct: 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIF----PIQDKQSWQNEYEVYS 71
Query: 515 LTKIRHRNIVKFYGFCSHALHS----FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMN 568
L ++H NI++F G +++ + E GSL+ L W + +
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA----NVVSWNELCH 125
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 85.7 bits (211), Expect = 1e-17
Identities = 98/638 (15%), Positives = 200/638 (31%), Gaps = 192/638 (30%)
Query: 3 VTDFLHSV--KARTDELAILGAPMEEED---LIEKIL------------DGLGDDYKELV 45
V D S+ K D I+ + L +L + L +YK L+
Sbjct: 38 VQDMPKSILSKEEIDH--IIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLM 95
Query: 46 RAVQA--RDTSI---SFDELHEKLLTFEATAHFSVLAFTGQDWPLYS-SIPDEIGNMKS- 98
++ R S+ + E ++L Q + Y+ S ++
Sbjct: 96 SPIKTEQRQPSMMTRMYIEQRDRLYN------------DNQVFAKYNVSRLQPYLKLRQA 143
Query: 99 LSDLQLSENI-LNGSIPLALGN----LTNLVVLDLST-NKLSGSIP-LSFANLTSLSILY 151
L +L+ ++N+ ++G LG+ + V L K+ I L+ N S +
Sbjct: 144 LLELRPAKNVLIDG----VLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVL 199
Query: 152 LYENSLCDSIPKEIGNMNSLS---ILDLSSNKLNGSIPLSLANLTNSL------------ 196
L I + + S L + S + L N L
Sbjct: 200 EMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW 259
Query: 197 -------KVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDL 249
K+L + V + LS+ ++ + S L+P+ + L+YLD
Sbjct: 260 NAFNLSCKILLTTRFKQVTDF------LSAATTTHISLDHHSMTLTPDEVKSLLLKYLDC 313
Query: 250 SA----------NTFHKS-IPESLSNLVKL--HYLNLSNNQFSQKIPNKIEKLIHLSELD 296
N S I ES+ + + ++ +++ ++ + I + + L +
Sbjct: 314 RPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLN---VLEPAE 370
Query: 297 LSHN-----IFREE--IPSQICSMQSLEKLNLSHNNLSGSIPRCF-EEMHWLSCID---- 344
+F IP+ + L + ++ S ++H S ++
Sbjct: 371 YRKMFDRLSVFPPSAHIPTIL-----LSLI---WFDVIKSDVMVVVNKLHKYSLVEKQPK 422
Query: 345 ---ISYNALQ----GLIPNSTAFRDAPMLALQGNKRLCGDIKRLPPC--KAFKS----HK 391
IS ++ + N A + + K D +PP + F S H
Sbjct: 423 ESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSD-DLIPPYLDQYFYSHIGHHL 481
Query: 392 QSMKKIWVVIVFPLLGTVALLISLIGLFFNFR--QRK-NGSQTQQSSPRNTLGLLSVLTF 448
++++ + +F + +F +FR ++K T ++ + L L L F
Sbjct: 482 KNIEHPERMTLFRM------------VFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKF 529
Query: 449 DGKIVHEEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQ-QE 507
YK I D + P + + +
Sbjct: 530 ------------------------------YK-----PYICD----NDPKYERLVNAILD 550
Query: 508 FLNEVNA-LTKIRHRNIVKFYGFCSHAL---HSFVVYE 541
FL ++ L ++ ++++ AL + E
Sbjct: 551 FLPKIEENLICSKYTDLLRI------ALMAEDEAIFEE 582
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.6 bits (133), Expect = 4e-08
Identities = 68/465 (14%), Positives = 124/465 (26%), Gaps = 165/465 (35%)
Query: 180 KLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGML----SSLIQLTLNNNELSGQLS 235
K N S L +L L + N ++ G+L + + + ++
Sbjct: 128 KYNVSRLQPYLKLRQALLELRPAKNVLI------DGVLGSGKTWVALDVCLSYKV----- 176
Query: 236 PELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSEL 295
F K+ +LNL N + + ++KL++ +
Sbjct: 177 -------------QCKMDF------------KIFWLNLKNCNSPETVLEMLQKLLYQIDP 211
Query: 296 DLSHNIFR-EEIPSQICSMQSLEKLNLSHNNLSGSIPRCF-------EEMHW----LSC- 342
+ + I +I S+Q+ + L C W LSC
Sbjct: 212 NWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY----ENCLLVLLNVQNAKAWNAFNLSCK 267
Query: 343 I-----DIS-YNALQG-------LIPNSTAFRDAPMLALQGNKRLCGDIKRLPPCKAFKS 389
I + L L +S + +L K L + LP
Sbjct: 268 ILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL-KYLDCRPQDLPR------ 320
Query: 390 HKQSMKKIWVVIVFPLLGTVALLISLIGLFF--------NFRQ--RKNGSQTQQSS---- 435
+ P +S+I N++ + +SS
Sbjct: 321 ---EVLTT-----NP------RRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVL 366
Query: 436 -P---RNTLGLLSVLTFDGKI------------VHEEIIRATNNFDDGHCIGNGGQGSVY 479
P R LSV I + +++ N V
Sbjct: 367 EPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHK--------YSLVE 418
Query: 480 KAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFY----GFCSHAL- 534
K K+ +P E ++ + HR+IV Y F S L
Sbjct: 419 K---------QPKESTISIPS---IYLELKVKLENEYAL-HRSIVDHYNIPKTFDSDDLI 465
Query: 535 --------HSFVVY-----EYLEMGSLAMNLSNDAAAEQFCWTKR 566
+S + + E+ E +L + D F + ++
Sbjct: 466 PPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLD-----FRFLEQ 505
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.9 bits (118), Expect = 2e-06
Identities = 47/317 (14%), Positives = 90/317 (28%), Gaps = 111/317 (35%)
Query: 2 TVTDFLHSVKARTDELAILGAPMEEEDLIEKILDGLGDDYKELVRAVQARDTSISFDELH 61
VTDFL + ++ L D + ++ + +L
Sbjct: 276 QVTDFLSAATTT-------------HISLDHHSMTLTPDEVK---SLLLKYLDCRPQDLP 319
Query: 62 EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSD-LQLSENILNGSIPLALGNL 120
E P SI I +S+ D L +N +
Sbjct: 320 R-----EVLTTN----------PRRLSI---IA--ESIRDGLATWDNWKH---------- 349
Query: 121 TNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNK 180
++ +KL+ I S L +++ LS+ S++
Sbjct: 350 -------VNCDKLTTIIESSLNVLEPAEYRKMFD---------------RLSVFPPSAH- 386
Query: 181 LNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGS 240
IP L L +++ + +++ L + +L + Q S
Sbjct: 387 ----IPTIL------LSLIWFDVIKSDVMV-----VVNKLHKYSL----VEKQPKESTIS 427
Query: 241 LIQLEYLDLSAN-----TFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLI----- 290
+ + YL+L H+SI + HY IP +++
Sbjct: 428 IPSI-YLELKVKLENEYALHRSIVD--------HYNIPKTFDSDDLIPPYLDQYFYSHIG 478
Query: 291 -HLSELDLSH--NIFRE 304
HL ++ +FR
Sbjct: 479 HHLKNIEHPERMTLFRM 495
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 29/112 (25%), Positives = 47/112 (41%), Gaps = 9/112 (8%)
Query: 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQ----QEFLNEVNALT 516
N + IG GG G V+K + + +V +K + QEF EV ++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 517 KIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMN 568
+ H NIVK YG + +V E++ G L L + A W+ ++
Sbjct: 79 NLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD--KAHPIKWSVKLR 126
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 46/293 (15%), Positives = 90/293 (30%), Gaps = 54/293 (18%)
Query: 89 IPDEIGNMKSLSDLQLSENILN--GSIPLA--LGNLTNLVVLDLSTNKLS---------- 134
+ + S+ ++ LS N + + L+ + + +L + + S
Sbjct: 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 83
Query: 135 GSIPLSFANLTSLSILYLYENSLCD----SIPKEIGNMNSLSILDLSSNK---------- 180
+ + L + L +N+ + + L L L +N
Sbjct: 84 RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 143
Query: 181 --LNGSIPLSLANLTNSLKVLYLSSNHI--VGEIPLGHGM--LSSLIQLTLNNNELSGQ- 233
L A L+ + N + L + + N + +
Sbjct: 144 RALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG 203
Query: 234 ----LSPELGSLIQLEYLDLSANTFH----KSIPESLSNLVKLHYLNLSNNQFS----QK 281
L L +L+ LDL NTF ++ +L + L L L++ S
Sbjct: 204 IEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 263
Query: 282 IPNKIEKLIH--LSELDLSHNIFREEIPSQICS-----MQSLEKLNLSHNNLS 327
+ + KL + L L L +N + + + M L L L+ N S
Sbjct: 264 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 39/225 (17%), Positives = 71/225 (31%), Gaps = 43/225 (19%)
Query: 146 SLSILYLYENSLCD----SIPKEIGNMNSLSILDLSSNKLN--GSIPLSLANLTN-SLKV 198
S+ L +++ S+ + +S+ + LS N + + LS + L++
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64
Query: 199 LYLSSNHI---VGEIPLGHGMLS-------SLIQLTLNNNELSGQ----LSPELGSLIQL 244
S EIP +L L + L++N L L L
Sbjct: 65 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124
Query: 245 EYLDLSANTFH----KSIPESLSNLVK---------LHYLNLSNNQFS----QKIPNKIE 287
E+L L N I +L L L + N+ ++ +
Sbjct: 125 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 184
Query: 288 KLIHLSELDLSHNIFREE-----IPSQICSMQSLEKLNLSHNNLS 327
L + + N R E + + Q L+ L+L N +
Sbjct: 185 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT 229
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 33/201 (16%), Positives = 66/201 (32%), Gaps = 41/201 (20%)
Query: 189 LANLTNSLKVLYLSSNHI--VGEIPLGHGMLS--SLIQLTLNNNELSGQ----LSPELGS 240
+A S++ L + I E + +L S+ ++ L+ N + + LS + S
Sbjct: 1 MARF--SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIAS 58
Query: 241 LIQLEYLDLSANTF----------HKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLI 290
LE + S + + ++L KLH + LS+N F + +
Sbjct: 59 KKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFL 118
Query: 291 ----HLSELDLSHNIFREE-------------IPSQICSMQSLEKLNLSHNNLSG----S 329
L L L +N + + + + L + N L
Sbjct: 119 SKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKE 178
Query: 330 IPRCFEEMHWLSCIDISYNAL 350
+ F+ L + + N +
Sbjct: 179 WAKTFQSHRLLHTVKMVQNGI 199
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 53/278 (19%), Positives = 98/278 (35%), Gaps = 45/278 (16%)
Query: 95 NMKSLSDLQLSENIL--NGSIPLA---LGNLTNLVVLDLSTNKLS--GSIPLSFA---NL 144
++ L LS N L ++ L ++ L+LS N L S L
Sbjct: 20 IPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIP 79
Query: 145 TSLSILYLYENSLCDSIPKEIGNM-----NSLSILDLSSNKL--NGSIPLS--LANLTNS 195
+++ L L N L E+ ++++LDL N S +NL S
Sbjct: 80 ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPAS 139
Query: 196 LKVLYLSSNHI--VGEIPLGHGMLS---SLIQLTLNNNELSGQLSPELGSLI-----QLE 245
+ L L N + L + + ++ L L N L+ + EL + +
Sbjct: 140 ITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVT 199
Query: 246 YLDLSANTFH----KSIPESL-SNLVKLHYLNLSNNQFS----QKIPNKIEKLIHLSELD 296
LDLSAN + S + LNL N + + + L HL +
Sbjct: 200 SLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVY 259
Query: 297 LSHNIFR-------EEIPSQICSMQSLEKLNLSHNNLS 327
L ++I + + + + ++Q + ++ + +
Sbjct: 260 LDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 8e-17
Identities = 54/278 (19%), Positives = 93/278 (33%), Gaps = 45/278 (16%)
Query: 95 NMKSLSDLQLSENIL--NGSIPLA---LGNLTNLVVLDLSTNKLS--GSIPLSFA---NL 144
S++ L LS N L S L N+ L+LS N LS S L
Sbjct: 49 TPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIP 108
Query: 145 TSLSILYLYENSLCDSIPKEIGNM-----NSLSILDLSSNKLN--GSIPLS--LANLTNS 195
++++L L N E S++ L+L N L S L LA + +
Sbjct: 109 FTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPAN 168
Query: 196 LKVLYLSSNHI--VGEIPLGHGMLS---SLIQLTLNNNELSGQLSPELGSLIQ-----LE 245
+ L L N++ L + S S+ L L+ N L + EL + +
Sbjct: 169 VNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVV 228
Query: 246 YLDLSANTFH----KSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLI-------HLSE 294
L+L N H +++ +L L + L + + + L +
Sbjct: 229 SLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIIL 288
Query: 295 LDLSHNIFREEIPSQICSM-----QSLEKLNLSHNNLS 327
+D + I ++ + +L + L
Sbjct: 289 VDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLI 326
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 6e-16
Identities = 53/281 (18%), Positives = 101/281 (35%), Gaps = 45/281 (16%)
Query: 116 ALGNLTNLVVLDLSTNKLS--GSIPLSFA---NLTSLSILYLYENSLCDSIPKEIGNM-- 168
+ LDLS N L ++ L A S++ L L NSL E+ +
Sbjct: 17 FTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILA 76
Query: 169 ---NSLSILDLSSNKLN--GSIPLS--LANLTNSLKVLYLSSNHI--VGEIPLGHGMLS- 218
+++ L+LS N L+ S L LA + ++ VL L N +
Sbjct: 77 AIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNL 136
Query: 219 --SLIQLTLNNNELSGQLSPELGSLIQ-----LEYLDLSANTFH----KSIPESLSNL-V 266
S+ L L N+L + S EL ++ + L+L N + + L+++
Sbjct: 137 PASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPA 196
Query: 267 KLHYLNLSNNQFSQKIPNKIEKLI-----HLSELDLSHNIFREEIPSQICSM----QSLE 317
+ L+LS N K ++ + H+ L+L N + + + L+
Sbjct: 197 SVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQ 256
Query: 318 KLNLSHNNLSGSIPRC-------FEEMHWLSCIDISYNALQ 351
+ L ++ + F + + +D + +
Sbjct: 257 TVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 48/244 (19%), Positives = 86/244 (35%), Gaps = 40/244 (16%)
Query: 97 KSLSDLQLSENIL--NGSIPLA---LGNLTNLVVLDLSTNKLS--GSIPLSFA---NLTS 146
+++ L L N S ++ L+L N L S L +
Sbjct: 109 FTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPAN 168
Query: 147 LSILYLYENSLCDSIPKEIGNM-----NSLSILDLSSNKLN--GSIPLS--LANLTNSLK 197
++ L L N+L E+ S++ LDLS+N L L+ +++ N +
Sbjct: 169 VNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVV 228
Query: 198 VLYLSSNHI----VGEIPLGHGMLSSLIQLTLNNNELSGQ-------LSPELGSLIQLEY 246
L L N + + + L L L + L+ + + L ++ ++
Sbjct: 229 SLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIIL 288
Query: 247 LDLSANTFHKSIPESLSNLVK-----LHYLNLSNN--QFSQKIPNKIEKL---IHLSELD 296
+D + H S +SNL++ +L N F+QK IE L L E
Sbjct: 289 VDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESI 348
Query: 297 LSHN 300
+
Sbjct: 349 QTCK 352
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 42/223 (18%), Positives = 84/223 (37%), Gaps = 43/223 (19%)
Query: 152 LYENSLCDSIPKEIGNMNSLSILDLSSNKL--NGSIPLS--LANLTNSLKVLYLSSNHIV 207
L + + + + + ++ LDLS N L ++ L AN S+ L LS N +
Sbjct: 5 LTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSL- 63
Query: 208 GEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFH----KSIPESL- 262
G L+Q+ + L+LS N + ++L
Sbjct: 64 -----GFKNSDELVQILAAIPA-------------NVTSLNLSGNFLSYKSSDELVKTLA 105
Query: 263 SNLVKLHYLNLSNNQFSQKIPNKIEKLI-----HLSELDLSHNIFREEIPSQICSM---- 313
+ + L+L N FS K ++ ++ ++ L+L N + ++ +
Sbjct: 106 AIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAI 165
Query: 314 -QSLEKLNLSHNNLS----GSIPRCFEEMHW-LSCIDISYNAL 350
++ LNL NNL+ + + + ++ +D+S N L
Sbjct: 166 PANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLL 208
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 30/159 (18%), Positives = 59/159 (37%), Gaps = 25/159 (15%)
Query: 97 KSLSDLQLSENILN--GSIPLA---LGNLTNLVVLDLSTNKLSGS----IPLSFANLTSL 147
S++ L LS N+L LA ++V L+L N L G + L +L L
Sbjct: 196 ASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHL 255
Query: 148 SILYLYENSLCD-------SIPKEIGNMNSLSILDLSSNKLN--GSIPLS--LANLTNSL 196
+YL + + + ++ N+ + ++D + +++ SIP+S + L+
Sbjct: 256 QTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKA 315
Query: 197 KVLYLSSNHI-----VGEIPLGHGMLSSLIQLTLNNNEL 230
V L + + + L + L
Sbjct: 316 DVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 5e-17
Identities = 22/83 (26%), Positives = 35/83 (42%), Gaps = 2/83 (2%)
Query: 467 GHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMA-CQQEFLNEVNALTKIRHRNIVK 525
IG GG G VY+A G+ V VK ++++ + E ++H NI+
Sbjct: 12 EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 526 FYGFCSHALHSFVVYEYLEMGSL 548
G C + +V E+ G L
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPL 93
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 1e-16
Identities = 31/109 (28%), Positives = 39/109 (35%), Gaps = 14/109 (12%)
Query: 455 EEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVN- 513
E +N IG G G+VYK L V VK F + Q F+NE N
Sbjct: 6 SEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF--SFANR----QNFINEKNI 58
Query: 514 -ALTKIRHRNIVKFYGFCSHALHS-----FVVYEYLEMGSLAMNLSNDA 556
+ + H NI +F +V EY GSL LS
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT 107
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 30/123 (24%), Positives = 46/123 (37%), Gaps = 10/123 (8%)
Query: 426 KNGSQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATNNFDDGHCIGNGGQGSVYKAKLPT 485
N S S S+ + I E++ + G IG G G VY +
Sbjct: 4 MNLSLLSARSFPRKASQTSIFLQEWDIPFEQL-------EIGELIGKGRFGQVYHGRW-H 55
Query: 486 GEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEM 545
GE V ++ +E + F EV A + RH N+V F G C H ++ +
Sbjct: 56 GE-VAIRLIDIERDNEDQ-LKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKG 113
Query: 546 GSL 548
+L
Sbjct: 114 RTL 116
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 5e-15
Identities = 20/100 (20%), Positives = 34/100 (34%), Gaps = 12/100 (12%)
Query: 454 HEEIIRATNNFDD---GHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLN 510
H I +F + G ++K + G + VK ++F
Sbjct: 4 HSGI-----DFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRK-SRDFNE 56
Query: 511 EVNALTKIRHRNIVKFYGFCSH--ALHSFVVYEYLEMGSL 548
E L H N++ G C A H ++ ++ GSL
Sbjct: 57 ECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSL 96
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 5e-15
Identities = 28/103 (27%), Positives = 49/103 (47%), Gaps = 6/103 (5%)
Query: 467 GHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVK 525
G +G G G K TGE++ +K+ DE Q+ FL EV + + H N++K
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEET-QRTFLKEVKVMRCLEHPNVLK 71
Query: 526 FYGFCSHALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMN 568
F G + EY++ G+L + + Q+ W++R++
Sbjct: 72 FIGVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVS 112
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 31/82 (37%), Positives = 41/82 (50%), Gaps = 4/82 (4%)
Query: 467 GHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKF 526
G IG+G G+VYK K G+ V VK + P Q F NEV L K RH NI+ F
Sbjct: 29 GQRIGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLF 85
Query: 527 YGFCSHALHSFVVYEYLEMGSL 548
G+ + +V ++ E SL
Sbjct: 86 MGYSTAP-QLAIVTQWCEGSSL 106
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 8e-14
Identities = 50/166 (30%), Positives = 76/166 (45%), Gaps = 17/166 (10%)
Query: 121 TNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEI-GNMNSLSILDLSSN 179
+ LDL + L+ +F LT L+ L L N L ++ + ++ L L L++N
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANN 93
Query: 180 KLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLT---LNNNELSGQLSP 236
+L S+PL + + L LYL N + +P G+ L +L LN N+L S
Sbjct: 94 QLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLP--SGVFDRLTKLKELRLNTNQLQ---SI 146
Query: 237 ELG---SLIQLEYLDLSANTFHKSIPE-SLSNLVKLHYLNLSNNQF 278
G L L+ L LS N +S+P + L KL + L NQF
Sbjct: 147 PAGAFDKLTNLQTLSLSTNQL-QSVPHGAFDRLGKLQTITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 49/139 (35%), Positives = 70/139 (50%), Gaps = 11/139 (7%)
Query: 95 NMKSLSDLQLSENILNGSIPL-ALGNLTNLVVLDLSTNKLSGSIPLS-FANLTSLSILYL 152
+ L+ L L N L ++ +LT L L L+ N+L+ S+PL F +LT L LYL
Sbjct: 57 GLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYL 114
Query: 153 YENSLCDSIPKEI-GNMNSLSILDLSSNKLNGSIPLSL-ANLTNSLKVLYLSSNHIVGEI 210
N L S+P + + L L L++N+L SIP LTN L+ L LS+N + +
Sbjct: 115 GGNQL-KSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTN-LQTLSLSTNQLQS-V 170
Query: 211 PLGH-GMLSSLIQLTLNNN 228
P G L L +TL N
Sbjct: 171 PHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 32/112 (28%), Positives = 51/112 (45%), Gaps = 6/112 (5%)
Query: 245 EYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKI-EKLIHLSELDLSHNIFR 303
E LDL + + L KL +LNL NQ Q + + + L L L L++N
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQL- 95
Query: 304 EEIPSQI-CSMQSLEKLNLSHNNLSGSIP-RCFEEMHWLSCIDISYNALQGL 353
+P + + L+KL L N L S+P F+ + L + ++ N LQ +
Sbjct: 96 ASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSI 146
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-13
Identities = 38/131 (29%), Positives = 65/131 (49%), Gaps = 9/131 (6%)
Query: 102 LQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPL-SFANLTSLSILYLYENSLCDS 160
++L +N + P A L +DLS N++S + +F L SL+ L LY N +
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKI-TE 94
Query: 161 IPKEI-GNMNSLSILDLSSNKLNGSIPL-SLANLTNSLKVLYLSSNHIVGEIPLGH-GML 217
+PK + + SL +L L++NK+N + + + +L N L +L L N + I G L
Sbjct: 95 LPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHN-LNLLSLYDNKL-QTIAKGTFSPL 151
Query: 218 SSLIQLTLNNN 228
++ + L N
Sbjct: 152 RAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 5e-12
Identities = 32/138 (23%), Positives = 60/138 (43%), Gaps = 7/138 (5%)
Query: 121 TNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEI-GNMNSLSILDLSSN 179
+ + L N + P +F+ L + L N + + + + SL+ L L N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGN 90
Query: 180 KLNGSIPLSL-ANLTNSLKVLYLSSNHIVGEIPLGH-GMLSSLIQLTLNNNELSGQLSPE 237
K+ +P SL L + L++L L++N I + + L +L L+L +N+L
Sbjct: 91 KIT-ELPKSLFEGLFS-LQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGT 147
Query: 238 LGSLIQLEYLDLSANTFH 255
L ++ + L+ N F
Sbjct: 148 FSPLRAIQTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-11
Identities = 30/112 (26%), Positives = 53/112 (47%), Gaps = 6/112 (5%)
Query: 245 EYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKI-EKLIHLSELDLSHNIFR 303
+ L NT P + S KL ++LSNNQ ++ + L L+ L L N
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGNKI- 92
Query: 304 EEIPSQI-CSMQSLEKLNLSHNNLSGSIPR-CFEEMHWLSCIDISYNALQGL 353
E+P + + SL+ L L+ N ++ + F+++H L+ + + N LQ +
Sbjct: 93 TELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTI 143
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 22/76 (28%), Positives = 39/76 (51%), Gaps = 4/76 (5%)
Query: 87 SSIPDEI-GNMKSLSDLQLSENILNGSIPL-ALGNLTNLVVLDLSTNKLSGSIPLSFANL 144
+ +P + + SL L L+ N +N + + A +L NL +L L NKL +F+ L
Sbjct: 93 TELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151
Query: 145 TSLSILYLYENSL-CD 159
++ ++L +N CD
Sbjct: 152 RAIQTMHLAQNPFICD 167
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-13
Identities = 34/148 (22%), Positives = 66/148 (44%), Gaps = 14/148 (9%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLAL-GNLTNLVVLDLSTNKLSGSIPLSFANLT 145
+ IP+ I + ++L+L+ N + L L ++ S NK++ +F +
Sbjct: 24 NKIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGAS 81
Query: 146 SLSILYLYENSLCDSIPKEI-GNMNSLSILDLSSNKLNGSIPL-SLANLTNSLKVLYLSS 203
++ + L N L +++ ++ + SL L L SN++ + S L++ +++L L
Sbjct: 82 GVNEILLTSNRL-ENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSS-VRLLSLYD 138
Query: 204 NHIVGEIPLGHGM---LSSLIQLTLNNN 228
N I + G L SL L L N
Sbjct: 139 NQIT-TVA--PGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 24/114 (21%), Positives = 48/114 (42%), Gaps = 8/114 (7%)
Query: 223 LTLNNNELSGQLSPE--LGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQ 280
L LNNNE + L L QL ++ S N + ++ + L++N+ +
Sbjct: 37 LRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRL-E 94
Query: 281 KIPNKI-EKLIHLSELDLSHNIFREEIPSQI-CSMQSLEKLNLSHNNLSGSIPR 332
+ +K+ + L L L L N + + + S+ L+L N ++ ++
Sbjct: 95 NVQHKMFKGLESLKTLMLRSNRI-TCVGNDSFIGLSSVRLLSLYDNQIT-TVAP 146
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 29/86 (33%), Positives = 38/86 (44%), Gaps = 9/86 (10%)
Query: 467 GHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKF 526
C+G G G V++ GE V VK F S DE + +E E+ +RH NI+ F
Sbjct: 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRET--ELYNTVMLRHENILGF 67
Query: 527 YGFCSHALHSFVVY----EYLEMGSL 548
+ HS Y EMGSL
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSL 93
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 28/126 (22%), Positives = 43/126 (34%), Gaps = 9/126 (7%)
Query: 425 RKNGSQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATNNFDDGHCIGNGGQGSVYKAK-L 483
++ Q+ P +LT K V E + +G G G V++ K
Sbjct: 21 SSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDK 80
Query: 484 PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYL 543
TG VK ++ + + E+ A + IV YG + E L
Sbjct: 81 QTGFQCAVK--------KVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132
Query: 544 EMGSLA 549
E GSL
Sbjct: 133 EGGSLG 138
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-12
Identities = 33/105 (31%), Positives = 52/105 (49%), Gaps = 6/105 (5%)
Query: 102 LQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSI 161
L L N +P L N +L ++DLS N++S SF+N+T L L L N L I
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL-RCI 93
Query: 162 PKEI-GNMNSLSILDLSSNKLNGSIPL-SLANLTNSLKVLYLSSN 204
P + SL +L L N ++ +P + +L+ +L L + +N
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLS-ALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 7e-09
Identities = 35/136 (25%), Positives = 59/136 (43%), Gaps = 30/136 (22%)
Query: 145 TSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSN 204
++ LYL N +PKE+ N L+++DLS+N+++ S +N+T L L LS N
Sbjct: 31 RDVTELYLDGNQF-TLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQ-LLTLILSYN 88
Query: 205 HIVGEIPLGH-GMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPE-SL 262
+ IP L SL L+L+ N++ +PE +
Sbjct: 89 RL-RCIPPRTFDGLKSLRLLSLHGNDI-------------------------SVVPEGAF 122
Query: 263 SNLVKLHYLNLSNNQF 278
++L L +L + N
Sbjct: 123 NDLSALSHLAIGANPL 138
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 8e-09
Identities = 30/95 (31%), Positives = 53/95 (55%), Gaps = 4/95 (4%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPL-SFANLT 145
+ +P E+ N K L+ + LS N ++ + N+T L+ L LS N+L IP +F L
Sbjct: 44 TLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLK 102
Query: 146 SLSILYLYENSLCDSIPKEI-GNMNSLSILDLSSN 179
SL +L L+ N + +P+ ++++LS L + +N
Sbjct: 103 SLRLLSLHGNDI-SVVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-08
Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 245 EYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKI-EKLIHLSELDLSHNIFR 303
L L N F +P+ LSN L ++LSNN+ + N+ + L L LS+N R
Sbjct: 34 TELYLDGNQF-TLVPKELSNYKHLTLIDLSNNRI-STLSNQSFSNMTQLLTLILSYNRLR 91
Query: 304 EEIPSQIC-SMQSLEKLNLSHNNLSGSIPR 332
IP + ++SL L+L N++S +P
Sbjct: 92 -CIPPRTFDGLKSLRLLSLHGNDIS-VVPE 119
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 5e-12
Identities = 24/88 (27%), Positives = 35/88 (39%), Gaps = 13/88 (14%)
Query: 467 GHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNE--VNALTKIRHRNIV 524
IG G G V+ K GE V VK F + + + E + +RH NI+
Sbjct: 42 VKQIGKGRYGEVWMGKW-RGEKVAVKVFFTT------EEASWFRETEIYQTVLMRHENIL 94
Query: 525 KFYGFCSHALHS----FVVYEYLEMGSL 548
F S +++ +Y E GSL
Sbjct: 95 GFIAADIKGTGSWTQLYLITDYHENGSL 122
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 7e-12
Identities = 22/85 (25%), Positives = 36/85 (42%), Gaps = 4/85 (4%)
Query: 466 DGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIV 524
D +G G G VY + L + +K+ P D Q E+ ++H+NIV
Sbjct: 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEI--PERDS-RYSQPLHEEIALHKHLKHKNIV 82
Query: 525 KFYGFCSHALHSFVVYEYLEMGSLA 549
++ G S + E + GSL+
Sbjct: 83 QYLGSFSENGFIKIFMEQVPGGSLS 107
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 31/97 (31%), Positives = 47/97 (48%), Gaps = 3/97 (3%)
Query: 459 RATNNFDDGHCIGNGGQGSVYKA-KLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTK 517
R T F + IG+G GSV+K K G I +K+ PL +Q L EV A
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAV 66
Query: 518 I-RHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLS 553
+ +H ++V+++ + H + EY GSLA +S
Sbjct: 67 LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAIS 103
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 27/86 (31%), Positives = 40/86 (46%), Gaps = 9/86 (10%)
Query: 467 GHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKF 526
IG G G V++ K GE V VK F S +E + +E E+ +RH NI+ F
Sbjct: 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFRE--AEIYQTVMLRHENILGF 101
Query: 527 YGFCSHALHS----FVVYEYLEMGSL 548
+ + ++V +Y E GSL
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSL 127
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-11
Identities = 39/184 (21%), Positives = 66/184 (35%), Gaps = 37/184 (20%)
Query: 163 KEIGNMNSLSILDLSSNKLNGS------IPLSLANLTNSLKVLYLSSNHIVGEIPLGHGM 216
+ S+ + +L+G + +L+ L K L LS+N+I
Sbjct: 12 RIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKA-CKHLALSTNNIE--------- 61
Query: 217 LSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNN 276
++S L + L L L N K I + L L +S N
Sbjct: 62 ------------KISS-----LSGMENLRILSLGRNLI-KKIENLDAVADTLEELWISYN 103
Query: 277 QFSQKIPNKIEKLIHLSELDLSHN-IFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFE 335
Q + + IEKL++L L +S+N I ++ ++ LE L L+ N L
Sbjct: 104 QIA-SLSG-IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNA 161
Query: 336 EMHW 339
+
Sbjct: 162 TSEY 165
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 6e-11
Identities = 44/176 (25%), Positives = 65/176 (36%), Gaps = 29/176 (16%)
Query: 92 EIGNMKSLSDLQLSENILNGS----IPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSL 147
E ++ + E + L L L LSTN + LS + +L
Sbjct: 15 EERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKISSLS--GMENL 72
Query: 148 SILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTN--SLKVLYLSSNH 205
IL L N + I ++L L +S N++ SL+ + +L+VLY+S+N
Sbjct: 73 RILSLGRNLIKK-IENLDAVADTLEELWISYNQIA-----SLSGIEKLVNLRVLYMSNNK 126
Query: 206 I--VGEI-PLGHGMLSSLIQLTLNNNELSGQLSPE----------LGSLIQLEYLD 248
I GEI L L L L L N L + L L+ LD
Sbjct: 127 ITNWGEIDKLAA--LDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-10
Identities = 41/182 (22%), Positives = 74/182 (40%), Gaps = 24/182 (13%)
Query: 141 FANLTSLSILYLYENSLCDSIPK------EIGNMNSLSILDLSSNKLNGSIPLSLANLTN 194
F S+ + L IP + + + L LS+N + I SL+ + N
Sbjct: 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNI-EKIS-SLSGMEN 71
Query: 195 SLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTF 254
L++L L N I +I + +L +L ++ N+++ LS + L+ L L +S N
Sbjct: 72 -LRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKI 127
Query: 255 HK-SIPESLSNLVKLHYLNLSNNQFSQKIPNK----------IEKLIHLSELDLSHNIFR 303
+ L+ L KL L L+ N +++L +L +LD +
Sbjct: 128 TNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD-GMPVDV 186
Query: 304 EE 305
+E
Sbjct: 187 DE 188
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 7e-10
Identities = 27/136 (19%), Positives = 58/136 (42%), Gaps = 8/136 (5%)
Query: 220 LIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHK--SIPESLSNLVKLHYLNLSNNQ 277
+ + T + + + + E ++L + +LS L +L LS N
Sbjct: 1 MAKATTIKDAIRIFEERKSVVATEAEKVELH-GMIPPIEKMDATLSTLKACKHLALSTNN 59
Query: 278 FSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEM 337
KI + + + +L L L N+ + +I + +LE+L +S+N ++ S+ E++
Sbjct: 60 IE-KISS-LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKL 114
Query: 338 HWLSCIDISYNALQGL 353
L + +S N +
Sbjct: 115 VNLRVLYMSNNKITNW 130
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 28/90 (31%), Positives = 47/90 (52%), Gaps = 6/90 (6%)
Query: 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR 519
FD +G G GSVYKA TG+IV +K+ P+ ++ QE + E++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDL---QEIIKEISIMQQCD 82
Query: 520 HRNIVKFYGFCSHALHSFVVYEYLEMGSLA 549
++VK+YG ++V EY GS++
Sbjct: 83 SPHVVKYYGSYFKNTDLWIVMEYCGAGSVS 112
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 22/87 (25%), Positives = 41/87 (47%), Gaps = 4/87 (4%)
Query: 464 FDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRN 522
++ +G+G G VYKAK TG + K + +E+ ++++ E+ L H
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYIVEIEILATCDHPY 77
Query: 523 IVKFYGFCSHALHSFVVYEYLEMGSLA 549
IVK G H +++ E+ G++
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVD 104
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 29/89 (32%), Positives = 40/89 (44%), Gaps = 10/89 (11%)
Query: 467 GHCIGNGGQGSVYKAKLP-----TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHR 521
+G G GSV + TGE+V VKK ++F E+ L ++H
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEILKSLQHD 71
Query: 522 NIVKFYGFCSHALHS--FVVYEYLEMGSL 548
NIVK+ G C A ++ EYL GSL
Sbjct: 72 NIVKYKGVCYSAGRRNLKLIMEYLPYGSL 100
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 4e-11
Identities = 20/82 (24%), Positives = 37/82 (45%), Gaps = 4/82 (4%)
Query: 467 GHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKF 526
IG+G G V+ + V +K + + +++F+ E + K+ H +V+
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKT----IREGAMSEEDFIEEAEVMMKLSHPKLVQL 68
Query: 527 YGFCSHALHSFVVYEYLEMGSL 548
YG C +V E++E G L
Sbjct: 69 YGVCLEQAPICLVTEFMEHGCL 90
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 29/89 (32%), Positives = 40/89 (44%), Gaps = 10/89 (11%)
Query: 467 GHCIGNGGQGSVYKAKLP-----TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHR 521
+G G GSV + TGE+V VKK ++F E+ L ++H
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEILKSLQHD 102
Query: 522 NIVKFYGFCSHALHS--FVVYEYLEMGSL 548
NIVK+ G C A ++ EYL GSL
Sbjct: 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSL 131
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 6e-11
Identities = 22/93 (23%), Positives = 37/93 (39%), Gaps = 6/93 (6%)
Query: 461 TNNFDDGHCIGNGGQ--GSVYKAK-LPTGEIVDVKKFH-SPLPDEMACQQEFLNEVNALT 516
++ IG G + +V A+ PTGE V V++ + +EM E++
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMV--TFLQGELHVSK 81
Query: 517 KIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLA 549
H NIV + +VV ++ GS
Sbjct: 82 LFNHPNIVPYRATFIADNELWVVTSFMAYGSAK 114
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 8e-11
Identities = 23/104 (22%), Positives = 45/104 (43%), Gaps = 15/104 (14%)
Query: 459 RATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTK 517
R +F+ C+G GG G V++AK +K+ LP+ +++ + EV AL K
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKR--IRLPNRELAREKVMREVKALAK 59
Query: 518 IRHRNIVKFYGFC------------SHALHSFVVYEYLEMGSLA 549
+ H IV+++ S ++ ++ + +L
Sbjct: 60 LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLK 103
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 8e-11
Identities = 25/83 (30%), Positives = 38/83 (45%), Gaps = 3/83 (3%)
Query: 467 GHCIGNGGQGSVYKAKLPTGEI-VDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVK 525
G IG G G V+ +L V VK LP ++ + +FL E L + H NIV+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDL--KAKFLQEARILKQYSHPNIVR 176
Query: 526 FYGFCSHALHSFVVYEYLEMGSL 548
G C+ ++V E ++ G
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDF 199
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 9e-11
Identities = 21/82 (25%), Positives = 34/82 (41%), Gaps = 4/82 (4%)
Query: 467 GHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKF 526
+G G G V K V +K M+ + EF+ E + + H +V+
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMS-EDEFIEEAKVMMNLSHEKLVQL 84
Query: 527 YGFCSHALHSFVVYEYLEMGSL 548
YG C+ F++ EY+ G L
Sbjct: 85 YGVCTKQRPIFIITEYMANGCL 106
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 21/87 (24%), Positives = 36/87 (41%), Gaps = 3/87 (3%)
Query: 464 FDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRN 522
F IG G G V+K T ++V +K L + ++ E+ L++
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 523 IVKFYGFCSHALHSFVVYEYLEMGSLA 549
+ K+YG +++ EYL GS
Sbjct: 82 VTKYYGSYLKDTKLWIIMEYLGGGSAL 108
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 45/145 (31%), Positives = 67/145 (46%), Gaps = 10/145 (6%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLS-FANLT 145
+S+P I + L L +N + P +L NL L L +N+L ++P+ F +LT
Sbjct: 32 ASVPAGIPT--NAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLT 88
Query: 146 SLSILYLYENSLCDSIPKEI-GNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSN 204
L++L L N L +P + + L L + NKL +P + LT+ L L L N
Sbjct: 89 QLTVLDLGTNQL-TVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTH-LTHLALDQN 145
Query: 205 HIVGEIPLGH-GMLSSLIQLTLNNN 228
+ IP G LSSL L N
Sbjct: 146 QL-KSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 44/152 (28%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 178 SNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPE 237
+K + S+P A + + ++LYL N I P L +L +L L +N+L +
Sbjct: 27 RSKRHASVP---AGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG---ALP 80
Query: 238 LG---SLIQLEYLDLSANTFHKSIPESL-SNLVKLHYLNLSNNQFSQKIPNKIEKLIHLS 293
+G SL QL LDL N +P ++ LV L L + N+ ++P IE+L HL+
Sbjct: 81 VGVFDSLTQLTVLDLGTNQL-TVLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLT 138
Query: 294 ELDLSHNIFREEIPSQICSMQSLEKLNLSHNN 325
L L N + + SL L N
Sbjct: 139 HLALDQNQLKSIPHGAFDRLSSLTHAYL-FGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 39/137 (28%), Positives = 64/137 (46%), Gaps = 12/137 (8%)
Query: 121 TNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEI-GNMNSLSILDLSSN 179
TN +L L N+++ P F +L +L LYL N L ++P + ++ L++LDL +N
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTN 98
Query: 180 KLNGSIPL----SLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLS 235
+L +P L +L L++ N + E+P G L+ L L L+ N+L
Sbjct: 99 QLT-VLPSAVFDRLVHLKE----LFMCCNKL-TELPRGIERLTHLTHLALDQNQLKSIPH 152
Query: 236 PELGSLIQLEYLDLSAN 252
L L + L N
Sbjct: 153 GAFDRLSSLTHAYLFGN 169
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 64/230 (27%), Positives = 97/230 (42%), Gaps = 49/230 (21%)
Query: 59 ELHEKLLT-FEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLAL 117
L +K +T + + + S+ I + ++ L L N L+ I AL
Sbjct: 25 NLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQG-IQYLPNVRYLALGGNKLH-DIS-AL 81
Query: 118 GNLTNLVVLDLSTNKLSGSIPLS-FANLTSLSILYLYENSLCDSIPKEIGN-MNSLSILD 175
LTNL L L+ N+L S+P F LT+L L L EN L S+P + + + +L+ L+
Sbjct: 82 KELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQL-QSLPDGVFDKLTNLTYLN 139
Query: 176 LSSNKLNGSIPL----SLANLTNSLKVLYLSSNHIVGEIPLGHGM---LSSLIQLTLNNN 228
L+ N+L S+P L NLT L LS N + +P G+ L+ L L L N
Sbjct: 140 LAHNQLQ-SLPKGVFDKLTNLTE----LDLSYNQL-QSLP--EGVFDKLTQLKDLRLYQN 191
Query: 229 ELSGQLSPELGSLIQLEYLDLSANTFHKSIPE-SLSNLVKLHYLNLSNNQ 277
+L KS+P+ L L Y+ L +N
Sbjct: 192 QL-------------------------KSVPDGVFDRLTSLQYIWLHDNP 216
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 8e-08
Identities = 49/181 (27%), Positives = 82/181 (45%), Gaps = 14/181 (7%)
Query: 175 DLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQL 234
+S+ P + L + + + L+S+ Q+ NN+++ +
Sbjct: 4 TVSTPIKQ-IFP---DDAFAETIKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDI--KS 55
Query: 235 SPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKI-EKLIHLS 293
+ L + YL L N I +L L L YL L+ NQ Q +PN + +KL +L
Sbjct: 56 VQGIQYLPNVRYLALGGNKL-HDIS-ALKELTNLTYLILTGNQL-QSLPNGVFDKLTNLK 112
Query: 294 ELDLSHNIFREEIPSQIC-SMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQG 352
EL L N + +P + + +L LNL+HN L F+++ L+ +D+SYN LQ
Sbjct: 113 ELVLVENQL-QSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS 171
Query: 353 L 353
L
Sbjct: 172 L 172
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 1e-10
Identities = 26/82 (31%), Positives = 36/82 (43%), Gaps = 4/82 (4%)
Query: 467 GHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKF 526
+G+G G V K V VK M+ + EF E + K+ H +VKF
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIK---EGSMS-EDEFFQEAQTMMKLSHPKLVKF 68
Query: 527 YGFCSHALHSFVVYEYLEMGSL 548
YG CS ++V EY+ G L
Sbjct: 69 YGVCSKEYPIYIVTEYISNGCL 90
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 24/83 (28%), Positives = 40/83 (48%), Gaps = 5/83 (6%)
Query: 467 GHCIGNGGQGSVYKAKLPTGEI-VDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVK 525
H +G G G VY+ + V VK D M +EFL E + +I+H N+V+
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTME-VEEFLKEAAVMKEIKHPNLVQ 280
Query: 526 FYGFCSHALHSFVVYEYLEMGSL 548
G C+ +++ E++ G+L
Sbjct: 281 LLGVCTREPPFYIITEFMTYGNL 303
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 25/91 (27%), Positives = 41/91 (45%), Gaps = 5/91 (5%)
Query: 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMA--CQQEFLNEVNALTKI 518
NF IG G VY+A L G V +KK + D M + + + E++ L ++
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV--QIFDLMDAKARADCIKEIDLLKQL 89
Query: 519 RHRNIVKFYGFCSHALHSFVVYEYLEMGSLA 549
H N++K+Y +V E + G L+
Sbjct: 90 NHPNVIKYYASFIEDNELNIVLELADAGDLS 120
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 44/234 (18%), Positives = 87/234 (37%), Gaps = 26/234 (11%)
Query: 117 LGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDL 176
+ NL L KL L L+ + E+ ++SL L+L
Sbjct: 22 IKNLDALENAQAIKKKLGKLGRQVLPPSELLDHLFFHYEFQNQRFSAEV--LSSLRQLNL 79
Query: 177 SSNKL--NGSIPLS--LANLTNSLKVLYLSSNHI--VGEIPLGHGMLSSLIQLTLNNNEL 230
+ ++ ++ L + ++L + L+S + G L + +L L N L
Sbjct: 80 AGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLP-VFLRARKLGLQLNSL 138
Query: 231 SGQLSPELGSLIQ-----LEYLDLSANTFH----KSIPESLSNLVKLHYLNLSNNQFS-- 279
+ +L L+ + L LS N + E L+ + +L+L +
Sbjct: 139 GPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDE 198
Query: 280 --QKIPNKIEKLIHLSELDLSHNIFREEIPSQICSM----QSLEKLNLSHNNLS 327
+ + ++++ L EL++++N + + SLE L+L N LS
Sbjct: 199 GLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELS 252
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 38/243 (15%), Positives = 82/243 (33%), Gaps = 33/243 (13%)
Query: 115 LALGNLTNLVVLDLSTNKLS--GSIPLSFA---NLTSLSILYLYENSLCDSIPKEIGNMN 169
+ L++L L+L+ +++ ++ +L + L L + + + +
Sbjct: 66 FSAEVLSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVF 125
Query: 170 -SLSILDLSSNKL--NGSIPLS--LANLTNSLKVLYLSSNHI--VGEIPLGHGMLS--SL 220
L L N L L L + + L LS+N + G L G+ S+
Sbjct: 126 LRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSV 185
Query: 221 IQLTLNNNELSGQ----LSPELGSLIQLEYLDLSANTFH----KSIPESLSNLVKLHYLN 272
L+L + L + L+ +L QL+ L+++ N ++ + L L+
Sbjct: 186 THLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLH 245
Query: 273 LSNNQFSQ-------KIPNKIEKLIHLSELDLSHNIFREEIPSQICSM----QSLEKLNL 321
L N+ S + E + E + + S ++ +
Sbjct: 246 LYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQRNLNSWDRARV 305
Query: 322 SHN 324
+
Sbjct: 306 QRH 308
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 44/281 (15%), Positives = 80/281 (28%), Gaps = 50/281 (17%)
Query: 96 MKSLSDLQLSENIL--NGSIPLA---LGNLTNLVVLDLSTNKLS--GSIPLSFANLTSLS 148
+ SL L L+ + +A L ++L++ +L G L
Sbjct: 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPV-FLRAR 129
Query: 149 ILYLYENSLCDSIPKEIG-----NMNSLSILDLSSNKLN--GSIPLSLANLTN-SLKVLY 200
L L NSL K++ + ++ L LS+N L G L N S+ L
Sbjct: 130 KLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLS 189
Query: 201 LSSNHI--VGEIPLGHGML--SSLIQLTLNNNELSGQ----LSPELGSLIQLEYLDLSAN 252
L + G L + L +L + N L+ LE L L N
Sbjct: 190 LLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFN 249
Query: 253 TFHKS-------IPESLSNLVKLHYLNLSNNQFSQK---------------IPNKIEKLI 290
+ + ++ S+ ++++ +
Sbjct: 250 ELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQRNLNSWDRARVQRHL 309
Query: 291 HLSELDLSHNIFREEIPSQICSM----QSLEKLNLSHNNLS 327
L DL + P + + + L +
Sbjct: 310 ELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSG 350
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 30/188 (15%), Positives = 62/188 (32%), Gaps = 18/188 (9%)
Query: 155 NSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGH 214
++ + I N+++L KL L + L L+
Sbjct: 12 RAVLAQLGCPIKNLDALENAQAIKKKLGKLGRQVLPP-SELLDHLFFHYE--FQNQRFSA 68
Query: 215 GMLSSLIQLTLNNNELSGQLSPELGSLIQ-----LEYLDLSANTF-HKSIPESLSNLVKL 268
+LSSL QL L ++ + +++ L+ ++L++ + L ++
Sbjct: 69 EVLSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRA 128
Query: 269 HYLNLSNNQFSQKIPNKI-----EKLIHLSELDLSHNIFREEIPSQICSM----QSLEKL 319
L L N + + ++ L LS+N + + S+ L
Sbjct: 129 RKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHL 188
Query: 320 NLSHNNLS 327
+L H L
Sbjct: 189 SLLHTGLG 196
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 24/89 (26%), Positives = 35/89 (39%), Gaps = 9/89 (10%)
Query: 467 GHCIGNGGQGSVYKAKLP-----TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHR 521
+G G G V + TGE V VK + E+ L + H
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILRNLYHE 83
Query: 522 NIVKFYGFCSHALHS--FVVYEYLEMGSL 548
NIVK+ G C+ + ++ E+L GSL
Sbjct: 84 NIVKYKGICTEDGGNGIKLIMEFLPSGSL 112
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-10
Identities = 26/128 (20%), Positives = 55/128 (42%), Gaps = 6/128 (4%)
Query: 198 VLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKS 257
++ L++ I E + +L L ++ + +L Q + +D S N +
Sbjct: 1 MVKLTAELI--EQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI-RK 56
Query: 258 IPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHN-IFREEIPSQICSMQSL 316
+ + L +L L ++NN+ + + L L+EL L++N + + S++SL
Sbjct: 57 L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSL 115
Query: 317 EKLNLSHN 324
L + N
Sbjct: 116 TYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 5e-09
Identities = 18/105 (17%), Positives = 42/105 (40%), Gaps = 5/105 (4%)
Query: 223 LTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKI 282
+ L + + + + + ++ LDL I + L + ++ S+N+ K+
Sbjct: 2 VKLTAELI--EQAAQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KL 57
Query: 283 PNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLS 327
L L L +++N ++ L +L L++N+L
Sbjct: 58 DG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 6e-09
Identities = 21/109 (19%), Positives = 44/109 (40%), Gaps = 9/109 (8%)
Query: 247 LDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEI 306
+ L+A ++ +N V+ L+L + I N L +D S N EI
Sbjct: 2 VKLTAELIEQA--AQYTNAVRDRELDLRGYK-IPVIENLGATLDQFDAIDFSDN----EI 54
Query: 307 PS--QICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGL 353
++ L+ L +++N + + + L+ + ++ N+L L
Sbjct: 55 RKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVEL 103
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 9e-08
Identities = 30/163 (18%), Positives = 62/163 (38%), Gaps = 24/163 (14%)
Query: 102 LQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSI 161
++L+ ++ + N LDL K+ I A L + +N +
Sbjct: 2 VKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI---- 54
Query: 162 PKEIGN---MNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHI--VGEI-PLGHG 215
+++ + L L +++N++ I L L L L++N + +G++ PL
Sbjct: 55 -RKLDGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELILTNNSLVELGDLDPLAS- 111
Query: 216 MLSSLIQLTLNNNELSGQLSPE-----LGSLIQLEYLDLSANT 253
L SL L + N ++ + + + Q+ LD
Sbjct: 112 -LKSLTYLCILRNPVTNK--KHYRLYVIYKVPQVRVLDFQKVK 151
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-07
Identities = 31/132 (23%), Positives = 48/132 (36%), Gaps = 13/132 (9%)
Query: 125 VLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGS 184
++ L+ + + + N L L + I ++ +D S N++
Sbjct: 1 MVKLTAELIEQA--AQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR-- 55
Query: 185 IPLSLANLTN--SLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELS--GQLSPELGS 240
L LK L +++N I L L +L L NN L G L P L S
Sbjct: 56 ---KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDP-LAS 111
Query: 241 LIQLEYLDLSAN 252
L L YL + N
Sbjct: 112 LKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 8e-07
Identities = 25/111 (22%), Positives = 40/111 (36%), Gaps = 5/111 (4%)
Query: 95 NMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYE 154
N +L L + I L +D S N++ + F L L L +
Sbjct: 17 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNN 73
Query: 155 NSLCDSIPKEIGNMNSLSILDLSSNKLNG-SIPLSLANLTNSLKVLYLSSN 204
N +C + L+ L L++N L LA+L + L L + N
Sbjct: 74 NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKS-LTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 6e-04
Identities = 15/68 (22%), Positives = 27/68 (39%), Gaps = 1/68 (1%)
Query: 93 IGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSG-SIPLSFANLTSLSILY 151
++ L L ++ N + L +L L L+ N L A+L SL+ L
Sbjct: 60 FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLC 119
Query: 152 LYENSLCD 159
+ N + +
Sbjct: 120 ILRNPVTN 127
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 26/130 (20%), Positives = 48/130 (36%), Gaps = 9/130 (6%)
Query: 424 QRKNGSQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATN---NFDDGHCIGNGGQGSVYK 480
+G + G+++ F + ++ + D IG G G V
Sbjct: 6 HHSSGVDLGTENLYFQSGVVTHEQFKAAL--RMVVDQGDPRLLLDSYVKIGEGSTGIVCL 63
Query: 481 AK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539
A+ +G V VK ++ NEV + +H N+V+ Y +V+
Sbjct: 64 AREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVL 120
Query: 540 YEYLEMGSLA 549
E+L+ G+L
Sbjct: 121 MEFLQGGALT 130
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 26/89 (29%), Positives = 37/89 (41%), Gaps = 10/89 (11%)
Query: 467 GHCIGNGGQGSVYKAKLP-----TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHR 521
+G G GSV + TG +V VK+ PD+ Q++F E+ L +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ---QRDFQREIQILKALHSD 84
Query: 522 NIVKFYGFCSHALHS--FVVYEYLEMGSL 548
IVK+ G +V EYL G L
Sbjct: 85 FIVKYRGVSYGPGRQSLRLVMEYLPSGCL 113
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 3e-10
Identities = 24/83 (28%), Positives = 40/83 (48%), Gaps = 5/83 (6%)
Query: 467 GHCIGNGGQGSVYKAKLPTGEI-VDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVK 525
H +G G G VY+ + V VK D M +EFL E + +I+H N+V+
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTME-VEEFLKEAAVMKEIKHPNLVQ 73
Query: 526 FYGFCSHALHSFVVYEYLEMGSL 548
G C+ +++ E++ G+L
Sbjct: 74 LLGVCTREPPFYIITEFMTYGNL 96
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 23/87 (26%), Positives = 42/87 (48%), Gaps = 4/87 (4%)
Query: 464 FDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRN 522
+ IG G G+VY A + TG+ V +++ + + ++ +NE+ + + ++ N
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPN 78
Query: 523 IVKFYGFCSHALHSFVVYEYLEMGSLA 549
IV + +VV EYL GSL
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLT 105
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 24/91 (26%), Positives = 40/91 (43%), Gaps = 7/91 (7%)
Query: 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH 520
++++ IG+G V A P E V +K+ L E L E+ A+++ H
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI--NLEKCQTSMDELLKEIQAMSQCHH 72
Query: 521 RNIVKFYG--FCSHALHSFVVYEYLEMGSLA 549
NIV +Y L ++V + L GS+
Sbjct: 73 PNIVSYYTSFVVKDEL--WLVMKLLSGGSVL 101
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 60.5 bits (146), Expect = 4e-10
Identities = 24/107 (22%), Positives = 37/107 (34%), Gaps = 7/107 (6%)
Query: 236 PELGSLIQLEYLDLSANTFHKSIP-ESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSE 294
L L L + + + L L +L L + + P+ LS
Sbjct: 25 HHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR 84
Query: 295 LDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLS 341
L+LS N + + SL++L LS N L C + WL
Sbjct: 85 LNLSFNALE-SLSWKTVQGLSLQELVLSGNPL-----HCSCALRWLQ 125
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 60.1 bits (145), Expect = 6e-10
Identities = 22/98 (22%), Positives = 34/98 (34%), Gaps = 2/98 (2%)
Query: 255 HKSIPESLSNLVKLHYLNLSNNQFSQKIPNK-IEKLIHLSELDLSHNIFREEIPSQICSM 313
L L L + N Q Q + + + L L L + + R P
Sbjct: 20 ALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFT 79
Query: 314 QSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQ 351
L +LNLS N L + + + L + +S N L
Sbjct: 80 PRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 60.1 bits (145), Expect = 6e-10
Identities = 24/96 (25%), Positives = 39/96 (40%), Gaps = 2/96 (2%)
Query: 88 SIPDEIGNMKSLSDLQLSENILNGSIPL-ALGNLTNLVVLDLSTNKLSGSIPLSFANLTS 146
+ ++L++L + + L L L L L + + L P +F
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 147 LSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLN 182
LS L L N+L +S+ + SL L LS N L+
Sbjct: 82 LSRLNLSFNAL-ESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 59.8 bits (144), Expect = 7e-10
Identities = 29/166 (17%), Positives = 49/166 (29%), Gaps = 32/166 (19%)
Query: 178 SNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGH-GMLSSLIQLTLNNNELSGQLSP 236
+ L N L LY+ + + + L L L LT+ + L
Sbjct: 16 TRDGALDSLHHLPGAEN-LTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR----- 69
Query: 237 ELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELD 296
++ + FH +L LNLS N + K + + L EL
Sbjct: 70 -----------FVAPDAFH--------FTPRLSRLNLSFNALE-SLSWKTVQGLSLQELV 109
Query: 297 LSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSC 342
LS N C+++ L++ L+
Sbjct: 110 LSGNPLHCS-----CALRWLQRWEEEGLGGVPEQKLQCHGQGPLAH 150
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.4 bits (138), Expect = 4e-09
Identities = 19/102 (18%), Positives = 34/102 (33%), Gaps = 3/102 (2%)
Query: 130 TNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKE-IGNMNSLSILDLSSNKLNGSIPLS 188
T + +L+ LY+ + + + L L + + L +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD 74
Query: 189 LANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNEL 230
+ T L L LS N + + SL +L L+ N L
Sbjct: 75 AFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.5 bits (133), Expect = 2e-08
Identities = 20/95 (21%), Positives = 39/95 (41%), Gaps = 1/95 (1%)
Query: 282 IPNKIEKLIHLSELDLSHNIFREEIPSQ-ICSMQSLEKLNLSHNNLSGSIPRCFEEMHWL 340
+ + +L+EL + + + + + + + L L + + L P F L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 341 SCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLC 375
S +++S+NAL+ L + L L GN C
Sbjct: 83 SRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 7e-10
Identities = 21/82 (25%), Positives = 36/82 (43%), Gaps = 5/82 (6%)
Query: 467 GHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKF 526
+G G G V+ A V VK P M+ + FL E N + ++H +VK
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMK---PGSMS-VEAFLAEANVMKTLQHDKLVKL 248
Query: 527 YGFCSHALHSFVVYEYLEMGSL 548
+ + +++ E++ GSL
Sbjct: 249 HAVVTKE-PIYIITEFMAKGSL 269
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 8e-10
Identities = 23/89 (25%), Positives = 33/89 (37%), Gaps = 8/89 (8%)
Query: 467 GHCIGNGGQGSVYKAK-LPTGEIVDVKKFH-SPLPDEMACQQEFLNEVNALTKIRHRNIV 524
IG G +VYK T V + L +Q F E L ++H NIV
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS--ERQRFKEEAEMLKGLQHPNIV 88
Query: 525 KFYGFCSHALHS----FVVYEYLEMGSLA 549
+FY + +V E + G+L
Sbjct: 89 RFYDSWESTVKGKKCIVLVTELMTSGTLK 117
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 9e-10
Identities = 27/83 (32%), Positives = 36/83 (43%), Gaps = 7/83 (8%)
Query: 467 GHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKF 526
IG G G V G V VK D A Q FL E + +T++RH N+V+
Sbjct: 26 LQTIGKGEFGDVMLGDY-RGNKVAVKCIK---NDATA--QAFLAEASVMTQLRHSNLVQL 79
Query: 527 YGFCSHALHS-FVVYEYLEMGSL 548
G ++V EY+ GSL
Sbjct: 80 LGVIVEEKGGLYIVTEYMAKGSL 102
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 21/82 (25%), Positives = 36/82 (43%), Gaps = 5/82 (6%)
Query: 467 GHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKF 526
+G G G V+ V VK M+ FL E N + +++H+ +V+
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMS-PDAFLAEANLMKQLQHQRLVRL 73
Query: 527 YGFCSHALHSFVVYEYLEMGSL 548
Y + +++ EY+E GSL
Sbjct: 74 YAVVTQE-PIYIITEYMENGSL 94
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-09
Identities = 30/115 (26%), Positives = 54/115 (46%), Gaps = 4/115 (3%)
Query: 212 LGHGMLSSLIQLTLNNNELSGQLSPELG-SLIQLEYLDLSANTFHKSIPESLSNLVKLHY 270
L + S + +L L+N+ + L +LE+L SI +L L KL
Sbjct: 11 LRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-TSI-ANLPKLNKLKK 68
Query: 271 LNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFRE-EIPSQICSMQSLEKLNLSHN 324
L LS+N+ S + EK +L+ L+LS N ++ + +++L+ L+L +
Sbjct: 69 LELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 6e-08
Identities = 27/114 (23%), Positives = 42/114 (36%), Gaps = 5/114 (4%)
Query: 95 NMKSLSDLQLSEN-ILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLY 153
+ +L L + G + L L L+ SI + L L L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELS 72
Query: 154 ENSLCDSIPKEIGNMNSLSILDLSSNKLNG-SIPLSLANLTNSLKVLYLSSNHI 206
+N + + +L+ L+LS NK+ S L L N LK L L + +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLEN-LKSLDLFNCEV 125
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-07
Identities = 24/101 (23%), Positives = 40/101 (39%), Gaps = 7/101 (6%)
Query: 227 NNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKI 286
+ EL + ++ L LD S + + +L +L+ N + I N +
Sbjct: 8 HLELRNRTPSDVKEL----VLDNSRSN-EGKLEGLTDEFEELEFLSTINVGLT-SIAN-L 60
Query: 287 EKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLS 327
KL L +L+LS N + +L LNLS N +
Sbjct: 61 PKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-07
Identities = 33/136 (24%), Positives = 56/136 (41%), Gaps = 10/136 (7%)
Query: 167 NMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHI--VGEIPLGHGMLSSLIQLT 224
+ + L L +++ N L + L+ L + + + +P L+ L +L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKLKKLE 70
Query: 225 LNNNELSGQLSPELGSLIQLEYLDLSANTFHK-SIPESLSNLVKLHYLNLSNNQFSQKI- 282
L++N +SG L L +L+LS N S E L L L L+L N + +
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLND 130
Query: 283 --PNKIEKLIHLSELD 296
N + L L+ LD
Sbjct: 131 YRENVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 5e-07
Identities = 21/94 (22%), Positives = 43/94 (45%), Gaps = 4/94 (4%)
Query: 260 ESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKL 319
+ S++ +L N +N K+ ++ L L + I + + + L+KL
Sbjct: 14 RTPSDVKELVLDNSRSN--EGKLEGLTDEFEELEFLSTINVGL-TSI-ANLPKLNKLKKL 69
Query: 320 NLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGL 353
LS N +SG + E+ L+ +++S N ++ L
Sbjct: 70 ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDL 103
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 5e-07
Identities = 27/117 (23%), Positives = 44/117 (37%), Gaps = 12/117 (10%)
Query: 140 SFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTN--SLK 197
+ +++ L + N + L L + L S+ANL LK
Sbjct: 15 TPSDVKELVLDNSRSNEG--KLEGLTDEFEELEFLSTINVGLT-----SIANLPKLNKLK 67
Query: 198 VLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELS--GQLSPELGSLIQLEYLDLSAN 252
L LS N + G + + +L L L+ N++ + P L L L+ LDL
Sbjct: 68 KLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEP-LKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 5e-05
Identities = 24/93 (25%), Positives = 39/93 (41%), Gaps = 3/93 (3%)
Query: 88 SIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSL 147
+ + L L L SI L L L L+LS N++SG + + +L
Sbjct: 33 KLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPNL 90
Query: 148 SILYLYENSLCD-SIPKEIGNMNSLSILDLSSN 179
+ L L N + D S + + + +L LDL +
Sbjct: 91 THLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 26/83 (31%), Positives = 34/83 (40%), Gaps = 7/83 (8%)
Query: 467 GHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKF 526
IG G G V G V VK D Q FL E + +T++RH N+V+
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIK---NDAT--AQAFLAEASVMTQLRHSNLVQL 251
Query: 527 YGFCSHALHSF-VVYEYLEMGSL 548
G +V EY+ GSL
Sbjct: 252 LGVIVEEKGGLYIVTEYMAKGSL 274
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 27/87 (31%), Positives = 43/87 (49%), Gaps = 2/87 (2%)
Query: 464 FDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRN 522
F D IG+G G+VY A+ + E+V +KK Q+ + EV L K+RH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 523 IVKFYGFCSHALHSFVVYEYLEMGSLA 549
+++ G +++V EY GS +
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSAS 141
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 21/90 (23%), Positives = 36/90 (40%), Gaps = 4/90 (4%)
Query: 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFH-SPLPDEMACQQEFLNEVNALTKIR 519
+ IG G G K G +K+ + S + + ++E EV L ++
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK--EREESRREVAVLANMK 81
Query: 520 HRNIVKFYGFCSHALHSFVVYEYLEMGSLA 549
H NIV++ ++V +Y E G L
Sbjct: 82 HPNIVQYRESFEENGSLYIVMDYCEGGDLF 111
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 24/89 (26%), Positives = 40/89 (44%), Gaps = 9/89 (10%)
Query: 467 GHCIGNGGQGSVYKAKL-----PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHR 521
+G G G V TGE+V VK + + + + E++ L + H
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQH--RSGWKQEIDILRTLYHE 93
Query: 522 NIVKFYGFCSHALHS--FVVYEYLEMGSL 548
+I+K+ G C A + +V EY+ +GSL
Sbjct: 94 HIIKYKGCCEDAGAASLQLVMEYVPLGSL 122
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 23/82 (28%), Positives = 35/82 (42%), Gaps = 5/82 (6%)
Query: 467 GHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKF 526
+G G G V+ V +K P M+ + FL E + K+RH +V+
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS-PEAFLQEAQVMKKLRHEKLVQL 327
Query: 527 YGFCSHALHSFVVYEYLEMGSL 548
Y S ++V EY+ GSL
Sbjct: 328 YAVVSEE-PIYIVTEYMSKGSL 348
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-09
Identities = 29/115 (25%), Positives = 54/115 (46%), Gaps = 4/115 (3%)
Query: 212 LGHGMLSSLIQLTLNNNELSGQLSPELGS-LIQLEYLDLSANTFHKSIPESLSNLVKLHY 270
L + +++ +L L+N + + L + + LE+L L S+ +L L KL
Sbjct: 18 LRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL-ISV-SNLPKLPKLKK 75
Query: 271 LNLSNNQFSQKIPNKIEKLIHLSELDLSHN-IFREEIPSQICSMQSLEKLNLSHN 324
L LS N+ + EKL +L+ L+LS N + + ++ L+ L+L +
Sbjct: 76 LELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-07
Identities = 31/112 (27%), Positives = 44/112 (39%), Gaps = 5/112 (4%)
Query: 98 SLSDLQLSENILN-GSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENS 156
++ +L L N G I NL L L L S+ + L L L L EN
Sbjct: 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKKLELSENR 82
Query: 157 LCDSIPKEIGNMNSLSILDLSSNKLNGSIPLS-LANLTNSLKVLYLSSNHIV 207
+ + + +L+ L+LS NKL L L L LK L L + +
Sbjct: 83 IFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLEC-LKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-07
Identities = 27/101 (26%), Positives = 42/101 (41%), Gaps = 7/101 (6%)
Query: 227 NNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKI 286
+ EL + + L+ LD + K I + V L +L+L N + N +
Sbjct: 15 HLELRNRTPAAVRELV----LDNCKSNDGK-IEGLTAEFVNLEFLSLINVGLI-SVSN-L 67
Query: 287 EKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLS 327
KL L +L+LS N + + +L LNLS N L
Sbjct: 68 PKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-06
Identities = 33/118 (27%), Positives = 46/118 (38%), Gaps = 12/118 (10%)
Query: 139 LSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTN--SL 196
+ A + L + N I +L L L + L S++NL L
Sbjct: 21 RTPAAVRELVLDNCKSNDG--KIEGLTAEFVNLEFLSLINVGLI-----SVSNLPKLPKL 73
Query: 197 KVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELS--GQLSPELGSLIQLEYLDLSAN 252
K L LS N I G + + L +L L L+ N+L L P L L L+ LDL
Sbjct: 74 KKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP-LKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-06
Identities = 21/91 (23%), Positives = 42/91 (46%), Gaps = 3/91 (3%)
Query: 264 NLVKLHYLNLSNNQFSQ-KIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLS 322
+ L L N + + KI + ++L L L + + S + + L+KL LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-V-SNLPKLPKLKKLELS 79
Query: 323 HNNLSGSIPRCFEEMHWLSCIDISYNALQGL 353
N + G + E++ L+ +++S N L+ +
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDI 110
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 3e-05
Identities = 26/94 (27%), Positives = 39/94 (41%), Gaps = 3/94 (3%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTS 146
I +L L L L S+ L L L L+LS N++ G + + L +
Sbjct: 39 GKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKKLELSENRIFGGLDMLAEKLPN 96
Query: 147 LSILYLYENSLCD-SIPKEIGNMNSLSILDLSSN 179
L+ L L N L D S + + + L LDL +
Sbjct: 97 LTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 23/82 (28%), Positives = 35/82 (42%), Gaps = 5/82 (6%)
Query: 467 GHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKF 526
+G G G V+ V +K P M+ + FL E + K+RH +V+
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS-PEAFLQEAQVMKKLRHEKLVQL 244
Query: 527 YGFCSHALHSFVVYEYLEMGSL 548
Y S ++V EY+ GSL
Sbjct: 245 YAVVSEE-PIYIVTEYMSKGSL 265
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 18/90 (20%), Positives = 35/90 (38%), Gaps = 11/90 (12%)
Query: 467 GHCIGNGGQGSVYKAKL-------PTGEI-VDVKKFHSPLPDEMACQQEFLNEVNALTKI 518
+G G ++K E V +K + F + ++K+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD---KAHRNYSESFFEAASMMSKL 69
Query: 519 RHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
H+++V YG C + +V E+++ GSL
Sbjct: 70 SHKHLVLNYGVCVCGDENILVQEFVKFGSL 99
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 3e-09
Identities = 49/148 (33%), Positives = 70/148 (47%), Gaps = 15/148 (10%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLS-FANLT 145
+S+P I + L L N L LT+L L L NKL S+P F LT
Sbjct: 20 TSVPTGIPA--QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLT 76
Query: 146 SLSILYLYENSLCDSIPKEI-GNMNSLSILDLSSNKLNGSIPLSL-ANLTNSLKVLYLSS 203
SL+ L L N L S+P + + L L L++N+L S+P + LT LK L L
Sbjct: 77 SLTYLNLSTNQL-QSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQ-LKDLRLYQ 133
Query: 204 NHIVGEIPLGHGM---LSSLIQLTLNNN 228
N + +P G+ L+SL + L++N
Sbjct: 134 NQLKS-VP--DGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 38/128 (29%), Positives = 57/128 (44%), Gaps = 13/128 (10%)
Query: 178 SNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPE 237
++ S+P + L L +N + L+SL QL L N+L S
Sbjct: 15 YSQGRTSVP---TGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ---SLP 68
Query: 238 LG---SLIQLEYLDLSANTFHKSIPESL-SNLVKLHYLNLSNNQFSQKIPNKI-EKLIHL 292
G L L YL+LS N +S+P + L +L L L+ NQ Q +P+ + +KL L
Sbjct: 69 NGVFNKLTSLTYLNLSTNQL-QSLPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQL 126
Query: 293 SELDLSHN 300
+L L N
Sbjct: 127 KDLRLYQN 134
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 49/167 (29%), Positives = 70/167 (41%), Gaps = 43/167 (25%)
Query: 121 TNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGN-MNSLSILDLSSN 179
LDL TN L F LTSL+ LYL N L S+P + N + SL+ L+LS+N
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKL-QSLPNGVFNKLTSLTYLNLSTN 86
Query: 180 KLNGSIPL----SLANLTNSLKVLYLSSNHIVGEIPLGHGM---LSSLIQLTLNNNELSG 232
+L S+P L L L L++N + +P G+ L+ L L L N+L
Sbjct: 87 QLQ-SLPNGVFDKLTQLKE----LALNTNQL-QSLP--DGVFDKLTQLKDLRLYQNQL-- 136
Query: 233 QLSPELGSLIQLEYLDLSANTFHKSIPE-SLSNLVKLHYLNLSNNQF 278
KS+P+ L L Y+ L +N +
Sbjct: 137 -----------------------KSVPDGVFDRLTSLQYIWLHDNPW 160
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 4e-09
Identities = 24/86 (27%), Positives = 40/86 (46%), Gaps = 5/86 (5%)
Query: 467 GHCIGNGGQGSVYKA--KLPTGEIVDV--KKFHSPLPDEMACQQEFLNEVNALTKIRHRN 522
+G+G G V + P+G+ V V K + + +F+ EVNA+ + HRN
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 523 IVKFYGFCSHALHSFVVYEYLEMGSL 548
+++ YG +V E +GSL
Sbjct: 83 LIRLYGVVLTP-PMKMVTELAPLGSL 107
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 23/105 (21%), Positives = 40/105 (38%), Gaps = 18/105 (17%)
Query: 459 RATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTK 517
R ++F++ +G G G V KA+ +KK + L+EV L
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKK----IRHTEEKLSTILSEVMLLAS 58
Query: 518 IRHRNIVKFYGFCSHALHS-------------FVVYEYLEMGSLA 549
+ H+ +V++Y + F+ EY E G+L
Sbjct: 59 LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLY 103
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 43/275 (15%), Positives = 93/275 (33%), Gaps = 17/275 (6%)
Query: 65 LTFEATAHFSVLAFTGQDWPLYSS--IPDEIGNMKSLSDLQLSENIL--NGSIPLALGNL 120
L + ++ ++W Y + + + N++ L + I+ LA
Sbjct: 78 LKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARA 137
Query: 121 TNLVVLDLST-NKLSGSIPLSFA-NLTSLSILYLYENSLCDSIPKEIG----NMNSLSIL 174
+L L L + + LS + + L + E+S + K + + SL +L
Sbjct: 138 DDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVL 197
Query: 175 DLSSNKLNGSIPLSLANLTN---SLKVLYLSSNHIVGEIPLGHG--MLSSLIQLTLNNNE 229
+ + P L + SL + + I+ + L +LN +
Sbjct: 198 NFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDI 257
Query: 230 LSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQF-SQKIPNKIEK 288
+ L +L L LS + +P ++ L+L ++ I+K
Sbjct: 258 GMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQK 316
Query: 289 LIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSH 323
+L L+ + I + + L++L +
Sbjct: 317 CPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIER 351
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 37/249 (14%), Positives = 80/249 (32%), Gaps = 31/249 (12%)
Query: 93 IGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYL 152
I +L L+ I + + + L L + + ++ ++ L
Sbjct: 314 IQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIAL 373
Query: 153 YENSLCDSIPKEIGNMNSLSILDLSSNKLN----GSIPLSLANLTNSLKVLYLSSNHIVG 208
+ C L + + + + SI L NL +++ L +
Sbjct: 374 AQG--C----------QELEYMAVYVSDITNESLESIGTYLKNLC-DFRLVLLDREERIT 420
Query: 209 EIPLGHGMLSSLIQLT----LNNNELSGQLSPELGSLI-----QLEYLDLSANTFH-KSI 258
++PL +G+ S LI G L+ S I + ++ L + +
Sbjct: 421 DLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGL 480
Query: 259 PESLSNLVKLHYLNLSNNQFSQK-IPNKIEKLIHLSELDLSH---NIFREEIPSQICSMQ 314
E L L + FS++ I + KL L L + ++ +++
Sbjct: 481 MEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYW 540
Query: 315 SLEKLNLSH 323
++E +
Sbjct: 541 NIELIPSRR 549
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 44/254 (17%), Positives = 81/254 (31%), Gaps = 26/254 (10%)
Query: 124 VVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIG------------NMNSL 171
V + L + F NL SL + ++ + IP+ G N+ L
Sbjct: 55 VTMALCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQL 114
Query: 172 SILDLSSNKLNGSIPLSLANLT-NSLKVLYLSSNHIVGEIPLGH--GMLSSLIQLTLNNN 228
+ ++ LA + L+ L L L + L + +
Sbjct: 115 KSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEES 174
Query: 229 ELSGQLSPELGSLIQ----LEYLDLSANTFHKSIPESLSNLVK----LHYLNLSNNQFS- 279
S + L L Q LE L+ F K P+ L + + L + + + +
Sbjct: 175 SFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE 234
Query: 280 -QKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMH 338
L L+ +I E + + L +L LS+ + +P F
Sbjct: 235 LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNE-MPILFPFAA 293
Query: 339 WLSCIDISYNALQG 352
+ +D+ Y L+
Sbjct: 294 QIRKLDLLYALLET 307
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 39/261 (14%), Positives = 76/261 (29%), Gaps = 30/261 (11%)
Query: 95 NMKSLSDLQLS--ENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYL 152
N +SL +++ E + A NL L+ + ++ L L L
Sbjct: 218 NCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGL 277
Query: 153 YENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNH-IVGEIP 211
+ +P + LDL L +L +L+VL + G
Sbjct: 278 SYMG-PNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEV 336
Query: 212 LGHGMLSSLIQLTLNNNELSGQLSPELGSL------------IQLEYLDLSANTF----H 255
L L +L + + E G + +LEY+ + +
Sbjct: 337 LAQYC-KQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESL 395
Query: 256 KSIPESLSNLVKLHYLNLSN---------NQFSQKIPNKIEKLIHLSELDLSHNIFREEI 306
+SI L NL + L + + + +KL + + +
Sbjct: 396 ESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGL 455
Query: 307 PSQICSMQSLEKLNLSHNNLS 327
++ + L + S
Sbjct: 456 SYIGQYSPNVRWMLLGYVGES 476
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 6e-09
Identities = 24/86 (27%), Positives = 41/86 (47%), Gaps = 6/86 (6%)
Query: 467 GHCIGNGGQGSVYKAKL--PTGEIVDV--KKFHSPLPDEMACQQEFLNEVNALTKIRHRN 522
IG+G G V +L P V V K + + +++FL+E + + + H N
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ--RRDFLSEASIMGQFDHPN 111
Query: 523 IVKFYGFCSHALHSFVVYEYLEMGSL 548
I++ G + + +V EY+E GSL
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSL 137
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 6e-09
Identities = 26/94 (27%), Positives = 42/94 (44%), Gaps = 12/94 (12%)
Query: 464 FDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHR 521
F+ +GNG G VYK + + TG++ +K + ++E E+N L K HR
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKV----MDVTGDEEEEIKQEINMLKKYSHHR 81
Query: 522 NIVKFYG------FCSHALHSFVVYEYLEMGSLA 549
NI +YG ++V E+ GS+
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT 115
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 7e-09
Identities = 14/84 (16%), Positives = 24/84 (28%), Gaps = 1/84 (1%)
Query: 467 GHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVK 525
G ++A V + QE L+ L++I + +
Sbjct: 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 526 FYGFCSHALHSFVVYEYLEMGSLA 549
VV E++ GSL
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQ 119
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 7e-09
Identities = 28/86 (32%), Positives = 43/86 (50%), Gaps = 11/86 (12%)
Query: 470 IGNGGQGSVYKAKLPTGE------IVDVKKFHSPLPDE-MACQQEFLNEVNALTKIRHRN 522
+G G G V+ A+ +V VK L D +A +++F E LT ++H +
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKA----LKDPTLAARKDFQREAELLTNLQHEH 78
Query: 523 IVKFYGFCSHALHSFVVYEYLEMGSL 548
IVKFYG C +V+EY++ G L
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDL 104
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 7e-09
Identities = 27/109 (24%), Positives = 44/109 (40%), Gaps = 26/109 (23%)
Query: 459 RATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQ-QEFLNEVNALT 516
R +F + IG+GG G V+KAK G+ +K + ++ EV AL
Sbjct: 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIK--------RVKYNNEKAEREVKALA 59
Query: 517 KIRHRNIVKFYGF-------------CSHALHSFVVY---EYLEMGSLA 549
K+ H NIV + G S + ++ E+ + G+L
Sbjct: 60 KLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLE 108
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-08
Identities = 37/105 (35%), Positives = 55/105 (52%), Gaps = 5/105 (4%)
Query: 102 LQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLS-FANLTSLSILYLYENSLCDS 160
L+L N L LT L L LS N++ S+P F LT L+ILYL+EN L S
Sbjct: 33 LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKL-QS 90
Query: 161 IPKEI-GNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSN 204
+P + + L L L +N+L S+P + + SL+ ++L +N
Sbjct: 91 LPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 4e-07
Identities = 37/111 (33%), Positives = 57/111 (51%), Gaps = 7/111 (6%)
Query: 121 TNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEI-GNMNSLSILDLSSN 179
++ L+L +NKL F LT L+ L L +N + S+P + + L+IL L N
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQI-QSLPDGVFDKLTKLTILYLHEN 86
Query: 180 KLNGSIPLSL-ANLTNSLKVLYLSSNHIVGEIPLGH-GMLSSLIQLTLNNN 228
KL S+P + LT LK L L +N + +P G L+SL ++ L+ N
Sbjct: 87 KLQ-SLPNGVFDKLTQ-LKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 3e-05
Identities = 33/118 (27%), Positives = 52/118 (44%), Gaps = 18/118 (15%)
Query: 245 EYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKI-EKLIHLSELDLSHNIFR 303
L+L +N L +L L+LS NQ Q +P+ + +KL L+ L L N
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQI-QSLPDGVFDKLTKLTILYLHENKL- 88
Query: 304 EEIPSQIC-SMQSLEKLNLSHNNLSGSIPR-CFEEMH-----WL-------SCIDISY 347
+ +P+ + + L++L L N L S+P F+ + WL SC I Y
Sbjct: 89 QSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDY 145
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 23/88 (26%), Positives = 41/88 (46%), Gaps = 8/88 (9%)
Query: 467 GHCIGNGGQGSVYKAKL------PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH 520
+G+G G VY+ ++ P+ V VK ++ + +FL E ++K H
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD--ELDFLMEALIISKFNH 92
Query: 521 RNIVKFYGFCSHALHSFVVYEYLEMGSL 548
+NIV+ G +L F++ E + G L
Sbjct: 93 QNIVRCIGVSLQSLPRFILMELMAGGDL 120
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 1e-08
Identities = 25/88 (28%), Positives = 38/88 (43%), Gaps = 8/88 (9%)
Query: 467 GHCIGNGGQGSVYKAKLPTGE------IVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH 520
G +G G G V KA + V VK ++ L+E N L ++ H
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE--LRDLLSEFNVLKQVNH 85
Query: 521 RNIVKFYGFCSHALHSFVVYEYLEMGSL 548
+++K YG CS ++ EY + GSL
Sbjct: 86 PHVIKLYGACSQDGPLLLIVEYAKYGSL 113
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 23/86 (26%), Positives = 41/86 (47%), Gaps = 6/86 (6%)
Query: 467 GHCIGNGGQGSVYKA--KLPTGEIVDV--KKFHSPLPDEMACQQEFLNEVNALTKIRHRN 522
+G G G V KLP+ + + V K ++ +++FL E + + + H N
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ--RRDFLGEASIMGQFDHPN 107
Query: 523 IVKFYGFCSHALHSFVVYEYLEMGSL 548
I++ G + + +V EY+E GSL
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSL 133
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 55.7 bits (133), Expect = 2e-08
Identities = 21/152 (13%), Positives = 49/152 (32%), Gaps = 21/152 (13%)
Query: 194 NSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGS--LIQLEYLDLSA 251
L L + + + +L L + + L + ++ L LE L L
Sbjct: 172 PLLNNLKIKGTNNLSIGKKPR---PNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYV 228
Query: 252 NTFHKSIPESLSNLV---------KLHYLNLSNNQFSQKIPNKI---EKLIHLSELDLSH 299
++ L +L + + + + + L L +D+S
Sbjct: 229 GVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISA 288
Query: 300 NIFR----EEIPSQICSMQSLEKLNLSHNNLS 327
+ + + ++ L+ +N+ +N LS
Sbjct: 289 GVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 52.3 bits (124), Expect = 2e-07
Identities = 31/220 (14%), Positives = 81/220 (36%), Gaps = 24/220 (10%)
Query: 129 STNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSIL----DLSSNKLNGS 184
+ ++ I + L+ + + I ++ +L L++ K+ G+
Sbjct: 123 DCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGT 182
Query: 185 IPLSLANLTNS-LKVLYLSSNHIVGEIP--LGHGMLSSLIQLTL-------NNNELSGQL 234
LS+ LK L + S + + + L +L +L L +
Sbjct: 183 NNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVF 242
Query: 235 SPEL--GSLIQLEYLDLSANTFHKSIPESLSN---LVKLHYLNLSNNQFS----QKIPNK 285
P L++L + + E L +L +++S + + + +
Sbjct: 243 RPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDH 302
Query: 286 IEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNN 325
++K+ HL +++ +N +E+ ++ + K+++S +
Sbjct: 303 VDKIKHLKFINMKYNYLSDEMKKELQKSLPM-KIDVSDSQ 341
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 24/87 (27%), Positives = 39/87 (44%), Gaps = 7/87 (8%)
Query: 467 GHCIGNGGQGSVYKA--KLPTGEI---VDVKKFHSPLPDEMACQQEFLNEVNALTKIRHR 521
IG G G VYK K +G+ V +K + ++ +FL E + + H
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR--VDFLGEAGIMGQFSHH 106
Query: 522 NIVKFYGFCSHALHSFVVYEYLEMGSL 548
NI++ G S ++ EY+E G+L
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGAL 133
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 23/88 (26%), Positives = 41/88 (46%), Gaps = 8/88 (9%)
Query: 467 GHCIGNGGQGSVYKAKL------PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH 520
+G+G G VY+ ++ P+ V VK ++ + +FL E ++K H
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD--ELDFLMEALIISKFNH 133
Query: 521 RNIVKFYGFCSHALHSFVVYEYLEMGSL 548
+NIV+ G +L F++ E + G L
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDL 161
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 23/88 (26%), Positives = 37/88 (42%), Gaps = 8/88 (9%)
Query: 467 GHCIGNGGQGSVYKAKL------PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH 520
IG G G V++A+ +V VK +M Q +F E + + +
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM--QADFQREAALMAEFDN 109
Query: 521 RNIVKFYGFCSHALHSFVVYEYLEMGSL 548
NIVK G C+ +++EY+ G L
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDL 137
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 24/85 (28%), Positives = 40/85 (47%), Gaps = 9/85 (10%)
Query: 470 IGNGGQGSVYKAKLPTGE------IVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNI 523
+G G G V+ A+ +V VK +Q+F E LT ++H++I
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA---RQDFQREAELLTMLQHQHI 105
Query: 524 VKFYGFCSHALHSFVVYEYLEMGSL 548
V+F+G C+ +V+EY+ G L
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDL 130
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 4e-08
Identities = 21/91 (23%), Positives = 42/91 (46%), Gaps = 7/91 (7%)
Query: 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH 520
++F+ +G G G V+K P+G ++ K H + + + + + E+ L +
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI--RNQIIRELQVLHECNS 90
Query: 521 RNIVKFYG--FCSHALHSFVVYEYLEMGSLA 549
IV FYG + + + E+++ GSL
Sbjct: 91 PYIVGFYGAFYSDGEI--SICMEHMDGGSLD 119
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 4e-08
Identities = 27/87 (31%), Positives = 41/87 (47%), Gaps = 4/87 (4%)
Query: 95 NMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPL-SFANLTSLSILYLY 153
+ L L+L N L G P A +++ L L NK+ I F L L L LY
Sbjct: 52 RLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLY 110
Query: 154 ENSLCDSIPKEI-GNMNSLSILDLSSN 179
+N + + ++NSL+ L+L+SN
Sbjct: 111 DNQI-SCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 32/122 (26%), Positives = 52/122 (42%), Gaps = 8/122 (6%)
Query: 160 SIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLG-HGMLS 218
IP++I + L L+ N+L L L L L N + I S
Sbjct: 22 EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGAS 78
Query: 219 SLIQLTLNNNELSGQLSPEL-GSLIQLEYLDLSANTFHKSIPE-SLSNLVKLHYLNLSNN 276
+ +L L N++ ++S ++ L QL+ L+L N + S +L L LNL++N
Sbjct: 79 HIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQI-SCVMPGSFEHLNSLTSLNLASN 136
Query: 277 QF 278
F
Sbjct: 137 PF 138
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 32/111 (28%), Positives = 41/111 (36%), Gaps = 14/111 (12%)
Query: 125 VLDLSTNKLSGSIPLS--FANLTSLSILYLYENSLCDSIPKEI-GNMNSLSILDLSSNKL 181
L L+ N+L I F L L L L N L I + + L L NK+
Sbjct: 33 ELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQL-TGIEPNAFEGASHIQELQLGENKI 90
Query: 182 NGSIPLSL-ANLTNSLKVLYLSSNHIVGEIPLGHGM---LSSLIQLTLNNN 228
I + L LK L L N I + G L+SL L L +N
Sbjct: 91 K-EISNKMFLGLHQ-LKTLNLYDNQISC-VM--PGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 25/91 (27%), Positives = 37/91 (40%), Gaps = 6/91 (6%)
Query: 245 EYLDLSANTFHKSIPESL-SNLVKLHYLNLSNNQFSQKIPNKI-EKLIHLSELDLSHNIF 302
L L+ N + + L L L L L NQ I E H+ EL L N
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQL-TGIEPNAFEGASHIQELQLGENKI 90
Query: 303 REEIPSQIC-SMQSLEKLNLSHNNLSGSIPR 332
+EI +++ + L+ LNL N +S +
Sbjct: 91 -KEISNKMFLGLHQLKTLNLYDNQIS-CVMP 119
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 17/90 (18%), Positives = 35/90 (38%), Gaps = 4/90 (4%)
Query: 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHR 521
+ IG+GG V++ +I +K + D + NE+ L K++
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQH 86
Query: 522 N--IVKFYGFCSHALHSFVVYEYLEMGSLA 549
+ I++ Y + + ++V E L
Sbjct: 87 SDKIIRLYDYEITDQYIYMVMECGN-IDLN 115
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 5e-08
Identities = 22/86 (25%), Positives = 36/86 (41%), Gaps = 6/86 (6%)
Query: 467 GHCIGNGGQGSVYKAKLPTGE---IVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRN 522
IG G G V KA++ +K+ + ++F E+ L K+ H N
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD--HRDFAGELEVLCKLGHHPN 87
Query: 523 IVKFYGFCSHALHSFVVYEYLEMGSL 548
I+ G C H + ++ EY G+L
Sbjct: 88 IINLLGACEHRGYLYLAIEYAPHGNL 113
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 6e-08
Identities = 19/88 (21%), Positives = 33/88 (37%), Gaps = 8/88 (9%)
Query: 467 GHCIGNGGQGSVYKAKLPTGE------IVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH 520
+G G G VY+ V +K + + EFLNE + + +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE--RIEFLNEASVMKEFNC 87
Query: 521 RNIVKFYGFCSHALHSFVVYEYLEMGSL 548
++V+ G S + V+ E + G L
Sbjct: 88 HHVVRLLGVVSQGQPTLVIMELMTRGDL 115
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 24/137 (17%), Positives = 44/137 (32%), Gaps = 9/137 (6%)
Query: 417 GLFFNFRQRKNGSQTQQSSPRNTLGLLSVLTFDGKIVHE--EIIRATNNFDDGHCIGNGG 474
+ R + P +T S + ++ + + R D +G G
Sbjct: 290 DGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIE-LGCGN 348
Query: 475 QGSVYKAKL--PTGEI-VDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCS 531
GSV + +I V +K +E + E + ++ + IV+ G C
Sbjct: 349 FGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD--TEEMMREAQIMHQLDNPYIVRLIGVCQ 406
Query: 532 HALHSFVVYEYLEMGSL 548
+V E G L
Sbjct: 407 AEAL-MLVMEMAGGGPL 422
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 7e-08
Identities = 18/88 (20%), Positives = 32/88 (36%), Gaps = 8/88 (9%)
Query: 467 GHCIGNGGQGSVYKAKLPTGE------IVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH 520
+G G VYK L V +K + ++EF +E +++H
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL--REEFRHEAMLRARLQH 71
Query: 521 RNIVKFYGFCSHALHSFVVYEYLEMGSL 548
N+V G + +++ Y G L
Sbjct: 72 PNVVCLLGVVTKDQPLSMIFSYCSHGDL 99
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 15/95 (15%), Positives = 36/95 (37%), Gaps = 8/95 (8%)
Query: 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHR 521
++ +G GG V + L G +K+ + ++E E + H
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD---REEAQREADMHRLFNHP 86
Query: 522 NIVKFYGFCSHALHS----FVVYEYLEMGSLAMNL 552
NI++ +C + +++ + + G+L +
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI 121
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 8e-08
Identities = 21/91 (23%), Positives = 35/91 (38%), Gaps = 10/91 (10%)
Query: 467 GHCIGNGGQGSVYKAKLPTGE----IVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRN 522
G +G G GSV + L + V VK + +EFL+E + H N
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE-IEEFLSEAACMKDFSHPN 97
Query: 523 IVKFYGFCS-----HALHSFVVYEYLEMGSL 548
+++ G C V+ +++ G L
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDL 128
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 9e-08
Identities = 18/98 (18%), Positives = 28/98 (28%), Gaps = 7/98 (7%)
Query: 456 EIIRATNNFDDGHCIGNGGQGSVYKAKLPTGE----IVDVKKFHSPLPDEMACQQEFLNE 511
I IG G G VY + +K + + FL E
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQ--VEAFLRE 72
Query: 512 VNALTKIRHRNIVKFYGFCSHAL-HSFVVYEYLEMGSL 548
+ + H N++ G V+ Y+ G L
Sbjct: 73 GLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDL 110
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 17/85 (20%), Positives = 33/85 (38%), Gaps = 4/85 (4%)
Query: 467 GHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH--RNIV 524
IG+GG V++ +I +K + D + NE+ L K++ I+
Sbjct: 61 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQHSDKII 119
Query: 525 KFYGFCSHALHSFVVYEYLEMGSLA 549
+ Y + + ++V E L
Sbjct: 120 RLYDYEITDQYIYMVMECGN-IDLN 143
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 18/82 (21%), Positives = 30/82 (36%), Gaps = 6/82 (7%)
Query: 470 IGNGGQGSVYKAKL--PTGEI-VDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKF 526
+G G GSV + +I V +K +E + E + ++ + IV+
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD--TEEMMREAQIMHQLDNPYIVRL 75
Query: 527 YGFCSHALHSFVVYEYLEMGSL 548
G C +V E G L
Sbjct: 76 IGVCQAEAL-MLVMEMAGGGPL 96
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 23/128 (17%), Positives = 43/128 (33%), Gaps = 9/128 (7%)
Query: 423 RQRKNGSQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATNNFDDGHCIGNGGQGSVYKAK 482
+ S + + L G + + + + +G+G G V +
Sbjct: 3 HHHHHSSGRENLYFQGDLQATP-----GMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCR 57
Query: 483 -LPTGEIVDVKKFH-SPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540
T +K + + + L EV L + H NI+K Y F + ++V
Sbjct: 58 DKVTHVERAIKIIRKTSVSTSS--NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115
Query: 541 EYLEMGSL 548
E + G L
Sbjct: 116 ECYKGGEL 123
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 22/86 (25%), Positives = 38/86 (44%), Gaps = 7/86 (8%)
Query: 467 GHCIGNGGQGSVYKA--KLPTGEIVDV--KKFHSPLPDEMACQQEFLNEVNALTKIRHRN 522
G CIG G G V++ P + V K + D + +++FL E + + H +
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV--REKFLQEALTMRQFDHPH 77
Query: 523 IVKFYGFCSHALHSFVVYEYLEMGSL 548
IVK G + +++ E +G L
Sbjct: 78 IVKLIGVITEN-PVWIIMELCTLGEL 102
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 19/86 (22%), Positives = 35/86 (40%), Gaps = 7/86 (8%)
Query: 467 GHCIGNGGQGSVYKAKL--PTGEIVDV--KKFHSPLPDEMACQQEFLNEVNALTKIRHRN 522
+G G G VY+ GE ++V K + +++F++E + + H +
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDN--KEKFMSEAVIMKNLDHPH 74
Query: 523 IVKFYGFCSHALHSFVVYEYLEMGSL 548
IVK G +++ E G L
Sbjct: 75 IVKLIGIIEEEPT-WIIMELYPYGEL 99
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 20/98 (20%), Positives = 34/98 (34%), Gaps = 4/98 (4%)
Query: 459 RATNNFDDGHCIGNGGQGSVYKA-KLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTK 517
+F +G+G G V+K G + VK+ SP + L EV + K
Sbjct: 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGP-KDRARKLAEVGSHEK 112
Query: 518 I-RHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSN 554
+ +H V+ ++ E SL +
Sbjct: 113 VGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEA 149
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 20/90 (22%), Positives = 40/90 (44%), Gaps = 5/90 (5%)
Query: 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH 520
+ + +G G +V++ + TG++ +K F++ + E L K+ H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNH 66
Query: 521 RNIVKFYGF--CSHALHSFVVYEYLEMGSL 548
+NIVK + + H ++ E+ GSL
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSL 96
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 16/87 (18%), Positives = 36/87 (41%), Gaps = 8/87 (9%)
Query: 467 GHCIGNGGQGSVYKAKL----PTGEI-VDVKKFHSPLPDEMACQQEFLNEVNALTKIRHR 521
+G+G G+VYK +I V +K+ + +E L+E + + +
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--NKEILDEAYVMASVDNP 77
Query: 522 NIVKFYGFCSHALHSFVVYEYLEMGSL 548
++ + G C + ++ + + G L
Sbjct: 78 HVCRLLGICLTS-TVQLITQLMPFGCL 103
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 21/92 (22%), Positives = 36/92 (39%), Gaps = 11/92 (11%)
Query: 467 GHCIGNGGQGSVYKAKLPTGE----IVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRN 522
G +G G GSV +A+L + V VK + + +EFL E + + H +
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSD-IEEFLREAACMKEFDHPH 86
Query: 523 IVKFYGFCS------HALHSFVVYEYLEMGSL 548
+ K G V+ +++ G L
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDL 118
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 17/85 (20%), Positives = 33/85 (38%), Gaps = 4/85 (4%)
Query: 467 GHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH--RNIV 524
IG+GG V++ +I +K + D + NE+ L K++ I+
Sbjct: 14 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQHSDKII 72
Query: 525 KFYGFCSHALHSFVVYEYLEMGSLA 549
+ Y + + ++V E L
Sbjct: 73 RLYDYEITDQYIYMVMECGN-IDLN 96
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 35/271 (12%), Positives = 87/271 (32%), Gaps = 26/271 (9%)
Query: 82 DWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSF 141
+YS + + K L L + + +P + L L+LS + +
Sbjct: 250 RPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKL 309
Query: 142 A----NLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLS------LAN 191
L L +L E++ + + ++ L + + ++ L+ ++
Sbjct: 310 LCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSM 369
Query: 192 LTNSLKVLYLSSNHI--VGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSL-------- 241
L+ + + I + ++ + L E L L
Sbjct: 370 GCPKLESVLYFCRQMTNAALITIARN-RPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIV 428
Query: 242 ---IQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQK-IPNKIEKLIHLSELDL 297
L L LS K + K+ L+++ S + + + L +L++
Sbjct: 429 EHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEI 488
Query: 298 SH-NIFREEIPSQICSMQSLEKLNLSHNNLS 327
+ + + ++++ L +S ++S
Sbjct: 489 RDCPFGDKALLANASKLETMRSLWMSSCSVS 519
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 40/232 (17%), Positives = 64/232 (27%), Gaps = 31/232 (13%)
Query: 107 NILNGSIPLALGNLTNLVVLDLSTNKLS----GSIPLSFANLTSLSILYLYENSLCDSIP 162
+ I + T L + L ++ I SF N L +
Sbjct: 91 GYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSC--EGFSTDGL 148
Query: 163 KEIG-NMNSLSILDLSSNKLNGSIPLSLANLTN---SLKVLYLSSNH-IVGEIPLGH--G 215
I +L LDL + ++ L++ + SL L +S V L
Sbjct: 149 AAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVT 208
Query: 216 MLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSN 275
+L L LN +L+ L QLE L Y
Sbjct: 209 RCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTG------------------GYTAEVR 250
Query: 276 NQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLS 327
+ + L L + +P+ L LNLS+ +
Sbjct: 251 PDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQ 302
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 8e-04
Identities = 40/252 (15%), Positives = 80/252 (31%), Gaps = 29/252 (11%)
Query: 124 VVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMN------------SL 171
V + ++ F + S+ + + + +P G L
Sbjct: 48 VFIGNCYAVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWL 107
Query: 172 SILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGH--GMLSSLIQLTLNNNE 229
+ L + +A + KVL LSS L +L +L L ++
Sbjct: 108 EEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESD 167
Query: 230 LSGQ----LSPELGSLIQLEYLDLSANTFHKSIPESLSNLVK----LHYLNLSNNQFSQK 281
+ LS + L L++S S +L LV L L L+ +K
Sbjct: 168 VDDVSGHWLSHFPDTYTSLVSLNISCLASEVS-FSALERLVTRCPNLKSLKLNRAVPLEK 226
Query: 282 IPNKIEKLIHLSELDLS------HNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFE 335
+ +++ L EL + + + L L+ + + +P +
Sbjct: 227 LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYS 286
Query: 336 EMHWLSCIDISY 347
L+ +++SY
Sbjct: 287 VCSRLTTLNLSY 298
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 24/100 (24%), Positives = 35/100 (35%), Gaps = 7/100 (7%)
Query: 454 HEEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGE----IVDVKKFHSPLPDEMACQQEFL 509
H I ++ IG G G VY L + VK + +FL
Sbjct: 17 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE--VSQFL 74
Query: 510 NEVNALTKIRHRNIVKFYGFCSHALHS-FVVYEYLEMGSL 548
E + H N++ G C + S VV Y++ G L
Sbjct: 75 TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 114
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 19/100 (19%), Positives = 28/100 (28%), Gaps = 9/100 (9%)
Query: 455 EEIIRATNNFDDGHCIGNGGQGSVYKAK------LPTGEIVDVKKFHSPLPDEMACQQEF 508
E + H +G G VY+A + +K P E
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEF---YIG 114
Query: 509 LNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
+ L +KFY S +V E G+L
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTL 154
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 26/133 (19%), Positives = 47/133 (35%), Gaps = 8/133 (6%)
Query: 422 FRQRKNGSQTQQSSPRNTLGLLSVLTFDGKIVHE-EIIRATNNFDDGHCIGNGGQGSVYK 480
+++ + + Q + + L ++ + V I ++ IG G G VY
Sbjct: 48 YKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYH 107
Query: 481 AKLPTGE----IVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHS 536
L + VK + +FL E + H N++ G C + S
Sbjct: 108 GTLLDNDGKKIHCAVKSLNRITDIGE--VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 165
Query: 537 -FVVYEYLEMGSL 548
VV Y++ G L
Sbjct: 166 PLVVLPYMKHGDL 178
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 23/82 (28%), Positives = 35/82 (42%), Gaps = 5/82 (6%)
Query: 470 IGNGGQGSVYKAKL--PTGEI-VDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKF 526
+G+G G+V K V VK + D A + E L E N + ++ + IV+
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP-ALKDELLAEANVMQQLDNPYIVRM 83
Query: 527 YGFCSHALHSFVVYEYLEMGSL 548
G C +V E E+G L
Sbjct: 84 IGICEAESW-MLVMEMAELGPL 104
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 25/92 (27%), Positives = 45/92 (48%), Gaps = 6/92 (6%)
Query: 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFH-SPLPDEMACQQEFLNEVNALTKIR 519
+++ + IG G G K + G+I+ K+ + + +Q ++EVN L +++
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA--EKQMLVSEVNLLRELK 63
Query: 520 HRNIVKFYG--FCSHALHSFVVYEYLEMGSLA 549
H NIV++Y ++V EY E G LA
Sbjct: 64 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLA 95
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 20/90 (22%), Positives = 40/90 (44%), Gaps = 5/90 (5%)
Query: 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH 520
+ + +G G +V++ + TG++ +K F++ + E L K+ H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNH 66
Query: 521 RNIVKFYGF--CSHALHSFVVYEYLEMGSL 548
+NIVK + + H ++ E+ GSL
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSL 96
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 26/97 (26%), Positives = 39/97 (40%), Gaps = 5/97 (5%)
Query: 457 IIRATNNFDD----GHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNE 511
+ +T F D +G G G V K TG+ VK + ++ L E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 512 VNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
V L ++ H NI+K Y F + ++V E G L
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL 113
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 3e-07
Identities = 21/88 (23%), Positives = 35/88 (39%), Gaps = 3/88 (3%)
Query: 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVK-KFHSPLPDEMACQQEFLNEVNALTKIRH 520
+ G +G GG ++ T E+ K S L ++ E++ + H
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAH 74
Query: 521 RNIVKFYGFCSHALHSFVVYEYLEMGSL 548
+++V F+GF FVV E SL
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSL 102
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 23/111 (20%), Positives = 44/111 (39%), Gaps = 3/111 (2%)
Query: 459 RATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTK 517
R +F+ C+G GG G V++AK +K+ LP+ +++ + EV AL K
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKR--IRLPNRELAREKVMREVKALAK 60
Query: 518 IRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMN 568
+ H IV+++ E E+ + ++ +
Sbjct: 61 LEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVK 111
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 23/92 (25%), Positives = 44/92 (47%), Gaps = 10/92 (10%)
Query: 459 RATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDE----MACQQEFLNEVN 513
++ +++ +G G G V K + TG IV +KKF D+ +A + E+
Sbjct: 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA-----MREIK 76
Query: 514 ALTKIRHRNIVKFYGFCSHALHSFVVYEYLEM 545
L ++RH N+V C ++V+E+++
Sbjct: 77 LLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH 108
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 3e-07
Identities = 24/81 (29%), Positives = 37/81 (45%), Gaps = 10/81 (12%)
Query: 470 IGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDE----MACQQEFLNEVNALTKIRHRNIV 524
IG G G V+K + TG+IV +KKF D +A L E+ L +++H N+V
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIA-----LREIRMLKQLKHPNLV 65
Query: 525 KFYGFCSHALHSFVVYEYLEM 545
+V+EY +
Sbjct: 66 NLLEVFRRKRRLHLVFEYCDH 86
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 21/88 (23%), Positives = 35/88 (39%), Gaps = 3/88 (3%)
Query: 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVK-KFHSPLPDEMACQQEFLNEVNALTKIRH 520
+ G +G GG ++ T E+ K S L ++ E++ + H
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAH 100
Query: 521 RNIVKFYGFCSHALHSFVVYEYLEMGSL 548
+++V F+GF FVV E SL
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSL 128
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 4e-07
Identities = 23/92 (25%), Positives = 40/92 (43%), Gaps = 15/92 (16%)
Query: 467 GHCIGNGGQGSVYKAKL----PTGEIVDV-----KKFHSPLPDEMACQQEFLNEVNALTK 517
G +G+G G V A TG + V K+ E + ++E+ +T+
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SER---EALMSELKMMTQ 104
Query: 518 I-RHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
+ H NIV G C+ + ++++EY G L
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDL 136
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 4e-07
Identities = 22/89 (24%), Positives = 34/89 (38%), Gaps = 9/89 (10%)
Query: 467 GHCIGNGGQGSVYKAKL------PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-R 519
G +G G G V +A V VK ++ ++E+ L+ +
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE--REALMSELKVLSYLGN 85
Query: 520 HRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
H NIV G C+ + V+ EY G L
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDL 114
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 22/94 (23%), Positives = 38/94 (40%), Gaps = 17/94 (18%)
Query: 467 GHCIGNGGQGSVYKAKLP--------TGEIVDVKKFHSPLPDEMACQQE---FLNEVNAL 515
G +G G G V A+ V VK A +++ ++E+ +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-----SDATEKDLSDLISEMEMM 128
Query: 516 TKI-RHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
I +H+NI+ G C+ +V+ EY G+L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 162
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 19/107 (17%), Positives = 38/107 (35%), Gaps = 15/107 (14%)
Query: 457 IIRATNNFDD----GHCIGNGGQGSVYKAK-LPTGEIVDVK----------KFHSPLPDE 501
+ + + +G+G G V K +K ++ +
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 502 MACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
+E NE++ L + H NI+K + + ++V E+ E G L
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL 133
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 8e-07
Identities = 21/91 (23%), Positives = 37/91 (40%), Gaps = 11/91 (12%)
Query: 467 GHCIGNGGQGSVYKAKLP--------TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI 518
G +G G G V A+ V VK ++ + ++E+ + I
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMMKMI 97
Query: 519 -RHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
+H+NI+ G C+ +V+ EY G+L
Sbjct: 98 GKHKNIINLLGACTQDGPLYVIVEYASKGNL 128
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 8e-07
Identities = 16/87 (18%), Positives = 36/87 (41%), Gaps = 8/87 (9%)
Query: 467 GHCIGNGGQGSVYKAKL----PTGEI-VDVKKFHSPLPDEMACQQEFLNEVNALTKIRHR 521
+G+G G+VYK +I V +K+ + +E L+E + + +
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--NKEILDEAYVMASVDNP 77
Query: 522 NIVKFYGFCSHALHSFVVYEYLEMGSL 548
++ + G C + ++ + + G L
Sbjct: 78 HVCRLLGICLTS-TVQLITQLMPFGCL 103
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 21/91 (23%), Positives = 37/91 (40%), Gaps = 11/91 (12%)
Query: 467 GHCIGNGGQGSVYKAKL--------PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI 518
G +G G G V A+ V VK ++ + ++E+ + I
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMMKMI 143
Query: 519 -RHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
+H+NI+ G C+ +V+ EY G+L
Sbjct: 144 GKHKNIINLLGACTQDGPLYVIVEYASKGNL 174
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 23/89 (25%), Positives = 37/89 (41%), Gaps = 9/89 (10%)
Query: 467 GHCIGNGGQGSVYKAKL------PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-R 519
G +G G G V +A V VK S + ++ ++E+ ++ + +
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE--KEALMSELKIMSHLGQ 108
Query: 520 HRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
H NIV G C+H V+ EY G L
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDL 137
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 22/90 (24%), Positives = 34/90 (37%), Gaps = 10/90 (11%)
Query: 467 GHCIGNGGQGSVYKAKL------PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-R 519
G +G G G V +A T V VK + ++E+ L I
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALMSELKILIHIGH 89
Query: 520 HRNIVKFYGFCSHA-LHSFVVYEYLEMGSL 548
H N+V G C+ V+ E+ + G+L
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 21/87 (24%), Positives = 39/87 (44%), Gaps = 8/87 (9%)
Query: 467 GHCIGNGGQGSVYKAKL----PTGEI-VDVKKFHSPLPDEMACQQEFLNEVNALTKIRHR 521
+G+G G+V+K + +I V +K + Q + + A+ + H
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK-SGRQS-FQAVTDHMLAIGSLDHA 75
Query: 522 NIVKFYGFCSHALHSFVVYEYLEMGSL 548
+IV+ G C + +V +YL +GSL
Sbjct: 76 HIVRLLGLCPGS-SLQLVTQYLPLGSL 101
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 22/86 (25%), Positives = 38/86 (44%), Gaps = 7/86 (8%)
Query: 467 GHCIGNGGQGSVYKA--KLPTGEIVDV--KKFHSPLPDEMACQQEFLNEVNALTKIRHRN 522
G CIG G G V++ P + V K + D + +++FL E + + H +
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV--REKFLQEALTMRQFDHPH 452
Query: 523 IVKFYGFCSHALHSFVVYEYLEMGSL 548
IVK G + +++ E +G L
Sbjct: 453 IVKLIGVITEN-PVWIIMELCTLGEL 477
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 18/93 (19%), Positives = 41/93 (44%), Gaps = 8/93 (8%)
Query: 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTK-IR 519
N+ ++ +G+G G V+K + TG ++ VK+ E + L +++ + K
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE--NKRILMDLDVVLKSHD 82
Query: 520 HRNIVKFYG--FCSHALHSFVVYEYLEMGSLAM 550
IV+ +G + + F+ E + + +
Sbjct: 83 CPYIVQCFGTFITNTDV--FIAMELMGTCAEKL 113
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 20/85 (23%), Positives = 36/85 (42%), Gaps = 12/85 (14%)
Query: 467 GHCIGNGGQGSVYKAK---LPTGEIVDVKKFHSP-LPDEMACQQEFLNEVNALTKIRHRN 522
G +G G G VYKAK + +K+ + E+ L +++H N
Sbjct: 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHPN 79
Query: 523 IVKFYG-FCSHALHS-FVVYEYLEM 545
++ F SHA +++++Y E
Sbjct: 80 VISLQKVFLSHADRKVWLLFDYAEH 104
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 2e-06
Identities = 21/89 (23%), Positives = 42/89 (47%), Gaps = 3/89 (3%)
Query: 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKK-FHSPLPDEMACQQEFLNEVNALTKIR 519
+F G+ +G G VY+A+ + TG V +K + Q+ NEV +++
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLK 69
Query: 520 HRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
H +I++ Y + + + ++V E G +
Sbjct: 70 HPSILELYNYFEDSNYVYLVLEMCHNGEM 98
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 25/91 (27%), Positives = 38/91 (41%), Gaps = 11/91 (12%)
Query: 467 GHCIGNGGQGSVYKAK---LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNI 523
CI +GG G +Y A + G V +K D A Q + E L ++ H +I
Sbjct: 85 KGCIAHGGLGWIYLALDRNVN-GRPVVLKGLV-HSGDAEA-QAMAMAERQFLAEVVHPSI 141
Query: 524 VKFYGFCSHALHS-----FVVYEYLEMGSLA 549
V+ + F H ++V EY+ SL
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLK 172
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 24/100 (24%), Positives = 38/100 (38%), Gaps = 8/100 (8%)
Query: 455 EEIIRATNNFDD----GHCIGNGGQGSVYKAK-LPTGEIVDVKKFH-SPLPDEMACQQEF 508
E + F + +G G G V K K T + VK + + ++
Sbjct: 11 RENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD--TSTI 68
Query: 509 LNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
L EV L K+ H NI+K + + ++V E G L
Sbjct: 69 LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL 108
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 21/97 (21%), Positives = 38/97 (39%), Gaps = 9/97 (9%)
Query: 459 RATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTK 517
+ ++ +G GG G V + TGE V +K+ L + ++ + E+ + K
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKN--RERWCLEIQIMKK 68
Query: 518 IRHRNIVKFY------GFCSHALHSFVVYEYLEMGSL 548
+ H N+V + + EY E G L
Sbjct: 69 LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDL 105
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 3e-06
Identities = 22/88 (25%), Positives = 45/88 (51%), Gaps = 1/88 (1%)
Query: 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH 520
+F+ G +G G G+VY A+ + I+ +K ++ + + EV + +RH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 521 RNIVKFYGFCSHALHSFVVYEYLEMGSL 548
NI++ YG+ A +++ EY +G++
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTV 96
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 3e-06
Identities = 25/80 (31%), Positives = 37/80 (46%), Gaps = 9/80 (11%)
Query: 470 IGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDE----MACQQEFLNEVNALTKIRHRNIVK 525
IG G G VYKA+ GE +KK DE + E++ L +++H NIVK
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT-----IREISILKELKHSNIVK 64
Query: 526 FYGFCSHALHSFVVYEYLEM 545
Y +V+E+L+
Sbjct: 65 LYDVIHTKKRLVLVFEHLDQ 84
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 4e-06
Identities = 22/84 (26%), Positives = 37/84 (44%), Gaps = 13/84 (15%)
Query: 470 IGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDE-------MACQQEFLNEVNALTKIRHR 521
+G G +VYKA+ T +IV +KK E A L E+ L ++ H
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTA-----LREIKLLQELSHP 72
Query: 522 NIVKFYGFCSHALHSFVVYEYLEM 545
NI+ H + +V++++E
Sbjct: 73 NIIGLLDAFGHKSNISLVFDFMET 96
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 47.9 bits (115), Expect = 4e-06
Identities = 24/80 (30%), Positives = 36/80 (45%), Gaps = 9/80 (11%)
Query: 470 IGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDE----MACQQEFLNEVNALTKIRHRNIVK 525
+G G G VYKAK G IV +K+ DE A + E++ L ++ H NIV
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA-----IREISLLKELHHPNIVS 83
Query: 526 FYGFCSHALHSFVVYEYLEM 545
+V+E++E
Sbjct: 84 LIDVIHSERCLTLVFEFMEK 103
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 21/88 (23%), Positives = 36/88 (40%), Gaps = 9/88 (10%)
Query: 467 GHCIGNGGQGSVYKAK-LPTGE-----IVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH 520
IG G V + TG+ IVDV KF S ++ E + ++H
Sbjct: 29 CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTS---SPGLSTEDLKREASICHMLKH 85
Query: 521 RNIVKFYGFCSHALHSFVVYEYLEMGSL 548
+IV+ S ++V+E+++ L
Sbjct: 86 PHIVELLETYSSDGMLYMVFEFMDGADL 113
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 6e-06
Identities = 33/95 (34%), Positives = 49/95 (51%), Gaps = 7/95 (7%)
Query: 112 SIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEI-GNMNS 170
S+P G T+ L L+ N+++ P F +L +L LY N L +IP + +
Sbjct: 26 SVPA--GIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKL-TAIPTGVFDKLTQ 82
Query: 171 LSILDLSSNKLNGSIPL-SLANLTNSLKVLYLSSN 204
L+ LDL+ N L SIP + NL SL +YL +N
Sbjct: 83 LTQLDLNDNHLK-SIPRGAFDNLK-SLTHIYLYNN 115
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 6e-06
Identities = 32/95 (33%), Positives = 47/95 (49%), Gaps = 7/95 (7%)
Query: 112 SIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEI-GNMNS 170
S+P G T VL L N+++ P F LT L+ L L N L +P + +
Sbjct: 23 SVPT--GIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQL-TVLPAGVFDKLTQ 79
Query: 171 LSILDLSSNKLNGSIPL-SLANLTNSLKVLYLSSN 204
L+ L L+ N+L SIP + NL SL ++L +N
Sbjct: 80 LTQLSLNDNQLK-SIPRGAFDNLK-SLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 39.5 bits (93), Expect = 8e-04
Identities = 22/74 (29%), Positives = 36/74 (48%), Gaps = 9/74 (12%)
Query: 215 GMLSSLIQLTLNNNELSGQLSPELG---SLIQLEYLDLSANTFHKSIPESL-SNLVKLHY 270
G+ ++ L L +N+++ E G L QL LDL N +P + L +L
Sbjct: 27 GIPTTTQVLYLYDNQIT---KLEPGVFDRLTQLTRLDLDNNQL-TVLPAGVFDKLTQLTQ 82
Query: 271 LNLSNNQFSQKIPN 284
L+L++NQ + IP
Sbjct: 83 LSLNDNQL-KSIPR 95
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 32/129 (24%), Positives = 53/129 (41%), Gaps = 9/129 (6%)
Query: 426 KNGSQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATNNFDDGHCIGNGGQGSVYKAK-LP 484
N S+ S RN + + LT D + V+ + +R + + +G+G G V A
Sbjct: 101 NNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALR--DEYIMSKTLGSGACGEVKLAFERK 158
Query: 485 TGEIVDVK-----KFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539
T + V ++ KF E E+ L K+ H I+K F + ++V
Sbjct: 159 TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIV 217
Query: 540 YEYLEMGSL 548
E +E G L
Sbjct: 218 LELMEGGEL 226
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 9e-06
Identities = 17/83 (20%), Positives = 34/83 (40%), Gaps = 4/83 (4%)
Query: 470 IGNGGQGSVYKAK-LPTGEIVDVK---KFHSPLPDEMACQQEFLNEVNALTKIRHRNIVK 525
+G+G V K + TG K K + +++ EV+ L +I+H N++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 526 FYGFCSHALHSFVVYEYLEMGSL 548
+ + ++ E + G L
Sbjct: 79 LHEVYENKTDVILILELVAGGEL 101
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 10/88 (11%), Positives = 25/88 (28%), Gaps = 1/88 (1%)
Query: 453 VHEEIIRATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNE 511
V + + + G + V+ + + E +K F + + +
Sbjct: 53 VDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEA 112
Query: 512 VNALTKIRHRNIVKFYGFCSHALHSFVV 539
A ++ + + L S V
Sbjct: 113 TFAAARLLGESPEEARDRRRLLLPSDAV 140
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 23/132 (17%), Positives = 47/132 (35%), Gaps = 10/132 (7%)
Query: 424 QRKNGSQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATNNFDD------GHCIGNGGQGS 477
+ S R + + + H + + +G G G
Sbjct: 45 NADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQ 104
Query: 478 VYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHS 536
V+K + TG + K + M ++E NE++ + ++ H N+++ Y
Sbjct: 105 VHKCEETATGLKLAAKIIKT---RGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDI 161
Query: 537 FVVYEYLEMGSL 548
+V EY++ G L
Sbjct: 162 VLVMEYVDGGEL 173
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 22/92 (23%), Positives = 38/92 (41%), Gaps = 4/92 (4%)
Query: 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVK---KFHSPLPDEMACQQEFLNEVNALT 516
+ +D G +G+G V K + TG K K S C++E EV+ L
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 517 KIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
++ H NI+ + + ++ E + G L
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGEL 102
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 25/107 (23%), Positives = 35/107 (32%), Gaps = 12/107 (11%)
Query: 447 TFDGKIVHEEIIRATNNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQ 505
E + + F G G G+V K TG V +KK D
Sbjct: 8 LNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ---DPRFRN 64
Query: 506 QEFLNEVNALTKIRHRNIVK-FYGFCSHALHSF------VVYEYLEM 545
+E L + L + H NIV+ F + VV EY+
Sbjct: 65 RE-LQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD 110
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 1e-05
Identities = 22/92 (23%), Positives = 39/92 (42%), Gaps = 4/92 (4%)
Query: 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVK---KFHSPLPDEMACQQEFLNEVNALT 516
++++ G +G+G V K + TG+ K K ++E EVN L
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 517 KIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
+IRH NI+ + + ++ E + G L
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGEL 95
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 23/100 (23%), Positives = 39/100 (39%), Gaps = 18/100 (18%)
Query: 459 RATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDE----MACQQEFLNEVN 513
+ ++ IG G G V+KA+ TG+ V +KK E A L E+
Sbjct: 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA-----LREIK 68
Query: 514 ALTKIRHRNIVKFYGFCSHALHS--------FVVYEYLEM 545
L ++H N+V C ++V+++ E
Sbjct: 69 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH 108
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 23/91 (25%), Positives = 42/91 (46%), Gaps = 8/91 (8%)
Query: 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTK-IR 519
+ D IG G GSV K P+G+I+ VK+ S + ++ Q++ L +++ + +
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE--QKQLLMDLDVVMRSSD 79
Query: 520 HRNIVKFYG--FCSHALHSFVVYEYLEMGSL 548
IV+FYG F ++ E +
Sbjct: 80 CPYIVQFYGALFREGDC--WICMELMSTSFD 108
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 19/103 (18%), Positives = 42/103 (40%), Gaps = 8/103 (7%)
Query: 451 KIVHEEIIRATNNFDD----GHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQ 505
K V + + + D +G+G G V++ TG + K ++P P + +
Sbjct: 36 KYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---K 92
Query: 506 QEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
NE++ + ++ H ++ + ++ E+L G L
Sbjct: 93 YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL 135
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 18/88 (20%), Positives = 31/88 (35%), Gaps = 8/88 (9%)
Query: 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RH 520
N +G G G+V G V VK+ L E+ LT+ H
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI------DFCDIALMEIKLLTESDDH 68
Query: 521 RNIVKFYGFCSHALHSFVVYEYLEMGSL 548
N++++Y + ++ E +L
Sbjct: 69 PNVIRYYCSETTDRFLYIALELCN-LNL 95
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 2e-05
Identities = 26/81 (32%), Positives = 38/81 (46%), Gaps = 10/81 (12%)
Query: 470 IGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDE----MACQQEFLNEVNALTKIRHRNIV 524
IG G G VYKA+ TGE+V +KK E A + E++ L ++ H NIV
Sbjct: 11 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-----IREISLLKELNHPNIV 65
Query: 525 KFYGFCSHALHSFVVYEYLEM 545
K ++V+E+L
Sbjct: 66 KLLDVIHTENKLYLVFEFLHQ 86
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 20/92 (21%), Positives = 37/92 (40%), Gaps = 4/92 (4%)
Query: 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVK---KFHSPLPDEMACQQEFLNEVNALT 516
+ +D G +G+G V K + TG K K S ++E EV+ L
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 517 KIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
++ H N++ + + ++ E + G L
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGEL 102
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 27/133 (20%), Positives = 45/133 (33%), Gaps = 12/133 (9%)
Query: 423 RQRKNGSQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATN-----NFDDGHCIGNGGQGS 477
Q+ N S G K ++ ++ H IG G G
Sbjct: 9 AQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGH 68
Query: 478 VYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYG-FCSHALH 535
V +A +V +KK D + C++ L E+ L ++ H ++VK +
Sbjct: 69 VCEAYDKLEKRVVAIKKILRVFEDLIDCKRI-LREIAILNRLNHDHVVKVLDIVIPKDVE 127
Query: 536 SF----VVYEYLE 544
F VV E +
Sbjct: 128 KFDELYVVLEIAD 140
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 22/90 (24%), Positives = 36/90 (40%), Gaps = 4/90 (4%)
Query: 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFH-SPLPDEMACQQEFLNEVNALTKI 518
++ +G G G V K K T + VK + + ++ L EV L K+
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD--TSTILREVELLKKL 78
Query: 519 RHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
H NI+K + + ++V E G L
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGEL 108
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 19/95 (20%), Positives = 30/95 (31%), Gaps = 8/95 (8%)
Query: 459 RATNNFDD----GHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVN 513
+ + + IG G G V A T KK + F E+
Sbjct: 2 STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK---YFVEDVDRFKQEIE 58
Query: 514 ALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
+ + H NI++ Y ++V E G L
Sbjct: 59 IMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGEL 93
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 15/87 (17%), Positives = 32/87 (36%), Gaps = 8/87 (9%)
Query: 463 NFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHR 521
+F +G+G +G++ + V VK+ C EV L + H
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP------ECFSFADREVQLLRESDEHP 78
Query: 522 NIVKFYGFCSHALHSFVVYEYLEMGSL 548
N+++++ ++ E +L
Sbjct: 79 NVIRYFCTEKDRQFQYIAIELCA-ATL 104
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 19/127 (14%), Positives = 46/127 (36%), Gaps = 4/127 (3%)
Query: 423 RQRKNGSQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATNNFDDGHCIGNGGQGSVYKAK 482
+ + + SS + + + V + +++D +G G G V++
Sbjct: 118 QGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVT 177
Query: 483 -LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541
TG K + + ++ E+ ++ +RH +V + ++YE
Sbjct: 178 ERATGNNFAAKFVMT---PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234
Query: 542 YLEMGSL 548
++ G L
Sbjct: 235 FMSGGEL 241
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 26/83 (31%), Positives = 39/83 (46%), Gaps = 14/83 (16%)
Query: 470 IGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYG 528
IGNG G VY+AKL +GE+V +KK L D+ E+ + K+ H NIV+
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFK----NRELQIMRKLDHCNIVRLRY 114
Query: 529 FCSHALHSF------VVYEYLEM 545
F + +V +Y+
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPE 137
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 19/135 (14%), Positives = 37/135 (27%), Gaps = 11/135 (8%)
Query: 425 RKNGSQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATNNFDD----GHCIGNGGQGSVYK 480
+ + + G A F IG G V +
Sbjct: 53 NLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRR 112
Query: 481 AK-LPTGE-----IVDVKKFHSPLPDEMACQQEFLNEVNALTKIR-HRNIVKFYGFCSHA 533
TG I++V ++ E + L ++ H +I+ +
Sbjct: 113 CVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172
Query: 534 LHSFVVYEYLEMGSL 548
F+V++ + G L
Sbjct: 173 SFMFLVFDLMRKGEL 187
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 3e-05
Identities = 20/88 (22%), Positives = 41/88 (46%), Gaps = 1/88 (1%)
Query: 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH 520
++FD G +G G G+VY A+ I+ +K ++ + + E+ + +RH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 521 RNIVKFYGFCSHALHSFVVYEYLEMGSL 548
NI++ Y + +++ E+ G L
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGEL 101
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 37/191 (19%), Positives = 72/191 (37%), Gaps = 16/191 (8%)
Query: 98 SLSDLQLSE-NILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYE-N 155
+ + LS I ++ L + L L L +LS I + A ++L L L +
Sbjct: 94 RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS 153
Query: 156 SLCDSIPKEIG-NMNSLSILDLSSNKL--NGSIPLSLANLTNSLKVLYLSS-NHIVGEIP 211
+ + + + + L L+LS + +++A+++ ++ L LS + +
Sbjct: 154 GFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSD 213
Query: 212 LGH--GMLSSLIQLTLNN-NELSGQLSPELGSLIQLEYLDLSANTFHKSIP----ESLSN 264
L +L+ L L++ L E L L++L LS I L
Sbjct: 214 LSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY---DIIPETLLELGE 270
Query: 265 LVKLHYLNLSN 275
+ L L +
Sbjct: 271 IPTLKTLQVFG 281
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 3e-05
Identities = 23/93 (24%), Positives = 42/93 (45%), Gaps = 12/93 (12%)
Query: 459 RATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQE-----FLNEV 512
+ + + +G G G VYKA T E V +K+ + ++E + EV
Sbjct: 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREV 84
Query: 513 NALTKIRHRNIVKFYGFCSHALHSFVVYEYLEM 545
+ L +++HRNI++ H +++EY E
Sbjct: 85 SLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN 117
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 21/94 (22%), Positives = 32/94 (34%), Gaps = 9/94 (9%)
Query: 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGE-----IVDVKKFHSPLPDEMACQQEFLNEVNA 514
+ IG G G V A T I++ K P ++ + EV
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDV---ERIKTEVRL 81
Query: 515 LTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
+ K+ H NI + Y + +V E G L
Sbjct: 82 MKKLHHPNIARLYEVYEDEQYICLVMELCHGGHL 115
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 4e-05
Identities = 22/92 (23%), Positives = 37/92 (40%), Gaps = 9/92 (9%)
Query: 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVK---KFHSPLPDEMACQQEFLNEVNALT 516
+ F +G+G G V+ + +G +K K S +P E E+ L
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQ-----IEAEIEVLK 75
Query: 517 KIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
+ H NI+K + + ++V E E G L
Sbjct: 76 SLDHPNIIKIFEVFEDYHNMYIVMETCEGGEL 107
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 15/96 (15%), Positives = 30/96 (31%), Gaps = 12/96 (12%)
Query: 461 TNNFDD----GHCIGNGGQGSVYKAK-LPTGEIVDVK---KFHSPLPDEMACQQEFLNEV 512
F + +G G V + + G+ D E
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK----LEREA 61
Query: 513 NALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
++H NIV+ + S H +++++ + G L
Sbjct: 62 RICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL 97
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 5e-05
Identities = 20/76 (26%), Positives = 35/76 (46%), Gaps = 1/76 (1%)
Query: 470 IGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYG 528
+G GG +VY A+ V +K P ++ + F EV+ +++ H+NIV
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 529 FCSHALHSFVVYEYLE 544
++V EY+E
Sbjct: 79 VDEEDDCYYLVMEYIE 94
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 44.4 bits (106), Expect = 6e-05
Identities = 25/81 (30%), Positives = 40/81 (49%), Gaps = 10/81 (12%)
Query: 470 IGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDE----MACQQEFLNEVNALTKIRHRNIV 524
IG G G+V+KAK T EIV +K+ DE A L E+ L +++H+NIV
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA-----LREICLLKELKHKNIV 64
Query: 525 KFYGFCSHALHSFVVYEYLEM 545
+ + +V+E+ +
Sbjct: 65 RLHDVLHSDKKLTLVFEFCDQ 85
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 6e-05
Identities = 24/127 (18%), Positives = 46/127 (36%), Gaps = 10/127 (7%)
Query: 423 RQRKNGSQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATNNFDDGHCIGNGGQGSVYKAK 482
++ S S+ T L+ DG + + + + F+ +G G VY+ K
Sbjct: 18 LYFQSMSSVTASAAPGTASLVPDYWIDGS--NRDALS--DFFEVESELGRGATSIVYRCK 73
Query: 483 -LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541
T + +K + ++ E+ L ++ H NI+K +V E
Sbjct: 74 QKGTQKPYALKVL-----KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128
Query: 542 YLEMGSL 548
+ G L
Sbjct: 129 LVTGGEL 135
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 6e-05
Identities = 19/94 (20%), Positives = 33/94 (35%), Gaps = 8/94 (8%)
Query: 461 TNNFDD----GHCIGNGGQGSVYKA-KLPTGEIVDVKKFH-SPLPDEMACQQEFLNEVNA 514
+ F D +G G V + TG K + L Q+ E
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD--FQKLEREARI 58
Query: 515 LTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
K++H NIV+ + ++V++ + G L
Sbjct: 59 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 92
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 7e-05
Identities = 24/96 (25%), Positives = 37/96 (38%), Gaps = 10/96 (10%)
Query: 459 RATNNFDD----GHCIGNGGQGSVYKAK-LPTGEIVDVKKFH-SPLPDEMACQQEFLNEV 512
T N +G+G V+ K TG++ +K SP + NE+
Sbjct: 2 MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD----SSLENEI 57
Query: 513 NALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
L KI+H NIV H ++V + + G L
Sbjct: 58 AVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL 93
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 8e-05
Identities = 23/89 (25%), Positives = 34/89 (38%), Gaps = 9/89 (10%)
Query: 467 GHCIGNGGQGSVYKAK-LPTGEIVDVK-----KFHSPLPDEMACQQEFLNEVNALTKIRH 520
+G+G G V A T + V +K KF E E+ L K+ H
Sbjct: 15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 521 RNIVKFYG-FCSHALHSFVVYEYLEMGSL 548
I+K F + + +V E +E G L
Sbjct: 75 PCIIKIKNFFDAEDYY--IVLELMEGGEL 101
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 8e-05
Identities = 18/90 (20%), Positives = 41/90 (45%), Gaps = 8/90 (8%)
Query: 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTK-IR 519
++ + +G G G V K + +P+G+I+ VK+ + + + Q+ L +++ + +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE--QKRLLMDLDISMRTVD 64
Query: 520 HRNIVKFYG--FCSHALHSFVVYEYLEMGS 547
V FYG F + + E ++
Sbjct: 65 CPFTVTFYGALFREGDVW--ICMELMDTSL 92
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 8e-05
Identities = 18/77 (23%), Positives = 36/77 (46%), Gaps = 3/77 (3%)
Query: 470 IGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYG 528
+GNG +VYK TG V +K+ + + E++ + +++H NIV+ Y
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA--IREISLMKELKHENIVRLYD 70
Query: 529 FCSHALHSFVVYEYLEM 545
+V+E+++
Sbjct: 71 VIHTENKLTLVFEFMDN 87
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 9e-05
Identities = 14/89 (15%), Positives = 31/89 (34%), Gaps = 5/89 (5%)
Query: 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR 519
+ +G G G V++ + + K D+ E++ L R
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIAR 59
Query: 520 HRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
HRNI+ + +++E++ +
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDI 88
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 21/100 (21%), Positives = 37/100 (37%), Gaps = 8/100 (8%)
Query: 455 EEIIRATNNFDD----GHCIGNGGQGSVYKA-KLPTGEIVDVKKFH-SPLPDEMACQQEF 508
E ++ A+ F D +G G V + TG K + L Q+
Sbjct: 18 EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR--DFQKL 75
Query: 509 LNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
E K++H NIV+ + ++V++ + G L
Sbjct: 76 EREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 115
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 1e-04
Identities = 23/100 (23%), Positives = 44/100 (44%), Gaps = 15/100 (15%)
Query: 459 RATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEF----LNEVN 513
AT+ ++ IG G G+VYKA+ +G V +K +P+ + EV
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR--VPNGGGGGGGLPISTVREVA 63
Query: 514 ALTKIR---HRNIVKFYGFCSHALHS-----FVVYEYLEM 545
L ++ H N+V+ C+ + +V+E+++
Sbjct: 64 LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ 103
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 22/85 (25%), Positives = 36/85 (42%), Gaps = 3/85 (3%)
Query: 462 NNFDDGHCIGNGGQGSVYKAKLP-TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH 520
+ +G G +VYK K T +V +K+ L E + EV+ L ++H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR--LEHEEGAPCTAIREVSLLKDLKH 59
Query: 521 RNIVKFYGFCSHALHSFVVYEYLEM 545
NIV + +V+EYL+
Sbjct: 60 ANIVTLHDIIHTEKSLTLVFEYLDK 84
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 22/101 (21%), Positives = 39/101 (38%), Gaps = 12/101 (11%)
Query: 470 IGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR-HRNIVKFY 527
+ GG VY+A+ + +G +K+ S ++ + + EV + K+ H NIV+F
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEK---NRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 528 GFCSHALHS-------FVVYEYLEMGSLAMNLSNDAAAEQF 561
S F++ L G L L +
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPL 133
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 21/88 (23%), Positives = 35/88 (39%), Gaps = 6/88 (6%)
Query: 467 GHCIGNGGQGSVYKAKLP-TGEIVDVKKFHSPLPDEMACQQE---FLNEVNALTKI-RHR 521
G +G G G V +A + + + E A E ++E+ L I H
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 522 NIVKFYGFCSHALHS-FVVYEYLEMGSL 548
N+V G C+ V+ E+ + G+L
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNL 114
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 21/102 (20%), Positives = 39/102 (38%), Gaps = 12/102 (11%)
Query: 459 RATNNFDD----GHCIGNGGQGSVYKAK-LPTGEIVDVKKF------HSPLPDEMACQQE 507
+T+ F + +G G V + PT + VK + ++
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 508 FLNEVNALTKI-RHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
L EV+ L K+ H NI++ F+V++ ++ G L
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL 111
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 24/90 (26%), Positives = 40/90 (44%), Gaps = 7/90 (7%)
Query: 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR 519
+N+ H IG G G VY A T + V +KK + D + C++ L E+ L +++
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKR-ILREITILNRLK 83
Query: 520 HRNIVKFYG-FCSHALHSF----VVYEYLE 544
I++ Y L F +V E +
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEIAD 113
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 28/129 (21%), Positives = 49/129 (37%), Gaps = 19/129 (14%)
Query: 424 QRKNGSQTQQSSPRNTLGLLSVLTFDGKIVHEEIIRATNNFDDGHCIGNGGQGSVYKAKL 483
+ + + + ++ VL DGK + I + + IGNG G V++AKL
Sbjct: 6 SNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIA----YTNCKVIGNGSFGVVFQAKL 61
Query: 484 PTGEIVDVKKFHSPLPDEMACQQEFLN-EVNALTKIRHRNIVKFYGFCSHALHS------ 536
+ V +KK + F N E+ + ++H N+V F
Sbjct: 62 VESDEVAIKKVLQ--------DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113
Query: 537 FVVYEYLEM 545
+V EY+
Sbjct: 114 NLVLEYVPE 122
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 571 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.97 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.96 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.92 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.92 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.91 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.9 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.88 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.88 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.86 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.85 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.84 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.83 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.83 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.83 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.83 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.82 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.81 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.81 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.81 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.8 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.8 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.8 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.79 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.79 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.78 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.78 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.78 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.78 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 99.77 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.77 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 99.76 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 99.76 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.76 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.75 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.75 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 99.75 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.74 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.74 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.73 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.72 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.72 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 99.72 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.71 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.71 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.7 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.7 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 99.7 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.7 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 99.7 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.69 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.68 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 99.67 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.66 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.65 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.63 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 99.63 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.63 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.62 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.62 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.61 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.61 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.6 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.6 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.57 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.57 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.54 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.53 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.53 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.51 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.51 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.51 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.51 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.5 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.49 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.49 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.49 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.48 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.48 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.48 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.47 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.47 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.47 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.46 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.46 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.46 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.46 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.45 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.45 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.45 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.44 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.44 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.44 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.43 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.43 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.43 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.43 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.43 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.43 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.43 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.43 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.42 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.42 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.42 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.42 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.42 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.42 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.42 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.42 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.42 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.41 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.41 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.41 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.41 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.41 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.41 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.4 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.4 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.4 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.4 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.4 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.4 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.4 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.4 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.4 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.39 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.39 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.39 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.39 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.39 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.39 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.39 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.39 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.39 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.39 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.38 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.38 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.38 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.38 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.38 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.37 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.37 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.37 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.37 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.37 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.37 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.37 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.37 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.37 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.37 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.37 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.37 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.36 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.36 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.36 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.36 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.36 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.36 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.36 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.36 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.36 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.36 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.36 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.36 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.36 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.36 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.36 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.35 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.35 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.35 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.35 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.35 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.35 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.35 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.35 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.34 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.34 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.34 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.34 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.34 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.34 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.34 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.34 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.34 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.34 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.34 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.34 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.34 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.33 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.33 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.33 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.33 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.33 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.32 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.32 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.32 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.32 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.32 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.32 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.31 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.31 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.31 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.31 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.31 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.31 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.31 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.31 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.31 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.31 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.3 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.3 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.3 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.3 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.3 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.3 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.3 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.3 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.3 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.29 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.29 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.29 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.29 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.29 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.29 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.29 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.28 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.28 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.27 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.27 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.27 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.26 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.26 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.26 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.26 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.25 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.25 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.25 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.25 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.25 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.25 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.25 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.25 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.24 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.24 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.24 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.24 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.23 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.23 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.23 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.23 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.23 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.23 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.23 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.23 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.22 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.22 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.22 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.22 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.22 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.21 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.21 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.21 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.21 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.2 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.2 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.2 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.19 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.19 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.19 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.19 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.19 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.19 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.19 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.19 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.18 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.18 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.18 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.18 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.17 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.17 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.16 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.16 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.16 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.15 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.15 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.14 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.14 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.14 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.14 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.14 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.14 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.13 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.13 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.12 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.11 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.11 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.1 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.09 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.08 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.07 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.07 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.06 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.06 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.05 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.05 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.04 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.03 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.03 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.03 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.02 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.02 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 99.01 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 98.99 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.99 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 98.99 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 98.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 98.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 98.85 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.81 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 98.78 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.76 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.58 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.48 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.48 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.39 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 98.35 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 98.34 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 98.26 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 98.11 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 98.03 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.55 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.38 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.18 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.13 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.09 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.58 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.47 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 95.6 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 93.86 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 93.67 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 93.29 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 93.25 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 92.61 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 91.18 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 87.77 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 87.36 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 83.69 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 83.06 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=395.79 Aligned_cols=346 Identities=34% Similarity=0.474 Sum_probs=291.4
Q ss_pred CCchhhcCCCCCCEEEccCCccc-------cCCCCccceeecccccccCCCCCCCc------------------cccccc
Q 044615 39 DDYKELVRAVQARDTSISFDELH-------EKLLTFEATAHFSVLAFTGQDWPLYS------------------SIPDEI 93 (571)
Q Consensus 39 ~~~~~l~~~~~l~~l~l~~n~l~-------~~~l~~l~~l~l~~n~l~~~~~~~~~------------------~~p~~~ 93 (571)
..|..+..+++|+.|+++.|.+. +..+++|+.|+++.|.+++.-...+. .+|..+
T Consensus 309 ~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~ 388 (768)
T 3rgz_A 309 AVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNL 388 (768)
T ss_dssp CCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTT
T ss_pred ccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhh
Confidence 35666777777777777777664 55666666677666666541000000 234444
Q ss_pred cC--CCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCC
Q 044615 94 GN--MKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSL 171 (571)
Q Consensus 94 ~~--l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L 171 (571)
.. +++|++|++++|.+++.+|..++++++|++|++++|.+++.+|..++++++|++|++++|.+.+.+|..+..+++|
T Consensus 389 ~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L 468 (768)
T 3rgz_A 389 CQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTL 468 (768)
T ss_dssp TCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTC
T ss_pred hhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCc
Confidence 43 6678888888888877888888888889999999998888888888889999999999999888888888899999
Q ss_pred CEEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEccc
Q 044615 172 SILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSA 251 (571)
Q Consensus 172 ~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~ 251 (571)
++|++++|++.+.+|..+..+++ |+.|++++|++++.+|..++.+++|+.|++++|++++.+|..++.+++|+.|++++
T Consensus 469 ~~L~L~~N~l~~~~p~~l~~l~~-L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 547 (768)
T 3rgz_A 469 ETLILDFNDLTGEIPSGLSNCTN-LNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNT 547 (768)
T ss_dssp CEEECCSSCCCSCCCGGGGGCTT-CCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCS
T ss_pred eEEEecCCcccCcCCHHHhcCCC-CCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCC
Confidence 99999999998888888888886 99999999999988898899999999999999999988999999999999999999
Q ss_pred Cccccccchhh---------------------------------------------------------------------
Q 044615 252 NTFHKSIPESL--------------------------------------------------------------------- 262 (571)
Q Consensus 252 n~l~~~~~~~l--------------------------------------------------------------------- 262 (571)
|.+.+.+|..+
T Consensus 548 N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~ 627 (768)
T 3rgz_A 548 NLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPT 627 (768)
T ss_dssp SEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCS
T ss_pred CccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchh
Confidence 98877666543
Q ss_pred -ccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCC
Q 044615 263 -SNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLS 341 (571)
Q Consensus 263 -~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~ 341 (571)
..+++|+.|++++|+++|.+|..++.++.|+.|+|++|.+++.+|..++.+++|+.|+|++|+++|.+|..+..++.|+
T Consensus 628 ~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~ 707 (768)
T 3rgz_A 628 FDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLT 707 (768)
T ss_dssp CSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCS
T ss_pred hhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCC
Confidence 3356789999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEECcCCcCcccCCCCCccCCCCcccccCCcCCCCCCCCCCCCCCc
Q 044615 342 CIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDIKRLPPCKAF 387 (571)
Q Consensus 342 ~L~ls~N~l~~~~~~~~~~~~~~~l~l~~n~~~c~~~~~~~~~~~~ 387 (571)
.||+++|+++|.+|....+..+...++.||+.+||.+ +++|...
T Consensus 708 ~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~--l~~C~~~ 751 (768)
T 3rgz_A 708 EIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP--LPRCDPS 751 (768)
T ss_dssp EEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTT--SCCCCSC
T ss_pred EEECcCCcccccCCCchhhccCCHHHhcCCchhcCCC--CcCCCCC
Confidence 9999999999999998889999999999999999975 3578643
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=373.17 Aligned_cols=327 Identities=32% Similarity=0.440 Sum_probs=272.9
Q ss_pred CCchhhcCC-CCCCEEEccCCccc------cCCCCccceeecccccccCCCCCCCcccccc-ccCCCCCCEEecccCcCc
Q 044615 39 DDYKELVRA-VQARDTSISFDELH------EKLLTFEATAHFSVLAFTGQDWPLYSSIPDE-IGNMKSLSDLQLSENILN 110 (571)
Q Consensus 39 ~~~~~l~~~-~~l~~l~l~~n~l~------~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~-~~~l~~L~~L~L~~n~i~ 110 (571)
..|..+... .+|+.|++++|.+. ++.+++|+.|+++.|.+++ .+|.. +.++++|++|+|++|.++
T Consensus 284 ~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-------~ip~~~l~~l~~L~~L~Ls~n~l~ 356 (768)
T 3rgz_A 284 EIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSG-------ELPMDTLLKMRGLKVLDLSFNEFS 356 (768)
T ss_dssp SCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEE-------ECCHHHHTTCTTCCEEECCSSEEE
T ss_pred ccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccC-------cCCHHHHhcCCCCCEEeCcCCccC
Confidence 567777775 99999999999887 7789999999999999987 56654 666777777777777666
Q ss_pred ccccccccC---------------------------CCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCc
Q 044615 111 GSIPLALGN---------------------------LTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPK 163 (571)
Q Consensus 111 ~~~~~~~~~---------------------------l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 163 (571)
+.+|..+.. +++|++|++++|.+++.+|..++++++|++|++++|.+.+.+|.
T Consensus 357 ~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 436 (768)
T 3rgz_A 357 GELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPS 436 (768)
T ss_dssp ECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCG
T ss_pred ccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccH
Confidence 555554433 45677777777777777788888888888888888888888888
Q ss_pred cccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCC
Q 044615 164 EIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQ 243 (571)
Q Consensus 164 ~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 243 (571)
.+..+++|++|++++|++.+.+|..+..++. |+.|++++|.+++.+|..+..+++|+.|++++|++++.+|.+++.+++
T Consensus 437 ~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 515 (768)
T 3rgz_A 437 SLGSLSKLRDLKLWLNMLEGEIPQELMYVKT-LETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLEN 515 (768)
T ss_dssp GGGGCTTCCEEECCSSCCCSCCCGGGGGCTT-CCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTT
T ss_pred HHhcCCCCCEEECCCCcccCcCCHHHcCCCC-ceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCC
Confidence 8888888888888888888888888888876 999999999988888888888899999999999999888888999999
Q ss_pred CCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhh------------------------------------
Q 044615 244 LEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIE------------------------------------ 287 (571)
Q Consensus 244 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~------------------------------------ 287 (571)
|+.|++++|.+.+.+|..+..+++|+.|++++|.+++.+|..+.
T Consensus 516 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 595 (768)
T 3rgz_A 516 LAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLE 595 (768)
T ss_dssp CCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEE
T ss_pred CCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccc
Confidence 99999999999888888899999999999999988877665432
Q ss_pred ----------------------------------cccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccc
Q 044615 288 ----------------------------------KLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRC 333 (571)
Q Consensus 288 ----------------------------------~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~ 333 (571)
.++.|+.|+|++|++++.+|..++.+++|+.|+|++|+++|.+|..
T Consensus 596 ~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~ 675 (768)
T 3rgz_A 596 FQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDE 675 (768)
T ss_dssp CTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGG
T ss_pred cccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChH
Confidence 2467888999999999999999999999999999999999999999
Q ss_pred cccCCCCCEEECcCCcCcccCCC-CCccCCCCcccccCCcC
Q 044615 334 FEEMHWLSCIDISYNALQGLIPN-STAFRDAPMLALQGNKR 373 (571)
Q Consensus 334 ~~~l~~L~~L~ls~N~l~~~~~~-~~~~~~~~~l~l~~n~~ 373 (571)
|..++.|+.|||++|+++|.+|. ...+..+..+++++|+.
T Consensus 676 l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l 716 (768)
T 3rgz_A 676 VGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNL 716 (768)
T ss_dssp GGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEE
T ss_pred HhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcc
Confidence 99999999999999999988886 35567788888888864
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=331.82 Aligned_cols=331 Identities=22% Similarity=0.225 Sum_probs=276.5
Q ss_pred CCCCCchhhcCCCCCCEEEccCCccc------cCCCCccceeecccccccCCCCCCCccc-cccccCCCCCCEEecccCc
Q 044615 36 GLGDDYKELVRAVQARDTSISFDELH------EKLLTFEATAHFSVLAFTGQDWPLYSSI-PDEIGNMKSLSDLQLSENI 108 (571)
Q Consensus 36 ~~~~~~~~l~~~~~l~~l~l~~n~l~------~~~l~~l~~l~l~~n~l~~~~~~~~~~~-p~~~~~l~~L~~L~L~~n~ 108 (571)
++..+|. -..++++|+|++|.+. +..+++|++|++++|.+.+ .+ |..|.++++|++|+|++|.
T Consensus 21 ~l~~lp~---l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~-------~i~~~~~~~l~~L~~L~Ls~n~ 90 (455)
T 3v47_A 21 GLHQVPE---LPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGL-------VIRNNTFRGLSSLIILKLDYNQ 90 (455)
T ss_dssp CCSSCCC---CCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTC-------EECTTTTTTCTTCCEEECTTCT
T ss_pred CcccCCC---CCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccc-------eECcccccccccCCEEeCCCCc
Confidence 4455555 2278999999999887 7788999999999998875 44 5678899999999999999
Q ss_pred CcccccccccCCCCCCEEEcccCcCccccccc--ccCCCCCCeeecccCcCcccCCcc-ccCCCCCCEEEccCCCCCccC
Q 044615 109 LNGSIPLALGNLTNLVVLDLSTNKLSGSIPLS--FANLTSLSILYLYENSLCDSIPKE-IGNMNSLSILDLSSNKLNGSI 185 (571)
Q Consensus 109 i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~-l~~l~~L~~L~L~~n~l~~~~ 185 (571)
+++..|..|+++++|++|+|++|.+++..+.. |..+++|++|+|++|.+.+..|.. +..+++|++|++++|++.+..
T Consensus 91 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 170 (455)
T 3v47_A 91 FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSIC 170 (455)
T ss_dssp TCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCC
T ss_pred cCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccC
Confidence 99888999999999999999999998755554 899999999999999998877766 889999999999999999877
Q ss_pred Chhhhhcc-CCCcEEEccCCcccccCCcc--------ccCCCCCcEEeCccCcCcCCCChhhhC----------------
Q 044615 186 PLSLANLT-NSLKVLYLSSNHIVGEIPLG--------HGMLSSLIQLTLNNNELSGQLSPELGS---------------- 240 (571)
Q Consensus 186 p~~~~~l~-~~L~~L~l~~n~~~~~~~~~--------~~~l~~L~~L~l~~n~l~~~~~~~~~~---------------- 240 (571)
|..+..+. .+|+.|++++|.+.+..+.. +..+++|+.|++++|.+.+..|..+..
T Consensus 171 ~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~ 250 (455)
T 3v47_A 171 EEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSY 250 (455)
T ss_dssp TTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCT
T ss_pred hhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeecccc
Confidence 77776652 23777888887776544332 224567777777777776544443321
Q ss_pred -----------------------CCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEc
Q 044615 241 -----------------------LIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDL 297 (571)
Q Consensus 241 -----------------------l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 297 (571)
.++|+.|++++|.+.+..|..+..+++|+.|++++|.+++..|..+..+++|+.|++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 330 (455)
T 3v47_A 251 NMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNL 330 (455)
T ss_dssp TTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEEC
Confidence 268999999999999888999999999999999999999888889999999999999
Q ss_pred cCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCcccCCCC-CccCCCCcccccCCcCCCC
Q 044615 298 SHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNS-TAFRDAPMLALQGNKRLCG 376 (571)
Q Consensus 298 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~-~~~~~~~~l~l~~n~~~c~ 376 (571)
++|.+.+..+..+..+++|+.|+|++|++++..|..|..+++|+.|++++|++++.++.. ..++.+..+++.+|+..|.
T Consensus 331 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 410 (455)
T 3v47_A 331 SQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 410 (455)
T ss_dssp CSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccC
Confidence 999999888889999999999999999999988999999999999999999999877753 5678889999999998774
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=329.14 Aligned_cols=332 Identities=21% Similarity=0.191 Sum_probs=290.0
Q ss_pred CCCCCchhhcCCCCCCEEEccCCccc------cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcC
Q 044615 36 GLGDDYKELVRAVQARDTSISFDELH------EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENIL 109 (571)
Q Consensus 36 ~~~~~~~~l~~~~~l~~l~l~~n~l~------~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i 109 (571)
++..+|..+. .+++.|+|++|.+. +..+++|+.|+|++|.+++ ..|..|.++++|++|+|++|.+
T Consensus 22 ~l~~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~-------~~~~~~~~l~~L~~L~L~~n~l 92 (477)
T 2id5_A 22 RFVAVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSA-------VEPGAFNNLFNLRTLGLRSNRL 92 (477)
T ss_dssp CCSSCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCE-------ECTTTTTTCTTCCEEECCSSCC
T ss_pred CcCcCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCE-------eChhhhhCCccCCEEECCCCcC
Confidence 4455666553 58899999999887 7789999999999999987 6688899999999999999999
Q ss_pred cccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhh
Q 044615 110 NGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSL 189 (571)
Q Consensus 110 ~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~ 189 (571)
+...+..|.++++|++|+|++|.+.+..+..|.++++|++|++++|.+.+..+..|..+++|++|++++|++++..+..+
T Consensus 93 ~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l 172 (477)
T 2id5_A 93 KLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEAL 172 (477)
T ss_dssp CSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHH
T ss_pred CccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHh
Confidence 97777788999999999999999998889999999999999999999998888899999999999999999986555567
Q ss_pred hhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCC
Q 044615 190 ANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLH 269 (571)
Q Consensus 190 ~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~ 269 (571)
..+++ |+.|++++|.+.+..+..+..+++|+.|++++|...+.++.......+|+.|++++|.++...+..+..+++|+
T Consensus 173 ~~l~~-L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 251 (477)
T 2id5_A 173 SHLHG-LIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLR 251 (477)
T ss_dssp TTCTT-CCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCC
T ss_pred cccCC-CcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccC
Confidence 77775 99999999999988888999999999999999988877777777777999999999999876667899999999
Q ss_pred EEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCc
Q 044615 270 YLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNA 349 (571)
Q Consensus 270 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~ 349 (571)
.|++++|.+++..+..+..+++|+.|+|++|++.+..|..|..+++|+.|+|++|++++..+..|..+++|+.|++++|+
T Consensus 252 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 331 (477)
T 2id5_A 252 FLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNP 331 (477)
T ss_dssp EEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSC
T ss_pred eeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCC
Confidence 99999999998888889999999999999999999889999999999999999999998888889999999999999999
Q ss_pred CcccCCCCCccCCCCcccccCCcCCCCC
Q 044615 350 LQGLIPNSTAFRDAPMLALQGNKRLCGD 377 (571)
Q Consensus 350 l~~~~~~~~~~~~~~~l~l~~n~~~c~~ 377 (571)
+++..+....+.......+.++...|..
T Consensus 332 l~c~c~~~~~~~~~~~~~~~~~~~~C~~ 359 (477)
T 2id5_A 332 LACDCRLLWVFRRRWRLNFNRQQPTCAT 359 (477)
T ss_dssp EECSGGGHHHHTTTTSSCCTTCCCBEEE
T ss_pred ccCccchHhHHhhhhccccCccCceeCC
Confidence 9876543222233334455666666643
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=333.85 Aligned_cols=114 Identities=19% Similarity=0.175 Sum_probs=81.4
Q ss_pred hhhcCCCCCCEEEccCCccc------cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccccc
Q 044615 42 KELVRAVQARDTSISFDELH------EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPL 115 (571)
Q Consensus 42 ~~l~~~~~l~~l~l~~n~l~------~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~ 115 (571)
..+.++++|++|++++|.+. +..+++|++|+|++|.+++ ..|..|+++++|++|+|++|.+++..+.
T Consensus 50 ~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~-------~~p~~~~~l~~L~~L~L~~n~l~~~~~~ 122 (606)
T 3vq2_A 50 YSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQS-------FSPGSFSGLTSLENLVAVETKLASLESF 122 (606)
T ss_dssp TTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCC-------CCTTSSTTCTTCCEEECTTSCCCCSSSS
T ss_pred hhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccc-------cChhhcCCcccCCEEEccCCcccccccc
Confidence 35667777777777777665 5567777777777777766 4567777777777777777777766666
Q ss_pred cccCCCCCCEEEcccCcCcc-cccccccCCCCCCeeecccCcCcccCC
Q 044615 116 ALGNLTNLVVLDLSTNKLSG-SIPLSFANLTSLSILYLYENSLCDSIP 162 (571)
Q Consensus 116 ~~~~l~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~ 162 (571)
.|+++++|++|++++|.+.+ .+|..|+++++|++|++++|.+.+..|
T Consensus 123 ~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~ 170 (606)
T 3vq2_A 123 PIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITV 170 (606)
T ss_dssp CCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECT
T ss_pred ccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecCh
Confidence 77777777777777777765 457777777777777777777665443
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=322.90 Aligned_cols=311 Identities=22% Similarity=0.220 Sum_probs=260.2
Q ss_pred chhhcCCCCCCEEEccCCccc-------cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccc
Q 044615 41 YKELVRAVQARDTSISFDELH-------EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSI 113 (571)
Q Consensus 41 ~~~l~~~~~l~~l~l~~n~l~-------~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~ 113 (571)
|..+.++++|++|++++|.+. +..+++|++|+|++|.+++ ..|..|+++++|++|+|++|.+++..
T Consensus 47 ~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~-------~~~~~~~~l~~L~~L~L~~n~l~~~~ 119 (455)
T 3v47_A 47 ETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQ-------LETGAFNGLANLEVLTLTQCNLDGAV 119 (455)
T ss_dssp TTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCE-------ECTTTTTTCTTCCEEECTTSCCBTHH
T ss_pred hhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCc-------cChhhccCcccCCEEeCCCCCCCccc
Confidence 678999999999999999764 7789999999999999987 66889999999999999999998766
Q ss_pred ccc--ccCCCCCCEEEcccCcCccccccc-ccCCCCCCeeecccCcCcccCCccccCC--CCCCEEEccCCCC-------
Q 044615 114 PLA--LGNLTNLVVLDLSTNKLSGSIPLS-FANLTSLSILYLYENSLCDSIPKEIGNM--NSLSILDLSSNKL------- 181 (571)
Q Consensus 114 ~~~--~~~l~~L~~L~L~~n~i~~~~~~~-~~~l~~L~~L~L~~n~l~~~~~~~l~~l--~~L~~L~L~~n~l------- 181 (571)
+.. |+.+++|++|+|++|.+++..|.. +.++++|++|++++|.+.+..|..+..+ .+|+.|++++|.+
T Consensus 120 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~ 199 (455)
T 3v47_A 120 LSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYW 199 (455)
T ss_dssp HHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTC
T ss_pred cCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhh
Confidence 555 999999999999999999887776 8999999999999999998888777655 3445555555544
Q ss_pred -------------------------CccCChhhhhcc--CCCcEEEccCCcccccC----------Ccccc--CCCCCcE
Q 044615 182 -------------------------NGSIPLSLANLT--NSLKVLYLSSNHIVGEI----------PLGHG--MLSSLIQ 222 (571)
Q Consensus 182 -------------------------~~~~p~~~~~l~--~~L~~L~l~~n~~~~~~----------~~~~~--~l~~L~~ 222 (571)
.+..|..+.... .+|+.|++++|...+.. +..+. ..++|+.
T Consensus 200 ~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ 279 (455)
T 3v47_A 200 LGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKT 279 (455)
T ss_dssp TTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCE
T ss_pred ccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceE
Confidence 444443333320 12444444444332210 01111 1368999
Q ss_pred EeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcC
Q 044615 223 LTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIF 302 (571)
Q Consensus 223 L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 302 (571)
|++++|.+.+..|..+..+++|+.|++++|.+.+..|..+.++++|+.|++++|.+++..+..+..+++|+.|+|++|.+
T Consensus 280 L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 359 (455)
T 3v47_A 280 CDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHI 359 (455)
T ss_dssp EECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCC
T ss_pred EEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcc
Confidence 99999999999999999999999999999999998899999999999999999999988889999999999999999999
Q ss_pred CcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCcccCCCCC
Q 044615 303 REEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNST 358 (571)
Q Consensus 303 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~ 358 (571)
++..|..+..+++|++|+|++|++++..+..|..+++|+.|++++|++++.+|...
T Consensus 360 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 415 (455)
T 3v47_A 360 RALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 415 (455)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred cccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCcch
Confidence 99889999999999999999999998888889999999999999999999988643
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=335.73 Aligned_cols=320 Identities=19% Similarity=0.238 Sum_probs=199.9
Q ss_pred CchhhcCCCCCCEEEccCCcccc-----------------------C--CCCccceeecccccccCCCCCCCcccccccc
Q 044615 40 DYKELVRAVQARDTSISFDELHE-----------------------K--LLTFEATAHFSVLAFTGQDWPLYSSIPDEIG 94 (571)
Q Consensus 40 ~~~~l~~~~~l~~l~l~~n~l~~-----------------------~--~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~ 94 (571)
+|++++++++|++|+|++|.++- + .+++|++|+|++|.+.+ .+|..++
T Consensus 198 ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~-------~~p~~l~ 270 (636)
T 4eco_A 198 VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLT-------KLPTFLK 270 (636)
T ss_dssp ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCS-------SCCTTTT
T ss_pred CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCc-------cChHHHh
Confidence 68889999999999999987653 2 78899999999999888 7888888
Q ss_pred CCCCCCEEecccCc-Ccc-cccccccCC------CCCCEEEcccCcCcccccc--cccCCCCCCeeecccCcCcccCCcc
Q 044615 95 NMKSLSDLQLSENI-LNG-SIPLALGNL------TNLVVLDLSTNKLSGSIPL--SFANLTSLSILYLYENSLCDSIPKE 164 (571)
Q Consensus 95 ~l~~L~~L~L~~n~-i~~-~~~~~~~~l------~~L~~L~L~~n~i~~~~~~--~~~~l~~L~~L~L~~n~l~~~~~~~ 164 (571)
++++|++|+|++|. +++ .+|..++.+ ++|++|++++|.++ .+|. .++++++|++|++++|.+.+.+| .
T Consensus 271 ~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~ 348 (636)
T 4eco_A 271 ALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-A 348 (636)
T ss_dssp TCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-C
T ss_pred cCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-h
Confidence 88899999998888 887 777777665 78888888888887 6676 78888888888888888776666 6
Q ss_pred ccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCC--CCcEEeCccCcCcCCCChhhh---
Q 044615 165 IGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLS--SLIQLTLNNNELSGQLSPELG--- 239 (571)
Q Consensus 165 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~--~L~~L~l~~n~l~~~~~~~~~--- 239 (571)
+..+++|++|++++|+++ .+|..+..++++|+.|++++|.++ .+|..+..++ +|+.|++++|.+.+..|..+.
T Consensus 349 ~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~ 426 (636)
T 4eco_A 349 FGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLD 426 (636)
T ss_dssp CEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTC
T ss_pred hCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccc
Confidence 666667777777777666 566666665533666666666665 4555444433 556666666665555555554
Q ss_pred ----CCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcc-------cCCCEEEccCCcCCcccch
Q 044615 240 ----SLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKL-------IHLSELDLSHNIFREEIPS 308 (571)
Q Consensus 240 ----~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l-------~~L~~L~Ls~n~l~~~~~~ 308 (571)
.+++|+.|++++|.++...+..+..+++|+.|++++|.++...+..+... ++|+.|+|++|.++ .+|.
T Consensus 427 ~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~ 505 (636)
T 4eco_A 427 PTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSD 505 (636)
T ss_dssp SSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCG
T ss_pred cccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCC-ccCh
Confidence 44555555555555553333333445555555555555552222222211 14555555555554 2444
Q ss_pred hcc--CCCCCCEEEccCCcCccccccccccCCCCCEEEC------cCCcCcccCCC-CCccCCCCcccccCCc
Q 044615 309 QIC--SMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDI------SYNALQGLIPN-STAFRDAPMLALQGNK 372 (571)
Q Consensus 309 ~~~--~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l------s~N~l~~~~~~-~~~~~~~~~l~l~~n~ 372 (571)
.+. .+++|+.|+|++|++++ +|..+..+++|+.|++ ++|++.+.+|. ...++.+..+++.+|.
T Consensus 506 ~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 577 (636)
T 4eco_A 506 DFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSND 577 (636)
T ss_dssp GGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSC
T ss_pred hhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCc
Confidence 443 55555555555555554 4445555555555555 23444444442 2334444455555554
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=337.21 Aligned_cols=305 Identities=21% Similarity=0.303 Sum_probs=239.0
Q ss_pred cCCCCccceeecccccccCCCCCCCc----------ccccccc--CCCCCCEEecccCcCcccccccccCCCCCCEEEcc
Q 044615 62 EKLLTFEATAHFSVLAFTGQDWPLYS----------SIPDEIG--NMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLS 129 (571)
Q Consensus 62 ~~~l~~l~~l~l~~n~l~~~~~~~~~----------~~p~~~~--~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~ 129 (571)
++++++|++|+|++|.+++.+....+ .+|+.++ ++++|++|+|++|.+.+.+|..|+++++|++|+++
T Consensus 202 l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls 281 (636)
T 4eco_A 202 VMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVA 281 (636)
T ss_dssp GGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECT
T ss_pred HhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECc
Confidence 55677888888888888871000000 0788888 88888888888888888888888888888888888
Q ss_pred cCc-Ccc-cccccccCC------CCCCeeecccCcCcccCCc--cccCCCCCCEEEccCCCCCccCChhhhhccCCCcEE
Q 044615 130 TNK-LSG-SIPLSFANL------TSLSILYLYENSLCDSIPK--EIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVL 199 (571)
Q Consensus 130 ~n~-i~~-~~~~~~~~l------~~L~~L~L~~n~l~~~~~~--~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L 199 (571)
+|+ +++ .+|..++++ ++|++|++++|.++ .+|. .++.+++|++|++++|++.|.+| .+..+++ |+.|
T Consensus 282 ~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~-L~~L 358 (636)
T 4eco_A 282 CNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIK-LASL 358 (636)
T ss_dssp TCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEE-ESEE
T ss_pred CCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCC-CCEE
Confidence 887 887 778777776 88888888888887 6777 78888888888888888887888 7777775 8888
Q ss_pred EccCCcccccCCccccCCCC-CcEEeCccCcCcCCCChhhhCCC--CCCEEEcccCccccccchhhc-------cCCCCC
Q 044615 200 YLSSNHIVGEIPLGHGMLSS-LIQLTLNNNELSGQLSPELGSLI--QLEYLDLSANTFHKSIPESLS-------NLVKLH 269 (571)
Q Consensus 200 ~l~~n~~~~~~~~~~~~l~~-L~~L~l~~n~l~~~~~~~~~~l~--~L~~L~L~~n~l~~~~~~~l~-------~l~~L~ 269 (571)
++++|.++ .+|..+..+++ |+.|++++|.++ .+|..+..++ +|+.|++++|.+.+..|..+. .+++|+
T Consensus 359 ~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~ 436 (636)
T 4eco_A 359 NLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVS 436 (636)
T ss_dssp ECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEE
T ss_pred ECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCC
Confidence 88888887 67777888888 888888888888 5676666654 888888888888888887777 777888
Q ss_pred EEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCC-------CCCEEEccCCcCccccccccc--cCCCC
Q 044615 270 YLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQ-------SLEKLNLSHNNLSGSIPRCFE--EMHWL 340 (571)
Q Consensus 270 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~-------~L~~L~Ls~n~l~~~~p~~~~--~l~~L 340 (571)
.|++++|.++...+..+..+++|+.|+|++|.++...+..+.... +|+.|+|++|+++ .+|..+. .+++|
T Consensus 437 ~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L 515 (636)
T 4eco_A 437 SINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYL 515 (636)
T ss_dssp EEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTC
T ss_pred EEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCc
Confidence 899999988855445566788899999999988843333333332 8889999999988 6777776 88889
Q ss_pred CEEECcCCcCcccCCCCCccCCCCcccccCCc
Q 044615 341 SCIDISYNALQGLIPNSTAFRDAPMLALQGNK 372 (571)
Q Consensus 341 ~~L~ls~N~l~~~~~~~~~~~~~~~l~l~~n~ 372 (571)
+.|++++|++++.++....+..+..+++.+|+
T Consensus 516 ~~L~Ls~N~l~~ip~~~~~l~~L~~L~Ls~N~ 547 (636)
T 4eco_A 516 VGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQR 547 (636)
T ss_dssp CEEECCSSCCSSCCCGGGGCSSCCEEECCSCB
T ss_pred CEEECCCCCCCCcChhhhcCCCCCEEECCCCc
Confidence 99999999998854455667788888887665
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=320.20 Aligned_cols=318 Identities=21% Similarity=0.236 Sum_probs=288.0
Q ss_pred CEEEccCCccc---cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccccccccCCCCCCEEE
Q 044615 51 RDTSISFDELH---EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLD 127 (571)
Q Consensus 51 ~~l~l~~n~l~---~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 127 (571)
+.++.+.+.+. ......++.|+|++|++++ ..|..|.++++|++|+|++|.+++..|..|.++++|++|+
T Consensus 14 ~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~-------~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 86 (477)
T 2id5_A 14 RAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKT-------LNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLG 86 (477)
T ss_dssp TEEECCSCCCSSCCSCCCTTCSEEECCSSCCCE-------ECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CEEEeCCCCcCcCCCCCCCCCcEEECCCCccce-------ECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEE
Confidence 45677766665 3334689999999999997 5577899999999999999999988899999999999999
Q ss_pred cccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCccc
Q 044615 128 LSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIV 207 (571)
Q Consensus 128 L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~ 207 (571)
|++|.++...+..|.++++|++|+|++|.+.+..|..|..+++|++|++++|.+.+..+..|..+++ |+.|++++|.++
T Consensus 87 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~l~~n~l~ 165 (477)
T 2id5_A 87 LRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNS-LEQLTLEKCNLT 165 (477)
T ss_dssp CCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTT-CCEEEEESCCCS
T ss_pred CCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCC-CCEEECCCCcCc
Confidence 9999999877778999999999999999999888999999999999999999999887888888886 999999999999
Q ss_pred ccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhh
Q 044615 208 GEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIE 287 (571)
Q Consensus 208 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~ 287 (571)
+..+..+..+++|+.|++++|.+.+..+..|..+++|+.|++++|.+.+.++.......+|+.|++++|.+++..+..+.
T Consensus 166 ~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~ 245 (477)
T 2id5_A 166 SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVR 245 (477)
T ss_dssp SCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHT
T ss_pred ccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhc
Confidence 77777789999999999999999998888999999999999999988777777777777999999999999976667899
Q ss_pred cccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCcccCCCC-CccCCCCcc
Q 044615 288 KLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNS-TAFRDAPML 366 (571)
Q Consensus 288 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~-~~~~~~~~l 366 (571)
.+++|+.|+|++|.+.+..+..+..+++|+.|+|++|++++..|..|..+++|+.|++++|++++..+.. ..+..+..+
T Consensus 246 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 325 (477)
T 2id5_A 246 HLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETL 325 (477)
T ss_dssp TCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEE
T ss_pred CccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEE
Confidence 9999999999999999988888999999999999999999999999999999999999999999887653 456788999
Q ss_pred cccCCcCCCC
Q 044615 367 ALQGNKRLCG 376 (571)
Q Consensus 367 ~l~~n~~~c~ 376 (571)
.+.+|+..|.
T Consensus 326 ~l~~N~l~c~ 335 (477)
T 2id5_A 326 ILDSNPLACD 335 (477)
T ss_dssp ECCSSCEECS
T ss_pred EccCCCccCc
Confidence 9999998885
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=319.11 Aligned_cols=315 Identities=22% Similarity=0.217 Sum_probs=195.3
Q ss_pred CCchhhcCCCCCCEEEccCCccc------cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCccc
Q 044615 39 DDYKELVRAVQARDTSISFDELH------EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGS 112 (571)
Q Consensus 39 ~~~~~l~~~~~l~~l~l~~n~l~------~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~ 112 (571)
.+|..+. .+++.|++++|.+. +..+++|++|+|++|++++ ..|..|+++++|++|+|++|.++ .
T Consensus 14 ~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~-------~~~~~~~~l~~L~~L~Ls~N~l~-~ 83 (520)
T 2z7x_B 14 HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY-------LDISVFKFNQELEYLDLSHNKLV-K 83 (520)
T ss_dssp SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCE-------EEGGGGTTCTTCCEEECCSSCCC-E
T ss_pred ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCC-------cChHHhhcccCCCEEecCCCcee-e
Confidence 3455444 67888888888766 5677788888888888776 55777788888888888888877 4
Q ss_pred ccccccCCCCCCEEEcccCcCcc-cccccccCCCCCCeeecccCcCcccCCccccCCCCC--CEEEccCCCC--CccCCh
Q 044615 113 IPLALGNLTNLVVLDLSTNKLSG-SIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSL--SILDLSSNKL--NGSIPL 187 (571)
Q Consensus 113 ~~~~~~~l~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L--~~L~L~~n~l--~~~~p~ 187 (571)
+|.. .+++|++|+|++|.+++ .+|..|+++++|++|++++|.+.+ ..+..+++| ++|++++|.+ .+..|.
T Consensus 84 lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~ 158 (520)
T 2z7x_B 84 ISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPE 158 (520)
T ss_dssp EECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTT
T ss_pred cCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccc
Confidence 5554 67788888888888776 356778888888888888887764 345556666 7777777766 444444
Q ss_pred hhhhcc--------------------------------------------------------------------------
Q 044615 188 SLANLT-------------------------------------------------------------------------- 193 (571)
Q Consensus 188 ~~~~l~-------------------------------------------------------------------------- 193 (571)
.+..+.
T Consensus 159 ~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~ 238 (520)
T 2z7x_B 159 GLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFI 238 (520)
T ss_dssp TTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHH
T ss_pred cccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHH
Confidence 433311
Q ss_pred --------CCCcEEEccCCcccccCCccc-----cCCCCCcEEeCccCcCcCCCC-hh----------------------
Q 044615 194 --------NSLKVLYLSSNHIVGEIPLGH-----GMLSSLIQLTLNNNELSGQLS-PE---------------------- 237 (571)
Q Consensus 194 --------~~L~~L~l~~n~~~~~~~~~~-----~~l~~L~~L~l~~n~l~~~~~-~~---------------------- 237 (571)
.+|+.|++++|.+++.+|..+ +.+++|+.+++++|.+ .+| ..
T Consensus 239 ~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~ 316 (520)
T 2z7x_B 239 RILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVH 316 (520)
T ss_dssp HHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCC
T ss_pred HHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccc
Confidence 147777777777776666655 4444444444444443 111 10
Q ss_pred ---hhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCcc--CcchhhhcccCCCEEEccCCcCCcccch-hcc
Q 044615 238 ---LGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQ--KIPNKIEKLIHLSELDLSHNIFREEIPS-QIC 311 (571)
Q Consensus 238 ---~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~--~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-~~~ 311 (571)
+..+++|+.|++++|.+++..|..+..+++|+.|++++|++++ .+|..+..+++|+.|++++|.+.+.+|. .+.
T Consensus 317 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~ 396 (520)
T 2z7x_B 317 MLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCS 396 (520)
T ss_dssp CCCCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCC
T ss_pred ccchhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhc
Confidence 1445566666666666665555666666666666666666654 3344556666666666666666553333 355
Q ss_pred CCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCcccCCCCCccCCCCcccccCCc
Q 044615 312 SMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNK 372 (571)
Q Consensus 312 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~l~l~~n~ 372 (571)
.+++|+.|++++|++++..|..+. +.|+.|++++|+++..++....+..+..+++.+|+
T Consensus 397 ~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~L~~N~ 455 (520)
T 2z7x_B 397 WTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQ 455 (520)
T ss_dssp CCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSC
T ss_pred cCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCcccccchhhhcCCCCCEEECCCCc
Confidence 556666666666666555554443 45666666666665443333445555556666554
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=321.47 Aligned_cols=323 Identities=21% Similarity=0.187 Sum_probs=185.0
Q ss_pred hhcCCCCCCEEEccCCccc------cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCccccccc
Q 044615 43 ELVRAVQARDTSISFDELH------EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLA 116 (571)
Q Consensus 43 ~l~~~~~l~~l~l~~n~l~------~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~ 116 (571)
.+.++++|++|++++|.+. +..+++|++|+|++|.+++ ..|..|+++++|++|+|++|.+++..|..
T Consensus 52 ~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~-------~~~~~~~~l~~L~~L~L~~n~i~~l~~~~ 124 (606)
T 3t6q_A 52 TFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIF-------MAETALSGPKALKHLFFIQTGISSIDFIP 124 (606)
T ss_dssp TSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSE-------ECTTTTSSCTTCCEEECTTSCCSCGGGSC
T ss_pred HhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccc-------cChhhhcccccccEeeccccCcccCCcch
Confidence 4444444444444444433 3444444444444444443 33444444444444444444444433444
Q ss_pred ccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCC--EEEccCCCCCccCChhhhhc--
Q 044615 117 LGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLS--ILDLSSNKLNGSIPLSLANL-- 192 (571)
Q Consensus 117 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~--~L~L~~n~l~~~~p~~~~~l-- 192 (571)
|+++++|++|++++|.+++.....+..+++|++|++++|.+.+..|..+..+++|+ .|++++|++.+..|..+...
T Consensus 125 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L 204 (606)
T 3t6q_A 125 LHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVF 204 (606)
T ss_dssp CTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEE
T ss_pred hccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhhccc
Confidence 44444445555544444433222233344455555555544444444444444444 44555554443333222110
Q ss_pred -----------------------------------------------c-CCCcEEEccCCcccccCCccccCCCCCcEEe
Q 044615 193 -----------------------------------------------T-NSLKVLYLSSNHIVGEIPLGHGMLSSLIQLT 224 (571)
Q Consensus 193 -----------------------------------------------~-~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~ 224 (571)
. .+|+.|++++|.+++..+..+..+++|++|+
T Consensus 205 ~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 284 (606)
T 3t6q_A 205 QSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELD 284 (606)
T ss_dssp EEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEE
T ss_pred cccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEe
Confidence 0 0244555555555544455566667777777
Q ss_pred CccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcch-hhhcccCCCEEEccCCcCC
Q 044615 225 LNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPN-KIEKLIHLSELDLSHNIFR 303 (571)
Q Consensus 225 l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~Ls~n~l~ 303 (571)
+++|.++ .+|..+..+++|+.|++++|.+.+..|..+..+++|+.|++++|.+.+.++. .+..+++|+.|++++|.+.
T Consensus 285 l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~ 363 (606)
T 3t6q_A 285 LTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIE 363 (606)
T ss_dssp CTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCC
T ss_pred ccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccc
Confidence 7777776 4566677777777777777777766666777777777777777777654443 3667777777777777776
Q ss_pred ccc--chhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCcccCCC--CCccCCCCcccccCCcC
Q 044615 304 EEI--PSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPN--STAFRDAPMLALQGNKR 373 (571)
Q Consensus 304 ~~~--~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~--~~~~~~~~~l~l~~n~~ 373 (571)
+.. +..+..+++|+.|++++|++++..|..|..+++|+.|++++|.+++..|. ...++.+..+++.+|..
T Consensus 364 ~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l 437 (606)
T 3t6q_A 364 TSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLL 437 (606)
T ss_dssp EEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCC
T ss_pred cccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCcc
Confidence 654 55677777777777777777777777777777777777777777766543 34556677777777654
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-36 Score=323.75 Aligned_cols=281 Identities=25% Similarity=0.297 Sum_probs=212.2
Q ss_pred cccCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCc-cccCCCC
Q 044615 92 EIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPK-EIGNMNS 170 (571)
Q Consensus 92 ~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~l~~l~~ 170 (571)
.|+++++|++|++++|.++ .+|..+..+++|++|++++|.+++..|..+.++++|++|++++|.+.+.+|. .+..+++
T Consensus 273 ~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~ 351 (606)
T 3t6q_A 273 TFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLEN 351 (606)
T ss_dssp TTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTT
T ss_pred HhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCc
Confidence 3667777788888877776 5677777777788888888877777677777777888888877777655543 4777788
Q ss_pred CCEEEccCCCCCccC--ChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCCh-hhhCCCCCCEE
Q 044615 171 LSILDLSSNKLNGSI--PLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSP-ELGSLIQLEYL 247 (571)
Q Consensus 171 L~~L~L~~n~l~~~~--p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L 247 (571)
|++|++++|++.+.. |..+..+++ |+.|++++|.+.+..|..+..+++|+.|++++|.+.+..+. .+..+++|+.|
T Consensus 352 L~~L~l~~n~l~~~~~~~~~~~~l~~-L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L 430 (606)
T 3t6q_A 352 LRELDLSHDDIETSDCCNLQLRNLSH-LQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430 (606)
T ss_dssp CCEEECCSSCCCEEEESTTTTTTCTT-CCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEE
T ss_pred CCEEECCCCccccccCcchhcccCCC-CCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEE
Confidence 888888888777544 556666665 88888888887777777777788888888888887766543 37778888888
Q ss_pred EcccCccccccchhhccCCCCCEEEcCCccCccC---cchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCC
Q 044615 248 DLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQK---IPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHN 324 (571)
Q Consensus 248 ~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~---~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n 324 (571)
++++|.+.+..|..+..+++|+.|++++|.+++. .+..+..+++|+.|++++|.+++..|..+..+++|+.|+|++|
T Consensus 431 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 510 (606)
T 3t6q_A 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHN 510 (606)
T ss_dssp ECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred ECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCC
Confidence 8888888777777778888888888888887652 2245777788888888888888777777888888888888888
Q ss_pred cCccccccccccCCCCCEEECcCCcCcccCCCC-CccCCCCcccccCCcCCC
Q 044615 325 NLSGSIPRCFEEMHWLSCIDISYNALQGLIPNS-TAFRDAPMLALQGNKRLC 375 (571)
Q Consensus 325 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~-~~~~~~~~l~l~~n~~~c 375 (571)
++++..|..|..++.| .|++++|++++.+|.. ..+..+..+++.+|++.|
T Consensus 511 ~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 561 (606)
T 3t6q_A 511 RLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561 (606)
T ss_dssp CCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEEC
T ss_pred ccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccc
Confidence 8888888888888888 8888888888776652 445667778888887776
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=318.17 Aligned_cols=322 Identities=20% Similarity=0.190 Sum_probs=210.5
Q ss_pred CCCCCchhhcCCCCCCEEEccCCccc------cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcC
Q 044615 36 GLGDDYKELVRAVQARDTSISFDELH------EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENIL 109 (571)
Q Consensus 36 ~~~~~~~~l~~~~~l~~l~l~~n~l~------~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i 109 (571)
++..+|..+. .+++.|++++|.+. +..+++|++|+|++|++++ ..|..|.++++|++|+|++|.+
T Consensus 42 ~L~~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-------~~~~~~~~l~~L~~L~Ls~N~l 112 (562)
T 3a79_B 42 NLTHVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRS-------LDFHVFLFNQDLEYLDVSHNRL 112 (562)
T ss_dssp CCCSCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCE-------ECTTTTTTCTTCCEEECTTSCC
T ss_pred CCccCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCc-------CCHHHhCCCCCCCEEECCCCcC
Confidence 4455666654 78999999999877 6788899999999999987 5678889999999999999999
Q ss_pred cccccccccCCCCCCEEEcccCcCccc-ccccccCCCCCCeeecccCcCcccCCccccCCCCC--CEEEccCCCC--Ccc
Q 044615 110 NGSIPLALGNLTNLVVLDLSTNKLSGS-IPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSL--SILDLSSNKL--NGS 184 (571)
Q Consensus 110 ~~~~~~~~~~l~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L--~~L~L~~n~l--~~~ 184 (571)
+ .+|.. .+++|++|+|++|.+++. .|..|+++++|++|++++|.+.+. .+..+++| ++|++++|++ .+.
T Consensus 113 ~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~ 186 (562)
T 3a79_B 113 Q-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGG 186 (562)
T ss_dssp C-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSS
T ss_pred C-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeeccccccccc
Confidence 8 56655 789999999999999864 467899999999999999998753 34455555 8888888888 555
Q ss_pred CChhhhhcc-----------------------------------------------------------------------
Q 044615 185 IPLSLANLT----------------------------------------------------------------------- 193 (571)
Q Consensus 185 ~p~~~~~l~----------------------------------------------------------------------- 193 (571)
.|..+..+.
T Consensus 187 ~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~ 266 (562)
T 3a79_B 187 ETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCS 266 (562)
T ss_dssp SCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHH
T ss_pred CcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHH
Confidence 454443321
Q ss_pred ---------CCCcEEEccCCcccccCCccc--------------------------------------------------
Q 044615 194 ---------NSLKVLYLSSNHIVGEIPLGH-------------------------------------------------- 214 (571)
Q Consensus 194 ---------~~L~~L~l~~n~~~~~~~~~~-------------------------------------------------- 214 (571)
.+|+.|++++|.+++.+|..+
T Consensus 267 ~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~ 346 (562)
T 3a79_B 267 VKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHM 346 (562)
T ss_dssp HHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCC
T ss_pred HHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccc
Confidence 137777777777776666544
Q ss_pred ---cCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccc--cchhhccCCCCCEEEcCCccCccCcc-hhhhc
Q 044615 215 ---GMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKS--IPESLSNLVKLHYLNLSNNQFSQKIP-NKIEK 288 (571)
Q Consensus 215 ---~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~--~~~~l~~l~~L~~L~Ls~n~l~~~~~-~~~~~ 288 (571)
..+++|++|++++|.+++..|..+..+++|+.|++++|.+++. .|..+.++++|+.|++++|.+++.+| ..+..
T Consensus 347 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~ 426 (562)
T 3a79_B 347 VCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAW 426 (562)
T ss_dssp CCCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCC
T ss_pred cCccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcC
Confidence 3445555566666655555555555556666666666555542 23445555566666666666555233 23455
Q ss_pred ccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCcccCCC-CCccCCCCccc
Q 044615 289 LIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPN-STAFRDAPMLA 367 (571)
Q Consensus 289 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~-~~~~~~~~~l~ 367 (571)
+++|+.|++++|.+++..|..+. ++|+.|+|++|+++ .+|..+..++.|+.|++++|+++..++. ...++.+..++
T Consensus 427 l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~ 503 (562)
T 3a79_B 427 AESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIW 503 (562)
T ss_dssp CTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEE
T ss_pred cccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEE
Confidence 55566666666655544443332 45666666666655 3444444556666666666666644443 34445555555
Q ss_pred ccCCcCCC
Q 044615 368 LQGNKRLC 375 (571)
Q Consensus 368 l~~n~~~c 375 (571)
+.+|++.|
T Consensus 504 l~~N~~~c 511 (562)
T 3a79_B 504 LHDNPWDC 511 (562)
T ss_dssp CCSCCBCC
T ss_pred ecCCCcCC
Confidence 66665544
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=336.18 Aligned_cols=210 Identities=27% Similarity=0.303 Sum_probs=112.6
Q ss_pred CccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCC
Q 044615 162 PKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSL 241 (571)
Q Consensus 162 ~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 241 (571)
|..+..+++|+.|+|++|++.+..|..|..+++ |+.|++++|.+++..|..+..+++|+.|++++|.+.+..+..|..+
T Consensus 283 ~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l 361 (844)
T 3j0a_A 283 SRVFETLKDLKVLNLAYNKINKIADEAFYGLDN-LQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFL 361 (844)
T ss_dssp SCCSSSCCCCCEEEEESCCCCEECTTTTTTCSS-CCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSC
T ss_pred hhhhhcCCCCCEEECCCCcCCCCChHHhcCCCC-CCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCC
Confidence 334444555555555555555444444544443 5555555555554445555555555555555555555444455555
Q ss_pred CCCCEEEcccCcccccc----------------------------------------chhhccCCCCCEEEcCCccCccC
Q 044615 242 IQLEYLDLSANTFHKSI----------------------------------------PESLSNLVKLHYLNLSNNQFSQK 281 (571)
Q Consensus 242 ~~L~~L~L~~n~l~~~~----------------------------------------~~~l~~l~~L~~L~Ls~n~l~~~ 281 (571)
++|+.|++++|.+++.. +..+..+++|+.|++++|++++.
T Consensus 362 ~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~ 441 (844)
T 3j0a_A 362 EKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSC 441 (844)
T ss_dssp CCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCC
T ss_pred CCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcCCccceeeCCCCccccc
Confidence 55555555555443210 00122344455555555544422
Q ss_pred cc------------------------------hhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccc
Q 044615 282 IP------------------------------NKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIP 331 (571)
Q Consensus 282 ~~------------------------------~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p 331 (571)
.+ ..+..+++|+.|+|++|.+++..|..|..+++|+.|+|++|++++..|
T Consensus 442 ~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~ 521 (844)
T 3j0a_A 442 SGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSH 521 (844)
T ss_dssp CSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCC
T ss_pred ccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccCh
Confidence 11 123334445555555555555555555566666666666666665555
Q ss_pred cccccCCCCCEEECcCCcCcccCCCCCccCCCCcccccCCcCCCC
Q 044615 332 RCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCG 376 (571)
Q Consensus 332 ~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~l~l~~n~~~c~ 376 (571)
..+. ++|+.|++++|++++.+|. .+..+..+++.+|++.|.
T Consensus 522 ~~~~--~~L~~L~Ls~N~l~~~~~~--~~~~L~~l~l~~Np~~C~ 562 (844)
T 3j0a_A 522 NDLP--ANLEILDISRNQLLAPNPD--VFVSLSVLDITHNKFICE 562 (844)
T ss_dssp CCCC--SCCCEEEEEEECCCCCCSC--CCSSCCEEEEEEECCCCS
T ss_pred hhhh--ccccEEECCCCcCCCCChh--HhCCcCEEEecCCCcccc
Confidence 4444 5566666666666666554 356788889999999984
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=328.25 Aligned_cols=319 Identities=19% Similarity=0.215 Sum_probs=243.8
Q ss_pred CchhhcCCCCCCEEEccCCcccc-----------------------C--CCCccceeecccccccCCCCCCCcccccccc
Q 044615 40 DYKELVRAVQARDTSISFDELHE-----------------------K--LLTFEATAHFSVLAFTGQDWPLYSSIPDEIG 94 (571)
Q Consensus 40 ~~~~l~~~~~l~~l~l~~n~l~~-----------------------~--~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~ 94 (571)
+|++++++++|+.|+|++|.++- + .+++|+.|+|+.|.+.+ .+|..|+
T Consensus 440 IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~-------~iP~~l~ 512 (876)
T 4ecn_A 440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMT-------QLPDFLY 512 (876)
T ss_dssp ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCC-------SCCGGGG
T ss_pred hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCc-------cChHHHh
Confidence 78899999999999999997652 2 78999999999999998 8899999
Q ss_pred CCCCCCEEecccCc-Ccc-cccccccCCC-------CCCEEEcccCcCcccccc--cccCCCCCCeeecccCcCcccCCc
Q 044615 95 NMKSLSDLQLSENI-LNG-SIPLALGNLT-------NLVVLDLSTNKLSGSIPL--SFANLTSLSILYLYENSLCDSIPK 163 (571)
Q Consensus 95 ~l~~L~~L~L~~n~-i~~-~~~~~~~~l~-------~L~~L~L~~n~i~~~~~~--~~~~l~~L~~L~L~~n~l~~~~~~ 163 (571)
++++|++|+|++|+ +++ .+|..++.++ +|++|+|++|.++ .+|. .|+++++|++|+|++|.+. .+|
T Consensus 513 ~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp- 589 (876)
T 4ecn_A 513 DLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE- 589 (876)
T ss_dssp GCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-
T ss_pred CCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-
Confidence 99999999999998 887 7887666554 9999999999998 7787 8999999999999999998 777
Q ss_pred cccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCC--CcEEeCccCcCcCCCChh---h
Q 044615 164 EIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSS--LIQLTLNNNELSGQLSPE---L 238 (571)
Q Consensus 164 ~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~--L~~L~l~~n~l~~~~~~~---~ 238 (571)
.+..+++|+.|++++|++. .+|..+..++++|+.|++++|.++ .+|..+..++. |+.|++++|++.+.+|.. +
T Consensus 590 ~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l 667 (876)
T 4ecn_A 590 AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSM 667 (876)
T ss_dssp CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCT
T ss_pred hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhh
Confidence 8999999999999999998 888888888755999999999988 67776666544 888888888887654422 2
Q ss_pred h--CCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhc--------ccCCCEEEccCCcCCcccch
Q 044615 239 G--SLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEK--------LIHLSELDLSHNIFREEIPS 308 (571)
Q Consensus 239 ~--~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~--------l~~L~~L~Ls~n~l~~~~~~ 308 (571)
. .+++|+.|++++|.+....+..+..+++|+.|+|++|.++ .+|..+.. +++|+.|+|++|+++ .+|.
T Consensus 668 ~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~ 745 (876)
T 4ecn_A 668 DDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSD 745 (876)
T ss_dssp TTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCG
T ss_pred ccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchH
Confidence 2 2346777777777776433333446777777777777776 33433222 236777777777776 4566
Q ss_pred hcc--CCCCCCEEEccCCcCccccccccccCCCCCEEECcC------CcCcccCCC-CCccCCCCcccccCCcC
Q 044615 309 QIC--SMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISY------NALQGLIPN-STAFRDAPMLALQGNKR 373 (571)
Q Consensus 309 ~~~--~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~------N~l~~~~~~-~~~~~~~~~l~l~~n~~ 373 (571)
.+. .+++|+.|+|++|++++ +|..+..+++|+.|+|++ |++.+.+|. ...++.+..+++.+|..
T Consensus 746 ~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L 818 (876)
T 4ecn_A 746 DFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI 818 (876)
T ss_dssp GGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC
T ss_pred HhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC
Confidence 665 77777777777777776 566677777777777755 556666554 34456667777777764
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-35 Score=327.57 Aligned_cols=307 Identities=22% Similarity=0.239 Sum_probs=266.2
Q ss_pred CCCCCchhhcCCCCCCEEEccCCccc------cCCCCccceeecccccccCCCCCCCccc-cccccCCCCCCEEecccCc
Q 044615 36 GLGDDYKELVRAVQARDTSISFDELH------EKLLTFEATAHFSVLAFTGQDWPLYSSI-PDEIGNMKSLSDLQLSENI 108 (571)
Q Consensus 36 ~~~~~~~~l~~~~~l~~l~l~~n~l~------~~~l~~l~~l~l~~n~l~~~~~~~~~~~-p~~~~~l~~L~~L~L~~n~ 108 (571)
++..+|. -..+++.|+|++|.++ +..+++|+.|+|++|...+ .+ |..|+++++|++|+|++|.
T Consensus 15 ~L~~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~-------~i~~~~f~~L~~L~~L~Ls~N~ 84 (844)
T 3j0a_A 15 NLTQVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPL-------TIDKEAFRNLPNLRILDLGSSK 84 (844)
T ss_dssp CSSCCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCC-------EECTTTTSSCTTCCEEECTTCC
T ss_pred CCCCCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCcc-------ccCHHHhcCCCCCCEEECCCCc
Confidence 4555666 4578999999999887 7889999999999997665 55 7789999999999999999
Q ss_pred CcccccccccCCCCCCEEEcccCcCccccccc--ccCCCCCCeeecccCcCcccCC-ccccCCCCCCEEEccCCCCCccC
Q 044615 109 LNGSIPLALGNLTNLVVLDLSTNKLSGSIPLS--FANLTSLSILYLYENSLCDSIP-KEIGNMNSLSILDLSSNKLNGSI 185 (571)
Q Consensus 109 i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~~ 185 (571)
+.+..|..|+++++|++|+|++|.+++..|.. |+++++|++|+|++|.+.+..+ ..|+++++|++|++++|.+.+..
T Consensus 85 l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~ 164 (844)
T 3j0a_A 85 IYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVC 164 (844)
T ss_dssp CCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCC
T ss_pred CcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeC
Confidence 99888999999999999999999998766655 9999999999999999987655 57999999999999999999888
Q ss_pred Chhhhhc--cCCCcEEEccCCcccccCCccccCCCC------CcEEeCccCcCcCCCChhhhC-----------------
Q 044615 186 PLSLANL--TNSLKVLYLSSNHIVGEIPLGHGMLSS------LIQLTLNNNELSGQLSPELGS----------------- 240 (571)
Q Consensus 186 p~~~~~l--~~~L~~L~l~~n~~~~~~~~~~~~l~~------L~~L~l~~n~l~~~~~~~~~~----------------- 240 (571)
+..+..+ . +|+.|+++.|.+.+..|..++.+++ |+.|++++|.+++..+..+..
T Consensus 165 ~~~l~~l~~~-~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~ 243 (844)
T 3j0a_A 165 EHELEPLQGK-TLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIM 243 (844)
T ss_dssp SGGGHHHHHC-SSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCC
T ss_pred HHHcccccCC-ccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccc
Confidence 8888876 5 4999999999998887777666655 999999999877655543322
Q ss_pred ---------------------CCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccC
Q 044615 241 ---------------------LIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSH 299 (571)
Q Consensus 241 ---------------------l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~ 299 (571)
.++|+.|++++|.+.+..+..+..+++|+.|++++|.+++..|..|..+++|+.|+|++
T Consensus 244 ~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~ 323 (844)
T 3j0a_A 244 GAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSY 323 (844)
T ss_dssp BCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEES
T ss_pred cccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCC
Confidence 26799999999999888888899999999999999999988888899999999999999
Q ss_pred CcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCccc
Q 044615 300 NIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGL 353 (571)
Q Consensus 300 n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 353 (571)
|.+.+..|..+..+++|+.|++++|.+++..+..|..+++|+.|++++|.+++.
T Consensus 324 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i 377 (844)
T 3j0a_A 324 NLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI 377 (844)
T ss_dssp CCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC
T ss_pred CCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc
Confidence 999888888899999999999999999888888899999999999999988764
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-35 Score=320.94 Aligned_cols=336 Identities=23% Similarity=0.247 Sum_probs=249.5
Q ss_pred chhhcCCC--CCCEEEccCCccc------cCCCCccceeecccccccCCCCCCC----------------------cccc
Q 044615 41 YKELVRAV--QARDTSISFDELH------EKLLTFEATAHFSVLAFTGQDWPLY----------------------SSIP 90 (571)
Q Consensus 41 ~~~l~~~~--~l~~l~l~~n~l~------~~~l~~l~~l~l~~n~l~~~~~~~~----------------------~~~p 90 (571)
|..+..+. +|+.|++++|.+. +..+++|+.|++++|.+++.....+ ..+|
T Consensus 239 ~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp 318 (680)
T 1ziw_A 239 NTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLP 318 (680)
T ss_dssp TTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CC
T ss_pred hhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhccccccccc
Confidence 34444443 3777777777665 5566777777777776665110000 0112
Q ss_pred c----cccCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcc--cccccccCC--CCCCeeecccCcCcccCC
Q 044615 91 D----EIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSG--SIPLSFANL--TSLSILYLYENSLCDSIP 162 (571)
Q Consensus 91 ~----~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~--~~~~~~~~l--~~L~~L~L~~n~l~~~~~ 162 (571)
. .|..+++|++|++++|.+.+..+..|.++++|++|++++|.+.. ..+..|..+ ++|+.|++++|.+.+..|
T Consensus 319 ~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~ 398 (680)
T 1ziw_A 319 KIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIES 398 (680)
T ss_dssp EECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECT
T ss_pred ccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeECh
Confidence 1 34455566666666666655555556666666666666655321 112222222 356666777777777777
Q ss_pred ccccCCCCCCEEEccCCCCCccCC-hhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCc--CCCChhhh
Q 044615 163 KEIGNMNSLSILDLSSNKLNGSIP-LSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELS--GQLSPELG 239 (571)
Q Consensus 163 ~~l~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~--~~~~~~~~ 239 (571)
..+..+++|+.|++++|++.+.+| ..+..++. |+.|++++|.+.+..+..+..+++|+.|++++|.+. +..|..+.
T Consensus 399 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~-L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~ 477 (680)
T 1ziw_A 399 DAFSWLGHLEVLDLGLNEIGQELTGQEWRGLEN-IFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQ 477 (680)
T ss_dssp TTTTTCTTCCEEECCSSCCEEECCSGGGTTCTT-CCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTT
T ss_pred hhhhCCCCCCEEeCCCCcCccccCcccccCccc-ccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccc
Confidence 888888899999999998876666 46666665 999999999888878888888899999999998886 46788899
Q ss_pred CCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcc--------hhhhcccCCCEEEccCCcCCcccchhcc
Q 044615 240 SLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIP--------NKIEKLIHLSELDLSHNIFREEIPSQIC 311 (571)
Q Consensus 240 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~--------~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 311 (571)
.+++|+.|++++|.+++..+..+.++++|+.|++++|.+++..+ ..+..+++|+.|+|++|++....+..|.
T Consensus 478 ~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~ 557 (680)
T 1ziw_A 478 PLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFK 557 (680)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred cCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcc
Confidence 99999999999999998888889999999999999999976422 2378889999999999999876666799
Q ss_pred CCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCcccCCCCC--ccCCCCcccccCCcCCCCC
Q 044615 312 SMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNST--AFRDAPMLALQGNKRLCGD 377 (571)
Q Consensus 312 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~--~~~~~~~l~l~~n~~~c~~ 377 (571)
++++|+.|+|++|++++..+..|..++.|+.|++++|++++.++... .++.+..+++.+|++.|..
T Consensus 558 ~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c 625 (680)
T 1ziw_A 558 DLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTC 625 (680)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCC
T ss_pred cccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCC
Confidence 99999999999999998888889999999999999999998877532 4678899999999999853
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=317.14 Aligned_cols=158 Identities=27% Similarity=0.301 Sum_probs=105.4
Q ss_pred cCCCCCcEEeCccCcCcCCC--ChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcc-hhhhcccC
Q 044615 215 GMLSSLIQLTLNNNELSGQL--SPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIP-NKIEKLIH 291 (571)
Q Consensus 215 ~~l~~L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~-~~~~~l~~ 291 (571)
..+++|+.|++++|.+++.. +..+..+++|+.|++++|.+.+..+. +..+++|+.|++++|.+++..+ ..+..+++
T Consensus 344 ~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~ 422 (570)
T 2z63_A 344 VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 422 (570)
T ss_dssp CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTT
T ss_pred ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCC
Confidence 34567888888888877543 56677777888888887777654433 6677777777777777665544 35666667
Q ss_pred CCEEEccCCcCCcccchhccCCCCCCEEEccCCcCc-cccccccccCCCCCEEECcCCcCcccCCC-CCccCCCCccccc
Q 044615 292 LSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLS-GSIPRCFEEMHWLSCIDISYNALQGLIPN-STAFRDAPMLALQ 369 (571)
Q Consensus 292 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~p~~~~~l~~L~~L~ls~N~l~~~~~~-~~~~~~~~~l~l~ 369 (571)
|+.|++++|.+.+..|..+..+++|+.|++++|.++ +.+|..+..+++|+.|++++|++++..|. ...++.+..+++.
T Consensus 423 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 502 (570)
T 2z63_A 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMA 502 (570)
T ss_dssp CCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCC
Confidence 777777777766666666666677777777777665 45666666666677777777766666543 3445566666666
Q ss_pred CCcC
Q 044615 370 GNKR 373 (571)
Q Consensus 370 ~n~~ 373 (571)
+|..
T Consensus 503 ~n~l 506 (570)
T 2z63_A 503 SNQL 506 (570)
T ss_dssp SSCC
T ss_pred CCcC
Confidence 6643
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=291.31 Aligned_cols=259 Identities=29% Similarity=0.507 Sum_probs=182.4
Q ss_pred CCCCEEecccCcCcc--cccccccCCCCCCEEEccc-CcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCE
Q 044615 97 KSLSDLQLSENILNG--SIPLALGNLTNLVVLDLST-NKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSI 173 (571)
Q Consensus 97 ~~L~~L~L~~n~i~~--~~~~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 173 (571)
.+++.|+|++|.+.+ .+|..|+++++|++|+|++ |.+.+.+|..|+++++|++|+|++|.+.+.+|..+..+++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 456677777777766 5666666666666666663 6666666666666666666666666666566666666666666
Q ss_pred EEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCC-CCCEEEcccC
Q 044615 174 LDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLI-QLEYLDLSAN 252 (571)
Q Consensus 174 L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~L~~n 252 (571)
|++++|++.+.+|..+..+ ++|++|++++|++++.+|..+..++ +|+.|++++|
T Consensus 130 L~Ls~N~l~~~~p~~~~~l-------------------------~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N 184 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSL-------------------------PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN 184 (313)
T ss_dssp EECCSSEEESCCCGGGGGC-------------------------TTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSS
T ss_pred EeCCCCccCCcCChHHhcC-------------------------CCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCC
Confidence 6666666555555555444 4444455555555444555555555 6666666666
Q ss_pred ccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCcccccc
Q 044615 253 TFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPR 332 (571)
Q Consensus 253 ~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~ 332 (571)
.+++.+|..+..++ |+.|++++|.+++..|..+..+++|+.|++++|.+++.+|. +..+++|++|++++|++++.+|.
T Consensus 185 ~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~ 262 (313)
T 1ogq_A 185 RLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQ 262 (313)
T ss_dssp EEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCG
T ss_pred eeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCCh
Confidence 66666666666665 77777777777766677777777777777777777765554 77788899999999999888899
Q ss_pred ccccCCCCCEEECcCCcCcccCCCCCccCCCCcccccCCcCCCCCCCCCCCC
Q 044615 333 CFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDIKRLPPC 384 (571)
Q Consensus 333 ~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~l~l~~n~~~c~~~~~~~~~ 384 (571)
.|..+++|+.|++++|++++.+|....++.+..+.+.+|+..|+.+. ++|
T Consensus 263 ~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~--~~C 312 (313)
T 1ogq_A 263 GLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL--PAC 312 (313)
T ss_dssp GGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTS--SCC
T ss_pred HHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCC--CCC
Confidence 99999999999999999998888877788899999999999998633 356
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=309.00 Aligned_cols=134 Identities=27% Similarity=0.327 Sum_probs=87.7
Q ss_pred hCCCCCCEEEcccCcccccc--chhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccc-hhccCCCC
Q 044615 239 GSLIQLEYLDLSANTFHKSI--PESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIP-SQICSMQS 315 (571)
Q Consensus 239 ~~l~~L~~L~L~~n~l~~~~--~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~-~~~~~l~~ 315 (571)
..+++|+.|++++|.+++.. +..+..+++|+.|++++|.+++..+. +..+++|+.|++++|.+.+..+ ..+..+++
T Consensus 344 ~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~ 422 (570)
T 2z63_A 344 VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 422 (570)
T ss_dssp CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTT
T ss_pred ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCC
Confidence 34566677777777666443 55666777777777777777654443 6667777777777777666544 35666777
Q ss_pred CCEEEccCCcCccccccccccCCCCCEEECcCCcCc-ccCC-CCCccCCCCcccccCCcC
Q 044615 316 LEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQ-GLIP-NSTAFRDAPMLALQGNKR 373 (571)
Q Consensus 316 L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~-~~~~-~~~~~~~~~~l~l~~n~~ 373 (571)
|+.|++++|.+++..|..|..+++|+.|++++|.++ +..| ....++.+..+++.+|..
T Consensus 423 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l 482 (570)
T 2z63_A 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482 (570)
T ss_dssp CCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCC
T ss_pred CCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCcc
Confidence 777777777777767777777777777777777765 3333 244556666677766653
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=325.45 Aligned_cols=276 Identities=22% Similarity=0.324 Sum_probs=146.3
Q ss_pred cccccc--CCCCCCEEecccCcCcccccccccCCCCCCEEEcccCc-Ccc-cccccccCCC-------CCCeeecccCcC
Q 044615 89 IPDEIG--NMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNK-LSG-SIPLSFANLT-------SLSILYLYENSL 157 (571)
Q Consensus 89 ~p~~~~--~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~-i~~-~~~~~~~~l~-------~L~~L~L~~n~l 157 (571)
+|+.++ ++++|++|+|++|.+.+.+|..|+++++|++|+|++|+ +++ .+|..+++++ +|++|+|++|.+
T Consensus 481 iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L 560 (876)
T 4ecn_A 481 ENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL 560 (876)
T ss_dssp TTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCC
T ss_pred CChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcC
Confidence 444444 55555555555555555555555555555555555554 444 4444433333 555555555555
Q ss_pred cccCCc--cccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCC-CcEEeCccCcCcCCC
Q 044615 158 CDSIPK--EIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSS-LIQLTLNNNELSGQL 234 (571)
Q Consensus 158 ~~~~~~--~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~-L~~L~l~~n~l~~~~ 234 (571)
. .+|. .+..+++|++|+|++|++. .+| .+..+++ |+.|++++|.++ .+|..+..+++ |+.|++++|.+. .+
T Consensus 561 ~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~-L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~l 634 (876)
T 4ecn_A 561 E-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVK-LTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YI 634 (876)
T ss_dssp C-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSE-ESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SC
T ss_pred C-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCc-ceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cC
Confidence 4 4444 4555555555555555554 444 4444443 555555555554 44444555555 555555555555 34
Q ss_pred ChhhhCCCC--CCEEEcccCccccccchh---hc--cCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccc
Q 044615 235 SPELGSLIQ--LEYLDLSANTFHKSIPES---LS--NLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIP 307 (571)
Q Consensus 235 ~~~~~~l~~--L~~L~L~~n~l~~~~~~~---l~--~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 307 (571)
|..+..++. |+.|++++|.+.+.+|.. +. .+++|+.|++++|.++...+..+..+++|+.|+|++|.+.. +|
T Consensus 635 p~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~-ip 713 (876)
T 4ecn_A 635 PNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTS-IP 713 (876)
T ss_dssp CSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSC-CC
T ss_pred chhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCc-cC
Confidence 444444332 555555555554433321 11 22356666666666663322333456667777777776663 33
Q ss_pred hhccC-C-------CCCCEEEccCCcCccccccccc--cCCCCCEEECcCCcCcccCCCCCccCCCCcccccCCc
Q 044615 308 SQICS-M-------QSLEKLNLSHNNLSGSIPRCFE--EMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNK 372 (571)
Q Consensus 308 ~~~~~-l-------~~L~~L~Ls~n~l~~~~p~~~~--~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~l~l~~n~ 372 (571)
..+.. . ++|+.|+|++|+++ .+|..+. .+++|+.|+|++|++++.++....++.+..+.+.+|+
T Consensus 714 ~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~lp~~l~~L~~L~~L~Ls~N~ 787 (876)
T 4ecn_A 714 ENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQR 787 (876)
T ss_dssp TTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSSCCCGGGGCTTCCEEECCCCB
T ss_pred hHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCccchhhhcCCCCCEEECCCCC
Confidence 33222 1 26777777777776 5566665 6677777777777777644444556666666666654
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=312.26 Aligned_cols=327 Identities=24% Similarity=0.233 Sum_probs=253.9
Q ss_pred chhhcCCCCCCEEEccCCccc------cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcc-cc
Q 044615 41 YKELVRAVQARDTSISFDELH------EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNG-SI 113 (571)
Q Consensus 41 ~~~l~~~~~l~~l~l~~n~l~------~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~-~~ 113 (571)
|..+.++.+|++|+|++|.+. +..+++|++|++++|.+++ ..|..++++++|++|++++|.+.+ .+
T Consensus 73 ~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-------~~~~~~~~l~~L~~L~L~~n~l~~~~l 145 (606)
T 3vq2_A 73 DKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS-------LESFPIGQLITLKKLNVAHNFIHSCKL 145 (606)
T ss_dssp TTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCC-------SSSSCCTTCTTCCEEECCSSCCCCCCC
T ss_pred HHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCcccc-------ccccccCCCCCCCEEeCCCCcccceec
Confidence 455677777888888777665 5677777777887777775 334567777778888888777765 45
Q ss_pred cccccCCCCCCEEEcccCcCcccccccccCCC------------------------------------------------
Q 044615 114 PLALGNLTNLVVLDLSTNKLSGSIPLSFANLT------------------------------------------------ 145 (571)
Q Consensus 114 ~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~------------------------------------------------ 145 (571)
|..|+++++|++|++++|.+++..|..|+.++
T Consensus 146 p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~ 225 (606)
T 3vq2_A 146 PAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCL 225 (606)
T ss_dssp CGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHH
T ss_pred hHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCceeeeeeccCCccchhHHHHHh
Confidence 77777777787777777777655444332222
Q ss_pred --------------------------------------------------------------------------------
Q 044615 146 -------------------------------------------------------------------------------- 145 (571)
Q Consensus 146 -------------------------------------------------------------------------------- 145 (571)
T Consensus 226 ~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~ 305 (606)
T 3vq2_A 226 QNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPK 305 (606)
T ss_dssp HTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCT
T ss_pred ccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccccccCCCCCEEEecCccchhhhhccc
Confidence
Q ss_pred --CCCeeecccCcCcccCCc--------------------cccCCCCCCEEEccCCCCCcc--CChhhhhccCCCcEEEc
Q 044615 146 --SLSILYLYENSLCDSIPK--------------------EIGNMNSLSILDLSSNKLNGS--IPLSLANLTNSLKVLYL 201 (571)
Q Consensus 146 --~L~~L~L~~n~l~~~~~~--------------------~l~~l~~L~~L~L~~n~l~~~--~p~~~~~l~~~L~~L~l 201 (571)
+|++|++++|.+ +.+|. .+..+++|++|++++|++++. .|..+..++. |+.|++
T Consensus 306 ~~~L~~L~l~~n~l-~~lp~~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~-L~~L~L 383 (606)
T 3vq2_A 306 HFKWQSLSIIRCQL-KQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNS-LRHLDL 383 (606)
T ss_dssp TCCCSEEEEESCCC-SSCCCCCCSSCCEEEEESCSSCEECCCCCCTTCCEEECCSSCEEEEEECCHHHHCCSC-CCEEEC
T ss_pred cccCCEEEcccccC-cccccCCCCccceeeccCCcCccchhhccCCCCCEEECcCCccCCCcchhhhhccCCc-ccEeEC
Confidence 122222222222 11110 122344555555555555433 2566666665 999999
Q ss_pred cCCcccccCCccccCCCCCcEEeCccCcCcCCCC-hhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCcc
Q 044615 202 SSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLS-PELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQ 280 (571)
Q Consensus 202 ~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~ 280 (571)
++|.+.+ +|..+..+++|+.|++++|.+.+..+ ..+..+++|+.|++++|.+.+..|..+.++++|+.|++++|.+++
T Consensus 384 ~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 462 (606)
T 3vq2_A 384 SFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKD 462 (606)
T ss_dssp CSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGG
T ss_pred CCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCC
Confidence 9999985 56888999999999999999998877 689999999999999999999899999999999999999999987
Q ss_pred -CcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCcccCCCCCc
Q 044615 281 -KIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTA 359 (571)
Q Consensus 281 -~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~ 359 (571)
.+|..+..+++|+.|++++|.+++..|..+..+++|+.|++++|++++..|..|..+++|+.|++++|+++..++....
T Consensus 463 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~ 542 (606)
T 3vq2_A 463 NTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQH 542 (606)
T ss_dssp GEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGG
T ss_pred cchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhh
Confidence 4788899999999999999999999999999999999999999999999999999999999999999999977666555
Q ss_pred cC-CCCcccccCCcCCCCC
Q 044615 360 FR-DAPMLALQGNKRLCGD 377 (571)
Q Consensus 360 ~~-~~~~l~l~~n~~~c~~ 377 (571)
+. .+..+++.+|++.|..
T Consensus 543 l~~~L~~l~l~~N~~~c~c 561 (606)
T 3vq2_A 543 FPKSLAFFNLTNNSVACIC 561 (606)
T ss_dssp SCTTCCEEECCSCCCCCSS
T ss_pred hcccCcEEEccCCCcccCC
Confidence 54 5899999999999853
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-34 Score=314.16 Aligned_cols=323 Identities=23% Similarity=0.248 Sum_probs=171.0
Q ss_pred hhcCCCCCCEEEccCCccc------cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCccccccc
Q 044615 43 ELVRAVQARDTSISFDELH------EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLA 116 (571)
Q Consensus 43 ~l~~~~~l~~l~l~~n~l~------~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~ 116 (571)
.+.++++|++|++++|.+. +..++.|++|+|++|.++. ..+..|+++++|++|+|++|.+++..|..
T Consensus 44 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-------l~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 116 (680)
T 1ziw_A 44 NFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQ-------LSDKTFAFCTNLTELHLMSNSIQKIKNNP 116 (680)
T ss_dssp GGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCC-------CCTTTTTTCTTCSEEECCSSCCCCCCSCT
T ss_pred HHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCc-------cChhhhccCCCCCEEECCCCccCccChhH
Confidence 3455555555555555444 3344555555555555543 11223555555555555555555444455
Q ss_pred ccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCcccc--CCCCCCEEEccCCCCCccCChhhhhcc-
Q 044615 117 LGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIG--NMNSLSILDLSSNKLNGSIPLSLANLT- 193 (571)
Q Consensus 117 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~--~l~~L~~L~L~~n~l~~~~p~~~~~l~- 193 (571)
|+++++|++|+|++|.+++..|..++++++|++|++++|.+.+..+..+. .+++|++|++++|++.+..|..+..+.
T Consensus 117 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~ 196 (680)
T 1ziw_A 117 FVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGR 196 (680)
T ss_dssp TTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSE
T ss_pred ccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhh
Confidence 55555555555555555555555555555555555555555544333322 335555555555555544443333221
Q ss_pred -------------------------CCCcEEEccCCcccccCCccccCCCC--CcEEeCccCcCcCCCChhhhCCCCCCE
Q 044615 194 -------------------------NSLKVLYLSSNHIVGEIPLGHGMLSS--LIQLTLNNNELSGQLSPELGSLIQLEY 246 (571)
Q Consensus 194 -------------------------~~L~~L~l~~n~~~~~~~~~~~~l~~--L~~L~l~~n~l~~~~~~~~~~l~~L~~ 246 (571)
.+|+.|++++|.+.+..|..+..++. |+.|++++|.+.+..+..|+.+++|+.
T Consensus 197 L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 276 (680)
T 1ziw_A 197 LFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEY 276 (680)
T ss_dssp ECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred hhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccE
Confidence 12555555555555555555555433 777777777777666667777777777
Q ss_pred EEcccCccccccchhhccCCCCCEEEcCCccCcc-----Ccc----hhhhcccCCCEEEccCCcCCcccchhccCCCCCC
Q 044615 247 LDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQ-----KIP----NKIEKLIHLSELDLSHNIFREEIPSQICSMQSLE 317 (571)
Q Consensus 247 L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~-----~~~----~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 317 (571)
|++++|.+.+..|..+.++++|+.|++++|...+ .+| ..+..+++|+.|++++|.+.+..+..|..+++|+
T Consensus 277 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 356 (680)
T 1ziw_A 277 FFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLK 356 (680)
T ss_dssp EECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCC
T ss_pred eeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCc
Confidence 7777777766666555555555555555443221 111 1344455555555555555555555555554444
Q ss_pred EEEcc----------------------------CCcCccccccccccCCCCCEEECcCCcCcccCCC--CCccCCCCccc
Q 044615 318 KLNLS----------------------------HNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPN--STAFRDAPMLA 367 (571)
Q Consensus 318 ~L~Ls----------------------------~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~--~~~~~~~~~l~ 367 (571)
.|+++ +|++++..|..|..+++|+.|++++|.+++.+|. ...+..+..++
T Consensus 357 ~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~ 436 (680)
T 1ziw_A 357 YLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIY 436 (680)
T ss_dssp EEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEE
T ss_pred EEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEe
Confidence 44443 3444444555555566666666666666554332 22334455555
Q ss_pred ccCCc
Q 044615 368 LQGNK 372 (571)
Q Consensus 368 l~~n~ 372 (571)
+.+|+
T Consensus 437 Ls~n~ 441 (680)
T 1ziw_A 437 LSYNK 441 (680)
T ss_dssp CCSCS
T ss_pred cCCCC
Confidence 55554
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=310.44 Aligned_cols=321 Identities=22% Similarity=0.243 Sum_probs=178.7
Q ss_pred hhhcCCCCCCEEEccCCccc------cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcc-ccc
Q 044615 42 KELVRAVQARDTSISFDELH------EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNG-SIP 114 (571)
Q Consensus 42 ~~l~~~~~l~~l~l~~n~l~------~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~-~~~ 114 (571)
..+.++++|++|++++|.+. +..+++|++|+|++|.+++ ..|..|+++++|++|+|++|.+++ ..|
T Consensus 44 ~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~-------~~~~~~~~l~~L~~L~Ls~n~l~~~~~~ 116 (549)
T 2z81_A 44 GDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSS-------LSSSWFGPLSSLKYLNLMGNPYQTLGVT 116 (549)
T ss_dssp STTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCS-------CCHHHHTTCTTCCEEECTTCCCSSSCSS
T ss_pred hhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCc-------cCHHHhccCCCCcEEECCCCcccccchh
Confidence 44555555555555555544 4455555555555555554 333345555555555555555553 234
Q ss_pred ccccCCCCCCEEEcccCc-CcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhcc
Q 044615 115 LALGNLTNLVVLDLSTNK-LSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLT 193 (571)
Q Consensus 115 ~~~~~l~~L~~L~L~~n~-i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~ 193 (571)
..++++++|++|++++|. +....+..|.++++|++|++++|.+.+..|..+..+++|++|+++.|.+. .+|..+....
T Consensus 117 ~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l 195 (549)
T 2z81_A 117 SLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADIL 195 (549)
T ss_dssp CSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST-THHHHHHHST
T ss_pred hhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCccc-ccchhhHhhc
Confidence 455555555555555555 22222345555555555665555555555555544444444444444332 2222222212
Q ss_pred CCCcEEEccCCcccccC--Ccc----------------------------------------------------------
Q 044615 194 NSLKVLYLSSNHIVGEI--PLG---------------------------------------------------------- 213 (571)
Q Consensus 194 ~~L~~L~l~~n~~~~~~--~~~---------------------------------------------------------- 213 (571)
.+|+.|++++|.+++.. |..
T Consensus 196 ~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~ 275 (549)
T 2z81_A 196 SSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESD 275 (549)
T ss_dssp TTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTT
T ss_pred ccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchh
Confidence 23666666666665421 000
Q ss_pred ------------------------------ccCCCCCcEEeCccCcCcCCCChhh-hCCCCCCEEEcccCccccccch--
Q 044615 214 ------------------------------HGMLSSLIQLTLNNNELSGQLSPEL-GSLIQLEYLDLSANTFHKSIPE-- 260 (571)
Q Consensus 214 ------------------------------~~~l~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~-- 260 (571)
+...++|+.|++++|.+. .+|..+ ..+++|+.|++++|.+.+..|.
T Consensus 276 ~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 354 (549)
T 2z81_A 276 VVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNS 354 (549)
T ss_dssp CCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHH
T ss_pred hhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccch
Confidence 000123445555555554 234443 4577777777777777665432
Q ss_pred -hhccCCCCCEEEcCCccCccCcc--hhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccc----
Q 044615 261 -SLSNLVKLHYLNLSNNQFSQKIP--NKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRC---- 333 (571)
Q Consensus 261 -~l~~l~~L~~L~Ls~n~l~~~~~--~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~---- 333 (571)
.+..+++|+.|++++|++++..+ ..+..+++|+.|++++|++++ +|..+..+++|+.|++++|+++.. |.+
T Consensus 355 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~~~~~~~L~~L~Ls~N~l~~l-~~~~~~~ 432 (549)
T 2z81_A 355 ACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTGIRVV-KTCIPQT 432 (549)
T ss_dssp TCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCCC-CCSCCCCCTTCCEEECTTSCCSCC-CTTSCTT
T ss_pred hhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCcc-CChhhcccccccEEECCCCCcccc-cchhcCC
Confidence 35667777777777777765432 346667777777777777763 565666666666666666666522 211
Q ss_pred --------------cccCCCCCEEECcCCcCcccCCCCCccCCCCcccccCCcCC
Q 044615 334 --------------FEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRL 374 (571)
Q Consensus 334 --------------~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~l~l~~n~~~ 374 (571)
...++.|+.|++++|+++. +|....++.+..+++.+|...
T Consensus 433 L~~L~Ls~N~l~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~l~~L~~L~Ls~N~l~ 486 (549)
T 2z81_A 433 LEVLDVSNNNLDSFSLFLPRLQELYISRNKLKT-LPDASLFPVLLVMKISRNQLK 486 (549)
T ss_dssp CSEEECCSSCCSCCCCCCTTCCEEECCSSCCSS-CCCGGGCTTCCEEECCSSCCC
T ss_pred ceEEECCCCChhhhcccCChhcEEECCCCccCc-CCCcccCccCCEEecCCCccC
Confidence 1257788888888888884 444556778888888888643
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=293.28 Aligned_cols=307 Identities=20% Similarity=0.188 Sum_probs=265.0
Q ss_pred cCCCCCCEEEccCCccc------cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCccccccccc
Q 044615 45 VRAVQARDTSISFDELH------EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALG 118 (571)
Q Consensus 45 ~~~~~l~~l~l~~n~l~------~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~ 118 (571)
..+.+++.++++++.+. +..+++|++|++++|.+++ ..|..|.++++|++|+|++|.+++..|..|+
T Consensus 42 ~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~-------~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 114 (390)
T 3o6n_A 42 ITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEE-------IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQ 114 (390)
T ss_dssp GGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCE-------ECTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred cccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccc-------cChhhccCCCCcCEEECCCCCCCcCCHHHhc
Confidence 35688999999999887 5678999999999999986 4566899999999999999999988888899
Q ss_pred CCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcE
Q 044615 119 NLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKV 198 (571)
Q Consensus 119 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~ 198 (571)
++++|++|+|++|.++...+..|.++++|++|++++|.+.+..|..+..+++|++|++++|++++. + +..++. |+.
T Consensus 115 ~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~--~~~l~~-L~~ 190 (390)
T 3o6n_A 115 NVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV-D--LSLIPS-LFH 190 (390)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC-C--GGGCTT-CSE
T ss_pred CCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc-c--cccccc-cce
Confidence 999999999999999966666679999999999999999988888899999999999999999853 3 445554 999
Q ss_pred EEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccC
Q 044615 199 LYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQF 278 (571)
Q Consensus 199 L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l 278 (571)
|++++|.+++. ...++|+.|++++|.+... |. ...++|+.|++++|.+++. ..+..+++|+.|++++|.+
T Consensus 191 L~l~~n~l~~~-----~~~~~L~~L~l~~n~l~~~-~~--~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l 260 (390)
T 3o6n_A 191 ANVSYNLLSTL-----AIPIAVEELDASHNSINVV-RG--PVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNEL 260 (390)
T ss_dssp EECCSSCCSEE-----ECCSSCSEEECCSSCCCEE-EC--CCCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCC
T ss_pred eeccccccccc-----CCCCcceEEECCCCeeeec-cc--cccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcC
Confidence 99999988742 3456899999999999865 32 2357899999999999764 5789999999999999999
Q ss_pred ccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCcccCCCCC
Q 044615 279 SQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNST 358 (571)
Q Consensus 279 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~ 358 (571)
++..|..+..+++|+.|++++|++++ +|..+..+++|+.|++++|+++ .+|..+..++.|+.|++++|+++... ..
T Consensus 261 ~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~--~~ 336 (390)
T 3o6n_A 261 EKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK--LS 336 (390)
T ss_dssp CEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC--CC
T ss_pred CCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeC--ch
Confidence 98889999999999999999999986 5666788999999999999998 56777888999999999999998774 45
Q ss_pred ccCCCCcccccCCcCCCC
Q 044615 359 AFRDAPMLALQGNKRLCG 376 (571)
Q Consensus 359 ~~~~~~~l~l~~n~~~c~ 376 (571)
.+..++.+++.+|++.|.
T Consensus 337 ~~~~L~~L~l~~N~~~~~ 354 (390)
T 3o6n_A 337 THHTLKNLTLSHNDWDCN 354 (390)
T ss_dssp TTCCCSEEECCSSCEEHH
T ss_pred hhccCCEEEcCCCCccch
Confidence 678889999999988774
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=301.61 Aligned_cols=307 Identities=25% Similarity=0.238 Sum_probs=254.5
Q ss_pred CEEEccCCccc---cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccccccccCCCCCCEEE
Q 044615 51 RDTSISFDELH---EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLD 127 (571)
Q Consensus 51 ~~l~l~~n~l~---~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 127 (571)
+.+++++|.++ ....+.++.|+|++|.+++ ..|..|.++++|++|+|++|.+++..|..|+++++|++|+
T Consensus 3 ~~l~ls~n~l~~ip~~~~~~L~~L~Ls~n~i~~-------~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 75 (520)
T 2z7x_B 3 FLVDRSKNGLIHVPKDLSQKTTILNISQNYISE-------LWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLD 75 (520)
T ss_dssp CEEECTTSCCSSCCCSCCTTCSEEECCSSCCCC-------CCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEE
T ss_pred ceEecCCCCcccccccccccccEEECCCCcccc-------cChhhccccccccEEecCCCccCCcChHHhhcccCCCEEe
Confidence 57999999888 2223789999999999987 5567899999999999999999988899999999999999
Q ss_pred cccCcCcccccccccCCCCCCeeecccCcCcc-cCCccccCCCCCCEEEccCCCCCccCChhhhhccCCC--cEEEccCC
Q 044615 128 LSTNKLSGSIPLSFANLTSLSILYLYENSLCD-SIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSL--KVLYLSSN 204 (571)
Q Consensus 128 L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L--~~L~l~~n 204 (571)
|++|.++ .+|.. .+++|++|+|++|.+.+ .+|..++.+++|++|++++|++.+ ..+..+.. | +.|++++|
T Consensus 76 Ls~N~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~-L~L~~L~l~~n 148 (520)
T 2z7x_B 76 LSHNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAH-LNISKVLLVLG 148 (520)
T ss_dssp CCSSCCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTT-SCEEEEEEEEC
T ss_pred cCCCcee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhcccccc-ceeeEEEeecc
Confidence 9999998 45555 89999999999999987 478899999999999999999985 35566664 7 99999999
Q ss_pred cc--cccCCccccCCC----------------------------------------------------------------
Q 044615 205 HI--VGEIPLGHGMLS---------------------------------------------------------------- 218 (571)
Q Consensus 205 ~~--~~~~~~~~~~l~---------------------------------------------------------------- 218 (571)
.+ .+..|..+..+.
T Consensus 149 ~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~ 228 (520)
T 2z7x_B 149 ETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLN 228 (520)
T ss_dssp TTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEE
T ss_pred cccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhcccc
Confidence 98 555565554422
Q ss_pred -------------------CCcEEeCccCcCcCCCChhh-----hCCCCCCEEEcccCccccccc-hh------------
Q 044615 219 -------------------SLIQLTLNNNELSGQLSPEL-----GSLIQLEYLDLSANTFHKSIP-ES------------ 261 (571)
Q Consensus 219 -------------------~L~~L~l~~n~l~~~~~~~~-----~~l~~L~~L~L~~n~l~~~~~-~~------------ 261 (571)
+|+.|++++|.+.+.+|..+ +.+++|+.+++++|.+ .+| ..
T Consensus 229 ~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~ 306 (520)
T 2z7x_B 229 NIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKN 306 (520)
T ss_dssp EEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSE
T ss_pred ccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeE
Confidence 56777777777777777766 6677666666666665 222 11
Q ss_pred -------------hccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCc--ccchhccCCCCCCEEEccCCcC
Q 044615 262 -------------LSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFRE--EIPSQICSMQSLEKLNLSHNNL 326 (571)
Q Consensus 262 -------------l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~--~~~~~~~~l~~L~~L~Ls~n~l 326 (571)
+..+++|++|++++|.+++..|..+..+++|+.|++++|++.+ .+|..+..+++|+.|++++|.+
T Consensus 307 L~l~~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l 386 (520)
T 2z7x_B 307 FTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSV 386 (520)
T ss_dssp EEEESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCC
T ss_pred EEcCCCccccccchhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcC
Confidence 1678999999999999999899999999999999999999987 5667899999999999999999
Q ss_pred cccccc-ccccCCCCCEEECcCCcCcccCCCCCccCCCCcccccCCcCC
Q 044615 327 SGSIPR-CFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRL 374 (571)
Q Consensus 327 ~~~~p~-~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~l~l~~n~~~ 374 (571)
++.+|. .+..++.|+.|++++|++++..|.... ..+..+++.+|...
T Consensus 387 ~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~-~~L~~L~Ls~N~l~ 434 (520)
T 2z7x_B 387 SYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP-PRIKVLDLHSNKIK 434 (520)
T ss_dssp BCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC-TTCCEEECCSSCCC
T ss_pred CcccccchhccCccCCEEECcCCCCCcchhhhhc-ccCCEEECCCCccc
Confidence 985555 588899999999999999887665322 67889999998654
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=306.03 Aligned_cols=333 Identities=24% Similarity=0.242 Sum_probs=253.2
Q ss_pred cCCCCCchhhcCCCCCCEEEccCCccc------cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCc
Q 044615 35 DGLGDDYKELVRAVQARDTSISFDELH------EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENI 108 (571)
Q Consensus 35 ~~~~~~~~~l~~~~~l~~l~l~~n~l~------~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~ 108 (571)
.++..+|..+. .+++.|||++|.++ |..+++|++|+|++|++++ ..|..|.++++|++|+|++|+
T Consensus 41 ~~l~~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~-------i~~~~f~~L~~L~~L~Ls~N~ 111 (635)
T 4g8a_A 41 LNFYKIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-------IEDGAYQSLSHLSTLILTGNP 111 (635)
T ss_dssp SCCSSCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCE-------ECTTTTTTCTTCCEEECTTCC
T ss_pred CCcCccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCC-------cChhHhcCCCCCCEEEccCCc
Confidence 35566777653 47899999999988 7889999999999999987 446679999999999999999
Q ss_pred CcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcc-cCCccccCCCCCCEEEccCCCCCccCCh
Q 044615 109 LNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCD-SIPKEIGNMNSLSILDLSSNKLNGSIPL 187 (571)
Q Consensus 109 i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~l~~l~~L~~L~L~~n~l~~~~p~ 187 (571)
+++..+..|.++++|++|+|++|++++..+..|+++++|++|+|++|.+.. ..|..+..+++|++|++++|++++..|.
T Consensus 112 l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 191 (635)
T 4g8a_A 112 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 191 (635)
T ss_dssp CCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGG
T ss_pred CCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccc
Confidence 998777889999999999999999998888889999999999999999975 3578889999999999999998765554
Q ss_pred hhhhccC-------------------------------------------------------------------------
Q 044615 188 SLANLTN------------------------------------------------------------------------- 194 (571)
Q Consensus 188 ~~~~l~~------------------------------------------------------------------------- 194 (571)
.+..+..
T Consensus 192 ~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~ 271 (635)
T 4g8a_A 192 DLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD 271 (635)
T ss_dssp GGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCC
T ss_pred cccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhcccccccccchhhcCCccccccccccccccccccccccc
Confidence 4433221
Q ss_pred ---------------------------------------------------------CCcEEEccCCcccccCCc-----
Q 044615 195 ---------------------------------------------------------SLKVLYLSSNHIVGEIPL----- 212 (571)
Q Consensus 195 ---------------------------------------------------------~L~~L~l~~n~~~~~~~~----- 212 (571)
+++.|++++|.+....+.
T Consensus 272 ~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L 351 (635)
T 4g8a_A 272 KSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSL 351 (635)
T ss_dssp TTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTC
T ss_pred ccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhh
Confidence 011222222221110000
Q ss_pred --------------cccCCCCCcEEeCccCcCcCC--C------------------------------------------
Q 044615 213 --------------GHGMLSSLIQLTLNNNELSGQ--L------------------------------------------ 234 (571)
Q Consensus 213 --------------~~~~l~~L~~L~l~~n~l~~~--~------------------------------------------ 234 (571)
....+++|+.|++++|.+... .
T Consensus 352 ~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~ 431 (635)
T 4g8a_A 352 KRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSN 431 (635)
T ss_dssp CEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSE
T ss_pred hhcccccccCCCCcccccccccccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhcc
Confidence 011234455555555544210 0
Q ss_pred ------ChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccC-ccCcchhhhcccCCCEEEccCCcCCcccc
Q 044615 235 ------SPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQF-SQKIPNKIEKLIHLSELDLSHNIFREEIP 307 (571)
Q Consensus 235 ------~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l-~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 307 (571)
+..+..+++++.++++.|.+....+..+..+++|+.|++++|.+ .+..|..+..+++|+.|+|++|++++..|
T Consensus 432 ~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~ 511 (635)
T 4g8a_A 432 LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 511 (635)
T ss_dssp EESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECT
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcCh
Confidence 11233445556666666666666666777788888888888874 34567788889999999999999999888
Q ss_pred hhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCcccCCCC-Ccc-CCCCcccccCCcCCCC
Q 044615 308 SQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNS-TAF-RDAPMLALQGNKRLCG 376 (571)
Q Consensus 308 ~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~-~~~-~~~~~l~l~~n~~~c~ 376 (571)
..|.++++|++|+|++|+|++..|..|..+++|+.||+++|++++.+|.. ..+ .++..+++.+|++.|.
T Consensus 512 ~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~ 582 (635)
T 4g8a_A 512 TAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 582 (635)
T ss_dssp TTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred HHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence 89999999999999999999888889999999999999999999988864 233 5788899999999884
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-34 Score=307.26 Aligned_cols=306 Identities=21% Similarity=0.195 Sum_probs=261.4
Q ss_pred CCCCCCEEEccCCccc------cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccccccccC
Q 044615 46 RAVQARDTSISFDELH------EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGN 119 (571)
Q Consensus 46 ~~~~l~~l~l~~n~l~------~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~ 119 (571)
.+.+++.+++++|.+. +..+++|+.|+|++|.+++ ..|..|+++++|++|+|++|.+++..|..|++
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~-------~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 121 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEE-------IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQN 121 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCE-------ECTTTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCC-------CChHHhcCCCCCCEEECCCCcCCCCCHHHHcC
Confidence 4678899999999877 5678999999999999987 55678999999999999999999888888999
Q ss_pred CCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEE
Q 044615 120 LTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVL 199 (571)
Q Consensus 120 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L 199 (571)
+++|++|+|++|.++...+..|+++++|++|+|++|.+.+..|..|..+++|++|++++|.+++. + +..++. |+.|
T Consensus 122 l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~--~~~l~~-L~~L 197 (597)
T 3oja_B 122 VPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV-D--LSLIPS-LFHA 197 (597)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC-C--GGGCTT-CSEE
T ss_pred CCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc-C--hhhhhh-hhhh
Confidence 99999999999999977777789999999999999999988888899999999999999999854 3 444554 9999
Q ss_pred EccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCc
Q 044615 200 YLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFS 279 (571)
Q Consensus 200 ~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~ 279 (571)
++++|.+++ +...++|+.|++++|.+....+. ..++|+.|++++|.+++ +..+..+++|+.|++++|.++
T Consensus 198 ~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~~~~---~~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~ 267 (597)
T 3oja_B 198 NVSYNLLST-----LAIPIAVEELDASHNSINVVRGP---VNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELE 267 (597)
T ss_dssp ECCSSCCSE-----EECCTTCSEEECCSSCCCEEECS---CCSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCC
T ss_pred hcccCcccc-----ccCCchhheeeccCCcccccccc---cCCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccC
Confidence 999998874 23456899999999988754332 23689999999999876 367889999999999999999
Q ss_pred cCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCcccCCCCCc
Q 044615 280 QKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTA 359 (571)
Q Consensus 280 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~ 359 (571)
+..|..+..+++|+.|+|++|.+++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|++++|.+++.. ...
T Consensus 268 ~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~--~~~ 343 (597)
T 3oja_B 268 KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK--LST 343 (597)
T ss_dssp EEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC--CCT
T ss_pred CCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC--hhh
Confidence 8888899999999999999999987 5667778899999999999998 56777888899999999999998774 346
Q ss_pred cCCCCcccccCCcCCCC
Q 044615 360 FRDAPMLALQGNKRLCG 376 (571)
Q Consensus 360 ~~~~~~l~l~~n~~~c~ 376 (571)
+..+..+++.+|++.|.
T Consensus 344 ~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 344 HHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp TCCCSEEECCSSCEEHH
T ss_pred cCCCCEEEeeCCCCCCh
Confidence 77888899999998874
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-33 Score=280.94 Aligned_cols=305 Identities=25% Similarity=0.315 Sum_probs=264.7
Q ss_pred chhhcCCCCCCEEEccCCccc----cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCccccccc
Q 044615 41 YKELVRAVQARDTSISFDELH----EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLA 116 (571)
Q Consensus 41 ~~~l~~~~~l~~l~l~~n~l~----~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~ 116 (571)
...+..+.+++.|+++++.+. +..+++|++|++++|.+++ +|. +.++++|++|++++|.++. + ..
T Consensus 37 ~~~~~~l~~L~~L~l~~~~i~~~~~~~~~~~L~~L~l~~n~i~~--------~~~-~~~l~~L~~L~L~~n~i~~-~-~~ 105 (347)
T 4fmz_A 37 VVTQEELESITKLVVAGEKVASIQGIEYLTNLEYLNLNGNQITD--------ISP-LSNLVKLTNLYIGTNKITD-I-SA 105 (347)
T ss_dssp EECHHHHTTCSEEECCSSCCCCCTTGGGCTTCCEEECCSSCCCC--------CGG-GTTCTTCCEEECCSSCCCC-C-GG
T ss_pred cccchhcccccEEEEeCCccccchhhhhcCCccEEEccCCcccc--------chh-hhcCCcCCEEEccCCcccC-c-hH
Confidence 455678899999999999887 6788999999999999886 444 8899999999999999985 3 36
Q ss_pred ccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCC
Q 044615 117 LGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSL 196 (571)
Q Consensus 117 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L 196 (571)
+..+++|++|++++|.+++..+ +..+++|++|++++|......+ .+..+++|++|++++|.+.+..+ +..++. |
T Consensus 106 ~~~l~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~-L 179 (347)
T 4fmz_A 106 LQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTD-L 179 (347)
T ss_dssp GTTCTTCSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTT-C
T ss_pred HcCCCcCCEEECcCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCC-C
Confidence 9999999999999999986543 8999999999999997665444 48999999999999999985433 677775 9
Q ss_pred cEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCc
Q 044615 197 KVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNN 276 (571)
Q Consensus 197 ~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n 276 (571)
+.|++++|.+.+..+ +..+++|+.|++++|.+.+..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|
T Consensus 180 ~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n 253 (347)
T 4fmz_A 180 YSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTN 253 (347)
T ss_dssp SEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred CEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCC
Confidence 999999999985443 7889999999999999986544 8899999999999999986544 889999999999999
Q ss_pred cCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCcccCCC
Q 044615 277 QFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPN 356 (571)
Q Consensus 277 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~ 356 (571)
.+++. ..+..+++|+.|++++|.+++. ..+..+++|+.|++++|++++..|..+..+++|+.|++++|++++..|
T Consensus 254 ~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~- 328 (347)
T 4fmz_A 254 QISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP- 328 (347)
T ss_dssp CCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG-
T ss_pred ccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC-
Confidence 99864 4688999999999999999874 458899999999999999999999999999999999999999999877
Q ss_pred CCccCCCCcccccCCcC
Q 044615 357 STAFRDAPMLALQGNKR 373 (571)
Q Consensus 357 ~~~~~~~~~l~l~~n~~ 373 (571)
...++.+..+++.+|+.
T Consensus 329 ~~~l~~L~~L~l~~N~i 345 (347)
T 4fmz_A 329 LASLSKMDSADFANQVI 345 (347)
T ss_dssp GGGCTTCSEESSSCC--
T ss_pred hhhhhccceeehhhhcc
Confidence 66788899999998863
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=305.43 Aligned_cols=326 Identities=19% Similarity=0.212 Sum_probs=261.5
Q ss_pred CCCCCchhhcCCCCCCEEEccCCccc------cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcC
Q 044615 36 GLGDDYKELVRAVQARDTSISFDELH------EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENIL 109 (571)
Q Consensus 36 ~~~~~~~~l~~~~~l~~l~l~~n~l~------~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i 109 (571)
++..+|..+. .+++.|++++|.+. +..+++|++|++++|++++ ..|..|+++++|++|+|++|.+
T Consensus 16 ~l~~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~-------~~~~~~~~l~~L~~L~Ls~n~l 86 (549)
T 2z81_A 16 SFTSIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINT-------IEGDAFYSLGSLEHLDLSDNHL 86 (549)
T ss_dssp CCSSCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCE-------ECTTTTTTCTTCCEEECTTSCC
T ss_pred ccccccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCc-------cChhhccccccCCEEECCCCcc
Confidence 4455676654 78999999999887 6789999999999999997 6678899999999999999999
Q ss_pred cccccccccCCCCCCEEEcccCcCccc-ccccccCCCCCCeeecccCcCcccC-CccccCCCCCCEEEccCCCCCccCCh
Q 044615 110 NGSIPLALGNLTNLVVLDLSTNKLSGS-IPLSFANLTSLSILYLYENSLCDSI-PKEIGNMNSLSILDLSSNKLNGSIPL 187 (571)
Q Consensus 110 ~~~~~~~~~~l~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L~L~~n~l~~~~-~~~l~~l~~L~~L~L~~n~l~~~~p~ 187 (571)
++..|..|+++++|++|++++|.+++. .|..++++++|++|++++|.+.+.+ +..+..+++|++|++++|++.+..|.
T Consensus 87 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 166 (549)
T 2z81_A 87 SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQ 166 (549)
T ss_dssp CSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTT
T ss_pred CccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChh
Confidence 988888899999999999999999863 5678999999999999999844444 46899999999999999999988999
Q ss_pred hhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCC--Chh----------------------------
Q 044615 188 SLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQL--SPE---------------------------- 237 (571)
Q Consensus 188 ~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~--~~~---------------------------- 237 (571)
.+..+.+ |+.|+++.|.+....+..+..+++|++|++++|.+.+.. +..
T Consensus 167 ~l~~l~~-L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~ 245 (549)
T 2z81_A 167 SLKSIRD-IHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245 (549)
T ss_dssp TTTTCSE-EEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHG
T ss_pred hhhcccc-CceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHH
Confidence 9998886 999999999986433333456889999999999887631 000
Q ss_pred ------------------------------------------------------------hhCCCCCCEEEcccCccccc
Q 044615 238 ------------------------------------------------------------LGSLIQLEYLDLSANTFHKS 257 (571)
Q Consensus 238 ------------------------------------------------------------~~~l~~L~~L~L~~n~l~~~ 257 (571)
+...++|+.|++++|.+. .
T Consensus 246 ~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ 324 (549)
T 2z81_A 246 LLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-L 324 (549)
T ss_dssp GGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-C
T ss_pred HhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-c
Confidence 011134555556666554 3
Q ss_pred cchhh-ccCCCCCEEEcCCccCccCcch---hhhcccCCCEEEccCCcCCcccc--hhccCCCCCCEEEccCCcCccccc
Q 044615 258 IPESL-SNLVKLHYLNLSNNQFSQKIPN---KIEKLIHLSELDLSHNIFREEIP--SQICSMQSLEKLNLSHNNLSGSIP 331 (571)
Q Consensus 258 ~~~~l-~~l~~L~~L~Ls~n~l~~~~~~---~~~~l~~L~~L~Ls~n~l~~~~~--~~~~~l~~L~~L~Ls~n~l~~~~p 331 (571)
+|..+ ..+++|+.|++++|.+++..|. .+..+++|+.|++++|.+++..+ ..+..+++|+.|++++|+++ .+|
T Consensus 325 ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp 403 (549)
T 2z81_A 325 VPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMP 403 (549)
T ss_dssp CCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCC
T ss_pred CCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCC
Confidence 44444 5799999999999999987653 36788999999999999987543 56899999999999999999 678
Q ss_pred cccccCCCCCEEECcCCcCcccCCCC------------------CccCCCCcccccCCcC
Q 044615 332 RCFEEMHWLSCIDISYNALQGLIPNS------------------TAFRDAPMLALQGNKR 373 (571)
Q Consensus 332 ~~~~~l~~L~~L~ls~N~l~~~~~~~------------------~~~~~~~~l~l~~n~~ 373 (571)
..+..+++|+.|++++|.++...... ..++.+..+++++|..
T Consensus 404 ~~~~~~~~L~~L~Ls~N~l~~l~~~~~~~L~~L~Ls~N~l~~~~~~l~~L~~L~Ls~N~l 463 (549)
T 2z81_A 404 DSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKL 463 (549)
T ss_dssp SCCCCCTTCCEEECTTSCCSCCCTTSCTTCSEEECCSSCCSCCCCCCTTCCEEECCSSCC
T ss_pred hhhcccccccEEECCCCCcccccchhcCCceEEECCCCChhhhcccCChhcEEECCCCcc
Confidence 88888888999998888887543321 1345566667777754
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=288.38 Aligned_cols=252 Identities=26% Similarity=0.397 Sum_probs=189.4
Q ss_pred CccceeecccccccCCCCCCCccccccccCCCCCCEEeccc-CcCcccccccccCCCCCCEEEcccCcCcccccccccCC
Q 044615 66 TFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSE-NILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANL 144 (571)
Q Consensus 66 ~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l 144 (571)
..++.|+|++|.+++. ..+|..++++++|++|+|++ |.+.+.+|..|+++++|++|+|++|.+++.+|..|.++
T Consensus 50 ~~l~~L~L~~~~l~~~-----~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l 124 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKP-----YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124 (313)
T ss_dssp CCEEEEEEECCCCSSC-----EECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGC
T ss_pred ceEEEEECCCCCccCC-----cccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCC
Confidence 5799999999999851 14788999999999999995 99999999999999999999999999999999999999
Q ss_pred CCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEe
Q 044615 145 TSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLT 224 (571)
Q Consensus 145 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~ 224 (571)
++|++|++++|.+.+.+|..+..+++|++|++++|++++.+|..+..+.++|+.|++++|.+++..|..+..++ |+.|+
T Consensus 125 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~ 203 (313)
T 1ogq_A 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVD 203 (313)
T ss_dssp TTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEE
T ss_pred CCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEE
Confidence 99999999999999899999999999999999999999889988888874488888888888776666666554 66666
Q ss_pred CccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCc
Q 044615 225 LNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFRE 304 (571)
Q Consensus 225 l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 304 (571)
+++|.+.+..|..+..+++|+.|++++|.+++.+|. +..+++|+.|++++|.+++
T Consensus 204 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-------------------------~~~l~~L~~L~Ls~N~l~~ 258 (313)
T 1ogq_A 204 LSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-------------------------VGLSKNLNGLDLRNNRIYG 258 (313)
T ss_dssp CCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-------------------------CCCCTTCCEEECCSSCCEE
T ss_pred CcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-------------------------ccccCCCCEEECcCCcccC
Confidence 666665555555555555555555555555433332 3444555555555555555
Q ss_pred ccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCc
Q 044615 305 EIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNA 349 (571)
Q Consensus 305 ~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~ 349 (571)
.+|..+..+++|+.|+|++|++++.+|.. ..+++|+.+++++|+
T Consensus 259 ~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 259 TLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302 (313)
T ss_dssp CCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred cCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence 55555555555555555555555555554 455556666666665
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=299.77 Aligned_cols=311 Identities=23% Similarity=0.237 Sum_probs=253.8
Q ss_pred CCCCEEEccCCccc---cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccccccccCCCCCC
Q 044615 48 VQARDTSISFDELH---EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLV 124 (571)
Q Consensus 48 ~~l~~l~l~~n~l~---~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 124 (571)
...+.+++++|+++ ....+.++.|+|++|.+++ ..|..|.++++|++|+|++|.+++..|..|+++++|+
T Consensus 31 ~~~~~l~ls~~~L~~ip~~~~~~L~~L~Ls~N~i~~-------~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 103 (562)
T 3a79_B 31 ELESMVDYSNRNLTHVPKDLPPRTKALSLSQNSISE-------LRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLE 103 (562)
T ss_dssp --CCEEECTTSCCCSCCTTSCTTCCEEECCSSCCCC-------CCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCC
T ss_pred CCCcEEEcCCCCCccCCCCCCCCcCEEECCCCCccc-------cChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCC
Confidence 34478999999888 2234789999999999997 5567899999999999999999988899999999999
Q ss_pred EEEcccCcCcccccccccCCCCCCeeecccCcCccc-CCccccCCCCCCEEEccCCCCCccCChhhhhccCCC--cEEEc
Q 044615 125 VLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDS-IPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSL--KVLYL 201 (571)
Q Consensus 125 ~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L--~~L~l 201 (571)
+|+|++|.++ .+|.. .+++|++|++++|.+.+. .|..|+++++|++|++++|++.+. .+..+.. | +.|++
T Consensus 104 ~L~Ls~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~-L~L~~L~L 176 (562)
T 3a79_B 104 YLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAH-LHLSCILL 176 (562)
T ss_dssp EEECTTSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTT-SCEEEEEE
T ss_pred EEECCCCcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhh-ceeeEEEe
Confidence 9999999998 45555 899999999999999873 468999999999999999999853 3444443 5 99999
Q ss_pred cCCcc--cccCCccccCCC-------------------------------------------------------------
Q 044615 202 SSNHI--VGEIPLGHGMLS------------------------------------------------------------- 218 (571)
Q Consensus 202 ~~n~~--~~~~~~~~~~l~------------------------------------------------------------- 218 (571)
++|.+ ++..|..+..+.
T Consensus 177 ~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L 256 (562)
T 3a79_B 177 DLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTL 256 (562)
T ss_dssp EESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEE
T ss_pred ecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEe
Confidence 99998 655555544432
Q ss_pred --------------------CCcEEeCccCcCcCCCChhh----------------------------------------
Q 044615 219 --------------------SLIQLTLNNNELSGQLSPEL---------------------------------------- 238 (571)
Q Consensus 219 --------------------~L~~L~l~~n~l~~~~~~~~---------------------------------------- 238 (571)
+|++|++++|.+.+.+|..+
T Consensus 257 ~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L 336 (562)
T 3a79_B 257 QHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKML 336 (562)
T ss_dssp EEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEE
T ss_pred cCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEE
Confidence 67788888888877666544
Q ss_pred -------------hCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccC--cchhhhcccCCCEEEccCCcCC
Q 044615 239 -------------GSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQK--IPNKIEKLIHLSELDLSHNIFR 303 (571)
Q Consensus 239 -------------~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~--~~~~~~~l~~L~~L~Ls~n~l~ 303 (571)
..+++|+.|++++|.+++..|..+.++++|+.|++++|++++. .|..+..+++|+.|++++|.+.
T Consensus 337 ~l~~n~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~ 416 (562)
T 3a79_B 337 SISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLN 416 (562)
T ss_dssp EEESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCB
T ss_pred EccCCCcccccCccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCC
Confidence 5678888999999988887888888899999999999988863 3466788889999999999988
Q ss_pred cccc-hhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCcccCCCCCccCCCCcccccCCcCC
Q 044615 304 EEIP-SQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRL 374 (571)
Q Consensus 304 ~~~~-~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~l~l~~n~~~ 374 (571)
+.+| ..+..+++|+.|++++|++++..|..+. +.|+.|++++|+++..++....++.+..+++.+|...
T Consensus 417 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~ 486 (562)
T 3a79_B 417 SHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLK 486 (562)
T ss_dssp SCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCCCCTTTTSSCCCSEEECCSSCCC
T ss_pred CccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCcccChhhcCCCCCCEEECCCCCCC
Confidence 7444 4578888999999999998877776654 6899999999999877666667788888999988744
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-32 Score=284.93 Aligned_cols=298 Identities=32% Similarity=0.407 Sum_probs=174.0
Q ss_pred hhcCCCCCCEEEccCCccc----cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCccccccccc
Q 044615 43 ELVRAVQARDTSISFDELH----EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALG 118 (571)
Q Consensus 43 ~l~~~~~l~~l~l~~n~l~----~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~ 118 (571)
.+..+.+|++|++++|.+. +..+++|+.|++++|.+++ ++. ++++++|++|++++|.+++..+ +.
T Consensus 63 ~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~l~~n~l~~--------~~~-~~~l~~L~~L~L~~n~l~~~~~--~~ 131 (466)
T 1o6v_A 63 GVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIAD--------ITP-LANLTNLTGLTLFNNQITDIDP--LK 131 (466)
T ss_dssp TGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC--------CGG-GTTCTTCCEEECCSSCCCCCGG--GT
T ss_pred chhhhcCCCEEECCCCccCCchhhhccccCCEEECCCCcccc--------Chh-hcCCCCCCEEECCCCCCCCChH--Hc
Confidence 3666777777777777666 5667777777777777765 233 6777777777777777765432 67
Q ss_pred CCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcE
Q 044615 119 NLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKV 198 (571)
Q Consensus 119 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~ 198 (571)
.+++|++|++++|.+.+. + .+..+++|++|+++ |.+.+. ..+..+++|++|++++|.+.+ + ..+..+++ |+.
T Consensus 132 ~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~l~~-L~~ 203 (466)
T 1o6v_A 132 NLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDL--KPLANLTTLERLDISSNKVSD-I-SVLAKLTN-LES 203 (466)
T ss_dssp TCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCC--GGGTTCTTCCEEECCSSCCCC-C-GGGGGCTT-CSE
T ss_pred CCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCc--hhhccCCCCCEEECcCCcCCC-C-hhhccCCC-CCE
Confidence 777777777777776643 2 34555555555553 222221 125566666666666666653 2 23445554 666
Q ss_pred EEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccC
Q 044615 199 LYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQF 278 (571)
Q Consensus 199 L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l 278 (571)
|++++|.+.+..| ++.+++|+.|++++|.+.+. +.+..+++|+.|++++|.+.+..+ +..+++|+.|++++|.+
T Consensus 204 L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l 277 (466)
T 1o6v_A 204 LIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQI 277 (466)
T ss_dssp EECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCC
T ss_pred EEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCcc
Confidence 6666666654433 44556666666666666542 345556666666666666654333 55566666666666666
Q ss_pred ccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCcccCCCCC
Q 044615 279 SQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNST 358 (571)
Q Consensus 279 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~ 358 (571)
++..+ +..+++|+.|++++|++.+..+ +..+++|+.|++++|++++..| +..++.|+.|++++|++++. +...
T Consensus 278 ~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~l~ 350 (466)
T 1o6v_A 278 SNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV-SSLA 350 (466)
T ss_dssp CCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC-GGGT
T ss_pred Ccccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc-hhhc
Confidence 54333 5555566666666666554333 4555666666666666655443 45555566666666655554 2333
Q ss_pred ccCCCCcccccCCc
Q 044615 359 AFRDAPMLALQGNK 372 (571)
Q Consensus 359 ~~~~~~~l~l~~n~ 372 (571)
.+..+..+++.+|+
T Consensus 351 ~l~~L~~L~l~~n~ 364 (466)
T 1o6v_A 351 NLTNINWLSAGHNQ 364 (466)
T ss_dssp TCTTCCEEECCSSC
T ss_pred cCCCCCEEeCCCCc
Confidence 44455555555554
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-32 Score=273.07 Aligned_cols=283 Identities=24% Similarity=0.351 Sum_probs=246.7
Q ss_pred hhhcCCCCCCEEEccCCccc----cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccccccc
Q 044615 42 KELVRAVQARDTSISFDELH----EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLAL 117 (571)
Q Consensus 42 ~~l~~~~~l~~l~l~~n~l~----~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~ 117 (571)
+.+..+.+|++|++++|.+. +..+++|++|++++|.++. +| .+.++++|++|++++|.+.+. +. +
T Consensus 60 ~~~~~~~~L~~L~l~~n~i~~~~~~~~l~~L~~L~L~~n~i~~--------~~-~~~~l~~L~~L~l~~n~i~~~-~~-~ 128 (347)
T 4fmz_A 60 QGIEYLTNLEYLNLNGNQITDISPLSNLVKLTNLYIGTNKITD--------IS-ALQNLTNLRELYLNEDNISDI-SP-L 128 (347)
T ss_dssp TTGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC--------CG-GGTTCTTCSEEECTTSCCCCC-GG-G
T ss_pred hhhhhcCCccEEEccCCccccchhhhcCCcCCEEEccCCcccC--------ch-HHcCCCcCCEEECcCCcccCc-hh-h
Confidence 34888999999999999887 7789999999999999886 33 589999999999999999854 33 8
Q ss_pred cCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCc
Q 044615 118 GNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLK 197 (571)
Q Consensus 118 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~ 197 (571)
..+++|++|++++|.....++ .+..+++|++|++++|.+.+..+ +..+++|++|++++|.+.+ ++. +..++. |+
T Consensus 129 ~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~-~~~-~~~l~~-L~ 202 (347)
T 4fmz_A 129 ANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED-ISP-LASLTS-LH 202 (347)
T ss_dssp TTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCC-CGG-GGGCTT-CC
T ss_pred ccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCcccc-ccc-ccCCCc-cc
Confidence 999999999999997654444 48999999999999999976433 8899999999999999985 443 667775 99
Q ss_pred EEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCcc
Q 044615 198 VLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQ 277 (571)
Q Consensus 198 ~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~ 277 (571)
.|++++|.+.+..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|.+++. ..+..+++|+.|++++|.
T Consensus 203 ~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~ 276 (347)
T 4fmz_A 203 YFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQ 276 (347)
T ss_dssp EEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSC
T ss_pred eeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCc
Confidence 99999999986544 7889999999999999996544 89999999999999999864 568999999999999999
Q ss_pred CccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCc
Q 044615 278 FSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQ 351 (571)
Q Consensus 278 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~ 351 (571)
+++. ..+..+++|+.|++++|.+.+..+..+..+++|+.|++++|++++..| +..++.|+.|++++|+++
T Consensus 277 l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 277 ISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp CCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred cCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 9865 458899999999999999999999999999999999999999998776 889999999999999986
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=281.96 Aligned_cols=312 Identities=23% Similarity=0.172 Sum_probs=263.2
Q ss_pred CCCchh-hcCCCCCCEEEccCCccc------cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCc
Q 044615 38 GDDYKE-LVRAVQARDTSISFDELH------EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILN 110 (571)
Q Consensus 38 ~~~~~~-l~~~~~l~~l~l~~n~l~------~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~ 110 (571)
..+|.. +..+++|+.|++++|.+. +..+++|+.|+|++|.+++ ..|..++++++|++|+|++|.++
T Consensus 58 ~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~-------~~~~~~~~l~~L~~L~L~~n~l~ 130 (390)
T 3o6n_A 58 RKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-------LPPHVFQNVPLLTVLVLERNDLS 130 (390)
T ss_dssp SEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCC-------CCTTTTTTCTTCCEEECCSSCCC
T ss_pred hhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCc-------CCHHHhcCCCCCCEEECCCCccC
Confidence 344544 688999999999999887 6789999999999999987 55777899999999999999999
Q ss_pred ccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhh
Q 044615 111 GSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLA 190 (571)
Q Consensus 111 ~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~ 190 (571)
...+..|.++++|++|++++|.+++..+..|.++++|++|++++|.+.+. .+..+++|+.|++++|.+.+. +
T Consensus 131 ~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~~-~---- 202 (390)
T 3o6n_A 131 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTL-A---- 202 (390)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSEE-E----
T ss_pred cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccccc-C----
Confidence 65556679999999999999999988888999999999999999999864 367789999999999998742 1
Q ss_pred hccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCE
Q 044615 191 NLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHY 270 (571)
Q Consensus 191 ~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 270 (571)
.+.+|+.|++++|.+... |. ...++|+.|++++|.+++. ..+..+++|+.|++++|.+.+..|..+..+++|+.
T Consensus 203 -~~~~L~~L~l~~n~l~~~-~~--~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 276 (390)
T 3o6n_A 203 -IPIAVEELDASHNSINVV-RG--PVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLER 276 (390)
T ss_dssp -CCSSCSEEECCSSCCCEE-EC--CCCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCE
T ss_pred -CCCcceEEECCCCeeeec-cc--cccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCE
Confidence 123599999999999865 33 2357999999999999864 67899999999999999999988999999999999
Q ss_pred EEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcC
Q 044615 271 LNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNAL 350 (571)
Q Consensus 271 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l 350 (571)
|++++|++++ +|..+..+++|+.|++++|++.+ +|..+..+++|+.|++++|+++... +..++.|+.|++++|++
T Consensus 277 L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~N~i~~~~---~~~~~~L~~L~l~~N~~ 351 (390)
T 3o6n_A 277 LYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDW 351 (390)
T ss_dssp EECCSSCCCE-EECSSSCCTTCCEEECCSSCCCC-CGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCE
T ss_pred EECCCCcCcc-cCcccCCCCCCCEEECCCCccee-cCccccccCcCCEEECCCCccceeC---chhhccCCEEEcCCCCc
Confidence 9999999985 56667789999999999999985 6777888999999999999998653 67789999999999999
Q ss_pred cccCCCCCccCCCCcccccCCcCCCC
Q 044615 351 QGLIPNSTAFRDAPMLALQGNKRLCG 376 (571)
Q Consensus 351 ~~~~~~~~~~~~~~~l~l~~n~~~c~ 376 (571)
++.... ..+..+....+.+++..|.
T Consensus 352 ~~~~~~-~~~~~~~~~~~~~~~~~c~ 376 (390)
T 3o6n_A 352 DCNSLR-ALFRNVARPAVDDADQHCK 376 (390)
T ss_dssp EHHHHH-HHTTTCCTTTBCCCCSCCC
T ss_pred cchhHH-HHHHHHHhhcccccCceec
Confidence 875322 2334444455566666664
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=298.13 Aligned_cols=312 Identities=23% Similarity=0.159 Sum_probs=266.4
Q ss_pred CCch-hhcCCCCCCEEEccCCccc------cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcc
Q 044615 39 DDYK-ELVRAVQARDTSISFDELH------EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNG 111 (571)
Q Consensus 39 ~~~~-~l~~~~~l~~l~l~~n~l~------~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~ 111 (571)
.+|. .+..+++|+.|+|++|.+. +..++.|+.|+|++|.+++ ..|..|+++++|++|+|++|.+++
T Consensus 65 ~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-------~~~~~~~~l~~L~~L~L~~n~l~~ 137 (597)
T 3oja_B 65 KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-------LPPHVFQNVPLLTVLVLERNDLSS 137 (597)
T ss_dssp EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCC-------CCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCC-------CCHHHHcCCCCCCEEEeeCCCCCC
Confidence 3444 4678999999999999887 7789999999999999998 567778999999999999999997
Q ss_pred cccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhh
Q 044615 112 SIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLAN 191 (571)
Q Consensus 112 ~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~ 191 (571)
..+..|+++++|++|+|++|.+++..|..|+++++|++|++++|.+.+. .+..+++|+.|++++|.+.+. ..
T Consensus 138 l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~l~~L~~L~l~~n~l~~l-----~~ 209 (597)
T 3oja_B 138 LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTL-----AI 209 (597)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC---CGGGCTTCSEEECCSSCCSEE-----EC
T ss_pred CCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc---ChhhhhhhhhhhcccCccccc-----cC
Confidence 6666789999999999999999999999999999999999999999864 256789999999999998852 12
Q ss_pred ccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEE
Q 044615 192 LTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYL 271 (571)
Q Consensus 192 l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 271 (571)
+.+|+.|++++|.+....+.. .++|+.|++++|.+++ +..+..+++|+.|+|++|.+.+..|..+..+++|+.|
T Consensus 210 -~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 283 (597)
T 3oja_B 210 -PIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERL 283 (597)
T ss_dssp -CTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEE
T ss_pred -CchhheeeccCCccccccccc---CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEE
Confidence 235999999999998544332 3689999999999996 4789999999999999999999999999999999999
Q ss_pred EcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCc
Q 044615 272 NLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQ 351 (571)
Q Consensus 272 ~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~ 351 (571)
+|++|.+++ +|..+..+++|+.|+|++|.+.+ +|..+..+++|+.|+|++|++++.. +..++.|+.|++++|+++
T Consensus 284 ~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~~-i~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~L~~L~l~~N~~~ 358 (597)
T 3oja_B 284 YISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDWD 358 (597)
T ss_dssp ECTTSCCCE-EECSSSCCTTCCEEECCSSCCCC-CGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCEE
T ss_pred ECCCCCCCC-CCcccccCCCCcEEECCCCCCCc-cCcccccCCCCCEEECCCCCCCCcC---hhhcCCCCEEEeeCCCCC
Confidence 999999986 56677789999999999999985 7778899999999999999998653 667889999999999998
Q ss_pred ccCCCCCccCCCCcccccCCcCCCCC
Q 044615 352 GLIPNSTAFRDAPMLALQGNKRLCGD 377 (571)
Q Consensus 352 ~~~~~~~~~~~~~~l~l~~n~~~c~~ 377 (571)
+.... ..+.......+.++...|+.
T Consensus 359 ~~~~~-~~~~~~~~~~~~~~~~~C~~ 383 (597)
T 3oja_B 359 CNSLR-ALFRNVARPAVDDADQHCKI 383 (597)
T ss_dssp HHHHH-HHTTTCCTTTBCCCCCCCCT
T ss_pred ChhHH-HHHHHHhhhccccccccCCc
Confidence 76432 23444555556677777764
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-32 Score=271.32 Aligned_cols=247 Identities=25% Similarity=0.275 Sum_probs=117.1
Q ss_pred CCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEc
Q 044615 97 KSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDL 176 (571)
Q Consensus 97 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 176 (571)
++|++|+|++|.+++..+..|+++++|++|+|++|.+++..|..|+++++|++|++++|.+. .+|..+. ++|++|++
T Consensus 52 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l 128 (330)
T 1xku_A 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRV 128 (330)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEEC
T ss_pred CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEEC
Confidence 34455555555554444444455555555555555554444444555555555555555543 2333222 44555555
Q ss_pred cCCCCCccCChhhhhccCCCcEEEccCCcccc--cCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCcc
Q 044615 177 SSNKLNGSIPLSLANLTNSLKVLYLSSNHIVG--EIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTF 254 (571)
Q Consensus 177 ~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~--~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 254 (571)
++|++.+..+..+..++. |+.|++++|.+.. ..+..+..+++|+.|++++|.+.. +|..+. ++|+.|++++|.+
T Consensus 129 ~~n~l~~~~~~~~~~l~~-L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l 204 (330)
T 1xku_A 129 HENEITKVRKSVFNGLNQ-MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKI 204 (330)
T ss_dssp CSSCCCBBCHHHHTTCTT-CCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCC
T ss_pred CCCcccccCHhHhcCCcc-ccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcC
Confidence 555554333333444443 5555555554432 334444445555555555555443 222221 4455555555555
Q ss_pred ccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCcccccccc
Q 044615 255 HKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCF 334 (571)
Q Consensus 255 ~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~ 334 (571)
++..+..+..+++|+.|++++|.+++..+..+..+++|+.|++++|.++ .+|..+..+++|+.|++++|++++..+..|
T Consensus 205 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f 283 (330)
T 1xku_A 205 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDF 283 (330)
T ss_dssp CEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSS
T ss_pred CccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhc
Confidence 4444445555555555555555555444444455555555555555554 244445555555555555555554444444
Q ss_pred ccC------CCCCEEECcCCcCc
Q 044615 335 EEM------HWLSCIDISYNALQ 351 (571)
Q Consensus 335 ~~l------~~L~~L~ls~N~l~ 351 (571)
+.. ..++.+++++|++.
T Consensus 284 ~~~~~~~~~~~l~~l~l~~N~~~ 306 (330)
T 1xku_A 284 CPPGYNTKKASYSGVSLFSNPVQ 306 (330)
T ss_dssp SCSSCCTTSCCCSEEECCSSSSC
T ss_pred CCcccccccccccceEeecCccc
Confidence 322 34455555555543
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-32 Score=274.48 Aligned_cols=246 Identities=24% Similarity=0.287 Sum_probs=121.7
Q ss_pred CCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEc
Q 044615 97 KSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDL 176 (571)
Q Consensus 97 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 176 (571)
++|++|+|++|.+++..|..|.++++|++|+|++|.+++..|..|+++++|++|++++|.+. .+|..+. ++|++|++
T Consensus 54 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l 130 (332)
T 2ft3_A 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRI 130 (332)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEEC
T ss_pred CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEEC
Confidence 34555555555555444445555555555555555555444555555555555555555554 2333222 45555555
Q ss_pred cCCCCCccCChhhhhccCCCcEEEccCCcccc--cCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCcc
Q 044615 177 SSNKLNGSIPLSLANLTNSLKVLYLSSNHIVG--EIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTF 254 (571)
Q Consensus 177 ~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~--~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 254 (571)
++|++.+..+..+..+++ |+.|++++|.++. ..+..+..+ +|+.|++++|.+++ +|..+. ++|+.|++++|.+
T Consensus 131 ~~n~i~~~~~~~~~~l~~-L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i 205 (332)
T 2ft3_A 131 HDNRIRKVPKGVFSGLRN-MNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKI 205 (332)
T ss_dssp CSSCCCCCCSGGGSSCSS-CCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCC
T ss_pred CCCccCccCHhHhCCCcc-CCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcC
Confidence 555554333333444443 5555555555532 334444444 55555555555553 222221 4555555555555
Q ss_pred ccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCcccccccc
Q 044615 255 HKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCF 334 (571)
Q Consensus 255 ~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~ 334 (571)
++..+..+..+++|+.|++++|.+++..+..+..+++|+.|++++|+++ .+|..+..+++|+.|++++|++++..+..|
T Consensus 206 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~ 284 (332)
T 2ft3_A 206 QAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDF 284 (332)
T ss_dssp CCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSS
T ss_pred CccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHc
Confidence 5444445555555555555555555444445555555555555555554 344445555555555555555554444444
Q ss_pred ccC------CCCCEEECcCCcCc
Q 044615 335 EEM------HWLSCIDISYNALQ 351 (571)
Q Consensus 335 ~~l------~~L~~L~ls~N~l~ 351 (571)
... ..|+.|++++|++.
T Consensus 285 ~~~~~~~~~~~l~~L~l~~N~~~ 307 (332)
T 2ft3_A 285 CPVGFGVKRAYYNGISLFNNPVP 307 (332)
T ss_dssp SCSSCCSSSCCBSEEECCSSSSC
T ss_pred cccccccccccccceEeecCccc
Confidence 332 34555555555554
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-31 Score=278.91 Aligned_cols=323 Identities=20% Similarity=0.171 Sum_probs=259.4
Q ss_pred hhhhcCCchhHHHHHhhccCCCCCchhhcCCCCCCEEEccCCccc----cCCCCccceeecccccccCCCCCCCcccccc
Q 044615 17 LAILGAPMEEEDLIEKILDGLGDDYKELVRAVQARDTSISFDELH----EKLLTFEATAHFSVLAFTGQDWPLYSSIPDE 92 (571)
Q Consensus 17 l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~l~l~~n~l~----~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~ 92 (571)
......+.................+.+++++++|+.|++++|.+. +..++.|+.|++++|.+++ +|
T Consensus 11 ~~~~~pd~~l~~~~~~~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~l~~l~~L~~L~Ls~n~l~~--------~~-- 80 (457)
T 3bz5_A 11 FNDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIEKLTGLTKLICTSNNITT--------LD-- 80 (457)
T ss_dssp HHHHCSSHHHHHHHHHHTTCCTTSEEEHHHHTTCCEEECCSSCCCCCTTGGGCTTCSEEECCSSCCSC--------CC--
T ss_pred cccccCcHHHHHHHHHhcCcCcccccChhHcCCCCEEEccCCCcccChhhcccCCCCEEEccCCcCCe--------Ec--
Confidence 334444443344444344444556778999999999999999887 6788999999999999987 34
Q ss_pred ccCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCC
Q 044615 93 IGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLS 172 (571)
Q Consensus 93 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~ 172 (571)
++.+++|++|++++|.+++. + ++.+++|++|++++|.+++. | ++.+++|++|++++|.+++. + ++.+++|+
T Consensus 81 ~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~ 151 (457)
T 3bz5_A 81 LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLT 151 (457)
T ss_dssp CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCC
T ss_pred cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee-c--cccCCcCC
Confidence 88899999999999999864 3 88999999999999999864 4 89999999999999999874 3 88999999
Q ss_pred EEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccC
Q 044615 173 ILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSAN 252 (571)
Q Consensus 173 ~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n 252 (571)
+|++++|+..+.+ .+..++. |+.|++++|.+++ +| ++.+++|+.|++++|.+++. .++.+++|+.|++++|
T Consensus 152 ~L~l~~n~~~~~~--~~~~l~~-L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N 222 (457)
T 3bz5_A 152 ELDCHLNKKITKL--DVTPQTQ-LTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSN 222 (457)
T ss_dssp EEECTTCSCCCCC--CCTTCTT-CCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSS
T ss_pred EEECCCCCccccc--ccccCCc-CCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCC
Confidence 9999999665555 3666665 9999999999986 44 78889999999999999975 3888999999999999
Q ss_pred ccccccchhhccCCCCCEEEcCCccCccCcchhhhccc-------CCCEEEccCCcCCcccchhccCCCCCCEEEccCCc
Q 044615 253 TFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLI-------HLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNN 325 (571)
Q Consensus 253 ~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~-------~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 325 (571)
.+++ +| +..+++|+.|++++|++++..+..+..+. +|+.|++++|.+.+.+| +..+++|+.|++++|.
T Consensus 223 ~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~ 297 (457)
T 3bz5_A 223 KLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNT 297 (457)
T ss_dssp CCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCT
T ss_pred cccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCc
Confidence 9987 45 88899999999999999987655544443 45666666666666665 5678999999999998
Q ss_pred Cccccccc--------cccCCCCCEEECcCCcCcccCCCCCccCCCCcccccCCcCC
Q 044615 326 LSGSIPRC--------FEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRL 374 (571)
Q Consensus 326 l~~~~p~~--------~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~l~l~~n~~~ 374 (571)
..+.+|.. +..++.|+.|++++|++++. + ...++.+..+++.+|+..
T Consensus 298 ~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l-~-l~~l~~L~~L~l~~N~l~ 352 (457)
T 3bz5_A 298 QLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL-D-VSHNTKLKSLSCVNAHIQ 352 (457)
T ss_dssp TCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC-C-CTTCTTCSEEECCSSCCC
T ss_pred ccceeccCCCcceEechhhcccCCEEECCCCccccc-c-cccCCcCcEEECCCCCCC
Confidence 77766642 45567899999999999985 3 566778888889888743
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-31 Score=267.29 Aligned_cols=287 Identities=23% Similarity=0.259 Sum_probs=234.2
Q ss_pred CCCCEEEccCCccc---cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccccccccCCCCCC
Q 044615 48 VQARDTSISFDELH---EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLV 124 (571)
Q Consensus 48 ~~l~~l~l~~n~l~---~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 124 (571)
.+++.++++.+.+. ....+.++.|++++|++++ ..+..|+++++|++|+|++|.+++..|..|+.+++|+
T Consensus 31 c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~-------~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 103 (330)
T 1xku_A 31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITE-------IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 103 (330)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCC-------BCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCC
T ss_pred CCCeEEEecCCCccccCccCCCCCeEEECCCCcCCE-------eChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCC
Confidence 36888999888776 2234678899999998886 4455788899999999999999887788899999999
Q ss_pred EEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCc--cCChhhhhccCCCcEEEcc
Q 044615 125 VLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNG--SIPLSLANLTNSLKVLYLS 202 (571)
Q Consensus 125 ~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~--~~p~~~~~l~~~L~~L~l~ 202 (571)
+|++++|.++ .+|..+. ++|++|++++|.+.+..+..+..+++|++|++++|.+.. ..+..+..+++ |+.|+++
T Consensus 104 ~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~-L~~L~l~ 179 (330)
T 1xku_A 104 RLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKK-LSYIRIA 179 (330)
T ss_dssp EEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTT-CCEEECC
T ss_pred EEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCC-cCEEECC
Confidence 9999999988 4554443 789999999999987777778899999999999998863 56677777776 9999999
Q ss_pred CCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCc
Q 044615 203 SNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKI 282 (571)
Q Consensus 203 ~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~ 282 (571)
+|.++. +|..+. ++|+.|++++|.+++..+..+..+++|+.|++++|.+++..+..+..+++|+.|++++|.++ .+
T Consensus 180 ~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~l 255 (330)
T 1xku_A 180 DTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KV 255 (330)
T ss_dssp SSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SC
T ss_pred CCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cC
Confidence 999874 454433 78999999999999888888999999999999999998877778889999999999999988 67
Q ss_pred chhhhcccCCCEEEccCCcCCcccchhccCC------CCCCEEEccCCcCcc--ccccccccCCCCCEEECcCCc
Q 044615 283 PNKIEKLIHLSELDLSHNIFREEIPSQICSM------QSLEKLNLSHNNLSG--SIPRCFEEMHWLSCIDISYNA 349 (571)
Q Consensus 283 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l------~~L~~L~Ls~n~l~~--~~p~~~~~l~~L~~L~ls~N~ 349 (571)
|..+..+++|+.|++++|.+++..+..|+.. +.|+.|++++|++.. ..|..|..+..++.+++++|+
T Consensus 256 p~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 256 PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred ChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 7788888999999999999988777766543 778899999998864 567788888889999998874
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-31 Score=276.99 Aligned_cols=298 Identities=29% Similarity=0.398 Sum_probs=257.9
Q ss_pred cCCCCCCEEEccCCccc----cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccccccccCC
Q 044615 45 VRAVQARDTSISFDELH----EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNL 120 (571)
Q Consensus 45 ~~~~~l~~l~l~~n~l~----~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l 120 (571)
..+.+++.|+++.+.+. +..+++|++|++++|.+++ +|. +.++++|++|++++|.+.+..+ ++++
T Consensus 43 ~~l~~l~~L~l~~~~i~~l~~~~~l~~L~~L~Ls~n~l~~--------~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l 111 (466)
T 1o6v_A 43 TDLDQVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTD--------ITP-LKNLTKLVDILMNNNQIADITP--LANL 111 (466)
T ss_dssp HHHHTCCEEECCSSCCCCCTTGGGCTTCCEEECCSSCCCC--------CGG-GTTCTTCCEEECCSSCCCCCGG--GTTC
T ss_pred hHhccccEEecCCCCCccCcchhhhcCCCEEECCCCccCC--------chh-hhccccCCEEECCCCccccChh--hcCC
Confidence 44678999999999887 6778999999999999986 344 8999999999999999986554 9999
Q ss_pred CCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEE
Q 044615 121 TNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLY 200 (571)
Q Consensus 121 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~ 200 (571)
++|++|++++|.+++..+ +.++++|++|++++|.+.+ ++ .+..+++|++|+++ |.+.+. + .+..++. |+.|+
T Consensus 112 ~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~-~-~~~~l~~-L~~L~ 183 (466)
T 1o6v_A 112 TNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDL-K-PLANLTT-LERLD 183 (466)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCC-G-GGTTCTT-CCEEE
T ss_pred CCCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCc-h-hhccCCC-CCEEE
Confidence 999999999999986543 8999999999999999975 34 58999999999997 455533 2 3777776 99999
Q ss_pred ccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCcc
Q 044615 201 LSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQ 280 (571)
Q Consensus 201 l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~ 280 (571)
+++|.+.+. ..+..+++|+.|++++|.+.+..+ ++.+++|+.|++++|.+.+. ..+..+++|+.|++++|.+++
T Consensus 184 l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~ 257 (466)
T 1o6v_A 184 ISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISN 257 (466)
T ss_dssp CCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC
T ss_pred CcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCcccc
Confidence 999999754 347889999999999999997655 78899999999999999764 468899999999999999987
Q ss_pred CcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCcccCCCCCcc
Q 044615 281 KIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAF 360 (571)
Q Consensus 281 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~ 360 (571)
..+ +..+++|+.|++++|.+.+..+ +..+++|+.|++++|++++..+ +..+++|+.|++++|++++..| ...+
T Consensus 258 ~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l 330 (466)
T 1o6v_A 258 LAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP-VSSL 330 (466)
T ss_dssp CGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG-GGGC
T ss_pred chh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh-hccC
Confidence 655 8899999999999999987554 8899999999999999997655 8899999999999999998876 5677
Q ss_pred CCCCcccccCCcCC
Q 044615 361 RDAPMLALQGNKRL 374 (571)
Q Consensus 361 ~~~~~l~l~~n~~~ 374 (571)
..+..+++.+|+..
T Consensus 331 ~~L~~L~l~~n~l~ 344 (466)
T 1o6v_A 331 TKLQRLFFYNNKVS 344 (466)
T ss_dssp TTCCEEECCSSCCC
T ss_pred ccCCEeECCCCccC
Confidence 88999999998754
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-31 Score=267.58 Aligned_cols=286 Identities=21% Similarity=0.241 Sum_probs=238.8
Q ss_pred CCCCEEEccCCccc---cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccccccccCCCCCC
Q 044615 48 VQARDTSISFDELH---EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLV 124 (571)
Q Consensus 48 ~~l~~l~l~~n~l~---~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 124 (571)
.+++.++++.+.+. ....+.++.|++++|.+++ ..|..|.++++|++|+|++|.+++..|..|+++++|+
T Consensus 33 c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~-------~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 105 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISE-------LRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQ 105 (332)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCE-------ECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCC
T ss_pred ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCc-------cCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCC
Confidence 36899999988877 2234689999999999886 4566889999999999999999988888999999999
Q ss_pred EEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCc--cCChhhhhccCCCcEEEcc
Q 044615 125 VLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNG--SIPLSLANLTNSLKVLYLS 202 (571)
Q Consensus 125 ~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~--~~p~~~~~l~~~L~~L~l~ 202 (571)
+|++++|.++ .+|..+. ++|++|++++|.+....+..+..+++|++|++++|.++. ..|..+..+ +|+.|+++
T Consensus 106 ~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l--~L~~L~l~ 180 (332)
T 2ft3_A 106 KLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL--KLNYLRIS 180 (332)
T ss_dssp EEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC--CCSCCBCC
T ss_pred EEECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC--ccCEEECc
Confidence 9999999998 4555444 789999999999987766778999999999999999863 556666666 49999999
Q ss_pred CCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCc
Q 044615 203 SNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKI 282 (571)
Q Consensus 203 ~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~ 282 (571)
+|.+++ +|..+. ++|+.|++++|.+.+..+..+..+++|+.|++++|.+.+..+..+..+++|+.|++++|.++ .+
T Consensus 181 ~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~l 256 (332)
T 2ft3_A 181 EAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RV 256 (332)
T ss_dssp SSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BC
T ss_pred CCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ec
Confidence 999985 554443 78999999999999888888999999999999999998887888999999999999999998 67
Q ss_pred chhhhcccCCCEEEccCCcCCcccchhccCC------CCCCEEEccCCcCc--cccccccccCCCCCEEECcCCc
Q 044615 283 PNKIEKLIHLSELDLSHNIFREEIPSQICSM------QSLEKLNLSHNNLS--GSIPRCFEEMHWLSCIDISYNA 349 (571)
Q Consensus 283 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l------~~L~~L~Ls~n~l~--~~~p~~~~~l~~L~~L~ls~N~ 349 (571)
|..+..+++|+.|++++|.+++..+..|+.. ++|+.|++++|++. +..|..|..++.|+.+++++|+
T Consensus 257 p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 257 PAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred ChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 7788899999999999999988777777653 67899999999987 6778889999999999998874
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=270.96 Aligned_cols=282 Identities=19% Similarity=0.179 Sum_probs=239.3
Q ss_pred CCCchhhcCCCCCCEEEccCCccc---cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCccccc
Q 044615 38 GDDYKELVRAVQARDTSISFDELH---EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIP 114 (571)
Q Consensus 38 ~~~~~~l~~~~~l~~l~l~~n~l~---~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~ 114 (571)
...| .+..+++|++|++++|.+. ++.+++|++|++++|.+++ +| ++++++|++|++++|.+++ +|
T Consensus 55 ~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~l~~L~~L~Ls~N~l~~--------~~--~~~l~~L~~L~L~~N~l~~-l~ 122 (457)
T 3bz5_A 55 TDMT-GIEKLTGLTKLICTSNNITTLDLSQNTNLTYLACDSNKLTN--------LD--VTPLTKLTYLNCDTNKLTK-LD 122 (457)
T ss_dssp CCCT-TGGGCTTCSEEECCSSCCSCCCCTTCTTCSEEECCSSCCSC--------CC--CTTCTTCCEEECCSSCCSC-CC
T ss_pred ccCh-hhcccCCCCEEEccCCcCCeEccccCCCCCEEECcCCCCce--------ee--cCCCCcCCEEECCCCcCCe-ec
Confidence 3344 6899999999999999888 7889999999999999987 33 8899999999999999986 44
Q ss_pred ccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccC
Q 044615 115 LALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTN 194 (571)
Q Consensus 115 ~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~ 194 (571)
++.+++|++|++++|.+++. .++.+++|++|++++|...+.+ .+..+++|++|++++|++++ +| +..++.
T Consensus 123 --~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~ 192 (457)
T 3bz5_A 123 --VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKL 192 (457)
T ss_dssp --CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTT
T ss_pred --CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCC
Confidence 89999999999999999974 3889999999999999665555 48899999999999999996 55 667765
Q ss_pred CCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCC-------C
Q 044615 195 SLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLV-------K 267 (571)
Q Consensus 195 ~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~-------~ 267 (571)
|+.|++++|.+++. .++.+++|+.|++++|++++ +| ++.+++|+.|++++|.+++..+..+.++. +
T Consensus 193 -L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~ 265 (457)
T 3bz5_A 193 -LNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTD 265 (457)
T ss_dssp -CCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTCC
T ss_pred -CCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCC
Confidence 99999999999865 47889999999999999998 45 88999999999999999987655555444 5
Q ss_pred CCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccch--------hccCCCCCCEEEccCCcCccccccccccCCC
Q 044615 268 LHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPS--------QICSMQSLEKLNLSHNNLSGSIPRCFEEMHW 339 (571)
Q Consensus 268 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--------~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~ 339 (571)
|+.|++++|.+.+.+| +..+++|+.|++++|...+.+|. .+..+++|+.|++++|++++. + +..++.
T Consensus 266 L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l-~--l~~l~~ 340 (457)
T 3bz5_A 266 LLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL-D--VSHNTK 340 (457)
T ss_dssp CSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC-C--CTTCTT
T ss_pred CCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCccccc-c--cccCCc
Confidence 5666677777666665 46789999999999987766654 255678999999999999985 3 889999
Q ss_pred CCEEECcCCcCccc
Q 044615 340 LSCIDISYNALQGL 353 (571)
Q Consensus 340 L~~L~ls~N~l~~~ 353 (571)
|+.|++++|++++.
T Consensus 341 L~~L~l~~N~l~~l 354 (457)
T 3bz5_A 341 LKSLSCVNAHIQDF 354 (457)
T ss_dssp CSEEECCSSCCCBC
T ss_pred CcEEECCCCCCCCc
Confidence 99999999999974
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-30 Score=282.85 Aligned_cols=307 Identities=22% Similarity=0.240 Sum_probs=245.3
Q ss_pred chhhcCCCCCCEEEccCCccc------cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCccccc
Q 044615 41 YKELVRAVQARDTSISFDELH------EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIP 114 (571)
Q Consensus 41 ~~~l~~~~~l~~l~l~~n~l~------~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~ 114 (571)
+.++.++++|++|+|++|.++ |..+++|++|+|++|++++ ..|..|.++++|++|+|++|.+++..+
T Consensus 69 ~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~-------l~~~~f~~L~~L~~L~Ls~N~l~~l~~ 141 (635)
T 4g8a_A 69 SYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS-------LALGAFSGLSSLQKLVAVETNLASLEN 141 (635)
T ss_dssp TTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE-------ECGGGGTTCTTCCEEECTTSCCCCSTT
T ss_pred HHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCC-------CCHHHhcCCCCCCEEECCCCcCCCCCh
Confidence 357899999999999999887 7789999999999999986 334678999999999999999998777
Q ss_pred ccccCCCCCCEEEcccCcCccc-ccccccCCCCCCeeecccCcCcccCCccccCC-------------------------
Q 044615 115 LALGNLTNLVVLDLSTNKLSGS-IPLSFANLTSLSILYLYENSLCDSIPKEIGNM------------------------- 168 (571)
Q Consensus 115 ~~~~~l~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l------------------------- 168 (571)
..|+++++|++|+|++|.++.. .|..++.+++|++|++++|.+.+..|..+..+
T Consensus 142 ~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~ 221 (635)
T 4g8a_A 142 FPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 221 (635)
T ss_dssp CCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTT
T ss_pred hhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccc
Confidence 7899999999999999999764 57888999999999999998765433322111
Q ss_pred --------------------------------------------------------------------------------
Q 044615 169 -------------------------------------------------------------------------------- 168 (571)
Q Consensus 169 -------------------------------------------------------------------------------- 168 (571)
T Consensus 222 ~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~ 301 (635)
T 4g8a_A 222 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDL 301 (635)
T ss_dssp TTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTT
T ss_pred cchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhh
Confidence
Q ss_pred --------------------------CCCCEEEccCCCCCccCCh-------------------hhhhccCCCcEEEccC
Q 044615 169 --------------------------NSLSILDLSSNKLNGSIPL-------------------SLANLTNSLKVLYLSS 203 (571)
Q Consensus 169 --------------------------~~L~~L~L~~n~l~~~~p~-------------------~~~~l~~~L~~L~l~~ 203 (571)
..|+.|++.+|.+....+. ....++ +|+.|+++.
T Consensus 302 ~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~-~L~~L~ls~ 380 (635)
T 4g8a_A 302 FNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLP-SLEFLDLSR 380 (635)
T ss_dssp TGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCT-TCCEEECCS
T ss_pred hhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCccccccc-ccccchhhc
Confidence 1222333333322111000 011122 256666666
Q ss_pred Ccccc-------------------------------------------------c-CCccccCCCCCcEEeCccCcCcCC
Q 044615 204 NHIVG-------------------------------------------------E-IPLGHGMLSSLIQLTLNNNELSGQ 233 (571)
Q Consensus 204 n~~~~-------------------------------------------------~-~~~~~~~l~~L~~L~l~~n~l~~~ 233 (571)
|.+.. . .+..+..+++++.++++.|.+.+.
T Consensus 381 n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~ 460 (635)
T 4g8a_A 381 NGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA 460 (635)
T ss_dssp SCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEEC
T ss_pred cccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccccccccccccccc
Confidence 55421 1 112345667788888899999988
Q ss_pred CChhhhCCCCCCEEEcccCccc-cccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccC
Q 044615 234 LSPELGSLIQLEYLDLSANTFH-KSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICS 312 (571)
Q Consensus 234 ~~~~~~~l~~L~~L~L~~n~l~-~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 312 (571)
.+..+..++.|+.|++++|.+. ...|..+..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..+..|..
T Consensus 461 ~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~ 540 (635)
T 4g8a_A 461 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC 540 (635)
T ss_dssp CTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTT
T ss_pred cccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhC
Confidence 8889999999999999999754 457788999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCEEEccCCcCccccccccccC-CCCCEEECcCCcCcccCC
Q 044615 313 MQSLEKLNLSHNNLSGSIPRCFEEM-HWLSCIDISYNALQGLIP 355 (571)
Q Consensus 313 l~~L~~L~Ls~n~l~~~~p~~~~~l-~~L~~L~ls~N~l~~~~~ 355 (571)
+++|+.|+|++|+|++..|..|..+ ++|+.|++++|++++.+.
T Consensus 541 l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 541 LNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp CTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred CCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 9999999999999999999999988 689999999999998654
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=264.15 Aligned_cols=275 Identities=19% Similarity=0.190 Sum_probs=210.6
Q ss_pred eeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCe
Q 044615 70 TAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSI 149 (571)
Q Consensus 70 ~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~ 149 (571)
..+.+.+.++ .+|..+. ++|++|++++|.+++..+..|.++++|++|++++|.+++..|..|.++++|++
T Consensus 35 ~c~~~~~~l~--------~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 104 (353)
T 2z80_A 35 ICKGSSGSLN--------SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEH 104 (353)
T ss_dssp EEECCSTTCS--------SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred EeeCCCCCcc--------ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCE
Confidence 3455555555 4666554 47888888888888666667888888888888888888777778888888888
Q ss_pred eecccCcCcccCCccccCCCCCCEEEccCCCCCccCCh--hhhhccCCCcEEEccCC-cccccCCccccCCCCCcEEeCc
Q 044615 150 LYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPL--SLANLTNSLKVLYLSSN-HIVGEIPLGHGMLSSLIQLTLN 226 (571)
Q Consensus 150 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~--~~~~l~~~L~~L~l~~n-~~~~~~~~~~~~l~~L~~L~l~ 226 (571)
|++++|.+++..+..+..+++|++|++++|++. .+|. .+..+++ |+.|++++| .+....+..+..+++|+.|+++
T Consensus 105 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~-L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~ 182 (353)
T 2z80_A 105 LDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTK-LQILRVGNMDTFTKIQRKDFAGLTFLEELEID 182 (353)
T ss_dssp EECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTT-CCEEEEEESSSCCEECTTTTTTCCEEEEEEEE
T ss_pred EECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCC-CcEEECCCCccccccCHHHccCCCCCCEEECC
Confidence 888888887654455788888888888888887 4444 5666665 888888888 4666667778888888888888
Q ss_pred cCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhh---cccCCCEEEccCCcCC
Q 044615 227 NNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIE---KLIHLSELDLSHNIFR 303 (571)
Q Consensus 227 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~---~l~~L~~L~Ls~n~l~ 303 (571)
+|.+.+..|..+..+++|+.|++++|.+....+..+..+++|+.|++++|.+++..+..+. ....++.++++++.+.
T Consensus 183 ~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~ 262 (353)
T 2z80_A 183 ASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKIT 262 (353)
T ss_dssp ETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCC
T ss_pred CCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhcccccccccc
Confidence 8888887788888888888888888888654444456688888899988888765544332 3566888888888876
Q ss_pred c----ccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCcccCCC
Q 044615 304 E----EIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPN 356 (571)
Q Consensus 304 ~----~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~ 356 (571)
+ .+|..+..+++|+.|++++|+++...+..|..+++|+.|++++|++++.+|.
T Consensus 263 ~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~~ 319 (353)
T 2z80_A 263 DESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 319 (353)
T ss_dssp HHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred CcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCCC
Confidence 5 3677788899999999999999855444568899999999999999887653
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-30 Score=256.60 Aligned_cols=232 Identities=25% Similarity=0.278 Sum_probs=141.6
Q ss_pred CCCCEEecccCcCcccccccccCCCCCCEEEcccCcCccc--ccccccCCCCCCeeecccCcCcccCCccccCCCCCCEE
Q 044615 97 KSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGS--IPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSIL 174 (571)
Q Consensus 97 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~--~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 174 (571)
++|++|+|++|.++...+..|.++++|++|+|++|.++.. .+..+..+++|++|++++|.+.. +|..+..+++|++|
T Consensus 28 ~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~-l~~~~~~l~~L~~L 106 (306)
T 2z66_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHL 106 (306)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEEE-EEEEEETCTTCCEE
T ss_pred CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCcccc-ChhhcCCCCCCCEE
Confidence 3555555555555533333345555555555555555422 13344445555555555555432 33344444455555
Q ss_pred EccCCCCCccCChhhhhccCCCcEEEccCCcccccCC-ccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCc
Q 044615 175 DLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIP-LGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANT 253 (571)
Q Consensus 175 ~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 253 (571)
++ ++|.+++..+ ..+..+++|++|++++|.+.+..+..+..+++|+.|++++|.
T Consensus 107 ~l-------------------------~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 161 (306)
T 2z66_A 107 DF-------------------------QHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNS 161 (306)
T ss_dssp EC-------------------------TTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCE
T ss_pred EC-------------------------CCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCc
Confidence 54 4444443322 345555666666666666665556666666777777777776
Q ss_pred ccc-ccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCcccccc
Q 044615 254 FHK-SIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPR 332 (571)
Q Consensus 254 l~~-~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~ 332 (571)
+.+ ..|..+..+++|+.|++++|.+++..|..+..+++|+.|++++|.+++..+..+..+++|+.|++++|++++..|.
T Consensus 162 l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 241 (306)
T 2z66_A 162 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 241 (306)
T ss_dssp EGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSS
T ss_pred cccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHH
Confidence 655 4566667777777777777777766666677777777777777777766666677777777777777777777777
Q ss_pred ccccCC-CCCEEECcCCcCcccC
Q 044615 333 CFEEMH-WLSCIDISYNALQGLI 354 (571)
Q Consensus 333 ~~~~l~-~L~~L~ls~N~l~~~~ 354 (571)
.+..++ .|+.|++++|++++..
T Consensus 242 ~~~~~~~~L~~L~L~~N~~~~~c 264 (306)
T 2z66_A 242 ELQHFPSSLAFLNLTQNDFACTC 264 (306)
T ss_dssp SCCCCCTTCCEEECTTCCEECSG
T ss_pred HHHhhhccCCEEEccCCCeeccc
Confidence 777763 7777777777777654
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=8.1e-29 Score=259.11 Aligned_cols=235 Identities=24% Similarity=0.242 Sum_probs=123.5
Q ss_pred ccccccCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCC
Q 044615 89 IPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNM 168 (571)
Q Consensus 89 ~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l 168 (571)
+|..+. ++|++|+|++|.+++..|..|.++++|++|+|++|.+++..+..|.++++|++|+|++|.+....+..|..+
T Consensus 69 iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 146 (452)
T 3zyi_A 69 VPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYL 146 (452)
T ss_dssp CCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSC
T ss_pred cCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhccc
Confidence 444443 456666666666665555566666666666666666665555556666666666666666655444455556
Q ss_pred CCCCEEEccCCCCCccCChhhhhccCCCcEEEccC-CcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEE
Q 044615 169 NSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSS-NHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYL 247 (571)
Q Consensus 169 ~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~-n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 247 (571)
++|++|+|++|++....+..+..+++ |+.|++++ |.+....+..+..+++|+.|++++|.+++. |
T Consensus 147 ~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~------------ 212 (452)
T 3zyi_A 147 SKLRELWLRNNPIESIPSYAFNRVPS-LMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P------------ 212 (452)
T ss_dssp TTCCEEECCSCCCCEECTTTTTTCTT-CCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C------------
T ss_pred CCCCEEECCCCCcceeCHhHHhcCCc-ccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c------------
Confidence 66666666666655333334444443 55555555 223222223344444555555555544432 1
Q ss_pred EcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCc
Q 044615 248 DLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLS 327 (571)
Q Consensus 248 ~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~ 327 (571)
.+..+++|+.|++++|.+++..|..|..+++|+.|++++|++.+..+..|..+++|+.|+|++|+++
T Consensus 213 -------------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 279 (452)
T 3zyi_A 213 -------------NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS 279 (452)
T ss_dssp -------------CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred -------------cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCC
Confidence 2444445555555555555444445555555555555555555544445555555555555555555
Q ss_pred cccccccccCCCCCEEECcCCcCcc
Q 044615 328 GSIPRCFEEMHWLSCIDISYNALQG 352 (571)
Q Consensus 328 ~~~p~~~~~l~~L~~L~ls~N~l~~ 352 (571)
+..+..|..+++|+.|++++|++.+
T Consensus 280 ~~~~~~~~~l~~L~~L~L~~Np~~C 304 (452)
T 3zyi_A 280 SLPHDLFTPLRYLVELHLHHNPWNC 304 (452)
T ss_dssp CCCTTSSTTCTTCCEEECCSSCEEC
T ss_pred ccChHHhccccCCCEEEccCCCcCC
Confidence 4444445555555555555555443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-29 Score=254.14 Aligned_cols=277 Identities=20% Similarity=0.202 Sum_probs=237.1
Q ss_pred CCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEE
Q 044615 95 NMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSIL 174 (571)
Q Consensus 95 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 174 (571)
.++.....+++++.++ .+|..+. ++|++|++++|.+++..+..|.++++|++|++++|.+.+..|..|..+++|++|
T Consensus 29 ~C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (353)
T 2z80_A 29 SCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL 105 (353)
T ss_dssp EECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence 4556667899999998 5676654 589999999999998777789999999999999999998888899999999999
Q ss_pred EccCCCCCccCChh-hhhccCCCcEEEccCCcccccCC-ccccCCCCCcEEeCccC-cCcCCCChhhhCCCCCCEEEccc
Q 044615 175 DLSSNKLNGSIPLS-LANLTNSLKVLYLSSNHIVGEIP-LGHGMLSSLIQLTLNNN-ELSGQLSPELGSLIQLEYLDLSA 251 (571)
Q Consensus 175 ~L~~n~l~~~~p~~-~~~l~~~L~~L~l~~n~~~~~~~-~~~~~l~~L~~L~l~~n-~l~~~~~~~~~~l~~L~~L~L~~ 251 (571)
++++|++++ +|.. +..+++ |++|++++|.++...+ ..+..+++|++|++++| .+....+..+..+++|+.|++++
T Consensus 106 ~Ls~n~l~~-~~~~~~~~l~~-L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~ 183 (353)
T 2z80_A 106 DLSYNYLSN-LSSSWFKPLSS-LTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDA 183 (353)
T ss_dssp ECCSSCCSS-CCHHHHTTCTT-CSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEE
T ss_pred ECCCCcCCc-CCHhHhCCCcc-CCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCC
Confidence 999999995 5554 777775 9999999999986544 47889999999999999 57777778899999999999999
Q ss_pred CccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhc---cCCCCCCEEEccCCcCcc
Q 044615 252 NTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQI---CSMQSLEKLNLSHNNLSG 328 (571)
Q Consensus 252 n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~---~~l~~L~~L~Ls~n~l~~ 328 (571)
|.+.+..|..+..+++|+.|++++|.++...+..+..+++|+.|++++|.+++..+..+ .....++.++|+++.+++
T Consensus 184 n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~ 263 (353)
T 2z80_A 184 SDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITD 263 (353)
T ss_dssp TTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCH
T ss_pred CCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccC
Confidence 99999889999999999999999999975544455678999999999999988655444 346778999999999986
Q ss_pred ----ccccccccCCCCCEEECcCCcCcccCCCC-CccCCCCcccccCCcCCCC
Q 044615 329 ----SIPRCFEEMHWLSCIDISYNALQGLIPNS-TAFRDAPMLALQGNKRLCG 376 (571)
Q Consensus 329 ----~~p~~~~~l~~L~~L~ls~N~l~~~~~~~-~~~~~~~~l~l~~n~~~c~ 376 (571)
.+|+.+..+++|+.|++++|+++..++.. ..++.+..+++.+|+..|.
T Consensus 264 ~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~ 316 (353)
T 2z80_A 264 ESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 316 (353)
T ss_dssp HHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred cchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCc
Confidence 46788999999999999999999766653 5678899999999988773
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.6e-30 Score=252.07 Aligned_cols=244 Identities=22% Similarity=0.214 Sum_probs=170.0
Q ss_pred CEEEccCCccc---cCCCCccceeecccccccCCCCCCCccccc-cccCCCCCCEEecccCcCccc--ccccccCCCCCC
Q 044615 51 RDTSISFDELH---EKLLTFEATAHFSVLAFTGQDWPLYSSIPD-EIGNMKSLSDLQLSENILNGS--IPLALGNLTNLV 124 (571)
Q Consensus 51 ~~l~l~~n~l~---~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~-~~~~l~~L~~L~L~~n~i~~~--~~~~~~~l~~L~ 124 (571)
+.++.+.+.++ ....+.++.|++++|.++. +|. .|.++++|++|+|++|.++.. .+..+..+++|+
T Consensus 10 ~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~--------i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~ 81 (306)
T 2z66_A 10 TEIRCNSKGLTSVPTGIPSSATRLELESNKLQS--------LPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLK 81 (306)
T ss_dssp TEEECCSSCCSSCCSCCCTTCCEEECCSSCCCC--------CCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCC
T ss_pred CEEEcCCCCcccCCCCCCCCCCEEECCCCccCc--------cCHhHhhccccCCEEECCCCccCcccCcccccccccccC
Confidence 46788877766 3344689999999999885 454 478999999999999999843 367778899999
Q ss_pred EEEcccCcCcccccccccCCCCCCeeecccCcCcccCC-ccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccC
Q 044615 125 VLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIP-KEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSS 203 (571)
Q Consensus 125 ~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~ 203 (571)
+|+|++|.+. .+|..+..+++|++|++++|.+.+..+ ..+..+++|++|++++|.+.+..+..+..++. |+.|++++
T Consensus 82 ~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~l~~ 159 (306)
T 2z66_A 82 YLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS-LEVLKMAG 159 (306)
T ss_dssp EEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTT-CCEEECTT
T ss_pred EEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcC-CCEEECCC
Confidence 9999999998 567779999999999999999986554 57888899999999998888666666666664 77777777
Q ss_pred Ccccc-cCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCc
Q 044615 204 NHIVG-EIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKI 282 (571)
Q Consensus 204 n~~~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~ 282 (571)
|.+.+ ..|..+..+++|+.|++++|.+++..|..+..+++|+.|++++|.+ ++..
T Consensus 160 n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l------------------------~~~~ 215 (306)
T 2z66_A 160 NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF------------------------FSLD 215 (306)
T ss_dssp CEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCC------------------------SBCC
T ss_pred CccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCcc------------------------CccC
Confidence 77664 3455555555555555555555544444444455555555555544 4444
Q ss_pred chhhhcccCCCEEEccCCcCCcccchhccCCC-CCCEEEccCCcCcc
Q 044615 283 PNKIEKLIHLSELDLSHNIFREEIPSQICSMQ-SLEKLNLSHNNLSG 328 (571)
Q Consensus 283 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~-~L~~L~Ls~n~l~~ 328 (571)
+..+..+++|+.|++++|.+.+..|..+..++ +|+.|+|++|++++
T Consensus 216 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~ 262 (306)
T 2z66_A 216 TFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 262 (306)
T ss_dssp SGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEEC
T ss_pred hhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeec
Confidence 44444555555555555555555555555553 56666666666554
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.2e-29 Score=247.76 Aligned_cols=237 Identities=20% Similarity=0.230 Sum_probs=195.6
Q ss_pred CCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEE
Q 044615 95 NMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSIL 174 (571)
Q Consensus 95 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 174 (571)
..++++.|+|++|.++ .+|..++.+++|++|+|++|.++ .+|..++++++|++|+|++|.+. .+|..+..+++|++|
T Consensus 79 ~~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L 155 (328)
T 4fcg_A 79 TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLREL 155 (328)
T ss_dssp TSTTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEE
T ss_pred cccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEE
Confidence 3477888888888887 67777888888888888888888 77888888888888888888887 678788888888888
Q ss_pred EccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCcc
Q 044615 175 DLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTF 254 (571)
Q Consensus 175 ~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 254 (571)
++++|++.+.+|..+... ..+..+..+++|+.|++++|.++ .+|..++.+++|+.|++++|.+
T Consensus 156 ~L~~n~~~~~~p~~~~~~----------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l 218 (328)
T 4fcg_A 156 SIRACPELTELPEPLAST----------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPL 218 (328)
T ss_dssp EEEEETTCCCCCSCSEEE----------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCC
T ss_pred ECCCCCCccccChhHhhc----------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCC
Confidence 888887777777654321 11223456788888888888888 6777888889999999999988
Q ss_pred ccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCcccccccc
Q 044615 255 HKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCF 334 (571)
Q Consensus 255 ~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~ 334 (571)
++ +|..+..+++|+.|++++|.+.+.+|..+..+++|+.|++++|.+.+.+|..+..+++|+.|+|++|++.+.+|+.+
T Consensus 219 ~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l 297 (328)
T 4fcg_A 219 SA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLI 297 (328)
T ss_dssp CC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGG
T ss_pred Cc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHH
Confidence 75 56678888999999999998888888888899999999999998888889889999999999999999999999999
Q ss_pred ccCCCCCEEECcCCcCcc
Q 044615 335 EEMHWLSCIDISYNALQG 352 (571)
Q Consensus 335 ~~l~~L~~L~ls~N~l~~ 352 (571)
..++.|+.+++..|.+..
T Consensus 298 ~~L~~L~~l~l~~~~~~~ 315 (328)
T 4fcg_A 298 AQLPANCIILVPPHLQAQ 315 (328)
T ss_dssp GGSCTTCEEECCGGGSCC
T ss_pred hhccCceEEeCCHHHHHH
Confidence 999999999988776653
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-29 Score=249.45 Aligned_cols=226 Identities=23% Similarity=0.320 Sum_probs=158.8
Q ss_pred CCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccC
Q 044615 64 LLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFAN 143 (571)
Q Consensus 64 ~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~ 143 (571)
....++.|+|++|.++. +|..++++++|++|+|++|.++ .+|..++.+++|++|+|++|.++ .+|..+++
T Consensus 79 ~~~~l~~L~L~~n~l~~--------lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~ 148 (328)
T 4fcg_A 79 TQPGRVALELRSVPLPQ--------FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIAS 148 (328)
T ss_dssp TSTTCCEEEEESSCCSS--------CCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGG
T ss_pred cccceeEEEccCCCchh--------cChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhc
Confidence 45789999999999874 7888999999999999999998 88999999999999999999998 77889999
Q ss_pred CCCCCeeecccCcCcccCCccccC---------CCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccc
Q 044615 144 LTSLSILYLYENSLCDSIPKEIGN---------MNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGH 214 (571)
Q Consensus 144 l~~L~~L~L~~n~l~~~~~~~l~~---------l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~ 214 (571)
+++|++|++++|++.+.+|..+.. +++|++|++++|+++ .+|..+..+++ |+.|++++|.+++ +|
T Consensus 149 l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~-L~~L~L~~N~l~~-l~--- 222 (328)
T 4fcg_A 149 LNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQN-LKSLKIRNSPLSA-LG--- 222 (328)
T ss_dssp CTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTT-CCEEEEESSCCCC-CC---
T ss_pred CcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCC-CCEEEccCCCCCc-Cc---
Confidence 999999999999988888887654 666666666666665 55555555553 5555555555542 33
Q ss_pred cCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCE
Q 044615 215 GMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSE 294 (571)
Q Consensus 215 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 294 (571)
..+..+++|+.|++++|.+.+.+|..+.++++|+.|++++|.+.+.+|..+..+++|+.
T Consensus 223 ---------------------~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~ 281 (328)
T 4fcg_A 223 ---------------------PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEK 281 (328)
T ss_dssp ---------------------GGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCE
T ss_pred ---------------------hhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCE
Confidence 33444555555555555555555555555555555555555555555555555555555
Q ss_pred EEccCCcCCcccchhccCCCCCCEEEccCCcC
Q 044615 295 LDLSHNIFREEIPSQICSMQSLEKLNLSHNNL 326 (571)
Q Consensus 295 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 326 (571)
|+|++|.+.+.+|..+..+++|+.+++..+.+
T Consensus 282 L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~ 313 (328)
T 4fcg_A 282 LDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313 (328)
T ss_dssp EECTTCTTCCCCCGGGGGSCTTCEEECCGGGS
T ss_pred EeCCCCCchhhccHHHhhccCceEEeCCHHHH
Confidence 55555555555555555555555555554443
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=256.82 Aligned_cols=236 Identities=26% Similarity=0.282 Sum_probs=127.2
Q ss_pred cccccccCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccC
Q 044615 88 SIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGN 167 (571)
Q Consensus 88 ~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~ 167 (571)
.+|..+. ++++.|+|++|.+++..+..|.++++|++|+|++|.++...+..|.++++|++|+|++|.++...+..|..
T Consensus 57 ~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 134 (440)
T 3zyj_A 57 EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVY 134 (440)
T ss_dssp SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCS
T ss_pred cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhc
Confidence 3555443 45666666666666555566666666666666666666555566666666666666666666544455666
Q ss_pred CCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCC-cccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCE
Q 044615 168 MNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSN-HIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEY 246 (571)
Q Consensus 168 l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n-~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 246 (571)
+++|++|++++|++....+..|..+++ |+.|++++| .+....+..+..+++|+.|++++|.++.. | .+..+
T Consensus 135 l~~L~~L~L~~N~i~~~~~~~~~~l~~-L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l----- 206 (440)
T 3zyj_A 135 LSKLKELWLRNNPIESIPSYAFNRIPS-LRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI-P-NLTPL----- 206 (440)
T ss_dssp CSSCCEEECCSCCCCEECTTTTTTCTT-CCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSC-C-CCTTC-----
T ss_pred cccCceeeCCCCcccccCHHHhhhCcc-cCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCccc-c-ccCCC-----
Confidence 666666666666665433334444443 566665553 23322233444555555555555555422 2 24444
Q ss_pred EEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcC
Q 044615 247 LDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNL 326 (571)
Q Consensus 247 L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 326 (571)
++|+.|+|++|.+++..|..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++
T Consensus 207 -------------------~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l 267 (440)
T 3zyj_A 207 -------------------IKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNL 267 (440)
T ss_dssp -------------------SSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCC
T ss_pred -------------------cccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCC
Confidence 4445555555544444444444455555555555555444444455555555555555555
Q ss_pred ccccccccccCCCCCEEECcCCcCcc
Q 044615 327 SGSIPRCFEEMHWLSCIDISYNALQG 352 (571)
Q Consensus 327 ~~~~p~~~~~l~~L~~L~ls~N~l~~ 352 (571)
++..+..|..+++|+.|+|++|++.+
T Consensus 268 ~~~~~~~~~~l~~L~~L~L~~Np~~C 293 (440)
T 3zyj_A 268 TLLPHDLFTPLHHLERIHLHHNPWNC 293 (440)
T ss_dssp CCCCTTTTSSCTTCCEEECCSSCEEC
T ss_pred CccChhHhccccCCCEEEcCCCCccC
Confidence 54444445555555555555555443
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-28 Score=256.20 Aligned_cols=243 Identities=23% Similarity=0.189 Sum_probs=193.7
Q ss_pred CCEEEccCCccc---cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccccccccCCCCCCEE
Q 044615 50 ARDTSISFDELH---EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVL 126 (571)
Q Consensus 50 l~~l~l~~n~l~---~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 126 (571)
...++.+...+. ....+.++.|+|++|++++ ..|..|.++++|++|+|++|.+++..+..|.++++|++|
T Consensus 56 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~-------~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 128 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQM-------IQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTL 128 (452)
T ss_dssp SCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCE-------ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred CcEEEECCCCcCccCCCCCCCccEEECcCCcCce-------ECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEE
Confidence 457788777766 3334689999999999997 567889999999999999999998888999999999999
Q ss_pred EcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCCh-hhhhccCCCcEEEccCCc
Q 044615 127 DLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPL-SLANLTNSLKVLYLSSNH 205 (571)
Q Consensus 127 ~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~-~~~~l~~~L~~L~l~~n~ 205 (571)
+|++|.++...+..|.++++|++|+|++|.+....+..|..+++|++|++++|+..+.++. .+..+.+ |+.|++++|.
T Consensus 129 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~-L~~L~L~~n~ 207 (452)
T 3zyi_A 129 ELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFN-LKYLNLGMCN 207 (452)
T ss_dssp ECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTT-CCEEECTTSC
T ss_pred ECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCC-CCEEECCCCc
Confidence 9999999988888899999999999999999987777899999999999999554445554 5667775 9999999999
Q ss_pred ccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchh
Q 044615 206 IVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNK 285 (571)
Q Consensus 206 ~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~ 285 (571)
+++. | .+..+++|+.|++++|.+++..|..|.++++|+.|++++|.+.+..+..|.++++|+.|+|++|++++..+..
T Consensus 208 l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 285 (452)
T 3zyi_A 208 IKDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDL 285 (452)
T ss_dssp CSSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTS
T ss_pred cccc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHH
Confidence 9854 3 4667778888888888877777777777777777777777777666666666666666666666666555555
Q ss_pred hhcccCCCEEEccCCcC
Q 044615 286 IEKLIHLSELDLSHNIF 302 (571)
Q Consensus 286 ~~~l~~L~~L~Ls~n~l 302 (571)
+..+++|+.|+|++|.+
T Consensus 286 ~~~l~~L~~L~L~~Np~ 302 (452)
T 3zyi_A 286 FTPLRYLVELHLHHNPW 302 (452)
T ss_dssp STTCTTCCEEECCSSCE
T ss_pred hccccCCCEEEccCCCc
Confidence 55555555555555544
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.1e-29 Score=242.77 Aligned_cols=252 Identities=22% Similarity=0.219 Sum_probs=145.5
Q ss_pred CEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCC
Q 044615 100 SDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSN 179 (571)
Q Consensus 100 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n 179 (571)
++++.+++.++ .+|..+ .++|++|++++|.+++..+..|..+++|++|++++|.+.+..|..+..+++|++|++++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 34555555554 233322 245555555555555544455555555555555555555554555555555555555555
Q ss_pred C-CCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCcccccc
Q 044615 180 K-LNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSI 258 (571)
Q Consensus 180 ~-l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 258 (571)
+ +....|..+..+++ |+.|++++|.+++..|..+..+++|++|++++|++.+..+..+..+++|+.|++++|.+++..
T Consensus 91 ~~l~~~~~~~~~~l~~-L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 169 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGR-LHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP 169 (285)
T ss_dssp TTCCCCCTTTTTTCTT-CCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred CCccccCHHHhcCCcC-CCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccC
Confidence 4 44333444444443 555555555555555555556666666666666666555555666667777777777666555
Q ss_pred chhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCC
Q 044615 259 PESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMH 338 (571)
Q Consensus 259 ~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~ 338 (571)
+..+..+++|+.|++++|.+++..|..+..+++|+.|++++|.+++..+..+..+++|+.|++++|++....+.. .-..
T Consensus 170 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~ 248 (285)
T 1ozn_A 170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWA 248 (285)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHH
T ss_pred HHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHHH
Confidence 555666677777777777776666666666677777777777776655556667777777777777765432211 1112
Q ss_pred CCCEEECcCCcCcccCCC
Q 044615 339 WLSCIDISYNALQGLIPN 356 (571)
Q Consensus 339 ~L~~L~ls~N~l~~~~~~ 356 (571)
+++.+..+.|.+.+..|.
T Consensus 249 ~l~~~~~~~~~~~c~~p~ 266 (285)
T 1ozn_A 249 WLQKFRGSSSEVPCSLPQ 266 (285)
T ss_dssp HHHHCCSEECCCBEEESG
T ss_pred HHHhcccccCccccCCch
Confidence 333344555666555543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-28 Score=253.26 Aligned_cols=245 Identities=24% Similarity=0.243 Sum_probs=207.4
Q ss_pred CCCEEEccCCccc---cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccccccccCCCCCCE
Q 044615 49 QARDTSISFDELH---EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVV 125 (571)
Q Consensus 49 ~l~~l~l~~n~l~---~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~ 125 (571)
....++.+...+. ....+.++.|+|++|+++. ..+..|.++++|++|+|++|.+++..+..|.++++|++
T Consensus 44 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~-------~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~ 116 (440)
T 3zyj_A 44 QFSKVICVRKNLREVPDGISTNTRLLNLHENQIQI-------IKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNT 116 (440)
T ss_dssp TSCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCE-------ECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCE
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCe-------eCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCE
Confidence 3467788877776 3344689999999999987 55678999999999999999999888899999999999
Q ss_pred EEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCCh-hhhhccCCCcEEEccCC
Q 044615 126 LDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPL-SLANLTNSLKVLYLSSN 204 (571)
Q Consensus 126 L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~-~~~~l~~~L~~L~l~~n 204 (571)
|+|++|.++...+..|..+++|++|+|++|.+....+..|..+++|++|++++|+..+.++. .|..+.+ |+.|++++|
T Consensus 117 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~-L~~L~L~~n 195 (440)
T 3zyj_A 117 LELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSN-LRYLNLAMC 195 (440)
T ss_dssp EECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSS-CCEEECTTS
T ss_pred EECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccc-cCeecCCCC
Confidence 99999999988788899999999999999999987778899999999999999554445554 5677775 999999999
Q ss_pred cccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcch
Q 044615 205 HIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPN 284 (571)
Q Consensus 205 ~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~ 284 (571)
.++. +| .+..+++|+.|++++|.+++..|..|.++++|+.|++++|.+++..+..|.++++|+.|+|++|++++..+.
T Consensus 196 ~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 273 (440)
T 3zyj_A 196 NLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHD 273 (440)
T ss_dssp CCSS-CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTT
T ss_pred cCcc-cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChh
Confidence 9984 44 478899999999999999988888899999999999999988887777888888888888888888766666
Q ss_pred hhhcccCCCEEEccCCcCC
Q 044615 285 KIEKLIHLSELDLSHNIFR 303 (571)
Q Consensus 285 ~~~~l~~L~~L~Ls~n~l~ 303 (571)
.+..+++|+.|+|++|.+.
T Consensus 274 ~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 274 LFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp TTSSCTTCCEEECCSSCEE
T ss_pred HhccccCCCEEEcCCCCcc
Confidence 6667777777777777653
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.9e-29 Score=243.74 Aligned_cols=256 Identities=23% Similarity=0.229 Sum_probs=199.2
Q ss_pred ceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCC
Q 044615 69 ATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLS 148 (571)
Q Consensus 69 ~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 148 (571)
+.++.+++.++ .+|..+ .++|++|+|++|.+++..+..|..+++|++|++++|.+++..|..|.++++|+
T Consensus 14 ~~~~c~~~~l~--------~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 83 (285)
T 1ozn_A 14 VTTSCPQQGLQ--------AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83 (285)
T ss_dssp CEEECCSSCCS--------SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred eEEEcCcCCcc--------cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCC
Confidence 34555555554 356544 36888888888888877777788888888888888888877788888888888
Q ss_pred eeecccCc-CcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCcc
Q 044615 149 ILYLYENS-LCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNN 227 (571)
Q Consensus 149 ~L~L~~n~-l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~ 227 (571)
+|++++|. +....|..+..+++|++|++++|++.+..|..+..+++ |+.|++++|.+++..+..++.+++|+.|++++
T Consensus 84 ~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 162 (285)
T 1ozn_A 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAA-LQYLYLQDNALQALPDDTFRDLGNLTHLFLHG 162 (285)
T ss_dssp EEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTT-CCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred EEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcC-CCEEECCCCcccccCHhHhccCCCccEEECCC
Confidence 88888887 76666778888888888888888888766777777775 88888888888876667788888899999999
Q ss_pred CcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccc
Q 044615 228 NELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIP 307 (571)
Q Consensus 228 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 307 (571)
|++++..+..+..+++|+.|++++|.+++..|..+..+++|+.|++++|.+++..+..+..+++|+.|++++|.+....+
T Consensus 163 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~ 242 (285)
T 1ozn_A 163 NRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (285)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred CcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCC
Confidence 98887777778888999999999999888888888889999999999999988777778888999999999998765332
Q ss_pred hhccCCCCCCEEEccCCcCcccccccccc
Q 044615 308 SQICSMQSLEKLNLSHNNLSGSIPRCFEE 336 (571)
Q Consensus 308 ~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~ 336 (571)
.. .-...++.+..+.+.+....|..+.+
T Consensus 243 ~~-~~~~~l~~~~~~~~~~~c~~p~~l~g 270 (285)
T 1ozn_A 243 AR-PLWAWLQKFRGSSSEVPCSLPQRLAG 270 (285)
T ss_dssp GH-HHHHHHHHCCSEECCCBEEESGGGTT
T ss_pred cH-HHHHHHHhcccccCccccCCchHhCC
Confidence 21 00122344456777887777776654
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-30 Score=271.63 Aligned_cols=307 Identities=20% Similarity=0.182 Sum_probs=160.0
Q ss_pred hhhcCCCCCCEEEccCCccc-------cCCCC----ccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCc
Q 044615 42 KELVRAVQARDTSISFDELH-------EKLLT----FEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILN 110 (571)
Q Consensus 42 ~~l~~~~~l~~l~l~~n~l~-------~~~l~----~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~ 110 (571)
..+..+++|++|++++|.+. ...+. +|++|+|++|.++... ...+|..+..+++|++|+|++|.++
T Consensus 50 ~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~---~~~l~~~l~~~~~L~~L~Ls~n~i~ 126 (461)
T 1z7x_W 50 SALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAG---CGVLSSTLRTLPTLQELHLSDNLLG 126 (461)
T ss_dssp HHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGG---HHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred HHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHH---HHHHHHHHccCCceeEEECCCCcCc
Confidence 34455566666666666554 12233 4666666666555311 1134555566666666666666655
Q ss_pred ccccccc-----cCCCCCCEEEcccCcCcccc----cccccCCCCCCeeecccCcCcccCCcccc-----CCCCCCEEEc
Q 044615 111 GSIPLAL-----GNLTNLVVLDLSTNKLSGSI----PLSFANLTSLSILYLYENSLCDSIPKEIG-----NMNSLSILDL 176 (571)
Q Consensus 111 ~~~~~~~-----~~l~~L~~L~L~~n~i~~~~----~~~~~~l~~L~~L~L~~n~l~~~~~~~l~-----~l~~L~~L~L 176 (571)
+..+..+ ...++|++|++++|.++... +..+..+++|++|++++|.+.+..+..+. .+++|++|++
T Consensus 127 ~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L 206 (461)
T 1z7x_W 127 DAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKL 206 (461)
T ss_dssp HHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEEC
T ss_pred hHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEc
Confidence 4333222 12345666666666655422 34444556666666666665443333222 2446666666
Q ss_pred cCCCCCcc----CChhhhhccCCCcEEEccCCcccccC-----CccccCCCCCcEEeCccCcCcCC----CChhhhCCCC
Q 044615 177 SSNKLNGS----IPLSLANLTNSLKVLYLSSNHIVGEI-----PLGHGMLSSLIQLTLNNNELSGQ----LSPELGSLIQ 243 (571)
Q Consensus 177 ~~n~l~~~----~p~~~~~l~~~L~~L~l~~n~~~~~~-----~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~ 243 (571)
++|.++.. ++..+..+++ |+.|++++|.++... +..+..+++|+.|++++|.++.. ++..+..+++
T Consensus 207 ~~n~l~~~~~~~l~~~l~~~~~-L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~ 285 (461)
T 1z7x_W 207 ESCGVTSDNCRDLCGIVASKAS-LRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKES 285 (461)
T ss_dssp TTSCCBTTHHHHHHHHHHHCTT-CCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTT
T ss_pred cCCCCcHHHHHHHHHHHHhCCC-ccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCC
Confidence 66665532 2344444443 666666666554321 11122355666666666665543 3444555666
Q ss_pred CCEEEcccCccccccchhhcc-----CCCCCEEEcCCccCccC----cchhhhcccCCCEEEccCCcCCcccchhccC--
Q 044615 244 LEYLDLSANTFHKSIPESLSN-----LVKLHYLNLSNNQFSQK----IPNKIEKLIHLSELDLSHNIFREEIPSQICS-- 312 (571)
Q Consensus 244 L~~L~L~~n~l~~~~~~~l~~-----l~~L~~L~Ls~n~l~~~----~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~-- 312 (571)
|+.|++++|.+++..+..+.. .++|+.|++++|.+++. ++..+..+++|+.|++++|.+.+..+..+..
T Consensus 286 L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l 365 (461)
T 1z7x_W 286 LKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGL 365 (461)
T ss_dssp CCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHH
T ss_pred cceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHH
Confidence 666666666655433333322 24666666666666543 2344445566666666666655443333322
Q ss_pred ---CCCCCEEEccCCcCcc----ccccccccCCCCCEEECcCCcCcc
Q 044615 313 ---MQSLEKLNLSHNNLSG----SIPRCFEEMHWLSCIDISYNALQG 352 (571)
Q Consensus 313 ---l~~L~~L~Ls~n~l~~----~~p~~~~~l~~L~~L~ls~N~l~~ 352 (571)
.++|+.|++++|.+++ .+|..+..+++|+.|++++|++++
T Consensus 366 ~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~ 412 (461)
T 1z7x_W 366 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 412 (461)
T ss_dssp TSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred cCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCH
Confidence 4566666666666654 455555566666666666666553
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-30 Score=254.98 Aligned_cols=250 Identities=22% Similarity=0.243 Sum_probs=185.4
Q ss_pred ccCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCc-cccccccc-------CCCCCCeeecccCcCcccCCcc
Q 044615 93 IGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLS-GSIPLSFA-------NLTSLSILYLYENSLCDSIPKE 164 (571)
Q Consensus 93 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~-~~~~~~~~-------~l~~L~~L~L~~n~l~~~~~~~ 164 (571)
++..++|++|++++|.+ .+|..+... |+.|+|++|.+. ..+|..+. ++++|++|+|++|.+.+..|..
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 114 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence 34556677777777777 455555433 677777777763 34455444 6778888888888887777776
Q ss_pred c--cCCCCCCEEEccCCCCCccCChhhhhcc----CCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCC--CCh
Q 044615 165 I--GNMNSLSILDLSSNKLNGSIPLSLANLT----NSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQ--LSP 236 (571)
Q Consensus 165 l--~~l~~L~~L~L~~n~l~~~~p~~~~~l~----~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~ 236 (571)
+ ..+++|++|++++|++++. |..+..+. ++|++|++++|.+.+..|..++.+++|++|++++|++.+. .+.
T Consensus 115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 193 (312)
T 1wwl_A 115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193 (312)
T ss_dssp SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence 5 7788888888888888765 77776661 3488888888888877777888888888888888887654 233
Q ss_pred hh--hCCCCCCEEEcccCcccc---ccchhhccCCCCCEEEcCCccCccCcc-hhhhcccCCCEEEccCCcCCcccchhc
Q 044615 237 EL--GSLIQLEYLDLSANTFHK---SIPESLSNLVKLHYLNLSNNQFSQKIP-NKIEKLIHLSELDLSHNIFREEIPSQI 310 (571)
Q Consensus 237 ~~--~~l~~L~~L~L~~n~l~~---~~~~~l~~l~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~n~l~~~~~~~~ 310 (571)
.+ ..+++|+.|++++|.+++ .....+.++++|+.|++++|.+++..| ..+..+++|+.|++++|.++ .+|..+
T Consensus 194 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~ 272 (312)
T 1wwl_A 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL 272 (312)
T ss_dssp HSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSC
T ss_pred HHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhc
Confidence 44 778889999999888873 222345677889999999999887664 45566788999999999987 466666
Q ss_pred cCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCcc
Q 044615 311 CSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQG 352 (571)
Q Consensus 311 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 352 (571)
. ++|+.|+|++|++++. |. +..+++|+.|++++|++++
T Consensus 273 ~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 273 P--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp C--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred c--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 5 7899999999999876 55 8888999999999998875
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-27 Score=249.57 Aligned_cols=285 Identities=26% Similarity=0.335 Sum_probs=164.0
Q ss_pred CCCCEEEccCCccc--cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccccccccCCCCCCE
Q 044615 48 VQARDTSISFDELH--EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVV 125 (571)
Q Consensus 48 ~~l~~l~l~~n~l~--~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~ 125 (571)
.+++.|++++|.+. -..+++|+.|++++|.+++ +|.. .++|++|++++|.+++ +| .|+++++|++
T Consensus 91 ~~L~~L~l~~n~l~~lp~~~~~L~~L~l~~n~l~~--------l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~ 157 (454)
T 1jl5_A 91 PHLESLVASCNSLTELPELPQSLKSLLVDNNNLKA--------LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKI 157 (454)
T ss_dssp TTCSEEECCSSCCSSCCCCCTTCCEEECCSSCCSC--------CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCE
T ss_pred CCCCEEEccCCcCCccccccCCCcEEECCCCccCc--------ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCE
Confidence 56777777777766 2234567777777777665 2211 1466777777776664 45 4666677777
Q ss_pred EEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCc
Q 044615 126 LDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNH 205 (571)
Q Consensus 126 L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~ 205 (571)
|++++|.+++ +|.. .++|++|++++|.+.+ +| .++.+++|++|++++|++++ +|... .+|+.|++++|.
T Consensus 158 L~l~~N~l~~-lp~~---~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~----~~L~~L~l~~n~ 226 (454)
T 1jl5_A 158 IDVDNNSLKK-LPDL---PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP----LSLESIVAGNNI 226 (454)
T ss_dssp EECCSSCCSC-CCCC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC----TTCCEEECCSSC
T ss_pred EECCCCcCcc-cCCC---cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc----CcccEEECcCCc
Confidence 7777776664 3432 2466666777666654 44 46666666666666666663 33221 236666666666
Q ss_pred ccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCcc--Ccc
Q 044615 206 IVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQ--KIP 283 (571)
Q Consensus 206 ~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~--~~~ 283 (571)
+. .+| .++.+++|+.|++++|++++ +|. .+++|+.|++++|.+.+ +|.. +++|+.|++++|.+++ ..|
T Consensus 227 l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~---~~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l~~~~ 296 (454)
T 1jl5_A 227 LE-ELP-ELQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGLSELP 296 (454)
T ss_dssp CS-SCC-CCTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEESCCC
T ss_pred CC-ccc-ccCCCCCCCEEECCCCcCCc-ccc---cccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcccCcC
Confidence 65 344 35566666666666666654 222 12455555555555543 2221 2344444444444443 111
Q ss_pred hh-------------hhcc-cCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCc
Q 044615 284 NK-------------IEKL-IHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNA 349 (571)
Q Consensus 284 ~~-------------~~~l-~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~ 349 (571)
.. +..+ ++|+.|++++|++++ +|.. +++|+.|++++|.+++ +|. .+++|+.|++++|+
T Consensus 297 ~~L~~L~l~~N~l~~i~~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~ 368 (454)
T 1jl5_A 297 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNP 368 (454)
T ss_dssp TTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSC
T ss_pred CcCCEEECcCCcCCcccCCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCC
Confidence 11 1122 478999999999886 5543 5889999999999984 555 47889999999999
Q ss_pred Ccc--cCCC-CCcc-------------CCCCcccccCCcCC
Q 044615 350 LQG--LIPN-STAF-------------RDAPMLALQGNKRL 374 (571)
Q Consensus 350 l~~--~~~~-~~~~-------------~~~~~l~l~~n~~~ 374 (571)
+++ .+|. ...+ .+++.+++.+|+..
T Consensus 369 l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~ 409 (454)
T 1jl5_A 369 LREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR 409 (454)
T ss_dssp CSSCCCCCTTCCEEECCC-----------------------
T ss_pred CCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCC
Confidence 998 4443 2222 56778888888754
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-30 Score=272.59 Aligned_cols=322 Identities=18% Similarity=0.109 Sum_probs=167.0
Q ss_pred hcCCCCCCEEEccCCccc----------cCCCCccceeecccccccCCCCCCCccccccc-cCCC----CCCEEecccCc
Q 044615 44 LVRAVQARDTSISFDELH----------EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEI-GNMK----SLSDLQLSENI 108 (571)
Q Consensus 44 l~~~~~l~~l~l~~n~l~----------~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~-~~l~----~L~~L~L~~n~ 108 (571)
+..+++++.|++++|.+. +..+++|++|+|++|.+++ ..+..+ ..++ +|++|+|++|.
T Consensus 24 ~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~-------~~~~~l~~~l~~~~~~L~~L~L~~n~ 96 (461)
T 1z7x_W 24 LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGD-------VGVHCVLQGLQTPSCKIQKLSLQNCC 96 (461)
T ss_dssp HHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHH-------HHHHHHHHTTCSTTCCCCEEECTTSC
T ss_pred HhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCCh-------HHHHHHHHHHhhCCCceeEEEccCCC
Confidence 344455666666666554 3344566666666665554 222222 1233 46666666666
Q ss_pred Ccc----cccccccCCCCCCEEEcccCcCccccccccc-----CCCCCCeeecccCcCcccC----CccccCCCCCCEEE
Q 044615 109 LNG----SIPLALGNLTNLVVLDLSTNKLSGSIPLSFA-----NLTSLSILYLYENSLCDSI----PKEIGNMNSLSILD 175 (571)
Q Consensus 109 i~~----~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~-----~l~~L~~L~L~~n~l~~~~----~~~l~~l~~L~~L~ 175 (571)
++. .++..+..+++|++|+|++|.++...+..+. ..++|++|++++|.+++.. +..+..+++|++|+
T Consensus 97 i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~ 176 (461)
T 1z7x_W 97 LTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELT 176 (461)
T ss_dssp CBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEE
T ss_pred CCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEE
Confidence 652 3355566666666666666665543332222 2345666666666655422 33444556666666
Q ss_pred ccCCCCCccCChhhhh----ccCCCcEEEccCCccccc----CCccccCCCCCcEEeCccCcCcCCC-----ChhhhCCC
Q 044615 176 LSSNKLNGSIPLSLAN----LTNSLKVLYLSSNHIVGE----IPLGHGMLSSLIQLTLNNNELSGQL-----SPELGSLI 242 (571)
Q Consensus 176 L~~n~l~~~~p~~~~~----l~~~L~~L~l~~n~~~~~----~~~~~~~l~~L~~L~l~~n~l~~~~-----~~~~~~l~ 242 (571)
+++|.+....+..+.. ...+|+.|++++|.++.. ++..+..+++|+.|++++|.+.+.. +..+..++
T Consensus 177 L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~ 256 (461)
T 1z7x_W 177 VSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSS 256 (461)
T ss_dssp CCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTC
T ss_pred CcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCC
Confidence 6666655332222222 111366666666665542 2344445566666666666655422 11122356
Q ss_pred CCCEEEcccCccccc----cchhhccCCCCCEEEcCCccCccCcchhhhcc-----cCCCEEEccCCcCCcc----cchh
Q 044615 243 QLEYLDLSANTFHKS----IPESLSNLVKLHYLNLSNNQFSQKIPNKIEKL-----IHLSELDLSHNIFREE----IPSQ 309 (571)
Q Consensus 243 ~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l-----~~L~~L~Ls~n~l~~~----~~~~ 309 (571)
+|+.|++++|.++.. ++..+..+++|+.|++++|.+++..+..+... ++|+.|++++|.+++. ++..
T Consensus 257 ~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 336 (461)
T 1z7x_W 257 RLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSV 336 (461)
T ss_dssp CCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred CceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHH
Confidence 666666666666543 34455556666666666666654333333221 4666666666666543 3444
Q ss_pred ccCCCCCCEEEccCCcCcccccccccc-----CCCCCEEECcCCcCcc----cCCC-CCccCCCCcccccCCc
Q 044615 310 ICSMQSLEKLNLSHNNLSGSIPRCFEE-----MHWLSCIDISYNALQG----LIPN-STAFRDAPMLALQGNK 372 (571)
Q Consensus 310 ~~~l~~L~~L~Ls~n~l~~~~p~~~~~-----l~~L~~L~ls~N~l~~----~~~~-~~~~~~~~~l~l~~n~ 372 (571)
+..+++|+.|++++|.+++..+..+.. .+.|+.|++++|.+++ .+|. ....+.+..+++.+|+
T Consensus 337 l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~ 409 (461)
T 1z7x_W 337 LAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNC 409 (461)
T ss_dssp HHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSS
T ss_pred HhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCC
Confidence 555566666666666665544443332 4566666666666653 2221 2234455555555554
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=252.07 Aligned_cols=266 Identities=22% Similarity=0.229 Sum_probs=207.7
Q ss_pred cceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCC
Q 044615 68 EATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSL 147 (571)
Q Consensus 68 l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L 147 (571)
++..+++.+.+.. .++..+..+++|++|+|++|.+++..|..|..+++|++|+|++|.+++..+ +..+++|
T Consensus 12 l~i~~ls~~~l~~-------~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L 82 (317)
T 3o53_A 12 YKIEKVTDSSLKQ-------ALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTL 82 (317)
T ss_dssp EEEESCCTTTHHH-------HHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTC
T ss_pred eeEeeccccchhh-------hHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCC
Confidence 3344555555543 333445567889999999999988777889999999999999999986554 8899999
Q ss_pred CeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCcc
Q 044615 148 SILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNN 227 (571)
Q Consensus 148 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~ 227 (571)
++|++++|.+.+.. ..++|++|++++|++++..+.. ++ +|+.|++++|.+++..+..++.+++|+.|++++
T Consensus 83 ~~L~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~-~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 153 (317)
T 3o53_A 83 RTLDLNNNYVQELL-----VGPSIETLHAANNNISRVSCSR---GQ-GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKL 153 (317)
T ss_dssp CEEECCSSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CS-SCEEEECCSSCCCSGGGBCTGGGSSEEEEECTT
T ss_pred CEEECcCCcccccc-----CCCCcCEEECCCCccCCcCccc---cC-CCCEEECCCCCCCCccchhhhccCCCCEEECCC
Confidence 99999999987532 3488999999999988644432 34 489999999999887777888888999999999
Q ss_pred CcCcCCCChhh-hCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCccc
Q 044615 228 NELSGQLSPEL-GSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEI 306 (571)
Q Consensus 228 n~l~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 306 (571)
|.+.+..+..+ ..+++|+.|++++|.+++. + ....+++|+.|++++|.+++. |..+..+++|+.|++++|.+++ +
T Consensus 154 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~~-l 229 (317)
T 3o53_A 154 NEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-I 229 (317)
T ss_dssp SCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-E
T ss_pred CCCCcccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCcccc-h
Confidence 99887766666 4688999999999988765 2 234588899999999998864 4458888899999999998875 6
Q ss_pred chhccCCCCCCEEEccCCcCc-cccccccccCCCCCEEECcC-CcCcccCC
Q 044615 307 PSQICSMQSLEKLNLSHNNLS-GSIPRCFEEMHWLSCIDISY-NALQGLIP 355 (571)
Q Consensus 307 ~~~~~~l~~L~~L~Ls~n~l~-~~~p~~~~~l~~L~~L~ls~-N~l~~~~~ 355 (571)
|..+..+++|+.|++++|+++ +..|..+..++.|+.+++++ +.+++..|
T Consensus 230 ~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~ 280 (317)
T 3o53_A 230 EKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE 280 (317)
T ss_dssp CTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSS
T ss_pred hhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCch
Confidence 777888899999999999998 67788888888888888873 44555444
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-26 Score=241.85 Aligned_cols=292 Identities=27% Similarity=0.330 Sum_probs=231.8
Q ss_pred CCchhhcCCCC-------------CCEEEccCCcccc--CCCCccceeecccccccCCCCCCCccccccccCCCCCCEEe
Q 044615 39 DDYKELVRAVQ-------------ARDTSISFDELHE--KLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQ 103 (571)
Q Consensus 39 ~~~~~l~~~~~-------------l~~l~l~~n~l~~--~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~ 103 (571)
..|.+++.+.+ ++.|++++|.++- ...+.|+.|++++|.+++ +|.. +++|++|+
T Consensus 49 ~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~~~~~L~~L~l~~n~l~~--------lp~~---~~~L~~L~ 117 (454)
T 1jl5_A 49 NAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPELPPHLESLVASCNSLTE--------LPEL---PQSLKSLL 117 (454)
T ss_dssp TSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCSCCTTCSEEECCSSCCSS--------CCCC---CTTCCEEE
T ss_pred cCCcccccchhcchhhhhhhhccCCCEEEecCCccccCCCCcCCCCEEEccCCcCCc--------cccc---cCCCcEEE
Confidence 56777777765 4999999999882 445789999999999986 4543 37899999
Q ss_pred cccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCc
Q 044615 104 LSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNG 183 (571)
Q Consensus 104 L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 183 (571)
+++|.+++ +|.. .++|++|++++|.+++ +| .|+++++|++|++++|.+.+ +|..+ ++|++|++++|++++
T Consensus 118 l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~ 187 (454)
T 1jl5_A 118 VDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE 187 (454)
T ss_dssp CCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS
T ss_pred CCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc
Confidence 99999985 3322 2689999999999996 66 69999999999999999985 56543 599999999999985
Q ss_pred cCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhc
Q 044615 184 SIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLS 263 (571)
Q Consensus 184 ~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~ 263 (571)
+| .+..++. |+.|++++|.+++ +|.. .++|+.|++++|.+. .+| .++.+++|+.|++++|.+++ +|.
T Consensus 188 -l~-~~~~l~~-L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~--- 254 (454)
T 1jl5_A 188 -LP-ELQNLPF-LTAIYADNNSLKK-LPDL---PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPD--- 254 (454)
T ss_dssp -CC-CCTTCTT-CCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCS---
T ss_pred -Cc-cccCCCC-CCEEECCCCcCCc-CCCC---cCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-ccc---
Confidence 66 5888886 9999999999986 4432 358999999999998 456 48999999999999999985 443
Q ss_pred cCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCc--ccchhc-------------cCC-CCCCEEEccCCcCc
Q 044615 264 NLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFRE--EIPSQI-------------CSM-QSLEKLNLSHNNLS 327 (571)
Q Consensus 264 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~--~~~~~~-------------~~l-~~L~~L~Ls~n~l~ 327 (571)
.+++|+.|++++|.+++ +|.. +++|+.|++++|.+++ ..|..+ ..+ ++|+.|++++|+++
T Consensus 255 ~~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l~~~~~~L~~L~l~~N~l~~i~~~~~~L~~L~Ls~N~l~ 330 (454)
T 1jl5_A 255 LPPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI 330 (454)
T ss_dssp CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCS
T ss_pred cccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcccCcCCcCCEEECcCCcCCcccCCcCcCCEEECCCCccc
Confidence 24799999999999986 4432 3677888888887766 222222 123 58899999999998
Q ss_pred cccccccccCCCCCEEECcCCcCcccCCCCCccCCCCcccccCCcCCC
Q 044615 328 GSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLC 375 (571)
Q Consensus 328 ~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~l~l~~n~~~c 375 (571)
+ +|.. +++|+.|++++|.+++.++ .+..+..+++.+|+..+
T Consensus 331 ~-lp~~---~~~L~~L~L~~N~l~~lp~---~l~~L~~L~L~~N~l~~ 371 (454)
T 1jl5_A 331 E-LPAL---PPRLERLIASFNHLAEVPE---LPQNLKQLHVEYNPLRE 371 (454)
T ss_dssp C-CCCC---CTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCSS
T ss_pred c-cccc---CCcCCEEECCCCccccccc---hhhhccEEECCCCCCCc
Confidence 6 5544 5889999999999997544 56889999999998654
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-28 Score=259.87 Aligned_cols=236 Identities=25% Similarity=0.265 Sum_probs=159.3
Q ss_pred CCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEE
Q 044615 95 NMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSIL 174 (571)
Q Consensus 95 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 174 (571)
.+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..| ++.+++|++|+|++|.+++.. ..++|++|
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~L 104 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETL 104 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE-----ECTTCCEE
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC-----CCCCcCEE
Confidence 34489999999999888778888888999999999998886655 888888888998888886532 23778888
Q ss_pred EccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhh-CCCCCCEEEcccCc
Q 044615 175 DLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELG-SLIQLEYLDLSANT 253 (571)
Q Consensus 175 ~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~L~~n~ 253 (571)
++++|.+.+..+.. ++ +|+.|++++|.+++..|..++.+++|+.|++++|.+++..|..+. .+++|+.|+|++|.
T Consensus 105 ~L~~N~l~~~~~~~---l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~ 180 (487)
T 3oja_A 105 HAANNNISRVSCSR---GQ-GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180 (487)
T ss_dssp ECCSSCCCCEEECC---CS-SCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSC
T ss_pred ECcCCcCCCCCccc---cC-CCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCc
Confidence 88888887544332 23 377777777777766666666677777777777777766665554 56677777777776
Q ss_pred cccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCc-ccccc
Q 044615 254 FHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLS-GSIPR 332 (571)
Q Consensus 254 l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~p~ 332 (571)
+++.. ....+++|+.|+|++|.+++..| .+..+++|+.|+|++|.+++ +|..+..+++|+.|++++|++. +.+|.
T Consensus 181 l~~~~--~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~ 256 (487)
T 3oja_A 181 IYDVK--GQVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRD 256 (487)
T ss_dssp CCEEE--CCCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHH
T ss_pred ccccc--ccccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHH
Confidence 66542 22346666666666666665333 35666666666666666654 4555666666666666666665 44455
Q ss_pred ccccCCCCCEEEC
Q 044615 333 CFEEMHWLSCIDI 345 (571)
Q Consensus 333 ~~~~l~~L~~L~l 345 (571)
.+..++.|+.+++
T Consensus 257 ~~~~l~~L~~l~~ 269 (487)
T 3oja_A 257 FFSKNQRVQTVAK 269 (487)
T ss_dssp HHTTCHHHHHHHH
T ss_pred HHHhCCCCcEEec
Confidence 5555544444443
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-29 Score=248.77 Aligned_cols=246 Identities=23% Similarity=0.228 Sum_probs=175.3
Q ss_pred CCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCc-cccccccc-------CCCCCCEEEcccCcCccc
Q 044615 65 LTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILN-GSIPLALG-------NLTNLVVLDLSTNKLSGS 136 (571)
Q Consensus 65 l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~-~~~~~~~~-------~l~~L~~L~L~~n~i~~~ 136 (571)
...|+.+++++|.+ . +|..+... |+.|+|++|.+. ..+|..+. ++++|++|+|++|.+++.
T Consensus 42 ~~~L~~l~l~~n~l-~--------~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~ 110 (312)
T 1wwl_A 42 GRSLEYLLKRVDTE-A--------DLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGT 110 (312)
T ss_dssp EEECTTHHHHCCTT-C--------CCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSC
T ss_pred CCCceeEeeccccc-c--------cHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccch
Confidence 44566666666666 2 35444432 667777777763 33454444 567777777777777766
Q ss_pred ccccc--cCCCCCCeeecccCcCcccCCccccCC-----CCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCccccc
Q 044615 137 IPLSF--ANLTSLSILYLYENSLCDSIPKEIGNM-----NSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGE 209 (571)
Q Consensus 137 ~~~~~--~~l~~L~~L~L~~n~l~~~~~~~l~~l-----~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~ 209 (571)
.|..+ ..+++|++|+|++|.+.+. |..+..+ ++|++|++++|++.+..|..+..+++ |+.|++++|++.+.
T Consensus 111 ~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~ 188 (312)
T 1wwl_A 111 APPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPA-LSTLDLSDNPELGE 188 (312)
T ss_dssp CCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSS-CCEEECCSCTTCHH
T ss_pred hHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCC-CCEEECCCCCcCcc
Confidence 66655 6777777777777777665 6656555 77777777777777655566666665 77777777776543
Q ss_pred --CCccc--cCCCCCcEEeCccCcCcCC---CChhhhCCCCCCEEEcccCccccccc-hhhccCCCCCEEEcCCccCccC
Q 044615 210 --IPLGH--GMLSSLIQLTLNNNELSGQ---LSPELGSLIQLEYLDLSANTFHKSIP-ESLSNLVKLHYLNLSNNQFSQK 281 (571)
Q Consensus 210 --~~~~~--~~l~~L~~L~l~~n~l~~~---~~~~~~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~Ls~n~l~~~ 281 (571)
.+..+ ..+++|++|++++|++++. ....+..+++|+.|++++|.+++..| ..+..+++|+.|++++|.++ .
T Consensus 189 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ 267 (312)
T 1wwl_A 189 RGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-Q 267 (312)
T ss_dssp HHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-S
T ss_pred hHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-h
Confidence 22233 6778888888888888732 22345678899999999999887664 45667889999999999998 5
Q ss_pred cchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCcc
Q 044615 282 IPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSG 328 (571)
Q Consensus 282 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 328 (571)
+|..+. ++|+.|++++|++++. |. +..+++|+.|++++|++++
T Consensus 268 ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 268 VPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp CCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred hhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 666555 7899999999999876 55 8889999999999999875
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-28 Score=243.89 Aligned_cols=261 Identities=18% Similarity=0.160 Sum_probs=219.2
Q ss_pred CCCEEEccCCccc------cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccccccccCCCC
Q 044615 49 QARDTSISFDELH------EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTN 122 (571)
Q Consensus 49 ~l~~l~l~~n~l~------~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~ 122 (571)
+++..+++.+.+. +..+++|+.|+|++|++++ ..|..|.++++|++|+|++|.+++..+ +..+++
T Consensus 11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~-------~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~ 81 (317)
T 3o53_A 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQ-------ISAADLAPFTKLELLNLSSNVLYETLD--LESLST 81 (317)
T ss_dssp EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCC-------CCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTT
T ss_pred ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCc-------CCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCC
Confidence 3455666666665 5567799999999999987 567889999999999999999986554 899999
Q ss_pred CCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEcc
Q 044615 123 LVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLS 202 (571)
Q Consensus 123 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~ 202 (571)
|++|++++|.+++.. ..++|++|++++|.+.+..+. .+++|++|++++|++++..+..+..++. |+.|+++
T Consensus 82 L~~L~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~-L~~L~Ls 152 (317)
T 3o53_A 82 LRTLDLNNNYVQELL-----VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSR-VQYLDLK 152 (317)
T ss_dssp CCEEECCSSEEEEEE-----ECTTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSS-EEEEECT
T ss_pred CCEEECcCCcccccc-----CCCCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCC-CCEEECC
Confidence 999999999998543 348999999999999876543 4688999999999999776777877776 9999999
Q ss_pred CCcccccCCccc-cCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccC
Q 044615 203 SNHIVGEIPLGH-GMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQK 281 (571)
Q Consensus 203 ~n~~~~~~~~~~-~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~ 281 (571)
+|.+++..+..+ ..+++|+.|++++|.+++. + ....+++|+.|++++|.+++. |..+..+++|+.|++++|.++ .
T Consensus 153 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~-~ 228 (317)
T 3o53_A 153 LNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLV-L 228 (317)
T ss_dssp TSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCC-E
T ss_pred CCCCCcccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCccc-c
Confidence 999998777666 4789999999999999865 2 334589999999999999865 455899999999999999998 4
Q ss_pred cchhhhcccCCCEEEccCCcCC-cccchhccCCCCCCEEEccCC-cCccccc
Q 044615 282 IPNKIEKLIHLSELDLSHNIFR-EEIPSQICSMQSLEKLNLSHN-NLSGSIP 331 (571)
Q Consensus 282 ~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~n-~l~~~~p 331 (571)
+|..+..+++|+.|++++|.+. +.++..+..+++|+.|+++++ .+++..|
T Consensus 229 l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~ 280 (317)
T 3o53_A 229 IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE 280 (317)
T ss_dssp ECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSS
T ss_pred hhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCch
Confidence 6778899999999999999998 778889999999999999844 4555443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.9e-28 Score=253.16 Aligned_cols=218 Identities=25% Similarity=0.240 Sum_probs=192.7
Q ss_pred CCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcE
Q 044615 119 NLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKV 198 (571)
Q Consensus 119 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~ 198 (571)
.+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..| +..+++|++|+|++|.+++. |. .+ +|+.
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l-~~----~~-~L~~ 103 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQEL-LV----GP-SIET 103 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEE-EE----CT-TCCE
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCC-CC----CC-CcCE
Confidence 34589999999999999888999999999999999999987655 89999999999999999853 32 23 5999
Q ss_pred EEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhc-cCCCCCEEEcCCcc
Q 044615 199 LYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLS-NLVKLHYLNLSNNQ 277 (571)
Q Consensus 199 L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~-~l~~L~~L~Ls~n~ 277 (571)
|++++|.+++..+. .+++|+.|++++|.+++..|..++.+++|+.|+|++|.+++..|..+. .+++|+.|+|++|.
T Consensus 104 L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~ 180 (487)
T 3oja_A 104 LHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180 (487)
T ss_dssp EECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSC
T ss_pred EECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCc
Confidence 99999999876654 357899999999999998888999999999999999999988888876 79999999999999
Q ss_pred CccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCc
Q 044615 278 FSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQ 351 (571)
Q Consensus 278 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~ 351 (571)
+++..+ ...+++|+.|+|++|.+++..| .+..+++|+.|+|++|.+++ +|..+..++.|+.|++++|++.
T Consensus 181 l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~ 250 (487)
T 3oja_A 181 IYDVKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFH 250 (487)
T ss_dssp CCEEEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBC
T ss_pred cccccc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCc
Confidence 987633 3468999999999999998544 58899999999999999996 6778999999999999999998
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-25 Score=238.94 Aligned_cols=259 Identities=23% Similarity=0.287 Sum_probs=213.7
Q ss_pred CCCEEEccCCccc---cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccccccccCCCCCCE
Q 044615 49 QARDTSISFDELH---EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVV 125 (571)
Q Consensus 49 ~l~~l~l~~n~l~---~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~ 125 (571)
+++.|++++|.++ ....++|+.|++++|.++. +|. .+++|++|+|++|.++ .+|. .+++|++
T Consensus 41 ~l~~L~ls~n~L~~lp~~l~~~L~~L~L~~N~l~~--------lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~ 105 (622)
T 3g06_A 41 GNAVLNVGESGLTTLPDCLPAHITTLVIPDNNLTS--------LPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLE 105 (622)
T ss_dssp CCCEEECCSSCCSCCCSCCCTTCSEEEECSCCCSC--------CCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCE
T ss_pred CCcEEEecCCCcCccChhhCCCCcEEEecCCCCCC--------CCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCE
Confidence 5789999999888 2233689999999999885 565 5789999999999998 4555 6789999
Q ss_pred EEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCc
Q 044615 126 LDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNH 205 (571)
Q Consensus 126 L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~ 205 (571)
|+|++|.+++. |. .+++|++|++++|.++. +|.. +++|++|++++|++++ +|.. ..+|+.|++++|.
T Consensus 106 L~Ls~N~l~~l-~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~~----~~~L~~L~L~~N~ 172 (622)
T 3g06_A 106 LSIFSNPLTHL-PA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPAL----PSELCKLWAYNNQ 172 (622)
T ss_dssp EEECSCCCCCC-CC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCCC----CTTCCEEECCSSC
T ss_pred EECcCCcCCCC-CC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCCc----cCCCCEEECCCCC
Confidence 99999999854 43 67899999999999975 5543 5899999999999984 5542 2359999999999
Q ss_pred ccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchh
Q 044615 206 IVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNK 285 (571)
Q Consensus 206 ~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~ 285 (571)
+++ +| ..+++|+.|++++|.+++. |. .+++|+.|++++|.++. +|. .+++|+.|++++|.+++ +|
T Consensus 173 l~~-l~---~~~~~L~~L~Ls~N~l~~l-~~---~~~~L~~L~L~~N~l~~-l~~---~~~~L~~L~Ls~N~L~~-lp-- 237 (622)
T 3g06_A 173 LTS-LP---MLPSGLQELSVSDNQLASL-PT---LPSELYKLWAYNNRLTS-LPA---LPSGLKELIVSGNRLTS-LP-- 237 (622)
T ss_dssp CSC-CC---CCCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSS-CCC---CCTTCCEEECCSSCCSC-CC--
T ss_pred CCC-Cc---ccCCCCcEEECCCCCCCCC-CC---ccchhhEEECcCCcccc-cCC---CCCCCCEEEccCCccCc-CC--
Confidence 985 45 4578999999999999863 33 35789999999999974 443 35889999999999986 44
Q ss_pred hhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCcccCCC
Q 044615 286 IEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPN 356 (571)
Q Consensus 286 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~ 356 (571)
..+++|+.|++++|.++. +|. .+++|+.|+|++|+|+ .+|..+..+++|+.|++++|++++..|.
T Consensus 238 -~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~ 302 (622)
T 3g06_A 238 -VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 302 (622)
T ss_dssp -CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHH
T ss_pred -CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHH
Confidence 456899999999999985 554 6789999999999999 6788999999999999999999987654
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-25 Score=216.96 Aligned_cols=228 Identities=25% Similarity=0.251 Sum_probs=145.2
Q ss_pred EEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCC
Q 044615 101 DLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNK 180 (571)
Q Consensus 101 ~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~ 180 (571)
.++..+..+. .+|..+. ++|++|++++|.+++..+..|.++++|++|++++|.+.+..+..+..+++|++|++++|+
T Consensus 11 ~~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 87 (276)
T 2z62_A 11 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87 (276)
T ss_dssp EEECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred eEEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCc
Confidence 3445555554 4555443 467777777777776666677777777777777777776666667777777777777777
Q ss_pred CCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccc-cc
Q 044615 181 LNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKS-IP 259 (571)
Q Consensus 181 l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~ 259 (571)
+++..+..+..+++ |+.|++++|.+.+..+. .+..+++|+.|++++|.+.+. +|
T Consensus 88 l~~~~~~~~~~l~~-L~~L~l~~n~l~~~~~~------------------------~~~~l~~L~~L~l~~n~l~~~~l~ 142 (276)
T 2z62_A 88 IQSLALGAFSGLSS-LQKLVAVETNLASLENF------------------------PIGHLKTLKELNVAHNLIQSFKLP 142 (276)
T ss_dssp CCEECTTTTTTCTT-CCEEECTTSCCCCSTTC------------------------CCTTCTTCCEEECCSSCCCCCCCC
T ss_pred cCccChhhhcCCcc-ccEEECCCCCccccCch------------------------hcccCCCCCEEECcCCccceecCc
Confidence 66544445555543 55555555555443333 344455555555555555432 35
Q ss_pred hhhccCCCCCEEEcCCccCccCcchhhhcccCCC----EEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccc
Q 044615 260 ESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLS----ELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFE 335 (571)
Q Consensus 260 ~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~----~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~ 335 (571)
..+..+++|+.|++++|.+++..+..+..+.+|+ .|++++|.+.+..+..+. ..+|+.|++++|.+++..+..|.
T Consensus 143 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~ 221 (276)
T 2z62_A 143 EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFD 221 (276)
T ss_dssp GGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTT
T ss_pred hhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhc
Confidence 5556666666666666666555555555555555 677777777665444443 34788888888888877667778
Q ss_pred cCCCCCEEECcCCcCcccCCCC
Q 044615 336 EMHWLSCIDISYNALQGLIPNS 357 (571)
Q Consensus 336 ~l~~L~~L~ls~N~l~~~~~~~ 357 (571)
.+++|+.|++++|++++..|..
T Consensus 222 ~l~~L~~L~l~~N~~~c~c~~l 243 (276)
T 2z62_A 222 RLTSLQKIWLHTNPWDCSCPRI 243 (276)
T ss_dssp TCCSCCEEECCSSCBCCCTTTT
T ss_pred ccccccEEEccCCcccccCCch
Confidence 8888888888888888776643
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.4e-25 Score=216.93 Aligned_cols=214 Identities=28% Similarity=0.282 Sum_probs=158.5
Q ss_pred cccccccCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccC
Q 044615 88 SIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGN 167 (571)
Q Consensus 88 ~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~ 167 (571)
.+|..+. ++|++|+|++|.+++..+..|.++++|++|++++|.+++..+..|.++++|++|++++|.+.+..+..+..
T Consensus 21 ~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 98 (276)
T 2z62_A 21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG 98 (276)
T ss_dssp SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTT
T ss_pred ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcC
Confidence 5777664 68999999999999877779999999999999999999888889999999999999999999888889999
Q ss_pred CCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCccccc-CCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCE
Q 044615 168 MNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGE-IPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEY 246 (571)
Q Consensus 168 l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 246 (571)
+++|++|++++|++.+..+..+..+++ |+.|++++|.+++. +|..+. .+++|+.
T Consensus 99 l~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~l~~n~l~~~~l~~~~~------------------------~l~~L~~ 153 (276)
T 2z62_A 99 LSSLQKLVAVETNLASLENFPIGHLKT-LKELNVAHNLIQSFKLPEYFS------------------------NLTNLEH 153 (276)
T ss_dssp CTTCCEEECTTSCCCCSTTCCCTTCTT-CCEEECCSSCCCCCCCCGGGG------------------------GCTTCCE
T ss_pred CccccEEECCCCCccccCchhcccCCC-CCEEECcCCccceecCchhhc------------------------cCCCCCE
Confidence 999999999999998655556666665 77777777776542 244444 4445555
Q ss_pred EEcccCccccccchhhccCCCCC----EEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEcc
Q 044615 247 LDLSANTFHKSIPESLSNLVKLH----YLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLS 322 (571)
Q Consensus 247 L~L~~n~l~~~~~~~l~~l~~L~----~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls 322 (571)
|++++|.+++..+..+..+++|+ .|++++|.+++..+..+. ..+|+.|++++|.+++..+..+..+++|+.|+++
T Consensus 154 L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 232 (276)
T 2z62_A 154 LDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLH 232 (276)
T ss_dssp EECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECC
T ss_pred EECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEcc
Confidence 55555555444444444444444 666666666654443333 3367777777777776655566777778888888
Q ss_pred CCcCccc
Q 044615 323 HNNLSGS 329 (571)
Q Consensus 323 ~n~l~~~ 329 (571)
+|++++.
T Consensus 233 ~N~~~c~ 239 (276)
T 2z62_A 233 TNPWDCS 239 (276)
T ss_dssp SSCBCCC
T ss_pred CCccccc
Confidence 8877653
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.4e-24 Score=230.17 Aligned_cols=257 Identities=26% Similarity=0.325 Sum_probs=212.8
Q ss_pred ccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCC
Q 044615 67 FEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTS 146 (571)
Q Consensus 67 ~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~ 146 (571)
.++.+++++|.++. +|..+. ++|++|+|++|.++ .+|. .+++|++|+|++|.++. +|. .+++
T Consensus 41 ~l~~L~ls~n~L~~--------lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~ 102 (622)
T 3g06_A 41 GNAVLNVGESGLTT--------LPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPV---LPPG 102 (622)
T ss_dssp CCCEEECCSSCCSC--------CCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSC-CCC---CCTT
T ss_pred CCcEEEecCCCcCc--------cChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCc-CCC---CCCC
Confidence 58899999999884 677665 89999999999998 4565 57899999999999984 554 7899
Q ss_pred CCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCc
Q 044615 147 LSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLN 226 (571)
Q Consensus 147 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~ 226 (571)
|++|++++|.+++ +|. .+++|++|++++|+++. +|..+ + +|+.|++++|.+++ +|. .+++|+.|+++
T Consensus 103 L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~l---~-~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~ 169 (622)
T 3g06_A 103 LLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVLP---P-GLQELSVSDNQLAS-LPA---LPSELCKLWAY 169 (622)
T ss_dssp CCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCCC---T-TCCEEECCSSCCSC-CCC---CCTTCCEEECC
T ss_pred CCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCCC---C-CCCEEECcCCcCCC-cCC---ccCCCCEEECC
Confidence 9999999999976 454 67899999999999984 66543 3 59999999999985 343 35789999999
Q ss_pred cCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCccc
Q 044615 227 NNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEI 306 (571)
Q Consensus 227 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 306 (571)
+|.+++ +| ..+++|+.|++++|.+++ +|. .+++|+.|++++|.++. +|. .+++|+.|++++|.+++ +
T Consensus 170 ~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l~~---~~~~L~~L~Ls~N~L~~-l 236 (622)
T 3g06_A 170 NNQLTS-LP---MLPSGLQELSVSDNQLAS-LPT---LPSELYKLWAYNNRLTS-LPA---LPSGLKELIVSGNRLTS-L 236 (622)
T ss_dssp SSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSS-CCC---CCTTCCEEECCSSCCSC-C
T ss_pred CCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCC---ccchhhEEECcCCcccc-cCC---CCCCCCEEEccCCccCc-C
Confidence 999996 44 557899999999999985 443 35789999999999985 443 34789999999999987 5
Q ss_pred chhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCcccCCCCCccCCCCcccccCCcCC
Q 044615 307 PSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRL 374 (571)
Q Consensus 307 ~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~l~l~~n~~~ 374 (571)
| ..+++|+.|+|++|.|+. +|. .+++|+.|++++|+++..++....++++..+++.+|+..
T Consensus 237 p---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~~lp~~l~~l~~L~~L~L~~N~l~ 297 (622)
T 3g06_A 237 P---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLS 297 (622)
T ss_dssp C---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCCSCCGGGGGSCTTCEEECCSCCCC
T ss_pred C---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCCcCCHHHhhccccCEEEecCCCCC
Confidence 5 567899999999999994 554 678899999999999976555667788899999999754
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=5.3e-24 Score=206.58 Aligned_cols=203 Identities=28% Similarity=0.331 Sum_probs=119.7
Q ss_pred CCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEcc
Q 044615 98 SLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLS 177 (571)
Q Consensus 98 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~ 177 (571)
+.+.++++++.++ .+|..+. ++|++|+|++|.++...+..|.++++|++|++++|.+....+..|..+++|++|+++
T Consensus 17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence 4667777777776 4555443 467777777777776666667777777777777777765544555667777777777
Q ss_pred CCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccc
Q 044615 178 SNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKS 257 (571)
Q Consensus 178 ~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 257 (571)
+|++.+..+..+..+++ |+.|++++|.+++ ..+..|..+++|+.|++++|.+++.
T Consensus 94 ~n~l~~~~~~~~~~l~~-L~~L~l~~n~l~~------------------------~~~~~~~~l~~L~~L~Ls~n~l~~~ 148 (270)
T 2o6q_A 94 DNKLQALPIGVFDQLVN-LAELRLDRNQLKS------------------------LPPRVFDSLTKLTYLSLGYNELQSL 148 (270)
T ss_dssp SSCCCCCCTTTTTTCSS-CCEEECCSSCCCC------------------------CCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred CCcCCcCCHhHcccccC-CCEEECCCCccCe------------------------eCHHHhCcCcCCCEEECCCCcCCcc
Confidence 77666433333333333 5555555554443 3333444455555555555555444
Q ss_pred cchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCcc
Q 044615 258 IPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSG 328 (571)
Q Consensus 258 ~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 328 (571)
.+..+..+++|+.|++++|.+++..+..+..+++|+.|++++|.+++..+..+..+++|+.|+|++|++..
T Consensus 149 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 219 (270)
T 2o6q_A 149 PKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC 219 (270)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeC
Confidence 44445555555555555555555444455555666666666666655545556666666666666666643
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=7.1e-24 Score=205.69 Aligned_cols=206 Identities=25% Similarity=0.296 Sum_probs=148.9
Q ss_pred CCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEc
Q 044615 122 NLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYL 201 (571)
Q Consensus 122 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l 201 (571)
+.++++++++.++ .+|..+. ++|++|++++|.+.+..+..|..+++|++|++++|+++
T Consensus 17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~------------------- 74 (270)
T 2o6q_A 17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ------------------- 74 (270)
T ss_dssp TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCS-------------------
T ss_pred CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccC-------------------
Confidence 3455555555555 2333322 34555555555555444444555555555555554443
Q ss_pred cCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccC
Q 044615 202 SSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQK 281 (571)
Q Consensus 202 ~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~ 281 (571)
...+..+..+++|++|++++|.+.+..+..+..+++|+.|++++|.+++..+..|..+++|+.|++++|.+++.
T Consensus 75 ------~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 148 (270)
T 2o6q_A 75 ------TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSL 148 (270)
T ss_dssp ------CCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred ------eeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCcc
Confidence 33333445566677777777777766666778888999999999998887778888999999999999999877
Q ss_pred cchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCcccCC
Q 044615 282 IPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIP 355 (571)
Q Consensus 282 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~ 355 (571)
.+..+..+++|+.|++++|.+++..+..|..+++|+.|++++|++++..+..|..++.|+.|++++|++.+..+
T Consensus 149 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 149 PKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred CHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 77778888999999999999988777778889999999999999987777778888899999999998876654
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=4.5e-25 Score=214.37 Aligned_cols=210 Identities=22% Similarity=0.216 Sum_probs=135.2
Q ss_pred cCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCc
Q 044615 118 GNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLK 197 (571)
Q Consensus 118 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~ 197 (571)
..+++|+.|++++|.++.. ..+..+++|++|++++|.+.+. ..+..+++|++|++++|++++..+..+..++. |+
T Consensus 38 ~~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~-L~ 112 (272)
T 3rfs_A 38 NELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTN-LK 112 (272)
T ss_dssp HHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTT-CC
T ss_pred ccccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcC-CC
Confidence 3444555555555554421 2344555555555555555431 24555555555555555555433333444443 66
Q ss_pred EEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCcc
Q 044615 198 VLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQ 277 (571)
Q Consensus 198 ~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~ 277 (571)
.|++++|.+++..+..++.+++|++|++++|.+++..+..+..+++|+.|++++|.+++..+..+..+++|+.|++++|.
T Consensus 113 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 192 (272)
T 3rfs_A 113 ELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQ 192 (272)
T ss_dssp EEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCc
Confidence 66666666555555556666677777777777776666666777777777777777776666667777888888888888
Q ss_pred CccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCC
Q 044615 278 FSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHW 339 (571)
Q Consensus 278 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~ 339 (571)
+++..+..+..+++|+.|++++|.+.+ .+++|+.|+++.|.++|.+|.++..++.
T Consensus 193 l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~l~~~~n~~~g~ip~~~~~~~~ 247 (272)
T 3rfs_A 193 LKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP 247 (272)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCBCC-------CTTTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred CCccCHHHHhCCcCCCEEEccCCCccc-------cCcHHHHHHHHHHhCCCcccCcccccCC
Confidence 877777677778888888888887653 4567888888888888888887776543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.3e-25 Score=215.34 Aligned_cols=220 Identities=23% Similarity=0.291 Sum_probs=153.0
Q ss_pred CCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEcc
Q 044615 123 LVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLS 202 (571)
Q Consensus 123 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~ 202 (571)
+..+++..+.+... .....+++|+.|++++|.+.. + ..+..+++|++|++++|++.+ + ..+..++. |+.|+++
T Consensus 21 l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~-L~~L~L~ 93 (272)
T 3rfs_A 21 TIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHD-I-SALKELTN-LTYLILT 93 (272)
T ss_dssp HHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCC-C-GGGTTCTT-CCEEECT
T ss_pred HHHHHhcCcccccc--cccccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCC-c-hhhcCCCC-CCEEECC
Confidence 33445555554433 234566777777777777653 2 346777777777777777764 2 35666664 7777777
Q ss_pred CCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCc
Q 044615 203 SNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKI 282 (571)
Q Consensus 203 ~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~ 282 (571)
+|.+++..+..+..+++|++|++++|++++..+..+..+++|+.|++++|.+++..+..+..+++|+.|++++|.+++..
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 173 (272)
T 3rfs_A 94 GNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLP 173 (272)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccC
Confidence 77777666666777777777777777777666666777777777777777777666666777777777777777777666
Q ss_pred chhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCcccCCC
Q 044615 283 PNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPN 356 (571)
Q Consensus 283 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~ 356 (571)
+..+..+++|+.|++++|.+++..+..+..+++|+.|++++|++.+. ++.|+.++++.|.++|.+|.
T Consensus 174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~ 240 (272)
T 3rfs_A 174 EGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRN 240 (272)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBC
T ss_pred HHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccC
Confidence 66667777777777777777776666677777777777777776643 44566777777777777665
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.92 E-value=4.1e-26 Score=233.59 Aligned_cols=255 Identities=18% Similarity=0.215 Sum_probs=164.9
Q ss_pred cccccccCCCCCCEEecccCcCccccc----ccccCCCCCCEEEcccCc---Ccccccccc-------cCCCCCCeeecc
Q 044615 88 SIPDEIGNMKSLSDLQLSENILNGSIP----LALGNLTNLVVLDLSTNK---LSGSIPLSF-------ANLTSLSILYLY 153 (571)
Q Consensus 88 ~~p~~~~~l~~L~~L~L~~n~i~~~~~----~~~~~l~~L~~L~L~~n~---i~~~~~~~~-------~~l~~L~~L~L~ 153 (571)
.++..+..+++|++|+|++|.++...+ ..+..+++|++|+|++|. +++.+|..+ ..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 567778888999999999998886544 346788899999998864 344445444 677888888888
Q ss_pred cCcCcc----cCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCc
Q 044615 154 ENSLCD----SIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNE 229 (571)
Q Consensus 154 ~n~l~~----~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~ 229 (571)
+|.+.. .+|..+..+++|++|+|++|.++...+..+..... . +..|.+.+ ..++|++|++++|+
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~---~--l~~~~~~~-------~~~~L~~L~L~~n~ 170 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQ---E--LAVNKKAK-------NAPPLRSIICGRNR 170 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHH---H--HHHHHHHH-------TCCCCCEEECCSSC
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHH---H--Hhhhhhcc-------cCCCCcEEECCCCC
Confidence 888876 35666777888888888888776433333332210 0 00001100 01445555555555
Q ss_pred CcC-CCC---hhhhCCCCCCEEEcccCcccc-----ccchhhccCCCCCEEEcCCccCc----cCcchhhhcccCCCEEE
Q 044615 230 LSG-QLS---PELGSLIQLEYLDLSANTFHK-----SIPESLSNLVKLHYLNLSNNQFS----QKIPNKIEKLIHLSELD 296 (571)
Q Consensus 230 l~~-~~~---~~~~~l~~L~~L~L~~n~l~~-----~~~~~l~~l~~L~~L~Ls~n~l~----~~~~~~~~~l~~L~~L~ 296 (571)
++. ..+ ..+..+++|+.|++++|.++. ..+..+..+++|+.|+|++|.++ +.+|..+..+++|+.|+
T Consensus 171 l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~ 250 (386)
T 2ca6_A 171 LENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELG 250 (386)
T ss_dssp CTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEE
T ss_pred CCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEE
Confidence 541 222 345556677777777776652 23336667777777777777775 44566667777777777
Q ss_pred ccCCcCCcc----cchhcc--CCCCCCEEEccCCcCcc----cccccc-ccCCCCCEEECcCCcCcccC
Q 044615 297 LSHNIFREE----IPSQIC--SMQSLEKLNLSHNNLSG----SIPRCF-EEMHWLSCIDISYNALQGLI 354 (571)
Q Consensus 297 Ls~n~l~~~----~~~~~~--~l~~L~~L~Ls~n~l~~----~~p~~~-~~l~~L~~L~ls~N~l~~~~ 354 (571)
|++|.+++. ++..+. .+++|+.|+|++|.+++ .+|..+ .++++|+.|++++|++++..
T Consensus 251 L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 251 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp CTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred CCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 777777654 445553 37788888888888876 366666 55788888888888887654
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.3e-25 Score=225.81 Aligned_cols=256 Identities=18% Similarity=0.193 Sum_probs=134.9
Q ss_pred eecccccccCCCCCCCccccccccCCCCCCEEecccCcCccccc----ccccCCC-CCCEEEcccCcCcccccccccCC-
Q 044615 71 AHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIP----LALGNLT-NLVVLDLSTNKLSGSIPLSFANL- 144 (571)
Q Consensus 71 l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~----~~~~~l~-~L~~L~L~~n~i~~~~~~~~~~l- 144 (571)
++++.|.+++ .+|..+...++|++|+|++|.+++..+ ..|..++ +|++|+|++|.+++..+..+..+
T Consensus 3 ~~ls~n~~~~-------~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l 75 (362)
T 3goz_A 3 YKLTLHPGSN-------PVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQIL 75 (362)
T ss_dssp EECCCCTTCC-------HHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHH
T ss_pred cccccccchH-------HHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHH
Confidence 4566666666 556555555557777777777765555 5566666 67777777777766655555554
Q ss_pred ----CCCCeeecccCcCcccCCccc----cCC-CCCCEEEccCCCCCccCChhhhhc----cCCCcEEEccCCcccccCC
Q 044615 145 ----TSLSILYLYENSLCDSIPKEI----GNM-NSLSILDLSSNKLNGSIPLSLANL----TNSLKVLYLSSNHIVGEIP 211 (571)
Q Consensus 145 ----~~L~~L~L~~n~l~~~~~~~l----~~l-~~L~~L~L~~n~l~~~~p~~~~~l----~~~L~~L~l~~n~~~~~~~ 211 (571)
++|++|+|++|.+++..+..+ ..+ ++|++|++++|++++..+..+... ..+|+.|++++|.++...+
T Consensus 76 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~ 155 (362)
T 3goz_A 76 AAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSS 155 (362)
T ss_dssp HTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCH
T ss_pred hccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHH
Confidence 667777777777665544433 233 666777777666664443333322 2235566666555543221
Q ss_pred ccccCCCCCcEEeCccCcCcCCCChhhhCCC-CCCEEEcccCccccccchhh----ccC-CCCCEEEcCCccCccC----
Q 044615 212 LGHGMLSSLIQLTLNNNELSGQLSPELGSLI-QLEYLDLSANTFHKSIPESL----SNL-VKLHYLNLSNNQFSQK---- 281 (571)
Q Consensus 212 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~l----~~l-~~L~~L~Ls~n~l~~~---- 281 (571)
.. ++..+..++ +|+.|+|++|.+++..+..+ ..+ ++|+.|++++|.+++.
T Consensus 156 ~~--------------------l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~ 215 (362)
T 3goz_A 156 DE--------------------LIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAE 215 (362)
T ss_dssp HH--------------------HHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHH
T ss_pred HH--------------------HHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHH
Confidence 11 111223333 45555555555544333222 222 3555555555555432
Q ss_pred cchhhhc-ccCCCEEEccCCcCCcccc----hhccCCCCCCEEEccCCcCccc-------cccccccCCCCCEEECcCCc
Q 044615 282 IPNKIEK-LIHLSELDLSHNIFREEIP----SQICSMQSLEKLNLSHNNLSGS-------IPRCFEEMHWLSCIDISYNA 349 (571)
Q Consensus 282 ~~~~~~~-l~~L~~L~Ls~n~l~~~~~----~~~~~l~~L~~L~Ls~n~l~~~-------~p~~~~~l~~L~~L~ls~N~ 349 (571)
++..+.. .++|+.|+|++|.+.+..+ ..+..+++|+.|+|++|.+.+. ++..+..++.|+.||+++|+
T Consensus 216 l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~ 295 (362)
T 3goz_A 216 LAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKE 295 (362)
T ss_dssp HHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCB
T ss_pred HHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCc
Confidence 2223333 2355555555555554332 2234455666666666653322 22244455566666666666
Q ss_pred Cccc
Q 044615 350 LQGL 353 (571)
Q Consensus 350 l~~~ 353 (571)
+...
T Consensus 296 l~~~ 299 (362)
T 3goz_A 296 IHPS 299 (362)
T ss_dssp CCGG
T ss_pred CCCc
Confidence 5543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.92 E-value=8.5e-26 Score=229.00 Aligned_cols=257 Identities=19% Similarity=0.163 Sum_probs=162.0
Q ss_pred EEEccCCccc------cCCCCccceeecccccccCCCCCCCccccccccCCC-CCCEEecccCcCcccccccccCC----
Q 044615 52 DTSISFDELH------EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMK-SLSDLQLSENILNGSIPLALGNL---- 120 (571)
Q Consensus 52 ~l~l~~n~l~------~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~-~L~~L~L~~n~i~~~~~~~~~~l---- 120 (571)
+.+++.|.++ ......|+.|+|++|.+++... ..+...+.+++ +|++|+|++|.+++..+..+..+
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~---~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~ 78 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSIST---VELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAI 78 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCH---HHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTS
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHH---HHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhcc
Confidence 4677888777 4455569999999999987110 01126778888 99999999999998777777765
Q ss_pred -CCCCEEEcccCcCccccccccc----CC-CCCCeeecccCcCcccCCccc----cC-CCCCCEEEccCCCCCccCChh-
Q 044615 121 -TNLVVLDLSTNKLSGSIPLSFA----NL-TSLSILYLYENSLCDSIPKEI----GN-MNSLSILDLSSNKLNGSIPLS- 188 (571)
Q Consensus 121 -~~L~~L~L~~n~i~~~~~~~~~----~l-~~L~~L~L~~n~l~~~~~~~l----~~-l~~L~~L~L~~n~l~~~~p~~- 188 (571)
++|++|+|++|.+++..+..+. .+ ++|++|+|++|.+++..+..+ .. .++|++|++++|+++...+..
T Consensus 79 ~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l 158 (362)
T 3goz_A 79 PANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDEL 158 (362)
T ss_dssp CTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHH
T ss_pred CCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHH
Confidence 9999999999999877766544 44 899999999999987666544 34 369999999999998543333
Q ss_pred ---hhhccCCCcEEEccCCcccccCCccc----cCC-CCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccch
Q 044615 189 ---LANLTNSLKVLYLSSNHIVGEIPLGH----GML-SSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPE 260 (571)
Q Consensus 189 ---~~~l~~~L~~L~l~~n~~~~~~~~~~----~~l-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 260 (571)
+...+.+|+.|++++|.+++..+..+ ... ++|+.|++++|.+++.... .++.
T Consensus 159 ~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~--------------------~l~~ 218 (362)
T 3goz_A 159 IQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYA--------------------ELAY 218 (362)
T ss_dssp HHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHH--------------------HHHH
T ss_pred HHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHH--------------------HHHH
Confidence 33333347777777777665443222 222 3555555555555432111 1222
Q ss_pred hhcc-CCCCCEEEcCCccCccCcc----hhhhcccCCCEEEccCCcCCcc-------cchhccCCCCCCEEEccCCcCcc
Q 044615 261 SLSN-LVKLHYLNLSNNQFSQKIP----NKIEKLIHLSELDLSHNIFREE-------IPSQICSMQSLEKLNLSHNNLSG 328 (571)
Q Consensus 261 ~l~~-l~~L~~L~Ls~n~l~~~~~----~~~~~l~~L~~L~Ls~n~l~~~-------~~~~~~~l~~L~~L~Ls~n~l~~ 328 (571)
.+.. .++|+.|++++|.+++..+ ..+..+++|+.|++++|.+.+. ++..+..+++|+.|++++|++..
T Consensus 219 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~ 298 (362)
T 3goz_A 219 IFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP 298 (362)
T ss_dssp HHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCG
T ss_pred HHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCC
Confidence 3333 2345555555555544322 1223345555555555553222 22344556666777777777665
Q ss_pred ccc
Q 044615 329 SIP 331 (571)
Q Consensus 329 ~~p 331 (571)
..+
T Consensus 299 ~~~ 301 (362)
T 3goz_A 299 SHS 301 (362)
T ss_dssp GGC
T ss_pred cch
Confidence 433
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-23 Score=206.42 Aligned_cols=204 Identities=27% Similarity=0.263 Sum_probs=120.1
Q ss_pred cccCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCC
Q 044615 92 EIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSL 171 (571)
Q Consensus 92 ~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L 171 (571)
.++++++++++++++|.++ .+|..+. ++++.|+|++|.+++..+..|.++++|++|+|++|.+++..+ ...+++|
T Consensus 5 ~~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L 79 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVL 79 (290)
T ss_dssp EEECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTC
T ss_pred cccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcC
Confidence 3566777888888888877 4555443 577888888888877777777788888888888887765432 2566777
Q ss_pred CEEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEccc
Q 044615 172 SILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSA 251 (571)
Q Consensus 172 ~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~ 251 (571)
++|++++|++. .+|..+..++. |+.|++++|++++..+..|. .+++|+.|++++
T Consensus 80 ~~L~Ls~N~l~-~l~~~~~~l~~-L~~L~l~~N~l~~l~~~~~~------------------------~l~~L~~L~L~~ 133 (290)
T 1p9a_G 80 GTLDLSHNQLQ-SLPLLGQTLPA-LTVLDVSFNRLTSLPLGALR------------------------GLGELQELYLKG 133 (290)
T ss_dssp CEEECCSSCCS-SCCCCTTTCTT-CCEEECCSSCCCCCCSSTTT------------------------TCTTCCEEECTT
T ss_pred CEEECCCCcCC-cCchhhccCCC-CCEEECCCCcCcccCHHHHc------------------------CCCCCCEEECCC
Confidence 77777777665 44544444443 55555555555443334444 444444444444
Q ss_pred CccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCc
Q 044615 252 NTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLS 327 (571)
Q Consensus 252 n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~ 327 (571)
|.+++..+..|..+++|+.|++++|++++..+..+..+++|+.|+|++|+++. +|..+..+++|+.|+|++|++.
T Consensus 134 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~-ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCCCSEEECCSCCBC
T ss_pred CCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCc-cChhhcccccCCeEEeCCCCcc
Confidence 44444434444445555555555555544444444455555555555555542 4444555556666666666654
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=6.3e-24 Score=207.95 Aligned_cols=204 Identities=25% Similarity=0.253 Sum_probs=120.6
Q ss_pred ccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCC
Q 044615 141 FANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSL 220 (571)
Q Consensus 141 ~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L 220 (571)
++++++|+++++++|.++. +|..+. ++++.|++++|++++..+..+..++. |+.|++++|.+++..+. +.+++|
T Consensus 6 ~~~l~~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~n~l~~~~~~--~~l~~L 79 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTR-LTQLNLDRAELTKLQVD--GTLPVL 79 (290)
T ss_dssp EECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTT-CCEEECTTSCCCEEECC--SCCTTC
T ss_pred ccccCCccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCC-CCEEECCCCccCcccCC--CCCCcC
Confidence 5566777777777777753 444432 56777777777776555556666654 77777777766643322 455666
Q ss_pred cEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCC
Q 044615 221 IQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHN 300 (571)
Q Consensus 221 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n 300 (571)
+.|++++|++. .+|..+..+++|+.|++++|.+++..+..|.++++|+.|++++|++++..+..|..+++|+.|+|++|
T Consensus 80 ~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 158 (290)
T 1p9a_G 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN 158 (290)
T ss_dssp CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred CEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCC
Confidence 66666666665 34445556666666666666665555555666666666666666665555555555556666666666
Q ss_pred cCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCcc
Q 044615 301 IFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQG 352 (571)
Q Consensus 301 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 352 (571)
++++..+..|..+++|+.|+|++|+++ .+|..+.....|+.+++++|++.+
T Consensus 159 ~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 159 NLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred cCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 665544444555556666666666555 344444445555555555555543
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-25 Score=230.23 Aligned_cols=254 Identities=20% Similarity=0.216 Sum_probs=176.3
Q ss_pred CCEEecccCcCcccccccccCCCCCCEEEcccCcCccccc----ccccCCCCCCeeecccCcC---cccCCccc------
Q 044615 99 LSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIP----LSFANLTSLSILYLYENSL---CDSIPKEI------ 165 (571)
Q Consensus 99 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~----~~~~~l~~L~~L~L~~n~l---~~~~~~~l------ 165 (571)
|+...++...+. .++..+..+++|++|+|++|.++...+ ..+..+++|++|+|++|.+ .+.+|..+
T Consensus 11 L~~~~l~~~~~~-~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~ 89 (386)
T 2ca6_A 11 LKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQA 89 (386)
T ss_dssp CEESSCCSHHHH-TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHH
T ss_pred cccCCCCHHHHH-HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHH
Confidence 333333333333 455667777888888888888876533 3366778888888877533 33444433
Q ss_pred -cCCCCCCEEEccCCCCCc----cCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhC
Q 044615 166 -GNMNSLSILDLSSNKLNG----SIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGS 240 (571)
Q Consensus 166 -~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 240 (571)
..+++|++|+|++|.+.. .+|..+..+++ |+.|++++|.++...+.. ++..+..
T Consensus 90 l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~-L~~L~L~~n~l~~~~~~~--------------------l~~~l~~ 148 (386)
T 2ca6_A 90 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP-LEHLYLHNNGLGPQAGAK--------------------IARALQE 148 (386)
T ss_dssp HTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTT-CCEEECCSSCCHHHHHHH--------------------HHHHHHH
T ss_pred HhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCC-CCEEECcCCCCCHHHHHH--------------------HHHHHHH
Confidence 566777777777776664 23444444443 555555555443221111 1122233
Q ss_pred C---------CCCCEEEcccCccc-cccc---hhhccCCCCCEEEcCCccCcc-----CcchhhhcccCCCEEEccCCcC
Q 044615 241 L---------IQLEYLDLSANTFH-KSIP---ESLSNLVKLHYLNLSNNQFSQ-----KIPNKIEKLIHLSELDLSHNIF 302 (571)
Q Consensus 241 l---------~~L~~L~L~~n~l~-~~~~---~~l~~l~~L~~L~Ls~n~l~~-----~~~~~~~~l~~L~~L~Ls~n~l 302 (571)
+ ++|+.|++++|.++ ..++ ..+..+++|+.|++++|.++. ..+..+..+++|+.|+|++|.+
T Consensus 149 l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l 228 (386)
T 2ca6_A 149 LAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF 228 (386)
T ss_dssp HHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCC
T ss_pred HhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCC
Confidence 3 89999999999997 3344 467789999999999999973 3344788899999999999999
Q ss_pred C----cccchhccCCCCCCEEEccCCcCccc----ccccccc--CCCCCEEECcCCcCcc----cCCC-C-CccCCCCcc
Q 044615 303 R----EEIPSQICSMQSLEKLNLSHNNLSGS----IPRCFEE--MHWLSCIDISYNALQG----LIPN-S-TAFRDAPML 366 (571)
Q Consensus 303 ~----~~~~~~~~~l~~L~~L~Ls~n~l~~~----~p~~~~~--l~~L~~L~ls~N~l~~----~~~~-~-~~~~~~~~l 366 (571)
+ ..+|..+..+++|+.|+|++|.+++. +|..+.. +++|+.|++++|.+++ .+|. . ..++.+..+
T Consensus 229 ~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L 308 (386)
T 2ca6_A 229 THLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL 308 (386)
T ss_dssp HHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEE
T ss_pred CcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEE
Confidence 6 56788899999999999999999876 5666644 8999999999999998 2443 2 236888999
Q ss_pred cccCCcCC
Q 044615 367 ALQGNKRL 374 (571)
Q Consensus 367 ~l~~n~~~ 374 (571)
.+.+|+..
T Consensus 309 ~l~~N~l~ 316 (386)
T 2ca6_A 309 ELNGNRFS 316 (386)
T ss_dssp ECTTSBSC
T ss_pred EccCCcCC
Confidence 99999753
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-23 Score=198.99 Aligned_cols=185 Identities=19% Similarity=0.225 Sum_probs=117.7
Q ss_pred cccccccCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCc-CcccccccccCCCCCCeeeccc-CcCcccCCccc
Q 044615 88 SIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNK-LSGSIPLSFANLTSLSILYLYE-NSLCDSIPKEI 165 (571)
Q Consensus 88 ~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~-i~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~l 165 (571)
.+|. +. ++|++|++++|.+++..+..|.++++|++|++++|. ++...+..|.++++|++|++++ |.+....+..|
T Consensus 25 ~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f 101 (239)
T 2xwt_C 25 RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDAL 101 (239)
T ss_dssp SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSE
T ss_pred ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHh
Confidence 4666 43 478888888888887666678888888888888886 7766666788888888888887 88876666778
Q ss_pred cCCCCCCEEEccCCCCCccCChhhhhccCCCc---EEEccCC-cccccCCccccCCCCCc-EEeCccCcCcCCCChhhhC
Q 044615 166 GNMNSLSILDLSSNKLNGSIPLSLANLTNSLK---VLYLSSN-HIVGEIPLGHGMLSSLI-QLTLNNNELSGQLSPELGS 240 (571)
Q Consensus 166 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~---~L~l~~n-~~~~~~~~~~~~l~~L~-~L~l~~n~l~~~~~~~~~~ 240 (571)
..+++|++|++++|++++ +|. +..+.. |+ .|++++| .+++..+..+..+++|+ .|++++|+++...+..+..
T Consensus 102 ~~l~~L~~L~l~~n~l~~-lp~-~~~l~~-L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~ 178 (239)
T 2xwt_C 102 KELPLLKFLGIFNTGLKM-FPD-LTKVYS-TDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG 178 (239)
T ss_dssp ECCTTCCEEEEEEECCCS-CCC-CTTCCB-CCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT
T ss_pred CCCCCCCEEeCCCCCCcc-ccc-cccccc-cccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC
Confidence 888888888888888774 554 555443 55 6666666 66554444455555555 5555555555322222222
Q ss_pred CCCCCEEEcccCc-cccccchhhccC-CCCCEEEcCCccCc
Q 044615 241 LIQLEYLDLSANT-FHKSIPESLSNL-VKLHYLNLSNNQFS 279 (571)
Q Consensus 241 l~~L~~L~L~~n~-l~~~~~~~l~~l-~~L~~L~Ls~n~l~ 279 (571)
++|+.|++++|. ++...+..|.++ ++|+.|++++|+++
T Consensus 179 -~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~ 218 (239)
T 2xwt_C 179 -TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218 (239)
T ss_dssp -CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCC
T ss_pred -CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccc
Confidence 445555555552 443333444444 44444444444444
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.90 E-value=9.3e-25 Score=219.16 Aligned_cols=250 Identities=16% Similarity=0.180 Sum_probs=142.8
Q ss_pred CCEEecccCcCcccccccccCC--CCCCEEEcccCcCcccccccccCCCCCCeeecccCcCccc-CCccccCCCCCCEEE
Q 044615 99 LSDLQLSENILNGSIPLALGNL--TNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDS-IPKEIGNMNSLSILD 175 (571)
Q Consensus 99 L~~L~L~~n~i~~~~~~~~~~l--~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~ 175 (571)
++.+++++|.+. +..+..+ ++++.|++++|.+.+..+. +..+++|++|++++|.+.+. +|..+..+++|++|+
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~ 124 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 124 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence 444555544443 2233333 4455555555555443332 33445555555555554433 344444555555555
Q ss_pred ccCCCCCccCChhhhhccCCCcEEEccCC-ccccc-CCccccCCCCCcEEeCccC-cCcCC-CChhhhCCC-CCCEEEcc
Q 044615 176 LSSNKLNGSIPLSLANLTNSLKVLYLSSN-HIVGE-IPLGHGMLSSLIQLTLNNN-ELSGQ-LSPELGSLI-QLEYLDLS 250 (571)
Q Consensus 176 L~~n~l~~~~p~~~~~l~~~L~~L~l~~n-~~~~~-~~~~~~~l~~L~~L~l~~n-~l~~~-~~~~~~~l~-~L~~L~L~ 250 (571)
+++|++++..+..+..+++ |+.|++++| .+++. ++..+..+++|++|++++| .+++. ++..+..++ +|+.|+++
T Consensus 125 L~~~~l~~~~~~~l~~~~~-L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~ 203 (336)
T 2ast_B 125 LEGLRLSDPIVNTLAKNSN-LVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS 203 (336)
T ss_dssp CTTCBCCHHHHHHHTTCTT-CSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred CcCcccCHHHHHHHhcCCC-CCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeC
Confidence 5555554444444444443 555555555 34321 3333445556666666666 55543 355566777 77777777
Q ss_pred cC--ccc-cccchhhccCCCCCEEEcCCcc-CccCcchhhhcccCCCEEEccCCc-CCcccchhccCCCCCCEEEccCCc
Q 044615 251 AN--TFH-KSIPESLSNLVKLHYLNLSNNQ-FSQKIPNKIEKLIHLSELDLSHNI-FREEIPSQICSMQSLEKLNLSHNN 325 (571)
Q Consensus 251 ~n--~l~-~~~~~~l~~l~~L~~L~Ls~n~-l~~~~~~~~~~l~~L~~L~Ls~n~-l~~~~~~~~~~l~~L~~L~Ls~n~ 325 (571)
+| .++ +.++..+..+++|+.|++++|. +++..+..+..+++|+.|++++|. +.......+..+++|+.|++++|
T Consensus 204 ~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~- 282 (336)
T 2ast_B 204 GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI- 282 (336)
T ss_dssp SCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-
T ss_pred CCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-
Confidence 77 344 3456666778888888888887 666666677778888888888884 33222235777888888888888
Q ss_pred CccccccccccC-CCCCEEECcCCcCcccCCCC
Q 044615 326 LSGSIPRCFEEM-HWLSCIDISYNALQGLIPNS 357 (571)
Q Consensus 326 l~~~~p~~~~~l-~~L~~L~ls~N~l~~~~~~~ 357 (571)
++.. .+..+ ..+..|++++|++++..|..
T Consensus 283 i~~~---~~~~l~~~l~~L~l~~n~l~~~~~~~ 312 (336)
T 2ast_B 283 VPDG---TLQLLKEALPHLQINCSHFTTIARPT 312 (336)
T ss_dssp SCTT---CHHHHHHHSTTSEESCCCSCCTTCSS
T ss_pred cCHH---HHHHHHhhCcceEEecccCccccCCc
Confidence 4432 23322 23555668888888877753
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1e-23 Score=208.89 Aligned_cols=203 Identities=22% Similarity=0.251 Sum_probs=135.6
Q ss_pred CCCCCEEecccCcCcccccccc--cCCCCCCEEEcccCcCccccc----ccccCCCCCCeeecccCcCcccCCccccCCC
Q 044615 96 MKSLSDLQLSENILNGSIPLAL--GNLTNLVVLDLSTNKLSGSIP----LSFANLTSLSILYLYENSLCDSIPKEIGNMN 169 (571)
Q Consensus 96 l~~L~~L~L~~n~i~~~~~~~~--~~l~~L~~L~L~~n~i~~~~~----~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~ 169 (571)
+++|++|+|++|.+.+..|..+ ..+++|++|+|++|.+++..+ ..+..+++|++|+|++|.+.+..|..+..++
T Consensus 90 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~ 169 (310)
T 4glp_A 90 YSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFP 169 (310)
T ss_dssp HSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCT
T ss_pred cCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCC
Confidence 3557777777777776666666 667777777777777765433 3345677777777777777666666777777
Q ss_pred CCCEEEccCCCCCcc--C--ChhhhhccCCCcEEEccCCcccccCC--c-cccCCCCCcEEeCccCcCcCCCChhhhCC-
Q 044615 170 SLSILDLSSNKLNGS--I--PLSLANLTNSLKVLYLSSNHIVGEIP--L-GHGMLSSLIQLTLNNNELSGQLSPELGSL- 241 (571)
Q Consensus 170 ~L~~L~L~~n~l~~~--~--p~~~~~l~~~L~~L~l~~n~~~~~~~--~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~l- 241 (571)
+|++|++++|++.+. + +..+..+++ |++|++++|.++...+ . .+..+++|++|++++|++.+..|..+..+
T Consensus 170 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~-L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~ 248 (310)
T 4glp_A 170 ALTSLDLSDNPGLGERGLMAALCPHKFPA-IQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCM 248 (310)
T ss_dssp TCCEEECCSCTTCHHHHHHTTSCTTSSCC-CCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCC
T ss_pred CCCEEECCCCCCccchhhhHHHhhhcCCC-CCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhcc
Confidence 777777777776531 1 111234443 7777777777752211 1 23556777777777777777666666555
Q ss_pred --CCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCc
Q 044615 242 --IQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFRE 304 (571)
Q Consensus 242 --~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 304 (571)
++|+.|++++|.++ .+|..+. ++|+.|++++|++++. |. +..+++|+.|++++|.++.
T Consensus 249 ~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 249 WSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred CcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 57888888888887 4555553 6888888888888754 32 5677888888888888764
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.6e-24 Score=215.94 Aligned_cols=235 Identities=17% Similarity=0.176 Sum_probs=113.3
Q ss_pred CCCCEEecccCcCcccccccccCCCCCCEEEcccCcCccc-ccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEE
Q 044615 97 KSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGS-IPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILD 175 (571)
Q Consensus 97 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 175 (571)
++++.|++++|.+.+..+. +..+++|++|++++|.+++. ++..+..+++|++|++++|.+.+..+..++.+++|++|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 3444444444444433322 23344444444444444432 344444444444444444444444444444444555555
Q ss_pred ccCC-CCCcc-CChhhhhccCCCcEEEccCC-ccccc-CCccccCCC-CCcEEeCccC--cCc-CCCChhhhCCCCCCEE
Q 044615 176 LSSN-KLNGS-IPLSLANLTNSLKVLYLSSN-HIVGE-IPLGHGMLS-SLIQLTLNNN--ELS-GQLSPELGSLIQLEYL 247 (571)
Q Consensus 176 L~~n-~l~~~-~p~~~~~l~~~L~~L~l~~n-~~~~~-~~~~~~~l~-~L~~L~l~~n--~l~-~~~~~~~~~l~~L~~L 247 (571)
+++| .+++. ++..+..+++ |+.|++++| .+++. ++..+..++ +|++|++++| .++ +.++..+..+++|+.|
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~-L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L 227 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSR-LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 227 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTT-CCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEE
T ss_pred CCCCCCCCHHHHHHHHhcCCC-CCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEE
Confidence 5444 33321 2333333333 555555555 44432 233344444 5555555555 232 2334455556666666
Q ss_pred EcccCc-cccccchhhccCCCCCEEEcCCcc-CccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCc
Q 044615 248 DLSANT-FHKSIPESLSNLVKLHYLNLSNNQ-FSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNN 325 (571)
Q Consensus 248 ~L~~n~-l~~~~~~~l~~l~~L~~L~Ls~n~-l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 325 (571)
++++|. +++..+..+..+++|+.|++++|. ++......+..+++|+.|++++| +.......+. .++..|++++|+
T Consensus 228 ~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~~~~~~~l~--~~l~~L~l~~n~ 304 (336)
T 2ast_B 228 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLK--EALPHLQINCSH 304 (336)
T ss_dssp ECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHH--HHSTTSEESCCC
T ss_pred eCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cCHHHHHHHH--hhCcceEEeccc
Confidence 666666 554555566666666666666663 22222224555666666666666 3322211221 224445567777
Q ss_pred Ccccccccccc
Q 044615 326 LSGSIPRCFEE 336 (571)
Q Consensus 326 l~~~~p~~~~~ 336 (571)
+++..|..+..
T Consensus 305 l~~~~~~~~~~ 315 (336)
T 2ast_B 305 FTTIARPTIGN 315 (336)
T ss_dssp SCCTTCSSCSS
T ss_pred CccccCCcccc
Confidence 77666665543
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=5.3e-23 Score=203.77 Aligned_cols=229 Identities=19% Similarity=0.182 Sum_probs=124.9
Q ss_pred CCCCEEecccCcCcccccc---cccCCCCCCEEEcccCcCcccccccc--cCCCCCCeeecccCcCcccCC----ccccC
Q 044615 97 KSLSDLQLSENILNGSIPL---ALGNLTNLVVLDLSTNKLSGSIPLSF--ANLTSLSILYLYENSLCDSIP----KEIGN 167 (571)
Q Consensus 97 ~~L~~L~L~~n~i~~~~~~---~~~~l~~L~~L~L~~n~i~~~~~~~~--~~l~~L~~L~L~~n~l~~~~~----~~l~~ 167 (571)
..++.+.+.++.++...-. .+..+++|++|++++|.+.+..|..+ ..+++|++|+|++|.+.+..+ ..+..
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 3466777777665422111 11223557777777777776666666 667777777777777765433 22345
Q ss_pred CCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEE
Q 044615 168 MNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYL 247 (571)
Q Consensus 168 l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 247 (571)
+++|++|++++|++.+..|..+..+++ |+.|++++|++.+... -..+..+..+++|+.|
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~~--------------------~~~~~~~~~l~~L~~L 202 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPA-LTSLDLSDNPGLGERG--------------------LMAALCPHKFPAIQNL 202 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTT-CCEEECCSCTTCHHHH--------------------HHTTSCTTSSCCCCSC
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCC-CCEEECCCCCCccchh--------------------hhHHHhhhcCCCCCEE
Confidence 566666666666665444444444443 5555555555432100 0001112345555555
Q ss_pred EcccCcccccc--ch-hhccCCCCCEEEcCCccCccCcchhhhcc---cCCCEEEccCCcCCcccchhccCCCCCCEEEc
Q 044615 248 DLSANTFHKSI--PE-SLSNLVKLHYLNLSNNQFSQKIPNKIEKL---IHLSELDLSHNIFREEIPSQICSMQSLEKLNL 321 (571)
Q Consensus 248 ~L~~n~l~~~~--~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l---~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 321 (571)
++++|.++... +. .+..+++|++|++++|.+++..|..+..+ ++|+.|+|++|+++. +|..+. ++|+.|+|
T Consensus 203 ~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~-lp~~~~--~~L~~L~L 279 (310)
T 4glp_A 203 ALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQ-VPKGLP--AKLRVLDL 279 (310)
T ss_dssp BCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCS-CCSCCC--SCCSCEEC
T ss_pred ECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCc-hhhhhc--CCCCEEEC
Confidence 55555553211 11 23455666666666666655545444444 466666666666653 444443 56777777
Q ss_pred cCCcCccccccccccCCCCCEEECcCCcCc
Q 044615 322 SHNNLSGSIPRCFEEMHWLSCIDISYNALQ 351 (571)
Q Consensus 322 s~n~l~~~~p~~~~~l~~L~~L~ls~N~l~ 351 (571)
++|++++. |. +..++.|+.|++++|+++
T Consensus 280 s~N~l~~~-~~-~~~l~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 280 SSNRLNRA-PQ-PDELPEVDNLTLDGNPFL 307 (310)
T ss_dssp CSCCCCSC-CC-TTSCCCCSCEECSSTTTS
T ss_pred CCCcCCCC-ch-hhhCCCccEEECcCCCCC
Confidence 77777653 22 456667777777777665
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=6.2e-23 Score=195.32 Aligned_cols=196 Identities=17% Similarity=0.190 Sum_probs=118.4
Q ss_pred CCCEEEcccCcCcccccccccCCCCCCeeecccCc-CcccCCccccCCCCCCEEEccC-CCCCccCChhhhhccCCCcEE
Q 044615 122 NLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENS-LCDSIPKEIGNMNSLSILDLSS-NKLNGSIPLSLANLTNSLKVL 199 (571)
Q Consensus 122 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~l~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~~L~~L 199 (571)
+|++|++++|++++..+..|.++++|++|++++|. +....+..|..+++|++|++++ |++++..+..|..+++ |+.|
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~-L~~L 110 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPL-LKFL 110 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTT-CCEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCC-CCEE
Confidence 67777777777776666677777777777777775 6655555677777777777776 6666433344444443 5555
Q ss_pred EccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCC---EEEcccC-ccccccchhhccCCCCC-EEEcC
Q 044615 200 YLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLE---YLDLSAN-TFHKSIPESLSNLVKLH-YLNLS 274 (571)
Q Consensus 200 ~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~---~L~L~~n-~l~~~~~~~l~~l~~L~-~L~Ls 274 (571)
++++|.+++ +|. +..+++|+ .|++++| .++...+..|.++++|+ .|+++
T Consensus 111 ~l~~n~l~~-lp~-------------------------~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~ 164 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-------------------------LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLY 164 (239)
T ss_dssp EEEEECCCS-CCC-------------------------CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECC
T ss_pred eCCCCCCcc-ccc-------------------------cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcC
Confidence 555555543 222 44444444 5566655 55554445556666666 66666
Q ss_pred CccCccCcchhhhcccCCCEEEccCCc-CCcccchhccCC-CCCCEEEccCCcCccccccccccCCCCCEEECcCC
Q 044615 275 NNQFSQKIPNKIEKLIHLSELDLSHNI-FREEIPSQICSM-QSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYN 348 (571)
Q Consensus 275 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~-l~~~~~~~~~~l-~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N 348 (571)
+|.++...+..+.. ++|+.|++++|+ +++..+..|..+ ++|+.|++++|++++..+. .++.|+.|+++++
T Consensus 165 ~n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 165 NNGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT 236 (239)
T ss_dssp SCCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred CCCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence 66665333333333 566666666663 665555566666 6777777777777643332 4556666666654
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=4.3e-22 Score=190.88 Aligned_cols=179 Identities=22% Similarity=0.253 Sum_probs=114.8
Q ss_pred CCEEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcc
Q 044615 171 LSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLS 250 (571)
Q Consensus 171 L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~ 250 (571)
.++++++++.++ .+|..+. .+++.|++++|.+++..+..+..+++|++|++++|.+++..+..|..+++|+.|+++
T Consensus 16 ~~~l~~~~~~l~-~~p~~~~---~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 16 KKEVDCQGKSLD-SVPSGIP---ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GTEEECTTCCCS-SCCSCCC---TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CeEEecCCCCcc-ccCCCCC---CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 344555555554 3443332 235566666666655555556666666666666666666555566666666666666
Q ss_pred cCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCcccc
Q 044615 251 ANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSI 330 (571)
Q Consensus 251 ~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 330 (571)
+|.+++..+..+..+++|+.|++++|.+++..+..+..+++|+.|+|++|.+++..+..+..+++|+.|+|++|++++..
T Consensus 92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 171 (251)
T 3m19_A 92 NNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVP 171 (251)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccC
Confidence 66666555566666677777777777776555555666777777777777776655556677777777777777777666
Q ss_pred ccccccCCCCCEEECcCCcCccc
Q 044615 331 PRCFEEMHWLSCIDISYNALQGL 353 (571)
Q Consensus 331 p~~~~~l~~L~~L~ls~N~l~~~ 353 (571)
+..|..+++|+.|++++|++++.
T Consensus 172 ~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 172 HGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TTTTTTCTTCCEEECCSCCBCTT
T ss_pred HHHHhCCCCCCEEEeeCCceeCC
Confidence 66677777777777777777655
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=8.1e-22 Score=188.99 Aligned_cols=179 Identities=26% Similarity=0.308 Sum_probs=108.6
Q ss_pred CCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEcc
Q 044615 98 SLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLS 177 (571)
Q Consensus 98 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~ 177 (571)
..++++++++.++ .+|..+. ++|+.|+|++|.+++..+..|.++++|++|+|++|.+.+..+..|..+++|++|+++
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 4566777777666 4554443 467777777777766666667777777777777777766666666667777777777
Q ss_pred CCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccc
Q 044615 178 SNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKS 257 (571)
Q Consensus 178 ~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 257 (571)
+|++++..+..+..+++ |+.|++++|.+++..+..+..+++|+.|++++|++++..+..|..+++|+.|+|++|.+++.
T Consensus 92 ~n~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 170 (251)
T 3m19_A 92 NNQLASLPLGVFDHLTQ-LDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSV 170 (251)
T ss_dssp TSCCCCCCTTTTTTCTT-CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCcccccChhHhcccCC-CCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCcc
Confidence 77666444444444443 66666666666544444455555666666666666554444555566666666666665555
Q ss_pred cchhhccCCCCCEEEcCCccCcc
Q 044615 258 IPESLSNLVKLHYLNLSNNQFSQ 280 (571)
Q Consensus 258 ~~~~l~~l~~L~~L~Ls~n~l~~ 280 (571)
.+..+..+++|+.|++++|.+..
T Consensus 171 ~~~~~~~l~~L~~L~l~~N~~~c 193 (251)
T 3m19_A 171 PHGAFDRLGKLQTITLFGNQFDC 193 (251)
T ss_dssp CTTTTTTCTTCCEEECCSCCBCT
T ss_pred CHHHHhCCCCCCEEEeeCCceeC
Confidence 44455555555555555555543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=3.4e-22 Score=197.56 Aligned_cols=191 Identities=27% Similarity=0.404 Sum_probs=89.6
Q ss_pred CCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEE
Q 044615 120 LTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVL 199 (571)
Q Consensus 120 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L 199 (571)
+++|++|++++|.++. ++ .+..+++|++|++++|.+.+..+ +..+++|++|++++|++.+ ++ .+..+++ |+.|
T Consensus 40 l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~-L~~L 112 (308)
T 1h6u_A 40 LDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQS-IKTL 112 (308)
T ss_dssp HHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTT-CCEE
T ss_pred cCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcCCCC-CCEE
Confidence 3444444444444432 22 24444444444444444433221 4444444444444444432 11 2333332 4444
Q ss_pred EccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCc
Q 044615 200 YLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFS 279 (571)
Q Consensus 200 ~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~ 279 (571)
++++|.+++. + .+..+++|+.|++++|.+++..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|.++
T Consensus 113 ~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~ 186 (308)
T 1h6u_A 113 DLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS 186 (308)
T ss_dssp ECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred ECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccC
Confidence 4444444321 1 13444455555555555543222 4555555566665555553322 555555666666666555
Q ss_pred cCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCc
Q 044615 280 QKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLS 327 (571)
Q Consensus 280 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~ 327 (571)
+..+ +..+++|+.|++++|++.+..+ +..+++|+.|++++|+++
T Consensus 187 ~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~ 230 (308)
T 1h6u_A 187 DISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT 230 (308)
T ss_dssp CCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEE
T ss_pred cChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeee
Confidence 4322 4555555555555555554332 555555666666555554
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=3.3e-22 Score=197.70 Aligned_cols=194 Identities=29% Similarity=0.420 Sum_probs=126.2
Q ss_pred cCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCE
Q 044615 94 GNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSI 173 (571)
Q Consensus 94 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 173 (571)
..+++|++|++++|.+.. ++ .+..+++|++|+|++|.+++..+ +..+++|++|++++|.+.+. ..+..+++|++
T Consensus 38 ~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~ 111 (308)
T 1h6u_A 38 ADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKT 111 (308)
T ss_dssp HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCE
T ss_pred HHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCE
Confidence 345666666666666653 33 45666666666666666664333 66666666666666666542 24666666666
Q ss_pred EEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCc
Q 044615 174 LDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANT 253 (571)
Q Consensus 174 L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 253 (571)
|++++|++++ ++. +..+++ |+.|++++|.+++..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|.
T Consensus 112 L~l~~n~l~~-~~~-l~~l~~-L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~ 184 (308)
T 1h6u_A 112 LDLTSTQITD-VTP-LAGLSN-LQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNK 184 (308)
T ss_dssp EECTTSCCCC-CGG-GTTCTT-CCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred EECCCCCCCC-chh-hcCCCC-CCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCc
Confidence 6666666663 332 555554 6777777776664333 5666777777777777765332 6777777888887777
Q ss_pred cccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCc
Q 044615 254 FHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFRE 304 (571)
Q Consensus 254 l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 304 (571)
+++..+ +..+++|+.|++++|++++..+ +..+++|+.|++++|.+++
T Consensus 185 l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 185 ISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred cCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence 765433 6777788888888888775543 6777888888888887765
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.88 E-value=7.3e-24 Score=229.55 Aligned_cols=319 Identities=13% Similarity=0.042 Sum_probs=168.8
Q ss_pred CCCEEEccCCc-cc-------cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCc----cccccc
Q 044615 49 QARDTSISFDE-LH-------EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILN----GSIPLA 116 (571)
Q Consensus 49 ~l~~l~l~~n~-l~-------~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~----~~~~~~ 116 (571)
+|+.|+|+.+. +. ...+++|++|+|++|.+++.... .++..+.++++|++|++++|.++ ..++..
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~---~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~ 215 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGK---WLHELAQHNTSLEVLNFYMTEFAKISPKDLETI 215 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSH---HHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchh---HHHHHHhcCCCccEEEeeccCCCccCHHHHHHH
Confidence 47777777765 22 23567777788877777652110 13334456677777777777765 234444
Q ss_pred ccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCc--------------------------ccCCccccCCCC
Q 044615 117 LGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLC--------------------------DSIPKEIGNMNS 170 (571)
Q Consensus 117 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~--------------------------~~~~~~l~~l~~ 170 (571)
+.++++|++|++++|.+.+ +|..+.++++|++|+++.+... ..+|..+..+++
T Consensus 216 ~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~l~~~~~~~~~ 294 (592)
T 3ogk_B 216 ARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQ 294 (592)
T ss_dssp HHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTTTGGGGGGGGGG
T ss_pred HhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchhHHHHHHhhcCC
Confidence 5566777777777777664 4455666666666666532211 123333344445
Q ss_pred CCEEEccCCCCCccCChh-hhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCcc-----------CcCcCCC-Chh
Q 044615 171 LSILDLSSNKLNGSIPLS-LANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNN-----------NELSGQL-SPE 237 (571)
Q Consensus 171 L~~L~L~~n~l~~~~p~~-~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~-----------n~l~~~~-~~~ 237 (571)
|++|++++|.+++..... +..+++ |+.|+++++.....++.....+++|+.|++++ |.+++.. +..
T Consensus 295 L~~L~Ls~~~l~~~~~~~~~~~~~~-L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l 373 (592)
T 3ogk_B 295 IRKLDLLYALLETEDHCTLIQKCPN-LEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIAL 373 (592)
T ss_dssp CCEEEETTCCCCHHHHHHHHTTCTT-CCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHH
T ss_pred CcEEecCCCcCCHHHHHHHHHhCcC-CCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHH
Confidence 555555555543222111 222332 55555542211111122223345566666652 3333221 112
Q ss_pred hhCCCCCCEEEcccCccccccchhhcc-CCCCCEEEcC----CccCccC-----cchhhhcccCCCEEEccCCc--CCcc
Q 044615 238 LGSLIQLEYLDLSANTFHKSIPESLSN-LVKLHYLNLS----NNQFSQK-----IPNKIEKLIHLSELDLSHNI--FREE 305 (571)
Q Consensus 238 ~~~l~~L~~L~L~~n~l~~~~~~~l~~-l~~L~~L~Ls----~n~l~~~-----~~~~~~~l~~L~~L~Ls~n~--l~~~ 305 (571)
...+++|+.|+++.|.+++..+..+.. +++|+.|+++ .|.+++. ++..+..+++|+.|++++|. +++.
T Consensus 374 ~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~ 453 (592)
T 3ogk_B 374 AQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDL 453 (592)
T ss_dssp HHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHH
T ss_pred HhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHH
Confidence 334666666666666665554444443 6666666664 4555542 23334556666677665432 4443
Q ss_pred cchhcc-CCCCCCEEEccCCcCccc-cccccccCCCCCEEECcCCcCcccC-CC-CCccCCCCcccccCCc
Q 044615 306 IPSQIC-SMQSLEKLNLSHNNLSGS-IPRCFEEMHWLSCIDISYNALQGLI-PN-STAFRDAPMLALQGNK 372 (571)
Q Consensus 306 ~~~~~~-~l~~L~~L~Ls~n~l~~~-~p~~~~~l~~L~~L~ls~N~l~~~~-~~-~~~~~~~~~l~l~~n~ 372 (571)
.+..+. .+++|+.|++++|++++. ++..+..+++|+.|++++|++++.. +. ...++.++.+++.+|+
T Consensus 454 ~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~ 524 (592)
T 3ogk_B 454 GLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYR 524 (592)
T ss_dssp HHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCB
T ss_pred HHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCc
Confidence 333332 366777777777777652 3344456677777777777765431 11 1234566667777765
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.3e-23 Score=224.39 Aligned_cols=303 Identities=13% Similarity=0.042 Sum_probs=223.4
Q ss_pred hcCCCCCCEEEccCCccc----------cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccc
Q 044615 44 LVRAVQARDTSISFDELH----------EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSI 113 (571)
Q Consensus 44 l~~~~~l~~l~l~~n~l~----------~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~ 113 (571)
...+++|+.|+|++|.+. ...++.|+.|+++.|.+++.. ...++..+.++++|++|+|++|.+.+ +
T Consensus 160 ~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~---~~~l~~~~~~~~~L~~L~L~~~~~~~-l 235 (592)
T 3ogk_B 160 VTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKIS---PKDLETIARNCRSLVSVKVGDFEILE-L 235 (592)
T ss_dssp HHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCC---HHHHHHHHHHCTTCCEEECSSCBGGG-G
T ss_pred HhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccC---HHHHHHHHhhCCCCcEEeccCccHHH-H
Confidence 347889999999999864 346788999999999887411 11455666788899999999888764 4
Q ss_pred cccccCCCCCCEEEcc---------------------------cCcCcccccccccCCCCCCeeecccCcCcccCC-ccc
Q 044615 114 PLALGNLTNLVVLDLS---------------------------TNKLSGSIPLSFANLTSLSILYLYENSLCDSIP-KEI 165 (571)
Q Consensus 114 ~~~~~~l~~L~~L~L~---------------------------~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~l 165 (571)
|..+..+++|+.|+++ ++. ...+|..+..+++|++|+|++|.+.+... ..+
T Consensus 236 ~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~-~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~ 314 (592)
T 3ogk_B 236 VGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMG-PNEMPILFPFAAQIRKLDLLYALLETEDHCTLI 314 (592)
T ss_dssp HHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCC-TTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHH
T ss_pred HHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccc-hhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHH
Confidence 5555666666666665 322 23456677889999999999999765433 346
Q ss_pred cCCCCCCEEEccCCCCCccCChhh-hhccCCCcEEEcc-----------CCcccccC-CccccCCCCCcEEeCccCcCcC
Q 044615 166 GNMNSLSILDLSSNKLNGSIPLSL-ANLTNSLKVLYLS-----------SNHIVGEI-PLGHGMLSSLIQLTLNNNELSG 232 (571)
Q Consensus 166 ~~l~~L~~L~L~~n~l~~~~p~~~-~~l~~~L~~L~l~-----------~n~~~~~~-~~~~~~l~~L~~L~l~~n~l~~ 232 (571)
..+++|++|+++ +.+.......+ ..++ +|+.|+++ .|.++... +.....+++|++|++..|.+++
T Consensus 315 ~~~~~L~~L~L~-~~~~~~~l~~~~~~~~-~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~ 392 (592)
T 3ogk_B 315 QKCPNLEVLETR-NVIGDRGLEVLAQYCK-QLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITN 392 (592)
T ss_dssp TTCTTCCEEEEE-GGGHHHHHHHHHHHCT-TCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCH
T ss_pred HhCcCCCEEecc-CccCHHHHHHHHHhCC-CCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccH
Confidence 889999999999 44443222233 4455 49999999 35665332 2223458899999999999988
Q ss_pred CCChhhhC-CCCCCEEEcc----cCccccc-----cchhhccCCCCCEEEcCCcc--CccCcchhhh-cccCCCEEEccC
Q 044615 233 QLSPELGS-LIQLEYLDLS----ANTFHKS-----IPESLSNLVKLHYLNLSNNQ--FSQKIPNKIE-KLIHLSELDLSH 299 (571)
Q Consensus 233 ~~~~~~~~-l~~L~~L~L~----~n~l~~~-----~~~~l~~l~~L~~L~Ls~n~--l~~~~~~~~~-~l~~L~~L~Ls~ 299 (571)
..+..+.. +++|+.|+++ .|.+++. ++..+.++++|+.|+++.|. +++..+..+. .+++|+.|++++
T Consensus 393 ~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~ 472 (592)
T 3ogk_B 393 ESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGY 472 (592)
T ss_dssp HHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECS
T ss_pred HHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccC
Confidence 77777766 9999999996 6677753 44457789999999998644 6655555454 488999999999
Q ss_pred CcCCcc-cchhccCCCCCCEEEccCCcCccc-cccccccCCCCCEEECcCCcCccc
Q 044615 300 NIFREE-IPSQICSMQSLEKLNLSHNNLSGS-IPRCFEEMHWLSCIDISYNALQGL 353 (571)
Q Consensus 300 n~l~~~-~~~~~~~l~~L~~L~Ls~n~l~~~-~p~~~~~l~~L~~L~ls~N~l~~~ 353 (571)
|.+++. ++..+.++++|+.|++++|.+++. ++.....+++|+.|++++|+++..
T Consensus 473 n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 473 VGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp CCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred CCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 999863 455668899999999999998765 344456789999999999998754
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=9.2e-21 Score=190.95 Aligned_cols=189 Identities=19% Similarity=0.153 Sum_probs=114.7
Q ss_pred cccccccCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCccccc-ccccCCCCCCe-eecccCcCcccCCccc
Q 044615 88 SIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIP-LSFANLTSLSI-LYLYENSLCDSIPKEI 165 (571)
Q Consensus 88 ~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~-~~~~~l~~L~~-L~L~~n~l~~~~~~~l 165 (571)
.+|..+. +++++|+|++|+|+...+.+|.++++|++|+|++|.+.+.+| ..|.++++|++ +.+..|++....|+.|
T Consensus 23 ~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f 100 (350)
T 4ay9_X 23 EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAF 100 (350)
T ss_dssp SCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSB
T ss_pred ccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhh
Confidence 4666552 578888888888875555678888888888888888755443 46777777765 4556677777667778
Q ss_pred cCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccC-CcccccCCccccCCC-CCcEEeCccCcCcCCCChhhhCCCC
Q 044615 166 GNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSS-NHIVGEIPLGHGMLS-SLIQLTLNNNELSGQLSPELGSLIQ 243 (571)
Q Consensus 166 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~-n~~~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~ 243 (571)
..+++|++|++++|++....+..+....+ +..|++.+ +.+....+..+..+. .++.|++++|+++...+. .....+
T Consensus 101 ~~l~~L~~L~l~~n~l~~~~~~~~~~~~~-l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~-~f~~~~ 178 (350)
T 4ay9_X 101 QNLPNLQYLLISNTGIKHLPDVHKIHSLQ-KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNS-AFNGTQ 178 (350)
T ss_dssp CCCTTCCEEEEEEECCSSCCCCTTCCBSS-CEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTT-SSTTEE
T ss_pred hhccccccccccccccccCCchhhcccch-hhhhhhccccccccccccchhhcchhhhhhccccccccCCChh-hccccc
Confidence 88888888888888877544444444443 66666654 445444444444432 455566666666543222 223345
Q ss_pred CCEEEccc-CccccccchhhccCCCCCEEEcCCccCcc
Q 044615 244 LEYLDLSA-NTFHKSIPESLSNLVKLHYLNLSNNQFSQ 280 (571)
Q Consensus 244 L~~L~L~~-n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~ 280 (571)
|+.|++++ |.++...+..|.++++|+.|++++|+++.
T Consensus 179 L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~ 216 (350)
T 4ay9_X 179 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS 216 (350)
T ss_dssp EEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCC
T ss_pred hhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCc
Confidence 55555543 33433333345555555555555555553
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.85 E-value=9e-21 Score=191.00 Aligned_cols=240 Identities=20% Similarity=0.157 Sum_probs=168.8
Q ss_pred CEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCC-ccccCCCCCCE-EEcc
Q 044615 100 SDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIP-KEIGNMNSLSI-LDLS 177 (571)
Q Consensus 100 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~-L~L~ 177 (571)
++++.++++++ .+|..+ .+++++|+|++|+|+.+.+.+|.++++|++|+|++|.+.+.+| ..|.++++|++ +.+.
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 56788888887 567665 3589999999999987777789999999999999999866555 46788888765 5666
Q ss_pred CCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCcc-CcCcCCCChhhhCCC-CCCEEEcccCccc
Q 044615 178 SNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNN-NELSGQLSPELGSLI-QLEYLDLSANTFH 255 (571)
Q Consensus 178 ~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~~~~l~-~L~~L~L~~n~l~ 255 (571)
.|++....|..|..+++ |+.|++++|.+....+..+....++..|++.+ +.+....+..|..+. .++.|++++|.++
T Consensus 89 ~N~l~~l~~~~f~~l~~-L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~ 167 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPN-LQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 167 (350)
T ss_dssp ETTCCEECTTSBCCCTT-CCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred CCcccccCchhhhhccc-cccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc
Confidence 78888666667777775 88888888888866666666666777777755 556655555666654 5777888888887
Q ss_pred cccchhhccCCCCCEEEcCC-ccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCcccccccc
Q 044615 256 KSIPESLSNLVKLHYLNLSN-NQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCF 334 (571)
Q Consensus 256 ~~~~~~l~~l~~L~~L~Ls~-n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~ 334 (571)
...+ ......+|+.|++++ |.++...+..|..+++|+.|+|++|+++...+.. +.+|+.|.+.++.--..+| .+
T Consensus 168 ~i~~-~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~---~~~L~~L~~l~~~~l~~lP-~l 242 (350)
T 4ay9_X 168 EIHN-SAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG---LENLKKLRARSTYNLKKLP-TL 242 (350)
T ss_dssp EECT-TSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSS---CTTCCEEECTTCTTCCCCC-CT
T ss_pred CCCh-hhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhh---hccchHhhhccCCCcCcCC-Cc
Confidence 5433 333456778888764 5555444456777888888888888887644433 4455555554443333555 36
Q ss_pred ccCCCCCEEECcCC
Q 044615 335 EEMHWLSCIDISYN 348 (571)
Q Consensus 335 ~~l~~L~~L~ls~N 348 (571)
..+++|+.++++++
T Consensus 243 ~~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 243 EKLVALMEASLTYP 256 (350)
T ss_dssp TTCCSCCEEECSCH
T ss_pred hhCcChhhCcCCCC
Confidence 67777777777654
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.84 E-value=3.9e-22 Score=216.04 Aligned_cols=319 Identities=13% Similarity=0.081 Sum_probs=173.6
Q ss_pred cCCCCCCEEEccCCccc------c-CCCCccceeecccc-cccCCCCCCCccccccccCCCCCCEEecccCcCccccccc
Q 044615 45 VRAVQARDTSISFDELH------E-KLLTFEATAHFSVL-AFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLA 116 (571)
Q Consensus 45 ~~~~~l~~l~l~~n~l~------~-~~l~~l~~l~l~~n-~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~ 116 (571)
..+.+|+.|+|+++.+. + ..+++|+.|+|++| .++. ..++..+.++++|++|+|++|.+++..+..
T Consensus 102 ~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~------~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~ 175 (594)
T 2p1m_B 102 SSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFST------DGLAAIAATCRNLKELDLRESDVDDVSGHW 175 (594)
T ss_dssp HHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEH------HHHHHHHHHCTTCCEEECTTCEEECCCGGG
T ss_pred HhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCH------HHHHHHHHhCCCCCEEeCcCCccCCcchHH
Confidence 46778888888888766 2 25778888888887 4443 024444557788888888888776544333
Q ss_pred c----cCCCCCCEEEcccCc--Ccc-cccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCC---------
Q 044615 117 L----GNLTNLVVLDLSTNK--LSG-SIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNK--------- 180 (571)
Q Consensus 117 ~----~~l~~L~~L~L~~n~--i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~--------- 180 (571)
+ ..+++|++|++++|. +.. .++..+.++++|++|++++|...+.+|..+..+++|++|+++.+.
T Consensus 176 l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~ 255 (594)
T 2p1m_B 176 LSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYS 255 (594)
T ss_dssp GGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHH
T ss_pred HHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccccCccchhhHH
Confidence 3 356688888888876 221 112223456788888887773222244455556666666544331
Q ss_pred -----------------CC----ccCChhhhhccCCCcEEEccCCcccccCC-ccccCCCCCcEEeCccCcCcCC-CChh
Q 044615 181 -----------------LN----GSIPLSLANLTNSLKVLYLSSNHIVGEIP-LGHGMLSSLIQLTLNNNELSGQ-LSPE 237 (571)
Q Consensus 181 -----------------l~----~~~p~~~~~l~~~L~~L~l~~n~~~~~~~-~~~~~l~~L~~L~l~~n~l~~~-~~~~ 237 (571)
+. ..++..+..+++ |+.|++++|.+++... ..+..+++|+.|++++| +... ++..
T Consensus 256 ~l~~~l~~~~~L~~Ls~~~~~~~~~l~~~~~~~~~-L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l 333 (594)
T 2p1m_B 256 GLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSR-LTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVL 333 (594)
T ss_dssp HHHHHHHTCTTCCEEECCBTCCGGGGGGGHHHHTT-CCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHH
T ss_pred HHHHHHhcCCCcccccCCcccchhhHHHHHHhhCC-CCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHH
Confidence 11 112222223443 7777777777653221 22345677777777766 3321 1122
Q ss_pred hhCCCCCCEEEcc---------cCccccccchhh-ccCCCCCEEEcCCccCccCcchhhh-cccCCCEEEcc--C----C
Q 044615 238 LGSLIQLEYLDLS---------ANTFHKSIPESL-SNLVKLHYLNLSNNQFSQKIPNKIE-KLIHLSELDLS--H----N 300 (571)
Q Consensus 238 ~~~l~~L~~L~L~---------~n~l~~~~~~~l-~~l~~L~~L~Ls~n~l~~~~~~~~~-~l~~L~~L~Ls--~----n 300 (571)
...+++|+.|++. .+.+++.....+ .++++|+.|.++.|.+++.....+. .+++|+.|+++ + |
T Consensus 334 ~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~ 413 (594)
T 2p1m_B 334 ASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPD 413 (594)
T ss_dssp HHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCC
T ss_pred HHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcc
Confidence 2346667777662 233433222222 2366666666666666554444343 35666666666 3 3
Q ss_pred cCCcc-----cchhccCCCCCCEEEccCCcCcccccccccc-CCCCCEEECcCCcCcccCCC-C-CccCCCCcccccCCc
Q 044615 301 IFREE-----IPSQICSMQSLEKLNLSHNNLSGSIPRCFEE-MHWLSCIDISYNALQGLIPN-S-TAFRDAPMLALQGNK 372 (571)
Q Consensus 301 ~l~~~-----~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~-l~~L~~L~ls~N~l~~~~~~-~-~~~~~~~~l~l~~n~ 372 (571)
.+++. ++..+..+++|+.|++++ .++...+..+.. +++|+.|++++|.+++..+. . ..++++..+.+.+|+
T Consensus 414 ~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~ 492 (594)
T 2p1m_B 414 YLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCP 492 (594)
T ss_dssp TTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCS
T ss_pred cccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCC
Confidence 34321 122244556666666655 454444444443 56666666666665432211 0 224555566666554
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.83 E-value=3.2e-20 Score=172.46 Aligned_cols=131 Identities=31% Similarity=0.314 Sum_probs=54.1
Q ss_pred CCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEc
Q 044615 122 NLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYL 201 (571)
Q Consensus 122 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l 201 (571)
+|++|++++|.+++..+..|.++++|++|++++|.+.+..+..|..+++|++|++++|++++..+..+..+++ |+.|++
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~-L~~L~L 107 (208)
T 2o6s_A 29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQ-LKELAL 107 (208)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT-CCEEEC
T ss_pred CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccC-CCEEEc
Confidence 4444444444444333333444444444444444444333333444444444444444444222222233332 444444
Q ss_pred cCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCc
Q 044615 202 SSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANT 253 (571)
Q Consensus 202 ~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 253 (571)
++|.+++..+..+..+++|+.|++++|++++..+..+..+++|+.|++++|.
T Consensus 108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 159 (208)
T 2o6s_A 108 NTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNP 159 (208)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCC
T ss_pred CCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCC
Confidence 4444333333333334444444444444443333334444444444444443
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.83 E-value=3.3e-20 Score=172.34 Aligned_cols=170 Identities=26% Similarity=0.226 Sum_probs=137.5
Q ss_pred cccccccCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccC
Q 044615 88 SIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGN 167 (571)
Q Consensus 88 ~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~ 167 (571)
.+|..+ .++|++|++++|.+++..+..|..+++|++|++++|.+++..+..|..+++|++|++++|.+.+..+..+..
T Consensus 21 ~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 98 (208)
T 2o6s_A 21 SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDK 98 (208)
T ss_dssp SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcC
Confidence 355544 358899999999988776777888899999999999998777777888999999999999988766667888
Q ss_pred CCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEE
Q 044615 168 MNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYL 247 (571)
Q Consensus 168 l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 247 (571)
+++|++|++++|++++..+..+..+++ |+.|++++|.+++..+..+..+++|+.|++++|.+.+ .+++|+.|
T Consensus 99 l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L 170 (208)
T 2o6s_A 99 LTQLKELALNTNQLQSLPDGVFDKLTQ-LKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYL 170 (208)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTT-CCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHH
T ss_pred ccCCCEEEcCCCcCcccCHhHhccCCc-CCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHH
Confidence 999999999999988655555667775 9999999999987766678888999999999997764 35678888
Q ss_pred EcccCccccccchhhccCCC
Q 044615 248 DLSANTFHKSIPESLSNLVK 267 (571)
Q Consensus 248 ~L~~n~l~~~~~~~l~~l~~ 267 (571)
+++.|.+++.+|..++.++.
T Consensus 171 ~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 171 SEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp HHHHHHCTTTBBCTTSSBCT
T ss_pred HHHHHhCCceeeccCccccC
Confidence 88888888888887776654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.83 E-value=5e-20 Score=195.40 Aligned_cols=193 Identities=28% Similarity=0.370 Sum_probs=97.1
Q ss_pred CCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEcc
Q 044615 98 SLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLS 177 (571)
Q Consensus 98 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~ 177 (571)
+|+.|+|++|.+++ +|..+. ++|++|+|++|.|+ .+| ..+++|++|+|++|.+++ +|. +.. +|++|+++
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 66666666666664 444442 56666666666666 344 335666666666666654 444 433 56666666
Q ss_pred CCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccc
Q 044615 178 SNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKS 257 (571)
Q Consensus 178 ~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 257 (571)
+|++++ +|. .++ +|+.|++++|.+++ +|. .+++|+.|++++|.+++ +|. +. ++|+.|+|++|.++ .
T Consensus 129 ~N~l~~-lp~---~l~-~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~ 194 (571)
T 3cvr_A 129 NNQLTM-LPE---LPA-LLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-S 194 (571)
T ss_dssp SSCCSC-CCC---CCT-TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-S
T ss_pred CCcCCC-CCC---cCc-cccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-c
Confidence 666653 443 222 35555555555553 332 34455555555555554 232 32 45555555555544 2
Q ss_pred cchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCcccccccccc
Q 044615 258 IPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEE 336 (571)
Q Consensus 258 ~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~ 336 (571)
+|. +.. +| +...+.|+.|+|++|.++. +|..+..+++|+.|+|++|++++.+|..+..
T Consensus 195 lp~-~~~--~L-----------------~~~~~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~ 252 (571)
T 3cvr_A 195 LPA-VPV--RN-----------------HHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQ 252 (571)
T ss_dssp CCC-CC---------------------------CCEEEECCSSCCCC-CCGGGGGSCTTEEEECCSSSCCHHHHHHHHH
T ss_pred hhh-HHH--hh-----------------hcccccceEEecCCCccee-cCHHHhcCCCCCEEEeeCCcCCCcCHHHHHH
Confidence 222 222 33 0000111555555555543 4444444555555555555555555555444
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.83 E-value=3e-20 Score=197.12 Aligned_cols=189 Identities=25% Similarity=0.340 Sum_probs=154.2
Q ss_pred ccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCC
Q 044615 67 FEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTS 146 (571)
Q Consensus 67 ~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~ 146 (571)
+++.|++++|.+++ +|..+. ++|++|+|++|.++ .+| ..+++|++|+|++|.|++ +|. +.+ +
T Consensus 60 ~L~~L~Ls~n~L~~--------lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~ 121 (571)
T 3cvr_A 60 QFSELQLNRLNLSS--------LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--S 121 (571)
T ss_dssp TCSEEECCSSCCSC--------CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--T
T ss_pred CccEEEeCCCCCCc--------cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--C
Confidence 89999999999885 666553 78999999999998 567 557999999999999997 666 665 9
Q ss_pred CCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCc
Q 044615 147 LSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLN 226 (571)
Q Consensus 147 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~ 226 (571)
|++|+|++|.+++ +|. .+++|++|++++|++++ +|. .++ +|+.|++++|.+++ +|. +. ++|+.|+++
T Consensus 122 L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~-~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls 188 (571)
T 3cvr_A 122 LKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPT-SLEVLSVRNNQLTF-LPE-LP--ESLEALDVS 188 (571)
T ss_dssp CCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCT-TCCEEECCSSCCSC-CCC-CC--TTCCEEECC
T ss_pred CCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCC-CcCEEECCCCCCCC-cch-hh--CCCCEEECc
Confidence 9999999999987 665 68999999999999985 665 334 59999999999987 665 55 899999999
Q ss_pred cCcCcCCCChhhhCCCCC-------CEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccC
Q 044615 227 NNELSGQLSPELGSLIQL-------EYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIH 291 (571)
Q Consensus 227 ~n~l~~~~~~~~~~l~~L-------~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 291 (571)
+|.++. +|. +.. +| +.|+|++|.++ .+|..+..+++|+.|+|++|.+++..|..+..+..
T Consensus 189 ~N~L~~-lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 189 TNLLES-LPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp SSCCSS-CCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred CCCCCc-hhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 999994 555 543 66 88888888887 46777777888888888888888877777766543
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.7e-21 Score=210.96 Aligned_cols=326 Identities=13% Similarity=0.054 Sum_probs=223.1
Q ss_pred hhhc-CCCCCCEEEccCC-ccc-------cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCc--Cc
Q 044615 42 KELV-RAVQARDTSISFD-ELH-------EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENI--LN 110 (571)
Q Consensus 42 ~~l~-~~~~l~~l~l~~n-~l~-------~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~--i~ 110 (571)
..+. .+++|+.|+++.+ .+. ...+++|++|++++|.+++.... .++.....+++|++|++++|. +.
T Consensus 123 ~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~---~l~~~~~~~~~L~~L~l~~~~~~~~ 199 (594)
T 2p1m_B 123 ELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGH---WLSHFPDTYTSLVSLNISCLASEVS 199 (594)
T ss_dssp HHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGG---GGGGSCTTCCCCCEEECTTCCSCCC
T ss_pred HHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchH---HHHHHhhcCCcCcEEEecccCCcCC
Confidence 3444 6889999999998 444 34789999999999998873211 233334477899999999986 32
Q ss_pred cc-ccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCc--------------------------Cc----c
Q 044615 111 GS-IPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENS--------------------------LC----D 159 (571)
Q Consensus 111 ~~-~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~--------------------------l~----~ 159 (571)
.. ++..+..+++|++|++++|.-...++..+..+++|++|+++.+. +. .
T Consensus 200 ~~~l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~ 279 (594)
T 2p1m_B 200 FSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPA 279 (594)
T ss_dssp HHHHHHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCGG
T ss_pred HHHHHHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccchh
Confidence 11 22233457899999999983222366667777888888755442 11 1
Q ss_pred cCCccccCCCCCCEEEccCCCCCccCChh-hhhccCCCcEEEccCCccccc-CCccccCCCCCcEEeCcc---------C
Q 044615 160 SIPKEIGNMNSLSILDLSSNKLNGSIPLS-LANLTNSLKVLYLSSNHIVGE-IPLGHGMLSSLIQLTLNN---------N 228 (571)
Q Consensus 160 ~~~~~l~~l~~L~~L~L~~n~l~~~~p~~-~~~l~~~L~~L~l~~n~~~~~-~~~~~~~l~~L~~L~l~~---------n 228 (571)
.++..+..+++|++|++++|.+++..... +..++ +|+.|++++| +... ++.....+++|+.|++.+ +
T Consensus 280 ~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~-~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~ 357 (594)
T 2p1m_B 280 YLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCP-KLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNV 357 (594)
T ss_dssp GGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCT-TCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSS
T ss_pred hHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCC-CcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCC
Confidence 22333346789999999999976433333 33455 4999999988 4322 222223578899998833 4
Q ss_pred cCcCCCChhhh-CCCCCCEEEcccCccccccchhhc-cCCCCCEEEcC--C----ccCccC-----cchhhhcccCCCEE
Q 044615 229 ELSGQLSPELG-SLIQLEYLDLSANTFHKSIPESLS-NLVKLHYLNLS--N----NQFSQK-----IPNKIEKLIHLSEL 295 (571)
Q Consensus 229 ~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~l~-~l~~L~~L~Ls--~----n~l~~~-----~~~~~~~l~~L~~L 295 (571)
.+++.....+. .+++|+.|.++.|.+++..+..+. .+++|+.|+++ + +.++.. ++..+..+++|+.|
T Consensus 358 ~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L 437 (594)
T 2p1m_B 358 ALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRL 437 (594)
T ss_dssp CCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEE
T ss_pred CCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEE
Confidence 55443333333 489999999988988876665654 58999999999 4 555522 22336678899999
Q ss_pred EccCCcCCcccchhccC-CCCCCEEEccCCcCcccccccc-ccCCCCCEEECcCCcCcccCCC--CCccCCCCcccccCC
Q 044615 296 DLSHNIFREEIPSQICS-MQSLEKLNLSHNNLSGSIPRCF-EEMHWLSCIDISYNALQGLIPN--STAFRDAPMLALQGN 371 (571)
Q Consensus 296 ~Ls~n~l~~~~~~~~~~-l~~L~~L~Ls~n~l~~~~p~~~-~~l~~L~~L~ls~N~l~~~~~~--~~~~~~~~~l~l~~n 371 (571)
++++ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|++++|.+++.... ...+++++.+++.+|
T Consensus 438 ~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~ 516 (594)
T 2p1m_B 438 SLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSC 516 (594)
T ss_dssp ECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESS
T ss_pred eecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCC
Confidence 9987 666655555655 8899999999999987666555 6689999999999998543221 234567888888887
Q ss_pred cC
Q 044615 372 KR 373 (571)
Q Consensus 372 ~~ 373 (571)
+.
T Consensus 517 ~~ 518 (594)
T 2p1m_B 517 SV 518 (594)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.81 E-value=5.9e-20 Score=179.85 Aligned_cols=170 Identities=29% Similarity=0.416 Sum_probs=86.3
Q ss_pred cCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCE
Q 044615 94 GNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSI 173 (571)
Q Consensus 94 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 173 (571)
..+++|++|++++|.+... + .+..+++|++|++++|.+++..+ +.++++|++|++++|.+.+ +| .+..+++|++
T Consensus 43 ~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~ 116 (291)
T 1h6t_A 43 NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKS 116 (291)
T ss_dssp HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCE
T ss_pred hhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCE
Confidence 3456666666666666532 2 35566666666666666664433 6666666666666666654 22 3566666666
Q ss_pred EEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCc
Q 044615 174 LDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANT 253 (571)
Q Consensus 174 L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 253 (571)
|++++|++.+ + ..+..+++ |+.|++++|.+++. ..+..+++|+.|++++|++++..+ +..+++|+.|++++|.
T Consensus 117 L~L~~n~i~~-~-~~l~~l~~-L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~ 189 (291)
T 1h6t_A 117 LSLEHNGISD-I-NGLVHLPQ-LESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNH 189 (291)
T ss_dssp EECTTSCCCC-C-GGGGGCTT-CCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred EECCCCcCCC-C-hhhcCCCC-CCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCc
Confidence 6666666653 2 23444443 55555555555432 233444444444444444443222 4444444444444444
Q ss_pred cccccchhhccCCCCCEEEcCCccC
Q 044615 254 FHKSIPESLSNLVKLHYLNLSNNQF 278 (571)
Q Consensus 254 l~~~~~~~l~~l~~L~~L~Ls~n~l 278 (571)
+++. + .+..+++|+.|++++|.+
T Consensus 190 i~~l-~-~l~~l~~L~~L~l~~n~i 212 (291)
T 1h6t_A 190 ISDL-R-ALAGLKNLDVLELFSQEC 212 (291)
T ss_dssp CCBC-G-GGTTCTTCSEEEEEEEEE
T ss_pred CCCC-h-hhccCCCCCEEECcCCcc
Confidence 4321 1 234444444444444443
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.81 E-value=9.7e-20 Score=195.31 Aligned_cols=174 Identities=28% Similarity=0.415 Sum_probs=116.0
Q ss_pred ccCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCC
Q 044615 93 IGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLS 172 (571)
Q Consensus 93 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~ 172 (571)
+..+++|+.|++++|.+.. ++ .+..+++|+.|+|++|.+++..+ +..+++|+.|+|++|.+.+ +| .+..+++|+
T Consensus 39 ~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~ 112 (605)
T 1m9s_A 39 QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLK 112 (605)
T ss_dssp HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCC
T ss_pred hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCC
Confidence 3456677777777777663 33 46667777777777777765444 6677777777777777754 23 566777777
Q ss_pred EEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccC
Q 044615 173 ILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSAN 252 (571)
Q Consensus 173 ~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n 252 (571)
.|+|++|++.+ + ..+..+++ |+.|+|++|.+++. ..+..+++|+.|+|++|.+.+..| +..+++|+.|+|++|
T Consensus 113 ~L~Ls~N~l~~-l-~~l~~l~~-L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N 185 (605)
T 1m9s_A 113 SLSLEHNGISD-I-NGLVHLPQ-LESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKN 185 (605)
T ss_dssp EEECTTSCCCC-C-GGGGGCTT-CSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred EEEecCCCCCC-C-ccccCCCc-cCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCC
Confidence 77777777764 2 34555654 77777777777653 456667777777777777775544 667777777777777
Q ss_pred ccccccchhhccCCCCCEEEcCCccCccC
Q 044615 253 TFHKSIPESLSNLVKLHYLNLSNNQFSQK 281 (571)
Q Consensus 253 ~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~ 281 (571)
.+++. ..+..+++|+.|+|++|.+++.
T Consensus 186 ~i~~l--~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 186 HISDL--RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp CCCBC--GGGTTCTTCSEEECCSEEEECC
T ss_pred CCCCC--hHHccCCCCCEEEccCCcCcCC
Confidence 77653 3467777777777777777654
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=4e-19 Score=166.34 Aligned_cols=156 Identities=20% Similarity=0.204 Sum_probs=102.8
Q ss_pred cEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCC-hhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCC
Q 044615 197 KVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLS-PELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSN 275 (571)
Q Consensus 197 ~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~ 275 (571)
+.+++++|.++. +|..+ ...++.|++++|++++..+ ..|..+++|+.|++++|.+++..+..|.++++|+.|+|++
T Consensus 14 ~~l~~s~n~l~~-iP~~~--~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLNK-IPEHI--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCSS-CCSCC--CTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCccc-CccCC--CCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 345555555542 33322 1234556666666655433 3356667777777777777666666677777777777777
Q ss_pred ccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCcccCC
Q 044615 276 NQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIP 355 (571)
Q Consensus 276 n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~ 355 (571)
|.+++..+..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..|..|..+++|+.|++++|++++..+
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 77776666667777777777777777777667777777777777777777777777777777777777777777765543
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.6e-19 Score=182.64 Aligned_cols=157 Identities=27% Similarity=0.216 Sum_probs=77.7
Q ss_pred CcEEEccCCcccccCCcccc-CCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcC
Q 044615 196 LKVLYLSSNHIVGEIPLGHG-MLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLS 274 (571)
Q Consensus 196 L~~L~l~~n~~~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls 274 (571)
++.|++++|.+++..+..+. .+++|+.|+|++|++++..+..|..+++|+.|+|++|.++...+..|.++++|+.|+|+
T Consensus 41 l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 120 (361)
T 2xot_A 41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLY 120 (361)
T ss_dssp CSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECC
Confidence 44444444444443333343 44455555555555554444445555555555555555544444445555555555555
Q ss_pred CccCccCcchhhhcccCCCEEEccCCcCCcccchhc---cCCCCCCEEEccCCcCccccccccccCCC--CCEEECcCCc
Q 044615 275 NNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQI---CSMQSLEKLNLSHNNLSGSIPRCFEEMHW--LSCIDISYNA 349 (571)
Q Consensus 275 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~---~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~--L~~L~ls~N~ 349 (571)
+|++++..+..|..+++|+.|+|++|.+++..+..| ..+++|+.|+|++|+|++..+..|..++. ++.|++++|+
T Consensus 121 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~ 200 (361)
T 2xot_A 121 NNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNP 200 (361)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSC
T ss_pred CCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCC
Confidence 555554444455555555555555555554333333 34555555555555555444444555544 2455555555
Q ss_pred Ccc
Q 044615 350 LQG 352 (571)
Q Consensus 350 l~~ 352 (571)
+.+
T Consensus 201 ~~C 203 (361)
T 2xot_A 201 LEC 203 (361)
T ss_dssp EEC
T ss_pred ccC
Confidence 543
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.80 E-value=4.7e-19 Score=165.89 Aligned_cols=134 Identities=19% Similarity=0.250 Sum_probs=70.7
Q ss_pred CCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEcc
Q 044615 219 SLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLS 298 (571)
Q Consensus 219 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls 298 (571)
+|+.|++++|++++..+..|..+++|+.|+|++|.+++..|..|.++++|++|+|++|.++...+..|..+++|+.|+|+
T Consensus 33 ~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 112 (220)
T 2v9t_B 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLN 112 (220)
T ss_dssp TCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECC
Confidence 44444444444444444444445555555555555544444555555555555555555554444444555555555555
Q ss_pred CCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCcc
Q 044615 299 HNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQG 352 (571)
Q Consensus 299 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 352 (571)
+|++++..+..|..+++|+.|+|++|++++..+..|..++.|+.|++++|++.+
T Consensus 113 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 113 ANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 555555555555555555555555555555555555555555555555555543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.80 E-value=4.2e-19 Score=173.78 Aligned_cols=186 Identities=24% Similarity=0.349 Sum_probs=97.4
Q ss_pred EEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCc
Q 044615 126 LDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNH 205 (571)
Q Consensus 126 L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~ 205 (571)
+++..+.+.+.. .+..+++|++|++++|.+... + .+..+++|++|++++|++++. +. +..+++ |+.|++++|.
T Consensus 29 ~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~-~~-l~~l~~-L~~L~l~~n~ 101 (291)
T 1h6t_A 29 DNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDI-KP-LANLKN-LGWLFLDENK 101 (291)
T ss_dssp HHTTCSCTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTT-CCEEECCSSC
T ss_pred HHhcCCCccccc--chhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCC-cc-cccCCC-CCEEECCCCc
Confidence 344444444322 234566666666666666532 2 355666666666666666532 22 444443 5555555555
Q ss_pred ccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchh
Q 044615 206 IVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNK 285 (571)
Q Consensus 206 ~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~ 285 (571)
+++. +.+..+++|+.|++++|.+++. ..+..+++|+.|++++|.+++. ..
T Consensus 102 l~~~--------------------------~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~ 151 (291)
T 1h6t_A 102 VKDL--------------------------SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TV 151 (291)
T ss_dssp CCCG--------------------------GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GG
T ss_pred CCCC--------------------------hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hh
Confidence 5431 1244455555555555554432 2344555555555555555443 34
Q ss_pred hhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCcc
Q 044615 286 IEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQG 352 (571)
Q Consensus 286 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 352 (571)
+..+++|+.|++++|.+.+..+ +..+++|+.|++++|.+++. | .+..+++|+.|++++|+++.
T Consensus 152 l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 152 LSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp GGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred hccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence 5555555555555555554333 55556666666666666542 2 25556666666666666554
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.79 E-value=4.2e-19 Score=179.55 Aligned_cols=177 Identities=31% Similarity=0.287 Sum_probs=103.0
Q ss_pred CEEecccCcCcccccccccCCCCCCEEEcccCcCccccccccc-CCCCCCeeecccCcCcccCCccccCCCCCCEEEccC
Q 044615 100 SDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFA-NLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSS 178 (571)
Q Consensus 100 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~ 178 (571)
+.++++++.++ .+|..+. +.++.|+|++|.|++..+..|. ++++|++|+|++|.+.+..+..|..+++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 34555555554 3343332 2355555555555555554454 555555555555555554445555555555566655
Q ss_pred CCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhh---hCCCCCCEEEcccCccc
Q 044615 179 NKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPEL---GSLIQLEYLDLSANTFH 255 (571)
Q Consensus 179 n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~---~~l~~L~~L~L~~n~l~ 255 (571)
|+++...+..|..+.+ |+.|+|++|.+++..|..|..+++|+.|+|++|+++...+..| ..+++|+.|+|++|.++
T Consensus 98 N~l~~~~~~~~~~l~~-L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQA-LEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp SCCCEECTTTTTTCTT-CCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CcCCcCCHHHhCCCcC-CCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 5555433334444443 6666666666655555666666666666666666665444444 45777777777777777
Q ss_pred cccchhhccCCC--CCEEEcCCccCcc
Q 044615 256 KSIPESLSNLVK--LHYLNLSNNQFSQ 280 (571)
Q Consensus 256 ~~~~~~l~~l~~--L~~L~Ls~n~l~~ 280 (571)
...+..+..++. |+.|+|++|.+..
T Consensus 177 ~l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 177 KLPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp CCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred ccCHHHhhhccHhhcceEEecCCCccC
Confidence 665566777766 3678888887753
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.79 E-value=6.9e-19 Score=188.71 Aligned_cols=192 Identities=27% Similarity=0.355 Sum_probs=121.1
Q ss_pred CCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEE
Q 044615 96 MKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILD 175 (571)
Q Consensus 96 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 175 (571)
+..+..+.++.+.+....+ +..+++|+.|++++|.+... + .+..+++|+.|+|++|.+.+..| +..+++|+.|+
T Consensus 20 l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~ 93 (605)
T 1m9s_A 20 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLF 93 (605)
T ss_dssp HHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEE
T ss_pred HHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEE
Confidence 3445566777777664433 45677788888888887643 3 47778888888888888775443 77788888888
Q ss_pred ccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccc
Q 044615 176 LSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFH 255 (571)
Q Consensus 176 L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 255 (571)
|++|++.+ +| .+..+++ |+.|+|++|.+.+. ..+..+++|+.|+|++|.+++. ..+..+++|+.|+|++|.+.
T Consensus 94 Ls~N~l~~-l~-~l~~l~~-L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~ 166 (605)
T 1m9s_A 94 LDENKIKD-LS-SLKDLKK-LKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS 166 (605)
T ss_dssp CCSSCCCC-CT-TSTTCTT-CCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCC
T ss_pred CcCCCCCC-Ch-hhccCCC-CCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCC
Confidence 88887763 33 4555554 77777777766542 2355566666666666666643 45556666666666666665
Q ss_pred cccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCc
Q 044615 256 KSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFRE 304 (571)
Q Consensus 256 ~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 304 (571)
+..| +..+++|+.|+|++|.+++. ..+..+++|+.|+|++|.+.+
T Consensus 167 ~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 167 DIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp CCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEEC
T ss_pred Cchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcC
Confidence 4433 55666666666666666543 235555666666666665544
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.4e-18 Score=162.63 Aligned_cols=153 Identities=21% Similarity=0.212 Sum_probs=107.0
Q ss_pred EEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCC-ccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEccc
Q 044615 173 ILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIP-LGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSA 251 (571)
Q Consensus 173 ~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~ 251 (571)
++++++|.++ .+|..+. ..++.|++++|.+++..+ ..+..+++|+.|++++|++++..+..|..+++|+.|+|++
T Consensus 15 ~l~~s~n~l~-~iP~~~~---~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEHIP---QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp EEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred EeEeCCCCcc-cCccCCC---CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 5555555554 3444332 235566666666665433 3356666777777777777766666677777777777777
Q ss_pred CccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccc
Q 044615 252 NTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGS 329 (571)
Q Consensus 252 n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 329 (571)
|.+++..+..|.++++|++|++++|.+++..|..+..+++|+.|+|++|.+++..|..|..+++|+.|+|++|++.+.
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 777766666777777888888888888777777777788888888888888777777888888888888888887754
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.8e-18 Score=161.98 Aligned_cols=150 Identities=22% Similarity=0.246 Sum_probs=77.6
Q ss_pred CEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCC
Q 044615 100 SDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSN 179 (571)
Q Consensus 100 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n 179 (571)
+.++++++.++ .+|..+. ++|+.|+|++|.|++..+..|..+++|++|+|++|.+.+..|..|..+++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 45666666665 3444433 45666666666666555556666666666666666666555666666666666666666
Q ss_pred CCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCc
Q 044615 180 KLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANT 253 (571)
Q Consensus 180 ~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 253 (571)
+++...+..|..+++ |+.|++++|.+++..|..+..+++|+.|+|++|.+++..+..|..+++|+.|++++|.
T Consensus 91 ~l~~l~~~~f~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 163 (220)
T 2v9t_B 91 KITELPKSLFEGLFS-LQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNP 163 (220)
T ss_dssp CCCCCCTTTTTTCTT-CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred cCCccCHhHccCCCC-CCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCC
Confidence 665322222333332 4444444444444334444444444444444444443333334444444444444443
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.78 E-value=2.2e-18 Score=162.40 Aligned_cols=137 Identities=24% Similarity=0.292 Sum_probs=80.1
Q ss_pred CCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEc
Q 044615 218 SSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDL 297 (571)
Q Consensus 218 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 297 (571)
++|+.|++++|.+++..|..|..+++|+.|+|++|.+....+..|..+++|+.|+|++|.+++..+..+..+++|+.|+|
T Consensus 40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L 119 (229)
T 3e6j_A 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFM 119 (229)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEec
Confidence 45555555555555555555555555555555555555444444555666666666666665554555555666666666
Q ss_pred cCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCcccCC
Q 044615 298 SHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIP 355 (571)
Q Consensus 298 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~ 355 (571)
++|+++ .+|..+..+++|+.|+|++|++++..+..|..+++|+.|++++|++++..+
T Consensus 120 s~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 120 CCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred cCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 666665 345555666666666666666665555556666666666666666655443
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=8.7e-22 Score=209.96 Aligned_cols=188 Identities=22% Similarity=0.216 Sum_probs=89.6
Q ss_pred cCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCc
Q 044615 118 GNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLK 197 (571)
Q Consensus 118 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~ 197 (571)
..+++|+.|+|++|.++ .+|..++++++|+.|++++|......|..+ ..+...+..|..+..+.+ |+
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll-----------~~~~~~~~~~~~l~~l~~-L~ 412 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLM-----------RALDPLLYEKETLQYFST-LK 412 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHH-----------HHHCTGGGHHHHHHHHHH-HH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHH-----------HhcccccCCHHHHHHHHh-cc
Confidence 44566666666666665 556666666666666665543110001000 001122334444444443 44
Q ss_pred EEE-ccCC-------------cccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhc
Q 044615 198 VLY-LSSN-------------HIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLS 263 (571)
Q Consensus 198 ~L~-l~~n-------------~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~ 263 (571)
.|+ ++.| .++...+ ..|+.|++++|.+++ +|. ++.+++|+.|+|++|.++ .+|..+.
T Consensus 413 ~L~~l~~n~~~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~ 483 (567)
T 1dce_A 413 AVDPMRAAYLDDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALA 483 (567)
T ss_dssp HHCGGGHHHHHHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGG
T ss_pred cCcchhhcccchhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhh
Confidence 444 3333 3322111 124555555555554 232 555555555555555554 3444555
Q ss_pred cCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCccc-chhccCCCCCCEEEccCCcCccc
Q 044615 264 NLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEI-PSQICSMQSLEKLNLSHNNLSGS 329 (571)
Q Consensus 264 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~Ls~n~l~~~ 329 (571)
++++|+.|+|++|.+++ +| .+..+++|+.|+|++|.+++.. |..++.+++|+.|+|++|++++.
T Consensus 484 ~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~ 548 (567)
T 1dce_A 484 ALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 548 (567)
T ss_dssp GCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred cCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCC
Confidence 55555555555555543 33 4445555555555555554443 44555555555555555555443
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=4.2e-19 Score=173.27 Aligned_cols=106 Identities=25% Similarity=0.450 Sum_probs=88.7
Q ss_pred cCCCccCeeeccCcceEEEEEcC------CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLP------TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALH 535 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~ 535 (571)
++|.+.+.||+|+||+||+|++. ++..||||+++.. .....++|.+|+++|++++|||||+++|+|.+++.
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 45788899999999999999842 4778999999753 23446789999999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhhccCC----------CccCCCHHHHhhhc
Q 044615 536 SFVVYEYLEMGSLAMNLSNDA----------AAEQFCWTKRMNAI 570 (571)
Q Consensus 536 ~~lv~e~~~~G~L~~~l~~~~----------~~~~l~w~~r~~ia 570 (571)
.|||||||++|+|.++|+..+ ....++|.++++|+
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 134 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIA 134 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHH
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHH
Confidence 999999999999999997542 23579999999886
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.77 E-value=6.4e-18 Score=159.23 Aligned_cols=134 Identities=26% Similarity=0.253 Sum_probs=68.9
Q ss_pred CCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEc
Q 044615 97 KSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDL 176 (571)
Q Consensus 97 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 176 (571)
++|++|+|++|.+++..|..|..+++|++|+|++|.++...+..|..+++|++|+|++|.+++..+..|..+++|++|+|
T Consensus 40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L 119 (229)
T 3e6j_A 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFM 119 (229)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEec
Confidence 44555555555555444555555555555555555554444444455555555555555554443444445555555555
Q ss_pred cCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCcccc
Q 044615 177 SSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHK 256 (571)
Q Consensus 177 ~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 256 (571)
++|+++ .+|.. +..+++|+.|++++|++++..+..+..+++|+.|++++|.+..
T Consensus 120 s~N~l~-~lp~~-------------------------~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 120 CCNKLT-ELPRG-------------------------IERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp CSSCCC-SCCTT-------------------------GGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred cCCccc-ccCcc-------------------------cccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence 555544 34444 4444555555555555554444445555666666666665543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=8.9e-19 Score=173.37 Aligned_cols=106 Identities=24% Similarity=0.441 Sum_probs=90.2
Q ss_pred cCCCccCeeeccCcceEEEEEcC------CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLP------TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALH 535 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~ 535 (571)
.+|...+.||+|+||+||+|+++ +++.||||+++.. .....++|.+|+++|++++|||||+++|+|.+.+.
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 117 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP 117 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 35677789999999999999853 4788999999753 23456789999999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhhccCCC------------ccCCCHHHHhhhc
Q 044615 536 SFVVYEYLEMGSLAMNLSNDAA------------AEQFCWTKRMNAI 570 (571)
Q Consensus 536 ~~lv~e~~~~G~L~~~l~~~~~------------~~~l~w~~r~~ia 570 (571)
.|||||||++|+|.++++.... ..+++|.++++|+
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 164 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHH
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHH
Confidence 9999999999999999986432 2469999999886
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.3e-18 Score=170.60 Aligned_cols=106 Identities=18% Similarity=0.261 Sum_probs=87.7
Q ss_pred CCCccCeeeccCcceEEEEEc------CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCee
Q 044615 463 NFDDGHCIGNGGQGSVYKAKL------PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHS 536 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~ 536 (571)
+++..+.||+|+||+||+|.+ .+++.||||+++..... ...++|.+|+.++++++|||||+++|+|.+.+..
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~--~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG--PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh--HHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 456678899999999999985 25678999999754322 3357899999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhccCCC-------------ccCCCHHHHhhhc
Q 044615 537 FVVYEYLEMGSLAMNLSNDAA-------------AEQFCWTKRMNAI 570 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~-------------~~~l~w~~r~~ia 570 (571)
|||||||++|||.++|+.+.. ...++|.++++||
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 151 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 151 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHH
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHH
Confidence 999999999999999975321 2469999999886
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.1e-20 Score=201.53 Aligned_cols=204 Identities=21% Similarity=0.178 Sum_probs=135.8
Q ss_pred cCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCc-------------CcccccccccCCCCCCeee-cccCcCcc
Q 044615 94 GNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNK-------------LSGSIPLSFANLTSLSILY-LYENSLCD 159 (571)
Q Consensus 94 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~-------------i~~~~~~~~~~l~~L~~L~-L~~n~l~~ 159 (571)
..+++|+.|+|++|.++ .+|..++.+++|+.|++++|. +.+.+|..++.+++|+.|+ ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~- 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD- 423 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence 45677777888887776 667777777777777776654 4455666677777777776 5555432
Q ss_pred cCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhh
Q 044615 160 SIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELG 239 (571)
Q Consensus 160 ~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 239 (571)
.|..+.+++|.+.. +|. . .|+.|++++|.+++ +|. ++.+++|+.|++++|.++ .+|..++
T Consensus 424 ----------~L~~l~l~~n~i~~-l~~-----~-~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~ 483 (567)
T 1dce_A 424 ----------DLRSKFLLENSVLK-MEY-----A-DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALA 483 (567)
T ss_dssp ----------HHHHHHHHHHHHHH-HHH-----T-TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGG
T ss_pred ----------hhhhhhhhcccccc-cCc-----c-CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhh
Confidence 22333344444431 111 1 26777777777764 444 677777777777777777 5666777
Q ss_pred CCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCc-chhhhcccCCCEEEccCCcCCcccch---hccCCCC
Q 044615 240 SLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKI-PNKIEKLIHLSELDLSHNIFREEIPS---QICSMQS 315 (571)
Q Consensus 240 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~Ls~n~l~~~~~~---~~~~l~~ 315 (571)
.+++|+.|+|++|.+++ +| .+.++++|+.|+|++|++++.. |..+..+++|+.|+|++|.+++.+|. .+..+++
T Consensus 484 ~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~ 561 (567)
T 1dce_A 484 ALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 561 (567)
T ss_dssp GCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTT
T ss_pred cCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcc
Confidence 77777777777777775 45 6777777888888888777665 77777777888888888877765442 2334777
Q ss_pred CCEEEc
Q 044615 316 LEKLNL 321 (571)
Q Consensus 316 L~~L~L 321 (571)
|+.|++
T Consensus 562 L~~L~l 567 (567)
T 1dce_A 562 VSSILT 567 (567)
T ss_dssp CSEEEC
T ss_pred cCccCC
Confidence 887764
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=4.9e-18 Score=156.15 Aligned_cols=151 Identities=19% Similarity=0.239 Sum_probs=82.3
Q ss_pred cCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCE
Q 044615 94 GNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSI 173 (571)
Q Consensus 94 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 173 (571)
..+++|++|++++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|.+.+..+..+..+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 45566667777776666 344 4666666777777666554 2235666666666666666666555666666666666
Q ss_pred EEccCCCCCccCChhhhhccCCCcEEEccCCc-ccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccC
Q 044615 174 LDLSSNKLNGSIPLSLANLTNSLKVLYLSSNH-IVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSAN 252 (571)
Q Consensus 174 L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~-~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n 252 (571)
|++++|++++..|..+..+++ |+.|++++|. ++ .+| .+..+++|+.|++++|++++. + .+..+++|+.|++++|
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~-L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N 191 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPK-VNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQ 191 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSS-CCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC
T ss_pred EEecCCccCcHhHHHHhhCCC-CCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCc
Confidence 666666666545555555543 5555555554 33 222 233444444444444444331 1 3333444444444444
Q ss_pred c
Q 044615 253 T 253 (571)
Q Consensus 253 ~ 253 (571)
.
T Consensus 192 ~ 192 (197)
T 4ezg_A 192 T 192 (197)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.1e-17 Score=153.69 Aligned_cols=149 Identities=21% Similarity=0.312 Sum_probs=87.9
Q ss_pred CcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCC
Q 044615 196 LKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSN 275 (571)
Q Consensus 196 L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~ 275 (571)
|+.|++++|.++ .+| .+..+++|++|++++|.+.. +..+..+++|+.|++++|.+++..+..+..+++|+.|++++
T Consensus 46 L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~ 121 (197)
T 4ezg_A 46 LTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISH 121 (197)
T ss_dssp CCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCS
T ss_pred ccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecC
Confidence 444444444444 222 34444555555555554432 23555666666666666666655566666666677777777
Q ss_pred ccCccCcchhhhcccCCCEEEccCCc-CCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCcc
Q 044615 276 NQFSQKIPNKIEKLIHLSELDLSHNI-FREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQG 352 (571)
Q Consensus 276 n~l~~~~~~~~~~l~~L~~L~Ls~n~-l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 352 (571)
|.+++..+..+..+++|+.|++++|. +.. ++ .+..+++|+.|++++|.+++. + .+..+++|+.|++++|++.+
T Consensus 122 n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~-~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 122 SAHDDSILTKINTLPKVNSIDLSYNGAITD-IM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp SBCBGGGHHHHTTCSSCCEEECCSCTBCCC-CG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC----
T ss_pred CccCcHhHHHHhhCCCCCEEEccCCCCccc-cH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCcccCC
Confidence 76666566666666777777777776 433 33 466677777777777777643 2 56667777777777776643
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=3.3e-18 Score=169.41 Aligned_cols=104 Identities=20% Similarity=0.260 Sum_probs=82.3
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|++.+.||+|+||+||+|+ ..+|+.||||++.+.... ....+.|.+|+++|++++|||||++++++.+.+.+||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 579999999999999999999 568999999999876543 345678999999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRM 567 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~ 567 (571)
|||+||+|.++|..++. ..+++.+..
T Consensus 103 Ey~~gg~L~~~i~~~~~-~~~~e~~~~ 128 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKG-VLFQEDQIL 128 (350)
T ss_dssp ECCTTCBHHHHHHHTTT-CCCCHHHHH
T ss_pred eCCCCCcHHHHHHHcCC-CCCCHHHHH
Confidence 99999999999975432 234444433
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=8.9e-19 Score=168.73 Aligned_cols=170 Identities=21% Similarity=0.323 Sum_probs=100.5
Q ss_pred CCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEE
Q 044615 96 MKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILD 175 (571)
Q Consensus 96 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 175 (571)
+.++..+++++|.+++. + .+..+++|++|++++|.++. ++ .+..+++|++|+|++|.+.+..+ +..+++|++|+
T Consensus 18 l~~l~~l~l~~~~i~~~-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~ 91 (263)
T 1xeu_A 18 LANAVKQNLGKQSVTDL-V-SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELS 91 (263)
T ss_dssp HHHHHHHHHTCSCTTSE-E-CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEE
T ss_pred HHHHHHHHhcCCCcccc-c-chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEE
Confidence 44555666666666532 2 45566666666666666653 33 46666666666666666654333 66666666666
Q ss_pred ccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccc
Q 044615 176 LSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFH 255 (571)
Q Consensus 176 L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 255 (571)
+++|++++ +|... . . +|+.|++++|.+++. ..+..+++|+.|++++|++++. + .+..+++|+.|++++|.++
T Consensus 92 L~~N~l~~-l~~~~-~-~-~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 92 VNRNRLKN-LNGIP-S-A-CLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp CCSSCCSC-CTTCC-C-S-SCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCC
T ss_pred CCCCccCC-cCccc-c-C-cccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCc
Confidence 66666663 33211 1 2 366666666666542 2355566666666666666643 2 4566666666666666665
Q ss_pred cccchhhccCCCCCEEEcCCccCccC
Q 044615 256 KSIPESLSNLVKLHYLNLSNNQFSQK 281 (571)
Q Consensus 256 ~~~~~~l~~l~~L~~L~Ls~n~l~~~ 281 (571)
+. ..+..+++|+.|++++|.++..
T Consensus 164 ~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 164 NT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp BC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred ch--HHhccCCCCCEEeCCCCcccCC
Confidence 44 4556666666666666666543
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=2e-18 Score=166.25 Aligned_cols=81 Identities=22% Similarity=0.294 Sum_probs=39.6
Q ss_pred CCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEc
Q 044615 242 IQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNL 321 (571)
Q Consensus 242 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 321 (571)
++|+.|++++|.+++. ..+..+++|+.|++++|++++. + .+..+++|+.|++++|.+++. ..+..+++|+.|++
T Consensus 106 ~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l 179 (263)
T 1xeu_A 106 ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDL 179 (263)
T ss_dssp SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEE
T ss_pred CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeC
Confidence 4455555555554432 2344555555555555555432 1 344455555555555555443 33445555555555
Q ss_pred cCCcCcc
Q 044615 322 SHNNLSG 328 (571)
Q Consensus 322 s~n~l~~ 328 (571)
++|++++
T Consensus 180 ~~N~~~~ 186 (263)
T 1xeu_A 180 TGQKCVN 186 (263)
T ss_dssp EEEEEEC
T ss_pred CCCcccC
Confidence 5555543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.1e-18 Score=191.79 Aligned_cols=185 Identities=25% Similarity=0.252 Sum_probs=74.7
Q ss_pred CCCEEEccCCccccCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccccccccCCCCCCEEEc
Q 044615 49 QARDTSISFDELHEKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDL 128 (571)
Q Consensus 49 ~l~~l~l~~n~l~~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L 128 (571)
+++.|+|+.|.+.......++.++|+.|.+.+ ++++.|.+. ..+..|..+++|+.|+|
T Consensus 174 ~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~---------------------~~~~~n~~~-~~~~~~~~l~~L~~L~L 231 (727)
T 4b8c_D 174 LTPKIELFANGKDEANQALLQHKKLSQYSIDE---------------------DDDIENRMV-MPKDSKYDDQLWHALDL 231 (727)
T ss_dssp ----------------------------------------------------------------------CCCCCCEEEC
T ss_pred ccceEEeeCCCCCcchhhHhhcCccCcccccC---------------------cccccccee-cChhhhccCCCCcEEEC
Confidence 35556666555553333445555555555443 223333333 34455555555556666
Q ss_pred ccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCcccc
Q 044615 129 STNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVG 208 (571)
Q Consensus 129 ~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~ 208 (571)
++|.+. .+|..+.++++|++|+|++|.++ .+|..|+.|++|++|+|++|+++ .+|..+..+.+ |+.|+|++|.++
T Consensus 232 s~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~-L~~L~L~~N~l~- 306 (727)
T 4b8c_D 232 SNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQ-LKYFYFFDNMVT- 306 (727)
T ss_dssp TTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTT-CSEEECCSSCCC-
T ss_pred CCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCC-CCEEECCCCCCC-
Confidence 555555 34444445556666666666555 45555555666666666666655 45555555554 666666666554
Q ss_pred cCCccccCCCCCcEEeCccCcCcCCCChhhhCCCC-CCEEEcccCccccccch
Q 044615 209 EIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQ-LEYLDLSANTFHKSIPE 260 (571)
Q Consensus 209 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~L~~n~l~~~~~~ 260 (571)
.+|..++.+++|+.|+|++|.+++.+|..+..+.. +..|+|++|.+++.+|.
T Consensus 307 ~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~ 359 (727)
T 4b8c_D 307 TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH 359 (727)
T ss_dssp CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_pred ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc
Confidence 34545555566666666666665555554433211 12245555555554443
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.72 E-value=2.2e-18 Score=189.36 Aligned_cols=224 Identities=23% Similarity=0.249 Sum_probs=74.0
Q ss_pred CCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEc
Q 044615 97 KSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDL 176 (571)
Q Consensus 97 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 176 (571)
+.++.|+|.+|.+.. .+.. .|+.++|+.|.|.+. ++..|.+. ..|+.+..+++|+.|+|
T Consensus 173 ~~~~~l~L~~n~~~~-~~~~-----~l~~l~Ls~~~i~~~--------------~~~~n~~~-~~~~~~~~l~~L~~L~L 231 (727)
T 4b8c_D 173 PLTPKIELFANGKDE-ANQA-----LLQHKKLSQYSIDED--------------DDIENRMV-MPKDSKYDDQLWHALDL 231 (727)
T ss_dssp ----------------------------------------------------------------------CCCCCCEEEC
T ss_pred CccceEEeeCCCCCc-chhh-----HhhcCccCcccccCc--------------ccccccee-cChhhhccCCCCcEEEC
Confidence 556777777777664 2322 233444444443321 22222222 23444445555555555
Q ss_pred cCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCcccc
Q 044615 177 SSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHK 256 (571)
Q Consensus 177 ~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 256 (571)
++|.+. .+|..++.+.. |+.|+|++|.++ .+|..++.+++|+.|+|++|.++ .+|..|+.+++|+.|+|++|.++
T Consensus 232 s~n~l~-~l~~~~~~l~~-L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~- 306 (727)
T 4b8c_D 232 SNLQIF-NISANIFKYDF-LTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT- 306 (727)
T ss_dssp TTSCCS-CCCGGGGGCCS-CSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-
T ss_pred CCCCCC-CCChhhcCCCC-CCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-
Confidence 555554 44444444443 555555555554 44444555555555555555555 34555555555555555555554
Q ss_pred ccchhhccCCCCCEEEcCCccCccCcchhhhcccC-CCEEEccCCcCCcccchhccCCCCCCEEEccCC--------cCc
Q 044615 257 SIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIH-LSELDLSHNIFREEIPSQICSMQSLEKLNLSHN--------NLS 327 (571)
Q Consensus 257 ~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~-L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n--------~l~ 327 (571)
.+|..|..+++|+.|+|++|.+++.+|..+..+.. +..++|++|.+.+.+|. .|+.|++++| .+.
T Consensus 307 ~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~------~l~~l~l~~n~~~~~~~~~l~ 380 (727)
T 4b8c_D 307 TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH------ERRFIEINTDGEPQREYDSLQ 380 (727)
T ss_dssp CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC------C--------------------
T ss_pred ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc------ccceeEeecccccccccCCcc
Confidence 34445555566666666666665555554433221 12345566666555543 2333444444 333
Q ss_pred cccccccccCCCCCEEECcCCcCcc
Q 044615 328 GSIPRCFEEMHWLSCIDISYNALQG 352 (571)
Q Consensus 328 ~~~p~~~~~l~~L~~L~ls~N~l~~ 352 (571)
+..+..+..+..+....+++|-+.+
T Consensus 381 ~~~~~~~~~l~~~~~~~ls~Nil~~ 405 (727)
T 4b8c_D 381 QSTEHLATDLAKRTFTVLSYNTLCQ 405 (727)
T ss_dssp ---------------------CCCG
T ss_pred ccccchhhcccccceeeeecccccc
Confidence 3333444455555666667776653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.9e-17 Score=161.54 Aligned_cols=103 Identities=30% Similarity=0.343 Sum_probs=86.6
Q ss_pred cCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
+++.+.+.||+|+||+||+|++.. .||||+++.... .....+.|.+|++++++++|||||+++|+|. .+.+|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmE 111 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQ 111 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEE
Confidence 467788999999999999998643 599999975443 3345678999999999999999999999885 456899999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||+||+|.++|+.... .++|.++++|+
T Consensus 112 y~~gGsL~~~l~~~~~--~l~~~~~~~i~ 138 (307)
T 3omv_A 112 WCEGSSLYKHLHVQET--KFQMFQLIDIA 138 (307)
T ss_dssp CCSSCBHHHHHHTSCC--CCCHHHHHHHH
T ss_pred cCCCCCHHHHHhhcCC--CCCHHHHHHHH
Confidence 9999999999975433 58999998876
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=99.72 E-value=2.8e-18 Score=167.11 Aligned_cols=94 Identities=18% Similarity=0.217 Sum_probs=83.0
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|++.+.||+|+||+||+|+ ..+|+.||||++.+.........+.+.+|+++|++++|||||++++++++.+.+|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 579999999999999999999 5689999999997543222233577999999999999999999999999999999999
Q ss_pred eccCCCChhhhhccC
Q 044615 541 EYLEMGSLAMNLSND 555 (571)
Q Consensus 541 e~~~~G~L~~~l~~~ 555 (571)
|||+||+|.++|++.
T Consensus 112 Ey~~gG~L~~~i~~~ 126 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI 126 (311)
T ss_dssp CCCTTEEHHHHHHHH
T ss_pred ecCCCCCHHHHHHHc
Confidence 999999999999854
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.71 E-value=1.7e-17 Score=151.85 Aligned_cols=131 Identities=24% Similarity=0.287 Sum_probs=82.7
Q ss_pred CcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCCh-hhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcC
Q 044615 196 LKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSP-ELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLS 274 (571)
Q Consensus 196 L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls 274 (571)
-+.+++++|.++ .+|..+. .+++.|++++|.+++..+. .+..+++|+.|+|++|.+++..|..|.++++|+.|+|+
T Consensus 10 ~~~l~~s~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEcCCCCcC-cCccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 356777777775 3444332 2667777777766655443 36666666666666666666666666666666666666
Q ss_pred CccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccc
Q 044615 275 NNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGS 329 (571)
Q Consensus 275 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 329 (571)
+|++++..+..|..+++|+.|+|++|++++..|..+..+++|+.|+|++|++++.
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 141 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence 6666665555566666666666666666666666666666666666666666544
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.8e-17 Score=165.33 Aligned_cols=235 Identities=14% Similarity=0.072 Sum_probs=115.0
Q ss_pred CCCCCEEecccCcCc--ccccccccCCCCCCEEEcccCcCcccccccccC--------CCCCCeeecccCcCcccCCccc
Q 044615 96 MKSLSDLQLSENILN--GSIPLALGNLTNLVVLDLSTNKLSGSIPLSFAN--------LTSLSILYLYENSLCDSIPKEI 165 (571)
Q Consensus 96 l~~L~~L~L~~n~i~--~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~--------l~~L~~L~L~~n~l~~~~~~~l 165 (571)
+++|++|||++|++. ...+.. ++.+..+.+..|. +.+..|.+ +++|+.|+|.+ .+....+.+|
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~---~~~~~~~~~~~~~---I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF 120 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGT---YPNGKFYIYMANF---VPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAF 120 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSS---SGGGCCEEECTTE---ECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTT
T ss_pred hccCeEEecCcceeEEecCcccc---ccccccccccccc---cCHHHhcccccccccccCCCcEEECCc-cccchhHHHh
Confidence 677888888888776 222211 2223444444442 33445556 77777777776 6665556667
Q ss_pred cCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCcc----cccCCccccCCCCCc-EEeCccCcCcCCCChh---
Q 044615 166 GNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHI----VGEIPLGHGMLSSLI-QLTLNNNELSGQLSPE--- 237 (571)
Q Consensus 166 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~----~~~~~~~~~~l~~L~-~L~l~~n~l~~~~~~~--- 237 (571)
.++++|+.|++.+|.+....+..|..... +..+.+..+.. .......|..+..|+ .+.+.... .++..
T Consensus 121 ~~~~~L~~l~l~~n~i~~i~~~aF~~~~~-l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~---~l~~~~~~ 196 (329)
T 3sb4_A 121 KGCDNLKICQIRKKTAPNLLPEALADSVT-AIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMG---KLEDEIMK 196 (329)
T ss_dssp TTCTTCCEEEBCCSSCCEECTTSSCTTTC-EEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTC---CHHHHHHH
T ss_pred hcCcccceEEcCCCCccccchhhhcCCCc-eEEecCcchhhhhccccccccccccccccceeEEecCCC---cHHHHHhh
Confidence 77777777777777776444444544332 44444433211 111122333334444 22222111 01111
Q ss_pred ------------------------h-hCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCC
Q 044615 238 ------------------------L-GSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHL 292 (571)
Q Consensus 238 ------------------------~-~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L 292 (571)
+ ..+++|+.++|++|.++...+.+|.++++|+.+++++| ++...+..|.++.+|
T Consensus 197 ~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L 275 (329)
T 3sb4_A 197 AGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRL 275 (329)
T ss_dssp TTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTC
T ss_pred cccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhc
Confidence 0 11445555555555454444444555555555555554 443444445555555
Q ss_pred C-EEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEE
Q 044615 293 S-ELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCI 343 (571)
Q Consensus 293 ~-~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 343 (571)
+ .+++.+ .++.+.+..|.++++|+.+++++|.++.+.+.+|.++++|+.+
T Consensus 276 ~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~l 326 (329)
T 3sb4_A 276 AGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLI 326 (329)
T ss_dssp CEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEE
T ss_pred cEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhh
Confidence 5 555544 3444444445555555555555555554444455555555444
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.70 E-value=3.5e-17 Score=149.69 Aligned_cols=129 Identities=26% Similarity=0.346 Sum_probs=65.3
Q ss_pred CEEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCc-cccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcc
Q 044615 172 SILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPL-GHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLS 250 (571)
Q Consensus 172 ~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~ 250 (571)
+++++++|+++ .+|..+.. +|+.|++++|.+++..+. .++.+++|+.|++++|++++..|..|..+++|+.|+|+
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~---~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL---HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT---TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CEEEcCCCCcC-cCccCCCC---CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 44555555553 34443321 255555555555443332 24455555555555555555445555555555555555
Q ss_pred cCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCc
Q 044615 251 ANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFRE 304 (571)
Q Consensus 251 ~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 304 (571)
+|.+++..+..|.++++|+.|++++|++++..|..+..+++|+.|+|++|.+.+
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 140 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccC
Confidence 555555444445555555555555555555445555555555555555555543
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.70 E-value=5.6e-17 Score=161.75 Aligned_cols=220 Identities=11% Similarity=0.051 Sum_probs=150.3
Q ss_pred CCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcC----cccCCccccCCCCC
Q 044615 96 MKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSL----CDSIPKEIGNMNSL 171 (571)
Q Consensus 96 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l----~~~~~~~l~~l~~L 171 (571)
+++|+.|+|.+ .++.+.+.+|.++++|+.|++.+|.+..+.+.+|..+.++..+.+..+.. .......|.++..|
T Consensus 100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L 178 (329)
T 3sb4_A 100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPL 178 (329)
T ss_dssp CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCC
T ss_pred cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccccc
Confidence 67777777766 66655566677777777777777776666666666666665555544221 11223345555555
Q ss_pred C-EEEccCCCCCccCChhhhhc---cCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEE
Q 044615 172 S-ILDLSSNKLNGSIPLSLANL---TNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYL 247 (571)
Q Consensus 172 ~-~L~L~~n~l~~~~p~~~~~l---~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 247 (571)
+ .+.+.... .++..+... ..++..+.+.++-...........+++|+.|++++|+++...+..|.++++|+.+
T Consensus 179 ~~~i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l 255 (329)
T 3sb4_A 179 ETTIQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKI 255 (329)
T ss_dssp EEEEEECTTC---CHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEE
T ss_pred ceeEEecCCC---cHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEE
Confidence 5 44443321 223322211 1235566655542211111111236899999999999998888889999999999
Q ss_pred EcccCccccccchhhccCCCCC-EEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEc
Q 044615 248 DLSANTFHKSIPESLSNLVKLH-YLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNL 321 (571)
Q Consensus 248 ~L~~n~l~~~~~~~l~~l~~L~-~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 321 (571)
++.+| +....+.+|.++++|+ .+++.+ .++...+..|.++++|+.+++++|.+..+.+..|.++++|+.++.
T Consensus 256 ~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 256 KLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp ECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred ECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 99998 7777788899999999 999998 777777889999999999999999999888889999999998864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=99.70 E-value=3e-17 Score=157.59 Aligned_cols=104 Identities=21% Similarity=0.257 Sum_probs=81.6
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|++.+.||+|+||+||+|+ ..+|+.||||++.+.........+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 689999999999999999999 5689999999998765444445678999999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
||| +|+|.+++.+++ .++..+...+
T Consensus 93 Ey~-~g~L~~~l~~~~---~l~e~~~~~~ 117 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD---KMSEQEARRF 117 (275)
T ss_dssp ECC-CEEHHHHHHHSC---SCCHHHHHHH
T ss_pred eCC-CCCHHHHHHHcC---CCCHHHHHHH
Confidence 999 689999997543 3555544433
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=1.9e-17 Score=163.72 Aligned_cols=101 Identities=26% Similarity=0.352 Sum_probs=85.7
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
..|+..+.||+|+||+||+|+ ..+|+.||||++....... .+.+.+|+++|++++|||||+++++|.+.+.+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 458999999999999999999 5689999999997543332 356889999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
|||+||+|.+++.+. .+++.+...|
T Consensus 151 Ey~~gg~L~~~l~~~----~l~e~~~~~~ 175 (346)
T 4fih_A 151 EFLEGGALTDIVTHT----RMNEEQIAAV 175 (346)
T ss_dssp CCCTTEEHHHHHHHS----CCCHHHHHHH
T ss_pred eCCCCCcHHHHHHcC----CCCHHHHHHH
Confidence 999999999999753 3566554444
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=4.5e-17 Score=159.09 Aligned_cols=105 Identities=20% Similarity=0.348 Sum_probs=84.5
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC------
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL------ 534 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~------ 534 (571)
++|++.+.||+|+||+||+|+ ..+|+.||||+++... .....+.+.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 468999999999999999999 5589999999997543 2344578999999999999999999999997654
Q ss_pred ------eeEEEEeccCCCChhhhhccCCCccCCCHHHHhh
Q 044615 535 ------HSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMN 568 (571)
Q Consensus 535 ------~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ 568 (571)
.+|+|||||++|+|.+++.........+|.....
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~ 122 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHH
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHH
Confidence 3799999999999999998765544556554433
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.69 E-value=5.1e-17 Score=157.33 Aligned_cols=102 Identities=23% Similarity=0.192 Sum_probs=83.5
Q ss_pred CccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEe----CCeeEEE
Q 044615 465 DDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSH----ALHSFVV 539 (571)
Q Consensus 465 ~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~----~~~~~lv 539 (571)
...+.||+|+||+||+|. ..+++.||||++...... ....+.|.+|++++++++|||||+++++|.+ ...+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 556789999999999999 558999999999754433 2446789999999999999999999999976 3458999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||||+||+|.+++++.+ .+++.....|+
T Consensus 108 mEy~~gg~L~~~l~~~~---~l~~~~~~~~~ 135 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFK---VMKIKVLRSWC 135 (290)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHH
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHH
Confidence 99999999999998543 46776665543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=5.5e-17 Score=164.53 Aligned_cols=101 Identities=26% Similarity=0.352 Sum_probs=85.8
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
+.|+..+.||+|+||+||+|+ ..+|+.||||++....... .+.+.+|+++|++++|||||+++++|.+.+.+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 569999999999999999999 5689999999997654333 356889999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
|||+||+|.++++.. .+++.+...|
T Consensus 228 Ey~~gG~L~~~i~~~----~l~e~~~~~~ 252 (423)
T 4fie_A 228 EFLEGGALTDIVTHT----RMNEEQIAAV 252 (423)
T ss_dssp ECCTTEEHHHHHHHS----CCCHHHHHHH
T ss_pred eCCCCCcHHHHHhcc----CCCHHHHHHH
Confidence 999999999999743 2555544433
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=7.7e-17 Score=158.89 Aligned_cols=99 Identities=22% Similarity=0.234 Sum_probs=84.2
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.+.|+..+.||+|+||+||+|+ ..+|+.||||+++..... .+|+.++++++|||||++++++.+.+.+|||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3457888899999999999999 568999999999764322 3799999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||||+||+|.++|++.+ .+++.+...|+
T Consensus 129 mEy~~gg~L~~~l~~~~---~l~e~~~~~~~ 156 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMG---CLPEDRALYYL 156 (336)
T ss_dssp ECCCTTCBHHHHHHHHS---SCCHHHHHHHH
T ss_pred EeccCCCcHHHHHHHcC---CCCHHHHHHHH
Confidence 99999999999998543 46776665553
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.67 E-value=2.7e-16 Score=140.52 Aligned_cols=135 Identities=23% Similarity=0.281 Sum_probs=95.3
Q ss_pred CCCcEEeCccCcCc-CCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEE
Q 044615 218 SSLIQLTLNNNELS-GQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELD 296 (571)
Q Consensus 218 ~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 296 (571)
++|+.|++++|.++ +.+|..+..+++|+.|++++|.+++. ..+..+++|+.|++++|.+++.+|..+..+++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 55666666666665 45565666677777777777777654 5667777777777777777766666666677777777
Q ss_pred ccCCcCCccc-chhccCCCCCCEEEccCCcCccccc---cccccCCCCCEEECcCCcCcccC
Q 044615 297 LSHNIFREEI-PSQICSMQSLEKLNLSHNNLSGSIP---RCFEEMHWLSCIDISYNALQGLI 354 (571)
Q Consensus 297 Ls~n~l~~~~-~~~~~~l~~L~~L~Ls~n~l~~~~p---~~~~~l~~L~~L~ls~N~l~~~~ 354 (571)
+++|.+++.. +..+..+++|+.|++++|++++..+ ..+..+++|+.|++++|.+...+
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~ 163 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEAP 163 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBCC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhcc
Confidence 7777776642 2567777888888888888876554 46777888888888888776543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=7.8e-17 Score=158.14 Aligned_cols=99 Identities=26% Similarity=0.267 Sum_probs=80.8
Q ss_pred CCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC----eeEE
Q 044615 463 NFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL----HSFV 538 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~----~~~l 538 (571)
+|...+.||+|+||+||+|++ +|+.||||++.... .....+.+|+..+.+++|||||+++|+|.+.+ .+||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 577888999999999999997 58999999986421 11223445666678899999999999998754 5799
Q ss_pred EEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 539 VYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||||++|+|.++|++. .++|..+++|+
T Consensus 79 V~Ey~~~gsL~~~l~~~----~l~~~~~~~i~ 106 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRY----TVTVEGMIKLA 106 (303)
T ss_dssp EEECCTTCBHHHHHHHC----CBCHHHHHHHH
T ss_pred EecCCCCCcHHHHHHhC----CCCHHHHHHHH
Confidence 99999999999999753 48999998875
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.65 E-value=1.1e-15 Score=136.53 Aligned_cols=132 Identities=27% Similarity=0.249 Sum_probs=67.2
Q ss_pred CCCCEEEcccCcCc-ccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEE
Q 044615 121 TNLVVLDLSTNKLS-GSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVL 199 (571)
Q Consensus 121 ~~L~~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L 199 (571)
++|++|++++|.++ +.+|..+..+++|++|++++|.+.+. ..+..+++|++|++++|++.+.+|..+..+++ |+.|
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~-L~~L 100 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPN-LTHL 100 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTT-CCEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCC-CCEE
Confidence 34555555555544 34444455555555555555555433 44555555555555555555444444444443 5555
Q ss_pred EccCCcccccC-CccccCCCCCcEEeCccCcCcCCCC---hhhhCCCCCCEEEcccCccc
Q 044615 200 YLSSNHIVGEI-PLGHGMLSSLIQLTLNNNELSGQLS---PELGSLIQLEYLDLSANTFH 255 (571)
Q Consensus 200 ~l~~n~~~~~~-~~~~~~l~~L~~L~l~~n~l~~~~~---~~~~~l~~L~~L~L~~n~l~ 255 (571)
++++|.+++.. +..+..+++|+.|++++|.+++..+ ..+..+++|+.|++++|.+.
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 55555554321 1344445555555555555554333 34555555555555555543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.64 E-value=4.6e-16 Score=135.99 Aligned_cols=127 Identities=24% Similarity=0.307 Sum_probs=79.5
Q ss_pred CCCcEEeCccCcCc-CCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEE
Q 044615 218 SSLIQLTLNNNELS-GQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELD 296 (571)
Q Consensus 218 ~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 296 (571)
++|+.|++++|.++ +.+|..+..+++|+.|++++|.+++. ..+..+++|+.|++++|.+++.+|..+..+++|+.|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 34555555555555 34455555566666666666666543 4556666666666666666655666666666677777
Q ss_pred ccCCcCCcc-cchhccCCCCCCEEEccCCcCccccc---cccccCCCCCEEECc
Q 044615 297 LSHNIFREE-IPSQICSMQSLEKLNLSHNNLSGSIP---RCFEEMHWLSCIDIS 346 (571)
Q Consensus 297 Ls~n~l~~~-~~~~~~~l~~L~~L~Ls~n~l~~~~p---~~~~~l~~L~~L~ls 346 (571)
+++|.+++. .+..+..+++|+.|++++|++++..+ ..+..+++|+.||++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 777766653 23566777777777777777776554 466777777777765
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.5e-14 Score=147.49 Aligned_cols=248 Identities=13% Similarity=0.113 Sum_probs=192.1
Q ss_pred CCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEE
Q 044615 95 NMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSIL 174 (571)
Q Consensus 95 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 174 (571)
.+..++.+.+.+ .++.+...+|.+. +|+.+.+..+ ++.+...+|.+. +|+.+.+.+ .+....+..|.++++|+.+
T Consensus 111 ~~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l 185 (401)
T 4fdw_A 111 ILKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKA 185 (401)
T ss_dssp ECSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEE
T ss_pred ecCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCee
Confidence 447788888864 4665667788774 7999998776 676777788874 699999875 6666667788999999999
Q ss_pred EccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCcc
Q 044615 175 DLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTF 254 (571)
Q Consensus 175 ~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 254 (571)
++..|+++ .++...+... +|+.+.+..+ +......+|.++++|+.+++..+ +.......|.+ .+|+.+.+. +.+
T Consensus 186 ~l~~n~l~-~I~~~aF~~~-~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i 259 (401)
T 4fdw_A 186 DLSKTKIT-KLPASTFVYA-GIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGV 259 (401)
T ss_dssp ECTTSCCS-EECTTTTTTC-CCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTC
T ss_pred ecCCCcce-EechhhEeec-ccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCc
Confidence 99988888 4555444455 4999999754 66666778888999999999875 55556667777 789999994 456
Q ss_pred ccccchhhccCCCCCEEEcCCccCc-----cCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccc
Q 044615 255 HKSIPESLSNLVKLHYLNLSNNQFS-----QKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGS 329 (571)
Q Consensus 255 ~~~~~~~l~~l~~L~~L~Ls~n~l~-----~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 329 (571)
......+|.++++|+.+.+.+|.+. ...+..|.++++|+.++|. +.+..+....|.++++|+.+.|..| ++.+
T Consensus 260 ~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I 337 (401)
T 4fdw_A 260 TNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQI 337 (401)
T ss_dssp CEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEE
T ss_pred cEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEE
Confidence 6666788999999999999888765 3556788899999999998 4577777788999999999999554 7777
Q ss_pred cccccccCCCCCEEECcCCcCcccCCC
Q 044615 330 IPRCFEEMHWLSCIDISYNALQGLIPN 356 (571)
Q Consensus 330 ~p~~~~~l~~L~~L~ls~N~l~~~~~~ 356 (571)
.+.+|.++ .|+.+++++|.+....+.
T Consensus 338 ~~~aF~~~-~L~~l~l~~n~~~~l~~~ 363 (401)
T 4fdw_A 338 NFSAFNNT-GIKEVKVEGTTPPQVFEK 363 (401)
T ss_dssp CTTSSSSS-CCCEEEECCSSCCBCCCS
T ss_pred cHHhCCCC-CCCEEEEcCCCCcccccc
Confidence 78899999 899999999977665443
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=5e-17 Score=158.24 Aligned_cols=103 Identities=18% Similarity=0.223 Sum_probs=79.2
Q ss_pred cCCCccCeeeccCcceEEEEEc----CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL----PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSF 537 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~ 537 (571)
++|++.+.||+|+||+||+|+. .+++.||||++++..... ....++.+|+++|++++|||||++++++.+.+..|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-RDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE-EECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh-HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 4699999999999999999973 257899999997643222 22346889999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhccCCCccCCCHHHHhh
Q 044615 538 VVYEYLEMGSLAMNLSNDAAAEQFCWTKRMN 568 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ 568 (571)
+|||||+||+|.++|.+.+ .++..+...
T Consensus 103 ivmEy~~gg~L~~~l~~~~---~l~e~~~~~ 130 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKEV---MFTEEDVKF 130 (304)
T ss_dssp EEECCCTTCEEHHHHHHHC---CCCHHHHHH
T ss_pred EEEEcCCCCCHHHHHHhcC---CCCHHHHHH
Confidence 9999999999999998543 355544433
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=2.6e-15 Score=137.21 Aligned_cols=110 Identities=30% Similarity=0.353 Sum_probs=67.7
Q ss_pred CCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEc
Q 044615 242 IQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNL 321 (571)
Q Consensus 242 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 321 (571)
++|+.|++++|.++ .+|..+.++++|+.|++++|.+++..+..|..+++|+.|+|++|.+++..+..|..+++|+.|+|
T Consensus 31 ~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 109 (193)
T 2wfh_A 31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSL 109 (193)
T ss_dssp TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEEC
Confidence 34555555555554 34455556666666666666666555555666666666666666666655556666666666666
Q ss_pred cCCcCccccccccccCCCCCEEECcCCcCcc
Q 044615 322 SHNNLSGSIPRCFEEMHWLSCIDISYNALQG 352 (571)
Q Consensus 322 s~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 352 (571)
++|+++...+..|..+++|+.|++++|++.+
T Consensus 110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 110 HGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 6666665555566666666666666666654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=4.4e-16 Score=155.34 Aligned_cols=114 Identities=20% Similarity=0.302 Sum_probs=90.5
Q ss_pred HHHHHHccCCCccCeeeccCcceEEEEEcC------CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCC-CCcccEE
Q 044615 455 EEIIRATNNFDDGHCIGNGGQGSVYKAKLP------TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH-RNIVKFY 527 (571)
Q Consensus 455 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~ 527 (571)
.++....++|++.+.||+|+||+||+|... +++.||||.+..... ....+.|.+|+++|++++| ||||+++
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 344444567999999999999999999842 235799999975432 2345789999999999966 8999999
Q ss_pred EEEEeC-CeeEEEEeccCCCChhhhhccCCC-------------ccCCCHHHHhhhc
Q 044615 528 GFCSHA-LHSFVVYEYLEMGSLAMNLSNDAA-------------AEQFCWTKRMNAI 570 (571)
Q Consensus 528 ~~~~~~-~~~~lv~e~~~~G~L~~~l~~~~~-------------~~~l~w~~r~~ia 570 (571)
|+|.+. +.+|||||||++|+|.++|+.... ...++|.+++.|+
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 191 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHH
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHH
Confidence 999764 568999999999999999975321 2458999888775
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.62 E-value=3.3e-14 Score=144.86 Aligned_cols=246 Identities=12% Similarity=0.093 Sum_probs=144.2
Q ss_pred cccCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCC
Q 044615 92 EIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSL 171 (571)
Q Consensus 92 ~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L 171 (571)
.|.++ +|+.+.+..+ ++.+...+|.+ .+|+.+.+.. .+..+.+.+|.++++|+.+++.+|.+.......|. ..+|
T Consensus 131 aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L 205 (401)
T 4fdw_A 131 AFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGI 205 (401)
T ss_dssp TTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCC
T ss_pred hcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-eccc
Confidence 34443 5666666554 55455556665 3577776664 45555556666677777777766666554444444 4667
Q ss_pred CEEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEccc
Q 044615 172 SILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSA 251 (571)
Q Consensus 172 ~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~ 251 (571)
+.+.+..+ +...-...|..+.+ |+.+++..| ++.....+|.. .+|+.+.+. +.+.......|.++++|+.+++.+
T Consensus 206 ~~l~lp~~-l~~I~~~aF~~~~~-L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l~~ 280 (401)
T 4fdw_A 206 EEVLLPVT-LKEIGSQAFLKTSQ-LKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVTNIASRAFYYCPELAEVTTYG 280 (401)
T ss_dssp SEEECCTT-CCEECTTTTTTCTT-CCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCCEECTTTTTTCTTCCEEEEES
T ss_pred CEEEeCCc-hheehhhHhhCCCC-CCEEecCCC-ccCcccccccc-CCccEEEeC-CCccEEChhHhhCCCCCCEEEeCC
Confidence 77766533 44333344555544 666766654 34344445555 566666663 345545556666667777777666
Q ss_pred Cccc-----cccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcC
Q 044615 252 NTFH-----KSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNL 326 (571)
Q Consensus 252 n~l~-----~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 326 (571)
|.+. ...+.+|.+|++|+.+.+.+ .++......|.++.+|+.++|..| ++.+...+|.++ +|+.+++++|.+
T Consensus 281 ~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~ 357 (401)
T 4fdw_A 281 STFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTP 357 (401)
T ss_dssp SCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSC
T ss_pred ccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCC
Confidence 5543 24455666667777777663 355555566666667777776443 555555566666 677777777666
Q ss_pred ccccccccccCC-CCCEEECcCCcC
Q 044615 327 SGSIPRCFEEMH-WLSCIDISYNAL 350 (571)
Q Consensus 327 ~~~~p~~~~~l~-~L~~L~ls~N~l 350 (571)
....+..|..++ .+..|.+..+.+
T Consensus 358 ~~l~~~~F~~~~~~l~~l~vp~~~~ 382 (401)
T 4fdw_A 358 PQVFEKVWYGFPDDITVIRVPAESV 382 (401)
T ss_dssp CBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred cccccccccCCCCCccEEEeCHHHH
Confidence 655555666553 455665555443
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.61 E-value=1.5e-15 Score=132.68 Aligned_cols=125 Identities=23% Similarity=0.186 Sum_probs=85.4
Q ss_pred CcEEEccCCccc-ccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcC
Q 044615 196 LKVLYLSSNHIV-GEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLS 274 (571)
Q Consensus 196 L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls 274 (571)
|+.|++++|.++ +.+|..+..+++|+.|++++|.+++. ..+..+++|+.|++++|.+++.+|..+..+++|+.|+++
T Consensus 19 l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls 96 (149)
T 2je0_A 19 VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLS 96 (149)
T ss_dssp CSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECT
T ss_pred CeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECC
Confidence 666666666665 45555566666677777777766654 556667777777777777766566666667777777777
Q ss_pred CccCccC-cchhhhcccCCCEEEccCCcCCcccc---hhccCCCCCCEEEcc
Q 044615 275 NNQFSQK-IPNKIEKLIHLSELDLSHNIFREEIP---SQICSMQSLEKLNLS 322 (571)
Q Consensus 275 ~n~l~~~-~~~~~~~l~~L~~L~Ls~n~l~~~~~---~~~~~l~~L~~L~Ls 322 (571)
+|.+++. .+..+..+++|+.|++++|.+++..+ ..+..+++|+.|+++
T Consensus 97 ~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 97 GNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp TSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 7777653 23567777777777777777766554 467777777777765
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.61 E-value=4e-15 Score=134.03 Aligned_cols=114 Identities=23% Similarity=0.242 Sum_probs=65.8
Q ss_pred CCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEc
Q 044615 242 IQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNL 321 (571)
Q Consensus 242 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 321 (571)
++|+.|++++|.+++..+..+..+++|++|++++|.+++..+..+..+++|+.|++++|.+++..+..+..+++|+.|++
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 107 (177)
T 2o6r_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELAL 107 (177)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEEC
Confidence 34555555555555444444555555555555555555444444555566666666666665555555566666666666
Q ss_pred cCCcCccccccccccCCCCCEEECcCCcCcccCC
Q 044615 322 SHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIP 355 (571)
Q Consensus 322 s~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~ 355 (571)
++|.+++..+..|..+++|+.|++++|++++.+|
T Consensus 108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 108 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred cCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 6666665555555666666666666666665444
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=7.6e-15 Score=134.08 Aligned_cols=128 Identities=25% Similarity=0.299 Sum_probs=94.0
Q ss_pred cEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCc
Q 044615 197 KVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNN 276 (571)
Q Consensus 197 ~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n 276 (571)
+.+++++|.++ .+|..+ .++|+.|++++|.++ .+|..|..+++|+.|+|++|.+++..+..|.++++|+.|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~--~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGI--PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCC--CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCC--CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 45556666555 334332 246677777777776 45567777778888888888877776777788888888888888
Q ss_pred cCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCcc
Q 044615 277 QFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSG 328 (571)
Q Consensus 277 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 328 (571)
.+++..+..|..+++|+.|+|++|.++...+..|..+++|+.|+|++|++..
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 8887777778888888888888888887666678888888888888888763
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.60 E-value=8.2e-15 Score=132.01 Aligned_cols=133 Identities=27% Similarity=0.298 Sum_probs=95.7
Q ss_pred CcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCC
Q 044615 196 LKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSN 275 (571)
Q Consensus 196 L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~ 275 (571)
.+.+++++|.++. +|..+ .++|+.|++++|++++..+..+..+++|+.|++++|.+++..+..+..+++|+.|++++
T Consensus 9 ~~~l~~~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCSS-CCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCcc-CCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 3455666665552 33222 25677777777777765556667777788888888777766666677788888888888
Q ss_pred ccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccc
Q 044615 276 NQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIP 331 (571)
Q Consensus 276 n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p 331 (571)
|.+++..+..+..+++|+.|++++|.+++..+..+..+++|+.|++++|++++..|
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 88877666667788888888888888877666667788888888888888876554
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=5.8e-15 Score=149.85 Aligned_cols=103 Identities=21% Similarity=0.321 Sum_probs=84.0
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC------C
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA------L 534 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~------~ 534 (571)
++|++.+.||+|+||+||+|+ ..+|+.||||++...... ....+.+.+|+++|++++|||||++++++... +
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV-VTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccc-hHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 469999999999999999999 568999999999765433 34467789999999999999999999998643 5
Q ss_pred eeEEEEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 535 HSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
.+|||||||+ |+|.+++...+ .+++.....|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~ 163 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYF 163 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS---CCCHHHHHHH
T ss_pred EEEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHH
Confidence 7899999996 68999997543 4666554443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.57 E-value=4.6e-15 Score=158.13 Aligned_cols=100 Identities=17% Similarity=0.323 Sum_probs=85.6
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|++.+.||+|+||+||+|. ..+|+.||||++.... ....+.+.+|+++|+.++|||||+++++|.+...+||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 579999999999999999999 5689999999997543 234577899999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHH
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKR 566 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r 566 (571)
|||+||+|.++|.++.. .+++.+.
T Consensus 234 E~~~gg~L~~~i~~~~~--~l~e~~~ 257 (573)
T 3uto_A 234 EFMSGGELFEKVADEHN--KMSEDEA 257 (573)
T ss_dssp ECCCCCBHHHHHTCTTS--CEEHHHH
T ss_pred eecCCCcHHHHHHHhCC--CCCHHHH
Confidence 99999999999975433 3444443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.54 E-value=1.5e-14 Score=130.05 Aligned_cols=133 Identities=21% Similarity=0.230 Sum_probs=96.2
Q ss_pred ccCCCCCcEEeCccCcCcCCCChhhhCC-CCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCC
Q 044615 214 HGMLSSLIQLTLNNNELSGQLSPELGSL-IQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHL 292 (571)
Q Consensus 214 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L 292 (571)
+..+.+|+.|++++|+++.. +. +..+ ++|+.|++++|.+++. ..+..+++|+.|++++|.+++..+..+..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 44566777777777777743 43 3333 4788888888887754 567778888888888888876555556778888
Q ss_pred CEEEccCCcCCcccch--hccCCCCCCEEEccCCcCcccccc----ccccCCCCCEEECcCCcCcc
Q 044615 293 SELDLSHNIFREEIPS--QICSMQSLEKLNLSHNNLSGSIPR----CFEEMHWLSCIDISYNALQG 352 (571)
Q Consensus 293 ~~L~Ls~n~l~~~~~~--~~~~l~~L~~L~Ls~n~l~~~~p~----~~~~l~~L~~L~ls~N~l~~ 352 (571)
+.|++++|.+.. +|. .+..+++|+.|++++|+++. .|. .+..++.|+.||++.|....
T Consensus 91 ~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 91 TELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp CEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred CEEECCCCcCCc-chhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 888888888854 444 67788888888888888874 454 37788888888888887643
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.53 E-value=1.5e-14 Score=130.23 Aligned_cols=134 Identities=21% Similarity=0.178 Sum_probs=72.2
Q ss_pred ccCCCCCCEEecccCcCcccccccccCCC-CCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCC
Q 044615 93 IGNMKSLSDLQLSENILNGSIPLALGNLT-NLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSL 171 (571)
Q Consensus 93 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~-~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L 171 (571)
+.++.+|++|++++|.++. +|. +..+. +|++|++++|.+++. ..+..+++|++|++++|.+++..+..+..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 4456667777777776663 333 33333 666666666666643 455666666666666666654433334556666
Q ss_pred CEEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCCh----hhhCCCCCCEE
Q 044615 172 SILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSP----ELGSLIQLEYL 247 (571)
Q Consensus 172 ~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~----~~~~l~~L~~L 247 (571)
++|++++|++. .+|. ...+..+++|+.|++++|.+.. .|. .+..+++|+.|
T Consensus 91 ~~L~L~~N~i~-~~~~-----------------------~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~L 145 (176)
T 1a9n_A 91 TELILTNNSLV-ELGD-----------------------LDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVL 145 (176)
T ss_dssp CEEECCSCCCC-CGGG-----------------------GGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEE
T ss_pred CEEECCCCcCC-cchh-----------------------hHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCcccee
Confidence 66666666554 3333 0123334444444444444442 222 25566666666
Q ss_pred EcccCccc
Q 044615 248 DLSANTFH 255 (571)
Q Consensus 248 ~L~~n~l~ 255 (571)
+++.|...
T Consensus 146 d~~~n~~~ 153 (176)
T 1a9n_A 146 DFQKVKLK 153 (176)
T ss_dssp TTEECCHH
T ss_pred CCCcCCHH
Confidence 66666554
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.53 E-value=3.5e-16 Score=143.82 Aligned_cols=149 Identities=23% Similarity=0.264 Sum_probs=98.6
Q ss_pred CcEEEccCCcccccCCc------cccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCC
Q 044615 196 LKVLYLSSNHIVGEIPL------GHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLH 269 (571)
Q Consensus 196 L~~L~l~~n~~~~~~~~------~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~ 269 (571)
++.++++.+.+.+..|. .+..+++|+.|++++|.+.+ +| .+..+++|+.|++++|.++ .+|..+..+++|+
T Consensus 20 l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~ 96 (198)
T 1ds9_A 20 VVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96 (198)
T ss_dssp CCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCS
T ss_pred ccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCC
Confidence 44444444444443333 55566666777777776665 44 6667777777777777776 4566666667777
Q ss_pred EEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccc-hhccCCCCCCEEEccCCcCcccccc----------ccccCC
Q 044615 270 YLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIP-SQICSMQSLEKLNLSHNNLSGSIPR----------CFEEMH 338 (571)
Q Consensus 270 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~n~l~~~~p~----------~~~~l~ 338 (571)
.|++++|.+++ +| .+..+++|+.|++++|.+.+..+ ..+..+++|+.|++++|++++..|. .+..++
T Consensus 97 ~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~ 174 (198)
T 1ds9_A 97 ELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLP 174 (198)
T ss_dssp EEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCS
T ss_pred EEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCC
Confidence 77787777765 33 56777778888888887765332 4677788888888888888766554 267778
Q ss_pred CCCEEECcCCcCc
Q 044615 339 WLSCIDISYNALQ 351 (571)
Q Consensus 339 ~L~~L~ls~N~l~ 351 (571)
+|+.|| +|.++
T Consensus 175 ~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 175 NLKKLD--GMPVD 185 (198)
T ss_dssp SCSEEC--CGGGT
T ss_pred CcEEEC--CcccC
Confidence 888776 55554
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.51 E-value=2.5e-16 Score=144.83 Aligned_cols=87 Identities=29% Similarity=0.307 Sum_probs=45.8
Q ss_pred ccCCCCCCEEecccCcCcccccc------cccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCcccc
Q 044615 93 IGNMKSLSDLQLSENILNGSIPL------ALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIG 166 (571)
Q Consensus 93 ~~~l~~L~~L~L~~n~i~~~~~~------~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~ 166 (571)
+.....++.++++.+.+.+..|. .+..+++|++|++++|.+++ +| .+.++++|++|++++|.+. .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 44456666777777766665554 45555555555555555543 33 4555555555555555554 2343344
Q ss_pred CCCCCCEEEccCCCCC
Q 044615 167 NMNSLSILDLSSNKLN 182 (571)
Q Consensus 167 ~l~~L~~L~L~~n~l~ 182 (571)
.+++|++|++++|+++
T Consensus 91 ~~~~L~~L~L~~N~l~ 106 (198)
T 1ds9_A 91 VADTLEELWISYNQIA 106 (198)
T ss_dssp HHHHCSEEEEEEEECC
T ss_pred cCCcCCEEECcCCcCC
Confidence 4444444444444444
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=1.4e-14 Score=143.89 Aligned_cols=113 Identities=31% Similarity=0.548 Sum_probs=96.4
Q ss_pred HHHHHHccCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC
Q 044615 455 EEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL 534 (571)
Q Consensus 455 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~ 534 (571)
.++...+++|+..+.||+|+||.||+|..++++.||||++..... ...+.+.+|++++++++||||+++++++.+.+
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS---QGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS---SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 344556788999999999999999999987899999999876532 23577999999999999999999999999999
Q ss_pred eeEEEEeccCCCChhhhhccCCC-ccCCCHHHHhhhc
Q 044615 535 HSFVVYEYLEMGSLAMNLSNDAA-AEQFCWTKRMNAI 570 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~~~~-~~~l~w~~r~~ia 570 (571)
..|+||||+++|+|.+++..... ...++|..++.|+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~ 145 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHH
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHH
Confidence 99999999999999999976432 3468898887765
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.51 E-value=9.4e-15 Score=155.18 Aligned_cols=96 Identities=19% Similarity=0.181 Sum_probs=77.8
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHH---HHHHHHHhhcCCCCcccEEEEEEeCCee
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEF---LNEVNALTKIRHRNIVKFYGFCSHALHS 536 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~---~~Ei~~l~~l~H~niv~l~~~~~~~~~~ 536 (571)
.++|++.++||+|+||+||+|+ ..+|+.||||++.+...........+ ..++.+++.++|||||+++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 3579999999999999999999 56899999999975322111112223 3446777888999999999999999999
Q ss_pred EEEEeccCCCChhhhhccCC
Q 044615 537 FVVYEYLEMGSLAMNLSNDA 556 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~ 556 (571)
|+|||||+||+|.++|.+.+
T Consensus 268 ylVmEy~~GGdL~~~l~~~~ 287 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG 287 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC
T ss_pred EEEEecCCCCcHHHHHHhcC
Confidence 99999999999999998543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=9.5e-14 Score=136.84 Aligned_cols=120 Identities=31% Similarity=0.484 Sum_probs=101.7
Q ss_pred ccccHHHHHHHccCCCcc------CeeeccCcceEEEEEcCCCCEEEEEEccCCCC-CchHhHHHHHHHHHHHhhcCCCC
Q 044615 450 GKIVHEEIIRATNNFDDG------HCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLP-DEMACQQEFLNEVNALTKIRHRN 522 (571)
Q Consensus 450 ~~~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~Ei~~l~~l~H~n 522 (571)
..+++.++..++.+|... +.||+|+||.||+|.. +++.||||++..... ......+.+.+|++++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 357788999999988876 8999999999999987 688999999975432 22234677999999999999999
Q ss_pred cccEEEEEEeCCeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 523 IVKFYGFCSHALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 523 iv~l~~~~~~~~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+++++++.+.+..++||||+++|+|.+++........++|..+..|+
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~ 139 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIA 139 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHH
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHH
Confidence 999999999999999999999999999999865555578998887765
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=3.8e-14 Score=141.04 Aligned_cols=118 Identities=30% Similarity=0.582 Sum_probs=99.8
Q ss_pred cccHHHHHHHccCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEE
Q 044615 451 KIVHEEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFC 530 (571)
Q Consensus 451 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~ 530 (571)
.++..++....++|+..+.||+|+||.||+|..++++.||||++....... ....+.+|++++++++||||+++++++
T Consensus 19 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp ECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred eecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEEEE
Confidence 467788999999999999999999999999997789999999997543221 123689999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChhhhhccCCC-ccCCCHHHHhhhc
Q 044615 531 SHALHSFVVYEYLEMGSLAMNLSNDAA-AEQFCWTKRMNAI 570 (571)
Q Consensus 531 ~~~~~~~lv~e~~~~G~L~~~l~~~~~-~~~l~w~~r~~ia 570 (571)
.+.+..++||||+++|+|.++++.... ...++|..+..|+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~ 137 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHH
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHH
Confidence 999999999999999999999986543 3458998887765
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.49 E-value=8.6e-14 Score=136.26 Aligned_cols=106 Identities=21% Similarity=0.307 Sum_probs=91.6
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
+.|++.+.||+|+||.||+|+ ..+++.||+|.+...........+.|.+|+.++++++||||+++++++.+.+..|+||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 469999999999999999999 5589999999997655555556778999999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||+++|+|.+++...+ .+++.....++
T Consensus 91 e~~~g~~L~~~l~~~~---~~~~~~~~~~~ 117 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHG---PLSVDTAINFT 117 (294)
T ss_dssp ECCCSCBHHHHHHHHC---SCCHHHHHHHH
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHH
Confidence 9999999999997543 46777666553
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=2.7e-14 Score=140.90 Aligned_cols=110 Identities=31% Similarity=0.363 Sum_probs=93.3
Q ss_pred HHccCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEE
Q 044615 459 RATNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFV 538 (571)
Q Consensus 459 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l 538 (571)
...++|++.+.||+|+||.||+|+. +|+.||||++...... ....++|.+|++++++++||||+++++++.+.+..++
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFH-AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCS-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence 3456799999999999999999986 5888999999765433 3446789999999999999999999999999999999
Q ss_pred EEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 539 VYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||||+++|+|.+++........+++..++.|+
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~ 143 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHH
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHH
Confidence 99999999999999865544458888777664
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=1.5e-13 Score=136.31 Aligned_cols=114 Identities=25% Similarity=0.305 Sum_probs=94.7
Q ss_pred ccccHHHHHHHccC----------CCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc
Q 044615 450 GKIVHEEIIRATNN----------FDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI 518 (571)
Q Consensus 450 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l 518 (571)
+.++++++..+++. |+..+.||+|+||.||+|+. .+|+.||||++....... .+.+.+|+.+++++
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l 99 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDY 99 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS---HHHHHHHHHHHTTC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH---HHHHHHHHHHHHhC
Confidence 45777887777654 66678999999999999995 489999999997654332 56789999999999
Q ss_pred CCCCcccEEEEEEeCCeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 519 RHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 519 ~H~niv~l~~~~~~~~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+||||+++++++...+..|+||||+++|+|.+++... .++|..+..|+
T Consensus 100 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~ 147 (321)
T 2c30_A 100 QHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVC 147 (321)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHH
T ss_pred CCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHH
Confidence 9999999999999999999999999999999998743 47788777664
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.48 E-value=1.1e-13 Score=137.94 Aligned_cols=106 Identities=20% Similarity=0.332 Sum_probs=86.7
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC------
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL------ 534 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~------ 534 (571)
++|++.+.||+|+||.||+|+. .+|+.||||++..... ....+.+.+|++++++++|||||+++++|.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST--TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 4689999999999999999995 4899999999975432 234578999999999999999999999986643
Q ss_pred ---------------------------------------------------eeEEEEeccCCCChhhhhccCCCccCCCH
Q 044615 535 ---------------------------------------------------HSFVVYEYLEMGSLAMNLSNDAAAEQFCW 563 (571)
Q Consensus 535 ---------------------------------------------------~~~lv~e~~~~G~L~~~l~~~~~~~~l~w 563 (571)
..|+|||||++|+|.+++..........|
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 37999999999999999987665556666
Q ss_pred HHHhhh
Q 044615 564 TKRMNA 569 (571)
Q Consensus 564 ~~r~~i 569 (571)
....+|
T Consensus 164 ~~~~~i 169 (332)
T 3qd2_B 164 GVCLHI 169 (332)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 555544
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.48 E-value=9.6e-14 Score=137.05 Aligned_cols=105 Identities=25% Similarity=0.437 Sum_probs=90.5
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.++|...+.||+|+||.||+|. ..+++.||+|.+... .....+.|.+|++++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI 85 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence 3568899999999999999999 457999999998543 234567899999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||+++|+|.++++.... .++|.++..|+
T Consensus 86 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~ 114 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMDS--QYPWSQRVSFA 114 (310)
T ss_dssp EECCTTCBHHHHHHHCCT--TSCHHHHHHHH
T ss_pred EEecCCCcHHHHHHhccC--CCCHHHHHHHH
Confidence 999999999999986433 57888877764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=5.8e-14 Score=140.86 Aligned_cols=91 Identities=23% Similarity=0.223 Sum_probs=78.8
Q ss_pred HHHccCCCccCeeeccCcceEEEEEc----CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEe
Q 044615 458 IRATNNFDDGHCIGNGGQGSVYKAKL----PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSH 532 (571)
Q Consensus 458 ~~~~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~ 532 (571)
....+.|++.+.||+|+||+||+|+. .+++.||||.+.+.. ...++.+|+++++.+ +|||||++++++.+
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~ 91 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRK 91 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence 34567899999999999999999973 257789999986542 135688999999988 69999999999999
Q ss_pred CCeeEEEEeccCCCChhhhhc
Q 044615 533 ALHSFVVYEYLEMGSLAMNLS 553 (571)
Q Consensus 533 ~~~~~lv~e~~~~G~L~~~l~ 553 (571)
.+..|+|||||++|+|.++++
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~~ 112 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDILN 112 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHHT
T ss_pred CCEEEEEEeCCCcccHHHHHc
Confidence 999999999999999999995
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.47 E-value=1.2e-13 Score=134.58 Aligned_cols=93 Identities=15% Similarity=0.070 Sum_probs=83.8
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
+.|++.+.||+|+||.||+|.. .+++.||||++...........+.|.+|+.++++++||||+++++++.+.+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 4699999999999999999994 569999999998765555555678999999999999999999999999999999999
Q ss_pred eccCCCChhhhhcc
Q 044615 541 EYLEMGSLAMNLSN 554 (571)
Q Consensus 541 e~~~~G~L~~~l~~ 554 (571)
||++||+|.+++++
T Consensus 111 e~~~g~~L~~~l~~ 124 (286)
T 3uqc_A 111 EWIRGGSLQEVADT 124 (286)
T ss_dssp ECCCEEEHHHHHTT
T ss_pred EecCCCCHHHHHhc
Confidence 99999999999964
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.47 E-value=1.3e-13 Score=139.80 Aligned_cols=105 Identities=24% Similarity=0.393 Sum_probs=88.8
Q ss_pred cCCCccCeeeccCcceEEEEEcC----CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLP----TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSF 537 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~ 537 (571)
.+|++.+.||+|+||.||+|+.. ++..||||.+.... .....++|.+|+.++++++|||||++++++.+.+..|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 46899999999999999999853 57789999997543 2344678999999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 538 VVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+||||+++|+|.++++..+ ..++|.+++.|+
T Consensus 123 lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~ 153 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHD--AQFTVIQLVGML 153 (373)
T ss_dssp EEEECCTTCBHHHHHHTTT--TCSCHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHH
Confidence 9999999999999998543 357888877664
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.47 E-value=1.2e-13 Score=137.32 Aligned_cols=106 Identities=21% Similarity=0.277 Sum_probs=88.5
Q ss_pred HccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEE
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFV 538 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l 538 (571)
..++|++.+.||+|+||.||+|. ..+|+.||||++...... ....+.+.+|+++++.++||||+++++++.+.+..|+
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 34679999999999999999999 468999999999754332 3446778999999999999999999999999999999
Q ss_pred EEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 539 VYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
||||+++|+|.+++...+ .+++.....+
T Consensus 92 v~e~~~~~~L~~~l~~~~---~l~~~~~~~~ 119 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAHG---RMKEKEARSK 119 (328)
T ss_dssp EECCCTTCBHHHHHHHHC---CCCHHHHHHH
T ss_pred EEECCCCCcHHHHHHHcC---CCCHHHHHHH
Confidence 999999999999997543 3555544443
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=1.5e-13 Score=132.63 Aligned_cols=103 Identities=21% Similarity=0.379 Sum_probs=88.3
Q ss_pred cCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
++|+..+.||+|+||.||+|...+++.||+|++...... .+++.+|++++++++||||+++++++.+....|+|||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 468899999999999999999778889999999764322 3679999999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+++|+|.+++..... .+++.....|+
T Consensus 86 ~~~~~~L~~~l~~~~~--~~~~~~~~~i~ 112 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQRG--LFAAETLLGMC 112 (269)
T ss_dssp CCTTCBHHHHHHTTTT--CCCHHHHHHHH
T ss_pred eCCCCcHHHHHHhcCc--ccCHHHHHHHH
Confidence 9999999999975433 46777666553
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=2.5e-13 Score=133.17 Aligned_cols=102 Identities=23% Similarity=0.333 Sum_probs=86.5
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.+.|+..+.||+|+||.||+|. ..+++.||||++....... .+.+.+|+.++++++|||||++++++...+..|+|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 3579999999999999999999 5689999999987543332 46789999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
|||+++|+|.+++.+. .+++.....|
T Consensus 96 ~e~~~~~~L~~~~~~~----~~~~~~~~~~ 121 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET----CMDEGQIAAV 121 (297)
T ss_dssp EECCTTCBHHHHHHHS----CCCHHHHHHH
T ss_pred EECCCCCCHHHHHhhc----CCCHHHHHHH
Confidence 9999999999999754 3555555444
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.46 E-value=2.9e-13 Score=120.78 Aligned_cols=89 Identities=22% Similarity=0.291 Sum_probs=48.1
Q ss_pred CCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEEC
Q 044615 266 VKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDI 345 (571)
Q Consensus 266 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l 345 (571)
++|+.|+|++|.+++..|..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|
T Consensus 30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 109 (170)
T 3g39_A 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL 109 (170)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence 34455555555555444445555555555555555555444444555555555555555555554445555555566666
Q ss_pred cCCcCcccC
Q 044615 346 SYNALQGLI 354 (571)
Q Consensus 346 s~N~l~~~~ 354 (571)
++|++++..
T Consensus 110 ~~N~~~c~c 118 (170)
T 3g39_A 110 LNNPWDCAC 118 (170)
T ss_dssp CSSCBCTTB
T ss_pred CCCCCCCCc
Confidence 666555443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=1.9e-13 Score=137.66 Aligned_cols=107 Identities=21% Similarity=0.276 Sum_probs=88.9
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCch---HhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCee
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEM---ACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHS 536 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~ 536 (571)
.+.|++.+.||+|+||.||+|. ..+|+.||||++.+...... ...+.+.+|+.++++++|||||++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 3569999999999999999999 45799999999976543211 1356799999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+||||+++|+|.+++...+ .+++.....|+
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~ 121 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE---SLSEEEATSFI 121 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS---CCBHHHHHHHH
T ss_pred EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHH
Confidence 99999999999999997532 46666665543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.45 E-value=2.8e-13 Score=120.88 Aligned_cols=107 Identities=27% Similarity=0.276 Sum_probs=77.4
Q ss_pred cceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCC
Q 044615 68 EATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSL 147 (571)
Q Consensus 68 l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L 147 (571)
.+.+++++|.++. +|..+. ++|++|+|++|.+++..|..|.++++|++|+|++|+|++..+..|.++++|
T Consensus 11 ~~~l~~s~n~l~~--------ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L 80 (170)
T 3g39_A 11 GTTVDCSGKSLAS--------VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQL 80 (170)
T ss_dssp TTEEECTTSCCSS--------CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTC
T ss_pred CCEEEeCCCCcCc--------cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCC
Confidence 4556666666653 555553 677788888888777667777777888888888888776666667777788
Q ss_pred CeeecccCcCcccCCccccCCCCCCEEEccCCCCCcc
Q 044615 148 SILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGS 184 (571)
Q Consensus 148 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 184 (571)
++|+|++|.+.+..+..|..+++|++|+|++|.+...
T Consensus 81 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 81 TQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred CEEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 8888888877766556677777778888877777643
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=3.3e-14 Score=146.56 Aligned_cols=114 Identities=18% Similarity=0.107 Sum_probs=89.9
Q ss_pred HHHHHHHccCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEe
Q 044615 454 HEEIIRATNNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSH 532 (571)
Q Consensus 454 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~ 532 (571)
..++....++|+..+.||+|+||+||+|+. .+++.||||++.+.........+.+.+|+.++..++|||||+++++|.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 344555678899999999999999999995 4688999999864221111122348899999999999999999999999
Q ss_pred CCeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 533 ALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 533 ~~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
.+..|+|||||++|+|.+++.+... .+++.....+
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~~--~l~e~~~~~~ 180 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFED--RLPEEMARFY 180 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTTT--CCCHHHHHHH
T ss_pred CCEEEEEEecCCCCcHHHHHHHccC--CCCHHHHHHH
Confidence 9999999999999999999986332 3566555443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.44 E-value=4e-14 Score=144.90 Aligned_cols=114 Identities=19% Similarity=0.113 Sum_probs=90.5
Q ss_pred HHHHHHHccCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEe
Q 044615 454 HEEIIRATNNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSH 532 (571)
Q Consensus 454 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~ 532 (571)
.++.....++|+..+.||+|+||+||+|+. .+|+.||||++.+.........+.+.+|+.++..++|||||++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 344445568899999999999999999994 5899999999964321111223458899999999999999999999999
Q ss_pred CCeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 533 ALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 533 ~~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
.+..|+||||+++|+|.+++.+.+. .+++.....+
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~~--~l~~~~~~~~ 167 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFGE--RIPAEMARFY 167 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSS--CCCHHHHHHH
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCC--CCCHHHHHHH
Confidence 9999999999999999999975432 3555554433
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.44 E-value=2.6e-13 Score=134.55 Aligned_cols=104 Identities=14% Similarity=0.135 Sum_probs=87.9
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.++|++.+.||+|+||.||+|. ..+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 3579999999999999999999 4578999999987432 3356789999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||+++|+|.+++.... ..+++.....|+
T Consensus 80 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~ 108 (321)
T 1tki_A 80 FEFISGLDIFERINTSA--FELNEREIVSYV 108 (321)
T ss_dssp ECCCCCCBHHHHHTSSS--CCCCHHHHHHHH
T ss_pred EEeCCCCCHHHHHHhcC--CCCCHHHHHHHH
Confidence 99999999999997543 246776665553
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.44 E-value=5.3e-13 Score=119.55 Aligned_cols=105 Identities=26% Similarity=0.283 Sum_probs=73.4
Q ss_pred ceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCC
Q 044615 69 ATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLS 148 (571)
Q Consensus 69 ~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 148 (571)
+.+++++|+++ .+|..+. ++|++|+|++|.+++..|..|.++++|++|+|++|+|++..+..|.++++|+
T Consensus 15 ~~l~~~~n~l~--------~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~ 84 (174)
T 2r9u_A 15 TLVNCQNIRLA--------SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLT 84 (174)
T ss_dssp SEEECCSSCCS--------SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred cEEEeCCCCCC--------ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhh
Confidence 45566666554 3555553 6777777777777766677777777777777777777766555667777777
Q ss_pred eeecccCcCcccCCccccCCCCCCEEEccCCCCCc
Q 044615 149 ILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNG 183 (571)
Q Consensus 149 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 183 (571)
+|+|++|.+.+..+..|..+++|++|+|++|.+..
T Consensus 85 ~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 85 QLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred EEECCCCccceeCHHHhccccCCCEEEeCCCCccc
Confidence 77777777775555557777777777777777763
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.43 E-value=3.2e-13 Score=136.24 Aligned_cols=106 Identities=18% Similarity=0.245 Sum_probs=89.4
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.++|++.+.||+|+||.||+|. ..+++.||+|++...... ....+.+.+|++++++++|||||++++++.+.+..|+|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3569999999999999999998 457999999999765433 34457799999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||+++|+|.+++.... .+++.....|+
T Consensus 107 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~ 134 (362)
T 2bdw_A 107 FDLVTGGELFEDIVARE---FYSEADASHCI 134 (362)
T ss_dssp ECCCCSCBHHHHHTTCS---CCCHHHHHHHH
T ss_pred EecCCCCCHHHHHHHcC---CCCHHHHHHHH
Confidence 99999999999997542 46666655543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.43 E-value=2.5e-13 Score=134.67 Aligned_cols=107 Identities=21% Similarity=0.343 Sum_probs=88.9
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC--eeEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL--HSFV 538 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~--~~~l 538 (571)
+.|.+.+.||+|+||.||+|. ..+++.||||++..... ....+.+.+|++++++++||||+++++++.... ..|+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 458899999999999999999 45799999999974322 123567889999999999999999999998765 7799
Q ss_pred EEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 539 VYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||||+++|+|.+++........+++.....|+
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~ 118 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHH
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHH
Confidence 99999999999999865544458888777664
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=1.9e-13 Score=131.86 Aligned_cols=106 Identities=16% Similarity=0.218 Sum_probs=89.6
Q ss_pred cCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC--CeeEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA--LHSFVV 539 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~--~~~~lv 539 (571)
++|+..+.||+|+||.||+|+.. ++.||||++...... ....+.|.+|+.++++++||||+++++++.+. ...++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWS-TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCC-HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 46889999999999999999974 888999999865433 34457799999999999999999999999887 778999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||+++|+|.++++... ...++|..+..|+
T Consensus 88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~ 117 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGT-NFVVDQSQAVKFA 117 (271)
T ss_dssp EECCTTCBHHHHHHSCS-SCCCCHHHHHHHH
T ss_pred ecccCCCcHHHHHhhcc-cCCCCHHHHHHHH
Confidence 99999999999998643 2357888777664
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=2.6e-13 Score=135.91 Aligned_cols=105 Identities=19% Similarity=0.221 Sum_probs=88.3
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCeeEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lv 539 (571)
++|+..+.||+|+||.||+|+. .+++.||||++.+.........+.+.+|+.++.++ +|||||++++++.+.+..|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 5689999999999999999994 57899999999865544445567789999999987 899999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
|||+++|+|.+++...+ .+++.....+
T Consensus 89 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~ 115 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR---KLPEEHARFY 115 (345)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHH
T ss_pred EeCCCCCcHHHHHHHcC---CCCHHHHHHH
Confidence 99999999999997542 3555555444
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.43 E-value=1.2e-13 Score=137.85 Aligned_cols=105 Identities=21% Similarity=0.196 Sum_probs=85.9
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|+..+.||+|+||+||+|+ ..+|+.||+|++.+.........+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 579999999999999999999 4579999999996532111223567889999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
||+++|+|.+++...+ .+++.+...+
T Consensus 85 E~~~gg~L~~~l~~~~---~~~~~~~~~~ 110 (337)
T 1o6l_A 85 EYANGGELFFHLSRER---VFTEERARFY 110 (337)
T ss_dssp ECCTTCBHHHHHHHHS---CCCHHHHHHH
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHH
Confidence 9999999999997542 3555544433
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.43 E-value=2.9e-13 Score=137.03 Aligned_cols=108 Identities=22% Similarity=0.380 Sum_probs=89.0
Q ss_pred ccCCCccCeeeccCcceEEEEEc--------CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKL--------PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCS 531 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~ 531 (571)
.++|++.+.||+|+||.||+|+. .++..||||++.... .....+.+.+|+++++++ +|||||+++++|.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 35688999999999999999973 245579999997542 334567899999999999 8999999999999
Q ss_pred eCCeeEEEEeccCCCChhhhhccCCC-------------ccCCCHHHHhhhc
Q 044615 532 HALHSFVVYEYLEMGSLAMNLSNDAA-------------AEQFCWTKRMNAI 570 (571)
Q Consensus 532 ~~~~~~lv~e~~~~G~L~~~l~~~~~-------------~~~l~w~~r~~ia 570 (571)
+.+..|+||||+++|+|.+++..... ...++|...++|+
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 209 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 209 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHH
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHH
Confidence 99999999999999999999986432 2357887776654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.43 E-value=1.3e-13 Score=136.53 Aligned_cols=106 Identities=19% Similarity=0.252 Sum_probs=86.6
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.++|++.+.||+|+||.||+|+ ..+|+.||+|++.+.........+.+.+|+.+++.++|||||++++++.+....|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 3569999999999999999999 458999999999753221223356788999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
|||+++|+|.+++.... .+++.....+
T Consensus 85 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~ 111 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ---RFPNPVAKFY 111 (318)
T ss_dssp ECCCCSCBHHHHHHHTS---SCCHHHHHHH
T ss_pred EeCCCCCCHHHHHHHcC---CCCHHHHHHH
Confidence 99999999999997543 3555554433
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=4.5e-14 Score=144.43 Aligned_cols=100 Identities=17% Similarity=0.198 Sum_probs=82.9
Q ss_pred HHHHHccCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC
Q 044615 456 EIIRATNNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL 534 (571)
Q Consensus 456 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~ 534 (571)
++....++|++.+.||+|+||+||+|+. .+++.||+|++.+.........+.+.+|+.+++.++|||||+++++|.+.+
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 4444567899999999999999999994 578999999986421111111245789999999999999999999999999
Q ss_pred eeEEEEeccCCCChhhhhccC
Q 044615 535 HSFVVYEYLEMGSLAMNLSND 555 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~~ 555 (571)
..|+|||||+||+|.+++++.
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~~ 163 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSNY 163 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHHC
T ss_pred EEEEEEeCCCCCcHHHHHHcC
Confidence 999999999999999999753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=3e-13 Score=134.31 Aligned_cols=105 Identities=24% Similarity=0.309 Sum_probs=85.9
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.++|++.+.||+|+||.||+|. ..+++.||||++...... ...+.+.+|+.+++.++|||||++++++.+.+..|+|
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 3579999999999999999999 458999999999754322 2245688999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||+++|+|.+++.... .+++.....|+
T Consensus 84 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~ 111 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDI---GMPEPDAQRFF 111 (323)
T ss_dssp EECCTTEEGGGGSBTTT---BCCHHHHHHHH
T ss_pred EEcCCCCcHHHHHhhcC---CCCHHHHHHHH
Confidence 99999999999997542 46777666554
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=3.4e-13 Score=133.97 Aligned_cols=105 Identities=24% Similarity=0.403 Sum_probs=87.6
Q ss_pred cCCCccCeeeccCcceEEEEEcC----CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLP----TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSF 537 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~ 537 (571)
+.|.+.+.||+|+||.||+|... .+..||||.+.... .....+.|.+|++++++++||||+++++++.+.+..|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 46888999999999999999853 34459999997543 2344678999999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 538 VVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+||||+++|+|.++++.... .++|..+..|+
T Consensus 127 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~ 157 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTHDG--QFTIMQLVGML 157 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTT--CSCHHHHHHHH
T ss_pred EEeeCCCCCcHHHHHHhccc--CCCHHHHHHHH
Confidence 99999999999999975433 57787777664
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.42 E-value=6.6e-13 Score=118.90 Aligned_cols=88 Identities=22% Similarity=0.286 Sum_probs=42.7
Q ss_pred CCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEEC
Q 044615 266 VKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDI 345 (571)
Q Consensus 266 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l 345 (571)
++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|++
T Consensus 33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L 112 (174)
T 2r9u_A 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL 112 (174)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence 34444444444444444444444444444445444444433333445555555555555555444444555555555555
Q ss_pred cCCcCccc
Q 044615 346 SYNALQGL 353 (571)
Q Consensus 346 s~N~l~~~ 353 (571)
++|++.+.
T Consensus 113 ~~N~~~c~ 120 (174)
T 2r9u_A 113 YNNPWDCE 120 (174)
T ss_dssp CSSCBCTT
T ss_pred CCCCcccc
Confidence 55555443
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=4.8e-13 Score=133.00 Aligned_cols=106 Identities=19% Similarity=0.274 Sum_probs=88.3
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCc---hHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDE---MACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSF 537 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~ 537 (571)
+.|+..+.||+|+||.||+|. ..+|+.||||.+....... ....+.+.+|+.++++++||||+++++++.+....|
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 358899999999999999999 4579999999997543321 123577999999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 538 VVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+||||+++|+|.+++... ..+++.....|+
T Consensus 91 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~ 120 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK---ESLTEEEATEFL 120 (326)
T ss_dssp EEEECCCSCBHHHHHTTS---SCCBHHHHHHHH
T ss_pred EEEEcCCCCCHHHHHHhc---CCcCHHHHHHHH
Confidence 999999999999999753 246777666554
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.42 E-value=4.6e-13 Score=135.07 Aligned_cols=102 Identities=24% Similarity=0.286 Sum_probs=86.5
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.++|++.+.||+|+||.||+|+ ..+++.||||++....... +.+.+|+.++++++|||||++++++.+.+..|+|
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 94 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAII 94 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence 3569999999999999999999 4589999999997654332 5688999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
|||+++|+|.+++...+ .+++.....|
T Consensus 95 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i 121 (361)
T 3uc3_A 95 MEYASGGELYERICNAG---RFSEDEARFF 121 (361)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHH
T ss_pred EEeCCCCCHHHHHHhcC---CCCHHHHHHH
Confidence 99999999999997533 3566655544
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=2.4e-13 Score=131.14 Aligned_cols=104 Identities=25% Similarity=0.372 Sum_probs=88.7
Q ss_pred ccCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
.++|++.+.||+|+||.||+|..+++..||||++...... .+++.+|++++.+++||||+++++++.+....|+||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 3568899999999999999999878888999999754322 367899999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||+++|+|.+++...+ ..+++..+..|+
T Consensus 83 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~ 110 (268)
T 3sxs_A 83 EYISNGCLLNYLRSHG--KGLEPSQLLEMC 110 (268)
T ss_dssp ECCTTCBHHHHHHHHG--GGCCHHHHHHHH
T ss_pred EccCCCcHHHHHHHcC--CCCCHHHHHHHH
Confidence 9999999999997542 247777776654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=1.5e-13 Score=135.71 Aligned_cols=106 Identities=21% Similarity=0.320 Sum_probs=88.9
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCe----e
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALH----S 536 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~----~ 536 (571)
+.|++.+.||+|+||.||+|+ ..+++.||||++...........+.+.+|++++++++||||+++++++..... .
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 569999999999999999999 56899999999987655555556789999999999999999999999876543 4
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+||||+++|+|.++++..+ .+++.....|+
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~ 122 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVI 122 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHC---SCCHHHHHHHH
T ss_pred EEEEecCCCCCHHHHHHhcC---CCCHHHHHHHH
Confidence 99999999999999997543 46777666554
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=1.7e-13 Score=139.25 Aligned_cols=106 Identities=24% Similarity=0.443 Sum_probs=88.8
Q ss_pred ccCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.++|...+.||+|+||.||+|.. .+++.||||.+.... .....++|.+|++++++++|||||++++++.+.+..|+|
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 35688899999999999999995 479999999987542 223456789999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||+++|+|.++++..+ ..+++...+.|+
T Consensus 191 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~ 219 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEG--ARLRVKTLLQMV 219 (377)
T ss_dssp EECCTTCBHHHHHHHHG--GGCCHHHHHHHH
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHH
Confidence 99999999999997543 247777766654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=1.5e-13 Score=139.27 Aligned_cols=105 Identities=18% Similarity=0.216 Sum_probs=87.0
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|++.+.||+|+||.||+|. ..+++.||+|++.+.........+.+.+|++++++++|||||+++++|.+.+..|+||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 468999999999999999999 5578999999986432222233567899999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
||+++|+|.+++.... .+++.....+
T Consensus 95 e~~~gg~L~~~l~~~~---~l~~~~~~~~ 120 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNV---HFKEETVKLF 120 (384)
T ss_dssp CCCTTEEHHHHHHTTC---CCCHHHHHHH
T ss_pred ecCCCCcHHHHHHhcC---CCCHHHHHHH
Confidence 9999999999998542 3666655544
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.41 E-value=1.9e-13 Score=137.19 Aligned_cols=105 Identities=20% Similarity=0.222 Sum_probs=86.8
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|+..+.||+|+||.||+|+ ..+|+.||||++.+.........+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 568999999999999999999 4589999999986532222233567899999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
||+++|+|.+++.+.+ .+++.....+
T Consensus 121 e~~~gg~L~~~l~~~~---~~~~~~~~~~ 146 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG---RFSEPHARFY 146 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHH
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHH
Confidence 9999999999998543 3555555444
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.41 E-value=2.1e-13 Score=136.90 Aligned_cols=107 Identities=19% Similarity=0.256 Sum_probs=86.7
Q ss_pred HccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCeeE
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHSF 537 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~ 537 (571)
..++|++.+.||+|+||+||+|+ ..+++.||||++.+.........+.+.+|++++..+ +|||||++++++.+.+..|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 34679999999999999999999 457999999999753222223456788999999988 7999999999999999999
Q ss_pred EEEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 538 VVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
+|||||++|+|.+++...+ .+++.....+
T Consensus 101 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~ 129 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSR---RFDEARARFY 129 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHH
Confidence 9999999999999997542 3566555444
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.41 E-value=3.3e-13 Score=131.24 Aligned_cols=104 Identities=21% Similarity=0.356 Sum_probs=85.9
Q ss_pred ccCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
.++|+..+.||+|+||.||+|...++..||||++...... .+++.+|++++.+++||||+++++++.+.+..|+||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 3468899999999999999999878889999999765332 367899999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||+++|+|.+++.... ..+++.....|+
T Consensus 99 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~ 126 (283)
T 3gen_A 99 EYMANGCLLNYLREMR--HRFQTQQLLEMC 126 (283)
T ss_dssp CCCTTCBHHHHHHCGG--GCCCHHHHHHHH
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHH
Confidence 9999999999997532 247777776654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.41 E-value=5.6e-13 Score=135.46 Aligned_cols=105 Identities=16% Similarity=0.279 Sum_probs=88.7
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.+.|++.+.||+|+||.||+|. ..+|+.||+|.+.... ......+.+|++++++++|||||++++++.+....|+|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 3569999999999999999999 4589999999997543 23356789999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||+++|+|.+++.... ..+++.....|+
T Consensus 127 ~E~~~gg~L~~~l~~~~--~~l~~~~~~~i~ 155 (387)
T 1kob_A 127 LEFLSGGELFDRIAAED--YKMSEAEVINYM 155 (387)
T ss_dssp EECCCCCBHHHHTTCTT--CCBCHHHHHHHH
T ss_pred EEcCCCCcHHHHHHhhc--CCCCHHHHHHHH
Confidence 99999999999997543 246777666554
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.41 E-value=2.5e-13 Score=141.57 Aligned_cols=107 Identities=23% Similarity=0.312 Sum_probs=88.4
Q ss_pred ccCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.++|.+.+.||+|+||.||+|+. .+|+.||||++...........+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 35699999999999999999994 58999999999643222222356789999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||+++|+|.+++...+ .+++.....|+
T Consensus 95 ~E~~~gg~L~~~l~~~~---~l~~~~~~~i~ 122 (476)
T 2y94_A 95 MEYVSGGELFDYICKNG---RLDEKESRRLF 122 (476)
T ss_dssp EECCSSEEHHHHTTSSS---SCCHHHHHHHH
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHH
Confidence 99999999999997542 46776665553
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.41 E-value=2.4e-13 Score=138.27 Aligned_cols=106 Identities=17% Similarity=0.194 Sum_probs=85.8
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCeeEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHSFV 538 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~l 538 (571)
.++|++.+.||+|+||+||+|+ ..+++.||||++.+.........+.+.+|..++.++ +|||||++++++.+.+..|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 4579999999999999999999 457889999999765433333345688999999887 89999999999999999999
Q ss_pred EEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 539 VYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
||||+++|+|.+++.+.+ .+++.....+
T Consensus 131 V~E~~~gg~L~~~l~~~~---~l~~~~~~~~ 158 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR---KLPEEHARFY 158 (396)
T ss_dssp EEECCTTCBHHHHHHHHS---SCCHHHHHHH
T ss_pred EEEcCCCCcHHHHHHHcC---CCCHHHHHHH
Confidence 999999999999997542 3666655544
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=8.5e-13 Score=130.18 Aligned_cols=110 Identities=21% Similarity=0.258 Sum_probs=89.6
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.++|++.+.||+|+||.||+|. ..+|+.||||++...........+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 3569999999999999999999 568999999999865444455677899999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCC-CccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDA-AAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~-~~~~l~w~~r~~ia 570 (571)
|||+++|+|.+++.... ....+++....+|+
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~ 142 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYF 142 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHH
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHH
Confidence 99999999999997421 22346666665543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.40 E-value=6.4e-13 Score=133.04 Aligned_cols=110 Identities=24% Similarity=0.402 Sum_probs=91.1
Q ss_pred HHccCCCccCeeeccCcceEEEEEcC------CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEe
Q 044615 459 RATNNFDDGHCIGNGGQGSVYKAKLP------TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSH 532 (571)
Q Consensus 459 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~ 532 (571)
...++|+..+.||+|+||.||+|+.. +++.||||.+.... .....+.|.+|++++++++||||+++++++.+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 34567999999999999999999853 45789999997543 23446789999999999999999999999999
Q ss_pred CCeeEEEEeccCCCChhhhhccCCC---------------------ccCCCHHHHhhhc
Q 044615 533 ALHSFVVYEYLEMGSLAMNLSNDAA---------------------AEQFCWTKRMNAI 570 (571)
Q Consensus 533 ~~~~~lv~e~~~~G~L~~~l~~~~~---------------------~~~l~w~~r~~ia 570 (571)
.+..|+||||+++|+|.+++..... ...++|.+++.|+
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 180 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIA 180 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHH
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHH
Confidence 9999999999999999999975321 1467888777664
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=2.1e-13 Score=136.43 Aligned_cols=108 Identities=18% Similarity=0.222 Sum_probs=86.5
Q ss_pred HHccCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCee
Q 044615 459 RATNNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHS 536 (571)
Q Consensus 459 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~ 536 (571)
...++|++.+.||+|+||.||+|+. .+|+.||||++.+.........+.+.+|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 3457899999999999999999994 57899999999753211112346688999999876 999999999999999999
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
|+||||+++|+|.+++...+ .+++.+...+
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~ 123 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCH---KFDLSRATFY 123 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHS---SCCHHHHHHH
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHH
Confidence 99999999999999997532 3666655544
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.40 E-value=6.5e-13 Score=135.52 Aligned_cols=108 Identities=19% Similarity=0.188 Sum_probs=90.2
Q ss_pred ccCCCccCeeecc--CcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeE
Q 044615 461 TNNFDDGHCIGNG--GQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSF 537 (571)
Q Consensus 461 ~~~~~~~~~lg~G--~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~ 537 (571)
.++|++.+.||+| +||.||+|+. .+++.||||++...... ....+.+.+|++++++++|||||++++++.+.+..|
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 3569999999999 9999999994 58999999999764332 344677889999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 538 VVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+|||||++|+|.+++..... ..+++.....|+
T Consensus 103 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~ 134 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFM-DGMNELAIAYIL 134 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCT-TCCCHHHHHHHH
T ss_pred EEEEccCCCCHHHHHhhhcc-cCCCHHHHHHHH
Confidence 99999999999999975422 246776665553
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.40 E-value=3.7e-13 Score=141.62 Aligned_cols=105 Identities=22% Similarity=0.379 Sum_probs=89.0
Q ss_pred ccCCCccCeeeccCcceEEEEEcC-CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKLP-TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
..+|+..+.||+|+||.||+|..+ ++..||||.+..... ..++|.+|+++|++++|||||+++++|.+....|+|
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 346888899999999999999954 588999999975432 257899999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||||++|+|.++++.... ..++|..++.|+
T Consensus 295 ~E~~~~g~L~~~l~~~~~-~~~~~~~~~~i~ 324 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 324 (495)
T ss_dssp EECCTTCBHHHHHHHSCT-TTSCHHHHHHHH
T ss_pred EEccCCCCHHHHHHhcCc-CCCCHHHHHHHH
Confidence 999999999999975432 357888777654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=6.2e-13 Score=130.11 Aligned_cols=107 Identities=19% Similarity=0.225 Sum_probs=90.6
Q ss_pred ccCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.++|...+.||+|+||.||+|.. .+++.||+|.+...........+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 35689999999999999999994 57899999999765444445567899999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||+++|+|.+++.... .+++.+...|+
T Consensus 94 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~ 121 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK---ALTEPEARYYL 121 (294)
T ss_dssp EECCTTCBHHHHHHHHC---SCCHHHHHHHH
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHH
Confidence 99999999999887532 46777666654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.40 E-value=2.7e-13 Score=131.51 Aligned_cols=108 Identities=22% Similarity=0.377 Sum_probs=89.2
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.++|++.+.||+|+||.||+|+ ..+|+.||||.+...........+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 4579999999999999999999 468999999998643211122246789999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||+++|+|.+++.... ..+++..+..|+
T Consensus 90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ 118 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV--KPFSENEARHFM 118 (278)
T ss_dssp EECCTTEEHHHHHHTCS--SCCCHHHHHHHH
T ss_pred EecCCCCcHHHHHhhcc--CCCCHHHHHHHH
Confidence 99999999999998543 257777766654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.40 E-value=6.2e-13 Score=140.47 Aligned_cols=107 Identities=21% Similarity=0.291 Sum_probs=85.8
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCch----------HhHHHHHHHHHHHhhcCCCCcccEEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEM----------ACQQEFLNEVNALTKIRHRNIVKFYGF 529 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~----------~~~~~~~~Ei~~l~~l~H~niv~l~~~ 529 (571)
.+.|.+.+.||+|+||.||+|. ..+++.||||++.+...... ...+.+.+|+.++++++|||||+++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 4679999999999999999999 45789999999976432211 235678999999999999999999999
Q ss_pred EEeCCeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 530 CSHALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 530 ~~~~~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+.+....|+|||||++|+|.+++.... .+++.....|+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~ 152 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIM 152 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHH
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHH
Confidence 999999999999999999999997542 47777666554
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=3.1e-13 Score=143.04 Aligned_cols=109 Identities=20% Similarity=0.248 Sum_probs=89.3
Q ss_pred ccCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.++|+..+.||+|+||.||+|+. .+|+.||||++.+.........+.+.+|++++++++|||||++++++.+.+..|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 35688999999999999999994 58999999999653222222346688999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||++||+|.+++...+. ..+++.....++
T Consensus 263 mEy~~gg~L~~~l~~~~~-~~l~e~~~~~i~ 292 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQ-AGFPEARAVFYA 292 (576)
T ss_dssp ECCCCSCBHHHHHHSSSS-CCCCHHHHHHHH
T ss_pred EEcCCCCcHHHHHHhcCC-CCCCHHHHHHHH
Confidence 999999999999985432 347777666553
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=5.9e-13 Score=129.63 Aligned_cols=109 Identities=28% Similarity=0.391 Sum_probs=90.5
Q ss_pred ccCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCeeEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHSFV 538 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~l 538 (571)
.++|++.+.||+|+||.||+|.. .+++.||||++....... ....++.+|+..+.++ +||||+++++++.+.+..++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 35699999999999999999994 589999999998654333 3456788999999999 99999999999999999999
Q ss_pred EEeccCCCChhhhhccCCC-ccCCCHHHHhhhc
Q 044615 539 VYEYLEMGSLAMNLSNDAA-AEQFCWTKRMNAI 570 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~~~-~~~l~w~~r~~ia 570 (571)
||||+++|+|.+++..... ...+++.....|+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~ 121 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLL 121 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHH
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHH
Confidence 9999999999999975321 1357777766654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.39 E-value=6.4e-13 Score=131.02 Aligned_cols=107 Identities=17% Similarity=0.254 Sum_probs=90.7
Q ss_pred ccCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.++|++.+.||+|+||.||+|.. .+++.||+|++...........+.+.+|+.++++++||||+++++++...+..|+|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 46799999999999999999994 57899999999765444444467899999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||+++|+|.+++...+ .+++.....|+
T Consensus 113 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~ 140 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG---PLAPPRAVAIV 140 (309)
T ss_dssp EECCCCEEHHHHHHHHC---SCCHHHHHHHH
T ss_pred EEecCCCCHHHHHHhcC---CCCHHHHHHHH
Confidence 99999999999997542 46777666554
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.39 E-value=5.4e-13 Score=138.02 Aligned_cols=105 Identities=14% Similarity=0.210 Sum_probs=86.7
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.++|++.+.||+|+||.||+|. ..+|+.||+|++...... ....+.+.+|++++++++|||||++++++.+.+..|+|
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4569999999999999999998 568999999999865432 34467799999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
||||++|+|.+++...+ .+++.....|
T Consensus 89 ~E~~~gg~L~~~i~~~~---~~~e~~~~~i 115 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE---YYSEADASHC 115 (444)
T ss_dssp ECCCBCCBHHHHHHHCS---CCCHHHHHHH
T ss_pred EEeCCCCCHHHHHHHcC---CCCHHHHHHH
Confidence 99999999999997543 3566555444
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.39 E-value=2.4e-13 Score=136.65 Aligned_cols=108 Identities=17% Similarity=0.214 Sum_probs=86.3
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCC--CchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLP--DEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFV 538 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l 538 (571)
+.|++.+.||+|+||.||+|. ..+++.||||++..... ......+.+.+|+.++++++|||||++++++.+.+..|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 459999999999999999998 55899999999863211 111125679999999999999999999999999999999
Q ss_pred EEeccCCCChhhhhccCC-CccCCCHHHHhhh
Q 044615 539 VYEYLEMGSLAMNLSNDA-AAEQFCWTKRMNA 569 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~~-~~~~l~w~~r~~i 569 (571)
|||||++|+|.+++.... ....+++.....|
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i 135 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHY 135 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHH
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHH
Confidence 999999999998886432 2234666655544
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.39 E-value=4.8e-13 Score=136.78 Aligned_cols=107 Identities=21% Similarity=0.343 Sum_probs=88.6
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC--eeEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL--HSFV 538 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~--~~~l 538 (571)
+.|.+.+.||+|+||.||+|. ..+|+.||||++..... ....+.+.+|++++++++|||||++++++.... ..|+
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 458899999999999999999 45799999999974322 123567889999999999999999999998765 6799
Q ss_pred EEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 539 VYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||||+++|+|.+++........+++..+..|+
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~ 118 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHH
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHH
Confidence 99999999999999865444447888777664
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=8.4e-13 Score=132.37 Aligned_cols=105 Identities=27% Similarity=0.355 Sum_probs=88.5
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
.|+..+.||+|+||.||+|+ ..+++.||||++...........+.+.+|++++++++|||||++++++.+.+..|+|||
T Consensus 55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 134 (348)
T 1u5q_A 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134 (348)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence 48888999999999999999 56899999999986654444556789999999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|++ |++.+++.... ..++|..+..|+
T Consensus 135 ~~~-g~l~~~l~~~~--~~l~~~~~~~i~ 160 (348)
T 1u5q_A 135 YCL-GSASDLLEVHK--KPLQEVEIAAVT 160 (348)
T ss_dssp CCS-EEHHHHHHHHT--SCCCHHHHHHHH
T ss_pred cCC-CCHHHHHHHhc--CCCCHHHHHHHH
Confidence 998 68888886433 257777776654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=7.3e-13 Score=132.24 Aligned_cols=107 Identities=19% Similarity=0.234 Sum_probs=90.8
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.++|.+.+.||+|+||.||++. ..+++.||+|++...........+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 4568999999999999999999 457899999999765444445567899999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||+++|+|.+++.... .+++.++..|+
T Consensus 120 ~e~~~~~~L~~~~~~~~---~l~~~~~~~i~ 147 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK---ALTEPEARYYL 147 (335)
T ss_dssp ECCCTTCBHHHHHHHHC---SCCHHHHHHHH
T ss_pred EecCCCCCHHHHHhccC---CCCHHHHHHHH
Confidence 99999999999987532 46777666654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=6.6e-13 Score=127.84 Aligned_cols=103 Identities=21% Similarity=0.356 Sum_probs=88.1
Q ss_pred cCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
++|+..+.||+|+||.||+|...+++.||+|.+...... .+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 468889999999999999999778889999999765322 3678999999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+++|+|.+++..... .+++.....++
T Consensus 84 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~ 110 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRG--LFAAETLLGMC 110 (267)
T ss_dssp CCTTCBHHHHHHHTTT--CCCHHHHHHHH
T ss_pred CCCCCcHHHHHhhCcc--cCCHHHHHHHH
Confidence 9999999999975432 46777666553
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=6.6e-13 Score=139.61 Aligned_cols=106 Identities=24% Similarity=0.329 Sum_probs=89.9
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
+.|+..+.||+|+||.||+|. ..+|+.||||++.+.........+.+.+|+.++++++|||||++++++.+.+..|+||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 358999999999999999999 4589999999997655443344678999999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||+++|+|.+++.... .+++.....|+
T Consensus 106 e~~~~~~L~~~~~~~~---~~~~~~~~~i~ 132 (484)
T 3nyv_A 106 EVYTGGELFDEIISRK---RFSEVDAARII 132 (484)
T ss_dssp CCCCSCBHHHHHHTCS---CCBHHHHHHHH
T ss_pred ecCCCCCHHHHHHhcC---CCCHHHHHHHH
Confidence 9999999999997543 46666665553
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.38 E-value=4.9e-13 Score=135.39 Aligned_cols=100 Identities=20% Similarity=0.319 Sum_probs=79.6
Q ss_pred ccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEeccC
Q 044615 466 DGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLE 544 (571)
Q Consensus 466 ~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 544 (571)
..+.||+|+||.||+|. ..+|+.||+|++.... ....+.+.+|++++++++|||||++++++.+.+..|+||||++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 169 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD 169 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 35679999999999998 5689999999997543 2345789999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCccCCCHHHHhhhc
Q 044615 545 MGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 545 ~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+|+|.+++.... ..++|..+..|+
T Consensus 170 ~~~L~~~l~~~~--~~l~~~~~~~i~ 193 (373)
T 2x4f_A 170 GGELFDRIIDES--YNLTELDTILFM 193 (373)
T ss_dssp TCEEHHHHHHTG--GGCCHHHHHHHH
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHH
Confidence 999999997532 247777766653
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.38 E-value=2.1e-12 Score=126.31 Aligned_cols=104 Identities=20% Similarity=0.208 Sum_probs=84.8
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
+|.....||+|+||.||+|. ..+++.||||.+..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS---RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch---HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence 35556689999999999999 56789999999976432 235679999999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
|+++|+|.+++........+++.....|
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 127 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFY 127 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHH
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHH
Confidence 9999999999986544445566655443
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.38 E-value=2.2e-13 Score=135.70 Aligned_cols=106 Identities=20% Similarity=0.241 Sum_probs=86.4
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.++|.+.+.||+|+||.||+|. ..+++.||||++...........+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4579999999999999999999 568999999998643211112235789999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||+ +|+|.+++...+ .+++.....++
T Consensus 88 ~E~~-~g~l~~~l~~~~---~l~~~~~~~i~ 114 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK---RMTEDEGRRFF 114 (336)
T ss_dssp ECCC-CEEHHHHHHHHC---SCCHHHHHHHH
T ss_pred EECC-CCcHHHHHHHcC---CCCHHHHHHHH
Confidence 9999 689999997543 46666665543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.38 E-value=2.2e-11 Score=124.35 Aligned_cols=284 Identities=11% Similarity=-0.002 Sum_probs=158.6
Q ss_pred hhcCCCCCCEEEccCCccc------cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCc--------
Q 044615 43 ELVRAVQARDTSISFDELH------EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENI-------- 108 (571)
Q Consensus 43 ~l~~~~~l~~l~l~~n~l~------~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~-------- 108 (571)
.+.++.+|+.+.+..+ ++ |.++.+|+.+++..+ ++. .-...|.++.+|+.+.+..+-
T Consensus 66 AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~-------I~~~aF~~c~~L~~i~~p~~l~~i~~~aF 136 (394)
T 4fs7_A 66 AFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKM-------IGRCTFSGCYALKSILLPLMLKSIGVEAF 136 (394)
T ss_dssp TTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCE-------ECTTTTTTCTTCCCCCCCTTCCEECTTTT
T ss_pred HhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceE-------ccchhhcccccchhhcccCceeeecceee
Confidence 3556677777777543 32 666777777777543 221 112234445555544443221
Q ss_pred -------------CcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEE
Q 044615 109 -------------LNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILD 175 (571)
Q Consensus 109 -------------i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 175 (571)
+......+|.++++|+.+.+.++. ..+....|.++.+|+.+.+..| +.......|.++..|+.+.
T Consensus 137 ~~~~~~~~~~~~~~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~ 214 (394)
T 4fs7_A 137 KGCDFKEITIPEGVTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENME 214 (394)
T ss_dssp TTCCCSEEECCTTCCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCC
T ss_pred ecccccccccCccccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceee
Confidence 111223345555566666665433 2244445555666666665544 3333344555555666555
Q ss_pred ccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccc
Q 044615 176 LSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFH 255 (571)
Q Consensus 176 L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 255 (571)
+..+... +......... |+.+.+..+ +.......+..+..++.+.+..+... .....|..+..++.+....+.+
T Consensus 215 ~~~~~~~--i~~~~~~~~~-l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i- 288 (394)
T 4fs7_A 215 FPNSLYY--LGDFALSKTG-VKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIV- 288 (394)
T ss_dssp CCTTCCE--ECTTTTTTCC-CCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEE-
T ss_pred cCCCceE--eehhhcccCC-CceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceee-
Confidence 5443322 2222222232 666655432 22233445566667777776655333 4445566667777766655433
Q ss_pred cccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccc
Q 044615 256 KSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFE 335 (571)
Q Consensus 256 ~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~ 335 (571)
....+..+.+|+.+.+.++ ++......|.++.+|+.++|..+ ++.+...+|.++++|+.+++..| ++.+...+|.
T Consensus 289 --~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~ 363 (394)
T 4fs7_A 289 --PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQ 363 (394)
T ss_dssp --CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBT
T ss_pred --ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhh
Confidence 2345667777887777654 44455566777778888877643 55555667777888888887665 6666667788
Q ss_pred cCCCCCEEECcCC
Q 044615 336 EMHWLSCIDISYN 348 (571)
Q Consensus 336 ~l~~L~~L~ls~N 348 (571)
++.+|+.+++..+
T Consensus 364 ~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 364 GCINLKKVELPKR 376 (394)
T ss_dssp TCTTCCEEEEEGG
T ss_pred CCCCCCEEEECCC
Confidence 8888887777543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=5.6e-13 Score=134.41 Aligned_cols=100 Identities=23% Similarity=0.378 Sum_probs=83.0
Q ss_pred HHHHHHHccCCCccCeeeccCcceEEEEEc------CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccE
Q 044615 454 HEEIIRATNNFDDGHCIGNGGQGSVYKAKL------PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKF 526 (571)
Q Consensus 454 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l 526 (571)
..+.....++|++.+.||+|+||.||+|+. .+++.||||++.... .....+.+.+|++++.++ +|||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 345555667899999999999999999972 356789999997543 233457799999999999 88999999
Q ss_pred EEEEEeCC-eeEEEEeccCCCChhhhhccC
Q 044615 527 YGFCSHAL-HSFVVYEYLEMGSLAMNLSND 555 (571)
Q Consensus 527 ~~~~~~~~-~~~lv~e~~~~G~L~~~l~~~ 555 (571)
++++.+.+ ..++||||+++|+|.++++..
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~ 121 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSK 121 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTT
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhc
Confidence 99998755 489999999999999999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.37 E-value=5.5e-13 Score=140.67 Aligned_cols=108 Identities=20% Similarity=0.246 Sum_probs=88.9
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|...+.||+|+||+||+|+. .+|+.||||++.+.........+.+.+|++++++++|||||++++++.+....|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 5688899999999999999994 579999999996532222223567899999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCC-ccCCCHHHHhhh
Q 044615 541 EYLEMGSLAMNLSNDAA-AEQFCWTKRMNA 569 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~-~~~l~w~~r~~i 569 (571)
||++||+|.+++..... ...+++.....+
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~ 294 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHH
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHH
Confidence 99999999999976432 335777766554
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=9.6e-13 Score=127.52 Aligned_cols=103 Identities=19% Similarity=0.263 Sum_probs=87.2
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
+.|++.+.||+|+||.||+|. ..++..||+|++....... .+.+.+|++++++++||||+++++++.+....|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 458999999999999999999 4578899999997543332 567999999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||+++|+|.+++.... .+++.....|+
T Consensus 86 e~~~~~~L~~~~~~~~---~~~~~~~~~i~ 112 (277)
T 3f3z_A 86 ELCTGGELFERVVHKR---VFRESDAARIM 112 (277)
T ss_dssp ECCCSCBHHHHHHHHC---SCCHHHHHHHH
T ss_pred eccCCCcHHHHHHHcC---CCCHHHHHHHH
Confidence 9999999999987543 36676666554
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.37 E-value=1e-12 Score=131.96 Aligned_cols=102 Identities=19% Similarity=0.283 Sum_probs=80.8
Q ss_pred ccCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.+.|++.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 45689999999999999999994 478899999997542 235688999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||+++|+|.+++...+ .+++.....|+
T Consensus 127 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~ 154 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKG---YYSERDAADAV 154 (349)
T ss_dssp ECCCCSCBHHHHHTTCS---SCCHHHHHHHH
T ss_pred EEeCCCCCHHHHHHhcC---CCCHHHHHHHH
Confidence 99999999999997543 46777666554
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.37 E-value=7.5e-13 Score=133.85 Aligned_cols=107 Identities=22% Similarity=0.343 Sum_probs=88.5
Q ss_pred cCCCccCeeeccCcceEEEEEcC------CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLP------TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALH 535 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~ 535 (571)
++|++.+.||+|+||.||+|... +++.||||++.... ......++.+|+.++++++|||||++++++.+...
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 46889999999999999999832 46789999996432 23445679999999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhhccCCC----ccCCCHHHHhhhc
Q 044615 536 SFVVYEYLEMGSLAMNLSNDAA----AEQFCWTKRMNAI 570 (571)
Q Consensus 536 ~~lv~e~~~~G~L~~~l~~~~~----~~~l~w~~r~~ia 570 (571)
.|+||||+++|+|.+++..... ...++|..++.|+
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~ 187 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHH
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHH
Confidence 9999999999999999985432 2358888777664
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.37 E-value=6.8e-13 Score=129.24 Aligned_cols=107 Identities=17% Similarity=0.215 Sum_probs=88.3
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
+.|.+.+.||+|+||.||+|. ..++..||+|.+...... ...+.+.+|++++++++||||+++++++.+....|+||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 358899999999999999999 457999999999754322 23577999999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCC-CccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDA-AAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~-~~~~l~w~~r~~ia 570 (571)
||+++|+|.+++.... ....+++.....|+
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~ 130 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELM 130 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHH
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHH
Confidence 9999999999996431 12357777666554
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=1e-12 Score=127.42 Aligned_cols=109 Identities=24% Similarity=0.341 Sum_probs=90.1
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEe--CCeeE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSH--ALHSF 537 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~--~~~~~ 537 (571)
.++|++.+.||+|+||.||+|. ..+++.||+|.+...... ....+.+.+|++++++++||||+++++++.+ ....|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 4579999999999999999999 458999999999765433 3446789999999999999999999998864 57899
Q ss_pred EEEeccCCCChhhhhccCC-CccCCCHHHHhhhc
Q 044615 538 VVYEYLEMGSLAMNLSNDA-AAEQFCWTKRMNAI 570 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~~-~~~~l~w~~r~~ia 570 (571)
+||||+++|+|.+++.... ....++|....+|+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~ 117 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 117 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHH
Confidence 9999999999999997532 22357888777664
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.37 E-value=4.9e-14 Score=142.24 Aligned_cols=95 Identities=22% Similarity=0.271 Sum_probs=45.8
Q ss_pred CCCCEEEcccCccccc----cchhhccCCCCCEEEcCCccCccCc----chhhhcccCCCEEEccCCcCCcc----cchh
Q 044615 242 IQLEYLDLSANTFHKS----IPESLSNLVKLHYLNLSNNQFSQKI----PNKIEKLIHLSELDLSHNIFREE----IPSQ 309 (571)
Q Consensus 242 ~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~Ls~n~l~~~~----~~~~~~l~~L~~L~Ls~n~l~~~----~~~~ 309 (571)
++|+.|+|++|.++.. ++..+..+++|++|+|++|.++... +..+...++|+.|+|++|.++.. +...
T Consensus 155 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~ 234 (372)
T 3un9_A 155 CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARA 234 (372)
T ss_dssp CCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHH
T ss_pred CccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHH
Confidence 3444444444444321 2223344455555555555554321 23344445566666666655432 2233
Q ss_pred ccCCCCCCEEEccCCcCcccccccccc
Q 044615 310 ICSMQSLEKLNLSHNNLSGSIPRCFEE 336 (571)
Q Consensus 310 ~~~l~~L~~L~Ls~n~l~~~~p~~~~~ 336 (571)
+...++|++|+|++|.|+......+..
T Consensus 235 L~~~~~L~~L~Ls~N~i~~~g~~~L~~ 261 (372)
T 3un9_A 235 AREHPSLELLHLYFNELSSEGRQVLRD 261 (372)
T ss_dssp HHHCSSCCEEECTTSSCCHHHHHHHHH
T ss_pred HHhCCCCCEEeccCCCCCHHHHHHHHH
Confidence 344566667777777666544444443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=1.6e-12 Score=126.59 Aligned_cols=105 Identities=28% Similarity=0.447 Sum_probs=85.9
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHh----HHHHHHHHHHHhhcCCCCcccEEEEEEeCCee
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMAC----QQEFLNEVNALTKIRHRNIVKFYGFCSHALHS 536 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~----~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~ 536 (571)
++|+..+.||+|+||.||+|+ ..+++.||||++.......... .+.+.+|++++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 568999999999999999999 4689999999997654332221 267999999999999999999999986554
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
++||||+++|+|.+++.+... .++|..+..|+
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~ 128 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLM 128 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTTS--CCCHHHHHHHH
T ss_pred eEEEEecCCCCHHHHHhcccC--CccHHHHHHHH
Confidence 799999999999999975433 57887777654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.37 E-value=1.1e-12 Score=127.54 Aligned_cols=106 Identities=22% Similarity=0.289 Sum_probs=88.4
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCc---hHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDE---MACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSF 537 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~ 537 (571)
++|++.+.||+|+||.||+|.. .+++.||+|.+....... ....+.+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 3588999999999999999994 479999999987543221 123578999999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 538 VVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+||||+++|+|.+++... ..+++..+..++
T Consensus 85 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~ 114 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK---ESLTEDEATQFL 114 (283)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHH
T ss_pred EEEeecCCCcHHHHHHhc---CCCCHHHHHHHH
Confidence 999999999999999753 246777766654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=1.1e-12 Score=129.51 Aligned_cols=105 Identities=23% Similarity=0.327 Sum_probs=84.4
Q ss_pred ccCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
.++|++.+.||+|+||.||+|+..+|+.||+|++...... ....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAED-EGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEeccccc-chhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 3569999999999999999999878999999999754322 233567899999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
||+++ +|.+++..... .+++.....|
T Consensus 99 e~~~~-~l~~~~~~~~~--~~~~~~~~~~ 124 (311)
T 3niz_A 99 EFMEK-DLKKVLDENKT--GLQDSQIKIY 124 (311)
T ss_dssp ECCSE-EHHHHHHTCTT--CCCHHHHHHH
T ss_pred cCCCC-CHHHHHHhccC--CCCHHHHHHH
Confidence 99985 88888875432 4666655544
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.37 E-value=3.7e-13 Score=130.65 Aligned_cols=108 Identities=24% Similarity=0.462 Sum_probs=87.9
Q ss_pred HccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEE
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFV 538 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l 538 (571)
+.++|++.+.||+|+||.||+|. ..++..||||++...........+.+.+|++++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 34679999999999999999998 55788999999864322222235678999999999999999999999999999999
Q ss_pred EEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 539 VYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||||+++|+|.+++.... .+++.....|+
T Consensus 87 v~e~~~~~~l~~~l~~~~---~~~~~~~~~~~ 115 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS---KFDEQRTATYI 115 (279)
T ss_dssp EECCCTTEEHHHHHHHHS---SCCHHHHHHHH
T ss_pred EEecCCCCcHHHHHHhcC---CCCHHHHHHHH
Confidence 999999999999997542 36666655543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.37 E-value=1e-12 Score=130.35 Aligned_cols=106 Identities=19% Similarity=0.245 Sum_probs=87.9
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCch---HhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEM---ACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSF 537 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~ 537 (571)
+.|++.+.||+|+||.||+|. ..+|+.||||.+........ ...+.+.+|+.++++++||||+++++++.+....|
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 458999999999999999999 45799999999975433221 13577999999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 538 VVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+||||+++|+|.+++.... .+++.....|+
T Consensus 92 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~ 121 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKE---SLSEEEATSFI 121 (321)
T ss_dssp EEECCCCSCBHHHHHHTCS---CEEHHHHHHHH
T ss_pred EEEEcCCCCcHHHHHHhcC---CCCHHHHHHHH
Confidence 9999999999999997532 46666665553
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.36 E-value=2.1e-12 Score=127.45 Aligned_cols=105 Identities=22% Similarity=0.300 Sum_probs=87.6
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|+..+.||+|+||.||+|.. .+|+.||||++..... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 5789999999999999999994 5799999999876532 2344567899999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||+++|+|.+++.... .+++.....|+
T Consensus 82 e~~~~~~l~~~~~~~~---~~~~~~~~~i~ 108 (311)
T 4agu_A 82 EYCDHTVLHELDRYQR---GVPEHLVKSIT 108 (311)
T ss_dssp ECCSEEHHHHHHHTSS---CCCHHHHHHHH
T ss_pred EeCCCchHHHHHhhhc---CCCHHHHHHHH
Confidence 9999999999887432 36666655543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.36 E-value=1.6e-12 Score=129.76 Aligned_cols=108 Identities=22% Similarity=0.388 Sum_probs=87.6
Q ss_pred ccCCCccCeeeccCcceEEEEEc--------CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKL--------PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCS 531 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~ 531 (571)
.++|.+.+.||+|+||.||+|.. .++..||||++.... .....+.+.+|+++++++ +||||+++++++.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 35789999999999999999984 356789999997543 234467799999999999 9999999999999
Q ss_pred eCCeeEEEEeccCCCChhhhhccCCC-------------ccCCCHHHHhhhc
Q 044615 532 HALHSFVVYEYLEMGSLAMNLSNDAA-------------AEQFCWTKRMNAI 570 (571)
Q Consensus 532 ~~~~~~lv~e~~~~G~L~~~l~~~~~-------------~~~l~w~~r~~ia 570 (571)
+.+..|+||||+++|+|.+++..... ...++|..++.|+
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 163 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 163 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHH
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHH
Confidence 99999999999999999999986432 1347887777654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.36 E-value=6.2e-13 Score=138.47 Aligned_cols=104 Identities=21% Similarity=0.310 Sum_probs=86.5
Q ss_pred ccCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
.++|+..+.||+|+||.||+|...++..||||.+..... ..+.|.+|++++++++|||||++++++. .+..|+||
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 456888999999999999999987788999999976432 2578999999999999999999999986 66789999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||++|+|.++++... ...+++..+++|+
T Consensus 262 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~ 290 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDE-GSKQPLPKLIDFS 290 (454)
T ss_dssp CCCTTCBHHHHHHSHH-HHTCCHHHHHHHH
T ss_pred eecCCCcHHHHHHhcc-CCCCCHHHHHHHH
Confidence 9999999999998542 2246676666553
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=7e-13 Score=128.37 Aligned_cols=107 Identities=22% Similarity=0.293 Sum_probs=87.9
Q ss_pred ccCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.++|.+.+.||+|+||.||+|.. .+|+.||||.+...........+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 35799999999999999999995 48999999998643221222356789999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||+++|+|.+++.... .+++.....++
T Consensus 90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~ 117 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG---RVEEMEARRLF 117 (276)
T ss_dssp EECCCSCBHHHHHHHHC---SCCHHHHHHHH
T ss_pred EeccCCCcHHHHHhccC---CCCHHHHHHHH
Confidence 99999999999997542 36666665543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.36 E-value=5.1e-13 Score=130.80 Aligned_cols=104 Identities=30% Similarity=0.436 Sum_probs=85.9
Q ss_pred cCCCccCeeeccCcceEEEEEc-----CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC--C
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-----PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA--L 534 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~--~ 534 (571)
++|++.+.||+|+||.||+|++ .+++.||||++.... ....+.|.+|++++++++||||+++++++... .
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 5688999999999999999983 368899999997532 34457899999999999999999999998653 5
Q ss_pred eeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 535 HSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
..++||||+++|+|.+++..... .++|..+..|+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~ 120 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYT 120 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHH
T ss_pred ceEEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHH
Confidence 58999999999999999975432 47777776654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=8.6e-13 Score=131.20 Aligned_cols=105 Identities=23% Similarity=0.325 Sum_probs=79.5
Q ss_pred ccCCCccCeeeccCcceEEEEEc----CCCCEEEEEEccCCCCC-chHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCe
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKL----PTGEIVDVKKFHSPLPD-EMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALH 535 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~ 535 (571)
.++|++.+.||+|+||.||+|+. .+++.||+|++.+.... .......+.+|+.++++++|||||++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35699999999999999999984 47899999999765322 12334568899999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhhccCCCccCCCHHHHhh
Q 044615 536 SFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMN 568 (571)
Q Consensus 536 ~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ 568 (571)
.|+||||+++|+|.+++...+ .+++.....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~ 125 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG---IFMEDTACF 125 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS---SCCHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHhCC---CCCHHHHHH
Confidence 999999999999999997532 345544433
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=6.5e-13 Score=129.54 Aligned_cols=104 Identities=18% Similarity=0.346 Sum_probs=85.9
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCC-------CEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTG-------EIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA 533 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~-------~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~ 533 (571)
++|.+.+.||+|+||.||+|.. .++ ..||+|.+.... ....+.+.+|++++++++||||+++++++.+.
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 4688999999999999999984 344 469999986432 23457899999999999999999999999999
Q ss_pred CeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 534 LHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 534 ~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+..|+||||+++|+|.+++..... .+++..+..|+
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~ 119 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNKN--CINILWKLEVA 119 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTGG--GCCHHHHHHHH
T ss_pred CCCEEEEECCCCCCHHHHHHhCCC--CCCHHHHHHHH
Confidence 999999999999999999985432 36676666554
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=1.1e-12 Score=130.16 Aligned_cols=101 Identities=25% Similarity=0.312 Sum_probs=83.8
Q ss_pred ccCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC----ee
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL----HS 536 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~----~~ 536 (571)
.++|++.+.||+|+||.||+|+.. ++.||||++... ......+.+|+.++++++|||||++++++.+.. ..
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC----chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 356999999999999999999864 789999998643 233455677999999999999999999998754 36
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+||||+++|+|.++++.. .++|..+..|+
T Consensus 98 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~ 127 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKAN----VVSWNELCHIA 127 (322)
T ss_dssp EEEEECCTTCBHHHHHHHC----CBCHHHHHHHH
T ss_pred EEEEecCCCCCHHHHHHhc----CCCHHHHHHHH
Confidence 9999999999999999753 37888777664
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=1.5e-12 Score=126.56 Aligned_cols=106 Identities=18% Similarity=0.245 Sum_probs=88.6
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.++|++.+.||+|+||.||+|. ..+++.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4679999999999999999999 457999999999754332 34457789999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||+++|+|.+++.... .+++.....++
T Consensus 84 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~ 111 (284)
T 3kk8_A 84 FDLVTGGELFEDIVARE---FYSEADASHCI 111 (284)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHH
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHH
Confidence 99999999999887542 46666655543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.36 E-value=7.2e-13 Score=137.84 Aligned_cols=104 Identities=21% Similarity=0.357 Sum_probs=86.5
Q ss_pred ccCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
.++|+..+.||+|+||.||+|....+..||||.+...... .+.|.+|++++++++|||||++++++.+ +..|+||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 3468889999999999999999877778999999764322 4679999999999999999999999865 6789999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||+++|+|.++++... ...+++...+.|+
T Consensus 258 e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~ 286 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGET-GKYLRLPQLVDMA 286 (452)
T ss_dssp CCCTTCBHHHHHSHHH-HTTCCHHHHHHHH
T ss_pred hhhcCCCHHHHHHhcC-CCCCCHHHHHHHH
Confidence 9999999999997432 2347777776654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=5.6e-13 Score=132.95 Aligned_cols=110 Identities=25% Similarity=0.360 Sum_probs=88.3
Q ss_pred HHccCCCccCeeeccCcceEEEEEc-CCC-----CEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEE
Q 044615 459 RATNNFDDGHCIGNGGQGSVYKAKL-PTG-----EIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCS 531 (571)
Q Consensus 459 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~-----~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~ 531 (571)
...++|...+.||+|+||.||+|.. .++ ..||+|.+.... .....+.+.+|+++++++ +||||+++++++.
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 3456799999999999999999984 333 479999997543 233467799999999999 8999999999999
Q ss_pred eCCeeEEEEeccCCCChhhhhccCCC-----------ccCCCHHHHhhhc
Q 044615 532 HALHSFVVYEYLEMGSLAMNLSNDAA-----------AEQFCWTKRMNAI 570 (571)
Q Consensus 532 ~~~~~~lv~e~~~~G~L~~~l~~~~~-----------~~~l~w~~r~~ia 570 (571)
+.+..|+||||+++|+|.+++..... ...+++...+.|+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHH
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHH
Confidence 99999999999999999999975321 2346777666554
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=1.3e-12 Score=128.92 Aligned_cols=93 Identities=29% Similarity=0.443 Sum_probs=80.7
Q ss_pred ccCCCccCeeeccCcceEEEEEc------CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKL------PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL 534 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~ 534 (571)
.++|.+.+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|++++++++||||+++++++.+.+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 45688999999999999999973 245789999997543 2344678999999999999999999999999999
Q ss_pred eeEEEEeccCCCChhhhhccC
Q 044615 535 HSFVVYEYLEMGSLAMNLSND 555 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~~ 555 (571)
..|+||||+++|+|.+++...
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~ 120 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRES 120 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHT
T ss_pred ceEEEEeecCCCCHHHHHHHH
Confidence 999999999999999999854
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.36 E-value=1.3e-12 Score=128.04 Aligned_cols=106 Identities=18% Similarity=0.188 Sum_probs=81.4
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCc-----------------------hHhHHHHHHHHHHHh
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDE-----------------------MACQQEFLNEVNALT 516 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~~~Ei~~l~ 516 (571)
.++|++.+.||+|+||.||+|. ..+++.||||++....... ....+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 4579999999999999999998 5578999999997543211 112356899999999
Q ss_pred hcCCCCcccEEEEEEe--CCeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 517 KIRHRNIVKFYGFCSH--ALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 517 ~l~H~niv~l~~~~~~--~~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+++||||+++++++.+ ....|+||||+++|+|.+++.. ..+++.....++
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~ 143 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYF 143 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHH
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHH
Confidence 9999999999999987 5678999999999999887643 246777666553
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.36 E-value=1.8e-12 Score=130.81 Aligned_cols=103 Identities=22% Similarity=0.323 Sum_probs=87.7
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|+..+.||+|+||.||+|. ..+++.||+|++.... .....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 568999999999999999999 4589999999997653 2344678999999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
||+++|+|.+++...+ .+++.....|
T Consensus 111 e~~~~~~L~~~l~~~~---~~~~~~~~~i 136 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKAG---RIPEQILGKV 136 (360)
T ss_dssp CCCTTCBHHHHHHHHS---SCCHHHHHHH
T ss_pred ECCCCCCHHHHHHHcC---CCCHHHHHHH
Confidence 9999999999997543 3566655544
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.36 E-value=9.3e-13 Score=128.37 Aligned_cols=105 Identities=22% Similarity=0.384 Sum_probs=89.0
Q ss_pred ccCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.++|++.+.||+|+||.||+|.. .++..||+|.+.... ...+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 45688999999999999999994 468899999997542 2357799999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||+++|+|.+++..... ..+++..+..|+
T Consensus 88 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~ 117 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 117 (288)
T ss_dssp EECCTTEEHHHHHHHCCT-TTSCHHHHHHHH
T ss_pred EEcCCCCcHHHHHHhccc-CCccHhHHHHHH
Confidence 999999999999975432 357787776654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.35 E-value=2.9e-12 Score=126.64 Aligned_cols=103 Identities=18% Similarity=0.289 Sum_probs=84.7
Q ss_pred cCCCcc-CeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCeeEE
Q 044615 462 NNFDDG-HCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHSFV 538 (571)
Q Consensus 462 ~~~~~~-~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~l 538 (571)
+.|++. +.||+|+||.||+|. ..+++.||||++...... ..+.+.+|++++.++ +||||+++++++.+.+..|+
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH---IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC---CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch---hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 457774 789999999999999 558999999999765322 256789999999884 79999999999999999999
Q ss_pred EEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 539 VYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||||+++|+|.+++.... .+++.....|+
T Consensus 89 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~ 117 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKRR---HFNELEASVVV 117 (316)
T ss_dssp EEECCTTCBHHHHHHHHS---SCCHHHHHHHH
T ss_pred EEEcCCCCcHHHHHhccC---CCCHHHHHHHH
Confidence 999999999999997542 46666555543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=1.9e-12 Score=127.13 Aligned_cols=105 Identities=20% Similarity=0.278 Sum_probs=85.6
Q ss_pred ccCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.+.|++.+.||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE---ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C---CHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH---HHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 45699999999999999999994 57999999998754322 357899999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||+++|+|.+++..... .+++.....|+
T Consensus 95 ~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~ 123 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDR--GLTEPQIQVVC 123 (302)
T ss_dssp EECCTTEEHHHHHHHHTS--CCCHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhhcc--CCCHHHHHHHH
Confidence 999999999999875332 46777666553
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=4.5e-13 Score=134.43 Aligned_cols=107 Identities=16% Similarity=0.151 Sum_probs=86.7
Q ss_pred HccCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCeeE
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHSF 537 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~ 537 (571)
..++|+..+.||+|+||.||+|+. .+++.||||++.+.........+.+.+|..++..+ +||||+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 356899999999999999999995 46889999999753221222356788999999987 8999999999999999999
Q ss_pred EEEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 538 VVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
+||||++||+|.+++...+ .+++.....+
T Consensus 98 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~ 126 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFY 126 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHhcC---CCCHHHHHHH
Confidence 9999999999999997532 3566655544
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.35 E-value=1.6e-12 Score=132.31 Aligned_cols=107 Identities=23% Similarity=0.358 Sum_probs=88.8
Q ss_pred cCCCccCeeeccCcceEEEEEc--------CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL--------PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSH 532 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~ 532 (571)
++|.+.+.||+|+||.||+|.. ..+..||||++.... .....+++.+|+++++++ +|||||++++++.+
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 4688899999999999999983 123579999997543 234467899999999999 99999999999999
Q ss_pred CCeeEEEEeccCCCChhhhhccCCC-------------ccCCCHHHHhhhc
Q 044615 533 ALHSFVVYEYLEMGSLAMNLSNDAA-------------AEQFCWTKRMNAI 570 (571)
Q Consensus 533 ~~~~~lv~e~~~~G~L~~~l~~~~~-------------~~~l~w~~r~~ia 570 (571)
.+..|+||||+++|+|.+++..... ...++|..+.+|+
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 197 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCA 197 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHH
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHH
Confidence 9999999999999999999986432 2358888887765
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.35 E-value=1.1e-13 Score=139.53 Aligned_cols=111 Identities=21% Similarity=0.324 Sum_probs=64.1
Q ss_pred CCCCEEEcccCccccccchhh-----ccCCCCCEEEcCCccCccC----cchhhhcccCCCEEEccCCcCCcc----cch
Q 044615 242 IQLEYLDLSANTFHKSIPESL-----SNLVKLHYLNLSNNQFSQK----IPNKIEKLIHLSELDLSHNIFREE----IPS 308 (571)
Q Consensus 242 ~~L~~L~L~~n~l~~~~~~~l-----~~l~~L~~L~Ls~n~l~~~----~~~~~~~l~~L~~L~Ls~n~l~~~----~~~ 308 (571)
++|+.|+|++|.++......+ ...++|+.|+|++|.++.. ++..+...++|+.|+|++|.+.+. ++.
T Consensus 126 ~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~ 205 (372)
T 3un9_A 126 LRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAA 205 (372)
T ss_dssp HTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHH
T ss_pred HhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHH
Confidence 355566666665544333322 2346677777777776542 233345566677777777776543 234
Q ss_pred hccCCCCCCEEEccCCcCccc----cccccccCCCCCEEECcCCcCcc
Q 044615 309 QICSMQSLEKLNLSHNNLSGS----IPRCFEEMHWLSCIDISYNALQG 352 (571)
Q Consensus 309 ~~~~l~~L~~L~Ls~n~l~~~----~p~~~~~l~~L~~L~ls~N~l~~ 352 (571)
.+...++|+.|+|++|.|+.. ++..+...+.|+.|||++|.++.
T Consensus 206 ~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 206 QLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp HGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCH
T ss_pred HHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCH
Confidence 455566777777777777643 23334445667777777776654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=6.6e-13 Score=134.19 Aligned_cols=95 Identities=21% Similarity=0.275 Sum_probs=72.6
Q ss_pred ccCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHH-HhhcCCCCcccEEEEEEeCCeeEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNA-LTKIRHRNIVKFYGFCSHALHSFV 538 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~-l~~l~H~niv~l~~~~~~~~~~~l 538 (571)
.++|+..+.||+|+||+||+|+. .+++.||||++.+.........+.+.+|..+ ++.++|||||++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 35799999999999999999994 5789999999976543333334567788877 577999999999999999999999
Q ss_pred EEeccCCCChhhhhccC
Q 044615 539 VYEYLEMGSLAMNLSND 555 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~ 555 (571)
||||+++|+|.+++.+.
T Consensus 117 v~E~~~gg~L~~~l~~~ 133 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE 133 (373)
T ss_dssp EEECCCSCBHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHhc
Confidence 99999999999999753
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.35 E-value=2.7e-12 Score=125.40 Aligned_cols=105 Identities=23% Similarity=0.318 Sum_probs=85.1
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|+..+.||+|+||.||+|. ..+++.||||++...... ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCc-CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 468999999999999999999 457999999999765433 234577889999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||+++ ++.+++..... .+++.....|+
T Consensus 81 e~~~~-~l~~~~~~~~~--~l~~~~~~~~~ 107 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDSCNG--DLDPEIVKSFL 107 (292)
T ss_dssp ECCSE-EHHHHHHHTTT--CCCHHHHHHHH
T ss_pred ecCCC-CHHHHHHhCCC--CCCHHHHHHHH
Confidence 99986 66666654322 46666665543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.35 E-value=1.5e-12 Score=127.07 Aligned_cols=104 Identities=25% Similarity=0.326 Sum_probs=86.0
Q ss_pred cCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
++|+..+.||+|+||.||+|+..+++.||||++...... ....+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 468899999999999999999878999999999754322 2234678899999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
|+++ +|.+++..... .+++.....+
T Consensus 81 ~~~~-~l~~~~~~~~~--~~~~~~~~~~ 105 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVCEG--GLESVTAKSF 105 (288)
T ss_dssp CCSE-EHHHHHHTSTT--CCCHHHHHHH
T ss_pred ecCC-CHHHHHHhccc--CCCHHHHHHH
Confidence 9986 99999875432 4666655544
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=1.5e-12 Score=128.44 Aligned_cols=108 Identities=22% Similarity=0.338 Sum_probs=89.3
Q ss_pred ccCCCccCeeeccCcceEEEEEc------CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeC
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKL------PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHA 533 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~ 533 (571)
.++|+..+.||+|+||.||+|.. .+++.||||.+.... .....+.+.+|+++++++ +||||+++++++.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 35688999999999999999973 356789999997543 234467899999999999 999999999999999
Q ss_pred CeeEEEEeccCCCChhhhhccCCC---------------ccCCCHHHHhhhc
Q 044615 534 LHSFVVYEYLEMGSLAMNLSNDAA---------------AEQFCWTKRMNAI 570 (571)
Q Consensus 534 ~~~~lv~e~~~~G~L~~~l~~~~~---------------~~~l~w~~r~~ia 570 (571)
+..++||||+++|+|.+++..... ...++|.....++
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFS 151 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHH
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHH
Confidence 999999999999999999985432 1247887777664
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.34 E-value=1.5e-12 Score=125.58 Aligned_cols=104 Identities=24% Similarity=0.321 Sum_probs=81.1
Q ss_pred cCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCc-hHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDE-MACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|+..+.||+|+||.||+|.. .++.||||++....... ....+.+.+|+++++.++||||+++++++.+.+..|+||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 5688999999999999999996 48899999987543322 233567999999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||+++|+|.+++... .+++.....|+
T Consensus 86 e~~~~~~L~~~~~~~----~~~~~~~~~i~ 111 (271)
T 3dtc_A 86 EFARGGPLNRVLSGK----RIPPDILVNWA 111 (271)
T ss_dssp ECCTTEEHHHHHTSS----CCCHHHHHHHH
T ss_pred EcCCCCCHHHHhhcC----CCCHHHHHHHH
Confidence 999999999999643 46666665543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.34 E-value=1.7e-12 Score=134.86 Aligned_cols=103 Identities=25% Similarity=0.346 Sum_probs=85.7
Q ss_pred ccCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC-eeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL-HSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~-~~~lv 539 (571)
.++|+..+.||+|+||.||+|... ++.||||.++... ..+.|.+|+++|++++|||||++++++.+.. ..|+|
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 456888999999999999999874 7799999997543 2467999999999999999999999987765 78999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||||++|+|.++++..+. ..+++..++.|+
T Consensus 266 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~ 295 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRGR-SVLGGDCLLKFS 295 (450)
T ss_dssp EECCTTCBHHHHHHHHCT-TTCCHHHHHHHH
T ss_pred EEecCCCcHHHHHHhcCC-CCCCHHHHHHHH
Confidence 999999999999986432 246777666554
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.34 E-value=2.3e-12 Score=124.63 Aligned_cols=105 Identities=24% Similarity=0.301 Sum_probs=87.7
Q ss_pred ccCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.++|++.+.||+|+||.||+|.. .+++.||||++...... ...+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 35689999999999999999994 57999999998644322 2357789999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||+++|+|.+++... ..+++.....++
T Consensus 84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~ 111 (276)
T 2yex_A 84 LEYCSGGELFDRIEPD---IGMPEPDAQRFF 111 (276)
T ss_dssp EECCTTEEGGGGSBTT---TBCCHHHHHHHH
T ss_pred EEecCCCcHHHHHhhc---cCCCHHHHHHHH
Confidence 9999999999999743 246666665543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=3.7e-13 Score=139.94 Aligned_cols=107 Identities=21% Similarity=0.171 Sum_probs=79.8
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.++|+..+.||+|+||.||+|. ..+|+.||||++.+...........+.+|++++++++||||+++++++.+.+..|+|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 4579999999999999999999 568999999999753222223346688999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||||++|+|.+++.... .+++.....|+
T Consensus 227 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~ 254 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER---VFSEDRARFYG 254 (446)
T ss_dssp ECCCSSCBHHHHHHHHS---CCCHHHHHHHH
T ss_pred EeeCCCCcHHHHHHhcC---CCCHHHHHHHH
Confidence 99999999999997542 46666665543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=1.7e-12 Score=136.82 Aligned_cols=104 Identities=20% Similarity=0.285 Sum_probs=82.0
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
+.|++.+.||+|+||.||+|+ ..++..||||++.+..... .....+.+|+.++++++|||||+++++|.+....|+||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 359999999999999999999 4589999999997654222 22467899999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
|||++|+|.+++.... .+++.....|
T Consensus 116 e~~~~g~L~~~~~~~~---~~~~~~~~~i 141 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM---KFNEVDAAVI 141 (494)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHH
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHH
Confidence 9999999999887542 3666655544
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.34 E-value=1.4e-12 Score=128.47 Aligned_cols=100 Identities=30% Similarity=0.445 Sum_probs=83.3
Q ss_pred cCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
++|++.+.||+|+||.||+|+. .++.||||.+... ...+.|.+|++++++++||||+++++++. +..|+|||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e 79 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVME 79 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEE
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEE
Confidence 4688899999999999999987 4788999998642 23577999999999999999999999886 44789999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
|+++|+|.+++........+++...+++
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 107 (307)
T 2eva_A 80 YAEGGSLYNVLHGAEPLPYYTAAHAMSW 107 (307)
T ss_dssp CCTTCBHHHHHHCSSSEECCCHHHHHHH
T ss_pred cCCCCCHHHHHhccCCCCccCHHHHHHH
Confidence 9999999999986654445677666654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=2.4e-12 Score=126.42 Aligned_cols=105 Identities=24% Similarity=0.364 Sum_probs=83.5
Q ss_pred cCCCccCeeeccCcceEEEEEc-----CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC--C
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-----PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA--L 534 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~--~ 534 (571)
..|+..+.||+|+||.||+|++ .+++.||||++...... ...+.+.+|++++++++||||+++++++.+. .
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG--NHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccc--hhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 3488899999999999999982 46889999999754322 2357799999999999999999999999876 6
Q ss_pred eeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 535 HSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
..++||||+++|+|.+++..... .+++..+..|+
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~ 132 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNKN--KINLKQQLKYA 132 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHH
T ss_pred eEEEEEEeCCCCcHHHHHHhccc--cCCHHHHHHHH
Confidence 68999999999999999965432 46777766654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.34 E-value=1.5e-12 Score=130.34 Aligned_cols=95 Identities=24% Similarity=0.438 Sum_probs=79.1
Q ss_pred HccCCCccCeeeccCcceEEEEEc------CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEe
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAKL------PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSH 532 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~ 532 (571)
..++|+..+.||+|+||.||+|.. .++..||||.+..... ....+.+.+|+.++.++ +||||+++++++..
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 346789999999999999999984 2456899999975422 23346799999999999 99999999999999
Q ss_pred CCeeEEEEeccCCCChhhhhccCC
Q 044615 533 ALHSFVVYEYLEMGSLAMNLSNDA 556 (571)
Q Consensus 533 ~~~~~lv~e~~~~G~L~~~l~~~~ 556 (571)
.+..|+||||+++|+|.+++....
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~ 144 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKR 144 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTT
T ss_pred CCccEEEEecCCCCcHHHHHhhcc
Confidence 999999999999999999998643
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=4.7e-12 Score=125.34 Aligned_cols=101 Identities=25% Similarity=0.363 Sum_probs=83.8
Q ss_pred CCccCeeeccCcceEEEEEc-----CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC--Cee
Q 044615 464 FDDGHCIGNGGQGSVYKAKL-----PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA--LHS 536 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~--~~~ 536 (571)
|+..+.||+|+||.||++.+ .+++.||||++.... .....+.+.+|++++++++||||+++++++.+. ...
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 110 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL 110 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence 48899999999999998863 267889999997542 234467799999999999999999999999884 678
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
++||||+++|+|.+++... .++|..+..|+
T Consensus 111 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~ 140 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLPRH----SIGLAQLLLFA 140 (318)
T ss_dssp EEEECCCTTCBHHHHGGGS----CCCHHHHHHHH
T ss_pred EEEEecccCCcHHHHHhhC----CCCHHHHHHHH
Confidence 9999999999999999754 26777666654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.34 E-value=1.3e-12 Score=131.03 Aligned_cols=97 Identities=22% Similarity=0.245 Sum_probs=82.2
Q ss_pred HHHHccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCC--CchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC
Q 044615 457 IIRATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLP--DEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA 533 (571)
Q Consensus 457 ~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~ 533 (571)
+....++|++.+.||+|+||.||+|. ..+++.||+|++.+... ......+.+.+|++++++++|||||++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 34455679999999999999999999 56889999999864321 1123457899999999999999999999999999
Q ss_pred CeeEEEEeccCCCChhhhhc
Q 044615 534 LHSFVVYEYLEMGSLAMNLS 553 (571)
Q Consensus 534 ~~~~lv~e~~~~G~L~~~l~ 553 (571)
+..++||||+++|+|.+++.
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~ 120 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLN 120 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEE
T ss_pred CeEEEEEeCCCCCcHHHHHH
Confidence 99999999999999999996
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.34 E-value=7.1e-13 Score=128.95 Aligned_cols=107 Identities=21% Similarity=0.410 Sum_probs=87.0
Q ss_pred ccCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.++|++.+.||+|+||.||+|.. .+++.||+|++...........+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 35699999999999999999994 57889999998643211112246789999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||+++|+|.+++...+ .+++.....++
T Consensus 93 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~ 120 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG---RFDEQRSATFM 120 (284)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhcC---CCCHHHHHHHH
Confidence 99999999999997542 36666655543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.34 E-value=2.2e-12 Score=126.83 Aligned_cols=102 Identities=21% Similarity=0.277 Sum_probs=83.6
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
+.|.+.+.||+|+||.||+|+ ..+|+.||+|++...... ..+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc---chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 468899999999999999999 458999999999754322 2456889999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
||+++|+|.+++...+ .+++.....+
T Consensus 86 e~~~~~~L~~~l~~~~---~~~~~~~~~~ 111 (304)
T 2jam_A 86 QLVSGGELFDRILERG---VYTEKDASLV 111 (304)
T ss_dssp CCCCSCBHHHHHHHHS---CCCHHHHHHH
T ss_pred EcCCCccHHHHHHHcC---CCCHHHHHHH
Confidence 9999999999997542 3566555544
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=2.4e-12 Score=128.05 Aligned_cols=108 Identities=23% Similarity=0.361 Sum_probs=86.5
Q ss_pred ccCCCccCeeeccCcceEEEEEc------CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKL------PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL 534 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~ 534 (571)
.++|++.+.||+|+||.||+|+. .+++.||||.+.... ......++.+|+.++++++||||+++++++.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 35699999999999999999983 357789999996432 2344567999999999999999999999999999
Q ss_pred eeEEEEeccCCCChhhhhccCCC----ccCCCHHHHhhhc
Q 044615 535 HSFVVYEYLEMGSLAMNLSNDAA----AEQFCWTKRMNAI 570 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~~~~----~~~l~w~~r~~ia 570 (571)
..|+||||+++|+|.+++..... ...++|..++.|+
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~ 146 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHH
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHH
Confidence 99999999999999999986432 1357887776654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=2.4e-12 Score=127.37 Aligned_cols=106 Identities=19% Similarity=0.340 Sum_probs=72.6
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.++|+..+.||+|+||.||+|. ..+|+.||+|++...... ...+.+.+|++++++++|||||++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE--GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTT--CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc--ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 4579999999999999999999 457999999999754322 2235788999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCC---CccCCCHHHHhhh
Q 044615 540 YEYLEMGSLAMNLSNDA---AAEQFCWTKRMNA 569 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~---~~~~l~w~~r~~i 569 (571)
|||++ |+|.+++.... ....+++.....+
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~ 113 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYF 113 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHH
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHH
Confidence 99998 69999987432 1234666665544
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=5e-12 Score=124.18 Aligned_cols=103 Identities=21% Similarity=0.291 Sum_probs=88.0
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
+.|+..+.||+|+||.||+|. ..+++.||||++...... ...+.+.+|+.++++++||||+++++++.+....|+||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 458899999999999999998 568999999999765432 23577999999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||+++|+|.+++... .+++.....++
T Consensus 100 e~~~~~~L~~~~~~~----~~~~~~~~~~~ 125 (303)
T 3a7i_A 100 EYLGGGSALDLLEPG----PLDETQIATIL 125 (303)
T ss_dssp ECCTTEEHHHHHTTS----CCCHHHHHHHH
T ss_pred EeCCCCcHHHHHhcC----CCCHHHHHHHH
Confidence 999999999999742 46777766654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.33 E-value=1.1e-12 Score=139.49 Aligned_cols=104 Identities=21% Similarity=0.357 Sum_probs=86.6
Q ss_pred ccCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
.++|++.+.||+|+||.||+|....+..||||++...... .++|.+|+++|++++|||||++++++.+ +..|+||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~ 340 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence 3568889999999999999999877788999999764322 4679999999999999999999999865 6789999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||++|+|.++++... ...++|.+.+.|+
T Consensus 341 e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~ 369 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGET-GKYLRLPQLVDMA 369 (535)
T ss_dssp CCCTTEEHHHHHSHHH-HTTCCHHHHHHHH
T ss_pred ehhcCCcHHHHHhhcC-CCCCCHHHHHHHH
Confidence 9999999999997432 2347777777664
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.33 E-value=1.6e-12 Score=133.76 Aligned_cols=107 Identities=20% Similarity=0.207 Sum_probs=84.2
Q ss_pred HccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCC-----chHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPD-----EMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA 533 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~ 533 (571)
..++|.+.+.||+|+||.||+|. ..+++.||||++.+.... .......+.+|++++++++|||||++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 34679999999999999999998 567899999998753211 1112235889999999999999999999985 5
Q ss_pred CeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 534 LHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 534 ~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+..|+||||+++|+|.+++.... .+++.....|+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~ 245 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYF 245 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHH
T ss_pred CceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHH
Confidence 56899999999999999997543 46777666553
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=2.8e-12 Score=125.58 Aligned_cols=107 Identities=20% Similarity=0.279 Sum_probs=88.1
Q ss_pred ccCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCc------hHhHHHHHHHHHHHhhcC-CCCcccEEEEEEe
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDE------MACQQEFLNEVNALTKIR-HRNIVKFYGFCSH 532 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~------~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~ 532 (571)
.++|+..+.||+|+||.||+|.. .+++.||||++....... ....+.+.+|+++++++. ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 46799999999999999999994 578999999997653211 123567889999999995 9999999999999
Q ss_pred CCeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 533 ALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 533 ~~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
....|+||||+++|+|.+++... ..+++.....++
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~ 130 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIM 130 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHH
T ss_pred CCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHH
Confidence 99999999999999999999753 246666665553
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.32 E-value=1.9e-12 Score=125.52 Aligned_cols=103 Identities=21% Similarity=0.356 Sum_probs=85.6
Q ss_pred cCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
++|+..+.||+|+||.||+|...++..||||.+...... .+.+.+|++++++++||||+++++++. .+..++|||
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 87 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE 87 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence 468899999999999999999877889999999754322 467999999999999999999999986 456899999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+++|+|.+++.... ...+++..+++|+
T Consensus 88 ~~~~~~L~~~l~~~~-~~~~~~~~~~~i~ 115 (279)
T 1qpc_A 88 YMENGSLVDFLKTPS-GIKLTINKLLDMA 115 (279)
T ss_dssp CCTTCBHHHHTTSHH-HHTCCHHHHHHHH
T ss_pred cCCCCCHHHHHhcCC-CCCCCHHHHHHHH
Confidence 999999999997532 1257777776654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.32 E-value=2.9e-12 Score=128.07 Aligned_cols=99 Identities=19% Similarity=0.221 Sum_probs=82.5
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCeeEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHSFV 538 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~l 538 (571)
.++|++.+.||+|+||.||+|. ..+++.||||++.+.... +.+|++++.++ +|||||++++++.+.+..|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 4569999999999999999999 457899999999765422 34688888887 79999999999999999999
Q ss_pred EEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 539 VYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
||||+++|+|.+++...+ .+++.....|
T Consensus 94 v~E~~~gg~L~~~i~~~~---~~~~~~~~~~ 121 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQK---FFSEREASAV 121 (342)
T ss_dssp EECCCCSCBHHHHHHTCT---TCCHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHH
Confidence 999999999999997543 3666655544
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=3e-12 Score=127.44 Aligned_cols=107 Identities=21% Similarity=0.354 Sum_probs=84.5
Q ss_pred HHccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeE
Q 044615 459 RATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSF 537 (571)
Q Consensus 459 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~ 537 (571)
...++|++.+.||+|+||.||+|. ..+++.||||++...... ....+.+.+|++++++++||||+++++++.+.+..|
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE-EGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccc-cccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 345679999999999999999998 568999999999755322 233466889999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 538 VVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+||||+++ +|.+++.... .+++.....|+
T Consensus 110 lv~e~~~~-~L~~~~~~~~---~~~~~~~~~i~ 138 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDKNP---DVSMRVIKSFL 138 (329)
T ss_dssp EEEECCSE-EHHHHHHHCT---TCCHHHHHHHH
T ss_pred EEEecCCC-CHHHHHhhcC---CCCHHHHHHHH
Confidence 99999984 9999997543 36666655543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=1.3e-12 Score=137.50 Aligned_cols=105 Identities=23% Similarity=0.285 Sum_probs=86.6
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
+.|++.+.||+|+||.||+|. ..+++.||||++.+.... ....+.+.+|++++++++|||||++++++.+....|+||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 459999999999999999999 458999999998643211 122567899999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||++|+|.+++.... .+++.....|+
T Consensus 101 e~~~~~~L~~~~~~~~---~~~~~~~~~i~ 127 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK---RFSEHDAARII 127 (486)
T ss_dssp CCCCSCBHHHHHHHHS---SCCHHHHHHHH
T ss_pred EcCCCCcHHHHHHhcC---CCCHHHHHHHH
Confidence 9999999999987542 46666655543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.32 E-value=4.3e-12 Score=125.97 Aligned_cols=95 Identities=24% Similarity=0.310 Sum_probs=80.9
Q ss_pred cCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcC-CCCcccEEEEEEeCCeeEEEEeccC
Q 044615 467 GHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR-HRNIVKFYGFCSHALHSFVVYEYLE 544 (571)
Q Consensus 467 ~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~ 544 (571)
.+.||+|+||.||+|. ..+++.||||++... ....+.+|+.+++.+. |||||++++++.+....|+||||++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~ 89 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN 89 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccC
Confidence 4789999999999999 457999999998642 2456789999999997 9999999999999999999999999
Q ss_pred CCChhhhhccCCCccCCCHHHHhhhc
Q 044615 545 MGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 545 ~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+|+|.+++.... .+++.....|+
T Consensus 90 ~~~L~~~l~~~~---~~~~~~~~~i~ 112 (325)
T 3kn6_A 90 GGELFERIKKKK---HFSETEASYIM 112 (325)
T ss_dssp SCBHHHHHHHCS---CCCHHHHHHHH
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHH
Confidence 999999998542 46777666553
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=4.1e-12 Score=126.55 Aligned_cols=106 Identities=21% Similarity=0.369 Sum_probs=87.9
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.++|+..+.||+|+||.||+|. ..+|+.||||++..... .....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 3568999999999999999999 45799999999875433 234456788999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||+++|+|.+++.... .+++.....|+
T Consensus 103 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~ 130 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPN---GLDYQVVQKYL 130 (331)
T ss_dssp EECCSEEHHHHHHHSTT---CCCHHHHHHHH
T ss_pred EecCCcchHHHHHhhcc---CCCHHHHHHHH
Confidence 99999999988876432 36777666553
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.31 E-value=1.8e-12 Score=128.59 Aligned_cols=110 Identities=21% Similarity=0.317 Sum_probs=89.4
Q ss_pred HHccCCCccCeeeccCcceEEEEEcC------CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEe
Q 044615 459 RATNNFDDGHCIGNGGQGSVYKAKLP------TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSH 532 (571)
Q Consensus 459 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~ 532 (571)
...++|++.+.||+|+||.||+|... +++.||||.+.... .......+.+|++++++++||||+++++++.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 99 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 99 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence 34567999999999999999999743 46789999997542 23445679999999999999999999999999
Q ss_pred CCeeEEEEeccCCCChhhhhccCCC-------ccCCCHHHHhhhc
Q 044615 533 ALHSFVVYEYLEMGSLAMNLSNDAA-------AEQFCWTKRMNAI 570 (571)
Q Consensus 533 ~~~~~lv~e~~~~G~L~~~l~~~~~-------~~~l~w~~r~~ia 570 (571)
.+..|+||||+++|+|.+++..... ...++|...++|+
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~ 144 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHH
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHH
Confidence 9999999999999999999975321 1346777776654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.31 E-value=4e-12 Score=126.74 Aligned_cols=105 Identities=24% Similarity=0.392 Sum_probs=85.8
Q ss_pred cCCCccCeeeccCcceEEEEEcC-C----CCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCee
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLP-T----GEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHS 536 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~ 536 (571)
..|...+.||+|+||.||+|... + +..||||.+.... .......+.+|++++++++||||+++++++.+.+..
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 45777899999999999999843 2 2359999997543 234456799999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
++||||+++|+|.+++..... .++|..++.|+
T Consensus 122 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~ 153 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREKDG--EFSVLQLVGML 153 (333)
T ss_dssp EEEEECCTTEEHHHHHHHTTT--CSCHHHHHHHH
T ss_pred EEEEeCCCCCcHHHHHHhCCC--CCCHHHHHHHH
Confidence 999999999999999975432 57777776654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.31 E-value=2.5e-12 Score=127.64 Aligned_cols=109 Identities=21% Similarity=0.332 Sum_probs=79.6
Q ss_pred ccCCCccCeeeccCcceEEEEEcC-CCC---EEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCee
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKLP-TGE---IVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHS 536 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~---~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~ 536 (571)
.++|++.+.||+|+||.||+|... ++. .||||++....... ...+.+.+|++++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 457999999999999999999854 333 79999997653332 3467899999999999999999999999877655
Q ss_pred ------EEEEeccCCCChhhhhccCC---CccCCCHHHHhhhc
Q 044615 537 ------FVVYEYLEMGSLAMNLSNDA---AAEQFCWTKRMNAI 570 (571)
Q Consensus 537 ------~lv~e~~~~G~L~~~l~~~~---~~~~l~w~~r~~ia 570 (571)
++||||+++|+|.+++.... ....+++..+.+|+
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~ 143 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHH
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHH
Confidence 99999999999999997432 12257887777664
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=2.9e-12 Score=127.38 Aligned_cols=104 Identities=25% Similarity=0.295 Sum_probs=86.4
Q ss_pred cCCCccCeeeccCcceEEEEEc-----CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEe--CC
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-----PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSH--AL 534 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~--~~ 534 (571)
++|+..+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++||||+++++++.. ..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ 99 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence 4689999999999999999983 368899999997542 3445779999999999999999999999874 56
Q ss_pred eeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 535 HSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
..|+||||+++|+|.+++..... .++|..+..|+
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~ 133 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYS 133 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHH
T ss_pred eEEEEEeecCCCCHHHHHHhccc--CCCHHHHHHHH
Confidence 68999999999999999975332 47777777654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.31 E-value=8.6e-13 Score=132.42 Aligned_cols=108 Identities=17% Similarity=0.254 Sum_probs=88.7
Q ss_pred ccCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCch--------------HhHHHHHHHHHHHhhcCCCCcccE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEM--------------ACQQEFLNEVNALTKIRHRNIVKF 526 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--------------~~~~~~~~Ei~~l~~l~H~niv~l 526 (571)
.++|++.+.||+|+||.||+|.. +++.||||.+........ ...+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 45799999999999999999998 899999999864321110 112789999999999999999999
Q ss_pred EEEEEeCCeeEEEEeccCCCChhhh------hccCCCccCCCHHHHhhhc
Q 044615 527 YGFCSHALHSFVVYEYLEMGSLAMN------LSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 527 ~~~~~~~~~~~lv~e~~~~G~L~~~------l~~~~~~~~l~w~~r~~ia 570 (571)
++++.+.+..|+||||+++|+|.++ +... ....++|..+..|+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~ 157 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCII 157 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHH
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHH
Confidence 9999999999999999999999999 5432 13467888777664
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.31 E-value=6.9e-12 Score=122.16 Aligned_cols=104 Identities=22% Similarity=0.272 Sum_probs=83.7
Q ss_pred cCCCccC-eeeccCcceEEEEEc---CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeE
Q 044615 462 NNFDDGH-CIGNGGQGSVYKAKL---PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSF 537 (571)
Q Consensus 462 ~~~~~~~-~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~ 537 (571)
++|.+.. .||+|+||.||+|.. .++..||||++.... .....+.+.+|++++++++||||+++++++ ..+..+
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~ 85 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM 85 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence 3455555 899999999999974 267789999997642 234567899999999999999999999999 556689
Q ss_pred EEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 538 VVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+||||+++|+|.+++.... ..+++..+..++
T Consensus 86 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ 116 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVGKR--EEIPVSNVAELL 116 (287)
T ss_dssp EEEECCTTEEHHHHHTTCT--TTSCHHHHHHHH
T ss_pred EEEEeCCCCCHHHHHHhCC--ccCCHHHHHHHH
Confidence 9999999999999997543 247777776654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.31 E-value=6e-12 Score=124.13 Aligned_cols=105 Identities=19% Similarity=0.208 Sum_probs=85.1
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCeeEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lv 539 (571)
++|+..+.||+|+||+||+|.. .+++.||||++....... ....++..|+..+.++ +|||||+++++|.+.+..|+|
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGP-KDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccCh-HHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 4599999999999999999995 489999999987554333 3345566677666555 999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||+ +|+|.+++...+ ..++|..+..|+
T Consensus 136 ~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~ 163 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWG--ASLPEAQVWGYL 163 (311)
T ss_dssp EECC-CCBHHHHHHHHC--SCCCHHHHHHHH
T ss_pred Eecc-CCCHHHHHHhcC--CCCCHHHHHHHH
Confidence 9999 679999987543 358898887765
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.31 E-value=4.1e-12 Score=126.26 Aligned_cols=105 Identities=30% Similarity=0.425 Sum_probs=85.7
Q ss_pred ccCCCccCeeeccCcceEEEEEc-----CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC-
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKL-----PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL- 534 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~- 534 (571)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 116 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence 34688999999999999999983 368899999997542 234578999999999999999999999987644
Q ss_pred -eeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 535 -HSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 535 -~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
..++||||+++|+|.+++..... .++|.+.+.|+
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~ 151 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYT 151 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHSTT--SSCHHHHHHHH
T ss_pred CceEEEEECCCCCCHHHHHHhccc--CCCHHHHHHHH
Confidence 68999999999999999986432 47777776654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=1.9e-12 Score=127.16 Aligned_cols=108 Identities=20% Similarity=0.281 Sum_probs=74.0
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.++|++.+.||+|+||.||+|. ..+++.||||++...... ...+++.+|+.++++++||||+++++++...+..|+|
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc--hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 4679999999999999999999 457899999998654322 2356788999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccC-----CCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSND-----AAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~-----~~~~~l~w~~r~~ia 570 (571)
|||+++|+|.+++... .....+++..+..|+
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~ 127 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHH
Confidence 9999999999999741 122357887777664
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.30 E-value=4.9e-12 Score=123.41 Aligned_cols=103 Identities=22% Similarity=0.190 Sum_probs=84.0
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEe----CCeeE
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSH----ALHSF 537 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~----~~~~~ 537 (571)
.|...+.||+|+||.||+|. ..++..||+|.+...... ....+.+.+|+.++++++||||+++++++.. ....|
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 36778899999999999998 557889999998754332 3446789999999999999999999999876 35689
Q ss_pred EEEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 538 VVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
+||||+++|+|.+++.... .+++.....|
T Consensus 106 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~ 134 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFK---VMKIKVLRSW 134 (290)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHH
T ss_pred EEEEecCCCCHHHHHHHcc---CCCHHHHHHH
Confidence 9999999999999997532 4666665554
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=5.7e-12 Score=122.35 Aligned_cols=105 Identities=20% Similarity=0.298 Sum_probs=84.8
Q ss_pred ccCCCccCeeeccCcceEEEEEcC----CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCee
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKLP----TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHS 536 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~ 536 (571)
.++|++.+.||+|+||.||+|... .+..||+|.+.... .....+.+.+|+.++++++||||+++++++ ..+..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~ 90 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPV 90 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSC
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCcc
Confidence 356889999999999999999843 24569999987542 234467899999999999999999999998 45678
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+||||+++|+|.+++.... ..++|.....++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ 122 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRK--YSLDLASLILYA 122 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHH
T ss_pred EEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHH
Confidence 99999999999999997543 247777776654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=3e-12 Score=124.74 Aligned_cols=106 Identities=23% Similarity=0.279 Sum_probs=88.4
Q ss_pred ccCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.+.|++.+.||+|+||.||+|.. .+++.||||++...... ....+.+.+|++++++++||||+++++++.+....|+|
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 35699999999999999999994 58999999998654322 12357799999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||+++|+|.+++.... .+++.....|+
T Consensus 100 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~ 127 (287)
T 2wei_A 100 GELYTGGELFDEIIKRK---RFSEHDAARII 127 (287)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHH
T ss_pred EEccCCCCHHHHHHhcC---CCCHHHHHHHH
Confidence 99999999999987432 46777666554
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.30 E-value=4.8e-12 Score=124.06 Aligned_cols=103 Identities=21% Similarity=0.320 Sum_probs=84.1
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEe-------
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSH------- 532 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~------- 532 (571)
.++|+..+.||+|+||.||+|+ ..+++.||||++.. .....+.+.+|++++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE----EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec----cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 3568999999999999999999 45899999999853 23445779999999999999999999999865
Q ss_pred ------CCeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 533 ------ALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 533 ------~~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
....|+||||+++|+|.+++..... .+++....+|
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i 121 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSENL--NQQRDEYWRL 121 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHHSCG--GGCHHHHHHH
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhcccc--ccchHHHHHH
Confidence 3568999999999999999985432 3555555444
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.30 E-value=2.1e-12 Score=127.77 Aligned_cols=107 Identities=15% Similarity=0.252 Sum_probs=85.8
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEe----CCe
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSH----ALH 535 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~----~~~ 535 (571)
.++|++.+.||+|+||.||+|. ..+++.||||++... .....+.+.+|++++++++||||+++++++.. ...
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 3569999999999999999999 468999999998643 23446789999999999999999999999973 347
Q ss_pred eEEEEeccCCCChhhhhccC-CCccCCCHHHHhhhc
Q 044615 536 SFVVYEYLEMGSLAMNLSND-AAAEQFCWTKRMNAI 570 (571)
Q Consensus 536 ~~lv~e~~~~G~L~~~l~~~-~~~~~l~w~~r~~ia 570 (571)
.|+||||+++|+|.+++... .....+++..+..|+
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~ 140 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLL 140 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHH
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHH
Confidence 89999999999999999752 123457887777664
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=5.7e-12 Score=125.24 Aligned_cols=107 Identities=24% Similarity=0.405 Sum_probs=85.5
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCEE--EEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCeeE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIV--DVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHSF 537 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~v--avK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~ 537 (571)
++|+..+.||+|+||.||+|+. .++..+ |+|.+..... ....+.+.+|+++++++ +||||+++++++.+.+..|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccc--hHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 4688999999999999999984 466654 9999874322 22346789999999999 9999999999999999999
Q ss_pred EEEeccCCCChhhhhccCC-------------CccCCCHHHHhhhc
Q 044615 538 VVYEYLEMGSLAMNLSNDA-------------AAEQFCWTKRMNAI 570 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~~-------------~~~~l~w~~r~~ia 570 (571)
+||||+++|+|.+++.... ....+++.+...|+
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 148 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHH
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHH
Confidence 9999999999999998643 12357777776654
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=3.4e-12 Score=126.60 Aligned_cols=104 Identities=20% Similarity=0.201 Sum_probs=80.6
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCC-----chHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPD-----EMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALH 535 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~ 535 (571)
++|.+.+.||+|+||.||+|. ..+++.||||.+...... .......+.+|++++++++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 469999999999999999998 457899999999754321 1122345889999999999999999999997655
Q ss_pred eEEEEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 536 SFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 536 ~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
.|+||||+++|+|.+++.... .+++.....+
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~ 119 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNK---RLKEATCKLY 119 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTC---CCCHHHHHHH
T ss_pred eEEEEecCCCCcHHHHHhccC---CCCHHHHHHH
Confidence 899999999999999997432 4666655544
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.30 E-value=3.3e-12 Score=129.07 Aligned_cols=104 Identities=16% Similarity=0.160 Sum_probs=85.7
Q ss_pred ccCCCccCeeeccCcceEEEEE------cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcC---CCCcccEEEEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK------LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR---HRNIVKFYGFCS 531 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~~~~~ 531 (571)
.+.|.+.+.||+|+||.||+|. ..+++.||||++.... ..++.+|++++.+++ |+||+++++++.
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 4568999999999999999993 4578999999997532 356778888888876 999999999999
Q ss_pred eCCeeEEEEeccCCCChhhhhccCC--CccCCCHHHHhhhc
Q 044615 532 HALHSFVVYEYLEMGSLAMNLSNDA--AAEQFCWTKRMNAI 570 (571)
Q Consensus 532 ~~~~~~lv~e~~~~G~L~~~l~~~~--~~~~l~w~~r~~ia 570 (571)
..+..|+|||||++|+|.+++.... ....++|..++.|+
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~ 178 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHH
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHH
Confidence 9999999999999999999997422 23468888887775
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.29 E-value=6.3e-12 Score=124.13 Aligned_cols=104 Identities=26% Similarity=0.385 Sum_probs=81.9
Q ss_pred HccCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEE
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFV 538 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l 538 (571)
..+.|++.+.||+|+||.||+|.. .+|+.||||.+..... .+.+.+|++++++++||||+++++++.+.+..|+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 345799999999999999999994 5799999999975431 3568899999999999999999999999999999
Q ss_pred EEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 539 VYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||||+++|+|.+++.... ..+++.....|+
T Consensus 102 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~ 131 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRN--KTLTEDEIATIL 131 (314)
T ss_dssp EEECCTTEEHHHHHHHHT--CCCCHHHHHHHH
T ss_pred EeecCCCCCHHHHHHhcC--CCCCHHHHHHHH
Confidence 999999999999997432 246776666553
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.29 E-value=5.6e-12 Score=127.28 Aligned_cols=110 Identities=16% Similarity=0.228 Sum_probs=89.7
Q ss_pred HHHccCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCc-----hHhHHHHHHHHHHHhhc-CCCCcccEEEEE
Q 044615 458 IRATNNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDE-----MACQQEFLNEVNALTKI-RHRNIVKFYGFC 530 (571)
Q Consensus 458 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~ 530 (571)
....++|++.+.||+|+||.||+|.. .+|+.||||++....... ....+.+.+|+.++.++ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 34456799999999999999999995 589999999997654221 12245688999999999 899999999999
Q ss_pred EeCCeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 531 SHALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 531 ~~~~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
......|+||||+++|+|.+++.+. ..+++.....|+
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~ 206 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIM 206 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHH
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHH
Confidence 9999999999999999999999743 246777666553
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=5.2e-12 Score=125.70 Aligned_cols=101 Identities=23% Similarity=0.175 Sum_probs=85.6
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCeeEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lv 539 (571)
++|++.+.||+|+||.||+|. ..+++.||||++...... +.+.+|+++++++ +||||+++++++...+..|+|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 569999999999999999999 568999999998754322 3578999999999 999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||+ +|+|.+++.... ..++|..++.|+
T Consensus 84 ~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~ 111 (330)
T 2izr_A 84 LELL-GPSLEDLFDLCD--RTFSLKTVLMIA 111 (330)
T ss_dssp EECC-CCBHHHHHHHTT--TCCCHHHHHHHH
T ss_pred EEeC-CCCHHHHHHHcC--CCCCHHHHHHHH
Confidence 9999 999999998542 357888777664
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.29 E-value=1.8e-12 Score=129.31 Aligned_cols=107 Identities=18% Similarity=0.144 Sum_probs=87.9
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCch-----HhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEM-----ACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL 534 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~-----~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~ 534 (571)
.++|+..+.||+|+||.||+|. ..+++.||||++........ ...+.+.+|++++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 4579999999999999999998 56899999999976543211 12345778999999999999999999999999
Q ss_pred eeEEEEeccCCC-ChhhhhccCCCccCCCHHHHhhhc
Q 044615 535 HSFVVYEYLEMG-SLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 535 ~~~lv~e~~~~G-~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
..++||||+.+| +|.+++.... .+++..+..|+
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~ 136 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIF 136 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHH
T ss_pred EEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHH
Confidence 999999999877 9999997543 47777766654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.29 E-value=6.1e-12 Score=135.68 Aligned_cols=102 Identities=20% Similarity=0.230 Sum_probs=82.3
Q ss_pred CCccC-eeeccCcceEEEEEcC---CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 464 FDDGH-CIGNGGQGSVYKAKLP---TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 464 ~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
+.+.+ .||+|+||.||+|... ++..||||+++.... ....++|.+|+++|++++|||||+++++|.. +..|+|
T Consensus 337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS--STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 33334 7999999999999743 566799999976432 2346789999999999999999999999976 568999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||||++|+|.+++.... ..++|..+..|+
T Consensus 414 ~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~ 442 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKR--EEIPVSNVAELL 442 (613)
T ss_dssp EECCTTCBHHHHHTTCT--TTSCHHHHHHHH
T ss_pred EEeCCCCcHHHHHhhcc--CCCCHHHHHHHH
Confidence 99999999999997543 357888777664
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.29 E-value=4.4e-12 Score=125.32 Aligned_cols=101 Identities=23% Similarity=0.372 Sum_probs=82.9
Q ss_pred HHHHHHHccCCCccCeeeccCcceEEEEEc------CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccE
Q 044615 454 HEEIIRATNNFDDGHCIGNGGQGSVYKAKL------PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKF 526 (571)
Q Consensus 454 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l 526 (571)
..+.....++|.+.+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|++++.++ +||||+++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 344444567899999999999999999972 356889999997543 233456799999999999 79999999
Q ss_pred EEEEEeCC-eeEEEEeccCCCChhhhhccCC
Q 044615 527 YGFCSHAL-HSFVVYEYLEMGSLAMNLSNDA 556 (571)
Q Consensus 527 ~~~~~~~~-~~~lv~e~~~~G~L~~~l~~~~ 556 (571)
++++...+ ..|+||||+++|+|.+++....
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 127 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 127 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCT
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcc
Confidence 99997754 5899999999999999998654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.28 E-value=4.1e-12 Score=123.44 Aligned_cols=101 Identities=27% Similarity=0.396 Sum_probs=83.6
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEe--------
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSH-------- 532 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~-------- 532 (571)
++|+..+.||+|+||.||+|.. .+++.||+|.+.... +.+.+|++++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 4589999999999999999995 489999999997542 346789999999999999999999865
Q ss_pred --------CCeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 533 --------ALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 533 --------~~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
....|+||||+++|+|.+++.... ...++|..+..|+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~ 128 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELF 128 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHH
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHH
Confidence 345899999999999999997542 2357777776654
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.28 E-value=8e-12 Score=122.39 Aligned_cols=105 Identities=27% Similarity=0.373 Sum_probs=82.9
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|+..+.||+|+||.||+|+. .+|+.||||++...... ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (299)
T 2r3i_A 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccc-hhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEE
Confidence 5789999999999999999994 58999999999754322 122467889999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
||++ |+|.+++..... ..+++.....|
T Consensus 82 e~~~-~~L~~~~~~~~~-~~~~~~~~~~~ 108 (299)
T 2r3i_A 82 EFLH-QDLKKFMDASAL-TGIPLPLIKSY 108 (299)
T ss_dssp ECCS-EEHHHHHHHTTT-TCCCHHHHHHH
T ss_pred Eccc-CCHHHHHHhhhc-cCCCHHHHHHH
Confidence 9998 699999975432 24666665554
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.27 E-value=9.4e-12 Score=121.35 Aligned_cols=104 Identities=33% Similarity=0.429 Sum_probs=83.5
Q ss_pred ccCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
.+.|++.+.||+|+||.||+|+.. ..||||++..... .....+.|.+|++++++++||||+++++++ .....++||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 356999999999999999999863 3599999976543 334567899999999999999999999965 556689999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||+++|+|.+++.... ..++|..++.|+
T Consensus 99 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~ 126 (289)
T 3og7_A 99 QWCEGSSLYHHLHASE--TKFEMKKLIDIA 126 (289)
T ss_dssp ECCCEEEHHHHHTTC-----CCHHHHHHHH
T ss_pred EecCCCcHHHHHhhcc--CCCCHHHHHHHH
Confidence 9999999999997543 357777776654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.27 E-value=9.9e-12 Score=124.39 Aligned_cols=104 Identities=18% Similarity=0.213 Sum_probs=87.6
Q ss_pred cCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCC--CCcccEEEEEEeCCeeEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH--RNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~~~~~~~~~~~lv 539 (571)
+.|++.+.||+|+||.||+|...+++.||||++...... ....+.+.+|++++.+++| |||+++++++.+....|+|
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccc-hHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 458999999999999999999878999999999765433 3446789999999999987 9999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|| +.+|+|.+++.... .+++..+..|+
T Consensus 88 ~e-~~~~~L~~~l~~~~---~~~~~~~~~i~ 114 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKK---SIDPWERKSYW 114 (343)
T ss_dssp EC-CCSEEHHHHHHHSC---CCCHHHHHHHH
T ss_pred Ee-CCCCCHHHHHHhcC---CCCHHHHHHHH
Confidence 99 56789999998543 46777666554
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.27 E-value=1.1e-11 Score=123.11 Aligned_cols=107 Identities=25% Similarity=0.382 Sum_probs=87.0
Q ss_pred HHHccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEe---
Q 044615 458 IRATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSH--- 532 (571)
Q Consensus 458 ~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~--- 532 (571)
....+.|++.+.||+|+||.||+|. ..+++.||||++...... .+.+.+|+.+++++ +||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 3456779999999999999999999 468999999999754322 36788999999998 89999999999987
Q ss_pred ---CCeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 533 ---ALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 533 ---~~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
.+..|+||||+++|+|.+++.... ...+++.....|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i 134 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYI 134 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHH
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHH
Confidence 467899999999999999997542 234666555444
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=1.2e-11 Score=126.09 Aligned_cols=104 Identities=18% Similarity=0.209 Sum_probs=87.0
Q ss_pred cCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcC--CCCcccEEEEEEeCCeeEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR--HRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~--H~niv~l~~~~~~~~~~~lv 539 (571)
..|++.+.||+|+||.||+|...+++.||||++...... ....+.+.+|++++++++ |||||++++++...+..|+|
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEeccccc-HHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 359999999999999999999777999999999765432 345678999999999996 59999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|| +.+|+|.+++.... .+++..+..|+
T Consensus 135 ~E-~~~~~L~~~l~~~~---~~~~~~~~~i~ 161 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK---SIDPWERKSYW 161 (390)
T ss_dssp EE-CCSEEHHHHHHHCS---SCCHHHHHHHH
T ss_pred Ee-cCCCCHHHHHHhcC---CCCHHHHHHHH
Confidence 99 67889999998543 46776666553
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=1e-11 Score=121.23 Aligned_cols=105 Identities=24% Similarity=0.333 Sum_probs=82.4
Q ss_pred ccCCCccC-eeeccCcceEEEEEc---CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCee
Q 044615 461 TNNFDDGH-CIGNGGQGSVYKAKL---PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHS 536 (571)
Q Consensus 461 ~~~~~~~~-~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~ 536 (571)
.+.|.+.+ .||+|+||.||+|.. .+++.||||++...... ....+++.+|++++++++||||+++++++ ..+..
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 34677777 999999999999952 35788999999755322 23467899999999999999999999999 56678
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+||||+++|+|.+++.... .+++.....|+
T Consensus 93 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~ 123 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQNR---HVKDKNIIELV 123 (291)
T ss_dssp EEEEECCTTEEHHHHHHHCT---TCCHHHHHHHH
T ss_pred EEEEEeCCCCCHHHHHHhCc---CCCHHHHHHHH
Confidence 99999999999999998542 36666665553
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=6.4e-12 Score=124.92 Aligned_cols=109 Identities=17% Similarity=0.190 Sum_probs=87.9
Q ss_pred HccCCCcc-CeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCee
Q 044615 460 ATNNFDDG-HCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHS 536 (571)
Q Consensus 460 ~~~~~~~~-~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~ 536 (571)
-.+.|.+. +.||+|+||.||+|. ..+++.||+|++....... .....+.+|+.++..+ +||||+++++++.+.+..
T Consensus 26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~ 104 (327)
T 3lm5_A 26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI 104 (327)
T ss_dssp HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence 33457666 889999999999999 4579999999997643332 3356789999999998 569999999999999999
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+||||+++|+|.+++.... ...+++.....|+
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~ 137 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLI 137 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHH
T ss_pred EEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHH
Confidence 99999999999999996532 2357777776654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=1.2e-11 Score=121.25 Aligned_cols=99 Identities=25% Similarity=0.402 Sum_probs=80.3
Q ss_pred ccCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhh--cCCCCcccEEEEEEeC----C
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTK--IRHRNIVKFYGFCSHA----L 534 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~~~~~~~----~ 534 (571)
.++|++.+.||+|+||.||+|.. +++.||||++... ..+.+.+|.+++.. ++||||+++++++... .
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR------DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 35699999999999999999987 6889999998642 23556677777666 8999999999997653 4
Q ss_pred eeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 535 HSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
..|+||||+++|+|.++++.. .++|..+++|+
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~ 111 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIV 111 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTTC----CBCHHHHHHHH
T ss_pred eeEEehhhccCCCHHHHHhhc----ccCHHHHHHHH
Confidence 589999999999999999643 47788777664
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=1e-11 Score=122.54 Aligned_cols=110 Identities=22% Similarity=0.364 Sum_probs=83.5
Q ss_pred HccCCCccCeeeccCcceEEEEEc-C---CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC-
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAKL-P---TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL- 534 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~~-~---~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~- 534 (571)
..++|.+.+.||+|+||.||+|.. . ++..||||.+...... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS-QREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCC-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccc-hhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 346788899999999999999973 2 3458999999765433 344577999999999999999999999998754
Q ss_pred ----eeEEEEeccCCCChhhhhccC---CCccCCCHHHHhhhc
Q 044615 535 ----HSFVVYEYLEMGSLAMNLSND---AAAEQFCWTKRMNAI 570 (571)
Q Consensus 535 ----~~~lv~e~~~~G~L~~~l~~~---~~~~~l~w~~r~~ia 570 (571)
..|+||||+++|+|.+++... .....+++.....|+
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~ 153 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHH
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHH
Confidence 359999999999999999532 223467888777664
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.25 E-value=8.7e-12 Score=122.54 Aligned_cols=108 Identities=18% Similarity=0.237 Sum_probs=82.8
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCc-hHhHHHHHHHHHHHhhcCCCCcccEEEEEE--eCCee
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDE-MACQQEFLNEVNALTKIRHRNIVKFYGFCS--HALHS 536 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~--~~~~~ 536 (571)
.++|.+.+.||+|+||.||+|. ..+++.||+|++....... ....+.+.+|++++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 3679999999999999999999 4578999999986432111 123567999999999999999999999984 44578
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+||||+++| +.+++.... ...+++.....|+
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~ 115 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYF 115 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHH
T ss_pred EEEehhccCC-HHHHHHhCc-ccccCHHHHHHHH
Confidence 9999999987 777776432 2357777766554
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=6.7e-12 Score=126.66 Aligned_cols=114 Identities=18% Similarity=0.227 Sum_probs=90.9
Q ss_pred HHHHHHHccCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCC--------chHhHHHHHHHHHHHhhcCCCCccc
Q 044615 454 HEEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPD--------EMACQQEFLNEVNALTKIRHRNIVK 525 (571)
Q Consensus 454 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~~~Ei~~l~~l~H~niv~ 525 (571)
..++....++|.+.+.||+|+||.||+|...+|+.||||++...... .....+.+.+|++++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 45667778999999999999999999999777999999998643221 1123477999999999999999999
Q ss_pred EEEEEEeC-----CeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 526 FYGFCSHA-----LHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 526 l~~~~~~~-----~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+++++... ...|+||||++ |+|.+++.... ..+++.....|+
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~ 140 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFM 140 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHH
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHH
Confidence 99999653 36799999998 68998887543 257777666554
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.25 E-value=1.2e-11 Score=121.19 Aligned_cols=105 Identities=21% Similarity=0.299 Sum_probs=83.0
Q ss_pred cCCCccCeeeccCcceEEEEEcC-C---CCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEe-CCee
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLP-T---GEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSH-ALHS 536 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~-~~~~ 536 (571)
..|+..+.||+|+||.||+|... + +..||+|.+... ......+.+.+|+.++++++||||+++++++.+ .+..
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 45888899999999999999843 2 235899998753 233456789999999999999999999998654 5678
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
++||||+++|+|.++++... ..+++..+..|+
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~ 134 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFG 134 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTT--CCCCHHHHHHHH
T ss_pred EEEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHH
Confidence 99999999999999997543 246777666554
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.25 E-value=1.1e-11 Score=123.25 Aligned_cols=104 Identities=19% Similarity=0.398 Sum_probs=78.8
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCE----EEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCee
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEI----VDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHS 536 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~----vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~ 536 (571)
++|+..+.||+|+||.||+|+ ..+++. ||+|.+.... .....++|.+|+.++++++|||||+++++|.+.. .
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 91 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence 468999999999999999998 445544 5888876432 2233578999999999999999999999998765 7
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
++||||+++|+|.+++..... .++|..++.|+
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~ 123 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREHKD--NIGSQYLLNWC 123 (327)
T ss_dssp EEEEECCTTCBHHHHHHHSTT--SCCHHHHHHHH
T ss_pred EEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHH
Confidence 799999999999999986433 47777766654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.25 E-value=7.3e-12 Score=125.54 Aligned_cols=107 Identities=21% Similarity=0.348 Sum_probs=78.2
Q ss_pred HccCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCch--HhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCee
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEM--ACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHS 536 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~ 536 (571)
..+.|+..+.||+|+||.||+|.. .+|+.||||++........ ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 456799999999999999999994 5799999999975432211 1134688999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
++||||+++ +|.+++..... .+++.....+
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~ 117 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSL--VLTPSHIKAY 117 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCS--SCCSSHHHHH
T ss_pred EEEEEcCCC-CHHHHHHhcCc--CCCHHHHHHH
Confidence 999999986 89988875432 3444444433
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.25 E-value=3.5e-10 Score=115.38 Aligned_cols=287 Identities=13% Similarity=0.055 Sum_probs=206.0
Q ss_pred hhhcCCCCCCEEEccCCccc-----cCCCCccceeecccc-------cccCCCC------CCCccc-cccccCCCCCCEE
Q 044615 42 KELVRAVQARDTSISFDELH-----EKLLTFEATAHFSVL-------AFTGQDW------PLYSSI-PDEIGNMKSLSDL 102 (571)
Q Consensus 42 ~~l~~~~~l~~l~l~~n~l~-----~~~l~~l~~l~l~~n-------~l~~~~~------~~~~~~-p~~~~~l~~L~~L 102 (571)
..+.++++|+.+++..+--. |..+..|+.+.+..+ .|.+... .....+ ...|.++++|+.+
T Consensus 88 ~aF~~c~~L~~i~lp~~l~~I~~~aF~~c~~L~~i~~p~~l~~i~~~aF~~~~~~~~~~~~~~~~i~~~aF~~c~~L~~i 167 (394)
T 4fs7_A 88 FAFENCSKLEIINIPDSVKMIGRCTFSGCYALKSILLPLMLKSIGVEAFKGCDFKEITIPEGVTVIGDEAFATCESLEYV 167 (394)
T ss_dssp TTTTTCTTCCEECCCTTCCEECTTTTTTCTTCCCCCCCTTCCEECTTTTTTCCCSEEECCTTCCEECTTTTTTCTTCCEE
T ss_pred hHhhCCCCCcEEEeCCCceEccchhhcccccchhhcccCceeeecceeeecccccccccCccccccchhhhcccCCCcEE
Confidence 44678899999999765222 666777766655432 1111000 001111 2457889999999
Q ss_pred ecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCC
Q 044615 103 QLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLN 182 (571)
Q Consensus 103 ~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~ 182 (571)
.+.++. .......|.++.+|+.+++..+ ++.+....|.++..|+.+.+..+... +.+......+|+.+.+..+ +.
T Consensus 168 ~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~ 242 (394)
T 4fs7_A 168 SLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FT 242 (394)
T ss_dssp ECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CC
T ss_pred ecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccCCCceEEECCC-ce
Confidence 998664 4466778999999999999877 56567778999999999988776543 2334455678999988654 33
Q ss_pred ccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhh
Q 044615 183 GSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESL 262 (571)
Q Consensus 183 ~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l 262 (571)
..-...+..... |+.+.+..+... .....|..+..++.+....+.+. ...|..+.+|+.+.+..+ +......+|
T Consensus 243 ~i~~~~f~~~~~-l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF 316 (394)
T 4fs7_A 243 ELGKSVFYGCTD-LESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAF 316 (394)
T ss_dssp EECSSTTTTCSS-CCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTT
T ss_pred eccccccccccc-ceeEEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhh
Confidence 233344555554 999999877543 55677888889998888766433 346788999999999765 555667789
Q ss_pred ccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCE
Q 044615 263 SNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSC 342 (571)
Q Consensus 263 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 342 (571)
.++.+|+.+++..+ ++......|.++.+|+.+++..+ ++.+...+|.++++|+.+++..+ ++ .+..+|.++++|+.
T Consensus 317 ~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~ 392 (394)
T 4fs7_A 317 ESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKW 392 (394)
T ss_dssp TTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEE
T ss_pred cCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcE
Confidence 99999999999755 66666788999999999999877 77777788999999999999765 33 33467888777765
Q ss_pred E
Q 044615 343 I 343 (571)
Q Consensus 343 L 343 (571)
+
T Consensus 393 I 393 (394)
T 4fs7_A 393 I 393 (394)
T ss_dssp E
T ss_pred E
Confidence 4
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.25 E-value=1.4e-11 Score=120.61 Aligned_cols=104 Identities=18% Similarity=0.222 Sum_probs=82.8
Q ss_pred CCCccCeeeccCcceEEEEEc-CCC---CEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCee-E
Q 044615 463 NFDDGHCIGNGGQGSVYKAKL-PTG---EIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHS-F 537 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~-~~~---~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~-~ 537 (571)
.|...+.||+|+||.||+|.. .++ ..||+|.+... ......+.|.+|++++++++||||+++++++.+.+.. +
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 356678999999999999983 333 37999998753 2334567899999999999999999999999876655 9
Q ss_pred EEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 538 VVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+||||+.+|+|.+++.... ..++|..+..|+
T Consensus 100 ~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~ 130 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQ--RNPTVKDLISFG 130 (298)
T ss_dssp EEECCCTTCBHHHHHHCTT--CCCBHHHHHHHH
T ss_pred EEEecccCCCHHHHHhccc--cCCCHHHHHHHH
Confidence 9999999999999998643 246777666554
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.24 E-value=1.4e-11 Score=126.00 Aligned_cols=100 Identities=17% Similarity=0.208 Sum_probs=79.4
Q ss_pred cCCCcc-CeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHh-hcCCCCcccEEEEEEe----CC
Q 044615 462 NNFDDG-HCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALT-KIRHRNIVKFYGFCSH----AL 534 (571)
Q Consensus 462 ~~~~~~-~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~-~l~H~niv~l~~~~~~----~~ 534 (571)
++|... +.||+|+||+||+|. ..+++.||||+++.. ..+.+|+.++. ..+||||++++++|.. ..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 456665 689999999999999 458999999998632 35678888874 4589999999999876 56
Q ss_pred eeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 535 HSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
..|+|||||++|+|.+++.... ...++|.....|+
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~ 167 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIM 167 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHH
T ss_pred EEEEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHH
Confidence 7899999999999999998643 2357787776654
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.24 E-value=2.2e-11 Score=122.10 Aligned_cols=94 Identities=26% Similarity=0.203 Sum_probs=71.1
Q ss_pred cccccccCCCCCCEEeccc-CcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCcccc
Q 044615 88 SIPDEIGNMKSLSDLQLSE-NILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIG 166 (571)
Q Consensus 88 ~~p~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~ 166 (571)
.+|. +..+++|++|+|++ |.+++..+..|.++++|+.|+|++|+|++..|..|.+|++|++|+|++|.+++..+..+.
T Consensus 23 ~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~ 101 (347)
T 2ifg_A 23 SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQ 101 (347)
T ss_dssp TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTC
T ss_pred ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcc
Confidence 4677 77778888888885 888776667788888888888888888877777788888888888888888765555555
Q ss_pred CCCCCCEEEccCCCCCc
Q 044615 167 NMNSLSILDLSSNKLNG 183 (571)
Q Consensus 167 ~l~~L~~L~L~~n~l~~ 183 (571)
.++ |+.|+|.+|.+..
T Consensus 102 ~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 102 GLS-LQELVLSGNPLHC 117 (347)
T ss_dssp SCC-CCEEECCSSCCCC
T ss_pred cCC-ceEEEeeCCCccC
Confidence 554 8888888877764
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=1.5e-11 Score=127.06 Aligned_cols=105 Identities=20% Similarity=0.302 Sum_probs=86.3
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC-----C
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA-----L 534 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~-----~ 534 (571)
.++|++.+.||+|+||.||+|. ..+++.||||++.... ......+++.+|++++++++|||||++++++... .
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 4579999999999999999999 5578999999997543 2334567899999999999999999999999776 5
Q ss_pred eeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 535 HSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
..|+||||++ |+|.++++.. ..+++.....|+
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~ 135 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTP---IFLTEEHIKTIL 135 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSS---CCCCHHHHHHHH
T ss_pred eEEEEEecCC-cCHHHHHhcc---CCCCHHHHHHHH
Confidence 6899999997 5999999754 246676665543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.24 E-value=8.9e-12 Score=126.05 Aligned_cols=104 Identities=22% Similarity=0.327 Sum_probs=81.9
Q ss_pred CCCccCeeeccCcceEEEEEcC--CC--CEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEe-CCeeE
Q 044615 463 NFDDGHCIGNGGQGSVYKAKLP--TG--EIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSH-ALHSF 537 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~-~~~~~ 537 (571)
.|...+.||+|+||.||+|... ++ ..||||.+.... .....++|.+|+.++++++|||||++++++.+ .+..|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 3667789999999999999842 22 368999986532 23446789999999999999999999998754 45789
Q ss_pred EEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 538 VVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+||||+++|+|.++++.... .++|...+.++
T Consensus 168 lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~ 198 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETH--NPTVKDLIGFG 198 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTC--CCBHHHHHHHH
T ss_pred EEEECCCCCCHHHHHhhccc--CCCHHHHHHHH
Confidence 99999999999999975433 46676665543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=2e-11 Score=119.63 Aligned_cols=100 Identities=17% Similarity=0.218 Sum_probs=81.5
Q ss_pred cCCCcc-CeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHH-hhcCCCCcccEEEEEEe----CC
Q 044615 462 NNFDDG-HCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNAL-TKIRHRNIVKFYGFCSH----AL 534 (571)
Q Consensus 462 ~~~~~~-~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l-~~l~H~niv~l~~~~~~----~~ 534 (571)
++|.+. +.||+|+||.||+|. ..+++.||+|++... ..+.+|+.++ +..+||||+++++++.. ..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 457776 779999999999999 568999999998632 4567899887 66799999999999987 67
Q ss_pred eeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 535 HSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
..|+||||+++|+|.+++..... ..+++.....|+
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~ 123 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIM 123 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHH
T ss_pred eEEEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHH
Confidence 78999999999999999986432 357777766654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.23 E-value=2.7e-11 Score=122.02 Aligned_cols=106 Identities=22% Similarity=0.174 Sum_probs=87.4
Q ss_pred HHccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcC-----CCCcccEEEEEEe
Q 044615 459 RATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR-----HRNIVKFYGFCSH 532 (571)
Q Consensus 459 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----H~niv~l~~~~~~ 532 (571)
...++|.+.+.||+|+||.||+|+ ..+++.||||++... ....+.+.+|+.+++.++ |||||++++++..
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~ 107 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY 107 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence 345689999999999999999999 468999999998642 233567888999999886 9999999999999
Q ss_pred CCeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 533 ALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 533 ~~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
.+..|+||||+ +|+|.+++..... ..+++.....|+
T Consensus 108 ~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~ 143 (360)
T 3llt_A 108 YDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYC 143 (360)
T ss_dssp TTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHH
T ss_pred CCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHH
Confidence 99999999999 8999999985432 246776665543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=2.8e-12 Score=137.22 Aligned_cols=107 Identities=21% Similarity=0.229 Sum_probs=86.1
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEe------CC
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSH------AL 534 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~------~~ 534 (571)
++|++.+.||+|+||.||+|.. .+|+.||||++.... .....+.+.+|++++++++||||+++++++.. .+
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 6799999999999999999984 579999999987542 33456789999999999999999999999765 66
Q ss_pred eeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 535 HSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
..|+||||+++|+|.+++........+++.....|+
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~ 127 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLL 127 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHH
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHH
Confidence 789999999999999999865544456666555543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.23 E-value=8.1e-12 Score=121.82 Aligned_cols=106 Identities=25% Similarity=0.397 Sum_probs=76.8
Q ss_pred cCCCccCeeeccCcceEEEEEc--CCCC--EEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL--PTGE--IVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSF 537 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~--~~~~--~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~ 537 (571)
++|++.+.||+|+||.||+|.. .+++ .||||++...........+.+.+|++++++++||||+++++++.+.. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 4689999999999999999984 2333 68999997654433445678999999999999999999999997765 88
Q ss_pred EEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 538 VVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+||||+++|+|.+++.... ..+++.....++
T Consensus 97 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ 127 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYA 127 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHH
T ss_pred eeEecccCCCHHHHHHhcc--CCcCHHHHHHHH
Confidence 9999999999999997542 246676665553
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.23 E-value=4.3e-12 Score=125.95 Aligned_cols=103 Identities=21% Similarity=0.284 Sum_probs=81.5
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|.+.+.||+|+||.||+|.. .+++.||||++...... .....+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 4688999999999999999994 58999999999754321 11224568999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
||++ |+|.+++...+. .+++.....|
T Consensus 80 e~~~-~~l~~~~~~~~~--~~~~~~~~~~ 105 (324)
T 3mtl_A 80 EYLD-KDLKQYLDDCGN--IINMHNVKLF 105 (324)
T ss_dssp ECCS-EEHHHHHHHTTT--CCCHHHHHHH
T ss_pred cccc-cCHHHHHHhcCC--CCCHHHHHHH
Confidence 9998 599999875433 4666655544
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.23 E-value=1e-11 Score=135.91 Aligned_cols=102 Identities=23% Similarity=0.368 Sum_probs=83.2
Q ss_pred cCCCccCeeeccCcceEEEEEcC--CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCe----
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLP--TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALH---- 535 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~---- 535 (571)
+.|++.+.||+|+||.||+|... +++.||||++.... .....+.|.+|++++++++|||||++++++...+.
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 57999999999999999999843 68999999986532 23445679999999999999999999999987665
Q ss_pred -eEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 536 -SFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 536 -~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
.|+||||++||+|.+++.. .++|.+++.|+
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~ 188 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYL 188 (681)
T ss_dssp EEEEEEECCCCEECC----C-----CCCHHHHHHHH
T ss_pred eeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHH
Confidence 6999999999999987753 57888887764
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.23 E-value=1.3e-11 Score=128.65 Aligned_cols=103 Identities=18% Similarity=0.283 Sum_probs=75.1
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC-----Ce
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA-----LH 535 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~-----~~ 535 (571)
++|++.+.||+|+||.||+|. ..+++.||||++.... ......+++.+|++++++++|||||++++++... ..
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 579999999999999999998 5589999999997543 3334567899999999999999999999999543 56
Q ss_pred eEEEEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 536 SFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 536 ~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
.|+||||+. |+|.+++.... .+++.....|
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~~ 161 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTPV---YLTELHIKTL 161 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSSC---CCCHHHHHHH
T ss_pred EEEEEeccc-cchhhhcccCC---CCCHHHHHHH
Confidence 899999985 69999997542 4666655544
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=2.4e-11 Score=117.87 Aligned_cols=105 Identities=18% Similarity=0.270 Sum_probs=83.6
Q ss_pred ccCCCccCeeeccCcceEEEEEcC----CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCee
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKLP----TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHS 536 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~ 536 (571)
.++|...+.||+|+||.||+|... ++..||+|.+.... .....+.|.+|++++++++||||+++++++.+ +..
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 87 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPT 87 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSC
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCC
Confidence 356889999999999999999842 23469999987643 23446789999999999999999999999865 456
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+||||+++|+|.+++..... .+++.....++
T Consensus 88 ~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~ 119 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERNKN--SLKVLTLVLYS 119 (281)
T ss_dssp EEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHH
T ss_pred EEEEecCCCCCHHHHHHhccc--cCCHHHHHHHH
Confidence 899999999999999975432 46676666553
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.22 E-value=4.1e-12 Score=127.85 Aligned_cols=105 Identities=18% Similarity=0.243 Sum_probs=85.0
Q ss_pred cCCCccCeeeccCcceEEEEEc----CCCCEEEEEEccCCCCC-chHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL----PTGEIVDVKKFHSPLPD-EMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALH 535 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~ 535 (571)
++|++.+.||+|+||.||+|+. .+++.||||++...... .....+.+.+|++++.++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5799999999999999999985 37899999998653211 112235577899999999 69999999999999999
Q ss_pred eEEEEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 536 SFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 536 ~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
.|+||||+++|+|.+++.... .+++.....+
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~ 164 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRE---RFTEHEVQIY 164 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHH
T ss_pred EEEEeecCCCCCHHHHHHHcC---CCCHHHHHHH
Confidence 999999999999999997542 4666665554
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.22 E-value=3.8e-11 Score=119.35 Aligned_cols=87 Identities=17% Similarity=0.283 Sum_probs=77.0
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcC-CCCcccEEEEEEe--CCeeE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR-HRNIVKFYGFCSH--ALHSF 537 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~--~~~~~ 537 (571)
++|++.+.||+|+||.||+|. ..+++.||||++.... .+.+.+|++++++++ ||||+++++++.+ ....+
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 569999999999999999998 5689999999987432 467899999999997 9999999999988 56789
Q ss_pred EEEeccCCCChhhhhcc
Q 044615 538 VVYEYLEMGSLAMNLSN 554 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~ 554 (571)
+||||+++|+|.+++..
T Consensus 110 lv~e~~~~~~l~~~~~~ 126 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQT 126 (330)
T ss_dssp EEEECCCCCCHHHHGGG
T ss_pred EEEeccCchhHHHHHHh
Confidence 99999999999998863
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=2.5e-11 Score=121.88 Aligned_cols=106 Identities=26% Similarity=0.411 Sum_probs=84.2
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEe-------
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSH------- 532 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~------- 532 (571)
.++|++.+.||+|+||.||+|+ ..+|+.||||++....... .....+.+|++++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 3569999999999999999999 4689999999996554322 224568899999999999999999999987
Q ss_pred -CCeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 533 -ALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 533 -~~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
.+..|+||||+++ +|.+.+..... .+++.....|+
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~ 130 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVLV--KFTLSEIKRVM 130 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTTS--CCCHHHHHHHH
T ss_pred CCceEEEEEeccCC-CHHHHHhhccC--CCCHHHHHHHH
Confidence 3468999999985 78888765433 46777666554
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.22 E-value=1.8e-12 Score=131.70 Aligned_cols=109 Identities=15% Similarity=0.156 Sum_probs=82.5
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHH---HHHhhcCCCCcccEE-------EE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEV---NALTKIRHRNIVKFY-------GF 529 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei---~~l~~l~H~niv~l~-------~~ 529 (571)
.++|.+.+.||+|+||.||+|. ..+|+.||||++...........+.|.+|+ +.+++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 4568889999999999999999 467999999999755444444567899999 556677899999998 77
Q ss_pred EEeCCe-----------------eEEEEeccCCCChhhhhccCCC----ccCCCHHHHhhhc
Q 044615 530 CSHALH-----------------SFVVYEYLEMGSLAMNLSNDAA----AEQFCWTKRMNAI 570 (571)
Q Consensus 530 ~~~~~~-----------------~~lv~e~~~~G~L~~~l~~~~~----~~~l~w~~r~~ia 570 (571)
+.+.+. .|+||||+ +|+|.+++...+. ...++|..++.|+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~ 212 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLT 212 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHH
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHH
Confidence 766542 78999999 6899999985321 1235566666554
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.22 E-value=3.2e-11 Score=120.89 Aligned_cols=104 Identities=22% Similarity=0.223 Sum_probs=78.0
Q ss_pred EEeCccC-cCcCCCChhhhCCCCCCEEEccc-CccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccC
Q 044615 222 QLTLNNN-ELSGQLSPELGSLIQLEYLDLSA-NTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSH 299 (571)
Q Consensus 222 ~L~l~~n-~l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~ 299 (571)
.++++++ +++. +|. +..+++|+.|+|++ |.+++..+..|.++++|+.|+|++|++++..|..|..+++|+.|+|++
T Consensus 12 ~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4577776 7774 555 77788888888885 888777777788888888888888888877777777888888888888
Q ss_pred CcCCcccchhccCCCCCCEEEccCCcCcc
Q 044615 300 NIFREEIPSQICSMQSLEKLNLSHNNLSG 328 (571)
Q Consensus 300 n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 328 (571)
|++++..+..+..++ |+.|+|.+|.+..
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 888776655565555 7778888777763
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.21 E-value=6.1e-12 Score=137.02 Aligned_cols=108 Identities=16% Similarity=0.148 Sum_probs=87.4
Q ss_pred HccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCeeE
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHSF 537 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~ 537 (571)
..++|++.+.||+|+||.||+|+ ..+++.||||++.+.........+.+.+|..++..+ +||+|+++++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 45689999999999999999999 457899999998753221222346688999999987 7999999999999999999
Q ss_pred EEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 538 VVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+||||+++|+|.++++..+ .+++.....|+
T Consensus 419 lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~ 448 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYA 448 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHH
T ss_pred EEEeCcCCCcHHHHHHhcC---CCCHHHHHHHH
Confidence 9999999999999998543 46666665543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=7.9e-12 Score=121.09 Aligned_cols=103 Identities=25% Similarity=0.341 Sum_probs=82.2
Q ss_pred ccCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC-CeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA-LHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~-~~~~lv 539 (571)
.++|+..+.||+|+||.||+|.. .|+.||||.+.... ..+.+.+|++++++++||||+++++++.+. +..|+|
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 93 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 93 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence 35689999999999999999987 48899999987532 246789999999999999999999997654 478999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||+++|+|.+++.... ...+++.....++
T Consensus 94 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~ 123 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSRG-RSVLGGDCLLKFS 123 (278)
T ss_dssp ECCCTTEEHHHHHHHHH-HHHCCHHHHHHHH
T ss_pred EecCCCCCHHHHHHhcc-cccCCHHHHHHHH
Confidence 99999999999997532 1235666555543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.21 E-value=2e-11 Score=118.89 Aligned_cols=108 Identities=16% Similarity=0.233 Sum_probs=82.2
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.++|++.+.||+|+||.||+|. ..+++.||||++...... ....+.+.+|...++.++||||+++++++.+.+..|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-QEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CH-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCc-HHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 3568999999999999999999 568999999999754322 22233445555568889999999999999999999999
Q ss_pred EeccCCCChhhhhccC-CCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSND-AAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~-~~~~~l~w~~r~~ia 570 (571)
|||++ |+|.+++... .....++|.....|+
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~ 115 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIA 115 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHH
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHH
Confidence 99998 5888887642 122357787776654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=2e-11 Score=131.96 Aligned_cols=98 Identities=23% Similarity=0.371 Sum_probs=79.8
Q ss_pred CeeeccCcceEEEEEc---CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEeccC
Q 044615 468 HCIGNGGQGSVYKAKL---PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLE 544 (571)
Q Consensus 468 ~~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 544 (571)
+.||+|+||.||+|.+ ..++.||||+++... ......++|.+|++++++++|||||++++++.. +..++|||||+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 4799999999999963 356789999997542 222346789999999999999999999999964 55789999999
Q ss_pred CCChhhhhccCCCccCCCHHHHhhhc
Q 044615 545 MGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 545 ~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+|+|.++++.. ..++|..+..|+
T Consensus 453 ~g~L~~~l~~~---~~l~~~~~~~i~ 475 (635)
T 4fl3_A 453 LGPLNKYLQQN---RHVKDKNIIELV 475 (635)
T ss_dssp TEEHHHHHHHC---TTCCHHHHHHHH
T ss_pred CCCHHHHHhhC---CCCCHHHHHHHH
Confidence 99999999743 247787777664
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.20 E-value=1.5e-11 Score=124.15 Aligned_cols=103 Identities=18% Similarity=0.285 Sum_probs=77.4
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC-----
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL----- 534 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~----- 534 (571)
.+.|+..+.||+|+||.||+|. ..+|+.||||++..... .....+++.+|++++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 4569999999999999999999 46899999999965432 3344677999999999999999999999997653
Q ss_pred -eeEEEEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 535 -HSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 535 -~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
..|+||||+ +++|.++++.. .+++.....+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~ 133 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFL 133 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHH
T ss_pred ceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHH
Confidence 469999999 78999999753 3555544443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=5.1e-11 Score=116.56 Aligned_cols=101 Identities=21% Similarity=0.248 Sum_probs=85.8
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCeeEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lv 539 (571)
++|++.+.||+|+||.||+|. ..+++.||||++..... .+.+.+|++++.++ +|||++++++++.+....++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 469999999999999999999 56899999999865432 23577899999999 899999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||+ +|+|.+++...+. .+++..+..|+
T Consensus 85 ~e~~-~~~L~~~l~~~~~--~~~~~~~~~i~ 112 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLCGR--KFSVKTVAMAA 112 (298)
T ss_dssp EECC-CCBHHHHHHHTTT--CCCHHHHHHHH
T ss_pred EEec-CCCHHHHHHHhcc--CCCHHHHHHHH
Confidence 9999 9999999985432 47787777664
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=9.6e-12 Score=123.50 Aligned_cols=104 Identities=23% Similarity=0.320 Sum_probs=80.2
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCE----EEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCee
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEI----VDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHS 536 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~----vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~ 536 (571)
++|+..+.||+|+||.||+|.. .+++. ||+|.+...... ...+.+.+|+.++++++||||+++++++. .+..
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 89 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSL 89 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC--SCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCcc
Confidence 4688999999999999999984 45554 788887543211 12345778999999999999999999986 5568
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
++||||+++|+|.+++..... .++|..+..|+
T Consensus 90 ~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~ 121 (325)
T 3kex_A 90 QLVTQYLPLGSLLDHVRQHRG--ALGPQLLLNWG 121 (325)
T ss_dssp EEEEECCTTCBSHHHHHSSGG--GSCTTHHHHHH
T ss_pred EEEEEeCCCCCHHHHHHHccc--cCCHHHHHHHH
Confidence 899999999999999985432 45666555543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.19 E-value=2.5e-11 Score=123.39 Aligned_cols=104 Identities=18% Similarity=0.229 Sum_probs=78.4
Q ss_pred HHccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC----
Q 044615 459 RATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA---- 533 (571)
Q Consensus 459 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~---- 533 (571)
...++|+..+.||+|+||.||+|. ..+|+.||||++...... ..+|+++++.++|||||++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 345689999999999999999998 568999999998654322 23799999999999999999998543
Q ss_pred ----------------------------------CeeEEEEeccCCCChhhhhccC-CCccCCCHHHHhhhc
Q 044615 534 ----------------------------------LHSFVVYEYLEMGSLAMNLSND-AAAEQFCWTKRMNAI 570 (571)
Q Consensus 534 ----------------------------------~~~~lv~e~~~~G~L~~~l~~~-~~~~~l~w~~r~~ia 570 (571)
...++||||++ |+|.+.+... .....+++.....|+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~ 147 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYI 147 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHH
Confidence 34889999999 5888777631 122356666655543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=2.7e-11 Score=121.06 Aligned_cols=99 Identities=26% Similarity=0.356 Sum_probs=83.5
Q ss_pred ccCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhh--cCCCCcccEEEEEEeCC----
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTK--IRHRNIVKFYGFCSHAL---- 534 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~~~~~~~~---- 534 (571)
.++|.+.+.||+|+||.||+|+. +++.||||++... ..+.+.+|++++.. ++||||+++++++....
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred cccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 45699999999999999999987 5889999998632 24567889998887 79999999999998876
Q ss_pred eeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 535 HSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
..|+||||+++|+|.+++.+. .++|..+..|+
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~ 145 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLA 145 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHH
T ss_pred eeEEEEeecCCCcHHHHHhcc----CccHHHHHHHH
Confidence 789999999999999999743 47777776654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.19 E-value=3.6e-11 Score=122.51 Aligned_cols=104 Identities=23% Similarity=0.375 Sum_probs=76.4
Q ss_pred HccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcC-CCCcccEEEEEEeCC--e
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR-HRNIVKFYGFCSHAL--H 535 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~~--~ 535 (571)
..++|++.+.||+|+||.||+|. ..+|+.||||++.... ......+.+.+|+.++.++. |||||++++++...+ .
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 35679999999999999999998 5689999999997543 23345677889999999997 999999999998654 6
Q ss_pred eEEEEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 536 SFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 536 ~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
.|+|||||+ |+|.++++.. .+++..+..+
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i 114 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN----ILEPVHKQYV 114 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT----CCCHHHHHHH
T ss_pred EEEEecccC-cCHHHHHHcC----CCCHHHHHHH
Confidence 899999998 5999998753 3555555443
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.19 E-value=3.9e-11 Score=118.07 Aligned_cols=108 Identities=22% Similarity=0.356 Sum_probs=82.0
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCC--chHhHHHHHHHHHHHhhc---CCCCcccEEEEEEeCC
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPD--EMACQQEFLNEVNALTKI---RHRNIVKFYGFCSHAL 534 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~~~~Ei~~l~~l---~H~niv~l~~~~~~~~ 534 (571)
.++|++.+.||+|+||.||+|+ ..+++.||||++...... .......+.+|+++++++ +||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 5679999999999999999999 468999999998643211 111134567788777666 4999999999998765
Q ss_pred -----eeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 535 -----HSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 535 -----~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
..++||||++ |+|.+++..... ..+++.....|+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~ 126 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLM 126 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHH
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHH
Confidence 5799999998 599999986433 347887776654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.19 E-value=2.7e-11 Score=119.77 Aligned_cols=100 Identities=24% Similarity=0.332 Sum_probs=76.8
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEE---------
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCS--------- 531 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~--------- 531 (571)
+.|...+.||+|+||.||+|.. .+++.||||++... .....+.+.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 5689999999999999999994 46999999998754 2344678999999999999999999999883
Q ss_pred -----eCCeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 532 -----HALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 532 -----~~~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
+....|+||||++ |+|.+++.+. .+++.....+
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~ 125 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLF 125 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHH
T ss_pred cccccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHH
Confidence 3467899999998 6999999643 3556555544
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=4.9e-11 Score=129.49 Aligned_cols=105 Identities=20% Similarity=0.302 Sum_probs=85.0
Q ss_pred ccCCCccCeeeccCcceEEEEEcC----CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCee
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKLP----TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHS 536 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~ 536 (571)
.++|++.+.||+|+||.||+|... .+..||||.+.... .....+.|.+|+.++++++|||||++++++. .+..
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 356888899999999999999853 24579999986532 2344578999999999999999999999984 5668
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+||||+++|+|.++++... ..++|..++.|+
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~ 497 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRK--FSLDLASLILYA 497 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHH
T ss_pred EEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHH
Confidence 99999999999999997543 247787776654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.19 E-value=1.9e-11 Score=121.89 Aligned_cols=103 Identities=16% Similarity=0.170 Sum_probs=79.3
Q ss_pred cCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCC-----chHhHHHHHHHHHHHhhcC---------CCCcccEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPD-----EMACQQEFLNEVNALTKIR---------HRNIVKFY 527 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~Ei~~l~~l~---------H~niv~l~ 527 (571)
++|++.+.||+|+||+||+|+. +|+.||||++...... .....+.+.+|++++++++ |||||++.
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 4588999999999999999987 6899999999765321 1223477889999998885 88888888
Q ss_pred EEEE------------------------------eCCeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 528 GFCS------------------------------HALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 528 ~~~~------------------------------~~~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
+.+. +.+..|+|||||++|++.+.+.+. .+++.....|
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~----~~~~~~~~~i 166 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK----LSSLATAKSI 166 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT----CCCHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc----CCCHHHHHHH
Confidence 8753 267899999999999887777532 3555555444
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.18 E-value=5.1e-11 Score=120.56 Aligned_cols=102 Identities=18% Similarity=0.285 Sum_probs=82.7
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC-----
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL----- 534 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~----- 534 (571)
.++|+..+.||+|+||.||+|. ..+++.||||++..... .....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 3579999999999999999998 55789999999975432 3344677899999999999999999999997664
Q ss_pred -eeEEEEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 535 -HSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 535 -~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
..|+||||+++ +|.+++.. .+++.....|
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i 132 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYL 132 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHHS-----CCCHHHHHHH
T ss_pred cceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHH
Confidence 78999999985 78888863 2555555443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.18 E-value=1.3e-11 Score=122.92 Aligned_cols=105 Identities=21% Similarity=0.292 Sum_probs=84.9
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcC-CCCcccEEEEEEe-------
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR-HRNIVKFYGFCSH------- 532 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~------- 532 (571)
.+|++.+.||+|+||.||+|+ ..+++.||||++... .....+.+.+|+.++.++. ||||+++++++..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 468999999999999999999 558999999998543 2344567899999999996 9999999999953
Q ss_pred -CCeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 533 -ALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 533 -~~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
....++||||++ |+|.+++........++|.....|+
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~ 142 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIF 142 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHH
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHH
Confidence 345799999996 7999999753333468888877764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.18 E-value=3.5e-11 Score=119.96 Aligned_cols=99 Identities=24% Similarity=0.353 Sum_probs=79.7
Q ss_pred ccCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhh--cCCCCcccEEEEEEeC----C
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTK--IRHRNIVKFYGFCSHA----L 534 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~~~~~~~----~ 534 (571)
.++|++.+.||+|+||.||+|+.. ++.||||++... ....+.+|.+++.. ++||||+++++++... .
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT------EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred ccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc------ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 357999999999999999999874 889999998532 12445566666554 4999999999999887 7
Q ss_pred eeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 535 HSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
..|+||||+++|+|.++++.. .++|.....|+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~ 140 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKST----TLDAKSMLKLA 140 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHH
T ss_pred ceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHH
Confidence 899999999999999999743 46777666654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.18 E-value=2.6e-11 Score=126.31 Aligned_cols=102 Identities=18% Similarity=0.296 Sum_probs=81.1
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC------
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA------ 533 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~------ 533 (571)
.++|+..+.||+|+||.||+|. ..+++.||||++.... ......+++.+|+++++.++|||||++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 4679999999999999999998 5679999999997542 2234467789999999999999999999999655
Q ss_pred CeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 534 LHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 534 ~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
...|+|||||++ ++.+.+.. .+++.+...|
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~ 169 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYL 169 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS-----CCCHHHHHHH
T ss_pred CeEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHH
Confidence 357999999986 46666653 2556555443
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.17 E-value=5.4e-11 Score=117.34 Aligned_cols=105 Identities=18% Similarity=0.203 Sum_probs=87.9
Q ss_pred ccCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcC--CCCcccEEEEEEeCCeeEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR--HRNIVKFYGFCSHALHSFV 538 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~--H~niv~l~~~~~~~~~~~l 538 (571)
.++|++.+.||+|+||.||+|...+++.||||++...... ....+.+.+|++++.+++ ||||+++++++.+.+..|+
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccccc-ccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 4569999999999999999999778999999999765433 345678999999999997 5999999999999999999
Q ss_pred EEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 539 VYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||| +.+|+|.+++.... .+++..+..|+
T Consensus 106 v~e-~~~~~L~~~l~~~~---~~~~~~~~~i~ 133 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKKK---SIDPWERKSYW 133 (313)
T ss_dssp EEC-CCSEEHHHHHHHCS---SCCHHHHHHHH
T ss_pred EEe-cCCCcHHHHHHhcC---CCCHHHHHHHH
Confidence 999 66889999998543 46777666554
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.17 E-value=5e-11 Score=118.42 Aligned_cols=104 Identities=19% Similarity=0.398 Sum_probs=82.6
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCE----EEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCee
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEI----VDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHS 536 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~----vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~ 536 (571)
++|++.+.||+|+||.||+|. ..+++. ||+|.+..... ....+.+.+|+.++++++||||+++++++.+.. .
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~ 91 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSS--CCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence 569999999999999999998 445554 57777754322 233578999999999999999999999998765 7
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
++||||+++|+|.+++..... .+++.....|+
T Consensus 92 ~~v~~~~~~g~L~~~l~~~~~--~~~~~~~~~i~ 123 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREHKD--NIGSQYLLNWC 123 (327)
T ss_dssp EEEECCCSSCBHHHHHHHTTT--CCCHHHHHHHH
T ss_pred eEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHH
Confidence 899999999999999986433 46676666553
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.16 E-value=4.2e-09 Score=107.32 Aligned_cols=286 Identities=10% Similarity=0.061 Sum_probs=160.7
Q ss_pred CCCEEEccCCc--cc---cCCCCccceeecccccccCCCCCCCccc-cccccCCCCCCEEecccCcCcccccccccCCCC
Q 044615 49 QARDTSISFDE--LH---EKLLTFEATAHFSVLAFTGQDWPLYSSI-PDEIGNMKSLSDLQLSENILNGSIPLALGNLTN 122 (571)
Q Consensus 49 ~l~~l~l~~n~--l~---~~~l~~l~~l~l~~n~l~~~~~~~~~~~-p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~ 122 (571)
.|+...+..+- +. |.++.+|+.+.+..+.-+. +..+ ..+|.++.+|+.+.+..+ ++.....+|..+.+
T Consensus 65 ~L~sI~iP~svt~Ig~~AF~~C~~L~~i~~~~n~p~~-----l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~ 138 (394)
T 4gt6_A 65 VLTSVQIPDTVTEIGSNAFYNCTSLKRVTIQDNKPSC-----VKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEE 138 (394)
T ss_dssp CCCEEEECTTCCEECTTTTTTCTTCCEEEEGGGCCCC-----CCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTT
T ss_pred cCEEEEECCCeeEEhHHHhhCCccCceEeecCCCCCe-----eeEechhhchhcccceeeccCCc-cceehhhhhhhhcc
Confidence 46666665431 11 6666677776666543221 1122 234556666666666543 34344556666667
Q ss_pred CCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEcc
Q 044615 123 LVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLS 202 (571)
Q Consensus 123 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~ 202 (571)
|+.+.+..+ +..+....|..+..|+.+.+..+ +......+|.. .+|+.+.+..+-.. .....|..... +......
T Consensus 139 L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~-l~~~~~~ 213 (394)
T 4gt6_A 139 LDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFA-LSTITSD 213 (394)
T ss_dssp CCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTT-CCEEEEC
T ss_pred cccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhccc-cceeccc
Confidence 777776543 23344555666666666666543 23233334432 45666666443221 22233333332 4444443
Q ss_pred CCcccccCCc-------------cccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCC
Q 044615 203 SNHIVGEIPL-------------GHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLH 269 (571)
Q Consensus 203 ~n~~~~~~~~-------------~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~ 269 (571)
.+........ .+.....+..+.+.. .+.......|.++..|+.+.+..+.. .....+|.++++|+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~-~v~~i~~~aF~~c~~L~~i~lp~~~~-~I~~~aF~~c~~L~ 291 (394)
T 4gt6_A 214 SESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPN-GVARIETHAFDSCAYLASVKMPDSVV-SIGTGAFMNCPALQ 291 (394)
T ss_dssp CSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCT-TEEEECTTTTTTCSSCCEEECCTTCC-EECTTTTTTCTTCC
T ss_pred ccccccccceeecccccccccccccccccccceEEcCC-cceEcccceeeecccccEEecccccc-eecCcccccccccc
Confidence 3322110000 001112233333322 22223345677788888888866543 34556778888888
Q ss_pred EEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCc
Q 044615 270 YLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNA 349 (571)
Q Consensus 270 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~ 349 (571)
.+.+. +.++......|.++.+|+.++|..+ ++.+...+|.++.+|+.+.+..+ ++.+...+|.++.+|+.+++.+|.
T Consensus 292 ~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~ 368 (394)
T 4gt6_A 292 DIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSR 368 (394)
T ss_dssp EEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCH
T ss_pred cccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCce
Confidence 88886 4455555667888888888888754 55556677888888888888644 666667788888888888888765
Q ss_pred C
Q 044615 350 L 350 (571)
Q Consensus 350 l 350 (571)
.
T Consensus 369 ~ 369 (394)
T 4gt6_A 369 S 369 (394)
T ss_dssp H
T ss_pred e
Confidence 4
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.16 E-value=1.7e-11 Score=120.97 Aligned_cols=109 Identities=17% Similarity=0.163 Sum_probs=79.8
Q ss_pred HHccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCch---HhHHHHHHHHHHHhhc----CCCCcccEEEEE
Q 044615 459 RATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEM---ACQQEFLNEVNALTKI----RHRNIVKFYGFC 530 (571)
Q Consensus 459 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~---~~~~~~~~Ei~~l~~l----~H~niv~l~~~~ 530 (571)
...++|++.+.||+|+||.||+|. ..+++.||||++........ .....+.+|+.++.++ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 345679999999999999999998 46889999999976543221 1233467899999988 899999999999
Q ss_pred EeCCeeEEEEec-cCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 531 SHALHSFVVYEY-LEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 531 ~~~~~~~lv~e~-~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
.+.+..++|||| +++|+|.+++...+ .++|..+..|+
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~ 145 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFF 145 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHH
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHH
Confidence 999999999999 89999999998543 47777776654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.16 E-value=3.1e-11 Score=121.81 Aligned_cols=104 Identities=20% Similarity=0.289 Sum_probs=76.9
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC------
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA------ 533 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~------ 533 (571)
.+.|+..+.||+|+||.||+|. ..+|+.||||++.... ......+.+.+|++++++++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 3679999999999999999998 5689999999997543 2334567889999999999999999999999754
Q ss_pred CeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 534 LHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 534 ~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
...|+||||+ +++|.++++.. .+++.....++
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~ 138 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLI 138 (367)
T ss_dssp CCCEEEEECC-CEECC-----C----CCCHHHHHHHH
T ss_pred CeEEEEeccc-CCCHHHHHhcC----CCCHHHHHHHH
Confidence 5679999999 68999988742 46666655543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.15 E-value=5.4e-11 Score=120.39 Aligned_cols=103 Identities=20% Similarity=0.339 Sum_probs=83.8
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCee---
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHS--- 536 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~--- 536 (571)
.+.|...+.||+|+||.||+|. ..+|+.||||++..... .....+.+.+|+.++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc-chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3579999999999999999998 55899999999976433 234467899999999999999999999999877654
Q ss_pred ---EEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 537 ---FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 537 ---~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+||||++ |+|.+++.. .+++.....|+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~ 150 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLV 150 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHH
T ss_pred eeEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHH
Confidence 99999998 689888742 26666665543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.15 E-value=7e-11 Score=118.65 Aligned_cols=103 Identities=23% Similarity=0.349 Sum_probs=84.0
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC-----C
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA-----L 534 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~-----~ 534 (571)
.++|++.+.||+|+||.||+|. ..+|+.||||++.... .......+.+|++++++++||||+++++++... .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 4579999999999999999999 4579999999996432 334456788999999999999999999998764 6
Q ss_pred eeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 535 HSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
..|+||||++ |+|.+++... .+++.....++
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~ 118 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFI 118 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHHC----CCCHHHHHHHH
T ss_pred eEEEEEeccC-ccHHHHHhhc----CCCHHHHHHHH
Confidence 7899999998 5999998753 46666665543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.14 E-value=9.2e-12 Score=123.19 Aligned_cols=105 Identities=22% Similarity=0.290 Sum_probs=85.2
Q ss_pred ccCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
.++|++.+.||+|+||.||+|.... .+|+|.+....... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 4679999999999999999998643 49999997543222 22355789999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||+++|+|.+++...+ ..+++..+..|+
T Consensus 109 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~ 136 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAK--IVLDVNKTRQIA 136 (319)
T ss_dssp BCCCSEEHHHHTTSSC--CCCCSHHHHHHH
T ss_pred ecccCCcHHHHHHhcC--CCCCHHHHHHHH
Confidence 9999999999997643 246666665553
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.14 E-value=3e-11 Score=120.99 Aligned_cols=105 Identities=20% Similarity=0.146 Sum_probs=78.8
Q ss_pred cCCCccCeeeccCcceEEEEEcC----CCCEEEEEEccCCCCCchH--------hHHHHHHHHHHHhhcCCCCcccEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLP----TGEIVDVKKFHSPLPDEMA--------CQQEFLNEVNALTKIRHRNIVKFYGF 529 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~--------~~~~~~~Ei~~l~~l~H~niv~l~~~ 529 (571)
++|.+.+.||+|+||.||+|... ++..+|||.+......... ..+.+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 56999999999999999999953 6788999999765322111 12347788999999999999999999
Q ss_pred EEe----CCeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 530 CSH----ALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 530 ~~~----~~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+.. ....|+||||+ +|+|.+++...+ .++|..+..|+
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~ 157 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLG 157 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHH
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHH
Confidence 988 67899999999 999999998543 57888777664
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.14 E-value=7.5e-11 Score=118.75 Aligned_cols=109 Identities=22% Similarity=0.143 Sum_probs=70.5
Q ss_pred HHHHHHccCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC
Q 044615 455 EEIIRATNNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA 533 (571)
Q Consensus 455 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~ 533 (571)
++.....++|++.+.||+|+||.||+|.. .+++.||||++...... ...+.+|++.++.++|||||++++++...
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~ 91 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTL 91 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEE
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhcc
Confidence 44566778899999999999999999994 57999999998654322 23566788889999999999999999764
Q ss_pred Ce-------eEEEEeccCCCChhhhhcc-CCCccCCCHHHHhh
Q 044615 534 LH-------SFVVYEYLEMGSLAMNLSN-DAAAEQFCWTKRMN 568 (571)
Q Consensus 534 ~~-------~~lv~e~~~~G~L~~~l~~-~~~~~~l~w~~r~~ 568 (571)
.. .++||||+++ +|.+.+.. ......+++.....
T Consensus 92 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~ 133 (360)
T 3e3p_A 92 GERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKV 133 (360)
T ss_dssp CSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHH
T ss_pred ccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHH
Confidence 43 7899999996 55544432 11222455554443
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.14 E-value=4.6e-09 Score=107.02 Aligned_cols=271 Identities=11% Similarity=0.084 Sum_probs=168.6
Q ss_pred ccccCCCCCCEEecccCc---CcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccC
Q 044615 91 DEIGNMKSLSDLQLSENI---LNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGN 167 (571)
Q Consensus 91 ~~~~~l~~L~~L~L~~n~---i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~ 167 (571)
.+|.++.+|+.+.+..|. ++.+...+|.++.+|+.+.+..+ ++.+....|..+.+|+.+.+..+ +.......|..
T Consensus 81 ~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~ 158 (394)
T 4gt6_A 81 NAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTVTIPEG-VTSVADGMFSY 158 (394)
T ss_dssp TTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT
T ss_pred HHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhcccccccccce-eeeecccceec
Confidence 456677777777776653 54445566777777777666544 34455556777777777777543 33344456677
Q ss_pred CCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChh----------
Q 044615 168 MNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPE---------- 237 (571)
Q Consensus 168 l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~---------- 237 (571)
+.+|+.+.+..+ +. .+....+.... |+.+.+..+.. ......+..+.++.......+.........
T Consensus 159 c~~L~~i~~~~~-~~-~I~~~aF~~~~-l~~i~ip~~~~-~i~~~af~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (394)
T 4gt6_A 159 CYSLHTVTLPDS-VT-AIEERAFTGTA-LTQIHIPAKVT-RIGTNAFSECFALSTITSDSESYPAIDNVLYEKSANGDYA 234 (394)
T ss_dssp CTTCCEEECCTT-CC-EECTTTTTTCC-CSEEEECTTCC-EECTTTTTTCTTCCEEEECCSSSCBSSSCEEEECTTSCEE
T ss_pred ccccccccccce-ee-Eeccccccccc-eeEEEECCccc-ccccchhhhccccceecccccccccccceeeccccccccc
Confidence 777777777554 33 22332223333 77777654432 234455666666666655444332111000
Q ss_pred ---hhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCC
Q 044615 238 ---LGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQ 314 (571)
Q Consensus 238 ---~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~ 314 (571)
+.....+..+.+.. .+......+|.++.+|+.+.+.++... .....|.+++.|+.+.+. +.+.......|.++.
T Consensus 235 ~~~~~~~~~~~~~~ip~-~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~ 311 (394)
T 4gt6_A 235 LIRYPSQREDPAFKIPN-GVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCI 311 (394)
T ss_dssp EEECCTTCCCSEEECCT-TEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCT
T ss_pred ccccccccccceEEcCC-cceEcccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCC
Confidence 01112233333322 233344567889999999999876543 556788899999999996 456666777899999
Q ss_pred CCCEEEccCCcCccccccccccCCCCCEEECcCCcCcccCCC-CCccCCCCcccccCCc
Q 044615 315 SLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPN-STAFRDAPMLALQGNK 372 (571)
Q Consensus 315 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~-~~~~~~~~~l~l~~n~ 372 (571)
+|+.++|..+ ++.+...+|.++.+|+.+.+..+ ++..... .....++..+.+.++.
T Consensus 312 ~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~ 368 (394)
T 4gt6_A 312 SLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSR 368 (394)
T ss_dssp TCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCH
T ss_pred CcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCce
Confidence 9999999764 77677889999999999999754 4433222 1233556777777664
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.14 E-value=7.7e-11 Score=118.93 Aligned_cols=103 Identities=20% Similarity=0.237 Sum_probs=84.0
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC-----C
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA-----L 534 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~-----~ 534 (571)
.+.|+..+.||+|+||.||+|. ..+++.||||++.... .....+.+.+|++++++++||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 4579999999999999999998 5578899999997532 234457799999999999999999999999765 3
Q ss_pred eeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 535 HSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
..|+||||++ |+|.+++... .+++.....|+
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~ 134 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKTQ----HLSNDHICYFL 134 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHHC----CCCHHHHHHHH
T ss_pred eEEEEEcccC-cCHHHHHHhC----CCCHHHHHHHH
Confidence 6899999998 5999998743 36666665543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.14 E-value=1.5e-10 Score=114.96 Aligned_cols=107 Identities=21% Similarity=0.270 Sum_probs=82.3
Q ss_pred ccCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHH-HHhhcCCCCcccEEEEEEeCCeeEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVN-ALTKIRHRNIVKFYGFCSHALHSFV 538 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~-~l~~l~H~niv~l~~~~~~~~~~~l 538 (571)
.++|+..+.||+|+||.||+|.. .+|+.||||++..... .....++.+|+. +++.++||||+++++++.+.+..|+
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l 98 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI 98 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence 35789999999999999999994 5899999999975432 233455667766 6788899999999999999999999
Q ss_pred EEeccCCCChhhhhccC--CCccCCCHHHHhhhc
Q 044615 539 VYEYLEMGSLAMNLSND--AAAEQFCWTKRMNAI 570 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~--~~~~~l~w~~r~~ia 570 (571)
||||+++ +|.+++... .....+++.....|+
T Consensus 99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~ 131 (327)
T 3aln_A 99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKIT 131 (327)
T ss_dssp EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHH
T ss_pred EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHH
Confidence 9999985 888777631 112356776665553
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.13 E-value=7.1e-11 Score=118.65 Aligned_cols=102 Identities=21% Similarity=0.337 Sum_probs=82.5
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCe-----
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALH----- 535 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~----- 535 (571)
++|...+.||+|+||.||+|. ..+|+.||||++..... .....+.+.+|+.++++++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 568999999999999999999 45799999999976432 33446778999999999999999999999987654
Q ss_pred -eEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 536 -SFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 536 -~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
.|+||||++ |+|.+++.. .+++.....|+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~ 132 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLV 132 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHH
T ss_pred eEEEEecccc-CCHHHHhcC-----CCCHHHHHHHH
Confidence 499999998 589887752 26666655543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.13 E-value=5e-11 Score=120.28 Aligned_cols=107 Identities=19% Similarity=0.236 Sum_probs=80.8
Q ss_pred ccCCCccCeeeccCcceEEEEEcCC------CCEEEEEEccCCCCCchHh--------HHHHHHHHHHHhhcCCCCcccE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKLPT------GEIVDVKKFHSPLPDEMAC--------QQEFLNEVNALTKIRHRNIVKF 526 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~--------~~~~~~Ei~~l~~l~H~niv~l 526 (571)
.++|++.+.||+|+||.||+|.... ++.||||++.......... ...+.+|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4579999999999999999998543 4789999987543211100 1224556667788899999999
Q ss_pred EEEEEeC----CeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 527 YGFCSHA----LHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 527 ~~~~~~~----~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
++++... ...|+||||+ +|+|.+++.... ..++|..++.|+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~ 158 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLS 158 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHH
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHH
Confidence 9999775 4589999999 999999997543 358888887765
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.12 E-value=1.4e-10 Score=115.65 Aligned_cols=101 Identities=17% Similarity=0.224 Sum_probs=77.3
Q ss_pred ccCCCccC-eeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHH-HHHhhcCCCCcccEEEEEEe----C
Q 044615 461 TNNFDDGH-CIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEV-NALTKIRHRNIVKFYGFCSH----A 533 (571)
Q Consensus 461 ~~~~~~~~-~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei-~~l~~l~H~niv~l~~~~~~----~ 533 (571)
.++|.+.+ .||+|+||.||+|.. .+++.||||++... . ...+|+ ..+..++||||+++++++.. .
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----P----KARQEVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----H----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----H----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 45688854 699999999999994 57999999998642 1 122333 34567799999999999976 4
Q ss_pred CeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 534 LHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 534 ~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
...|+||||+++|+|.+++..... ..+++.+...|+
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~ 134 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERGD-QAFTEREAAEIM 134 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHH
T ss_pred ceEEEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHH
Confidence 558999999999999999986432 357777776654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.11 E-value=2.8e-11 Score=121.54 Aligned_cols=99 Identities=18% Similarity=0.166 Sum_probs=80.8
Q ss_pred cCCCccCeeeccCcceEEEEEcC---------CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCccc-------
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLP---------TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVK------- 525 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~------- 525 (571)
++|++.+.||+|+||.||+|+.. .++.||||.+... +.+.+|++++++++|||||+
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 57999999999999999999854 3789999998743 35779999999999999998
Q ss_pred --------EEEEEEe-CCeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 526 --------FYGFCSH-ALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 526 --------l~~~~~~-~~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+++++.. ....|+||||+ +|+|.+++.... ...++|..+..|+
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~ 165 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVA 165 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHH
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHH
Confidence 6778776 78899999999 999999998542 2468888887765
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.11 E-value=6.1e-11 Score=117.63 Aligned_cols=109 Identities=22% Similarity=0.376 Sum_probs=82.5
Q ss_pred HHccCCCccCeeeccCcceEEEEEc--CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc---CCCCcccEEEEEE--
Q 044615 459 RATNNFDDGHCIGNGGQGSVYKAKL--PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI---RHRNIVKFYGFCS-- 531 (571)
Q Consensus 459 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l---~H~niv~l~~~~~-- 531 (571)
...++|++.+.||+|+||.||+|.. .+++.||+|++....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 3456899999999999999999985 468899999986432211 1123466787777665 8999999999997
Q ss_pred ---eCCeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 532 ---HALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 532 ---~~~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
.....++||||++ |+|.+++..... ..+++.....|+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~ 126 (326)
T 1blx_A 87 RTDRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMM 126 (326)
T ss_dssp ECSSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHH
T ss_pred ccCCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHH
Confidence 4567899999998 699999975432 247777766554
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.10 E-value=2.8e-10 Score=117.40 Aligned_cols=103 Identities=17% Similarity=0.203 Sum_probs=84.4
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc------CCCCcccEEEEEEeCC
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI------RHRNIVKFYGFCSHAL 534 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l------~H~niv~l~~~~~~~~ 534 (571)
..|++.+.||+|+||.||+|. ..+++.||||++... ....+.+.+|++++..+ +|+||+++++++....
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 469999999999999999998 557899999999743 23346688888888776 6779999999999999
Q ss_pred eeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 535 HSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
..++||||+. |+|.+++..... ..++|.....|+
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~ 206 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFA 206 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHH
T ss_pred eEEEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHH
Confidence 9999999997 699999975432 347887776654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.09 E-value=1.9e-10 Score=114.58 Aligned_cols=99 Identities=31% Similarity=0.402 Sum_probs=75.7
Q ss_pred ccCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHH--HhhcCCCCcccEEEEEEe-----C
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNA--LTKIRHRNIVKFYGFCSH-----A 533 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~--l~~l~H~niv~l~~~~~~-----~ 533 (571)
.++|++.+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++++.. .
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR 84 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence 35799999999999999999976 68899999986321 2344455544 556899999999987653 2
Q ss_pred CeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 534 LHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 534 ~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
...|+||||+++|+|.+++.... .+|..+.+|+
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~ 117 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLA 117 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHH
T ss_pred ceEEEEEecCCCCcHHHHHhhcc----cchhHHHHHH
Confidence 35789999999999999997543 3666665553
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.08 E-value=1.7e-10 Score=117.67 Aligned_cols=103 Identities=17% Similarity=0.181 Sum_probs=81.9
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcC--------CCCcccEEEEEE-
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR--------HRNIVKFYGFCS- 531 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~--------H~niv~l~~~~~- 531 (571)
++|++.+.||+|+||.||+|+ ..+++.||||++... ....+.+.+|++++++++ ||||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 579999999999999999998 567899999999643 234567899999999885 788999999997
Q ss_pred ---eCCeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 532 ---HALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 532 ---~~~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
.....|+||||+ +|++.+++..... ..+++.....|+
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~i~ 152 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKSNY-QGLPLPCVKKII 152 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHTTT-SCCCHHHHHHHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhccc-CCCCHHHHHHHH
Confidence 456789999999 5677777754322 357777766654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.07 E-value=3.3e-10 Score=110.56 Aligned_cols=102 Identities=19% Similarity=0.214 Sum_probs=82.4
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEE-EeCCeeEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFC-SHALHSFV 538 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~-~~~~~~~l 538 (571)
.++|++.+.||+|+||.||+|+ ..+++.||||++...... +++.+|+++++.++|++++..++++ ......++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 4679999999999999999999 468999999998754322 3588999999999998877666665 56778899
Q ss_pred EEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 539 VYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||||+ +|+|.+++..... .+++..+..|+
T Consensus 83 v~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~ 111 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCSR--KFSLKTVLLLA 111 (296)
T ss_dssp EEECC-CCBHHHHHHHTTT--CCCHHHHHHHH
T ss_pred EEEec-CCCHHHHHHhhcc--CCCHHHHHHHH
Confidence 99999 8999999974332 47777776654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.07 E-value=1.4e-10 Score=118.92 Aligned_cols=101 Identities=19% Similarity=0.263 Sum_probs=72.6
Q ss_pred CCc-cCeeeccCcceEEEEEcC---CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEe--CCeeE
Q 044615 464 FDD-GHCIGNGGQGSVYKAKLP---TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSH--ALHSF 537 (571)
Q Consensus 464 ~~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~--~~~~~ 537 (571)
|+. +++||+|+||.||+|+.+ +++.||||++..... .+.+.+|++++++++|||||++++++.. ....|
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 555 568999999999999843 678999999975432 2467899999999999999999999965 67899
Q ss_pred EEEeccCCCChhhhhccCC------CccCCCHHHHhhhc
Q 044615 538 VVYEYLEMGSLAMNLSNDA------AAEQFCWTKRMNAI 570 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~~------~~~~l~w~~r~~ia 570 (571)
+||||+++ +|.+++.... ....+++.....|+
T Consensus 97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 134 (405)
T 3rgf_A 97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLL 134 (405)
T ss_dssp EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHH
T ss_pred EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHH
Confidence 99999984 8888886321 12247777666554
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.06 E-value=2.6e-10 Score=112.63 Aligned_cols=106 Identities=15% Similarity=0.160 Sum_probs=72.9
Q ss_pred ccCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.++|+..+.||+|+||.||+|.. .+|+.||||++...... ....+.+..+..+++.++||||+++++++.+.+..|+|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 35688899999999999999994 58999999999765322 22233444555678889999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||+ ++.+..+..... ..+++.....|+
T Consensus 103 ~e~~-~~~~~~l~~~~~--~~~~~~~~~~~~ 130 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRMQ--GPIPERILGKMT 130 (318)
T ss_dssp ECCC-SEEHHHHHHHHT--SCCCHHHHHHHH
T ss_pred Eecc-CCcHHHHHHHhc--cCCCHHHHHHHH
Confidence 9999 445555444322 246666655543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.06 E-value=3.7e-10 Score=110.24 Aligned_cols=103 Identities=18% Similarity=0.212 Sum_probs=79.3
Q ss_pred HccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEE-EeCCeeE
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFC-SHALHSF 537 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~-~~~~~~~ 537 (571)
..++|+..+.||+|+||.||+|. ..+++.||||++...... +.+.+|+++++.++|++++..++++ ...+..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 34679999999999999999999 468999999987644322 3478899999999998877777666 5677889
Q ss_pred EEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 538 VVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+||||+ +|+|.+++..... .+++..+..|+
T Consensus 82 lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~ 111 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFCSR--KFSLKTVLLLA 111 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTS--CCCHHHHHHHH
T ss_pred EEEEcc-CCCHHHHHHHhcC--CCCHHHHHHHH
Confidence 999999 9999999974332 47777776664
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.05 E-value=3.1e-10 Score=113.05 Aligned_cols=103 Identities=17% Similarity=0.185 Sum_probs=84.1
Q ss_pred cCCCccCeeeccCcceEEEEEc--CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCC------cccEEEEEEeC
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL--PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRN------IVKFYGFCSHA 533 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~n------iv~l~~~~~~~ 533 (571)
++|++.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+++++.++|++ ++++++++.+.
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 4699999999999999999984 36889999998643 234567889999998887665 99999999999
Q ss_pred CeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 534 LHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 534 ~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+..|+||||+ +|+|.+++...+. ..+++.....|+
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~ 124 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMA 124 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHH
T ss_pred CcEEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHH
Confidence 9999999999 8899999975432 356776666553
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.05 E-value=1.4e-10 Score=117.37 Aligned_cols=94 Identities=9% Similarity=0.032 Sum_probs=65.7
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc--CCCCcccEE-------EEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI--RHRNIVKFY-------GFC 530 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l--~H~niv~l~-------~~~ 530 (571)
..+|...+.||+|+||.||+|. ..+++.||||++...........+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 3458899999999999999999 458999999999876654555567788885544433 799988765 455
Q ss_pred EeC-----------------CeeEEEEeccCCCChhhhhccC
Q 044615 531 SHA-----------------LHSFVVYEYLEMGSLAMNLSND 555 (571)
Q Consensus 531 ~~~-----------------~~~~lv~e~~~~G~L~~~l~~~ 555 (571)
... ...|+|||||+ |+|.+++...
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~ 181 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL 181 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh
Confidence 433 33799999999 8999999854
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.04 E-value=1.8e-10 Score=117.38 Aligned_cols=101 Identities=20% Similarity=0.196 Sum_probs=73.2
Q ss_pred cCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCe------
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALH------ 535 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~------ 535 (571)
..|...+.||+|+||.||+|+...+..||+|++...... ..+|+++++.++|||||++++++.....
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 459999999999999999999766666999988644322 2379999999999999999999976443
Q ss_pred eEEEEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 536 SFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 536 ~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
.|+||||++++.+............+++.....+
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 146 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLY 146 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHH
T ss_pred EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHH
Confidence 7899999997544333321112234556554433
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.03 E-value=2.3e-10 Score=117.68 Aligned_cols=100 Identities=26% Similarity=0.302 Sum_probs=75.3
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC------C
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA------L 534 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~------~ 534 (571)
..|+..+.||+|+||.||+|+. .+|+.||||++..... .+.+|++++++++|||||+++++|... .
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 3588899999999999999995 5799999999865432 133799999999999999999998652 2
Q ss_pred eeEEEEeccCCCChhhhhccC-CCccCCCHHHHhhh
Q 044615 535 HSFVVYEYLEMGSLAMNLSND-AAAEQFCWTKRMNA 569 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~~-~~~~~l~w~~r~~i 569 (571)
..++||||+++ ++.+.+... .....++|.....+
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~ 161 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLY 161 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHH
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHH
Confidence 36799999986 676666431 12235666655544
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.03 E-value=2.2e-10 Score=118.11 Aligned_cols=88 Identities=16% Similarity=0.240 Sum_probs=73.9
Q ss_pred cCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 540 (571)
.+|...+.||+|+||+||.....+++.||||++..... ..+.+|+++++++ +|||||++++++.+....|+||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 35888899999999997655555899999999975432 2256899999999 8999999999999999999999
Q ss_pred eccCCCChhhhhccCC
Q 044615 541 EYLEMGSLAMNLSNDA 556 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~ 556 (571)
|||+ |+|.+++....
T Consensus 98 E~~~-g~L~~~l~~~~ 112 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKD 112 (432)
T ss_dssp ECCS-EEHHHHHHSSS
T ss_pred ECCC-CCHHHHHHhcC
Confidence 9997 59999998654
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.03 E-value=8.2e-11 Score=116.48 Aligned_cols=108 Identities=16% Similarity=0.196 Sum_probs=85.7
Q ss_pred HccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCch---HhHHHHHHHHHHHhhcC--CCCcccEEEEEEeC
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEM---ACQQEFLNEVNALTKIR--HRNIVKFYGFCSHA 533 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~---~~~~~~~~Ei~~l~~l~--H~niv~l~~~~~~~ 533 (571)
..++|++.+.||+|+||.||+|. ..+++.||||++........ ...+.+.+|+.++++++ ||||+++++++...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 34679999999999999999998 56889999999975432211 11245778999999996 59999999999999
Q ss_pred CeeEEEEeccCC-CChhhhhccCCCccCCCHHHHhhhc
Q 044615 534 LHSFVVYEYLEM-GSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 534 ~~~~lv~e~~~~-G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+..++||||+.+ |+|.+++...+ .+++.....|+
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~ 155 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITERG---ALQEELARSFF 155 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHH
T ss_pred CcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHH
Confidence 999999999986 89999997532 46666655543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.02 E-value=3.3e-10 Score=117.05 Aligned_cols=86 Identities=20% Similarity=0.234 Sum_probs=72.5
Q ss_pred CCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCeeEEEEec
Q 044615 464 FDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHSFVVYEY 542 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~ 542 (571)
|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|++++.++ +|||||++++++.+.+..|+||||
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 4556889999999998766668999999998642 135678999999876 899999999999999999999999
Q ss_pred cCCCChhhhhccCC
Q 044615 543 LEMGSLAMNLSNDA 556 (571)
Q Consensus 543 ~~~G~L~~~l~~~~ 556 (571)
|+ |+|.+++....
T Consensus 91 ~~-gsL~~~l~~~~ 103 (434)
T 2rio_A 91 CN-LNLQDLVESKN 103 (434)
T ss_dssp CS-EEHHHHHHTC-
T ss_pred CC-CCHHHHHhccC
Confidence 96 69999998643
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.02 E-value=9.1e-10 Score=114.82 Aligned_cols=102 Identities=20% Similarity=0.200 Sum_probs=82.5
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCC-CCcccEEEEEEeCCeeEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH-RNIVKFYGFCSHALHSFV 538 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~~~~~~~~~~~l 538 (571)
.++|++.+.||+|+||.||+|. ..+++.||||++...... +++.+|++++..++| ++++.+..++...+..++
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 3579999999999999999999 568999999998754322 347899999999987 556666677777889999
Q ss_pred EEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 539 VYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||||+ +|+|.+++..... .++|..++.|+
T Consensus 81 vme~~-g~sL~~ll~~~~~--~l~~~~~~~i~ 109 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFCSR--KLSLKTVLMLA 109 (483)
T ss_dssp EEECC-CCBHHHHHHHTTT--CCCHHHHHHHH
T ss_pred EEECC-CCCHHHHHHhhcC--CCCHHHHHHHH
Confidence 99999 9999999974332 57888777765
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=99.01 E-value=4.2e-10 Score=112.48 Aligned_cols=83 Identities=16% Similarity=0.316 Sum_probs=41.4
Q ss_pred CCCCCEEEcccCccccccchhhc---cCCCCCEEEcCCccCccCc----chhhhcccCCCEEEccCCcCCcccchhccC-
Q 044615 241 LIQLEYLDLSANTFHKSIPESLS---NLVKLHYLNLSNNQFSQKI----PNKIEKLIHLSELDLSHNIFREEIPSQICS- 312 (571)
Q Consensus 241 l~~L~~L~L~~n~l~~~~~~~l~---~l~~L~~L~Ls~n~l~~~~----~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~- 312 (571)
+++|+.|+|.+|.+.+..+..+. .+++|+.|+|+.|.+++.. +..+..+++|+.|+|++|.++......+..
T Consensus 251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~a 330 (362)
T 2ra8_A 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKS 330 (362)
T ss_dssp CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHH
T ss_pred CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHH
Confidence 45555555555555433222222 3456666666666655432 222334566666666666655443333332
Q ss_pred CCCCCEEEccCCc
Q 044615 313 MQSLEKLNLSHNN 325 (571)
Q Consensus 313 l~~L~~L~Ls~n~ 325 (571)
+ ...++++.++
T Consensus 331 l--g~~~~~~~~~ 341 (362)
T 2ra8_A 331 L--PMKIDVSDSQ 341 (362)
T ss_dssp C--CSEEECCSBC
T ss_pred c--CCEEEecCCc
Confidence 2 3446666655
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=98.99 E-value=4e-10 Score=113.99 Aligned_cols=103 Identities=17% Similarity=0.168 Sum_probs=83.4
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcC-----------CCCcccEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR-----------HRNIVKFYGF 529 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----------H~niv~l~~~ 529 (571)
++|.+.+.||+|+||.||+|+ ..+++.||||++... ....+.+.+|++++.+++ ||||++++++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 569999999999999999999 568999999999743 233567889999998876 8999999999
Q ss_pred EEeCC----eeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 530 CSHAL----HSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 530 ~~~~~----~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+...+ ..++||||+ +|+|.+++..... ..+++.....|+
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~ 137 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQIS 137 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHH
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHH
Confidence 98654 789999999 8999999975432 246776666554
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.99 E-value=7e-10 Score=110.86 Aligned_cols=149 Identities=17% Similarity=0.240 Sum_probs=87.3
Q ss_pred CcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhh--CCCCCCEEEccc--Cccccc-----cchhh--cc
Q 044615 196 LKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELG--SLIQLEYLDLSA--NTFHKS-----IPESL--SN 264 (571)
Q Consensus 196 L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~--~l~~L~~L~L~~--n~l~~~-----~~~~l--~~ 264 (571)
|+.|++++|.-. .++. +. +++|+.|++..+.+.......+. .+|+|+.|+|+. |...+. +...+ ..
T Consensus 174 L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~ 250 (362)
T 2ra8_A 174 LNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDR 250 (362)
T ss_dssp CCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTT
T ss_pred CcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCC
Confidence 666666655211 1121 22 56777777776666543333333 577888887753 221111 11122 24
Q ss_pred CCCCCEEEcCCccCccCcchhhh---cccCCCEEEccCCcCCccc----chhccCCCCCCEEEccCCcCcccccccccc-
Q 044615 265 LVKLHYLNLSNNQFSQKIPNKIE---KLIHLSELDLSHNIFREEI----PSQICSMQSLEKLNLSHNNLSGSIPRCFEE- 336 (571)
Q Consensus 265 l~~L~~L~Ls~n~l~~~~~~~~~---~l~~L~~L~Ls~n~l~~~~----~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~- 336 (571)
+++|+.|+|.+|.+....+..+. .+++|+.|+|+.|.+.+.. +..+..+++|+.|+|++|.++...-..+..
T Consensus 251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~a 330 (362)
T 2ra8_A 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKS 330 (362)
T ss_dssp CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHH
T ss_pred CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHH
Confidence 68888888888887654433332 4678888888888877642 233345688888888888877554444443
Q ss_pred CCCCCEEECcCCc
Q 044615 337 MHWLSCIDISYNA 349 (571)
Q Consensus 337 l~~L~~L~ls~N~ 349 (571)
+ ...++++.|+
T Consensus 331 l--g~~~~~~~~~ 341 (362)
T 2ra8_A 331 L--PMKIDVSDSQ 341 (362)
T ss_dssp C--CSEEECCSBC
T ss_pred c--CCEEEecCCc
Confidence 2 3557777665
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=98.99 E-value=1e-09 Score=111.49 Aligned_cols=104 Identities=23% Similarity=0.196 Sum_probs=83.9
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcC-CC-----CcccEEEEEEeC
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR-HR-----NIVKFYGFCSHA 533 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~-----niv~l~~~~~~~ 533 (571)
.++|++.+.||+|+||.||+|. ..+++.||||++... ....+++.+|++++..++ |+ +|+++++++...
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 4679999999999999999998 457889999999743 233567788999888875 45 499999999999
Q ss_pred CeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 534 LHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 534 ~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+..|+||||++ |+|.+++..... ..++|..+..|+
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~ 163 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFA 163 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHH
T ss_pred CceEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHH
Confidence 99999999996 599999985432 247777776654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=98.96 E-value=1.3e-09 Score=109.30 Aligned_cols=103 Identities=17% Similarity=0.193 Sum_probs=82.8
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCC-CEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCC------cccEEEEEEeC
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTG-EIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRN------IVKFYGFCSHA 533 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~-~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~n------iv~l~~~~~~~ 533 (571)
++|++.+.||+|+||.||+|.. .++ +.||+|++... ....+.+.+|+.++++++|++ ++.+++++...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 5799999999999999999984 444 68999999643 234567889999999988776 99999999999
Q ss_pred CeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 534 LHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 534 ~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+..|+||||+ +|++.+++..... ..+++.....|+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~ 129 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENNF-QPYPLPHVRHMA 129 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHH
T ss_pred CeEEEEEecc-CCChHHHHHhccC-CCCCHHHHHHHH
Confidence 9999999999 6678787765432 357777776654
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=98.90 E-value=1.6e-09 Score=114.78 Aligned_cols=89 Identities=13% Similarity=0.071 Sum_probs=64.8
Q ss_pred CccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCch-----HhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 465 DDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEM-----ACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 465 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
...+.||+|+||.||+|.. .++.+|+|+......... ...++|.+|++++++++||||+++..++...+..|+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3457899999999999954 578899998765333221 1245689999999999999999766666678888999
Q ss_pred EeccCCCChhhhhcc
Q 044615 540 YEYLEMGSLAMNLSN 554 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~ 554 (571)
|||+++|+|.++++.
T Consensus 418 mE~~~ggsL~~~l~~ 432 (540)
T 3en9_A 418 MSYINGKLAKDVIED 432 (540)
T ss_dssp EECCCSEEHHHHSTT
T ss_pred EECCCCCCHHHHHHH
Confidence 999999999999875
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=98.85 E-value=3.1e-09 Score=102.74 Aligned_cols=95 Identities=16% Similarity=0.117 Sum_probs=71.1
Q ss_pred HHHHHHHccCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCch---------------HhHHHHHHHHHHHhhc
Q 044615 454 HEEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEM---------------ACQQEFLNEVNALTKI 518 (571)
Q Consensus 454 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~~Ei~~l~~l 518 (571)
...+......|.+.+.||+|+||.||+|...+|+.||||.+........ .....+.+|+++++++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 3445555667888899999999999999987799999999965322110 2356799999999999
Q ss_pred CCCCcccEEEEEEeCCeeEEEEeccCCCChhhhhc
Q 044615 519 RHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLS 553 (571)
Q Consensus 519 ~H~niv~l~~~~~~~~~~~lv~e~~~~G~L~~~l~ 553 (571)
+| +++.+++.. +..|+||||++||+|.+ +.
T Consensus 162 ~~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~ 191 (282)
T 1zar_A 162 QG---LAVPKVYAW-EGNAVLMELIDAKELYR-VR 191 (282)
T ss_dssp TT---SSSCCEEEE-ETTEEEEECCCCEEGGG-CC
T ss_pred cC---CCcCeEEec-cceEEEEEecCCCcHHH-cc
Confidence 84 555555533 45699999999999998 53
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.81 E-value=5.8e-07 Score=90.84 Aligned_cols=280 Identities=12% Similarity=0.043 Sum_probs=142.9
Q ss_pred CCCCCCEEEccCCccc------cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccccccccC
Q 044615 46 RAVQARDTSISFDELH------EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGN 119 (571)
Q Consensus 46 ~~~~l~~l~l~~n~l~------~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~ 119 (571)
...+++...+... ++ |.++.+|+.+.|..+ ++. .-..+|.++ +|+.+.+..+ +..+...+|..
T Consensus 44 ~~~~i~~v~ip~~-vt~Ig~~aF~~C~~L~~I~lp~~-v~~-------Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~ 112 (379)
T 4h09_A 44 DRDRISEVRVNSG-ITSIGEANFNSCYNMTKVTVAST-VTS-------IGDGAFADT-KLQSYTGMER-VKKFGDYVFQG 112 (379)
T ss_dssp GGGGCSEEEECTT-EEEECTTTTTTCTTCCEEEECTT-CCE-------ECTTTTTTC-CCCEEEECTT-CCEECTTTTTT
T ss_pred cccCCEEEEeCCC-ccChHHHHhhCCCCCCEEEeCCc-ceE-------echhhhcCC-CCceEECCce-eeEeccceecc
Confidence 3445555555432 22 555666666665432 221 112234444 4555555433 33333444443
Q ss_pred CCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCC------------h
Q 044615 120 LTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIP------------L 187 (571)
Q Consensus 120 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p------------~ 187 (571)
.+|+.+.+..+- .......|.+. +|+.+.+..+ +.......+..+.+++.+.+..+....... .
T Consensus 113 -~~L~~i~lp~~~-~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (379)
T 4h09_A 113 -TDLDDFEFPGAT-TEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILE 188 (379)
T ss_dssp -CCCSEEECCTTC-CEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEE
T ss_pred -CCcccccCCCcc-ccccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceec
Confidence 356666665442 22333334433 3444444332 233334455666666666655443221100 0
Q ss_pred hhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCC
Q 044615 188 SLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVK 267 (571)
Q Consensus 188 ~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~ 267 (571)
.+..... +..+.+.... .......+....+|+.+.+..+ +.......+.++..|+.+.+..+ ++.....+|.++.+
T Consensus 189 ~~~~~~~-~~~~~~~~~~-~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~ 264 (379)
T 4h09_A 189 SYPAAKT-GTEFTIPSTV-KTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTA 264 (379)
T ss_dssp ECCTTCC-CSEEECCTTC-CEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTT
T ss_pred ccccccc-ccccccccce-eEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeeh
Confidence 0111111 2233222211 1122334455566666666543 33344455666777777777654 44444556677777
Q ss_pred CCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECc
Q 044615 268 LHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDIS 346 (571)
Q Consensus 268 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls 346 (571)
|+.+.+..+ +.......|.++.+|+.+.+.++.++.+....|.++.+|+.+.|..+ ++.+...+|.++.+|+.+.+.
T Consensus 265 l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip 341 (379)
T 4h09_A 265 LKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYP 341 (379)
T ss_dssp CCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCC
T ss_pred hcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEEC
Confidence 777777544 44344456677777777777777666666667777777777777543 555556677777777766654
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=98.78 E-value=6.7e-09 Score=110.59 Aligned_cols=88 Identities=19% Similarity=0.103 Sum_probs=65.3
Q ss_pred eeeccCcceEEEEE-cCCCCEEEEEEccCCCCC-------chHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCeeEEE
Q 044615 469 CIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPD-------EMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 469 ~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-------~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lv 539 (571)
..+.|+.|.+..++ .-.|+.||||++.+.... .....++|.+|+++|+++ .|+||+++++++++.+..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35667777666655 446899999999765321 123356799999999999 799999999999999999999
Q ss_pred EeccCCCChhhhhccCC
Q 044615 540 YEYLEMGSLAMNLSNDA 556 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~ 556 (571)
|||++||+|.++|.+.+
T Consensus 321 MEyv~G~~L~d~i~~~~ 337 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE 337 (569)
T ss_dssp EECCCSEEHHHHHHTTC
T ss_pred EecCCCCcHHHHHHhCC
Confidence 99999999999998654
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.76 E-value=1.3e-06 Score=88.25 Aligned_cols=277 Identities=10% Similarity=0.008 Sum_probs=187.2
Q ss_pred hhhcCCCCCCEEEccCCccc-----cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCccccccc
Q 044615 42 KELVRAVQARDTSISFDELH-----EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLA 116 (571)
Q Consensus 42 ~~l~~~~~l~~l~l~~n~l~-----~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~ 116 (571)
..+.++.+|+.+.|..+--. |..+ .|+.+.+..+ +. .+++......+|+.+.+..+ +.......
T Consensus 63 ~aF~~C~~L~~I~lp~~v~~Ig~~aF~~c-~l~~i~~~~~-l~--------~I~~~aF~~~~L~~i~lp~~-~~~i~~~~ 131 (379)
T 4h09_A 63 ANFNSCYNMTKVTVASTVTSIGDGAFADT-KLQSYTGMER-VK--------KFGDYVFQGTDLDDFEFPGA-TTEIGNYI 131 (379)
T ss_dssp TTTTTCTTCCEEEECTTCCEECTTTTTTC-CCCEEEECTT-CC--------EECTTTTTTCCCSEEECCTT-CCEECTTT
T ss_pred HHhhCCCCCCEEEeCCcceEechhhhcCC-CCceEECCce-ee--------EeccceeccCCcccccCCCc-cccccccc
Confidence 45778899999999755222 4444 4555544321 22 33333223358999999865 33344555
Q ss_pred ccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcc------------cCCccccCCCCCCEEEccCCCCCcc
Q 044615 117 LGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCD------------SIPKEIGNMNSLSILDLSSNKLNGS 184 (571)
Q Consensus 117 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~------------~~~~~l~~l~~L~~L~L~~n~l~~~ 184 (571)
|.+. +|+.+.+..+ ++.+....|....+++.+.+..+.... .....+.....+..+.+...... .
T Consensus 132 F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-i 208 (379)
T 4h09_A 132 FYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTVKT-V 208 (379)
T ss_dssp TTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTCCE-E
T ss_pred cccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceeccccccccccccccccceeE-E
Confidence 6554 6777776554 444666778888888888776544321 11223445556666666443322 3
Q ss_pred CChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhcc
Q 044615 185 IPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSN 264 (571)
Q Consensus 185 ~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~ 264 (571)
....+.... +|+.+.+..+ +.......+..+..|+.+.+..+ ++......|.++.+|+.+.+..+ +......+|.+
T Consensus 209 ~~~~f~~~~-~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~ 284 (379)
T 4h09_A 209 TAYGFSYGK-NLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSG 284 (379)
T ss_dssp CTTTTTTCS-SCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTT
T ss_pred eeccccccc-ccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccc
Confidence 333444444 4888888654 34355667788889999998775 55566678888999999999754 55455678899
Q ss_pred CCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCC
Q 044615 265 LVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMH 338 (571)
Q Consensus 265 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~ 338 (571)
+++|+.+.+.++.++......|.++.+|+.+.|..+ ++.+...+|.++++|+.+.+..+ ++.+-..+|.++.
T Consensus 285 c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c~ 356 (379)
T 4h09_A 285 CSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGSS 356 (379)
T ss_dssp CTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTSS
T ss_pred ccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCCC
Confidence 999999999999888777789999999999999755 66666778999999999998654 6656666777664
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.58 E-value=4.1e-08 Score=88.42 Aligned_cols=115 Identities=14% Similarity=0.153 Sum_probs=66.2
Q ss_pred hhhCCCCCCEEEcccC-ccccc----cchhhccCCCCCEEEcCCccCccCc----chhhhcccCCCEEEccCCcCCcc--
Q 044615 237 ELGSLIQLEYLDLSAN-TFHKS----IPESLSNLVKLHYLNLSNNQFSQKI----PNKIEKLIHLSELDLSHNIFREE-- 305 (571)
Q Consensus 237 ~~~~l~~L~~L~L~~n-~l~~~----~~~~l~~l~~L~~L~Ls~n~l~~~~----~~~~~~l~~L~~L~Ls~n~l~~~-- 305 (571)
.+...++|+.|+|++| .+... +...+...++|++|+|++|.+.... ...+...+.|+.|+|++|.+...
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~ 110 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI 110 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence 3444555666666665 55432 2333445566666666666665322 23334445677777777766543
Q ss_pred --cchhccCCCCCCEEEc--cCCcCccc----cccccccCCCCCEEECcCCcCc
Q 044615 306 --IPSQICSMQSLEKLNL--SHNNLSGS----IPRCFEEMHWLSCIDISYNALQ 351 (571)
Q Consensus 306 --~~~~~~~l~~L~~L~L--s~n~l~~~----~p~~~~~l~~L~~L~ls~N~l~ 351 (571)
+...+...++|++|+| ++|.++.. +.+.+...+.|+.|++++|.+.
T Consensus 111 ~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 111 LALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 3344555667777777 66777643 2334445577788888777664
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.48 E-value=4.5e-08 Score=88.17 Aligned_cols=92 Identities=16% Similarity=0.132 Sum_probs=53.8
Q ss_pred cccCCCCCCEEecccC-cCccc----ccccccCCCCCCEEEcccCcCccc----ccccccCCCCCCeeecccCcCccc--
Q 044615 92 EIGNMKSLSDLQLSEN-ILNGS----IPLALGNLTNLVVLDLSTNKLSGS----IPLSFANLTSLSILYLYENSLCDS-- 160 (571)
Q Consensus 92 ~~~~l~~L~~L~L~~n-~i~~~----~~~~~~~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~L~~n~l~~~-- 160 (571)
.+...+.|++|+|++| .+... +...+...++|++|+|++|.|... +...+...++|++|+|++|.+.+.
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~ 110 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI 110 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence 3455667777777777 66532 234445556677777777776532 223344456677777777776542
Q ss_pred --CCccccCCCCCCEEEc--cCCCCCc
Q 044615 161 --IPKEIGNMNSLSILDL--SSNKLNG 183 (571)
Q Consensus 161 --~~~~l~~l~~L~~L~L--~~n~l~~ 183 (571)
+...+...++|++|+| ++|.+..
T Consensus 111 ~~l~~~L~~n~~L~~L~L~~~~N~i~~ 137 (185)
T 1io0_A 111 LALVEALQSNTSLIELRIDNQSQPLGN 137 (185)
T ss_dssp HHHHHGGGGCSSCCEEECCCCSSCCCH
T ss_pred HHHHHHHHhCCCceEEEecCCCCCCCH
Confidence 2334555566666766 5666653
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.48 E-value=4.6e-08 Score=92.66 Aligned_cols=80 Identities=30% Similarity=0.385 Sum_probs=52.9
Q ss_pred ccCCCCCEEEcCCccCcc--CcchhhhcccCCCEEEccCCcCCcccchhccCCC--CCCEEEccCCcCccccc-------
Q 044615 263 SNLVKLHYLNLSNNQFSQ--KIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQ--SLEKLNLSHNNLSGSIP------- 331 (571)
Q Consensus 263 ~~l~~L~~L~Ls~n~l~~--~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~--~L~~L~Ls~n~l~~~~p------- 331 (571)
.++++|+.|+|++|.+++ .+|..+..+++|+.|+|++|++.+. ..+..+. +|++|+|++|++.+..|
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 456777777777777766 3345566777777777777777654 2233333 78888888888876554
Q ss_pred cccccCCCCCEEE
Q 044615 332 RCFEEMHWLSCID 344 (571)
Q Consensus 332 ~~~~~l~~L~~L~ 344 (571)
..+..+++|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 2356677777775
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.39 E-value=6.5e-08 Score=91.64 Aligned_cols=65 Identities=29% Similarity=0.402 Sum_probs=33.0
Q ss_pred CCCCCCEEEcccCcCcc--cccccccCCCCCCeeecccCcCcccCCccccCCC--CCCEEEccCCCCCccC
Q 044615 119 NLTNLVVLDLSTNKLSG--SIPLSFANLTSLSILYLYENSLCDSIPKEIGNMN--SLSILDLSSNKLNGSI 185 (571)
Q Consensus 119 ~l~~L~~L~L~~n~i~~--~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~--~L~~L~L~~n~l~~~~ 185 (571)
++++|++|+|++|+|++ .+|..+..+++|+.|+|++|.+.+. ..+..+. +|++|+|++|.+.+.+
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~ 236 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTF 236 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGC
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCcccc
Confidence 45556666666666554 2234445555666666666655543 1222222 5555555555555433
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=98.35 E-value=2.7e-07 Score=94.51 Aligned_cols=108 Identities=17% Similarity=0.167 Sum_probs=70.7
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCC-CCcc---------------
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH-RNIV--------------- 524 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H-~niv--------------- 524 (571)
..|...+.||+|+||.||+|. ..+|+.||||++...........+.|.+|+.+++.++| +|..
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 457778899999999999999 66899999999985444433446779999999999987 2211
Q ss_pred ------cEEEEEEe-----CCeeEEEEeccCCCChhhhhcc----CCCccCCCHHHHhhhc
Q 044615 525 ------KFYGFCSH-----ALHSFVVYEYLEMGSLAMNLSN----DAAAEQFCWTKRMNAI 570 (571)
Q Consensus 525 ------~l~~~~~~-----~~~~~lv~e~~~~G~L~~~l~~----~~~~~~l~w~~r~~ia 570 (571)
.+..++.. ....+++|+++ +|+|.+++.. ......++|..++.|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~ 217 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLT 217 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHH
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHH
Confidence 11111111 12356777755 5799998851 1223457788877763
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=2.7e-07 Score=87.83 Aligned_cols=87 Identities=15% Similarity=0.168 Sum_probs=61.6
Q ss_pred CCCccCeeeccCcceEEEEEc-CCCCE--EEEEEccCCCCCc---------------------hHhHHHHHHHHHHHhhc
Q 044615 463 NFDDGHCIGNGGQGSVYKAKL-PTGEI--VDVKKFHSPLPDE---------------------MACQQEFLNEVNALTKI 518 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~~---------------------~~~~~~~~~Ei~~l~~l 518 (571)
-|++.+.||+|+||.||+|.. .+|+. ||||+++...... ......+.+|++++.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367788999999999999996 78989 9999976432110 01124688999999999
Q ss_pred CCCCc--ccEEEEEEeCCeeEEEEeccCC-C----Chhhhhc
Q 044615 519 RHRNI--VKFYGFCSHALHSFVVYEYLEM-G----SLAMNLS 553 (571)
Q Consensus 519 ~H~ni--v~l~~~~~~~~~~~lv~e~~~~-G----~L~~~l~ 553 (571)
.|+++ +..+++ ...++||||+.+ | +|.++..
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~ 165 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR 165 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh
Confidence 88864 344432 356899999942 4 6666544
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=98.26 E-value=3.9e-07 Score=79.97 Aligned_cols=93 Identities=11% Similarity=0.073 Sum_probs=67.8
Q ss_pred cccccccCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCc-CcccccccccCC----CCCCeeecccCc-CcccC
Q 044615 88 SIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNK-LSGSIPLSFANL----TSLSILYLYENS-LCDSI 161 (571)
Q Consensus 88 ~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~-i~~~~~~~~~~l----~~L~~L~L~~n~-l~~~~ 161 (571)
.+|.....-..|+.||++++.++...-..+.++++|++|+|++|. |+..--..++.+ ++|++|+|++|. +++..
T Consensus 52 ~LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~G 131 (176)
T 3e4g_A 52 HLPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKG 131 (176)
T ss_dssp GSCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHH
T ss_pred cCCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHH
Confidence 345433223568899999988887766777888999999999985 665444455554 368999998875 76654
Q ss_pred CccccCCCCCCEEEccCCC
Q 044615 162 PKEIGNMNSLSILDLSSNK 180 (571)
Q Consensus 162 ~~~l~~l~~L~~L~L~~n~ 180 (571)
-..+..+++|++|++++|.
T Consensus 132 l~~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 132 IIALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp HHHGGGCTTCCEEEEESCT
T ss_pred HHHHhcCCCCCEEECCCCC
Confidence 5567788889999998886
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=98.11 E-value=4e-06 Score=83.50 Aligned_cols=97 Identities=9% Similarity=0.038 Sum_probs=62.9
Q ss_pred HHHHHHccCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCC-----c------hHhHH--------HHHHHHHHH
Q 044615 455 EEIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPD-----E------MACQQ--------EFLNEVNAL 515 (571)
Q Consensus 455 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----~------~~~~~--------~~~~Ei~~l 515 (571)
..+.....-|.+.+.||+|+||.||+|..++|+.||||+++..... . ..... ...+|...|
T Consensus 88 ~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL 167 (397)
T 4gyi_A 88 HTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM 167 (397)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence 3444444458999999999999999999888999999987642110 0 00001 124567777
Q ss_pred hhcCCCCcccEEEEEEeCCeeEEEEeccCCCChhhhhc
Q 044615 516 TKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLS 553 (571)
Q Consensus 516 ~~l~H~niv~l~~~~~~~~~~~lv~e~~~~G~L~~~l~ 553 (571)
.++.++++.-..-+... ..+|||||++|+.|.++..
T Consensus 168 ~rL~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~ 203 (397)
T 4gyi_A 168 KALYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSS 203 (397)
T ss_dssp HHHHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCC
T ss_pred HHHHhcCCCCCeeeecc--CceEEEEecCCccHhhhcc
Confidence 77765554322222222 2379999999999876553
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=98.03 E-value=3.6e-06 Score=73.85 Aligned_cols=84 Identities=11% Similarity=0.133 Sum_probs=50.2
Q ss_pred CCCCEEEcccCccccccchhhccCCCCCEEEcCCcc-CccCcchhhhcc----cCCCEEEccCCc-CCcccchhccCCCC
Q 044615 242 IQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQ-FSQKIPNKIEKL----IHLSELDLSHNI-FREEIPSQICSMQS 315 (571)
Q Consensus 242 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~-l~~~~~~~~~~l----~~L~~L~Ls~n~-l~~~~~~~~~~l~~ 315 (571)
.+|+.||++++.++..-...+.++++|+.|+|++|. ++...-..+..+ ++|+.|+|++|. ++...-..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 356666666666655544555666677777777664 544333334432 357777777663 65554455666677
Q ss_pred CCEEEccCCc
Q 044615 316 LEKLNLSHNN 325 (571)
Q Consensus 316 L~~L~Ls~n~ 325 (571)
|+.|+++++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 7777777664
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00015 Score=68.83 Aligned_cols=91 Identities=12% Similarity=0.007 Sum_probs=71.5
Q ss_pred HHHccCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcC-CCCcccEEEEEEeCCee
Q 044615 458 IRATNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR-HRNIVKFYGFCSHALHS 536 (571)
Q Consensus 458 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~~~~ 536 (571)
.....+|......+.|+.+.||++... ++.+++|......... ...+.+|+++++.+. |..+.++++++...+..
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~ 85 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence 344567888888888889999999854 6889999986421111 235789999998884 67788999999998999
Q ss_pred EEEEeccCCCChhhhh
Q 044615 537 FVVYEYLEMGSLAMNL 552 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l 552 (571)
|+||||++|.++.+.+
T Consensus 86 ~lv~e~i~G~~l~~~~ 101 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEY 101 (263)
T ss_dssp EEEEECCSSEEHHHHC
T ss_pred EEEEEecCCeehhhcc
Confidence 9999999999998753
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00027 Score=63.16 Aligned_cols=111 Identities=19% Similarity=0.246 Sum_probs=60.9
Q ss_pred CCCCCCEEEcccC-ccccc----cchhhccCCCCCEEEcCCccCccC----cchhhhcccCCCEEEccCCcCCcc----c
Q 044615 240 SLIQLEYLDLSAN-TFHKS----IPESLSNLVKLHYLNLSNNQFSQK----IPNKIEKLIHLSELDLSHNIFREE----I 306 (571)
Q Consensus 240 ~l~~L~~L~L~~n-~l~~~----~~~~l~~l~~L~~L~Ls~n~l~~~----~~~~~~~l~~L~~L~Ls~n~l~~~----~ 306 (571)
.-+.|+.|+|++| .+... +...+..-+.|+.|+|++|.+... +...+..-..|+.|+|++|.|... +
T Consensus 39 ~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~al 118 (197)
T 1pgv_A 39 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 118 (197)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred cCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHH
Confidence 3445666666553 44321 334445556666677777666532 223344456677777777776543 2
Q ss_pred chhccCCCCCCEEEccCC---cCccc----cccccccCCCCCEEECcCCcC
Q 044615 307 PSQICSMQSLEKLNLSHN---NLSGS----IPRCFEEMHWLSCIDISYNAL 350 (571)
Q Consensus 307 ~~~~~~l~~L~~L~Ls~n---~l~~~----~p~~~~~l~~L~~L~ls~N~l 350 (571)
-..+..-+.|++|+|++| .+... +.+.+..-+.|+.|+++.|.+
T Consensus 119 a~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 119 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 234455566777777754 33321 233445556777777766543
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.13 E-value=0.00033 Score=62.58 Aligned_cols=89 Identities=15% Similarity=0.216 Sum_probs=48.5
Q ss_pred hhCCCCCCEEEcccCccccc----cchhhccCCCCCEEEcCCccCccCc----chhhhcccCCCEEEccCC---cCCc--
Q 044615 238 LGSLIQLEYLDLSANTFHKS----IPESLSNLVKLHYLNLSNNQFSQKI----PNKIEKLIHLSELDLSHN---IFRE-- 304 (571)
Q Consensus 238 ~~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~Ls~n~l~~~~----~~~~~~l~~L~~L~Ls~n---~l~~-- 304 (571)
+..-+.|+.|+|++|.+.+. +...+..-+.|+.|+|+.|.|+... ...+..-..|+.|+|++| .+..
T Consensus 66 L~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g 145 (197)
T 1pgv_A 66 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQV 145 (197)
T ss_dssp HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHH
T ss_pred HhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHH
Confidence 34445566666666666532 2233444566777777777665432 223344456777777654 2322
Q ss_pred --ccchhccCCCCCCEEEccCCcC
Q 044615 305 --EIPSQICSMQSLEKLNLSHNNL 326 (571)
Q Consensus 305 --~~~~~~~~l~~L~~L~Ls~n~l 326 (571)
.+...+..-+.|+.|+++.|.+
T Consensus 146 ~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 146 EMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHHHHhCCCcCeEeccCCCc
Confidence 1233455566777777776654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.09 E-value=0.00068 Score=63.95 Aligned_cols=81 Identities=12% Similarity=0.095 Sum_probs=59.8
Q ss_pred CCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCC--cccEEEEEEeCCeeEEEE
Q 044615 463 NFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRN--IVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~~~~~~~~~~~lv~ 540 (571)
+|......+.|..+.||++...+|..+++|...... ...+.+|+++++.+.+.+ +.+++++...++..|+||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 444433334556699999987778889999976431 134678999998886544 456888888877889999
Q ss_pred eccCCCChh
Q 044615 541 EYLEMGSLA 549 (571)
Q Consensus 541 e~~~~G~L~ 549 (571)
||++|.++.
T Consensus 95 e~i~G~~l~ 103 (264)
T 1nd4_A 95 GEVPGQDLL 103 (264)
T ss_dssp ECCSSEETT
T ss_pred EecCCcccC
Confidence 999998884
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.58 E-value=0.0042 Score=51.60 Aligned_cols=57 Identities=18% Similarity=0.233 Sum_probs=31.7
Q ss_pred EEEccCCcCC-cccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCcc
Q 044615 294 ELDLSHNIFR-EEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQG 352 (571)
Q Consensus 294 ~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 352 (571)
.++.+++.++ ..+|..+ -++|+.|+|++|+|+...+..|..+++|+.|+|++|++..
T Consensus 12 ~v~Cs~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~C 69 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAF--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRC 69 (130)
T ss_dssp EEECCSSCCCTTTSCSCC--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBC
T ss_pred EEEeCCCCCccccCCCCC--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeec
Confidence 4555555554 1233222 1246666666666665555666666666666666666543
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.47 E-value=0.0043 Score=51.55 Aligned_cols=35 Identities=23% Similarity=0.236 Sum_probs=15.1
Q ss_pred CCeeecccCcCcccCCccccCCCCCCEEEccCCCC
Q 044615 147 LSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKL 181 (571)
Q Consensus 147 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l 181 (571)
|++|+|++|.|+...+..|..+++|++|+|++|.+
T Consensus 33 l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 33 TTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp CSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred CCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 44444444444433333344444444444444443
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=95.60 E-value=0.015 Score=57.67 Aligned_cols=81 Identities=14% Similarity=0.233 Sum_probs=57.2
Q ss_pred ccCeeeccCcceEEEEEcCCCCEEEEEEcc--CCCCCchHhHHHHHHHHHHHhhcC--CCCcccEEEEEEeC---CeeEE
Q 044615 466 DGHCIGNGGQGSVYKAKLPTGEIVDVKKFH--SPLPDEMACQQEFLNEVNALTKIR--HRNIVKFYGFCSHA---LHSFV 538 (571)
Q Consensus 466 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~Ei~~l~~l~--H~niv~l~~~~~~~---~~~~l 538 (571)
..+.++.|.++.||+.... +..+++|+.. ..... .....+.+|+++++.+. +..++++++++.+. +..|+
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 3567899999999999865 4678888875 32211 11346788999999886 45688899988766 45789
Q ss_pred EEeccCCCChh
Q 044615 539 VYEYLEMGSLA 549 (571)
Q Consensus 539 v~e~~~~G~L~ 549 (571)
||||++|..+.
T Consensus 119 vme~v~G~~l~ 129 (359)
T 3dxp_A 119 IMEFVSGRVLW 129 (359)
T ss_dssp EEECCCCBCCC
T ss_pred EEEecCCeecC
Confidence 99999998774
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=93.86 E-value=0.097 Score=49.88 Aligned_cols=78 Identities=15% Similarity=0.200 Sum_probs=54.9
Q ss_pred CCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCC---CCcccEEEEEEeCCeeEEEE
Q 044615 464 FDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH---RNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H---~niv~l~~~~~~~~~~~lv~ 540 (571)
......+|.|..+.||+....+|+.|.+|+-....... ...|.+|.+.|+.+.- --+.+++++ . ..++||
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~ 89 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAM 89 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEE
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEE
Confidence 44466789999999999998899999999865433221 2457889988887732 134455443 2 247899
Q ss_pred eccCCCCh
Q 044615 541 EYLEMGSL 548 (571)
Q Consensus 541 e~~~~G~L 548 (571)
||++++..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=93.67 E-value=0.19 Score=48.44 Aligned_cols=75 Identities=20% Similarity=0.209 Sum_probs=59.6
Q ss_pred cCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcC---CCCcccEEEEEEeCCeeEEEEecc
Q 044615 467 GHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR---HRNIVKFYGFCSHALHSFVVYEYL 543 (571)
Q Consensus 467 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~~~~~~~~~~~lv~e~~ 543 (571)
.+.++.|.+..+|+... ++..+++|.-... ....|.+|.+.|+.+. ...+.++++++...+..|+||||+
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 45789999999999886 4678889986532 2466889998888773 356888999888888899999999
Q ss_pred CCCCh
Q 044615 544 EMGSL 548 (571)
Q Consensus 544 ~~G~L 548 (571)
++..+
T Consensus 114 ~G~~~ 118 (312)
T 3jr1_A 114 NKSKN 118 (312)
T ss_dssp CCCCC
T ss_pred cCCCC
Confidence 98865
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=93.29 E-value=0.07 Score=53.56 Aligned_cols=79 Identities=16% Similarity=0.090 Sum_probs=49.8
Q ss_pred cCeeeccCcceEEEEEcC-CCCEEEEEEccCCCC--Cc--hHhHHHHHHHHHHHhhcCC--CCcc-cEEEEEEeCCeeEE
Q 044615 467 GHCIGNGGQGSVYKAKLP-TGEIVDVKKFHSPLP--DE--MACQQEFLNEVNALTKIRH--RNIV-KFYGFCSHALHSFV 538 (571)
Q Consensus 467 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~--~~~~~~~~~Ei~~l~~l~H--~niv-~l~~~~~~~~~~~l 538 (571)
.+.+|.|.++.||++... +++.++||...+... .. ....+++.+|.+++..+.+ |..+ +++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457899999999999743 578899998754321 00 0113456788888887632 3344 55543 4455689
Q ss_pred EEeccCCCC
Q 044615 539 VYEYLEMGS 547 (571)
Q Consensus 539 v~e~~~~G~ 547 (571)
||||+++..
T Consensus 113 vmE~l~g~~ 121 (397)
T 2olc_A 113 VMEDLSHLK 121 (397)
T ss_dssp EECCCTTSE
T ss_pred EEEeCCCcc
Confidence 999998743
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=93.25 E-value=0.36 Score=45.21 Aligned_cols=78 Identities=10% Similarity=0.078 Sum_probs=57.3
Q ss_pred eeeccCcc-eEEEEEcC-CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcC-CCCcccEEEEEEeCCeeEEEEeccCC
Q 044615 469 CIGNGGQG-SVYKAKLP-TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR-HRNIVKFYGFCSHALHSFVVYEYLEM 545 (571)
Q Consensus 469 ~lg~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~ 545 (571)
.+..|..| .||+.... .+..+.+|.-.. .....+.+|...|+.+. +--+.++++++.+.+..|+|||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 45556655 58988744 567788998643 22456888999888773 22367888999999999999999999
Q ss_pred CChhhhh
Q 044615 546 GSLAMNL 552 (571)
Q Consensus 546 G~L~~~l 552 (571)
.++.+..
T Consensus 105 ~~~~~~~ 111 (272)
T 4gkh_A 105 KTAFQVL 111 (272)
T ss_dssp EEHHHHH
T ss_pred ccccccc
Confidence 8776544
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=87.77 E-value=1.4 Score=42.21 Aligned_cols=75 Identities=16% Similarity=0.080 Sum_probs=54.7
Q ss_pred cCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCC---CcccEEEEEE-eCCeeEEEEec
Q 044615 467 GHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHR---NIVKFYGFCS-HALHSFVVYEY 542 (571)
Q Consensus 467 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~---niv~l~~~~~-~~~~~~lv~e~ 542 (571)
...++.|....||+. |..+++|.-.. ......+.+|.+++..+.+. .+.+.+.++. ..+..|+||||
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence 456788888899987 56788888421 12346789999999998653 3566677664 34557899999
Q ss_pred cCCCChhh
Q 044615 543 LEMGSLAM 550 (571)
Q Consensus 543 ~~~G~L~~ 550 (571)
++|..+.+
T Consensus 95 i~G~~l~~ 102 (306)
T 3tdw_A 95 VQGQILGE 102 (306)
T ss_dssp CCSEECHH
T ss_pred cCCeECch
Confidence 99988765
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=87.36 E-value=0.066 Score=54.89 Aligned_cols=63 Identities=8% Similarity=-0.090 Sum_probs=18.1
Q ss_pred ccCeeeccCcceEEEEEcCC-CCEEEE------EEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEe
Q 044615 466 DGHCIGNGGQGSVYKAKLPT-GEIVDV------KKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSH 532 (571)
Q Consensus 466 ~~~~lg~G~~g~V~~~~~~~-~~~vav------K~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~ 532 (571)
..+.+| ||.||+|.+.. ..+||| |........ ......|.+|..++...+|||+++.+++...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~-~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVS-EKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCcccccccccc-ccccccccccccccccccccccCCCcceEEe
Confidence 345565 99999999643 467888 665432211 2234568899999999999999999887754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=83.69 E-value=0.88 Score=43.44 Aligned_cols=75 Identities=19% Similarity=0.113 Sum_probs=51.3
Q ss_pred cCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcC-CCC--cccEEEEEEeCC---eeEEEE
Q 044615 467 GHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR-HRN--IVKFYGFCSHAL---HSFVVY 540 (571)
Q Consensus 467 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~n--iv~l~~~~~~~~---~~~lv~ 540 (571)
.+.++.|.+..||+.. ..+++|..... .....+.+|+++++.+. +.. +.+.++.....+ ..|+||
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 4568999999999753 56888985421 23467889999998873 333 344544433332 358999
Q ss_pred eccCCCChhh
Q 044615 541 EYLEMGSLAM 550 (571)
Q Consensus 541 e~~~~G~L~~ 550 (571)
||++|..+.+
T Consensus 96 ~~i~G~~l~~ 105 (304)
T 3sg8_A 96 TKIKGVPLTP 105 (304)
T ss_dssp ECCCCEECCH
T ss_pred cccCCeECCc
Confidence 9999988764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=83.06 E-value=0.35 Score=47.45 Aligned_cols=83 Identities=5% Similarity=-0.032 Sum_probs=54.3
Q ss_pred Cee-eccCcceEEEEEcC-------CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCC---CCcccEEEEEEeC---
Q 044615 468 HCI-GNGGQGSVYKAKLP-------TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH---RNIVKFYGFCSHA--- 533 (571)
Q Consensus 468 ~~l-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H---~niv~l~~~~~~~--- 533 (571)
+.+ +.|....+|+.... +++.+++|...............+.+|+++++.+.. -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 78888999988753 266788888654220000001346688888877632 3567788877655
Q ss_pred CeeEEEEeccCCCChhh
Q 044615 534 LHSFVVYEYLEMGSLAM 550 (571)
Q Consensus 534 ~~~~lv~e~~~~G~L~~ 550 (571)
+..|+||||++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999877654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 571 | ||||
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-25 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-21 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-12 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-22 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-20 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-04 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-20 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-15 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-19 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-19 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-19 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-18 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-18 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-17 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-17 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-17 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-17 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-17 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-17 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-17 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-17 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-16 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-16 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-16 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-16 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-16 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-16 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-16 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-16 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-16 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-16 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-15 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-15 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-15 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-15 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-15 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-15 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-15 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-14 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-14 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-14 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-14 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-13 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-13 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-13 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-13 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-13 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-13 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-13 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-13 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-13 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-13 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-12 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-12 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-12 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-04 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-12 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-12 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-12 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-12 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-12 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-12 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-11 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-11 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-11 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-10 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-10 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-10 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-10 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-09 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-05 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-07 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-08 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 8e-08 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 9e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 4e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 5e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.003 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 3e-07 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 4e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-07 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 9e-07 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-06 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-07 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-07 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-06 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 1e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 9e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 5e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 6e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 8e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 3e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 8e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 0.002 |
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 105 bits (262), Expect = 1e-25
Identities = 63/282 (22%), Positives = 104/282 (36%), Gaps = 16/282 (5%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTS 146
+P ++ + L L N + NL NL L L NK+S P +FA L
Sbjct: 23 EKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVK 80
Query: 147 LSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKV-LYLSSNH 205
L LYL +N L +P+++ L + N++ L + V L +
Sbjct: 81 LERLYLSKNQL-KELPEKMPKTLQE--LRVHENEITKVRKSVFNGLNQMIVVELGTNPLK 137
Query: 206 IVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNL 265
G + L + + + ++ + G L L L N K SL L
Sbjct: 138 SSGIENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGL 194
Query: 266 VKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNN 325
L L LS N S + HL EL L++N ++P + + ++ + L +NN
Sbjct: 195 NNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNN 253
Query: 326 LSGSIPRCFEEMHW------LSCIDISYNALQGLIPNSTAFR 361
+S F + S + + N +Q + FR
Sbjct: 254 ISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 295
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 91.6 bits (226), Expect = 4e-21
Identities = 55/269 (20%), Positives = 102/269 (37%), Gaps = 14/269 (5%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANL 144
+ + N+K+L L L N ++ P A L L L LS N+L L
Sbjct: 43 ITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTL 102
Query: 145 TSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSN 204
L + + S+ + M + L + K +G + + L + ++
Sbjct: 103 QELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQGMKK-LSYIRIADT 160
Query: 205 HIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSN 264
+I + G+ SL +L L+ N+++ + L L L L LS N+ SL+N
Sbjct: 161 NI---TTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLAN 217
Query: 265 LVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFRE------EIPSQICSMQSLEK 318
L L+L+NN+ K+P + ++ + L +N P S
Sbjct: 218 TPHLRELHLNNNKL-VKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSG 276
Query: 319 LNLSHNNLSGS--IPRCFEEMHWLSCIDI 345
++L N + P F ++ + + +
Sbjct: 277 VSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 65.8 bits (159), Expect = 2e-12
Identities = 38/162 (23%), Positives = 64/162 (39%), Gaps = 4/162 (2%)
Query: 195 SLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTF 254
L+V+ S + ++P + L L NN+++ + +L L L L N
Sbjct: 11 HLRVVQCSDLGLE-KVP--KDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 255 HKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQ 314
K P + + LVKL L LS NQ + + L L + R+ + + + M
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 315 SLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPN 356
+E L + SG F+ M LS I I+ + +
Sbjct: 128 VVE-LGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQG 168
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 56.6 bits (135), Expect = 2e-09
Identities = 25/129 (19%), Positives = 40/129 (31%)
Query: 244 LEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFR 303
LDL N + NL LH L L NN+ S+ P L+ L L LS N +
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 304 EEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDA 363
E ++Q L + S+ +M + + +
Sbjct: 93 ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKL 152
Query: 364 PMLALQGNK 372
+ +
Sbjct: 153 SYIRIADTN 161
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 55.0 bits (131), Expect = 7e-09
Identities = 25/145 (17%), Positives = 49/145 (33%), Gaps = 2/145 (1%)
Query: 256 KSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQS 315
+ +P+ L L+L NN+ ++ + L +L L L +N + P +
Sbjct: 23 EKVPKDLPPDTA--LLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVK 80
Query: 316 LEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLC 375
LE+L LS N L + + + L + ++ + N L K
Sbjct: 81 LERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG 140
Query: 376 GDIKRLPPCKAFKSHKQSMKKIWVV 400
+ K + + I +
Sbjct: 141 IENGAFQGMKKLSYIRIADTNITTI 165
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 54.7 bits (130), Expect = 9e-09
Identities = 38/172 (22%), Positives = 68/172 (39%), Gaps = 11/172 (6%)
Query: 66 TFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVV 125
F V+ MK LS +++++ + + G +L
Sbjct: 119 VFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTE 175
Query: 126 LDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSI 185
L L NK++ S L +L+ L L NS+ + N L L L++NKL +
Sbjct: 176 LHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KV 234
Query: 186 PLSLANLTNSLKVLYLSSNHI------VGEIPLGHGMLSSLIQLTLNNNELS 231
P LA+ ++V+YL +N+I P + +S ++L +N +
Sbjct: 235 PGGLADHKY-IQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.7 bits (231), Expect = 7e-22
Identities = 56/260 (21%), Positives = 91/260 (35%), Gaps = 5/260 (1%)
Query: 112 SIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSL 171
++P+ + + L N++S SF +L+IL+L+ N L + L
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 172 SILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELS 231
LDLS N S+ + + L L+L + P L++L L L +N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 232 GQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIH 291
L L +L L N + L L L L N+ + P+ L
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 292 LSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQ 351
L L L N + +++L+ L L+ N R WL S + +
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVP 261
Query: 352 GLIPNSTAFRDAPMLALQGN 371
+P + L N
Sbjct: 262 CSLPQR--LAGRDLKRLAAN 279
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.7 bits (218), Expect = 4e-20
Identities = 59/267 (22%), Positives = 98/267 (36%), Gaps = 8/267 (2%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTS 146
++P I + + L N ++ + NL +L L +N L+ +F L
Sbjct: 24 QAVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL 81
Query: 147 LSILYLYENSLCDSI-PKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNH 205
L L L +N+ S+ P + L L L + L +L+ LYL N
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHL-DRCGLQELGPGLFRGLAALQYLYLQDNA 140
Query: 206 IVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNL 265
+ L +L L L+ N +S L L+ L L N P + +L
Sbjct: 141 LQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL 200
Query: 266 VKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNN 325
+L L L N S + L L L L+ N + + + L+K S +
Sbjct: 201 GRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSE 259
Query: 326 LSGSIPRCFEEMHWLSCIDISYNALQG 352
+ S+P + + ++ N LQG
Sbjct: 260 VPCSLP---QRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.9 bits (164), Expect = 4e-13
Identities = 35/150 (23%), Positives = 61/150 (40%), Gaps = 5/150 (3%)
Query: 83 WPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFA 142
L + D ++ +L+ L L N ++ A L +L L L N+++ P +F
Sbjct: 139 NALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFR 198
Query: 143 NLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLS 202
+L L LYL+ N+L + + + +L L L+ N L L+ S
Sbjct: 199 DLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR--ARPLWAWLQKFRGS 256
Query: 203 SNHIVGEIPLGHGMLSSLIQLTLNNNELSG 232
S+ + +P L+ L N+L G
Sbjct: 257 SSEVPCSLPQR---LAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.0 bits (159), Expect = 1e-12
Identities = 45/200 (22%), Positives = 73/200 (36%), Gaps = 7/200 (3%)
Query: 81 QDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLS 140
+ L S P + L L L L P L L L L N L +
Sbjct: 89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDT 148
Query: 141 FANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLY 200
F +L +L+ L+L+ N + + ++SL L L N++ P + +L LY
Sbjct: 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL-MTLY 207
Query: 201 LSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQ-LEYLDLSANTFHKSIP 259
L +N++ L +L L LN+N L L+ S++ S+P
Sbjct: 208 LFANNLSALPTEALAPLRALQYLRLNDNPWVC--DCRARPLWAWLQKFRGSSSEVPCSLP 265
Query: 260 ESLSNLVKLHYLNLSNNQFS 279
+ L+ L+ N
Sbjct: 266 QRLAG---RDLKRLAANDLQ 282
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 90.8 bits (224), Expect = 2e-20
Identities = 51/182 (28%), Positives = 81/182 (44%), Gaps = 15/182 (8%)
Query: 95 NMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYE 154
+ +L +L L+ N L L +LTNL LDL+ N++S PLS LT L+ L L
Sbjct: 217 ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLS--GLTKLTELKLGA 272
Query: 155 NSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGH 214
N + + P + L+ L N +S + +L L L N+I P+
Sbjct: 273 NQISNISP-----LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSS 327
Query: 215 GMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLS 274
L+ L +L NN++S L +L + +L N P L+NL ++ L L+
Sbjct: 328 --LTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLN 381
Query: 275 NN 276
+
Sbjct: 382 DQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 89.7 bits (221), Expect = 5e-20
Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 141 FANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLY 200
A LT+L L N + D P I + +L L L+ N+L +LA+LTN L L
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTN-LTDLD 247
Query: 201 LSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPE 260
L++N I PL L+ L +L L N++S L L L L+L+ N P
Sbjct: 248 LANNQISNLAPLSG--LTKLTELKLGANQISN--ISPLAGLTALTNLELNENQLEDISPI 303
Query: 261 SLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLN 320
S NL L YL L N S P + L L L ++N + S + ++ ++ L+
Sbjct: 304 S--NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLS 357
Query: 321 LSHNNLSGSIPRCFEEMHWLSCIDISYNA 349
HN +S P + ++ + ++ A
Sbjct: 358 AGHNQISDLTP--LANLTRITQLGLNDQA 384
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 78.5 bits (192), Expect = 3e-16
Identities = 40/190 (21%), Positives = 77/190 (40%), Gaps = 15/190 (7%)
Query: 166 GNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTL 225
+ +L L ++N+++ P + +L L L+ N + L L++L L L
Sbjct: 194 AKLTNLESLIATNNQISDITP---LGILTNLDELSLNGNQLKDIGTLAS--LTNLTDLDL 248
Query: 226 NNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNK 285
NN++S L L +L L L AN P + + N+ + +
Sbjct: 249 ANNQISN--LAPLSGLTKLTELKLGANQISNISPLAGLTALTNLE----LNENQLEDISP 302
Query: 286 IEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDI 345
I L +L+ L L N + P + S+ L++L ++N +S + ++ +
Sbjct: 303 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSA 358
Query: 346 SYNALQGLIP 355
+N + L P
Sbjct: 359 GHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 66.9 bits (162), Expect = 2e-12
Identities = 33/133 (24%), Positives = 57/133 (42%), Gaps = 27/133 (20%)
Query: 92 EIGNMKSLSDLQLSENILNGSIPLA--------------------LGNLTNLVVLDLSTN 131
+ + L++L+L N ++ PLA + NL NL L L N
Sbjct: 258 PLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFN 317
Query: 132 KLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLAN 191
+S P+S +LT L L+ N + S + N+ +++ L N+++ PL+ N
Sbjct: 318 NISDISPVS--SLTKLQRLFFANNKV--SDVSSLANLTNINWLSAGHNQISDLTPLA--N 371
Query: 192 LTNSLKVLYLSSN 204
LT + L L+
Sbjct: 372 LTR-ITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 63.1 bits (152), Expect = 2e-11
Identities = 64/315 (20%), Positives = 107/315 (33%), Gaps = 68/315 (21%)
Query: 95 NMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYE 154
++ ++ LQ + SI + L NL ++ S N+L+ PL NLT L + +
Sbjct: 42 DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITPLK--NLTKLVDILMNN 97
Query: 155 NSLCDSIPK------------------------------------EIGNMNSLSILDLSS 178
N + D P I ++++LS L
Sbjct: 98 NQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQ 157
Query: 179 NKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPEL 238
G+ L L N + L + L++L L NN++S +
Sbjct: 158 QLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGI 217
Query: 239 GSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLS 298
+ L+ L L+ N +L++L L L+L+NNQ S P + L L+EL L
Sbjct: 218 LT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLG 271
Query: 299 HNIFREEIPSQICSMQS--------------------LEKLNLSHNNLSGSIPRCFEEMH 338
N P + + L L L NN+S P +
Sbjct: 272 ANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLT 329
Query: 339 WLSCIDISYNALQGL 353
L + + N + +
Sbjct: 330 KLQRLFFANNKVSDV 344
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 56.2 bits (134), Expect = 4e-09
Identities = 50/252 (19%), Positives = 104/252 (41%), Gaps = 28/252 (11%)
Query: 119 NLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSS 178
L + L ++ ++ + +L ++ L + + +N+L+ ++ S+
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 75
Query: 179 NKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLS--- 235
N+L PL NLT L + +++N I PL + + + L N L
Sbjct: 76 NQLTDITPLK--NLTK-LVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 236 ------------PELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIP 283
++ +L L L + + + L+NL L L++S+N+ S
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD--I 190
Query: 284 NKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCI 343
+ + KL +L L ++N + P I + +L++L+L+ N L + L+ +
Sbjct: 191 SVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDL 246
Query: 344 DISYNALQGLIP 355
D++ N + L P
Sbjct: 247 DLANNQISNLAP 258
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 3e-04
Identities = 11/44 (25%), Positives = 20/44 (45%), Gaps = 2/44 (4%)
Query: 88 SIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTN 131
S + N+ +++ L N ++ P L NLT + L L+
Sbjct: 342 SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 88.3 bits (217), Expect = 8e-20
Identities = 57/270 (21%), Positives = 103/270 (38%), Gaps = 7/270 (2%)
Query: 118 GNLTNLVVLDLSTNKLSG--SIPLSFANLTSLSILYLYEN-SLCDSIPKEIGNMNSLSIL 174
+ LDLS L IP S ANL L+ LY+ +L IP I + L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 175 DLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQL 234
++ + +L L S N + G +P L +L+ +T + N +SG +
Sbjct: 107 YITHTN-VSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI 165
Query: 235 SPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSE 294
GS +L + + + + + + + ++
Sbjct: 166 PDSYGSFSKLFTSMTISRN-RLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQ 224
Query: 295 LDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLI 354
++ ++L L+L +N + G++P+ ++ +L +++S+N L G I
Sbjct: 225 KIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284
Query: 355 PNSTAFRDAPMLALQGNKRLCGDIKRLPPC 384
P + + A NK LCG LP C
Sbjct: 285 PQGGNLQRFDVSAYANNKCLCG--SPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 74.4 bits (181), Expect = 4e-15
Identities = 62/267 (23%), Positives = 111/267 (41%), Gaps = 6/267 (2%)
Query: 70 TAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENI-LNGSIPLALGNLTNLVVLDL 128
T + L +G + P IP + N+ L+ L + L G IP A+ LT L L +
Sbjct: 49 TYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYI 108
Query: 129 STNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLS 188
+ +SG+IP + + +L L N+L ++P I ++ +L + N+++G+IP S
Sbjct: 109 THTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDS 168
Query: 189 LANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLD 248
+ + + +S N + G+IP L+ N +
Sbjct: 169 YGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHL 228
Query: 249 LSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPS 308
+ LS + +L NN+ +P + +L L L++S N EIP
Sbjct: 229 AKNSLAFDLGKVGLSKNLNGL--DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286
Query: 309 QICSMQSLEKLNLSHNN-LSGS-IPRC 333
++Q + ++N L GS +P C
Sbjct: 287 -GGNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.9 bits (212), Expect = 2e-19
Identities = 20/87 (22%), Positives = 35/87 (40%), Gaps = 4/87 (4%)
Query: 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHR 521
+ +G G G V K V +K + + + EF+ E + + H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKM----IKEGSMSEDEFIEEAKVMMNLSHE 59
Query: 522 NIVKFYGFCSHALHSFVVYEYLEMGSL 548
+V+ YG C+ F++ EY+ G L
Sbjct: 60 KLVQLYGVCTKQRPIFIITEYMANGCL 86
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.1 bits (210), Expect = 4e-19
Identities = 20/87 (22%), Positives = 39/87 (44%), Gaps = 4/87 (4%)
Query: 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHR 521
+ IG+G G V+ + V +K + + +++F+ E + K+ H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKT----IREGAMSEEDFIEEAEVMMKLSHP 60
Query: 522 NIVKFYGFCSHALHSFVVYEYLEMGSL 548
+V+ YG C +V+E++E G L
Sbjct: 61 KLVQLYGVCLEQAPICLVFEFMEHGCL 87
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.7 bits (209), Expect = 7e-19
Identities = 23/110 (20%), Positives = 41/110 (37%), Gaps = 6/110 (5%)
Query: 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHR 521
+G G G V+ V VK L FL E N + +++H+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKS----LKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 522 NIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAIK 571
+V+ Y + +++ EY+E GSL L + + K ++
Sbjct: 69 RLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAA 116
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 84.7 bits (209), Expect = 1e-18
Identities = 25/92 (27%), Positives = 43/92 (46%), Gaps = 1/92 (1%)
Query: 464 FDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRN 522
F D IG+G G+VY A+ + E+V +KK Q+ + EV L K+RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 523 IVKFYGFCSHALHSFVVYEYLEMGSLAMNLSN 554
+++ G +++V EY + + +
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVH 108
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.7 bits (209), Expect = 1e-18
Identities = 22/96 (22%), Positives = 41/96 (42%), Gaps = 3/96 (3%)
Query: 460 ATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI 518
++F+ +G G G V+K P+G ++ K H + + + + + E+ L +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI--RNQIIRELQVLHEC 61
Query: 519 RHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSN 554
IV FYG + E+++ GSL L
Sbjct: 62 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 97
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 81.7 bits (201), Expect = 2e-17
Identities = 19/105 (18%), Positives = 46/105 (43%), Gaps = 7/105 (6%)
Query: 451 KIVHEEIIRATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFL 509
+I H+ ++ +++D +G G G V++ TG K +P + ++
Sbjct: 18 EIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVR 71
Query: 510 NEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSN 554
E+ ++ +RH +V + ++YE++ G L +++
Sbjct: 72 KEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD 116
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 80.6 bits (198), Expect = 2e-17
Identities = 23/109 (21%), Positives = 42/109 (38%), Gaps = 15/109 (13%)
Query: 455 EEIIRATNNFDD---------GHCIGNGGQGSVYKAKLP----TGEIVDVKKFHSPLPDE 501
E+ A F IG G G V L V +K S ++
Sbjct: 10 EDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK 69
Query: 502 MACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAM 550
+++FL+E + + + H N++ G + + ++ E++E GSL
Sbjct: 70 Q--RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS 116
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 79.0 bits (194), Expect = 5e-17
Identities = 21/99 (21%), Positives = 39/99 (39%), Gaps = 5/99 (5%)
Query: 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR 519
++ ++ G +G GG V+ A+ L V VK + L + + F E +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 520 HRNIVKFYGFCSHALHS----FVVYEYLEMGSLAMNLSN 554
H IV Y + ++V EY++ +L +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT 104
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.3 bits (195), Expect = 6e-17
Identities = 17/91 (18%), Positives = 31/91 (34%), Gaps = 1/91 (1%)
Query: 459 RATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTK 517
+ +F G +G G +V A+ L T +K + E + +++
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 518 IRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
+ H VK Y + Y + G L
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL 95
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 79.0 bits (194), Expect = 7e-17
Identities = 24/92 (26%), Positives = 42/92 (45%), Gaps = 5/92 (5%)
Query: 462 NNFDDGHCIGNGGQGSVYKAKLP-TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH 520
+ H +G G G VY+ V VK L ++ +EFL E + +I+H
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT----LKEDTMEVEEFLKEAAVMKEIKH 72
Query: 521 RNIVKFYGFCSHALHSFVVYEYLEMGSLAMNL 552
N+V+ G C+ +++ E++ G+L L
Sbjct: 73 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 104
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.5 bits (193), Expect = 8e-17
Identities = 26/88 (29%), Positives = 36/88 (40%), Gaps = 7/88 (7%)
Query: 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHR 521
IG G G V G V VK + A Q FL E + +T++RH
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHS 60
Query: 522 NIVKFYGFCSHALHS-FVVYEYLEMGSL 548
N+V+ G ++V EY+ GSL
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSL 88
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.5 bits (193), Expect = 8e-17
Identities = 32/99 (32%), Positives = 45/99 (45%), Gaps = 6/99 (6%)
Query: 456 EIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNAL 515
EI G IG+G G+VYK K V + +P P ++ Q F NEV L
Sbjct: 4 EIPD--GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL---QAFKNEVGVL 58
Query: 516 TKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSN 554
K RH NI+ F G+ + +V ++ E SL +L
Sbjct: 59 RKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHI 96
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.1 bits (192), Expect = 9e-17
Identities = 23/94 (24%), Positives = 46/94 (48%), Gaps = 1/94 (1%)
Query: 462 NNFDDGHCIGNGGQGSVYKAKLP-TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH 520
+F+ G +G G G+VY A+ + I+ +K ++ + + EV + +RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 521 RNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSN 554
NI++ YG+ A +++ EY +G++ L
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQK 99
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 79.3 bits (195), Expect = 1e-16
Identities = 17/95 (17%), Positives = 41/95 (43%), Gaps = 7/95 (7%)
Query: 458 IRATNNFDD---GHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVN 513
++ + +D +G+G G V++ TG + K ++P P + + NE++
Sbjct: 22 VKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEIS 78
Query: 514 ALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
+ ++ H ++ + ++ E+L G L
Sbjct: 79 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL 113
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 78.2 bits (192), Expect = 2e-16
Identities = 20/95 (21%), Positives = 37/95 (38%), Gaps = 3/95 (3%)
Query: 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR 519
+ +D +G G V A+ T ++V +K + + NE+ L KI+
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--EGSMENEIAVLHKIK 65
Query: 520 HRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSN 554
H NIV H +++ + + G L +
Sbjct: 66 HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE 100
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.4 bits (190), Expect = 2e-16
Identities = 25/116 (21%), Positives = 43/116 (37%), Gaps = 8/116 (6%)
Query: 456 EIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNAL 515
EI R + +G G G V+ V +K L + FL E +
Sbjct: 13 EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKT----LKPGTMSPEAFLQEAQVM 66
Query: 516 TKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAIK 571
K+RH +V+ Y S ++V EY+ GSL ++ + + ++
Sbjct: 67 KKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSL-LDFLKGETGKYLRLPQLVDMAA 120
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.2 bits (187), Expect = 5e-16
Identities = 25/110 (22%), Positives = 41/110 (37%), Gaps = 3/110 (2%)
Query: 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH 520
++D +G G G V A T E V VK + + C + E+ + H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNH 62
Query: 521 RNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570
N+VKFYG ++ EY G L + D + + + +
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 112
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.3 bits (187), Expect = 5e-16
Identities = 24/110 (21%), Positives = 40/110 (36%), Gaps = 5/110 (4%)
Query: 462 NNFDDGHCIGNGGQGSVYKAKLP----TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTK 517
+ +G+G G V + + V VK + + +F+ EVNA+
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 518 IRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRM 567
+ HRN+++ YG +V E +GSL L R
Sbjct: 68 LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY 116
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.6 bits (188), Expect = 6e-16
Identities = 24/101 (23%), Positives = 45/101 (44%), Gaps = 4/101 (3%)
Query: 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR 519
+ IG G G+VY A + TG+ V +++ + + ++ +NE+ + + +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENK 75
Query: 520 HRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSNDAAAEQ 560
+ NIV + +VV EYL GSL ++ E
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG 116
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.3 bits (187), Expect = 6e-16
Identities = 24/89 (26%), Positives = 38/89 (42%), Gaps = 5/89 (5%)
Query: 470 IGNGGQGSVYKAKLP---TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKF 526
+G+G G+V K + V VK + D A + E L E N + ++ + IV+
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP-ALKDELLAEANVMQQLDNPYIVRM 73
Query: 527 YGFCSHALHSFVVYEYLEMGSLAMNLSND 555
G C +V E E+G L L +
Sbjct: 74 IGICEAE-SWMLVMEMAELGPLNKYLQQN 101
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.4 bits (187), Expect = 7e-16
Identities = 26/104 (25%), Positives = 39/104 (37%), Gaps = 11/104 (10%)
Query: 456 EIIRATNNFDDGHCIGNGGQGSVYKAKL------PTGEIVDVKKFHSPLPDEMACQQEFL 509
E R N G +G G G V +A V VK + ++ +
Sbjct: 19 EFPR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK--PSAHLTEREALM 74
Query: 510 NEVNALTKI-RHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNL 552
+E+ L+ + H NIV G C+ + V+ EY G L L
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL 118
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 76.1 bits (186), Expect = 7e-16
Identities = 26/109 (23%), Positives = 43/109 (39%), Gaps = 1/109 (0%)
Query: 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHR 521
+ IG G G VYKA+ GE +KK DE + E++ L +++H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHS 60
Query: 522 NIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570
NIVK Y +V+E+L+ + + E + +
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL 109
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.0 bits (186), Expect = 8e-16
Identities = 19/91 (20%), Positives = 38/91 (41%), Gaps = 4/91 (4%)
Query: 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVK---KFHSPLPDEMACQQEFLNEVNALTK 517
+ +D G +G+G V K + TG K K + +++ EV+ L +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 518 IRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
I+H N++ + + ++ E + G L
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGEL 100
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 75.9 bits (186), Expect = 1e-15
Identities = 19/110 (17%), Positives = 38/110 (34%), Gaps = 1/110 (0%)
Query: 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH 520
+F +G G G V+ + G +K + + + +E L+ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 521 RNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570
I++ +G A F++ +Y+E G L L +
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV 113
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.4 bits (185), Expect = 1e-15
Identities = 22/98 (22%), Positives = 46/98 (46%), Gaps = 7/98 (7%)
Query: 455 EEIIRATN---NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLN 510
E + R N ++ +G+G G VYKA+ T + K + +E+ ++++
Sbjct: 2 EHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL---EDYMV 58
Query: 511 EVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
E++ L H NIVK + + +++ E+ G++
Sbjct: 59 EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV 96
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.3 bits (182), Expect = 2e-15
Identities = 27/95 (28%), Positives = 49/95 (51%), Gaps = 4/95 (4%)
Query: 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHR 521
+++ + IG G G K + G+I+ K+ E A +Q ++EVN L +++H
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHP 63
Query: 522 NIVKFYGFCSHALHS--FVVYEYLEMGSLAMNLSN 554
NIV++Y ++ ++V EY E G LA ++
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK 98
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 74.5 bits (182), Expect = 3e-15
Identities = 27/99 (27%), Positives = 43/99 (43%), Gaps = 8/99 (8%)
Query: 462 NNFDDGHCIGNGGQGSVYKAKLP------TGEIVDVKKFHSPLPDEMACQQEFLNEVNAL 515
NN + IG G G V++A+ P +V VK +M Q +F E +
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM--QADFQREAALM 70
Query: 516 TKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSN 554
+ + NIVK G C+ +++EY+ G L L +
Sbjct: 71 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRS 109
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.6 bits (180), Expect = 4e-15
Identities = 24/97 (24%), Positives = 41/97 (42%), Gaps = 9/97 (9%)
Query: 456 EIIRATNNFDDGHCIGNGGQGSVYKAKLP----TGEIVDVKKFHSPLPDEMACQQEFLNE 511
EI R + G CIG G G V++ V +K + D + +++FL E
Sbjct: 3 EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV--REKFLQE 58
Query: 512 VNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
+ + H +IVK G + +++ E +G L
Sbjct: 59 ALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGEL 94
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 74.4 bits (182), Expect = 6e-15
Identities = 22/97 (22%), Positives = 34/97 (35%), Gaps = 4/97 (4%)
Query: 462 NNFDDGHCIGNGGQGSVYKAKLP-TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR- 519
N+F IG GG G VY + TG++ +K + LNE L+ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 520 --HRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSN 554
IV + + + G L +LS
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ 100
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.0 bits (178), Expect = 9e-15
Identities = 22/103 (21%), Positives = 37/103 (35%), Gaps = 10/103 (9%)
Query: 456 EIIRATNNFDDGHCIGNGGQGSVYKAKL------PTGEIVDVKKFHSPLPDEMACQQEFL 509
E+ R +G G G VY+ V +K + + EFL
Sbjct: 16 EVAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE--RIEFL 71
Query: 510 NEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNL 552
NE + + + ++V+ G S + V+ E + G L L
Sbjct: 72 NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 114
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.5 bits (177), Expect = 1e-14
Identities = 24/100 (24%), Positives = 42/100 (42%), Gaps = 9/100 (9%)
Query: 462 NNFDDGHCIGNGGQGSVYKA------KLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNAL 515
N + G +G+G G V A K V VK ++ ++E+ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE--REALMSELKMM 94
Query: 516 TKI-RHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSN 554
T++ H NIV G C+ + ++++EY G L L +
Sbjct: 95 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRS 134
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.4 bits (174), Expect = 3e-14
Identities = 25/95 (26%), Positives = 38/95 (40%), Gaps = 2/95 (2%)
Query: 462 NNFDDGHCIGNGGQGSVYKAKLP-TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-R 519
N+ IG G G V KA++ G +D ++F E+ L K+
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 520 HRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSN 554
H NI+ G C H + ++ EY G+L L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK 104
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.9 bits (173), Expect = 4e-14
Identities = 19/88 (21%), Positives = 30/88 (34%), Gaps = 6/88 (6%)
Query: 470 IGNGGQGSVYKAKL---PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKF 526
+G G GSV + V +K +E + E + ++ + IV+
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD--TEEMMREAQIMHQLDNPYIVRL 74
Query: 527 YGFCSHALHSFVVYEYLEMGSLAMNLSN 554
G C A +V E G L L
Sbjct: 75 IGVC-QAEALMLVMEMAGGGPLHKFLVG 101
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.1 bits (171), Expect = 9e-14
Identities = 15/83 (18%), Positives = 30/83 (36%), Gaps = 5/83 (6%)
Query: 467 GHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVK 525
+G G G V++ + + K D Q E++ L RHRNI+
Sbjct: 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILH 65
Query: 526 FYGFCSHALHSFVVYEYLEMGSL 548
+ +++E++ +
Sbjct: 66 LHESFESMEELVMIFEFISGLDI 88
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.9 bits (168), Expect = 1e-13
Identities = 23/90 (25%), Positives = 35/90 (38%), Gaps = 6/90 (6%)
Query: 470 IGNGGQGSVYKAKLP-TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYG 528
IG G +VYK T V + + + +Q F E L ++H NIV+FY
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 529 FCSHALHS----FVVYEYLEMGSLAMNLSN 554
+ +V E + G+L L
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYLKR 105
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.7 bits (167), Expect = 2e-13
Identities = 27/87 (31%), Positives = 39/87 (44%), Gaps = 2/87 (2%)
Query: 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHR 521
NF IG G G VYKA+ TGE+V +KK E + E++ L ++ H
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHP 61
Query: 522 NIVKFYGFCSHALHSFVVYEYLEMGSL 548
NIVK ++V+E+L
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLK 88
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.1 bits (168), Expect = 2e-13
Identities = 19/89 (21%), Positives = 27/89 (30%), Gaps = 3/89 (3%)
Query: 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR 519
+ + IG G G V A V +KK Q L E+ L + R
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC--QRTLREIKILLRFR 64
Query: 520 HRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
H NI+ + YL +
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLM 93
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.3 bits (166), Expect = 3e-13
Identities = 23/91 (25%), Positives = 38/91 (41%), Gaps = 7/91 (7%)
Query: 462 NNFDDGHCIGNGGQGSVYKAKLPTGE-----IVDVKKFHSPLPDEMACQQEFLNEVNALT 516
+ IG G G VYK L T V +K + ++ + +FL E +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ--RVDFLGEAGIMG 64
Query: 517 KIRHRNIVKFYGFCSHALHSFVVYEYLEMGS 547
+ H NI++ G S ++ EY+E G+
Sbjct: 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGA 95
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.3 bits (166), Expect = 3e-13
Identities = 26/92 (28%), Positives = 36/92 (39%), Gaps = 9/92 (9%)
Query: 467 GHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKF 526
IG G G V++ K GE V VK F S E+ +RH NI+ F
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS----WFREAEIYQTVMLRHENILGF 62
Query: 527 YGFCSH----ALHSFVVYEYLEMGSLAMNLSN 554
+ ++V +Y E GSL L+
Sbjct: 63 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR 94
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.7 bits (167), Expect = 3e-13
Identities = 24/113 (21%), Positives = 37/113 (32%), Gaps = 9/113 (7%)
Query: 463 NFDDGHCIGNGGQGSVYKAKLP----TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI 518
+F++ IG G G VY L VK + +FL E +
Sbjct: 30 HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE--VSQFLTEGIIMKDF 85
Query: 519 RHRNIVKFYGFCSHALHS-FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570
H N++ G C + S VV Y++ G L + N+
Sbjct: 86 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 138
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.0 bits (165), Expect = 4e-13
Identities = 22/88 (25%), Positives = 39/88 (44%), Gaps = 3/88 (3%)
Query: 470 IGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEM--ACQQEFLNEVNALTKIRHRNIVKF 526
+G G +VYKA+ T +IV +KK E + L E+ L ++ H NI+
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 527 YGFCSHALHSFVVYEYLEMGSLAMNLSN 554
H + +V++++E + N
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDN 93
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.2 bits (166), Expect = 4e-13
Identities = 18/89 (20%), Positives = 31/89 (34%), Gaps = 2/89 (2%)
Query: 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTK-IR 519
+F +G G G V+ A+ T + +K + + + E L+
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 520 HRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
H + + + F V EYL G L
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDL 90
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.9 bits (165), Expect = 6e-13
Identities = 21/95 (22%), Positives = 30/95 (31%), Gaps = 1/95 (1%)
Query: 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH 520
N+FD +G G G V + TG +K + + E L RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 521 RNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSND 555
+ V EY G L +LS +
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE 99
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 66.6 bits (162), Expect = 9e-13
Identities = 20/94 (21%), Positives = 37/94 (39%), Gaps = 8/94 (8%)
Query: 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQ------QEFLNEVNAL 515
N++ +G G V + PT + VK + + + L EV+ L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 516 TKIR-HRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
K+ H NI++ F+V++ ++ G L
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL 97
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.4 bits (161), Expect = 2e-12
Identities = 19/106 (17%), Positives = 39/106 (36%), Gaps = 6/106 (5%)
Query: 455 EEIIRAT----NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFL 509
+E+ + + D +G+G G+V A TG V +KK + P E+ ++
Sbjct: 7 QEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR-AY 65
Query: 510 NEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSND 555
E+ L +RH N++ + ++ +
Sbjct: 66 RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGK 111
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.7 bits (159), Expect = 2e-12
Identities = 24/88 (27%), Positives = 41/88 (46%), Gaps = 2/88 (2%)
Query: 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH 520
++ IG G G+V+KAK T EIV +K+ DE L E+ L +++H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKH 60
Query: 521 RNIVKFYGFCSHALHSFVVYEYLEMGSL 548
+NIV+ + +V+E+ +
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLK 88
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.1 bits (157), Expect = 2e-12
Identities = 42/213 (19%), Positives = 65/213 (30%), Gaps = 10/213 (4%)
Query: 92 EIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILY 151
E+ + S ++ + L ++P L + +L LS N L + T L+ L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 152 LYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIP 211
L L +L +L N L L T + S + + +P
Sbjct: 62 LDRAELTKLQ-----VDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLP 116
Query: 212 LGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYL-DLSANTFHKSIPESLSNLVKLHY 270
LG +Q L P L + L+ N + L+ L L
Sbjct: 117 LGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDT 176
Query: 271 LNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFR 303
L L N IP L L N +
Sbjct: 177 LLLQENSLYT-IPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.0 bits (136), Expect = 1e-09
Identities = 46/212 (21%), Positives = 81/212 (38%), Gaps = 7/212 (3%)
Query: 164 EIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQL 223
E+ + S ++ L ++P +L +L+LS N + + L QL
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALP---PDLPKDTTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 224 TLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIP 283
L+ EL+ + + ++ +S+P L L L++S N+ +
Sbjct: 61 NLDRAELTKLQVDGT---LPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPL 117
Query: 284 NKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCI 343
+ L L EL L N + P + LEKL+L++NNL+ + L +
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
Query: 344 DISYNALQGLIPNSTAFRDAPMLALQGNKRLC 375
+ N+L + P L GN LC
Sbjct: 178 LLQENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.3 bits (90), Expect = 8e-04
Identities = 23/165 (13%), Positives = 45/165 (27%), Gaps = 5/165 (3%)
Query: 237 ELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELD 296
E+ + ++ ++P L L+LS N + L++L+
Sbjct: 5 EVSKVASHLEVNCDKRNL-TALPPDLPKDTT--ILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 297 LSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPN 356
L ++ L L+LSHN L +
Sbjct: 62 LDR--AELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGA 119
Query: 357 STAFRDAPMLALQGNKRLCGDIKRLPPCKAFKSHKQSMKKIWVVI 401
+ L L+GN+ L P + + + +
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELP 164
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.7 bits (159), Expect = 3e-12
Identities = 22/96 (22%), Positives = 39/96 (40%), Gaps = 11/96 (11%)
Query: 462 NNFDDGHCIGNGGQGSVYKAKLP--------TGEIVDVKKFHSPLPDEMACQQEFLNEVN 513
+ G +G G G V A+ V VK S ++ + ++E+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEME 70
Query: 514 ALTKI-RHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
+ I +H+NI+ G C+ +V+ EY G+L
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 106
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.0 bits (160), Expect = 3e-12
Identities = 26/116 (22%), Positives = 47/116 (40%), Gaps = 14/116 (12%)
Query: 463 NFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHR 521
++ D IGNG G VY+AKL +GE+V +KK ++ E+ + K+ H
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHC 73
Query: 522 NIVKFYGFCSHA------LHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAIK 571
NIV+ F + ++ +V +Y+ + A + +
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 64.8 bits (157), Expect = 6e-12
Identities = 20/94 (21%), Positives = 35/94 (37%), Gaps = 1/94 (1%)
Query: 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH 520
+ FD +G G G V K +G +K ++ + LNE L +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 521 RNIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSN 554
+VK + ++V EY+ G + +L
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR 134
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.0 bits (155), Expect = 7e-12
Identities = 17/97 (17%), Positives = 32/97 (32%), Gaps = 6/97 (6%)
Query: 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPL---PDEMACQQEFLNEVNALTK 517
+ + G +G+GG GSVY + V +K E+ EV L K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 518 IR--HRNIVKFYGFCSHALHSFVVYEYLEMGSLAMNL 552
+ +++ + ++ E E +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF 100
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.4 bits (156), Expect = 7e-12
Identities = 21/98 (21%), Positives = 43/98 (43%), Gaps = 9/98 (9%)
Query: 456 EIIRATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVD----VKKFHSPLPDEMACQQEFLN 510
I++ T F +G+G G+VYK +P GE V +K+ + +E L+
Sbjct: 4 RILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--NKEILD 60
Query: 511 EVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLEMGSL 548
E + + + ++ + G C + ++ + + G L
Sbjct: 61 EAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCL 97
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.5 bits (156), Expect = 8e-12
Identities = 18/86 (20%), Positives = 33/86 (38%), Gaps = 2/86 (2%)
Query: 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR 519
+ + +G+G GSV A TG V VKK P + ++ E+ L ++
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMK 75
Query: 520 HRNIVKFYGFCSHALHSFVVYEYLEM 545
H N++ + A + +
Sbjct: 76 HENVIGLLDVFTPARSLEEFNDVYLV 101
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.8 bits (154), Expect = 1e-11
Identities = 22/106 (20%), Positives = 40/106 (37%), Gaps = 10/106 (9%)
Query: 458 IRATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALT 516
+ ++ IG G G V+KA+ TG+ V +KK E L E+ L
Sbjct: 6 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF-PITALREIKILQ 64
Query: 517 KIRHRNIVKFYGFCSHAL--------HSFVVYEYLEMGSLAMNLSN 554
++H N+V C ++V+++ E + +
Sbjct: 65 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV 110
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.7 bits (154), Expect = 1e-11
Identities = 20/115 (17%), Positives = 40/115 (34%), Gaps = 6/115 (5%)
Query: 462 NNFDDGHCIGNGGQGSVYKAKL----PTGEIVDVKKFH-SPLPDEMACQQEFLNEVNALT 516
NF+ +G G G V+ + TG++ +K + + + + E L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 517 KIRHR-NIVKFYGFCSHALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570
IR +V + ++ +Y+ G L +LS + + I
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI 138
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 62.2 bits (150), Expect = 4e-11
Identities = 17/99 (17%), Positives = 33/99 (33%), Gaps = 7/99 (7%)
Query: 458 IRATNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALT 516
+R N + G IG+G G +Y + GE V +K + E
Sbjct: 3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-----QLHIESKIYK 57
Query: 517 KIRHRNIVKFYGFC-SHALHSFVVYEYLEMGSLAMNLSN 554
++ + +C + ++ +V E L +
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFC 96
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.1 bits (147), Expect = 1e-10
Identities = 17/94 (18%), Positives = 35/94 (37%), Gaps = 8/94 (8%)
Query: 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH 520
+ + IG+G QG V A V +KK P ++ ++ E+ + + H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR-AYRELVLMKCVNH 75
Query: 521 RNIVKFYGFCSHALHS------FVVYEYLEMGSL 548
+NI+ + ++V E ++
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC 109
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 60.6 bits (146), Expect = 1e-10
Identities = 15/91 (16%), Positives = 33/91 (36%), Gaps = 10/91 (10%)
Query: 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR- 519
+++ +G G V++A + E V VK +++ E+ L +R
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP------VKKKKIKREIKILENLRG 88
Query: 520 HRNIVKFYGFCSHALHS--FVVYEYLEMGSL 548
NI+ + +V+E++
Sbjct: 89 GPNIITLADIVKDPVSRTPALVFEHVNNTDF 119
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.9 bits (144), Expect = 2e-10
Identities = 21/92 (22%), Positives = 35/92 (38%), Gaps = 6/92 (6%)
Query: 459 RATNNFDDGHCIGNGGQGSVYKAK--LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALT 516
RA ++ IG G G V+KA+ G V +K+ +E + EV L
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-PLSTIREVAVLR 62
Query: 517 KI---RHRNIVKFYGFCSHALHSFVVYEYLEM 545
+ H N+V+ + C+ + L
Sbjct: 63 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVF 94
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.2 bits (140), Expect = 9e-10
Identities = 16/88 (18%), Positives = 27/88 (30%), Gaps = 14/88 (15%)
Query: 467 GHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIV 524
+G G G V + T E +K + EV + + +IV
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 68
Query: 525 KFYGFCSHAL----HSFVVYEYLEMGSL 548
+ + +V E L+ G L
Sbjct: 69 RIVDVYENLYAGRKCLLIVMECLDGGEL 96
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 56.2 bits (134), Expect = 2e-09
Identities = 37/218 (16%), Positives = 77/218 (35%), Gaps = 21/218 (9%)
Query: 119 NLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSS 178
L N + + + ++ ++ A+L ++ L + + + + +N+L L+L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQ--ADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 179 NKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSS------LIQLTLNNNELSG 232
N++ PL L++ ++ L L
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 233 QLSPELGSLIQLEYLDL-------SANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNK 285
L +L + + L S S L+NL KL L +N+ S P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 286 IEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSH 323
+ L +L E+ L +N + P + + +L + L++
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.2 bits (108), Expect = 3e-06
Identities = 19/72 (26%), Positives = 35/72 (48%), Gaps = 4/72 (5%)
Query: 81 QDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLS 140
S + N+ L+ L+ +N ++ PL +L NL+ + L N++S PL+
Sbjct: 157 SIGNAQVSDLTPLANLSKLTTLKADDNKISDISPL--ASLPNLIEVHLKNNQISDVSPLA 214
Query: 141 FANLTSLSILYL 152
N ++L I+ L
Sbjct: 215 --NTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 5e-05
Identities = 24/203 (11%), Positives = 62/203 (30%), Gaps = 21/203 (10%)
Query: 167 NMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLN 226
+ + + + + ++ + A+L + L + + + L++LI L L
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDG-ITTLSAFGTGVTTIEGVQY--LNNLIGLELK 71
Query: 227 NNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKI 286
+N+++ + + I L + +I S + + +
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 287 EKLIHLSEL--------------DLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPR 332
+ L LS + + + ++ L L N +S P
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190
Query: 333 CFEEMHWLSCIDISYNALQGLIP 355
+ L + + N + + P
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSP 212
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 8e-05
Identities = 20/61 (32%), Positives = 32/61 (52%), Gaps = 4/61 (6%)
Query: 117 LGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDL 176
L NL+ L L NK+S P A+L +L ++L N + D P + N ++L I+ L
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
Query: 177 S 177
+
Sbjct: 225 T 225
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.8 bits (136), Expect = 2e-09
Identities = 26/107 (24%), Positives = 41/107 (38%), Gaps = 12/107 (11%)
Query: 456 EIIRATNNFDDGHCIGNGGQGSVYKA------KLPTGEIVDVKKFHSPLPDEMACQQEFL 509
E R + G +G G G V +A K T V VK + +
Sbjct: 9 EFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALM 64
Query: 510 NEVNALTKIRHR-NIVKFYGFCSHALHS-FVVYEYLEMGSLAMNLSN 554
+E+ L I H N+V G C+ V+ E+ + G+L+ L +
Sbjct: 65 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 111
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.7 bits (137), Expect = 2e-09
Identities = 14/106 (13%), Positives = 31/106 (29%), Gaps = 5/106 (4%)
Query: 242 IQLEYLDLSANTF-HKSIPESLSNLVKLHYLNLSNNQFS----QKIPNKIEKLIHLSELD 296
+ ++ LD+ E L L + + L + + + I + + L+EL+
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 297 LSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSC 342
L N + + + +L S
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST 107
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.1 bits (120), Expect = 2e-07
Identities = 18/93 (19%), Positives = 36/93 (38%), Gaps = 9/93 (9%)
Query: 122 NLVVLDLSTNKLSGS-IPLSFANLTSLSILYLYENSL----CDSIPKEIGNMNSLSILDL 176
++ LD+ +LS + L ++ L + L C I + +L+ L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 177 SSNKLNG----SIPLSLANLTNSLKVLYLSSNH 205
SN+L + L + ++ L L +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.4 bits (118), Expect = 3e-07
Identities = 17/93 (18%), Positives = 29/93 (31%), Gaps = 9/93 (9%)
Query: 254 FHKSIPESLSNLVKLHYLNLSNNQFS----QKIPNKIEKLIHLSELDLSHNIFREEIPSQ 309
+ L L L++ S + + L ELDLS+N + Q
Sbjct: 357 VRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQ 416
Query: 310 ICS-----MQSLEKLNLSHNNLSGSIPRCFEEM 337
+ LE+L L S + + +
Sbjct: 417 LVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.8 bits (114), Expect = 1e-06
Identities = 19/94 (20%), Positives = 32/94 (34%), Gaps = 15/94 (15%)
Query: 243 QLEYLDLSANTFH----KSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLI-----HLS 293
L L L+ S+ +L L L+LSNN ++ + + L
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 294 ELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLS 327
+L L + EE+ L+ L +L
Sbjct: 430 QLVLYDIYWSEEME------DRLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 3e-06
Identities = 21/93 (22%), Positives = 33/93 (35%), Gaps = 12/93 (12%)
Query: 119 NLTNLVVLDLSTNKLSG----SIPLSFANLTSLSILYLYENSLCDSIPKEIG-----NMN 169
+ L VL L+ +S S+ + SL L L N L D+ ++
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 170 SLSILDLSSNKLNGSIPLSLANLT---NSLKVL 199
L L L + + L L SL+V+
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 3e-06
Identities = 17/95 (17%), Positives = 34/95 (35%), Gaps = 9/95 (9%)
Query: 170 SLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHI----VGEIPLGHGMLSSLIQLTL 225
+ LD+ +L+ + L L +V+ L + +I + +L +L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 226 NNNELSGQLSPELGSLIQ-----LEYLDLSANTFH 255
+NEL + +Q ++ L L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 4e-06
Identities = 20/116 (17%), Positives = 37/116 (31%), Gaps = 13/116 (11%)
Query: 72 HFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNG----SIPLALGNLTNLVVLD 127
+ +D + L L L++ ++ S+ L +L LD
Sbjct: 344 ELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELD 403
Query: 128 LSTNKLSGSIPLSFA-----NLTSLSILYLYENSLCDSIPKEIG----NMNSLSIL 174
LS N L + L L L LY+ + + + + SL ++
Sbjct: 404 LSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 4e-06
Identities = 20/81 (24%), Positives = 36/81 (44%), Gaps = 9/81 (11%)
Query: 218 SSLIQLTLNNNELSGQ----LSPELGSLIQLEYLDLSANTFHKSIPESLSNLVK-----L 268
S L L L + ++S L+ L + L LDLS N + L V+ L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 269 HYLNLSNNQFSQKIPNKIEKL 289
L L + +S+++ ++++ L
Sbjct: 429 EQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 2e-05
Identities = 22/99 (22%), Positives = 36/99 (36%), Gaps = 14/99 (14%)
Query: 141 FANLTSLSILYLYENSL----CDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLA----NL 192
+ L +L+L + + C S+ + +SL LDLS+N L + L L
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 193 TNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELS 231
L+ L L + E+ L L + L
Sbjct: 425 GCLLEQLVLYDIYWSEEME------DRLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 3e-05
Identities = 19/94 (20%), Positives = 33/94 (35%), Gaps = 11/94 (11%)
Query: 95 NMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSG----SIPLSFANLTSLSIL 150
+++SL D+Q E + + L L V+ L L+ I + +L+ L
Sbjct: 3 DIQSL-DIQ-CEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 151 YLYENSLCDSIPKEIG-----NMNSLSILDLSSN 179
L N L D + + L L +
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 5e-05
Identities = 9/68 (13%), Positives = 24/68 (35%), Gaps = 5/68 (7%)
Query: 290 IHLSELDLSHNIFREEIPSQICS-MQSLEKLNLSHNNLSG----SIPRCFEEMHWLSCID 344
+ + LD+ + +++ +Q + + L L+ I L+ ++
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 345 ISYNALQG 352
+ N L
Sbjct: 62 LRSNELGD 69
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 6e-04
Identities = 12/77 (15%), Positives = 26/77 (33%), Gaps = 4/77 (5%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNG----SIPLALGNLTNLVVLDLSTNKLSGSIPLSFA 142
+ + + ++ ++L + L I AL L L+L +N+L
Sbjct: 17 ARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVL 76
Query: 143 NLTSLSILYLYENSLCD 159
+ + SL +
Sbjct: 77 QGLQTPSCKIQKLSLQN 93
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 52.4 bits (125), Expect = 5e-09
Identities = 30/123 (24%), Positives = 49/123 (39%), Gaps = 5/123 (4%)
Query: 102 LQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSI 161
L L+ L ++ L L + LDLS N+L P + A L L +L +N
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDN--ALEN 57
Query: 162 PKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLI 221
+ N+ L L L +N+L S + L +L L N + E + + L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 222 QLT 224
++
Sbjct: 118 SVS 120
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.5 bits (120), Expect = 2e-08
Identities = 26/121 (21%), Positives = 48/121 (39%), Gaps = 8/121 (6%)
Query: 173 ILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSG 232
+L L+ L ++ L L + L LS N + P L L L ++ +
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLL-VTHLDLSHNRLRALPP-ALAALRCLE--VLQASDNAL 55
Query: 233 QLSPELGSLIQLEYLDLSANTFHK-SIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIH 291
+ + +L +L+ L L N + + + L + +L LNL N + E+L
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAE 114
Query: 292 L 292
+
Sbjct: 115 M 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.5 bits (120), Expect = 3e-08
Identities = 29/107 (27%), Positives = 45/107 (42%), Gaps = 6/107 (5%)
Query: 223 LTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKI 282
L L + +L+ L L+ + +LDLS N ++P +L+ L L L S+N
Sbjct: 3 LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVD 59
Query: 283 PNKIEKLIHLSELDLSHN-IFREEIPSQICSMQSLEKLNLSHNNLSG 328
L EL L +N + + + S L LNL N+L
Sbjct: 60 GVANL--PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.2 bits (114), Expect = 1e-07
Identities = 21/109 (19%), Positives = 40/109 (36%), Gaps = 6/109 (5%)
Query: 246 YLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREE 305
L L+ ++ L L+ + +L+LS+N+ P + L L L S N
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENV 58
Query: 306 IPSQICSMQSLEKLNLSHNNL-SGSIPRCFEEMHWLSCIDISYNALQGL 353
++L L +N L + + L +++ N+L
Sbjct: 59 DGVANLPRL--QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.2 bits (109), Expect = 6e-07
Identities = 30/127 (23%), Positives = 50/127 (39%), Gaps = 9/127 (7%)
Query: 197 KVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHK 256
+VL+L+ + L L + L L++N L P L +L LE L A+
Sbjct: 1 RVLHLAHKDLTVLCHLEQ--LLLVTHLDLSHNRLRAL-PPALAALRCLEVLQ--ASDNAL 55
Query: 257 SIPESLSNLVKLHYLNLSNNQFSQ-KIPNKIEKLIHLSELDLSHNIFREE---IPSQICS 312
+ ++NL +L L L NN+ Q + L L+L N +E
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 313 MQSLEKL 319
+ S+ +
Sbjct: 116 LPSVSSI 122
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 55.2 bits (132), Expect = 5e-09
Identities = 16/87 (18%), Positives = 30/87 (34%), Gaps = 7/87 (8%)
Query: 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH 520
++ G IG G G +++ L + V +K + + +E +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-----RRSDAPQLRDEYRTYKLLAG 59
Query: 521 RN-IVKFYGFCSHALHSFVVYEYLEMG 546
I Y F LH+ +V + L
Sbjct: 60 CTGIPNVYYFGQEGLHNVLVIDLLGPS 86
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.4 bits (124), Expect = 4e-08
Identities = 41/232 (17%), Positives = 80/232 (34%), Gaps = 14/232 (6%)
Query: 126 LDLSTNKLSGSIPLSFANLTSLSILYLY-ENSLCDSIPKEIGNMNSLSILDLSSNKLNGS 184
LDL+ L P L S ++ S D E + + +DLS++ + S
Sbjct: 5 LDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 61
Query: 185 IPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPE-----LG 239
+ + + L+ L L + I S+L++L L+ + + +
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121
Query: 240 SLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSN---NQFSQKIPNKIEKLIHLSELD 296
L +L T + LNLS N + + + +L LD
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 181
Query: 297 LSHNIFR-EEIPSQICSMQSLEKLNLSH-NNLSGSIPRCFEEMHWLSCIDIS 346
LS ++ + + + L+ L+LS ++ E+ L + +
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVF 233
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.8 bits (118), Expect = 8e-08
Identities = 28/154 (18%), Positives = 51/154 (33%), Gaps = 6/154 (3%)
Query: 225 LNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPN 284
L ++ QL + L L LN ++ + +
Sbjct: 4 LKPEQVE-QLKLIMSKRYDGSQQALDLKGLRS--DPDLVAQNIDVVLNRRSSMAA-TLRI 59
Query: 285 KIEKLIHLSELDLSHNIFR--EEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSC 342
E + L L+LS+N +++ S + +L+ LNLS N L + L
Sbjct: 60 IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEE 119
Query: 343 IDISYNALQGLIPNSTAFRDAPMLALQGNKRLCG 376
+ + N+L + + + A RL G
Sbjct: 120 LWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDG 153
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.0 bits (103), Expect = 9e-06
Identities = 30/146 (20%), Positives = 50/146 (34%), Gaps = 13/146 (8%)
Query: 112 SIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSL 171
+ L + + L L +L +S+ ++ N+ L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNR-RSSMAATLRIIEENIPEL 67
Query: 172 SILDLSSNKLNG--SIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNE 229
L+LS+N+L + + N LK+L LS N + E L L +L L+ N
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPN-LKILNLSGNELKSERELDKIKGLKLEELWLDGNS 126
Query: 230 LSGQLSPE-------LGSLIQLEYLD 248
LS + +L LD
Sbjct: 127 LSDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.1 bits (98), Expect = 4e-05
Identities = 19/114 (16%), Positives = 38/114 (33%), Gaps = 3/114 (2%)
Query: 88 SIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSG--SIPLSFANLT 145
++ L ++ ++ + N+ L+ L+LS N+L +
Sbjct: 33 RSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAP 91
Query: 146 SLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVL 199
+L IL L N L + L L L N L+ + ++ +
Sbjct: 92 NLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERF 145
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (90), Expect = 5e-04
Identities = 25/100 (25%), Positives = 38/100 (38%), Gaps = 9/100 (9%)
Query: 85 LYSSIPDEIGNMKSLSDLQLSENILNG--SIPLALGNLTNLVVLDLSTNKLSGSIPLSFA 142
+ +++ N+ L L LS N L + + NL +L+LS N+L L
Sbjct: 53 MAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKI 112
Query: 143 NLTSLSILYLYENSLCDSIPKE-------IGNMNSLSILD 175
L L+L NSL D+ + L LD
Sbjct: 113 KGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.4 bits (121), Expect = 1e-07
Identities = 22/101 (21%), Positives = 35/101 (34%), Gaps = 13/101 (12%)
Query: 103 QLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIP 162
N + I +L L++S NKL +P L L N L +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHL-AEVP 320
Query: 163 KEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSS 203
+ N L L + N L P ++ + L ++S
Sbjct: 321 ELPQN---LKQLHVEYNPLR-EFPDIPESVED----LRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.6 bits (119), Expect = 3e-07
Identities = 22/96 (22%), Positives = 39/96 (40%), Gaps = 10/96 (10%)
Query: 225 LNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPN 284
N S ++ LE L++S N +P L L S N ++ +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKL-IELPALPPRL---ERLIASFNHLAE-VPE 321
Query: 285 KIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLN 320
+ +L +L + +N R E P S++ L ++N
Sbjct: 322 LPQ---NLKQLHVEYNPLR-EFPDIPESVEDL-RMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.5 bits (111), Expect = 2e-06
Identities = 25/100 (25%), Positives = 35/100 (35%), Gaps = 13/100 (13%)
Query: 128 LSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPL 187
N S I SL L + N L +P L L S N L +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPE 321
Query: 188 SLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNN 227
NL K L++ N + E P + S+ L +N+
Sbjct: 322 LPQNL----KQLHVEYNPLR-EFP---DIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.4 bits (108), Expect = 5e-06
Identities = 22/85 (25%), Positives = 37/85 (43%), Gaps = 8/85 (9%)
Query: 269 HYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSG 328
N S +I + + L EL++S+N E+P+ LE+L S N+L+
Sbjct: 263 PPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA- 317
Query: 329 SIPRCFEEMHWLSCIDISYNALQGL 353
+P E L + + YN L+
Sbjct: 318 EVP---ELPQNLKQLHVEYNPLREF 339
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.2 bits (105), Expect = 1e-05
Identities = 17/78 (21%), Positives = 37/78 (47%), Gaps = 10/78 (12%)
Query: 195 SLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTF 254
SL+ L +S+N ++ E+P + L +L + N L+ ++ + L+ L + N
Sbjct: 285 SLEELNVSNNKLI-ELP---ALPPRLERLIASFNHLA-EVPELPQN---LKQLHVEYNPL 336
Query: 255 HKSIPESLSNLVKLHYLN 272
+ P+ ++ L +N
Sbjct: 337 -REFPDIPESVEDL-RMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 37.9 bits (86), Expect = 0.003
Identities = 17/97 (17%), Positives = 33/97 (34%), Gaps = 5/97 (5%)
Query: 243 QLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIF 302
Q L+L+ S+PE +L L S N + ++P + L L + +
Sbjct: 39 QAHELELNNLGL-SSLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL 93
Query: 303 REEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHW 339
+ P S +L + S + + +
Sbjct: 94 SDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNN 130
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (114), Expect = 3e-07
Identities = 19/105 (18%), Positives = 41/105 (39%), Gaps = 5/105 (4%)
Query: 249 LSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPS 308
L+A ++ +N V+ L+L + I N L +D S N
Sbjct: 3 LTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDN--EIRKLD 57
Query: 309 QICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGL 353
++ L+ L +++N + + + L+ + ++ N+L L
Sbjct: 58 GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVEL 102
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (93), Expect = 2e-04
Identities = 23/151 (15%), Positives = 47/151 (31%), Gaps = 10/151 (6%)
Query: 128 LSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPL 187
L+ + + + N L L + I ++ +D S N++ L
Sbjct: 3 LTAELIEQA--AQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR---KL 56
Query: 188 SLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYL 247
L LK L +++N I L L +L L NN L + + ++
Sbjct: 57 DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTY 116
Query: 248 DLSANTFHKSIP----ESLSNLVKLHYLNLS 274
+ + + ++ L+
Sbjct: 117 LCILRNPVTNKKHYRLYVIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (89), Expect = 4e-04
Identities = 25/140 (17%), Positives = 47/140 (33%), Gaps = 4/140 (2%)
Query: 95 NMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYE 154
N +L L + I L +D S N++ L L L +
Sbjct: 16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTLLVNN 72
Query: 155 NSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGH 214
N +C + L+ L L++N L L SL L + N + +
Sbjct: 73 NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRL 132
Query: 215 GMLSSLIQLT-LNNNELSGQ 233
++ + Q+ L+ ++ +
Sbjct: 133 YVIYKVPQVRVLDFQKVKLK 152
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 49.2 bits (116), Expect = 3e-07
Identities = 33/194 (17%), Positives = 64/194 (32%), Gaps = 21/194 (10%)
Query: 119 NLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSS 178
+ +L ++ ++ + L S+ + + + I + +++ L L+
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 179 NKLNGSIPLS--------------LANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLT 224
NKL PL+ + +L++ + L S + L L QL
Sbjct: 78 NKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLE 137
Query: 225 LNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPN 284
+ + S + + I L+ L KL L LS N S
Sbjct: 138 SLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISD--LR 194
Query: 285 KIEKLIHLSELDLS 298
+ L +L L+L
Sbjct: 195 ALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 9e-07
Identities = 29/204 (14%), Positives = 69/204 (33%), Gaps = 17/204 (8%)
Query: 143 NLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLS 202
L + S+ D++ + +NS+ + +++ + + L N + L+L+
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQ--YLPN-VTKLFLN 76
Query: 203 SNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESL 262
N + L++L L + + ++ + I +
Sbjct: 77 GNKLTD-----IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLV 131
Query: 263 SNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLS 322
+N + ++ L L L L N + +P + + L+ L LS
Sbjct: 132 HLPQLESLYLGNNKITDITVLSR---LTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLS 186
Query: 323 HNNLSGSIPRCFEEMHWLSCIDIS 346
N++S R + L +++
Sbjct: 187 KNHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 47.3 bits (111), Expect = 1e-06
Identities = 34/209 (16%), Positives = 69/209 (33%), Gaps = 29/209 (13%)
Query: 88 SIPDEIG------NMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSF 141
++P I L + + ++ L ++ + + + + +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQ- 65
Query: 142 ANLTSLSILYLYENSL---------------CDSIPKEIGNMNSLSILDLSSNKLNGSIP 186
L +++ L+L N L K + + L S L +
Sbjct: 66 -YLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGI 124
Query: 187 LSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEY 246
+ L + ++ L + L+ L L+L +N++S L L +L+
Sbjct: 125 SDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISD--IVPLAGLTKLQN 182
Query: 247 LDLSANTFHKSIPESLSNLVKLHYLNLSN 275
L LS N S +L+ L L L L +
Sbjct: 183 LYLSKNHI--SDLRALAGLKNLDVLELFS 209
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 48.2 bits (114), Expect = 5e-07
Identities = 12/91 (13%), Positives = 27/91 (29%), Gaps = 11/91 (12%)
Query: 467 GHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQ-------EFLNEVNALTKIR 519
G +G G + +V+ VK ++ F +
Sbjct: 5 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 520 HRNIVKFYGFCSHALHSF----VVYEYLEMG 546
R + K G ++++ V+ E ++
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNAVLMELIDAK 95
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 49.3 bits (116), Expect = 7e-07
Identities = 11/85 (12%), Positives = 29/85 (34%), Gaps = 10/85 (11%)
Query: 464 FDDG-----HCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTK 517
+ D +G G +V+ AK + V +K + + +E+ L +
Sbjct: 10 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG----DKVYTEAAEDEIKLLQR 65
Query: 518 IRHRNIVKFYGFCSHALHSFVVYEY 542
+ + K ++ + + +
Sbjct: 66 VNDADNTKEDSMGANHILKLLDHFN 90
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.6 bits (111), Expect = 1e-06
Identities = 34/223 (15%), Positives = 68/223 (30%), Gaps = 8/223 (3%)
Query: 112 SIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSL 171
IP L N + L KL +F+ L + + +N + + I ++ +
Sbjct: 22 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79
Query: 172 SILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLG---HGMLSSLIQLTLNNN 228
N A L SN + +P H + L+ + N N
Sbjct: 80 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139
Query: 229 ELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEK 288
+ + + +G + L L+ N + + + NN + +
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199
Query: 289 LIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIP 331
LD+S + +++ L + NL +P
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP 239
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (91), Expect = 4e-04
Identities = 35/241 (14%), Positives = 69/241 (28%), Gaps = 12/241 (4%)
Query: 146 SLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVL---YLS 202
S + E+ + IP ++ + L KL + + + K+
Sbjct: 9 SNRVFLCQESKV-TEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65
Query: 203 SNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESL 262
I ++ L + NN + + +Q + + + +
Sbjct: 66 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125
Query: 263 SNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLS 322
S L + + N + + + + L L+ N +E Q E
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185
Query: 323 HNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDIKRLP 382
+NNL F +DIS + L + L + L K+LP
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSY--GLENLKKLRARSTYNL----KKLP 239
Query: 383 P 383
Sbjct: 240 T 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (91), Expect = 5e-04
Identities = 30/225 (13%), Positives = 67/225 (29%), Gaps = 8/225 (3%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTS 146
+ IP ++ ++ +L+ L A +L +++S N + I +
Sbjct: 21 TEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLP 78
Query: 147 LSILYL---YENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSS 203
N L + N +L ++ + + +L L + +
Sbjct: 79 KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNI 138
Query: 204 NHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLS 263
N E G+ + L LN N + + E N + +
Sbjct: 139 NIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFH 198
Query: 264 NLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPS 308
L++S + +E L L + +++P+
Sbjct: 199 GASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL---KKLPT 240
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.9 bits (107), Expect = 2e-06
Identities = 21/109 (19%), Positives = 41/109 (37%), Gaps = 2/109 (1%)
Query: 268 LHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICS-MQSLEKLNLSHNNL 326
L + + + + +L+EL + + + + + + L L + + L
Sbjct: 10 SSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68
Query: 327 SGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLC 375
P F LS +++S+NAL+ L + L L GN C
Sbjct: 69 RFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.2 bits (100), Expect = 1e-05
Identities = 25/117 (21%), Positives = 39/117 (33%), Gaps = 3/117 (2%)
Query: 236 PELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEK-LIHLSE 294
P+ L + + L L L + N Q Q + + + L L
Sbjct: 2 PDACCPHGSSGLRCTRDGA-LDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 295 LDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQ 351
L + + R P L +LNLS N L S+ + L + +S N L
Sbjct: 61 LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (86), Expect = 9e-04
Identities = 23/134 (17%), Positives = 43/134 (32%), Gaps = 3/134 (2%)
Query: 145 TSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSN 204
S L + + +L+ L + + + + L L+ L + +
Sbjct: 8 HGSSGLRCTRDGA-LDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 205 HIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSI-PESLS 263
+ P L +L L+ N L LS + + L+ L LS N H S L
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQ 125
Query: 264 NLVKLHYLNLSNNQ 277
+ + +
Sbjct: 126 RWEEEGLGGVPEQK 139
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 43.3 bits (100), Expect = 2e-05
Identities = 38/181 (20%), Positives = 65/181 (35%), Gaps = 7/181 (3%)
Query: 146 SLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNH 205
+ + L IP++I + L L+ N+L L L L L N
Sbjct: 9 EGTTVDCTGRGL-KEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQ 65
Query: 206 IVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNL 265
+ G P S + +L L N++ + L QL+ L+L N +P S +L
Sbjct: 66 LTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHL 125
Query: 266 VKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNN 325
L LN + + L + L+ R PS ++ ++ +L H+
Sbjct: 126 NSLTSLN-LASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS---KVRDVQIKDLPHSE 181
Query: 326 L 326
Sbjct: 182 F 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 42.5 bits (98), Expect = 5e-05
Identities = 17/95 (17%), Positives = 33/95 (34%), Gaps = 5/95 (5%)
Query: 111 GSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNS 170
L L L+L N++S +P SF +L SL+ L ++ +
Sbjct: 92 EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN-LASNPFNCNCHLAWFAEW 150
Query: 171 LSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNH 205
L L+ P + + +++ L +
Sbjct: 151 LRKKSLNGGAARCGAPSKVRD----VQIKDLPHSE 181
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 39.0 bits (89), Expect = 6e-04
Identities = 17/97 (17%), Positives = 39/97 (40%), Gaps = 4/97 (4%)
Query: 86 YSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLT 145
+ L L L +N ++ +P + +L +L L+L++N + + L++
Sbjct: 91 KEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAE 149
Query: 146 SLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLN 182
L L + P ++ + + I DL ++
Sbjct: 150 WLRKKSLNGGAARCGAPSKVRD---VQIKDLPHSEFK 183
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 38.6 bits (88), Expect = 8e-04
Identities = 22/97 (22%), Positives = 38/97 (39%), Gaps = 5/97 (5%)
Query: 134 SGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLT 193
F L L L LY+N + +P ++NSL+ L+L+SN N + L+
Sbjct: 91 KEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA--WFA 148
Query: 194 NSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNEL 230
L+ L+ P + + L ++E
Sbjct: 149 EWLRKKSLNGGAARCGAP---SKVRDVQIKDLPHSEF 182
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 3e-05
Identities = 27/187 (14%), Positives = 61/187 (32%), Gaps = 15/187 (8%)
Query: 142 ANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYL 201
L L + ++ D++ + +++ ++ L + SI + L N L +
Sbjct: 15 TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SID-GVEYLNN-LTQINF 69
Query: 202 SSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPES 261
S+N + PL + I + N L+ + + + +
Sbjct: 70 SNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 129
Query: 262 LSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNL 321
L+ L + S + DL + ++ +LE+L++
Sbjct: 130 LNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP----------LANLTTLERLDI 179
Query: 322 SHNNLSG 328
S N +S
Sbjct: 180 SSNKVSD 186
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.6 bits (96), Expect = 8e-05
Identities = 28/190 (14%), Positives = 67/190 (35%), Gaps = 19/190 (10%)
Query: 119 NLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSS 178
L + L ++ ++ + +L ++ L + + +N+L+ ++ S+
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 71
Query: 179 NKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELS------- 231
N+L PL + + I L + +L + + +
Sbjct: 72 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131
Query: 232 ------GQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNK 285
+S L+ ++ + + L+NL L L++S+N+ S +
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISV 189
Query: 286 IEKLIHLSEL 295
+ KL +L L
Sbjct: 190 LAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.001
Identities = 39/206 (18%), Positives = 70/206 (33%), Gaps = 25/206 (12%)
Query: 81 QDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLS 140
QD P+ D + L + + ++ +L + L + SI
Sbjct: 4 QDTPINQIFTDT--ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SID-G 57
Query: 141 FANLTSLSILYLYENSLCDSIP---------------KEIGNMNSLSILDLSSNKLNGSI 185
L +L+ + N L D P + ++ +L+ L +
Sbjct: 58 VEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQ 117
Query: 186 PLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLE 245
+ L N + L + L+SL QL ++N+++ L +L LE
Sbjct: 118 ITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTD--LKPLANLTTLE 175
Query: 246 YLDLSANTFHKSIPESLSNLVKLHYL 271
LD+S+N S L+ L L L
Sbjct: 176 RLDISSNKV--SDISVLAKLTNLESL 199
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.8 bits (96), Expect = 1e-04
Identities = 13/103 (12%), Positives = 26/103 (25%), Gaps = 5/103 (4%)
Query: 244 LEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFS----QKIPNKIEKLIHLSELDLSH 299
L+ ++ KS+ L + + LS N + + I L + S
Sbjct: 10 LKLDAITTEDE-KSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68
Query: 300 NIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSC 342
+++ L + L L
Sbjct: 69 IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQE 111
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.9 bits (91), Expect = 5e-04
Identities = 37/315 (11%), Positives = 87/315 (27%), Gaps = 30/315 (9%)
Query: 87 SSIPDEIGNMKSLSDLQLSENILNG----SIPLALGNLTNLVVLDLSTN---KLSGSIPL 139
S+ + S+ ++ LS N + + + + +L + + S ++ IP
Sbjct: 21 KSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPE 80
Query: 140 SFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVL 199
+ L + +++ S I LS + + L L
Sbjct: 81 ALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAK 140
Query: 200 YLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIP 259
+ + + N +G + + L + P
Sbjct: 141 IARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP 200
Query: 260 ESLSN------------LVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIP 307
E + + V N + S + ++ +L EL L+ +
Sbjct: 201 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGA 260
Query: 308 SQI------CSMQSLEKLNLSHNNLSGSIPRCFEEMHW-----LSCIDISYNALQGLIPN 356
+ + L+ L L +N + R + + L ++++ N
Sbjct: 261 AAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDV 320
Query: 357 STAFRDAPMLALQGN 371
R+ +G
Sbjct: 321 VDEIREVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.7 bits (88), Expect = 0.001
Identities = 15/90 (16%), Positives = 29/90 (32%), Gaps = 5/90 (5%)
Query: 97 KSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSG----SIPLSFANLTSLSILYL 152
KSL ++ S+ L ++ + LS N + + + A+ L I
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 153 YENSLCDSIPKEIGNMNSLSILDLSSNKLN 182
+ + + L L KL+
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLH 96
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.7 bits (88), Expect = 0.001
Identities = 15/89 (16%), Positives = 32/89 (35%), Gaps = 6/89 (6%)
Query: 146 SLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNG----SIPLSLANLTNSLKVLYL 201
SL + + S+ + +S+ + LS N + + ++A+ + L++
Sbjct: 9 SLKLDAITTEDE-KSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKD-LEIAEF 66
Query: 202 SSNHIVGEIPLGHGMLSSLIQLTLNNNEL 230
S L L+Q L +L
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKL 95
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.2 bits (84), Expect = 0.004
Identities = 13/85 (15%), Positives = 32/85 (37%), Gaps = 8/85 (9%)
Query: 219 SLIQLTLNNNELSGQ----LSPELGSLIQLEYLDLSANTFH----KSIPESLSNLVKLHY 270
S+ +L + ++ + + L ++ + LS NT + + E++++ L
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 271 LNLSNNQFSQKIPNKIEKLIHLSEL 295
S+ + E L L +
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQA 88
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 37.4 bits (85), Expect = 0.002
Identities = 23/81 (28%), Positives = 34/81 (41%), Gaps = 11/81 (13%)
Query: 87 SSIPDEIGN---MKSLSDLQLSENILNGSIPL------ALGNLTNLVVLDLSTNKLSGSI 137
++I D I KS+ + + L+G IP L L L LSTN + I
Sbjct: 5 TTIKDAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KI 63
Query: 138 PLSFANLTSLSILYLYENSLC 158
S + + +L IL L N +
Sbjct: 64 S-SLSGMENLRILSLGRNLIK 83
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 571 | |||
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.98 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.95 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.94 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.79 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.79 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.78 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.76 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.75 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.74 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.73 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.73 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.71 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.71 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.71 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 99.7 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.7 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.69 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.69 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.69 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.69 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.68 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.68 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.67 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.67 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 99.67 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.67 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.67 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.67 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.67 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.67 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.66 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.66 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.65 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.65 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.65 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.64 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.64 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.64 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.63 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.62 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.62 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.62 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.61 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.61 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.6 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.6 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.59 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.59 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.58 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.58 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.56 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.56 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.56 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.56 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.55 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.54 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.54 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.54 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.53 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.52 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.52 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.52 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.52 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.51 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.51 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.5 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.49 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.48 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.47 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.44 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.41 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.4 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.4 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.4 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.39 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.38 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.37 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.37 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.35 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.32 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.32 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.31 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.28 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.28 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.25 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.23 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 98.75 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 98.67 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.52 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.46 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.92 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.72 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.33 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.08 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 93.51 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 91.85 |
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.98 E-value=8.5e-32 Score=265.33 Aligned_cols=259 Identities=28% Similarity=0.489 Sum_probs=175.1
Q ss_pred CCCEEecccCcCcc--cccccccCCCCCCEEEccc-CcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEE
Q 044615 98 SLSDLQLSENILNG--SIPLALGNLTNLVVLDLST-NKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSIL 174 (571)
Q Consensus 98 ~L~~L~L~~n~i~~--~~~~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 174 (571)
+++.|+|++|.+.+ .+|..++++++|++|+|++ |.+++.+|..|++|++|++|+|++|.+.+..+..+..+.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~---- 126 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKT---- 126 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTT----
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhh----
Confidence 45556666655554 2445555555555555543 4444445555555555555555555554444444444444
Q ss_pred EccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCC-CEEEcccCc
Q 044615 175 DLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQL-EYLDLSANT 253 (571)
Q Consensus 175 ~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~L~~n~ 253 (571)
|+.++++.|.+.+.+|..+..++.++.+++++|.+.+.+|..+..+..+ +.++++.|+
T Consensus 127 ---------------------L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~ 185 (313)
T d1ogqa_ 127 ---------------------LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNR 185 (313)
T ss_dssp ---------------------CCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSE
T ss_pred ---------------------hcccccccccccccCchhhccCcccceeecccccccccccccccccccccccccccccc
Confidence 5555555555544455555555555666666666655566666665554 667777777
Q ss_pred cccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccc
Q 044615 254 FHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRC 333 (571)
Q Consensus 254 l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~ 333 (571)
+++..|..+..+..+ .++++.+...+.+|..+..++.++.+++++|.+.+.++ .+..+++|+.|+|++|+++|.+|+.
T Consensus 186 l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~ 263 (313)
T d1ogqa_ 186 LTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQG 263 (313)
T ss_dssp EEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGG
T ss_pred ccccccccccccccc-cccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChH
Confidence 777666666666444 67777777777777777778888888888888876544 5778889999999999999899999
Q ss_pred cccCCCCCEEECcCCcCcccCCCCCccCCCCcccccCCcCCCCCCCCCCCCC
Q 044615 334 FEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGNKRLCGDIKRLPPCK 385 (571)
Q Consensus 334 ~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~l~l~~n~~~c~~~~~~~~~~ 385 (571)
|..+++|+.|+|++|+++|.+|....++.+..+++.+|+.+|+.+ +|+|+
T Consensus 264 l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~p--lp~c~ 313 (313)
T d1ogqa_ 264 LTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP--LPACT 313 (313)
T ss_dssp GGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTT--SSCCC
T ss_pred HhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCC--CCCCC
Confidence 999999999999999999988887778888899999999999853 57774
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=1.5e-31 Score=263.62 Aligned_cols=252 Identities=25% Similarity=0.371 Sum_probs=181.1
Q ss_pred CccceeecccccccCCCCCCCccccccccCCCCCCEEeccc-CcCcccccccccCCCCCCEEEcccCcCcccccccccCC
Q 044615 66 TFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSE-NILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANL 144 (571)
Q Consensus 66 ~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l 144 (571)
..++.|+|+++.+++. ..+|..++++++|++|+|++ |.++|.+|..|+++++|++|+|++|++.+..+..+..+
T Consensus 50 ~~v~~L~L~~~~l~g~-----~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~ 124 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKP-----YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124 (313)
T ss_dssp CCEEEEEEECCCCSSC-----EECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGC
T ss_pred EEEEEEECCCCCCCCC-----CCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccch
Confidence 3688899999988872 25899999999999999997 88999999999999999999999999999999999999
Q ss_pred CCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEe
Q 044615 145 TSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLT 224 (571)
Q Consensus 145 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~ 224 (571)
+.|+++++++|.+.+.+|..+..+++|+++++++|.+.+.+|..+..+...++.++++.|++++..|..+..+..+ .++
T Consensus 125 ~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~ 203 (313)
T d1ogqa_ 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVD 203 (313)
T ss_dssp TTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEE
T ss_pred hhhcccccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccc
Confidence 9999999999999999999999999999999999999988998888877645778888888777666655554333 455
Q ss_pred CccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCc
Q 044615 225 LNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFRE 304 (571)
Q Consensus 225 l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 304 (571)
+.++...+..|..+..+++|+.+++++|.+.+.++ .+..+++|+.|++++|++++.+|..+..+++|+.|+|++|+++|
T Consensus 204 l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g 282 (313)
T d1ogqa_ 204 LSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282 (313)
T ss_dssp CCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEE
T ss_pred ccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccc
Confidence 55555555555555555555555555555544332 34444555555555555544444444444444444444444444
Q ss_pred ccchhccCCCCCCEEEccCCc
Q 044615 305 EIPSQICSMQSLEKLNLSHNN 325 (571)
Q Consensus 305 ~~~~~~~~l~~L~~L~Ls~n~ 325 (571)
.+|. ++.+++|+.+++++|+
T Consensus 283 ~iP~-~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 283 EIPQ-GGNLQRFDVSAYANNK 302 (313)
T ss_dssp ECCC-STTGGGSCGGGTCSSS
T ss_pred cCCC-cccCCCCCHHHhCCCc
Confidence 4442 3334444444444443
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.95 E-value=4e-26 Score=231.00 Aligned_cols=300 Identities=26% Similarity=0.323 Sum_probs=236.5
Q ss_pred hhcCCCCCCEEEccCCccc----cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCccccccccc
Q 044615 43 ELVRAVQARDTSISFDELH----EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALG 118 (571)
Q Consensus 43 ~l~~~~~l~~l~l~~n~l~----~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~ 118 (571)
....+.+++.|++++++++ +..+++|++|+|++|++++ +| .++++++|++|++++|.+.+.. .++
T Consensus 39 ~~~~l~~l~~L~l~~~~I~~l~gl~~L~nL~~L~Ls~N~l~~--------l~-~l~~L~~L~~L~L~~n~i~~i~--~l~ 107 (384)
T d2omza2 39 SQTDLDQVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTD--------IT-PLKNLTKLVDILMNNNQIADIT--PLA 107 (384)
T ss_dssp CHHHHTTCCEEECCSSCCCCCTTGGGCTTCCEEECCSSCCCC--------CG-GGTTCTTCCEEECCSSCCCCCG--GGT
T ss_pred CHHHhCCCCEEECCCCCCCCccccccCCCCCEEeCcCCcCCC--------Cc-cccCCccccccccccccccccc--ccc
Confidence 3456778999999999887 6688999999999999986 44 3889999999999999998543 388
Q ss_pred CCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCc----------------------------------------
Q 044615 119 NLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLC---------------------------------------- 158 (571)
Q Consensus 119 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~---------------------------------------- 158 (571)
.+++|+.|++++|.+++..+. .....+..+....|.+.
T Consensus 108 ~l~~L~~L~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (384)
T d2omza2 108 NLTNLTGLTLFNNQITDIDPL--KNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSN 185 (384)
T ss_dssp TCTTCCEEECCSSCCCCCGGG--TTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSS
T ss_pred ccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccchhhhhcccccccccccccc
Confidence 999999999999988754332 22333333333332211
Q ss_pred -ccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChh
Q 044615 159 -DSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPE 237 (571)
Q Consensus 159 -~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 237 (571)
...+..+..+++++.+++++|.+++..| +.... +|+.|++++|.++.. ..+..+++|+.|++++|.+++.. .
T Consensus 186 ~~~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~-~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~--~ 258 (384)
T d2omza2 186 KVSDISVLAKLTNLESLIATNNQISDITP--LGILT-NLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA--P 258 (384)
T ss_dssp CCCCCGGGGGCTTCSEEECCSSCCCCCGG--GGGCT-TCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--G
T ss_pred ccccccccccccccceeeccCCccCCCCc--ccccC-CCCEEECCCCCCCCc--chhhcccccchhccccCccCCCC--c
Confidence 1123456678999999999999986544 33444 499999999998742 35778899999999999998643 4
Q ss_pred hhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCC
Q 044615 238 LGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLE 317 (571)
Q Consensus 238 ~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 317 (571)
+..+++|+.|++++|.+.+.. .+..++.++.+.++.|.+++. ..+..+++++.|++++|++++.. .+..+++|+
T Consensus 259 ~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~ 332 (384)
T d2omza2 259 LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQ 332 (384)
T ss_dssp GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCC
T ss_pred ccccccCCEeeccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCC
Confidence 788999999999999987543 477889999999999999753 35788899999999999998754 378899999
Q ss_pred EEEccCCcCccccccccccCCCCCEEECcCCcCcccCCCCCccCCCCcccccCC
Q 044615 318 KLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPNSTAFRDAPMLALQGN 371 (571)
Q Consensus 318 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~l~l~~n 371 (571)
+|++++|++++ ++ .+..+++|+.|++++|++++.+| ...++.++.+.+.+|
T Consensus 333 ~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~N 383 (384)
T d2omza2 333 RLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQ 383 (384)
T ss_dssp EEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCE
T ss_pred EEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh-hccCCCCCEeeCCCC
Confidence 99999999985 33 68999999999999999998765 556778888888876
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.94 E-value=2e-25 Score=225.69 Aligned_cols=283 Identities=31% Similarity=0.389 Sum_probs=225.6
Q ss_pred cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccc
Q 044615 62 EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSF 141 (571)
Q Consensus 62 ~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~ 141 (571)
...+.++++|+++++.++. + +.+..+++|++|+|++|++++. | .++++++|++|++++|.+.+.. .+
T Consensus 40 ~~~l~~l~~L~l~~~~I~~--------l-~gl~~L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i~~i~--~l 106 (384)
T d2omza2 40 QTDLDQVTTLQADRLGIKS--------I-DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIADIT--PL 106 (384)
T ss_dssp HHHHTTCCEEECCSSCCCC--------C-TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCCG--GG
T ss_pred HHHhCCCCEEECCCCCCCC--------c-cccccCCCCCEEeCcCCcCCCC-c-cccCCccccccccccccccccc--cc
Confidence 3456789999999998875 3 3578899999999999999864 3 3999999999999999998654 38
Q ss_pred cCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCC---------------------------------------
Q 044615 142 ANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLN--------------------------------------- 182 (571)
Q Consensus 142 ~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~--------------------------------------- 182 (571)
+++++|+.|++++|.+.+..+ ......+..+....|.+.
T Consensus 107 ~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (384)
T d2omza2 107 ANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISS 184 (384)
T ss_dssp TTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCS
T ss_pred ccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccc
Confidence 899999999999999875433 233444444444333221
Q ss_pred --ccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccch
Q 044615 183 --GSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPE 260 (571)
Q Consensus 183 --~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 260 (571)
......+..++. ++.+++++|.+++..| ....++|+.|++++|+++.. +.+..+++|+.|++++|.+++..
T Consensus 185 ~~~~~~~~~~~l~~-~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~-- 257 (384)
T d2omza2 185 NKVSDISVLAKLTN-LESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA-- 257 (384)
T ss_dssp SCCCCCGGGGGCTT-CSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--
T ss_pred cccccccccccccc-cceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCC--
Confidence 012234455554 9999999999987654 45678999999999999853 46889999999999999998654
Q ss_pred hhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCC
Q 044615 261 SLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWL 340 (571)
Q Consensus 261 ~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L 340 (571)
.+..+++|+.|++++|.+++.. .+..++.++.+++++|.+.+. ..+..+++++.|++++|++++.. .+..+++|
T Consensus 258 ~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L 331 (384)
T d2omza2 258 PLSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKL 331 (384)
T ss_dssp GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTC
T ss_pred cccccccCCEeeccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCC
Confidence 3788999999999999998654 377889999999999999763 35888999999999999999764 38899999
Q ss_pred CEEECcCCcCcccCCCCCccCCCCcccccCCcC
Q 044615 341 SCIDISYNALQGLIPNSTAFRDAPMLALQGNKR 373 (571)
Q Consensus 341 ~~L~ls~N~l~~~~~~~~~~~~~~~l~l~~n~~ 373 (571)
+.|++++|++++. +....+++++.+++.+|+.
T Consensus 332 ~~L~L~~n~l~~l-~~l~~l~~L~~L~l~~N~l 363 (384)
T d2omza2 332 QRLFFANNKVSDV-SSLANLTNINWLSAGHNQI 363 (384)
T ss_dssp CEEECCSSCCCCC-GGGGGCTTCCEEECCSSCC
T ss_pred CEEECCCCCCCCC-hhHcCCCCCCEEECCCCcC
Confidence 9999999999875 3566678899999999864
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=5.5e-25 Score=215.30 Aligned_cols=254 Identities=24% Similarity=0.281 Sum_probs=193.0
Q ss_pred cccccccCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccC
Q 044615 88 SIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGN 167 (571)
Q Consensus 88 ~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~ 167 (571)
.+|..+. +++++|+|++|+|+...+.+|.++++|++|++++|.+....|..|.++++|++|++++|++.. +|.. .
T Consensus 24 ~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~-l~~~--~ 98 (305)
T d1xkua_ 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEK--M 98 (305)
T ss_dssp SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSB-CCSS--C
T ss_pred ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccCc-Cccc--h
Confidence 5777664 678999999999886555678889999999999999988778889999999999999998874 4543 3
Q ss_pred CCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCcccc--cCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCC
Q 044615 168 MNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVG--EIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLE 245 (571)
Q Consensus 168 l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~--~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 245 (571)
...+..|++.+|.+.+..+..+.... .+..++...|.... ..+..+..+++|+.+++.+|.+.. +|.. .+++|+
T Consensus 99 ~~~l~~L~~~~n~l~~l~~~~~~~~~-~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~-l~~~--~~~~L~ 174 (305)
T d1xkua_ 99 PKTLQELRVHENEITKVRKSVFNGLN-QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQG--LPPSLT 174 (305)
T ss_dssp CTTCCEEECCSSCCCBBCHHHHTTCT-TCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSS--CCTTCS
T ss_pred hhhhhhhhccccchhhhhhhhhhccc-cccccccccccccccCCCccccccccccCccccccCCccc-cCcc--cCCccC
Confidence 45788888988888854433444444 37778887775432 334566777888888888888774 3332 357888
Q ss_pred EEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCc
Q 044615 246 YLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNN 325 (571)
Q Consensus 246 ~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 325 (571)
.|++++|......+..+.+++.++.|++++|.+++..+..+..+++|++|+|++|+++. +|..+..+++|+.|+|++|+
T Consensus 175 ~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~-lp~~l~~l~~L~~L~Ls~N~ 253 (305)
T d1xkua_ 175 ELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNN 253 (305)
T ss_dssp EEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSS-CCTTTTTCSSCCEEECCSSC
T ss_pred EEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccccccc-cccccccccCCCEEECCCCc
Confidence 88888888887778888888888888888888887777788888888888888888875 56778888888888888888
Q ss_pred Ccccccccc------ccCCCCCEEECcCCcCc
Q 044615 326 LSGSIPRCF------EEMHWLSCIDISYNALQ 351 (571)
Q Consensus 326 l~~~~p~~~------~~l~~L~~L~ls~N~l~ 351 (571)
|+......| ..+..|+.|++++|+++
T Consensus 254 i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 254 ISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp CCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred cCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 886544444 34567778888888765
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=6e-25 Score=215.02 Aligned_cols=270 Identities=23% Similarity=0.315 Sum_probs=228.4
Q ss_pred CCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEcc
Q 044615 98 SLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLS 177 (571)
Q Consensus 98 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~ 177 (571)
.++.+|=+++.++ .+|..+. +++++|+|++|+|+...+.+|.++++|++|++++|.+....|..|..+++|++|+++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 5678888888887 6677664 689999999999997777789999999999999999998888899999999999999
Q ss_pred CCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCc--CCCChhhhCCCCCCEEEcccCccc
Q 044615 178 SNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELS--GQLSPELGSLIQLEYLDLSANTFH 255 (571)
Q Consensus 178 ~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~--~~~~~~~~~l~~L~~L~L~~n~l~ 255 (571)
+|+++ .+|..+. ..++.|+++.|.+.+..+..+.....+..++...|... ...+..+..+++|+.+++++|.+.
T Consensus 88 ~n~l~-~l~~~~~---~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~ 163 (305)
T d1xkua_ 88 KNQLK-ELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 163 (305)
T ss_dssp SSCCS-BCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred CCccC-cCccchh---hhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc
Confidence 99998 5665433 24899999999998777667777888889998887543 344567888999999999999987
Q ss_pred cccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccc
Q 044615 256 KSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFE 335 (571)
Q Consensus 256 ~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~ 335 (571)
. +|.. .+++|+.|++++|..++..+..+..++.++.|++++|.+.+..+..+.++++|++|+|++|+|+ .+|..|.
T Consensus 164 ~-l~~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~ 239 (305)
T d1xkua_ 164 T-IPQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLA 239 (305)
T ss_dssp S-CCSS--CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTT
T ss_pred c-cCcc--cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccc
Confidence 4 4443 3679999999999999888999999999999999999999988999999999999999999998 5688999
Q ss_pred cCCCCCEEECcCCcCcccCCCC-------CccCCCCcccccCCcCCCCCC
Q 044615 336 EMHWLSCIDISYNALQGLIPNS-------TAFRDAPMLALQGNKRLCGDI 378 (571)
Q Consensus 336 ~l~~L~~L~ls~N~l~~~~~~~-------~~~~~~~~l~l~~n~~~c~~~ 378 (571)
.+++|+.|++++|+++...... .....+..+++.+|++.+.+.
T Consensus 240 ~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~ 289 (305)
T d1xkua_ 240 DHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEI 289 (305)
T ss_dssp TCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGS
T ss_pred cccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcC
Confidence 9999999999999999764432 123557788899999766543
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.5e-25 Score=216.89 Aligned_cols=214 Identities=22% Similarity=0.206 Sum_probs=119.0
Q ss_pred cccccccCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecc-cCcCcccCCcccc
Q 044615 88 SIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLY-ENSLCDSIPKEIG 166 (571)
Q Consensus 88 ~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~-~n~l~~~~~~~l~ 166 (571)
.+|..+. +++++|+|++|.|+...+.+|.++++|++|++++|.+....+..+..+..++.+... .|.+....+..|.
T Consensus 25 ~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~ 102 (284)
T d1ozna_ 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFH 102 (284)
T ss_dssp SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTT
T ss_pred ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhc
Confidence 3454443 456666666666665444556666666666666666666555556666666665543 3444444455566
Q ss_pred CCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCE
Q 044615 167 NMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEY 246 (571)
Q Consensus 167 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 246 (571)
++++|++|++++|.+... .+..+...++|+.+++++|++++..+..|..+++|+.
T Consensus 103 ~l~~L~~L~l~~n~~~~~-------------------------~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~ 157 (284)
T d1ozna_ 103 GLGRLHTLHLDRCGLQEL-------------------------GPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTH 157 (284)
T ss_dssp TCTTCCEEECTTSCCCCC-------------------------CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred ccccCCEEecCCcccccc-------------------------cccccchhcccchhhhccccccccChhHhccccchhh
Confidence 666666666666555432 3333333444444444444444444444555555555
Q ss_pred EEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcC
Q 044615 247 LDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNL 326 (571)
Q Consensus 247 L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 326 (571)
|++++|.+....+.+|.++++|+.+++++|++++..|..|..+++|+.|++++|.+.+..+..|..+++|+.|++++|++
T Consensus 158 L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l 237 (284)
T d1ozna_ 158 LFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237 (284)
T ss_dssp EECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCE
T ss_pred cccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCC
Confidence 55555555555555555555555555555555555555555555566666666665555555555666666666666655
Q ss_pred cc
Q 044615 327 SG 328 (571)
Q Consensus 327 ~~ 328 (571)
.+
T Consensus 238 ~C 239 (284)
T d1ozna_ 238 VC 239 (284)
T ss_dssp EC
T ss_pred CC
Confidence 53
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=3.8e-25 Score=214.08 Aligned_cols=227 Identities=22% Similarity=0.220 Sum_probs=176.5
Q ss_pred EecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCC
Q 044615 102 LQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKL 181 (571)
Q Consensus 102 L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l 181 (571)
++.++++++ .+|..+. +++++|+|++|+|+...+.+|.++++|++|++++|.+....+..+..+..+..+...
T Consensus 16 v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~---- 88 (284)
T d1ozna_ 16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS---- 88 (284)
T ss_dssp EECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC----
T ss_pred EEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccc----
Confidence 445555554 4444332 345666666666655544555566666666666555554444444444444444332
Q ss_pred CccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchh
Q 044615 182 NGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPES 261 (571)
Q Consensus 182 ~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 261 (571)
..|.++...+..+..+++|+.|++++|.+....+..+...++|+.+++++|.+++..+..
T Consensus 89 --------------------~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~ 148 (284)
T d1ozna_ 89 --------------------DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDT 148 (284)
T ss_dssp --------------------SCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT
T ss_pred --------------------cccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhH
Confidence 233344445666778889999999999998777888889999999999999999877888
Q ss_pred hccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCC
Q 044615 262 LSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLS 341 (571)
Q Consensus 262 l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~ 341 (571)
|..+++|+.|++++|++++..+..|.++++|+.+++++|++++..|..|..+++|+.|++++|++++..+..|..++.|+
T Consensus 149 f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~ 228 (284)
T d1ozna_ 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQ 228 (284)
T ss_dssp TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCC
T ss_pred hccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccC
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999999999999
Q ss_pred EEECcCCcCcccCC
Q 044615 342 CIDISYNALQGLIP 355 (571)
Q Consensus 342 ~L~ls~N~l~~~~~ 355 (571)
.|++++|++.+..+
T Consensus 229 ~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 229 YLRLNDNPWVCDCR 242 (284)
T ss_dssp EEECCSSCEECSGG
T ss_pred EEEecCCCCCCCcc
Confidence 99999999987654
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=1.1e-22 Score=194.37 Aligned_cols=202 Identities=27% Similarity=0.274 Sum_probs=113.7
Q ss_pred cCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCE
Q 044615 94 GNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSI 173 (571)
Q Consensus 94 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 173 (571)
.+...+.+++.+++.++ .+|..+. ++|++|+|++|.|++..+.+|.++++|++|+|++|.++. +| .++.+++|++
T Consensus 7 ~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~ 81 (266)
T d1p9ag_ 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGT 81 (266)
T ss_dssp ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCE
T ss_pred cccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-cccccccccc
Confidence 34455666677777776 4565443 467777777777776666667777777777777777753 22 2456666777
Q ss_pred EEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCc
Q 044615 174 LDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANT 253 (571)
Q Consensus 174 L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 253 (571)
|++++|++. ..+..+..++. |+.|++++|.+....+. .+..+.+++.|++++|.
T Consensus 82 L~Ls~N~l~-~~~~~~~~l~~-L~~L~l~~~~~~~~~~~------------------------~~~~l~~l~~L~l~~n~ 135 (266)
T d1p9ag_ 82 LDLSHNQLQ-SLPLLGQTLPA-LTVLDVSFNRLTSLPLG------------------------ALRGLGELQELYLKGNE 135 (266)
T ss_dssp EECCSSCCS-SCCCCTTTCTT-CCEEECCSSCCCCCCSS------------------------TTTTCTTCCEEECTTSC
T ss_pred ccccccccc-ccccccccccc-cccccccccccceeecc------------------------ccccccccccccccccc
Confidence 777666665 23334444443 55555555444433333 33444444444444444
Q ss_pred cccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCc
Q 044615 254 FHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLS 327 (571)
Q Consensus 254 l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~ 327 (571)
+....+..+..+++|+.|++++|++++..+..|..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|++.
T Consensus 136 l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 136 LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred cceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 44444444444555555555555555444445555555555555555555 34545555666666666666554
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=1.1e-22 Score=194.28 Aligned_cols=202 Identities=25% Similarity=0.262 Sum_probs=124.2
Q ss_pred CCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcE
Q 044615 143 NLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQ 222 (571)
Q Consensus 143 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~ 222 (571)
+...+.+++.+++.++. +|..+. ++|++|+|++|++++..+..|..+++ |+.|++++|.++.. + .++.+++|+.
T Consensus 8 ~~~~~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~-L~~L~L~~N~l~~l-~-~~~~l~~L~~ 81 (266)
T d1p9ag_ 8 KVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTR-LTQLNLDRAELTKL-Q-VDGTLPVLGT 81 (266)
T ss_dssp CSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTT-CCEEECTTSCCCEE-E-CCSCCTTCCE
T ss_pred ccCCCeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhcccc-cccccccccccccc-c-cccccccccc
Confidence 44555666777777763 565442 46777777777776444455666654 77777777776632 2 2345666677
Q ss_pred EeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcC
Q 044615 223 LTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIF 302 (571)
Q Consensus 223 L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 302 (571)
|++++|++.. .+..+..+++|+.|++++|.+....+..+..+.+++.|++++|.++...+..+..++.|+.+++++|++
T Consensus 82 L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l 160 (266)
T d1p9ag_ 82 LDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160 (266)
T ss_dssp EECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred cccccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccc
Confidence 7776666664 344566666666666666666655555566666666666666666655555555666666666666666
Q ss_pred CcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCcc
Q 044615 303 REEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQG 352 (571)
Q Consensus 303 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 352 (571)
++..+..|..+++|++|+|++|+|+ .+|+.+..++.|+.|+|++|++.+
T Consensus 161 ~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 161 TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred cccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence 6655555666666666666666666 455555556666666666665543
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.79 E-value=6.4e-19 Score=163.73 Aligned_cols=188 Identities=26% Similarity=0.355 Sum_probs=100.1
Q ss_pred CCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcE
Q 044615 119 NLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKV 198 (571)
Q Consensus 119 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~ 198 (571)
.+.+|+.|++.+|.|+.. ..+.++++|++|++++|.+.+.. .+..+++|+++++++|.++ .++ .+..++. |+.
T Consensus 39 ~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~-L~~ 111 (227)
T d1h6ua2 39 DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLA--PLKNLTKITELELSGNPLK-NVS-AIAGLQS-IKT 111 (227)
T ss_dssp HHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEEECCSCCCS-CCG-GGTTCTT-CCE
T ss_pred HcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeeccc--ccccccccccccccccccc-ccc-ccccccc-ccc
Confidence 344444444444444422 12444444444444444443321 1444444444544444443 121 2333333 555
Q ss_pred EEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccC
Q 044615 199 LYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQF 278 (571)
Q Consensus 199 L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l 278 (571)
++++++...+. ..+...+.+..+.++++.+... ..+..+++|+.|++++|.+.+. ..+.++++|+.|++++|++
T Consensus 112 l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l 185 (227)
T d1h6ua2 112 LDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKI 185 (227)
T ss_dssp EECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCC
T ss_pred ccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccc--hhhcccccceecccCCCcc
Confidence 55554444321 1233445555666665555432 2355566677777777766532 2366677777777777777
Q ss_pred ccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccC
Q 044615 279 SQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSH 323 (571)
Q Consensus 279 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~ 323 (571)
++. + .+..+++|+.|+|++|++++..| +.++++|+.|++++
T Consensus 186 ~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 186 SDI-S-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226 (227)
T ss_dssp CCC-G-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEE
T ss_pred CCC-h-hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEeeC
Confidence 643 2 26677777777777777765432 67777787777763
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.79 E-value=1.4e-18 Score=161.49 Aligned_cols=189 Identities=28% Similarity=0.381 Sum_probs=114.7
Q ss_pred ccCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCC
Q 044615 93 IGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLS 172 (571)
Q Consensus 93 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~ 172 (571)
+..+.+|+.|++.+|.++. + ..+..+++|++|++++|.+++..| +..+++|+++++++|.++. + ..+..+++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~-i-~~l~~l~~L~ 110 (227)
T d1h6ua2 37 QADLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-V-SAIAGLQSIK 110 (227)
T ss_dssp HHHHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-C-GGGTTCTTCC
T ss_pred HHHcCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeecccc--ccccccccccccccccccc-c-cccccccccc
Confidence 3455667777777776663 3 246667777777777777664433 6666777777777766653 2 2466677777
Q ss_pred EEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccC
Q 044615 173 ILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSAN 252 (571)
Q Consensus 173 ~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n 252 (571)
+++++++...+. ..+..... ++.+.++.+.+... ..+...++|+.|++++|.+.+. ..++++++|+.|++++|
T Consensus 111 ~l~l~~~~~~~~--~~~~~~~~-~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n 183 (227)
T d1h6ua2 111 TLDLTSTQITDV--TPLAGLSN-LQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDN 183 (227)
T ss_dssp EEECTTSCCCCC--GGGTTCTT-CCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSS
T ss_pred cccccccccccc--chhccccc-hhhhhchhhhhchh--hhhccccccccccccccccccc--hhhcccccceecccCCC
Confidence 777766665532 22333333 66666666666432 2345566677777777766532 23666677777777777
Q ss_pred ccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEcc
Q 044615 253 TFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLS 298 (571)
Q Consensus 253 ~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls 298 (571)
.+++. + .+.++++|++|++++|++++.. .+..+++|+.|+++
T Consensus 184 ~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 184 KISDI-S-PLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLT 225 (227)
T ss_dssp CCCCC-G-GGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEE
T ss_pred ccCCC-h-hhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEee
Confidence 66542 2 3666677777777777766433 25666777777665
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=1.2e-18 Score=163.69 Aligned_cols=142 Identities=18% Similarity=0.157 Sum_probs=87.2
Q ss_pred cccccccCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCccc-ccccccCCCCCCeeeccc-CcCcccCCccc
Q 044615 88 SIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGS-IPLSFANLTSLSILYLYE-NSLCDSIPKEI 165 (571)
Q Consensus 88 ~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L~L~~-n~l~~~~~~~l 165 (571)
.+|..+. +++++|+|++|.++...+.+|.++++|++|++++|.+... .+..|.+++++++|.+.. |.+....+..|
T Consensus 22 ~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~ 99 (242)
T d1xwdc1 22 EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAF 99 (242)
T ss_dssp SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSE
T ss_pred CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccc
Confidence 4665543 4688888888888755556778888888888888877654 345677888888887653 56666666777
Q ss_pred cCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCC-CCcEEeCccCcCc
Q 044615 166 GNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLS-SLIQLTLNNNELS 231 (571)
Q Consensus 166 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~-~L~~L~l~~n~l~ 231 (571)
.++++|++|++++|++....+..+....+.+..+...++.+....+..+..++ .++.|++++|+++
T Consensus 100 ~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~ 166 (242)
T d1xwdc1 100 QNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 166 (242)
T ss_dssp ECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred cccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc
Confidence 88888888888888776332222222122244444455555433333333322 4444555555444
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.76 E-value=1.3e-16 Score=158.03 Aligned_cols=93 Identities=26% Similarity=0.255 Sum_probs=62.0
Q ss_pred CCCEEEccCCccc--cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccccccccCCCCCCEE
Q 044615 49 QARDTSISFDELH--EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVL 126 (571)
Q Consensus 49 ~l~~l~l~~n~l~--~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 126 (571)
+++.|||++++++ -...++|++|+|++|+++. +|..+ .+|+.|++++|+++ .++.. .+.|++|
T Consensus 39 ~l~~LdLs~~~L~~lp~~~~~L~~L~Ls~N~l~~--------lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L 103 (353)
T d1jl5a_ 39 QAHELELNNLGLSSLPELPPHLESLVASCNSLTE--------LPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYL 103 (353)
T ss_dssp TCSEEECTTSCCSCCCSCCTTCSEEECCSSCCSS--------CCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEE
T ss_pred CCCEEEeCCCCCCCCCCCCCCCCEEECCCCCCcc--------cccch---hhhhhhhhhhcccc-hhhhh---ccccccc
Confidence 5677888887776 2334677888888877764 55543 46777788887776 23321 1357888
Q ss_pred EcccCcCcccccccccCCCCCCeeecccCcCc
Q 044615 127 DLSTNKLSGSIPLSFANLTSLSILYLYENSLC 158 (571)
Q Consensus 127 ~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~ 158 (571)
++++|.+.. +|. ++.+++|++|++++|.+.
T Consensus 104 ~L~~n~l~~-lp~-~~~l~~L~~L~l~~~~~~ 133 (353)
T d1jl5a_ 104 GVSNNQLEK-LPE-LQNSSFLKIIDVDNNSLK 133 (353)
T ss_dssp ECCSSCCSS-CCC-CTTCTTCCEEECCSSCCS
T ss_pred ccccccccc-ccc-hhhhccceeecccccccc
Confidence 888887763 443 567778888888777765
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=2.9e-18 Score=160.97 Aligned_cols=218 Identities=19% Similarity=0.154 Sum_probs=128.4
Q ss_pred CEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccC-CccccCCCCCCEEEccC
Q 044615 100 SDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSI-PKEIGNMNSLSILDLSS 178 (571)
Q Consensus 100 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~l~~l~~L~~L~L~~ 178 (571)
+.++.+++.++ .+|..+. +++++|+|++|.|+...+..|.++++|++|++++|.+...+ +..|..+++++++.+..
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 57777777777 5665543 47888888888887666667888888888888888876543 34577788888877654
Q ss_pred -CCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccc
Q 044615 179 -NKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKS 257 (571)
Q Consensus 179 -n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 257 (571)
|++....+..|..++. |+.+++++|.+....+. . .+..+..+..+...++.+...
T Consensus 88 ~n~l~~~~~~~~~~l~~-L~~l~l~~~~l~~~~~~--~---------------------~~~~l~~l~~~~~~n~~l~~i 143 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPN-LQYLLISNTGIKHLPDV--H---------------------KIHSLQKVLLDIQDNINIHTI 143 (242)
T ss_dssp CTTCCEECTTSEECCTT-CCEEEEESCCCCSCCCC--T---------------------TTCBSSCEEEEEESCTTCCEE
T ss_pred ccccccccccccccccc-ccccccchhhhcccccc--c---------------------ccccccccccccccccccccc
Confidence 4555444444455553 66666666655432111 1 112223333333444444433
Q ss_pred cchhhccCC-CCCEEEcCCccCccCcchhhhcccCCCEE-EccCCcCCcccchhccCCCCCCEEEccCCcCccccccccc
Q 044615 258 IPESLSNLV-KLHYLNLSNNQFSQKIPNKIEKLIHLSEL-DLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFE 335 (571)
Q Consensus 258 ~~~~l~~l~-~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L-~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~ 335 (571)
.+..+.+++ .++.|++++|+++...+..+ ...+++.+ ++++|.++...+..|.++++|+.|++++|+++...+..|.
T Consensus 144 ~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~ 222 (242)
T d1xwdc1 144 ERNSFVGLSFESVILWLNKNGIQEIHNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE 222 (242)
T ss_dssp CTTSSTTSBSSCEEEECCSSCCCEECTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCT
T ss_pred cccccccccccceeeecccccccccccccc-cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHc
Confidence 334444433 56666666666654333333 23333333 4566666654455567777777777777777755555566
Q ss_pred cCCCCCEEEC
Q 044615 336 EMHWLSCIDI 345 (571)
Q Consensus 336 ~l~~L~~L~l 345 (571)
+++.|+.+++
T Consensus 223 ~l~~L~~l~~ 232 (242)
T d1xwdc1 223 NLKKLRARST 232 (242)
T ss_dssp TCCEEESSSE
T ss_pred CCcccccCcC
Confidence 6655555444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=1e-19 Score=187.48 Aligned_cols=321 Identities=20% Similarity=0.152 Sum_probs=203.8
Q ss_pred CCCEEEccCCccc-------cCCCCccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCccc----ccccc
Q 044615 49 QARDTSISFDELH-------EKLLTFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGS----IPLAL 117 (571)
Q Consensus 49 ~l~~l~l~~n~l~-------~~~l~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~----~~~~~ 117 (571)
+|+.||++.|+++ +..+++++.|+|++|.++.. .+..++..+..+++|++|||++|.|+.. +...+
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~---~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l 79 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEA---RCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGL 79 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHH---HHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTT
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHH---HHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHH
Confidence 4677888888776 45667777888888877641 1224455667777888888888877532 12222
Q ss_pred c-CCCCCCEEEcccCcCccc----ccccccCCCCCCeeecccCcCcccCC------------------------------
Q 044615 118 G-NLTNLVVLDLSTNKLSGS----IPLSFANLTSLSILYLYENSLCDSIP------------------------------ 162 (571)
Q Consensus 118 ~-~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~L~~n~l~~~~~------------------------------ 162 (571)
. ..++|++|+|++|.++.. ++..+..+++|++|++++|.+.....
T Consensus 80 ~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~ 159 (460)
T d1z7xw1 80 QTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE 159 (460)
T ss_dssp CSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH
T ss_pred hcCCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhc
Confidence 2 234688888888877643 34456677788888887776542100
Q ss_pred ---ccccCCCCCCEEEccCCCC-----------------------------Ccc----CChhhhhccCCCcEEEccCCcc
Q 044615 163 ---KEIGNMNSLSILDLSSNKL-----------------------------NGS----IPLSLANLTNSLKVLYLSSNHI 206 (571)
Q Consensus 163 ---~~l~~l~~L~~L~L~~n~l-----------------------------~~~----~p~~~~~l~~~L~~L~l~~n~~ 206 (571)
..+...+.++.++++.+.. ... ....+.... .++.++++.|.+
T Consensus 160 ~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~-~~~~l~~~~n~~ 238 (460)
T d1z7xw1 160 PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKA-SLRELALGSNKL 238 (460)
T ss_dssp HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCT-TCCEEECCSSBC
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccc-cccccchhhccc
Confidence 0011234455555544432 210 001122233 489999999876
Q ss_pred ccc-----CCccccCCCCCcEEeCccCcCcCCC----ChhhhCCCCCCEEEcccCccccccchhh-----ccCCCCCEEE
Q 044615 207 VGE-----IPLGHGMLSSLIQLTLNNNELSGQL----SPELGSLIQLEYLDLSANTFHKSIPESL-----SNLVKLHYLN 272 (571)
Q Consensus 207 ~~~-----~~~~~~~l~~L~~L~l~~n~l~~~~----~~~~~~l~~L~~L~L~~n~l~~~~~~~l-----~~l~~L~~L~ 272 (571)
... .+........++.+++++|.+.... ...+...+.++.+++++|.+++.....+ ...+.|+.++
T Consensus 239 ~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~ 318 (460)
T d1z7xw1 239 GDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLW 318 (460)
T ss_dssp HHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEE
T ss_pred cccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccc
Confidence 432 2233445678999999999886432 2345668899999999999865333222 2346899999
Q ss_pred cCCccCccCcchh----hhcccCCCEEEccCCcCCcc----cchhc-cCCCCCCEEEccCCcCccc----cccccccCCC
Q 044615 273 LSNNQFSQKIPNK----IEKLIHLSELDLSHNIFREE----IPSQI-CSMQSLEKLNLSHNNLSGS----IPRCFEEMHW 339 (571)
Q Consensus 273 Ls~n~l~~~~~~~----~~~l~~L~~L~Ls~n~l~~~----~~~~~-~~l~~L~~L~Ls~n~l~~~----~p~~~~~l~~ 339 (571)
+++|.++...... +...++|++|+|++|.+.+. ++..+ ...+.|+.|+|++|+|+.. +++.+...++
T Consensus 319 l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~ 398 (460)
T d1z7xw1 319 VKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHS 398 (460)
T ss_dssp CTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCC
T ss_pred ccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCC
Confidence 9999987654333 34556899999999998653 23333 3467899999999999753 4556677899
Q ss_pred CCEEECcCCcCcccCCC-----C-CccCCCCcccccCCcC
Q 044615 340 LSCIDISYNALQGLIPN-----S-TAFRDAPMLALQGNKR 373 (571)
Q Consensus 340 L~~L~ls~N~l~~~~~~-----~-~~~~~~~~l~l~~n~~ 373 (571)
|++||+++|+++..... . .....++.+.+.+|..
T Consensus 399 L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~ 438 (460)
T d1z7xw1 399 LRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 438 (460)
T ss_dssp CCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCC
T ss_pred CCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCC
Confidence 99999999998742110 0 0112466677776654
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.73 E-value=3.8e-18 Score=153.91 Aligned_cols=174 Identities=22% Similarity=0.272 Sum_probs=102.1
Q ss_pred EEEccCCcccccCCccccCCCCCcEEeCccCcCcC-CCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCc
Q 044615 198 VLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSG-QLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNN 276 (571)
Q Consensus 198 ~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n 276 (571)
.++.+++.++ .+|..+ .+++++|+|++|++++ ..+..|.++++|+.|+|++|.+....+..+..+++|+.|++++|
T Consensus 12 ~v~Cs~~~L~-~iP~~l--p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCC--CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEEeCCCcC-ccCCCC--CCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 4444444444 233322 1345555555555543 23344566666666666666666666666666666666666666
Q ss_pred cCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCcccCCC
Q 044615 277 QFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLIPN 356 (571)
Q Consensus 277 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~ 356 (571)
+++...+..|.++++|+.|+|++|++++..+..|..+++|++|+|++|.+....+.. .-..+++.+.+..|.+++..|.
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~-~~~~~l~~~~l~~~~~~c~~p~ 167 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGAPS 167 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH-HHHHHHHHHCCSGGGCBBCSST
T ss_pred cccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchH-HHhhhhhhhcccCCCeEeCCCh
Confidence 666655666666667777777777776666666777777777777777765432211 1112344555666777665553
Q ss_pred CCccCCCCcccccCCcCCCCC
Q 044615 357 STAFRDAPMLALQGNKRLCGD 377 (571)
Q Consensus 357 ~~~~~~~~~l~l~~n~~~c~~ 377 (571)
.++.....++..|...|..
T Consensus 168 --~l~~~~l~~L~~n~l~C~~ 186 (192)
T d1w8aa_ 168 --KVRDVQIKDLPHSEFKCSS 186 (192)
T ss_dssp --TTTTSBGGGSCTTTCCCCC
T ss_pred --hhcCCEeeecCHhhCcCCC
Confidence 4556666777777777743
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=4.5e-18 Score=161.34 Aligned_cols=103 Identities=21% Similarity=0.375 Sum_probs=90.4
Q ss_pred cCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
++|+..+.||+|+||+||+|+.++++.||||++...... .++|.+|++++++++|||||+++|+|.+.+..|+|||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E 80 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 80 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence 468889999999999999999888889999999754322 4679999999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||++|+|.+++.... ..++|..+++|+
T Consensus 81 ~~~~g~L~~~l~~~~--~~~~~~~~~~i~ 107 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQR--GLFAAETLLGMC 107 (263)
T ss_dssp CCTTCBHHHHHHTTT--TCCCHHHHHHHH
T ss_pred ecCCCcHHHHhhccc--cCCCHHHHHHHH
Confidence 999999999997543 358888888765
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=4.6e-17 Score=148.84 Aligned_cols=164 Identities=30% Similarity=0.395 Sum_probs=71.2
Q ss_pred CCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEE
Q 044615 120 LTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVL 199 (571)
Q Consensus 120 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L 199 (571)
+.+|+.|++++|.++... .+..+++|++|++++|.+++. + .++.+++|++|++++|+++. +| .+..+++ |+.|
T Consensus 45 L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~-L~~L 117 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVKD-LS-SLKDLKK-LKSL 117 (210)
T ss_dssp HHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTT-CCEE
T ss_pred hcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCc-c-ccccCccccccccccccccc-cc-ccccccc-cccc
Confidence 344555555555554321 244455555555555555432 1 23445555555555554442 22 2333332 3444
Q ss_pred EccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCc
Q 044615 200 YLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFS 279 (571)
Q Consensus 200 ~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~ 279 (571)
++++|.+ .. ...+..+++++.+++++|.+++ +..+..+++|+.+++++|+++
T Consensus 118 ~l~~~~~------------------------~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~ 169 (210)
T d1h6ta2 118 SLEHNGI------------------------SD--INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS 169 (210)
T ss_dssp ECTTSCC------------------------CC--CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCC
T ss_pred ccccccc------------------------cc--cccccccccccccccccccccc--ccccccccccccccccccccc
Confidence 4433333 21 1123334444444444444432 122334444555555555544
Q ss_pred cCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEcc
Q 044615 280 QKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLS 322 (571)
Q Consensus 280 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls 322 (571)
+.. .+..+++|+.|++++|++++ ++ .+.++++|+.|+|+
T Consensus 170 ~i~--~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 170 DIV--PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp CCG--GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred ccc--cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence 321 14445555555555555543 22 35555555555554
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=3.3e-17 Score=148.49 Aligned_cols=160 Identities=28% Similarity=0.365 Sum_probs=74.2
Q ss_pred CCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEE
Q 044615 121 TNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLY 200 (571)
Q Consensus 121 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~ 200 (571)
.++++|++++|.++.. ..+..+++|++|++++|.+++.. .++++++|++|++++|.+.. ++ .+..+.. |+.|+
T Consensus 40 ~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~--~l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~-L~~L~ 112 (199)
T d2omxa2 40 DQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIAD-IT-PLANLTN-LTGLT 112 (199)
T ss_dssp TTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CG-GGTTCTT-CSEEE
T ss_pred cCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCcc--cccCCccccccccccccccc-cc-ccccccc-ccccc
Confidence 3444444444444321 12334444444444444443321 14444444444444444431 21 1333332 44444
Q ss_pred ccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCcc
Q 044615 201 LSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQ 280 (571)
Q Consensus 201 l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~ 280 (571)
+++|.+... ..+..+++|+.|++++|++.. + +.+..+++|+.|++.+|.+++. ..+.++++|+.|++++|++++
T Consensus 113 l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l--~~l~~l~~L~~L~ls~N~i~~ 186 (199)
T d2omxa2 113 LFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDL--KPLANLTTLERLDISSNKVSD 186 (199)
T ss_dssp CCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC
T ss_pred ccccccccc--cccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCC--ccccCCCCCCEEECCCCCCCC
Confidence 444444321 123445555555555555542 1 2355566666666666665543 235566666666666666654
Q ss_pred CcchhhhcccCCCEE
Q 044615 281 KIPNKIEKLIHLSEL 295 (571)
Q Consensus 281 ~~~~~~~~l~~L~~L 295 (571)
. + .+..+++|+.|
T Consensus 187 i-~-~l~~L~~L~~L 199 (199)
T d2omxa2 187 I-S-VLAKLTNLESL 199 (199)
T ss_dssp C-G-GGGGCTTCSEE
T ss_pred C-c-cccCCCCCCcC
Confidence 2 2 35556666554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=6.4e-17 Score=147.86 Aligned_cols=165 Identities=29% Similarity=0.410 Sum_probs=109.0
Q ss_pred CCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEE
Q 044615 95 NMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSIL 174 (571)
Q Consensus 95 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 174 (571)
.+.+|+.|++++|.++.. + .+..+++|++|+|++|+|++.. .++.+++|++|++++|.+++ +| .+..+++|+.|
T Consensus 44 ~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L 117 (210)
T d1h6ta2 44 ELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSL 117 (210)
T ss_dssp HHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEE
T ss_pred HhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-ccccccccccc
Confidence 467788888888888743 2 4677888889999888887543 36788889999998888875 34 47888889999
Q ss_pred EccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCcc
Q 044615 175 DLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTF 254 (571)
Q Consensus 175 ~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 254 (571)
++++|.+.. + ..+..++. ++.+++++|.+++ +..+..+++|+.+++++|++++. + .+.++++|+.|++++|.+
T Consensus 118 ~l~~~~~~~-~-~~l~~l~~-l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i 190 (210)
T d1h6ta2 118 SLEHNGISD-I-NGLVHLPQ-LESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHI 190 (210)
T ss_dssp ECTTSCCCC-C-GGGGGCTT-CCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCC
T ss_pred ccccccccc-c-cccccccc-ccccccccccccc--ccccccccccccccccccccccc-c-cccCCCCCCEEECCCCCC
Confidence 998888762 2 34555554 7777777777653 22344455666666666665532 1 255555555555555555
Q ss_pred ccccchhhccCCCCCEEEcC
Q 044615 255 HKSIPESLSNLVKLHYLNLS 274 (571)
Q Consensus 255 ~~~~~~~l~~l~~L~~L~Ls 274 (571)
++ ++ .+.++++|+.|+|+
T Consensus 191 ~~-l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 191 SD-LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp CB-CG-GGTTCTTCSEEEEE
T ss_pred CC-Ch-hhcCCCCCCEEEcc
Confidence 43 22 35555555555554
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.71 E-value=5.2e-18 Score=152.95 Aligned_cols=157 Identities=23% Similarity=0.240 Sum_probs=80.9
Q ss_pred CcEEEccCCccccc-CCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcC
Q 044615 196 LKVLYLSSNHIVGE-IPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLS 274 (571)
Q Consensus 196 L~~L~l~~n~~~~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls 274 (571)
+++|+|++|.|+.. .+..|..+++|+.|++++|.+....+..+..+++|+.|+|++|++....+.+|.++++|+.|+|+
T Consensus 31 l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~ 110 (192)
T d1w8aa_ 31 TTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLY 110 (192)
T ss_dssp CSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECC
T ss_pred CCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccC
Confidence 45555555555432 23344455555555555555555555555555555555555555555555555555555555555
Q ss_pred CccCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcCCcCcccC
Q 044615 275 NNQFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISYNALQGLI 354 (571)
Q Consensus 275 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 354 (571)
+|+|++..+..|..+++|++|+|++|.+.......+ -...++.+.+..|.++...|..+ ..++.++++.|.+++..
T Consensus 111 ~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~-~~~~l~~~~l~~~~~~c~~p~~l---~~~~l~~L~~n~l~C~~ 186 (192)
T d1w8aa_ 111 DNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEFKCSS 186 (192)
T ss_dssp SSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH-HHHHHHHHCCSGGGCBBCSSTTT---TTSBGGGSCTTTCCCCC
T ss_pred CccccccCHHHhcCCcccccccccccccccccchHH-HhhhhhhhcccCCCeEeCCChhh---cCCEeeecCHhhCcCCC
Confidence 555555555555555556666665555543221110 00123334455566655555433 33455677777776654
Q ss_pred CC
Q 044615 355 PN 356 (571)
Q Consensus 355 ~~ 356 (571)
+.
T Consensus 187 ~~ 188 (192)
T d1w8aa_ 187 EN 188 (192)
T ss_dssp C-
T ss_pred CC
Confidence 43
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=1e-16 Score=145.14 Aligned_cols=162 Identities=33% Similarity=0.437 Sum_probs=79.0
Q ss_pred CCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCCEE
Q 044615 95 NMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSIL 174 (571)
Q Consensus 95 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 174 (571)
.+++|++|++++|.++. + +.+..+++|++|++++|++++..| ++++++|++|++++|.+.. ++ .+..+++|+.|
T Consensus 38 ~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L 111 (199)
T d2omxa2 38 DLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGL 111 (199)
T ss_dssp HHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEE
T ss_pred HhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cc-ccccccccccc
Confidence 34455555555555542 2 234455555555555555553322 5555555555555555432 22 24555555555
Q ss_pred EccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCcc
Q 044615 175 DLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTF 254 (571)
Q Consensus 175 ~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 254 (571)
++++|.+... ..+..++. |+.|++++|.+.. + ..+..+++|+.|++.+|++++. ..++++++|+.|++++|++
T Consensus 112 ~l~~~~~~~~--~~~~~l~~-L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l--~~l~~l~~L~~L~ls~N~i 184 (199)
T d2omxa2 112 TLFNNQITDI--DPLKNLTN-LNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDL--KPLANLTTLERLDISSNKV 184 (199)
T ss_dssp ECCSSCCCCC--GGGTTCTT-CSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCCEEECCSSCC
T ss_pred cccccccccc--cccchhhh-hHHhhhhhhhhcc-c-ccccccccccccccccccccCC--ccccCCCCCCEEECCCCCC
Confidence 5555554421 22334443 5555555555542 1 2344455555555555555532 1245555555555555555
Q ss_pred ccccchhhccCCCCCEE
Q 044615 255 HKSIPESLSNLVKLHYL 271 (571)
Q Consensus 255 ~~~~~~~l~~l~~L~~L 271 (571)
++. +.+.++++|++|
T Consensus 185 ~~i--~~l~~L~~L~~L 199 (199)
T d2omxa2 185 SDI--SVLAKLTNLESL 199 (199)
T ss_dssp CCC--GGGGGCTTCSEE
T ss_pred CCC--ccccCCCCCCcC
Confidence 432 234455555543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=8.6e-18 Score=158.56 Aligned_cols=103 Identities=21% Similarity=0.359 Sum_probs=90.5
Q ss_pred cCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
++|+..+.||+|+||+||+|+.++++.||||.+++.... .++|.+|+.++++++|||||+++|+|.+.+..++|||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E 79 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence 579999999999999999999888889999999865433 4679999999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+++|+|.+++.... ..+.|..+++|+
T Consensus 80 y~~~g~l~~~~~~~~--~~~~~~~~~~i~ 106 (258)
T d1k2pa_ 80 YMANGCLLNYLREMR--HRFQTQQLLEMC 106 (258)
T ss_dssp CCTTEEHHHHHHSGG--GCCCHHHHHHHH
T ss_pred ccCCCcHHHhhhccc--cCCcHHHHHHHH
Confidence 999999999987543 357888887765
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.71 E-value=2e-15 Score=149.30 Aligned_cols=261 Identities=24% Similarity=0.246 Sum_probs=160.0
Q ss_pred CccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCC
Q 044615 66 TFEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLT 145 (571)
Q Consensus 66 ~~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~ 145 (571)
.+++.|+|+.+.++. +|+. .++|++|+|++|+|+ .+|.. +.+|+.|++++|.++. ++. + .+
T Consensus 38 ~~l~~LdLs~~~L~~--------lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~~-l~~-l--p~ 98 (353)
T d1jl5a_ 38 RQAHELELNNLGLSS--------LPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLKA-LSD-L--PP 98 (353)
T ss_dssp HTCSEEECTTSCCSC--------CCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CCS-C--CT
T ss_pred cCCCEEEeCCCCCCC--------CCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccch-hhh-h--cc
Confidence 368899999998874 6753 478999999999998 66765 4589999999999873 332 1 24
Q ss_pred CCCeeecccCcCcccCCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeC
Q 044615 146 SLSILYLYENSLCDSIPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTL 225 (571)
Q Consensus 146 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l 225 (571)
.|++|++++|.+.. +|. ++.+++|++|++++|.+.. .+... ..+..+.+..+... ....+..++.++.+++
T Consensus 99 ~L~~L~L~~n~l~~-lp~-~~~l~~L~~L~l~~~~~~~-~~~~~----~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l 169 (353)
T d1jl5a_ 99 LLEYLGVSNNQLEK-LPE-LQNSSFLKIIDVDNNSLKK-LPDLP----PSLEFIAAGNNQLE--ELPELQNLPFLTAIYA 169 (353)
T ss_dssp TCCEEECCSSCCSS-CCC-CTTCTTCCEEECCSSCCSC-CCCCC----TTCCEEECCSSCCS--SCCCCTTCTTCCEEEC
T ss_pred cccccccccccccc-ccc-hhhhccceeeccccccccc-ccccc----ccccchhhcccccc--ccccccccccceeccc
Confidence 69999999999974 564 6789999999999998873 33222 12556666555443 2334455666666666
Q ss_pred ccCcCcCCC------------------ChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhh
Q 044615 226 NNNELSGQL------------------SPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIE 287 (571)
Q Consensus 226 ~~n~l~~~~------------------~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~ 287 (571)
.+|...... ...+..++.|+.+++++|.... .+. ...++..+.+.++.+.... ..
T Consensus 170 ~~n~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~-~~~---~~~~l~~~~~~~~~~~~~~-~~-- 242 (353)
T d1jl5a_ 170 DNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLTDLP-EL-- 242 (353)
T ss_dssp CSSCCSSCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEECCSSCCSCCC-CC--
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccc-ccc---ccccccccccccccccccc-cc--
Confidence 665543211 1123456667777777665542 221 2334555555555543211 10
Q ss_pred cccCCCEE--------------------EccCCcCCcccchhccCCCCCCEEEccCCcCccccccccccCCCCCEEECcC
Q 044615 288 KLIHLSEL--------------------DLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPRCFEEMHWLSCIDISY 347 (571)
Q Consensus 288 ~l~~L~~L--------------------~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ls~ 347 (571)
...+... ++..+.+.+ ....+++|++|+|++|+|+ .+|.. +++|+.|++++
T Consensus 243 -~~~l~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~----~~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~ 313 (353)
T d1jl5a_ 243 -PQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRS----LCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASF 313 (353)
T ss_dssp -CTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSE----ECCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCS
T ss_pred -cccccccccccccccccccccchhcccccccCcccc----ccccCCCCCEEECCCCccC-ccccc---cCCCCEEECCC
Confidence 1122222 222222221 1223467777777777776 34432 45677777777
Q ss_pred CcCcccCCCCCccCCCCcccccCCcC
Q 044615 348 NALQGLIPNSTAFRDAPMLALQGNKR 373 (571)
Q Consensus 348 N~l~~~~~~~~~~~~~~~l~l~~n~~ 373 (571)
|+++..+ . ...+++.+++.+|+.
T Consensus 314 N~L~~l~-~--~~~~L~~L~L~~N~L 336 (353)
T d1jl5a_ 314 NHLAEVP-E--LPQNLKQLHVEYNPL 336 (353)
T ss_dssp SCCSCCC-C--CCTTCCEEECCSSCC
T ss_pred CcCCccc-c--ccCCCCEEECcCCcC
Confidence 7777543 2 234667777777763
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=1.3e-17 Score=158.44 Aligned_cols=104 Identities=24% Similarity=0.312 Sum_probs=85.8
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|++.+.||+|+||+||+|+ ..+|+.||||+++..... ...+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 579999999999999999999 458999999999765332 22456899999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||++|+|.+++.... .+++.+...|+
T Consensus 83 Ey~~gg~L~~~l~~~~---~l~e~~~~~i~ 109 (271)
T d1nvra_ 83 EYCSGGELFDRIEPDI---GMPEPDAQRFF 109 (271)
T ss_dssp ECCTTEEGGGGSBTTT---BCCHHHHHHHH
T ss_pred eccCCCcHHHHHhcCC---CCCHHHHHHHH
Confidence 9999999999997543 46666665543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.70 E-value=1.1e-17 Score=160.52 Aligned_cols=104 Identities=22% Similarity=0.383 Sum_probs=90.1
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|+..+.||+|+||+||+|.. .+++.||||+++.... ..++|.+|+++|++++|||||+++|+|.+.+..|+||
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 4688889999999999999994 5789999999975432 2467999999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||++|+|.+++.+.. ...++|..+++|+
T Consensus 93 E~~~~g~l~~~l~~~~-~~~~~~~~~~~i~ 121 (287)
T d1opja_ 93 EFMTYGNLLDYLRECN-RQEVSAVVLLYMA 121 (287)
T ss_dssp ECCTTCBHHHHHHHSC-TTTSCHHHHHHHH
T ss_pred ecccCcchHHHhhhcc-ccchHHHHHHHHH
Confidence 9999999999997543 3468998887765
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=3e-18 Score=176.34 Aligned_cols=300 Identities=18% Similarity=0.129 Sum_probs=205.6
Q ss_pred ccceeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcc----cccccccCCCCCCEEEcccCcCccc----cc
Q 044615 67 FEATAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNG----SIPLALGNLTNLVVLDLSTNKLSGS----IP 138 (571)
Q Consensus 67 ~l~~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~----~~~~~~~~l~~L~~L~L~~n~i~~~----~~ 138 (571)
.|+.||++++++++.+ +...+..++++++|+|++|.++. .+...+..+++|++|||++|.|+.. +.
T Consensus 3 ~l~~ld~~~~~i~~~~------~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~ 76 (460)
T d1z7xw1 3 DIQSLDIQCEELSDAR------WAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVL 76 (460)
T ss_dssp EEEEEEEESCCCCHHH------HHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHH
T ss_pred CCCEEEeeCCcCChHH------HHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHH
Confidence 5889999999998732 34445678999999999999874 3455677899999999999998642 22
Q ss_pred cccc-CCCCCCeeecccCcCccc----CCccccCCCCCCEEEccCCCCCccCChh-------------------------
Q 044615 139 LSFA-NLTSLSILYLYENSLCDS----IPKEIGNMNSLSILDLSSNKLNGSIPLS------------------------- 188 (571)
Q Consensus 139 ~~~~-~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~~p~~------------------------- 188 (571)
..+. ...+|++|+|++|.+++. ++..+..+++|++|++++|.+.......
T Consensus 77 ~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~ 156 (460)
T d1z7xw1 77 QGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAA 156 (460)
T ss_dssp HTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGG
T ss_pred HHHhcCCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchh
Confidence 2222 235799999999999754 3456788999999999999875211000
Q ss_pred --------hhhccCCCcEEEccCCccccc-----------CC----------------------ccccCCCCCcEEeCcc
Q 044615 189 --------LANLTNSLKVLYLSSNHIVGE-----------IP----------------------LGHGMLSSLIQLTLNN 227 (571)
Q Consensus 189 --------~~~l~~~L~~L~l~~n~~~~~-----------~~----------------------~~~~~l~~L~~L~l~~ 227 (571)
+.... .++.++++.+..... .+ ..+...+.++.+++.+
T Consensus 157 ~~~~~~~~l~~~~-~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~ 235 (460)
T d1z7xw1 157 SCEPLASVLRAKP-DFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGS 235 (460)
T ss_dssp GHHHHHHHHHHCT-TCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCS
T ss_pred hhccccccccccc-ccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhh
Confidence 01111 356666665543210 00 0112346788888888
Q ss_pred CcCcCC-----CChhhhCCCCCCEEEcccCccccc----cchhhccCCCCCEEEcCCccCccCcchhh-----hcccCCC
Q 044615 228 NELSGQ-----LSPELGSLIQLEYLDLSANTFHKS----IPESLSNLVKLHYLNLSNNQFSQKIPNKI-----EKLIHLS 293 (571)
Q Consensus 228 n~l~~~-----~~~~~~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~-----~~l~~L~ 293 (571)
|.+... ..........++.+++++|.+... ....+...+.+..+++++|.++......+ .....|+
T Consensus 236 n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~ 315 (460)
T d1z7xw1 236 NKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLE 315 (460)
T ss_dssp SBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCC
T ss_pred ccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccc
Confidence 876432 123344577899999999988643 23445678899999999999875433322 2345799
Q ss_pred EEEccCCcCCcccch----hccCCCCCCEEEccCCcCccc----cccccc-cCCCCCEEECcCCcCcccC----C-CCCc
Q 044615 294 ELDLSHNIFREEIPS----QICSMQSLEKLNLSHNNLSGS----IPRCFE-EMHWLSCIDISYNALQGLI----P-NSTA 359 (571)
Q Consensus 294 ~L~Ls~n~l~~~~~~----~~~~l~~L~~L~Ls~n~l~~~----~p~~~~-~l~~L~~L~ls~N~l~~~~----~-~~~~ 359 (571)
.+++++|.+...... .+...++|++|+|++|+++.. +++.+. ..+.|+.|+|++|+++... + ....
T Consensus 316 ~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~ 395 (460)
T d1z7xw1 316 SLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLA 395 (460)
T ss_dssp EEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHH
T ss_pred cccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhc
Confidence 999999998765433 345567899999999999753 233333 4577999999999997521 1 1123
Q ss_pred cCCCCcccccCCcC
Q 044615 360 FRDAPMLALQGNKR 373 (571)
Q Consensus 360 ~~~~~~l~l~~n~~ 373 (571)
.+.+..+++++|+.
T Consensus 396 ~~~L~~L~Ls~N~i 409 (460)
T d1z7xw1 396 NHSLRELDLSNNCL 409 (460)
T ss_dssp CCCCCEEECCSSSC
T ss_pred CCCCCEEECCCCcC
Confidence 46788999999864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=2.4e-17 Score=159.00 Aligned_cols=106 Identities=18% Similarity=0.263 Sum_probs=89.1
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCc---hHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDE---MACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSF 537 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~ 537 (571)
+.|++.+.||+|+||+||+|+ ..+|+.||||++.+..... ....+.|.+|+++|++++|||||++++++.+.+..|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 469999999999999999999 4689999999997543322 123578999999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 538 VVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+|||||++|+|.+++.+.+ .+++.....|+
T Consensus 90 iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~ 119 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKE---SLTEEEATEFL 119 (293)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHH
T ss_pred EEEEcCCCccccchhcccc---ccchhHHHHHH
Confidence 9999999999999997543 46676655543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=9.3e-18 Score=158.72 Aligned_cols=106 Identities=24% Similarity=0.465 Sum_probs=88.6
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|++.+.||+|+||+||+|+. .+++.||||++.+.........+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 5699999999999999999994 589999999986533222233567999999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||++|+|.+++...+ .+++.....|+
T Consensus 86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~ 112 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS---KFDEQRTATYI 112 (263)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHH
T ss_pred eecCCCcHHHHHhhcC---CCCHHHHHHHH
Confidence 9999999999997543 46666655543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=1.4e-17 Score=158.09 Aligned_cols=108 Identities=24% Similarity=0.342 Sum_probs=88.1
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEe--CCeeEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSH--ALHSFV 538 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~--~~~~~l 538 (571)
++|++.+.||+|+||+||+|+ ..+|+.||||++...... ....+.+.+|++++++++|||||++++++.+ .+.+|+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 579999999999999999998 568999999999876543 3446779999999999999999999999965 456899
Q ss_pred EEeccCCCChhhhhccCC-CccCCCHHHHhhhc
Q 044615 539 VYEYLEMGSLAMNLSNDA-AAEQFCWTKRMNAI 570 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~~-~~~~l~w~~r~~ia 570 (571)
|||||++|+|.+++.+.. ....+++.....|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~ 115 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 115 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHH
Confidence 999999999999997432 23357777666554
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=1.7e-17 Score=158.03 Aligned_cols=103 Identities=21% Similarity=0.356 Sum_probs=87.9
Q ss_pred cCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
++|++.+.||+|+||+||+|..++++.||||+++..... .++|.+|++++++++|||||+++|++. .+..|+|||
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~E 87 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE 87 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEE
Confidence 468889999999999999999888889999999754322 467999999999999999999999885 456799999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||++|+|.+++.... ...++|..+++|+
T Consensus 88 y~~~g~L~~~~~~~~-~~~l~~~~~~~i~ 115 (272)
T d1qpca_ 88 YMENGSLVDFLKTPS-GIKLTINKLLDMA 115 (272)
T ss_dssp CCTTCBHHHHTTSHH-HHTCCHHHHHHHH
T ss_pred eCCCCcHHHHHhhcC-CCCCCHHHHHHHH
Confidence 999999999887542 3468999998876
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.68 E-value=3.9e-17 Score=158.13 Aligned_cols=105 Identities=24% Similarity=0.319 Sum_probs=90.5
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
.|+..+.||+|+||+||+|+ ..+|+.||||++...........+.|.+|+++|++++|||||++++++.+.+..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 38889999999999999998 56899999999987665555556789999999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||++|++..++..+ ..++|.+...|+
T Consensus 96 ~~~~g~l~~~~~~~---~~l~e~~~~~i~ 121 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK---KPLQEVEIAAVT 121 (309)
T ss_dssp CCSEEHHHHHHHHT---SCCCHHHHHHHH
T ss_pred ecCCCchHHHHHhC---CCCCHHHHHHHH
Confidence 99999998776543 257888776654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=1.3e-17 Score=159.85 Aligned_cols=105 Identities=18% Similarity=0.171 Sum_probs=87.3
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|++.+.||+|+||+||+|+ ..+|+.||||++.+.........+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 469999999999999999999 4689999999987532222233567999999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
|||++|+|.+++...+ .+++.....+
T Consensus 88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~ 113 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG---SFDETCTRFY 113 (288)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHH
T ss_pred EccCCCCHHHhhhccC---CCCHHHHHHH
Confidence 9999999999987543 3555555443
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=3.1e-17 Score=157.25 Aligned_cols=104 Identities=17% Similarity=0.240 Sum_probs=87.8
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
+.|++.+.||+|+||+||+|+ ..+++.||||++...... ..+.|.+|++++++++|||||++++++.+.+..|+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE---ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG---GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH---HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 458899999999999999999 568999999999765322 3467899999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||++|+|.+++.+... .+++.+...|+
T Consensus 89 Ey~~~g~L~~~~~~~~~--~l~e~~~~~i~ 116 (288)
T d2jfla1 89 EFCAGGAVDAVMLELER--PLTESQIQVVC 116 (288)
T ss_dssp ECCTTEEHHHHHHHHTS--CCCHHHHHHHH
T ss_pred ecCCCCcHHHHHHhcCC--CCCHHHHHHHH
Confidence 99999999999875432 46776665543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=8.6e-17 Score=154.32 Aligned_cols=101 Identities=23% Similarity=0.336 Sum_probs=85.8
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|+..+.||+|+||+||+|+ ..+|+.||||++....... .+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 469999999999999999999 5689999999997543322 467999999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
|||++|+|.+++.+. .++..+...|
T Consensus 97 Ey~~gg~L~~~~~~~----~l~~~~~~~i 121 (293)
T d1yhwa1 97 EYLAGGSLTDVVTET----CMDEGQIAAV 121 (293)
T ss_dssp ECCTTCBHHHHHHHS----CCCHHHHHHH
T ss_pred EecCCCcHHHHhhcc----CCCHHHHHHH
Confidence 999999999988643 3555554443
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.67 E-value=5.6e-17 Score=159.77 Aligned_cols=104 Identities=16% Similarity=0.319 Sum_probs=89.3
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|++.+.||+|+||+||+|+ ..+|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 479999999999999999999 5689999999997543 234577999999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||+||+|.+++.+..+ .+++.....|+
T Consensus 103 E~~~gg~L~~~l~~~~~--~l~e~~~~~i~ 130 (350)
T d1koaa2 103 EFMSGGELFEKVADEHN--KMSEDEAVEYM 130 (350)
T ss_dssp CCCCSCBHHHHHTCTTS--CBCHHHHHHHH
T ss_pred EcCCCCCHHHHHHhhcC--CCCHHHHHHHH
Confidence 99999999999975433 47777666554
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=3.8e-17 Score=159.66 Aligned_cols=105 Identities=22% Similarity=0.306 Sum_probs=89.5
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv 539 (571)
.++|++.+.||+|+||+||+|+ ..+|+.||+|+++.... ....+++.+|+.+|++++|||||+++++|.+.+..|+|
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC--TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4579999999999999999999 56899999999976432 23357899999999999999999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||||+||+|.+++.+.+ .+++.....++
T Consensus 83 mEy~~gg~L~~~l~~~~---~l~~~~~~~~~ 110 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAG---RIPEQILGKVS 110 (322)
T ss_dssp EECCTTEEHHHHHHHHS---SCCHHHHHHHH
T ss_pred EEcCCCCcHHHHHhhcC---CCCHHHHHHHH
Confidence 99999999999997543 46776655543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=6.6e-17 Score=157.55 Aligned_cols=102 Identities=15% Similarity=0.139 Sum_probs=86.6
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|++.+.||+|+||+||+|. ..+|+.||||+++... .....+.+|+++|++++|||||++++++.+.+.+|+||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 569999999999999999999 4589999999997642 22456889999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
|||+||+|.+++...+. .+++.+...|
T Consensus 81 E~~~gg~L~~~i~~~~~--~l~e~~~~~i 107 (321)
T d1tkia_ 81 EFISGLDIFERINTSAF--ELNEREIVSY 107 (321)
T ss_dssp CCCCCCBHHHHHTSSSC--CCCHHHHHHH
T ss_pred ecCCCCcHHHHHHhcCC--CCCHHHHHHH
Confidence 99999999999975432 3566555444
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=9.2e-17 Score=153.01 Aligned_cols=104 Identities=33% Similarity=0.419 Sum_probs=87.0
Q ss_pred ccCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
.++|++.+.||+|+||+||+|+.+ ..||||+++...... ...+.|.+|++++++++|||||++++++. .+..|+||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~ 82 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVT 82 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCT-THHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEE
Confidence 357899999999999999999864 359999997654332 44678999999999999999999999875 45689999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||++|+|.++++.... .++|..+++|+
T Consensus 83 Ey~~~g~L~~~l~~~~~--~~~~~~~~~i~ 110 (276)
T d1uwha_ 83 QWCEGSSLYHHLHIIET--KFEMIKLIDIA 110 (276)
T ss_dssp ECCCEEEHHHHHHTSCC--CCCHHHHHHHH
T ss_pred ecCCCCCHHHHHhhccC--CCCHHHHHHHH
Confidence 99999999999975433 58899888775
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.67 E-value=6.2e-17 Score=156.21 Aligned_cols=105 Identities=23% Similarity=0.416 Sum_probs=86.6
Q ss_pred cCCCccCeeeccCcceEEEEEcC-CCC---EEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLP-TGE---IVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSF 537 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~-~~~---~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~ 537 (571)
++|+..+.||+|+||+||+|..+ +++ .||||.+.... .....++|.+|+++|++++|||||+++|+|.+++..|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 103 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM 103 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 45677789999999999999853 333 58899886543 2344678999999999999999999999999999999
Q ss_pred EEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 538 VVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+|||||++|+|.+++....+ .++|.++++|+
T Consensus 104 iv~Ey~~~g~L~~~~~~~~~--~l~~~~~~~i~ 134 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQNDG--QFTVIQLVGML 134 (299)
T ss_dssp EEEECCTTEEHHHHHHTTTT--CSCHHHHHHHH
T ss_pred EEEEecCCCcceeeeccccC--CCCHHHHHHHH
Confidence 99999999999999885433 58999988875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.66 E-value=5.4e-17 Score=157.04 Aligned_cols=104 Identities=20% Similarity=0.276 Sum_probs=83.3
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
+.|++.+.||+|+||+||+|+ ..+|+.||||++.+..... ..+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 459999999999999999999 4589999999997654332 2456889999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||+||+|.+++.+.+ .+++.+...|+
T Consensus 87 E~~~gg~L~~~l~~~~---~l~e~~~~~~~ 113 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKG---FYTERDASRLI 113 (307)
T ss_dssp CCCCSCBHHHHHHTCS---CCCHHHHHHHH
T ss_pred eccCCCcHHHhhhccc---CCCHHHHHHHH
Confidence 9999999999997543 46666655543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.66 E-value=1.3e-16 Score=152.01 Aligned_cols=106 Identities=20% Similarity=0.302 Sum_probs=89.4
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCch------HhHHHHHHHHHHHhhcC-CCCcccEEEEEEeC
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEM------ACQQEFLNEVNALTKIR-HRNIVKFYGFCSHA 533 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~------~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~ 533 (571)
++|++.+.||+|+||+||+|+ ..+|+.||||++++...... ...+.+.+|+.++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 579999999999999999999 56899999999976543321 22456899999999997 99999999999999
Q ss_pred CeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 534 LHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 534 ~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+..|||||||++|||.++|+..+ .++|.+...++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~ 116 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIM 116 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHH
T ss_pred cceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHH
Confidence 99999999999999999997543 47777766654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.65 E-value=6.2e-17 Score=154.76 Aligned_cols=103 Identities=21% Similarity=0.360 Sum_probs=88.2
Q ss_pred cCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
++|++.+.||+|+||+||+|..++++.||||++...... .+.|.+|+.++++++|||||+++|+|. .+..|+|||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~E 91 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTE 91 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEE
Confidence 468999999999999999999877788999999754322 467999999999999999999999985 456899999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||++|+|..++.... ...++|.+++.||
T Consensus 92 y~~~g~l~~~~~~~~-~~~l~~~~~~~i~ 119 (285)
T d1fmka3 92 YMSKGSLLDFLKGET-GKYLRLPQLVDMA 119 (285)
T ss_dssp CCTTCBHHHHHSHHH-HTTCCHHHHHHHH
T ss_pred ecCCCchhhhhhhcc-cccchHHHHHHHH
Confidence 999999999987542 2358999999886
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.65 E-value=1.2e-16 Score=157.39 Aligned_cols=103 Identities=17% Similarity=0.284 Sum_probs=87.0
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|++.+.||+|+||+||+|+ ..+|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 469999999999999999999 5689999999997643 233567899999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
|||+||+|.+++...+. .++..+...|
T Consensus 106 E~~~gg~L~~~~~~~~~--~l~e~~~~~i 132 (352)
T d1koba_ 106 EFLSGGELFDRIAAEDY--KMSEAEVINY 132 (352)
T ss_dssp ECCCCCBHHHHTTCTTC--CBCHHHHHHH
T ss_pred EcCCCChHHHHHHhcCC--CCCHHHHHHH
Confidence 99999999998875432 3565555444
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.65 E-value=1.8e-16 Score=151.53 Aligned_cols=104 Identities=21% Similarity=0.258 Sum_probs=84.1
Q ss_pred cCCCccC-eeeccCcceEEEEEcC---CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeE
Q 044615 462 NNFDDGH-CIGNGGQGSVYKAKLP---TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSF 537 (571)
Q Consensus 462 ~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~ 537 (571)
++|...+ +||+|+||+||+|..+ ++..||||+++... .....++|.+|+++|++++|||||+++|+|.+ +..|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~ 84 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 84 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence 3456666 4999999999999743 45579999997543 23446789999999999999999999999965 4679
Q ss_pred EEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 538 VVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+|||||++|+|.+++.... ..++|..+.+|+
T Consensus 85 lvmE~~~~g~L~~~l~~~~--~~l~~~~~~~i~ 115 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKR--EEIPVSNVAELL 115 (285)
T ss_dssp EEEECCTTEEHHHHHTTCT--TTSCHHHHHHHH
T ss_pred EEEEeCCCCcHHHHhhccc--cCCCHHHHHHHH
Confidence 9999999999999986543 358888888775
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.64 E-value=1.5e-16 Score=152.08 Aligned_cols=106 Identities=21% Similarity=0.313 Sum_probs=90.6
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC----ee
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL----HS 536 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~----~~ 536 (571)
++|++.+.||+|+||+||+|+ ..+|+.||||++++....+....+.|.+|++++++++|||||++++++...+ ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 469999999999999999999 5689999999998776655566778999999999999999999999998754 37
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+|||||+||+|.+++...+ .++|.+...|+
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~ 117 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVI 117 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHC---SCCHHHHHHHH
T ss_pred EEEEECCCCCEehhhhcccC---CCCHHHHHHHH
Confidence 99999999999999987543 47777766654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.64 E-value=4.5e-17 Score=153.84 Aligned_cols=102 Identities=25% Similarity=0.345 Sum_probs=84.8
Q ss_pred cCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEe-CCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSH-ALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~-~~~~~lv~ 540 (571)
++|+..+.||+|+||.||+|.. .|+.||||+++... ..+.|.+|++++++++|||||+++|+|.+ .+.+|+||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 80 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence 4688889999999999999998 47889999996532 24679999999999999999999999865 46689999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||+++|+|.+++..+. ...++|..+++||
T Consensus 81 ey~~~g~L~~~l~~~~-~~~l~~~~~~~i~ 109 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRG-RSVLGGDCLLKFS 109 (262)
T ss_dssp CCCTTEEHHHHHHHHH-HHHCCHHHHHHHH
T ss_pred eccCCCCHHHHHHhcC-CCCCCHHHHHHHH
Confidence 9999999999997542 2358999888876
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.64 E-value=2e-16 Score=149.98 Aligned_cols=103 Identities=22% Similarity=0.197 Sum_probs=83.4
Q ss_pred CCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEe----CCeeEE
Q 044615 464 FDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSH----ALHSFV 538 (571)
Q Consensus 464 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~----~~~~~l 538 (571)
|+..+.||+|+||+||+|. ..+++.||+|.+...... ....+.|.+|+++|++++|||||++++++.+ ...+|+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 3556789999999999999 457899999999754433 2446789999999999999999999999975 346899
Q ss_pred EEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 539 VYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 539 v~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||||++|+|.+++.+.. .+++.....|+
T Consensus 90 vmE~~~~g~L~~~l~~~~---~~~~~~~~~~~ 118 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFK---VMKIKVLRSWC 118 (270)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHH
T ss_pred EEeCCCCCcHHHHHhccc---cccHHHHHHHH
Confidence 999999999999997542 46666655543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.63 E-value=3e-16 Score=149.58 Aligned_cols=98 Identities=23% Similarity=0.362 Sum_probs=79.0
Q ss_pred CeeeccCcceEEEEEcC---CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEeccC
Q 044615 468 HCIGNGGQGSVYKAKLP---TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEYLE 544 (571)
Q Consensus 468 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 544 (571)
+.||+|+||+||+|.++ +++.||||+++.... +....++|.+|+++|++++|||||+++|+|.+ +..|+|||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence 46999999999999743 456899999975432 23446789999999999999999999999965 45789999999
Q ss_pred CCChhhhhccCCCccCCCHHHHhhhc
Q 044615 545 MGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 545 ~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+|+|.+++++. ..++|..+++|+
T Consensus 91 ~g~L~~~l~~~---~~l~~~~~~~i~ 113 (277)
T d1xbba_ 91 LGPLNKYLQQN---RHVKDKNIIELV 113 (277)
T ss_dssp TEEHHHHHHHC---TTCCHHHHHHHH
T ss_pred CCcHHHHHhhc---cCCCHHHHHHHH
Confidence 99999999854 358898888775
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=4.5e-16 Score=149.14 Aligned_cols=216 Identities=18% Similarity=0.177 Sum_probs=110.6
Q ss_pred CCCCCCEEecccCcCccc-ccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccC-cCcccC-CccccCCCCC
Q 044615 95 NMKSLSDLQLSENILNGS-IPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYEN-SLCDSI-PKEIGNMNSL 171 (571)
Q Consensus 95 ~l~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n-~l~~~~-~~~l~~l~~L 171 (571)
...+|++|||+++.++.. ++..+..+++|++|+|++|.++...+..++.+++|++|+++++ .+++.. ......+++|
T Consensus 44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L 123 (284)
T d2astb2 44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 123 (284)
T ss_dssp CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTC
T ss_pred cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhc
Confidence 345677777777766533 3344566777777777777776666666677777777777764 343211 1123456677
Q ss_pred CEEEccCCC-CCcc-CChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCcCcCC-CChhhhCCCCCCEEE
Q 044615 172 SILDLSSNK-LNGS-IPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNELSGQ-LSPELGSLIQLEYLD 248 (571)
Q Consensus 172 ~~L~L~~n~-l~~~-~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~ 248 (571)
++|++++|. ++.. +...+....++|+.|+++++.. .++.. +......+++|+.|+
T Consensus 124 ~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~----------------------~i~~~~l~~l~~~~~~L~~L~ 181 (284)
T d2astb2 124 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK----------------------NLQKSDLSTLVRRCPNLVHLD 181 (284)
T ss_dssp CEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGG----------------------GSCHHHHHHHHHHCTTCSEEE
T ss_pred cccccccccccccccchhhhcccccccchhhhccccc----------------------ccccccccccccccccccccc
Confidence 777776653 3211 1122333333455555554321 11111 111223455566666
Q ss_pred cccC-ccccccchhhccCCCCCEEEcCCc-cCccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcC
Q 044615 249 LSAN-TFHKSIPESLSNLVKLHYLNLSNN-QFSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNL 326 (571)
Q Consensus 249 L~~n-~l~~~~~~~l~~l~~L~~L~Ls~n-~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 326 (571)
+++| .+++.....+..+++|++|++++| .+++.....+..+++|+.|+++++.-.+.+......+|+|+ +..+++
T Consensus 182 L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~~~d~~l~~l~~~lp~L~---i~~~~l 258 (284)
T d2astb2 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ---INCSHF 258 (284)
T ss_dssp CTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTSSCTTCHHHHHHHSTTSE---ESCCCS
T ss_pred cccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCCCCHHHHHHHHHhCcccc---ccCccC
Confidence 6554 344444455556666666666663 34444444455566666666666521112222223344443 355555
Q ss_pred ccccccccc
Q 044615 327 SGSIPRCFE 335 (571)
Q Consensus 327 ~~~~p~~~~ 335 (571)
+...+..+.
T Consensus 259 s~~~~~~~~ 267 (284)
T d2astb2 259 TTIARPTIG 267 (284)
T ss_dssp CCTTCSSCS
T ss_pred CCCCCCccC
Confidence 554444443
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.62 E-value=1.6e-16 Score=154.35 Aligned_cols=95 Identities=20% Similarity=0.310 Sum_probs=82.8
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|++.+.||+|+||+||+|+ ..+|+.||||++++.........+.+.+|+.++++++|||||++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 579999999999999999999 4689999999997543222234577999999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCC
Q 044615 541 EYLEMGSLAMNLSNDA 556 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~ 556 (571)
|||+||+|.+++....
T Consensus 84 E~~~gg~l~~~~~~~~ 99 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ 99 (316)
T ss_dssp CCCCSCBHHHHHHHTS
T ss_pred eecCCccccccccccc
Confidence 9999999999987543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=3.2e-16 Score=152.12 Aligned_cols=107 Identities=24% Similarity=0.401 Sum_probs=86.2
Q ss_pred cCCCccCeeeccCcceEEEEEcC-CCC--EEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCCeeE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLP-TGE--IVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHALHSF 537 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~ 537 (571)
++|+..+.||+|+||+||+|+.+ +|. .||||+++..... ...++|.+|+++++++ +|||||+++|+|.+.+..|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccCh--HHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 46888899999999999999954 554 4778887643322 2356799999999998 7999999999999999999
Q ss_pred EEEeccCCCChhhhhccCC-------------CccCCCHHHHhhhc
Q 044615 538 VVYEYLEMGSLAMNLSNDA-------------AAEQFCWTKRMNAI 570 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~~-------------~~~~l~w~~r~~ia 570 (571)
+||||+++|+|.++|+... ....++|..++.++
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 133 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 133 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHH
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHH
Confidence 9999999999999997542 23568999888775
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=4.9e-16 Score=148.92 Aligned_cols=230 Identities=17% Similarity=0.157 Sum_probs=141.9
Q ss_pred CCEEecccCcCcccccccccCCCCCCEEEcccCcCccc-ccccccCCCCCCeeecccCcCcccCCccccCCCCCCEEEcc
Q 044615 99 LSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGS-IPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLSILDLS 177 (571)
Q Consensus 99 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~ 177 (571)
+..+.++...+.... .......+|++||+++|.++.. ++..+.++++|++|+|++|.+.+..+..+..+++|++|+++
T Consensus 25 ~~~lrl~~~~~~~~~-~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls 103 (284)
T d2astb2 25 VIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS 103 (284)
T ss_dssp CSEEECTTCEECSCC-CSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECT
T ss_pred ceEeeccccccccch-hhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccc
Confidence 345555555443222 2223445777777777776543 33446677777777777777766666667777777777777
Q ss_pred CC-CCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCc-CcCC-CChhhh-CCCCCCEEEcccCc
Q 044615 178 SN-KLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNE-LSGQ-LSPELG-SLIQLEYLDLSANT 253 (571)
Q Consensus 178 ~n-~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~-l~~~-~~~~~~-~l~~L~~L~L~~n~ 253 (571)
+| .++...-..+. ..+++|++|+++++. ++.. ....+. ..++|+.|+++++.
T Consensus 104 ~c~~itd~~l~~l~------------------------~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~ 159 (284)
T d2astb2 104 GCSGFSEFALQTLL------------------------SSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYR 159 (284)
T ss_dssp TCBSCCHHHHHHHH------------------------HHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCG
T ss_pred ccccccccccchhh------------------------HHHHhccccccccccccccccchhhhcccccccchhhhcccc
Confidence 64 33311001111 123445555555432 2211 111222 34689999998753
Q ss_pred --cccc-cchhhccCCCCCEEEcCCcc-CccCcchhhhcccCCCEEEccCC-cCCcccchhccCCCCCCEEEccCCcCcc
Q 044615 254 --FHKS-IPESLSNLVKLHYLNLSNNQ-FSQKIPNKIEKLIHLSELDLSHN-IFREEIPSQICSMQSLEKLNLSHNNLSG 328 (571)
Q Consensus 254 --l~~~-~~~~l~~l~~L~~L~Ls~n~-l~~~~~~~~~~l~~L~~L~Ls~n-~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 328 (571)
+++. +...+.++++|+.|++++|. +++.....+..+++|+.|++++| .+++.....++.+++|+.|+++++--.+
T Consensus 160 ~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~~~d~ 239 (284)
T d2astb2 160 KNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDG 239 (284)
T ss_dssp GGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTSSCTT
T ss_pred cccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCCCCHH
Confidence 4332 33345678999999999974 77777778889999999999995 6777777778899999999999882222
Q ss_pred ccccccccCCCCCEEECcCCcCcccCCC
Q 044615 329 SIPRCFEEMHWLSCIDISYNALQGLIPN 356 (571)
Q Consensus 329 ~~p~~~~~l~~L~~L~ls~N~l~~~~~~ 356 (571)
..+.....+++|+ +..++++...+.
T Consensus 240 ~l~~l~~~lp~L~---i~~~~ls~~~~~ 264 (284)
T d2astb2 240 TLQLLKEALPHLQ---INCSHFTTIARP 264 (284)
T ss_dssp CHHHHHHHSTTSE---ESCCCSCCTTCS
T ss_pred HHHHHHHhCcccc---ccCccCCCCCCC
Confidence 2333334566654 567777766443
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=1.7e-16 Score=155.29 Aligned_cols=95 Identities=22% Similarity=0.232 Sum_probs=83.0
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|++.+.||+|+||+||+|+ ..+|+.||||++.+.........+.+.+|+.+|++++|||||++++++.+.+.+|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 579999999999999999999 5689999999997543222233577899999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCC
Q 044615 541 EYLEMGSLAMNLSNDA 556 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~ 556 (571)
|||+||+|.+++.+.+
T Consensus 85 ey~~gg~L~~~~~~~~ 100 (337)
T d1o6la_ 85 EYANGGELFFHLSRER 100 (337)
T ss_dssp ECCTTCBHHHHHHHHS
T ss_pred eccCCCchhhhhhccc
Confidence 9999999999998643
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=8e-16 Score=147.26 Aligned_cols=105 Identities=25% Similarity=0.396 Sum_probs=87.9
Q ss_pred cCCCccCeeeccCcceEEEEEcCC-C----CEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCee
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPT-G----EIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHS 536 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~-~----~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~ 536 (571)
+.|+..+.||+|+||+||+|.++. + ..||||++..... .....+|.+|++++++++|||||+++|++.+.+..
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC--hHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence 458888999999999999998542 2 3699999975432 33456799999999999999999999999999999
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
++|||||++|++.+++.... ..++|.++++|+
T Consensus 85 ~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~ 116 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREKD--GEFSVLQLVGML 116 (283)
T ss_dssp EEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHH
T ss_pred EEEEEecccCcchhhhhccc--ccccHHHHHHHH
Confidence 99999999999999887543 368999988876
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=3.5e-16 Score=152.22 Aligned_cols=95 Identities=19% Similarity=0.243 Sum_probs=80.0
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHh-hcCCCCcccEEEEEEeCCeeEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALT-KIRHRNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~-~l~H~niv~l~~~~~~~~~~~lv 539 (571)
++|++.+.||+|+||+||+|+ ..+|+.||||++++.........+.+.+|+.++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 579999999999999999999 5589999999997532222233566788888765 68999999999999999999999
Q ss_pred EeccCCCChhhhhccCC
Q 044615 540 YEYLEMGSLAMNLSNDA 556 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~ 556 (571)
||||++|+|.++++...
T Consensus 82 mEy~~~g~L~~~i~~~~ 98 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH 98 (320)
T ss_dssp EECCTTCBHHHHHHHHS
T ss_pred EeecCCCcHHHHhhccC
Confidence 99999999999997543
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.59 E-value=2.5e-16 Score=155.78 Aligned_cols=253 Identities=17% Similarity=0.194 Sum_probs=149.1
Q ss_pred cccccccCCCCCCEEecccCcCccc----ccccccCCCCCCEEEcccCcCccc----------ccccccCCCCCCeeecc
Q 044615 88 SIPDEIGNMKSLSDLQLSENILNGS----IPLALGNLTNLVVLDLSTNKLSGS----------IPLSFANLTSLSILYLY 153 (571)
Q Consensus 88 ~~p~~~~~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~L~~n~i~~~----------~~~~~~~l~~L~~L~L~ 153 (571)
.+...+.....|+.|+|++|.+... +...+...++|+.|+++++..... +...+...++|+.|+|+
T Consensus 22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~ 101 (344)
T d2ca6a1 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 101 (344)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccc
Confidence 3455667788899999999887643 234566778899999887754321 12234556777888887
Q ss_pred cCcCccc----CCccccCCCCCCEEEccCCCCCccCChhhhhccCCCcEEEccCCcccccCCccccCCCCCcEEeCccCc
Q 044615 154 ENSLCDS----IPKEIGNMNSLSILDLSSNKLNGSIPLSLANLTNSLKVLYLSSNHIVGEIPLGHGMLSSLIQLTLNNNE 229 (571)
Q Consensus 154 ~n~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~ 229 (571)
+|.+... +...+...++|++|++++|.+.......+... +..+.. .......+.|+.+++++|.
T Consensus 102 ~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~---l~~~~~---------~~~~~~~~~L~~l~l~~n~ 169 (344)
T d2ca6a1 102 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARA---LQELAV---------NKKAKNAPPLRSIICGRNR 169 (344)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHH---HHHHHH---------HHHHHTCCCCCEEECCSSC
T ss_pred ccccccccccchhhhhcccccchheeccccccccccccccccc---cccccc---------ccccccCcccceeeccccc
Confidence 7777543 22234456777777777776642111111110 000000 0001223456666666665
Q ss_pred CcCCC----ChhhhCCCCCCEEEcccCccccc-----cchhhccCCCCCEEEcCCccCccC----cchhhhcccCCCEEE
Q 044615 230 LSGQL----SPELGSLIQLEYLDLSANTFHKS-----IPESLSNLVKLHYLNLSNNQFSQK----IPNKIEKLIHLSELD 296 (571)
Q Consensus 230 l~~~~----~~~~~~l~~L~~L~L~~n~l~~~-----~~~~l~~l~~L~~L~Ls~n~l~~~----~~~~~~~l~~L~~L~ 296 (571)
+.... ...+...+.|+.|++++|.++.. +...+..+++|+.|++++|.++.. +...+...++|++|+
T Consensus 170 i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~ 249 (344)
T d2ca6a1 170 LENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELG 249 (344)
T ss_dssp CTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEE
T ss_pred ccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhh
Confidence 54321 22344566777777777776532 233456677778888887777533 234456677788888
Q ss_pred ccCCcCCcccchhc----c--CCCCCCEEEccCCcCcccc----ccccc-cCCCCCEEECcCCcCcc
Q 044615 297 LSHNIFREEIPSQI----C--SMQSLEKLNLSHNNLSGSI----PRCFE-EMHWLSCIDISYNALQG 352 (571)
Q Consensus 297 Ls~n~l~~~~~~~~----~--~l~~L~~L~Ls~n~l~~~~----p~~~~-~l~~L~~L~ls~N~l~~ 352 (571)
|++|.+.+.....+ . ..+.|++|++++|.++... ..++. +.+.|+.|++++|.+..
T Consensus 250 Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp CTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred hhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 88887765432222 2 2356888888888876432 23332 46778888888888753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=5.2e-16 Score=147.55 Aligned_cols=106 Identities=25% Similarity=0.383 Sum_probs=78.7
Q ss_pred cCCCccCeeeccCcceEEEEEc--CCC--CEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL--PTG--EIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSF 537 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~--~~~--~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~ 537 (571)
++|++.+.||+|+||+||+|+. .++ ..||||++.+.........++|.+|++++++++|||||+++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 4689999999999999999984 233 3689999987655555556789999999999999999999999965 4678
Q ss_pred EEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 538 VVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+|||||++|++.+++..+. ..++|..+++++
T Consensus 87 lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~ 117 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYA 117 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHH
T ss_pred eeeeeecCcchhhhhhccc--CCCCHHHHHHHH
Confidence 9999999999999887543 258888887765
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.58 E-value=1.2e-15 Score=147.54 Aligned_cols=113 Identities=23% Similarity=0.392 Sum_probs=92.8
Q ss_pred HHHHHccCCCccCeeeccCcceEEEEEcC------CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEE
Q 044615 456 EIIRATNNFDDGHCIGNGGQGSVYKAKLP------TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGF 529 (571)
Q Consensus 456 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~ 529 (571)
++....++|+..+.||+|+||+||+|+.+ +++.||||++.... .....++|.+|++++++++||||++++++
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 33445668999999999999999999843 45789999997543 23446789999999999999999999999
Q ss_pred EEeCCeeEEEEeccCCCChhhhhccCCC---------------------ccCCCHHHHhhhc
Q 044615 530 CSHALHSFVVYEYLEMGSLAMNLSNDAA---------------------AEQFCWTKRMNAI 570 (571)
Q Consensus 530 ~~~~~~~~lv~e~~~~G~L~~~l~~~~~---------------------~~~l~w~~r~~ia 570 (571)
|.+.+..++||||+++|+|.++++.... ...++|..++.||
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 146 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIA 146 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHH
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHH
Confidence 9999999999999999999999974321 2358888888775
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=1.2e-15 Score=149.04 Aligned_cols=107 Identities=21% Similarity=0.381 Sum_probs=84.6
Q ss_pred cCCCccCeeeccCcceEEEEEcC-CC-----CEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCC
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLP-TG-----EIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHAL 534 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~-~~-----~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~ 534 (571)
++|++.+.||+|+||+||+|+.. .+ ..||||.+..... ....+.|.+|+.++.++ +|||||+++++|.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC--HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 56889999999999999999843 22 3699999865432 23346799999999998 8999999999999999
Q ss_pred eeEEEEeccCCCChhhhhccCCC--------------------ccCCCHHHHhhhc
Q 044615 535 HSFVVYEYLEMGSLAMNLSNDAA--------------------AEQFCWTKRMNAI 570 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~~~~--------------------~~~l~w~~r~~ia 570 (571)
..|+|||||++|+|.++|+.... ...++|..++.|+
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 170 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFA 170 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHH
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHH
Confidence 99999999999999999976432 1358888887765
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.56 E-value=2.6e-15 Score=144.94 Aligned_cols=106 Identities=26% Similarity=0.380 Sum_probs=82.5
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|++.+.||+|+||+||+|+ ..+|+.||||+++..... ....+++.+|++++++++|||||++++++.+++..|+||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 579999999999999999999 568999999999754322 223567999999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||+.++ +.+++... ....++|.....++
T Consensus 81 e~~~~~-~~~~~~~~-~~~~l~e~~~~~~~ 108 (298)
T d1gz8a_ 81 EFLHQD-LKKFMDAS-ALTGIPLPLIKSYL 108 (298)
T ss_dssp ECCSEE-HHHHHHHT-TTTCCCHHHHHHHH
T ss_pred eecCCc-hhhhhhhh-cccCCCHHHHHHHH
Confidence 999865 44444322 22357777766654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.56 E-value=2.2e-15 Score=146.24 Aligned_cols=107 Identities=22% Similarity=0.341 Sum_probs=88.8
Q ss_pred cCCCccCeeeccCcceEEEEEc------CCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeCC
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL------PTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHAL 534 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~ 534 (571)
++|+..+.||+|+||.||+|+. .+++.||||++++.. ......+|.+|+.+++++ +|||||+++|+|.+.+
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 5688899999999999999973 245689999997653 234466799999999999 7999999999999999
Q ss_pred eeEEEEeccCCCChhhhhccCCC---------------ccCCCHHHHhhhc
Q 044615 535 HSFVVYEYLEMGSLAMNLSNDAA---------------AEQFCWTKRMNAI 570 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~~~~---------------~~~l~w~~r~~ia 570 (571)
..|+|||||++|+|.++++.... ...++|..+.+|+
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 151 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFS 151 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHH
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHH
Confidence 99999999999999999975421 2357888877765
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.56 E-value=1.3e-15 Score=150.69 Aligned_cols=94 Identities=20% Similarity=0.207 Sum_probs=77.1
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHH---HHHHHHhhcCCCCcccEEEEEEeCCeeE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFL---NEVNALTKIRHRNIVKFYGFCSHALHSF 537 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~---~Ei~~l~~l~H~niv~l~~~~~~~~~~~ 537 (571)
++|++.+.||+|+||.||+|+ ..+|+.||||++.+...........+. +|+++++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 579999999999999999999 558999999998643221111223344 4467788889999999999999999999
Q ss_pred EEEeccCCCChhhhhccC
Q 044615 538 VVYEYLEMGSLAMNLSND 555 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~ 555 (571)
+|||||+||+|.++|.+.
T Consensus 84 ivmE~~~gg~L~~~l~~~ 101 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH 101 (364)
T ss_dssp EEECCCCSCBHHHHHHHH
T ss_pred EEEEecCCCcHHHHHHhc
Confidence 999999999999999754
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.56 E-value=2.9e-15 Score=145.11 Aligned_cols=107 Identities=21% Similarity=0.325 Sum_probs=89.5
Q ss_pred cCCCccCeeeccCcceEEEEEcC------CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLP------TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALH 535 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~ 535 (571)
++|+..+.||+|+||.||+|... +++.||||+++... .......|.+|+.++++++|||||+++|+|...+.
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 56888999999999999999742 35789999997543 33445679999999999999999999999999999
Q ss_pred eEEEEeccCCCChhhhhccCC-------CccCCCHHHHhhhc
Q 044615 536 SFVVYEYLEMGSLAMNLSNDA-------AAEQFCWTKRMNAI 570 (571)
Q Consensus 536 ~~lv~e~~~~G~L~~~l~~~~-------~~~~l~w~~r~~ia 570 (571)
.++|||||++|+|.+++.... ....++|..+++|+
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 139 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHH
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHH
Confidence 999999999999999987432 22457888888875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.55 E-value=1.9e-15 Score=148.83 Aligned_cols=105 Identities=20% Similarity=0.222 Sum_probs=86.9
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
++|++.+.||+|+||+||+|+ ..+|+.||||++.+.........+.+.+|+++|++++|||||++++++.+....|+||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 469999999999999999999 4689999999986533222233567999999999999999999999999999999999
Q ss_pred eccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 541 EYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 541 e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
||+.+|+|.+++...+ .+++.....|
T Consensus 121 e~~~~g~l~~~l~~~~---~l~e~~~~~i 146 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG---RFSEPHARFY 146 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHH
T ss_pred ccccccchhhhHhhcC---CCCHHHHHHH
Confidence 9999999999997543 3555544433
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.54 E-value=1.3e-15 Score=150.42 Aligned_cols=89 Identities=28% Similarity=0.288 Sum_probs=46.6
Q ss_pred hCCCCCCEEEcccCccccc----cchhhccCCCCCEEEcCCccCccCcchh----hhc--ccCCCEEEccCCcCCccc--
Q 044615 239 GSLIQLEYLDLSANTFHKS----IPESLSNLVKLHYLNLSNNQFSQKIPNK----IEK--LIHLSELDLSHNIFREEI-- 306 (571)
Q Consensus 239 ~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~Ls~n~l~~~~~~~----~~~--l~~L~~L~Ls~n~l~~~~-- 306 (571)
..+++|+.|++++|.++.. +...+..+++|++|++++|.+++..... +.. .+.|+.|++++|.+....
T Consensus 212 ~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~ 291 (344)
T d2ca6a1 212 AYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVR 291 (344)
T ss_dssp GGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHH
T ss_pred cchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHH
Confidence 3445555555555555322 2234455566666666666665432222 221 245666777766665422
Q ss_pred --chhcc-CCCCCCEEEccCCcCc
Q 044615 307 --PSQIC-SMQSLEKLNLSHNNLS 327 (571)
Q Consensus 307 --~~~~~-~l~~L~~L~Ls~n~l~ 327 (571)
...+. .+++|+.|+|++|++.
T Consensus 292 ~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 292 TLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp HHHHHHHHHCTTCCEEECTTSBSC
T ss_pred HHHHHHHccCCCCCEEECCCCcCC
Confidence 22222 4566777777777775
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=9.3e-15 Score=141.45 Aligned_cols=100 Identities=22% Similarity=0.341 Sum_probs=81.4
Q ss_pred cCeeeccCcceEEEEEcCC----CCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEe-CCeeEEEEe
Q 044615 467 GHCIGNGGQGSVYKAKLPT----GEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSH-ALHSFVVYE 541 (571)
Q Consensus 467 ~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~-~~~~~lv~e 541 (571)
.++||+|+||+||+|.+.. ...||||+++.. ......++|.+|+++|++++|||||+++|++.+ +...++|||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 4679999999999998532 235899999743 234556889999999999999999999999876 468899999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
||++|+|.++++.... .++|..+++|+
T Consensus 110 ~~~~g~l~~~~~~~~~--~~~~~~~~~i~ 136 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETH--NPTVKDLIGFG 136 (311)
T ss_dssp CCTTCBHHHHHHCTTC--CCBHHHHHHHH
T ss_pred EeecCchhhhhccccc--cchHHHHHHHH
Confidence 9999999999985443 46777777665
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=4.9e-15 Score=144.97 Aligned_cols=101 Identities=17% Similarity=0.212 Sum_probs=80.9
Q ss_pred ccCCCccC-eeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEe----C
Q 044615 461 TNNFDDGH-CIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSH----A 533 (571)
Q Consensus 461 ~~~~~~~~-~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~----~ 533 (571)
.++|.+.. .||+|+||+||+|+ ..+++.||||+++.. ..+.+|++++.++ +|||||+++++|.+ .
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 35788764 69999999999999 568999999998632 4577899987654 89999999999976 3
Q ss_pred CeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 534 LHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 534 ~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
..+|+|||||+||+|.++|.+++. ..+++.+...|+
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~ 117 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIM 117 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHH
T ss_pred CEEEEEEECCCCCcHHHHHHhcCC-CCcCHHHHHHHH
Confidence 568999999999999999985432 357776655543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=7.3e-15 Score=141.80 Aligned_cols=100 Identities=26% Similarity=0.266 Sum_probs=79.4
Q ss_pred cCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC----eeE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL----HSF 537 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~----~~~ 537 (571)
++|...+.||+|+||.||+|+. +|+.||||+++... .....+.+|+..+..++|||||+++++|.+.+ ..|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 3577788999999999999986 68899999986321 11222334555567889999999999998754 579
Q ss_pred EEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 538 VVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+|||||++|+|.++|++. .++|..+++++
T Consensus 78 lv~Ey~~~g~L~~~l~~~----~l~~~~~~~~~ 106 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY----TVTVEGMIKLA 106 (303)
T ss_dssp EEEECCTTCBHHHHHHHC----CBCHHHHHHHH
T ss_pred EEEecccCCCHHHHHhcC----CCCHHHHHHHH
Confidence 999999999999999753 48899988775
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=1.3e-14 Score=141.11 Aligned_cols=104 Identities=19% Similarity=0.398 Sum_probs=82.0
Q ss_pred cCCCccCeeeccCcceEEEEEc-CCCC----EEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCee
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL-PTGE----IVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHS 536 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~ 536 (571)
.+|+..+.||+|+||+||+|.. .+|+ .||+|.+.... .....++|.+|++++++++|||||+++|+|.++ ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 4699999999999999999984 4554 58899886432 223357899999999999999999999999865 46
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+++|||+.+|+|.+++.... ..++|..+++|+
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~ 117 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHK--DNIGSQYLLNWC 117 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTS--SSCCHHHHHHHH
T ss_pred eEEEEeccCCcccccccccc--cCCCHHHHHHHH
Confidence 78899999999999887543 358888887765
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=1.7e-14 Score=125.24 Aligned_cols=128 Identities=20% Similarity=0.172 Sum_probs=86.8
Q ss_pred ccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCC
Q 044615 214 HGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLS 293 (571)
Q Consensus 214 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 293 (571)
+.+..++++|+|++|+++.. +..+..+++|+.|++++|.++.. +.+..+++|+.|++++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccc
Confidence 34555677777777777643 44556677777777777777643 3467777777888888877765555566777788
Q ss_pred EEEccCCcCCcccc-hhccCCCCCCEEEccCCcCcccc---ccccccCCCCCEEE
Q 044615 294 ELDLSHNIFREEIP-SQICSMQSLEKLNLSHNNLSGSI---PRCFEEMHWLSCID 344 (571)
Q Consensus 294 ~L~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~n~l~~~~---p~~~~~l~~L~~L~ 344 (571)
.|++++|++..... ..+..+++|+.|++++|+++... +..+..+++|+.||
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred cceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 88888887765322 35677788888888888776432 22466777787776
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=1.1e-14 Score=138.46 Aligned_cols=104 Identities=20% Similarity=0.309 Sum_probs=84.6
Q ss_pred cCCCccCeeeccCcceEEEEEcC----CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLP----TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSF 537 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~ 537 (571)
++|++.+.||+|+||+||+|... .+..||||.++... .....+.|.+|++++++++|||||+++|++. .+..|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 46889999999999999999843 23468899886433 3344678999999999999999999999995 56789
Q ss_pred EEEeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 538 VVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
+||||+++|++.+++..... .++|..++.++
T Consensus 84 iv~E~~~~g~l~~~~~~~~~--~l~~~~~~~~~ 114 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVRKY--SLDLASLILYA 114 (273)
T ss_dssp EEEECCTTEEHHHHHHHTTT--TSCHHHHHHHH
T ss_pred EEEEeccCCcHHhhhhccCC--CCCHHHHHHHH
Confidence 99999999999998875433 57888777664
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=1.1e-14 Score=126.53 Aligned_cols=110 Identities=23% Similarity=0.217 Sum_probs=68.0
Q ss_pred ccCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccCCCCCC
Q 044615 93 IGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGNMNSLS 172 (571)
Q Consensus 93 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~ 172 (571)
+.+..+|++|+|++|+|+. ++..+..+++|++|+|++|.|+.. +.|..+++|++|++++|.++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccc
Confidence 5566677777777777763 455556677777777777777643 2466777777777777777654444455677777
Q ss_pred EEEccCCCCCccCC--hhhhhccCCCcEEEccCCccc
Q 044615 173 ILDLSSNKLNGSIP--LSLANLTNSLKVLYLSSNHIV 207 (571)
Q Consensus 173 ~L~L~~n~l~~~~p--~~~~~l~~~L~~L~l~~n~~~ 207 (571)
+|++++|++.. ++ ..+..+++ |+.|++++|.++
T Consensus 91 ~L~L~~N~i~~-~~~l~~l~~l~~-L~~L~l~~N~i~ 125 (162)
T d1a9na_ 91 ELILTNNSLVE-LGDLDPLASLKS-LTYLCILRNPVT 125 (162)
T ss_dssp EEECCSCCCCC-GGGGGGGGGCTT-CCEEECCSSGGG
T ss_pred cceeccccccc-cccccccccccc-cchhhcCCCccc
Confidence 77777776652 22 12333333 555555554443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.51 E-value=9.6e-15 Score=140.06 Aligned_cols=105 Identities=23% Similarity=0.307 Sum_probs=86.2
Q ss_pred cCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYE 541 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e 541 (571)
++|+..+.||+|+||+||+|+.++|+.||||+++..... ....+.+.+|+.+|++++|||||++++++.+.+..|++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 478999999999999999999888999999999765422 2335779999999999999999999999999999999999
Q ss_pred ccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 542 YLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 542 ~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|+.++.+..+....+ .++......|+
T Consensus 81 ~~~~~~~~~~~~~~~---~l~~~~~~~i~ 106 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCEG---GLESVTAKSFL 106 (286)
T ss_dssp CCSEEHHHHHHTSTT---CCCHHHHHHHH
T ss_pred eehhhhHHHHHhhcC---CcchhhhHHHH
Confidence 999887776665432 35555555443
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=6.3e-15 Score=142.31 Aligned_cols=89 Identities=25% Similarity=0.377 Sum_probs=70.9
Q ss_pred ccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCch--HhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEEec
Q 044615 466 DGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEM--ACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVYEY 542 (571)
Q Consensus 466 ~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 542 (571)
..+.||+|+||+||+|+ ..+|+.||||+++....... ...+.+.+|+.++++++|||||++++++.+.+..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 35789999999999999 45899999999976543221 1234689999999999999999999999999999999999
Q ss_pred cCCCChhhhhcc
Q 044615 543 LEMGSLAMNLSN 554 (571)
Q Consensus 543 ~~~G~L~~~l~~ 554 (571)
+++|++..+...
T Consensus 82 ~~~~~~~~~~~~ 93 (299)
T d1ua2a_ 82 METDLEVIIKDN 93 (299)
T ss_dssp CSEEHHHHHTTC
T ss_pred hcchHHhhhhhc
Confidence 999887766653
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.50 E-value=5.8e-14 Score=115.79 Aligned_cols=101 Identities=31% Similarity=0.364 Sum_probs=62.8
Q ss_pred eeecccccccCCCCCCCccccccccCCCCCCEEecccCcCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCe
Q 044615 70 TAHFSVLAFTGQDWPLYSSIPDEIGNMKSLSDLQLSENILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSI 149 (571)
Q Consensus 70 ~l~l~~n~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~ 149 (571)
.|+|++|+++. +| .+.++++|++|++++|.++ .+|..|+.+++|++|++++|.|+.. | .++.+++|++
T Consensus 2 ~L~Ls~n~l~~--------l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~ 69 (124)
T d1dcea3 2 VLHLAHKDLTV--------LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQE 69 (124)
T ss_dssp EEECTTSCCSS--------CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCE
T ss_pred EEEcCCCCCCC--------Cc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCe
Confidence 45666666653 23 3566667777777777766 4555666677777777777776633 3 3666677777
Q ss_pred eecccCcCcccC-CccccCCCCCCEEEccCCCCC
Q 044615 150 LYLYENSLCDSI-PKEIGNMNSLSILDLSSNKLN 182 (571)
Q Consensus 150 L~L~~n~l~~~~-~~~l~~l~~L~~L~L~~n~l~ 182 (571)
|++++|.+.... ...+..+++|++|++++|++.
T Consensus 70 L~l~~N~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 70 LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp EECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred EECCCCccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 777777665432 234566666666666666665
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.49 E-value=2e-14 Score=138.57 Aligned_cols=107 Identities=23% Similarity=0.350 Sum_probs=82.8
Q ss_pred cCCCccCeeeccCcceEEEEEcC-C-------CCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKLP-T-------GEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSH 532 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~~-~-------~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~ 532 (571)
++|++.+.||+|+||.||+|+.. . +..||||++.+... .....++.+|+..+.++ +|||||+++++|.+
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC--hHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 46888999999999999999832 2 24799999976432 34457799999999888 89999999999999
Q ss_pred CCeeEEEEeccCCCChhhhhccCCC-------------ccCCCHHHHhhhc
Q 044615 533 ALHSFVVYEYLEMGSLAMNLSNDAA-------------AEQFCWTKRMNAI 570 (571)
Q Consensus 533 ~~~~~lv~e~~~~G~L~~~l~~~~~-------------~~~l~w~~r~~ia 570 (571)
.+..|+|||||++|+|.++|..+.. ...++|.+++.++
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 141 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCA 141 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHH
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHH
Confidence 9999999999999999999975431 2458888887765
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=5.3e-14 Score=135.29 Aligned_cols=93 Identities=26% Similarity=0.353 Sum_probs=82.2
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCCeeEEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHALHSFVVY 540 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lv~ 540 (571)
+.|++.+.||+|+||+||+|+ ..+++.||||+++..... ....+++.+|+.++++++|||||++++++.+....++||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCC-hHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 469999999999999999999 568999999999765432 344678999999999999999999999999999999999
Q ss_pred eccCCCChhhhhccC
Q 044615 541 EYLEMGSLAMNLSND 555 (571)
Q Consensus 541 e~~~~G~L~~~l~~~ 555 (571)
||+.++++..+++..
T Consensus 81 ~~~~~~~l~~~~~~~ 95 (292)
T d1unla_ 81 EFCDQDLKKYFDSCN 95 (292)
T ss_dssp ECCSEEHHHHHHHTT
T ss_pred eeccccccccccccc
Confidence 999999998888754
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.47 E-value=2.2e-13 Score=112.29 Aligned_cols=87 Identities=31% Similarity=0.400 Sum_probs=39.6
Q ss_pred hhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCCEEEccCCcCCccc-chhccCCCCC
Q 044615 238 LGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLSELDLSHNIFREEI-PSQICSMQSL 316 (571)
Q Consensus 238 ~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~-~~~~~~l~~L 316 (571)
+..+++|++|++++|.++ .+|..+..+++|+.|++++|.+++. | .+..+++|+.|++++|++.... ...+..+++|
T Consensus 16 l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L 92 (124)
T d1dcea3 16 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRL 92 (124)
T ss_dssp GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTC
T ss_pred cccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCCccCCCCCchhhcCCCCC
Confidence 444444445555544444 2333444444555555555544422 2 2444445555555555444322 1234444555
Q ss_pred CEEEccCCcCc
Q 044615 317 EKLNLSHNNLS 327 (571)
Q Consensus 317 ~~L~Ls~n~l~ 327 (571)
+.|++++|+++
T Consensus 93 ~~L~l~~N~i~ 103 (124)
T d1dcea3 93 VLLNLQGNSLC 103 (124)
T ss_dssp CEEECTTSGGG
T ss_pred CEEECCCCcCC
Confidence 55555555543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.44 E-value=2e-14 Score=136.60 Aligned_cols=105 Identities=16% Similarity=0.203 Sum_probs=83.6
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCch---HhHHHHHHHHHHHhhcC--CCCcccEEEEEEeCCe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEM---ACQQEFLNEVNALTKIR--HRNIVKFYGFCSHALH 535 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~---~~~~~~~~Ei~~l~~l~--H~niv~l~~~~~~~~~ 535 (571)
++|++.+.||+|+||+||+|+ ..+|+.||||++.+...... ....++.+|+.++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 469999999999999999999 56899999999975432221 12234778999999986 8999999999999999
Q ss_pred eEEEEeccCC-CChhhhhccCCCccCCCHHHHhhh
Q 044615 536 SFVVYEYLEM-GSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 536 ~~lv~e~~~~-G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
.|+||||+.+ +++.+++.... .+++.....+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~ 115 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG---ALQEELARSF 115 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHH
T ss_pred EEEEEEeccCcchHHHHHhccC---CCCHHHHHHH
Confidence 9999999986 68888887542 4666655444
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.41 E-value=2.3e-13 Score=133.05 Aligned_cols=86 Identities=17% Similarity=0.281 Sum_probs=74.4
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcC-CCCcccEEEEEEeC--CeeE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR-HRNIVKFYGFCSHA--LHSF 537 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~--~~~~ 537 (571)
++|++.+.||+|+||+||+|+ ..+|+.||||++++.. .+++.+|+++|++++ ||||+++++++... ...+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 469999999999999999999 5689999999996432 367889999999995 99999999999854 5689
Q ss_pred EEEeccCCCChhhhhc
Q 044615 538 VVYEYLEMGSLAMNLS 553 (571)
Q Consensus 538 lv~e~~~~G~L~~~l~ 553 (571)
+|||||++|+|.++.+
T Consensus 109 ~v~e~~~~~~L~~~~~ 124 (328)
T d3bqca1 109 LVFEHVNNTDFKQLYQ 124 (328)
T ss_dssp EEEECCCSCBGGGTTT
T ss_pred EEEeecCCCcHHHHhc
Confidence 9999999999987653
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.40 E-value=1.2e-13 Score=136.29 Aligned_cols=100 Identities=25% Similarity=0.293 Sum_probs=76.1
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC------Ce
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA------LH 535 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~------~~ 535 (571)
+|+..++||+|+||+||+|+ ..+|+.||||++...... ..+|+++|++++|||||+++++|... ..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 48888999999999999999 568999999999764322 23799999999999999999999653 34
Q ss_pred eEEEEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 536 SFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 536 ~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
.|+|||||++|.+....+.......++|.+...|
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i 127 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 127 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHH
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHH
Confidence 7899999987654443332223345777665544
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.40 E-value=1.2e-13 Score=135.98 Aligned_cols=103 Identities=18% Similarity=0.285 Sum_probs=77.0
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC-----
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL----- 534 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~----- 534 (571)
.+.|++.+.||+|+||+||+|. ..+|+.||||++.+... .....+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 3569999999999999999999 56899999999976543 3345678999999999999999999999997654
Q ss_pred -eeEEEEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 535 -HSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 535 -~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
..|+||||| +++|.++++.. .+++.....|
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~ 126 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFL 126 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHH
T ss_pred ceEEEEEecc-cccHHHHHHhc----cccHHHHHHH
Confidence 479999999 56787777532 3666655544
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.40 E-value=1.7e-13 Score=132.00 Aligned_cols=108 Identities=21% Similarity=0.342 Sum_probs=82.4
Q ss_pred ccCCCccCeeeccCcceEEEEEcC------CCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc-CCCCcccEEEEEEeC
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAKLP------TGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI-RHRNIVKFYGFCSHA 533 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~ 533 (571)
.++|++.+.||+|+||+||+|... +++.||||+++.... ....+.+.+|+.++.++ +|||||.+++++.+.
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 357999999999999999999832 346899999975432 23456788898888776 689999999998764
Q ss_pred -CeeEEEEeccCCCChhhhhccCCC-------------ccCCCHHHHhhhc
Q 044615 534 -LHSFVVYEYLEMGSLAMNLSNDAA-------------AEQFCWTKRMNAI 570 (571)
Q Consensus 534 -~~~~lv~e~~~~G~L~~~l~~~~~-------------~~~l~w~~r~~ia 570 (571)
...++|||||++|+|.++++.... ...++|.+++.|+
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 140 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 140 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHH
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHH
Confidence 468999999999999999975321 2358888887765
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.39 E-value=1.5e-13 Score=135.48 Aligned_cols=104 Identities=19% Similarity=0.257 Sum_probs=83.1
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC-----C
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA-----L 534 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~-----~ 534 (571)
.+.|++.+.||+|+||+||+|+ ..+|+.||||++.+... +....+++.+|++++++++|||||++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 4569999999999999999999 56899999999986543 334456799999999999999999999999643 3
Q ss_pred eeEEEEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 535 HSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
..+++|||+.+|+|.+++..+ .+++.....|
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i 126 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFL 126 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTC----CCCHHHHHHH
T ss_pred ceEEEEEeecCCchhhhcccc----cccHHHHHHH
Confidence 346777888999999999643 3555554443
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.38 E-value=2.4e-13 Score=134.26 Aligned_cols=90 Identities=19% Similarity=0.329 Sum_probs=73.1
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC------C
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA------L 534 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~------~ 534 (571)
+.|++.++||+|+||+||+|+ ..+|+.||||++...... ....+++.+|+.++++++|||||+++++|... .
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC-HHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 569999999999999999999 558999999999765433 34456799999999999999999999999643 6
Q ss_pred eeEEEEeccCCCChhhhhc
Q 044615 535 HSFVVYEYLEMGSLAMNLS 553 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l~ 553 (571)
..|+|||||.+|.+ +.+.
T Consensus 96 ~~~iv~Ey~~~~l~-~~~~ 113 (355)
T d2b1pa1 96 DVYLVMELMDANLC-QVIQ 113 (355)
T ss_dssp EEEEEEECCSEEHH-HHHT
T ss_pred eeEEEEeccchHHH-Hhhh
Confidence 78999999986544 4443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.37 E-value=2.9e-13 Score=133.06 Aligned_cols=102 Identities=20% Similarity=0.174 Sum_probs=78.5
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeCC----ee
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHAL----HS 536 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~----~~ 536 (571)
..|++.+.||+|+||+||+|. ..+|+.||||++++.. .....+++.+|+.+|++++|||||++++++.... ..
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 469999999999999999998 5689999999997543 2344678999999999999999999999997653 23
Q ss_pred EEEEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 537 FVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 537 ~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
+++++|+.+|+|.+++..+ .+++.....+
T Consensus 86 ~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i 114 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ----HLSNDHICYF 114 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC----CCCHHHHHHH
T ss_pred EEEEEeecCCchhhhhhcC----CCCHHHHHHH
Confidence 4555677899999999743 3666655444
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.37 E-value=4.8e-14 Score=137.06 Aligned_cols=95 Identities=20% Similarity=0.296 Sum_probs=79.9
Q ss_pred cCCCccCeeeccCcceEEEEEc----CCCCEEEEEEccCCCCC-chHhHHHHHHHHHHHhhcCC-CCcccEEEEEEeCCe
Q 044615 462 NNFDDGHCIGNGGQGSVYKAKL----PTGEIVDVKKFHSPLPD-EMACQQEFLNEVNALTKIRH-RNIVKFYGFCSHALH 535 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~Ei~~l~~l~H-~niv~l~~~~~~~~~ 535 (571)
++|++.+.||+|+||+||+|+. .+|+.||||++++.... +....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999973 25889999999754321 12234568899999999977 899999999999999
Q ss_pred eEEEEeccCCCChhhhhccCC
Q 044615 536 SFVVYEYLEMGSLAMNLSNDA 556 (571)
Q Consensus 536 ~~lv~e~~~~G~L~~~l~~~~ 556 (571)
.|+||||+.+|+|.+++...+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~ 124 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE 124 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS
T ss_pred eeeeeecccccHHHHHHHhcc
Confidence 999999999999999997543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.35 E-value=6.6e-13 Score=129.11 Aligned_cols=92 Identities=24% Similarity=0.402 Sum_probs=73.1
Q ss_pred ccCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCcccEEEEEEeC------
Q 044615 461 TNNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVKFYGFCSHA------ 533 (571)
Q Consensus 461 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~------ 533 (571)
.++|++.+.||+|+||+||+|+ ..+|+.||||++....... ...+++.+|+++|++++||||+++++++...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 4679999999999999999999 5689999999987654332 3346788999999999999999999998653
Q ss_pred --CeeEEEEeccCCCChhhhhc
Q 044615 534 --LHSFVVYEYLEMGSLAMNLS 553 (571)
Q Consensus 534 --~~~~lv~e~~~~G~L~~~l~ 553 (571)
...|+||||+++|.+.....
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~ 109 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSN 109 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTC
T ss_pred cCceEEEEEeccCCCccchhhh
Confidence 45799999999887765544
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.32 E-value=4e-14 Score=127.27 Aligned_cols=42 Identities=31% Similarity=0.349 Sum_probs=19.1
Q ss_pred cccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcC
Q 044615 114 PLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSL 157 (571)
Q Consensus 114 ~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l 157 (571)
+.++..+++|++|+|++|+|+.. + .+..+++|++|+|++|.+
T Consensus 41 ~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i 82 (198)
T d1m9la_ 41 DATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLI 82 (198)
T ss_dssp HHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEE
T ss_pred hhHHhcccccceeECcccCCCCc-c-cccCCccccChhhccccc
Confidence 33444444555555555544422 2 244444444444444444
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.32 E-value=6.6e-14 Score=125.82 Aligned_cols=126 Identities=25% Similarity=0.272 Sum_probs=69.3
Q ss_pred ccCCCCCcEEeCccCcCcCCCChhhhCCCCCCEEEcccCccccccchhhccCCCCCEEEcCCccCccCcchhhhcccCCC
Q 044615 214 HGMLSSLIQLTLNNNELSGQLSPELGSLIQLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQFSQKIPNKIEKLIHLS 293 (571)
Q Consensus 214 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 293 (571)
+..+++|++|++++|+++.. + .+..+++|+.|++++|.++ .++.....+++|+.|++++|+++.. ..+..+++|+
T Consensus 44 l~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~L~ 118 (198)
T d1m9la_ 44 LSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLVNLR 118 (198)
T ss_dssp HHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHHHHSS
T ss_pred HhcccccceeECcccCCCCc-c-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--cccccccccc
Confidence 34444555555555555432 2 3555566666666666554 2333334445566666666666532 2355666666
Q ss_pred EEEccCCcCCcccc-hhccCCCCCCEEEccCCcCccccccc----------cccCCCCCEEE
Q 044615 294 ELDLSHNIFREEIP-SQICSMQSLEKLNLSHNNLSGSIPRC----------FEEMHWLSCID 344 (571)
Q Consensus 294 ~L~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~n~l~~~~p~~----------~~~l~~L~~L~ 344 (571)
.|++++|+++.... ..+..+++|+.|+|++|++....+.. +..+++|+.||
T Consensus 119 ~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 119 VLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp EEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred ccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 66666666654321 34666677777777777665433321 44566666665
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.31 E-value=2.4e-12 Score=123.27 Aligned_cols=101 Identities=21% Similarity=0.249 Sum_probs=82.9
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCC-CCcccEEEEEEeCCeeEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH-RNIVKFYGFCSHALHSFVV 539 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~~~~~~~~~~~lv 539 (571)
++|++.+.||+|+||+||+|+ ..+|+.||||++...... +.+.+|++.++.++| +|++.+++++.+....|+|
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 469999999999999999999 558999999998654322 346788889998876 8999999999999999999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||+ +|+|.++++..+. .+++.....|+
T Consensus 80 me~~-~~~l~~~~~~~~~--~~~~~~~~~i~ 107 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGR--KFSVKTVAMAA 107 (293)
T ss_dssp EECC-CCBHHHHHHHTTT--CCCHHHHHHHH
T ss_pred EEec-CCCHHHHHHhhcc--chhhHHHHHHH
Confidence 9999 6899999875433 46777666654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.28 E-value=1e-12 Score=126.97 Aligned_cols=107 Identities=20% Similarity=0.301 Sum_probs=76.0
Q ss_pred HccCCCccCeeeccCcceEEEEEc-CC-CCEEEEEEccCCCCCchHhHHHHHHHHHHHhhc---CCCCcccEEEEEEe--
Q 044615 460 ATNNFDDGHCIGNGGQGSVYKAKL-PT-GEIVDVKKFHSPLPDEMACQQEFLNEVNALTKI---RHRNIVKFYGFCSH-- 532 (571)
Q Consensus 460 ~~~~~~~~~~lg~G~~g~V~~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l---~H~niv~l~~~~~~-- 532 (571)
..++|++.+.||+|+||+||+|+. ++ ++.||||++....... .....+.+|+.+++.+ +|||||+++++|..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 346899999999999999999984 44 6679999986533221 1123466777776655 89999999999864
Q ss_pred ---CCeeEEEEeccCCCChhhhhccCCCccCCCHHHHhhh
Q 044615 533 ---ALHSFVVYEYLEMGSLAMNLSNDAAAEQFCWTKRMNA 569 (571)
Q Consensus 533 ---~~~~~lv~e~~~~G~L~~~l~~~~~~~~l~w~~r~~i 569 (571)
....|++|||+++|++........ ..+++.....|
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~--~~~~~~~~~~~ 121 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDM 121 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCT--TCSCHHHHHHH
T ss_pred cccCceEEEEEEeccCCchhhhhhccC--CCCCHHHHHHH
Confidence 246899999999987765544332 23555544443
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.28 E-value=3.9e-12 Score=109.27 Aligned_cols=92 Identities=26% Similarity=0.159 Sum_probs=44.0
Q ss_pred ccccccCCCCCCEEecccC-cCcccccccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCccccC
Q 044615 89 IPDEIGNMKSLSDLQLSEN-ILNGSIPLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPKEIGN 167 (571)
Q Consensus 89 ~p~~~~~l~~L~~L~L~~n-~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~ 167 (571)
+|..+..+++|++|++++| .++...+.+|.++++|+.|+|++|+|+.+.+.+|..+++|++|+|++|++....+..+ .
T Consensus 23 ~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~-~ 101 (156)
T d2ifga3 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTV-Q 101 (156)
T ss_dssp TTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTT-C
T ss_pred CcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcccChhhh-c
Confidence 3444444555555555433 2443334445555555555555555554445555555555555555555543222222 2
Q ss_pred CCCCCEEEccCCCC
Q 044615 168 MNSLSILDLSSNKL 181 (571)
Q Consensus 168 l~~L~~L~L~~n~l 181 (571)
..+|+.|+|++|.+
T Consensus 102 ~~~l~~L~L~~Np~ 115 (156)
T d2ifga3 102 GLSLQELVLSGNPL 115 (156)
T ss_dssp SCCCCEEECCSSCC
T ss_pred cccccccccCCCcc
Confidence 22455555555544
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.25 E-value=1.7e-11 Score=105.19 Aligned_cols=108 Identities=20% Similarity=0.152 Sum_probs=80.7
Q ss_pred CCCEEEcccCccccccchhhccCCCCCEEEcCCcc-CccCcchhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEc
Q 044615 243 QLEYLDLSANTFHKSIPESLSNLVKLHYLNLSNNQ-FSQKIPNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNL 321 (571)
Q Consensus 243 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~n~-l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 321 (571)
..+.++.+++.+. ..|..+..+++|++|++++|+ ++...+..|.++++|+.|+|++|+++.+.+..|..+++|+.|+|
T Consensus 9 ~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 87 (156)
T d2ifga3 9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (156)
T ss_dssp SSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred CCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceec
Confidence 3456777777765 356667778888888887654 77666677888888888888888888777777888888888888
Q ss_pred cCCcCccccccccccCCCCCEEECcCCcCcc
Q 044615 322 SHNNLSGSIPRCFEEMHWLSCIDISYNALQG 352 (571)
Q Consensus 322 s~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 352 (571)
++|+|+...+..|..+ .|+.|+|++|++.+
T Consensus 88 s~N~l~~l~~~~~~~~-~l~~L~L~~Np~~C 117 (156)
T d2ifga3 88 SFNALESLSWKTVQGL-SLQELVLSGNPLHC 117 (156)
T ss_dssp CSSCCSCCCSTTTCSC-CCCEEECCSSCCCC
T ss_pred cCCCCcccChhhhccc-cccccccCCCcccC
Confidence 8888886555556544 58888888888754
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.23 E-value=1.3e-11 Score=118.60 Aligned_cols=101 Identities=18% Similarity=0.166 Sum_probs=77.4
Q ss_pred cCCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCCCCccc-EEEEEEeCCeeEEE
Q 044615 462 NNFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRHRNIVK-FYGFCSHALHSFVV 539 (571)
Q Consensus 462 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~-l~~~~~~~~~~~lv 539 (571)
+.|++.+.||+|+||+||+|+ ..+|+.||||++...... +++.+|++++++++|+|+|. +.+++.+.+..++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 459999999999999999998 568999999998754322 34779999999998776554 45556778889999
Q ss_pred EeccCCCChhhhhccCCCccCCCHHHHhhhc
Q 044615 540 YEYLEMGSLAMNLSNDAAAEQFCWTKRMNAI 570 (571)
Q Consensus 540 ~e~~~~G~L~~~l~~~~~~~~l~w~~r~~ia 570 (571)
|||+. |++.+.+..... .+++.....++
T Consensus 82 me~~~-~~l~~~~~~~~~--~~~~~~~~~~~ 109 (299)
T d1ckia_ 82 MELLG-PSLEDLFNFCSR--KFSLKTVLLLA 109 (299)
T ss_dssp EECCC-CBHHHHHHHTTT--CCCHHHHHHHH
T ss_pred EEEcC-CchhhhhhhccC--CCcHHHHHHHH
Confidence 99995 567666654332 47777776654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.75 E-value=6.5e-09 Score=102.22 Aligned_cols=86 Identities=19% Similarity=0.240 Sum_probs=66.7
Q ss_pred CCCccCeeeccCcceEEEEE-cCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcC-----------CCCcccEEEEE
Q 044615 463 NFDDGHCIGNGGQGSVYKAK-LPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR-----------HRNIVKFYGFC 530 (571)
Q Consensus 463 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----------H~niv~l~~~~ 530 (571)
.|++.++||+|+||+||+|+ ..+|+.||||++++.. ...+.+.+|++++++++ |||||++++++
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 49999999999999999999 5689999999997532 23466788999888775 57899999888
Q ss_pred Ee--CCeeEEEEeccCCCChhhhh
Q 044615 531 SH--ALHSFVVYEYLEMGSLAMNL 552 (571)
Q Consensus 531 ~~--~~~~~lv~e~~~~G~L~~~l 552 (571)
.. ....+++|+++..+......
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~ 113 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLAL 113 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHH
T ss_pred eeccccceeeeeeecccccccccc
Confidence 64 45677788877665544333
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=98.67 E-value=1.6e-08 Score=89.53 Aligned_cols=82 Identities=20% Similarity=0.218 Sum_probs=60.9
Q ss_pred CccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCC---------------chHhHHHHHHHHHHHhhcCCCCcccEEEE
Q 044615 465 DDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPD---------------EMACQQEFLNEVNALTKIRHRNIVKFYGF 529 (571)
Q Consensus 465 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------------~~~~~~~~~~Ei~~l~~l~H~niv~l~~~ 529 (571)
.+++.||+|+||.||+|...+|+.||||+++..... .......+.+|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 467899999999999999778999999987642211 00112345678899999999999988765
Q ss_pred EEeCCeeEEEEeccCCCChhh
Q 044615 530 CSHALHSFVVYEYLEMGSLAM 550 (571)
Q Consensus 530 ~~~~~~~~lv~e~~~~G~L~~ 550 (571)
. . .+++|||++++.+.+
T Consensus 83 ~--~--~~lvme~~~~~~~~~ 99 (191)
T d1zara2 83 E--G--NAVLMELIDAKELYR 99 (191)
T ss_dssp E--T--TEEEEECCCCEEGGG
T ss_pred c--C--CEEEEEeeccccccc
Confidence 3 2 379999999876543
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.52 E-value=4.9e-09 Score=90.07 Aligned_cols=84 Identities=30% Similarity=0.249 Sum_probs=50.1
Q ss_pred cccCCCCCCEEecccCcCcccc--cccccCCCCCCEEEcccCcCcccccccccCCCCCCeeecccCcCcccCCc------
Q 044615 92 EIGNMKSLSDLQLSENILNGSI--PLALGNLTNLVVLDLSTNKLSGSIPLSFANLTSLSILYLYENSLCDSIPK------ 163 (571)
Q Consensus 92 ~~~~l~~L~~L~L~~n~i~~~~--~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~------ 163 (571)
.+.++++|++|+|++|+|+... +..+..+++|+.|+|++|.|+...+-.+....+|+.|++++|.+......
T Consensus 60 ~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~ 139 (162)
T d1koha1 60 IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYIS 139 (162)
T ss_dssp HHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHH
T ss_pred HHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHH
Confidence 3345677777777777776432 34455667777777777777654433334445677777777776543332
Q ss_pred -cccCCCCCCEEE
Q 044615 164 -EIGNMNSLSILD 175 (571)
Q Consensus 164 -~l~~l~~L~~L~ 175 (571)
.+..+|+|+.||
T Consensus 140 ~i~~~~P~L~~LD 152 (162)
T d1koha1 140 AIRERFPKLLRLD 152 (162)
T ss_dssp HHHTTSTTCCEET
T ss_pred HHHHHCCCCCEEC
Confidence 134566666654
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.46 E-value=1.4e-08 Score=87.16 Aligned_cols=87 Identities=29% Similarity=0.242 Sum_probs=57.6
Q ss_pred cchhhccCCCCCEEEcCCccCccCc--chhhhcccCCCEEEccCCcCCcccchhccCCCCCCEEEccCCcCcccccc---
Q 044615 258 IPESLSNLVKLHYLNLSNNQFSQKI--PNKIEKLIHLSELDLSHNIFREEIPSQICSMQSLEKLNLSHNNLSGSIPR--- 332 (571)
Q Consensus 258 ~~~~l~~l~~L~~L~Ls~n~l~~~~--~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~--- 332 (571)
++.....+++|++|+|++|+++... +..+..+++|+.|+|++|.++...+-.+.....|+.|++++|+++.....
T Consensus 57 l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~ 136 (162)
T d1koha1 57 LRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQST 136 (162)
T ss_dssp HHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHH
T ss_pred hHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchh
Confidence 3444456777888888888876542 34566778888888888887764443444455688888888888754332
Q ss_pred ----ccccCCCCCEEE
Q 044615 333 ----CFEEMHWLSCID 344 (571)
Q Consensus 333 ----~~~~l~~L~~L~ 344 (571)
.+..+|+|+.||
T Consensus 137 y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 137 YISAIRERFPKLLRLD 152 (162)
T ss_dssp HHHHHHTTSTTCCEET
T ss_pred HHHHHHHHCCCCCEEC
Confidence 245677777775
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.92 E-value=8.8e-06 Score=69.45 Aligned_cols=109 Identities=19% Similarity=0.218 Sum_probs=57.8
Q ss_pred CCCCCEEEcccC-ccccc----cchhhccCCCCCEEEcCCccCccC----cchhhhcccCCCEEEccCCcCCcc----cc
Q 044615 241 LIQLEYLDLSAN-TFHKS----IPESLSNLVKLHYLNLSNNQFSQK----IPNKIEKLIHLSELDLSHNIFREE----IP 307 (571)
Q Consensus 241 l~~L~~L~L~~n-~l~~~----~~~~l~~l~~L~~L~Ls~n~l~~~----~~~~~~~l~~L~~L~Ls~n~l~~~----~~ 307 (571)
.++|+.|+|+++ .++.. +...+...++|++|+|++|.+... +...+...+.|+.|+|++|.+... +-
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 345555555542 23221 222344555566666666665422 222334445666666666666543 22
Q ss_pred hhccCCCCCCEEEccCCcCccc-------cccccccCCCCCEEECcCCc
Q 044615 308 SQICSMQSLEKLNLSHNNLSGS-------IPRCFEEMHWLSCIDISYNA 349 (571)
Q Consensus 308 ~~~~~l~~L~~L~Ls~n~l~~~-------~p~~~~~l~~L~~L~ls~N~ 349 (571)
..+...++|++|++++|.+... +...+..-+.|+.|+++++.
T Consensus 94 ~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 2345566777777777654422 23344556777777776653
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.72 E-value=1.8e-05 Score=67.50 Aligned_cols=88 Identities=15% Similarity=0.141 Sum_probs=47.2
Q ss_pred hhCCCCCCEEEcccCccccc----cchhhccCCCCCEEEcCCccCccCc----chhhhcccCCCEEEccCCcCCcc----
Q 044615 238 LGSLIQLEYLDLSANTFHKS----IPESLSNLVKLHYLNLSNNQFSQKI----PNKIEKLIHLSELDLSHNIFREE---- 305 (571)
Q Consensus 238 ~~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~Ls~n~l~~~~----~~~~~~l~~L~~L~Ls~n~l~~~---- 305 (571)
+...++|+.|+|++|.+... +...+...+.|+.|+|++|.++... ...+...+.|++|++++|.+...
T Consensus 40 L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~ 119 (167)
T d1pgva_ 40 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQV 119 (167)
T ss_dssp HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHH
T ss_pred HhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHH
Confidence 34445566666666655432 2233444566666666666665432 22344445677777766654321
Q ss_pred ---cchhccCCCCCCEEEccCCc
Q 044615 306 ---IPSQICSMQSLEKLNLSHNN 325 (571)
Q Consensus 306 ---~~~~~~~l~~L~~L~Ls~n~ 325 (571)
+...+...++|+.|+++.+.
T Consensus 120 ~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 120 EMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHHHHhCCCccEeeCcCCC
Confidence 23344456777777776654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.33 E-value=9.1e-05 Score=62.80 Aligned_cols=88 Identities=14% Similarity=0.187 Sum_probs=45.6
Q ss_pred hccCCCCCEEEcCCccCccCc----chhhhcccCCCEEEccCCcCCcc----cchhccCCCCCCEEEc--cCCcCcc---
Q 044615 262 LSNLVKLHYLNLSNNQFSQKI----PNKIEKLIHLSELDLSHNIFREE----IPSQICSMQSLEKLNL--SHNNLSG--- 328 (571)
Q Consensus 262 l~~l~~L~~L~Ls~n~l~~~~----~~~~~~l~~L~~L~Ls~n~l~~~----~~~~~~~l~~L~~L~L--s~n~l~~--- 328 (571)
+...++|++|++++|.++... ...+...+.++.+++++|.+... +...+...++|+.++| ++|.+..
T Consensus 42 l~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~ 121 (166)
T d1io0a_ 42 LKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVE 121 (166)
T ss_dssp HTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHH
T ss_pred HhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHH
Confidence 344555555666655554321 12233445566666666655432 2234455566665444 3455543
Q ss_pred -ccccccccCCCCCEEECcCCc
Q 044615 329 -SIPRCFEEMHWLSCIDISYNA 349 (571)
Q Consensus 329 -~~p~~~~~l~~L~~L~ls~N~ 349 (571)
.+.+.+...+.|+.|+++.+.
T Consensus 122 ~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 122 MEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HHHHHHHHHCSSCCEEECCCSS
T ss_pred HHHHHHHHhCCCcCEEeCcCCC
Confidence 233344556777777776654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.08 E-value=4.8e-05 Score=64.65 Aligned_cols=110 Identities=17% Similarity=0.132 Sum_probs=51.6
Q ss_pred CCCCCCEEeccc-CcCccc----ccccccCCCCCCEEEcccCcCccc----ccccccCCCCCCeeecccCcCccc----C
Q 044615 95 NMKSLSDLQLSE-NILNGS----IPLALGNLTNLVVLDLSTNKLSGS----IPLSFANLTSLSILYLYENSLCDS----I 161 (571)
Q Consensus 95 ~l~~L~~L~L~~-n~i~~~----~~~~~~~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~L~~n~l~~~----~ 161 (571)
+.+.|++|+|++ +.++.. +...+...++|++|+|++|.++.. +...+...+.++.+++++|.+... +
T Consensus 15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l 94 (166)
T d1io0a_ 15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILAL 94 (166)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHH
T ss_pred cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHH
Confidence 445566666655 334321 223334455566666666655432 122234445666666666655432 1
Q ss_pred CccccCCCCCCEEEcc--CCCCCc----cCChhhhhccCCCcEEEccCCc
Q 044615 162 PKEIGNMNSLSILDLS--SNKLNG----SIPLSLANLTNSLKVLYLSSNH 205 (571)
Q Consensus 162 ~~~l~~l~~L~~L~L~--~n~l~~----~~p~~~~~l~~~L~~L~l~~n~ 205 (571)
...+...++|+.++|+ +|.+.. .+...+...++ |+.|+++.+.
T Consensus 95 ~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~-L~~L~l~~~~ 143 (166)
T d1io0a_ 95 VEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTT-LLKFGYHFTQ 143 (166)
T ss_dssp HHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSS-CCEEECCCSS
T ss_pred HHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCC-cCEEeCcCCC
Confidence 2334455566654443 344432 12222333333 6666665544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=93.51 E-value=0.084 Score=47.10 Aligned_cols=93 Identities=13% Similarity=0.031 Sum_probs=62.0
Q ss_pred HHHHHccCCCccCeeeccCcceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcC-CCCcccEEEEEEeCC
Q 044615 456 EIIRATNNFDDGHCIGNGGQGSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIR-HRNIVKFYGFCSHAL 534 (571)
Q Consensus 456 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~~ 534 (571)
++....+.|+..+..+-++-+.||+... +++.+.+|+........ ...+.+|...+..+. +--+.+++++...++
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~ 83 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDG 83 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCC
Confidence 4455556666555433344468998865 56667888876433222 234668888877663 333677888888889
Q ss_pred eeEEEEeccCCCChhhhh
Q 044615 535 HSFVVYEYLEMGSLAMNL 552 (571)
Q Consensus 535 ~~~lv~e~~~~G~L~~~l 552 (571)
..|+||++++|..+.+..
T Consensus 84 ~~~lv~~~l~G~~~~~~~ 101 (263)
T d1j7la_ 84 WSNLLMSEADGVLCSEEY 101 (263)
T ss_dssp EEEEEEECCSSEEHHHHT
T ss_pred ceEEEEEecccccccccc
Confidence 999999999998876544
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=91.85 E-value=0.22 Score=43.86 Aligned_cols=74 Identities=14% Similarity=0.094 Sum_probs=52.2
Q ss_pred eeccCc-ceEEEEEcCCCCEEEEEEccCCCCCchHhHHHHHHHHHHHhhcCC--CCcccEEEEEEeCCeeEEEEeccCCC
Q 044615 470 IGNGGQ-GSVYKAKLPTGEIVDVKKFHSPLPDEMACQQEFLNEVNALTKIRH--RNIVKFYGFCSHALHSFVVYEYLEMG 546 (571)
Q Consensus 470 lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~~~~~~~~~~~lv~e~~~~G 546 (571)
+..|.. +.||+....++..+.+|.-...... .+.+|++.++.+.. --+.+++++..+++..++||||++|-
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~------~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN------ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTTS------CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCHh------HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 344543 5789998877888889986544322 35677777765532 33567788888888899999999987
Q ss_pred Chh
Q 044615 547 SLA 549 (571)
Q Consensus 547 ~L~ 549 (571)
++.
T Consensus 92 ~~~ 94 (255)
T d1nd4a_ 92 DLL 94 (255)
T ss_dssp ETT
T ss_pred ccc
Confidence 664
|